Gastrointestinal	O
:	O
No	B-negation
dysphagia	O
,	O
no	B-negation
vomiting	O
,	O
and	O
no	B-negation
abdominal	B-bodyloc
pain	O
(	O
apparent	O
)	O
.	O

Eyes	O
:	O
no	B-negation
eye	B-bodyloc
pain	O
,	O
eyes	B-bodyloc
not	B-negation
red	O
,	O
no	B-negation
dryness	O
of	O
the	O
eyes	B-bodyloc
,	O
no	B-negation
itching	O
of	O
the	O
eyes	B-bodyloc
,	O
no	B-negation
discharge	O
from	O
the	O
eyes	B-bodyloc
and	O
no	B-negation
eyesight	O
problems	O
.	O

Physical	O
Therapy	O
Referral	O
Outpatient	O
Referral	O
Requested	O
for	O
:	O
20Mar2014	B-temporal

During	O
the	O
last	O
couple	O
of	O
weeks	O
he	O
feels	O
his	O
symptoms	O
are	O
progressing	O
.	O

LDL	O
183	B-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
H	B-labvalue
0	B-reference_range
-	I-reference_range
129	I-reference_range

Intermittent	O
Claudication	O
443	O
.	O
9	O

Family	O
History	O
Paternal	B-subject
history	O
of	O
Malignant	O
Mesothelioma	O
Of	O
The	O
Lung	B-bodyloc
V16	O
.	O
1	O

Heart	O
sounds	O
:	O
normal	B-labvalue
S1	O
,	O
normal	B-labvalue
S2	O
,	O
no	B-negation
S3	O
and	O
no	B-negation
S4	O
.	O

History	O
of	O
Closed	O
Epiphyseal	O
Fracture	O
Of	O
The	O
Distal	O
Phalanx	O
Of	O
The	O
Left	O
Fourth	O
Toe	B-bodyloc
826	O
.	O
0	O

walk	O
,	O
no	B-negation
ataxia	O
and	O
not	B-negation
limping	O
.	O

Neurological	O
:	O
left	B-bodyloc
arm	I-bodyloc
weakness	O
,	O
left	B-bodyloc
hand	I-bodyloc
weakness	O
,	O
left	B-bodyloc
leg	I-bodyloc
weakness	O
,	O
poor	O
coordination	O
,	O
difficulty	O
writing	O
,	O
anesthesia	O
(	O
left	O
)	O
,	O
numbness	O
(	O
left	O
)	O
,	O
headache	O
and	O
difficulty	O
walking	O
,	O
but	O
no	B-negation
confusion	O
,	O
no	B-negation
memory	O
loss	O
and	O
no	B-negation
tremor	O
was	O
seen	O

The	O
patient	O
describes	O
symptoms	O
as	O
severe	O
and	O
unchanged	O
.	O

Allergies	O
Penicillins	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
groin	O
:	O
Normal	B-labvalue
.	O

She	O
was	O
hospitalized	O
in	O
June	B-temporal
at	O
Cypress	O
Creek	O
May	O
23rd	O
to	O
the	O
28thand	O
then	O
Ben	O
Taub	O
June	B-temporal
1	I-temporal
to	I-temporal
June	I-temporal
8	O
.	O

ON	O
RT	O
.	O
,	O
butnegative	O
Straight	O
Leg	O
Raise	O
.	O

RSI	O
:	O
8	O
/	O
45	O

Family	B-subject
history	O
of	O
Hypertension	O
V17	O
.	O
49	O

Exercise	O
includes	O
walkingandbiking	O
.	O
Smoking	O
:	O
He	O
does	O
not	O
use	O
tobacco	O
.	O
Alcohol	O
:	O
He	O
denies	O
alcohol	O
use	O
.	O

[	O
QL	O
]	O
VITAMIN	O
D	O
,	O
25	O
-	O
HYDROXY	O
,	O
LC	O
/	O
MS	O
/	O
MS	O
Requested	O
for	O
:	O
26Nov2012	B-temporal

The	O
rhythm	O
was	O
regular	B-labvalue
.	O

Left	O
long	O
finger	O
digital	O
artery	O
,	O
digital	O
nerve	O
radial	O
and	O
ulnar	O
repair	O
x2	O
5	O
.	O

At	O
L4	O
-	O
5	O
there	O
is	O
2mm	O
diffuse	O
posterior	O
protrusion	O
with	O
mild	B-severity
proximal	B-bodyloc
foraminal	I-bodyloc
narrowing	O
,	O
slightly	O
worse	O
on	O
the	O
right	O

Adnexa	O
/	O
parametria	O
:	O
Normal	O

Nasal	B-bodyloc
Passage	O
Blockage	O
(	O
Stuffiness	O
)	O
478	O
.	O
19	O

Inspection	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
Normal	B-labvalue

Cardiovascular	O

(	O
tib	O
.	O
)	O
:	O
Normal	O
.	O

[	O
QLH	O
]	O
CBC	O
(	O
INCLUDES	O
DIFF	O
/	O
PLT	O
)	O
Done	O
:	O
05Apr2013	B-temporal

GroupHeading90End	O
GroupHeading120Start	O
Treatmept	O
plan	O
includes	O
caffeine	O
restrictisp	O
and	O
alcohol	O
abstinence	O
.	O

History	O
of	O
Ventricular	O
Shunt	O
To	O
Abdominal	O
Cavity	O

No	B-negation
hx	O
of	O
STDs	O

Streptococcal	O
Sore	O
Throat	B-bodyloc
034	O
.	O
0	O

5	O
.	O

pH	O
:	O
5	B-labvalue
Of	O
Interest	O

History	O
of	O
Hyperlipidemia	O
272	O
.	O
4	O

Right	O
Ext	O
.	O

Levaquin	O
TABS	B-form

Social	O
History	O
Current	O
Some	O
Day	O
Smoker	O
305	O
.	O
1	O

f	O
His	O
osy	O
of	O
Light	B-severity
Bleeding	O
Between	O
Periods	O
(	O
Spotting	O
)	O
(	B-course
Resolved	I-course
)	O

-	O
didn	O
'	O
t	O
receive	O
TDaP	O
or	O
Flu	O
in	O
pregnancy	O
,	O
declined	O
.	O

Chief	O
Complaint	O

The	O
left	B-bodyloc
external	I-bodyloc
canal	I-bodyloc
was	O
not	B-negation
tender	O
,	O
was	O
not	O
swollenand	O
was	O
not	B-negation
erythematous	O
.	O

Orientation	O
to	O
person	O
,	O
place	O
and	O
time	O
:	O
Normal	B-labvalue

Abdomen	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
,	O
no	B-negation
syncope	O
and	O
no	B-negation
edema	O
.	O

Cranial	O
nerves	O
XII	O
:	O
there	O
was	O
no	B-negation
tongue	B-bodyloc
deviation	O
with	O
protrusion	O
.	O

CVS	O
Pharmacy	O
callnng	O
to	O
confirm	O
prescription	O
that	O
was	O
sent	O
in	O
on	O
patient	O
.	O

Examination	O
of	O
digits	O
and	O
nails	O
:	O
Normal	B-labvalue
.	O

Gait	O
evaluation	O
demonstrated	O
antalgia	O
on	O
the	O
left	B-bodyloc
.	O

Social	O
History	O
Never	O
A	O
Smoker	O

Eye	O
,	O
otolaryngeal	O
,	O
cardiovascular	O
,	O
pulmonary	O
,	O
genitourinary	O
,	O
skin	O
,	O
psychiatric	O
,	O
endocrine	O
and	O
hematologic	O
review	O
of	O
systems	O
are	O
normal	O
.	O

Surgical	O
History	O
History	O
of	O
Appendectomy	O

Hematologic	O
/	O
Lymphatic	O
:	O
no	B-negation
swollen	O
glands	B-bodyloc
.	O

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

Examination	O
of	O
the	O
head	O
and	O
face	O
:	O
Normal	B-labvalue

The	O
toes	O
were	O
normal	O
and	O
with	O
full	O
range	O
of	O
motion	O
.	O

PRIOR	O
SEIZURE	O
WORKUP	O
:	O
EEG	O
that	O
was	O
abnormal	O
,	O
although	O
she	O
does	O
not	O
know	O
what	O
it	O
showed	O
,	O
but	O
it	O
was	O
done	O
as	O
a	O
child	O
.	O

Chief	O
Complaint	O

The	O
eyelids	O
were	O
normal	O
bilaterally	O
.	O

DOD	O
:	O
5/14/2013	B-temporal

Assessment	O
of	O
range	O
of	O
motion	O
:	O
Normal	B-labvalue
.	O

NEUROLOGIC	O
:	O
Cranial	O
nerves	O
II	O
through	O
XII	O
are	O
intact	O
.	O

Throat	O
,	O
Neck	O
,	O
and	O
Back	O

GroupHeading20End	O
GroupHeading1Start	O
GroupHeading1End	O
GroupHeading2Start	O
GroupHeading2End	O
GroupHeading3Start	O
GroupHeading3End	O
GroupHeading4Start	O
GroupHeading4End	O
GroupHeading5Start	O
GroupHeading5End	O
GroupHeading6Start	O
GroupHeading6End	O
GroupHeading7Start	O
GroupHeading7End	O
GroupHeading8Start	O
GroupHeading8End	O
GroupHeading9Start	O
GroupHeading9End	O
GroupHeading10Start	O
GroupHeading10End	O
GroupHeading11Start	O
GroupHeading11End	O
GroupHeading12Start	O
GroupHeading12End	O
GroupHeading13Start	O
GroupHeading13End	O
GroupHeading14Start	O

Ordered	O
;	O
For	O
:	O
Atrial	B-bodyloc
Fibrillation	O
(	O
427	O
.	O
31	O
)	O
;	O
Ordered	O
By	O
:	O
ABDELMELEK	O
,	O
LOURICE	O
Perform	O
:	O
In	O
Office	O
Due	O
:	O
02Aug2013	B-temporal
;	O
Last	O
Updated	O
By	O
:	O
Avellaneda	O
,	O
Mayra	O

[	O
QLH	O
]	O
CBC	O
(	O
INCLUDES	O
DIFF	O
/	O
PLT	O
)	O
Requested	O
for	O
:	O
19Mar2014	B-temporal

The	O
patient	O
will	O
follow	O
up	O
with	O
me	O
as	O
scheduled	O
.	O

Occupation	O
:	O

Respiratory	O
rate	O
:	O
the	O
respiratory	O
rate	O
was	O
normal	B-labvalue
.	O

Active	O
Problems	O
Fatigue	O
780	O
.	O
79	O

History	O
of	O
Diabetes	O
Mellitus	O
With	O
Foot	B-bodyloc
Ulcer	O

Procedure	O

Implant	O
.	O

Furosemide	O
40	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
3	B-frequency
TIMES	I-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
28Feb2011	B-temporal
to	O
(	O
Evaluate	O
:	O
25May2012	B-temporal
)	O
Requested	O
for	O
:	O
27Dec2011	B-temporal
;	O
Last	O
Rx	O
:	O
27Dec2011	B-temporal

Stroke	O
Syndrome	O
436	O

Chief	O
Complaint	O

A	O
head	B-bodyloc
tremor	O
was	O
not	B-negation
observed	I-negation
.	O

Omeprazole	O
40	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
Delayed	I-form
Release	I-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
13Oct2011	B-temporal
to	O
(	O
Evaluate	O
:	O
12Nov2011	B-temporal
)	O
Requested	O
for	O
:	O
13Oct2011	B-temporal
;	O
Last	O
Rx	O
:	O
13Oct2011	B-temporal

Inspection	O
/	O
palpation	O
of	O
joints	O
,	O
bones	O
,	O
and	O
muscles	O
:	O
Normal	B-labvalue
.	O

Examination	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue
.	O

Functional	O
Constipation	O
564	O
.	O
09	O

History	O
of	O
Hip	O
Surgery	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
neck	O
:	O
No	B-negation
lymphadenopathy	O
.	O

Vitals	O
18Jun2013	B-temporal
12	B-temporal
:	I-temporal
37PM	I-temporal
BMI	O
Calculated	O
38	B-labvalue
.	I-labvalue
5	I-labvalue
BSA	O
Calculated	O
2	B-labvalue
.	I-labvalue
41	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
11	I-labvalue
in	I-labvalue
Weight	O
275	B-labvalue
lb	I-labvalue
Systolic	O
130	B-labvalue
,	O
RUE	O
,	O
Sitting	O
Diastolic	O
68	B-labvalue
,	O
RUE	O
,	O
Sitting	O
Temperature	O
97	B-labvalue
.	I-labvalue
8	I-labvalue
F	I-labvalue
,	O
Oral	O
Heart	O
Rate	O
64	B-labvalue
,	O
R	O
Radial	O
Pulse	O
Quality	O
Regular	B-labvalue
,	O
R	O
Radial	O

A1c	O
better	O
.	O

LABORATORY	O
STUDIES	O
:	O

Active	O
Problems	O
Cesarean	O
Delivery	O
669	O
.	O
70	O

Valtrex	O
500	B-strength
mg	I-strength
QD	B-frequency

Assessment	O
of	O
stability	O
:	O
Normal	B-labvalue
.	O

no	B-negation
CVA	O
tenderness	O

Test	O
Name	O
Result	O
Flag	O
Reference	O
Hematocrit	O
41	B-labvalue
.	I-labvalue
9	I-labvalue
%	I-labvalue
L	O
42	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
54	I-reference_range
.	I-reference_range

Apr	B-temporal
8	I-temporal
2013	I-temporal
3	B-temporal
:	I-temporal
39PM	I-temporal
CST	O
Author	O

9	O
.	O

Delivered	O
:	O
2004	B-temporal
.	O

Family	B-subject
history	O
of	O
Hyperlipidemia	O

Hyst	O
,	O
Bilateral	O
Oophrectomy	O
.	O

Psychiatric	O
:	O
no	B-negation
sleep	O
disturbances	O
.	O

Social	O
History	O
Former	O
Smoker	O
V15	O
.	O
82	O

Constitutional	O
:	O
no	B-negation
fever	O
and	O
no	B-negation
chills	O
.	O

The	O
patient	O
presents	O
with	O
complaints	O
of	O
sudden	O
onset	O
of	O
severe	B-severity
vomiting	O
(	O
Patient	O
has	O
not	O
had	O
very	O
much	O
to	O
eat	O
or	O
drink	O
since	O
yesterday	B-temporal
as	O
a	O
result	O
of	O
these	O
symptoms	O
)	O
.	O

Right	O
Ext	O
.	O

The	O
patient	O
has	O
never	B-negation
had	O
a	O
problem	O
with	O
anesthesia	O
.	O

Respiratory	O
No	B-negation
respiratory	O
distress	O
,	O
normal	B-labvalue
respiratory	O
rhythm	O
and	O
effort	O

Discussion	O
/	O
Signatures	O
Electronically	O
signed	O
by	O
:	O
LESLIE	O
GARB	O
,	O
M	O
.	O
D	O
.	O

Pulmonary	O

BMI	O
Calculated	O
:	O
25	B-labvalue
.	I-labvalue
95	I-labvalue

Neck	O
:	O
Neck	O
:	O
Normal	O
.	O

Digital	O
rectal	O
exam	O
of	O
prostate	O
:	O
Normal	B-labvalue
.	O

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

Inspection	O
of	O
lips	O
,	O
teethand	O
gums	O
:	O
Abnormal	O
.	O
(	O
missing	O
teeth	O
on	O
the	O
top	O
.	O

Neurological	O
:	O
no	B-negation
convulsions	O
,	O
no	B-negation
dizziness	O
,	O
no	B-negation
fainting	O
,	O
no	B-negation
limb	B-bodyloc
weakness	O
,	O
no	B-negation
difficulty	O
walking	O
,	O
no	B-negation
leg	B-bodyloc
weakness	O
,	O
not	B-negation
falling	O
and	O
no	B-negation
numbness	O
.	O

Vaccines	O
:	O
RNI	O
-	O
MMR	O
not	O
documented	O
as	O
given	O
in	O
MAR	O
,	O
will	O
need	O
vaccine	O
given	O
however	O
we	O
do	O
not	O
carry	O
.	O

Birth	O
Weight	O
:	O
6lbs	B-labvalue
,	I-labvalue
1oz	I-labvalue

SOCIAL	O
HISTORY	O
:	O
The	O
patient	O
is	O
still	O
a	O
smoker	O
.	O

Does	O
note	O
heavy	B-severity
menstrual	O
periods	O
since	O
Mirena	O
IUD	O
removed	B-negation
due	O
to	O
complaint	O
of	O
discharge	O
.	O

wwc	O

Simvastatin	O
40	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
IN	I-frequency
THE	I-frequency
EVENING	I-frequency
;	O
Therapy	O
:	O
13Sep2010	B-temporal
to	O
(	O
Evaluate	O
:	O
03Aug2013	B-temporal
)	O
Requested	O
for	O
:	O
04Feb2013	B-temporal
;	O
Last	O
Rx	O
:	O
04Feb2013	B-temporal

Birth	O
Control	O
:	O
hysterectomy	O
.	O

ENT	O
:	O
no	B-negation
earache	O
,	O
no	B-negation
hearing	O
loss	O
,	O
no	B-negation
epistaxis	O
,	O
no	B-negation
nasal	B-bodyloc
discharge	O
,	O
no	B-negation
sore	O
throat	B-bodyloc
and	O
no	B-negation
hoarseness	O
.	O

Requested	O
for	O
:	O
23Feb2012	B-temporal
;	O
Last	O
Rx	O
:	O
23Feb2012	B-temporal

Thrombophlebitis	O
Of	O
Deep	B-bodyloc
Vessels	I-bodyloc
Of	O
The	O
Lower	B-bodyloc
Extremity	I-bodyloc
451	O
.	O
19	O

Constitutional	O
:	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
,	O
not	B-negation
feeling	O
poorly	O
(	O
malaise	O
)	O
and	O
not	B-negation
feeling	O
tired	O
(	O
fatigue	O
)	O
.	O

Postoperative	O
infection	O
(	O
not	B-negation
on	O
Mupirocin	O
postop	O
,	O
just	O
Budesonide	O
)	O

Physical	O
Therapy	O
Referral	O
Outpatient	O
Referral	O
Requested	O
for	O
:	O
16Apr2013	B-temporal

Benign	B-severity
Essential	O
Hypertension	O
401	O
.	O
1	O

Alert	O
,	O
no	B-negation
distress	O
,	O
oriented	O
.	O

Discharge	O
Medications	O
:	O

Discussion	O
/	O
Attending	O
Note	O

4	O
.	O

Cervical	O
Spine	O
:	O
Normal	O
(	O
showed	O
no	B-negation
tenderness	O
on	O
palpation	O
)	O
.	O

Examination	O
of	O
the	O
palate	O
showed	O
no	B-negation
abnormalities	O
.	O

Neurological	O
normal	O
neurologic	O
development	O
for	O
age	O
,	O
cranial	O
nerves	O
2	O
-	O
12	O
were	O
intactanddeep	O
tendon	O
reflexes	O
were	O
2	O
+	O
and	O
symmetric	O
.	O

Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

Assessment	O
of	O
respiratory	O
effort	O
was	O
significant	O
for	O
normal	B-labvalue
respiratory	O
rhythm	O
and	O
effort	O
.	O

CT	O
chest	O
showed	O
a	O
small	O
solitary	O
nodule	O
in	O
left	B-bodyloc
apex	I-bodyloc
.	O

-	O
Negative	B-negation
for	O
metastatic	O
disease	O
(	O
0	O
of	O
1	O
lymph	B-bodyloc
node	I-bodyloc
)	O
.	O

;	O
Mar	B-temporal
25	I-temporal
2014	I-temporal
11	B-temporal
:	I-temporal
28AM	I-temporal
(	O
Author	O
)	O

[	O
QLH	O
]	O
TSH	O
,	O
3RD	O
GENERATION	O
Requested	O
for	O
:	O
16Nov2012	B-temporal

9085	O
Site	O
Memorial	O
City	O
Iro2man	O

Eth	O
:	O
Edema	O

Cranial	O
nerves	O
III	O
,	O
IV	O
,	O
and	O
VI	O
:	O
the	O
extraocular	O
motions	O
were	O
intact	B-labvalue
.	O

Past	O
Medical	O
History	O
1	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O
The	O
patient	O
is	O
5	B-labvalue
'	I-labvalue
8	I-labvalue
"	I-labvalue
tall	O
and	O
she	O
weighs	O
171	B-labvalue
lbs	I-labvalue
.	O

She	O
modified	O
her	O
AODL	O
and	O
avoiding	O
known	O
pain	O
triggers	O
.	O

Reactive	O
Airway	B-bodyloc
Disease	O
493	O
.	O
90	O

[	O
QLH	O
]	O
IMMUNOGLOBULIN	O
G	O
SUBCLASSES	O
PANEL	O
Requested	O
for	O
:	O
05Dec2011	B-temporal

CV	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
,	O
no	B-negation
fainting	O
and	O
no	B-negation
murmurs	O
were	O
heard	O
.	O

Native	O
Language	O
English	O

Uses	O
Safety	O
Equipment	O
-	O
Seatbelts	O
17	B-temporal
Aug	I-temporal
2012	I-temporal
;	O
uses	O
booster	O
seat	O
.	O
eg	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Allergies	O
Penicillins	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
and	O
no	B-negation
cough	O
.	O

HM	O
-	O
pap	O
WNL	O
5	B-temporal
/	I-temporal
2012	I-temporal
.	O

He	O
can	O
'	O
t	O
hold	O
food	O
or	O
liquids	O
downeg	O

Cranial	O
nerves	O
XI	O
:	O
shoulder	O
shrug	O
was	O
intact	B-labvalue
bilaterally	I-labvalue
.	O

no	B-negation
Retinal	B-bodyloc
hemorrhage	O
per	O
opthamology	O
aptt	O

Total	O
Protein	O
7	B-labvalue
.	I-labvalue
6	I-labvalue
g	I-labvalue
/	I-labvalue
dl	I-labvalue
6	B-reference_range
.	I-reference_range
4	I-reference_range
-	I-reference_range
8	I-reference_range
.	I-reference_range
4	I-reference_range

f	O
/	O
u	O
with	O
me	O
prn	O
after	O
labs	O

No	B-negation
murmurs	O
were	O
heard	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O
Resume	O
home	O
medications	O
,	O
but	O
increase	O
Lasix	O
to	O
80	B-strength
mg	I-strength
every	B-frequency
morning	I-frequency
,	O
Lovenox	O
30	B-strength
mg	I-strength
subcu	B-route
daily	B-frequency
x2	B-duration
weeks	I-duration
,	O
Vicodin	O
5	B-strength
/	I-strength
500	I-strength
mg	I-strength
one	B-dosage
to	I-dosage
two	I-dosage
every	B-frequency
four	I-frequency
to	I-frequency
six	I-frequency
hours	I-frequency
p	B-frequency
.	I-frequency
r	I-frequency
.	I-frequency
n	I-frequency
.	O
pain	O
,	O
Combivent	O
nebulizer	O
every	B-frequency
four	I-frequency
hours	I-frequency
while	O
awake	O
for	O
difficulty	O
breathing	O
,	O
Zithromax	O
one	B-duration
week	I-duration
250	B-strength
mg	I-strength
daily	B-frequency
,	O
and	O
guaifenesin	O
long	O
-	O
acting	O
one	B-dosage
twice	B-frequency
a	I-frequency
day	I-frequency
b	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	O

Test	O
Name	O
Result	O
Flag	O
Reference	O

RESPIRATORY	O

Stress	O
Test	O
:	O
NEVER	B-negation

No	B-negation
masses	O
palpated	O
.	O

A	O
right	B-bodyloc
inguinal	I-bodyloc
hernia	O
was	O
present	O
,	O
which	O
was	O
reducible	O
.	O

PLAN	O
:	O
1	O
.	O

Examination	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue
.	O

SOCIAL	O
HISTORY	O
:	O
Significant	O
history	O
of	O
alcohol	O
abuse	O
,	O
according	O
to	O
the	O
emergency	O
room	O
physician	O
,	O
who	O
sees	O
her	O
on	O
a	O
regular	O
basis	O
.	O

0	I-reference_range
Mean	O
Platrlet	O
Volume	O
8	B-labvalue
.	I-labvalue
9	I-labvalue
fL	I-labvalue
7	B-reference_range
.	I-reference_range
4	I-reference_range
-	I-reference_range
10	I-reference_range
.	I-reference_range

Hypothyroidism	O
244	O
.	O
9	O

Assessment	O
Mastodynia	O
Of	O
The	O
Left	B-bodyloc
Breast	I-bodyloc
611	O
.	O
71	O

Skin	O

social	O
history	O
reviewed	O

Cranial	O
nerves	O
XII	O
:	O
there	O
was	O
no	B-negation
tongue	B-bodyloc
deviation	O
with	O
protrusion	O
.	O

No	B-negation
erythema	O
,	O
warmth	O
or	O
evidence	O
of	O
infection	O
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Plan	O
Glimepiride	O
1	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
1	B-dosage
/	I-dosage
2	I-dosage
tab	B-form
twice	B-frequency
a	I-frequency
day	I-frequency
with	I-frequency
food	I-frequency
;	O
Therapy	O
:	O
03Jan2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
10Jun2013	B-temporal
)	O

Previous	O
diagnosis	O
of	O
asthma	O
:	O
No	B-negation

History	O
of	O
Alcohol	O

Vaccines	O
up	O
to	O
date	O
per	O
new	O
Hib	O
schedule	O
.	O

Headache	O
784	O
.	O
0	O

BSA	O
Calculated	O
:	O
1	B-labvalue
.	I-labvalue
76	I-labvalue

Cranial	O
nerves	O
XI	O
:	O
shoulder	O
shrug	O
was	O
intact	B-labvalue
bilaterally	O
.	O

Stool	O
sample	O
for	O
occult	O
blood	O
:	O
Normal	B-labvalue
.	O

Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

No	B-negation
wheezing	O
was	O
heard	O
.	O

BILIRUBIN	O
NEG	B-labvalue

"	O

Constitutional	O

History	O
of	O
Hyperlipidemia	O
272	O
.	O
4	O

Psychiatric	O
:	O
no	B-negation
anxiety	O
and	O
no	B-negation
depression	O
.	O

SUMAtriptan	O
Succinate	O
50	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
EVERY	B-frequency
2	I-frequency
HOURS	I-frequency
AS	B-frequency
NEEDED	I-frequency
FOR	O
MIGRAINE	O
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

The	O
right	O
external	O
canal	O
was	O
normal	O
.	O

No	B-negation
contraindications	O
to	O
OCP	O
and	O
pt	O
states	O
that	O
she	O
can	O
remember	O
to	O
take	O
pills	O
at	O
same	O
time	O
every	O
day	O
.	O

Patient	O
sees	O
Dr	O
.	O
Wirfel	O
for	O
diabetes	O
.	O

Neck	O

Dr	O
.	O
[	O
*	O
*	O
First	O
Name	O
(	O
STitle	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
Name	O
(	O
STitle	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
Telephone	O
/	O
Fax	O
(	O
1	O
)	O
170	O
*	O
*	O
]	O
Follow	O
-	O
up	O
appointment	O
should	O
be	O
in	O
1	O
month	O
Dr	O
.	O
[	O
*	O
*	O
Last	O
Name	O
(	O
STitle	O
)	O
2392	O
*	O
*	O
]	O
(	O
PCP	O
)	O
2	O
weeks	O
Dr	O
.	O
[	O
*	O
*	O
Last	O
Name	O
(	O
STitle	O
)	O
*	O
*	O
]	O
(	O
Cardiologist	O
)	O
2	O
weeks	O
-	O
Please	O
see	O
cardiologist	O
regarding	O
restarting	O
HCTZ	O
after	O
lasix	O
is	O
completed	O
.	O

Physical	O
Exam	O

Right	O
Quadriceps	O
(	O
femor	O
.	O
)	O
:	O
Normal	O
.	O

Symptoms	O
are	O
not	O
improved	O
by	O
rest	O
,	O
analgesics	O
and	O
ice	O
.	O

BTL	O
after	O
delivery	O
.	O

-	O
deseires	O
OCP	O
for	O
BCM	O
.	O

Allergy	O
symptoms	O
:	O
itchy	O
eyes	B-bodyloc

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Current	O
Meds	O
Aspirin	O
81	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
Chewable	I-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
16Sep2013	B-temporal
)	O
to	O

Examination	O
of	O
the	O
chest	O
:	O
Normal	B-labvalue

RESPIRATORY	O

f	O
RSV	O
MAB	O
(	O
Synagis	O
)	O
(	O
Lot	O
#	O
:	O
11E27	O
-	O
81	O
)	O
-	O
Administered	O
on	O
:	O
12/14/2012	B-temporal

Hematologic	O
/	O
Lymphatic	O
:	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
and	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
.	O

Physical	O
Exam	O
:	O
Inadequate	O
complete	O
Otolaryngologic	O
exam	O
including	O
mirror	O
.	O

Endocrine	O
:	O
no	B-negation
muscle	B-bodyloc
weakness	O
.	O

Flexible	O
laryngoscopy	O
.	O

Pulmonary	O
:	O
No	B-negation
dyspnea	O
,	O
no	B-negation
cough	O
,	O
and	O
no	B-negation
wheezing	O
.	O

The	O
Amrix	O
is	O
to	O
be	O
taken	O
at	O
about	O
6	B-temporal
-	I-temporal
7	I-temporal
o	I-temporal
'	I-temporal
clock	I-temporal
in	I-temporal
the	I-temporal
evening	I-temporal
because	O
it	O
peaks	O
at	O
its	O
most	O
effectiveness	O
about	O
8	O
hours	O
later	O
.	O

Cranial	O
nerves	O
V	O
:	O
sensation	O
to	O
the	O
face	O
and	O
masseter	O
strength	O
were	O
intact	B-labvalue
.	O

Examination	O
of	O
reflexes	O
:	O
Normal	B-labvalue
.	O

;	O
Dec	B-temporal
5	I-temporal
2011	I-temporal
3	B-temporal
:	I-temporal
10PM	I-temporal
(	O
Author	O
)	O

Respiratory	O
:	O
normal	O
,	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
and	O
no	B-negation
cough	O
.	O

She	O
has	O
normal	O
bladder	O
and	O
bowel	O
function	O
.	O

Constitutional	O
:	O
no	B-negation
fever	O
,	O
no	O
chillsandfatigue	O
.	O

She	O
states	O
her	O
cycles	O
have	O
been	O
heavier	O
over	O
the	B-temporal
last	I-temporal
8	I-temporal
months	I-temporal
with	O
increased	B-course
PMS	O
and	O
cramping	O
.	O

Skin	O

Musculoskeletal	O
:	O
joint	B-bodyloc
stiffness	O
.	O

Paternal	B-subject
history	O
of	O
Adenocarcinoma	O
Of	O
The	O
Stomach	B-bodyloc
V16	O
.	O
0	O

PredniSONE	O
5	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
3	B-dosage
TABLETS	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
08Oct2012	B-temporal
to	O
(	O
Evaluate	O
:	O
06Apr2013	B-temporal
)	O
Requested	O
for	O
:	O
08Oct2012	B-temporal
;	O
Last	O
Rx	O
:	O
08Oct2012	B-temporal

Complete	O
Unilateral	B-bodyloc
Vocal	I-bodyloc
Cord	I-bodyloc
Paralysis	O
478	O
.	O
32	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

[	O
QLH	O
]	O
PSA	O
,	O
TOTAL	O
Done	O
:	O
21Mar2012	B-temporal
12	B-temporal
:	I-temporal
00AM	I-temporal

PAST	O
MEDICAL	O
HISTORY	O
:	O
Chronic	B-course
knee	B-bodyloc
pain	O
.	O

UTI	O
:	O
Start	O
Cipro	O
.	O

He	O
is	O
requ	O
bring	O
refills	O
on	O
all	O
his	O
medication	O
.	O

Associated	O
symptoms	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
claudication	O
,	O
no	B-negation
near	O
syncope	O
,	O
no	B-negation
syncope	O
,	O
no	B-negation
weakness	O
and	O
no	B-negation
edema	O
.	O

Family	O
History	O
Paternal	B-subject
history	O
of	O
Coronary	B-bodyloc
Artery	I-bodyloc
Disease	O
V17	O
.	O
49	O

Symptoms	O
:	O
breast	B-bodyloc
pain	O
,	O
but	O
no	B-negation
breast	B-bodyloc
lump	O
,	O
no	B-negation
breast	B-bodyloc
nodularity	O
,	O
no	B-negation
breast	B-bodyloc
redness	O
,	O
no	B-negation
nipple	B-bodyloc
soreness	O
,	O
no	B-negation
localized	O
swelling	O
,	O
no	O
localized	O
drainage	O
and	O
no	B-negation
rash	O
.	O

Migraine	O
Headache	O
346	O
.	O
90	O

On	O
postoperative	O
day	O
#	O
2	O
,	O
he	O
was	O
passing	O
flatus	O
and	O
has	O
had	O
bowel	O
movements	O
.	O

9	I-reference_range
T3	O
Uptake	O
38	B-labvalue
%	I-labvalue
24	B-reference_range
-	I-reference_range
39	I-reference_range
Thyroxine	O
(	O
T4	O
)	O
7	B-labvalue
.	I-labvalue
9	I-labvalue
ug	I-labvalue
/	I-labvalue
dL	I-labvalue
4	B-reference_range
.	I-reference_range
5	I-reference_range
-	I-reference_range
12	I-reference_range
.	I-reference_range

Maternal	B-subject
history	O
of	O
Hypertension	O
V17	O
.	O
49	O

No	B-negation
frontal	B-bodyloc
tenderness	O
.	O

The	O
Hgb	O
A1c	O
was	O
6	B-labvalue
.	I-labvalue
3	I-labvalue
%	I-labvalue
.	O

There	O
were	O
no	B-negation
thyroid	B-bodyloc
nodules	O
.	O

MAX	O
2	O
DOSES	O
/	O
24	O
HOURS	O
;	O
Therapy	O
:	O
21Jul2011	B-temporal
to	O
(	O
Evaluate	O
:	O
10Aug2011	B-temporal
)	O

Jugular	O
Veins	O
:	O
the	O
JVP	O
was	O
not	B-labvalue
elevated	I-labvalue
.	O

Examination	O
of	O
liver	O
and	O
spleen	O
:	O
Normal	B-labvalue
.	O

History	O
of	O
Pap	O
Smear	O
Reported	O
Positive	B-labvalue
795	O
.	O
19	O

f	O
His	O
osy	O
of	O
Advanced	B-severity
Multigravida	O
(	O
659	O
.	O
60	O
)	O
;	O
(	O
Resolved	B-course
)	O

PSYCHIATRIC	O
:	O
no	B-negation
depression	O
and	O
no	B-negation
anxiety	O
.	O

Attending	O
Note	O

Chief	O
Complaint	O

He	O
is	O
photosensitive	O
and	O
sound	O
sensitive	O
but	O
has	O
no	B-negation
nausea	O
or	O
vomiting	O
.	O

left	B-bodyloc
multidigit	I-bodyloc
trauma	O
,	O
s	O
/	O
p	O
table	O
saw	O
injury	O

2	B-dosage
PATCHES	I-dosage
IN	O
AM	O
OFF	O
IN	O
PM	O
;	O
Therapy	O
:	O

[	O
U	O
]	O
MRI	O
LOWER	O
EXTREMITY	O
WO	O
CONTRAST	O
LEFT	O
Requested	O
for	O
:	O
05Jul2013	B-temporal

1	O
.	O

Family	O
History	O
1	O

Past	O
Medical	O
History	O

Palpation	O
of	O
the	O
face	O
and	O
sinuses	O
:	O
Abnormal	O
.	O

Respiratory	O
:	O
no	B-negation
cough	O
,	O
does	B-negation
not	I-negation
sneeze	O
all	B-temporal
the	I-temporal
time	I-temporal
,	O
normal	O
breathing	O
rate	O
and	O
no	B-negation
nasal	B-bodyloc
flaring	O
.	O

Denied	O

Cerumen	O
Impaction	O
380	O
.	O
4	O

Dry	O
Eye	B-bodyloc
Syndrome	O
375	O
.	O
15	O

5	O
.	O

UTP	O
-	O
Discussion	O
/	O

He	O
says	O
that	O
the	O
dystonia	O
is	O
not	B-negation
as	O
severe	B-severity
right	B-temporal
now	I-temporal
.	O

Cardiovascular	O
Peripheral	O
vascular	O
exam	O
:	O
Abnormal	O
.	O

Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

Upon	O
admission	O
,	O
the	O
patient	O
reported	O
an	O
approximate	O
two	O
-	O
week	O
history	O
of	O
dyspnea	O
on	O
exertion	O
and	O
some	O
mild	B-severity
chest	B-bodyloc
pain	O
.	O

No	B-negation
wheezing	O
was	O
heard	O
.	O

Examination	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue
The	O
neck	O
was	O
normal	O
in	O
appearanceand	O
was	O
supple	O
.	O

General	O
:	O
sitting	O
comfortably	O
in	O
wheelchair	O
,	O
mild	B-severity
respiratory	O
distress	O
,	O
breathing	O
heavily	O
from	O
mouth	B-bodyloc

MA	O
Breast	O
mammogram	O
bilateral	O
77056	O
Requested	O
for	O
:	O
23Oct2012	B-temporal

Scope	O
:	O
3	O
mm	O
30	O
degree	O
telescope	O
.	O

Surgical	O
History	O
History	O
of	O
Cervical	O
Loop	O
Electrosurgical	O
Excision	O
(	O
LEEP	O
)	O

Adnexa	O
/	O
parametria	O
:	O
Normal	O
.	O
No	B-negation
masses	O
,	O
nontender	O
.	O

MUSCULOSKELETAL	O
:	O
Normal	B-labvalue
gait	O
and	O
station	O
.	O

Integumentary	O
:	O
no	B-negation
skin	B-bodyloc
lesions	O
and	O
no	B-negation
skin	B-bodyloc
wound	O
.	O

ED	O
;	O
Options	O
discussed	O
.	O

Vitals	O
20Jul2013	B-temporal
11	B-temporal
:	I-temporal
01AM	I-temporal
Systolic	O
110	B-labvalue
,	O
RUE	O
,	O
Sitting	O
Diastolic	O
64	B-labvalue
,	O
RUE	O
,	O
Sitting	O
Temperature	O
96	B-labvalue
.	I-labvalue
3	I-labvalue
F	I-labvalue
,	O
Oral	O
Heart	O
Rate	O
64	B-labvalue
,	O
R	O
Radial	O
Pulse	O
Quality	O
Regular	B-labvalue
,	O
R	O
Radial	O

Nontoxic	O
Multinodular	O
Goiter	O
241	O
.	O
1	O

No	B-negation
pulse	O
delay	O
and	O
no	B-negation
pulse	O
discrepancy	O
.	O

Peripheral	O
vascular	O
exam	O
:	O
Normal	B-labvalue

Surgical	O
History	O
1	O
.	O

Previous	B-temporal
Resection	O
:	O
No	B-negation
.	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
,	O
the	O
heart	O
rate	O
was	O
not	B-labvalue
fast	I-labvalue
and	O
the	O
heart	O
rate	O
was	O
not	B-labvalue
slow	I-labvalue
.	O

History	O
of	O
Drug	O
Use	O

I	O
have	O
seen	O
and	O
examined	O
BRADEN	O
ELLER	O
with	O
the	O
resident	O
.	O

Denied	O
1	O
.	O

Abdomen	O

Risk	O
Factors	O
:	O
exposure	O
to	O
mono	O
,	O
but	O
not	O
tobacco	O
use	O
,	O
secondhand	O
smoke	O
,	O
exposure	O
to	O
strep	O
and	O
impaired	O
immunity	O
.	O

Forearm	B-bodyloc
Injury	O
959	O
.	O
3	O

Assessment	O
of	O
muscle	O
strength	O
/	O
tone	O
:	O
Normal	B-labvalue

Cardiovascular	O
:	O
no	B-negation
palpitations	O
and	O
no	B-negation
intermittent	O
leg	B-bodyloc
claudication	O
.	O

Examination	O
of	O
gait	O
and	O
station	O
:	O
Normal	B-labvalue
.	O

No	B-negation
murmurs	O
were	O
heard	O
.	O

Singulair	O
10	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Therapy	O
:	O
27Apr2009	B-temporal
to	O
Requested	O
for	O
:	O
15Jun2009	B-temporal

History	O
of	O
Present	O
Illness	O

Description	O
of	O
patient	O
'	O
s	O
judgement	O
and	O
insight	O
:	O
Normal	B-labvalue

Type	O
2	O
Diabetes	O
Mellitus	O
250	O
.	O
00	O

GLUCOSE	O
NEG	B-labvalue

Counseling	O
/	O
Counseling	O
/	O
Edu	O

LORazepam	O
1	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
OTHER	O
Take	O
one	O
before	O
MRI	O
scan	O
.	O

Patietn	O
has	O
been	O
using	O
neb	B-route
tx	O
q	B-frequency
4	I-frequency
hours	I-frequency
,	O
albuterol	O
x	B-duration
2	I-duration
days	I-duration
for	O
wheezing	O
.	O
H	O
/	O
O	O
Bronchitis	O
,	O
patient	O
with	O
cough	O
:	O
productive	O
:	O
brown	O
,	O
nasal	B-bodyloc
congestion	O
.	O

Medical	O
Decision	O
Making	O
:	O

[	O
QLH	O
]	O
CMP	O
W	O
/	O
EGFR	O
Requested	O
for	O
:	O
14Oct2013	B-temporal

She	O
denies	B-negation
polydipsia	O
,	O
polyuria	O
,	O
or	O
nocturia	O
.	O

Fourth	O
pregnancy	O
:	O

Requested	O
for	O
:	O
19Mar2014	B-temporal

Peripheral	B-bodyloc
Vascular	I-bodyloc
Disease	O
443	O
.	O
9	O

Motor	O
Strength	O
:	O
motor	O
strength	O
was	O
normal	B-labvalue
in	O
all	O
muscle	O
groups	O
.	O

Culture	O
:	O
Left	O
,	O
middle	O
meatus	O
,	O
FR	O
/	O
FS	O

Cerebellar	O
:	O
the	O
cerebellar	O
function	O
was	O
normal	O
.	O

History	O
of	O
Jaw	O
Surgery	O

Pupils	O
:	O
.	O

This	O
will	O
keep	O
the	O
spasm	O
down	O
to	O
a	O
minimum	O
and	O
last	O
throughout	O
the	O
night	O
to	O
help	O
the	O
patient	O
sleep	O
better	O
.	O

Involuntary	O
Movements	O
:	O
no	B-negation
involuntary	O
movements	O
were	O
seen	O
.	O

Frontal	B-bodyloc
sinuses	I-bodyloc
:	O
tender	O
to	O
palpation	O
on	O
the	O
rightandtender	O
to	O
palpation	O
on	O
the	O
left	O
.	O

If	O
not	O
she	O
would	O
require	O
tracheostomy	O
.	O

Amenorrhea	O
.	O

Examination	O
of	O
the	O
abdomen	O
:	O
Normal	B-labvalue
.	O

Levemir	O
FlexPen	O
100	B-strength
UNIT	I-strength
/	I-strength
ML	I-strength
Subcutaneous	B-route
Solution	B-form
;	O
INJECT	O
50	B-dosage
UNITS	I-dosage
UNDER	B-route
SKIN	I-route
EVERY	O
EVENING	O
MAY	O
SELF	O
TITRATE	O
UP	O
TO	O
60	O
UNITS	O
;	O
Therapy	O
:	O
15Apr2013	B-temporal
to	O
(	O
Evaluate	O
:	O
04Jun2014	B-temporal
)	O
Requested	O
for	O
:	O
15Apr2014	B-temporal
;	O
Last	O
Rx	O
:	O
15Apr2014	B-temporal
;	O
Status	O
:	O
ACTIVE	O
-	O
Retrospective	O
Authorization	O

The	O
patient	O
also	O
had	O
a	O
history	O
of	O
sinusitis	O
and	O
so	O
a	O
sinus	O
CT	O
scan	O
was	O
obtained	O
,	O
which	O
was	O
normal	B-labvalue
.	O

She	O
denies	B-negation
paresthesia	O
/	O
numbness	O
of	O
feet	B-bodyloc
.	O

Examination	O
of	O
the	O
anus	O
,	O
perineum	O
and	O
rectum	O
:	O
Normal	B-labvalue

Yesterday	B-temporal
(	O
6/13/2013	B-temporal
)	O
she	O
was	O
notified	O
the	O
urine	O
culture	O
returned	O
negative	B-labvalue
at	O
the	O
clinic	O
and	O
was	O
advised	O
to	O
finish	O
her	O
cipro	O
treatment	O
.	O

The	O
rhythm	O
was	O
regular	B-labvalue
.	O

Can	O
follow	O
up	O
as	O
needed	O
.	O

Cardiovascular	O

TSH	O
:	O
3	B-labvalue
.	I-labvalue
180	I-labvalue
uIU	I-labvalue
/	I-labvalue
mL	I-labvalue
Reference	O
Range	O
0	B-reference_range
.	I-reference_range
450	I-reference_range
-	I-reference_range
4	I-reference_range
.	I-reference_range
500	I-reference_range

History	O
of	O
Present	O
Illness	O
The	O
patient	O
is	O
being	O
seen	O
for	O
post	O
-	O
op	O
visit	O
.	O

History	O
of	O
Present	O
Illness	O
The	O
patient	O
is	O
being	O
seen	O
for	O
post	O
-	O
op	O
visit	O
.	O

Lortab	O
5	B-strength
-	I-strength
500	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
EVERY	B-frequency
6	I-frequency
HOURS	I-frequency
AS	B-frequency
NEEDED	I-frequency
FOR	O
PAIN	O
;	O
Therapy	O
:	O
28Aug2013	B-temporal
to	O

Neurological	O
:	O
confusion	O
,	O
memory	O
loss	O
,	O
difficulty	O
walking	O
and	O
frequent	O
falls	O
,	O
but	O
no	B-negation
dizziness	O
,	O
no	B-negation
fainting	O
,	O
no	B-negation
lightheadedness	O
,	O
no	B-negation
vertigo	O
,	O
no	B-negation
headache	O
and	O
able	O
to	O
walk	O
.	O

Arterial	O
Pulses	O
:	O
Normal	O
(	O
equal	O
bilaterally	O
)	O
.	O

Chief	O
Complaint	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Active	O
Problems	O
Gynecologic	O
Services	O
Intrauterine	O
Device	O
(	O
IUD	O
)	O
Checking	O
V25	O
.	O
42	O

Nortriptyline	O
HCl	O
75	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Last	O
Rx	O
:	O
09Jan2014	B-temporal
;	O
Status	O
:	O

Chief	O
Complaint	O

eGFR	O
of	O
60	B-reference_range
-	I-reference_range
89	I-reference_range
mayabe	O
normalain	O
some	O
populations	O
,	O
particularly	O
the	O
elderly	O
,	O
for	O

Chief	O
Complaint	O
1	O
.	O

Allergies	O
Penicillins	O

No	B-negation
murmurs	O
were	O
heard	O
.	O

3	O

Sample	O
Name	O
:	O
ORIF	O
-	O
Discharge	O
Summary	O

The	O
patient	O
was	O
given	O
saEnles	O
of	O
Celebrex	O
200	B-strength
mg	I-strength
to	O
take	O
after	O
she	O
finishes	O
the	O
DexPak	O
Jr	O
.	O
.	O

Inspection	O
of	O
the	O
conjunctiva	O
and	O
lids	O
:	O
Normal	B-labvalue
.	O

CKD	O
stage	B-severity
4	I-severity
.	I-severity

MRI	O
Brain	O
5/18/10	B-temporal
-	O
Performed	O
at	O
Hermann	O
under	O
pseudonym	O
Sonia	O
Medina	O
,	O
no	B-negation
brain	B-bodyloc
lesions	O
.	O

Zolpidem	O
Tartrate	O
10	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
AT	B-frequency
BEDTIME	I-frequency
AS	B-frequency
NEEDED	I-frequency
;	O
Last	O
Rx	O
:	O
04Sep2013	B-temporal

Family	B-subject
history	O
of	O
Cancer	O

Examination	O
of	O
extremities	O
for	O
edema	O
and	O
/	O
or	O
varicosities	O
:	O
Normal	O

Examination	O
of	O
the	O
abdomen	O
:	O
Normal	B-labvalue
.	O

Lasted	O
45	O
second	O
witnessed	O
by	O
friend	O
.	O

History	O
of	O
Present	O
Illness	O

Social	O
History	O
:	O

Regurinng	O
Patient	O
:	O
OLIVEIRA	O
,	O
SHANNON	O
,	O
Status	O
:	O
In	O
Progress	O

Fx	O
.	O
hip	B-bodyloc

Results	O
/	O
Assessment	O
1	O
.	O

Appropriate	B-labvalue
mood	O
and	O
affect	O
.	O

Paternal	B-subject
history	O
of	O
Hypertension	O
V17	O
.	O
49	O

3ML	I-strength
Subcutaneous	B-route
Solution	B-form
;	O
INJECT	O
30	B-dosage
MG	I-dosage
Every	B-frequency
twelve	I-frequency
hours	I-frequency
;	O

Psychiatric	O
:	O
no	B-negation
anxiety	O
,	O
no	B-negation
depression	O
and	O
no	B-negation
emotional	O
problems	O
.	O

Gynecological	O
Problems	O
.	O

Genitourinary	O

Essential	O
Hypertension	O
401	O
.	O
9	O

;	O
Mar	B-temporal
20	I-temporal
2014	I-temporal
12	B-temporal
:	I-temporal
58PM	I-temporal
(	O
Author	O
)	O

(	O
radial	O
)	O
:	O
Normal	O
.	O

She	O
is	O
also	O
here	O
for	O
her	O
pelvic	O
ultrasound	O
results	O
.	O

amp	O
4	O
.	O
5v	O
reduced	O
4	O
.	O
1	O
4	O
.	O
3	O
v	O
reduced	O
4	O
.	O
0	O

I	O
have	O
discussed	O
the	O
case	O
with	O
the	O
resident	O
and	O
agree	O
with	O
the	O
assessment	O
and	O
plan	O
as	O
delineated	O
in	O
the	O
note	O
above	O
.	O

Obstructive	O
Sleep	O
Apnea	O
327	O
.	O
23	O

Right	O
Digit	O
Flex	O
.	O

Weight	O
:	O
148	B-labvalue
lb	I-labvalue

FOLLOWUP	O
:	O
Follow	O
up	O
with	O
Dr	O
.	O
Y	O
in	O
7	O
to	O
10	O
days	O
in	O
office	O
.	O

I	O
have	O
discussed	O
the	O
case	O
with	O
the	O
resident	O
and	O
agree	O
with	O
the	O
diagnosis	O
and	O
plan	O
.	O

[	O
QLH	O
]	O
CMP	O
Requested	O
for	O
:	O
07Mar2011	B-temporal

Signatures	O
Electronically	O
signed	O
by	O
:	O
MICHAEL	O
CHATER	O
,	O
M	O
.	O
D	O
.	O

Mammogram	O
today	B-temporal
,	O
f	O
/	O
u	O
in	O
6	B-temporal
months	I-temporal
,	O
continue	O
to	O
assess	O
screening	O

The	O
patient	O
has	O
been	O
following	O
up	O
for	O
the	O
DBS	O
programming	O
with	O
the	O
result	O
of	O
improvement	O
in	O
her	O
posture	O
.	O

Mupirocin	O
2	B-strength
%	I-strength
External	B-form
Ointment	I-form
;	O
APPLY	O
AS	O
DIRECTED	O
;	O
Therapy	O
:	O
20Aug2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
20Aug2013	B-temporal
)	O
Requested	O
for	O
:	O
20Aug2013	B-temporal

[	O
QLH	O
]	O
CBC	O
(	O
INCLUDES	O
DIFF	O
/	O
PLT	O
)	O
Status	O
:	O
Complete	O
Done	O
:	O
02Jul2013	B-temporal

Family	O
History	O
Maternal	B-subject
history	O
of	O
Aortic	B-bodyloc
Aneurysm	O

Place	O
of	O
Delivery	O
:	O
Women	O
'	O
s	O
.	O

Ears	O
,	O
Nose	O
,	O
Mouth	O
,	O
and	O
throat	O
:	O
External	O
ears	O
without	B-negation
lesions	O
.	O

Examination	O
of	O
thyroid	O
:	O
Normal	B-labvalue
.	O

Vitals	O
31Oct2013	B-temporal
08	B-temporal
:	I-temporal
33AM	I-temporal
BMI	O
Calculated	O
33	B-labvalue
.	I-labvalue
75	I-labvalue
BSA	O
Calculated	O
2	B-labvalue
.	I-labvalue
05	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
6	I-labvalue
in	I-labvalue
Weight	O
210	B-labvalue
lb	I-labvalue
Systolic	O
121	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
60	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Temperature	O
99	B-labvalue
.	I-labvalue
3	I-labvalue
F	I-labvalue
,	O
Tympanic	O
Heart	O
Rate	O
76	B-labvalue
Respiration	O
16	B-labvalue
Respiration	O
Quality	O
Normal	B-labvalue
LMP	O
T	O
.	O

Height	O
:	O
5	B-labvalue
ft	I-labvalue
5	I-labvalue
in	I-labvalue

(	O
femor	O
.	O
)	O
:	O
Normal	O
.	O

1	O
.	O

Furosemide	O
40	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
05Sep2012	B-temporal
to	O

Can	O
follow	O
up	O
as	O
needed	O
.	O

Depressisp	O
311	O

Current	O
Meds	O
Aspirin	O
81	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
02Mar2006	B-temporal
to	O
Requested	O
for	O
:	O
02Mar2006	B-temporal

Repair	O
of	O
lacerations	O
,	O
20	O
-	O
cm	O
11	O
.	O

Surgical	O
History	O
History	O
of	O
Brain	O
Surgery	O

Psychiatric	O
:	O
depression	O
,	O
but	O
no	B-negation
anxiety	O
.	O

MCHC	O
32	B-labvalue
.	I-labvalue
8	I-labvalue
g	I-labvalue
/	I-labvalue
dl	I-labvalue
32	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
36	I-reference_range
.	I-reference_range
0	I-reference_range

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
,	O
no	O
coughandno	O
orthopnea	O
.	O

Generalized	O
tenderness	O
and	O
crepitus	O
palpated	O
.	O

(	O
Medical	O
Transcription	O
Sample	O
Report	O
)	O

Sample	O
Type	O
/	O
Medical	O
Specialty	O
:	O
General	O
Medicine	O
Sample	O

Pt	O
was	O
counseled	O
to	O
call	O
back	O
to	O
office	O
if	B-condition
diarrhea	O
worsens	B-course
or	O
blood	O
in	O
stool	O

Patient	O
was	O
not	B-negation
observed	I-negation
to	O
be	O
obese	O
.	O

No	B-negation
Significant	O
Family	O
History	O

Taking	O
Blood	O
Thinners	O
For	O
A	O
Long	O
Time	O
V58	O
.	O
61	O

Systolic	O
:	O
174	B-labvalue

-	O
No	B-negation
pathologic	O
abnormalities	O
.	O

Constitutional	O

Reason	O
For	O
Visit	O

Left	O
Wrist	O
Flex	O
.	O

Carvedilol	O
25	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
ONE	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
TWICE	B-frequency
A	I-frequency
DAY	I-frequency
Requested	O
for	O
:	O
04Oct2013	B-temporal
;	O
Last	O
Rx	O
:	O
04Oct2013	B-temporal

He	O
uses	O
BAHA	O
on	O
the	O
right	O
ear	O
and	O
hearing	O
well	O
with	O
it	O
.	O

Plan	O
Allergic	O
Rhinitis	O
(	O
477	O
.	O
9	O
)	O

Discharge	O
Condition	O
:	O

Plan	O

History	O
of	O
Nephrotic	O
Syndrome	O
V13	O
.	O
03	O

Examination	O
of	O
pupils	O
and	O
irises	O
:	O
Normal	B-labvalue

Constitutional	O
:	O
no	B-negation
fever	O
and	O
no	B-negation
chills	O
.	O

MUSCULOSKELETAL	O
:	O
no	B-negation
muscle	B-bodyloc
pain	O
and	O
no	B-negation
muscle	B-bodyloc
weakness	O
.	O

;	O
Aug	B-temporal
20	I-temporal
2013	I-temporal
4	B-temporal
:	I-temporal
48PM	I-temporal
(	O
Author	O
)	O

Palpation	O
of	O
the	O
face	O
and	O
sinuses	O
:	O
Normal	B-labvalue

2	O
.	O

Allergies	O
No	B-negation
Known	O
Allergies	O

Allergies	O
Codeine	O
Derivatives	O

Glucose	O
-	O
6	O
-	O
PD	O
Quantitative	O
:	O
13	B-labvalue
.	I-labvalue
7	I-labvalue
U	I-labvalue
/	I-labvalue
gHgb	I-labvalue
Reference	O
Range	O
7	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
20	I-reference_range
.	I-reference_range
5	I-reference_range

Eosinophils	O
:	O
0	B-labvalue
.	I-labvalue
3	I-labvalue
%	I-labvalue
Reference	O
Range	O
0	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
4	I-reference_range
.	I-reference_range
0	I-reference_range

HIB	O
;	O
02/01/2008	B-temporal

[	O
QLH	O
]	O
TSH	O
,	O
3RD	O
GENERATION	O
Requested	O
for	O
:	O
18Dec2013	B-temporal

Visit	O
For	O
:	O
Screening	O
Exam	O
Malignant	O
Neoplasm	O
Breast	O
V76	O
.	O
10	O

[	O
L	O
]	O
Lipid	O
Panel	O
w	O
/	O
o	O
Chol	O
/	O
HDL	O
Ratio	O
Requested	O
for	O
:	O
21Nov2013	B-temporal

Patient	O
was	O
observed	O
to	O
be	O
obese	O
.	O

Chronic	B-course
Reflux	O
Esophagitis	O
530	O
.	O
11	O

IP	O
/	O
FS	O
/	O
N	O
/	O
SF	O
Due	O
:	O
20Feb2014	B-temporal
;	O
Last	O
Updated	O
By	O
:	O
Fleming	O
,	O
Sonya	O

[	O
QLH	O
]	O
HEMATOCRIT	O
Done	O
:	O
19Aug2010	B-temporal
12	B-temporal
:	I-temporal
47PM	I-temporal

Furosemide	O
40	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
DAILY	B-frequency
;	O
Therapy	O
:	O
15Jan2013	B-temporal
to	O
(	O
Evaluate	O
:	O
14Jul2013	B-temporal
)	O
Requested	O
for	O
:	O
15Jan2013	B-temporal
;	O
Last	O
Rx	O
:	O
15Jan2013	B-temporal

Segmented	O
Neutrophils	O
67	B-labvalue
.	I-labvalue
4	I-labvalue
%	I-labvalue
45	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
75	I-reference_range
.	I-reference_range
0	I-reference_range

Total	O
pregnancies	O
0	O
.	O

Physical	O
Exam	O

Other	O
Symptoms	O
:	O
has	O
been	O
on	O
cipro	O
for	O
?	B-uncertain
uti	O
but	O
no	B-negation
urinary	O
sx	O
.	O
and	O
culture	O
was	O
negative	B-labvalue
.	O

Examination	O
of	O
thyroid	O
:	O
Normal	B-labvalue
.	O

History	O
of	O
Open	O
Treatment	O
Of	O
Fracture	O
Of	O
Fibular	O
Shaft	O

Physical	O
Exam	O

[	O
L	O
]	O
CBC	O
+	O
Platelet	O
+	O
Hem	O
Review	O
Requested	O
for	O
:	O
02Nov2012	B-temporal

NECK	O
:	O
Supple	O
,	O
nontender	O
,	O
and	O
full	O
range	O
of	O
motion	O
.	O

History	O
of	O
Polycystic	O
Ovarian	B-bodyloc
Syndrome	O
256	O
.	O
4	O

GroupHeading61End	O
GroupHeading62Start	O
GroupHeading62End	O
GroupHeading63Start	O
GroupHeading63End	O
GroupHeading64Start	O
GroupHeading64End	O
GroupHeading65Start	O
GroupHeading65End	O
UTP	O
-	O
FemaleMulti	O
-	O
SystemExamCopy	O
-	O
mp1f760502	O
-	O
82e9	O
-	O
4b23	O
-	O
9c02	O
-	O
016b9e2fc8c1FormEnd	O
PhytucalExamSectispEnd	O
AssessmeptSectispStart	O
Assessmept	O

Carotid	O
pulses	O
:	O
Normal	B-labvalue
.	O

4	O
.	O

Current	B-temporal
treatment	O
includes	O
sodium	O
restriction	O
.	O

Esophageal	B-bodyloc
Reflux	O
530	O
.	O
81	O

&	O
uln	O
.	O
)	O
:	O
Normal	O
.	O

;	O
Oct	B-temporal
18	I-temporal
2012	I-temporal
3	B-temporal
:	I-temporal
03PM	I-temporal
(	O
Author	O
)	O

She	O
is	O
now	O
status	O
post	O
posterior	B-bodyloc
fossa	I-bodyloc
decompression	O
by	O
Dr	O
.	O
Tandon	O
.	O

Inspection	O
of	O
lips	O
,	O
teethand	O
gums	O
:	O
Normal	B-labvalue
.	O

DEXA	O
:	O
never	B-temporal

GLUCOSE	O
84	B-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
65	B-reference_range
-	I-reference_range
99	I-reference_range

Allergies	O

Physical	O
Exam	O

Benazepril	O
HCl	O
20	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
TWICE	B-frequency
DAILY	I-frequency
Requested	O
for	O
:	O
25Feb2014	B-temporal
;	O
Last	O
Rx	O
:	O
25Feb2014	B-temporal
;	O
Edited	O

Cycle	O
intervals	O
have	O
been	O
regular	O
and	O
occur	O
approximately	O
every	O
30	O
days	O
.	O

She	O
was	O
doing	O
well	O
with	O
good	O
p	O
.	O
o	O
.	O
s	O
,	O
good	O
airway	O
,	O
good	O
voice	O
,	O
and	O
desiring	O
to	O
be	O
discharged	O
home	O
.	O

Headache	O
.	O

Neurological	O
:	O
no	B-negation
dizziness	O
,	O
no	B-negation
lightheadedness	O
,	O
no	B-negation
vertigo	O
and	O
no	B-negation
headache	O
.	O

General	O
appearance	O
:	O
Normal	B-labvalue
.	O

Medications	O
:	O
The	O
patient	O
is	O
not	B-negation
on	O
any	O
medication	O
at	O
this	B-temporal
time	I-temporal
.	O

Throat	O
,	O
Neck	O
,	O
and	O
Back	O
Cervical	O
Spine	O
:	O
Normal	O
(	O
full	O
range	O
of	O
motion	O
)	O
.	O

Head	O
and	O
Face	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
JOHN	O
MOORE	O
,	O
P	O
.	O
A	O
.	O

History	O
of	O
Vaginal	B-bodyloc
Candidiasis	O
112	O
.	O
1	O

Mammogram	O
-	O
Abnormal	O
793	O
.	O
80	O

Results	O
/	O
Assessment	O
Edema	O
782	O
.	O
3	O

Counseling	O
/	O
Discussion	O
/	O
Discussion	O
/	O
Summary	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
.	O

Her	O
course	O
was	O
complicated	O
by	O
pulmonary	B-bodyloc
embolus	O
,	O
pneumonia	O
,	O
and	O
subdural	B-bodyloc
hematoma	O
while	O
on	O
anticoagulation	O
.	O

Inspection	O
of	O
breasts	O
:	O
Normal	B-labvalue
.	O

Social	O
History	O
Never	O
A	O
Smoker	O

Cardiovascular	O
:	O
orthopnea	O
,	O
but	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
,	O
no	B-negation
increased	O
heart	B-bodyloc
rate	O
,	O
no	B-negation
decrease	O
in	O
heart	B-bodyloc
rate	O
,	O
no	B-negation
edema	O
and	O
no	B-negation
intermittent	O
leg	B-bodyloc
claudication	O
.	O

OB	O
History	O

Patient	O
denies	B-negation
any	O
chest	B-bodyloc
pain	O
,	O
no	B-negation
SOB	O
,	O
no	B-negation
DOE	O
,	O
no	B-negation
LE	B-bodyloc
edema	O
,	O
no	B-negation
palpitations	O
,	O
no	B-negation
snoring	O
,	O
no	B-negation
orhtopnea	O
,	O
no	B-negation
PND	O
,	O
no	B-negation
syncopy	O
,	O
occasional	O
dizziness	O
with	O
panic	O
attacks	O
.	O

Clinically	O
he	O
has	O
improved	O
significantly	O
and	O
is	O
almost	O
back	O
to	O
normal	O
and	O
is	O
very	O
excited	O
about	O
this	O
.	O

NKDA	O

Cranial	O
Nerve	O
VII	O
:	O
facial	O
strength	O
was	O
intact	B-labvalue
bilaterally	O
.	O

History	O
of	O
Present	O
Illness	O

9085	O
Site	O
Bellaire	O
Women	O
'	O
s	O
Center	O

Mometasone	O
Furoate	O
Powder	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
03Nov2011	B-temporal
)	O
to	O

Rebif	O
44	B-strength
MCG	I-strength
/	I-strength
0	I-strength
.	I-strength

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

PHYSICAL	O
EXAMINATION	O
:	O
Abdomen	B-bodyloc
was	O
diffusely	O
tender	O
.	O

Oropharynx	O
:	O
Normal	O
.	O

2	O
.	O

Hydrocortisone	O
CREA	O
;	O
INSERT	O
CAPSULE	B-form
prn	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
03Sep2013	B-temporal
)	O
to	O

Denied	O

He	O
lives	O
with	O
his	O
spouse	O
and	O
has	O
no	O
children	O
.	O

[	O
QLH	O
]	O
IRON	O
AND	O
TOTAL	O
IRON	O
BINDING	O
CAPACITY	O
Done	O
:	O
19Jul2011	B-temporal
12	B-temporal
:	I-temporal
28PM	I-temporal

9085	O
Site	O
Pedi	O
High	O
Risk	O

Tibial	O
(	O
peron	O
.	O
)	O
Strength	O
:	O
5	B-labvalue
/	I-labvalue
5	I-labvalue
.	O

LYMPH	O
:	O
Cervical	O
lymph	O
nodes	O
.	O

Constitutional	O
:	O
alert	O
,	O
interactive	O
,	O
healthy	O
appearing	O
,	O
in	O
no	B-negation
acute	B-course
distress	O
,	O
well	O
nourished	O
and	O
well	O
developed	O
.	O

Facial	B-bodyloc
or	O
sinus	B-bodyloc
pressure	O
:	O
None	B-negation

Chief	O
Complaint	O

She	O
denies	B-negation
depression	O
,	O
postpartum	O
sadness	O
,	O
or	O
desire	O
to	O
hurt	O
herself	O
or	O
the	O
baby	O
.	O

Assessment	O
1	O

Mammogram	O
8	B-temporal
/	I-temporal
2012	I-temporal
NL	O

Current	B-temporal
treatment	O
includes	O
albuterol	O
by	O
inhalation	B-route
,	O
long	O
-	O
acting	O
beta	O
agonists	O
,	O
inhaled	O
anticholinergics	O
and	O
inhaled	O
corticosteroids	O
.	O

[	O
QLH	O
]	O
HEMOGLOBIN	O
A1c	O
Requested	O
for	O
:	O
25Feb2014	B-temporal

OB	O
History	O

Disease	O
management	O
:	O
the	O
patient	O
is	O
doing	O
well	O
with	O
her	O
goals	O
.	O

Chronic	B-course
Bronchitis	O
491	O
.	O
9	O

Recent	O
and	O
remote	O
memory	O
:	O
Normal	B-labvalue

The	O
patient	O
presented	O
to	O
our	O
emergency	O
room	O
for	O
worsening	B-course
abdominal	B-bodyloc
pain	O
as	O
well	O
as	O
swelling	O
of	O
the	O
right	B-bodyloc
lower	I-bodyloc
leg	I-bodyloc
.	O

Supraclavicular	O
lymph	O
nodes	O
are	O
normal	O
in	O
size	O
and	O
nontender	O

;	O
Apr	B-temporal
3	I-temporal
2014	I-temporal
1	B-temporal
:	I-temporal
52PM	I-temporal
(	O
Author	O
)	O

0	I-reference_range
Mean	O
Crll	O
Hemoglobin	O
26	B-labvalue
.	I-labvalue
6	I-labvalue
pg	I-labvalue
L	B-labvalue
27	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
31	I-reference_range
.	I-reference_range

Larynx	O
:	O
Unable	O
to	O
visualize	O
.	O

Eyes	O

UTP	O
-	O
HM	O
,	O
The	O
patient	O
is	O
being	O
seen	O
for	O
a	O

History	O
of	O
Viral	O
Infection	O
079	O
.	O
99	O

Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

No	B-negation
rhonchi	O
were	O
heard	O
.	O

Symptoms	O
:	O
sneezing	O
,	O
nasal	B-bodyloc
congestion	O
and	O
runny	O
nose	O
,	O
but	O
no	B-negation
sore	O
throat	B-bodyloc
,	O
no	B-negation
scratchy	O
throat	B-bodyloc
,	O
no	B-negation
dry	O
cough	O
,	O
no	B-negation
wheezing	O
,	O
no	B-negation
fever	O
and	O
no	B-negation
chills	O
.	O

General	O
Health	O
:	O
The	O
patient	O
'	O
s	O
health	O
since	O
the	O
last	O
visit	O
is	O
described	O
as	O
good	O
.	O

Skin	O

Vitamin	O
E	O
400	B-strength
UNIT	I-strength
Oral	B-route
Capsule	B-form
;	O
Take	O
Vitamin	O
E	O
800	B-strength
units	I-strength
daily	B-frequency
;	O
Therapy	O
:	O
15Apr2013	B-temporal
to	O

Palpation	O
of	O
chest	O
:	O
Normal	B-labvalue
.	O

Well	O
hydrated	O
.	O

1	O
.	O

GroupHeading42End	O
GroupHeading43Start	O
GroupHeading43End	O
GroupHeading44Start	O
GroupHeading44End	O
GroupHeading45Start	O
GroupHeading45End	O
GroupHeading46Start	O
GroupHeading46End	O
GroupHeading47Start	O
Musculoskeletal	O
Examinatisp	O
of	O
gait	O
and	O
statisp	O
:	O
Abnormal	B-labvalue
Uses	O
cane	O
to	O
ambulate	O
.	O

6	O
.	O

2	O
.	O

There	O
was	O
full	B-labvalue
rotation	O
,	O
good	B-labvalue
flexion	O
,	O
good	B-labvalue
extension	O
,	O
good	B-labvalue
abduction	O
,	O
and	O
good	B-labvalue
adduction	O
of	O
both	O
hips	O
.	O

Promethazine	O
HCl	O
25	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
EVERY	B-frequency
6	I-frequency
HOURS	I-frequency
AS	B-frequency
NEEDED	I-frequency
FOR	O
NAUSEA	O
;	O
Therapy	O
:	O
to	O
(	O
Evaluate	O
:	O
22Jun2013	B-temporal
)	O
;	O
Last	O
Rx	O
:	O
14Jun2013	B-temporal

-	O
Lasix	O
20mg	B-strength
po	B-route
qdaily	B-frequency

Examination	O
of	O
thyroid	O
:	O
Normal	B-labvalue
.	O

He	O
had	O
a	O
workup	O
at	O
Texas	O
Children	O
'	O
s	O
Hospital	O
and	O
no	O
etiology	O
was	O
found	O
.	O

4	I-reference_range
Sodium	O
Lvl	O
140	B-labvalue
mEq	I-labvalue
/	I-labvalue
l	I-labvalue
135	B-reference_range
-	I-reference_range
145	I-reference_range
VerifiedResults	O
_	O
0	O
_	O
twCiteListControlEnda	O
VerifiedResultsSectionEnda	O
SignaturesSectionSg2StaSignatures	O

Allergies	O
Montelukast	O
Sodium	O
TABS	B-form

No	B-negation
wheezing	O
was	O
heard	O
.	O

NEUROLOGICAL	O
:	O
no	B-negation
seizures	O
.	O

Constitutional	O
:	O
no	B-negation
fever	O
,	O
not	B-negation
feeling	O
poorly	O
(	O
malaise	O
)	O
,	O
not	B-negation
feeling	O
tired	O
(	O
fatigue	O
)	O
andno	O
recent	B-temporal
weight	O
loss	O
.	O

No	B-negation
history	O
of	O
pelvic	B-bodyloc
inflammatory	O
disease	O
.	O
No	B-negation
history	O
of	O
cervical	O
surgery	O
.	O

UTP	O
-	O
Discussion	O
/	O

Hypothyroidism	O
244	O
.	O
9	O

EARS	O
,	O
NOSE	O
,	O
MOUTH	O
AND	O
THROAT	O

Examination	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

He	O
had	O
an	O
sinus	B-bodyloc
exacerbation	O
since	O
last	O
visit	O
and	O
saw	O
his	O
FP	O
who	O
gave	O
him	O
some	O
antibiotics	O
.	O

;	O
Jul	B-temporal
22	I-temporal
2013	I-temporal
8	B-temporal
:	I-temporal
56PM	I-temporal
(	O
Author	O
)	O

History	O
of	O
Male	O
Erectile	O
Disorder	O
302	O
.	O
72	O

Bowel	O
sounds	O
were	O
normal	B-labvalue
.	O

Acute	B-course
Upper	B-bodyloc
Respiratory	I-bodyloc
Infection	O
465	O
.	O
9	O

Verbal	O
consent	O
was	O
obtained	O
prior	O
to	O
the	O
procedure	O
.	O

Recent	O
and	O
remote	O
memory	O
:	O
Normal	B-labvalue
.	O

Family	O
History	O
Family	B-subject
history	O
of	O
Coronary	B-bodyloc
Artery	I-bodyloc
Disease	O
V17	O
.	O
49	O

Past	O
Medical	O
History	O
History	O
of	O
Atrial	B-bodyloc
Fibrillation	O
427	O
.	O
31	O

History	O
of	O
Osteopenia	O
733	O
.	O
90	O

assisted	O
technology	O
.	O

Otoscopic	O
examination	O
:	O
Normal	O

She	O
has	O
no	B-negation
complications	O
from	O
hypertension	O
.	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

Lymphatic	O

Maxalt	O
10	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
Every	B-frequency
twelve	I-frequency
hours	I-frequency
PRN	B-frequency
headache	O
;	O
Therapy	O
:	O
06Dec2012	B-temporal
to	O
(	O
Evaluate	O
:	O
21Dec2012	B-temporal
)	O
;	O
Last	O
Rx	O
:	O
06Dec2012	B-temporal

Ears	O
,	O
Nose	O
,	O
Mouth	O
,	O
and	O
Throat	O

Percussion	O
of	O
chest	O
:	O
Normal	B-labvalue
.	O

Risks	O
:	O
increased	B-course
risk	O
for	O
falling	O
.	O

Mean	O
Cell	O
Volume	O
90	B-labvalue
.	I-labvalue
9	I-labvalue
fL	I-labvalue
81	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
99	I-reference_range
.	I-reference_range
0	I-reference_range

Gynecological	O
Problems	O
.	O

For	O
f	O
/	O
u	O
after	O
post	O
tx	O
CTsinus	O
;	O
pan	B-bodyloc
sinus	I-bodyloc
opacification	O
.	O

Cardiovascular	O

Physical	O
Exam	O

6	O
.	O

Test	O
Name	O
Result	O
Flag	O
Reference	O

(	O
Medical	O
Transcription	O
Sample	O
Report	O
)	O

Appropriate	B-labvalue
gait	O
and	O
station	O
upon	O
examination	O
.	O

Dulera	O
100	B-strength
-	I-strength
5	I-strength
MCG	I-strength
/	I-strength
ACT	I-strength
Inhalation	B-route
Aerosol	B-form
;	O
INHALE	B-route
2	B-dosage
PUFFS	B-form
TWICE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
31Oct2013	B-temporal
)	O
to	O

Pertinent	O
medical	O
history	O
:	O
no	O
head	O
trauma	O
and	O
no	B-negation
cyclic	O
Vomiting	O
.	O

The	O
patient	O
has	O
been	O
discharged	O
on	O
NeoSure	O
and	O
expressed	O
breast	O
milk	O
.	O

Nasal	B-bodyloc
congestion	O
:	O
Severe	B-severity

Hematologic	O
/	O
Lymphatic	O
:	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
,	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
and	O
no	B-negation
swollen	O
glands	B-bodyloc
.	O

Marital	O
History	O
-	O
Currently	O
Married	O

[	O
QLH	O
]	O
HEMOGLOBIN	O
A1c	O
Requested	O
for	O
:	O
04Apr2014	B-temporal

Dorsalis	O
pedis	O
:	O
right	O
2	O
+	O
and	O
left	O
2	O
+	O
.	O

MAXIMUM	O
4	O
TABLETS	O
DAILY	O
;	O
Therapy	O
:	O
27Feb2007	B-temporal
to	O
(	O
Evaluate	O
:	O
17Feb2013	B-temporal
)	O

Sample	O
Type	O
/	O
Medical	O
Specialty	O
:	O
General	O
Medicine	O

Physical	O
Exam	O

She	O
would	O
get	O
yearly	O
CT	O
scan	O
to	O
check	O
stablity	O
.	O

Resp	O
:	O
no	B-negation
cough	O
,	O
no	B-negation
wheezing	O
,	O
not	B-negation
feeling	O
short	O
of	O
breath	O
,	O
no	B-negation
painful	O
inspirations	O
were	O
observed	O
,	O
no	B-negation
snoring	O
and	O
no	B-negation
tightness	O
due	O
to	O
taking	O
a	O
breath	O
.	O

Marital	O
History	O
-	O
Currently	O
Married	O

Results	O
/	O
Results	O
/	O
Data	O
[	O
QLH	O
]	O
Hemoglobin	O
and	O
Hematocrit	O
06Dec2012	B-temporal
11	B-temporal
:	I-temporal
16AM	I-temporal
INGRAM	O
,	O
JELANI	O

Due	O
For	O
:	O
a	O
hemoglobin	O
A1C	O
.	O

Family	B-subject
history	O
of	O
Heart	B-bodyloc
Disease	O
V17	O
.	O
49	O

Pt	O
did	O
not	O
want	O
to	O
stay	O
for	O
testing	O
today	B-temporal
and	O
will	O
make	O
future	O
appt	O
for	O
STI	O
screening	O
.	O

Presents	O
for	O
colpo	O
and	O
BTL	O
scheduling	O
.	O

Loratadine	O
10	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
31Oct2013	B-temporal
)	O
to	O

Orientation	O
to	O
person	O
,	O
place	O
,	O
and	O
time	O
:	O
Normal	B-labvalue
.	O

This	O
was	O
done	O
and	O
did	O
not	O
really	O
show	O
what	O
the	O
cecum	O
on	O
the	O
barium	O
enema	O
.	O

-	O
Fallopian	B-bodyloc
tube	I-bodyloc
with	O
no	B-negation
pathologic	O
abnormalities	O
.	O

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

Probable	B-uncertain
early	O
RR	O
MS	O
,	O
currently	O
stable	B-course
.	O

Sensory	O
:	O
no	B-negation
sensory	O
abnormalities	O
were	O
noted	O
.	O

[	O
QLH	O
]	O
HEMOGLOBIN	O
A1c	O
Done	O
:	O
25Sep2013	B-temporal
12	B-temporal
:	I-temporal
14PM	I-temporal

Imuran	O
50	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
20Feb2013	B-temporal
)	O
to	O

XR	O
KNEE	O
1	O
OR	O
2	O
VWS	O
RIGHT	O
:	O
Images	O
acquired	O
,	O
not	O
reported	O
on	O
this	O
accession	O
number	O
.	O

Pantoprazole	O
Sodium	O
40	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
Delayed	I-form
Release	I-form
;	O
TAKE	O
ONE	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
EVERY	B-frequency
DAY	I-frequency
;	O
Therapy	O
:	O
21Mar2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
21Mar2013	B-temporal
)	O
Requested	O
for	O
:	O
21Mar2013	B-temporal
;	O
Edited	O

The	O
abdomen	O
was	O
soft	O
and	O
nontender	O
.	O

Patient	O
is	O
58	O
yo	O
male	O
with	O
history	O
of	O
DM	O
type	O
I	O
,	O
HLD	O
,	O
HTN	O
,	O
homocysteinemia	O
,	O
PVD	O
s	O
/	O
p	O
bilateral	O
femoral	O
stents	O
who	O
presents	O
for	O
follow	O
up	O
.	O

Psychiatric	O

The	O
heart	O
rate	O
was	O
normal	B-labvalue
.	O

Advance	O
Directives	O

The	O
patient	O
is	O
being	O
seen	O
for	O
a	O
routine	O
clinic	O
follow	O
-	O
up	O
.	O

Vitals	O
UTP	O
Adult	O
Vital	O
Signs	O
[	O
Data	O
Includes	O
:	O
Current	O
Encounter	O
]	O
18Mar2014	B-temporal
09	B-temporal
:	I-temporal
06AM	I-temporal
Systolic	O
:	O
177	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
:	O
79	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Heart	O
Rate	O
:	O
77	B-labvalue
,	O
L	O
Radial	O
Pulse	O
Quality	O
:	O
Normal	B-labvalue
,	O
L	O
Radial	O

Apr	B-temporal
4	I-temporal
2012	I-temporal
10	B-temporal
:	I-temporal
13AM	I-temporal
(	O
Author	O
)	O

HOSPITAL	O
COURSE	O
:	O
This	O
is	O
a	O
53	O
-	O
year	O
-	O
old	O
African	O
American	O
male	O
patient	O
of	O
Dr	O
.	O
X	O
who	O
was	O
admitted	O
through	O
the	O
emergency	O
room	O
.	O

Socirl	O
History	O

Denied	O

HEENT	O
:	O
oropharynx	O
benign	O
,	O

EHL	O
,	O
FHL	O
are	O
5	B-labvalue
/	I-labvalue
5	I-labvalue
.	O

Associated	O
symptoms	O
:	O
edema	O
,	O
but	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
claudication	O
,	O
no	B-negation
near	O
syncope	O
,	O
no	B-negation
syncope	O
,	O
no	B-negation
weakness	O
and	O
no	B-negation
paresthesias	O
.	O

1	O
)	O
T2DM	O
:	O
H	O
/	O
o	O
of	O
A1DM	O
and	O
A2DM	O
in	O
prior	O
pregnancies	O
.	O

History	O
of	O
Chronic	B-course
Reflux	O
Esophagitis	O
530	O
.	O
11	O

Assessment	O
Contusion	O
With	O
Intact	O
Skin	B-bodyloc
Surface	O
924	O
.	O
9	O

Genitourinary	O
:	O
no	B-negation
urinary	O
incontinence	O
.	O

Meningo	O
(	O
Menactra	O
)	O
;	O
26	B-temporal
Jun	I-temporal
2008	I-temporal

Tenderness	O
:	O
deltoidandsubacromial	O
bursa	O
.	O

I	O
have	O
discussed	O
the	O
case	O
with	O
the	O
resident	O
and	O
agree	O
with	O
the	O
diagnosis	O
and	O
plan	O
.	O

Cervix	O
:	O
Normal	O
.	O

Overall	O
,	O
her	O
symptoms	O
have	O
improved	B-course
.	O

The	O
patient	O
states	O
he	O
has	O
been	O
doing	O
well	O
with	O
his	O
Type	O
II	O
Diabetes	O
control	O
since	O
the	B-temporal
last	I-temporal
visit	I-temporal
.	O

Cardiovascular	O
:	O
no	B-negation
palpitations	O
.	O

Cardiovascular	O

CARDIOVASCULAR	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
and	O
not	B-negation
expressed	O
as	O
feeling	O
short	O
of	O
breath	O
.	O

Reports	O
orthopnea	O
and	O
back	B-bodyloc
pain	O
.	O

Unobstructed	O

Endocrine	O
:	O
no	B-negation
proptosis	O
,	O
no	B-negation
hot	O
flashes	O
,	O
no	B-negation
muscle	B-bodyloc
weakness	O
,	O
no	B-negation
deepening	O
of	O
the	O
voice	O
and	O
no	B-negation
feelings	O
of	O
weakness	O
.	O

Both	O
cornea	O
were	O
normal	O
in	O
appearance	O
.	O

No	B-negation
enlarged	O
nodes	B-bodyloc
.	O

Description	O
of	O
patient	O
'	O
s	O
judgement	O
and	O
insight	O
:	O
Normal	B-labvalue
.	O

Palpation	O
of	O
breasts	O
and	O
axillae	O
:	O
Normal	B-labvalue
,	O
no	B-negation
masses	O
palpated	O
.	O

Medications	O
:	O
Medication	O
(	O
s	O
)	O
:	O
a	O
statin	O
.	O

He	O
had	O
declined	O
thyroid	O
USG	O
several	O
times	O
in	O
the	O
past	O

Social	O
History	O
Being	O
A	O
Social	O
Drinker	O

Vitamin	O
C	O
1000	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
19Aug2013	B-temporal
)	O
to	O

Integumentary	O
:	O
no	B-negation
skin	B-bodyloc
lesions	O
.	O

;	O
Oct	B-temporal
7	I-temporal
2013	I-temporal
11	B-temporal
:	I-temporal
40PM	I-temporal
(	O
Author	O
)	O

Height	O
:	O
5	B-labvalue
ft	I-labvalue
3	I-labvalue
in	I-labvalue

Respiratory	O
:	O
cough	O
,	O
but	O
no	O
shortness	O
of	O
breathand	O
no	B-negation
wheezing	O
.	O

Patient	O
Specific	O
Education	O
Given	O
Done	O
:	O
12Apr2014	B-temporal

[	O
H	O
]	O
Obstetrics	O
Panel	O
(	O
includes	O
CBCw	O
/	O
Diff	O
,	O
RPR	O
,	O
HbsAg	O
,	O
RubIgG	O
,	O
Type	O
&	O
Screen	O
)	O
Done	O
:	O
08May2013	B-temporal

Cardiovascular	O

No	B-negation
bronchial	O
breath	O
sounds	O
were	O
heard	O
.	O

CSF	O
had	O
increased	B-labvalue
IgG	O
Index	O
and	O
one	B-labvalue
oligoclonal	O
band	O
.	O

Maternal	B-subject
aunt	I-subject
'	I-subject
s	I-subject
history	O
of	O
Alzheimer	O
Disease	O

Test	O
Name	O
Result	O
Flag	O
Reference	O

She	O
had	O
a	O
healthy	O
9	O
lb	O
female	O
who	O
is	O
bottle	O
fed	O
.	O

No	B-negation
masses	O
palpated	O
.	O

Endocrine	O
:	O
muscle	B-bodyloc
weakness	O
.	O

Counseling	O
/	O
Counseling	O
/	O
Edu	O
The	O
patient	O
was	O
counseled	O
regarding	O
instructions	O
for	O
management	O
,	O
patient	O
and	O
family	O
education	O
and	O
importance	O
of	O
compliance	O
with	O
treatment	O
.	O

Saline	O
irrigation	O

Family	O
History	O
Paternal	O
history	O
of	O
CABG	O
(	O
CABG	O
)	O

THE	O
PATIENT	O
DID	O
NOT	B-negation
HAVE	I-negation
ANY	O
RADICULAR	O
PAIN	O
.	O

Currently	O
,	O
the	O
condition	O
is	O
moderate	O
in	O
severity	O
and	O
worsening	O
.	O

GLUCOSE	O
:	O
NEG	B-labvalue

Cranial	O
nerves	O
VII	O
:	O
facial	O
strength	O
was	O
intact	B-labvalue
bilaterally	I-labvalue
.	O

Valsartan	O
-	O
Hydrochlorothiazide	O
160	B-strength
-	I-strength
25	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
31Oct2013	B-temporal
to	O
(	O
Evaluate	O
:	O
30Dec2013	B-temporal
)	O
;	O
Last	O
Rx	O
:	O
31Oct2013	B-temporal

6700	O
West	O
Loop	O
South	O
,	O
Suite	O
450	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
LaVone	O
Smith	O
,	O
M	O
.	O
D	O
.	O

Hou	O
ton	O
,	O
Texas	O
77079	O
Family	B-subject
Hi	O
tory	O
:	O
Liver	B-bodyloc
trouble	O
and	O
lupus	O
.	O

Past	O
Medical	O
History	O
History	O
of	O
Dysthymic	O
Disorder	O
V11	O
.	O
2	O

Dilation	O
and	O
curettage	O
performed	O
.	O

GASTROINTESTINAL	O
:	O
Abdomen	O
is	O
normal	O
and	O
nontender	O
.	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Eyes	O
:	O
normal	O
.	O

Palpation	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
Normal	B-labvalue

This	O
is	O
a	O
cortisone	O
that	O
the	O
patient	O
will	O
take	O
for	O
13	B-duration
days	I-duration
.	O

I	O
have	O
personally	O
interviewed	O
the	O
patient	O
with	O
the	O
resident	O
and	O
I	O
agree	O
with	O
the	O
assessment	O
and	O
plan	O
as	O
delineated	O
in	O
the	O
note	O
above	O
.	O

History	O
of	O
Present	O
Illness	O
:	O

;	O
Nov	B-temporal
16	I-temporal
2012	I-temporal
8	B-temporal
:	I-temporal
48AM	I-temporal

ebody	O

[	O
QLH	O
]	O
HEMOGLOBIN	O
A1c	O

HEENT	O
:	O
no	B-negation
epistaxis	O
,	O
no	B-negation
cervicalgia	O

Psychiatric	O

Respiratory	O
:	O
wheezing	O
and	O
cough	O
,	O
but	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
shortness	O
of	O
breath	O
during	O
exertion	O
,	O
no	B-negation
orthopnea	O
and	O
no	B-negation
PND	O
.	O

Inspection	O
/	O
palpation	O
of	O
joints	O
,	O
bones	O
,	O
and	O
muscles	O
:	O
Normal	B-labvalue
.	O

Musculoskeletal	O
:	O
no	B-negation
arthralgias	O
,	O
no	B-negation
joint	B-bodyloc
pain	O
,	O
no	B-negation
joint	B-bodyloc
swelling	O
,	O
no	B-negation
joint	B-bodyloc
stiffness	O
,	O
no	B-negation
limb	B-bodyloc
pain	O
and	O
no	B-negation
limb	B-bodyloc
swelling	O
.	O

LEUKOCYTES	O
NEG	B-labvalue

History	O
of	O
Oophorectomy	O
V88	O
.	O
01	O

Cranial	O
Nerves	O
:	O

Genitourinary	O
:	O
no	B-negation
dysuria	O
,	O
no	B-negation
incontinence	O
,	O
no	B-negation
pelvic	B-bodyloc
pain	O
,	O
no	B-negation
dysmenorrhea	O
,	O
no	B-negation
vaginal	O
discharge	O
and	O
no	B-negation
unexplained	O
vaginal	B-bodyloc
bleeding	O
.	O

Examination	O
of	O
the	O
anus	O
,	O
perineum	O
and	O
rectum	O
:	O
Normal	B-labvalue
.	O

No	O
changes	O
in	O
management	O
were	O
made	O
at	O
the	O
last	O
visit	O
.	O

Right	O
Interossei	O
(	O
unl	O
.	O
)	O
:	O
Normal	O
.	O

f	O
Essential	O
Hypertension	O
(	O
401	O
.	O
9	O
)	O
;	O
(	O
Active	O
)	O

Symptoms	O
:	O
Denies	B-negation
numbness	O
of	O
the	O
feet	B-bodyloc
,	O
denies	B-negation
a	O
foot	B-bodyloc
ulcer	O
,	O
denies	B-negation
foot	B-bodyloc
pain	O
,	O
denies	B-negation
vomiting	O
and	O
denies	B-negation
visual	O
impairment	O
.	O

No	B-negation
wheezing	O
was	O
heard	O
.	O

UTP	O
-	O
Headache	O
,	O

Results	O
/	O
Assessment	O
Colonic	B-bodyloc
Diverticulosis	O
562	O
.	O
10	O

3	O
.	O

Pa	O
irt	O
s	O
with	O
extremrs	O
in	O
muscle	B-bodyloc
mass	O
or	O
diet	O
.	O

Current	O
Meds	O
Aspirin	O
Adult	O
Low	O
Strength	O
81	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
Chewable	I-form
;	O
Therapy	O
:	O
24Nov2012	B-temporal
to	O

Ordered	O
Lisiopril	O
5mg	B-strength
po	B-route
qday	B-frequency
for	O
HTN	O

He	O
is	O
currently	B-temporal
on	O
insulin	O
pump	B-form
.	O

Constitutional	O
:	O
no	B-negation
fever	O
.	O

Maxillary	B-bodyloc
sinuses	I-bodyloc
:	O
tender	O
to	O
palpation	O
on	O
the	O
left	O
,	O
but	O
non	O
-	O
tender	O
on	O
the	O
right	O
.	O

BuPROPion	O
HCl	O
ER	O
(	O
XL	O
)	O
300	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
Extended	I-form
Release	I-form
24	I-form
Hour	I-form
;	O
TAKE	O
ONE	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
ONE	B-frequency
TIME	I-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
28Feb2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
30Jan2014	B-temporal
)	O
Requested	O
for	O
:	O
30Jan2014	B-temporal

Helen	O
Dunnington	O
,	O
MD	O
.	O

Examination	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

Vitals	O
29Mar2013	B-temporal
08	B-temporal
:	I-temporal
20AM	I-temporal
BMI	O
Calculated	O
15	B-labvalue
.	I-labvalue
56	I-labvalue
BSA	O
Calculated	O
0	B-labvalue
.	I-labvalue
4	I-labvalue
Height	O
2	B-labvalue
ft	I-labvalue
4	I-labvalue
.	I-labvalue
74	I-labvalue
in	I-labvalue
Weight	O
18	B-labvalue
lb	I-labvalue
4	I-labvalue
.	I-labvalue
42	I-labvalue
oz	I-labvalue
Blood	O
Pressue	O
Comments	O
Unable	O
to	O
obtain	O
Temperature	O
98	B-labvalue
.	I-labvalue
5	I-labvalue
F	I-labvalue
,	O
Tympanic	O

Hypothyroidism	O
244	O
.	O
9	O

Cranial	O
nerves	O
:	O
Normal	O
.	O

External	O
inspection	O
of	O
ears	O
and	O
nose	O
:	O
Normal	B-labvalue
.	O

XRAY	O
Shoulder	O
series	O
73030	O
Requested	O
for	O
:	O
20Feb2013	B-temporal

[	O
QLH	O
]	O
FERRITIN	O
Requested	O
for	O
:	O
25Feb2014	B-temporal

Head	O
and	O
Face	O

Active	O
Problems	O
Abnormal	O
Electrocardiogram	O
794	O
.	O
31	O

Abdominal	O
aorta	O
:	O
Normal	O
.	O

Health	O
Management	O

Review	O
of	O
Systems	O

Quest	O
Diagnostics	O
Nichols	O
Institute	O

Maternal	B-subject
history	O
of	O
Arthritis	O
V17	O
.	O
7	O

Disp	O
:	O
*	O
40	O
Tablet	O
(	O
s	O
)	O
*	O
Refills	O
:	O
*	O
0	O
*	O
6	O
.	O

History	O
of	O
Drug	O
Use	O

He	O
also	O
denies	B-negation
back	B-bodyloc
pain	O
which	O
he	O
complained	O
of	O
at	O
last	O
visit	O
.	O

pt	O
feve	O
ish	O
osday	O
,	O
temp	O
99	B-labvalue
.	I-labvalue
5	I-labvalue
f	O
/	O
u	O
on	O
CHF	O
note	O
completed	O
and	O
scdnned	O
into	O
chart	O
for	O
detailsMBedk	O
RNMSN	O
Electronidally	O
signed	O
by	O
:	O
Maureen	O
Bedk	O
GNP	O
-	O
BC	O
Feb	B-temporal
11	I-temporal
2013	I-temporal
5	B-temporal
:	I-temporal
53PM	I-temporal
CST	O

Delivered	O
:	O
2010	O
.	O

Cranial	O
Nerve	O
XI	O
:	O
shoulder	O
shrug	O
was	O
intact	B-labvalue
bilaterally	I-labvalue
.	O

Home	O
monitoring	O
:	O
The	O
patient	O
checks	O
his	O
blood	O
sugars	O
regularly	O
.	O
Glycemic	O
control	O
has	O
been	O
good	O
.	O
The	O
patient	O
reports	O
no	B-negation
symptomatic	O
hypoglycemic	O
epsidodes	O
.	O
BG	O
:	O
92	B-labvalue
-	I-labvalue
110	I-labvalue
.	O

Levothyroxine	O
Sodium	O
50	B-strength
MCG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
ONE	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
ONE	B-frequency
TIME	I-frequency
DAILY	I-frequency
;	O

He	O
was	O
neither	B-negation
prediabetic	O
nor	B-negation
has	O
diabetes	O
.	O

I	O
have	O
personally	O
reviewed	O
:	O
resident	O
note	O
,	O
current	O
lab	O
results	O
and	O
radiology	O
results	O
.	O

I	O
agree	O
with	O
all	O
components	O
of	O
the	O
exam	O
.	O

Pt	O
is	O
here	O
for	O
f	O
/	O
u	O
-	O
meds	O

Pertinent	O
medical	O
history	O
:	O
diabetesanddyslipidemia	O
,	O
but	O
no	B-negation
retinopathy	O
and	O
no	B-negation
angina	O
.	O

HOSPITAL	O
COURSE	O
:	O
The	O
patient	O
was	O
admitted	O
and	O
consented	O
for	O
operation	O
,	O
and	O
taken	O
to	O
the	O
operating	O
room	O
for	O
open	O
reduction	O
and	O
internal	O
fixation	O
of	O
right	O
Schatzker	O
III	O
tibial	B-bodyloc
plateau	I-bodyloc
fracture	O
and	O
partial	O
medial	O
meniscectomy	O
performed	O
without	O
incidence	O
.	O

Results	O
/	O
Results	O
/	O
Data	O
XRAY	O
Chest	O
2	O
views	O
71020	O
24Mar2014	B-temporal
04	B-temporal
:	I-temporal
13PM	I-temporal
BAI	O
,	O
KRISTY	O

Skin	O
:	O
no	B-negation
change	O
in	O
skin	B-bodyloc
,	O
showed	O
no	B-negation
erythema	O
,	O
does	O
not	B-negation
show	I-negation
signs	I-negation
of	I-negation
slowing	O
healing	O
,	O
no	B-negation
rash	O
and	O
no	B-negation
itching	O
.	O

This	O
study	O
was	O
consistent	O
with	O
subacute	B-course
to	I-course
chronic	I-course
right	O
partial	O
common	O
peroneal	O
neuropathy	O
at	O
the	O
fibular	B-bodyloc
head	I-bodyloc
.	O

1	O
Influenza	O
26Oct2006	B-temporal
Td	O
/	O
DT	O
2002	B-temporal

Disturbance	O
Of	O
Gait	O
781	O
.	O
2	O

Eyes	O
:	O
no	B-negation
itching	O
of	O
the	O
eyes	B-bodyloc
.	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
and	O
no	B-negation
vomiting	O
.	O

Constitutional	O

Neurologic	O

He	O
is	O
doing	O
well	O
.	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
SCOTT	O
HUNG	O
,	O
M	O
.	O
D	O
.	O

2	O
.	O

Blood	O
pressure	O
has	O
been	O
well	O
controlled	O
at	O
home	O
,	O
denies	B-negation
elevated	B-course
blood	O
pressure	O
,	O
headaches	O
,	O
dizziness	O
,	O
visual	O
changes	O
,	O
weakness	O
,	O
numbness	O
,	O
chest	B-bodyloc
pain	O
,	O
palpitations	O
or	O
other	O
concerns	O
.	O

Flexeril	O
5	B-strength
MG	I-strength
TABS	B-form
;	O
Take	O
one	B-dosage
tab	B-form
po	B-route
TID	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
29Oct2012	B-temporal
)	O
to	O

Patient	O
requires	O
the	O
use	O
of	O
the	O
following	O
adaptive	O
skills	O
or	O
devices	O
:	O

Houstin	O
,	O
TX	O
77024	O

STEWART	O
,	O
LARISSA	O
-	O
26	B-temporal
Jul	I-temporal
2013	I-temporal
4	B-temporal
:	I-temporal
27	I-temporal
PM	I-temporal
TASK	O
IN	O
PROGRESS	O
Pharmacy	O
received	O
all	O
e	O
-	O
rx	O
but	O
they	O
wanted	O
to	O
know	O
if	O
they	O
could	O
dispense	O
sulfacetamide	O
9	B-strength
%	I-strength
and	O
sulfur	O
4	B-strength
%	I-strength
instead	O
of	O
10	B-strength
%	I-strength
/	I-strength
5	I-strength
%	I-strength
I	O
told	O
them	O
that	O
it	O
would	O
be	O
fi	O
e	O
.	O
eg	O

Doing	O
well	O
and	O
incision	O
well	O
healed	O
.	O

3	O
.	O

History	O
of	O
Present	O
Illness	O

Neurological	O
:	O
no	B-negation
confusion	O
,	O
no	B-negation
convulsions	O
,	O
no	B-negation
dizziness	O
,	O
no	B-negation
fainting	O
,	O
no	B-negation
limb	B-bodyloc
weakness	O
and	O
no	B-negation
difficulty	O
walking	O
.	O

Left	O
Foot	O
:	O
The	O
foot	O
was	O
normal	O
.	O

Examination	O
of	O
cranial	O
nerves	O
:	O
Normal	B-labvalue
.	O

Birth	O
Control	O
:	O
condoms	O
.	O

Examination	O
of	O
sensation	O
:	O
Normal	B-labvalue
.	O

Cut	O
aricept	O
to	O
half	O
,	O
husband	O
to	O
call	O
and	O
see	O
if	O
there	O
is	O
any	O
improvement	O
,	O
gait	O
and	O
balance	O
rehab	O

Respiratory	O
:	O
no	B-negation
wheezing	O
and	O
no	B-negation
cough	O
.	O

Screening	O
:	O
Cervical	O
cancer	O
screening	O
includes	O
Papanicolaou	O
cytology	O
last	B-temporal
year	I-temporal
.	O

My	O
full	O
evaluation	O
follows	O
:	O

[	O
QLH	O
]	O
CBC	O
(	O
INCLUDES	O
DIFF	O
/	O
PLT	O
)	O
Requested	O
for	O
:	O
25Feb2014	B-temporal

Signatures	O
Electronically	O
signed	O
by	O
:	O
TIFFANY	O
TRACY	O
,	O
M	O
.	O
D	O
.	O

History	O
of	O
Present	O
Illness	O

LMP	O
:	O
27Mar2013	B-temporal

Musculoskeletal	O

He	O
says	O
there	O
was	O
minimal	B-severity
bleeding	O
but	O
no	B-negation
purulent	O
drainage	O
.	O

Ambulatosy	O
Health	O
Care	O
Facilities	O
Monica	O
Olvera	O
Address	O
:	O
UNK	O

Cardiovascular	B-bodyloc

No	O
heavy	O
lifting	O
,	O
no	O
driving	O
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Hirsutism	O
704	O
.	O
1	O

Abdominrl	B-bodyloc
Pain	O
20	B-temporal
Dec	I-temporal
2011	I-temporal
(	O
789	O
.	O
00	O
)	O

Vitals	O
14Jun2013	B-temporal
08	B-temporal
:	I-temporal
46AM	I-temporal
Systolic	O
110	B-labvalue
Diastolic	O
62	B-labvalue
Temperature	O
97	B-labvalue
.	I-labvalue
4	I-labvalue
F	I-labvalue
Heart	O
Rate	O
72	B-labvalue

Surgical	O
History	O
Denied	O

Physical	O
Exam	O

You	O
may	O
shower	O
.	O

Comorbid	O
Illnesses	O
:	O
coronary	B-bodyloc
artery	I-bodyloc
disease	O
,	O
diabetes	O
mellitus	O
and	O
hypertension	O
.	O

Plan	O
US	O
Pelvic	O
with	O
Transvaginal	O
and	O
Pelvic	O
Doppler	O
Requested	O
for	O
:	O
14Jan2013	B-temporal

(	O
281	O
)	O
530	O
-	O
9768	O
(	O
Work	O
ptone	O
)	O
Patient	O
Contacts	O

If	O
she	O
tolerates	O
and	O
would	O
like	O
to	O
continue	O
on	O
OCPs	O
,	O
then	O
she	O
will	O
call	O
clinic	O
for	O
refill	O
rx	O
.	O

UTP	O
-	O
FemaleMulti	O
-	O
SystemExamCopy	O
-	O
mp1f760502	O
-	O
82e9	O
-	O
4b23	O
-	O
9c02	O
-	O
016b9e2fc8c1FormStart	O
GroupHeading1Start	O
GroupHeading1End	O
GroupHeading2Start	O
Constitutional	O
General	O
appearance	O
:	O
Normal	B-labvalue
Well	B-labvalue
developed	I-labvalue
,	O
well	B-labvalue
nourished	I-labvalue
,	O
morbidly	B-severity
obese	O
,	O
well	B-labvalue
hydrated	I-labvalue
and	O
appearance	O
reflects	O
stated	O
age	O
.	O

3	O
.	O

Examination	O
of	O
digits	O
and	O
nails	O
:	O
Normal	B-labvalue
.	O

The	O
baby	O
improved	O
with	O
diazoxide	O
,	O
hypoglycemic	O
issues	O
resolved	B-course
and	O
then	O
began	B-course
again	I-course
.	O

Nasal	B-bodyloc
obstruction	O
:	O
Mild	B-severity

Pulmonary	O

Motor	O
:	O
Normal	O
.	O

Palpation	O
of	O
the	O
face	O
and	O
sinuses	O
:	O
Normal	B-labvalue
.	O

Total	O
pregnancies	O
3	O
.	O
3	O
live	O
births	O
.	O
2	O
full	O
-	O
term	O
.	O
1	O
premature	O
delivery	O
(	O
s	O
)	O
.	O
3	O
cesarean	O
delivery	O
(	O
s	O
)	O
.	O

I	O
personally	O
spent	O
60	O
mins	O
in	O
face	O
-	O
to	O
-	O
face	O
time	O
with	O
the	O
patient	O
and	O
programming	O
,	O
observing	O
response	O
.	O

Assessment	O
of	O
hearing	O
:	O
Normal	B-labvalue
.	O

Examination	O
of	O
thyroid	O
:	O
Normal	B-labvalue
.	O

History	O
of	O
Septoplasty	O

Jugular	O
Veins	O
:	O
the	O
JVP	O
was	O
not	B-labvalue
elevated	I-labvalue
.	O
Thyroid	O
:	O
Normal	O
.	O

Medications	O
:	O
The	O
patient	O
is	O
adherent	O
with	O
her	O
medication	O
regimen	O
.	O
The	O
patient	O
complains	O
of	O
medication	O
side	O
effects	O
.	O

Active	O
Problems	O
Acute	B-course
Upper	B-bodyloc
Respiratory	I-bodyloc
Infection	O
465	O
.	O
9	O

He	O
has	O
a	O
h	O
/	O
o	O
bilateral	O
EAC	O
atresia	O
,	O
microtia	O
and	O
left	O
atresia	O
repair	O
.	O

The	O
oropharynx	O
was	O
normal	O
.	O

Review	O
of	O
Systems	O

2	O
.	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
,	O
no	B-negation
cough	O
,	O
no	B-negation
shortness	O
of	O
breath	O
during	O
exertion	O
,	O
no	B-negation
orthopnea	O
and	O
no	B-negation
PND	O
.	O

The	O
patient	O
is	O
to	O
continue	O
CPM	O
machine	O
while	O
in	O
bed	O
along	O
with	O
antiembolic	O
stockings	O
.	O

He	O
is	O
not	B-negation
circumcised	O
.	O

History	O
of	O
Depression	O
311	O

Lumbosacral	O
Spine	O
:	O
Normal	O
(	O
no	B-negation
tenderness	O
on	O
palpation	O
)	O
.	O

Results	O
/	O
Physical	O
Exam	O

Results	O
/	O
Results	O
/	O
Data	O
Physical	O
Exam	O
Cholesterol	O
Urinalysis	O
Colonoscopy	O
EGD	O
EKG	O
Stress	O
Test	O
Echo	O
Cardiac	O
Cath	O
Peripheral	O
Vascular	O
Screen	O
Carotid	O
Vascular	O
Screen	O
AAA	O
ABI	O
/	O
PVR	O
Diabetes	O
Screen	O
Other	O
Mammogram	O
PAP	O
Dexa	O
Prostate	O
/	O
PSA	O

Last	O
pap	O
result	O
was	O
normal	B-labvalue
7/19/11	B-temporal
.	O

Occupation	O
:	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
.	O

Breast	O
pumping	O
.	O

Chronic	B-course
Maxillary	B-bodyloc
Sinusitis	O
473	O
.	O
0	O
*	O
Corticosteroid	O
sensitive	O
-	O
had	O
2	O
episodes	O
of	O
hyponatremia	O
*	O

History	O
of	O
Cesarean	O
Section	O

I	O
have	O
discussed	O
the	O
case	O
with	O
the	O
resident	O
and	O
agree	O
with	O
the	O
diagnosis	O
of	O
autoimmune	O
myositis	O
.	O

not	O
recommended	O
in	O
the	O
following	O
populations	O
:	O

History	O
of	O
pneumonia	O
.	O

Patient	O
is	O
doing	O
well	O
.	O

Lipitor	O
20	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
02Jun2005	B-temporal
to	O
(	O
Evaluate	O
:	O
14Sep2012	B-temporal
)	O
Requested	O
for	O
:	O
17Sep2012	B-temporal
;	O
Last	O
Rx	O
:	O
20Sep2011	B-temporal

f	O
Prevnar	O
13	O
Intramuscular	B-route
Suspension	B-form
(	O
Lot	O
#	O
:	O
F80381	O
)	O
-	O
Administered	O
on	O
:	O
01/11/2013	B-temporal

(	O
tib	O
.	O
)	O
Strength	O
:	O
5	B-labvalue
/	I-labvalue
5	I-labvalue
.	O

Genitourinary	O
:	O
no	B-negation
dysuria	O
,	O
no	B-negation
urinary	O
frequency	O
,	O
no	B-negation
incontinence	O
,	O
no	B-negation
itching	O
or	O
burning	O
,	O
no	B-negation
urinary	O
hesitancy	O
,	O
no	B-negation
pelvic	B-bodyloc
pain	O
,	O
no	B-negation
dysmenorrhea	O
,	O
no	B-negation
nocturia	O
,	O
no	B-negation
vaginal	O
discharge	O
and	O
no	B-negation
unexplained	O
vaginal	B-bodyloc
bleeding	O
.	O

Examination	O
of	O
liver	O
and	O
spleen	O
:	O
Normal	B-labvalue
.	O

Respiration	O
:	O
18	B-labvalue

CurrentMeds	O
_	O
4	O
_	O
twCiteListControlEnd	O
CurrentMedsSectispEnd	O
ImmunizatispsSectispStart	O
Immunizatisps	O

She	O
was	O
instructed	O
to	O
follow	O
up	O
in	O
the	O
surgical	O
office	O
within	O
one	O
week	O
after	O
discharge	O
.	O

Facial	B-bodyloc
or	O
sinus	B-bodyloc
pain	O
:	O
None	B-negation

Social	O
History	O
Alcohol	O
Use	O

Overweight	O
LM	O
.	O

Alcohol	O

1	O
.	O

Electronically	O
signed	O
by	O
:	O
AMBER	O
ZULFIQAR	O
,	O
M	O
.	O
D	O
.	O

Left	O
Adduct	O
.	O

Surgical	O
History	O
History	O
of	O
Adenoidectomy	O

Maternal	B-subject
grandmother	I-subject
'	I-subject
s	I-subject
history	O
of	O
Type	O
2	O
Diabetes	O
Mellitus	O

Discussed	O
importance	O
of	O
compliance	O
and	O
finger	O
sticks	O
,	O
as	O
well	O
as	O
bringing	O
logs	O
to	O
clinic	O
appt	O
.	O

Once	O
her	O
phase	O
1	O
has	O
been	O
scheduled	O
she	O
is	O
to	O
call	O
my	O
office	O
to	O
schedule	O
the	O
appointment	O
for	O
one	O
week	O
later	O
to	O
go	O
over	O
the	O
findings	O
preferably	O
with	O
a	O
family	O
member	O
present	O
as	O
well	O
.	O

Since	O
her	O
last	O
appointment	O
,	O
she	O
has	O
been	O
doing	O
well	O
.	O

Palpation	O
of	O
breasts	O
and	O
axillae	O
:	O
Normal	B-labvalue

Neurological	O
:	O
alert	O
,	O
but	O
no	B-negation
dizziness	O
,	O
no	B-negation
fainting	O
and	O
no	B-negation
tingling	O
.	O

Examination	O
of	O
the	O
abdomen	O
:	O
Normal	B-labvalue
The	O
abdomen	O
was	O
flat	O
.	O

Family	B-subject
history	O
of	O
Heart	B-bodyloc
Disease	O
V17	O
.	O
49	O

Allergies	O
Penicillins	O

IPV	O
;	O
01/07/2012	B-temporal
.	O
eg	O

Right	B-bodyloc
cornea	I-bodyloc
:	O
Exam	O
showed	O
an	O
opacity	O
.	O

Sample	O
Name	O
:	O
Toothache	O
-	O
ER	O
Visit	O

Former	O
Smoker	O
V15	O
.	O
82	O

Family	O
history	O
of	O
Stroke	O
Syndrome	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
groin	O
:	O
Normal	B-labvalue
.	O

Coordination	O
:	O
Normal	B-labvalue
.	O

Reason	O
For	O
Visit	O

Neck	O
:	O
Normal	O
.	O

Chol	O
/	O
HDL	O
Ratio	O
4	O
.	O
8	O
O	O
GLUCOSE	O
85	B-labvalue
O	O

Hx	O
of	O
abnormal	O
PAP	O
(	O
LSIL	O
)	O
s	O
/	O
p	O
colpo	O
.	O

Examination	O
of	O
the	O
abdomen	O
:	O
Normal	B-labvalue

Upper	O
Extremities	O
:	O

Symptoms	O
:	O
Stable	B-course
memory	O
impairment	O
,	O
denies	B-negation
agitation	O
,	O
denies	B-negation
aggression	O
,	O
denies	B-negation
depression	O
,	O
denies	O
sleep	O
disturbancesanddenies	O
wandering	O
.	O

Coordination	O
:	O
Normal	B-labvalue
.	O

Family	O
History	O
1	O
.	O

Platelet	O
:	O
586	B-labvalue
K	I-labvalue
/	I-labvalue
CMM	I-labvalue
Abnormal	O
High	O
Reference	O
Range	O
133	B-reference_range
-	I-reference_range
450	I-reference_range

I	O
have	O
discussed	O
the	O
case	O
with	O
the	O
resident	O
and	O
agree	O
with	O
the	O
diagnosis	O
and	O
plan	O
.	O

Attending	O
Note	O

Examination	O
of	O
digits	O
and	O
nails	O
:	O
Normal	B-labvalue
.	O

Plan	O
Nasonex	O
50	B-strength
MCG	I-strength
/	I-strength
ACT	I-strength
Nasal	B-route
Suspension	B-form
;	O
USE	O
2	B-dosage
SPRAYS	B-form
IN	O
EACH	B-route
NOSTRIL	I-route
ONCE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
27Aug2012	B-temporal
to	O
(	O
Evaluate	O
:	O
26Oct2012	B-temporal
)	O
Requested	O
for	O
:	O
27Aug2012	B-temporal
;	O
Last	O
Rx	O
:	O
27Aug2012	B-temporal
;	O

Cervix	O
:	O
Normal	O

General	O
appearance	O
:	O
Normal	B-labvalue
.	O

Requ0sted	O
patient	O
schedule	O
f	O
/	O
u	O
visit	O
in	O
3	B-temporal
weeks	I-temporal
.	O
eg	O

Test	O
Name	O
Result	O
Flag	O
Reference	O

Pulmonary	O
:	O
no	B-negation
respiratory	O
distress	O
,	O
normal	B-labvalue
respiratory	O
rhythm	O
and	O
effort	O
and	O
bilateral	O
breath	O
sounds	O
clear	B-labvalue
to	O
auscultation	O
.	O

Patient	O
instructed	O
to	O
avoid	O
strenuous	O
activity	O
for	O
3	O
day	O
(	O
s	O
)	O
.	O

Lymphatic	O

Marital	O
History	O
-	O
Single	O

Inspection	O
of	O
breasts	O
:	O
Normal	B-labvalue
.	O

Musc	O
:	O
no	B-negation
joint	B-bodyloc
swelling	O
,	O
no	B-negation
joint	B-bodyloc
pain	O
and	O
no	B-negation
soft	B-bodyloc
tissue	I-bodyloc
swelling	O
.	O

Integumentary	O
:	O
no	B-negation
breast	B-bodyloc
pain	O
,	O
no	B-negation
breast	B-bodyloc
mass	O
,	O
no	B-negation
changes	O
in	O
mole	B-bodyloc
(	O
s	O
)	O
,	O
no	B-negation
rash	O
,	O
no	B-negation
itching	O
.	O

Inspection	O
of	O
lips	O
,	O
teethand	O
gums	O
:	O
Abnormal	O
.	O
No	B-negation
misslalignment	O
,	O
missing	O
teeth	O
,	O
healing	O
laceration	O
of	O
the	O
left	B-bodyloc
lower	I-bodyloc
lip	I-bodyloc
noted	O
,	O
stures	O
intact	O
,	O
no	B-negation
bleeding	O
,	O
no	B-negation
discharge	O
,	O
no	B-negation
oozing	O
,	O
no	B-negation
cellulitis	O
.	O

Social	O
History	O

Under	O
the	O
primary	O
care	O
exception	O
I	O
did	O
not	O
personally	O
interview	O
or	O
examine	O
the	O
patient	O
.	O

Head	O
CT	O
showing	O
no	B-negation
evidence	I-negation
of	O
acute	O
intracranial	B-bodyloc
abnormalities	O
.	O

Family	O
History	O
Maternal	B-subject
grandmother	I-subject
'	O
s	O
history	O
of	O
Alzheimer	O
Disease	O

No	B-negation
rhonchi	O
were	O
heard	O
.	O

Examination	O
of	O
the	O
abdomen	O
:	O
Normal	B-labvalue
Diabetic	O
Foot	O
Exam	O
:	O

Pulmonary	O
no	B-negation
shortness	O
of	O
breathe	O
,	O
no	B-negation
wheezing	O
,	O
no	B-negation
cough	O

No	B-negation
wheezing	O
was	O
heard	O
.	O

Palpation	O
of	O
chest	O
:	O
Normal	B-labvalue
.	O

No	B-negation
edema	O
.	O

Second	O
pregnancy	O
:	O
.	O

The	O
lateral	O
motion	O
was	O
minimally	B-labvalue
limited	I-labvalue
,	O
The	O
patient	O
had	O
a	O
nor8rouheeltotoe	O
gait	O
.	O

Uloric	O
40	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
EVERY	B-frequency
DAY	I-frequency
;	O
Therapy	O
:	O
29Oct2012	B-temporal
to	O
(	O
Evaluate	O
:	O
21Jun2013	B-temporal
)	O
Requested	O
for	O
:	O
21Feb2013	B-temporal
;	O
Last	O
Rx	O
:	O
21Feb2013	B-temporal

Genitourinary	O
:	O
no	B-negation
dysuria	O
,	O
no	B-negation
urinary	O
frequency	O
,	O
no	B-negation
incontinence	O
and	O
no	B-negation
pelvic	B-bodyloc
pain	O
.	O

RESPIRATIONS	O
:	O
No	B-negation
shortness	O
of	O
breath	O
or	O
cough	O
.	O

6	O
)	O
RTC	O
3	O
week	O
.	O

Axillary	O
lymph	O
nodes	O
are	O
nontender	O
and	O
appropriate	O
in	O
size	O

She	O
states	O
she	O
has	O
had	O
this	O
lesion	O
for	O
about	O
2	B-temporal
years	I-temporal
and	O
has	O
tried	O
OTC	O
preparations	O
without	B-negation
resolution	I-negation
of	I-negation
wart	O
.	O

Patient	O
agrees	O
to	O
proceed	O
.	O

Normal	O
appearance	O
for	O
chronological	O
age	O
,	O
does	O
not	B-negation
appear	O
chronically	O
ill	O
.	O

;	O
Oct	B-temporal
18	I-temporal
2012	I-temporal
2	B-temporal
:	I-temporal
57PM	I-temporal
(	O
Co	O
-	O
author	O
)	O

GENERAL	O
:	O
She	O
is	O
a	O
very	O
obtunded	O
female	O
who	O
upon	O
arousal	O
is	O
not	O
able	O
to	O
provide	O
any	O
information	O
of	O
any	O
use	O
.	O

4	O
.	O

I	O
personally	O
examined	O
the	O
patient	O
with	O
the	O
resident	O
,	O
I	O
was	O
present	O
for	O
all	O
of	O
the	O
exam	O

Eye	O
Lids	O
:	O
.	O

Cardiovascular	O

Dymista	O
137	B-strength
-	I-strength
50	I-strength
MCG	I-strength
/	I-strength
ACT	I-strength
Nasal	B-route
Suspension	B-form
;	I-form
INSTILL	I-form
1	B-dosage
SQUIRT	B-form
TWICE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
16Nov2012	B-temporal
to	O
(	O
Evaluate	O
:	O
14Jun2013	B-temporal
)	O
;	O
Last	O
Rx	O
:	O
16Nov2012	B-temporal

Examination	O
of	O
sensation	O
:	O
Normal	B-labvalue
.	O

Personai	O
Hx	O
g5	O

Interpretation	O
/	O
Result	O
SEE	O
NOTE	O

Family	O
History	O
Family	B-subject
history	O
of	O
Heart	B-bodyloc
Disease	O
V17	O
.	O
49	O

Attending	O
Note	O

Genitourinary	O
:	O
no	B-negation
dysuria	O
,	O
no	B-negation
pelvic	B-bodyloc
pain	O
and	O
no	B-negation
vaginal	B-bodyloc
discharge	O
.	O

Vitamin	O
B	O
-	O
12	O
1000	B-strength
MCG	I-strength
Sublingual	B-route
Tablet	B-form
Sublingual	B-route
;	O
TAKE	O
AS	O
DIRECTED	O
;	O
Therapy	O
:	O
27Jun2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
27Jun2013	B-temporal
)	O

Surrounding	O
Tissue	O
:	O
non	O
-	O
erythematous	O
,	O
normal	O
temperature	O
,	O
non	O
-	O
tender	O
,	O
not	B-negation
indurated	O
,	O
not	B-negation
fluctuant	O
.	O

General	O
Appearance	O
:	O
Normal	B-labvalue
.	O

She	O
does	O
not	O
get	O
any	O
regular	O
exercise	O
.	O

Medication	O
(	O
s	O
)	O
:	O
Metformin	O
HClandSulfonylurea	O
.	O

Segs	O
-	O
Bands	O
#	O
:	O
5	B-labvalue
.	I-labvalue
8	I-labvalue
K	I-labvalue
/	I-labvalue
CMM	I-labvalue
Reference	O
Range	O
1	B-reference_range
.	I-reference_range
5	I-reference_range
-	I-reference_range
8	I-reference_range
.	I-reference_range
1	I-reference_range

Timely	O
and	O
accurate	O
insulin	O
bolusing	O
reiterated	O

Cardiovascular	O

Assessment	O
of	O
range	O
of	O
motion	O
:	O
Normal	B-labvalue
.	O

Mometasone	O
Furoate	O
0	B-strength
.	I-strength
1	I-strength
%	I-strength
External	O
Cream	B-form
;	O
APPLY	O
SPARINGLY	O
TO	O
AFFECTED	O
AREAS	O
TWICE	B-frequency
DAILY	I-frequency
.	I-frequency
(	I-frequency
AM	I-frequency
AND	I-frequency
PM	I-frequency
)	I-frequency
;	O
Therapy	O
:	O
24Oct2012	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
24Oct2012	B-temporal
)	O

She	O
will	O
continue	O
to	O
inject	B-form
Copaxone	O
as	O
prescribed	O
.	O

No	B-negation
facial	B-bodyloc
skin	I-bodyloc
lesions	O
.	O

Losartan	O
Potassium	O
100	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
ONCE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
29Oct2012	B-temporal
to	O
(	O
Evaluate	O
:	O
02Feb2014	B-temporal
)	O
Requested	O
for	O
:	O
21Nov2013	B-temporal
;	O
Last	O
Rx	O
:	O
04Nov2013	B-temporal

Please	O
review	O
the	O
New	O
Patient	O
Hi	O
tory	O
check	O
sheet	O
for	O
the	O
coEnlete	O
Review	O
of	O
Sy	O
tems	O
and	O
Past	O
Family	O
and	O
Social	O
Hi	O
tories	O
.	O

Paternal	B-subject
history	O
of	O
Diabetes	O
Mellitus	O
V18	O
.	O
0	O

Follow	O
-	O
up	O
PRN	O
Outpatient	O
Follow	O
-	O
up	O
Done	O
:	O
18Oct2012	B-temporal
02	B-temporal
:	I-temporal
58PM	I-temporal
proceed	O
with	O
IG	O
-	O
ESS	O
on	O
the	O
right	O

The	O
data	O
above	O
are	O
ob	O
ained	O
from	O
the	O
National	O
Kidney	O
Disease	O
Education	O
Program	O

External	O
inspection	O
of	O
ears	O
and	O
nose	O
:	O
Normal	B-labvalue

Examination	O
of	O
the	O
head	O
and	O
face	O
:	O
Normal	B-labvalue
.	O

Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

The	O
heart	O
rate	O
was	O
normal	B-labvalue
.	O

Vitals	O
21Mar2013	B-temporal
09	B-temporal
:	I-temporal
07AM	I-temporal
BMI	O
Calculated	O
34	B-labvalue
.	I-labvalue
65	I-labvalue
BSA	O
Calculated	O
2	B-labvalue
.	I-labvalue
27	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
10	I-labvalue
in	I-labvalue
Weight	O
242	B-labvalue
lb	I-labvalue
Systolic	O
140	B-labvalue
Diastolic	O
100	B-labvalue
Temperature	O
97	B-labvalue
F	I-labvalue

General	O
Appearance	O
:	O
Normal	B-labvalue
.	O

MT	O
/	O
MM	O
:	O
Eo	O
mucin	O

Pupils	O
:	O
.	O

Immunizations	O
Influenza	O
-	O
-	O
-	O
Series1	O
:	O
08Oct2012	B-temporal

History	O
of	O
Hypertension	O
401	O
.	O
9	O

Musculoskeletal	O
:	O
no	B-negation
joint	B-bodyloc
pain	O
and	O
no	B-negation
limb	B-bodyloc
pain	O
.	O

Social	O
History	O
Never	O
A	O
Smoker	O

twNoteSignatureControlEnd	O
SignaturesSectionEnd	O

Continue	O
NPH	O
25	B-strength
qam	B-frequency
,	O
Regular	O
10	O
with	O
dinner	O
.	O

OPERATIVE	O
PROCEDURES	O

Vitals	O
UTP	O
Adult	O
Vital	O
Signs	O
[	O
Data	O
Includes	O
:	O
Current	O
Encounter	O
]	O

We	O
will	O
increase	O
her	O
Zonisamide	O
and	O
will	O
also	O
check	O
levels	O
today	B-temporal
of	O
her	O
dilantin	O
and	O
Zonisamide	O
.	O

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

Procedure	O

Palpation	O
of	O
cervical	O
lymph	O
nodes	O
:	O
Normal	B-labvalue
.	O

I	O
have	O
personally	O
reviewed	O
:	O
resident	O
note	O
.	O

History	O
of	O
Vertigo	O
780	O
.	O
4	O

Palpation	O
of	O
cervical	O
lymph	O
nodes	O
:	O
Normal	B-labvalue
.	O

f	O
AUDIT	O
04/05/2013	B-temporal

;	O
Mar	B-temporal
27	I-temporal
2013	I-temporal
8	B-temporal
:	I-temporal
38PM	I-temporal
(	O
Author	O
)	O

ENT	O
:	O
no	B-negation
earache	O
and	O
no	B-negation
hearing	O
loss	O
.	O

Plan	O
Mupirocin	O
2	B-strength
%	I-strength
External	B-form
Ointment	I-form
;	O
SQUIRT	O
ENTIRE	O
TUBE	O
INTO	O
NEILMED	O
,	O
FILL	O
WITHWATER	O
,	O
LET	O
SIT	O
10MIN	O
,	O
IRRIGATE	O
REPEAT	O
3XDAILY	B-frequency
;	O
Therapy	O
:	O
01Dec2011	B-temporal
to	O
(	O
Evaluate	O
:	O
31Dec2011	B-temporal
)	O
;	O
Last	O

Electronically	O
signed	O
by	O
:	O
LEE	O
BAR	O
-	O
ELI	O
,	O
M	O
.	O
D	O
.	O
;	O

Eyes	O

IPV	O
;	O
12/07/2007	B-temporal

Left	O
knee	O
:	O

Systolic	O
:	O
120	B-labvalue
,	O
RUE	O
,	O
Sitting	O

Pregnancy	O
Test	O
Negative	B-labvalue
V72	O
.	O
41	O

Examination	O
of	O
the	O
head	O
and	O
face	O
:	O
Normal	B-labvalue
.	O

Lymphatic	O

Diastolic	O
:	O
80	B-labvalue
,	O
RUE	O
,	O
Sitting	O

Temperature	O
:	O
98	B-labvalue
.	I-labvalue
5	I-labvalue
F	I-labvalue
,	O
Oral	O

Past	O
Medical	O
History	O
History	O
of	O
Blood	O
Pressure	O
Isolated	O
Elevated	O
796	O
.	O
2	O

Abdomen	O
:	O
Normal	O
.	O
CS	O
incision	O
well	O
approximated	O
,	O
no	B-negation
erythema	O
,	O
warmth	O
,	O
tenderness	O
.	O

Respiratory	O
:	O
no	B-negation
cough	O
and	O
no	B-negation
shortness	O
of	O
breath	O
during	O
exertion	O
.	O

Bactrim	O
SOLN	B-form

Assessment	O
Hyperlipidemia	O
272	O
.	O
4	O

Vitamin	O
D2	O
25	O
-	O
OH	O
<	B-labvalue
4	I-labvalue
ng	I-labvalue
/	I-labvalue
ml	I-labvalue

The	O
oral	O
mucosa	O
was	O
normal	O
.	O

External	O
inspection	O
of	O
ears	O
and	O
nose	O
:	O
Normal	B-labvalue

Constitutional	O

DR	O
.	O
MATHU	O
-	O
HE	O
AGREED	O
WITH	O
CHANGES	O
AND	O
DID	O
A	O
T	O
.	O
M	O
.	O
T	O
.	O

Associated	O
symptoms	O
include	O
no	B-negation
polyuria	O
,	O
no	B-negation
polydipsia	O
,	O
no	B-negation
recent	B-temporal
weight	O
gain	O
and	O
no	B-negation
recent	B-temporal
weight	O
loss	O
.	O

He	O
has	O
been	O
having	O
some	O
right	B-bodyloc
hip	I-bodyloc
pain	O
and	O
cough	O
.	O

8	O
.	O

Magnesium	O
TABS	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
16Sep2013	B-temporal
)	O
to	O

She	O
also	O
has	O
been	O
inconsistent	O
with	O
her	O
PNV	O
postpartum	O
.	O

Chronic	B-course
Constipation	O
564	O
.	O
00	O

Examination	O
of	O
the	O
skin	O
for	O
lesions	O
:	O
Abnormal	O
Skin	B-bodyloc
tag	O
(	O
s	O
)	O
noted	O
(	O
on	O
the	O
chest	O
)	O
.	O

HEMOGLOBIN	O
11	B-labvalue
.	I-labvalue
3	I-labvalue
g	I-labvalue
/	I-labvalue
dl	I-labvalue
L	I-labvalue
11	B-reference_range
.	I-reference_range
7	I-reference_range
-	I-reference_range
15	I-reference_range
.	I-reference_range
5	I-reference_range

2	O
.	O

Examination	O
for	O
hernias	O
:	O
Normal	B-labvalue
.	O

History	O
of	O
Gout	O

General	O
appearance	O
:	O
Abnormal	O
Healthy	O
appearing	O
,	O
not	B-negation
acutely	B-course
ill	O
,	O
not	B-negation
chronically	B-course
ill	O
,	O
not	B-negation
uncomfortable	O
,	O
clothing	O
appropriate	O
,	O
well	O
groomedandwell	O
hydrated	O
.	O

Attending	O
Note	O

Past	O
Medical	O
History	O

Hyponatremia	O
.	O

Leg	B-bodyloc
Weakness	O

Current	O
Meds	O
1	O
.	O

GroupHeading14End	O
GroupHeading15Start	O
GroupHeading15End	O
GroupHeading16Start	O
GroupHeading16End	O
GroupHeading17Start	O
GroupHeading17End	O
GroupHeading18Start	O
GroupHeading18End	O
CounselingDocumeptatiop80b073a3	O
-	O
29fe	O
-	O
4f81	O
-	O
9167	O
-	O
250822535ffdFormEnd	O
DietandExerciseConcerns168bcae2	O
-	O
802b	O
-	O
4534	O
-	O
aadc	O
-	O
dc170d927144FormStart	O
GroupHeading4Start	O
GroupHeading4End	O
GroupHeading6Start	O
Impression	O
:	O
diet	O
and	O
exercise	O
counseling	O
.	O

Family	B-subject
history	O
of	O
Asthma	O

Secretions	O
:	O
Clear	B-negation

Cranial	O
nerves	O
XI	O
:	O
shoulder	O
shrug	O
was	O
intact	O
bilaterally	O
.	O

Head	O
and	O
Face	O

Atrial	B-bodyloc
Flutter	O
427	O
.	O
32	O

Delivered	O
:	O
2006	B-temporal
.	O

Reproductive	O
health	O
:	O
the	O
patient	O
is	O
premenopausal	O
.	O

Neck	O

[	O
QLH	O
]	O
HEMOGLOBIN	O
Done	O
:	O
20Oct2010	B-temporal
09	B-temporal
:	I-temporal
10AM	I-temporal

Past	O
treatment	O
has	O
included	O
application	O
of	O
ice	O
,	O
elevation	O
and	O
nonsteroidal	O
anti	O
-	O
inflammatory	O
drugs	O
.	O

Additionally	O
,	O
the	O
patient	O
underwent	O
flexible	O
cystoscopy	O
,	O
which	O
revealed	O
no	B-negation
gross	O
strictures	O
or	O
any	O
other	O
abnormalities	O
in	O
the	O
penile	O
nor	O
prostatic	O
urethra	O
.	O

Inspection	O
of	O
the	O
nasal	O
mucosa	O
,	O
septum	O
and	O
turbinates	O
:	O
Normal	B-labvalue
.	O

Constitutional	O

The	O
rhythm	O
was	O
regular	B-labvalue
.	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
cough	O
,	O
no	B-negation
shortness	O
of	O
breath	O
during	O
exertion	O
,	O
no	B-negation
orthopnea	O
and	O
no	B-negation
PND	O
.	O

The	O
staff	O
reports	O
to	O
me	O
that	O
her	O
appetite	O
is	O
good	O
and	O
that	O
she	O
is	O
eating	O
as	O
well	O
as	O
ever	O
.	O

At	O
initial	O
visit	O
,	O
this	O
patient	O
complained	O
of	O
recurrent	O
episodes	O
of	O
translational	O
vertigo	O
sensation	O
,	O
lightheadedness	O
and	O
headache	O
.	O

Her	O
seizure	O
frequency	O
has	O
worsened	B-course
since	O
February	B-temporal
of	I-temporal
this	I-temporal
year	I-temporal
.	O

Follow	O
-	O
up	O
visit	O
in	O
6	O
weeks	O
Outpatient	O
Follow	O
-	O
up	O
Requested	O
for	O
:	O
24Oct2012	B-temporal

LDL	O
198	B-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
H	B-labvalue
0	B-reference_range
-	I-reference_range
129	I-reference_range

History	O
of	O
Present	O
Illness	O
The	O
patient	O
is	O
being	O
seen	O
for	O

Counseling	O
/	O
Counseling	O
/	O
Edu	O
The	O
was	O
counseled	O
regarding	O
instructions	O
for	O
management	O
,	O
risk	O
factor	O
reductions	O
,	O
prognosis	O
,	O
patient	O
and	O
family	O
educationandrisks	O
and	O
benefits	O
of	O
treatment	O
options	O
.	O

The	O
left	O
external	O
canal	O
was	O
normal	O
.	O

Previous	B-temporal
CT	O
or	O
MRI	O
:	O
Yes	O

No	B-negation
masses	O
palpated	O
.	O

Active	O
Problems	O
Allergic	O
Rhinitis	O
477	O
.	O
9	O

Pupils	O
were	O
equal	O
in	O
size	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
.	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
,	O
the	O
heart	O
rate	O
was	O
not	B-labvalue
fast	I-labvalue
,	O
the	O
heart	O
rate	O
was	O
not	B-labvalue
slow	I-labvalue
,	O
no	B-negation
intermittent	O
leg	B-bodyloc
claudication	O
and	O
no	B-negation
edema	O
.	O

Examination	O
of	O
the	O
oropharynx	O
:	O
Normal	B-labvalue

Ordered	O
;	O
For	O
:	O
Nasal	B-bodyloc
Polyps	O
(	O
471	O
.	O
9	O
)	O
;	O
Ordered	O
By	O
:	O
Stanley	O
,	O
Douglas	O
Performed	O
:	O
Due	O
:	O
17Jan2013	B-temporal
;	O
Last	O
Updated	O
By	O
:	O
Drake	O
,	O
Suzanne	O

Test	O
Name	O
Result	O
Flag	O
Reference	O

Tiredness	O
:	O
None	B-negation

Abdominal	O
Aorta	O
:	O
no	B-negation
abnormalities	O
and	O
no	B-negation
bruit	O
heard	O
.	O

Right	O
Quadriceps	O
(	O
femor	O
.	O
)	O
Atrophy	O
.	O

Nasal	B-bodyloc
obstruction	O
:	O
None	B-negation

Thigh	O
(	O
obtur	O
.	O
)	O
:	O
Normal	O
.	O

1	O
.	O

History	O
of	O
hysterectomy	O
.	O

Streptococcal	O
Sore	O
Throat	O
034	O
.	O
0	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
neck	O
:	O
Normal	B-labvalue
.	O

Patient	O
is	O
experiencing	O
dysmenorrhea	O
.	O

4	I-reference_range
Platrlet	O
183	B-labvalue
K	I-labvalue
/	I-labvalue
CMM	I-labvalue
133	B-reference_range
-	I-reference_range
450	I-reference_range
Red	O
Blood	O
Crll	O
4	B-labvalue
.	I-labvalue
79	I-labvalue
M	I-labvalue
/	I-labvalue
CMM	I-labvalue
4	B-reference_range
.	I-reference_range
70	I-reference_range
-	I-reference_range
6	I-reference_range
.	I-reference_range

5	B-temporal
/	I-temporal
10	I-temporal
-	O
She	O
has	O
symptoms	O
suggestive	B-uncertain
of	O
mild	B-severity
R	O
ON	O
and	O
myelopathy	O
.	O

ENT	O
:	O
no	B-negation
nasal	B-bodyloc
discharge	O
and	O
no	B-negation
earache	O
.	O

Peripheral	O
Pulses	O
:	O
full	B-labvalue
.	O

Community	O
-	O
acquired	O
Pneumonia	O
486	O

Active	O
Problems	O
Abnormal	O
Hepatic	B-bodyloc
Enzyme	O
790	O
.	O
5	O

Plan	O
[	O
L	O
]	O
ANA	O
w	O
/	O
Reflex	O
Requested	O
for	O
:	O
29Oct2012	B-temporal

BUN	O
/	O
Creatinine	O
Ratio	O
11	B-labvalue
6	B-reference_range
-	I-reference_range
25	I-reference_range

The	O
p	O
.	O
o	O
.	O
feeds	O
were	O
held	O
and	O
IV	B-route
D10	O
water	O
was	O
given	O
.	O

Maternal	B-subject
history	O
of	O
Cancer	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
axillae	O
:	O
No	B-negation
lymphadenopathy	O
.	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
JELANI	O
INGRAM	O
,	O
M	O
.	O
D	O
.	O

Dermatophyrosis	O
of	O
feet	B-bodyloc
;	O
Good	O
skin	O
hygiene	O
,	O
trial	O
of	O
clotrimazole	O
topical	B-route
as	O
directed	O
.	O

Constitutional	O

Diovan	O
320	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
27Apr2012	B-temporal
to	O
(	O
Evaluate	O
:	O
02May2014	B-temporal
)	O
Requested	O
for	O
:	O
07May2013	B-temporal
;	O
Last	O
Rx	O
:	O
07May2013	B-temporal

Exacerbating	O
factors	O
:	O
bearing	O
weight	O
and	O
walking	O
.	O

Multiple	O
tattoos	O
.	O

Social	O
History	O
Never	O
A	O
Smoker	O

Review	O
of	O
Systems	O

Systolic	O
:	O
120	B-labvalue
,	O
LUE	O
,	O
Sitting	O

No	B-negation
pain	O
,	O
tingling	O
or	O
swelling	O
in	O
the	O
upper	B-bodyloc
extremities	I-bodyloc
.	O

Last	O
pap	O
result	O
was	O
normal	B-labvalue
9	B-temporal
/	I-temporal
2012	I-temporal
.	O

D	O
.	O

Follow	O
Up	O
:	O
after	O
imaging	O
study	O
completed	O

COLOR	O
URINE	O
:	O
LIGHT	B-labvalue
YELLOW	I-labvalue

Marital	O
History	O
-	O
Currently	O
Married	O

Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

External	O
inspection	O
of	O
ears	O
and	O
nose	O
:	O
Normal	B-labvalue
.	O

OB	O
History	O

Cranial	O
nerves	O
VIII	O
:	O
hearing	O
was	O
intact	B-labvalue
.	O

UTP	O
-	O
HM	O
,	O
The	O
patient	O
is	O
being	O
seen	O
for	O
a	O

Family	O
History	O
Family	B-subject
history	O
of	O
Diabetes	O
Mellitus	O
V18	O
.	O
0	O

Allergies	O
1	O

Assessment	O
Nausea	O
With	O
Vomiting	O
787	O
.	O
01	O

Tobacco	O
Use	O

Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

Skin	O

Neck	B-bodyloc
pain	O
with	O
right	O
upper	O
extremity	O
radiculopathy	O
.	O

Lymph	O
nodes	O
in	O
neck	O
:	O
Normal	O
.	O
Lymph	O
nodes	O
in	O
axillae	O
:	O
Normal	O
.	O

Cholesterol	O
:	O
4	B-temporal
/	I-temporal
2013	I-temporal

Electronically	O
signed	O
by	O
:	O
PATTI	O
JAYNE	O
ROSS	O
,	O
M	O
.	O
D	O
.	O

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

Constitutional	O
:	O
feeling	O
tired	O
(	O
fatigue	O
)	O
,	O
but	O
no	B-negation
fever	O
and	O
no	B-negation
chills	O
.	O

No	B-negation
recent	B-temporal
weight	O
change	O
.	O

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

Musculoskeletal	O

Constitutional	O

Follow	O
-	O
up	O
visit	O
in	O
2	O
weeks	O
Outpatient	O
Follow	O
-	O
up	O
Requested	O
for	O
:	O
31Oct2013	B-temporal

Constitutional	O
:	O
recent	B-temporal
15	O
lb	O
weight	O
gain	O
,	O
but	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
,	O
not	B-negation
feeling	O
poorly	O
(	O
malaise	O
)	O
and	O
not	B-negation
feeling	O
tired	O
(	O
fatigue	O
)	O
.	O

Patient	O
also	O
complains	O
of	O
worsening	B-course
shortness	O
of	O
breath	O
,	O
wheezing	O
,	O
breathing	O
from	O
mouth	B-bodyloc
x	O
2	B-temporal
weeks	I-temporal
.	O

No	B-negation
rhonchi	O
were	O
heard	O
.	O

[	O
U	O
]	O
XRAY	O
KNEE	O
1	O
OR	O
2	O
VWS	O
LEFT	O
73560	O

ENT	O
:	O
normal	B-labvalue
.	O

Current	O
Meds	O

f	O
Exogenous	O
Obesity	O
(	O
278	O
.	O
00	O
)	O
;	O
(	O
Active	O
)	O

Constitutional	O
:	O
no	B-negation
fever	O
,	O
not	B-negation
feeling	O
poorly	O
(	O
malaise	O
)	O
and	O
not	B-negation
feeling	O
tired	O
(	O
fatigue	O
)	O
.	O

"	O
I	O
have	O
headaches	O
again	O
.	O
"	O

Benign	B-severity
Essential	O
Hypertension	O
401	O
.	O
1	O

No	B-negation
vaginal	B-bodyloc
discharge	O
.	O

Involuntary	O
Movements	O
:	O
no	B-negation
involuntary	O
movements	O
were	O
seen	O
.	O

Clear	O
nasal	B-bodyloc
discharge	O
:	O
Mild	B-severity

Late	O
Effects	O
Of	O
An	O
Open	O
Wound	O
906	O
.	O
0	O

Age	O
at	O
menarche	O
was	O
13	O
.	O

Patient	O
Name	O
:	O
RAYLYNN	O
ASHAN	O
GEE	O

Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

there	O
aar	O
2	O
small	O
warty	O
lesions	O
on	O
the	O
medial	O
aspect	O
of	O
the	O
right	B-bodyloc
thumb	I-bodyloc
,	O
no	B-negation
oozing	O
,	O
no	B-negation
discharge	O
,	O
no	B-negation
gangrene	O
,	O
no	B-negation
necrosis	O
.	O

Concussion	O
850	O
.	O
9	O

Examination	O
of	O
the	O
head	O
and	O
face	O
:	O
Normal	B-labvalue
.	O
Mild	O
reproducibl	O
etenderness	O
at	O
Left	B-bodyloc
TMJ	I-bodyloc
,	O
no	B-negation
defromity	O
,	O
no	B-negation
crepitus	O
,	O
no	B-negation
gross	O
miss	O
-	O
allignment	O
or	O
deformity	O
.	O

Review	O
of	O
Systems	O
Orthopedic	O
ROS	O
Follow	O
Up	O
:	O

Elevated	O
liver	B-bodyloc
function	O
tests	O
.	O

Assessment	O
1	O
.	O

Chest	O

No	B-negation
Known	O
Drug	O
Allergies	O

Health	O
Maintenance	O
V70	O
.	O
0	O

Dr	O
.	O
Malhotra	O
had	O
left	O
ear	O
cleaning	O
last	B-temporal
week	I-temporal
in	O
our	O
office	O
.	O

Pulmonary	O

1	O
.	O

Cholesterol	O
Education	O
Program	O
(	O
ATP	O
III	O
,	O
2001	O
)	O
.	O

to	O

The	O
neck	O
was	O
normal	O
in	O
appearance	O
and	O
was	O
supple	O
.	O

Left	O
Peronei	O
(	O
peron	O
.	O
)	O
:	O
Normal	O
.	O

Parent	O
was	O
given	O
a	O
well	O
baby	O
handout	O
for	O
the	O
9	O
month	O
visit	O
.	O
eg	O

Lymphatic	O

GI	O
:	O
no	B-negation
diarrhea	O
,	O
no	B-negation
abdominal	B-bodyloc
pain	O
and	O
no	B-negation
vomiting	O
.	O

Heart	O
The	O
heart	O
rate	O
was	O
normal	B-labvalue
.	O

Murmurs	O
785	O
.	O
2	O

Informed	O
him	O
I	O
will	O
discuss	O
his	O
status	O
with	O
Dr	O
.	O
Blevins	O
when	O
he	O
returns	O
and	O
determine	O
our	O
next	O
step	O
in	O
his	O
treatment	O
plan	O
if	O
the	O
new	O
medication	O
does	B-negation
not	I-negation
improve	B-course
symptoms	O
.	O

Seizures	O

The	O
patient	O
is	O
being	O
seen	O
for	O
a	O
routine	O
clinic	O
follow	O
-	O
up	O
.	O

Itchy	O
nose	B-bodyloc
/	O
eyes	B-bodyloc
/	O
throat	B-bodyloc
:	O
None	B-negation

Dizziness	O
and	O
headache	O

She	O
has	O
tried	O
yogurt	O
,	O
but	O
no	B-negation
OTC	O
products	O
for	O
this	O
.	O

Varicosities	O
noted	O
bilaterally	B-bodyloc
.	O
Neg	B-labvalue
.	O

Results	O
/	O
Results	O
/	O
Data	O

FentaNYL	O
50	B-strength
MCG	I-strength
/	I-strength
HR	I-strength
Transdermal	B-form
Patch	I-form
72	I-form
Hour	I-form
;	O
PLACE	O
1	B-dosage
PATCH	B-form
AS	O
DIRECTED	O
every	B-frequency
72	I-frequency
hr	I-frequency
;	O
Therapy	O
:	O
24Aug2011	B-temporal
to	O
(	O
Evaluate	O
:	O
13Jul2012	B-temporal
)	O

KETONES	O
:	O
NEG	B-labvalue

Debridement	O
:	O

She	O
is	O
now	O
status	O
post	O
posterior	O
fossa	O
decompression	O
by	O
Dr	O
.	O
Tandon	O
with	O
resolution	B-course
of	O
her	O
symptoms	O
.	O

Cesarean	O
delivery	O
.	O

She	O
is	O
to	O
follow	O
the	O
principles	O
and	O
exercises	O
in	O
the	O
booklet	O
.	O

[	O
O	O
]	O
Lipid	O
Panel	O
(	O
In	O
Office	O
)	O
18Apr2014	B-temporal
02	B-temporal
:	I-temporal
18PM	I-temporal
CHIU	O
,	O
ALICE	O

Endocervical	O
/	O
transformation	O
zone	O
component	O
absent	O
.	O

History	O
of	O
Complete	O
Colonoscopy	O

Dyspepsia	O
536	O
.	O
8	O

Social	O
History	O
"	O
Alcohol	O
Use	O

The	O
patient	O
has	O
had	O
no	B-negation
adverse	O
reaction	O
to	O
a	O
blood	O
transfusion	O
.	O

Ordered	O
;	O
For	O
:	O
Palpitations	O
(	O
785	O
.	O
1	O
)	O
;	O
Ordered	O
By	O
:	O
CHEN	O
,	O
YEN	O
I	O
Perform	O
:	O
In	O
Office	O
Due	O
:	O
15Apr2013	B-temporal
;	O
Last	O
Updated	O
By	O
:	O
Guizar	O
,	O
Rosio	O

f	O
[	O
QLH	O
]	O
MICROALBUMIN	O
,	O
RANDOM	O
URINE	O
(	O
W	O
/	O
CREATININE	O
)	O
02/15/2013	B-temporal
1	O
year	O

No	B-negation
Known	O
Drug	O
Allergies	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitationsandthe	O
heart	O
rate	O
was	O
not	B-labvalue
fast	I-labvalue
.	O

Place	O
of	O
Delivery	O
:	O
MHH	O
.	O

no	B-negation
CVA	O
tenderness	O

GroupHeading11End	O
GroupHeading10Start	O
GroupHeading10End	O
GroupHeading9Start	O
GroupHeading9End	O
GroupHeading8Start	O
GroupHeading8End	O
GroupHeading7Start	O
GroupHeading7End	O
GroupHeading6Start	O
GroupHeading6End	O
GroupHeading15Start	O
GroupHeading15End	O
UTP	O
-	O
Complete	O
-	O
Female50f4265f	O
-	O
fcb5	O
-	O
4fac	O
-	O
bd62	O
-	O
4c3fe73ea6e3FoamEnd	O
ReviewofSystemsSectispEnd	O
PhytucalExamSectispStart	O
Phytucal	O
Exam	O

CHARLIE	O
ROCKEMORE	O
presents	O
with	O
complaints	O
of	O
fatigue	O
.	O

Good	O
bilateral	O
breath	O
sounds	O
are	O
noted	O
.	O

Abdomen	O

LAST	O
COLONOSCOPY	O
(	O
11	B-temporal
/	I-temporal
2010	I-temporal
)	O
.	O

Heart	O
Rate	O
:	O
100	B-labvalue

He	O
says	O
he	O
is	O
taking	O
his	O
insulin	O
and	O
check	O
sugars	O
AM	O
and	O
PM	O
but	O
forgot	O
to	O
bring	O
his	O
glucose	O
chart	O
,	O
according	O
to	O
him	O
his	O
sugars	O
run	O
in	O
200	B-labvalue
'	I-labvalue
s	I-labvalue
and	O
as	O
high	O
as	O
in	O
300	B-labvalue
'	I-labvalue
s	I-labvalue
.	O

History	O
of	O
Dilation	O
And	O
Curettage	O

Acetaminophen	O
500	B-strength
mg	I-strength
Capsule	B-form
Sig	O
:	O
[	O
*	O
*	O
12	B-temporal
-	I-temporal
24	I-temporal
*	O
*	O
]	O
Capsules	B-form
PO	B-route
Q6H	B-frequency
(	I-frequency
every	I-frequency
6	I-frequency
hours	I-frequency
)	I-frequency
as	B-frequency
needed	I-frequency
for	O
pain	O
,	O
fever	O
.	O

Constitutional	O

Palpation	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
Normal	B-labvalue
.	O

Hearing	O
in	O
the	O
right	O
ear	O
:	O
normal	B-labvalue
.	O

Allergies	O
:	O

No	B-negation
murmurs	O
were	O
heard	O
.	O

Foley	O
was	O
removed	O
on	O
POD	O
#	O
0	O
.	O

Examination	O
of	O
thyroid	O
:	O
Normal	B-labvalue
.	O

Cardiovascular	O

History	O
of	O
Nicotine	O
Dependence	O
305	O
.	O
1	O

Eyes	O
:	O
no	B-negation
eye	B-bodyloc
pain	O
,	O
no	O
blurred	O
visionandno	O
eyesight	O
problems	O
.	O

Status	O
:	O
clean	O
,	O
dry	O
,	O
uncomplicatedandhealing	O
well	O
.	O

Pt	O
prefers	O
to	O
transfer	O
her	O
.	O

Carotid	O
Arteries	O
:	O
Normal	B-labvalue
.	O

Description	O
:	O
Symptomatic	O
thyroid	B-bodyloc
goiter	O
.	O

In	O
view	O
of	O
F	O
.	O
H	O
.	O
will	O
send	O
for	O
Colonoscopy	O
.	O

Right	O
complete	O
atresia	O
,	O
left	O
repaired	O
atresia	O
.	O

Results	O
/	O
Results	O
/	O
Data	O

On	O
a	O
scale	O
of	O
1	B-labvalue
to	I-labvalue
10	I-labvalue
,	O
the	O
patient	O
rates	O
the	O
pain	O
as	O
4	B-severity
.	O

no	B-negation
h	O
/	O
o	O
CAD	O
,	O
HTN	O
,	O
HLP	O
,	O
DM	O
,	O
Cancer	O

Dicyclomine	O
HCl	O
CAPS	B-form
;	O
TAKE	O
2	B-dosage
CAPSULE	B-form
PRN	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
24Sep2013	B-temporal
)	O
to	O

Range	O
of	O
motion	O
adequate	O
.	O

Never	O
A	O
Smoker	O

Electronically	O
Signed	O
by	O
:	O
George	O
,	O
Verghese	O
,	O
MD	O

By	O
report	O
,	O
there	O
is	O
fair	O
compliance	O
with	O
treatment	O
,	O
fair	O
tolerance	O
of	O
treatment	O
and	O
fair	O
symptom	O
control	O
.	O

Cough	O
:	O
None	B-negation

Genitourinary	O
:	O
urinary	O
incontinence	O
.	O

Atenolol	O
50	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
;	O
RPT	O
.	O
eg	O

Levemir	O
FlexPen	O
100	B-strength
UNIT	I-strength
/	I-strength
ML	I-strength
Subcutaneous	B-route
Solution	B-form
;	O
5	B-dosage
units	I-dosage
am	B-frequency
;	O
4	B-dosage
units	I-dosage
at	B-frequency
night	I-frequency
;	O
Therapy	O
:	O
24Nov2012	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
10Dec2012	B-temporal
)	O

Assessment	O
Osteoarthritis	O
Of	O
The	O
Knee	B-bodyloc
Left	O
715	O
.	O
96	O

Examination	O
of	O
pupils	O
and	O
irises	O
:	O
Normal	B-labvalue
.	O

Vitals	O
08Apr2014	B-temporal
11	B-temporal
:	I-temporal
41AM	I-temporal
BMI	O
Calculated	O
46	B-labvalue
.	I-labvalue
15	I-labvalue
BSA	O
Calculated	O
2	B-labvalue
.	I-labvalue
38	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
7	I-labvalue
in	I-labvalue
Weight	O
294	B-labvalue
lb	I-labvalue
Systolic	O
130	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
86	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Temperature	O
98	B-labvalue
.	I-labvalue
3	I-labvalue
F	I-labvalue
,	O
Oral	O
Heart	O
Rate	O
84	B-labvalue

Indication	O
:	O
.	O

Alert	O
and	O
cooperative	O
.	O

Examination	O
of	O
digits	O
and	O
nails	O
:	O
Normal	B-labvalue
.	O

old	O
AA	O
female	O
w	O
th	O
h	O
/	O
o	O
HTN	O
,	O
OA	O
of	O
multiple	B-bodyloc
sites	I-bodyloc
,	O
morbid	B-severity
obesity	O
presepting	O
to	O
clinic	O
today	O
c	O
/	O
o	O
acid	O
reflux	O
symptoms	O
and	O
heartburn	O
.	O

Neck	O

The	O
patient	O
had	O
undergone	O
a	O
48	O
-	O
hour	O
ambulatory	O
EEG	O
monitoring	O
in	O
May	B-temporal
2012	I-temporal
.	O

Integumentary	O
:	O
normal	O
.	O

Abduction	O
:	O
restricted	O
active	O
range	O
of	O
motion	O
120	O
degrees	O
.	O

LevETIRAcetam	O
500	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
TWICE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
29Mar2010	B-temporal
to	O
(	O
Evaluate	O
:	O
23Mar2014	B-temporal
)	O
Requested	O
for	O
:	O
22Jan2014	B-temporal
;	O
Last	O
Rx	O
:	O
22Jan2014	B-temporal
;	O
Status	O
:	O

Results	O
/	O
Results	O
/	O
Data	O
Physical	O
Exam	O
Cholesterol	O
Urinalysis	O
Colonoscopy	O
EGD	O
EKG	O
Stress	O
Test	O
Echo	O
Cardiac	O
Cath	O
Peripheral	O
Vascular	O
Screen	O
Carotid	O
Vascular	O
Screen	O
AAA	O
ABI	O
/	O
PVR	O
Diabetes	O
Screen	O
Other	O
Mammogram	O
PAP	O
Dexa	O
Prostate	O
/	O
PSA	O

Palpation	O
of	O
the	O
face	O
and	O
sinuses	O
:	O
Normal	B-labvalue

Constitutional	O

The	O
patient	O
is	O
being	O
seen	O
for	O
postpartum	O
follow	O
up	O
.	O

Denied	O

Edema	O
:	O
Normal	O
(	O
not	B-negation
present	I-negation
)	O
.	O

Comorbid	O
Illnesses	O
:	O
hypertension	O
.	O

Assessment	O
of	O
muscle	O
strength	O
/	O
tone	O
:	O
Normal	B-labvalue
.	O

Murmurs	O
:	O
no	B-negation
murmurs	O
heard	O
.	O

Physical	O
Exam	O

Cranial	O
nerves	O
VII	O
:	O
facial	O
strength	O
was	O
intact	B-labvalue
bilaterally	I-labvalue
.	O

Psychiatric	O

GI	O
Stomach	O
UGI	O
and	O
Esophagus	O
Ba	O
swallow	O
Status	O
:	O
Complete	O
Done	O
:	O
21Mar2013	B-temporal

f	O
AUDIT	O
05/23/2013	B-temporal

Hematocrit	O
41	B-labvalue
.	I-labvalue
2	I-labvalue
%	I-labvalue
36	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
48	I-reference_range
.	I-reference_range
0	I-reference_range

Secretions	O
:	O
None	O

Inspection	O
of	O
the	O
conjunctiva	O
and	O
lids	O
:	O
Normal	B-labvalue
.	O

Social	O
History	O
Former	O
Smoker	O
V15	O
.	O
82	O

Knee	B-bodyloc
Swelling	O
719	O
.	O
08	O

staples	O
removed	O

Electronically	O
signed	O
by	O
:	O
PAMELA	O
PROMECENE	O
-	O
COOK	O
,	O
M	O
.	O
D	O
.	O

Plan	O
Follow	O
-	O
up	O
visit	O
in	O
3	O
weeks	O
Outpatient	O
Follow	O
-	O
up	O
Requested	O
for	O
:	O
07Aug2013	B-temporal

Signatures	O
Electronically	O
signed	O
by	O
:	O
CHAU	O
TRAN	O
,	O
M	O
.	O
D	O
.	O

Intake	O
and	O
output	O
were	O
closely	O
monitored	O
.	O

history	O
of	O
thyroid	B-bodyloc
nodule	O
s	O
/	O
p	O
biopsy	O
,	O
benign	B-labvalue
resutls	I-labvalue
(	O
4	B-temporal
-	I-temporal
5	I-temporal
years	I-temporal
ago	I-temporal
)	O
,	O
will	O
repeat	O
ultrasound	O
today	B-temporal
.	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
or	O
discomfort	O
,	O
no	B-negation
palpitations	O
,	O
no	B-negation
atrial	B-bodyloc
fibrillation	O
,	O
no	B-negation
rheumatic	O
fever	O
,	O
edema	O
was	O
not	B-negation
present	I-negation
,	O
no	B-negation
dyspnea	O
,	O
no	B-negation
neurological	O
symptoms	O
,	O
no	B-negation
fainting	O
,	O
no	B-negation
headache	O
,	O
no	B-negation
dizziness	O
,	O
no	B-negation
seizure	O
was	O
observed	O

Carotid	O
pulses	O
:	O
Normal	B-labvalue

I	O
examined	O
and	O
discussed	O
the	O
patient	O
with	O
the	O
resident	O
and	O
agree	O
with	O
the	O
above	O
findings	O
,	O
assessment	O
and	O
plan	O
in	O
the	O
resident	O
note	O
.	O

)	O
.	O

Apr	B-temporal
10	I-temporal
2012	I-temporal
1	B-temporal
:	I-temporal
30PM	I-temporal
(	O
Author	O
)	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
STALEY	O
BROD	O
,	O
M	O
.	O
D	O
.	O

Skin	O
:	O
No	B-negation
pruritus	O
.	O

History	O
of	O
Generalized	O
Anxiety	O
Disorder	O
V11	O
.	O
2	O

(	O
tib	O
.	O
)	O
:	O
Normal	O
.	O

Constitutional	O

Otitis	O
Externa	O
380	O
.	O
10	O

She	O
reports	O
occasional	O
alcohol	O
use	O
and	O
WINE	O
/	O
BEER	O
.	O

Range	O
of	O
motion	O
and	O
motor	O
strength	O
testing	O
of	O
the	O
hips	O
not	O
performed	O
at	O
this	O
time	O
due	O
to	O
pain	O
.	O

[	O
QLH	O
]	O
FERRITIN	O
Done	O
:	O
19Jul2011	B-temporal
12	B-temporal
:	I-temporal
28PM	I-temporal

AispEnic	O
Rhinitis	O
477	O
.	O
9	O

General	O
-	O
AOx3	O
,	O
NAD	O
Chest	O
-	O
CTAB	O
CV	O
-	O
RRR	O
,	O
S1	O
/	O
S2	O
appreciated	B-labvalue
Abd	O
-	O
soft	O
,	O
nontender	O
,	O
nondistended	O
Extremity	O
-	O
left	O
upper	O
extremity	O
:	O
patient	O
with	O
significant	O
multiple	O
injuries	O
of	O
the	O
hand	B-bodyloc
as	O
follows	O
.	O

Calcium	O
Lvl	O
9	B-labvalue
.	I-labvalue
8	I-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
8	B-reference_range
.	I-reference_range
5	I-reference_range
-	I-reference_range
10	I-reference_range
.	I-reference_range
5	O

Skin	O

Cardiovascular	O
Peripheral	O
vascular	O
exam	O
:	O
Normal	B-labvalue
Carotid	B-bodyloc
:	O
right	O
2	O
+	O
,	O
left	O
2	O
+	O
,	O
no	B-negation
bruit	O
on	O
the	O
right	O
and	O
no	B-negation
bruit	O
on	O
the	O
left	O
.	O

Family	B-subject
history	O
of	O
Stroke	O
Syndrome	O
V17	O
.	O
1	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Social	O
History	O
Drinking	O
In	O
Moderation	O
(	O
2	O
Drinks	O
/	O
Day	O
Or	O
Fewer	O
)	O

Skin	B-bodyloc
No	B-negation
open	O
lesions	O
.	O

Patient	O
was	O
not	B-negation
observed	I-negation
to	O
be	O
obese	O
.	O

diminished	O
quad	O
control	O
and	O
tone	O
Pain	O
produced	O
upon	O
palpation	O
of	O
the	O
left	O
hip	O
of	O
the	O
anterior	O
aspectandof	O
the	O
lateral	O
aspectof	O
the	O
hipandof	O
the	O
greater	O
trochanter	O
.	O

Examination	O
of	O
gait	O
and	O
station	O
:	O
Normal	B-labvalue
.	O

Discussion	O
/	O
Discussion	O
/	O
Summary	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

Patient	O
:	O
PETRUS	O
,	O
EDWARD	O
F	O
;	O
DOB	O
:	O
6/19/1955	B-temporal
;	O
MRN	O
:	O
1894641	O

CV	O
:	O
The	O
patient	O
was	O
stable	O
from	O
a	O
cardiovascular	O
standpoint	O
;	O
vital	O
signs	O
were	O
routinely	O
monitored	O
.	O

Facial	B-bodyloc
or	O
sinus	B-bodyloc
pain	O
:	O
None	B-negation

No	B-negation
other	O
complaints	O
.	O

Discuss	O
Sleep	O
Apnea	O
,	O
Pulmonologist	O

Genitourinary	O
:	O
no	B-negation
dysuria	O
,	O
no	B-negation
incontinence	O
,	O
no	B-negation
urinary	O
hesitancy	O
,	O
no	B-negation
nocturia	O
,	O
no	B-negation
genital	B-bodyloc
lesions	O
and	O
no	B-negation
testicular	B-bodyloc
pain	O
.	O

Physical	O
Exam	O
General	O
appearance	O
:	O
Normal	B-labvalue
.	O

Examination	O
of	O
pupils	O
and	O
irises	O
:	O
Normal	B-labvalue
.	O

6	O
.	O

Occupation	O
:	O

Family	B-subject
history	O
of	O
Coronary	B-bodyloc
Artery	I-bodyloc
Disease	O
V17	O
.	O
49	O

Never	O
A	O
Smoker	O

Hyperlipidemia	O
272	O
.	O
4	O

Special	O
Test	O
:	O
a	B-labvalue
positive	I-labvalue
medial	O
McMurray	O
meniscal	O
integrity	O
test	O
.	O

Miscarriage	O
first	O
trimester	O
,	O
spontaneous	O
.	O

An	O

Cardiovascular	O

Examination	O
of	O
the	O
chest	O
:	O
Normal	B-labvalue

Plan	O
Wheelchair	O
Miscellaneous	O
;	O
USE	O
AS	O
DIRECTED	O
;	O
Therapy	O
:	O
30Oct2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
30Oct2013	B-temporal
)	O
;	O

I	O
have	O
discussed	O
the	O
case	O
with	O
the	O
resident	O
and	O
agree	O
with	O
the	O
diagnosis	O
and	O
plan	O
.	O

History	O
of	O
Alcohol	O
Use	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

[	O
*	O
*	O
Hospital	O
119	O
*	O
*	O
]	O
Homecare	O

Paternal	B-subject
history	O
of	O
Cancer	O

Cycle	O
intervals	O
have	O
been	O
regular	O
.	O

Murmurs	O
785	O
.	O
2	O

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

Eyes	O

Family	O
History	O
Maternal	B-subject
grandmother	I-subject
'	I-subject
s	I-subject
history	O
of	O
Diabetes	O
Mellitus	O
V18	O
.	O
0	O

Motor	O
Strength	O
:	O
hemiparesis	O
was	O
present	O
on	O
the	O
right	O
.	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
and	O
no	O

The	O
patient	O
is	O
here	O
in	O
late	O
followup	O
because	O
of	O
headaches	O
.	O

MetFORMIN	O
HCl	O
ER	B-form
500	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
Extended	I-form
Release	I-form
24	I-form
Hour	I-form
;	O
2	B-dosage
tabs	B-form
am	B-frequency
;	O
2	B-dosage
tab	B-form
pm	B-frequency
;	O
Therapy	O
:	O
02Jan2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
10Jun2013	B-temporal
)	O

Chest	O

Max	O
:	O
Normal	B-labvalue

Posterior	O
tibialis	O
pulse	O
was	O
2	B-labvalue
+	I-labvalue
on	I-labvalue
the	I-labvalue
right	I-labvalue
and	O
2	B-labvalue
+	I-labvalue
on	I-labvalue
the	I-labvalue
left	I-labvalue
.	O

8	I-strength
MG	I-strength
/	I-strength
ML	I-strength
Ophthalmic	B-form
Solution	I-form
;	O
INSTILL	O
1	B-dosage
DROP	I-dosage
INTO	O
BOTH	O

Continue	O
all	O
other	O
med	O
dose	O
Discussed	O
the	O
importance	O
of	O
DM	O
control	O
and	O
its	O
complications	O
.	O

Digital	O
rectal	O
exam	O
of	O
prostate	O
:	O
Normal	B-labvalue
.	O

Constitutional	O
:	O
no	B-negation
fever	O
and	O
no	B-negation
chills	O
.	O

No	B-negation
Acu	O
.	O
distress	O
.	O

Examination	O
of	O
the	O
head	O
and	O
face	O
:	O
Normal	B-labvalue
.	O

Familial	O
Hypercholesterolemia	O
272	O
.	O
0	O

Occupation	O
:	O
Denied	O

[	O
QLH	O
]	O
VALPROIC	O
ACID	O
Requested	O
for	O
:	O
20May2013	B-temporal

SKIN	O
:	O
No	B-negation
rashes	O
or	O
lesions	O
.	O

Lyrica	O
100	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
AT	B-frequency
BEDTIME	I-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
29Oct2012	B-temporal
)	O
to	O

When	O
tolerating	O
oral	O
intake	O
,	O
the	O
patient	O
was	O
transitioned	O
to	O
oral	B-route
pain	O
medications	O
.	O

Appearance	O
:	O
Normal	B-labvalue
appearance	I-labvalue
.	O

Constitutional	O
:	O
no	B-negation
fever	O
and	O
no	B-negation
chills	O
.	O

Will	O
give	O
her	O
Rx	O
for	O
Zpack	O
to	O
be	O
filled	O
only	O
for	O
worsenig	B-course
symtomps	O
after	B-temporal
4	I-temporal
days	I-temporal
or	O
temp	O
>	O
100	B-labvalue
.	I-labvalue
2	I-labvalue
.	O

Physical	O
Exam	O

Tramadol	O
-	O
Acetaminophen	O
37	B-strength
.	I-strength
5	I-strength
-	I-strength
325	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
EVERY	B-frequency
4	I-frequency
TO	I-frequency
6	I-frequency
HOURS	I-frequency
AS	O
NEEDED	O
FOR	O
PAIN	O
;	O
Therapy	O
:	O
16Apr2013	B-temporal
to	O
(	O
Evaluate	O
:	O
21Apr2013	B-temporal
)	O
Requested	O
for	O
:	O
16Apr2013	B-temporal
;	O
Last	O
Rx	O
:	O
16Apr2013	B-temporal
;	O
Edited	O

RT	O

EARS	O
,	O
NOSE	O
,	O
MOUTH	O
AND	O
THROAT	O

Denied	O
ChilduEnrolled	O
In	O
Day	O
-	O
care	O

Anesthesia	O
:	O
epidural	O
.	O

Examination	O
of	O
the	O
abdomen	O
:	O
Normal	B-labvalue
The	O
abdomen	O
was	O
rounded	O
.	O

Tympanic	O
membranes	O
without	B-negation
erythema	O
,	O
bulging	O
or	O
retraction	O
.	O

Inspection	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
Abnormal	O
.	O
(	O
1cm	O
blister	O
on	O
medial	O
aspect	O
of	O
left	B-bodyloc
hand	I-bodyloc
,	O
scabbed	O
over	O
,	O
healing	O
well	O
without	B-negation
signs	O
of	O
cellulitis	O
)	O
.	O

Otherwise	O
,	O
she	O
has	O
no	B-negation
concerns	O
today	B-temporal
.	O

Headache	O
784	O
.	O
0	O

Orientation	O
to	O
person	O
,	O
place	O
,	O
and	O
time	O
:	O
Normal	B-labvalue
.	O

Continue	O
salt	O
water	O
gargles	O
,	O
Tylenol	O
or	O
advil	O

Not	O
much	O
changed	O
since	O
last	O
visit	O
.	O

Ability	O
to	O
communicate	O
:	O
Normal	B-labvalue
.	O

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

Test	O
Name	O
Result	O
Flag	O
Reference	O

Obesity	O
278	O
.	O
00	O

The	O
patient	O
was	O
encouraged	O
to	O
get	O
up	O
and	O
ambulate	O
as	O
early	O
as	O
possible	O
.	O

Genitourinary	O

Given	O
diarrhoea	O
Diet	O
.	O
Report	O
new	B-course
sx	O
.	O

Chief	O
Complaint	O

Paterpal	B-subject
histisy	O
of	O
Essential	O
Hypertensisp	O

Constitutional	O
:	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
,	O
not	B-negation
feeling	O
poorly	O
(	O
malaise	O
)	O
,	O
not	B-negation
feeling	O
tired	O
(	O
fatigue	O
)	O
,	O
no	B-negation
recent	B-temporal
weight	O
gain	O
and	O
no	B-negation
recent	B-temporal
weight	O
loss	O
.	O

Headache	O
:	O
None	B-negation

Tremor	O
781	O
.	O
0	O

The	O
symptoms	O
occur	O
intermittently	O
.	O

Facial	B-bodyloc
or	O
sinus	B-bodyloc
pressure	O
:	O
None	B-negation

[	O
QLH	O
]	O
FERRITIN	O
Done	O
:	O
28Feb2011	B-temporal
10	B-temporal
:	I-temporal
28AM	I-temporal

Cardiovascular	O

Examination	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue
.	O

Eyes	O
:	O
no	B-negation
eye	B-bodyloc
pain	O
and	O
eyes	B-bodyloc
not	B-negation
red	O
.	O

No	B-negation
Known	O
Drug	O
Allergies	O

Procedure	O

Regular	O
Weightbearing	O
Exercises	O

First	O
pregnancy	O
:	O

Peripheral	O
Vascular	O
Exam	O
:	O
Normal	B-labvalue
.	O

Histisy	O
of	O
Present	O
Illness	O

Headache	O
784	O
.	O
0	O

Family	O
History	O
Family	B-subject
history	O
of	O
Benign	B-severity
Essential	O
Hypertension	O

Endocrinology	O
Medical	O
Summary	O
Patient	O
Detail	O
for	O
LORETTA	O
JONES	O
MRN	O
:	O
1885771	O
Contact	O
LORETTA	O
JONES	O
Date	O
Of	O
Birth	O
November	B-temporal
6	I-temporal
,	I-temporal
1959	I-temporal
Address	O
16626	O
STRATHMORE	O
MANOR	O
LN	O

Left	O
ring	O
finger	O
radial	O
and	O
ulnar	O
digital	O
nerve	O
repair	O
x2	O
8	O
.	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

US	O
Extremity	O
lower	O
venous	O
Doppler	O
Unilat	O
05Jun2012	B-temporal
04	B-temporal
:	I-temporal
01PM	I-temporal
Pelini	O
,	O
Susan	O
Test	O
Name	O
Result	O
Flag	O
Reference	O
Extremity	O
lower	O
venous	O
Doppler	O
Unilat	O

Current	O
Meds	O
No	B-negation
Reported	O
Medications	O

Discussion	O
/	O
Signatures	O
Electronically	O
signed	O
by	O
:	O
LESLIE	O
GARB	O
,	O
M	O
.	O
D	O
.	O

Nasal	B-bodyloc
discharge	O
.	O

Hematologic	O
/	O
Lymphatic	O
:	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
and	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
.	O

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

Lymphatic	O

Examination	O
of	O
the	O
oropharynx	O
:	O
Normal	B-labvalue

He	O
believes	O
the	O
lightheadedness	O
and	O
panic	O
sensation	O
was	O
stress	O
related	O
and	O
with	O
a	O
decreased	O
stress	O
level	O
in	O
his	O
life	O
now	O
,	O
he	O
is	O
no	B-negation
longer	I-negation
having	O
the	O
symptoms	O
.	O

Neurological	O
:	O
no	B-negation
dizziness	O
,	O
no	B-negation
fainting	O
,	O
no	B-negation
limb	B-bodyloc
weakness	O
and	O
no	B-negation
difficulty	O
walking	O
.	O

Cardiovascular	O
:	O
lower	B-bodyloc
extremity	I-bodyloc
edema	O
,	O
but	O
no	B-negation
chest	B-bodyloc
pain	O
and	O
no	B-negation
palpitations	O

Lumbago	O
724	O
.	O
2	O

His	O
diet	O
was	O
advanced	O
when	O
appropriate	O
,	O
which	O
was	O
tolerated	O
well	O
.	O

Language	O
:	O
No	B-negation
dysphasia	O
/	O
aphasia	O
was	O
observed	O
.	O

Up	O
to	O
140	O
after	O
meal	O
.	O

Lymphatic	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
rate	O
and	O
rhythm	O
,	O
normal	B-labvalue
S1	O
and	O
S2	O
,	O
no	B-negation
murmurs	O
.	O

An	O
intention	O
tremor	O
was	O
not	B-negation
observed	I-negation
on	O
the	O
right	O
and	O
not	O
observed	O
on	O
the	O
left	O
.	O

IMPRESSION	O
:	O
No	B-negation
evidence	I-negation
of	I-negation
above	B-bodyloc
-	I-bodyloc
knee	I-bodyloc
DVT	O
.	O

Risk	O
factors	O
:	O
air	O
pollution	O
exposure	O
,	O
but	O
no	O
smoking	O
and	O
no	O
exposure	O
to	O
an	O
ill	O
person	O
.	O

;	O
Apr	B-temporal
4	I-temporal
2012	I-temporal
10	B-temporal
:	I-temporal
13AM	I-temporal
(	O
Author	O
)	O

2	O
.	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
and	O
no	B-negation
palpitations	O
.	O

Examination	O
of	O
the	O
palate	O
showed	O
no	B-negation
abnormalities	O
.	O

Recent	O
and	O
remote	O
memory	O
:	O
Normal	B-labvalue
.	O

Review	O
of	O
Systems	O

Heart	O
Rate	O
:	O
88	B-labvalue

Social	O
History	O
Never	O
A	O
Smoker	O

Current	O
Orders	O
[	O
L	O
]	O
Drawing	O
Fee	O
Requested	O
for	O
:	O
20Mar2014	B-temporal

Right	O
Toe	O
Flex	O
.	O

Pulmonary	O
Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

;	O
Jun	B-temporal
3	I-temporal
2013	I-temporal
12	B-temporal
:	I-temporal
44PM	I-temporal
(	O
Author	O
)	O

No	B-negation
vaginal	B-bodyloc
discharge	O
.	O

No	B-negation
acute	B-course
distress	O
,	O
well	O
nourished	O
.	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
,	O
no	B-negation
cough	O
,	O
no	B-negation
shortness	O
of	O
breath	O
during	O
exertion	O
and	O
no	B-negation
orthopnea	O
.	O

PredniSONE	O
20	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
1	B-dosage
tab	B-form
po	B-route
bid	B-frequency
x	O
5d	O
,	O
then	O
1	B-dosage
tab	B-form
po	B-route
qd	B-frequency
x	O
5	O
;	O
Therapy	O
:	O
07Oct2013	B-temporal
to	O
(	O
Evaluate	O
:	O
17Oct2013	B-temporal
)	O
Requested	O
for	O
:	O
07Oct2013	B-temporal
;	O
Last	O
Rx	O
:	O
07Oct2013	B-temporal
;	O
Edited	O

US	O
Breast	O
Unilat	O
76645	O
Requested	O
for	O
:	O
19Nov2012	B-temporal

;	O
Jan	B-temporal
3	I-temporal
2013	I-temporal
8	B-temporal
:	I-temporal
08PM	I-temporal
(	O
Author	O
)	O

UTP	O
-	O
Discussion	O
/	O

(	O
Medical	O
Transcription	O
Sample	O
Report	O
)	O

Total	O
pregnancies	O
4	O
.	O
3	O
live	O
births	O
.	O
3	O
living	O
.	O
2	O
full	O
-	O
term	O
.	O
1	O
premature	O
delivery	O
(	O
s	O
)	O
.	O
1	O
spontaneous	O
abortion	O
(	O
s	O
)	O
.	O
3	O
cesarean	O
delivery	O
(	O
s	O
)	O
.	O

Crestor	O
TABS	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
03Nov2011	B-temporal
)	O
to	O

FamHx	O
:	O
Diabetes	O
Mellitus	O
(	O
V18	O
.	O
0	O
)	O

History	O
of	O
Post	O
-	O
Traumatic	O
Dystonia	O
Musculorum	O
Deformans	O
333	O
.	O
6	O

Personal	O
Hx	O
g5	O

Diastolic	O
:	O
64	B-labvalue
,	O
RUE	O
,	O
Sitting	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
cough	O
and	O
no	B-negation
shortness	O
of	O
breath	O
during	O
exertion	O
.	O

Denied	O

One	O
isolated	O
elevated	O
BP	O
,	O
advise	O
to	O
continue	O
to	O
monitor	O

Examination	O
of	O
extremities	O
for	O
edema	O
and	O
/	O
or	O
varicosities	O
:	O
Normal	B-labvalue
.	O

Social	O
History	O
Marital	O
History	O
-	O
Currently	O
Married	O

Peripheral	O
Pulses	O
:	O
full	B-labvalue
.	O

If	O
her	O
headaches	O
persist	B-course
or	O
change	B-course
over	B-temporal
the	I-temporal
next	I-temporal
week	I-temporal
then	O
I	O
will	O
proceed	O
with	O
a	O
brain	O
MRI	O
.	O

Neurologic	O

Jaw	O
swelling	O
The	O
patient	O
is	O
being	O
seen	O
for	O
an	O
initial	O
evaluation	O
of	O
facial	B-bodyloc
pain	O
.	O

Musculoskeletal	O
:	O
arthralgias	O
.	O

History	O
of	O
Ischemic	O
Stroke	O
434	O
.	O
90	O

Pt	O
will	O
do	O
through	O
his	O
work	O
.	O

Ambien	O
TABS	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
24Apr2013	B-temporal
)	O
to	O

Patient	O
also	O
complains	O
of	O
athelete	O
foot	B-bodyloc
and	O
dry	O
skin	B-bodyloc
.	O

Blood	O
pressure	O
control	O
has	O
been	O
good	O
(	O
see	O
above	O
)	O
.	O

Weight	O
:	O
318	B-labvalue
lb	I-labvalue

Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

EYES	O
:	O
no	B-negation
double	O
vision	O
and	O
no	B-negation
blurred	O
vision	O
.	O

3	O
.	O

HEENT	O
:	O
Eyes	O
:	O
Lids	O
and	O
conjunctiva	O
.	O

Examination	O
of	O
liver	O
and	O
spleen	O
:	O
Normal	B-labvalue
.	O

History	O
of	O
Alcohol	O
Use	O

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

She	O
is	O
bottle	O
feeding	O
baby	O
and	O
states	O
that	O
she	O
is	O
bonding	O
well	O
with	O
him	O
.	O

The	O
patient	O
has	O
not	B-negation
been	O
vaccinated	O
for	O
HPV	O
.	O

The	O
patient	O
was	O
not	O
in	O
a	O
condition	O
to	O
undergo	O
any	O
kind	O
of	O
chemotherapy	O
,	O
being	O
on	O
the	O
ventilator	O
.	O

Atorvastatin	O
Calcium	O
20	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
17Sep2012	B-temporal
to	O
(	O
Evaluate	O
:	O
18Apr2013	B-temporal
)	O
Requested	O
for	O
:	O
27Dec2012	B-temporal
;	O
Last	O
Rx	O
:	O
19Dec2012	B-temporal

Dorsalis	O
pedis	O
pulse	O
was	O
2	B-labvalue
+	I-labvalue
on	I-labvalue
the	I-labvalue
right	I-labvalue
and	O
2	B-labvalue
+	I-labvalue
on	I-labvalue
the	I-labvalue
left	I-labvalue
.	O
Peripheral	O
vascular	O
exam	O
:	O
Normal	B-labvalue
.	O

Atorvastatin	O
20	B-strength
mg	I-strength
Tablet	B-form
Sig	O
:	O
One	B-dosage
(	I-dosage
1	I-dosage
)	I-dosage
Tablet	B-form
PO	B-route
DAILY	B-frequency
(	I-frequency
Daily	I-frequency
)	I-frequency
.	O

Current	O
Meds	O
BuPROPion	O
HCl	O
ER	O
(	O
XL	O
)	O
150	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
Extended	I-form
Release	I-form
24	I-form
Hour	I-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
17Feb2014	B-temporal
)	O
to	O

NexIUM	O
40	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
Delayed	I-form
Release	I-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
14Feb2012	B-temporal
to	O
(	O
Evaluate	O
:	O
12Aug2012	B-temporal
)	O
Requested	O
for	O
:	O
14Feb2012	B-temporal
;	O
Last	O
Rx	O
:	O
14Feb2012	B-temporal

[	O
QLH	O
]	O
HEMOGLOBIN	O
A1c	O
Requested	O
for	O
:	O
02Jul2013	B-temporal

Gastric	B-bodyloc
Ulcer	O
531	O
.	O
90	O

Discussed	O
the	O
importance	O
of	O
lipid	O
control	O

-	O
cont	O
Atenolol	O
25	B-strength
mg	I-strength
po	B-route
daily	B-frequency

Current	O
treatment	O
includes	O
potassium	O
supplement	B-form
,	O
thiazide	O
diuretic	O
and	O
angiotensin	O
receptor	O
blockers	O
.	O

Examination	O
of	O
cranial	O
nerves	O
:	O
Normal	B-labvalue
.	O

f	O
Lancets	O
Super	O
Thin	O
MISC	O
;	O
dispense	O
BD	O
brand	O
;	O
Start	O
Date	O
:	O
12/19/2006	B-temporal
(	O
Active	O
)	O

Facial	B-bodyloc
or	O
sinus	B-bodyloc
pain	O
:	O
None	B-negation

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

Counseling	O
/	O
Signatures	O
Electronically	O
signed	O
by	O
:	O
LOURICE	O
ABDELMELEK	O
,	O
M	O
.	O
D	O
.	O

Assessment	O
of	O
respiratory	O
effort	O
was	O
significant	O
for	O
normal	B-labvalue
respiratory	O
rhythm	O
and	O
effort	O
.	O

Plan	O
Pravastatin	O
Sodium	O
20	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
AT	I-frequency
BEDTIME	I-frequency
Requested	O
for	O
:	O
17Feb2014	B-temporal
;	O
Last	O
Rx	O
:	O
17Feb2014	B-temporal
;	O
Edited	O

The	O
patient	O
presents	O
with	O
complaints	O
of	O
constipation	O
(	O
Has	O
a	O
bowel	O
movement	O
2	O
-	O
3	O
times	O
per	O
week	O
and	O
strains	O
when	O
having	O
a	O
bowel	O
movement	O
.	O

Psychiatric	O
:	O
no	B-negation
anxiety	O
.	O

Immunizations	O
*	O
*	O
Printed	O
in	O
Appendix	O
#	O
1	O
below	O
.	O

Po	O
assium	O
Lvl	O
5	B-labvalue
.	I-labvalue
0	I-labvalue
mEq	I-labvalue
/	I-labvalue
l	I-labvalue
3	B-reference_range
.	I-reference_range
5	I-reference_range
-	I-reference_range
5	I-reference_range
.	I-reference_range

General	O
appearance	O
:	O
Normal	B-labvalue
.	O

Family	B-subject
history	O
of	O
Diabetes	O
Mellitus	O
V18	O
.	O
0	O

Patient	O
Specific	O
Education	O
Given	O
Done	O
:	O
12Jan2012	B-temporal

The	O
patient	O
was	O
comfortable	O
,	O
stabilized	O
,	O
breathing	O
well	O
.	O

PT	O
MUST	O
MAKE	O
OFFICE	O
APPT	O
/	O
LABS	O
;	O
Therapy	O
:	O
24Feb2013	B-temporal
to	O

Past	O
Medical	O
History	O
Denied	O

History	O
of	O
Gastric	O
Laparoscopy	O

Patient	O
agreed	O
and	O
indicated	O
understanding	O
.	O

Hematologic	O
/	O
Lymphatic	O
:	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
,	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
,	O
no	B-negation
swollen	O
glands	B-bodyloc
and	O
no	B-negation
swollen	O
glands	B-bodyloc
in	O
the	O
neck	B-bodyloc
.	O

History	O
of	O
Present	O
Illness	O
The	O
patient	O
is	O
being	O
seen	O
for	O

Bronchitis	O
490	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Cranial	O
nerves	O
V	O
:	O
sensation	O
to	O
the	O
face	O
and	O
masseter	O
strength	O
were	O
intact	B-labvalue
.	O

Middle	O
Turbinate	O
:	O
Normal	O
position	O
.	O

-	O
Negative	B-negation
for	O
metastatic	O
disease	O
(	O
0	O
of	O
8	O
lymph	B-bodyloc
nodes	I-bodyloc
)	O
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Location	O
:	O
Left	O
subacromial	O
bursa	O
.	O

Inspection	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
Normal	B-labvalue
.	O
No	B-negation
rash	O
,	O
no	B-negation
clubbing	O
,	O
no	B-negation
cyanosis	O
.	O

Abdominal	O
aorta	O
:	O
Normal	B-labvalue
.	O

Consent	O
:	O
Risks	O
/	O
benefits	O
/	O
alternatives	O
reviewed	O
.	O

29	O
year	O
old	O
with	O
intractable	O
seizures	O
here	O
for	O
follow	O
up	O
.	O

Adnexa	O
/	O
parametria	O
:	O
Normal	O
.	O

History	O
of	O

to	O

The	O
patient	O
is	O
currently	O
asymptomatic	O
.	O

Inspection	O
of	O
lips	O
,	O
teethand	O
gums	O
:	O
Abnormal	O
.	O

Depression	O
311	O

Assessment	O
Anemia	O
285	O
.	O
9	O

Cycle	O
intervals	O
are	O
irregular	O
.	O

Patient	O
has	O
checked	O
his	O
glucose	O
during	O
this	O
time	O
and	O
reports	O
the	O
range	O
to	O
be	O
between	O
110	B-labvalue
-	I-labvalue
130	I-labvalue
.	O

Disease	O
complications	O
:	O
no	B-negation
coronary	B-bodyloc
artery	I-bodyloc
disease	O
,	O
no	B-negation
peripheral	O
vascular	O
disease	O
and	O
no	B-negation
carotid	B-bodyloc
stenosis	O
.	O

Hyperlipidemia	O
:	O
Due	O
for	O
lipid	O
panel	O
.	O

Dissection	O
of	O
dorsal	O
vein	O
for	O
vein	O
graft	O
harvest	O
The	O
patient	O
tolerated	O
the	O
procedures	O
well	O
Neuro	O
:	O
Post	O
-	O
operatively	O
,	O
the	O
patient	O
received	O
Dilaudid	O
IV	B-route
/	O
PCA	O
with	O
good	O
effect	O
and	O
adequate	O
pain	O
control	O
.	O

The	O
last	O
clinic	O
visit	O
was	O
1	B-temporal
month	I-temporal
(	I-temporal
s	I-temporal
)	I-temporal
ago	I-temporal
.	O

Examination	O
of	O
the	O
oropharynx	O
:	O
Normal	B-labvalue
.	O

Neck	O

Facial	B-bodyloc
or	O
sinus	B-bodyloc
pressure	O
:	O
Moderate	B-severity

Drug	O
Use	O

Hyperlipidemia	O
272	O
.	O
4	O

History	O
of	O
Multiple	O
Sclerosis	O
340	O

Delivery	O
type	O
:	O
cesarean	O
delivery	O
.	O

The	O
eyes	O
get	O
stuck	O
in	O
looking	O
in	O
a	O
certain	O
direction	O
.	O

Allergies	O
1	O
.	O

;	O
Nov	B-temporal
28	I-temporal
2012	I-temporal
2	B-temporal
:	I-temporal
31PM	I-temporal
(	O
Author	O
)	O

Capillary	O
refills	O
were	O
normal	B-labvalue
in	O
the	O
toes	O
.	O

Denies	B-negation
numbness	O
of	O
the	O
feet	B-bodyloc
,	O
denies	B-negation
a	O
foot	B-bodyloc
ulcer	O
,	O
denies	B-negation
foot	B-bodyloc
pain	O
,	O
denies	B-negation
vomiting	O
,	O
denies	B-negation
visual	O
impairment	O
and	O
denies	O
.	O

Tdap	O
;	O
INJECT	O
0	B-dosage
.	I-dosage
5	I-dosage
ML	I-dosage
ONCE	O
;	O
Dose	O
:	O
0	B-dosage
.	I-dosage
5	I-dosage
;	O
Route	O
:	O
Intramuscular	B-route
;	O
Site	O
:	O
Left	O
Deltoid	O
;	O
Done	O
:	O
26Nov2012	B-temporal
10	B-temporal
:	I-temporal
54AM	I-temporal
;	O
Status	O
:	O
Complete	O

Plan	O
Levofloxacin	O
500	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
FOR	B-duration
28	I-duration
DAYS	I-duration
;	O
Therapy	O
:	O
22Aug2011	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
22Aug2011	B-temporal
)	O
Requested	O
for	O
:	O
22Aug2011	B-temporal
;	O
Edited	O

Neurological	O
:	O
patient	O
is	O
alert	O
.	O

Social	O
History	O
Marital	O
History	O
-	O
Single	O

Backache	O
724	O
.	O
5	O

f	O
RSV	O
MAB	O
(	O
Synagis	O
)	O
(	O
Lot	O
#	O
:	O
11E27	O
-	O
81	O
)	O
-	O
Administered	O
on	O
:	O
11/16/2012	B-temporal

Inspection	O
of	O
breasts	O
:	O
Normal	B-labvalue

Complications	O
:	O
presenting	O
no	B-negation
drainage	O
.	O

Abdomen	O
:	O
Non	O
-	O
tender	O
,	O
no	B-negation
masses	O
.	O

His	O
pain	O
is	O
located	O
on	O
the	O
lateral	B-bodyloc
aspect	I-bodyloc
of	I-bodyloc
his	I-bodyloc
knee	I-bodyloc
and	O
radiates	O
down	O
to	O
his	O
ankle	B-bodyloc
and	O
then	O
also	O
up	O
to	O
his	O
hip	B-bodyloc
.	O

Denies	O
F	O
.	O
H	O
.	O
of	O
Colon	B-bodyloc
CA	O
.	O

BUN	O
/	O
Creatinine	O
Ratio	O
:	O
19	B-labvalue
Reference	O
Range	O
9	B-reference_range
-	I-reference_range
20	I-reference_range

2	O
.	O

He	O
was	O
told	O
that	O
he	O
would	O
probably	O
outgrow	O
it	O
.	O

Examination	O
of	O
extremities	O
for	O
edema	O
and	O
/	O
or	O
varicosities	O
:	O
Abnormal	O
Mild	B-severity
+	I-severity
+	I-severity
+	I-severity
pitting	O
edema	O
to	O
the	O
right	B-bodyloc
ankle	I-bodyloc
.	O
Mild	B-severity
persistent	O
bruising	O
from	O
surgery	O
at	O
back	O
of	O
Rt	O
.	O
calf	O
.	O

Female	O
.	O

His	O
one	O
other	O
sister	O
is	O
healthy	O
.	O
He	O
has	O
a	O
38	O
year	O
old	O
daughter	B-subject
who	O
was	O
diagnosed	O
with	O
breast	B-bodyloc
cancer	O
at	O
the	O
age	O
of	O
33	O
and	O
is	O
now	O
cancer	O
free	B-negation
.	O

Nasal	O
Findings	O
:	O
.	O

No	B-negation
urinary	O
symptoms	O
.	O

General	O
appearance	O
:	O
Normal	O
Well	O
developed	O
,	O
well	O
nourished	O
and	O
appearance	O
reflects	O
stated	O
age	O
.	O

Allergies	O
Penicillins	O

-	O
mood	O
stable	O
,	O
EPDS	O
6	O
/	O
30FreeTextEntry1End	O
The	O
patient	O
is	O
being	O
seen	O
for	O
postpartum	O
follow	O
up	O
.	O

ENT	O
:	O
no	B-negation
earache	O
,	O
no	B-negation
hearing	O
loss	O
,	O
no	B-negation
epistaxis	O
and	O
no	B-negation
nasal	B-bodyloc
discharge	O
.	O

Pulmonary	O

Potassium	O
Chloride	O
ER	O
10	B-strength
MEQ	I-strength
Oral	B-route
Tablet	B-form
Extended	I-form
Release	I-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
27Sep2012	B-temporal
to	O
(	O
Evaluate	O
:	O
26Mar2013	B-temporal
)	O
Requested	O
for	O
:	O
27Sep2012	B-temporal
;	O
Last	O
Rx	O
:	O
27Sep2012	B-temporal

NECK	O
:	O
Soft	O
and	O
supple	O
.	O

Psych	O
not	B-negation
feeling	O
nervous	O
,	O
no	B-negation
anxiety	O
,	O
no	O
depressionand	O
no	B-negation
hallucinations	O
.	O

Eyes	O
:	O
no	B-negation
quadrantanopsia	O
.	O

Levemir	O
FlexPen	O
100	B-strength
UNIT	I-strength
/	I-strength
ML	I-strength
Subcutaneous	B-route
Solution	B-form
;	O
4	B-dosage
units	I-dosage
am	B-frequency
;	O
4	B-dosage
units	I-dosage
at	B-frequency
night	I-frequency
;	O
Therapy	O
:	O
24Nov2012	B-temporal
to	O

Left	B-bodyloc
Hip	I-bodyloc
:	O
no	B-negation
erythema	O
,	O
no	B-negation
warmth	O
,	O
no	B-negation
swelling	O
,	O
no	B-negation
ecchymosis	O
and	O
no	B-negation
deformity	O
.	O

She	O
screened	O
positive	O
for	O
both	O
BV	O
and	O
trichmonas	O
.	O

Tobacco	O
Use	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
vomiting	O
,	O
no	B-negation
constipation	O
and	O
no	B-negation
diarrhea	O
.	O

He	O
is	O
clinically	O
asymptomatic	O
currently	O
and	O
will	O
contact	O
us	O
if	B-condition
there	O
is	O
any	O
change	O
in	O
his	O
neurological	O
status	O
.	O

Virrl	O
Gastroenteritis	O
(	O
008	O
.	O
8	O
)	O
.	O
eg	O

Ability	O
to	O
communicate	O
:	O
Normal	O
.	O

Physical	O
Exam	O

Results	O
/	O
Assessment	O
Type	O
1	O
Diabetes	O
Mellitus	O
250	O
.	O
01	O

May	O
use	O
Gatorade	O
/	O
Pedialyte	O
for	O
al	O
rehydration	O
.	O

Plan	O
Doxycycline	O
Hyclate	O
100	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
TWICE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
11Apr2014	B-temporal
to	O
(	O
Evaluate	O
:	O
21Apr2014	B-temporal
)	O
Requested	O
for	O
:	O
11Apr2014	B-temporal
;	O
Last	O
Rx	O
:	O
11Apr2014	B-temporal
;	O
Edited	O

Dysmenorrhea	O
625	O
.	O
3	O

Secretions	O
:	O
None	B-negation

Gastrointestinal	O
:	O
no	B-negation
constipation	O
and	O
no	B-negation
diarrhea	O
.	O

Will	O
notify	O
patient	O
with	O
results	O
.	O

Assessment	O
of	O
stability	O
:	O
Normal	B-labvalue
.	O

Ipratropium	O
Bromide	O
0	B-strength
.	I-strength
02	I-strength
%	I-strength
Inhalation	B-route
Solution	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
24Jul2013	B-temporal
)	O
to	O

Maternal	B-subject
history	O
of	O
Hyperlipidemia	O

'	O
Mr	O
.	O

Counseling	O
/	O
Counseling	O
/	O
Edu	O
The	O
patient	O
was	O
counseled	O
regarding	O
diagnostic	O
results	O
,	O
instructions	O
for	O
management	O
,	O
risk	O
factor	O
reductions	O
,	O
prognosis	O
,	O
patient	O
and	O
family	O
education	O
,	O
impressions	O
,	O
risks	O
and	O
benefits	O
of	O
treatment	O
optionsandimportance	O
of	O
compliance	O
with	O
treatment	O
.	O

1	O
.	O

ENT	O
:	O
hearing	O
loss	O
,	O
but	O
no	B-negation
hoarseness	O
,	O
no	B-negation
drainage	O
of	O
ear	B-bodyloc
,	O
no	B-negation
vertigo	O
,	O
no	B-negation
snoring	O
was	O
observed	O
,	O
no	B-negation
daytime	O
sleepiness	O
,	O
no	B-negation
mouth	B-bodyloc
sores	O
,	O
no	B-negation
tooth	B-bodyloc
problems	O
,	O
no	B-negation
dysphagia	O
and	O
no	B-negation
tinnitus	O

The	O
straightleg	O
raising	O
test	O
was	O
negative	B-labvalue
,	I-labvalue
bilaterally	I-labvalue
up	I-labvalue
to	I-labvalue
90	I-labvalue
.	O

Cranial	O
nerves	O
XII	O
:	O
there	O
was	O
no	B-negation
tongue	B-bodyloc
deviation	O
with	O
protrusion	O
.	O

Mean	O
Platelet	O
Volume	O
:	O
7	B-labvalue
.	I-labvalue
3	I-labvalue
fL	I-labvalue
Abnormal	O
Low	O
Reference	O
Range	O
7	B-reference_range
.	I-reference_range
4	I-reference_range
-	I-reference_range
10	I-reference_range
.	I-reference_range
4	I-reference_range

Current	O
Meds	O
Aspirin	O
325	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
25Feb2009	B-temporal
to	O
Requested	O
for	O
:	O
25Feb2009	B-temporal

Other	O
Symptoms	O
:	O
back	B-bodyloc
pain	O
.	O

Psychiatric	O

Assessment	O
of	O
hearing	O
:	O
Normal	B-labvalue
.	O

Pravastatin	O
Sodium	O
20	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
AS	I-frequency
DIRECTED	I-frequency
;	O
Therapy	O
:	O
12Jan2012	B-temporal
to	O
(	O
Evaluate	O
:	O
08Oct2012	B-temporal
)	O
;	O
Last	O
Rx	O
:	O
12Jan2012	B-temporal

Disturbance	O
Of	O
Gait	O
781	O
.	O
2	O

f	O
/	O
u	O
6	O
weeks	O

no	B-negation
CVA	O
tenderness	O

Genitourinary	O
:	O
no	B-negation
dysuria	O
,	O
no	B-negation
incontinence	O
,	O
no	B-negation
urinary	O
hesitancy	O
and	O
no	B-negation
nocturia	O
.	O

Ordered	O
;	O
For	O
:	O
Prediabetes	O
(	O
790	O
.	O
29	O
)	O
;	O
Ordered	O
By	O
:	O
ABDELMELEK	O
,	O
LOURICE	O
Performed	O
:	O
Order	O
Comments	O
:	O
MANAGEMENT	O
,	O
METHODIST	O
WEIGHT	O

Peripheral	O
Vascular	O
Exam	O
:	O
Normal	B-labvalue

Cardiovascular	O
:	O
normal	O
.	O

Constitutional	O
:	O
normal	O
.	O

Joint	B-bodyloc
Pain	O
,	O
Localized	O
In	O
The	O
Knee	B-bodyloc
719	O
.	O
46	O

Respiratory	O
effort	O
:	O
No	B-negation
increased	O
work	O
of	O
breathing	O
or	O
signs	O
of	O
respiratory	B-bodyloc
distress	O
.	O

The	O
patient	O
presents	O
with	O
complaints	O
of	O
cough	O
,	O
described	O
as	O
dry	O
.	O

Procedure	O
Procedure	O
Date	O
Da	O
e	O
Comple	O
ed	O
Status	O
Dilation	O
And	O
Curettage	O
-	O
-	O
Resolved	O
Endometiial	O
Biopsy	O
By	O
HystLioscopy	O
-	O
-	O
Resolved	O
Cervical	O
Coniza	O
ion	O
Loop	O
Electrode	O
Excision	O
-	O
-	O
Resolved	O
Cervical	O
Cerclage	O
During	O
Pregnancy	O
-	O
Abdominal	O
Approach	O
-	O
-	O
Resolved	O
Immuniza	O
ion	O
f	O
Tdap	O
(	O
Adacel	O
)	O
(	O
Lot	O
#	O
:	O
C4366AA	O
)	O
-	O
Administered	O
on	O
:	O
05/06/2013	B-temporal

6410	O
Fannin	O
,	O
Suite	O
500	O

Gastrointestinal	O
:	O
normal	O
.	O

0	O

twNoteSignatureControlStart	O
Electronically	O
signed	O
by	O
:	O
Bal	O
Reddy	O
,	O
M	O
.	O
D	O
.	O

Left	O
Foot	O
:	O

ABSOLUTE	O
MONOCYTES	O
448	B-labvalue
cells	I-labvalue
/	I-labvalue
uL	I-labvalue
200	B-reference_range
-	I-reference_range
950	I-reference_range

No	B-negation
dysmenorrhea	O
.	O

Denied	O

1	O
.	O

Cerebellar	O
:	O
the	O
cerebellar	O
function	O
was	O
normal	B-labvalue
.	O

Associated	O
symptoms	O
:	O
no	B-negation
rash	O
,	O
no	B-negation
fever	O
,	O
no	B-negation
fatigue	O
,	O
no	B-negation
headache	O
and	O
no	B-negation
hoarseness	O
.	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
other	O
areas	O
:	O
No	B-negation
lymphadenopathy	O
.	O

S	O
/	O
P	O
Right	O
shoulder	O
diagnostic	O
scope	O
,	O
subacromial	O
decompression	O
DOS	O
:	O
1/2/2014	B-temporal
;	O
the	O
pt	O
states	O
her	O
PT	O
requested	O
more	O
sessions	O
b	O
/	O
c	O
she	O
is	O
not	O
progressing	O
as	O
quickly	O
as	O
she	O
should	O
.	O

Physical	O
Exam	O

3	O
.	O
add	O
mupiriocin	O
irrigations	O

He	O
has	O
started	O
treatment	O
for	O
allergies	O
with	O
near	B-course
resolution	I-course
of	O
headaches	O
and	O
vertigo	O
.	O

Cyproheptadine	O
HCl	O
4	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
TWICE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
08Jun2012	B-temporal
to	O
(	O
Evaluate	O
:	O
08Jul2012	B-temporal
)	O
Requested	O
for	O
:	O
08Jun2012	B-temporal
;	O
Last	O
Rx	O
:	O
08Jun2012	B-temporal

Musc	O
:	O
joint	B-bodyloc
pain	O
,	O
joint	B-bodyloc
swelling	O
and	O
muscle	B-bodyloc
aches	O
,	O
butshowed	O
no	B-negation
erythema	O
,	O
no	B-negation
warmth	O
,	O
no	B-negation
joint	B-bodyloc
instability	O
and	O
no	B-negation
stiffness	O
of	O
joint	B-bodyloc
.	O

GroupHeading71Start	O
GroupHeading71End	O
GroupHeading59Start	O
GroupHeading59End	O
GroupHeading60Start	O
GroupHeading60End	O
GroupHeading70Start	O
GroupHeading70End	O
GroupHeading61Start	O
Psychiatric	O
Descriptisp	O
of	O
patient	O
'	O
s	O
judgemept	O
and	O
insight	O
:	O
Normal	B-labvalue
Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

f	O
Ocella	O
TABS	B-form
(	O
Active	O
)	O

Subglottis	O
:	O
visualized	O
portions	O
normal	O
.	O

Age	O
at	O
menarche	O
was	O
9	O
.	O

ENDOCRINE	O
:	O
no	B-negation
cold	O
intolerance	O
,	O
no	B-negation
heat	O
intolerance	O
and	O
no	B-negation
excessive	O
thirst	O
.	O

Mood	O
and	O
affect	O
:	O
Abnormal	O
.	O

1	O
)	O
Ovarian	B-bodyloc
cyst	O
/	O
pain	O
:	O
Discussed	O
with	O
patient	O
ultrasound	O
results	O
and	O
presence	O
of	O
small	O
cysts	O
,	O
and	O
as	O
possible	B-uncertain
cause	O
of	O
pain	O
.	O

Eyes	O
:	O
no	B-negation
eye	B-bodyloc
pain	O
and	O
no	B-negation
discharge	O
from	O
the	O
eyes	B-bodyloc
.	O

Associated	O
symptoms	O
include	O
no	B-negation
focal	O
neurologic	O
deficits	O
and	O
no	B-negation
memory	O
loss	O
.	O

ALPRAZolam	O
0	B-strength
.	I-strength
25	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
TWICE	B-frequency
DAILY	I-frequency
;	O
Last	O
Rx	O
:	O
11Oct2013	B-temporal

FR	O
/	O
FS	O
:	O
Normal	B-labvalue

Diagnosed	O
with	O
T2DM	O
in	O
November	B-temporal
2011	I-temporal
,	O
with	O
HbA1C	O
reported	O
at	O
11	B-labvalue
.	I-labvalue
1	I-labvalue
.	O

Select	O
-	O
OB	O
+	O
DHA	O
29	B-strength
-	I-strength
1	I-strength
&	I-strength
250	I-strength
MG	I-strength
Oral	B-route
Miscellaneous	O
;	O
chew	O
or	O
swallow	O
oneblue	B-dosage
select	O
ob	O
caplet	B-form

BAHA	O
on	O
the	O
right	O
helps	O
hearing	O
.	O

Never	O
A	O
Smoker	O

MessagetoPa	O
irt	O
Sec	O
ionStart	O
Message	O
to	O
Pa	O
irt	O
Overall	O
,	O
your	O
labs	O
look	B-labvalue
good	I-labvalue
.	O

Social	O
History	O
Being	O
A	O
Social	O
Drinker	O

Consent	O
:	O
Risks	O
/	O
benefits	O
/	O
alternatives	O
reviewed	O
.	O

age	O
group	O
:	O
>	O
=60	O
ml	O
/	O
min	O
/	O
1	O
.	O
73	O
sq	O
m	O

Weight	O
Issues	O
:	O
He	O
does	O
not	O
have	O
any	O
weight	O
concerns	O
.	O
Exercise	O
:	O
He	O
exercises	O
regularly	O
.	O

Maternal	B-subject
aunt	I-subject
'	I-subject
s	I-subject
history	O
of	O
Seizure	O
Disorder	O
V17	O
.	O
2	O

Current	O
Meds	O
Aspirin	O
81	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
Delayed	I-form
Release	I-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
AS	O
DIRECTED	O
;	O
Therapy	O
:	O
03Jan2013	B-temporal
to	O

History	O
of	O
Tobacco	O
Use	O

LIPID	O
PANEL	O
Requested	O
for	O
:	O
04Aug2011	B-temporal

Examination	O
of	O
gait	O
and	O
station	O
:	O
Normal	B-labvalue
.	O

Never	O
A	O
Smoker	O

Her	O
seizure	O
frequency	O
decreased	O
,	O
but	O
she	O
was	O
hit	O
from	O
behind	O
in	O
a	O
car	O
accident	O
2	B-temporal
weeks	I-temporal
ago	I-temporal
and	O
they	O
increased	O
following	O
this	O
.	O

The	O
right	O
and	O
left	O
knee	O
prostheses	O
remain	O
well	O
fixed	O
and	O
in	O
good	O
alignment	O
.	O

Assessment	O
of	O
range	O
of	O
motion	O
:	O
Normal	B-labvalue
.	O

The	O
patient	O
will	O
require	O
nursing	O
,	O
physical	O
therapy	O
,	O
occupational	O
therapy	O
,	O
and	O
social	O
work	O
consults	O
.	O

INTEGUMENTARY	O
:	O
no	B-negation
rashes	O
and	O
no	B-negation
ulcers	O
.	O

MA	O
Digital	O
Mammo	O
Screening	O
Bil	O
G0202	B-labvalue
Requested	O
for	O
:	O
14Aug2013	B-temporal

Musculoskeletal	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
MARTIN	O
CITARDI	O
,	O
M	O
.	O
D	O
.	O

Was	O
taking	O
Optoflex	O
pills	B-form
for	O
hip	B-bodyloc
pain	O
which	O
helped	O
but	O
he	O
has	O
since	O
run	O
out	O
.	O

Examination	O
of	O
extremities	O
for	O
edema	O
and	O
/	O
or	O
varicosities	O
:	O
Abnormal	O
.	O

Aspirin	O
81	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Therapy	O
:	O
05Aug2013	B-temporal
to	O

Orientation	O
to	O
person	O
,	O
place	O
and	O
time	O
.	O

;	O
Apr	B-temporal
29	I-temporal
2013	I-temporal
9	B-temporal
:	I-temporal
08AM	I-temporal
(	O
Author	O
)	O

Maternal	B-subject
grandfather	I-subject
'	I-subject
s	I-subject
history	O
of	O
Laryngeal	B-bodyloc
Cancer	O
V16	O
.	O
2	O

Auscultation	O
of	O
lungs	O
:	O
Abnormal	O
Crackles	O
were	O
heard	O
over	O
both	O
bases	O
.	O

STI	O
screening	O
-	O
Pt	O
initially	O
stated	O
that	O
she	O
desired	O
repeat	O
testing	O
for	O
gonorrhea	O
/	O
chlamydia	O
today	B-temporal
.	O

;	O
Aug	B-temporal
27	I-temporal
2012	I-temporal
3	B-temporal
:	I-temporal
46PM	I-temporal
(	O
Author	O
)	O

Glucose	O
,	O
Serum	O
:	O
84	B-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue
Reference	O
Range	O
65	B-reference_range
-	I-reference_range
99	I-reference_range

Symptoms	O
:	O
no	B-negation
headache	O
,	O
no	B-negation
confusion	O
,	O
no	B-negation
dizziness	O
and	O
no	B-negation
shortness	O
of	O
breath	O
.	O

Associated	O
symptoms	O
include	O
no	B-negation
polyuria	O
.	O

Examination	O
for	O
hernias	O
:	O
Abnormal	O
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O
Unable	O
to	O
obtain	O
.	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
,	O
no	B-negation
cough	O
,	O
no	B-negation
shortness	O
of	O
breath	O
during	O
exertion	O
,	O
no	B-negation
orthopnea	O
and	O
no	B-negation
PND	O
.	O

Pt	O
has	O
no	B-negation
lesions	O
or	O
prodrome	O
at	O
this	B-temporal
time	I-temporal
.	O

Psychiatric	O

Neck	O

Complete	O
-	O
Female	O

Respiratory	O
:	O
Pulmonary	O
:	O
normal	B-labvalue
respiratory	O
rhythm	O
and	O
effort	O
,	O
clear	B-labvalue
bilateral	O
breath	O
sounds	O
and	O
palpation	O
of	O
the	O
chest	B-bodyloc
revealed	O
no	B-negation
abnormalities	O
.	O

Examination	O
of	O
extremities	O
for	O
edema	O
and	O
/	O
or	O
varicosities	O
:	O
Normal	B-labvalue

No	B-negation
o	O
rl	O
ulcers	O
,	O
normal	O
pharyngeal	O
walls	O
.	O

Neck	B-bodyloc
pain	O
with	O
right	O
upper	O
extremity	O
radiculopathy	O
.	O

insomnia	O

Pulmonary	O

Inspection	O
of	O
lips	O
,	O
teethand	O
gums	O
:	O
Abnormal	O
Examination	O
of	O
the	O
teeth	O
revealed	O
upper	O
dentures	O
.	O

NITRITE	O
:	O
-	O

Chief	O
Complaint	O

Intraoperatively	O
,	O
approximately	O
four	O
enlarged	O
renal	B-bodyloc
cysts	O
and	O
six	O
smaller	O
renal	B-bodyloc
cysts	O
were	O
initially	O
removed	O
.	O

Reason	O
For	O
Visit	O

Lisinopril	O
-	O
Hydrochlorothiazide	O
10	B-strength
-	I-strength
12	I-strength
.	I-strength
5	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
DAILY	B-frequency
.	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

Examination	O
of	O
cranial	O
nerves	O
:	O
Normal	B-labvalue
.	O

States	O
he	O
continues	O
to	O
ice	O
and	O
elevate	O
it	O
as	O
well	O
.	O

Gait	O
:	O
the	O
gait	O
and	O
station	O
were	O
normal	B-labvalue
.	O

He	O
still	O
has	O
had	O
no	B-negation
episodes	O
of	O
loss	O
of	O
awareness	O
.	O

Denied	O

Radiological	O
Data	O

Rhythm	O
Disorder	O
427	O
.	O
9	O

X	O
-	O
ray	O
of	O
the	O
chest	O
shows	O
the	O
possibility	O
of	O
free	O
air	O
;	O
therefore	O
,	O
a	O
CT	O
scan	O
was	O
obtained	O
because	O
of	O
the	O
patient	O
'	O
s	O
physical	O
examination	O
,	O
which	O
shows	O
no	B-negation
evidence	I-negation
of	O
intra	B-bodyloc
-	I-bodyloc
abdominal	I-bodyloc
pathology	O
.	O

Vitals	O
UTP	O
Adult	O

Jul	B-temporal
26	I-temporal
2013	I-temporal
9	B-temporal
:	I-temporal
22AM	I-temporal
CST	O
Author	O

True	O
Vocal	O
Folds	O
:	O
full	B-labvalue
range	O
of	O
motion	O
bilaterally	O

Results	O
/	O
Assessment	O
1	O
.	O

Colonoscopy	O
12	B-temporal
/	I-temporal
2013	I-temporal
.	O

Follow	O
-	O
up	O
visit	O
in	O
6	O
weeks	O
Outpatient	O
Follow	O
-	O
up	O
Status	O
:	O
Complete	O
Done	O
:	O
22Aug2011	B-temporal

No	B-negation
obvious	O
wound	O
.	O

Assessment	O
of	O
muscle	O
strength	O
/	O
tone	O
:	O
Normal	B-labvalue

Signatures	O
Electronically	O
signed	O
by	O
:	O
SCOTT	O
HUNG	O
,	O
M	O
.	O
D	O
.	O

Postpartum	O
-	O
denies	B-negation
depression	O
,	O
bonding	O
well	O
with	O
baby	O
,	O
doing	O
well	O

Electronically	O
signed	O
by	O
:	O
SANAH	O
ALI	O
,	O
M	O
.	O
D	O
.	O
;	O

MetFORMIN	O
HCl	O
1000	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
EVERY	B-frequency
12	I-frequency
HOURS	I-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
27Jan2014	B-temporal
to	O
(	O
Evaluate	O
:	O
27Apr2014	B-temporal
)	O
Requested	O
for	O
:	O
27Jan2014	B-temporal
;	O
Last	O
Rx	O
:	O
27Jan2014	B-temporal

Ability	O
to	O
communicate	O
:	O
Normal	B-labvalue
.	O

External	O
inspection	O
of	O
ears	O
and	O
nose	O
:	O
Normal	B-labvalue
.	O

XR	O
HIPS	O
BILATERAL	O
MIN	O
2	O
VWS	O
AND	O
AP	O
PELVIS	O
:	O
Images	O
acquired	O
,	O
not	O
reported	O
on	O
this	O

Family	O
History	O
Paternal	B-subject
grandfather	I-subject
'	I-subject
s	I-subject
history	O
of	O
Colon	B-bodyloc
Cancer	O
V16	O
.	O
0	O

[	O
QLH	O
]	O
CBC	O
(	O
INCLUDES	O
DIFF	O
/	O
PLT	O
)	O
Done	O
:	O
27Feb2014	B-temporal
11	B-temporal
:	I-temporal
00AM	I-temporal

Advise	O
mother	O
to	O
continue	O
to	O
use	O
ciprodex	O
in	O
left	O
ear	O
.	O

Esophageal	B-bodyloc
Reflux	O
530	O
.	O
81	O

Physical	O
Exam	O

The	O
patient	O
was	O
extubated	O
,	O
and	O
he	O
was	O
pronounced	O
expired	O
on	O
08/21/08	B-temporal
at	O
01	B-temporal
:	I-temporal
40	I-temporal
hours	I-temporal
.	O

Not	B-negation
acutely	B-course
distressed	O
.	O

Review	O
of	O
Systems	O

Neck	O

Tylenol	O
fo	O
pain	O
and	O
has	O
even	O
done	O
her	O
own	O
grocery	O
shopping	O
with	O
the	O
walker	O
.	O

Current	O
Meds	O
HumuLIN	O
N	O
100	B-strength
UNIT	I-strength
/	I-strength
ML	I-strength
Subcutaneous	B-route
Suspension	B-form
;	O
INJECT	B-route
30	B-dosage
UNITS	I-dosage
IN	B-frequency
THE	I-frequency
MORNING	I-frequency
AND	O
20	B-dosage
UNITS	I-dosage
IN	B-frequency
THE	I-frequency
EVENING	I-frequency
UNDER	O
THE	O
SKIN	O
;	O
Therapy	O
:	O
05Apr2012	B-temporal
to	O
(	O
Evaluate	O
:	O
02Dec2013	B-temporal
)	O
Requested	O
for	O
:	O
05Jun2013	B-temporal
;	O
Last	O
Rx	O
:	O
05Jun2013	B-temporal

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Prolia	O
60	B-strength
MG	I-strength
/	I-strength
ML	I-strength
Subcutaneous	B-route
Solution	B-form
;	O
INJECT	O
SUBCUTANEOUSLY	B-route
60	B-strength
MG	I-strength
/	I-strength
1	I-strength
ML	I-strength
EVERY	B-frequency
6	I-frequency
MONTHS	I-frequency
;	O
Therapy	O
:	O
29Nov2012	B-temporal
to	O
(	O
Evaluate	O
:	O
12Nov2013	B-temporal
)	O
Requested	O
for	O
:	O
14Aug2013	B-temporal
;	O
Last	O

Total	O
time	O
of	O
encounter	O
was	O
25	O
minutesand15	O
minutes	O
was	O
spent	O
counseling	O
.	O

Male	O
Erectile	O
Disorder	O
302	O
.	O
72	O

[	O
*	O
*	O
2162-1-8	B-temporal
*	O
*	O
]	O
Three	O
Vessel	O
Coronary	O
Artery	O
Bypass	O
Grafting	O
utilizing	O
left	O
internal	O
mammary	O
artery	O
to	O
left	O
anterior	O
descending	O
;	O
saphenous	O
vein	O
grafts	O
to	O
obtuse	O
marginal	O
and	O
posterior	O
descending	O
artery	O
.	O

Since	O
then	O
,	O
the	O
nausea	O
and	O
lightheadedness	O
has	O
not	O
resolved	B-course
)	O
.	O

Orientation	O
to	O
person	O
,	O
place	O
and	O
time	O
.	O

History	O
of	O
Depression	O
311	O

The	O
tongue	O
was	O
normal	O
.	O

He	O
thinks	O
he	O
had	O
negative	B-labvalue
brain	O
imaging	O
studies	O
at	O
the	O
age	O
of	O
12	O
but	O
none	O
since	O
.	O

Accu	O
-	O
Chek	O
Multiclix	O
Lancets	O
Miscellaneous	O
;	O
Test	O
7x	O
per	O
day	O
;	O
Therapy	O
:	O
08Jul2011	B-temporal
to	O
(	O
Evaluate	O
:	O
12Apr2014	B-temporal
)	O
Requested	O
for	O
:	O
17Apr2013	B-temporal
;	O
Last	O
Rx	O
:	O
17Apr2013	B-temporal

Active	O
Problems	O
Acute	B-course
Upper	B-bodyloc
Respiratory	I-bodyloc
Infection	O
465	O
.	O
9	O

She	O
will	O
keep	O
us	O
up	O
-	O
dated	O
if	B-condition
any	O
significant	O
changes	O
.	O

Constitutional	O

However	O
,	O
he	O
complains	O
about	O
some	O
stuffiness	O
and	O
drainage	O
in	O
the	O
same	O
ear	B-bodyloc
for	O
the	B-temporal
last	I-temporal
several	I-temporal
days	I-temporal
and	O
wanted	O
to	O
be	O
seen	O
again	O

There	O
are	O
no	B-negation
new	B-course
dental	O
fractures	O
.	O

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

[	O
QLH	O
]	O
HEMOGLOBIN	O
A1c	O
Requested	O
for	O
:	O
02Jul2012	B-temporal

History	O
of	O
Present	O
Illness	O
24yo	O
G2P2	O
s	O
/	O
p	O
CS	O
7/21/2012	B-temporal
here	O
for	O
postpartum	O
check	O
.	O

Integumentary	O
:	O
no	B-negation
skin	B-bodyloc
lesions	O
,	O
no	B-negation
skin	B-bodyloc
wound	O
,	O
no	B-negation
pruritus	O
,	O
no	B-negation
change	O
in	O
a	O
mole	O
,	O
no	B-negation
dry	O
skin	B-bodyloc
and	O
no	B-negation
unusual	O
growth	O
on	O
the	O
skin	B-bodyloc
.	O

Patient	O
has	O
no	B-negation
history	O
of	O
sexually	O
transmitted	O
infection	O
.	O

2	O
.	O

Comorbid	O
problems	O
include	O
coronary	B-bodyloc
artery	I-bodyloc
disease	O
,	O
but	O
no	B-negation
cardiac	B-bodyloc
failure	O
,	O
no	B-negation
left	B-bodyloc
ventricular	I-bodyloc
hypertrophy	O
,	O
no	B-negation
stroke	O
,	O
no	B-negation
peripheral	B-bodyloc
vascular	I-bodyloc
disease	O
,	O
no	B-negation
hypertensive	O
nephropathy	O
and	O
no	B-negation
hypertensive	O
retinopathy	O
.	O

Orientation	O
to	O
person	O
,	O
place	O
and	O
time	O
:	O
Normal	B-labvalue
.	O

No	B-negation
wheezing	O
was	O
heard	O
.	O

The	O
tongue	O
was	O
normal	O
.	O

Current	O
Meds	O
Alendronate	O
Sodium	O
70	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
ONCE	B-frequency
WEEKLY	I-frequency
Requested	O
for	O
:	O
02Aug2013	B-temporal
;	O
Last	O
Rx	O
:	O
02Aug2013	B-temporal
;	O
Status	O
:	O
ACTIVE	O
-	O
Retrospective	O
Authorization	O

Family	B-subject
history	O
of	O
Thoracic	B-bodyloc
Spine	I-bodyloc
Appearance	O
Dowager	O
'	O
S	O
Hump	O

No	B-negation
assicated	O
hearing	O
loss	O
,	O
tinnitus	O
,	O
chest	B-bodyloc
pain	O
,	O
dyspnea	O
,	O
abdominal	B-bodyloc
pain	O
,	O
diarrhea	O
,	O
excessive	O
salivation	O
,	O
or	O
sweating	O
.	O

;	O
Aug	B-temporal
16	I-temporal
2012	I-temporal
4	B-temporal
:	I-temporal
30PM	I-temporal
(	O
Author	O
)	O

Plan	O
Advair	O
Diskus	B-form
100	B-strength
-	I-strength
50	I-strength
MCG	I-strength
/	I-strength
DOSE	I-strength
Inhalation	B-route
Aerosol	B-form
Powder	I-form
Breath	I-form
Activated	I-form
;	O
INHALE	B-route
1	B-dosage
PUFF	B-form
TWICE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
24Mar2014	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
24Mar2014	B-temporal
)	O
Requested	O
for	O
:	O
24Mar2014	B-temporal
;	O
Edited	O

Do	O
SMBG	O
and	O
bring	O
meter	O
.	O

No	B-negation
muscle	B-bodyloc
or	O
joint	B-bodyloc
aches	O
.	O

I	O
examined	O
and	O
discussed	O
the	O
patient	O
with	O
the	O
resident	O
and	O
agree	O
with	O
the	O
above	O
findings	O
,	O
assessment	O
and	O
plan	O
in	O
the	O
resident	O
note	O
.	O

Chief	O
Complaint	O

Respiratory	O
rate	O
:	O
the	O
respiratory	O
rate	O
was	O
normal	B-labvalue
.	O

External	O
inspection	O
of	O
ears	O
and	O
nose	O
:	O
Normal	B-labvalue
.	O

Allergies	O
Fosamax	O
TABS	B-form

Palpation	O
of	O
lymph	O
nodes	O
in	O
neck	O
:	O
Normal	B-labvalue
.	O

NITRITE	O
Negative	B-labvalue

No	B-negation
ac	O
.	O
distress	O
.	O

Judgment	O
and	O
insight	O
:	O
Normal	B-labvalue
.	O

Plan	O
Cefdinir	O
300	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
EVERY	B-frequency
12	I-frequency
HOURS	I-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
07Oct2013	B-temporal
to	O
(	O
Complete	O
:	O
17Oct2013	B-temporal
)	O
Requested	O
for	O
:	O
07Oct2013	B-temporal
;	O
Last	O
Rx	O
:	O
07Oct2013	B-temporal
;	O
Edited	O

be	O
multiplied	O
by	O
the	O
estimated	O
BMI	O
.	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
neck	O
:	O
Normal	B-labvalue
.	O

Plan	O
[	O
Q	O
]	O
LIPID	O
PANEL	O
WITH	O
REFLEX	O
TO	O
DIRECT	O
LDL	O
Requested	O
for	O
:	O
31Oct2013	B-temporal

works	O
as	O
commercial	O
driver	O
tob	O
-	O
2pk	O
/	O
day	O
,	O
prev	O
4pk	O
/	O
day	O
EtOH	O
-	O
social	O
illicit	O
-	O
denies	O

Nasal	O
endoscopy	O
.	O

Eyes	O

Associated	O
symptoms	O
include	O
no	B-negation
focal	O
neurologic	O
deficits	O
and	O
no	B-negation
memory	O
loss	O
.	O

Integumentary	O
:	O
no	B-negation
dry	O
skin	B-bodyloc
and	O
no	B-negation
flakes	O
on	O
scalp	B-bodyloc
.	O

Cornea	O
:	O
.	O

The	O
patient	O
'	O
s	O
symptoms	O
resolved	B-course
at	O
that	O
point	O
including	O
her	O
headaches	O
.	O

Genitourinary	O
:	O
no	B-negation
dysuria	O
,	O
no	B-negation
urinary	O
frequency	O
,	O
no	B-negation
incontinence	O
and	O
no	B-negation
pelvic	B-bodyloc
pain	O
.	O

Cardiovascular	O

Uterus	O
:	O
Normal	O

Follow	O
-	O
up	O
visit	O
in	O
2	O
weeks	O
Outpatient	O
Follow	O
-	O
up	O
Status	O
:	O
Complete	O
Done	O
:	O
07Jan2013	B-temporal

Recent	O
and	O
remote	O
memory	O
:	O
Normal	B-labvalue
.	O

Abdomen	O

Results	O
/	O
Results	O
/	O
Data	O
Physical	O
Exam	O
Cholesterol	O
Urinalysis	O
Colonoscopy	O
EGD	O
EKG	O
Stress	O
Test	O
Echo	O
Cardiac	O
Cath	O
Peripheral	O
Vascular	O
Screen	O
Carotid	O
Vascular	O
Screen	O
AAA	O
ABI	O
/	O
PVR	O
Diabetes	O
Screen	O
Other	O
Mammogram	O
PAP	O
Dexa	O
Prostate	O
/	O
PSA	O

Marital	O
History	O
-	O
Single	O

Cranial	O
nerves	O
I	O
:	O
the	O
olfactory	O
nerve	O
demonstrated	O
normal	O
function	O
.	O

Marital	O
History	O
-	O
Currently	O
Married	O

Cortical	O
function	O
:	O
Normal	B-labvalue
.	O

EYES	O
-	O
PERRL	O
,	O
red	O
reflex	O
bilaterally	O
,	O
follows	O
face	O
.	O

The	O
use	O
of	O
adaptive	O
skills	O
or	O
devices	O
is	O
contraindicated	O
or	O
not	O
tolerated	O
by	O
the	O
patient	O
for	O
12	O
weeks	O
for	O
the	O
following	O
reasons	O
:	O
.	O
Excessive	O
pain	O
experienced	O
by	O
the	O
patient	O
.	O
Unstable	O
gait	O
contributing	O
to	O
increased	O
risk	O
for	O
fall	O
or	O
injury	O
to	O
the	O
patient	O
.	O

History	O
of	O
Present	O
Illness	O
56	O
year	O
old	O
with	O
FIGO	B-severity
grade	I-severity
2	I-severity
stage	I-severity
IA	I-severity
endometrioid	O
endometrial	B-bodyloc
adenocarcinoma	O
s	O
/	O
/	O
p	O
robotic	O
-	O
>	O
converted	O
to	O
ex	O
-	O
lap	O
/	O
TAH	O
/	O
BSO	O
with	O
staging	O
(	O
pelvic	B-bodyloc
nodes	O
)	O
secondary	O
to	O
inability	O
to	O
ventilate	O
secondary	O
to	O
morbid	O
obesity	O
on	O
November	B-temporal
15	I-temporal
,	I-temporal
2012	I-temporal
.	O

Since	O
her	O
last	O
visit	O
,	O
she	O
saw	O
Dr	O
.	O
Martin	O
.	O

Lisinopril	O
TABS	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
03Nov2011	B-temporal
)	O
to	O

[	O
QLH	O
]	O
CMP	O
W	O
/	O
EGFR	O
Done	O
:	O
18Dec2012	B-temporal
11	B-temporal
:	I-temporal
30AM	I-temporal

Prostate	O
/	O
PSA	O
:	O
N	O
/	O
A	O

Other	O
facial	B-bodyloc
/	O
head	B-bodyloc
injuries	O
:	O
No	O

Betamethasone	O
Powder	B-form
;	O
CMPD	O
Betamethatsone	O
0	B-strength
.	I-strength
75mg	I-strength
add	O
1	B-dosage
capsule	B-form
to	O
Neil	O
-	O
Med	O
system	O
.	O

Electronically	O
signed	O
by	O
:	O
STALEY	O
BROD	O
,	O
M	O
.	O
D	O
.	O

(	O
Medical	O
Transcription	O
Sample	O
Report	O
)	O

Inspection	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
Normal	B-labvalue
.	O

Abn	O
Pap	O
-	O
DEXA	O
7	B-temporal
/	I-temporal
2010	I-temporal

Pt	O
c	O
/	O
o	O
sinus	B-bodyloc
pain	O

Follow	O
-	O
up	O
visit	O
in	O
3	O
weeks	O
Outpatient	O
Follow	O
-	O
up	O
Requested	O
for	O
:	O
16Apr2013	B-temporal

[	O
QLH	O
]	O
CBC	O
(	O
INCLUDES	O
DIFF	O
/	O
PLT	O
)	O
15Jan2013	B-temporal
12	B-temporal
:	I-temporal
00PM	I-temporal
AGUILAR	O
,	O
MARTHA	O

Genitourinary	O
:	O
no	B-negation
dysuria	O
,	O
no	B-negation
incontinence	O
,	O
no	B-negation
pelvic	B-bodyloc
pain	O
,	O
no	B-negation
dysmenorrhea	O
,	O
no	B-negation
vaginal	O
discharge	O
and	O
no	B-negation
unexplained	O
vaginal	B-bodyloc
bleeding	O
.	O

Omeprazole	O
20	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
Delayed	I-form
Release	I-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
EVERY	I-frequency
MORNING	I-frequency
BEFORE	O
BREAKFAST	O
;	O
Therapy	O
:	O
26Apr2013	B-temporal
to	O
(	O
Evaluate	O
:	O
10Sep2013	B-temporal
)	O
Requested	O
for	O
:	O
13May2013	B-temporal
;	O
Last	O
Rx	O
:	O
13May2013	B-temporal

5	O
.	O

Discolored	O
nasal	B-bodyloc
discharge	O
:	O
Mild	B-severity

3	O
.	O

Visit	O
For	O
:	O
Postpartum	O
Exam	O
V24	O
.	O
2	O

Flexible	O
laryngoscopy	O
.	O

Chest	O
:	O
Normal	O
.	O

RESPIRATIONS	O
:	O
At	B-temporal
the	I-temporal
time	I-temporal
of	I-temporal
admission	I-temporal
,	O
baby	O
was	O
not	O
having	O
any	O
apnea	O
spells	O
,	O
no	B-negation
bradycardia	O
or	O
desaturations	O
,	O
was	O
saturating	O
well	O
on	O
room	O
air	O
and	O
continued	O
to	O
do	O
well	O
on	O
room	O
air	O
until	O
the	O
time	O
of	O
discharge	O
.	O

Assessment	O
of	O
muscle	O
strength	O
/	O
tone	O
:	O
Normal	B-labvalue

Musculoskeletal	O
:	O
joint	O
painandneck	O
pain	O
.	O

Preventive	O
measures	O
:	O
stop	O
exposure	O
to	O
smoke	O
,	O
frequent	O
hand	O
washing	O
,	O
decreased	O
exposure	O
to	O
other	O
children	O

Sensory	O
:	O
no	B-negation
sensory	O
abnormalities	O
were	O
noted	O
.	O

History	O
of	O
Bladder	B-bodyloc
Cancer	O

A	O
bandage	O
was	O
applied	O
.	O

QUEST	O
DIAGNOSTICS	O
HOUSTON	O

Palpation	O
of	O
the	O
face	O
for	O
sinus	B-bodyloc
tenderness	O
:	O
No	B-negation
maxillary	B-bodyloc
tenderness	O
.	O

f	O
Knee	B-bodyloc
Pain	O
Elicited	B-course
By	I-course
Motion	I-course
(	O
Active	O
)	O
f	O
Iatrogenic	O
Hypotension	O
(	O
458	O
.	O
29	O
)	O
;	O
(	O
Active	O
)	O

CARBON	O
DIOXIDE	O
23	B-labvalue
mmol	I-labvalue
/	I-labvalue
L	I-labvalue
19	B-reference_range
-	I-reference_range
30	I-reference_range

She	O
denies	B-negation
fevers	O
/	O
chills	O
/	O
abdominal	B-bodyloc
pain	O
.	O

Smoker	O
,	O
Current	O
Status	O
Unknown	O
305	O
.	O
1	O

Risk	O
factors	O
:	O
no	B-negation
obesity	O
,	O
no	O
pregnancy	O
and	O
no	B-negation
breast	B-bodyloc
or	O
chest	B-bodyloc
trauma	O
.	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

Dymista	O
137	B-strength
-	I-strength
50	I-strength
MCG	I-strength
/	I-strength
ACT	I-strength
Nasal	B-route
Suspension	B-form
;	O
INSTILL	B-route
1	B-dosage
SQUIRT	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
31Oct2013	B-temporal
)	O
to	O

ROM	O
0	B-labvalue
to	I-labvalue
128	I-labvalue
.	O

Review	O
of	O
Systems	O

Breath	O
sounds	O
were	O
not	B-labvalue
diminished	I-labvalue
.	O

Examination	O
of	O
gait	O
and	O
station	O
:	O
Normal	B-labvalue
.	O

REASON	O
FOR	O
CONSULTATION	O
:	O
Possible	B-uncertain
free	O
air	O
under	O
the	O
diaphragm	B-bodyloc
.	O

Denied	O

She	O
was	O
judged	O
stable	O
for	O
discharge	O
home	O
on	O
09/25/08	B-temporal
,	O
tolerating	O
a	O
diet	O
well	O
,	O
having	O
no	B-negation
fever	O
,	O
stable	O
vital	O
signs	O
,	O
and	O
good	O
pain	O
control	O
.	O

GU	O
-	O
Nor8al	B-labvalue
female	O
genitalia	O
for	O
age	O
-	O
no	B-negation
labial	B-bodyloc
adhesions	O
.	O

Examination	O
of	O
cranial	O
nerves	O
:	O
Normal	B-labvalue
.	O

Abdomen	O

[	O
U	O
]	O
XRAY	O
KNEE	O
,	O
BOTH	O
,	O
STANDING	O
,	O
AP	O
73565	O
Done	O
:	O
06Nov2013	B-temporal
01	B-temporal
:	I-temporal
26PM	I-temporal

1	O
.	O

Medications	O
:	O
Medication	O
(	O
s	O
)	O
:	O
a	O
statin	O
.	O

MetFORMIN	O
HCl	O
ER	B-form
500	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
Extended	I-form
Release	I-form
24	I-form
Hour	I-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
TWICE	B-frequency
A	I-frequency
DAY	I-frequency
(	O
NEED	O
OFFICE	O
VISIT	O
)	O
;	O
Therapy	O
:	O
07Oct2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
07Oct2013	B-temporal
)	O
Requested	O
for	O
:	O
07Oct2013	B-temporal

Electronically	O
signed	O
by	O
:	O
STALEY	O
BROD	O
,	O
M	O
.	O
D	O
.	O

Endoscopy	O
Was	O
Performed	O
Using	O
:	O
flexible	O
digital	O
scope	O
.	O

Type	O
2	O
Diabetes	O
Mellitus	O
-	O
Uncomplicated	B-course
,	O
Uncontrolled	B-course
250	O
.	O
02	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
axillae	O
:	O
Normal	B-labvalue
.	O

Endocrine	O
:	O
N	O
/	O
A	O
.	O

5	O
.	O

Head	O
and	O
Face	O

Inspection	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
Normal	B-labvalue

Tibial	O
:	O
Normal	O
.	O

Social	O
History	O
Current	O
Every	O
Day	O
Smoker	O
305	O
.	O
1	O

Motor	O
Strength	O
:	O
motor	O
strength	O
was	O
normal	B-labvalue
in	O
all	O
muscle	O
groups	O
.	O
No	B-negation
pronator	O
drift	O
on	O
the	O
right	O
.	O
No	B-negation
pronator	O
drift	O
on	O
the	O
left	O
.	O

Cranial	O
nerves	O
III	O
,	O
IV	O
,	O
and	O
VI	O
:	O
the	O
extraocular	O
motions	O
were	O
intact	B-labvalue
.	O

Examination	O
of	O
cranial	O
nerves	O
:	O
Normal	B-labvalue
.	O

Vitals	O
21Jun2013	B-temporal
11	B-temporal
:	I-temporal
37AM	I-temporal
BMI	O
Calculated	O
46	B-labvalue
.	I-labvalue
15	I-labvalue
BSA	O
Calculated	O
2	B-labvalue
.	I-labvalue
38	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
7	I-labvalue
in	I-labvalue
Weight	O
294	B-labvalue
lb	I-labvalue
Systolic	O
120	B-labvalue
Diastolic	O
81	B-labvalue
Temperature	O
98	B-labvalue
.	I-labvalue
4	I-labvalue
F	I-labvalue
Heart	O
Rate	O
94	B-labvalue

General	O
appearance	O
:	O
Normal	B-labvalue
.	O

Reflexes	O
:	O
Normal	B-labvalue
.	O
Sensation	O
:	O
Normal	B-labvalue
.	O

Pulmonary	O
:	O
Respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O
Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

;	O
Oct	B-temporal
10	I-temporal
2013	I-temporal
2	B-temporal
:	I-temporal
56PM	I-temporal
(	O
Author	O
)	O

Cardiovascular	O

Social	O
History	O
Former	O
Smoker	O
V15	O
.	O
82	O

Heart	O
sounds	O
:	O
normal	B-labvalue
S1	I-labvalue
,	O
normal	B-labvalue
S2	I-labvalue
,	O
no	B-labvalue
S3	I-labvalue
and	O
no	O
No	B-negation
murmurs	O
were	O
heard	O
.	O

History	O
of	O
Mastitis	O
611	O
.	O
0	O

Tongue	O
is	O
dry	O
but	O
skin	B-bodyloc
turgour	O
is	O
nml	O
.	O

Diagnosis	O
:	O
Allergic	O
Rhinitis	O

7	O
.	O

Cranial	O
nerves	O
IX	O
and	O
X	O
:	O
there	O
was	O
normal	B-labvalue
movement	O
of	O
the	O
soft	O
palate	O
and	O
normal	B-labvalue
gag	O
.	O

Eyes	O

Past	O
Medical	O
History	O
History	O
of	O
Nasal	B-bodyloc
Polyps	O
471	O
.	O
9	O

Rebound	O
headache	O
,	O
improved	B-course

SHE	O
PRESENTS	O
WITH	O
A	B-temporal
2	I-temporal
-	I-temporal
3	I-temporal
MONTH	I-temporal
HISTORY	O
OF	O
PAIN	O
IN	O
THE	O
LOWER	B-bodyloc
BACK	I-bodyloc
AND	O
LEFT	B-bodyloc
HIP	I-bodyloc
AREA	O
.	O

Leiomyoma	O
Of	O
The	O
Uterus	B-bodyloc
218	O
.	O
9	O

Cough	O
:	O
Moderate	B-severity

Examination	O
of	O
gait	O
and	O
station	O
:	O
Normal	B-labvalue
.	O

MT	O
/	O
MM	O
:	O
Crust	O

Procedure	O

Mouth	O
and	O
oropharynx	O
shows	O
multiple	O
denture	O
and	O
multiple	O
dental	B-bodyloc
caries	O
.	O

The	O
tongue	O
was	O
normal	O
.	O

Bladder	O
:	O
Normal	O
.	O

[	O
QLH	O
]	O
LIPID	O
PANEL	O
23Feb2012	B-temporal
09	B-temporal
:	I-temporal
45AM	I-temporal
Hardwicke	O
,	O
Robin	O

Arthralgia	O
Of	O
The	O
Left	B-bodyloc
Shoulder	I-bodyloc
Region	O
719	O
.	O
41	O

Surgical	O
History	O
History	O
of	O
Cesarean	O
Section	O

Comments	O
:	O
2	O
/	O
2	O
PTL	O
.	O

whom	O
the	O
CKD	O
-	O
EPI	O
formula	O
has	O
not	O
beet	O
extensively	O
valida	O
ed	O
.	O

The	O
patient	O
spent	O
the	O
next	O
several	O
days	O
on	O
the	O
floor	O
,	O
nonweightbearing	O
with	O
CPM	O
machine	O
in	O
place	O
,	O
developed	O
a	O
brief	O
period	O
of	O
dyspnea	O
,	O
which	O
seems	O
to	O
have	O
resolved	B-course
and	O
may	O
have	O
been	O
a	O
combination	O
of	O
bronchitis	O
,	O
thick	O
secretions	O
,	O
and	O
fluid	O
overload	O
.	O

"	O
Never	O
A	O
Smoker	O

4	O
.	O

Review	O
of	O
Systems	O

Family	B-subject
history	O
of	O
Breast	B-bodyloc
Cancer	O

Physical	O
Exam	O

Active	O
Problems	O
Anemia	O
285	O
.	O
9	O

Tol	O
po	B-route
,	O
no	B-negation
N	O
/	O
V	O
,	O
nl	O
BM	O
,	O
no	B-negation
urinary	O
sx	O
.	O

Temperature	O
:	O
98	B-labvalue
.	I-labvalue
2	I-labvalue
F	I-labvalue
,	O
Oral	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
neck	O
:	O
Normal	B-labvalue
.	O

Musculoskeletal	O
:	O
no	B-negation
arthralgias	O
.	O

Genitourinary	O
:	O
no	B-negation
dysuria	O
,	O
no	B-negation
incontinence	O
,	O
no	B-negation
pelvic	B-bodyloc
pain	O
,	O
no	B-negation
dysmenorrhea	O
,	O
no	B-negation
vaginal	B-bodyloc
discharge	O
and	O
no	B-negation
unexplained	O
vaginal	B-bodyloc
bleeding	O
.	O

Inspection	O
of	O
wound	O
:	O
Normal	B-labvalue
.	O

Osteopenia	O
733	O
.	O
90	O

Past	O
Medical	O
History	O
Problems	O

Color	O
:	O
Normal	O

Abdomen	O

Vitals	O
06Dec2012	B-temporal
09	B-temporal
:	I-temporal
58AM	I-temporal
BMI	O
Calculated	O
19	B-labvalue
.	I-labvalue
01	I-labvalue
BSA	O
Calculated	O
1	B-labvalue
.	I-labvalue
91	I-labvalue
Height	O
6	B-labvalue
ft	I-labvalue
2	I-labvalue
in	I-labvalue
Weight	O
148	B-labvalue
lb	I-labvalue
2	I-labvalue
oz	I-labvalue
Systolic	O
110	B-labvalue
,	O
RUE	O
,	O
Sitting	O
Diastolic	O
80	B-labvalue
,	O
RUE	O
,	O
Sitting	O
Temperature	O
97	B-labvalue
.	I-labvalue
6	I-labvalue
F	I-labvalue
,	O
Oral	O
Heart	O
Rate	O
74	B-labvalue
,	O
R	O
Radial	O
Respiration	O
16	B-labvalue

Social	O
History	O
Denied	O

[	O
L	O
]	O
Lipid	O
Panel	O
w	O
/	O
Chol	O
/	O
HDL	O
Ratio	O
Requested	O
for	O
:	O
02Nov2012	B-temporal

Never	O
A	O
Smoker	O

Birth	O
Weight	O
:	O
6lbs	B-labvalue

Physical	O
Exam	O

CC	O
:	O
F	O
/	O
u	O
Uncontrolled	B-course
DM	O

Psychiatric	O

Intertrigo	O
695	O
.	O
89	O

Thyroid	O
:	O
Normal	O
.	O

Physical	O
Exam	O

supplementation	O
.	O

Percussion	O
of	O
chest	O
:	O
Normal	B-labvalue
.	O

Amantadines	O

NexIUM	O
40	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
Delayed	I-form
Release	I-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
20Aug2013	B-temporal
)	O
to	O

Labia	O
majora	O
:	O
normal	O
.	O

Heart	O
sounds	O
:	O
normal	B-labvalue
S1	O
and	O
normal	B-labvalue
S2	O
.	O

twNoteSignatureControlSg2Sta	O
Electronically	O
signed	O
by	O
:	O
KEVIN	O
HWANG	O
,	O
M	O
.	O
D	O
.	O

The	O
patient	O
reports	O
no	O
change	O
in	O
the	O
condition	O
.	O

Nose	B-bodyloc
bleeds	O
:	O
None	B-negation

both	O
claves	O
are	O
soft	O
and	O
non	B-negation
tender	O
.	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
SANCAK	O
YUKSEL	O
,	O
M	O
.	O
D	O
.	O

Endocrine	O
:	O
no	B-negation
polydipsia	O
,	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
,	O
no	B-negation
constant	O
hunger	O

He	O
exercises	O
3	O
or	O
more	O
times	O
per	O
week	O
.	O

Integumentary	O
:	O
no	B-negation
pruritus	O

Unremarkable	B-labvalue
MRA	O
of	O
the	O
circle	O
of	O
Willis	O

Chief	O
Complaint	O

Tender	O
Traps	O
and	O
post	O
cervical	O
muscles	O
and	O
thoracic	O
musculature	O
.	O

Hypertension	O
401	O
.	O
9	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
and	O
no	O

Electronically	O
signed	O
by	O
:	O
LESLIE	O
GARB	O
,	O
M	O
.	O
D	O
.	O

Results	O
/	O
Results	O
/	O
Data	O
Physical	O
Exam	O
Cholesterol	O
Urinalysis	O
Colonoscopy	O
EGD	O
EKG	O
Stress	O
Test	O
Echo	O
Cardiac	O
Cath	O
Peripheral	O
Vascular	O
Screen	O
Carotid	O
Vascular	O
Screen	O
AAA	O
ABI	O
/	O
PVR	O
Diabetes	O
Screen	O
Other	O
Mammogram	O
PAP	O
Dexa	O
Prostate	O
/	O
PSA	O

f	O
Aspirin	O
81	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
.	O
;	O
Start	O
Date	O
:	O
12/19/2006	B-temporal
(	O
Active	O
)	O

He	O
has	O
not	O
been	O
following	O
any	O
diet	O
or	O
exercise	O
regimen	O
at	O
home	O
.	O

Mononeuritis	O
355	O
.	O
9	O

Eyes	O

The	O
liver	B-bodyloc
was	O
nontender	O
and	O
not	B-negation
enlarged	O
.	O

Mood	O
Disorder	O
Of	O
Unknown	O
(	O
Axis	O
III	O
)	O
Etiology	O
293	O
.	O
83	O

Head	O
and	O
face	O
:	O
Normocephalic	O
;	O
atraumatic	O
.	O

LMP	O
:	O
16Feb2014	B-labvalue

Diabetes	O
With	O
Neurological	O
Complications	O
250	O
.	O
60	O

It	O
is	O
all	O
localized	O
.	O

Pravastatin	O
Sodium	O
TABS	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
15Nov2012	B-temporal
)	O
to	O

Interval	O
symptoms	O
:	O
stable	O
weight	O
gain	O
,	O
denies	B-negation
cold	O
intolerance	O
,	O
stable	O
fatigue	O
,	O
denies	B-negation
weakness	O
,	O
denies	B-negation
constipation	O
,	O
denies	B-negation
dyspnea	O
on	O
exertion	O
,	O
denies	B-negation
trouble	O
concentrating	O
,	O
denies	B-negation
hair	O
loss	O
and	O
denies	B-negation
dry	O
skin	B-bodyloc
.	O

Examination	O
of	O
liver	O
and	O
spleen	O
:	O
Normal	B-labvalue
.	O

Palpation	O
of	O
breasts	O
and	O
axillae	O
:	O
Normal	B-labvalue
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Since	O
his	O
last	O
visit	O
,	O
patient	O
'	O
s	O
symptoms	O
have	O
signicantly	B-course
improved	I-course
.	O

Problems	O
f	O
Normal	O
Routine	O
His	O
osy	O
And	O
Physical	O
Adult	O
(	O
V70	O
.	O
0	O
)	O
;	O
(	O
Active	O
)	O

Ambulatory	O
Health	O
Care	O
Facilaties	O
SHAHLA	O
NADER	O
-	O
EFTEKHARI	O
Address	O
:	O
UNK	O

EGD	O
:	O
11	B-temporal
/	I-temporal
2013	I-temporal

Eustachian	O
tube	O
opening	O
normal	O
.	O

Current	O
Meds	O
1	O

BSA	O
Calculated	O
:	O
1	B-labvalue
.	I-labvalue
64	I-labvalue

hip	O
is	O
recovering	O
well	O
and	O
has	O
regained	O
40	O
%	O
of	O
ROM	O
.	O

7	O

Her	O
BP	O
is	O
normal	B-labvalue
today	B-temporal
and	O
she	O
took	O
her	O
medicatiop	O
this	B-temporal
morning	I-temporal
.	O

Cervical	O
Spine	O
:	O
Normal	O
(	O
showed	O
no	B-negation
tenderness	O
on	O
palpation	O
)	O
.	O

Examination	O
of	O
gait	O
and	O
station	O
:	O
Abnormal	O
(	O
using	O
a	O
walker	O
.	O

Review	O
of	O
Systems	O

Exposed	O
To	O
Hepatitis	O
V01	O
.	O
79	O

Electronically	O
signed	O
by	O
:	O
LETICIA	O
CRUZ	O
,	O
P	O
.	O
A	O
.	O

(	O
tib	O
.	O
)	O
:	O
Normal	O
.	O

Sample	O
Type	O
/	O
Medical	O
Specialty	O
:	O
Discharge	O
Summary	O
Sample	O

Discussion	O
/	O
Discussion	O
/	O
Summary	O

Itchy	O
nose	B-bodyloc
/	O
eyes	B-bodyloc
/	O
throat	B-bodyloc
:	O
None	B-severity

5	O
.	O

The	O
patient	O
was	O
also	O
taking	O
a	O
Thiazide	O
diuretic	O
which	O
could	O
have	O
contribured	O
.	O

PROTEIN	O
TRACE	O
O	O

The	O
patient	O
left	O
OR	O
with	O
transfer	O
to	O
the	O
PACU	O
and	O
subsequently	O
to	O
the	O
hospital	O
floor	O
.	O

Cardiovascular	O
Peripheral	O
vascular	O
exam	O
:	O
Normal	B-labvalue
Radial	O
:	O
right	O
2	O
+	O
and	O
left	O
2	O
+	O
.	O

Neck	O
:	O
Normal	O
.	O

General	O
appearance	O
:	O
Normal	B-labvalue
Appears	O
healthy	O
,	O
within	O
normal	O
limits	O
of	O
ideal	O
weight	O
,	O
well	O
hydrated	O
and	O
appearance	O
reflects	O
stated	O
age	O
.	O

Reason	O
For	O
Visit	O

Male	O
.	O

Sample	O
Name	O
:	O
Neonatal	O
Discharge	O
Summary	O
-	O
1	O

Pupils	O
were	O
equal	O
in	O
size	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
.	O

HEAD	O
-	O
Nor8ocephalic	O
and	O
atraumatic	O
.	O

Examination	O
of	O
reflexes	O
:	O
Normal	B-labvalue
.	O

"	O
History	O
of	O
Current	O
Smoker	O

He	O
denies	B-negation
hypoglycemia	O
.	O

Motor	O
Survey	O
:	O
the	O
motor	O
survey	O
was	O
normal	B-labvalue
.	O

Patient	O
has	O
no	B-negation
history	I-negation
of	I-negation
sexually	O
transmitted	O
infection	O
.	O

Constitutional	O
:	O
feeling	O
tired	O
(	O
fatigue	O
)	O
.	O

Alcohol	O

Second	O
pregnancy	O
:	O
.	O

Today	B-temporal
,	O
she	O
failed	B-labvalue
hearing	O
test	O
on	O
the	O
left	O
,	O
so	O
we	O
need	O
to	O
check	O
her	O
hearing	O
again	O
after	O
left	O
tube	O
is	O
cleaned	O
out	O
without	B-negation
debris	O
.	O

Cervical	O
Spine	O
:	O
Normal	O
(	O
exhibited	O
no	B-negation
muscle	B-bodyloc
spasm	O
)	O
.	O

She	O
has	O
elected	O
definitive	O
therapy	O
with	O
a	O
total	O
vaginal	O
hysterectomy	O
.	O

She	O
continues	O
to	O
have	O
erythema	O
at	O
the	O
injection	O
site	O
as	O
well	O
as	O
flu	O
-	O
like	O
symptoms	O
which	O
improve	B-course
w	O
/	O
Tylenol	O
.	O

Review	O
of	O
Systems	O

Psychiatric	O
:	O
not	B-negation
suicidal	O
,	O
no	B-negation
sleep	O
disturbances	O
,	O
no	B-negation
anxiety	O
,	O
no	B-negation
depression	O
,	O
no	B-negation
personality	O
change	O
and	O
no	B-negation
emotional	O
problems	O
.	O

;	O
Dec	B-temporal
3	I-temporal
2012	I-temporal
2	B-temporal
:	I-temporal
27PM	I-temporal
(	O
Author	O
)	O

Examination	O
of	O
extremities	O
for	O
edema	O
and	O
/	O
or	O
varicosities	O
:	O
Abnormal	O
.	O
Edema	O
around	O
ankles	B-bodyloc
bilaterally	I-bodyloc
.	O

Integumentary	O
:	O
skin	B-bodyloc
lesion	O
(	O
bruising	O
from	O
vasculitis	O
)	O
.	O

UTP	O
-	O
Discussion	O
/	O

History	O
of	O
Drug	O
Use	O

NEUROLOGIC	O
:	O
No	B-negation
vision	O
or	O
hearing	O
change	O
.	O

History	O
of	O
Hypertension	O
401	O
.	O
9	O

Gastroenterology	O
Referral	O
Outpatient	O
Referral	O
Requested	O
for	O
:	O
26Nov2012	B-temporal

1	I-strength
%	I-strength
Otic	B-form
Suspension	I-form
;	O
INSTILL	O
4	B-dosage
DROPS	I-dosage
IN	O
THE	O
AFFECTED	O
EAR	B-bodyloc
(	O
S	O
)	O
TWICE	B-frequency

Temperature	O
:	O
98	B-labvalue
.	I-labvalue
1	I-labvalue
F	I-labvalue
,	O
Oral	O

Respiratory	O
:	O
normal	O
,	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
and	O
no	B-negation
cough	O
.	O

Sulfa	O
Drugs	O

Wet	O
to	O
dry	O
dressing	O
changes	O
.	O

Temperature	O
:	O
97	B-labvalue
.	I-labvalue
3	I-labvalue
F	I-labvalue
,	O
Oral	O

Constitutional	O
:	O
General	O
appearance	O
:	O
Normal	B-labvalue
.	O

The	O
lab	O
showing	O
normal	B-labvalue
antegrade	I-labvalue
flow	I-labvalue
across	O
the	O
right	O
coronary	O
artery	O
as	O
well	O
as	O
the	O
left	O
main	O
and	O
left	O
anterior	O
descending	O
coronary	O
artery	O
,	O
then	O
the	O
circumflex	O
coronary	O
artery	O
.	O

Pulmonary	O

Ordered	O
;	O
For	O
:	O
Health	O
Maintenance	O
(	O
V20	O
.	O
2	O
)	O
;	O
Ordered	O
By	O
:	O
CHATER	O
,	O
MICHAEL	O
Performed	O
:	O
Due	O
:	O
13Jun2013	B-temporal
;	O
Last	O
Updated	O
By	O
:	O
Drake	O
,	O
Suzanne	O

SKIN	O
:	O
Clear	O
.	O
eg	O

f	O
History	O
of	O
Bronchopulmonary	O
Dysplasia	O
Of	O
Fetus	O
Or	O
Newborn	O
Comments	O
:	O
NCPAP	O
x	O
4	O
wks	O
,	O
never	B-negation
intubated	O
,	O
discharged	O
on	O
1	O
/	O
8	O
LPM	O
via	O
NC	O
(	O
770	O
.	O
7	O
)	O
;	O
(	O
Resolved	O
)	O

Abnormal	O
Liver	B-bodyloc
Function	O
Test	O
790	O
.	O
6	O

Test	O
Name	O
Result	O
Flag	O
Reference	O

Hi	O
tory	O
,	O
nutritional	O
screening	O
,	O
developmental	O
surveillanGe	O
(	O
PEDS	O
)	O
and	O
mental	O
health	O
screening	O

LYMPHOCYTES	O
28	B-labvalue
.	I-labvalue
4	I-labvalue
%	I-labvalue
MCH	O
30	B-labvalue
.	I-labvalue
0	I-labvalue
pg	I-labvalue
27	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
33	I-reference_range
.	I-reference_range
0	I-reference_range

Lymphatic	O
Palpatiop	O
of	O
lymph	O
nodes	O
in	O
neck	O
:	O
Normal	B-labvalue
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

1	O
.	O

The	O
neck	B-bodyloc
was	O
not	B-negation
swollen	O
,	O
was	O
non	O
-	O
tender	O
,	O
was	O
not	O
warm	O
and	O
had	O
no	B-negation
masses	O
.	O

Previous	B-temporal
Surgery	O
:	O
Yes	O
.	O

Visit	O
For	O
:	O
Prenatal	O
Exam	O
High	O
-	O
Risk	O
Pregnancy	O
V23	O
.	O
9	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
neck	O
:	O
Normal	B-labvalue
.	O

Discharge	O
Medications	O
:	O

Patient	O
denies	B-negation
chest	B-bodyloc
pain	O
or	O
SOB	O
.	O

Current	O
Meds	O
g3	O

Mood	O
and	O
Affect	O
:	O
appropriate	B-labvalue
mood	I-labvalue
and	I-labvalue
appropriate	I-labvalue
affect	I-labvalue
.	O

The	O
patient	O
is	O
not	B-negation
currently	O
on	O
medication	O
for	O
this	O
problem	O
.	O

29	O
yo	O
P2002	O
s	O
/	O
p	O
Repeat	O
C	O
/	O
D	O
(	O
scheduled	O
)	O
for	O
a	O
postoperative	O
check	O
.	O

Tiredness	O
:	O
None	B-negation

History	O
of	O
Present	O
Illness	O

Vitals	O
UTP	O
Adult	O
Vital	O
Signs	O
[	O
Data	O
Includes	O
:	O
Current	O
Encounter	O
]	O

Cranial	O
nerves	O
VII	O
:	O
facial	O
strength	O
was	O
intact	B-labvalue
bilaterally	I-labvalue
.	O

Procedure	O

Inspection	O
of	O
the	O
conjunctiva	O
and	O
lids	O
:	O
Normal	B-labvalue
Both	O
conjunctiva	O
showed	O
no	O
hyperemia	O
,	O
no	B-negation
watery	O
discharge	O
and	O
no	B-negation
purulent	O
discharge	O
.	O

The	O
patient	O
states	O
her	O
hyperlipidemia	O
has	O
been	O
under	O
good	O
control	O
since	O
the	O
last	O
visit	O
.	O

+	O
hx	O
of	O
hyst	O
due	O
to	O
fibroids	O
.	O

The	O
patient	O
was	O
seen	O
more	B-temporal
than	I-temporal
1	I-temporal
year	I-temporal
ago	I-temporal
.	O

Assessment	O
Esophageal	B-bodyloc
Reflux	O
530	O
.	O
81	O

Procedure	O

No	B-negation
UGI	O
Sx	O
.	O

15	O
minutes	O
was	O
spent	O
counseling	O
.	O

Assessment	O

MAXIMUM	O
4	O
TABLETS	O
DAILY	O
;	O
Therapy	O
:	O
27Feb2007	B-temporal
to	O
(	O
Evaluate	O
:	O
09Aug2014	B-temporal
)	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

2	O
.	O

Examination	O
of	O
reflexes	O
:	O
Normal	B-labvalue
.	O

Ordered	O
;	O
For	O
:	O
Adult	O
Sleep	O
Apnea	O
(	O
780	O
.	O
57	O
)	O
;	O
Ordered	O
By	O
:	O
ABDELMELEK	O
,	O
LOURICE	O
Performed	O
:	O
Order	O
Comments	O
:	O
RICHARD	O
CASTRIOTTA	O
,	O
M	O
.	O

Specialty	O
:	O
General	O
Medicine	O
Sample	O

The	O
patient	O
is	O
due	O
for	O
a	O
lipid	O
panelandliver	O
function	O
tests	O
.	O

Musculoskeletal	O
:	O
no	B-negation
arthralgias	O
and	O
no	B-negation
joint	B-bodyloc
pain	O
.	O

Examination	O
of	O
cranial	O
nerves	O
:	O
Normal	B-labvalue
.	O

POTASSIUM	O
5	B-labvalue
.	I-labvalue
1	I-labvalue
mmol	I-labvalue
/	I-labvalue
L	I-labvalue
3	B-reference_range
.	I-reference_range
5	I-reference_range
-	I-reference_range
5	I-reference_range
.	I-reference_range
3	I-reference_range

ENT	O
:	O
nasal	B-bodyloc
discharge	O
and	O
sore	O
throat	B-bodyloc
,	O
but	O
no	B-negation
earache	O
.	O

Current	O
Meds	O
Betamethasone	O
Powder	B-form
;	O
Empty	O
one	B-strength
0	I-strength
.	I-strength
75	I-strength
mg	I-strength
capsule	B-form
into	O
Neil	O
Med	O
SinusRinse	O
system	O
;	O
irrigate	O
each	O
side	O
BID	B-frequency
;	O
Therapy	O
:	O
30Jan2013	B-temporal
to	O
(	O
Evaluate	O
:	O
30May2013	B-temporal
)	O
Requested	O
for	O
:	O
01Feb2013	B-temporal
;	O
Last	O
Rx	O
:	O
30Jan2013	B-temporal

US	O
ABDOMINAL	O
COMPLETE	O
Requested	O
for	O
:	O
09Jan2012	B-temporal

Never	O
A	O
Smoker	O

Examination	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue
.	O

Feels	O
minimally	O
improved	O
.	O

Physical	O
Exam	O

Kazim	O
Sheikh	O
,	O
MD	O

MPV	O
:	O
9	B-labvalue
.	I-labvalue
3	I-labvalue
fL	I-labvalue
Reference	O
Range	O
7	B-reference_range
.	I-reference_range
4	I-reference_range
-	I-reference_range
10	I-reference_range
.	I-reference_range
4	I-reference_range

History	O
of	O
Simple	O
Goiter	O
240	O
.	O
0	O

Site	O
:	O
Dermatology	O

Exam	O
benign	O
,	O
patient	O
stable	O
,	O
no	B-negation
warning	O
signs	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

No	B-negation
Known	O
Allergies	O

Instruments	O
:	O
Maxillary	O
seekerandAlligator	O
forceps	O
.	O

The	O
heart	O
rate	O
was	O
normal	B-labvalue
.	O

Conjunctiva	O
and	O
lids	B-bodyloc
:	O
No	B-negation
erythema	O
,	O
swelling	O
or	O
discharge	O
.	O

Edema	O
:	O
Normal	O
(	O
not	B-negation
present	I-negation
)	O
.	O

[	O
QLH	O
]	O
Differential	O
Done	O
:	O
09Oct2012	B-temporal
10	B-temporal
:	I-temporal
51AM	I-temporal

Psychiatric	O

Mr	O
.	O
Morales	O
presents	O
for	O
a	O
follow	O
up	O
clinic	O
appointment	O
.	O

f	O
Asymptomatic	O
(	O
Natural	O
)	O
Menopause	O
(	O
V49	O
.	O
81	O
)	O
;	O
(	O
Active	O
)	O

Palpation	O
of	O
breasts	O
and	O
axillae	O
:	O
Normal	B-labvalue
No	B-negation
masses	O
palpated	O
in	O
the	O
right	B-bodyloc
breast	I-bodyloc
.	O

;	O
Jun	B-temporal
18	I-temporal
2013	I-temporal
6	B-temporal
:	I-temporal
40PM	I-temporal
(	O
Author	O
)	O

PAST	O
MEDICAL	O
HISTORY	O
:	O
Significant	O
for	O
alcohol	O
abuse	O
.	O

Peripheral	O
vascular	O
exam	O
:	O
Normal	B-labvalue

Carotid	O
pulses	O
:	O
Normal	B-labvalue

Name	O
:	O
Normal	O
Physical	O
Exam	O
Template	O
-	O
6	O

ABSOLUTE	O
NEUTROPHILS	O
3186	B-labvalue
cells	I-labvalue
/	I-labvalue
uL	I-labvalue
1500	B-reference_range
-	I-reference_range
7800	I-reference_range

TX	O
HealthSteps	O
g52	O

History	O
of	O
Acute	B-course
Conjunctivitis	O
372	O
.	O
00	O

Breast	O
cancer	O
screening	O
includes	O
last	O
mammogram	O
done	B-temporal
10	I-temporal
/	I-temporal
2012	I-temporal
.	O

The	O
patient	O
presents	O
with	O
complaints	O
of	O
no	B-negation
dysuria	O
(	O
RESOLVED	O
)	O
.	O

Assessment	O
g11	O
Nor8al	O
routine	O
hi	O
tory	O
and	O
pEnd	O
Grouwell	O
-	O
baby	O
(	O
birth	O
-	O
2	O
yr	O
)	O
(	O
V20	O
.	O
2	O
)	O
eg	O

Pelvic	B-bodyloc
Pain	O
625	O
.	O
9	O

Family	O
History	O
Paternal	B-subject
grandfather	I-subject
'	I-subject
s	I-subject
history	O
of	O
Alzheimer	O
Disease	O

Total	O
pregnancies	O
3	O
.	O
1	O
live	O
births	O
.	O
1	O
living	O
.	O
2	O
spontaneous	O
abortion	O
(	O
s	O
)	O
.	O

Place	O
of	O
Delivery	O
:	O
MHSW	O
.	O

Birth	O
Weight	O
:	O
9lbs	B-labvalue

Symptoms	O
:	O
The	O
patient	O
is	O
currently	O
asymptomatic	O
.	O

Lantus	O
SoloStar	O
100	B-strength
UNIT	I-strength
/	I-strength
ML	I-strength
Subcutaneous	B-route
Solution	B-form
;	O
START	O
WITH	O
6	B-dosage
UNITS	I-dosage
DAILY	B-frequency
AND	O
INCREASE	O
BY	O
2	O
UNITS	O
EVERY	O
OTHER	O
DAY	O
;	O
Therapy	O
:	O
29Jul2013	B-temporal
to	O
(	O
Evaluate	O
:	O
12Apr2014	B-temporal
)	O
Requested	O
for	O
:	O
12Jan2014	B-temporal
;	O
Last	O
Rx	O
:	O
12Jan2014	B-temporal

-	O
Cervix	B-bodyloc
:	O
Nabothian	O
cysts	O
and	O
mild	B-severity
chronic	B-course
inflammation	O
,	O
with	O
no	B-negation
tumor	O
involvement	O
.	O

Neurological	O
:	O
no	B-negation
dizziness	O
and	O
no	B-negation
fainting	O
.	O

;	O
Mar	B-temporal
1	I-temporal
2012	I-temporal
3	B-temporal
:	I-temporal
38PM	I-temporal
(	O
Author	O
)	O

Cranial	O
nerves	O
V	O
:	O
sensation	O
to	O
the	O
face	O
and	O
masseter	O
strength	O
were	O
intact	B-labvalue
.	O

History	O
of	O
Present	O
Illness	O

Pulmonary	O

The	O
symptoms	O
occur	O
constantly	O
.	O

Social	O
History	O
Exercising	O
Erratically	O

Neurological	O
:	O
no	B-negation
confusion	O
,	O
no	B-negation
convulsions	O
,	O
no	B-negation
dizziness	O
,	O
no	B-negation
fainting	O
,	O
no	B-negation
limb	B-bodyloc
weakness	O
,	O
no	B-negation
difficulty	O
walking	O
,	O
no	B-negation
speech	O
difficulties	O
,	O
no	B-negation
facial	B-bodyloc
weakness	O
,	O
no	B-negation
arm	B-bodyloc
weakness	O
,	O
no	B-negation
leg	B-bodyloc
weakness	O
,	O
no	B-negation
numbness	O
,	O
no	B-negation
tingling	O
,	O
no	B-negation
vertigo	O
and	O
not	B-negation
falling	O
.	O

Breasts	O
:	O
No	B-negation
breast	B-bodyloc
lump	O
and	O
no	B-negation
nipple	B-bodyloc
discharge	O
.	O

Family	O
History	O
Sororal	B-subject
history	O
of	O
Diabetes	O
Mellitus	O
V18	O
.	O
0	O

GroupHeading19End	O
GroupHeading22Start	O
GroupHeading22End	O
GroupHeading23Start	O
GroupHeading23End	O
GroupHeading20Start	O
Total	O
time	O
of	O
encounter	O
was	O
30	O
minutes	O
and	O
15	O
minutes	O
was	O
spent	O
counseling	O
.	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
neck	O
:	O
Normal	B-labvalue
.	O

Akinsan	O
Dosekun	O
,	O
MD	O

Inspection	O
of	O
wound	O
:	O
Normal	B-labvalue
.	O

The	O
abdomen	O
was	O
soft	O
and	O
nontender	O
.	O

Paronychia	O
Of	O
The	O
Finger	B-bodyloc
681	O
.	O
02	O

Constitutional	O
:	O
fever	O
(	O
subjective	O
but	O
no	B-negation
incr	O
.	O
temp	O
)	O
,	O
chills	O
and	O
feeling	O
poorly	O
(	O
malaise	O
)	O
,	O
but	O
not	B-negation
feeling	O
tired	O
(	O
fatigue	O
)	O
.	O

Coordination	O
:	O
Normal	O
.	O

Current	O
Meds	O
Prenatal	O
Vitamins	O
0	B-strength
.	I-strength
8	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Therapy	O
:	O
05Sep2012	B-temporal
to	O

Physical	O
Exam	O

Assessment	O
of	O
range	O
of	O
motion	O
:	O
Normal	B-labvalue
.	O

Select	O
-	O
OB	O
+	O
DHA	O
29	B-strength
-	I-strength
1	I-strength
&	I-strength
250	I-strength
MG	I-strength
Oral	B-route
Miscellaneous	O
;	O
TAKE	O
1	B-strength
MG	I-strength
Daily	B-frequency
;	O
Therapy	O
:	O
11May2011	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
11May2011	B-temporal
)	O

;	O
Nov	B-temporal
12	I-temporal
2013	I-temporal
1	B-temporal
:	I-temporal
00PM	I-temporal
(	O
Author	O
)	O

No	B-negation
vaginal	B-bodyloc
discharge	O
.	O

Delivered	O
:	O
1998	B-temporal
.	O

2	O
.	O

Assessment	O
Acute	B-course
Sinusitis	O
461	O
.	O
9	O

History	O
of	O
Decubitus	O
Ulcer	O
Of	O
The	O
Lower	B-bodyloc
Back	I-bodyloc
707	O
.	O
03	O

History	O
of	O
Present	O
Illness	O

No	B-negation
evidence	I-negation
of	I-negation
depression	O
.	O

No	B-negation
rhonchi	O
were	O
heard	O
.	O

Discussion	O
/	O
Attending	O
Note	O

[	O
QLH	O
]	O
CBC	O
(	O
INCLUDES	O
DIFF	O
/	O
PLT	O
)	O
Requested	O
for	O
:	O
17Feb2014	B-temporal

pt	O
wants	O
to	O
discuss	O
the	O
possible	O
reasons	O
for	O
the	O
cramps	O

0	I-reference_range
Glucose	O
Lvl	O
83	B-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
70	B-reference_range
-	I-reference_range
99	I-reference_range
Adult	O
referetce	O
range	O
values	O
reflect	O
the	O
clinical	O
guidelines	O

DIET	O
:	O
Regular	O
.	O

I	O
pesonally	O
evaluated	O
hte	O
patient	O
face	O
-	O
to	O
-	O
face	O
direct	O
time	O
was	O
60	O
minutes	O
.	O

Surgical	O
History	O
History	O
of	O
Bronchoscopy	O

;	O
Oct	B-temporal
9	I-temporal
2013	I-temporal
4	O
:	B-temporal
58PM	I-temporal
(	O
Author	O
)	O

Place	O
of	O
Delivery	O
:	O
MHH	O
.	O

Flovent	O
AERO	B-form

Acute	B-course
Vernal	O
Conjunctivitis	O
372	O
.	O
03	O

Mild	B-severity
effusion	O
only	O
.	O

f	O
Influenzr	O
(	O
Split	O
)	O
(	O
Lot	O
#	O
:	O
U4531BA	O
)	O
-	O
Administered	O
on	O
:	O
01/11/2013	B-temporal

X	O
-	O
RAYS	O
:	O
There	O
were	O
no	B-negation
xrays	O
taken	O
today	B-temporal
but	O
the	O
xrays	O
that	O
were	O
taken	O
a	O
couple	B-temporal
of	I-temporal
years	I-temporal
ago	I-temporal
where	O
reviewed	O
.	O

Patient	O
is	O
doing	O
better	O
,	O
still	O
sore	O
in	O
the	O
jaw	B-bodyloc
,	O
but	O
improving	B-course
.	O

Normal	O
per	O
patient	O
.	O

Cardiovascular	O

Family	O
History	O
Family	O
history	O
of	O
No	O
Significant	O
Family	O
History	O

CV	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
,	O
no	B-negation
fainting	O
and	O
no	B-negation
murmurs	O
were	O
heard	O
.	O

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

Pulmonary	O

Heart	O
sounds	O
:	O
normal	B-labvalue
S1	O
,	O
normal	B-labvalue
S2	O
,	O
no	B-negation
S3	O
and	O
no	B-negation
S4	O
.	O

Genitourinary	O
:	O
no	B-negation
dysuria	O
.	O

Associated	O
symptoms	O
include	O
weakness	O
of	O
the	O
leg	B-bodyloc
,	O
but	O
no	B-negation
swelling	O
,	O
no	B-negation
decreased	O
range	O
of	O
motion	O
,	O
no	B-negation
difficulty	O
flexing	O
the	O
hip	B-bodyloc
joint	I-bodyloc
,	O
no	B-negation
difficulty	O
ambulating	O
,	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
,	O
no	B-negation
localized	O
rash	O
,	O
no	O
low	O
back	O
pain	O
and	O
no	B-negation
numbness	O
in	O
the	O
leg	B-bodyloc
.	O

Zonisamide	O
100	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
3	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
29Sep2011	B-temporal
to	O
(	O
Evaluate	O
:	O
16Mar2012	B-temporal
)	O
Requested	O
for	O
:	O
17Nov2011	B-temporal
;	O
Last	O
Rx	O
:	O
17Nov2011	B-temporal

PSYCHIATRIC	O
:	O
Normal	O
with	O
no	B-negation
overt	O
depression	O
or	O
suicidal	O
ideations	O
.	O

Pulmonary	O

History	O
of	O
Skin	B-bodyloc
Cancer	O
V10	O
.	O
83	O

The	O
abdomen	O
was	O
normal	B-labvalue
to	O
percussion	O
.	O

-	O
to	O
receive	O
17	O
-	O
OHP	O
weekly	O
starting	O
at	O
16	O
wga	O
.	O

2	O
.	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
,	O
the	O
heart	O
rate	O
was	O
not	B-labvalue
fast	I-labvalue
,	O
the	O
heart	O
rate	O
was	O
not	B-labvalue
slow	I-labvalue
,	O
no	B-negation
intermittent	O
leg	B-bodyloc
claudication	O
and	O
no	B-negation
edema	O
.	O

The	O
abdomen	O
was	O
soft	O
and	O
nontender	O
.	O

Exercising	O
Regularly	O

Chest	O

Hypertension	O
401	O
.	O
9	O

No	B-negation
fibroids	O
noted	O
.	O

AST	O
32	B-labvalue
u	I-labvalue
/	I-labvalue
l	I-labvalue
10	B-reference_range
-	I-reference_range
35	I-reference_range

2	O
.	O

Immunize	O
if	B-condition
not	B-negation
UTD	O
.	O

repeat	O
tid	O
;	O
Therapy	O
:	O
12Mar2013	B-temporal
to	O
(	O
Evaluate	O
:	O
10Jun2013	B-temporal
)	O
Requested	O
for	O
:	O
01Apr2013	B-temporal
;	O
Last	O

She	O
states	O
her	O
bleeding	O
is	O
light	O
.	O

GroupHeading12End	O
GroupHeading11Start	O
Musculoskeletal	O
:	O
no	B-negation
arthralgias	O
.	O

From	O
National	O
Kidney	O
Disease	O
Education	O
Program	O
(	O
NKDEP	O
)	O

Facial	O
strength	O
:	O
Symmetric	B-labvalue
.	O

Past	O
Medical	O
History	O
History	O
of	O
Type	O
2	O
Diabetes	O
Mellitus	O
250	O
.	O
00	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

No	B-negation
Active	O
Problems	O
.	O
eg	O

Demerol	O
SOLN	B-form

No	B-negation
fever	O
and	O
no	B-negation
recent	B-temporal
weight	O
change	O
(	O
unexpected	O
)	O
.	O

Cervical	O
Spine	O
:	O
Normal	B-labvalue
(	O
full	O
range	O
of	O
motion	O
)	O
.	O

Cervical	B-bodyloc
Spine	I-bodyloc
Stenosis	O
723	O
.	O
0	O

Allergic	O
Rhinitis	O
477	O
.	O
9	O

discharge	O
summary	O
,	O
dnr	O
,	O
pronounced	O
expired	O
,	O
extubated	O
,	O
death	O
summary	O
,	O
lung	B-bodyloc
carcinoma	O
,	O
pleural	B-bodyloc
effusion	O
,	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

Lymphatic	O

The	O
patient	O
has	O
a	O
history	O
of	O
an	O
astroctyoma	O
and	O
status	O
post	O
surgical	O
resection	O
with	O
whole	O
brain	O
radiation	O
therapy	O
.	O

296	O
.	O
20	O

Urinary	B-bodyloc
Tract	I-bodyloc
Infection	O
599	O
.	O
0	O

Vaccination	O
:	O
patient	O
received	O
her	O
influenza	O
vaccination	O
today	B-temporal
.	O

She	O
is	O
to	O
call	O
our	O
office	O
once	O
the	O
study	O
has	O
been	O
completed	O
.	O

Social	O
History	O
Never	O
A	O
Smoker	O

Cranial	O
nerves	O
II	O
:	O
visual	O
acuity	O
and	O
visual	O
fields	O
were	O
intact	B-labvalue
.	O

TM	O
perforation	O
was	O
observed	O
,	O
no	B-negation
infection	O
or	O
purulent	O
discharge	O
.	O

Delivered	O
:	O
2/8/13	B-temporal
.	O

UTP	O
-	O
Discussion	O
/	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
groin	O
:	O
Normal	B-labvalue
.	O

2	O
.	O
continue	O
budesonide	O
irrigations	O
/	O
taper	B-dosage
prednisone	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O
The	O
patient	O
is	O
a	O
36	O
-	O
year	O
-	O
old	O
,	O
white	O
female	O
,	O
gravida	O
7	O
,	O
para	O
5	O
,	O
last	O
period	O
mid	O
March	O
,	O
status	O
post	O
tubal	O
ligation	O
.	O

Neurological	O
:	O
no	B-negation
limb	B-bodyloc
weakness	O
and	O
no	B-negation
difficulty	O
walking	O
.	O

Diovan	O
TABS	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
15Nov2012	B-temporal
)	O
to	O

The	O
patient	O
had	O
a	O
CT	O
scan	O
of	O
the	O
chest	O
,	O
which	O
revealed	O
a	O
left	B-bodyloc
pleural	I-bodyloc
effusion	O
,	O
extensive	O
mediastinal	B-bodyloc
mass	O
,	O
left	B-bodyloc
hilar	I-bodyloc
adenopathy	O
,	O
causing	O
complete	O
obstruction	O
of	O
the	O
left	B-bodyloc
lower	I-bodyloc
lobe	I-bodyloc
and	O
the	O
lingula	B-bodyloc
and	O
the	O
left	B-bodyloc
pulmonary	I-bodyloc
vein	I-bodyloc
,	O
and	O
the	O
multiple	O
nodules	O
on	O
the	O
right	B-bodyloc
side	I-bodyloc
of	I-bodyloc
his	I-bodyloc
chest	I-bodyloc
.	O

Reason	O
For	O
Visit	O

Pulmonary	O
Clear	O
breath	O
sounds	O
.	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
neck	O
:	O
Abnormal	O
(	O
large	O
prominent	O
swelling	O
of	O
submandibular	B-bodyloc
LN	O
and	O
surround	O
soft	O
tissue	O
of	O
R	O
side	O
of	O
jaw	O
.	O

The	O
patient	O
was	O
requested	O
to	O
have	O
reevaluation	O
within	O
two	O
days	O
.	O

Continue	O
with	O
hydration	O
,	O
Imodium	O
OTC	O
to	O
reduce	O
frequency	O
.	O

Routine	O
Gynecological	O
Exam	O
V72	O
.	O
31	O

Past	O
Medical	O
History	O
1	O

Endocrine	O
:	O
no	B-negation
proptosis	O
.	O

Physical	O
Exam	O
Right	O
Knee	O
:	O
Appearance	O
:	O
Normal	B-labvalue
no	B-negation
ecchymosis	O
and	O
no	B-negation
erythema	O
.	O

Results	O
/	O
Assessment	O
Benign	B-severity
Paroxysmal	O
Positional	O
Vertigo	O
386	O
.	O
11	O

[	O
QLH	O
]	O
CULTURE	O
,	O
URINE	O
,	O
ROUTINE	O
Requested	O
for	O
:	O
08May2013	B-temporal

Drug	O
Use	O

levaquin	O
500	B-strength
qd	B-frequency
x	B-duration
28	I-duration
days	I-duration

Lithium	O
Bromide	O
POWD	B-form

Psychiatric	O
:	O
normal	O
.	O

DWA	O
Dr	O
.	O
Ali	O

BMI	O
Calculated	O
:	O
30	B-labvalue
.	I-labvalue
73	I-labvalue

Carotid	O
pulses	O
:	O
Normal	B-labvalue
.	O

Apr	B-temporal
4	I-temporal
2012	I-temporal
10	B-temporal
:	I-temporal
15AM	I-temporal
(	O
Author	O
)	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
.	O

Vitals	O
30Oct2013	B-temporal
11	B-temporal
:	I-temporal
35AM	I-temporal
Systolic	O
118	B-labvalue
Diastolic	O
68	B-labvalue
Temperature	O
98	B-labvalue
F	I-labvalue
Heart	O
Rate	O
72	B-labvalue

LORazepam	O
1	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
OTHER	O
Take	O
one	O
before	O
MRI	O
scan	O
.	O

Current	O
Orders	O
Requested	O
for	O
:	O
14Dec2013	B-temporal

Heart	O
Rate	O
:	O
65	B-labvalue

Nares	O
patent	O
.	O

Examination	O
of	O
gait	O
and	O
station	O
:	O
Abnormal	O
.	O

Weight	O
:	O
145	B-labvalue
lb	I-labvalue
4	I-labvalue
oz	I-labvalue

Cardiovascular	O
:	O
no	O
chest	O
painandthe	O
heart	O
rate	O
was	O
not	B-labvalue
fast	I-labvalue
.	O

LMP	O
:	O
the	O
last	O
menstrual	O
period	O
was	O
11/23/11	B-temporal
.	O

good	O
hydration	O
stCtus	O
.	O

Warfarin	O
Sodium	O
6	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
AS	O
DIRECTED	O
;	O
Therapy	O
:	O
05Sep2012	B-temporal

Follow	O
up	O
.	O

The	O
rhythm	O
was	O
regular	B-labvalue
.	O

Monocytes	O
#	O
:	O
0	B-labvalue
.	I-labvalue
5	I-labvalue
K	I-labvalue
/	I-labvalue
CMM	I-labvalue
Reference	O
Range	O
0	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
0	I-reference_range
.	I-reference_range
8	I-reference_range

Ddue	O
to	O
anatomic	O
constraints	O
,	O
awake	O
fiberoptic	O
vocal	O
cord	O
augmentation	O
is	O
not	O
a	O
possibility	O
for	O
Ms	O
.	O
Davis	O
;	O
she	O
will	O
need	O
to	O
be	O
taken	O
to	O
OR	O
under	O
GA	O
due	O
to	O
the	O
inability	O
to	O
see	O
her	O
vocal	O
folds	O
during	O
flexible	O
exam	O
.	O

Immunizations	O

Chief	O
Complaint	O
:	O

-	O
cont	O
Metoprolol	O
ER	B-form
50	B-strength
mg	I-strength
po	B-route
daily	B-frequency

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

Patient	O
elected	O
trial	O
of	O
viagra	O
,	O
potential	O
side	O
effects	O
discussed	O
.	O

ENT	O
:	O
no	B-negation
earache	O
,	O
no	B-negation
hearing	O
loss	O
,	O
no	B-negation
nasal	B-bodyloc
discharge	O
,	O
no	B-negation
sore	O
throat	B-bodyloc
and	O
no	B-negation
hoarseness	O
.	O

A1c	O
improved	O
to	O
7	B-labvalue
.	I-labvalue
2	I-labvalue
%	I-labvalue
.	O

Sleep	O
,	O
sleep	O
,	O
skin	O
and	O
hematologic	O
review	O
of	O
systems	O
are	O
normal	O
.	O

Left	O
Hypothenar	O
(	O
uln	O
.	O
)	O
:	O
Normal	O
.	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
LOURDES	O
ECO	O
,	O
M	O
.	O
D	O
.	O

"	O

Plan	O
[	O
QL	O
]	O
PROTEIN	O
,	O
TOTAL	O
W	O
/	O
CREAT	O
,	O
24	O
HOUR	O
URINE	O
Requested	O
for	O
:	O
10Feb2014	B-temporal

Cardiovascular	O

Vitals	O
26Nov2012	B-temporal
08	B-temporal
:	I-temporal
22AM	I-temporal
BMI	O
Calculated	O
30	B-labvalue
.	I-labvalue
96	I-labvalue
BSA	O
Calculated	O
2	B-labvalue
.	I-labvalue
1	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
9	I-labvalue
in	I-labvalue
Weight	O
209	B-labvalue
lb	I-labvalue
Systolic	O
122	B-labvalue
,	O
Sitting	O
Diastolic	O
70	B-labvalue
,	O
Sitting	O
Temperature	O
97	B-labvalue
.	I-labvalue
9	I-labvalue
F	I-labvalue
,	O
Oral	O
Heart	O
Rate	O
68	B-labvalue

)	O
PO	B-route
DAILY	B-frequency
(	I-frequency
Daily	I-frequency
)	I-frequency
.	O

Heart	O
Rate	O
:	O
74	B-labvalue

trace	B-severity
pitting	O
edema	O
and	O
hyperpigmentation	O
bilaterally	O
.	O

Anesthesia	O
:	O
epidural	O
.	O

Colorectal	O
cancer	O
screening	O
includes	O
no	B-negation
previous	O
colonoscopy	O
.	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

History	O
of	O
Burns	O
949	O
.	O
0	O

Hyperlipidemia	O
272	O
.	O
4	O

Please	O
see	O
attached	O
medication	O
list	O
.	O

Post	O
-	O
nasal	B-bodyloc
drip	O
:	O
None	B-negation

order	O
fasting	O
labs	O
-	O
mail	O
results	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O
Significant	O
for	O
alcohol	O
abuse	O
.	O

Eyes	O
:	O
no	B-negation
eyesight	O
problems	O
.	O

Sugars	O
run	O
from	O
56	B-labvalue
-	I-labvalue
216	I-labvalue
.	O

Inspection	O
of	O
the	O
conjunctiva	O
and	O
lids	O
:	O
Normal	B-labvalue

Patient	O
reports	O
to	O
be	O
feeling	O
well	O
and	O
asymptomatic	O
today	O
.	O

She	O
had	O
soft	O
tissue	O
of	O
neck	O
xray	O
done	O
on	O
2/25/12	B-temporal
that	O
was	O
negative	B-labvalue
.	O

Constitutional	O

Examination	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue
The	O
neck	O
was	O
normal	O
in	O
appearanceandwas	O
supple	O
.	O

SX	O
AGGRAVATED	O
BY	O
VALSALVA	O
.	O

Arterial	O
Pulses	O
:	O
Normal	B-labvalue
(	O
equal	O
bilaterally	O
)	O
.	O

Urine	O
Dipstick	O
(	O
In	O
Office	O
)	O
Done	O
:	O
21Nov2013	B-temporal
10	B-temporal
:	I-temporal
22AM	I-temporal

Follow	O
-	O
up	O
visit	O
in	O
6	O
weeks	O
Outpatient	O
Follow	O
-	O
up	O
Status	O
:	O
Complete	O
Done	O
:	O
03Jun2013	B-temporal

Medications	O
:	O
The	O
patient	O
is	O
not	O
adherent	O
with	O
her	O
medication	O
regimen	O
.	O

Inspection	O
of	O
breasts	O
:	O
Normal	B-labvalue
.	O

Associated	O
symptoms	O
include	O
no	B-negation
syncope	O
,	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
and	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
.	O

Onglyza	O
5	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
EVERY	B-frequency
DAY	I-frequency
;	O
Therapy	O
:	O
25Apr2013	B-temporal
to	O
(	O
Evaluate	O
:	O
22Sep2013	B-temporal
)	O
Requested	O
for	O
:	O
25Apr2013	B-temporal
;	O
Last	O
Rx	O
:	O
25Apr2013	B-temporal

Sample	O
Type	O
/	O
Medical	O
Specialty	O
:	O
General	O
Medicine	O

Social	O
His	O
osy	O

Eosinophils	O
6	B-labvalue
.	I-labvalue
5	I-labvalue
%	I-labvalue
H	B-labvalue
0	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
4	I-reference_range
.	I-reference_range
0	I-reference_range

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
,	O
no	B-negation
cough	O
,	O
no	B-negation
shortness	O
of	O
breath	O
during	O
exertion	O
,	O
no	B-negation
orthopnea	O
and	O
no	B-negation
PND	O
.	O

Service	O
:	O
CARDIOTHORACIC	O

ASSESSMENT	O
:	O
No	B-negation
intra	B-bodyloc
-	I-bodyloc
abdominal	I-bodyloc
pathology	O
.	O

Cardiovascular	O
Peripheral	O
vascular	O
exam	O
:	O
Normal	B-labvalue

Last	O
pap	O
:	O
april	B-temporal
6	I-temporal
,	I-temporal
2011	I-temporal
,	O
pap	O
negative	B-labvalue
for	O
intraepithelial	B-bodyloc
lesions	O
.	O

Neurological	O
:	O
no	B-negation
confusion	O
,	O
no	B-negation
convulsions	O
,	O
no	B-negation
dizziness	O
,	O
no	B-negation
fainting	O
,	O
no	B-negation
tingling	O
,	O
no	B-negation
limb	B-bodyloc
weakness	O
and	O
no	B-negation
difficulty	O
walking	O
.	O

Diastolic	O
:	O
73	B-labvalue
,	O
LUE	O
,	O
Sitting	O

In	O
fact	O
,	O
on	O
11/25/2012	B-temporal
,	O
she	O
got	O
an	B-route
intra	I-route
-	I-route
articular	I-route
cortico	O
-	O
steriod	O
injection	O
from	O
another	O
othopedics	O
surgeon	O
.	O

A	O
cognitive	O
exam	O
was	O
preformed	O
and	O
yeilded	O
the	O
following	O
results	O
(	O
mild	B-severity
decrease	B-course
in	O
memory	O
,	O
substantially	O
improved	O
with	O
Exelon	O
patches	O
)	O
TERRY	O
is	O
orientated	O
to	O
person	O
,	O
orientated	O
to	O
place	O
,	O
orientated	O
to	O
time	O
.	O

The	O
patient	O
has	O
a	O
normal	B-labvalue
respiratory	O
rate	O
,	O
no	O
signs	O
of	O
consolidation	O
and	O
no	B-negation
egophony	O
.	O

Color	O
:	O
Normal	B-labvalue

Dietary	O
interventions	O
:	O
increase	O
fluids	O

BSA	O
Calculated	O
:	O
1	B-labvalue
.	I-labvalue
86	I-labvalue

Thyroid	O
:	O
Normal	O
.	O

Procedure	O
Procedure	O
Date	O
Date	O
Completed	O
Status	O
Tubal	O
Ligation	O
-	O
-	O
Resolved	O
Immunization	O
f	O
Influenza	O
(	O
Whole	O
)	O
(	O
Lot	O
#	O
:	O
79241	O
)	O
-	O
Administered	O
on	O
:	O
09/17/2007	B-temporal
f	O
Influenza	O
(	O
Lot	O
#	O
:	O
42750aa	O
)	O
-	O
Administered	O
on	O
:	O
11/18/2008	B-temporal

Eyes	O
:	O
no	B-negation
eye	B-bodyloc
pain	O
and	O
no	B-negation
eyesight	O
problems	O
.	O

Cranial	O
nerves	O
IX	O
and	O
X	O
:	O
there	O
was	O
normal	B-labvalue
movement	O
of	O
the	O
soft	O
palate	O
and	O
normal	B-labvalue
gag	O
.	O

Comments	O
:	O
2	O
/	O
2	O
PTL	O
.	O

HEMATOLOGIC	O
/	O
LYMPHATIC	O
:	O
no	B-negation
anemia	O
,	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
and	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
.	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
HANIA	O
BAJWA	O
,	O
M	O
.	O
D	O
.	O

History	O
of	O
Pulmonary	B-bodyloc
Hypertension	O
416	O
.	O
8	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
.	O

Keywords	O
:	O
discharge	O
summary	O
,	O
pap	O
smear	O
,	O
total	O
vaginal	O
hysterectomy	O
,	O
hysterectomy	O
,	O
microinvasive	O
,	O
carcinoma	O
,	O
cervix	O
,	O

Vitals	O
11Apr2014	B-temporal
04	B-temporal
:	I-temporal
28PM	I-temporal
Systolic	O
130	B-labvalue
Diastolic	O
60	B-labvalue
Temperature	O
98	B-labvalue
.	I-labvalue
8	I-labvalue
F	I-labvalue
Heart	O
Rate	O
82	B-labvalue

Current	O
Meds	O
Aspirin	O
Low	O
Dose	O
81	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
06Nov2012	B-temporal
)	O
to	O

Bone	O
density	O
study	O
was	O
performed	O
.	O

I	O
have	O
recommended	O
him	O
to	O
follow	O
up	O
in	O
a	O
year	O
or	O
sooner	O
if	O
indicated	O
.	O

Synthroid	O
50	B-strength
MCG	I-strength
Oral	B-route
Tablet	B-form
;	O
Therapy	O
:	O
03Sep2009	B-temporal
to	O
Requested	O
for	O
:	O
21Sep2009	B-temporal

HEMATOLOGIC	O
/	O
LYMPHATIC	O
:	O
No	B-negation
lymph	B-bodyloc
node	I-bodyloc
swelling	O
has	O
been	O
noted	O
.	O

No	B-negation
intranasal	B-bodyloc
mass	O
or	O
polyp	O
was	O
found	O
.	O

Current	O
Orders	O
[	O
QLH	O
]	O
CBC	O
(	O
INCLUDES	O
DIFF	O
/	O
PLT	O
)	O
Requested	O
for	O
:	O
07Mar2011	B-temporal

Hearing	O
:	O
Normal	B-labvalue
.	O

Respiratory	O
:	O
shortness	O
of	O
breath	O
during	O
exertion	O
,	O
but	O
no	B-negation
cough	O
and	O
no	B-negation
PND	O
.	O

7	O
.	O

The	O
abdomen	O
was	O
normal	B-labvalue
to	O
percussion	O
.	O

I	O
personally	O
examined	O
the	O
patient	O
with	O
the	O
resident	O

Physical	O
Exam	O

Hematologic	O
/	O
Lymphatic	O
:	O
no	B-negation
swollen	O
glands	B-bodyloc

Pregnancy	O
-	O
induced	O
Hypertension	O
642	O
.	O
90	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
groin	O
:	O
Normal	B-labvalue
.	O

Immunizations	O

Denied	B-negation
General	O
Surgery	O
.	O
eg	O

Thrombocytopenia	O
287	O
.	O
5	O

NEUROLOGICAL	O
:	O
no	B-negation
seizures	O
.	O

GASTROINTESTINAL	O
:	O
No	B-negation
tenderness	O
or	O
mass	O
.	O

Integumentary	O
:	O
skin	B-bodyloc
lesion	O
.	O

The	O
etiology	O
of	O
the	O
air	O
under	O
the	O
diaphragm	B-bodyloc
is	O
actually	O
a	O
colonic	B-bodyloc
air	O
that	O
is	O
anterior	O
superior	O
to	O
the	O
dome	O
of	O
the	O
diaphragm	O
,	O
near	O
the	O
dome	O
of	O
the	O
liver	O
.	O

UTP	O
Pediatric	O
Vital	O
Signs	O
Recorded	O
by	O
Miranda	O
,	O
Kayla	O
on	O
July	B-temporal
24	I-temporal
,	I-temporal
2013	I-temporal
01	B-temporal
:	I-temporal
24	I-temporal
PM	I-temporal

[	O
Q	O
]	O
URINE	O
PROTEIN	O
,	O
TOTAL	O
,	O
RANDOM	O
(	O
W	O
/	O
O	O
CREATININE	O
)	O
Done	O
:	O
28Feb2011	B-temporal
10	B-temporal
:	I-temporal
28AM	I-temporal

Inspection	O
of	O
the	O
conjunctiva	O
and	O
lids	O
:	O
Normal	B-labvalue
.	O

Nasal	O
mucosa	O
,	O
septum	O
,	O
and	O
turbinates	O
:	O
Abnormal	O
.	O

The	O
heart	O
rate	O
was	O
normal	B-labvalue
.	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
.	O

Hematologic	O
/	O
Lymphatic	O
:	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
,	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
,	O
no	B-negation
swollen	O
glands	B-bodyloc
and	O
no	B-negation
swollen	O
glands	B-bodyloc
in	O
the	O
neck	B-bodyloc
.	O

Examination	O
of	O
digits	O
and	O
nails	O
:	O
Normal	B-labvalue
.	O

Eth	O
:	O
Normal	O

Bus	O
:	O
(	O
832	O
)	O
325	O
-	O
7222	O

Social	O
History	O
Former	O
Smoker	O
V15	O
.	O
82	O

Colonscopy	O
:	O
never	B-temporal

1	O
.	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
and	O
no	B-negation
palpitations	O
.	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
vomiting	O
and	O
no	B-negation
nausea	O
.	O

History	O
of	O
Gestational	O
Diabetes	O
Mellitus	O
-	O
Postpartum	O
Condition	O
Or	O
Prior	B-temporal
Complicated	O
Delivery	O

Ok	O
to	O
return	O
to	O
work	O
.	O
Cluster	O
headache	O
keep	O
a	O
diary	O
follow	O
up	O
in	O
1	B-temporal
month	I-temporal
.	O

The	O
abdomen	O
was	O
normal	O
to	O
percussion	O
.	O

Hypopharynx	O
:	O
normal	O
mucosa	O
and	O
appearance	O

I	O
agree	O
with	O
:	O
all	O
the	O
components	O
of	O
the	O
exam	O
.	O

ECG	O
-	O
12	O
Lead	O
Requested	O
for	O
:	O
13Nov2012	B-temporal

No	B-negation
rales	O
or	O
crackles	O
were	O
heard	O
.	O

Otoscopic	O
examination	O
:	O
Normal	B-labvalue

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

;	O
Apr	B-temporal
12	I-temporal
2014	I-temporal
12	B-temporal
:	I-temporal
26PM	I-temporal
(	O
Author	O
)	O

The	O
patient	O
often	O
associates	O
most	O
of	O
these	O
symptoms	O
with	O
his	O
GERD	O
.	O

Cranial	O
nerves	O
VII	O
:	O
facial	O
strength	O
was	O
intact	B-labvalue
bilaterally	O
.	O

[	O
LH	O
]	O
Vitamin	O
D	O
,	O
25	O
-	O
Hydroxy	O
,	O
Total	O
*	O
(	O
E	O
)	O
Done	O
:	O
18Dec2012	B-temporal
11	B-temporal
:	I-temporal
30AM	I-temporal

History	O
of	O
Morbid	O
Obesity	O
278	O
.	O
01	O

Neurological	O
:	O
arm	B-bodyloc
weakness	O
,	O
leg	B-bodyloc
weakness	O
,	O
tingling	O
and	O
a	O
burning	O
sensation	O
.	O

ENT	O
:	O
no	B-negation
hearing	O
loss	O
.	O

Vitals	O
09Jan2014	B-temporal
11	B-temporal
:	I-temporal
20AM	I-temporal
BMI	O
Calculated	O
28	B-labvalue
.	I-labvalue
45	I-labvalue
BSA	O
Calculated	O
1	B-labvalue
.	I-labvalue
9	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
6	I-labvalue
in	I-labvalue
Weight	O
177	B-labvalue
lb	I-labvalue
Systolic	O
93	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
60	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Temperature	O
97	B-labvalue
.	I-labvalue
8	I-labvalue
F	I-labvalue
,	O
Tympanic	O
Heart	O
Rate	O
63	B-labvalue
,	O
L	O
Radial	O
Respiration	O
15	B-labvalue
Respiration	O
Quality	O
Normal	B-labvalue

Chronic	B-course
Obstructive	O
Pulmonary	B-bodyloc
Disease	O
496	O

No	B-negation
acute	B-course
cardiopulmonary	O
process	O
.	O

Constitutional	O

Constitutional	O
:	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
and	O
no	B-negation
fatigue	O
.	O

She	O
consumes	O
a	O
diverse	O
and	O
healthy	O
diet	O
.	O
She	O
does	O
not	O
have	O
any	O
weight	O
concerns	O
.	O
She	O
does	O
not	O
use	O
tobacco	O
.	O
She	O
denies	O
alcohol	O
use	O
.	O
She	O
denies	O
drug	O
use	O
.	O

Color	O
:	O
Normal	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

No	B-negation
cervical	O
lymphadenopathy	O
.	O

Exacerbations	O
:	O
More	O
than	O
6	O
times	O
/	O
yr	O
.	O

The	O
episodes	O
occur	O
daily	O
.	O

over	O
digit	B-bodyloc
distal	I-bodyloc
to	O
injury	O
5th	B-bodyloc
digit	I-bodyloc
:	O
laceration	O
on	O
volar	O
aspect	O
at	O
level	O
of	O
DIP	B-bodyloc
with	O
no	B-negation
exposed	O
flexor	O
tendon	B-bodyloc
;	O
capillary	O
refill	O
<	B-labvalue
1sec	I-labvalue
,	O
dopplerable	O
signal	O
of	O
both	O
radial	O
and	O
ulnar	O
digital	O
arteries	O
;	O
sensorium	O
to	O
light	O
touch	O
intact	O

He	O
had	O
ear	B-bodyloc
drainage	O
once	O
,	O
used	O
abx	O
drops	B-form
and	O
drainage	O
has	O
resolved	B-course
.	O

Orientation	O
to	O
person	O
,	O
place	O
and	O
time	O
:	O
Normal	B-labvalue
Mental	O
Status	O
:	O
oriented	O
to	O
person	O
,	O
place	O
,	O
and	O
time	O
.	O

Discuss	O
Dentist	O
appt	O

Monocytes	O
:	O
5	B-labvalue
.	I-labvalue
9	I-labvalue
%	I-labvalue
Reference	O
Range	O
2	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
12	I-reference_range
.	I-reference_range
0	I-reference_range

Viagra	O
100	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
AS	O
DIRECTED	O
;	O
Therapy	O
:	O
02Nov2012	B-temporal
to	O
(	O
Evaluate	O
:	O
27Nov2013	B-temporal
)	O
Requested	O
for	O
:	O
02Nov2012	B-temporal
;	O
Last	O
Rx	O
:	O
02Nov2012	B-temporal

Baby	O
was	O
born	O
at	O
ABCD	O
Hospital	O
at	O
1333	B-temporal
on	O
07/14/2006	B-temporal
.	O

He	O
has	O
started	O
treatment	O
for	O
allergies	O
with	O
near	B-course
resolution	I-course
of	O
headaches	O
and	O
vertigo	O
.	O

f	O
Living	O
With	O
Parents	O
(	O
Active	O
)	O

Psychiatric	O
:	O
normal	O
,	O
not	B-negation
suicidal	O
,	O
no	B-negation
sleep	O
disturbances	O
and	O
no	B-negation
anxiety	O
.	O

TraMADol	O
HCl	O
50	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
EVERY	B-frequency
6	I-frequency
HOURS	I-frequency
AS	B-frequency
NEEDED	I-frequency
FOR	O
PAIN	O
Requested	O
for	O
:	O
23Aug2013	B-temporal
;	O
Last	O
Rx	O
:	O
23Aug2013	B-temporal

EMG	O
/	O
NCS	O
:	O
irritative	O
myopathy	O

Electronically	O
signed	O
by	O
:	O
RONDA	O
ALEXANDER	O
,	O
M	O
.	O
D	O
.	O

Examination	O
of	O
pupils	O
and	O
irises	O
:	O
Normal	B-labvalue

Neurological	O
:	O
not	O
alert	O
,	O
no	B-negation
confusion	O
,	O
no	B-negation
convulsions	O
,	O
no	B-negation
tinnitus	O
,	O
no	B-negation
dizziness	O
,	O
no	B-negation
fainting	O
,	O
no	B-negation
tingling	O
,	O
no	B-negation
limb	B-bodyloc
weakness	O
and	O
no	B-negation
difficulty	O
walking	O
.	O

SocialHistisy	O
_	O
10	O
_	O
twCiteListControlStart	O
Alcohol	O
Use	O

Weight	O
:	O
280	B-labvalue
lb	I-labvalue

[	O
QLH	O
]	O
FERRITIN	O
Done	O
:	O
11Nov2011	B-temporal
12	B-temporal
:	I-temporal
55PM	I-temporal

Anemia	O
285	O
.	O
9	O

Adderall	O
TABS	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
AS	O
DIRECTED	O
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
31Jan2012	B-temporal
)	O
to	O

Patient	O
agrees	O
to	O
proceed	O
.	O

Her	O
sleep	O
deprived	O
EEG	O
suggested	B-uncertain
a	O
generalized	O
epilepsy	O
,	O
but	O
her	O
23	O
houris	O
suggests	B-uncertain
a	O
focal	O
epilepsy	O
.	O

A1c	O
7	B-labvalue
.	I-labvalue
2	I-labvalue
%	I-labvalue

Abdomen	O

Middle	O
Turbinate	O
:	O
Normal	B-labvalue
position	I-labvalue
.	O

LORazepam	O
1	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
OTHER	O
Take	O
one	O
before	O
MRI	O
scan	O
.	O

MRI	O
lumbar	O
spine	O
9/20/12	B-temporal

Normrl	O
nasal	O
mucosa	O
.	O

Palpation	O
of	O
heart	O
:	O
Normal	B-labvalue
PMI	O
,	O
no	B-negation
thrills	O
.	O

Family	B-subject
history	O
of	O
Pancreatitis	O

He	O
still	O
repeatedly	O
declined	O
insulin	O
.	O

twNoteSignatureControlEnd	O
SignaturesSectispEnd	O

Discussed	O
the	O
importance	O
of	O
lipid	O
control	O

MUSCULOSKELETAL	O
:	O
no	B-negation
muscle	B-bodyloc
pain	O
and	O
no	B-negation
muscle	B-bodyloc
weakness	O
.	O

Examination	O
of	O
the	O
head	O
and	O
face	O
:	O
Normal	B-labvalue
.	O

4	O
.	O

Test	O
Name	O
Result	O
Flag	O
Reference	O

External	O
inspection	O
of	O
ears	O
and	O
nose	O
:	O
Normal	B-labvalue
.	O

Eos	O
:	O
1	B-labvalue
%	I-labvalue
Reference	O
Range	O
0	B-reference_range
-	I-reference_range
7	I-reference_range

Percussion	O
:	O
.	O

NexIUM	O
40	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
Delayed	I-form
Release	I-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
25Jul2012	B-temporal
to	O

The	O
trachea	O
was	O
midline	O
.	O

No	B-negation
diaphoresis	O
.	O

No	B-negation
lymphadenopathy	O
.	O

Medical	O
Decision	O
Making	O
:	O

No	B-negation
masses	O
palpated	O
.	O

[	O
U	O
]	O
XRAY	O
KNEE	O
1	O
OR	O
2	O
VWS	O
LEFT	O
73560	O
Done	O
:	O
06Nov2013	B-temporal
12	B-temporal
:	I-temporal
00AM	I-temporal

The	O
patient	O
is	O
being	O
seen	O
for	O
a	O
health	O
maintenance	O
and	O
recently	O
did	O
wwe	O
evaluation	O
.	O

Menorrhagia	O
626	O
.	O
2	O

Family	O
History	O
Paternal	B-subject
history	O
of	O
Asthma	O
V17	O
.	O
5	O

Optic	O
Disc	O
:	O
Normal	O
.	O

Family	O
History	O
Family	B-subject
history	O
of	O
Breast	B-bodyloc
Cancer	O
V16	O
.	O
3	O

Allergies	O
_	O
20	O
_	O
twCiteListControlStart	O
No	B-negation
Known	O
Drug	O
Allergies	O

I	O
explained	O
this	O
in	O
detail	O
with	O
her	O
and	O
her	O
adoptive	O
mother	O
over	O
the	O
telephone	O
.	O

Description	O
:	O
Total	O
vaginal	O
hysterectomy	O
.	O

Hypothyroidism	O
244	O
.	O
9	O

Chief	O
Complaint	O

HEMATOLOGIC	O
/	O
LYMPHATIC	O
:	O
no	B-negation
anemia	O
,	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
and	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
.	O

stable	O
on	O
albuterol	O
inhaler	B-form
prn	B-frequency
,	O

Monocytes	O
5	B-labvalue
.	I-labvalue
8	I-labvalue
%	I-labvalue
2	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
12	I-reference_range
.	I-reference_range
0	I-reference_range

Signatures	O
Electronically	O
signed	O
by	O
:	O
AMBER	O
ZULFIQAR	O
,	O
M	O
.	O
D	O
.	O

Coordination	O
:	O
Normal	B-labvalue

ENT	O
:	O
no	B-negation
earache	O
,	O
no	B-negation
nasal	B-bodyloc
discharge	O
,	O
no	B-negation
sore	O
throat	B-bodyloc
and	O
no	B-negation
hoarseness	O
.	O

She	O
has	O
no	B-negation
other	O
medical	O
complaints	O
.	O

Tenderness	O
:	O
None	O
except	O
the	O
distal	O
IT	O
band	O
,	O
but	O
not	O
over	O
the	O
lateral	O
joint	O
line	O
and	O
not	O
over	O
the	O
medial	O
joint	O
line	O
.	O

Skin	O

Place	O
of	O
Delivery	O
:	O
MHH	O
.	O

She	O
wants	O
botox	O
teatments	O
.	O

bodyMessage	O
g28	O

Head	O
and	O
Face	O
:	O
the	O
head	O
was	O
normocephalic	O
,	O
threre	O
was	O
no	B-negation
evidence	I-negation
of	I-negation
injury	O
and	O
no	B-negation
facial	B-bodyloc
abnormalities	O
were	O
observed	O
.	O

Chest	O

restart	O
prednisone	O
burst	O
then	O
taper	O
to	O
5mg	B-strength
qd	B-frequency

Inspection	O
of	O
breasts	O
:	O
Normal	B-labvalue
.	O

I	O
agree	O
with	O
the	O
history	O
,	O
exam	O
and	O
plan	O
of	O
care	O
as	O
documented	O
in	O
the	O
resident	O
note	O
.	O

Glyburide	O
5	B-strength
mg	I-strength
BID	B-frequency

Symptoms	O
:	O
cheek	O
painandcheek	O
pressure	O
,	O
but	O
no	B-negation
forehead	B-bodyloc
pain	O
,	O
no	B-negation
forehead	B-bodyloc
pressure	O
,	O
no	B-negation
cough	O
,	O
no	B-negation
ear	B-bodyloc
fullness	O
,	O
no	B-negation
ear	B-bodyloc
pain	O
and	O
no	B-negation
ear	B-bodyloc
pressure	O
.	O

Examination	O
of	O
the	O
abdomen	O
:	O
Normal	B-labvalue
.	O

Male	O
.	O

Family	B-subject
history	O
of	O
Malignant	O
Pancreatic	B-bodyloc
Neoplasm	O

His	O
ENT	O
workup	O
was	O
apparently	O
negative	B-labvalue
except	O
for	O
allergy	O
-	O
related	O
symptoms	O
.	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
neck	O
:	O
Normal	B-labvalue
.	O

Chief	O
Complaint	O

Height	O
:	O
4	B-labvalue
ft	I-labvalue
11	I-labvalue
in	I-labvalue

Palpation	O
of	O
heart	O
:	O
Normal	B-labvalue

Diarrhea	O
:	O
resolved	B-course
.	O

Patient	O
Specific	O
Education	O
Given	O
Done	O
:	O
01Oct2013	B-temporal

Head	O
and	O
Face	O
:	O
Head	O
and	O
face	O
:	O
Normal	O
.	O
Palpation	O
of	O
the	O
face	O
for	O
sinus	B-bodyloc
tenderness	O
:	O
Normal	B-labvalue
.	O
Salivary	O
glands	O
:	O
Normal	O
.	O
Facial	O
strength	O
:	O
Normal	B-labvalue
.	O

Electronically	O
signed	O
by	O
:	O
MARTIN	O
CITARDI	O
,	O
M	O
.	O
D	O
.	O

Neck	O

Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
,	O
the	O
heart	O
rate	O
was	O
not	B-labvalue
fast	I-labvalue
,	O
the	O
heart	O
rate	O
was	O
not	B-labvalue
slow	I-labvalue
,	O
no	B-negation
intermittent	O
leg	B-bodyloc
claudication	O
and	O
no	B-negation
edema	O
.	O

Excessive	O
bleeding	O
(	O
menorrhagia	O
)	O
.	O

Pulses	O
equal	O
at	O
carotid	O
.	O

;	O
Aug	B-temporal
22	I-temporal
2011	I-temporal
5	B-temporal
:	I-temporal
36PM	I-temporal
(	O
Author	O
)	O

Name	O
:	O
Leiomyosarcoma	O

(	O
832	O
)	O
325	O
-	O
7161	O
(	O
Work	O
phone	O
)	O
Pharmacy	O
Walgreen	O
Drug	O
Store	O
04513	O

2	O
.	O

Head	O
and	O
Face	O

Neurological	O
:	O
no	B-negation
dizziness	O
,	O
no	B-negation
lightheadedness	O
,	O
no	B-negation
vertigo	O
and	O
no	O

Constitutional	O
:	O
not	B-negation
feeling	O
tired	O
(	O
fatigue	O
)	O
.	O

Physical	O
Exam	O

Hypercholesterolemia	O
272	O
.	O
0	O

Peripheral	O
Vision	O
:	O
Normal	B-labvalue
(	O
full	O
)	O
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Eye	O
Lids	O
:	O
.	O

Pulmonary	O

DISCHARGE	O
CONDITION	O
:	O
Good	O
.	O

Appearance	O
-	O
normal	O
except	O
as	O
noted	O
:	O
left	O
kneeandleft	O
knee	O
with	O
varus	O
deformity	O
and	O
mild	B-severity
swelling	O
.	O

The	O
patient	O
'	O
s	O
last	O
LDL	O
was	O
72	B-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue
.	O
/	O

Inspection	O
of	O
breasts	O
:	O
Normal	B-labvalue
.	O

Fish	O
Oil	O
OIL	O
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
15Nov2012	B-temporal
)	O
to	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
groin	O
:	O
Normal	B-labvalue
.	O

Headache	O
:	O
None	B-negation

NECK	O
:	O
Trachea	O
is	O
midline	O
.	O

Examination	O
of	O
the	O
head	O
and	O
face	O
:	O
Normal	B-labvalue

The	O
abdomen	O
was	O
soft	O
and	O
nontender	O
.	O

Examination	O
of	O
the	O
abdomen	O
:	O
Normal	B-labvalue
The	O
abdomen	O
was	O
flat	O
.	O

Examination	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue
.	O

Provider	O
:	O
SIRUNYA	O
SILAPUNT	O

Her	O
knee	B-bodyloc
symptoms	O
are	O
adversely	O
affecting	O
her	O
overall	O
QOL	O
and	O
general	O
well	O
being	O
.	O

Discussion	O
/	O
Signatures	O
Electronically	O
signed	O
by	O
:	O
JULIA	O
ADROGUE	O
,	O
M	O
.	O
D	O
.	O

Pulses	O
:	O
Normal	B-labvalue
.	O

Escitalopram	O
Oxalate	O
20	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
0	B-dosage
.	I-dosage
5	I-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
30Sep2010	B-temporal
to	O
(	O
Evaluate	O
:	O
01Aug2013	B-temporal
)	O
Requested	O
for	O
:	O
06Aug2012	B-temporal
;	O
Last	O
Rx	O
:	O
06Aug2012	B-temporal

Mental	O
Status	O
:	O
A	O
mental	O
status	O
exam	O
was	O
performed	O
and	O
was	O
normal	B-labvalue
.	O

Good	O
.	O

When	O
he	O
was	O
a	O
ninth	O
-	O
grade	O
the	O
spells	O
diminished	B-course
in	O
frequency	O
and	O
intensity	O
and	O
then	O
completely	O
stopped	B-course
.	O

Genitourinary	O
:	O
no	B-negation
dysuria	O
and	O
no	B-negation
urinary	O
hesitancy	O
.	O

Alcohol	O

She	O
denies	B-negation
recent	B-temporal
GC	O
use	O
.	O

He	O
had	O
repeatedly	O
and	O
vehemently	O
refused	B-negation
insulin	O
therapy	O
in	O
the	B-temporal
past	I-temporal
.	O

3	O
-	O
,	O
2	O
-	O
,	O
1	O
+	O
9	O
-	O
,	O
10	O
+	O

Inspection	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
Normal	B-labvalue
.	O

Description	O
of	O
patient	O
'	O
s	O
judgement	O
and	O
insight	O
:	O
Normal	B-labvalue
.	O

Hypertension	O
401	O
.	O
9	O

Chief	O
Complaint	O

Patient	O
:	O
TUMBLIN	O
,	O
PAYTIN	O
;	O
DOB	O
:	O
8/15/2011	B-temporal
;	O
MRN	O
:	O
3757454	O

Palpation	O
of	O
the	O
face	O
and	O
sinuses	O
:	O
Normal	B-labvalue

Current	O
Meds	O
Advil	O
CAPS	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
16Nov2012	B-temporal
)	O
to	O

TSH	O
1	B-labvalue
.	I-labvalue
570	I-labvalue
uIU	I-labvalue
/	I-labvalue
ml	I-labvalue
0	B-reference_range
.	I-reference_range
360	I-reference_range
-	I-reference_range
3	I-reference_range
.	I-reference_range
740	I-reference_range

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
,	O
no	B-negation
intermittent	O
leg	B-bodyloc
claudication	O
and	O
no	B-negation
edema	O
.	O

THE	O
PAIN	O
WAS	O
GRADUAL	O
IN	O
ONSET	O
,	O
AND	O
SHE	O
DECRIBES	O
IT	O
AS	O
A	O
PRESSURE	O
AND	O
DEEP	B-bodyloc
ACHING	I-bodyloc
PAIN	O
.	O

External	O
inspection	O
of	O
ears	O
and	O
nose	O
:	O
Normal	B-labvalue
.	O

Gait	O
:	O
the	O
gait	O
and	O
station	O
were	O
normal	B-labvalue
.	O

Constitutional	O

Patient	O
is	O
being	O
followed	O
by	O
internal	O
medicine	O
and	O
is	O
taking	O
Warfarin	O
5	B-strength
mg	I-strength
daily	B-frequency
.	O

Examination	O
of	O
the	O
abdomen	O
:	O
Normal	B-labvalue
.	O

Eyes	O

Constitutional	O
:	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
,	O
no	B-negation
malaise	O
,	O
no	B-negation
fatigue	O
,	O
no	B-negation
recent	B-temporal
weight	O
gain	O
and	O
no	B-negation
recent	B-temporal
weight	O
loss	O
.	O

;	O
Oct	B-temporal
9	I-temporal
2013	I-temporal
5	B-temporal
:	I-temporal
02PM	I-temporal
(	O
Author	O
)	O

1	O
vaginal	O
delivery	O
(	O
s	O
)	O
.	O

Eustachian	O
Tube	O
:	O
normal	O
torus	O
tubarius	O
bilaterally	O
w	O
/	O
o	O
obstruction	O

Saw	O
cardiologist	O
Dr	O
.	O
Jain	O
who	O
doubled	O
both	O
the	O
Coreg	O
and	O
the	O
lisinopril	O
.	O

Localized	O
Primary	O
Osteoarthritis	O
Of	O
The	O
Knee	B-bodyloc
715	O
.	O
16	O

Miscarriage	O
first	O
trimester	O
.	O

Neuro	O
Emphasis	O
:	O

Medications	O
:	O
Medication	O
(	O
s	O
)	O
:	O
a	O
statin	O
.	O

HPI	O
g2	O
Patient	O
started	O
vomiting	O
3	B-temporal
days	I-temporal
ago	I-temporal
.	O

ALT	O
28	B-labvalue
u	I-labvalue
/	I-labvalue
l	I-labvalue
6	B-reference_range
-	I-reference_range
40	I-reference_range

No	B-negation
fever	O
/	O
chills	O
.	O

Alert	O
and	O
oriented	O
times	O
three	O
.	O

Family	O
History	O
Family	B-subject
history	O
of	O
Breast	B-bodyloc
Cancer	O
V16	O
.	O
3	O

Difficulty	O
with	O
left	B-bodyloc
foot	I-bodyloc
balance	O
There	O
was	O
no	B-negation
past	O
-	O
pointing	O
Finger	O
to	O
nose	B-bodyloc
dysmetria	O
was	O
present	O
bilaterally	O
.	O

Test	O
Name	O
Result	O
Flag	O
Reference	O

Any	O
higher	O
dose	O
he	O
says	O
makes	O
him	O
nauseated	O
.	O

Patient	O
is	O
s	O
/	O
p	O
BMT	O
in	O
Feb	B-temporal
2013	I-temporal
and	O
doing	O
well	O
post	O
operatively	O
.	O

No	O
HPI	O
available	O
.	O

Delivered	O
:	O
1999	B-temporal
.	O

Respiratory	O
:	O
cough	O
,	O
but	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
,	O
no	B-negation
shortness	O
of	O
breath	O
during	O
exertion	O
,	O
no	B-negation
orthopnea	O
and	O
no	B-negation
PND	O
.	O

I	O
personally	O
examined	O
the	O
patient	O
with	O
the	O
resident	O

Chief	O
Complaint	O
Chief	O
Complaint	O
:	O

Atypical	O
Face	B-bodyloc
Pain	O
350	O
.	O
2	O
Empty	O
nose	B-bodyloc
syndrome	O

Reports	O
erratic	O
CBGs	O
with	O
AMBG	O
100s	B-labvalue
to	I-labvalue
200s	I-labvalue
;	O
RBG	O
reportedly	O
highly	O
variable	O
.	O

Heart	O
Rate	O
:	O
88	B-labvalue

MethylPREDNISolone	O
Acetate	O
80	B-strength
MG	I-strength
/	I-strength
ML	I-strength
Injection	B-form
Suspension	I-form
;	O
INJECT	O
1	B-dosage
ML	I-dosage
Intramuscular	B-route
;	O
Done	O
:	O
07Oct2013	B-temporal
04	B-temporal
:	I-temporal
58PM	I-temporal
;	O
Status	O
:	O
COMPLETE	O
Ordered	O
;	O
For	O
:	O
Acute	B-course
Bronchitis	O
(	O
466	O
.	O
0	O
)	O
;	O
Rx	O
By	O
:	O
CRUZ	O
,	O
LETICIA	O
;	O
Dose	O
of	O
1	B-dosage
ML	I-dosage
;	O
Intramuscular	B-route
;	O
Administered	O
;	O
Last	O
Updated	O
By	O
:	O
Reed	O
,	O
Jennifer	O

HIV	O
1	O
/	O
O	O
/	O
2	O
:	O
Negative	B-labvalue
Reference	O
Range	O
Negative	B-reference_range

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

I	O
examined	O
and	O
discussed	O
the	O
patient	O
with	O
the	O
resident	O
and	O
agree	O
with	O
the	O
above	O
findings	O
,	O
assessment	O
and	O
plan	O
in	O
the	O
resident	O
note	O
.	O

History	O
of	O
Present	O
Illness	O
44	O
y	O
/	O
o	O
here	O
today	O
for	O
WWE	O
.	O

Interval	O
symptoms	O
:	O
improved	B-course
heartburn	O
,	O
denies	B-negation
chest	B-bodyloc
pain	O
,	O
improved	O
abdominal	B-bodyloc
pain	O
and	O
denies	B-negation
dysphagia	O
.	O

Oral	B-bodyloc
Thrush	O
(	O
112	O
.	O
0	O
)	O

Fluticasone	O
Propionate	O
50	B-strength
MCG	I-strength
/	I-strength
ACT	I-strength
Nasal	B-route
Suspension	B-form
;	O
USE	O
2	B-dosage
SPRAYS	B-form
IN	O
EACH	B-route
NOSTRIL	I-route
ONCE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
12Oct2012	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
28Oct2013	B-temporal
)	O
Requested	O
for	O
:	O
28Oct2013	B-temporal

UTP	O
-	O
HM	O
,	O

Ethmoid	O
sinuses	O
:	O
non	O
-	O
tender	O
on	O
the	O
right	O
and	O
non	O
-	O
tender	O
on	O
the	O
left	O
.	O

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

History	O
of	O
Drug	O
Use	O

Atrophic	O
pattern	O
;	O
predominantly	O
parabasal	B-bodyloc
cells	I-bodyloc

Menstrual	O
History	O
.	O

LABORATORY	O
DATA	O
AND	O
DIAGNOSTIC	O
STUDIES	O
:	O

Relieving	O
factors	O
:	O
non	O
-	O
prescription	O
cough	O
medicine	O
use	O
.	O

F	O
/	O
u	O
in	O
3	O
weeks	O
for	O
Prenatal	O
visit	O
.	O

External	O
inspection	O
of	O
ears	O
and	O
nose	O
:	O
Normal	B-labvalue
.	O

Lab	O
orders	O
submitted	O
for	O
this	O
patient	O
were	O
not	O
performed	O

Eth	O
:	O
Normal	O

Aspirin	O
81	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
20Aug2013	B-temporal
)	O
to	O

Skin	O
:	O
no	B-negation
rash	O
.	O

[	O
QLH	O
]	O
IRON	O
AND	O
TOTAL	O
IRON	O
BINDING	O
CAPACITY	O
Requested	O
for	O
:	O
21Dec2011	B-temporal

pt	O
here	O
for	O
physical	O

Appropriate	B-labvalue
gait	O
and	O
station	O
upon	O
examination	O
.	O

Involuntary	O
Movements	O
:	O
no	B-negation
involuntary	O
movements	O
were	O
seen	O
.	O

Cerebellar	O
:	O
the	O
cerebellar	O
function	O
was	O
normal	B-labvalue
.	O

Genitourinary	O
:	O
no	B-negation
dysuria	O
and	O
no	B-negation
pelvic	B-bodyloc
pain	O
.	O

I	O
agree	O
with	O
all	O
the	O
components	O
of	O
the	O
exam	O
as	O
delineated	O
in	O
the	O
resident	O
note	O
above	O
.	O

Appropriate	O
mood	O
and	O
affect	O
.	O

History	O
of	O
Present	O
Illness	O
The	O
patient	O
is	O
being	O
seen	O
for	O
follow	O
-	O
up	O
of	O
a	O
hospitalization	O
for	O
diverticulitis	O
.	O

Nephrotic	O
Syndrome	O
Due	O
To	O
Minimal	B-severity
Change	O
Glomerulonephritis	O
581	O
.	O
3	O

[	O
QLH	O
]	O
CBC	O
(	O
INCLUDES	O
DIFF	O
/	O
PLT	O
)	O

Examination	O
of	O
gait	O
and	O
station	O
:	O
Normal	B-labvalue
.	O

Ability	O
to	O
communicate	O
:	O
Normal	B-labvalue
.	O

She	O
was	O
on	O
just	O
100	B-strength
mg	I-strength
a	B-frequency
day	I-frequency
with	O
the	O
first	O
hospitalization	O
and	O
then	O
increased	O
subsequently	O
from	O
Ben	O
Taub	O
as	O
1200	O
mg	O
daily	O
.	O

[	O
U	O
]	O
XRAY	O
FEMUR	O
2	O
VWS	O
RIGHT	O
73550	O
Requested	O
for	O
:	O
25Mar2014	B-temporal

The	O
patient	O
presents	O
with	O
complaints	O
of	O
constant	O
episodes	O
of	O
moderate	B-severity
right	B-bodyloc
foot	I-bodyloc
localized	O
tenderness	O
,	O
described	O
as	O
dull	O
and	O
aching	O
,	O
non	O
-	O
radiating	O
.	O

Simvastatin	O
40	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
AT	I-frequency
BEDTIME	I-frequency
;	O
Therapy	O
:	O
26Nov2008	B-temporal
to	O
(	O
Evaluate	O
:	O
30Mar2014	B-temporal
)	O
Requested	O
for	O
:	O
08Apr2013	B-temporal
;	O
Last	O
Rx	O
:	O
04Apr2013	B-temporal

Skin	O

2	O
.	O

Examination	O
of	O
extremities	O
for	O
edema	O
and	O
/	O
or	O
varicosities	O
:	O
Abnormal	O
.	O

Gout	O
274	O
.	O
9	O

The	O
toes	O
were	O
normal	O
and	O
with	O
full	B-labvalue
range	O
of	O
motion	O
.	O

History	O
of	O
Hemochromatosis	O
275	O
.	O
03	O

History	O
of	O
Pregnancy	O
Complicated	O
By	O
Diabetes	O
Mellitus	O
648	O
.	O
00	O

She	O
is	O
taking	O
her	O
labetalol	O
200mg	B-strength
po	B-route
bid	B-frequency
.	O

general	O
medicine	O
,	O
diabetes	O
,	O
hypertension	O
,	O
asthma	O
,	O
cholecystectomy	O
,	O
fishbone	O
,	O
foreign	O
body	O
,	O
airway	O
compromise	O
,	O
airway	O
,	O

Eyes	O

Cut	O
aricept	O
to	O
half	O
,	O
husband	O
to	O
call	O
and	O
see	O
if	O
there	O
is	O
any	O
improvement	O
,	O
gait	O
and	O
balance	O
rehab	O

1	O
.	O

-	O
PVD	O
-	O
follow	O
up	O
with	O
Cardiology	O
;	O
continue	O
ASA	O
and	O
simvastatin	O

Vitamin	O
D	O
25	O
OH	O
51	B-labvalue
ng	I-labvalue
/	I-labvalue
ml	I-labvalue
30	B-reference_range
-	I-reference_range
100	I-reference_range

upon	O
admission	O
:	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

Electronically	O
Signed	O
by	O
:	O
Pande	O
,	O
Leena	O
P	O
,	O
MD	O
03/24/14	B-temporal

She	O
desires	O
birth	O
control	O
and	O
is	O
interested	O
in	O
Mirena	O
.	O

Family	B-subject
history	O
of	O
Ovarian	B-bodyloc
Cancer	O

History	O
of	O
Present	O
Illness	O

[	O
*	O
*	O
Location	O
(	O
un	O
)	O
1110	O
*	O
*	O
]	O
VNA	O

Current	O
Meds	O
Betamethasone	O
Valerate	O
0	B-strength
.	I-strength
1	I-strength
%	O
External	O
Cream	B-form
;	O
APPLY	O
SPARINGLY	B-frequency
TO	O
AFFECTED	O
AREA	O
(	O
S	O
)	O
3	B-frequency
TIMES	I-frequency
A	I-frequency
DAY	I-frequency
;	O
Therapy	O
:	O
11Dec2012	B-temporal
to	O
(	O
Evaluate	O
:	O
28May2013	B-temporal
)	O
Requested	O
for	O
:	O
13May2013	B-temporal
;	O
Last	O
Rx	O
:	O
13May2013	B-temporal

Description	O
:	O
The	O
patient	O
is	O
a	O
60	O
-	O
year	O
-	O
old	O
female	O
patient	O
who	O
off	O
and	O
on	O
for	O
the	O
past	O
10	O
to	O
12	O
months	O
has	O
had	O
almost	O
daily	O
diarrhea	O
,	O
nausea	O
,	O
inability	O
to	O
eat	O
.	O

The	O
patient	O
is	O
not	O
currently	O
being	O
treated	O
for	O
this	O
problem	O
.	O

Well	O
ChilduEducation	O

Headache	O
:	O
Moderate	B-severity

Claritin	O
10	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Status	O
:	O
DISCONTINUED	O

Sample	O
Name	O
:	O
Normal	O
Physical	O
Exam	O
Template	O
-	O
5	O

Mucinex	O
DM	O
Maximum	O
Strength	O
60	B-strength
-	I-strength
1200	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
Extended	I-form
Release	I-form
12	I-form
Hour	I-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
EVERY	B-frequency
12	I-frequency
HOURS	I-frequency
AS	B-frequency
NEEDED	I-frequency
FOR	O
CONGESTION	O
;	O
Therapy	O
:	O
23Jul2013	B-temporal
to	O

General	O
appearance	O
:	O
Normal	B-labvalue
.	O

Shoulder	B-bodyloc
Impingement	O
726	O
.	O
2	O

Physical	O
Exam	O
General	O
appearance	O
:	O
Normal	B-labvalue
.	O

No	B-negation
wheezing	O
was	O
heard	O
.	O

Delivered	O
:	O
2011	O
.	O

Psychologicro	O
:	O
No	B-negation
high	O
irritability	O
,	O
no	B-negation
sleep	O
disturbances	O
,	O
and	O
not	B-negation
crying	O
for	O
no	O
reason	O
.	O

Cutaneous	B-bodyloc
Candidiasis	O
(	O
112	O
.	O
3	O
)	O

Levothyroxine	O
Sodium	O
100	B-strength
MCG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
AS	I-frequency
DIRECTED	I-frequency
;	O
Therapy	O
:	O
17Jan2012	B-temporal
to	O
(	O
Evaluate	O
:	O
25Sep2012	B-temporal
)	O
Requested	O
for	O
:	O
27Jun2012	B-temporal
;	O
Last	O
Rx	O
:	O
27Jun2012	B-temporal

(	O
radial	O
)	O
:	O
Normal	O
.	O

medication	O
and	O
f	O
/	O
u	O

Palpation	O
of	O
chest	O
:	O
Normal	B-labvalue
.	O

He	O
has	O
not	B-negation
had	O
fever	O
,	O
rash	O
,	O
or	O
sorethroat	O
,	O
nasal	B-bodyloc
congestion	O
.	O

Liver	O
and	O
spleen	O
:	O
No	B-negation
hepatomegaly	O
or	O
splenomegaly	O
.	O

Tenderness	O
:	O
left	O
paraspinal	O
and	O
right	O
paraspinal	O
.	O

-	O
continue	O
physical	O
therapy	O
/	O
rehab	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
HOLLY	O
VARNER	O
,	O
M	O
.	O
D	O
.	O

Pulmonary	O

Review	O
of	O
Systems	O
Complete	O
-	O
Female	O
Neuro	O
Emphasis	O
:	O

[	O
QLH	O
]	O
ZONISAMIDE	O
(	O
ZONEGRAN	O
[	O
R	O
]	O
)	O
Requested	O
for	O
:	O
17Nov2011	B-temporal

31	O
year	O
old	O
CF	O
with	O
no	B-negation
significant	O
PMH	O
came	O
in	O
for	O
Nasal	B-bodyloc
congestion	O
and	O
headache	O

Examination	O
of	O
the	O
abdomen	O
:	O
Normal	B-labvalue

She	O
describes	O
this	O
as	O
improving	O
.	O

Pulmonary	O
:	O
N	O
/	O
A	O
.	O

Hyperlipidemia	O
272	O
.	O
4	O

Eyes	O

Would	O
like	O
Implanon	O
for	O
BCM	O
.	O

Ketek	O
TABS	B-form
;	O
TAKE	O
2	B-dosage
TABLETS	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
02Nov2012	B-temporal
)	O
to	O

Eyes	O
:	O
no	B-negation
eye	B-bodyloc
pain	O
,	O
eyes	B-bodyloc
not	B-negation
red	O
,	O
no	B-negation
eyesight	O
problems	O
,	O
no	B-negation
purulent	O
discharge	O
from	O
the	O
eyes	B-bodyloc
,	O
no	B-negation
dryness	O
of	O
the	O
eyes	B-bodyloc
and	O
no	B-negation
itching	O
of	O
the	O
eyes	B-bodyloc
.	O

She	O
consumes	O
a	O
diverse	O
and	O
healthy	O
diet	O
.	O
She	O
does	O
not	B-negation
have	I-negation
any	O
weight	O
concerns	O
.	O

Pulmonary	O

Peripheral	O
Vision	O
:	O
Normal	B-labvalue
(	O
full	O
)	O
.	O

Coordination	O
:	O
Normal	B-labvalue
.	O

History	O
of	O
Diabetes	O
Mellitus	O
250	O
.	O
00	O

Hematologic	O
/	O
Lymphatic	O
:	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
,	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
,	O
no	B-negation
swollen	O
glands	B-bodyloc
and	O
no	B-negation
swollen	O
glands	B-bodyloc
in	O
the	O
neck	B-bodyloc
.	O

Adnexa	O
/	O
parametria	O
:	O
Normal	O

Family	B-subject
history	O
of	O
Ovarian	B-bodyloc
Cancer	O

Follow	O
up	O
in	O
1	O
year	O
.	O

Family	B-subject
history	O
of	O
Breast	B-bodyloc
Cancer	O

;	O
Mar	B-temporal
4	I-temporal
2013	I-temporal
11	B-temporal
:	I-temporal
02PM	I-temporal
(	O
Author	O
)	O

Hydrocodone	O
-	O
Acetaminophen	O
10	B-strength
-	I-strength
500	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
EVERY	B-frequency
4	I-frequency
TO	I-frequency
6	I-frequency
HOURS	I-frequency
AS	B-frequency
NEEDED	I-frequency
FOR	O
PAIN	O
;	O
Last	O
Rx	O
:	O
11Dec2013	B-temporal

Gastrointestinal	O
:	O
(	O
Per	O
Hpi	O
)	O
.	O

Pharyngeal	O
Findings	O
:	O

Cortical	O
function	O
:	O
Normal	B-labvalue
.	O

Recent	O
and	O
remote	O
memory	O
:	O
Normal	B-labvalue

History	O
of	O
Tonsillectomy	O
With	O
Adenoidectomy	O

Vitals	O
UTP	O
Adult	O
Vital	O
Signs	O
[	O
Data	O
Includes	O
:	O
Current	O
Encounter	O
]	O

I	O
discussed	O
with	O
the	O
patient	O
and	O
her	O
husband	O
at	O
great	O
length	O
regarding	O
notifying	O
me	O
if	B-condition
there	O
are	O
any	O
new	O
episodes	O
or	O
any	O
seizures	O
that	O
occur	O
.	O

Esophageal	B-bodyloc
Reflux	O
530	O
.	O
81	O

XRAY	O
Chest	O
2	O
views	O
71020	O
Requested	O
for	O
:	O
01Apr2013	B-temporal

SHE	O
STARTED	O
TO	O
HAVE	O
PROBLEMS	O
ON	O
SUNDAY	O
,	O
07/14/13	B-temporal
;	O
48	B-temporal
HOURS	I-temporal
AGO	I-temporal
.	O

with	O
extremrs	O
of	O
body	O
mass	O
index	O
for	O
purposes	O
of	O
drug	O
dosing	O
,	O
the	O
eGFR	O
should	O

7	O
days	O
-	O
150	O
yrs	O
:	O
70	O
-	O
99	O
mg	O
/	O
dL	O
(	O
fasting	O
)	O
,	O
based	O
on	O
the	O
clinical	O

Examination	O
of	O
the	O
head	O
and	O
face	O
:	O
Normal	B-labvalue

EYES	O
:	O
no	B-negation
double	O
vision	O
and	O
no	B-negation
blurred	O
vision	O
.	O

Results	O
/	O
Assessment	O
Abnormal	O
Weight	O
Loss	O
783	O
.	O
21	O

Azithromycin	O
250	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
2	B-dosage
TABLETS	B-form
ON	O
DAY	B-temporal
1	I-temporal
THEN	O
TAKE	O
1	B-dosage
TABLET	B-form
A	B-frequency
DAY	I-frequency
FOR	B-duration
4	I-duration
DAYS	I-duration
;	O
Therapy	O
:	O
04Apr2014	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
04Apr2014	B-temporal
)	O
Requested	O
for	O
:	O
04Apr2014	B-temporal

The	O
patient	O
is	O
being	O
seen	O
for	O
worsening	B-course
symptoms	O
.	O

Immunizations	O
*	O
*	O
Printed	O
in	O
Appendix	O
#	O
1	O
below	O
.	O

HISTORY	O
OF	O
PRESENTING	O
ILLNESS	O
:	O
The	O
baby	O
is	O
an	O
ex	O
-	O
32	B-temporal
weeks	I-temporal
small	O
for	O
gestational	O
age	O
infant	O
with	O
birth	O
weight	O
1102	B-labvalue
.	O

Paternal	B-subject
grandfather	I-subject
'	I-subject
s	I-subject
history	O
of	O
Hypertension	O
V17	O
.	O
49	O

The	O
patient	O
presents	O
with	O
complaints	O
of	O
arthralgias	O
(	O
right	B-bodyloc
hip	I-bodyloc
)	O
.	O

d	O
/	O
c	O
'	O
d	O
prednisone	O
,	O
water	O
restricted	O
.	O

Classic	O
Migraine	O
(	O
With	O
Aura	O
)	O
With	O
Intractable	O
Migraine	O
346	O
.	O
01	O

Assessment	O
Health	O
Maintenance	O
V70	O
.	O
0	O

Vitals	O
UTP	O
Adult	O
Vital	O
Signs	O
[	O
Data	O
Includes	O
:	O
Current	O
Encounter	O
]	O
04Aug2011	B-temporal
08	O
:	O
52AM	B-temporal
BMI	O
Calculated	O
:	O
25	B-labvalue
.	I-labvalue
48	I-labvalue
BSA	O
Calculated	O
:	O
1	B-labvalue
.	I-labvalue
94	I-labvalue
Height	O
:	O
5	B-labvalue
ft	I-labvalue
9	I-labvalue
in	I-labvalue
Weight	O
:	O
172	B-labvalue
lb	I-labvalue
Systolic	O
:	O
103	B-labvalue
Diastolic	O
:	O
63	B-labvalue
Heart	O
Rate	O
:	O
60	B-labvalue

There	O
is	O
no	B-negation
organomegaly	O
and	O
no	B-negation
rebound	O
tenderness	O
.	O

Never	O
A	O
Smoker	O

Alert	O
and	O
cooperative	O
.	O

Assessment	O
of	O
muscle	O
strength	O
/	O
tone	O
:	O
Normal	B-labvalue
.	O

I	O
personally	O
examined	O
the	O
patient	O
with	O
the	O
resident	O
I	O
agree	O
with	O
:	O
all	O
the	O
components	O
of	O
the	O
exam	O
.	O

Side	O
effects	O
of	O
IVIG	O
including	O
acute	B-course
renal	B-bodyloc
failure	O
,	O
aseptic	O
menigitis	O
,	O
headaches	O
,	O
nausea	O
and	O
thrombosis	O
were	O
discussed	O
as	O
well	O
.	O

She	O
is	O
on	O
coumadin	O
tabs	B-form
1	O
/	O
2	O
,	O
1	O
alt	O
.	O

Middle	O
Turbinate	O
:	O
Normal	B-labvalue
position	I-labvalue
.	O

Keywords	O
:	O

Use	O
1	B-dosage
dose	I-dosage
in	O
Neil	O
-	O
Med	O

Denied	O

EMG	O
/	O
NCS	O
9/19/12	B-temporal

RTC	O
6	O
mos	O
or	O
PRN	O
.	O

CV	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
,	O
no	B-negation
fainting	O
and	O
no	B-negation
murmurs	O
were	O
heard	O
.	O

8	O
.	O

pt	O
is	O
foolowing	O
up	O
with	O
Dr	O
Melton	O
for	O
pain	O
mangemnt	O
is	O
much	O
betterPt	O
has	O
f	O
/	O
u	O
Appt	O
with	O
Her	O
back	O
surgeon	O
Dr	O
Prasarn	O
.	O

Ordered	O
;	O
For	O
:	O
Diabetes	O
Mellitus	O
(	O
250	O
.	O
00	O
)	O
;	O
Ordered	O
By	O
:	O
ELLIS	O
,	O
MARK	O
Due	O
:	O
11Nov2013	B-temporal
;	O
Last	O
Updated	O
By	O
:	O
Reed	O
,	O
Jennifer	O

History	O
of	O
Viral	O
Exanthem	O
057	O
.	O
9	O

Called	O
in	O
rx	O
to	O
CVS	O
7132184491	O
l	O
/	O
m	O
on	O
v	O
/	O
m	O
and	O
sent	O
retail	O
.	O

Pulmonary	O

Shoulder	O
Pain	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O
S1	O
,	O
S2	O
,	O
no	B-negation
murmur	O
,	O
no	B-negation
gallop	O
.	O
Peripheral	O
vascular	O
exam	O
:	O
Normal	B-labvalue
.	O

Examination	O
of	O
the	O
oropharynx	O
:	O
Normal	B-labvalue
The	O
oral	O
mucosa	O
was	O
normal	O
.	O

f	O
History	O
of	O
Respiratory	O
Distress	O
Syndrome	O
Of	O
Newborn	O
(	O
769	O
)	O
;	O
(	O
Resolved	B-course
)	O

R	O
GPI	O
:	O
Amplitue	O
-	O
4	O
.	O
3	O
,	O
Pulse	O
Width	O
-	O
reduced	O
to	O
120	O
microseconds	O
,	O
Rate	O
-	O
160	O
,	O
Contacts	O
-	O
10	O
+	O
and	O
9	O
-	O
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Prenatal	O
course	O
was	O
complicated	O
by	O
low	O
amniotic	O
fluid	O
index	O
and	O
hypertension	O
.	O

[	O
QLH	O
]	O
T3	O
,	O
FREE	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
JELANI	O
INGRAM	O
,	O
M	O
.	O
D	O
.	O

Denied	O

Jul	B-temporal
9	I-temporal
2012	I-temporal
12	B-temporal
:	I-temporal
53PM	I-temporal
(	O
Author	O
)	O

Neurological	O
:	O
no	B-negation
dizziness	O
and	O
no	B-negation
fainting	O
.	O

Examination	O
of	O
liver	O
and	O
spleen	O
:	O
Normal	B-labvalue
.	O

Constitutional	O
:	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
,	O
not	B-negation
feeling	O
poorly	O
(	O
malaise	O
)	O
,	O
not	B-negation
feeling	O
tired	O
(	O
fatigue	O
)	O
,	O
no	O
recent	O
weight	O
gain	O
and	O
no	B-negation
recent	B-temporal
weight	O
loss	O
.	O

Lymphocytes	O
19	B-labvalue
.	I-labvalue
6	I-labvalue
%	I-labvalue
L	B-labvalue
20	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
40	I-reference_range
.	I-reference_range
0	I-reference_range

f	O
His	O
osy	O
of	O
Anxiety	O
(	O
Symptom	O
)	O
(	O
300	O
.	O
00	O
)	O
;	O
(	O
Resolved	B-course
)	O

Psychiatric	O
:	O
no	B-negation
depression	O
.	O

Assessment	O
Complete	O
Unilateral	B-bodyloc
Vocal	I-bodyloc
Cord	I-bodyloc
Paralysis	O
478	O
.	O
32	O

The	O
patient	O
expressed	O
understanding	O
and	O
agreed	O
to	O
proceed	O
.	O

Examination	O
of	O
the	O
extremities	O
revealed	O
no	B-negation
fingernail	B-bodyloc
clubbing	O
,	O
well	O
perfused	O
fingers	O
,	O
well	O
perfused	O
toes	O
and	O
no	B-negation
nail	B-bodyloc
splinter	O
hemorrhages	O
.	O

;	O
Start	O
Date	O
:	O
04/16/2012	B-temporal
;	O
End	O
Date	O
:	O
01/01/1900	B-temporal
(	O
Active	O
)	O

;	O
Aug	B-temporal
22	I-temporal
2011	I-temporal
3	B-temporal
:	I-temporal
33PM	I-temporal
(	O
Author	O
)	O

Cranial	O
nerves	O
XII	O
:	O
there	O
was	O
no	B-negation
tongue	B-bodyloc
deviation	O
with	O
protrusion	O
.	O

HAD	O
THERMAL	O
ABLATION	O
2010	B-temporal
.	O

"	O
Never	O
A	O
Smoker	O
Denied	O
"	O

No	O
heavy	O
lifting	O
/	O
pushing	O
/	O
pulling	O
.	O

Skin	B-bodyloc
No	B-negation
open	O
lesions	O
.	O

CBGs	O
80s	B-labvalue
to	I-labvalue
190s	I-labvalue
.	O

Examination	O
of	O
the	O
oropharynx	O
:	O
Normal	B-labvalue
.	O

Chest	O
:	O
Normal	O
.	O

Examination	O
of	O
cranial	O
nerves	O
:	O
Normal	B-labvalue
.	O

Denied	O

This	O
would	O
last	O
a	O
short	O
time	O
and	O
then	O
his	O
vision	O
seemed	O
to	O
close	O
in	O
and	O
he	O
felt	O
off	O
balance	O
like	O
he	O
was	O
falling	O
forward	O
or	O
downward	O
.	O

Coronary	B-bodyloc
Artery	I-bodyloc
Disease	O
414	O
.	O
00	O

Examination	O
of	O
gait	O
and	O
station	O
:	O
Normal	B-labvalue
.	O

The	O
patient	O
apparently	O
is	O
doing	O
well	O
with	O
slight	O
dysphagia	O
,	O
we	O
treated	O
her	O
with	O
Decadron	O
and	O
we	O
will	O
send	O
her	O
home	O
with	O
Medrol	O
.	O

Examination	O
of	O
the	O
oropharynx	O
:	O
Abnormal	O
Examination	O
of	O
the	O
oropharynx	O
showed	O
no	B-negation
white	O
patches	O
.	O

Psychiatric	O
:	O
anxiety	O
,	O
but	O
not	B-negation
suicidal	O
,	O
no	B-negation
sleep	O
disturbances	O
,	O
no	B-negation
depression	O
,	O
no	B-negation
personality	O
change	O
and	O
no	B-negation
emotional	O
problems	O
.	O

Severe	B-severity
nausea	O
.	O

Involuntary	O
Movements	O
:	O
no	B-negation
involuntary	O
movements	O
were	O
seen	O
.	O

Hyperlipidemia	O
272	O
.	O
4	O

f	O
History	O
of	O
Hypertension	O
(	O
401	O
.	O
9	O
)	O
;	O
(	B-course
Resolved	I-course
)	O

HEENT	O
:	O
PERRLA	O
,	O
EOMI	O
,	O
dry	O
mouth	B-bodyloc
,	O
hearing	O
loss	O
bilaterally	O

GroupHeading47End	O
GroupHeading48Start	O
GroupHeading48End	O
GroupHeading49Start	O
GroupHeading49End	O
GroupHeading50Start	O
GroupHeading50End	O
GroupHeading51Start	O
GroupHeading51End	O
GroupHeading52Start	O
GroupHeading52End	O
GroupHeading53Start	O
GroupHeading53End	O
GroupHeading54Start	O
GroupHeading54End	O
GroupHeading55Start	O
GroupHeading55End	O
GroupHeading74Start	O
GroupHeading74End	O
GroupHeading69Start	O
GroupHeading69End	O
GroupHeading56Start	O
GroupHeading56End	O
GroupHeading57Start	O
GroupHeading57End	O
GroupHeading58Start	O
GroupHeading58End	O

No	B-negation
frontal	B-bodyloc
tenderness	O
.	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
vomiting	O
and	O
no	B-negation
melena	O
.	O

Current	O
Orders	O
[	O
QH	O
]	O
CMP	O
W	O
/	O
EGFR	O
Requested	O
for	O
:	O
03May2011	B-temporal

Pt	O
w	O
/	O
CRSwNP	O
and	O
mucocel	O
POV3	O
.	O

There	O
was	O
some	O
narrowing	O
at	O
L5S1	B-bodyloc
.	O

Exacerbating	O
factors	O
:	O
spring	O
allergens	O
.	O

No	B-negation
murmurs	O
were	O
heard	O
.	O

The	O
JVP	O
was	O
normal	B-labvalue
.	O
A	O
sustained	O
hepatojugular	O
reflux	O
was	O
not	B-negation
present	I-negation
.	O

injection	O

Mean	O
Cell	O
Hemoglobin	O
Concentration	O
(	O
for	O
H	O
&	O
H	O
)	O
33	B-labvalue
.	I-labvalue
7	I-labvalue
g	I-labvalue
/	I-labvalue
dl	I-labvalue
32	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
36	I-reference_range
.	I-reference_range
0	I-reference_range

Cortical	O
function	O
:	O
Normal	B-labvalue
.	O

The	O
abdomen	O
was	O
soft	O
and	O
nontender	O
.	O

ALLERGIES	O
:	O
No	B-negation
known	O
allergies	O
to	O
medications	O
.	O

(	O
radial	O
)	O
:	O
Normal	O
.	O

uses	O
caffinated	O
drinks	O
,	O
but	O
no	B-negation
breast	B-bodyloc
cancer	O
and	O
no	B-negation
fibrocystic	O
breast	B-bodyloc
disease	O
.	O

Rotator	O
Cuff	O
:	O
positive	B-labvalue
Painful	O
Arc	O
,	O
positive	O
Drop	O
Arm	O
testandpositive	O
Empty	O
Can	O
test	O
.	O

[	O
QLH	O
]	O
HEMOGLOBIN	O
Done	O
:	O
03Nov2010	B-temporal
09	B-temporal
:	I-temporal
55AM	I-temporal

History	O
of	O
History	O
Of	O
Prior	B-temporal
Surgery	O

History	O
of	O
Focal	O
Torsion	O
Dystonia	O
333	O
.	O
89	O

Symptoms	O
:	O
no	B-negation
headache	O
,	O
no	B-negation
confusion	O
,	O
no	B-negation
visual	O
disturbance	O
,	O
no	B-negation
dizziness	O
and	O
no	B-negation
shortness	O
of	O
breath	O
.	O

Will	O
increase	O
insulin	O
dose	O
to	O
35	B-dosage
units	I-dosage
AM	B-frequency
and	O
25	B-dosage
units	I-dosage
PM	B-frequency

History	O
of	O
Hyperlipidemia	O
272	O
.	O
4	O

The	O
nasal	O
cavity	O
was	O
examined	O
using	O
a	O
speculum	O
.	O

Gabapentin	O
300	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
3	B-frequency
TIMES	I-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
08Apr2011	B-temporal
to	O
(	O
Evaluate	O
:	O
06Jan2014	B-temporal
)	O
Requested	O
for	O
:	O
11Jan2013	B-temporal
;	O
Last	O
Rx	O
:	O
11Jan2013	B-temporal

Surgical	O
History	O
History	O
of	O
Arthrodesis	O
Cervical	B-bodyloc

Oral	O
Evaluation	O
&	O
Fluoride	O
Varnish	O
in	O
the	O
Medical	O
Home	O
Visit	O
Documentation	O
.	O

She	O
does	O
not	O
remember	O
doing	O
anything	O
,	O
doing	O
any	O
bending	O
or	O
twisting	O
.	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
vomiting	O
,	O
no	B-negation
nausea	O
,	O
no	O
melenaand	O
no	B-negation
change	O
in	O
stool	O
.	O

Review	O
of	O
Systems	O
Complete	O
-	O
Male	O
Neuro	O
Emphasis	O
:	O
Constitutional	O
,	O
eye	O
,	O
otolaryngeal	O
,	O
cardiovascular	O
,	O
pulmonary	O
,	O
Sleep	O
,	O
gastrointestinal	O
,	O
genitourinary	O
,	O
musculoskeletal	O
,	O
skin	O
,	O
neurological	O
,	O
psychiatric	O
,	O
endocrine	O
and	O
hematologic	O
review	O
of	O
systems	O
are	O
normal	O
.	O

Hearing	O
:	O
Normal	B-labvalue
.	O

Pedal	O
pulses	O
:	O
2	B-labvalue
+	I-labvalue
bilaterally	I-labvalue
.	O

GroupHeading2End	O
GroupHeading3Start	O
GroupHeading3End	O
GroupHeading78Start	O
Head	O
and	O
Face	O
Examinatisp	O
of	O
the	O
head	O
and	O
face	O
:	O
Normal	B-labvalue
Palpatiop	O
of	O
the	O
face	O
and	O
sinuses	O
:	O
Normal	B-labvalue
GroupHeading78End	O
GroupHeading79Start	O
GroupHeading79End	O
GroupHeading80Start	O
GroupHeading80End	O
GroupHeading11Start	O
GroupHeading11End	O
GroupHeading12Start	O
GroupHeading12End	O
GroupHeading14Start	O
GroupHeading14End	O
GroupHeading13Start	O
GroupHeading13End	O
GroupHeading4Start	O
GroupHeading4End	O
GroupHeading5Start	O
GroupHeading5End	O
GroupHeading6Start	O

Reminded	O
to	O
do	O
SMBG	O
AC	O

He	O
has	O
no	B-negation
significant	O
interval	O
events	O
.	O

Discussion	O
/	O
Discussion	O
/	O
Summary	O

Integumentary	O
:	O
nail	B-bodyloc
changes	O
,	O
but	O
no	B-negation
rash	O
,	O
no	B-negation
skin	B-bodyloc
lesions	O
,	O
no	B-negation
skin	B-bodyloc
wound	O
,	O
no	B-negation
itching	O
,	O
no	B-negation
breast	B-bodyloc
pain	O
,	O
no	B-negation
breast	B-bodyloc
lump	O
and	O
no	B-negation
change	O
in	O
a	O
mole	B-bodyloc
.	O

Immunizations	O

History	O
of	O
Shoulder	O
Surgery	O

aches	O
.	O

Abdomen	O

Left	O
Gastroc	O
.	O

Active	O
Problems	O
Abnormal	O
Electrocardiogram	O
794	O
.	O
31	O

Patient	O
denies	B-negation
chest	B-bodyloc
pain	O
,	O
cough	O
,	O
abdominal	B-bodyloc
pain	O
.	O

Reports	O
excessive	O
nasal	B-bodyloc
discharge	O
.	O

;	O
Nov	B-temporal
2	I-temporal
2012	I-temporal
1	B-temporal
:	I-temporal
44PM	I-temporal
(	O
Author	O
)	O

VerifiedResul	O
s	O
_	O
0	O
_	O
twCiteLis	O
ControlStart	O
[	O
QLH	O
]	O
CBC	O
(	O
INCLUDES	O
DIFF	O
/	O
PLT	O
)	O
15Aug2013	B-temporal
01	B-temporal
:	I-temporal
10PM	I-temporal
JOHNSON	O
,	O
PHILIP	O
Test	O
Name	O
Resul	O
Flag	O
Referetce	O
Hematocrit	O
40	B-labvalue
.	I-labvalue
0	I-labvalue
%	I-labvalue
L	B-labvalue
42	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
54	I-reference_range
.	I-reference_range

Wheezing	O
:	O
None	B-negation

Signatures	O
Electronically	O
signed	O
by	O
:	O
LEE	O
BAR	O
-	O
ELI	O
,	O
M	O
.	O
D	O
.	O

Doing	O
well	O
,	O
no	O
c	O
/	O
o	O
,	O
bottle	O
feeding	O
,	O
infant	O
doing	O
well	O
.	O

Chest	O
:	O
normal	O
appearance	O
and	O
no	B-negation
tenderness	O
.	O

ENT	O
:	O
no	B-negation
earache	O
,	O
no	B-negation
hearing	O
loss	O
and	O
no	B-negation
sore	O
throat	B-bodyloc
.	O

Assessment	O
Plantar	B-bodyloc
Fasciitis	O
728	O
.	O
71	O

uWell	O
ChilduExam	O
Give	O
parent	O
PEDS	O
&	O
mark	O
paper	O
chart	O
;	O
Dental	O
Evaluation	O
with	O
or	O
without	O
varnish	O
-	O
-	O
start	O
ndan	O
for	O
resident	O
and	O
mark	O
paper	O
charteg	O

Single	O
JP	O
drain	O
was	O
left	O
in	O
place	O
.	O

False	O
Vocal	O
Folds	O
:	O
normal	O

Allergies	O

Continue	O
regimen	O
.	O

No	B-negation
masses	O
palpated	O
.	O

[	O
QLH	O
]	O
T4	O
,	O
FREE	O
11Nov2013	B-temporal
09	B-temporal
:	I-temporal
30AM	I-temporal
GOODINE	O
,	O
GLENDA	O

No	B-negation
constipation	O
.	O

Arterial	O
Pulses	O
:	O
Normal	O
(	O
equal	O
bilaterally	O
)	O
.	O

NexIUM	O
40	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
Delayed	I-form
Release	I-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
IN	B-frequency
THE	I-frequency
MORNING	I-frequency
;	O
Therapy	O
:	O
29Oct2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
04Apr2014	B-temporal
)	O
Requested	O
for	O
:	O
04Apr2014	B-temporal

OB	O
History	O

The	O
old	O
foot	B-bodyloc
ulcer	O
has	O
healed	O
.	O

Recorded	O
as	O
Task	O

Aug	B-temporal
15	I-temporal
2012	I-temporal
3	B-temporal
:	I-temporal
26PM	I-temporal
(	O
Author	O
)	O

Pharyngeal	O
walls	O
and	O
pyriform	O
sinuses	O
:	O
Normal	O
.	O

Involuntary	O
Movements	O
:	O
no	B-negation
involuntary	O
movements	O
were	O
seen	O
.	O

*	O
keep	O
your	O
left	O
hand	O
in	O
the	O
doral	O
blocking	O
splint	O
at	O
all	O
times	O
except	O
when	O
showering	O
*	O
while	O
showering	O
,	O
you	O
may	O
either	O
take	O
off	O
the	O
splint	O
and	O
let	O
water	O
indirectly	O
run	O
over	O
the	O
left	O
hand	O
(	O
no	O
soap	O
)	O
or	O
place	O
the	O
splint	O
and	O
hand	O
in	O
a	O
plastic	O
bag	O
to	O
keep	O
dry	O
*	O
a	O
visiting	O
nurse	O
has	O
been	O
arranged	O
for	O
daily	O
dressing	O
changes	O
*	O
continue	O
to	O
refrain	O
from	O
caffeine	O
or	O
nicotine	O
intake	O
*	O
continue	O
aspirin	O
and	O
antibiotics	O
until	O
follow	O
-	O
up	O
in	O
Hand	O
Clinic	O
Return	O
to	O
the	O
ER	O
if	O
:	O

Heart	O
sounds	O
:	O
normal	B-labvalue
S1	O
,	O
normal	B-labvalue
S2	O
,	O
no	B-negation
S3	O
and	O
no	B-negation
S4	O
.	O

Benign	B-severity
Essential	O
Hypertension	O
401	O
.	O
1	O

He	O
expresses	O
understanding	O
.	O

[	O
QL	O
]	O
COMPREHENSIVE	O
METABOLIC	O
PANEL	O
W	O
/	O
O	O
eGFR	O

Physical	O
Exam	O

ENT	O
:	O
earache	O
.	O

History	O
of	O
Volvulus	O
560	O
.	O
2	O

Marital	O
History	O
-	O
Currently	O
Married	O

individuals	O
the	O
eGFR	O
will	O
be	O
>	B-reference_range
90	I-reference_range
mL	I-reference_range
/	I-reference_range
min	I-reference_range
/	I-reference_range
1	I-reference_range
.	I-reference_range
73m2	I-reference_range
.	I-reference_range

MT	B-bodyloc
/	I-bodyloc
MM	I-bodyloc
:	O
Mucoid	O
,	O
PusandPolypoid	O

Denied	O

Discussed	O
plan	O
with	O
Attending	O

Inspection	O
of	O
the	O
conjunctiva	O
and	O
lids	O
:	O
Normal	B-labvalue
.	O

Genitourinary	O
:	O
Urine	O
odor	O
is	O
nor8al	O
,	O
no	B-negation
change	O
in	O
urine	O
volume	O
,	O
and	O
no	B-negation
dysuria	O
.	O

General	O
appearance	O
:	O
Normal	O

Carotid	B-bodyloc
:	O
right	O
2	O
+	O
,	O
left	O
2	O
+	O
,	O
no	B-negation
bruit	O
on	O
the	O
right	O
and	O
no	B-negation
bruit	O
on	O
the	O
left	O
.	O

GroupHeading120End	O
GroupHeading138Start	O
GroupHeading138End	O
GroupHeading140Start	O
Patient	O
discussisp	O
:	O
discussed	O
w	O
th	O
the	O
patient	O
.	O

Results	O
/	O
Results	O
/	O
Data	O
Urine	O
Dipstick	O
(	O
In	O
Office	O
)	O
17Feb2014	B-temporal
11	B-temporal
:	I-temporal
33AM	I-temporal
ECO	O
,	O
LOURDES	O

Rx	O
:	O
01Dec2011	O

Medisation	O

Hearing	O
:	O
Normal	B-labvalue
.	O

Anxiety	O
Disorder	O
Of	O
Unknown	O
(	O
Axis	O
III	O
)	O
Etiology	O
293	O
.	O
84	O

LDL	O
Cholesterol	O
Calc	O
:	O
125	B-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue
Abnormal	O
High	O
Reference	O
Range	O
0	B-reference_range
-	I-reference_range
99	I-reference_range

Marital	O
History	O
-	O
Divorced	O
V61	O
.	O
03	O

Examination	O
of	O
the	O
oropharynx	O
showed	O
no	B-negation
lesions	O
.	O

ENT	O
:	O
no	B-negation
earache	O
,	O
no	B-negation
hearing	O
loss	O
,	O
no	B-negation
nasal	B-bodyloc
discharge	O
,	O
no	B-negation
sore	O
throat	B-bodyloc
and	O
no	B-negation
hoarseness	O
sinus	B-bodyloc
pressure	O
.	O

"	O
Smoker	O
,	O
Current	O
Status	O
Unknown	O
305	O
.	O
1	O

Examination	O
of	O
cranial	O
nerves	O
:	O
Normal	B-labvalue
.	O

Pharyngeal	O
walls	O
and	O
pyriform	O
sinuses	O
:	O
Normal	B-labvalue
.	O

There	O
was	O
no	B-negation
nasal	B-bodyloc
discharge	O
.	O

2	O
.	O

Nor8al	O
Routine	O
Hi	O
tory	O
And	O
PEnd	O
GrouWell	O
-	O
baby	O
(	O
Birth	O
-	O
2	O
Yr	O
)	O
(	O
V20	O
.	O
2	O
)	O
.	O
eg	O

A	O
PREVIOUS	O
DOCTOR	O
PRESCRIBED	O
LIDODERM	O
5	B-strength
%	I-strength
PATCHES	B-form
WHICH	O
HELPS	O
.	O

-	O
tumor	O
is	O
located	O
on	O
the	O
left	B-bodyloc
side	I-bodyloc
(	O
anterior	B-bodyloc
,	I-bodyloc
lateral	I-bodyloc
and	O
posterior	B-bodyloc
walls	I-bodyloc
of	I-bodyloc
upper	I-bodyloc
left	I-bodyloc
uterine	I-bodyloc
cavity	I-bodyloc
)	O
.	O

6410	O
Fannin	O
Street	O
,	O
Suite	O
600	O

No	B-negation
murmurs	O
were	O
heard	O
.	O

Musculoskeletal	O
:	O
joint	B-bodyloc
pain	O
(	O
discussed	O
MRI	O
.	O

Paternal	B-subject
history	O
of	O
Alzheimer	O
Disease	O

No	B-negation
Known	O
Drug	O
Allergies	O

[	O
QLH	O
]	O
PROTHROMBIN	O
TIME	O
-	O
INR	O
Requested	O
for	O
:	O
20Mar2014	B-temporal

Keywords	O
:	O
general	O
medicine	O
,	O
diabetic	O
control	O
,	O
insulin	O
prior	O
to	O
meals	O
,	O
low	O
blood	O
glucoses	O
,	O
sliding	O
scale	O
,	O
lantus	O
insulin	O
,	O
diabetes	O
,	O
mellitus	O
,	O
lantus	O
,	O
glucoses	O
,	O

Family	O
member	O
already	O
discontinued	O
Plavix	O
as	O
of	O
2/16/2013	B-temporal
.	O

Symptoms	O
partially	B-course
improved	I-course
with	O
corticosteroids	O
.	O

Treatmrt	O
Plan	O
f	O
[	O
QH	O
]	O
STREPTOCOCCUS	O
,	O
GROUP	O
B	O
CULTURE	O
(	O
Genital	O
Strep	O
Screen	O
)	O
05/22/2013	B-temporal
Routine	O

Need	O
For	O
Vaccination	O
Pneumococcal	O
V03	O
.	O
82	O

Recent	O
laboratory	O
results	O
:	O
25	O
-	O
hydroxyvitamin	O
D	O
ng	B-labvalue
/	I-labvalue
mL	I-labvalue
.	O

Gastrointestinal	O
:	O
no	B-negation
heartburn	O
.	O

History	O
of	O
Total	O
Hip	O
Replacement	O

Reglan	O
TABS	B-form

General	O
appearance	O
:	O
Normal	B-labvalue
Appears	O
healthy	O
and	O
well	O
nourished	O
.	O

Assessment	O
Diabetes	O
Mellitus	O
250	O
.	O
00	O

Dilaudid	O
POWD	B-form

Marital	O
History	O
-	O
Currently	O
Married	O

Restart	O
Glimepiride	O
and	O
continue	O
metformin	O
.	O

Associated	O
symptoms	O
:	O
no	B-negation
morning	O
headaches	O
,	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
depression	O
,	O
no	B-negation
sore	O
throat	B-bodyloc
and	O
no	B-negation
dry	O
throat	B-bodyloc
.	O

Patient	O
was	O
not	B-negation
observed	I-negation
to	O
be	O
obese	O
.	O

Left	O
partial	O
nephrectomy	O
.	O

On	O
her	O
visit	O
2	B-temporal
weeks	I-temporal
ago	I-temporal
,	O
she	O
was	O
noted	O
to	O
have	O
moderate	B-severity
vaginal	B-bodyloc
discharge	O
.	O

Platelet	O
285	B-labvalue
K	I-labvalue
/	I-labvalue
CMM	I-labvalue
133	B-reference_range
-	I-reference_range
450	I-reference_range

[	O
QLH	O
]	O
CBC	O
(	O
INCLUDES	O
DIFF	O
/	O
PLT	O
)	O
Requested	O
for	O
:	O
21Nov2013	B-temporal

Triamcinolone	O
Acetonide	O
0	B-strength
.	I-strength
1	I-strength
%	O
External	O
Cream	B-form
;	O
APPLY	O
2	B-frequency
-	I-frequency
3	I-frequency
TIMES	I-frequency
DAILY	I-frequency
TO	O
AFFECTED	O
AREA	O
(	O
S	O
)	O
;	O
Therapy	O
:	O
03May2011	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
03May2011	B-temporal
)	O

Cervical	O
Spine	O
:	O
Normal	O
(	O
exhibited	O
no	B-negation
muscle	B-bodyloc
spasm	O
)	O
.	O

Symptoms	O
are	O
made	O
worse	B-course
by	O
walking	O
,	O
climbing	O
stairs	O
,	O
exercise	O
and	O
talking	O
,	O
but	O
not	O
by	O
lying	O
down	O
and	O
coughing	O
.	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
.	O

Ophthalmoscopic	O
examination	O
:	O
Normal	B-labvalue
.	O

Eyes	O

GroupHeading18End	O
GroupHeading19Start	O
GroupHeading19End	O
GroupHeading20Start	O
GroupHeading20End	O
GroupHeading21Start	O
GroupHeading21End	O
GroupHeading22Start	O
GroupHeading22End	O
GroupHeading23Start	O
Cardiovascular	O
Auscultatiop	O
of	O
heast	O
:	O
Normal	B-labvalue
.	O

Hematologic	O
/	O
Lymphatic	O
:	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
,	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
,	O
no	B-negation
swollen	O
glands	B-bodyloc
and	O
no	B-negation
swollen	O
glands	B-bodyloc
in	O
the	O
neck	B-bodyloc
.	O

Examination	O
of	O
urethra	O
:	O
Normal	B-labvalue

Social	O
History	O
Never	O
A	O
Smoker	O

She	O
required	O
intravenous	B-route
narcotics	O
for	O
pain	O
control	O
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
rate	O
and	O
rhythm	O
,	O
normal	B-labvalue
S1	O
and	O
S2	O
,	O
no	B-negation
murmurs	O
.	O

Breath	O
sounds	O
were	B-negation
not	I-negation
diminished	O
.	O

Consent	O
:	O
Risks	O
/	O
benefits	O
/	O
alternatives	O
reviewed	O
.	O

Heart	O
Rate	O
:	O
60	B-labvalue

Respiratory	O
rate	O
:	O
the	O
respiratory	O
rate	O
was	O
normal	B-labvalue
.	O

Neck	O

Follow	O
-	O
up	O
visit	O
in	O
2	B-temporal
months	I-temporal
Outpatient	O
Follow	O
-	O
up	O
Requested	O
for	O
:	O
19Mar2014	B-temporal

Complications	O
:	O
no	B-negation
peripheral	O
neuropathy	O
,	O
no	B-negation
peripheral	B-bodyloc
vascular	I-bodyloc
disease	O
,	O
no	B-negation
gastroparesis	O
,	O
no	B-negation
nephropathy	O
and	O
no	B-negation
coronary	B-bodyloc
artery	I-bodyloc
disease	O
.	O

RESPIRATORY	O
:	O
no	B-negation
wheezing	O
and	O
no	B-negation
cough	O
.	O

Plantar	B-bodyloc
Warts	O
078	O
.	O
12	O

Primary	O
Hypothyroidism	O
244	O
.	O
9	O

Right	O
Toe	O
Flex	O
.	O

Physical	O
Exam	O

Peripheral	O
vascular	O
exam	O
:	O
Normal	B-labvalue

Will	O
use	O
Miralax	O
for	O
constipation	O
-	O
avoid	O
vicodin	O
.	O

Oysco	O
500	O
+	O
D	O
500	B-strength
-	I-strength
200	I-strength
MG	I-strength
-	I-strength
UNIT	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
AS	O
DIRECTED	O
;	O
Therapy	O
:	O
14Jun2012	B-temporal
to	O

LT	O

The	O
abdomen	O
was	O
flat	O
.	O

With	O
these	O
new	O
changes	O
his	O
headaches	O
have	O
nearly	B-course
resolved	I-course
.	O

AST	O
16	B-labvalue
u	I-labvalue
/	I-labvalue
l	I-labvalue
0	B-reference_range
-	I-reference_range
37	I-reference_range

Health	O
Maintenance	O
V70	O
.	O
0	O
75M	O
POV3	O
for	O
CRSwNP	O

Clear	O
nasal	B-bodyloc
discharge	O
:	O
None	B-negation

The	O
bilateral	B-bodyloc
nasal	I-bodyloc
mucosa	I-bodyloc
was	O
boggy	O
.	O

2	O
.	O

PROBLEM	O
LIST	O
:	O
1	O
.	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

Ovary	O
and	O
fallopian	O
tube	O
,	O
left	O
,	O
salpingo	O
-	O
oophorectomy	O
:	O

Assessment	O
Health	O
Maintenance	O
V70	O
.	O
0	O

Test	O
Name	O
Result	O
Flag	O
Reference	O

Co	O
Q	O
-	O
10	O
100	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
31Oct2013	B-temporal
)	O
to	O

T4	O
,	O
FREE	O
1	B-labvalue
.	I-labvalue
2	I-labvalue
ng	I-labvalue
/	I-labvalue
dl	I-labvalue
0	B-reference_range
.	I-reference_range
8	I-reference_range
-	I-reference_range
1	I-reference_range
.	I-reference_range
8	I-reference_range

Cranial	O
nerves	O
II	O
:	O
visual	O
acuity	O
and	O
visual	O
fields	O
were	O
intact	B-labvalue
.	O

URINE	O
BLOOD	O
Trace	B-labvalue
-	O
lysed	O
A	O

General	O
appearance	O
:	O
Abnormal	O
.	O

2	O
.	O

;	O
Apr	B-temporal
12	I-temporal
2014	I-temporal
6	B-temporal
:	I-temporal
21PM	I-temporal
(	O
Author	O
)	O

The	O
left	B-bodyloc
face	I-bodyloc
showed	O
central	O
7th	B-bodyloc
nerve	I-bodyloc
weakness	O
.	O

CARDIOVASCULAR	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
and	O
not	B-negation
expressed	O
as	O
feeling	O
short	O
of	O
breath	O
.	O

Constitutional	O
:	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
,	O
no	B-negation
malaise	O
,	O
no	B-negation
fatigue	O
,	O
no	B-negation
recent	B-temporal
weight	O
gain	O
and	O
no	B-negation
recent	B-temporal
weight	O
loss	O
.	O

Mood	O
and	O
affect	O
:	O
Normal	O
.	O

Assessment	O
of	O
hearing	O
:	O
Normal	B-labvalue
.	O

No	B-negation
nasal	B-route
steroids	O
.	O

INFORMATION	O
-	O
Rx	O
Benefit	O
Plan	O

She	O
underwent	O
a	O
CTA	O
,	O
which	O
showed	O
no	B-negation
evidence	I-negation
of	O
pulmonary	B-bodyloc
embolism	O
and	O
the	O
patient	O
was	O
started	O
on	O
prophylactic	B-dosage
doses	I-dosage
of	O
Lovenox	O
at	O
40	B-strength
mg	I-strength
a	B-frequency
day	I-frequency
.	O

Percussion	O
of	O
chest	O
:	O
Normal	B-labvalue
.	O

f	O
MethylPREDNISolone	O
(	O
Pak	O
)	O
4	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
AS	O
DIRECTED	O
.	O
;	O
Start	O
Date	O
:	O
11/30/2012	B-temporal
(	O
Active	O
)	O
f	O
Cyclobenzaprine	O
HCl	O
10	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
3	B-frequency
TIMES	I-frequency
DAILY	I-frequency
AS	B-frequency
NEEDED	I-frequency
.	O
;	O
Start	O
Date	O
:	O
11/30/2012	B-temporal
(	O
Active	O
)	O

Cough	O
,	O
The	O
patient	O
is	O
being	O
seen	O
for	O
an	O
initial	O
evaluation	O
of	O
an	O
existing	O
diagnosis	O
of	O
chronic	B-course
cough	O
.	O

distilled	O
water	O
,	O
irrigate	O
3	B-frequency
x	I-frequency
a	I-frequency
day	I-frequency
;	O
Therapy	O
:	O
12Mar2013	B-temporal
to	O
(	O
Evaluate	O
:	O
10Jun2013	B-temporal
)	O
Requested	O
for	O
:	O

CHD	O
Risk	O
3	B-labvalue
.	I-labvalue
03	I-labvalue
L	B-labvalue
3	B-reference_range
.	I-reference_range
90	I-reference_range
-	I-reference_range
5	I-reference_range
.	I-reference_range
80	I-reference_range

REVIEW	O
OF	O
SYSTEMS	O
:	O
CONSTITUTIONAL	O
:	O
No	B-negation
fever	O
,	O
chills	O
,	O
or	O
weight	O
loss	O
.	O

glut	O
.	O
)	O
:	O
Normal	O
.	O

Diltiazem	O
HCl	O
60	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
EVERY	B-frequency
8	I-frequency
HOURS	I-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
05Jun2012	B-temporal
)	O
to	O

Patient	O
returns	O
for	O
stress	O
test	O
and	O
follow	O
up	O
to	O
stress	O
test	O
.	O

Health	O
Maintenance	O
V20	O
.	O
2	O
CRScNP	O
possibly	B-uncertain
AFRS	O
doign	O
well	O
on	O
today	B-temporal
'	I-temporal
s	I-temporal
exam	O
sympotomatically	O
,	O
but	O
has	O
had	O
a	B-course
progression	I-course
of	O
polyps	O
since	O
last	O
visit	O

Examination	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue

Endocrine	O
:	O
no	B-negation
proptosis	O
,	O
no	B-negation
hot	O
flashes	O
,	O
no	B-negation
muscle	B-bodyloc
weakness	O
,	O
no	B-negation
erectile	O
dysfunction	O
,	O
no	B-negation
deepening	O
of	O
the	O
voice	O
and	O
no	B-negation
feelings	O
of	O
weakness	O
.	O

-	O
-	O
CBC	O
,	O
LFT	O
,	O
Vit	O
D	O
today	B-temporal
.	O

Never	O
A	O
Smoker	O

REASON	O
FOR	O
FOLLOWUP	O
:	O
CKD	O
stage	B-severity
4	I-severity
.	O

Never	O
A	O
Smoker	O

There	O
was	O
no	B-negation
flaccidity	O
or	O
hypotonicity	O
observed	O
.	O

Attending	O
Note	O

Discolored	O
nasal	B-bodyloc
discharge	O
:	O
Severe	B-severity

Advised	O
stretching	O
and	O
provided	O
new	O
prescription	O
for	O
PT	O
.	O

Son	O
stated	O
that	O
his	O
sister	O
stays	O
with	O
the	O
patient	O
and	O
is	O
now	O
preparing	O
his	O
pill	O
box	O
.	O

Peripheral	O
Vision	O
:	O
Normal	B-labvalue
(	O
full	O
)	O
.	O

Diastolic	O
:	O
70	B-labvalue
,	O
LUE	O
,	O
Sitting	O

Orientation	O
to	O
person	O
,	O
place	O
and	O
time	O
:	O
Normal	B-labvalue
.	O

Estradiol	O
0	B-strength
.	I-strength
5	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
TWICE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
12Jun2013	B-temporal
)	O
to	O

BILIRUBIN	O
:	O
NEG	B-labvalue

NECK	O

Follow	O
up	O
/	O
CT	O
results	O
.	O

UTP	O
-	O
Discussion	O
/	O

The	O
patient	O
states	O
he	O
has	O
been	O
stable	O
with	O
his	O
blood	O
pressure	O
control	O
since	O
the	O
last	O
visit	O
.	O

;	O
Oct	B-temporal
29	I-temporal
2012	I-temporal
5	B-temporal
:	I-temporal
41PM	I-temporal
(	O
Author	O
)	O

Denied	B-negation
Asthma	O

Atarax	O
TABS	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
24Apr2013	B-temporal
)	O
to	O

Current	B-temporal
treatment	O
includes	O
increased	O
oral	O
fluid	O
intake	O
and	O
steam	O
inhalation	O
.	O

3	O
.	O

External	O
genitalia	O
:	O
normal	O
.	O

Attending	O
Note	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
.	O

Assessment	O
Chronic	B-course
Mucoid	O
Otitis	O
Media	O
381	O
.	O
20	O

Ocular	O
motility	O
:	O
Extraocular	O
muscles	O
intact	B-labvalue
.	O

Physical	O
Exam	O

History	O
of	O
Spasmodic	O
Torticollis	O
333	O
.	O
83	O

given	O
palpitation	O
,	O
elevated	O
BP	O
and	O
history	O
of	O
thyroid	B-bodyloc
nodule	O
,	O
will	O
order	O
cardiac	O
echo	O
for	O
evaluation	O
.	O

Inspection	O
of	O
lips	O
,	O
teethand	O
gums	O
:	O
Normal	B-labvalue

[	O
QLH	O
]	O
IMMUNOGLOBULINS	O
Requested	O
for	O
:	O
05Dec2011	B-temporal
Nasal	O
endoscopy	O
today	B-temporal

)	O
(	O
s	O
)	O
*	O
Refills	O
:	O
*	O
0	O
*	O
5	O
.	O

Oropharynx	O
:	O
Normal	O
.	O

Description	O
:	O
Normal	O
physical	O
exam	O
template	O
.	O

Vitals	O
04Sep2013	B-temporal
09	B-temporal
:	I-temporal
23AM	I-temporal
BMI	O
Calculated	O
19	B-labvalue
.	I-labvalue
84	I-labvalue
BSA	O
Calculated	O
1	B-labvalue
.	I-labvalue
47	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
2	I-labvalue
in	I-labvalue
Weight	O
107	B-labvalue
lb	I-labvalue
12	I-labvalue
.	I-labvalue
8	I-labvalue
oz	I-labvalue
Systolic	O
112	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
79	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Temperature	O
98	B-labvalue
.	I-labvalue
2	I-labvalue
F	I-labvalue
,	O
Oral	O
Heart	O
Rate	O
72	B-labvalue

Inspection	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
Normal	B-labvalue
Normal	B-labvalue
color	O
and	O
pigmentation	O
,	O
no	B-negation
cyanosis	O
,	O
no	B-negation
erythema	O
and	O
no	B-negation
pallor	O
.	O

Levothyroxine	O
Sodium	O
50	B-strength
MCG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
AS	I-frequency
DIRECTED	I-frequency
;	O
Therapy	O
:	O
08Nov2012	O
to	O
(	O
Evaluate	O
:	O
09Feb2014	B-temporal
)	O
Requested	O
for	O
:	O
21Nov2013	B-temporal
;	O
Last	O
Rx	O
:	O
11Nov2013	B-temporal

Hip	B-bodyloc
Fracture	O
820	O
.	O
8	O

;	O
Feb	B-temporal
17	I-temporal
2014	I-temporal
1	B-temporal
:	I-temporal
14PM	I-temporal
(	O
Author	O
)	O

Middle	O
Turbinate	O
:	O
Normal	O
position	O
.	O

Anesthesia	O
:	O
epidural	O
.	O

Vaginitis	O
resolved	B-course
.	O

It	O
is	O
known	O
to	O
occur	O
in	O
patients	O
who	O
have	O
lost	O
weight	O
and	O
given	O
that	O
he	O
has	O
improved	O
almost	O
back	O
to	O
normal	O
this	O
would	O
be	O
good	O
correlation	O
to	O
this	O
hypothesis	O
that	O
weight	O
loss	O
can	O
induce	O
focal	O
mononeuropathy	O
at	O
the	O
fibular	B-bodyloc
head	I-bodyloc
.	O

Peripheral	O
Vascular	O
Exam	O
:	O
Normal	B-labvalue
.	O

[	O
U	O
]	O
XRAY	O
WRIST	O
MIN	O
3	O
VWS	O
LEFT	O
73110	O
Requested	O
for	O
:	O
08Apr2014	B-temporal

Language	O
:	O
No	B-negation
dysphasia	O
/	O
aphasia	O
was	O
observed	O
.	O

Nasal	B-bodyloc
Polyps	O
471	O
.	O
9	O

Male	O
.	O

Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

Social	O
History	O
Denied	O

The	O
risks	O
,	O
benefits	O
and	O
anticipated	O
outcomes	O
of	O
the	O
procedure	O
,	O
the	O
risks	O
and	O
benefits	O
to	O
the	O
alterntive	O
of	O
the	O
procedure	O
,	O
and	O
the	O
roles	O
and	O
tasks	O
of	O
personnel	O
involved	O
were	O
discussed	O
with	O
the	O
patient	O
,	O
and	O
the	O
patient	O
consents	O
to	O
the	O
procedure	O
and	O
agrees	O
to	O
proceed	O
.	O

Cranial	O
nerves	O
XII	O
:	O
there	O
was	O
no	B-negation
tongue	B-bodyloc
deviation	O
with	O
protrusion	O
.	O

Antihistamines	O
(	O
past	B-temporal
12	I-temporal
months	I-temporal
)	O
:	O
Loratadine	O
(	O
Claritin	O
)	O

White	O
Blood	O
Cell	O
6	B-labvalue
.	I-labvalue
1	I-labvalue
K	I-labvalue
/	I-labvalue
CMM	I-labvalue
3	B-reference_range
.	I-reference_range
7	I-reference_range
-	I-reference_range
10	I-reference_range
.	I-reference_range
4	I-reference_range

ValACYclovir	O
HCl	O
1	B-strength
GM	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
3	B-frequency
TIMES	I-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
07Apr2011	B-temporal
to	O
(	O
Evaluate	O
:	O
02Jun2011	B-temporal
)	O
;	O
Last	O
Rx	O
:	O
07Apr2011	B-temporal

Pt	O
will	O
f	O
/	O
u	O
with	O
Dr	O
.	O
Lee	O
,	O
her	O
PCP	O
,	O
for	O
diabetes	O
control	O
.	O

Cholesterol	O
Education	O
Program	O
(	O
ATP	O
III	O
,	O
2001	O
)	O
.	O

[	O
QLH	O
]	O
LIPID	O
PANEL	O
29Nov2012	B-temporal
10	B-temporal
:	I-temporal
35AM	I-temporal
Hardwicke	O
,	O
Robin	O

The	O
abdomen	O
was	O
rounded	O
.	O

Aug	B-temporal
6	I-temporal
2012	I-temporal
3	B-temporal
:	I-temporal
24PM	I-temporal
(	O
Author	O
)	O

The	O
patient	O
underwent	O
bronchoscopy	O
,	O
which	O
is	O
positive	B-labvalue
for	O
non	O
-	O
small	O
cell	O
lung	B-bodyloc
CA	O
.	O

Shortness	O
Of	O
Breath	O
786	O
.	O
05	O

Current	O
Orders	O
[	O
L	O
]	O
Miscellaneous	O
Problem	O
Done	O
:	O
18Apr2013	B-temporal
11	B-temporal
:	I-temporal
00PM	I-temporal

The	O
patient	O
states	O
her	O
hyperlipidemia	O
has	O
been	O
under	O
good	O
control	O
since	O
the	O
last	O
visit	O
.	O

Osteoporosis	O
Senile	O
733	O
.	O
01	O

Advised	O
she	O
d	O
/	O
c	O
.	O

Keep	O
a	O
Headache	O
diary	O

History	O
of	O
Present	O
Illness	O
48	O
yo	O
man	O
with	O
abnormal	O
ECG	O
presents	O
for	O
evaluation	O
after	O
teradmill	O
stress	O
test	O
.	O

Former	O
Smoker	O
V15	O
.	O
82	O

Paternal	B-subject
grandmother	I-subject
'	I-subject
s	I-subject
history	O
of	O
Acute	B-course
Myocardial	B-bodyloc
Infarction	O
V17	O
.	O
3	O

Family	O
History	O
Family	B-subject
history	O
of	O
Diabetes	O
Mellitus	O
V18	O
.	O
0	O

Vaccines	O
Prophylactic	O
Need	O
Against	O
Influenza	O
V04	O
.	O
81	O

Description	O
:	O
Open	O
reduction	O
and	O
internal	O
fixation	O
(	O
ORIF	O
)	O
of	O
right	B-bodyloc
Schatzker	I-bodyloc
III	I-bodyloc
tibial	I-bodyloc
plateau	I-bodyloc
fracture	O
with	O
partial	O
medial	O
meniscectomy	O
.	O

Creatinine	O
Lvl	O
0	B-labvalue
.	I-labvalue
8	I-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
0	B-reference_range
.	I-reference_range
5	I-reference_range
-	I-reference_range
1	I-reference_range
.	I-reference_range
4	I-reference_range

Occupation	O
:	O
Retired	O

Hemoglobin	O
13	B-labvalue
.	I-labvalue
9	I-labvalue
g	I-labvalue
/	I-labvalue
dl	I-labvalue
12	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
16	I-reference_range
.	I-reference_range
0	I-reference_range

Family	O
History	O

Collected	O
-	O
-	O

Neck	O
:	O
No	B-negation
neck	B-bodyloc
stiffness	O
,	O
no	B-negation
lump	O
or	O
swelling	O
in	O
the	O
neck	B-bodyloc
,	O
and	O
no	B-negation
swollen	O
glands	B-bodyloc
in	I-bodyloc
the	I-bodyloc
neck	I-bodyloc
.	O

History	O
of	O
Alcohol	O
Use	O

No	B-negation
friction	O
rub	O
heard	O
.	O

Levaquin	O
500	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
26Jan2011	B-temporal
to	O
(	O
Evaluate	O
:	O
16Feb2011	B-temporal
)	O
;	O
Last	O
Rx	O
:	O
26Jan2011	B-temporal

patient	O
report	O
sthat	O
he	O
did	O
not	B-negation
take	O
his	O
blood	O
pressure	O
medication	O
today	B-temporal
.	O

Examination	O
of	O
cranial	O
nerves	O
:	O
Normal	B-labvalue
.	O

Mean	O
Cell	O
Hemoglobin	O
:	O
26	B-labvalue
.	I-labvalue
4	I-labvalue
pg	I-labvalue
Abnormal	O
Low	O
Reference	O
Range	O
27	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
31	I-reference_range
.	I-reference_range
0	I-reference_range

ENT	O
:	O
no	B-negation
epistaxis	O
and	O
no	O
throat	O
.	O

Ciprofloxacin	O
HCl	O
500	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
EVERY	B-frequency
12	I-frequency
HOURS	I-frequency
;	O
Therapy	O
:	O
04Mar2008	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
04Mar2008	B-temporal
)	O
Requested	O
for	O
:	O
04Mar2008	B-temporal

Angelina	O
Edwards	O
,	O
MD	O
Electronically	O
signed	O
by	O
:	O
ANGELINA	O
EDWARDS	O
M	O
.	O
D	O
.	O

LMP	O
.	O

Examination	O
of	O
bladder	O
:	O
Normal	B-labvalue

Jugular	O
Veins	O
:	O
the	O
JVP	O
was	O
not	B-labvalue
elevated	I-labvalue
.	O

Joint	B-bodyloc
Pain	O
Fingers	B-bodyloc
719	O
.	O
44	O

Neuro	O
Emphasis	O
:	O

Motor	O
Strength	O
:	O
Head	O
and	O
Neck	O
Muscles	O
:	O
Right	O
Neck	O
Flexors	O
Strength	O
:	O
5	O
/	O
5	O
.	O

NECK	O
:	O
Soft	O
and	O
supple	O
.	O

She	O
denies	B-negation
swelling	O
in	O
her	O
hands	B-bodyloc
.	O

Dehydration	O
(	O
Na	O
,	O
H2O	O
)	O
276	O
.	O
51	O

Influenza	O
#	O
1	O
or	O
#	O
2	O
if	O
not	O
already	O
done	O
if	B-condition
flu	O
season	O
(	O
typically	O
Oct	B-temporal
to	O
March	B-temporal
)	O

Respiratory	O
No	B-negation
respiratory	B-bodyloc
distress	O
,	O
normal	B-labvalue
respiratory	O
rhythm	O
and	O
effort	O

Bisoprolol	O
Fumarate	O
5	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Take	O
1	B-dosage
/	I-dosage
2	I-dosage
a	I-dosage
tablet	B-form
daily	B-frequency
Requested	O
for	O
:	O
07Oct2013	B-temporal
;	O
Last	O
Rx	O
:	O
07Oct2013	B-temporal
;	O
Status	O
:	O
ACTIVE	O
-	O
Retrospective	O
Authorization	O

Little	O
Noses	O
Decongestant	O
0	B-strength
.	I-strength
125	I-strength
%	I-strength
Nasal	B-form
Solution	I-form
;	O
2	B-dosage
drops	I-dosage
each	O
nostril	O
;	O
Therapy	O
:	O
25Mar2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
25Mar2013	B-temporal
)	O
Requested	O
for	O
:	O
25Mar2013	B-temporal
;	O
Status	O
:	O
ACTIVE	O
-	O
Retrospective	O
Authorization	O

[	O
QLH	O
]	O
CBC	O
(	O
INCLUDES	O
DIFF	O
/	O
PLT	O
)	O
Requested	O
for	O
:	O
29Oct2012	B-temporal

Patient	O
discussion	O
:	O
discussed	O
with	O
the	O
patient	O
,	O
discussed	O
with	O
the	O
patient	O
'	O
s	O
family	O
,	O
follow	O
-	O
up	O
1	B-temporal
week	I-temporal
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O
The	O
patient	O
is	O
a	O
77	O
-	O
year	O
-	O
old	O
female	O
who	O
is	O
unable	O
to	O
give	O
any	O
information	O
.	O

Indication	O
:	O
.	O

Heart	O
size	O
and	O
central	O
vasculature	O
are	O
within	O
normal	O
limits	O
.	O

Patient	O
prefers	O
to	O
schedule	O
at	O
her	O
convenience	O
for	O
cryotherapy	O
in	O
the	O
following	O
visits	O
.	O

Hyperlipidemia	O
272	O
.	O
4	O

Gestational	O
Diabetes	O
Mellitus	O
648	O
.	O
80	O

Past	O
Medical	O
History	O
Problems	O

Palpation	O
of	O
cervical	O
lymph	O
nodes	O
:	O
Normal	B-labvalue
.	O

Results	O
/	O
Results	O
/	O
Data	O

Electronically	O
signed	O
by	O
:	O
SEE	O
-	O
LONG	O
WONG	O
,	O
NP	O
;	O
Feb	B-temporal
25	I-temporal
2013	I-temporal
8	B-temporal
:	I-temporal
35AM	I-temporal
(	O
Author	O
)	O

General	O
appearance	O
:	O
Normal	O
.	O

Ms	O
.	O
Mayes	O
previously	O
underwent	O
a	O
Baclofen	O
pump	B-form
trial	O
.	O

Discussion	O
/	O
Signatures	O
Electronically	O
signed	O
by	O
:	O
SEE	O
-	O
LONG	O
WONG	O
,	O
NP	O
;	O
Feb	B-temporal
22	I-temporal
2013	I-temporal
3	B-temporal
:	I-temporal
02PM	I-temporal
(	O
Author	O
)	O

Is	O
not	O
breast	O
-	O
feeding	O
.	O

Pedal	O
pulses	O
:	O
Normal	B-labvalue
.	O

The	O
patient	O
seemed	O
to	O
be	O
recovering	O
well	O
.	O

History	O
of	O
Present	O
Illness	O

Bowel	O
sounds	O
were	O
normal	O
.	O

Ordered	O
;	O
For	O
:	O
Atrial	B-bodyloc
Fibrillation	O
(	O
427	O
.	O
31	O
)	O
;	O
Ordered	O
By	O
:	O
ABDELMELEK	O
,	O
LOURICE	O
Perform	O
:	O
In	O
Office	O
Due	O
:	O
02Aug2013	B-temporal
;	O
Last	O
Updated	O
By	O
:	O
Avellaneda	O
,	O
Mayra	O

individuals	O
the	O
eGFR	O
will	O
be	O
>	B-reference_range
90	I-reference_range
mL	I-reference_range
/	I-reference_range
min	I-reference_range
/	I-reference_range
1	I-reference_range
.	I-reference_range
73m2	I-reference_range
.	I-reference_range

No	B-negation
CP	O
/	O
SOB	O
.	O

No	B-negation
murmurs	O
were	O
heard	O
.	O

No	B-negation
rhonchi	O
were	O
heard	O
.	O

She	O
was	O
taken	O
to	O
the	O
operating	O
room	O
on	O
04/02/2007	B-temporal
where	O
a	O
total	O
vaginal	O
hysterectomy	O
was	O
performed	O
under	O
general	O
anesthesia	O
.	O

Neurological	O
:	O
no	B-negation
dizziness	O
and	O
no	B-negation
fainting	O
.	O

Peripheral	O
Vision	O
:	O
Normal	B-labvalue
(	O
full	O
)	O
.	O

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

f	O
EST	O
,	O
Provider	O
:	O
PEDI	O
,	O
HIGH	O
,	O
Status	O
:	O
Pen	O
,	O
Tnme	O
:	O
9	B-temporal
:	I-temporal
30	I-temporal
AM	I-temporal
05/17/2013	B-temporal

[	O
QLH	O
]	O
BASIC	O
METABOLIC	O
PANEL	O
W	O
/	O
EGFR	O
Done	O
:	O
19Jul2011	B-temporal
12	B-temporal
:	I-temporal
28PM	I-temporal

Developmental	O
Milestones	O
g37	O

Type	O
2	O
Diabetes	O
Mellitus	O
250	O
.	O
00	O

Mean	O
Cell	O
Volume	O
92	B-labvalue
.	I-labvalue
7	I-labvalue
fL	I-labvalue
81	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
99	I-reference_range
.	I-reference_range
0	I-reference_range

3	O
.	O

ASSESSMENT	O
:	O
No	B-negation
intra	B-bodyloc
-	I-bodyloc
abdominal	I-bodyloc
pathology	O
.	O

History	O
of	O
Upper	B-bodyloc
Respiratory	I-bodyloc
Infection	O
465	O
.	O
9	O

Here	O
for	O
further	O
evaluation	O
and	O
treatment	O
.	O

Pupils	O
were	O
equal	O
in	O
size	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
.	O

Hyperlipidemia	O
272	O
.	O
4	O

2	O
.	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Chief	O
Complaint	O

MA	O
Breast	O
mammogram	O
bilateral	O
77056	O
Requested	O
for	O
:	O
25Sep2013	B-temporal

She	O
is	O
coping	O
well	O
however	O
understandably	O
very	O
worried	O
.	O

HEENT	O
:	O
Atraumatic	O
.	O

[	O
U	O
]	O
XRAY	O
CHEST	O
2	O
VWS	O
71020	O
Requested	O
for	O
:	O
11Apr2014	B-temporal

CHD	O
Risk	O
2	B-labvalue
.	I-labvalue
99	I-labvalue
L	B-labvalue
3	B-reference_range
.	I-reference_range
90	I-reference_range
-	I-reference_range
5	I-reference_range
.	I-reference_range
80	I-reference_range

Shoulder	O
:	O

;	O
Mar	B-temporal
1	I-temporal
2012	I-temporal
2	B-temporal
:	I-temporal
19PM	I-temporal
(	O
Co	O
-	O
author	O
)	O

ebody	O

-	O
still	O
slight	B-severity
lochia	O

Instructions	O
have	O
been	O
given	O
.	O

Tx	O
options	O
discussed	O
and	O
elects	O
OCPs	O
.	O
risk	O
of	O
DVT	O
,	O
PE	O
,	O
Stroke	O
,	O
MI	O
,	O
breast	B-bodyloc
dx	O
discussed	O
.	O

Return	O
to	O
Clinic	O
in	O
6	B-temporal
months	I-temporal
time	O
.	O

Assessment	O
of	O
muscle	O
strength	O
/	O
tone	O
:	O
Normal	B-labvalue

Bentyl	O
TABS	B-form
;	O
25mg	B-strength
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
29Sep2011	B-temporal
)	O
to	O

Assessment	O

Past	O
Medical	O
History	O
History	O
of	O
Allergic	O
Rhinitis	O
477	O
.	O
9	O

History	O
of	O
Present	O
Illness	O
36	O
yo	O
G5P1122	O
at	O
11w1d	O
by	O
LMP	O
c	O
/	O
w	O
8	O
week	O
clinic	O
TVUS	O
,	O
with	O
T2DM	O
,	O
AMA	O
,	O
h	O
/	O
o	O
PPROM	O
with	O
PTB	O

Abdomen	O
:	O
soft	O
,	O
nontender	O
,	O
normoactive	B-labvalue
bowel	O
sounds	O

Recent	B-temporal
measurements	O
:	O
hemoglobin	O
A1c	O
6	B-labvalue
.	I-labvalue
4	I-labvalue
%	I-labvalue
.	O

f	O
Ergocalciferol	O
50000	B-strength
UNIT	I-strength
Oral	B-route
Capsule	B-form
;	O
one	B-dosage
capsule	B-form
once	B-frequency
monthly	I-frequency
;	O
Start	O
Date	O
:	O
11/15/2011	B-temporal
(	O
Active	O
)	O

ALLERGIES	O
:	O
UNABLE	O
TO	O
EVALUATE	O
.	O

Hgb	O
:	O
12	B-labvalue
.	I-labvalue
9	I-labvalue
g	I-labvalue
/	I-labvalue
dl	I-labvalue
Reference	O
Range	O
12	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
16	I-reference_range
.	I-reference_range
0	I-reference_range

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Optic	O
Disc	O
:	O
Normal	O
.	O

The	O
tonsils	O
were	O
normal	O
.	O

Scope	O
:	O
3	O
mm	O
30	O
degree	O
telescope	O
.	O

Pregnancy	O
c	O
/	O
b	O
A1DM	O
.	O

Hematologic	O
/	O
Lymphatic	O
:	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
,	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
,	O
no	B-negation
swollen	O
glands	B-bodyloc
and	O
no	B-negation
swollen	O
glands	B-bodyloc
in	O
the	O
neck	B-bodyloc
.	O

Examination	O
of	O
thyroid	O
:	O
Normal	B-labvalue
.	O

He	O
exercises	O
3	O
or	O
more	O
times	O
per	O
week	O
.	O

History	O
of	O
Present	O
Illness	O

Never	O
A	O
Smoker	O

left	O
index	O
digital	O
artery	O
,	O
digital	O
nerve	O
repair	O
radial	O
and	O
ulnar	O
nerve	O
repair	O
x2	O
2	O
.	O

She	O
has	O
no	B-negation
significant	O
interval	O
events	O
.	O

Itchy	O
nose	B-bodyloc
/	O
eyes	B-bodyloc
/	O
throat	B-bodyloc
:	O
Mild	B-severity

He	O
has	O
no	B-negation
pain	O
or	O
complaints	O
of	O
the	O
left	B-bodyloc
lower	I-bodyloc
extremity	I-bodyloc
.	O

Assessment	O
_	O
80	O
_	O
twCiteListControlEnd	O
AssessmentSectispEnd	O
PlapSectispStart	O
Plap	O
Plap	O
_	O
2	O
_	O
twCiteListControlStart	O
Urine	O
Dipstick	O
(	O
In	O
Office	O
)	O
Requested	O
for	O
:	O
14Mar2013	B-temporal

The	O
abdomen	O
was	O
soft	O
and	O
nontender	O
.	O

[	O
QLH	O
]	O
HEMATOCRIT	O
Done	O
:	O
27Dec2010	B-temporal
01	B-temporal
:	I-temporal
30PM	I-temporal

Denies	B-negation
intermenstrual	O
bleeding	O
or	O
postcoital	O
bleeding	O
.	O

Active	O
Problems	O
Joint	B-bodyloc
Pain	O
,	O
Localized	O
In	O
The	O
Knee	B-bodyloc
719	O
.	O
46	O

SPECIFIC	O
GRAVITY	O
:	O
1	B-labvalue
.	I-labvalue
000	I-labvalue
Of	O
Interest	O

[	O
O	O
]	O
CBC	O
(	O
in	O
office	O
)	O
Requested	O
for	O
:	O
11Apr2014	B-temporal

Counseling	O
/	O
Counseling	O
/	O
Edu	O
The	O
patient	O
and	O
patient	O
'	O
s	O
family	O
was	O
counseled	O
regarding	O
diagnostic	O
results	O
,	O
instructions	O
for	O
management	O
,	O
risk	O
factor	O
reductions	O
,	O
prognosis	O
,	O
patient	O
and	O
family	O
education	O
,	O
risks	O
and	O
benefits	O
of	O
treatment	O
optionsandimportance	O
of	O
compliance	O
with	O
treatment	O
.	O

The	O
left	O
tympanic	O
membrane	O
was	O
normal	O
,	O
was	O
not	O
red	O
and	O
was	O
not	B-negation
bulging	O
.	O

Anterior	O
cervical	O
discectomy	O
with	O
decompression	O
C4	O
-	O
C5	O
,	O
C5	O
-	O
C6	O
,	O
and	O
C6	O
-	O
C7	O
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Genitourinary	O
:	O
no	B-negation
dysuria	O
,	O
no	B-negation
incontinence	O
and	O
no	B-negation
pelvic	B-bodyloc
pain	O
.	O

c	O
/	O
o	O
nasal	B-bodyloc
discharge	O

The	O
patient	O
'	O
s	O
last	O
LDL	O
was	O
high	B-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue
.	O

Simvastatin	O
40	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
AT	I-frequency
BEDTIME	I-frequency
;	O
Therapy	O
:	O
26Mar2012	B-temporal
to	O
(	O
Evaluate	O
:	O
24Jun2012	B-temporal
)	O
Requested	O
for	O
:	O
26Mar2012	B-temporal
;	O
Last	O
Rx	O
:	O
26Mar2012	B-temporal

Respiratory	O
:	O
no	O
shortness	O
of	O
breathand	O
no	B-negation
cough	O
.	O

11	B-temporal
/	I-temporal
09	I-temporal
and	O
12	B-temporal
/	I-temporal
09	I-temporal
-	O
Recurrent	B-course
episodes	O
of	O
more	O
extensive	O
numbness	O
with	O
eventual	O
involvement	O
of	O
the	O
chest	B-bodyloc
and	I-bodyloc
arms	I-bodyloc
.	O

LT	O
Inferior	O
Turbinate	O

By	O
report	O
,	O
there	O
is	O
fair	O
adherence	O
with	O
treatment	O
.	O

Appendix	O
#	O
1	O

Vitals	O
01Oct2013	B-temporal
04	B-temporal
:	I-temporal
16PM	I-temporal
BMI	O
Calculated	O
47	B-labvalue
.	I-labvalue
97	I-labvalue
BSA	O
Calculated	O
2	B-labvalue
.	I-labvalue
26	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
4	I-labvalue
in	I-labvalue
Weight	O
281	B-labvalue
lb	I-labvalue
Systolic	O
128	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
90	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Heart	O
Rate	O
84	B-labvalue
,	O
R	O
Radial	O
Pulse	O
Quality	O
Normal	B-labvalue
,	O
R	O
Radial	O
Respiration	O
20	B-labvalue
Respiration	O
Quality	O
Normal	B-labvalue

History	O
of	O
Present	O
Illness	O

Hydrochlorothiazide	O
25	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
17Dec2013	B-temporal
)	O

The	O
patient	O
presents	O
with	O
complaints	O
of	O
no	B-negation
dizziness	O
(	O
RESOLVED	O
)	O
.	O

Inspection	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
Normal	B-labvalue

Gastrointestinal	B-bodyloc
:	O
nauseaandconstipation	O
,	O
but	O
no	B-negation
vomiting	O
.	O

(	O
med	O
.	O

Examination	O
of	O
thyroid	O
:	O
Normal	B-labvalue
.	O

Bili	O
Total	O
0	B-labvalue
.	I-labvalue
2	I-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
0	B-reference_range
.	I-reference_range
2	I-reference_range
-	I-reference_range
1	I-reference_range
.	I-reference_range
3	I-reference_range

CARDIOVASCULAR	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
AMBER	O
ZULFIQAR	O
,	O
M	O
.	O
D	O
.	O
;	O

She	O
did	O
not	O
bring	O
her	O
meter	O
.	O

Lower	O
Extremities	O
:	O
Right	O
Iliopsoas	O
(	O
femor	O
.	O
)	O
:	O
Normal	O
.	O

Discharge	O
Disposition	O
:	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
LaVone	O
Smith	O
,	O
M	O
.	O
D	O
.	O
;	O

f	O
EPD	O
,	O
Provider	O
:	O
NADER	O
-	O
EFTEKHARI	O
,	O
SHAHLA	O
,	O
Status	O
:	O
Pen	O
,	O
Time	O
:	O
9	B-temporal
:	I-temporal
45	I-temporal
AM	I-temporal
04/25/2013	B-temporal

Current	O
Orders	O
[	O
QLH	O
]	O
LIPID	O
PANEL	O
Requested	O
for	O
:	O
11Dec2013	B-temporal

He	O
uses	O
a	O
voice	O
writer	O
.	O

The	O
patient	O
is	O
instructed	O
that	O
he	O
no	O
longer	O
needs	O
to	O
follow	O
up	O
in	O
our	O
clin	O
c	O
and	O
can	O
follow	O
up	O
a	O
p	O
.	O
r	O
.	O
n	O
.	O
basis	O
.	O

Previous	B-temporal
sinus	O
or	O
nasal	O
surgery	O
:	O
No	B-negation

Constitutional	O

PSYCHIATRIC	O
:	O
no	B-negation
depression	O
and	O
no	B-negation
anxiety	O
.	O

B	O
/	O
S	O
is	O
96	B-labvalue
-	I-labvalue
183	I-labvalue
in	B-temporal
a	I-temporal
.	I-temporal
m	I-temporal
.	O

Mood	O
and	O
affect	O
:	O
Abnormal	O
.	O
Patients	O
mood	O
seems	O
to	O
be	O
depressed	O
.	O

Stool	O
sample	O
for	O
occult	O
blood	O
:	O
Normal	B-labvalue
.	O

Valtrex	O
500	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
14Sep2011	B-temporal
to	O
(	O
Evaluate	O
:	O
15Nov2011	B-temporal
)	O
;	O
Last	O
Rx	O
:	O
16Sep2011	B-temporal

Current	O
Meds	O
Lotrel	O
5	B-strength
-	I-strength
20	I-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
08Oct2012	B-temporal
)	O
to	O

History	O
of	O
Present	O
Illness	O
The	O
patient	O
states	O
he	O
has	O
been	O
with	O
his	O
Type	O
II	O
Diabetes	O
control	O
since	O
the	O
last	O
visit	O
.	O

ENT	O
:	O
no	B-negation
epistaxis	O
and	O
no	B-negation
sore	O
throat	B-bodyloc
.	O

Encourage	O
follow	O
-	O
up	O
with	O
neurology	O

The	O
liver	B-bodyloc
was	O
nontender	O
and	O
not	B-negation
enlarged	O
.	O

Motor	O
Survey	O
:	O
the	O
motor	O
survey	O
was	O
normal	B-labvalue
.	O

Microinvasive	O
carcinoma	O
of	O
the	O
cervix	B-bodyloc
.	O

Constitutional	O

CALCIUM	O
8	B-labvalue
.	I-labvalue
9	I-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
8	B-reference_range
.	I-reference_range
6	I-reference_range
-	I-reference_range
10	I-reference_range
.	I-reference_range
4	I-reference_range

Pulmonary	O

0	O
-	O
7	O
days	O
:	O
41	O
-	O
90	O
mg	O
/	O
dL	O

CC	O
:	O
John	O
Yoo	O
,	O
MD	O
CC	O
:	O
John	O
Kirkwood	O
,	O
MD	O

Continue	O
to	O
follow	O
-	O
up	O
with	O
internal	O
medicine	O
as	O
indicated	O
.	O

Inspection	O
of	O
lips	O
,	O
teethand	O
gums	O
:	O
Normal	B-labvalue

Birth	O
Control	O
:	O
bilateral	O
tubal	O
ligation	O
.	O

Examination	O
of	O
thyroid	O
:	O
Normal	B-labvalue
.	O

He	O
is	O
experiencing	O
dysphasia	O
/	O
aphasia	O
(	O
severly	O
dysarthric	O
)	O
.	O

Genitourinary	O
:	O
no	B-negation
dysuria	O
.	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
and	O
no	B-negation
cough	O
.	O

Pulmonary	O

Examination	O
of	O
digits	O
and	O
nails	O
:	O
Normal	B-labvalue
.	O

Physical	O
Exam	O

ACTIVE	O
-	O
Retrospective	O
Authorization	O
;	O
Edited	O

Pulmonary	O

Tenderness	O
:	O
subacromial	B-bodyloc
bursa	I-bodyloc
.	O

Cinnamon	O
CAPS	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
26Feb2014	B-temporal
)	O
to	O

OCC	O
.	O

Neurological	O
:	O
no	B-negation
dizziness	O
.	O

Arthralgia	O
Of	O
The	O
Right	B-bodyloc
Shoulder	I-bodyloc
Region	O
719	O
.	O
41	O

Examination	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue

Pravastatin	O
Sodium	O
40	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
AT	I-frequency
BEDTIME	I-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
21Jan2014	B-temporal
)	O
to	O

Facial	O
strength	O
:	O
Symmetric	B-labvalue
.	O

In	O
the	O
interim	O
patient	O
has	O
been	O
started	O
on	O
Allergy	O
Injections	O
by	O
ENT	O
.	O

[	O
QLH	O
]	O
HPV	O
,	O
high	O
-	O
risk	O
29Nov2012	B-temporal
04	B-temporal
:	I-temporal
30PM	I-temporal
Hardwicke	O
,	O
Robin	O

to	O

Electronically	O
signed	O
by	O
:	O
SAMER	O
FAKHRI	O
,	O
M	O
.	O
D	O
.	O

Assessment	O
Hyperlipidemia	O
272	O
.	O
4	O

Continue	O
lexapro	O
and	O
aricept	O
,	O
memory	O
stable	O
per	O
husband	O

Visit	O
For	O
:	O
Preoperative	O
Exam	O
V72	O
.	O
84	O

;	O
Aug	B-temporal
16	I-temporal
2012	I-temporal
3	B-temporal
:	I-temporal
55PM	I-temporal
(	O
Author	O
)	O

Birth	O
Control	O
:	O
oral	O
contraceptive	O
pills	O
.	O

Attending	O
Note	O

Discolored	O
nasal	B-bodyloc
discharge	O
:	O
None	B-negation

Height	O
:	O
5	B-labvalue
ft	I-labvalue
1	I-labvalue
in	I-labvalue

Place	O
of	O
Delivery	O
:	O
MHH	O
.	O

In	O
fact	O
she	O
barely	O
get	O
out	O
of	O
wheel	O
chair	O
.	O

Skin	B-bodyloc
and	I-bodyloc
subcutaneous	I-bodyloc
tissue	I-bodyloc
:	O
Abnormal	O
.	O

History	O
of	O
Present	O
Illness	O

3	O
.	O

Eyes	O
:	O
no	B-negation
eye	B-bodyloc
pain	O
,	O
eyes	B-bodyloc
not	B-negation
red	O
,	O
no	B-negation
eyesight	O
problems	O
,	O
no	B-negation
purulent	O
discharge	O
from	O
the	O
eyes	B-bodyloc
,	O
no	B-negation
dryness	O
of	O
the	O
eyes	B-bodyloc
and	O
no	B-negation
itching	O
of	O
the	O
eyes	B-bodyloc
.	O

[	O
U	O
]	O
XRAY	O
HIPS	O
BILATERAL	O
MIN	O
2	O
VWS	O
AND	O
AP	O
PELVIS	O
73520	O

Pedal	O
pulses	O
:	O
Normal	B-labvalue
.	O
Peripheral	O
vascular	O
exam	O
:	O
Normal	B-labvalue
.	O

HEMATOLOGIC	O
/	O
LYMPHATIC	O
:	O
no	B-negation
anemia	O
,	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
and	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
.	O

2	B-dosage
tablets	B-form
daily	B-frequency
;	O
Therapy	O
:	O
02Oct2006	B-temporal
to	O
Requested	O
for	O
:	O
02Oct2006	B-temporal

01Apr2013	B-temporal
;	O
Last	O
Rx	O
:	O
12Mar2013	B-temporal

discharge	O
summary	O
,	O
diarrhea	O
,	O
nausea	O
,	O
inability	O
to	O
eat	O
,	O
egd	O
,	O
colonoscopy	O
,	O
biopsies	O
,	O
barium	O
enema	O
,	O
cecum	O
,	O
barium	O
,	O
admission	O
,	O

History	O
of	O
Fatty	O
Liver	B-bodyloc
571	O
.	O
8	O

Ordered	O
;	O
For	O
:	O
Adult	O
Sleep	O
Apnea	O
(	O
780	O
.	O
57	O
)	O
;	O
Ordered	O
By	O
:	O
ABDELMELEK	O
,	O
LOURICE	O
Performed	O
:	O
Order	O
Comments	O
:	O
RICHARD	O
CASTRIOTTA	O
,	O
M	O
.	O

Description	O
of	O
patient	O
'	O
s	O
judgement	O
and	O
insight	O
:	O
Normal	B-labvalue

This	O
was	O
>	O
50	O
%	O
of	O
the	O
visit	O
.	O

LMP	O
:	O
Hyst	O
11/01/2013	B-temporal

Final	O
pathology	O
report	O
was	O
free	B-negation
of	I-negation
residual	O
disease	O
.	O

Plan	O
Azithromycin	O
250	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
2	B-dosage
TABLETS	B-form
ON	O
DAY	O
1	O
THEN	O
TAKE	O
1	B-dosage
TABLET	B-form
A	B-frequency
DAY	I-frequency
FOR	O
4	B-duration
DAYS	I-duration
;	O
Therapy	O
:	O
24Feb2014	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
24Feb2014	B-temporal
)	O

;	O
Sep	B-temporal
30	I-temporal
2012	I-temporal
3	B-temporal
:	I-temporal
25PM	I-temporal
(	O
Author	O
)	O

Examination	O
of	O
the	O
oropharynx	O
:	O
Normal	B-labvalue
Examination	O
of	O
the	O
palate	O
showed	O
no	B-negation
abnormalities	O
.	O

HEAD	O
AND	O
FACE	O

MA	O
Breast	O
mammogram	O
screen	O
bilateral	O
77057	O
Requested	O
for	O
:	O
31Oct2013	B-temporal

Cranial	O
nerves	O
III	O
,	O
IV	O
,	O
and	O
VI	O
:	O
the	O
extraocular	O
motions	O
were	O
intact	B-labvalue
.	O

Discussion	O
/	O
Attending	O
Note	O

Albumin	O
Lvl	O
4	B-labvalue
.	I-labvalue
8	I-labvalue
g	I-labvalue
/	I-labvalue
dl	I-labvalue
3	B-reference_range
.	I-reference_range
5	I-reference_range
-	I-reference_range
5	I-reference_range
.	I-reference_range
0	O

Plan	O
[	O
O	O
]	O
Hemoglobin	O
A1c	O
(	O
in	O
office	O
)	O
Done	O
:	O
18Apr2014	B-temporal
02	B-temporal
:	I-temporal
21PM	I-temporal

Inspection	O
of	O
the	O
nasal	O
mucosa	O
,	O
septum	O
and	O
turbinates	O
:	O
Normal	B-labvalue
.	O

3	I-reference_range
BUN	O
30	B-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
H	B-labvalue
7	B-reference_range
-	I-reference_range
22	I-reference_range
BUN	O
/	O
CreatinineaRatio	O
11	B-labvalue
6	B-reference_range
-	I-reference_range
25	I-reference_range
Calcium	O
Lvl	O
9	B-labvalue
.	I-labvalue
8	I-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
8	B-reference_range
.	I-reference_range
5	I-reference_range
-	I-reference_range
10	I-reference_range
.	I-reference_range

DTaP	O
;	O
09	B-temporal
Nov	I-temporal
2007	I-temporal

Measles	O
;	O
27	B-temporal
Jun	I-temporal
2008	I-temporal

;	O
Dec	B-temporal
1	I-temporal
2011	I-temporal
12	B-temporal
:	I-temporal
23PM	I-temporal
(	O
Author	O
)	O

Musculoskeletal	O
:	O
.	O

f	O
Hypertension	O
(	O
401	O
.	O
9	O
)	O
;	O
(	O
Active	O
)	O

Cranial	O
nerves	O
V	O
:	O
sensation	O
to	O
the	O
face	O
and	O
masseter	O
strength	O
were	O
intact	B-labvalue
.	O

Middle	O
Turbinate	O
:	O
Normal	O
position	O
.	O

Neck	O
:	O
Supple	O
,	O
symmetric	O
,	O
trachea	O
midline	O
,	O
no	B-negation
masses	O
.	O

No	B-negation
rales	O
or	O
crackles	O
were	O
heard	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O
The	O
patient	O
gave	O
us	O
an	O
updated	O
New	O
Patient	O
Hi	O
tory	O
intake	O
sheet	O
.	O

Esophageal	B-bodyloc
Reflux	O
530	O
.	O
81	O

Motor	O
Strength	O
:	O
hemiparesis	O
was	O
present	O
on	B-bodyloc
the	I-bodyloc
left	I-bodyloc
.	O

IMPRESSION	O
:	O

There	O
is	O
no	B-negation
radiation	O
.	O

Bilateral	O
nipple	O
examination	O
revealed	O
normal	O
appearance	O
and	O
no	B-negation
discharge	O
.	O

Examination	O
of	O
bladder	O
:	O
Normal	B-labvalue

Past	O
Medical	O
History	O

/	O

LYMPHATIC	O

Gastrointestinal	O
:	O
no	B-negation
constipation	O
,	O
no	B-negation
diarrhea	O
and	O
no	B-negation
melena	O

[	O
Q	O
]	O
PROTEIN	O
,	O
TOTAL	O
W	O
/	O
CREAT	O
,	O
RANDOM	O
URINE	O
Done	O
:	O
19Jul2011	B-temporal
12	B-temporal
:	I-temporal
28PM	I-temporal

At	O
that	O
time	O
he	O
had	O
episodes	O
where	O
he	O
would	O
get	O
a	O
sensation	O
of	O
lightheadedness	O
.	O

No	O
Reason	O
for	O
Ref	O
Aral	O
was	O
given	O
.	O

Allergic	O
Rhinitis	O
477	O
.	O
9	O

Plan	O

Peripheral	O
Vision	O
:	O
Normal	B-labvalue
(	O
full	O
)	O
.	O

Examination	O
of	O
both	O
hips	O
revealed	O
the	O
patient	O
to	O
have	O
a	O
full	B-labvalue
range	O
of	O
motion	O
.	O

;	O
Jul	B-temporal
25	I-temporal
2012	I-temporal
11	B-temporal
:	I-temporal
02AM	I-temporal
(	O
Author	O
)	O

Multiple	O
specimens	O
of	O
the	O
cyst	O
wall	O
were	O
sent	O
for	O
pathology	O
.	O

Examination	O
of	O
urethra	O
:	O
Normal	B-labvalue

Height	O
Comments	O
:	O
Reported	O

He	O
was	O
thus	O
also	O
a	O
suspicion	O
for	O
osseous	B-bodyloc
metastatic	O
disease	O
involving	O
the	O
right	O
scapula	O
with	O
a	O
left	B-bodyloc
large	I-bodyloc
pleural	I-bodyloc
effusion	O
.	O

Maternal	B-subject
grandfather	I-subject
'	I-subject
s	I-subject
history	O
of	O
Stroke	O
Syndrome	O
V17	O
.	O
1	O

Conductive	O
Hearing	O
Loss	O
Of	O
Both	B-bodyloc
Ears	I-bodyloc
389	O
.	O
06	O

Review	O
of	O
Systems	O

[	O
QLH	O
]	O
CBC	O
(	O
INCLUDES	O
DIFF	O
/	O
PLT	O
)	O
Requested	O
for	O
:	O
05Dec2011	B-temporal

Pregnancy	O
Test	O
Positive	B-labvalue
V72	I-labvalue
.	I-labvalue
42	I-labvalue

Allergies	O
Medication	O

HEENT	O
:	O
No	B-negation
headache	O
,	O
no	B-negation
neck	O
pain	O
,	O
the	O
toothache	O
pain	O
for	O
the	O
past	O
three	O
days	O
as	O
previously	O
mentioned	O
.	O

Family	O
history	O
of	O
Family	O
History	O

She	O
states	O
she	O
has	O
not	O
been	O
checking	O
her	O
postprandial	O
BS	O
'	O
s	O
at	O
home	O
.	O

However	O
,	O
due	O
to	O
increased	B-course
seizure	O
frequency	O
,	O
she	O
was	O
determined	O
not	O
to	O
be	O
a	O
good	O
candidate	O
.	O

He	O
was	O
also	O
found	O
to	O
have	O
conductive	O
hearing	O
loss	O
bilaterally	O
.	O

Polycystic	O
Ovarian	B-bodyloc
Syndrome	O
256	O
.	O
4	O

LMP	O
.	O

Nasal	B-bodyloc
Polyps	O
471	O
.	O
9	O

Examination	O
of	O
the	O
head	O
and	O
face	O
:	O
Normal	B-labvalue

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

pt	O
is	O
here	O
to	O
see	O
Dr	O
.	O
Ingram	O
for	O
ER	O
follow	O
up	O

Integumentary	O
:	O
skin	B-bodyloc
lesion	O
.	O

Neurologic	O

Height	O
:	O
5	B-labvalue
ft	I-labvalue
5	I-labvalue
in	I-labvalue

f	O
/	O
b	O
Dr	O
.	O
Nader	O
,	O
next	O
appt	O
3/6/12	O

Date	O
:	O
07/26/2013	B-temporal
03	B-temporal
:	I-temporal
37	I-temporal
PM	I-temporal
,	O
Created	O
B	O
(	O
:	O
Vidri	O
e	O
,	O
Susan	O

Pupils	O
equal	O
,	O
round	O
,	O
reactive	O
to	O
light	O
and	O
accommodation	O
.	O

this	O
is	O
a	O
55	O
-	O
year	O
-	O
old	O
woman	O
with	O
relapsing	O
remitting	O
multiple	O
sclerosis	O
injecting	O
Copaxone	O
for	O
the	O
last	O
10	B-duration
years	I-duration
.	O

SKIN	O
:	O
No	B-negation
rashes	O
or	O
lesions	O
.	O

Plan	O
Escitalopram	O
Oxalate	O
10	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Last	O
Rx	O
:	O
21Nov2013	B-temporal

f	O
AUDIT	O
02/15/2013	B-temporal

The	O
abdomen	O
was	O
soft	O
and	O
nontender	O
.	O

She	O
was	O
prescribed	O
a	O
ciprofloxacin	O
regimen	O
.	O

The	O
patient	O
is	O
a	O
little	O
overweight	O
but	O
otherwise	O
appears	O
to	O
be	O
healthy	O
.	O

LUNGS	B-bodyloc
:	O
Bilaterally	O
diminished	O
.	O

Patella	B-bodyloc
-	I-bodyloc
femoral	I-bodyloc
joint	I-bodyloc
space	O
rediced	O
markedly	O
.	O

Other	O
:	O
N	O
/	O
A	O
.	O

Motor	O
Survey	O
:	O
the	O
motor	O
survey	O
was	O
normal	B-labvalue
.	O

Tympanic	O
Membrane	O
Perforation	O
384	O
.	O
20	O

Cranial	O
nerves	O
II	O
:	O
visual	O
acuity	O
and	O
visual	O
fields	O
were	O
intact	B-labvalue
.	O

Benign	B-severity
Prostatic	B-bodyloc
Hypertrophy	O
600	O
.	O
00	O

Crepitus	O
palpated	O
.	O

Chief	O
Complaint	O

Cardiovascular	O
:	O
N	O
/	O
A	O
.	O

He	O
did	O
not	O
feel	O
that	O
his	O
strength	O
had	O
improved	O
with	O
the	O
steroid	O
treatment	O
.	O

;	O
Oct	B-temporal
17	I-temporal
2011	I-temporal
12	B-temporal
:	I-temporal
19PM	I-temporal
(	O
Author	O
)	O

10	O
.	O

Maternal	O
history	O
of	O
Diabetes	O
Mellitus	O
V18	O
.	O
0	O

Musculoskeletal	O
:	O
limb	B-bodyloc
swelling	O
,	O
butno	O
arthralgias	O
,	O
no	O
joint	O
painandno	O
limb	B-bodyloc
pain	O
.	O

Chief	O
CoEndaint	O
g1	O

Motor	O
Strength	O
:	O
motor	O
strength	O
was	O
normal	B-labvalue
in	O
all	O
muscle	O
groups	O
.	O

(	O
Medical	O
Transcription	O
Sample	O
Report	O
)	O

NovoLOG	O
FlexPen	O
100	B-strength
UNIT	I-strength
/	I-strength
ML	I-strength
Subcutaneous	B-route
Solution	B-form
;	O
INJECT	O
60	B-dosage
UNIT	I-dosage
DAILY	B-frequency
im	B-route
divided	O
dosage	O
pre	O
-	O
meal	O
based	O
on	O
insulin	O
sliding	B-dosage
scale	I-dosage
.	O

Birth	O
Weight	O
:	O
7lbs	B-labvalue
,	I-labvalue
10oz	I-labvalue

6410	O
FANNIN	O
#	O
600	O

ENT	O
:	O
no	B-negation
earache	O
,	O
no	B-negation
hearing	O
loss	O
,	O
no	B-negation
epistaxis	O
,	O
no	B-negation
nasal	B-bodyloc
discharge	O
,	O
no	B-negation
sore	O
throat	B-bodyloc
and	O
no	B-negation
hoarseness	O
.	O

Medications	O
:	O
the	O
patient	O
is	O
adherent	O
to	O
her	O
medication	O
regimen	O
,	O
butshe	O
denies	B-negation
medication	O
side	O
effects	O
.	O

-	O
breast	O
feeding	O
,	O
no	B-negation
breast	B-bodyloc
pain	O
,	O
tenderness	O
,	O
good	O
latch	O

HOSPITAL	O
COURSE	O
:	O
The	O
patient	O
was	O
taken	O
to	O
the	O
operating	O
room	O
by	O
Dr	O
.	O
X	O
who	O
is	O
covering	O
for	O
ENT	O
and	O
noted	O
that	O
she	O
had	O
airway	O
compromise	O
and	O
a	O
rather	O
large	O
fishbone	O
noted	O
and	O
that	O
was	O
removed	O
.	O

f	O
Hypertension	O
(	O
401	O
.	O
9	O
)	O
;	O
(	O
Active	O
)	O

Skin	O

Given	O
sample	O
pack	O
of	O
Lo	O
Loestrin	O
Fe	O
.	O

Diabetes	O
Mellitus	O
250	O
.	O
00	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Constitutional	O

Family	O
History	O
Paternal	B-subject
history	O
of	O
Diabetes	O
Mellitus	O
V18	O
.	O
0	O

Musculoskeletal	O

Tingling	O
(	O
Paresthesia	O
)	O
782	O
.	O
0	O

1	O
.	O

The	O
patient	O
was	O
treated	O
with	O
IV	B-route
antibiotics	O
and	O
ventilatory	O
support	O
and	O
at	O
the	O
time	O
of	O
this	O
dictation	O
,	O
she	O
has	O
recently	O
been	O
taken	O
to	O
the	O
operating	O
room	O
where	O
it	O
was	O
felt	O
that	O
the	O
airway	O
sufficient	O
and	O
she	O
was	O
extubated	O
.	O

[	O
O	O
]	O
Hemoglobin	O
A1c	O
(	O
in	O
office	O
)	O
Status	O
:	O
Resulted	O
-	O
Requires	O
Verification	O
,	O
Retrospective	O
Authorization	O
Done	O
:	O
01Jan0001	B-temporal
12	B-temporal
:	I-temporal
00AM	I-temporal

W	O
.	O

Plan	O
[	O
H	O
]	O
Pap	O
ThinPrep	O
Requested	O
for	O
:	O
08May2013	B-temporal

Genitourinary	O
:	O
no	B-negation
dysuria	O
,	O
no	B-negation
incontinence	O
,	O
no	B-negation
pelvic	B-bodyloc
pain	O
,	O
no	B-negation
dysmenorrhea	O
,	O
no	B-negation
genital	B-bodyloc
lesions	O
and	O
no	B-negation
testicular	B-bodyloc
pain	O
.	O

1	B-dosage
Influenza	O
26Sep2012	B-temporal

The	O
patient	O
presents	O
with	O
complaints	O
of	O
gradual	O
onset	O
of	O
mild	B-severity
right	B-bodyloc
facial	I-bodyloc
skin	I-bodyloc
lesion	O
,	O
described	O
as	O
draining	O
and	O
bumps	O
.	O

atient	O
with	O
left	B-bodyloc
renal	I-bodyloc
cell	O
carcinoma	O
,	O
left	B-bodyloc
renal	I-bodyloc
cyst	O
,	O
had	O
robotic	O
-	O
Assisted	O
laparoscopic	O
left	O
renal	O
cyst	O
decortication	O
and	O
cystoscopy	O
.	O

Eth	O
:	O
Normal	O

Examination	O
of	O
the	O
abdomen	O
:	O
Normal	B-labvalue

KJC	O
,	O
CT	O
(	O
ASCP	O
)	O

Musculoskeletal	O
:	O
joint	B-bodyloc
pain	O

Joint	B-bodyloc
Pain	O
,	O
Localized	O
In	O
The	O
Left	B-bodyloc
Shoulder	I-bodyloc
719	O
.	O
41	O

No	B-negation
rales	O
or	O
crackles	O
were	O
heard	O
.	O

Musculoskeletal	O
:	O
joint	B-bodyloc
pain	O
.	O

Patient	O
is	O
here	O
for	O
a	O
follow	O
up	O
of	O
the	O
ears	O
.	O

Generalized	O
hypertonicity	O
was	O
observed	O
.	O
No	B-negation
muscle	B-bodyloc
rigidity	O
was	O
observed	O
.	O
Cogwheel	O
rigidity	O
was	O
present	O
in	O
both	B-bodyloc
arms	I-bodyloc
.	O
There	O
was	O
no	B-negation
cogwheel	O
rigidity	O
of	O
the	O
legs	B-bodyloc
.	O

Visit	O
For	O
:	O
Prenatal	O
Exam	O
High	O
-	O
Risk	O
Pregnancy	O
V23	O
.	O
9	O

Appears	O
healthy	O
,	O
comfortable	O
,	O
within	O
normal	O
limits	O
of	O
ideal	O
weight	O
,	O
clothing	O
appropriate	O
,	O
well	O
groomed	O
,	O
well	O
hydrated	O
,	O
appearance	O
reflects	O
stated	O
ageandAlert	O
.	O

Maternal	O
history	O
of	O
Mother	O
Deceased	O
At	O
Age	O
69	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
axillae	O
:	O
Normal	B-labvalue
.	O

AispEnies	O
_	O
20	O
_	O
twCiteListControlStart	O
No	O
Known	O
Drar	O
AispEnies	O

5ML	I-strength
Subcutaneous	B-route
Solution	B-form
;	O
INJECT	O
0	B-dosage
.	I-dosage

Lymphatic	O

No	B-negation
pain	O
,	O
tingling	O
or	O
swelling	O
in	O
the	O
lower	B-bodyloc
extremities	I-bodyloc

Examination	O
of	O
the	O
chest	O
:	O
Normal	B-labvalue

She	O
consumes	O
a	O
diverse	O
and	O
healthy	O
diet	O
.	O
She	O
does	O
not	O
use	O
tobacco	O
.	O

Last	O
MMG	O
2012	B-temporal
WNL	B-labvalue

Vitals	O
UTP	O
Adult	O
Vital	O
Signs	O
[	O
Data	O
Includes	O
:	O
Current	O
Encounter	O
]	O
16Nov2012	B-temporal
08	B-temporal
:	I-temporal
56AM	I-temporal
16Nov2012	B-temporal
08	B-temporal
:	I-temporal
43AM	I-temporal
BMI	O
Calculated	O
23	B-labvalue
.	I-labvalue
85	I-labvalue
23	B-labvalue
.	I-labvalue
85	I-labvalue
BSA	O
Calculated	O
1	B-labvalue
.	I-labvalue
88	I-labvalue
1	B-labvalue
.	I-labvalue
88	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
9	I-labvalue
in	I-labvalue
5	B-labvalue
ft	I-labvalue
9	I-labvalue
in	I-labvalue
Weight	O
161	B-labvalue
lb	I-labvalue
161	B-labvalue
lb	I-labvalue
Systolic	O
134	B-labvalue
134	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
82	B-labvalue
82	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Temperature	O
98	B-labvalue
.	I-labvalue
3	I-labvalue
F	I-labvalue
,	O
Oral	O
Heart	O
Rate	O
67	B-labvalue
,	O
L	O
Radial	O
Pulse	O
Quality	O
Normal	B-labvalue
,	O
L	O
Radial	O

no	B-negation
masses	O
present	O
.	O

*	O
If	B-condition
you	O
have	O
shaking	O
chills	O
,	O
fever	O
greater	O
than	O
101	O
.	O
5	O
(	O
F	O
)	O
degrees	O
or	O
38	O
(	O
C	O
)	O
degrees	O
,	O
increased	B-course
redness	O
,	O
swelling	O
or	O
discharge	O
from	O
incision	O
,	O
chest	B-bodyloc
pain	O
,	O
shortness	O
of	O
breath	O
,	O
or	O
anything	O
else	O
that	O
is	O
troubling	O
you	O
.	O

[	O
QLH	O
]	O
T4	O
,	O
FREE	O
Requested	O
for	O
:	O
16Mar2012	B-temporal

The	O
heart	O
rate	O
was	O
normal	B-labvalue
.	O

Examination	O
of	O
gait	O
and	O
station	O
:	O
Normal	B-labvalue
.	O

Musculoskeletal	O

She	O
no	B-negation
longer	I-negation
has	I-negation
nausea	O
.	O

No	B-negation
Known	O
Drug	O
Allergies	O
.	O
eg	O

TSH	O
1	B-labvalue
.	I-labvalue
83	I-labvalue
MIU	I-labvalue
/	I-labvalue
L	I-labvalue
0	B-reference_range
.	I-reference_range
40	I-reference_range
-	I-reference_range
4	I-reference_range
.	I-reference_range
50	I-reference_range

5	I-dosage
ML	I-dosage
3	B-frequency
TIMES	I-frequency
WEEKLY	I-frequency
AS	O
DIRECTED	O
;	O

*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O

She	O
denies	B-negation
any	O
cramping	O
or	O
pelvic	B-bodyloc
pain	O
.	O

Optic	O
Disc	O
:	O
Normal	O
.	O

Lactobacillus	O
Extra	O
Strength	O
Oral	B-route
Capsule	B-form
;	O
TAKE	O
AS	O
DIRECTED	O
;	O
Therapy	O
:	O
15Aug2012	B-temporal
to	O
Lipitor	O
20	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
/	I-dosage
2	I-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
05Jun2012	B-temporal
)	O
to	O

Alert	O
and	O
cooperative	O

Skin	O

Peripheral	O
vascular	O
exam	O
:	O
Normal	B-labvalue

Associated	O
symptoms	O
:	O
no	B-negation
chills	O
,	O
no	B-negation
fever	O
,	O
no	B-negation
diplopia	O
,	O
no	B-negation
periorbital	B-bodyloc
redness	O
,	O
no	B-negation
periorbital	B-bodyloc
swelling	O
,	O
no	B-negation
nausea	O
,	O
no	B-negation
neck	B-bodyloc
stiffness	O
and	O
no	B-negation
sore	O
throat	B-bodyloc
.	O

Current	O
Meds	O
Advair	O
Diskus	B-form
250	B-strength
-	I-strength
50	I-strength
MCG	I-strength
/	I-strength
DOSE	I-strength
Inhalation	B-route
Aerosol	B-form
Powder	I-form
Breath	I-form
Activated	I-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
02Jul2013	B-temporal
)	O
to	O

Worse	O
yesterday	B-temporal
with	O
drainge	O
,	O
sore	O
throat	B-bodyloc
,	O
heavy	O
chest	B-bodyloc
,	O
itchy	O
in	O
ears	B-bodyloc
and	O
eyes	B-bodyloc
,	O
headache	O
,	O
sinus	B-bodyloc
pressure	O
,	O
non	O
-	O
prod	O
cough	O
.	O

She	O
was	O
treated	O
by	O
a	O
physical	O
therapist	O
and	O
is	O
continue	O
to	O
do	O
HEPs	O
as	O
directed	O
as	O
pain	O
tolerated	O
.	O

On	O
day	O
#	O
12	O
,	O
was	O
transferred	O
to	O
ABCD	O
.	O

Examination	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue
.	O

2/1/12	B-temporal
-	O
Vitamin	O
D	O
is	O
low	B-labvalue
,	O
CBC	O
has	O
mild	B-severity
anemia	O
and	O
slightly	B-severity
low	O
polys	O
.	O

No	B-negation
sinus	O
congestion	O
,	O
pressure	O
or	O
pain	O
,	O
no	B-negation
ear	O
pain	O
,	O
no	B-negation
hearing	O
change	O
,	O
no	B-negation
eye	O
pain	O
or	O
vision	O
change	O
.	O

No	B-negation
rales	O
or	O
crackles	O
were	O
heard	O
.	O

6410	O
FANNIN	O
#	O
600	O

Neck	O
:	O
Normal	O
.	O

No	B-negation
Known	O
Allergies	O

CARDIOVASCULAR	O
:	O
Infant	O
was	O
hemodynamically	O
stable	O
on	O
admission	O
from	O
Madera	O
.	O

Musculoskeletal	O
:	O
no	B-negation
arthralgias	O
,	O
no	B-negation
joint	B-bodyloc
pain	O
,	O
no	B-negation
joint	B-bodyloc
swelling	O
,	O
no	B-negation
joint	B-bodyloc
stiffness	O
,	O
no	B-negation
limb	B-bodyloc
pain	O
and	O
no	B-negation
limb	B-bodyloc
swelling	O
.	O

Anesthesia	O
:	O
nasal	O
topical	O
lidocaineandnasal	O
topical	B-route
oxymetazoline	O
.	O

Hearing	O
is	O
grossly	O
intact	O
.	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

He	O
has	O
not	O
needed	O
to	O
take	O
any	O
medications	O
for	O
the	O
headaches	O
.	O

Current	O
Meds	O
Colace	O
100	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
TWICE	B-frequency
DAILY	I-frequency
AS	B-frequency
NEEDED	I-frequency
;	O
Therapy	O
:	O
06Jun2013	B-temporal
to	O
(	O
Evaluate	O
:	O
05Aug2013	B-temporal
)	O
Requested	O
for	O
:	O
06Jun2013	B-temporal
;	O
Last	O
Rx	O
:	O
06Jun2013	B-temporal

One	O
Touch	O
Ultra	O
Test	O
Strips	O
;	O
1	O
strip	O
4	O
x	O
daily	O
,	O
V58	O
.	O
67	O
,	O
250	O
.	O
42	O
;	O
Therapy	O
:	O
01Apr2009	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
30Nov2009	B-temporal
)	O
Requested	O
for	O
:	O
30Nov2009	B-temporal

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
and	O
no	B-negation
palpitations	O
.	O

Past	O
Medical	O
History	O
1	O
.	O

LABORATORY	O
STUDIES	O
:	O
Show	O
a	O
normal	B-labvalue
white	O
blood	O
cell	O
count	O
with	O
no	O
shift	O
.	O

[	O
QLH	O
]	O
CMP	O
W	O
/	O
EGFR	O
Requested	O
for	O
:	O
21Nov2013	B-temporal

Past	O
Medical	O
History	O
History	O
of	O
Acute	B-course
Cystitis	O
595	O
.	O
0	O

Musculoskeletal	O

No	B-negation
decreased	O
response	O
to	O
pain	O
and	O
temperature	O
stimulation	O
.	O

Diastolic	O
:	O
98	B-labvalue
,	O
LUE	O
,	O
Sitting	O

History	O
of	O
Gout	O

Color	O
:	O
Normal	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
vomiting	O
,	O
no	B-negation
constipation	O
,	O
no	B-negation
diarrhea	O
,	O
no	B-negation
heartburn	O
and	O
no	B-negation
melena	O
.	O

Normal	B-labvalue
Examination	O
V70	B-labvalue
.	I-labvalue
0	I-labvalue

Active	O
Problems	O
Hypercholesterolemia	O
272	O
.	O
0	O

Vitamin	O
B	O
-	O
12	O
1000	B-strength
MCG	I-strength
Oral	B-route
Tablet	B-form
;	O
one	B-dosage
daily	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
30Sep2013	B-temporal
)	O
to	O

Palpation	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
Normal	B-labvalue
turgor	O
.	O

refill	O
meds	O
today	O
per	O
request	O

After	O
discussion	O
of	O
multiple	O
management	O
strategies	O
with	O
the	O
patient	O
including	O
:	O

Gestational	O
age	O
:	O
40	O
weeks	O
.	O

Eyes	O
:	O
no	B-negation
eye	B-bodyloc
pain	O
,	O
eyes	B-bodyloc
not	B-negation
red	O
,	O
no	B-negation
dryness	O
of	O
the	O
eyes	B-bodyloc
,	O
no	B-negation
itching	O
of	O
the	O
eyes	B-bodyloc
,	O
no	B-negation
discharge	O
from	O
the	O
eyes	B-bodyloc
and	O
no	B-negation
eyesight	O
problems	O
.	O

Constitutional	O

Risk	O
factors	O
:	O
obesityandphysical	O
inactivity	O
,	O
but	O
no	O
alcohol	O
use	O
and	O
no	O
smoking	O
.	O

Max	O
:	O
Eo	O
mucin	O

Associated	O
symptoms	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
limb	B-bodyloc
pain	O
,	O
no	B-negation
joint	B-bodyloc
pain	O
,	O
no	B-negation
flank	B-bodyloc
mass	O
,	O
no	B-negation
urinary	O
retention	O
,	O
no	B-negation
dyspnea	O
,	O
no	B-negation
hemoptysis	O
,	O
no	B-negation
headache	O
,	O
no	B-negation
memory	O
impairment	O
and	O
no	B-negation
hearing	O
loss	O
.	O

Joint	B-bodyloc
Pain	O
,	O
Localized	O
In	O
The	O
Knee	B-bodyloc
719	O
.	O
46	O

Integumentary	O
:	O
no	B-negation
skin	B-bodyloc
lesions	O
.	O

f	O
Carvedilol	O
25	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
TWICE	B-frequency
DAILY	I-frequency
,	O
WITH	B-frequency
MORNING	I-frequency
AND	I-frequency
EVENING	I-frequency
MEAL	I-frequency
;	O
Start	O
Date	O
:	O
09/17/2009	B-temporal
;	O
End	O
Date	O
:	O
01/01/1900	B-temporal
(	O
Active	O
)	O

Social	O
History	O
Marital	O
History	O
-	O
Separated	O

Type	O
2	O
Diabetic	O
Gastropathy	O
250	O
.	O
80	O

Check	O
A1c	O
.	O

Psychiatric	O

The	O
heart	O
rate	O
was	O
normal	B-labvalue
.	O

Current	O
Meds	O
Astelin	O
137	B-strength
MCG	I-strength
/	O
SPRAY	B-form
Nasal	B-route
Solution	B-form
;	O
INSERT	O
2	B-dosage
SQUIRTS	B-form
IN	O
EACH	B-route
NOSTRIL	I-route
TWICE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
02Nov2012	B-temporal
)	O
to	O

The	O
patient	O
was	O
seen	O
by	O
Dr	O
.	O
Y	O
.	O

By	O
report	O
,	O
there	O
is	O
good	O
compliance	O
with	O
treatment	O
.	O

Exacerbating	O
factors	O
:	O
stress	O
,	O
weight	O
gain	O
,	O
excess	O
dietary	O
salt	O
and	O
skipping	O
medications	O
,	O
but	O
not	O
exacerbated	O
by	O
alcohol	O
use	O
.	O

Head	O
and	O
face	O
:	O
Normal	O
.	O

Had	O
attempted	O
to	O
wean	O
her	O
off	O
Dilantin	O
but	O
was	O
not	O
able	O
to	O
tolerate	O
side	O
effects	O
of	O
medication	O
(	O
Topamax	O
made	O
her	O
suicidal	O
)	O
.	O

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

History	O
of	O
Chronic	B-course
Fatigue	O
Syndrome	O
780	O
.	O
71	O

General	O
appearance	O
:	O
Normal	B-labvalue

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

Test	O
Performed	O
at	O
:	O

Examination	O
of	O
sensation	O
:	O
Normal	B-labvalue
.	O

Constitutional	O
:	O
recent	O
weight	O
gain	O
,	O
but	O
no	B-negation
fever	O
and	O
no	B-negation
chills	O
.	O

Dysphagia	O
787	O
.	O
20	O

Cycle	O
intervals	O
have	O
been	O
regular	O
.	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
,	O
no	B-negation
cough	O
,	O
no	B-negation
shortness	O
of	O
breath	O
during	O
exertion	O
,	O
no	B-negation
orthopnea	O
and	O
no	B-negation
PND	O
.	O

[	O
QLH	O
]	O
LIPID	O
PANEL	O
Done	O
:	O
25Sep2013	B-temporal
12	B-temporal
:	I-temporal
14PM	I-temporal

2	O
.	O

Assessment	O
of	O
hearing	O
:	O
Normal	B-labvalue
.	O

US	O
-	O
VENOUS	O
DOPPLER	O
ULTRASOUND	O
LEFT	O
LOWER	O
EXTREMITY	O
:	O
CLINICAL	O
INDICATION	O
:	O
Pain	O
and	O
swelling	O

Assessment	O
Diabetes	O
Mellitus	O
250	O
.	O
00	O

The	O
patient	O
is	O
being	O
seen	O
for	O
a	O
routine	O
clinic	O
follow	O
-	O
up	O
of	O
pre	O
-	O
diabetes	O
.	O

Chief	O
Complaint	O

025	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Therapy	O
:	O
21Jul2011	B-temporal
to	O

Recommend	O
saline	O
irrigations	B-route

PredniSONE	O
10	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
15Jan2013	B-temporal
to	O
(	O
Evaluate	O
:	O
20Jan2013	B-temporal
)	O
Requested	O
for	O
:	O
15Jan2013	B-temporal
;	O
Last	O
Rx	O
:	O
15Jan2013	B-temporal

Inspection	O
of	O
the	O
conjunctiva	O
and	O
lids	O
:	O
Normal	B-labvalue

Tamsulosin	O
HCl	O
0	B-strength
.	I-strength
4	I-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
BY	B-route
MOUTH	I-route
EVERY	B-frequency
DAY	I-frequency
;	O
Therapy	O
:	O
30Nov2012	B-temporal
to	O
(	O
Evaluate	O
:	O
03May2014	B-temporal
)	O
Requested	O
for	O
:	O
21Nov2013	B-temporal
;	O
Last	O
Rx	O
:	O
04Nov2013	B-temporal

TraMADol	O
HCl	O
50	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
1	B-dosage
-	I-dosage
2	I-dosage
PO	B-route
Q6	B-frequency
hrs	I-frequency
PRN	B-frequency
for	O
pain	O
;	O
Therapy	O
:	O
09Jan2014	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
09Jan2014	B-temporal
)	O

The	O
abdomen	B-bodyloc
was	O
soft	O
and	O
nontender	O
.	O

Sodium	O
,	O
Serum	O
:	O
140	B-labvalue
mmol	I-labvalue
/	I-labvalue
L	I-labvalue
Reference	O
Range	O
134	B-reference_range
-	I-reference_range
144	I-reference_range

Respiratory	O
effort	O
:	O
Abnormal	O
.	O

eGFR	O
NON	O
-	O
AFR	O
.	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
.	O

Gastrointestinal	O
:	O
constipation	O
.	O

Abdomen	O
:	O
normal	B-labvalue
bowel	O
sounds	O
,	O
soft	O
,	O
non	O
-	O
tender	O
,	O
no	B-negation
hepato	O
-	O
splenomegaly	O
,	O
nondistended	O
,	O
no	B-negation
abdominal	B-bodyloc
mass	O
palpated	O
and	O
no	B-negation
hernia	O
was	O
discovered	O
.	O

[	O
QLH	O
]	O
TSH	O
,	O
3RD	O
GENERATION	O
W	O
/	O
REFLEX	O
TO	O
FT4	O
Requested	O
for	O
:	O
31Oct2013	B-temporal

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
vomiting	O
,	O
no	B-negation
constipation	O
,	O
no	B-negation
diarrhea	O
,	O
no	B-negation
heartburn	O
and	O
no	B-negation
melena	O
.	O

Gynecologic	O
Services	O
Contraceptive	O
General	O
Counseling	O
V25	O
.	O
09	O

She	O
reports	O
the	O
use	O
of	O
marijuana	O
.	O

Eyes	O
:	O
no	B-negation
eye	B-bodyloc
pain	O
.	O

Congestion	O
:	O
Yes	O
.	O

Diastolic	O
:	O
62	B-labvalue

Allergies	O
Levaquin	O
TABS	B-form

Discussion	O
/	O
Discussion	O
/	O
Summary	O

pt	O
states	O
the	O
lump	O
in	O
her	O
axilla	B-bodyloc
that	O
she	O
had	O
previously	O
has	O
resolved	B-course
.	O

History	O
of	O
Headache	O
784	O
.	O
0	O

Will	O
need	O
referral	O
to	O
FP	O
for	O
vaccine	O
.	O

Explained	O
the	O
lack	O
of	O
efficacy	O
of	O
cold	O
medications	O
.	O

;	O
Jan	B-temporal
17	I-temporal
2013	I-temporal
5	B-temporal
:	I-temporal
37PM	I-temporal
(	O
Author	O
)	O

Lymphatic	O

Neurologic	O

MA	O
Digital	O
Mammo	O
DX	O
Uni	O
G0206	O
Requested	O
for	O
:	O
19Nov2012	B-temporal

43	O
year	O
old	O
CF	O
with	O
h	O
/	O
o	O
HTN	O
,	O
HLP	O
,	O
DM	O
came	O
in	O
for	O
follow	O
up	O

RTC	O
for	O
12	O
month	O
WCC	O
or	O
sooner	O
if	O
needed	O
.	O

Neck	O

Abdomen	O
:	O
Normal	O
.	O

Community	O
-	O
acquired	O
Pneumonia	O
486	O

The	O
patient	O
was	O
also	O
previously	O
diagnosed	O
with	O
normal	O
-	O
pressure	O
hydrocephalus	O
and	O
she	O
has	O
a	O
VP	O
shunt	O
.	O

Simvastatin	O
20	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
ONE	B-dosage
(	I-dosage
1	I-dosage
)	I-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
ONCE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
22Nov2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
24Feb2014	B-temporal
)	O
Requested	O
for	O
:	O
24Feb2014	B-temporal

Advance	O
Directives	O

Hz	O
160	O
160	O

Review	O
of	O
Systems	O

Itchy	O
nose	B-bodyloc
/	O
eyes	B-bodyloc
/	O
throat	B-bodyloc
:	O
Mild	B-severity

Chief	O
Complaint	O

Thyroid	O
:	O
Normal	O
.	O

Examination	O
of	O
pupils	O
and	O
irises	O
:	O
Abnormal	O
.	O

He	O
was	O
last	O
seen	O
by	O
us	O
in	O
Jan	B-temporal
2013	I-temporal
at	O
which	O
time	O
he	O
was	O
having	O
gross	O
hematuria	O
and	O
active	B-course
nephrolithiasis	O
.	O

Lumbosacral	O
Spine	O
:	O
Normal	O
(	O
no	B-negation
tenderness	O
on	O
palpation	O
)	O
.	O

Assessment	O
of	O
stability	O
:	O
Normal	B-labvalue
.	O

No	B-negation
wheezing	O
was	O
heard	O
.	O

Family	O
History	O
1	O
.	O

4	I-reference_range
Sodium	O
Lvl	O
144	B-labvalue
mEq	I-labvalue
/	I-labvalue
l	I-labvalue
135	B-reference_range
-	I-reference_range
145	I-reference_range
[	O
QLH	O
]	O
LIPID	O
PANEL	O
15Aug2013	B-temporal
01	B-temporal
:	I-temporal
10PM	I-temporal
JOHNSON	O
,	O
PHILIP	O
Test	O
Name	O
Resul	O
Flag	O
Referetce	O
CHD	O
Risk	O
4	B-labvalue
.	I-labvalue
10	I-labvalue
4	B-reference_range
.	I-reference_range
00	I-reference_range
-	I-reference_range
7	I-reference_range
.	I-reference_range

Exercising	O
Regularly	O

On	O
postoperative	O
day	O
#	O
1	O
,	O
she	O
was	O
tolerating	O
her	O
diet	O
,	O
began	O
on	O
thyroid	O
hormone	O
replacement	O
,	O
and	O
remained	O
afebrile	O
with	O
stable	B-labvalue
vital	O
signs	O
.	O

She	O
is	O
on	O
MDII	O
with	O
Lvemir	O
4	B-dosage
units	I-dosage
bid	B-frequency
;	O
HL	O
1	O
:	O
12	O
(	O
B	O
&	O
L	O
)	O
;	O
1	O
:	O
15	O
(	O
S	O
)	O
.	O

Paternal	B-subject
history	O
of	O
Hypertension	O
V17	O
.	O
49	O

Examination	O
of	O
the	O
extremities	O
revealed	O
no	B-negation
fingernail	O
clubbing	O
and	O
well	O
perfused	O
fingers	O
.	O

Assessment	O
of	O
hearing	O
:	O
Normal	B-labvalue
.	O

Pulmonary	O

Cranial	O
nerves	O
III	O
,	O
IV	O
,	O
and	O
VI	O
:	O
Abnormal	O
.	O
(	O
disconjugate	O
,	O
exptropia	O
)	O

Blood	O
sugars	O
have	O
been	O
well	O
controlled	O
120s	B-labvalue
.	O

Beans	O

Constitutional	O
:	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
,	O
not	B-negation
feeling	O
poorly	O
(	O
malaise	O
)	O
,	O
not	B-negation
feeling	O
tired	O
(	O
fatigue	O
)	O
,	O
no	O
recent	O
weight	O
gain	O
and	O
no	B-negation
recent	B-temporal
weight	O
loss	O
.	O

Her	O
anxiety	O
is	O
about	O
the	O
same	O
as	O
it	O
'	O
s	O
been	O
and	O
she	O
says	O
her	O
Citalopram	O
is	O
working	O
but	O
does	O
not	O
completely	O
eliminate	O
her	O
anxiety	O
.	O

He	O
has	O
not	O
been	O
taking	O
his	O
hydrochlorothiazide	O
lately	B-temporal
as	O
he	O
does	O
not	B-negation
have	I-negation
any	O
problems	O
currently	O
with	O
swelling	O
.	O

Examination	O
of	O
pupils	O
and	O
irises	O
:	O
Normal	B-labvalue
.	O

Orientation	O
to	O
person	O
,	O
place	O
and	O
time	O
:	O
Normal	B-labvalue
.	O

-	O
Ophtho	O
appt	O
in	O
November	B-temporal
2011	I-temporal
will	O
send	O
ROI	O
at	O
next	O
visit	O
-	O
or	O
check	O
Epic	O
,	O
it	O
was	O
at	O
El	O
Franco	O
Lee	O
clinic	O
(	O
HCHD	O
)	O
.	O

Plan	O
Lisinopril	O
10	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
01Mar2012	B-temporal
to	O
(	O
Evaluate	O
:	O
30Apr2012	B-temporal
)	O
;	O
Last	O
Rx	O
:	O
01Mar2012	B-temporal

Atorvastatin	O
Calcium	O
80	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
EVERY	B-frequency
DAY	I-frequency
;	O
Therapy	O
:	O
29Oct2012	B-temporal
to	O
(	O
Evaluate	O
:	O
20Oct2013	B-temporal
)	O
Requested	O
for	O
:	O
23Apr2013	B-temporal
;	O
Last	O
Rx	O
:	O
23Apr2013	B-temporal

Ovarian	B-bodyloc
Cyst	O
620	O
.	O
2	O

Eth	O
:	O
Eo	O
mucin	O

Pulmonary	O

Examination	O
of	O
gait	O
and	O
station	O
:	O
Abnormal	O
.	O

Hypothyroidism	O
244	O
.	O
9	O

Vitals	O
12Jan2012	B-temporal
09	B-temporal
:	I-temporal
44AM	I-temporal
BMI	O
Calculated	O
33	B-labvalue
.	I-labvalue
69	I-labvalue
BSA	O
Calculated	O
1	B-labvalue
.	I-labvalue
89	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
3	I-labvalue
in	I-labvalue
Weight	O
190	B-labvalue
lb	I-labvalue
2	I-labvalue
oz	I-labvalue
Systolic	O
132	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
72	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Temperature	O
98	B-labvalue
.	I-labvalue
1	I-labvalue
F	I-labvalue
,	O
Oral	O
Heart	O
Rate	O
82	B-labvalue
,	O
R	O
Radial	O
Pulse	O
Quality	O
Normal	B-labvalue
,	O
R	O
Radial	O
Respiration	O
16	B-labvalue
Respiration	O
Quality	O
Normal	B-labvalue

My	O
full	O
evaluation	O
follows	O
:	O

No	B-negation
previous	O
FESS	O
.	O

Vitals	O
19Mar2014	B-temporal
10	B-temporal
:	I-temporal
42AM	I-temporal
BMI	O
Calculated	O
25	B-labvalue
.	I-labvalue
4	I-labvalue
BSA	O
Calculated	O
1	B-labvalue
.	I-labvalue
63	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
2	I-labvalue
in	I-labvalue
Weight	O
138	B-labvalue
lb	I-labvalue
Systolic	O
110	B-labvalue
,	O
RUE	O
,	O
Sitting	O
Diastolic	O
68	B-labvalue
,	O
RUE	O
,	O
Sitting	O
Temperature	O
98	B-labvalue
.	I-labvalue
9	I-labvalue
F	I-labvalue
,	O
Oral	O
Heart	O
Rate	O
84	B-labvalue
,	O
R	O
Radial	O
Pulse	O
Quality	O
Regular	B-labvalue
,	O
R	O
Radial	O

Family	O
history	O
:	O
breast	O
cystsandpt	O
.	O

[	O
QLH	O
]	O
ERYTHROPOIETIN	O
Requested	O
for	O
:	O
19Mar2014	B-temporal

The	O
patient	O
denies	B-negation
any	O
recent	O
illness	O
or	O
injuries	O
.	O

Inspection	O
of	O
the	O
conjunctiva	O
and	O
lids	O
:	O
Normal	B-labvalue

GroupHeading23End	O
GroupHeading24Start	O
GroupHeading24End	O
GroupHeading25Start	O
GroupHeading25End	O
GroupHeading26Start	O
GroupHeading26End	O
GroupHeading81Start	O
GroupHeading81End	O
GroupHeading82Start	O
GroupHeading82End	O
GroupHeading83Start	O
GroupHeading83End	O
GroupHeading84Start	O
GroupHeading84End	O
GroupHeading31Start	O
GroupHeading31End	O
GroupHeading66Start	O
GroupHeading66End	O
GroupHeading67Start	O
GroupHeading67End	O
GroupHeading68Start	O
GroupHeading68End	O
GroupHeading85Start	O
GroupHeading85End	O
GroupHeading32Start	O
Abdomen	O

[	O
QLH	O
]	O
TESTOSTERONE	O
,	O
FREE	O
AND	O
TOTAL	O
,	O
LC	O
/	O
MS	O
/	O
MS	O
Requested	O
for	O
:	O
29Oct2012	B-temporal

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Pulmonary	O

Unremarkable	B-labvalue
MRI	O
of	O
the	O
internal	O
auditory	O
canals	O

Age	O
at	O
menarche	O
was	O
11	O
.	O

Cranial	O
nerves	O
XII	O
:	O
there	O
was	O
no	B-negation
tongue	B-bodyloc
deviation	O
with	O
protrusion	O
.	O

Conductive	O
Hearing	O
Loss	O
Of	O
Both	O
Ears	B-bodyloc
389	O
.	O
06	O

Metformin	O
850	B-strength
mg	I-strength
Tablet	B-form
Sig	O
:	O
One	B-dosage
(	I-dosage
1	I-dosage
)	I-dosage
Tablet	B-form
PO	B-route
TID	B-frequency
(	I-frequency
3	I-frequency
times	I-frequency
a	I-frequency
day	I-frequency
)	I-frequency
.	O

His	O
EMG	O
nerve	O
conduction	O
studies	O
were	O
done	O
by	O
Dr	O
.	O
Nguyen	O
,	O
and	O
he	O
was	O
found	O
to	O
have	O
a	O
right	O
superficial	O
peroneal	O
response	O
was	O
absent	O
,	O
and	O
sensory	O
nerve	O
conductions	O
of	O
the	O
left	O
superficial	O
peroneal	O
nerve	O
were	O
normal	O
.	O

Maternal	B-subject
history	O
of	O
Diabetes	O
Mellitus	O
V18	O
.	O
0	O

Constitutional	O

ENT	O
:	O
no	B-negation
hearing	O
loss	O
,	O
no	B-negation
sore	O
throat	B-bodyloc
and	O
no	B-negation
hoarseness	O
.	O

Pupils	O
were	O
equal	O
in	O
size	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
.	O

The	O
oral	O
mucosa	O
was	O
dry	O
,	O
butwas	O
normal	O
.	O

3	O
.	O

Abdomen	O

Cardiovascular	O
Regular	B-labvalue
rate	O
and	O
rhythm	O
.	O
No	B-negation
edema	O
.	O

Maneuvers	O
demonstrated	O
a	B-labvalue
negative	I-labvalue
Homan	O
'	O
s	O
sign	O
.	O

no	B-negation
urinary	O
incontinence	O

Maternal	B-subject
history	O
of	O
Thyroid	B-bodyloc
Disorder	O
V18	O
.	O
19	O

1	O
.	O

713-448-4522	O
,	O
option	O
3	O
.	O

History	O
of	O
Migraine	O
Headache	O
346	O
.	O
90	O

Review	O
of	O
Systems	O
Complete	O
-	O
Female	O
Neuro	O
Emphasis	O
:	O

The	O
abdomen	O
was	O
normal	B-labvalue
to	O
percussion	O
.	O

Constitutional	O
:	O
no	B-negation
fever	O
and	O
no	B-negation
chills	O
.	O

This	O
problem	O
has	O
not	O
been	O
previously	O
evaluated	O
.	O

Nasal	O
endoscopy	O
.	O

Normal	B-labvalue
Examination	O
V70	O
.	O
0	O

-	O
CBC	O
,	O
BMP	O
,	O
liver	O
profile	O

f	O
RSV	O
MAB	O
(	O
Synagis	O
)	O
(	O
Lot	O
#	O
:	O
11F01	O
-	O
81	O
)	O
-	O
Administered	O
on	O
:	O
03/08/2013	B-temporal

Symptoms	O
are	O
made	O
worse	B-course
by	O
inhaled	O
bronchodilator	O
use	O
Symptoms	O
are	O
unchanged	O
(	O
white	O
,	O
thicker	O
sputum	O
)	O
.	O

Genitourinary	O
:	O
normal	O
,	O
no	B-negation
dysuria	O
,	O
no	B-negation
urinary	O
frequency	O
,	O
no	B-negation
incontinence	O
and	O
no	B-negation
pelvic	B-bodyloc
pain	O
.	O

Vaginal	B-bodyloc
Discharge	O
623	O
.	O
5	O

Houston	O
,	O
TX	O
77030	O

Examination	O
of	O
extremities	O
for	O
edema	O
and	O
/	O
or	O
varicosities	O
:	O
Normal	B-labvalue
.	O

B	O
.	O
P	O
.	O
this	B-temporal
a	I-temporal
.	I-temporal
m	I-temporal
.	I-temporal
155	B-labvalue
/	I-labvalue
74	I-labvalue
and	O
b	O
/	O
s	O
was	O
199	B-labvalue
p	O
.	O
p	O
.	O

Since	O
then	O
,	O
he	O
has	O
been	O
doing	O
well	O
.	O

History	O
of	O
Present	O
Illness	O
Ms	O
davenport	O
has	O
been	O
doing	O
very	O
well	O
.	O

Weight	O
:	O
220	B-labvalue
lb	I-labvalue

Patient	O
Specific	O
Education	O
Given	O
Done	O
:	O
30Jul2013	B-temporal

BASOPHILS	O
0	B-labvalue
.	I-labvalue
4	I-labvalue
%	I-labvalue

GI	O
:	O
no	B-negation
heartburn	O
,	O
no	B-negation
diarrhea	O
,	O
no	B-negation
nausea	O
,	O
no	B-negation
black	O
or	O
tarry	O
stools	O
,	O
no	B-negation
vomiting	O
and	O
no	B-negation
constipation	O
.	O

H	O
/	O
o	O
LSIL	O
pap	O
s	O
/	O
p	O
colpo	O
during	O
pregnancy	O
.	O

Plan	O
Lisinopril	O
20	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
DAILY	B-frequency
AT	I-frequency
BEDTIME	I-frequency
;	O
Therapy	O
:	O
27Apr2010	B-temporal
to	O
(	O
Evaluate	O
:	O
10Jul2012	B-temporal
)	O
Requested	O
for	O
:	O
12Jan2012	B-temporal
;	O
Last	O
Rx	O
:	O
12Jan2012	B-temporal

History	O
of	O
Alcohol	O
Use	O

Genitourinary	O
:	O
no	B-negation
dysuria	O
,	O
no	B-negation
hematuria	O
,	O
urine	O
odor	O
is	O
normal	B-labvalue

Hyperhidrosis	O
705	O
.	O
21	O

Constitutional	O
:	O
recent	B-temporal
weight	O
gain	O
,	O
but	O
no	B-negation
fever	O
,	O
not	B-negation
feeling	O
poorly	O
(	O
malaise	O
)	O
and	O
not	B-negation
feeling	O
tired	O
(	O
fatigue	O
)	O
.	O

Extremities	O
move	O
times	O
four	O
.	O

all	O
r	O
/	O
b	O
/	O
a	O
/	O
c	O
d	O
/	O
w	O
pt	O
re	O
:	O
B	O
IG	O
-	O
FESS	O

Integumentary	O
:	O
no	B-negation
skin	B-bodyloc
lesions	O
and	O
no	B-negation
skin	B-bodyloc
wound	O
.	O

Family	O
History	O
Family	O
history	O
of	O
No	O
Significant	O
Family	O
History	O

Nasal	O
mucosa	O
,	O
septum	O
,	O
and	O
turbinates	O
:	O
Normal	O
.	O

no	B-negation
insomnia	O

7	O
.	O

1	O
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

The	O
heart	O
rate	O
was	O
normal	B-labvalue
.	O

Left	O
total	O
hip	O
joint	O
replacement	O
recommended	O
.	O

Examination	O
of	O
the	O
abdomen	O
:	O
Abnormal	O
The	O
abdomen	B-bodyloc
was	O
obese	O
.	O

At	B-temporal
the	I-temporal
time	I-temporal
of	I-temporal
admission	I-temporal
to	O
the	O
ABCD	O
,	O
the	O
patient	O
was	O
not	B-negation
on	O
any	O
antibiotics	O
and	O
his	O
clinically	O
condition	O
has	O
remained	O
stable	O
.	O

DBS	O
therapy	O
response	O
is	O
not	O
sustained	O
and	O
she	O
looks	O
the	O
same	O
as	O
when	O
I	O
first	O
saw	O
her	O
.	O

Maternal	B-subject
history	O
of	O
Colon	B-bodyloc
Cancer	O
V16	O
.	O
0	O

3	O
.	O

Integumentary	O
:	O
no	B-negation
breast	B-bodyloc
pain	O
,	O
no	B-negation
breast	B-bodyloc
mass	O
,	O
no	B-negation
changes	O
in	O
mole	O
(	O
s	O
)	O
,	O
no	B-negation
rash	O
,	O
no	B-negation
itching	O
.	O

Likely	B-uncertain
postobstructive	O
pneumonia	O
.	O

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
FRANK	O
SCHROEDER	O
,	O
M	O
.	O
D	O
.	O

Examination	O
of	O
extremities	O
for	O
edema	O
and	O
/	O
or	O
varicosities	O
:	O
Normal	B-labvalue
.	O

Social	O
History	O
Never	O
A	O
Smoker	O

Review	O
of	O
Systems	O
Complete	O
-	O
Female	O
Neuro	O
Emphasis	O
:	O
Constitutional	O
,	O
eye	O
,	O
otolaryngeal	O
,	O
cardiovascular	O
,	O
respiratory	O
,	O
sleep	O
,	O
sleep	O
,	O
gastrointestinal	O
,	O
genitourinary	O
,	O
musculoskeletal	O
,	O
skin	O
,	O
neurological	O
,	O
psychiatric	O
,	O
endocrine	O
and	O
hematologic	O
review	O
of	O
systems	O
are	O
normal	O
.	O

Left	O
Digit	O
Ext	O
.	O

Patient	O
requires	O
the	O
use	O
of	O
a	O
walker	O
for	O
mobility	O
.	O
For	O
stabilization	O
.	O

Examination	O
of	O
cranial	O
nerves	O
:	O
Normal	B-labvalue
.	O

Hirsutism	O
704	O
.	O
1	O

F	O
.	O
U	O
.	O
on	O
anemia	O
.	O

Paternal	B-subject
history	O
of	O
Polyps	O
Of	O
The	O
Sigmoid	B-bodyloc
Colon	I-bodyloc

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

WWE	O
lmp	O
11/4/13	B-temporal
bcp	O
-	O
mgm	O
9	B-temporal
/	I-temporal
2012	I-temporal
colonoscopy	O
-	O
dexa	O
-	O

No	B-negation
rhonchi	O
were	O
heard	O
.	O

Bowel	O
sounds	O
were	O
normal	B-labvalue
.	O

Neurologic	O

Granuloma	O
Annulare	O
695	O
.	O
89	O

Adnexa	B-bodyloc
/	I-bodyloc
parametria	I-bodyloc
appeared	O
abnormal	O
.	O
Slightly	O
enlarged	O
left	B-bodyloc
adnexa	I-bodyloc
.	O

He	O
is	O
disabled	O
but	O
tries	O
to	O
teach	O
theatre	O
approximately	O
an	O
hour	O
a	O
week	O
or	O
a	O
month	O
at	O
the	O
High	O
School	O
for	O
the	O
Performing	O
Arts	O
.	O

50	O
yo	O
man	O
with	O
HTN	O
and	O
bradycardia	O
presents	O
for	O
evaluation	O
.	O

Inspection	O
of	O
breasts	O
:	O
Normal	B-labvalue

to	O

Surgical	O
History	O
Colostomy	O

2	O
.	O

Examination	O
of	O
extremities	O
for	O
edema	O
and	O
/	O
or	O
varicosities	O
:	O
Normal	B-labvalue
.	O

Eyes	O
:	O
normal	B-labvalue
.	O

General	O
appearance	O
:	O
Normal	B-labvalue
.	O

not	O
recommrtded	O
in	O
the	O
following	O
popula	O
ions	O
:	O

Ophthalmoscopic	O
examination	O
:	O
Normal	B-labvalue
Both	O
retina	O
were	O
normal	O
.	O

Cardiovascular	O

Diabetes	O
With	O
Neurological	O
Complications	O
250	O
.	O
60	O

Will	O
need	O
further	O
w	O
/	O
u	O
for	O
old	O
symptoms	O

Allergies	O
No	B-negation
Known	O
Allergies	O

f	O
Influenzr	O
(	O
Split	O
)	O
(	O
Lot	O
#	O
:	O
U4531BA	O
)	O
-	O
Administered	O
on	O
:	O
02/08/2013	B-temporal

Diastolic	O
:	O
61	B-labvalue

Omeprazole	O
20	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
Delayed	I-form
Release	I-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Last	O
Rx	O
:	O
24Oct2012	B-temporal

Past	O
Medical	O
History	O
Denied	O

Exercising	O
Regularly	O

Facial	O
strength	O
:	O
Abnormal	O
.	O

Overall	O
patient	O
afebrile	O
,	O
vitals	O
stable	O
,	O
clinically	O
well	O
appearing	O
.	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
HELEN	O
DUNNINGTON	O
,	O
M	O
.	O
D	O
.	O

Ovary	O
and	O
fallopian	O
tube	O
,	O
right	O
,	O
salpingo	O
-	O
oophorectomy	O
:	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
neck	O
:	O
No	B-negation
lymphadenopathy	O
.	O

Presentation	O
included	O
cough	O
and	O
non	O
-	O
productive	O
cough	O
.	O

Review	O
of	O
Systems	O

GASTROINTESTINAL	O
:	O
No	B-negation
abdominal	B-bodyloc
pain	O
.	O

Discussion	O
/	O
Signatures	O
Electronically	O
signed	O
by	O
:	O
LARISSA	O
MEYER	O
,	O
M	O
.	O
D	O
.	O

Social	O
History	O
Problems	O

Obesity	O
278	O
.	O
00	O

Patient	O
has	O
history	O
of	O
sexually	O
transmitted	O
infection	O
genital	B-bodyloc
herpes	O
.	O

[	O
QH	O
]	O
HEPATITIS	O
B	O
VIRUS	O
DNA	O
,	O
QN	O
,	O
REAL	O
TIME	O
PCR	O
Requested	O
for	O
:	O
07Sep2011	B-temporal

-	O
will	O
consider	O
injection	O
planning	O
at	O
that	O
time	O

)	O
Sig	O
:	O
Two	B-dosage
(	O
2	O
)	O
Tablet	B-form
,	I-form
Delayed	I-form
Release	I-form
(	O
E	O
.	O
C	O
.	O

Musculoskeletro	O
:	O
No	B-negation
soft	B-bodyloc
tissue	I-bodyloc
swelling	O
,	O
no	B-negation
localized	O
joint	B-bodyloc
pain	O
,	O
and	O
no	B-negation
bone	B-bodyloc
pain	O
.	O

Review	O
of	O
Systems	O
Orthopedic	O
ROS	O
Follow	O
Up	O
:	O

Home	O
monitoring	O
:	O
The	O
patient	O
checks	O
his	O
blood	O
sugar	O
sporadically	O
.	O
Glycemic	O
control	O
has	O
been	O
poor	O
.	O
The	O
patient	O
reports	O
no	B-negation
symptomatic	O
hypoglycemic	O
epsidodes	O
.	O

Monocytes	O
(	O
Absolute	O
)	O
:	O
0	B-labvalue
.	I-labvalue
8	I-labvalue
x10E3	I-labvalue
/	I-labvalue
uL	I-labvalue
Reference	O
Range	O
0	B-reference_range
.	I-reference_range
1	I-reference_range
-	I-reference_range
1	I-reference_range
.	I-reference_range
0	I-reference_range

Results	O
/	O
Assessment	O
Localized	O
Primary	O
Osteoarthritis	O
Of	O
Hip	B-bodyloc
715	O
.	O
15	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Lymphatic	O

Mother	O
is	O
a	O
20	O
-	O
year	O
-	O
old	O
gravida	O
1	O
,	O
para	O
0	O
female	O
who	O
received	O
prenatal	O
care	O
.	O

Retrospective	O
Authorization	O

The	O
patient	O
states	O
she	O
has	O
been	O
doing	O
well	O
with	O
her	O
blood	O
pressure	O
control	O
since	O
the	O
last	O
visit	O
.	O

Examination	O
of	O
the	O
head	O
and	O
face	O
:	O
Normal	B-labvalue

Comorbid	O
Illnesses	O
:	O
diabetes	O
mellitus	O
and	O
hypertension	O
.	O

Genitourinary	O
:	O
normal	O
,	O
no	B-negation
dysuria	O
,	O
no	B-negation
vaginal	B-bodyloc
discharge	O
and	O
no	B-negation
unexplained	O
vaginal	B-bodyloc
bleeding	O
.	O

Constitutional	O
:	O
feeling	O
tired	O
(	O
fatigue	O
)	O
,	O
but	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
and	O
not	B-negation
feeling	O
poorly	O
(	O
malaise	O
)	O
.	O

Disp	O
:	O
*	O
60	O
Capsule	O
(	O
s	O
)	O
*	O
Refills	O
:	O
*	O
2	O
*	O
5	O
.	O

Inspection	O
of	O
lips	O
,	O
teethand	O
gums	O
:	O
Normal	B-labvalue
The	O
lips	O
were	O
normal	O
with	O
no	B-negation
lesions	O
.	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
axillae	O
:	O
No	B-negation
lymphadenopathy	O
.	O

PYLORI	O
IGG	O
ANTIBODY	O
,	O
QUANTITATIVE	O
Requested	O
for	O
:	O
21Mar2013	B-temporal

MA	O
Breast	O
mammogram	O
screen	O
bilateral	O
Requested	O
for	O
:	O
16Nov2012	B-temporal

Stressed	O
the	O
importance	O
of	O
consistent	O
MNT	O
and	O
med	O
compliance	O
in	O
DM	O
control	O

Lymphatic	O

Hypothyroidism	O
244	O
.	O
9	O

BMI	O
Calculated	O
:	O
26	B-labvalue
.	I-labvalue
82	I-labvalue

Brain	O
w	O
/	O
wo	O
contrast	O
MRI	O
and	O
MRA	O
:	O

Measured	O
pulse	O
during	O
exam	O
with	O
a	O
rate	O
of	O
41	B-labvalue
.	O
Peripheral	O
vascular	O
exam	O
:	O
Normal	B-labvalue
.	O

Genitourinary	O

Hypothyroidism	O
244	O
.	O
9	O

Cranial	O
nerves	O
XI	O
:	O
shoulder	O
shrug	O
was	O
intact	B-labvalue
bilaterally	I-labvalue
.	O

Physical	O
Exam	O
:	O
Inadequate	O
complete	O
Otolaryngologic	O
exam	O
including	O
mirror	O
.	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
groin	O
:	O
No	B-negation
lymphadenopathy	O
.	O

Active	O
Problems	O
Benign	B-severity
Pigmented	O
Nevus	O
216	O
.	O
9	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
Christie	O
Mileur	O
,	O
M	O
.	O
D	O
.	O

;	O
Jan	B-temporal
10	I-temporal
2014	I-temporal
12	B-temporal
:	I-temporal
57PM	I-temporal
(	O
Author	O
)	O

General	O
Appearance	O
:	O
Abnormal	O
.	O

BP	O
mild	B-severity
range	O
today	O
,	O
was	O
previously	O
on	O
lisinopril	O
/	O
HCTZ	O
10	B-strength
/	I-strength
2	I-strength
.	I-strength
5	I-strength
prior	O
to	O
pregnancy	O
.	O

Skin	O
:	O
N	O
/	O
A	O
.	O

Sensory	O
:	O
no	B-negation
sensory	O
abnormalities	O
were	O
noted	O
.	O

Omeprazole	O
CPDR	O
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
15Nov2012	B-temporal
)	O
to	O

[	O
Q	O
]	O
VITAMIN	O
D	O
,	O
25	O
HYDROXY	O
AND	O
1	O
,	O
25	O
DIHYDROXY	O
,	O
LC	O
/	O
MS	O
/	O
MS	O
Requested	O
for	O
:	O
24Oct2012	B-temporal

ENT	O
:	O
no	B-negation
earache	O
,	O
no	B-negation
hearing	O
loss	O
,	O
no	B-negation
epistaxis	O
,	O
no	B-negation
nasal	B-bodyloc
discharge	O
,	O
no	B-negation
hoarseness	O
and	O
no	B-negation
sore	O
throat	B-bodyloc
.	O

[	O
QH	O
]	O
GLUCOSE	O
-	O
6	O
-	O
PHOSPHATE	O
DEHYDROGENASE	O
,	O
QUANT	O
.	O

Chief	O
Complaint	O

She	O
denies	B-negation
any	O
fever	O
,	O
nasal	B-bodyloc
congestion	O
,	O
chest	B-bodyloc
congestion	O
,	O
coughing	O
,	O
dysphagia	O
,	O
no	B-negation
obstruction	O
,	O
no	B-negation
change	O
in	O
appetites	O
.	O

hives	O
(	O
old	O
)	O
.	O

left	O
long	O
finger	O
flexor	O
digitorum	O
profundus	O
repair	O
6	O
.	O

Irritable	O
Bowel	B-bodyloc
Syndrome	O
564	O
.	O
1	O

Urine	O
Dipstick	O
(	O
In	O
Office	O
)	O

This	O
was	O
repaired	O
intraoperatively	O
without	O
difficulty	O
.	O

MONOCYTES	O
8	B-labvalue
.	I-labvalue
3	I-labvalue
%	I-labvalue

XR	O
KNEE	O
1	O
OR	O
2	O
VWS	O
LEFT	O
:	O
Images	O
acquired	O
,	O
not	O
reported	O
on	O
this	O
accession	O
number	O
.	O

8	O
.	O

Description	O
of	O
patient	O
'	O
s	O
judgement	O
and	O
insight	O
:	O
Normal	B-labvalue
.	O

Current	O
Orders	O
MA	O
Digital	O
Mammo	O
Screening	O
Bil	O
G0202	O
Requested	O
for	O
:	O
19Aug2013	B-temporal

4	O
.	O

Colposcopy	O
,	O
BTL	O
scheduling	O
.	O

Examination	O
of	O
thyroid	O
:	O
Normal	B-labvalue
.	O

Living	O
Independently	O
Alone	O
V60	O
.	O
3	O

Wrist	B-bodyloc
Sprain	O
842	O
.	O
00	O

Creatinine	O
Lvl	O
1	B-labvalue
.	I-labvalue
1	I-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
0	B-reference_range
.	I-reference_range
5	I-reference_range
-	I-reference_range
1	I-reference_range
.	I-reference_range
4	I-reference_range

Total	O
pregnancies	O
5	O
.	O
4	O
live	O
births	O
.	O
4	O
living	O
.	O
4	O
premature	O
delivery	O
(	O
s	O
)	O
.	O
1	O
induced	O
abortion	O
(	O
s	O
)	O
.	O
Dilation	O
and	O
curettage	O
.	O

f	O
DTaP	O
-	O
HepB	O
-	O
IPV	O
(	O
Pediarix	O
)	O
(	O
Lot	O
#	O
:	O
AC21B370AA	O
)	O
-	O
Administered	O
on	O
:	O
01/11/2013	B-temporal

No	O
relieving	O
factors	O
are	O
noted	O
.	O

Constitutional	O
:	O
recent	B-temporal
weight	O
gain	O
,	O
but	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
,	O
no	B-negation
malaise	O
,	O
no	B-negation
fatigue	O
and	O
no	B-negation
recent	B-temporal
weight	O
loss	O
.	O

Date	O
of	O
Birth	O
:	O
[	O
*	O
*	O
2106-7-20	B-temporal
*	O
*	O
]	O
Sex	O
:	O
M	O

Preventive	O
Medicine	O
Estab	O
Patient	O
Checkup	O
Adult	O
Over	O
64	O
V70	O
.	O
0	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

Otoscopic	O
examination	O
:	O
Normal	B-labvalue

bodyVital	O
Signs	O
g31	O

6	O
.	O

Abdomen	O

The	O
patient	O
presents	O
with	O
complaints	O
of	O
a	O
tendency	O
for	O
easy	O
bruising	O
(	O
lifelong	O
)	O
.	O

I	O
was	O
physically	O
present	O
for	O
nasal	O
endoscopy	O
(	O
scope	O
insertion	O
/	O
removal	O
)	O
.	O

2009	B-temporal
MH	O
Katy	O
Term	O
Male	O
,	O
9lbs	O
,	O
repeat	O
CS	O
,	O
preE	O

Healthcare	O
Providers	O

Never	O
Drank	O
Alcohol	O

Lymphatic	O
:	O
N	O
/	O
A	O
.	O

Benicar	O
40	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
20Aug2013	B-temporal
)	O
to	O

Otoscopic	O
examination	O
:	O
Normal	B-labvalue
The	O
right	B-bodyloc
tympanic	I-bodyloc
membrane	I-bodyloc
was	O
not	O
redand	O
was	O
not	B-negation
bulging	O
.	O

Past	O
Medical	O
History	O
History	O
of	O
Obesity	O
278	O
.	O
00	O

Assessment	O
of	O
muscle	O
strength	O
/	O
tone	O
:	O
Normal	B-labvalue

Procedure	O

Examination	O
of	O
reflexes	O
:	O
Normal	B-labvalue
.	O

Neurologic	O

Good	O
.	O

3	O
.	O

First	O
EEG	O
showed	O
generalized	O
sharp	O
waves	O
difficult	O
to	O
distinguish	O
from	O
vertex	O
waves	O
.	O

Allergies	O
No	B-negation
Known	O
Allergies	O

Reason	O
For	O
Visit	O

Peripheral	B-bodyloc
Neuropathy	O
356	O
.	O
9	O

Former	O
Smoker	O
V15	O
.	O
82	O

Neck	O

HOUSTON	O
,	O
TEXAS	O
77030	O

Metoprol0l	O
Tartrate	O
50	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
TWICE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
06Aug2012	B-temporal
to	O
(	O
Evaluate	O
:	O
05Aug2013	B-temporal
)	O
Requested	O
fis	O
:	O
07Jan2013	B-temporal
;	O
Last	O
Rx	O
:	B-temporal
07Jan2013	I-temporal

ALT	O
(	O
SGPT	O
)	O
:	O
25	B-labvalue
IU	I-labvalue
/	I-labvalue
L	I-labvalue
Reference	O
Range	O
0	B-reference_range
-	I-reference_range
44	I-reference_range

Active	O
Problems	O
1	O
.	O

History	O
of	O
Total	O
Hip	O
Replacement	O

Motor	O
:	O
Quadriceps	O
atrophy	O
.	O

The	O
extensor	O
halluces	O
longus	O
,	O
anterior	O
tibialis	O
,	O
po	O
terior	O
tibialis	O
,	O
and	O
peroneals	O
were	O
of	O
coEnarable	O
strength	O
,	O
bilaterally	O
.	O

Albumin	O
,	O
Serum	O
:	O
4	B-labvalue
.	I-labvalue
6	I-labvalue
g	I-labvalue
/	I-labvalue
dL	I-labvalue
Reference	O
Range	O
3	B-reference_range
.	I-reference_range
5	I-reference_range
-	I-reference_range
5	I-reference_range
.	I-reference_range
5	I-reference_range

ormal	O
Physical	O
Exam	O
Template	O
.	O

IPV	O
;	O
27	B-temporal
Jun	I-temporal
2011	I-temporal

Chronic	B-course
Kidney	B-bodyloc
Disease	O
,	O
Stage	O
585	O
.	O
9	O

Current	O
Meds	O
Lithium	O
Carbonate	O
300	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
3	B-frequency
TIMES	I-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
27Jan2012	B-temporal
to	O

Current	O
Meds	O
Camrese	O
0	B-strength
.	I-strength
15	I-strength
-	I-strength
0	I-strength
.	I-strength

The	O
patient	O
states	O
his	O
hyperlipidemia	O
has	O
been	O
under	O
good	O
control	O
since	O
the	O
last	O
visit	O
.	O

Xrays	O
NAD	B-labvalue

Vitals	O
UTP	O
Adult	O
Vital	O
Signs	O
[	O
Data	O
Includes	O
:	O
Current	O
Encounter	O
]	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

Cardiovascular	O
:	O
edema	O
,	O
butno	O
chest	B-bodyloc
pain	O
,	O
no	B-negation
radiating	O
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
,	O
no	B-negation
increased	O
heart	B-bodyloc
rate	O
,	O
no	B-negation
decrease	O
in	O
heart	B-bodyloc
rate	O
,	O
no	O
intermittent	O
leg	O
claudicationandno	O
syncope	O
.	O

4	O
.	O

No	B-negation
rhonchi	O
were	O
heard	O
.	O

Genitourinary	O
:	O
no	B-negation
pelvic	B-bodyloc
pain	O
,	O
no	B-negation
vaginal	B-bodyloc
discharge	O
and	O
no	B-negation
unexplained	O
vaginal	B-bodyloc
bleeding	O
.	O

Electronically	O
signed	O
by	O
:	O
RYAN	O
MURPHY	O
,	O
M	O
.	O
D	O
.	O

HEENT	O
:	O
No	B-negation
rinnitus	O
or	O
rhinitis	O
.	O

Prior	O
pregnancies	O
:	O
.	O

[	O
QLH	O
]	O
HEMOGLOBIN	O
A1c	O
Done	O
:	O
18Dec2012	B-temporal
11	B-temporal
:	I-temporal
30AM	I-temporal

Description	O
of	O
patient	O
'	O
s	O
judgement	O
and	O
insight	O
:	O
Normal	B-labvalue
.	O

Brief	O
Hospital	O
Course	O
:	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
,	O
no	B-negation
cough	O
and	O
no	B-negation
shortness	O
of	O
breath	O
during	O
exertion	O
.	O

External	O
inspection	O
of	O
ears	O
and	O
nose	O
:	O
Normal	B-labvalue
.	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
and	O
no	B-negation
cough	O
.	O

The	O
patient	O
'	O
s	O
last	O
LDL	O
was	O
53	B-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue
.	O

Cranial	O
nerves	O
VIII	O
:	O
Abnormal	O
.	O

It	O
does	O
not	O
appear	O
to	O
be	O
mechanical	O
or	O
balance	O
,	O
but	O
he	O
is	O
unable	O
to	O
characterize	O
the	O
etiology	O
.	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O
Clear	O
,	O
no	B-negation
wheezing	O
,	O
no	B-negation
ronchi	O
,	O
no	B-negation
rales	O
.	O

INDICATIONS	O
FOR	O
THE	O
SURGERY	O
:	O
Briefly	O
,	O
the	O
patient	O
is	O
a	O
71	O
-	O
year	O
-	O
old	O
female	O
referred	O
with	O
increasingly	B-course
symptomatic	O
large	O
nodular	O
thyroid	B-bodyloc
goiter	O
.	O

Surgical	O
History	O
History	O
of	O
Spinal	B-bodyloc
Arthrodesis	O
For	O
Deformity	O

[	O
QLH	O
]	O
CMP	O
Requested	O
for	O
:	O
10Apr2012	B-temporal

Esophageal	B-bodyloc
Reflux	O
530	O
.	O
81	O

Risks	O
of	O
surgery	O
,	O
including	O
but	O
not	B-negation
limited	O
to	O
anesthesia	O
,	O
infection	O
,	O
bleeding	O
,	O
orbital	B-bodyloc
injury	O
,	O
intracranial	B-bodyloc
injury	O
,	O
anosmia	O
/	O
hyposmia	O
,	O
epiphora	O
,	O
voice	O
changes	O
,	O
need	O
for	O
additional	O
prodedures	O
,	O
etc	O
.	O

History	O
of	O
Routine	O
Gynecological	O
Exam	O
V72	O
.	O
31	O

Therapy	O
:	O
10Feb2010	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
10Feb2010	B-temporal
)	O
Requested	O
for	O
:	O
10Feb2010	B-temporal

Headache	O
:	O
Mild	B-severity

Discussion	O
/	O
Discussion	O
/	O
Summary	O

Previous	B-temporal
Surgery	O
:	O
No	B-negation
.	O

Past	O
Meds	O
g30	O

Electronically	O
signed	O
by	O
:	O
Raymond	O
Martin	O
,	O
M	O
.	O
D	O
.	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
neck	O
:	O
Normal	B-labvalue
.	O

The	O
last	O
health	O
maintenance	O
visit	O
was	O
1	B-temporal
year	I-temporal
(	I-temporal
s	I-temporal
)	I-temporal
ago	I-temporal
.	O

CeleBREX	O
200	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
ONE	B-dosage
CAPSULE	B-form
EVERY	B-frequency
DAY	I-frequency
;	O
Therapy	O
:	O
16Aug2010	B-temporal
to	O
(	O
Evaluate	O
:	O
03Jun2013	B-temporal
)	O
Requested	O
for	O
:	O
08Jun2012	B-temporal
;	O
Last	O
Rx	O
:	O
08Jun2012	B-temporal

2	O
.	O

Reference	O
Ranges	O
:	O

Examination	O
of	O
cranial	O
nerves	O
:	O
Normal	B-labvalue
.	O

(	O
femor	O
.	O
)	O
Atrophy	O
.	O

-	O
no	O
intercourse	O
since	O
delivery	O
.	O

T3	O
,	O
FREE	O
2	B-labvalue
.	I-labvalue
7	I-labvalue
pg	I-labvalue
/	I-labvalue
ml	I-labvalue
2	B-reference_range
.	I-reference_range
3	I-reference_range
-	I-reference_range
4	I-reference_range
.	I-reference_range
2	I-reference_range

Lymphatic	O

"	O
History	O
of	O
Drug	O
Use	O

He	O
denies	B-negation
ear	B-bodyloc
pain	O
,	O
drainage	O
,	O
or	O
ringing	O
in	O
the	O
ears	B-bodyloc
.	O

Lymphs	O
(	O
Absolute	O
)	O
:	O
2	B-labvalue
.	I-labvalue
4	I-labvalue
x10E3	I-labvalue
/	I-labvalue
uL	I-labvalue
Reference	O
Range	O
0	B-reference_range
.	I-reference_range
7	I-reference_range
-	I-reference_range
4	I-reference_range
.	I-reference_range
5	I-reference_range

;	O
Dec	B-temporal
17	I-temporal
2013	I-temporal
12	B-temporal
:	I-temporal
23PM	I-temporal
(	O
Author	O
)	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
,	O
no	B-negation
cough	O
,	O
no	B-negation
shortness	O
of	O
breath	O
during	O
exertion	O
,	O
no	B-negation
orthopnea	O
and	O
no	B-negation
PND	O
.	O

Respiratory	O
No	B-negation
respiratory	B-bodyloc
distress	O
,	O
normal	B-labvalue
respiratory	O
rhythm	O
and	O
effort	O
,	O
Clear	B-labvalue
bilateral	O
breath	O
sounds	O

Assessment	O
Chronic	B-course
Sinusitis	O
473	O
.	O
9	O

Neurological	O
:	O
no	B-negation
dizziness	O
and	O
no	B-negation
fainting	O
.	O

(	O
Medical	O
Transcription	O
Sample	O
Report	O
)	O

Neurological	O
:	O
normalandpatient	O
is	O
alert	O
.	O

Family	B-subject
history	O
of	O
Sickle	O
Cell	O
Hb	O
-	O
Ss	O
Disease	O

Examination	O
of	O
the	O
oropharynx	O
:	O
Abnormal	O
.	O
Moderate	B-severity
erythema	O
posterior	B-bodyloc
pharynx	I-bodyloc
.	O

Associated	O
symptoms	O
include	O
no	B-negation
polyuria	O
,	O
no	B-negation
polydipsia	O
and	O
no	B-negation
recent	B-temporal
weight	O
gain	O
.	O

DISCHARGE	O
CONDITION	O
:	O
Guarded	O
.	O

The	O
tongue	O
was	O
normal	O
.	O

4	O
.	O

[	O
QLH	O
]	O
HEMATOCRIT	O
Done	O
:	O
06Oct2010	B-temporal
10	B-temporal
:	I-temporal
39AM	I-temporal

Family	O
History	O
Family	O
history	O
of	O
Breast	B-bodyloc
Cancer	O
V16	O
.	O
3	O

He	O
states	O
usually	O
around	O
every	B-temporal
6	I-temporal
months	I-temporal
he	O
gets	O
his	O
L	O
.	O
ear	O
cleaned	O
.	O

(	O
713	O
)	O
486	O
-	O
7500	O
(	O
Work	O
pEone	O
)	O
Patient	O
Contacts	O

GLOBULIN	O
2	B-labvalue
.	I-labvalue
6	I-labvalue
G	I-labvalue
/	I-labvalue
DL	I-labvalue
CALC	O
1	B-reference_range
.	I-reference_range
9	I-reference_range
-	I-reference_range
3	I-reference_range
.	I-reference_range
7	I-reference_range

Eyes	O

Cardiovascular	O

Benign	B-severity
Localized	O
Prostatic	B-bodyloc
Hyperplasia	O
With	O
Urinary	B-bodyloc
Obstruction	O
600	O
.	O
21	O

Observed	O
mood	O
and	O
affect	O
:	O
appropriate	O
affect	O
and	O
appropriate	O
mood	O
.	O

Pulmonary	O

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

Desires	O
IUD	O
for	O
BCM	O
.	O

DTRs	O
symmetric	O
2	O
out	O
of	O
4	O
bilateral	O
upper	O
and	O
lower	O
extremity	O
,	O
elbow	O
,	O
patella	O
and	O
ankle	O
.	O

Long	O
(	O
peron	O
.	O
)	O
Strength	O
:	O
5	B-labvalue
/	I-labvalue
5	I-labvalue
.	O

Leiomyosarcoma	O
.	O

Endocrine	O
:	O
no	B-negation
muscle	B-bodyloc
weakness	O
.	O

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

Cardiovascular	O

Examination	O
of	O
reflexes	O
:	O
Normal	B-labvalue
.	O

VH	O
-	O
10I	O
:	O
14	O
/	O
40	O

Thyroid	O
is	O
normal	O
.	O

Patient	O
Specific	O
Education	O
Given	O
Done	O
:	O
03Jan2013	B-temporal

89	O
year	O
old	O
man	O
with	O
PMH	O
of	O
HTN	O
,	O
CVA	O
(	O
March	B-temporal
/	I-temporal
2012	I-temporal
)	O
with	O
residual	B-course
left	O
sied	O
paralysis	O
presents	O
to	O
clinic	O
with	O
complaints	O
of	O
bilateral	B-bodyloc
lower	I-bodyloc
extremity	I-bodyloc
swelling	O
,	O
nontender	O
.	O

Skin	O

Lymphatic	O

ENT	O
:	O
normal	O
,	O
no	B-negation
epistaxis	O
and	O
no	B-negation
sore	O
throat	B-bodyloc
.	O

Recent	O
and	O
remote	O
memory	O
:	O
Normal	B-labvalue
.	O

Denied	O

Thrombocytopenia	O
.	O

Dr	O
.	O
Murphy	O
was	O
in	O
the	O
clinic	O
and	O
supervised	O
this	O
visit	O
.	O

History	O
of	O
Tubal	O
Ligation	O
V25	O
.	O
2	O

Started	O
the	O
lexapro	O
-	O
10	B-strength
mg	I-strength
in	O
am	O
-	O
ok	O
so	O
far	O
-	O
may	O
increase	O
to	O
20	B-strength
mg	I-strength
in	B-duration
two	I-duration
weeks	I-duration
.	O

Skin	O

Influenza	O
(	O
Split	O
)	O
;	O
every	O
1	O
year	O
;	O
Last	O
05Dec2007	B-temporal
;	O
Deferred	O
11Feb2013	B-temporal
;	O
Status	O
:	O
Temporary	O
Deferral	O

[	O
QLH	O
]	O
LIPID	O
PANEL	O
Requested	O
for	O
:	O
17Feb2014	B-temporal

-	O
In	O
-	O
situ	O
endometrial	B-bodyloc
adenocarcinoma	O
,	O
endometrioid	O
type	O
,	O
is	O
seen	O
at	O
the	O
adjacent	B-bodyloc
flat	I-bodyloc
endometrium	I-bodyloc
.	O

Left	O
total	O
knee	O
replacement	O
recommended	O
.	O

He	O
did	O
tend	O
to	O
get	O
a	O
panic	O
sensation	O
.	O

No	B-negation
mass	O
.	O

Lung	B-bodyloc
Cancer	O
162	O
.	O
9	O

History	O
of	O
Hysterectomy	O
V45	O
.	O
77	O

Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

FR	O
/	O
FS	O
:	O
PusandCrustFS	O
stent	O
in	O
place	O
.	O

Description	O
of	O
patient	O
'	O
s	O
judgement	O
and	O
insight	O
:	O
Normal	B-labvalue

Cardiovascular	O
Regular	B-labvalue
rate	O
and	O
rhythm	O
.	O
No	B-negation
edema	O
.	O

Results	O
/	O
Assessment	O
Health	O
Maintenance	O
V70	O
.	O
0	O

Materpal	B-subject
histisy	O
of	O
Essential	O
Hypertensisp	O

Delayed	O
Developmental	O
Milestones	O
Speech	O
783	O
.	O
42	O

Otoscopic	O
examination	O
:	O
Normal	B-labvalue
.	O

He	O
has	O
been	O
complaining	O
of	O
abdominrl	B-bodyloc
pain	O
.	O

Assessment	O
of	O
stability	O
:	O
Normal	B-labvalue
.	O

4	O
.	O

Examination	O
of	O
cranial	O
nerves	O
:	O
Normal	B-labvalue
.	O

The	O
patient	O
presents	O
with	O
complaints	O
of	O
cough	O
,	O
described	O
as	O
tight	O
and	O
dry	O
.	O

Physical	O
Exam	O
General	O
appearance	O
:	O
Normal	B-labvalue
.	O
NAD	O
.	O

All	O
questions	O
were	O
answered	O
.	O

She	O
had	O
repeat	O
xray	O
on	O
2/25/12	B-temporal
that	O
showed	O
5	O
mm	O
noncalcified	O
pulmonary	B-bodyloc
nodule	O
projected	O
in	O
the	O
right	O
midlung	O
zone	O
.	O

EARS	O
,	O
NOSE	O
,	O
MOUTH	O
AND	O
THROAT	O

MEDICATIONS	O
:	O
Unable	O
to	O
evaluate	O
.	O

Coordination	O
:	O
Normal	O
.	O

EMS	O
called	O
;	O
BP	O
,	O
sugar	O
and	O
ECG	O
were	O
normal	B-labvalue
.	O

Administration	O

Pulmonary	O

DISCHARGE	O
DIAGNOSES	O

Has	O
script	O
for	O
zomig	O
,	O
ER	O
precautions	O
.	O

Delivery	O
type	O
:	O
vaginal	O
.	O

Review	O
of	O
Systems	O

T2DM	O

History	O
of	O
Backache	O
724	O
.	O
5	O

The	O
abdomen	O
was	O
soft	O
and	O
nontender	O
.	O

[	O
QLH	O
]	O
CBC	O
(	O
INCLUDES	O
DIFF	O
/	O
PLT	O
)	O
Requested	O
for	O
:	O
24Oct2012	B-temporal

Never	O
Drank	O
Alcohol	O

Orientation	O
to	O
person	O
,	O
place	O
,	O
and	O
time	O
:	O
Normal	B-labvalue
.	O

Aseptic	O
Necrosis	O
Of	O
The	O
Femoral	B-bodyloc
Head	I-bodyloc
Left	O
733	O
.	O
42	O

Chief	O
Complaint	O

Keralyt	O
6	B-strength
%	I-strength
External	B-form
Gel	I-form
;	O
APPLY	O
AS	O
DIRECTED	O
;	O
Therapy	O
:	O
31Oct2012	B-temporal
to	O
(	O
Evaluate	O
:	O
29Jan2013	B-temporal
)	O
;	O
Last	O
Rx	O
:	O
31Oct2012	B-temporal

Temperature	O
:	O
98	B-labvalue
.	I-labvalue
6	I-labvalue
F	I-labvalue

HumuLIN	O
N	O
100	B-strength
UNIT	I-strength
/	I-strength
ML	I-strength
Subcutaneous	B-route
Suspension	B-form
;	O
INJECT	O
40	B-dosage
UNITS	I-dosage
IN	B-frequency
THE	I-frequency
MORNING	I-frequency
AND	O
25	B-dosage
UNITS	I-dosage
IN	B-frequency
THE	I-frequency
EVENING	I-frequency
UNDER	B-route
THE	I-route
SKIN	I-route
;	O
Therapy	O
:	O
05Apr2012	B-temporal
to	O
(	O
Evaluate	O
:	O
18Jan2014	B-temporal
)	O
Requested	O
for	O
:	O
22Jul2013	B-temporal
;	O
Last	O
Rx	O
:	O
22Jul2013	B-temporal

Pulmonary	O

Atenolol	O
25	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
26Feb2014	B-temporal
to	O
(	O
Evaluate	O
:	O
24Sep2014	B-temporal
)	O
Requested	O
for	O
:	O
26Feb2014	B-temporal
;	O
Last	O
Rx	O
:	O
26Feb2014	B-temporal

Use	O
1	B-dosage
capsule	B-form
in	O
Neil	O
-	O
Med	O
,	O
add	O

Neck	O
:	O
Neck	O
:	O
the	O
appearance	O
of	O
the	O
neck	O
was	O
normal	B-labvalue
and	O
the	O
thyroid	B-bodyloc
was	O
not	B-negation
enlarged	O
.	O

Immunizations	O

Surgical	O
History	O
History	O
of	O
Dilation	O
And	O
Curettage	O

I	O
have	O
personally	O
interviewed	O
the	O
patient	O
with	O
the	O
resident	O
and	O
I	O
agree	O
with	O
the	O
assessment	O
and	O
plan	O
as	O
delineated	O
in	O
the	O
note	O
above	O
.	O

Denied	O
Secondhand	O
Tobacco	O
Smoke	O
In	O
Home	O
.	O
eg	O

No	B-negation
submandibular	B-bodyloc
gland	I-bodyloc
mass	O
/	O
tenderness	O
.	O

Being	O
A	O
Social	O
Drinker	O

Scalp	B-bodyloc
and	I-bodyloc
Hair	I-bodyloc
:	O
no	B-negation
abnormalities	O
.	O

f	O
Preterm	O
Infant	O
-	O
1	O
,	O
000	O
-	O
1	O
,	O
249	O
G	O
.	O
(	O
765	O
.	O
14	O
)	O
;	O
(	O
Active	O
)	O

discharge	O
summary	O
,	O
nodular	O
,	O
symptomatic	O
thyroid	B-bodyloc
goiter	O
,	O
thyroidectomy	O
,	O
goiter	O
,	O

Vitals	O
21Nov2013	B-temporal
10	B-temporal
:	I-temporal
12AM	I-temporal
BMI	O
Calculated	O
31	B-labvalue
.	I-labvalue
94	I-labvalue
BSA	O
Calculated	O
1	B-labvalue
.	I-labvalue
85	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
3	I-labvalue
in	I-labvalue
Weight	O
180	B-labvalue
lb	I-labvalue
4	I-labvalue
oz	I-labvalue
Systolic	O
137	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
91	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Temperature	O
98	B-labvalue
.	I-labvalue
3	I-labvalue
F	I-labvalue
,	O
Temporal	O
Heart	O
Rate	O
79	B-labvalue
Respiration	O
16	B-labvalue
Respiration	O
Quality	O
Normal	B-labvalue
LMP	O
04Nov2013	B-labvalue

She	O
used	O
to	O
take	O
Nexium	O
40mg	B-strength
about	O
1	B-temporal
year	I-temporal
ago	I-temporal
which	O
really	O
helped	O
hes	O
symptoms	O
.	O

Skin	O
and	O
subcutaneous	O
tissue	O
:	O
Normal	O
without	B-negation
rashes	O
or	O
lesions	O
.	O

-	O
Tumor	O
is	O
FIGO	B-severity
grade	I-severity
2	I-severity
,	O
with	O
gland	O
formation	O
and	O
focal	O
morular	O
metaplasia	O
.	O

Past	O
Medical	O
History	O
History	O
of	O
Eczematoid	O
Dermatitis	O
692	O
.	O
9	O

Examination	O
of	O
the	O
skin	O
for	O
lesions	O
:	O
Abnormal	O
.	O

Mental	O
Status	O
:	O
A	O
mental	O
status	O
exam	O
was	O
performed	O
and	O
was	O
normal	B-labvalue
.	O

twNoteSignatureControlEnda	O
SignaturesSectionEnda	O

Vitals	O
24Oct2012	B-temporal
07	B-temporal
:	I-temporal
57AM	I-temporal
BMI	O
Calculated	O
40	B-labvalue
.	I-labvalue
3	I-labvalue
BSA	O
Calculated	O
2	B-labvalue
.	I-labvalue
33	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
8	I-labvalue
.	I-labvalue
5	I-labvalue
in	I-labvalue
Weight	O
269	B-labvalue
lb	I-labvalue
Systolic	O
130	B-labvalue
,	O
RUE	O
,	O
Sitting	O
Diastolic	O
94	B-labvalue
,	O
RUE	O
,	O
Sitting	O
Temperature	O
97	B-labvalue
.	I-labvalue
7	I-labvalue
F	I-labvalue
,	O
Oral	O
Heart	O
Rate	O
84	B-labvalue
,	O
R	O
Radial	O
Pulse	O
Quality	O
Regular	B-labvalue
,	O
R	O
Radial	O

DISCHARGE	O
PLAN	O
:	O
Follow	O
up	O
with	O
me	O
in	O
the	O
office	O
in	O
5	O
to	O
7	O
days	O
to	O
resume	O
all	O
pre	O
-	O
admission	O
medications	O
.	O

Age	O
at	O
menarche	O
was	O
14	O
.	O

It	O
was	O
cleaned	O
,	O
superiorly	O
a	O
TM	O
perforation	O
seen	O
as	O
usual	O
,	O
no	B-negation
purulent	O
discharge	O
.	O

The	O
last	O
menstrual	O
period	O
was	O
6/1/13	B-temporal
.	O
The	O
duration	O
of	O
the	O
menstrual	O
period	O
was	O
abnormal	O
lasting	O
>	O
7	O
days	O
days	O
.	O
There	O
was	O
excessive	O
bleeding	O
.	O

Osteoporosis	O
(	O
733	O
.	O
00	O
)	O
,	O
Health	O
Maintenance	O
(	O
V70	O
.	O
0	O
)	O

Multilevel	O
facet	O
degeneration	O
.	O

UTP	O
-	O
OB	O
/	O
Patient	O
here	O
for	O
.	O

No	B-negation
anterior	B-bodyloc
cervical	I-bodyloc
node	I-bodyloc
enlargement	O
,	O
no	B-negation
posterior	B-bodyloc
cervical	I-bodyloc
node	I-bodyloc
enlargement	O
,	O
no	B-negation
submandibular	O
node	O
enlargement	O
and	O
no	B-negation
supraclavicular	B-bodyloc
node	I-bodyloc
enlargement	O
.	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
MYA	O
SCHIESS	O
,	O
M	O
.	O
D	O
.	O

Examination	O
of	O
cranial	O
nerves	O
:	O
Normal	B-labvalue
.	O

He	O
has	O
significant	O
rigidity	O
.	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

I	O
agree	O
with	O
the	O
history	O
,	O
exam	O
and	O
plan	O
of	O
care	O
as	O
documented	O
in	O
the	O
resident	O
note	O
.	O

Comments	O
:	O
2	O
/	O
2	O
PTL	O
.	O

Gait	O
evaluation	O
demonstrated	O
antalgia	O
on	O
the	O
left	O
and	O
limping	O
on	O
the	O
left	O
,	O
but	O
no	B-negation
antalgia	O
on	O
the	O
right	O
,	O
no	B-negation
spasticity	O
on	O
the	O
right	O
,	O
no	O
spasticity	O
on	O
the	O
left	O
and	O
no	B-negation
limping	O
on	B-bodyloc
the	I-bodyloc
right	I-bodyloc
.	O

;	O
May	B-temporal
9	I-temporal
2013	I-temporal
8	B-temporal
:	I-temporal
42PM	I-temporal
(	O
Author	O
)	O

Septum	O
:	O
Midline	O
.	O

Discussion	O
/	O
Discussion	O
/	O
Summary	O

Psychiatric	O

Discussion	O
/	O
SummarySectionStart	O
Discussion	O
Ms	O
.	O
Moore	O
,	O

Furosemide	O
TABS	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
03Nov2011	B-temporal
)	O
to	O

General	O
appearance	O
:	O
Normal	B-labvalue
.	O

Current	O
Meds	O
Cytomel	O
5	B-strength
MCG	I-strength
Oral	B-route
Tablet	B-form
;	O
Therapy	O
:	O
30Jul2013	B-temporal
to	O

He	O
has	O
been	O
doing	O
well	O
since	O
last	O
visit	O
10	B-temporal
months	I-temporal
ago	I-temporal
other	O
than	O
feeling	O
little	O
bit	O
stuffy	O
on	O
the	O
left	B-bodyloc
ear	I-bodyloc
.	O

Pertinent	O
medical	O
history	O
:	O
no	B-negation
obstructive	O
sleep	O
apnea	O
.	O

Musculoskeletal	O

BACK	O
:	O
Nontender	O
on	O
midline	O
.	O

Lisinopril	O
5	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
01Oct2013	B-temporal
to	O
(	O
Evaluate	O
:	O
30Mar2014	B-temporal
)	O
;	O
Last	O
Rx	O
:	O
01Oct2013	B-temporal

Heart	O
sounds	O
:	O
abnormal	O
S1	O
,	O
abnormal	O
S2	O
.	O

Head	O
and	O
Face	O

Review	O
of	O
Systems	O

US	O
Soft	O
Tissue	O
Head	O
/	O
Neck	O
76536	O
Requested	O
for	O
:	O
12Nov2013	B-temporal

GroupHeading140End	O
DietandExerciseConcerns168bcae2	O
-	O
802b	O
-	O
4534	O
-	O
aadc	O
-	O
dc170d927144FormEnd	O
Counseling	O
/	O
EduSectispEnd	O
SignaturesSectispStart	O
Signatures	O

NITRITE	O
NEG	B-labvalue

Breathing	O
was	O
normal	B-labvalue
.	O

Assessment	O
Predominantly	O
right	O
-	O
sided	O
process	O
,	O
likely	B-uncertain
AFRS	O
(	O
his	B-subject
daughter	I-subject
had	O
it	O
)	O
or	O
unlikely	O
,	O
an	O
IP	O
or	O
neoplasm	O
(	O
although	O
endoscopic	O
appearance	O
is	O
consistent	O
with	O
polyp	O
)	O

Head	O
and	O
Face	O

He	O
has	O
returned	O
to	O
baseline	O
and	O
his	O
sense	O
of	O
smell	O
is	O
good	O

Date	O
of	O
Birth	O
:	O
08/03/2013	B-temporal
.	O

Indication	O
:	O
Chronic	O
rhinosinusitis	O
follow	O
-	O
up	O
.	O

Cervix	O
:	O
Normal	B-labvalue
Examination	O
of	O
the	O
cervix	O
revealed	O
normal	B-labvalue
findings	I-labvalue
.	O

Dexa	O
Scan	O
(	O
Dual	O
Energy	O
X	O
-	O
Ray	O
)	O
Requested	O
for	O
:	O
12Jan2012	B-temporal

Heart	O
sounds	O
:	O
normal	B-labvalue
S1	O
,	O
normal	B-labvalue
S2	O
,	O
no	B-negation
S3	O
and	O
no	B-negation
S4	O
.	O

Discharge	O
Instructions	O
:	O

2	O
.	O

Tylenol	O
325	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
20Aug2013	B-temporal
)	O
to	O

CARDIOVASCULAR	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
and	O
not	B-negation
expressed	I-negation
as	O
feeling	O
short	O
of	O
breath	O
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

DOT	O
:	O
5/15/2013	B-temporal

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
vomiting	O
and	O
no	B-negation
heartburn	O
.	O

Vaccines	O
Prophylactic	O
Need	O
Against	O
Influenza	O
V04	O
.	O
81	O

Reflexes	O
:	O
the	O
reflexes	O
were	O
normal	B-labvalue
.	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
,	O
no	B-negation
syncope	O
and	O
no	B-negation
edema	O
.	O

deficiency	O
,	O
while	O
levels	O
between	O
20	O
ng	O
/	O
mL	O
and	O
30	O

Normal	O
Routine	O
History	O
And	O
Physical	O
Adult	O
V70	O
.	O
0	O

Musculoskeletal	O

Assessment	O
of	O
hearing	O
:	O
Normal	B-labvalue
.	O

General	O
appearance	O
:	O
Normal	B-labvalue
.	O

Neurologic	O

Cardiovascular	O

Patient	O
does	O
not	B-negation
have	I-negation
a	O
history	O
of	O
a	O
positive	O
pap	O
smear	O
.	O

AP	O
Pelvis	O
bilateral	O
hip	O
films	O
demonstrate	O
well	O
seated	O
acetabulum	O
and	O
femoral	O
components	O
right	O
and	O
left	O
hip	O
in	O
satisfactory	O
alignment	O
bilaterally	O

Lumbosacral	O
Spine	O
:	O
Appearance	O
:	O
no	B-negation
erythema	O
,	O
no	B-negation
ecchymosis	O
and	O
no	B-negation
swelling	O
.	O

Pneumonia	O
486	O

Eosinophils	O
#	O
0	B-labvalue
.	I-labvalue
4	I-labvalue
K	I-labvalue
/	I-labvalue
CMM	I-labvalue
0	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
0	I-reference_range
.	I-reference_range
5	I-reference_range

History	O
of	O
Alcohol	O
Use	O

Counseling	O
/	O
Counseling	O
/	O
Edu	O
The	O
patient	O
and	O
patient	O
'	O
s	O
family	O
was	O
counseled	O
regarding	O
diagnostic	O
results	O
,	O
prognosis	O
,	O
impressions	O
,	O
risks	O
and	O
benefits	O
of	O
treatment	O
optionsandimportance	O
of	O
compliance	O
with	O
treatment	O
.	O

DTaP	O
;	O
12/07/2007	B-temporal

Hearing	O
left	O
ear	O
:	O
.	O

She	O
had	O
staples	O
removed	B-negation
at	O
TMC	O
office	O
2	O
days	O
ago	O
,	O
but	O
presents	O
today	O
with	O
some	O
leakage	O
from	O
wound	O
and	O
small	O
amount	O
of	O
separation	O
peri	B-bodyloc
-	I-bodyloc
umbilically	I-bodyloc
.	O

Family	B-subject
history	O
of	O
Thyroid	B-bodyloc
Disorder	O

Denied	B-negation
Family	B-subject
history	O
of	O
Hearing	O
Loss	O

Integumentary	O
:	O
no	B-negation
skin	B-bodyloc
lesions	O
.	O

He	O
was	O
told	O
that	O
he	O
would	O
probably	O
outgrow	O
it	O
.	O

Advise	O
hydration	O
.	O

Crusting	O
removed	O
from	O
Bilateral	O
,	O
middle	O
meatus	O
,	O
FR	O
/	O
FS	O

On	O
a	O
scale	O
of	O
1	O
to	O
10	O
,	O
the	O
patient	O
rates	O
the	O
pain	O
as	O
2	B-severity
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O
Stable	B-course
ex	O
-	O
32	B-temporal
-	I-temporal
weeks	I-temporal
preemie	O
.	O

Resume	O
routine	O
follow	O
-	O
up	O
in	O
6	O
months	O
.	O

Heart	O
sounds	O
:	O
normal	B-labvalue
S1	O
and	O
normal	B-labvalue
S2	O
.	O

Examination	O
of	O
sensation	O
:	O
Normal	B-labvalue
.	O

f	O
Lisinopril	O
40	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
EVERY	B-frequency
DAY	I-frequency
;	O
Start	O
Date	O
:	O
04/21/2008	B-temporal
;	O
End	O
Date	O
:	O
01/01/1900	B-temporal
(	O
Active	O
)	O

The	O
history	O
was	O
reported	O
by	O
mother	O
.	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
YEN	O
I	O
CHEN	O
,	O
M	O
.	O
D	O
.	O

Patient	O
currently	B-temporal
taking	O
valtrex	O
500	B-strength
mg	I-strength
QD	B-frequency
but	O
is	O
inconsistently	O
taking	O
.	O

1	O
.	O

Place	O
of	O
Delivery	O
:	O
Katy	O
.	O

Right	O
Gluteus	O
Max	O
.	O

Discussion	O
/	O
Plan	O

Head	O
and	O
Face	O

The	O
surrounding	O
skin	O
was	O
normal	O
.	O

Keywords	O
:	O

Current	O
Meds	O
None	O
-	O
No	B-negation
Current	B-temporal
Medications	O
;	O
Therapy	O
:	O
25Feb2010	B-temporal
to	O
Requested	O
for	O
:	O
25Feb2010	B-temporal

History	O
of	O
Drug	O
Use	O

Past	O
Medical	O
History	O
History	O
of	O
Acute	B-course
Frontal	B-bodyloc
Sinusitis	O
461	O
.	O
1	O

He	O
has	O
one	B-subject
brother	I-subject
and	O
one	B-subject
sister	I-subject
who	O
have	O
high	O
cholesterol	O
.	O
He	O
has	O
two	O
other	B-subject
sisters	I-subject
who	O
have	O
headaches	O
attributed	O
to	O
MVAs	O
.	O

Inspection	O
/	O
palpation	O
of	O
joints	O
,	O
bones	O
,	O
and	O
muscles	O
:	O
Normal	B-labvalue
.	O

Vitals	O
07Oct2013	B-temporal
04	B-temporal
:	I-temporal
24PM	I-temporal
BMI	O
Calculated	O
60	B-labvalue
.	I-labvalue
7	I-labvalue
BSA	O
Calculated	O
3	B-labvalue
.	I-labvalue
06	I-labvalue
Height	O
6	B-labvalue
ft	I-labvalue
1	I-labvalue
in	I-labvalue
Weight	O
458	B-labvalue
lb	I-labvalue
Systolic	O
130	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
84	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Temperature	O
97	B-labvalue
.	I-labvalue
8	I-labvalue
F	I-labvalue
,	O
Temporal	O
Heart	O
Rate	O
72	B-labvalue
,	O
L	O
Radial	O
Pulse	O
Quality	O
Normal	B-labvalue
,	O
L	O
Radial	O
Respiration	O
18	B-labvalue
Respiration	O
Quality	O
Normal	B-labvalue

Morbid	O
Obesity	O
278	O
.	O
01	O

There	O
is	O
no	B-negation
fluctuance	O
or	O
suggestion	O
of	O
abscess	O
.	O

BMI	O
Calculated	O
:	O
49	B-labvalue
.	I-labvalue
91	I-labvalue

Wart	O
-	O
Unclear	B-uncertain
if	I-uncertain
true	I-uncertain
varruca	O
.	O

No	B-negation
facial	B-bodyloc
skin	I-bodyloc
lesions	O
.	O

Post	O
-	O
nasal	B-bodyloc
drip	O
:	O
Severe	B-severity

Traumatic	O
Brain	B-bodyloc
Injury	O
854	O
.	O
00	O

[	O
QLH	O
]	O
TSH	O
,	O
3RD	O
GENERATION	O
Requested	O
for	O
:	O
13Nov2012	B-temporal

on	O
depoprovera	O
16yo	O
until	O
25yo	O

Auscultation	O
of	O
lungs	O
:	O
Clear	B-labvalue
to	O
auscultation	O
.	O

Questios	O
and	O
concerns	O
addressed	O
.	O

She	O
is	O
only	O
taking	O
Rebif	O
once	B-frequency
/	I-frequency
week	I-frequency
.	O

Symptoms	O
:	O
Denies	B-negation
palpitations	O
,	O
denies	B-negation
chest	B-bodyloc
pain	O
,	O
denies	B-negation
exercise	O
intolerance	O
,	O
denies	B-negation
dyspnea	O
on	O
exertionanddenies	O
dizziness	O
.	O

History	O
of	O
Cesarean	O
Section	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
,	O
the	O
heart	O
rate	O
was	O
not	B-labvalue
fast	I-labvalue
and	O
the	O
heart	O
rate	O
was	O
not	B-labvalue
slow	I-labvalue
.	O

Tylox	O
CAPS	B-form

5	I-reference_range
Monocy	O
es	O
10	B-labvalue
.	I-labvalue
1	I-labvalue
%	I-labvalue
2	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
12	I-reference_range
.	I-reference_range

The	O
patient	O
presents	O
with	O
complaints	O
of	O
no	B-negation
near	O
syncope	O
(	O
lightheadedness	O
)	O
.	O

Questions	O
and	O
concerns	O
address	O
.	O

UTP	O
-	O
OB	O
/	O
Patient	O
here	O
for	O
a	O
well	O
woman	O
visit	O
.	O

I	O
think	O
his	O
overall	O
neurological	O
complaints	O
are	O
related	O
to	O
do	O
this	O
and	O
possibly	B-uncertain
his	O
allergies	O
.	O

Heart	O
Rate	O
:	O
75	B-labvalue

OB	O
History	O

Lisinopril	O
5	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
05Jun2012	B-temporal
)	O
to	O

Surgical	O
History	O
History	O
of	O
Breast	O
Surgery	O
Lumpectomy	O

Observed	O
mood	O
and	O
affect	O
:	O
appropriate	B-labvalue
affectandappropriate	O
mood	O
.	O

Hemoglobin	O
A1c	O
:	O
4	B-labvalue
.	I-labvalue
9	I-labvalue
%	I-labvalue

Birth	O
weight	O
was	O
8	B-labvalue
lbs	I-labvalue
,	I-labvalue
9	I-labvalue
oz	I-labvalue
.	O

Pulse	O
Width	O
270	O
-	O
caused	O
a	O
"	O
fog	O
"	O
120	O
-	O
increased	O
to	O
180	O

Neck	O

HOUSTON	O
,	O
TX	O
77090	O
Gender	O
Female	O
Marital	O
Status	O
(	O
713	O
)	O
822	O
-	O
9328	O
(	O
Home	O
phone	O
)	O
Language	O
English	O
-	O
preferred	O
Reason	O
for	O
Referral	O

Husband	O
is	O
unable	O
to	O
classify	O
the	O
exact	O
cause	O
of	O
the	O
fall	O
.	O

Family	O
History	O
Paternal	B-subject
history	O
of	O
Coronary	B-bodyloc
Arteriosclerosis	O
V17	O
.	O
49	O

Diabetic	O
Foot	O
Exam	O
:	O

normal	O
No	B-negation
breast	B-bodyloc
masses	O
were	O
palpable	O
.	O

Red	O
Cell	O
Diameter	O
Width	O
:	O
16	B-labvalue
.	I-labvalue
8	I-labvalue
%	I-labvalue
Abnormal	O
High	O
Reference	O
Range	O
11	B-reference_range
.	I-reference_range
5	I-reference_range
-	I-reference_range
14	I-reference_range
.	I-reference_range
5	I-reference_range

If	O
we	O
can	O
then	O
we	O
will	O
try	O
to	O
increase	O
his	O
Sinemet	O
to	O
maybe	O
the	B-strength
25	I-strength
/	I-strength
250	I-strength
or	O
25	B-strength
/	I-strength
100	I-strength
-	I-strength
mg	I-strength
pills	B-form
to	O
improve	O
his	O
movement	O
.	O

Eyes	O

Psoriatic	O
Arthropathy	O
696	O
.	O
0	O

IP	O
/	O
N	O
/	O
SF	O
Due	O
:	O
17Aug2013	B-temporal
;	O
Last	O
Updated	O
By	O
:	O
Fleming	O
,	O
Sonya	O

Reflexes	O
:	O
the	O
reflexes	O
were	O
normal	B-labvalue
.	O

D	O
.	O

2	O
.	O

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

"	O
Never	O
A	O
Smoker	O

RED	O
BLOOD	O
CELL	O
COUNT	O
3	B-labvalue
.	I-labvalue
77	I-labvalue
Million	I-labvalue
/	I-labvalue
uL	I-labvalue
L	B-labvalue
3	B-reference_range
.	I-reference_range
80	I-reference_range
-	I-reference_range
5	I-reference_range
.	I-reference_range
10	I-reference_range

Benign	B-severity
Essential	O
Hypertension	O
401	O
.	O
1	O

Examination	O
of	O
the	O
oropharynx	O
:	O
Normal	B-labvalue

The	O
thyroid	B-bodyloc
was	O
not	B-negation
enlarged	O
.	O

There	O
was	O
an	O
incidental	O
cystotomy	O
at	O
the	O
time	O
of	O
the	O
creation	O
of	O
the	O
bladder	O
flap	O
.	O

The	O
baby	O
is	O
a	O
girl	O
.	O

Plan	O
Levofloxacin	O
750	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
FOR	O
SINUSITIS	O
&	O
BRONCHITIS	O
;	O
Therapy	O
:	O
12Apr2014	B-temporal
to	O
(	O
Complete	O
:	O
26Apr2014	B-temporal
)	O
;	O
Last	O
Rx	O
:	O
12Apr2014	B-temporal

Pregnancy	O
Test	O
Positive	B-labvalue
V72	O
.	O
42	O

Nasopharynx	O
:	O
Adenoids	O
normal	O
.	O

A	O
grade	B-severity
2	I-severity
systolic	O
murmur	O
was	O
heard	O
at	O
the	O
LUSB	O
.	O

-	O

Assessment	O
of	O
respiratory	O
effort	O
was	O
significant	O
for	O
normal	B-labvalue
respiratory	O
rhythm	O
and	O
effort	O
.	O

Auscultation	O
of	O
lungs	O
:	O
Abnormal	O
.	O

Social	O
History	O
"	O
Caffeine	O
Use	O

;	O
Jun	B-temporal
13	I-temporal
2013	I-temporal
9	B-temporal
:	I-temporal
42AM	I-temporal
(	O
Author	O
)	O

Nasopharynx	O
:	O
Adenoids	O
normal	O
.	O

He	O
is	O
doing	O
much	O
better	O
since	O
he	O
has	O
started	O
Atenolol	O
.	O

History	O
of	O
Thalassemia	O
Minor	O
282	O
.	O
46	O

RDW	O
:	O
13	B-labvalue
.	I-labvalue
6	I-labvalue
%	I-labvalue
Reference	O
Range	O
12	B-reference_range
.	I-reference_range
3	I-reference_range
-	I-reference_range
15	I-reference_range
.	I-reference_range
4	I-reference_range

7	O
.	O

Eyes	O

Neck	O
is	O
nontender	O
.	O

I	O
was	O
present	O
and	O
available	O
in	O
clinic	O
.	O

bodyVitai	O
Signs	O
g31	O
Recorded	O
by	O
Coffey	O
,	O
Francine	O
on	O
10	B-temporal
Apr	I-temporal
2013	I-temporal
09	B-temporal
:	I-temporal
17	I-temporal
AM	I-temporal
BP	O
:	O
104	B-labvalue
/	I-labvalue
63	I-labvalue
,	O
LUE	O
,	O
Sitting	O
,	O
HR	O
:	O
64	B-labvalue
b	I-labvalue
/	I-labvalue
min	I-labvalue
,	O
Apical	O
,	O
Normrl	B-labvalue
,	O
Temp	O
:	O
98	B-labvalue
.	I-labvalue
3	I-labvalue
F	I-labvalue
,	O
O	O
rl	O
,	O
Height	O
:	O
49	B-labvalue
.	I-labvalue
000000	I-labvalue
in	I-labvalue
,	O
Weight	O
:	O
45	B-labvalue
.	I-labvalue
000000	I-labvalue
lb	I-labvalue
,	O
BMI	O
:	O
13	B-labvalue
.	I-labvalue
2	I-labvalue
kg	I-labvalue
/	I-labvalue
m2	I-labvalue
,	O
BSA	O
Calculated	O
:	O
0	B-labvalue
.	I-labvalue
85	I-labvalue
,	O
BMI	O
Calculated	O
:	O
13	B-labvalue
.	I-labvalue
27	I-labvalue
.	O
eg	O

ActiveProblems	O
_	O
10	O
_	O
twCiteListControlStart	O
Acne	O
706	O
.	O
1	O

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

Endocrine	O
:	O
no	B-negation
hot	O
flashes	O
,	O
no	B-negation
changes	O
in	O
appetite	O
,	O
no	B-negation
unusual	O
sensitivity	O
to	O
changes	O
in	O
temperature	O
and	O
no	B-negation
feelings	O
of	O
excessive	O
thirst	O
.	O

reduced	O
to	O
180	O
-	O
alert	O
and	O
good	O
mouth	O
closure	O

1	O
2	O
Hepatitis	O
A	O
28May2010	B-temporal
28Nov2011	B-temporal
Influenza	O
26Sep2011	B-temporal
Pneumococcal	O
01Mar2010	B-temporal
Tdap	O
27May2009	B-temporal

PROTEIN	O
Negative	B-labvalue

3	O
.	O

5	O
.	O

nexium	O
,	O
lipitor	O
,	O
enalapril	O

Examination	O
of	O
both	O
knees	O
revealed	O
the	O
patient	O
to	O
have	O
full	B-labvalue
flexion	O
and	O
full	B-labvalue
extension	O
.	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
.	O

Family	B-subject
history	O
of	O
Breast	B-bodyloc
Cancer	O

Test	O
Name	O
Result	O
Flag	O
Reference	O

History	O
of	O
Male	O
Erectile	O
Disorder	O
Due	O
To	O
Physical	O
Condition	O
607	O
.	O
84	O

Current	O
Meds	O
Biotin	O
5000	B-strength
MCG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
31Oct2013	B-temporal
)	O
to	O

Arterial	O
Pulses	O
:	O
Normal	B-labvalue
(	O
equal	O
bilaterally	O
)	O
.	O

Consent	O
:	O
Risks	O
/	O
benefits	O
/	O
alternatives	O
reviewed	O
.	O

There	O
is	O
no	B-negation
evidence	I-negation
of	I-negation
abnormal	O
wear	O
bilaterally	O
.	O

Neurological	O
:	O
no	B-negation
confusion	O
,	O
no	B-negation
dizziness	O
,	O
no	B-negation
fainting	O
,	O
no	B-negation
limb	B-bodyloc
weakness	O
and	O
no	B-negation
difficulty	O
walking	O
.	O

Carotid	O
:	O
NEVER	O

Cardiovascular	O

I	O
examined	O
and	O
discussed	O
the	O
patient	O
with	O
the	O
resident	O
and	O
agree	O
with	O
the	O
above	O
findings	O
,	O
assessment	O
and	O
plan	O
in	O
the	O
resident	O
note	O
.	O

Social	O
Activities	O
:	O
The	O
patient	O
is	O
currently	O
living	O
with	O
family	O
.	O

Follow	O
Up	O
:	O
Return	O
to	O
the	O
clinic	O
as	O
needed	O

Palpation	O
of	O
the	O
face	O
and	O
sinuses	O
:	O
Normal	B-labvalue
.	O

NEUROLOGICAL	O
:	O
no	B-negation
seizures	O
.	O

Mean	O
Cell	O
Hemoglobin	O
30	B-labvalue
.	I-labvalue
4	I-labvalue
pg	I-labvalue
27	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
31	I-reference_range
.	I-reference_range
0	I-reference_range

Extraocular	O
motions	O
are	O
intact	B-labvalue
bilaterally	I-labvalue
.	O

Hyperlipidemia	O
272	O
.	O
4	O

Eth	O
:	O
PolypoidandPolyps	O

Her	O
left	B-bodyloc
hip	I-bodyloc
persistent	O
pain	O
and	O
lack	O
of	O
range	O
of	O
motion	O
with	O
stiffness	O
are	O
adversely	O
affecting	O
her	O
overall	O
QOL	O
and	O
general	O
well	O
being	O
.	O

Cardiovascular	O
:	O
no	B-negation
palpitations	O
and	O
no	B-negation
intermittent	O
leg	B-bodyloc
claudication	O
.	O

EYES	O

Neck	O

Tab	O
Doxyccline	O
100	B-strength
mg	I-strength
PO	B-route
BID	B-frequency
x	O
10	B-duration
days	I-duration
for	O
facial	B-bodyloc
lesions	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

Sensory	O
:	O
no	B-negation
sensory	O
abnormalities	O
were	O
noted	O
.	O

Eyes	O
:	O
no	B-negation
eyesight	O
problems	O
.	O

Pantoprazole	O
40	B-strength
mg	I-strength
Tablet	B-form
,	I-form
Delayed	I-form
Release	I-form
(	O
E	O
.	O
C	O
.	O

Review	O
of	O
Systems	O

Otoscopic	O
examination	O
:	O
Abnormal	O
.	O
Bilateal	O
otitis	O
serous	O
.	O

Spinal	O
instrumentation	O
C4	O
through	O
C7	O
.	O

Ms	O
Wathen	O
is	O
an	O
established	O
patient	O
with	O
Dr	O
Derek	O
Jones	O
practice	O
with	O
known	O
diagnosis	O
of	O
left	B-bodyloc
hip	I-bodyloc
severe	B-severity
osteoarthritis	O
with	O
femoral	B-bodyloc
avasculalr	I-bodyloc
necrosis	O
.	O

The	O
buccal	O
membranes	O
are	O
normal	O
.	O

RT	O

Color	O
nml	O
.	O
Ability	O
to	O
communicate	O
:	O
Normal	B-labvalue
.	O

Family	B-subject
history	O
of	O
Hypertension	O
V17	O
.	O
49	O

Diabetes	O
Mellitus	O
250	O
.	O
00	O

;	O
Jan	B-temporal
5	I-temporal
2014	I-temporal
3	B-temporal
:	I-temporal
58PM	I-temporal
(	O
Review	O
)	O

Head	O
and	O
Face	O

NEXT	O
VISIT	O
LIPIDS	O
,	O
CMP	O
,	O
A1C	O
,	O
MICROALB	O
,	O
URIC	O
AC	O
.	O

Small	O
For	O
Gestational	O
Age	O
At	O
Delivery	O
(	O
764	O
.	O
00	O
)	O
.	O
eg	O

Symptoms	O
:	O
enlarged	O
lymph	B-bodyloc
node	I-bodyloc
(	O
s	O
)	O
,	O
palpable	O
lymph	B-bodyloc
node	I-bodyloc
(	O
s	O
)	O
,	O
visible	O
lymph	B-bodyloc
node	I-bodyloc
(	O
s	O
)	O
andpainful	O
lymph	O
node	O
(	O
s	O
)	O
,	O
but	O
no	B-negation
rash	O
,	O
no	B-negation
skin	B-bodyloc
lesions	O
,	O
no	B-negation
sore	O
throat	B-bodyloc
,	O
no	B-negation
fever	O
,	O
no	B-negation
malaise	O
,	O
no	B-negation
weight	O
gain	O
and	O
no	B-negation
weight	O
loss	O
.	O

Neurological	O
:	O
alert	O
,	O
but	O
no	B-negation
dizziness	O
,	O
no	B-negation
fainting	O
,	O
no	B-negation
tingling	O
and	O
no	B-negation
diplopia	O
.	O

Pupils	O
:	O
.	O

Endocrine	O
:	O
no	B-negation
muscle	B-bodyloc
weakness	O
.	O

She	O
reports	O
a	O
seizure	O
history	O
since	O
birth	O
secondary	O
to	O
her	O
biological	O
mom	O
doing	O
methamphetamines	O
.	O

Denies	B-negation
fever	O
,	O
rash	O
,	O
abnormal	O
bleeding	O
or	O
bruising	O
,	O
or	O
other	O
concerns	O
.	O

no	B-negation
sutures	O
visible	O
,	O
butpink	O
rugae	O
,	O
no	O
discharge	O
,	O
no	B-negation
tenderness	O
and	O
no	B-negation
active	O
bleeding	O
.	O

Uterus	O
:	O
Normal	O
.	O
Small	O
anteverted	O
.	O

Hyperlipidemia	O
272	O
.	O
4	O

Active	O
Problems	O
1	O
.	O

Peripheral	O
Pulses	O
:	O
full	B-labvalue
.	O

Eosinophilic	O
material	O
removed	O
from	O
Right	O
,	O
Left	O
,	O
Bilateral	O

The	O
data	O
above	O
are	O
obtainedafrom	O
the	O
National	O
Kidney	O
Disease	O
Education	O
Program	O

Constitutional	O

Max	O
:	O
Clr	O
mucusClear	O
mucus	O
at	O
max	O
antrosotmy	O
,	O
suspect	B-uncertain
imparied	O
mucociliary	O
clearance	O
.	O

red	O
spot	O
on	O
left	B-bodyloc
breast	I-bodyloc

advised	O
pt	O
to	O
return	O
to	O
her	O
GI	O
as	O
she	O
probably	O
could	O
benefit	O
from	O
an	O
endoscopy	O
.	O

Active	O
Problems	O
1	O
.	O

LT	O

0	I-reference_range
Mean	O
Crll	O
Volume	O
83	B-labvalue
.	I-labvalue
5	I-labvalue
fL	I-labvalue
80	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
94	I-reference_range
.	I-reference_range

Examination	O
of	O
cranial	O
nerves	O
:	O
Normal	B-labvalue
.	O

Musculoskeletal	O
:	O
.	O

normal	O
No	B-negation
breast	B-bodyloc
masses	O
were	O
palpable	O
.	O

A1c	O
okay	O
.	O

Otolaryngeal	O
,	O
cardiovascular	O
,	O
respiratory	O
,	O
sleep	O
,	O
gastrointestinal	O
,	O
genitourinary	O
,	O
skin	O
,	O
endocrine	O
and	O
hematologic	O
review	O
of	O
systems	O
are	O
normal	O
.	O

Plan	O
[	O
L	O
]	O
CMP14	O
Requested	O
for	O
:	O
13Nov2012	B-temporal

Health	O
education	O
/	O
anticipatory	O
guidance	O

Surgery	O
scheduled	O
for	O
Nov	B-temporal
7th	I-temporal
.	O

Lymphocytes	O
:	O
20	B-labvalue
.	I-labvalue
0	I-labvalue
%	I-labvalue
Reference	O
Range	O
20	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
40	I-reference_range
.	I-reference_range
0	I-reference_range

Denied	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
,	O
the	O
heart	O
rate	O
was	O
not	B-labvalue
fast	I-labvalue
,	O
the	O
heart	O
rate	O
was	O
not	B-labvalue
slow	I-labvalue
,	O
no	B-negation
intermittent	O
leg	B-bodyloc
claudication	O
and	O
no	B-negation
edema	O
.	O

Cranial	O
nerves	O
XII	O
:	O
there	O
was	O
no	B-negation
tongue	B-bodyloc
deviation	O
with	O
protrusion	O
.	O

Examination	O
of	O
cranial	O
nerves	O
:	O
Normal	B-labvalue
.	O

PT	O
.	O
is	O
here	O
today	B-temporal
for	O
post	O
op	O
on	O
ear	O
tubes	O
.	O

Past	O
Medical	O
History	O
History	O
of	O
Bronchitis	O
490	O

LMP	O
.	O

Pina	O
with	O
a	O
recent	O
diagnosis	O
of	O
possible	B-uncertain
autoimmune	O
myositis	O
is	O
here	O
in	O
the	O
clinic	O
today	B-temporal
for	O
a	O
f	O
/	O
u	O
visit	O
after	O
4	B-temporal
-	I-temporal
week	I-temporal
once	O
a	O
week	O
one	O
gram	O
IVMP	O
infusion	O
.	O

Paternal	B-subject
history	O
of	O
Heart	B-bodyloc
Disease	O
V17	O
.	O
49	O

ALLERGIES	O
:	O
No	B-negation
known	O
drug	O
allergies	O
.	O

Appropriate	B-labvalue
mood	O
and	O
affect	O
.	O

Basal	O
Cell	O
Carcinoma	O
Of	O
The	O
Skin	O
Of	O
The	O
Face	B-bodyloc
173	O
.	O
31	O

ADMITTING	O
DIAGNOSES	O
:	O

Examination	O
of	O
sensation	O
:	O
Normal	B-labvalue
.	O

History	O
of	O
Seizure	O
Disorder	O
345	O
.	O
90	O

5	O
.	O

Eyes	O
:	O
no	B-negation
eye	B-bodyloc
pain	O
.	O

Nose	B-bodyloc
bleeds	O
:	O
None	B-negation

Vitals	O
18Feb2013	B-temporal
09	B-temporal
:	I-temporal
30AM	I-temporal
BMI	O
Calculated	O
25	B-labvalue
.	I-labvalue
03	I-labvalue
BSA	O
Calculated	O
2	B-labvalue
.	I-labvalue
15	I-labvalue
Height	O
6	B-labvalue
ft	I-labvalue
2	I-labvalue
in	I-labvalue
Weight	O
195	B-labvalue
lb	I-labvalue
Systolic	O
171	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
104	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Temperature	O
99	B-labvalue
F	I-labvalue
,	O
Tympanic	O
Heart	O
Rate	O
72	B-labvalue

PredniSONE	O
20	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
08Oct2012	B-temporal
)	O
to	O

GENERAL	O
:	O
She	O
is	O
a	O
very	O
obtunded	O
female	O
who	O
upon	O
arousal	O
is	O
not	O
able	O
to	O
provide	O
any	O
information	O
of	O
any	O
use	O
.	O

History	O
of	O
Herpes	O
Simplex	O
Type	O
Ii	O
054	O
.	O
10	O

Psychiatric	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
GLORIA	O
NWUGA	O
,	O
NP	O
;	O
Mar	B-temporal
24	I-temporal
2014	I-temporal
9	B-temporal
:	I-temporal
32AM	I-temporal
(	O
Author	O
)	O

Constitutional	O
:	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
and	O
no	O

he	O
points	O
to	O
thwe	O
throat	O
as	O
a	O
site	O
for	O
causing	O
the	O
cough	O

The	O
right	O
tympanic	O
membrane	O
was	O
normal	O
,	O
was	O
not	O
redand	O
was	O
not	B-negation
bulging	O
.	O

Patient	O
does	O
not	B-negation
have	I-negation
a	O
history	O
of	O
a	O
positive	O
pap	O
smear	O
.	O

Status	O
:	O
cleanandhealing	O
well	O
.	O

Examination	O
of	O
pupils	O
and	O
irises	O
:	O
Normal	B-labvalue

-	O
echo	O
NL	O

Psychiatry	O
:	O
Psychiatric	O
:	O
insight	O
and	O
judgment	O
were	O
intact	B-labvalue
,	O
the	O
affect	O
was	O
normal	B-labvalue
and	O
the	O
mood	O
was	O
normal	B-labvalue
.	O

Test	O
Name	O
Result	O
Flag	O
Reference	O
Chest	O
2	O
views	O
-	O
Chest	O
x	O
-	O
ray	O
2	O
views	O

AFTER	I-frequency
2	I-frequency
HOURS	I-frequency
.	O

Cranial	O
Nerve	O
XI	O
:	O
shoulder	O
shrug	O
was	O
intact	B-labvalue
bilaterally	I-labvalue
.	O

Family	O
History	O

Urine	O
Dipstick	O
(	O
In	O
Office	O
)	O
09Oct2013	B-temporal
04	B-temporal
:	I-temporal
41PM	I-temporal
TRAN	O
,	O
CHAU	O

Disp	O
:	O
*	O
60	O
Capsule	O
(	O
s	O
)	O
*	O
Refills	O
:	O
*	O
0	O
*	O
3	O
.	O

Musculoskeletal	O
:	O
no	B-negation
arthralgias	O
,	O
no	B-negation
joint	B-bodyloc
pain	O
,	O
no	B-negation
joint	B-bodyloc
swelling	O
,	O
no	B-negation
joint	B-bodyloc
stiffness	O
,	O
no	B-negation
limb	B-bodyloc
pain	O
and	O
no	B-negation
limb	B-bodyloc
swelling	O
.	O

Past	O
Medical	O
History	O
History	O
of	O
Bacterial	O
Vaginosis	O
616	O
.	O
10	O

Lips	O
,	O
teeth	O
,	O
and	O
gums	O
:	O
Normal	O
.	O

;	O
Mar	B-temporal
26	I-temporal
2014	I-temporal
7	B-temporal
:	I-temporal
44PM	I-temporal
(	O
Author	O
)	O

Appearance	O
reflects	O
stated	O
age	O
.	O

Denied	O

Constitutional	O

Plan	O

History	O
of	O
Depression	O
311	O

Current	O
Meds	O
Aleve	O
TABS	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
04Mar2013	B-temporal
)	O
to	O

Examination	O
of	O
extremities	O
for	O
edema	O
and	O
/	O
or	O
varicosities	O
:	O
Normal	B-labvalue
.	O

Forward	O
flexion	O
:	O
restricted	O
active	O
range	O
of	O
motion	O
160	O
degrees	O
.	O

Denied	O

Medications	O
:	O
The	O
patient	O
is	O
adherent	O
with	O
her	O
medication	O
regimen	O
.	O
She	O
denies	B-negation
medication	O
side	O
effects	O
.	O

Eyes	O
:	O
no	B-negation
eye	B-bodyloc
pain	O
,	O
eyes	B-bodyloc
not	B-negation
red	O
,	O
no	B-negation
dryness	O
of	O
the	O
eyes	B-bodyloc
,	O
no	B-negation
itching	O
of	O
the	O
eyes	B-bodyloc
,	O
no	B-negation
discharge	O
from	O
the	O
eyes	B-bodyloc
and	O
no	B-negation
eyesight	O
problems	O
.	O

ENT	O
:	O
no	B-negation
earache	O
.	O

Normal	O
Pregnancy	O
V22	O
.	O
2	O

Active	O
Problems	O
Acute	B-course
Upper	B-bodyloc
Respiratory	I-bodyloc
Infection	O
465	O
.	O
9	O

Diazoxide	O
was	O
started	O
5	B-dosage
mg	I-dosage
/	I-dosage
kg	I-dosage
per	B-route
os	I-route
every	B-frequency
8	I-frequency
hours	I-frequency
and	O
fingersticks	O
were	O
done	O
to	O
monitor	O
blood	O
glucose	O
level	O
.	O

Past	O
Medical	O
History	O
History	O
of	O
Allergic	O
Rhinitis	O
477	O
.	O
9	O

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

History	O
of	O
Present	O
Illness	O

Pupils	O
:	O
.	O

DO	O
NOT	O
EXCEED	O
6	O
TABLETS	O
IN	O
24	O
HOURS	O
;	O
Therapy	O
:	O
19Apr2013	B-temporal
to	O

Examination	O
of	O
the	O
head	O
and	O
face	O
:	O
Normal	B-labvalue
.	O

Vitals	O
_	O
11189	O
_	O
twCiteListControlEnd	O
VitalsSectionEnd	O
ChiefComplaintSectionStart	O
Chief	O
Complaint	O
headache	O
and	O
palpitation	O
ChiefComplaint	O
_	O
90	O
_	O
twCiteListControlStart	O
ChiefComplaint	O
_	O
90	O
_	O
twCiteListControlEnd	O
ChiefComplaintSectionEnd	O
AllergiesSectionStart	O
Allergies	O

Cough	O
:	O
None	B-negation

Head	O
and	O
Face	O

Diastolic	O
:	O
70	B-labvalue
,	O
RUE	O
,	O
Sitting	O

L	O
:	O
consistent	O
with	O
non	O
patent	O
tube	O
,	O
patient	O
is	O
currently	B-temporal
using	O
drops	O
to	O
clear	O
debris	O
Results	O
/	O

F	O
/	O
U	O
on	O
sinus	O

Max	O
:	O
Polypoid	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
,	O
the	O
heart	O
rate	O
was	O
not	B-labvalue
fast	I-labvalue
and	O
the	O
heart	O
rate	O
was	O
not	B-labvalue
slow	I-labvalue
.	O

Social	O
History	O
Being	O
A	O
Social	O
Drinker	O

Also	O
developed	O
postural	O
dizzyness	O
which	O
appears	O
to	O
be	O
getting	O
less	O
,	O
but	O
still	O
there	O

Orientation	O
to	O
person	O
,	O
place	O
and	O
time	O
:	O
Normal	B-labvalue

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
,	O
no	B-negation
cough	O
,	O
no	B-negation
shortness	O
of	O
breath	O
during	O
exertion	O
,	O
no	B-negation
orthopnea	O
and	O
no	B-negation
PND	O
.	O

Reflexes	O
:	O
the	O
reflexes	O
were	O
normal	B-labvalue
.	O

Eyes	O
:	O
eyes	B-bodyloc
not	B-negation
red	O
and	O
no	B-negation
eyesight	O
problems	O
.	O

Plan	O
Hydrochlorothiazide	O
12	B-strength
.	I-strength
5	I-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Last	O
Rx	O
:	O
24Oct2012	B-temporal

The	O
motor	O
nerve	O
conduction	O
of	O
the	O
left	O
peroneal	O
were	O
normal	O
.	O

;	O
Oct	B-temporal
20	I-temporal
2013	I-temporal
10	B-temporal
:	I-temporal
01PM	I-temporal
(	O
Author	O
)	O

Secretions	O
:	O
None	B-negation

Never	O
A	O
Smoker	O

Patient	O
is	O
sexually	O
active	O
.	O

Middle	O
Turbinate	O
:	O
Normal	O
position	O
.	O

Breast	B-bodyloc
Pain	O
611	O
.	O
71	O

Status	O
Post	O
:	O
Total	O
Joint	O
Arthroplasty	O
in	O
acceptable	O
alignment	O
with	O
no	B-negation
evidence	I-negation
of	I-negation
hardware	O
failure	O
or	O
loss	O
of	O
reduction	O
.	O

Allergies	O
Penicillins	O

Ciprofloxacin	O
HCl	O
250	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
EVERY	B-frequency
12	I-frequency
HOURS	I-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
09Oct2013	B-temporal
to	O
(	O
Evaluate	O
:	O
12Oct2013	B-temporal
)	O
;	O
Last	O
Rx	O
:	O
09Oct2013	B-temporal

minimal	B-severity
lochia	O

Neck	O
:	O
No	B-negation
neck	B-bodyloc
stiffness	O
,	O
no	B-negation
lump	O
or	O
swelling	O
in	O
the	O
neck	B-bodyloc
,	O
and	O
no	B-negation
swollen	O
glands	B-bodyloc
in	O
the	O
neck	B-bodyloc
.	O

Plan	O
[	O
L	O
]	O
Blood	O
Drawing	O
Requested	O
for	O
:	O
02Nov2012	B-temporal

History	O
of	O
Drug	O
Use	O

MetroNIDAZOLE	O
500	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
TWICE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
08Jun2012	B-temporal
to	O
(	O
Evaluate	O
:	O
15Jun2012	B-temporal
)	O
Requested	O
for	O
:	O
08Jun2012	B-temporal
;	O
Last	O
Rx	O
:	O
08Jun2012	B-temporal

LABORATORY	O
DATA	O
:	O
Creatinine	O
1	B-labvalue
.	I-labvalue
41	I-labvalue
(	O
range	O
1	B-reference_range
.	I-reference_range
5	I-reference_range
-	I-reference_range
2	I-reference_range
.	I-reference_range

Visit	O
For	O
:	O
Preoperative	O
Exam	O
V72	O
.	O
84	O

Constitutional	O

The	O
patient	O
does	O
have	O
OxyContin	O
and	O
Vicodin	O
at	O
home	O
which	O
he	O
uses	O
for	O
his	O
knee	B-bodyloc
pain	O
but	O
he	O
wants	O
more	O
pain	O
medicines	O
because	O
he	O
does	O
not	O
want	O
to	O
use	O
up	O
that	O
medicine	O
for	O
his	O
toothache	O
when	O
he	O
wants	O
to	O
say	O
this	O
with	O
me	O
.	O

Never	O
A	O
Smoker	O

History	O
of	O
Mitral	B-bodyloc
Valve	I-bodyloc
Disorder	O
424	O
.	O
0	O

Assessment	O
Benign	B-severity
Essential	O
Hypertension	O
401	O
.	O
1	O

GONORRHOEAE	O
DNA	O
PROBE	O
,	O
ENDOCX	O
OR	O
MALE	O
URETHRA	O
Requested	O
for	O
:	O
08May2013	B-temporal

[	O
QLH	O
]	O
TSH	O
,	O
3RD	O
GENERATION	O
11Nov2013	B-temporal
09	B-temporal
:	I-temporal
30AM	I-temporal
GOODINE	O
,	O
GLENDA	O

Neck	O

Mental	O
Status	O
:	O
A	O
mental	O
status	O
exam	O
was	O
performed	O
and	O
was	O
normal	B-labvalue
.	O

AmLODIPine	O
Besylate	O
10	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
AS	O
DIRECTED	O
Requested	O
for	O
:	O
25Feb2014	B-temporal
;	O
Last	O
Rx	O
:	O
25Feb2014	B-temporal
;	O
Edited	O

Routine	O
Gynecological	O
Exam	O
With	O
Cervical	O
Pap	O
Smear	O
V72	O
.	O
31	O

Reflexes	O
:	O
the	O
reflexes	O
were	O
normal	B-labvalue
.	O

Musculoskeletal	O

5	O
.	O

Lower	B-bodyloc
extremities	I-bodyloc
have	O
developed	O
bruising	O
and	O
several	O
areas	O
with	O
skin	B-bodyloc
tears	O

Observed	O
mood	O
and	O
affect	O
:	O
depressed	O
.	O

History	O
of	O
Fatigue	O
780	O
.	O
79	O

Vitamin	O
D	O
CAPS	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
15Nov2012	B-temporal
)	O
to	O

Description	O
:	O
Death	O
summary	O
of	O
patient	O
with	O
advanced	O
non	O
-	O
small	O
cell	O
lung	B-bodyloc
carcinoma	O
with	O
left	B-bodyloc
malignant	O
pleural	O
effusion	O
status	O
post	O
chest	O
tube	O
insertion	O
status	O
post	O
chemical	O
pleurodesis	O
.	O

[	O
Q	O
]	O
LIPID	O
PANEL	O
WITH	O
REFLEX	O
TO	O
DIRECT	O
LDL	O
Requested	O
for	O
:	O
25Feb2014	B-temporal

Inspection	O
of	O
the	O
conjunctiva	O
and	O
lids	O
:	O
Normal	B-labvalue

Eyes	O
:	O
purulent	O
discharge	O
from	O
the	O
eyes	B-bodyloc
.	O

Surgical	O
History	O
1	O
.	O

Her	O
headaches	O
were	O
not	O
responding	O
to	O
pain	O
medication	O
and	O
so	O
on	O
07/24/2008	B-temporal
,	O
we	O
obtained	O
a	O
head	O
CT	O
that	O
showed	O
no	B-negation
evidence	I-negation
of	O
acute	O
intracranial	B-bodyloc
abnormalities	O
.	O

Penicillins	O

Keywords	O
:	O

History	O
of	O
Tobacco	O
Use	O

NexIUM	O
40	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
Delayed	I-form
Release	I-form
;	O
Therapy	O
:	O
21Jul2011	B-temporal
to	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

No	B-negation
rhonchi	O
were	O
heard	O
.	O

Musculoskeletal	O
:	O
no	B-negation
arthralgias	O
,	O
no	B-negation
joint	B-bodyloc
pain	O
,	O
no	B-negation
joint	B-bodyloc
swelling	O
,	O
no	B-negation
joint	B-bodyloc
stiffness	O
,	O
no	B-negation
limb	B-bodyloc
pain	O
and	O
no	B-negation
limb	B-bodyloc
swelling	O
.	O

Social	O
History	O
Former	O
Smoker	O
V15	O
.	O
82	O

0	I-reference_range
A	O
/	O
G	O
Ratio	O
1	B-labvalue
.	I-labvalue
5	I-labvalue
0	B-reference_range
.	I-reference_range
7	I-reference_range
-	I-reference_range
1	I-reference_range
.	I-reference_range

Vitals	O
05Jan2012	B-temporal
02	B-temporal
:	I-temporal
21PM	I-temporal
BMI	O
Calculated	O
24	B-labvalue
.	I-labvalue
12	I-labvalue
BSA	O
Calculated	O
1	B-labvalue
.	I-labvalue
64	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
3	I-labvalue
in	I-labvalue
Weight	O
136	B-labvalue
lb	I-labvalue
2	I-labvalue
oz	I-labvalue
Systolic	O
112	B-labvalue
,	O
RUE	O
,	O
Sitting	O
Diastolic	O
70	B-labvalue
,	O
RUE	O
,	O
Sitting	O
Temperature	O
98	B-labvalue
F	I-labvalue
,	O
Oral	O
Heart	O
Rate	O
78	B-labvalue
,	O
R	O
Radial	O
Respiration	O
16	B-labvalue

Musculoskeletal	O
:	O
no	B-negation
arthralgias	O
,	O
no	B-negation
joint	B-bodyloc
pain	O
,	O
no	B-negation
joint	B-bodyloc
swelling	O
,	O
no	B-negation
joint	B-bodyloc
stiffness	O
,	O
no	B-negation
limb	B-bodyloc
pain	O
and	O
no	B-negation
limb	B-bodyloc
swelling	O
.	O

follow	O
up	O
and	O
heartburn	O
,	O
no	O
Rx	O
for	O
lipids	O
+	O

Family	O
History	O
Family	O
history	O
of	O
History	O
Unobtainable	O

Call	O
with	O
fever	O
,	O
redness	O
or	O
drainage	O
from	O
incisions	O
or	O
weight	O
gain	O
more	O
than	O
2	O
pounds	O
in	O
one	O
day	O
or	O
five	O
in	O
one	O
week	O
.	O

CONSTITUTIONAL	O
:	O
Normal	O
appearance	O
for	O
chronological	O
age	O
,	O
does	O
not	B-negation
appear	O
chronically	B-course
ill	O
.	O

;	O
Oct	B-temporal
2	I-temporal
2013	I-temporal
5	B-temporal
:	I-temporal
16PM	I-temporal
(	O
Author	O
)	O

[	O
Q	O
]	O
URINALYSIS	O
REFLEX	O
Done	O
:	O
19Jul2011	B-temporal
12	B-temporal
:	I-temporal
28PM	I-temporal

Bilateral	B-bodyloc
ankle	I-bodyloc
2	O
+	O
pitting	O
edema	O
.	O

f	O
History	O
of	O
Constipation	O
(	O
564	O
.	O
00	O
)	O
;	O
(	O
Resolved	B-course
)	O

Delivery	O
type	O
:	O
cesarean	O
delivery	O
.	O

General	O
Health	O
:	O
She	O
has	O
regular	O
dental	O
visits	O
.	O
She	O
denies	B-negation
vision	O
problems	O
.	O
She	O
denies	B-negation
hearing	O
loss	O
.	O

Head	O
and	O
Face	O

Allergies	O
Medication	O

Abdominal	O
aorta	O
:	O
Normal	B-labvalue
.	O

-	O
CXR	O
,	O
will	O
follow	O
results	O

She	O
had	O
an	O
abnormal	O
Pap	O
smear	O
in	O
the	B-temporal
80s	I-temporal
,	O
which	O
she	O
failed	O
to	O
followup	O
on	O
until	O
this	O
year	O
.	O

Review	O
of	O
Systems	O

UTP	O
-	O
OB	O
/	O
Patient	O
here	O
for	O
Postsurgical	O
Exam	O
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

MI	O
(	O
[	O
*	O
*	O
2081	B-bodyloc
*	O
*	O
]	O
)	O
,	O
hyperlipidemia	O
,	O
GERD	O
,	O
nephrotic	O
syndrome	O
,	O
pneumothorax	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
other	O
areas	O
:	O
Normal	B-labvalue
.	O

The	O
zonisamide	O
seemed	O
to	O
help	O
until	O
she	O
was	O
involved	O
in	O
the	O
car	O
acciden	O
.	O

Physical	O
Exam	O
Prenatal	O
Exam	O
:	O
the	O
estimated	O
gestational	O
age	O
was	O
11	O
weeks	O
,	O
the	O
fetal	O
heat	O
rate	O
was	O
160	B-labvalue
bpm	I-labvalue
,	O
no	O
fetal	O
movement	O
observed	O
,	O
no	B-negation
contractions	O
were	O
present	O

Results	O
/	O
Assessment	O
Pregnancy	O
V22	O
.	O
2	O

Eyes	O
:	O
no	B-negation
eye	B-bodyloc
pain	O
,	O
eyes	B-bodyloc
not	B-negation
red	O
and	O
no	B-negation
purulent	O
discharge	O
from	O
the	O
eyes	B-bodyloc
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Joint	B-bodyloc
Pain	O
,	O
Localized	O
In	O
The	O
Left	B-bodyloc
Shoulder	I-bodyloc
719	O
.	O
41	O

Past	O
Medical	O
History	O
History	O
of	O
Asthma	O
493	O
.	O
90	O

Constitutional	O
:	O
feeling	O
tired	O
(	O
fatigue	O
)	O
andrecent	O
weight	O
loss	O
.	O

1	O
2	O
3	O
Hepatitis	O
B	O
03Sep2010	B-temporal
05Oct2010	B-temporal
07Mar2011	B-temporal
Tdap	O
2005	B-temporal
H1N1	O
Influenza	O
Inj	B-form
07Jan2010	B-temporal

Past	O
Medical	O
History	O
History	O
of	O
Previously	O
Well	O

Type	O
2	O
Diabetes	O
Mellitus	O
-	O
Uncomplicated	O
,	O
Controlled	B-course
250	O
.	O
00	O

Menstrual	O
History	O
.	O

Results	O
/	O
Assessment	O
Bronchospasm	O
519	O
.	O
11	O

Current	O
Meds	O
1	O
.	O

The	O
neck	O
was	O
supple	O
.	O

History	O
of	O
Upper	B-bodyloc
Respiratory	I-bodyloc
Infection	O
465	O
.	O
9	O

Nose	B-bodyloc
bleeds	O
:	O
Mild	B-severity

Resp	O
:	O
cough	O
,	O
but	O
no	B-negation
dyspnea	O
and	O
no	B-negation
wheezing	O
.	O

;	O
Apr	B-temporal
9	I-temporal
2012	I-temporal
1	B-temporal
:	I-temporal
45PM	I-temporal
(	O
Author	O
)	O

Paternal	B-subject
grandmother	I-subject
'	O
s	O
history	O
of	O
Seizure	O
Disorder	O
V17	O
.	O
2	O

Bystolic	O
5	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
27Dec2012	B-temporal
to	O
(	O
Evaluate	O
:	O
10Jan2013	B-temporal
)	O

Neuro	O
:	O
no	B-negation
numbness	O
,	O
no	B-negation
tremor	O
was	O
seen	O
,	O
no	B-negation
tingling	O
,	O
no	B-negation
seizures	O
were	O
observed	O
,	O
gait	O
is	O
steady	B-labvalue
and	O
no	B-negation
dizziness	O
.	O

FLUoxetine	O
HCl	O
10	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
Requested	O
for	O
:	O
26Feb2014	B-temporal
;	O
Last	O
Rx	O
:	O
26Feb2014	B-temporal

Family	B-subject
history	O
of	O
Thromboembolic	O
Disease	O

Ms	O
Fretwell	O
had	O
using	O
different	O
adaptive	O
devices	O
such	O
as	O
knee	O
sleeve	O
,	O
which	O
did	O
not	O
improved	O
her	O
knee	B-bodyloc
functional	O
status	O
.	O

History	O
of	O
Patent	O
Ductus	O
Arteriosus	O
747	O
.	O
0	O

GLUCOSE	O
negative	B-labvalue

Pt	O
seen	O
with	O
NP	O
(	O
not	O
resident	O
)	O
.	O

Blood	O
Pressue	O
Comments	O
:	O
Reported	O

The	O
patient	O
has	O
been	O
treated	O
with	O
medications	O
,	O
which	O
has	O
been	O
unrelenting	O
.	O

Aug	B-temporal
15	I-temporal
2012	I-temporal
5	B-temporal
:	I-temporal
47PM	I-temporal
(	O
Author	O
)	O

Social	O
History	O
Being	O
A	O
Social	O
Drinker	O

Denied	O

Continue	O
betamethsone	O
/	O
MP	O
nasal	O
rinses	O
for	O
now	B-temporal

(	O
peron	O
.	O
)	O
Strength	O
:	O
5	B-labvalue
/	I-labvalue
5	I-labvalue
.	O

Chest	O

2	O
)	O
RTC	O
post	O
US	O
or	O
sooner	O
as	O
needed	O
.	O

Macular	B-bodyloc
Degeneration	O
362	O
.	O
50	O

Hepatitis	O
A	O
;	O
27	B-temporal
Jun	I-temporal
2011	I-temporal

BSA	O
Calculated	O
:	O
1	B-labvalue
.	I-labvalue
65	I-labvalue

Neurological	O
:	O
patient	O
is	O
alert	O
,	O
not	B-negation
confused	O
,	O
not	B-negation
experiencing	I-negation
convulsions	O
,	O
no	B-negation
tinnitus	O
and	O
no	B-negation
dizziness	O
.	O

Mental	O
Status	O
:	O
oriented	O
to	O
person	O
,	O
place	O
,	O
and	O
time	O
,	O
normal	O
attention	O
skills	O
,	O
normal	O
language	O
skills	O
and	O
normal	O
fund	O
of	O
knowledge	O
.	O

No	B-negation
intra	B-bodyloc
-	I-bodyloc
abdominal	I-bodyloc
pathology	O
.	O

[	O
QLH	O
]	O
TSH	O
,	O
3RD	O
GENERATION	O
W	O
/	O
REFLEX	O
TO	O
FT4	O
Requested	O
for	O
:	O
25Feb2014	B-temporal

Signatures	O
Electronically	O
signed	O
by	O
:	O
BEHROOZ	O
SAFFARI	O
,	O
M	O
.	O
D	O
.	O

Description	O
of	O
patient	O
'	O
s	O
judgement	O
and	O
insight	O
:	O
Normal	B-labvalue

Surgical	O
History	O
History	O
of	O
Prostate	O
Surgery	O

Vicodin	O
,	O
Motrin	O
,	O
and	O
Macrodantin	O
at	B-frequency
bedtime	I-frequency
for	O
urinary	O
tract	O
infection	O
suppression	O
.	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Past	O
Medisal	O
Histisy	O

I	O
personally	O
performed	O
the	O
following	O
critical	O
portion	O
of	O
the	O
exam	O
:	O

HEMATOLOGIC	O
/	O
LYMPHATIC	O
:	O
no	B-negation
anemia	O
,	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
and	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
.	O

Inspection	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
Normal	B-labvalue
.	O

&	O
uln	O
.	O
)	O
:	O
Normal	O
.	O

2	O
.	O

Family	O
History	O
Maternal	B-subject
history	O
of	O
Anemia	O
V18	O
.	O
2	O

Lymphatic	O

Encoun	O
ers	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
,	O
no	B-negation
syncope	O
and	O
no	O

Examination	O
of	O
the	O
penis	O
:	O
Normal	B-labvalue
.	O

[	O
QLH	O
]	O
MICROALBUMIN	O
,	O
RANDOM	O
URINE	O
(	O
W	O
/	O
CREATININE	O
)	O
Requested	O
for	O
:	O
04Apr2014	B-temporal

-	O
cont	O
Atenolol	O
25	B-strength
mg	I-strength
po	B-route
daily	B-frequency

Test	O
Name	O
Result	O
Flag	O
Reference	O
CHOLESTEROL	O
,	O
TOTAL	O
15	B-labvalue
O	O
HDL	O
CHOLESTEROL	O
31	B-labvalue
O	O
TRIGLYCERIDES	O
199	B-labvalue
O	O
LDL	O
-	O
CHOLESTEROL	O
80	B-labvalue
O	O
NON	O
HDL	O
CHOLESTEROL	O
120	B-labvalue
O	O
T	O
.	O

URINE	O
BLOOD	O
POSITIVE	O
ABOUT	O
250	B-labvalue
O	O

The	O
neck	B-bodyloc
was	O
swollenand	O
was	O
tender	O
.	O

Inspection	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
Normal	B-labvalue
.	O

Pt	O
instructed	O
to	O
continue	O
taking	O
her	O
coumadin	O
and	O
to	O
take	O
her	O
lovenox	O
.	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Neurological	O
:	O
no	B-negation
confusion	O
,	O
no	B-negation
convulsions	O
,	O
no	B-negation
dizziness	O
,	O
no	B-negation
fainting	O
,	O
no	B-negation
limb	B-bodyloc
weakness	O
and	O
no	B-negation
difficulty	O
walking	O
.	O

Orientation	O
to	O
person	O
,	O
place	O
and	O
time	O
:	O
Normal	B-labvalue
.	O

She	O
has	O
been	O
sedated	O
with	O
Ativan	O
and	O
came	O
into	O
the	O
emergency	O
room	O
obtunded	O
and	O
unable	O
to	O
give	O
any	O
history	O
.	O

ValACYclovir	O
HCl	O
1	B-strength
GM	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
3	B-frequency
TIMES	I-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
07Apr2011	O
to	O
(	O
Evaluate	O
:	O
12Nov2013	B-temporal
)	O
Requested	O
for	O
:	O
14Aug2013	B-temporal
;	O
Last	O
Rx	O
:	O
14Aug2013	B-temporal
;	O
Status	O
:	O
ACTIVE	O
-	O

Physical	O
Exam	O

No	B-negation
JVD	O
.	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
LESLIE	O
GARB	O
,	O
M	O
.	O
D	O
.	O

Female	O
.	O

Polycystic	O
Ovarian	B-bodyloc
Syndrome	O
256	O
.	O
4	O

Estradiol	O
0	B-strength
.	I-strength
5	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Therapy	O
:	O
03Sep2009	B-temporal
to	O
Requested	O
for	O
:	O
21Sep2009	B-temporal

She	O
is	O
awaiting	O
follow	O
up	O
with	O
Dr	O
.	O
Bull	O
regarding	O
breast	O
mass	O
biopsy	O
and	O
treatment	O
.	O

Bowel	O
sounds	O
are	O
normal	B-labvalue
.	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
and	O
no	B-negation
vomiting	O
.	O

VITAL	O
SIGNS	O
:	O
Temp	O
98	B-labvalue
.	I-labvalue
3	I-labvalue
,	O
heart	O
rate	O
82	B-labvalue
,	O
respiratory	O
rate	O
24	B-labvalue
,	O
and	O
blood	O
pressure	O
141	B-labvalue
/	I-labvalue
70	I-labvalue
.	O

We	O
will	O
have	O
Dr	O
.	O
X	O
evaluate	O
her	O
before	O
she	O
leaves	O
to	O
make	O
sure	O
I	O
do	O
not	O
have	O
any	O
problem	O
with	O
her	O
going	O
home	O
.	O

On	O
admission	O
,	O
the	O
patient	O
'	O
s	O
white	O
blood	O
count	O
was	O
3	B-labvalue
.	I-labvalue
4	I-labvalue
,	O
hemoglobin	O
11	B-labvalue
.	I-labvalue
3	I-labvalue
,	O
platelet	O
count	O
82	B-labvalue
,	O
and	O
ANC	O
of	O
2400	B-labvalue
.	O

Simvastatin	O
40	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
EVERY	B-frequency
NIGHT	I-frequency
AT	I-frequency
BEDTIME	I-frequency
;	O
Therapy	O
:	O
09Sep2008	B-temporal
to	O
(	O
Evaluate	O
:	O
07Apr2012	B-temporal
)	O
Requested	O
for	O
:	O
13May2011	B-temporal
;	O
Last	O
Rx	O
:	O
13May2011	B-temporal

EKG	O
:	O
11	B-temporal
/	I-temporal
2011	I-temporal

Cranial	O
nerves	O
VII	O
:	O
facial	O
strength	O
was	O
intact	B-labvalue
bilaterally	O
.	O

MetFORMIN	O
HCl	O
500	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Take	O
1	B-dosage
tablet	B-form
by	B-route
mouth	I-route
twice	B-frequency
a	I-frequency
day	I-frequency
;	O
Therapy	O
:	O
09Sep2008	B-temporal
to	O
(	O
Evaluate	O
:	O
07Apr2012	B-temporal
)	O
Requested	O
for	O
:	O
13May2011	B-temporal
;	O
Last	O
Rx	O
:	O
13May2011	B-temporal

MessagetoPa	O
irt	O
Sec	O
ionEnd	O
VerifiedResul	O
sSec	O
ionStart	O
Resul	O
s	O

The	O
patient	O
had	O
severe	B-severity
shortness	O
of	O
breath	O
,	O
chest	B-bodyloc
pain	O
,	O
a	O
left	O
-	O
sided	O
chest	O
tube	O
was	O
inserted	O
,	O
and	O
pleural	O
effusion	O
was	O
positive	O
for	O
malignant	O
cells	O
.	O

Post	O
-	O
nasal	B-bodyloc
drip	O
:	O
Mild	B-severity

Counseling	O
/	O
Signatures	O
Electronically	O
signed	O
by	O
:	O
DEEPA	O
VASUDEVAN	O
,	O
M	O
.	O
D	O
.	O

Bus	O
:	O
832-667-5673	O

Examination	O
of	O
pupils	O
and	O
irises	O
:	O
Normal	B-labvalue

Neck	O

Magnesium	O
400	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
31Oct2013	B-temporal
)	O
to	O

Cervix	O
:	O
Normal	O
,	O
no	B-negation
lesions	O
.	O

43	O
year	O
old	O
AAF	O
G4P4004	O
with	O
h	O
/	O
o	O
back	B-bodyloc
injury	O
,	O
ankle	B-bodyloc
injury	O
in	O
Decembers	O
/	O
p	O
MVA	O
with	O
multiple	O
surgery	O
is	O
using	O
a	O
walker	O
,	O
Pt	O
gets	O
PT	O
twice	O
a	O
week	O
for	O
1	B-temporal
hour	I-temporal
.	O

Neurological	O
:	O
patient	O
is	O
alert	O
.	O

The	O
patient	O
expressed	O
understanding	O
and	O
agreed	O
to	O
proceed	O
.	O

Denied	O

Onset	O
was	O
gradual	O
3	B-temporal
day	I-temporal
(	I-temporal
s	I-temporal
)	I-temporal
ago	I-temporal
.	O

Allergies	O
Amoxicillin	O
TABS	B-form

Cardiovascular	O

The	O
abdomen	O
was	O
soft	O
and	O
nontender	O
.	O

Musculoskeletal	O

glut	O
.	O
)	O
:	O
Normal	O
.	O

Neurological	O
:	O
no	B-negation
confusion	O
,	O
no	B-negation
convulsions	O
,	O
no	B-negation
dizziness	O
,	O
no	B-negation
fainting	O
,	O
no	B-negation
limb	B-bodyloc
weakness	O
and	O
no	B-negation
difficulty	O
walking	O
.	O

Salivary	O
glands	O
:	O
No	B-negation
parotid	B-bodyloc
gland	I-bodyloc
mass	O
/	O
tenderness	O
.	O

Cycle	O
intervals	O
have	O
been	O
regular	O
.	O

Disp	O
:	O
*	O
20	O
Capsule	O
(	O
s	O
)	O
*	O
Refills	O
:	O
*	O
1	O
*	O

2	O
.	O

Paternal	B-subject
grandfather	I-subject
'	I-subject
s	I-subject
history	O
of	O
Diabetes	O
Mellitus	O
V18	O
.	O
0	O

Lisinopril	O
40	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
03Oct2011	B-temporal
to	O
(	O
Evaluate	O
:	O
30Jan2014	B-temporal
)	O
Requested	O
for	O
:	O
04Feb2013	B-temporal
;	O
Last	O
Rx	O
:	O
04Feb2013	B-temporal

Endocrine	O
:	O
no	B-negation
muscle	B-bodyloc
weakness	O
.	O

The	O
lungs	O
were	O
normal	B-labvalue
to	O
percussion	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O
Stable	O
.	O

Color	O
:	O
Normal	O

Osteomyelitis	O
730	O
.	O
20	O

Metabolic	O
screening	O
includes	O
DEXA	O
within	B-temporal
the	I-temporal
past	I-temporal
five	I-temporal
years	I-temporal
.	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Hyperlipidemia	O
272	O
.	O
4	O

Furosemide	O
TABS	B-form

Tendonitis	O
726	O
.	O
90	O

PSH	O
g33	O

Levothyroxine	O
Sodium	O
75	B-strength
MCG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Last	O
Rx	O
:	O
17Feb2014	B-temporal

Constitutional	O
:	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
,	O
not	B-negation
feeling	O
poorly	O
(	O
malaise	O
)	O
and	O
not	B-negation
feeling	O
tired	O
(	O
fatigue	O
)	O
.	O

PLAN	O
:	O
Have	O
her	O
admitted	O
to	O
the	O
medical	O
service	O
for	O
treatment	O
of	O
her	O
hyponatremia	O
.	O

Discussion	O
/	O
Signatures	O
Electronically	O
signed	O
by	O
:	O
LESLIE	O
GARB	O
,	O
M	O
.	O
D	O
.	O

Endocrine	O
:	O
no	B-negation
proptosis	O
,	O
no	B-negation
muscle	B-bodyloc
weakness	O
,	O
no	B-negation
erectile	O
dysfunction	O
,	O
no	B-negation
deepening	O
of	O
the	O
voice	O
and	O
no	B-negation
feelings	O
of	O
weakness	O
.	O

Reflexes	O
:	O
the	O
reflexes	O
were	O
normal	B-labvalue
.	O

Adult	O
Sleep	O
Apnea	O
780	O
.	O
57	O

f	O
EOB	O
,	O
Provider	O
:	O
SCHROEDER	O
,	O
BARBARA	O
,	O
Status	O
:	O
Pen	O
,	O
Time	O
:	O
3	B-temporal
:	I-temporal
15	I-temporal
PM	I-temporal
05/29/2013	B-temporal

Skin	O

4	O
.	O

Examination	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue
.	O

Ibuprofen	O
800	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
3	B-frequency
TIMES	I-frequency
DAILY	I-frequency
WITH	O
FOOD	O
AS	B-frequency
NEEDED	I-frequency
;	O
Therapy	O
:	O
21Jun2013	B-temporal
to	O
(	O
Evaluate	O
:	O
01Jul2013	B-temporal
)	O
Requested	O
for	O
:	O
21Jun2013	B-temporal
;	O
Last	O
Rx	O
:	O
21Jun2013	B-temporal
;	O

History	O
of	O
Present	O
Illness	O
The	O
patient	O
is	O
being	O
seen	O
for	O
a	O
routine	O
clinic	O
follow	O
-	O
up	O
of	O
essential	O
hypertension	O
.	O

Nuts	O

Claritin	O
TABS	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
31Jan2012	B-temporal
)	O
to	O

Topiramate	O
100	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Therapy	O
:	O
27Jan2012	B-temporal
to	O

Genitourinary	O

Denied	O

Electronically	O
signed	O
by	O
:	O
Kimberly	O
Smith	O
M	O
.	O
D	O
.	O
;	O
07/31/2013	B-temporal
1	B-temporal
:	I-temporal
35	I-temporal
PM	I-temporal
CST	O
;	O
Co	O
-	O
author	O
.	O
eg	O

GroupHeading64Start	O
GroupHeading64End	O
GroupHeading65Start	O
GroupHeading65End	O
UTP	O
-	O
FemaleMulti	O
-	O
SystemExamCopy	O
-	O
mp1f760502	O
-	O
82e9	O
-	O
4b23	O
-	O
9c02	O
-	O
016b9e2fc8c1FoamEnd	O
PhytucalExamSectispEnd	O
Results	O
/	O
DataSectispStart	O
Results	O
/	O
Data	O

3	I-reference_range
BUN	O
17	B-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
7	B-reference_range
-	I-reference_range
22	I-reference_range
BUN	O
/	O
Creatinine	O
Ratio	O
15	B-labvalue
6	B-reference_range
-	I-reference_range
25	I-reference_range
Calcium	O
Lvl	O
8	B-labvalue
.	I-labvalue
9	I-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
8	B-reference_range
.	I-reference_range
5	I-reference_range
-	I-reference_range
10	I-reference_range
.	I-reference_range

She	O
claimed	O
she	O
feel	O
like	O
a	O
nodule	O
on	O
the	O
side	O
of	O
her	O
throat	B-bodyloc
.	O

Psychiatric	O

ROM	O
:	O
Full	B-labvalue
.	O

Head	O
and	O
Face	O

Examination	O
of	O
cranial	O
nerves	O
:	O
Normal	B-labvalue
.	O

FASTING	O

Tibial	O
:	O
Normal	O
.	O

No	B-negation
rhonchi	O
were	O
heard	O
.	O

NEUROLOGIC	O
:	O
No	B-negation
headache	O
or	O
vision	O
changes	O
.	O

At	O
this	O
time	O
,	O
she	O
wishes	O
to	O
proceed	O
with	O
continued	O
speech	O
therapy	O
.	O

Cranial	O
nerves	O
II	O
:	O
visual	O
acuity	O
and	O
visual	O
fields	O
were	O
intact	B-labvalue
.	O

ODONTALGIA	O
.	O

66	O
year	O
old	O
female	O
with	O
previous	B-temporal
right	O
rotator	O
cuff	O
repair	O
,	O
now	B-temporal
with	O
recurrent	B-course
left	B-bodyloc
shoulder	I-bodyloc
pain	O
and	O
weakness	O
.	O

Coronary	B-bodyloc
artery	I-bodyloc
disease	O
-	O
s	O
/	O
p	O
CABG	O
Hypertension	O
Non	O
insulin	O
dependent	O
diabetes	O
mellitus	O
Peptic	O
ulcer	O
disease	O
Hypercholesterolemia	O
Anemia	O

Anesthesia	O
:	O
none	O
.	O

f	O
RSV	O
MAB	O
(	O
Synagis	O
)	O
(	O
Lot	O
#	O
:	O
11e2781	O
)	O
-	O
Administered	O
on	O
:	O
01/11/2013	B-temporal

Omeprazole	O
40	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
Delayed	I-form
Release	I-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
07May2013	B-temporal
)	O
to	O

Canals	O
without	B-negation
lesion	O
.	O

Head	O
and	O
Face	O

I	O
have	O
personally	O
reviewed	O
current	O
lab	O
results	O
.	O

He	O
also	O
declines	O
insulin	O
.	O

Systolic	O
:	O
112	B-labvalue
,	O
LUE	O
,	O
Sitting	O

Left	O
renal	O
cyst	O
decortication	O
.	O

Peripheral	O
vascular	O
system	O
:	O
Normal	O
.	O

No	B-negation
complaints	O
today	B-temporal
.	O

UREA	O
NITROGEN	O
(	O
BUN	O
)	O
25	B-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
7	B-reference_range
-	I-reference_range
25	I-reference_range

The	O
swelling	O
is	O
noticeable	O
both	O
in	O
the	B-temporal
morning	I-temporal
and	O
the	B-temporal
evening	I-temporal
.	O

Obesity	O
278	O
.	O
00	O

Examination	O
of	O
cranial	O
nerves	O
:	O
Normal	B-labvalue
(	O
No	B-negation
Nystagmus	O
)	O
.	O

Second	O
pregnancy	O
:	O
.	O

Gabapentin	O
100	B-strength
mg	I-strength
Capsule	B-form
Sig	O
:	O
One	B-dosage
(	I-dosage
1	I-dosage
)	I-dosage
Capsule	B-form
PO	B-route
Q8H	B-frequency
(	I-frequency
every	I-frequency
8	I-frequency
hours	I-frequency
)	I-frequency
.	O

PAYTIN	O
TUMBLIN	O
is	O
an	O

She	O
reports	O
both	O
the	O
headaches	O
and	O
memory	O
difficulties	O
are	O
stable	B-course
.	O

Within	O
24	O
hours	O
,	O
he	O
awoke	O
neurologically	O
intact	O
and	O
was	O
extubated	O
.	O

Elevated	O
AST	O
at	O
138	O
,	O
with	O
a	O
normal	B-labvalue
ALT	O
at	O
38	B-labvalue
.	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
LESLIE	O
GARB	O
,	O
M	O
.	O
D	O
.	O

Long	O
(	O
peron	O
.	O
)	O
:	O
Normal	O
.	O

Gait	O
and	O
station	O
:	O
Normal	B-labvalue
.	O

Fatigue	O
780	O
.	O
79	O

No	O
HPI	O
available	O
.	O

No	O
Reason	O
for	O
Referral	O
was	O
given	O
.	O

Surgical	O
History	O
History	O
of	O
Cesarean	O
Section	O
Low	O
Transverse	O

Discussion	O
/	O
Discussion	O
/	O
Summary	O

Interval	O
Events	O
:	O
Started	O
taking	O
statin	O
.	O

Screening	O
Exam	O
Venereal	O
Disease	O
V74	O
.	O
5	O

However	O
,	O
his	O
BP	O
has	O
improved	O
.	O

Battery	O
re	O
-	O
charged	O
overnight	O
once	O
/	O
week	O
.	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
vomiting	O
,	O
no	B-negation
nausea	O
,	O
no	B-negation
melena	O
and	O
no	B-negation
change	O
in	O
stool	O
.	O

Musculoskeletal	O

The	O
history	O
of	O
right	B-bodyloc
hip	I-bodyloc
pain	O
could	O
be	O
secondary	O
to	O
metastatic	O
disease	O
.	O

Past	O
Medical	O
History	O
History	O
of	O
Acute	B-course
Myocardial	B-bodyloc
Infarction	O
V12	O
.	O
59	O

8	O
.	O

Orientation	O
to	O
person	O
,	O
place	O
,	O
and	O
time	O
:	O
Normal	B-labvalue
.	O

f	O
EST	O
,	O
Provider	O
:	O
HASHEMI	O
,	O
NEDA	O
,	O
Status	O
:	O
Pen	O
,	O
Time	O
:	O
8	B-temporal
:	I-temporal
00	I-temporal
AM	I-temporal
06/20/2013	B-temporal

General	O
appearance	O
:	O
Normal	B-labvalue
.	O

Past	O
Medical	O
History	O
1	O
.	O

HTN	O
:	O

Topical	O
Nasal	O
Sprays	O
:	O
Mometasone	O
(	O
Nasonex	O
)	O

History	O
of	O
Present	O
Illness	O

Cognition	O
is	O
normal	B-labvalue
)	O
.	O

61	O
y	O
/	O
o	O
RH	O
M	O
with	O
hyperlipidemia	O
,	O
previous	O
statin	O
use	O
stopped	O
in	O
2007	B-temporal
with	O
progressive	B-course
weakness	O
and	O
elevated	O
CK	O
.	O
Per	O
patient	O
after	O
stopping	O
the	O
statin	O
even	O
though	O
his	O
CK	O
went	O
down	O
,	O
it	O
was	O
never	O
normalized	O
.	O

Social	O
History	O
Marital	O
History	O
-	O
Currently	O
Married	O

His	O
swelling	O
did	B-course
not	I-course
improve	I-course
with	O
the	O
Mobic	O
.	O

ECG	O
:	O
sinus	B-labvalue
rhythm	I-labvalue
,	O
rate	O
54	B-labvalue
PlanSectionEnd	O
SignaturesSectionStart	O
Signatures	O

denies	O
alcohol	O
or	O
drug	O
use	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
vomiting	O
,	O
no	B-negation
constipation	O
,	O
no	B-negation
diarrhea	O
,	O
no	B-negation
heartburn	O
and	O
no	B-negation
melena	O
.	O

3	O
.	O

DISCHARGE	O
INSTRUCTIONS	O
:	O
The	O
patient	O
has	O
been	O
educated	O
on	O
CPR	O
measures	O
.	O

History	O
of	O
Sinusitis	O
473	O
.	O
9	O

No	O
driving	O
etc	O
;	O

History	O
of	O
Present	O
Illness	O

Examination	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue
The	O
neck	B-bodyloc
was	O
asymmetric	O
,	O
butwas	O
normal	O
in	O
appearanceand	O
was	O
supple	O
.	O

Orientation	O
to	O
person	O
,	O
place	O
and	O
time	O
:	O
Normal	B-labvalue
Mental	O
Status	O
:	O
oriented	O
to	O
person	O
,	O
place	O
,	O
and	O
time	O
.	O

Neurological	O
:	O
no	B-negation
dizziness	O
and	O
no	O

Eyes	O
:	O
no	B-negation
eye	B-bodyloc
pain	O
,	O
no	B-negation
eyesight	O
problems	O
and	O
no	B-negation
itching	O
of	O
the	O
eyes	B-bodyloc
.	O

Symptoms	O
:	O
pain	O
,	O
swelling	O
and	O
decreased	O
range	O
of	O
motion	O
,	O
but	O
no	B-negation
redness	O
,	O
no	B-negation
"	O
popping	O
"	O
sound	O
at	O
injury	O
,	O
no	B-negation
knee	B-bodyloc
bruising	O
,	O
no	B-negation
locking	O
,	O
no	B-negation
clicking	O
and	O
no	B-negation
instability	O
.	O

Vitals	O
19Oct2012	B-temporal
08	B-temporal
:	I-temporal
56AM	I-temporal
BMI	O
Calculated	O
27	B-labvalue
.	I-labvalue
57	I-labvalue
BSA	O
Calculated	O
1	B-labvalue
.	I-labvalue
82	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
5	I-labvalue
in	I-labvalue
Weight	O
165	B-labvalue
lb	I-labvalue
8	I-labvalue
oz	I-labvalue
Systolic	O
116	B-labvalue
,	O
RUE	O
,	O
Sitting	O
Diastolic	O
78	B-labvalue
,	O
RUE	O
,	O
Sitting	O
Temperature	O
98	B-labvalue
F	I-labvalue
,	O
Oral	O
Heart	O
Rate	O
63	B-labvalue

ResultsData	O
_	O
0	O
_	O
twCiteListControlStart	O
Pregnancy	O
Test	O
14Mar2013	B-temporal
09	B-temporal
:	I-temporal
47AM	I-temporal
ABDELMELEK	O
,	O
LOURICE	O
Test	O
Name	O
Result	O
Flag	O
Reference	O
Pregnancy	O
Test	O
,	O
Urine	O
positive	B-labvalue
A	O
ResultsData	O
_	O
0	O
_	O
twCiteListControlEnd	O
Results	O
/	O
DataSectispEnd	O
AssessmentSectispStart	O
Assessment	O

Mild	B-severity
atrophy	O
noted	O
.	O

Examination	O
of	O
the	O
oropharynx	O
:	O
Normal	B-labvalue

5	O
.	O

Onset	O
was	O
sudden	B-course
.	O

Patient	O
was	O
not	O
observed	O
to	O
be	O
obese	O
.	O

Assessment	O
Acp	O
Staging	O
Stage	O
1	O
Hypertension	O
:	O
140	O
-	O
159	O
/	O
90	O
-	O
99	O
401	O
.	O
9	O

Heart	O
sounds	O
:	O
normal	B-labvalue
S1	O
and	O
normal	B-labvalue
S2	O
.	O

GlyBURIDE	O
-	O
MetFORMIN	O
5	B-strength
-	I-strength
500	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
2	B-dosage
TABLET	B-form
TWICE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
21Aug2006	B-temporal
-	O
Requested	O
for	O
:	O
24May2010	B-temporal
;	O
Last	O
Rx	O
:	O
24May2010	B-temporal
;	O
Status	O
:	O
NEED	O
INFORMATION	O
-	O
Rx	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
John	O
Wallbillich	O
,	O
M	O
.	O
D	O
.	O

Dermatitis	O
692	O
.	O
9	O

Therapy	O
:	O
25May2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
02Aug2013	B-temporal
)	O
Requested	O
for	O
:	O
02Aug2013	B-temporal

Trichomonas	O
Vulvovaginitis	O
131	O
.	O
01	O

Systolic	O
:	O
137	B-labvalue

Orientation	O
to	O
person	O
,	O
place	O
and	O
time	O
:	O
Normal	B-labvalue
.	O

RESPIRATORY	O
:	O
Good	O
respiratory	O
effort	O
.	O

She	O
is	O
aware	O
of	O
the	O
future	O
need	O
of	O
Pap	O
smears	O
.	O

Pulmonary	O

His	O
CSRU	O
course	O
was	O
otherwise	O
uncomplicated	O
and	O
he	O
transferred	O
to	O
the	O
SDU	O
on	O
postoperative	O
day	O
three	O
.	O

No	O
HPI	O
available	O
.	O

Saline	O
SOLN	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
04Mar2013	B-temporal
)	O
to	O

Ms	O
.	O
Morris	O
has	O
noticed	O
swelling	O
in	O
bilateral	O
ankles	O
for	O
several	B-temporal
months	I-temporal
.	O

Family	O
history	O
of	O
Mother	O
Deceased	O
At	O
Age	O
_	O
_	O
_	O
_	O

[	O
L	O
]	O
Lipid	O
Panel	O
w	O
/	O
Chol	O
/	O
HDL	O
Ratio	O
Requested	O
for	O
:	O
16Nov2012	B-temporal

Tobacco	O
Use	O
305	O
.	O
1	O

Joint	B-bodyloc
Pain	O
,	O
Localized	O
In	O
The	O
Left	B-bodyloc
Shoulder	I-bodyloc
719	O
.	O
41	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
WILBUR	O
JONES	O
,	O
M	O
.	O
D	O
.	O

Lymphatic	O

Skin	O

History	O
of	O
Dermatitis	O
692	O
.	O
9	O

Examination	O
of	O
extremities	O
for	O
edema	O
and	O
/	O
or	O
varicosities	O
:	O
Normal	B-labvalue
.	O

She	O
was	O
instructed	O
to	O
contact	O
my	O
office	O
within	O
the	O
next	O
week	O
.	O

Family	B-subject
history	O
:	O
migraines	O
,	O
but	O
no	B-negation
cerebral	B-bodyloc
aneurysm	O
.	O

;	O
Aug	B-temporal
8	I-temporal
2013	I-temporal
1	B-temporal
:	I-temporal
33PM	I-temporal
(	O
Author	O
)	O

Surgical	O
History	O
History	O
of	O
Appendectomy	O

[	O
QLH	O
]	O
HPV	O
,	O
high	O
-	O
risk	O
Requested	O
for	O
:	O
08May2013	B-temporal

Associated	O
symptoms	O
include	O
polydipsia	O
,	O
but	O
no	B-negation
polyuria	O
,	O
no	B-negation
recent	B-temporal
weight	O
gain	O
and	O
no	B-negation
recent	B-temporal
weight	O
loss	O
.	O

Testosterone	O
Cypionate	O
100	B-strength
MG	I-strength
/	I-strength
ML	I-strength
Intramuscular	B-route
Oil	B-form
;	O
Inject	B-route
Half	B-dosage
ML	I-dosage
or	I-dosage
(	I-dosage
50mg	I-dosage
)	I-dosage
Intramuscular	B-route
every	B-frequency
month	I-frequency
;	O
Therapy	O
:	O
25Oct2012	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
25Oct2012	B-temporal
)	O

Cortical	O
function	O
:	O
Normal	B-labvalue
.	O

Topiramate	O
50	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
one	B-dosage
tablet	B-form
at	B-frequency
bedtime	I-frequency
;	O
Therapy	O
:	O
11Apr2012	B-temporal
to	O
(	O
Evaluate	O
:	O
29May2014	B-temporal
)	O
Requested	O
for	O
:	O
03Jun2013	B-temporal
;	O
Last	O
Rx	O
:	O
03Jun2013	B-temporal

RESPIRATORY	O
:	O
no	B-negation
wheezing	O
and	O
no	B-negation
cough	O
.	O

Throat	O
,	O
Neck	O
,	O
and	O
Back	O

Test	O
Name	O
Result	O
Flag	O
Reference	O
Glucose	O
POC	O
Lifescan	O
185	O

Interval	O
Events	O
:	O
Patient	O
has	O
been	O
taking	O
Metformin	O
more	O
consistantly	O
.	O

Assessment	O
of	O
hearing	O
:	O
Normal	B-labvalue
.	O

NO	O
AC	O
.	O

Peripheral	O
Vision	O
:	O
Normal	O
(	O
full	O
)	O
.	O

The	O
abdomen	O
was	O
soft	O
and	O
nontender	O
.	O

HDL	O
Cholesterol	O
:	O
48	B-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue
Reference	O
Range	O
>	B-reference_range
39	I-reference_range

Examination	O
of	O
the	O
oropharynx	O
:	O
Normal	B-labvalue
.	O

Medications	O
:	O
the	O
patient	O
is	O
adherent	O
to	O
her	O
medication	O
regimen	O
,	O
butshe	O
denies	B-negation
medication	O
side	O
effects	O
.	O

Using	O
sterile	O
technique	O
,	O
the	O
aspiration	O
/	O
injection	O
needle	O
was	O
then	O
directed	O
from	O
a	O
anterior	O
aspect	O
.	O

BMI	O
Calculated	O
:	O
25	B-labvalue
.	I-labvalue
03	I-labvalue

Prednsione	O
over	O
next	O
weel	O
for	O
relief	O
before	O
surgery	O

History	O
of	O
Muscle	B-bodyloc
Spasm	O
728	O
.	O
85	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
,	O
no	B-negation
cough	O
and	O
no	B-negation
shortness	O
of	O
breath	O
during	O
exertion	O
.	O

ABSOLUTE	O
BASOPHILS	O
22	B-labvalue
cells	I-labvalue
/	I-labvalue
uL	I-labvalue
0	B-reference_range
-	I-reference_range
200	I-reference_range

Examination	O
of	O
extremities	O
for	O
edema	O
and	O
/	O
or	O
varicosities	O
:	O
Normal	B-labvalue
.	O

Review	O
of	O
Systems	O

Plan	O

[	O
L	O
]	O
CMP14	O
Requested	O
for	O
:	O
29Oct2012	B-temporal

Current	O
Orders	O
[	O
L	O
]	O
Please	O
Note	O
Done	O
:	O
11Oct2012	B-temporal
11	B-temporal
:	I-temporal
00PM	I-temporal

Never	O
Drank	O
Alcohol	O

Social	O
History	O
Problems	O

Disp	O
:	O
*	O
30	O
Tablet	O
(	O
s	O
)	O
*	O
Refills	O
:	O
*	O
0	O
*	O
12	O
.	O

Valtrex	O
500	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
PRN	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
27Aug2013	B-temporal
)	O
to	O

Levothyroxine	O
Sodium	O
100	B-strength
MCG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
AS	I-frequency
DIRECTED	I-frequency
;	O
Therapy	O
:	O
17Jan2012	B-temporal
to	O
(	O
Evaluate	O
:	O
30Oct2012	B-temporal
)	O
Requested	O
for	O
:	O
02Jul2012	B-temporal
;	O
Last	O
Rx	O
:	O
02Jul2012	B-temporal
;	O
Edited	O

Inspection	O
of	O
the	O
conjunctiva	O
and	O
lids	O
:	O
Normal	B-labvalue

She	O
flew	O
in	O
from	O
New	O
York	O
3	B-temporal
days	I-temporal
ago	I-temporal
.	O
No	B-negation
leg	B-bodyloc
pain	O
.	O

BILIRUBIN	O
:	O
-	O

Preventive	O
Medicine	O
Services	O

;	O
Oct	B-temporal
19	I-temporal
2012	I-temporal
10	B-temporal
:	I-temporal
33AM	I-temporal
(	O
Author	O
)	O

3	O
.	O

No	B-negation
murmurs	O
were	O
heard	O
.	O

Breath	O
sounds	O
were	O
not	B-labvalue
diminished	I-labvalue
.	O

History	O
of	O
Present	O
Illness	O
The	O
patient	O
is	O
being	O
seen	O
for	O
follow	O
-	O
up	O
of	O
gastroesophageal	B-bodyloc
reflux	O
disease	O
.	O

EYES	O
:	O
no	B-negation
double	O
vision	O
and	O
no	B-negation
blurred	O
vision	O
.	O

Language	O
:	O
No	B-negation
dysphasia	O
/	O
aphasia	O
was	O
observed	O
.	O

Hal	O
.	O

Occupation	O
:	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

I	O
was	O
present	O
in	O
the	O
clinic	O
on	O
3/27/13	B-temporal
to	O
review	O
care	O
with	O
Dr	O
.	O
Dunnington	O
and	O
I	O
agree	O
.	O

Colonoscopy	O
did	O
reveal	O
diverticulosis	O
and	O
EGD	O
showed	O
retained	O
bile	O
and	O
possible	B-uncertain
gastritis	O
.	O

Assessment	O
of	O
stability	O
:	O
Normal	B-labvalue

No	B-negation
wheezing	O
was	O
heard	O
.	O

Nasopharynx	O
:	O
Unable	O
to	O
visualize	O
.	O

Pramipexole	O
Dihydrochloride	O
0	B-strength
.	I-strength
25	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
TWO	B-dosage
TABLETS	B-form
BY	B-route
MOUTH	I-route
AT	B-frequency
BEDTIME	I-frequency
;	O
Therapy	O
:	O
04Oct2013	B-temporal
to	O
(	O
Evaluate	O
:	O
02Apr2014	B-temporal
)	O
Requested	O
for	O
:	O
04Oct2013	B-temporal
;	O
Last	O
Rx	O
:	O
04Oct2013	B-temporal

Chief	O
Complaint	O

Gestational	O
Age	O
:	O
40	O
.	O

[	O
Q	O
]	O
THINPREP	O
TIS	O
PAP	O
AND	O
HR	O
HPV	O
DNA	O
REFLEX	O
GENOTYPES	O
16	O
,	O
18	O
Requested	O
for	O
:	O
27Feb2014	B-temporal

Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

Home	O
monitoring	O
:	O
The	O
patient	O
checks	O
her	O
blood	O
pressure	O
regularly	O
.	O

Peripheral	O
vascular	O
system	O
:	O
Normal	B-labvalue
.	O

Palpable	B-labvalue
radial	O
and	O
ulnar	O
pulses	O
in	O
the	O
upper	O
extremities	O
.	O

CONSTITUTIONAL	O

Hydrochlorothiazide	O
12	B-strength
.	I-strength
5	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
DAILY	B-frequency
;	O
Therapy	O
:	O
20Nov2012	B-temporal
to	O
(	O
Evaluate	O
:	O
28Jul2013	B-temporal
)	O
Requested	O
for	O
:	O
29Apr2013	B-temporal
;	O
Last	O
Rx	O
:	O
29Apr2013	B-temporal

Delivered	O
:	O
11/18/2012	B-temporal
.	O

Symptoms	O
:	O
Denies	B-negation
intermittent	O
leg	B-bodyloc
claudication	O
,	O
denies	B-negation
muscle	B-bodyloc
pain	O
and	O
denies	B-negation
muscle	B-bodyloc
weakness	O

Diabetes	O
Mellitus	O
With	O
Foot	B-bodyloc
Ulcer	O
250	O
.	O
80	O

GroupHeading6End	O
GroupHeading16Start	O
GroupHeading16End	O
GroupHeading18Start	O
GroupHeading18End	O
GroupHeading20Start	O
Currently	O
,	O
the	O
patient	O
has	O
an	O
inadequate	O
diet	O
and	O
has	O
an	O
inadequate	O
exercise	O
regimen	O
.	O

7	O
)	O
s	O
/	O
p	O
flu	O
shot	O
10	B-temporal
/	I-temporal
2011	I-temporal
.	O

UTP	O
Adult	O
Vital	O
Signs	O
Recorded	O
by	O
Valdez	O
,	O
Flor	O
on	O
March	B-temporal
21	I-temporal
,	I-temporal
2013	I-temporal
11	B-temporal
:	I-temporal
07	I-temporal
AM	I-temporal
Height	O
:	O
61	B-labvalue
in	I-labvalue
,	O
Weight	O
:	O
174	B-labvalue
lb	I-labvalue
,	O
BMI	O
:	O
32	B-labvalue
.	I-labvalue
85	I-labvalue
,	O
BSA	O
:	O
1	B-labvalue
.	I-labvalue
78	I-labvalue
BP	O
:	O
112	B-labvalue
/	I-labvalue
75	I-labvalue
mm	I-labvalue
Hg	O
RUE	O
Sitting	O

No	B-negation
nausea	O
or	O
vomiting	O
.	O

Comorbid	O
Illnesses	O
:	O
hypertension	O
,	O
hyperlipidemia	O
and	O
obesity	O
.	O

UTP	O
-	O
Discussion	O
/	O
26	O
yo	O
G1P1001	O
here	O
for	O
postpartum	O
visit	O
after	O
TSVD	O

Pravastatin	O
Sodium	O
40	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
1	B-dosage
tab	B-form
at	B-frequency
night	I-frequency
;	O
Therapy	O
:	O
24Nov2012	B-temporal
to	O

RT	O

Problems	O
f	O
Vacc	O
Prophylactic	O
Need	O
Against	O
Respiratory	O
Syncytiao	O
Virus	O
(	O
V04	O
.	O
82	O
)	O
;	O
(	O
Active	O
)	O

Decrease	O
In	O
Appetite	O
783	O
.	O
0	O

She	O
subsequently	O
underwent	O
DBS	O
placement	O
in	O
bilateral	O
globus	O
pallidus	O
internus	O
nuclei	O
and	O
has	O
responded	O
to	O
this	O
therapy	O
.	O

Cardiovascular	O

[	O
QL	O
]	O
THYROID	O
PANEL	O
WITH	O
TSH	O
,	O
3RD	O
GENERATION	O
Done	O
:	O
10Apr2014	B-temporal
11	B-temporal
:	I-temporal
00PM	I-temporal

Surgical	O
History	O
History	O
of	O
Hernia	O
Repair	O

Coordination	O
:	O
normal	B-labvalue
balance	O
,	O
negative	B-labvalue
Romberg	O
'	O
s	O
sign	O
and	O
no	B-negation
dysdiadochokinesia	O
.	O

MRI	O
of	O
the	O
Brain	O
Unremarkable	B-labvalue

Past	O
Medical	O
History	O
History	O
of	O
Acute	B-course
Maxillary	B-bodyloc
Sinusitis	O
461	O
.	O
0	O

Urethral	O
meatus	O
:	O
Normal	O
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

to	O

[	O
QLH	O
]	O
FOLATE	O
,	O
SERUM	O
Requested	O
for	O
:	O
21Dec2011	B-temporal

CARDIOVASCULAR	O

Examination	O
of	O
thyroid	O
:	O
Normal	B-labvalue
.	O

Head	O
and	O
face	O
:	O
Normocephalic	O
;	O
atraumatic	O
.	O

DTaP	O
;	O
05	B-temporal
Oct	I-temporal
2007	I-temporal

She	O
reports	O
a	O
subjective	O
fever	O
,	O
headache	O
,	O
and	O
denies	B-negation
any	O
urinary	B-bodyloc
symptoms	O
.	O

History	O
of	O
Cholecystectomy	O

-	O
-	O
RTC	O
6	O
months	O
.	O

Breath	O
sounds	O
were	O
not	B-labvalue
diminished	I-labvalue
.	O

Eyes	O

History	O
of	O
Obstructive	O
Sleep	O
Apnea	O
327	O
.	O
23	O

[	O
QLH	O
]	O
HEMATOCRIT	O
Done	O
:	O
10Dec2010	B-temporal
10	B-temporal
:	I-temporal
02AM	I-temporal

I	O
agree	O
with	O
all	O
components	O
of	O
the	O
exam	O
except	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
,	O
no	B-negation
cough	O
,	O
no	B-negation
orthopnea	O
and	O
no	B-negation
PND	O
.	O

Diabetes	O
Mellitus	O
250	O
.	O
00	O

Gated	O
images	O
revealed	O
a	O
large	O
,	O
reversible	O
,	O
moderate	B-severity
intensity	O
perfusion	O
defect	O
involving	O
the	B-bodyloc
PDA	I-bodyloc
territory	I-bodyloc
.	O

Dense	O
breast	B-bodyloc
tissue	I-bodyloc
L	I-bodyloc
side	O
;	O
clinical	O
impression	O
of	O
fibrocystic	O
breast	B-bodyloc
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Neurologic	O

(	O
Medical	O
Transcription	O
Sample	O
Report	O
)	O

Ordered	O
;	O
For	O
:	O
Pregnancy	O
Test	O
Positive	B-labvalue
(	O
V72	O
.	O
42	O
)	O
;	O
Ordered	O
By	O
:	O
ABDELMELEK	O
,	O
LOURICE	O
Performed	O
:	O
Due	O
:	O
24Mar2013	B-temporal
;	O
Last	O
Updated	O
By	O
:	O
Fleming	O
,	O
Sonya	O
OB	O
/	O
GYN	O
Referral	O
Outpatient	O
Referral	O
Status	O
:	O
Complete	O
Done	O
:	O
14Mar2013	B-temporal

Diagnosis	O

Past	B-temporal
treatment	O
has	O
included	O
Lopid	O
BID	B-frequency
.	O

Child	O
Enrolled	O
In	O
Day	O
-	O
care	O

Eyes	O

Current	O
Meds	O
Aspirin	O
EC	O
Low	B-strength
Strength	I-strength
81	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
Delayed	I-form
Release	I-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
AS	O
DIRECTED	O
;	O
Therapy	O
:	O
25Mar2013	B-temporal
to	O
(	O
Evaluate	O
:	O
24Apr2013	B-temporal
)	O
;	O
Last	O
Rx	O
:	O
25Mar2013	B-temporal

She	O
is	O
currently	O
undergoing	O
treatment	O
of	O
a	O
"	O
sinus	B-bodyloc
infection	O
"	O
and	O
is	O
on	O
Levofloxian	O
and	O
she	O
reportedly	O
is	O
getting	O
much	O
improved	O
.	O

Magnesium	O
250	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
31Oct2013	B-temporal
)	O
to	O

Preventive	O
Medicine	O
Services	O

[	O
QLH	O
]	O
CREATINE	O
KINASE	O
,	O
TOTAL	O
Requested	O
for	O
:	O
17Feb2014	B-temporal

No	B-negation
pulse	O
delay	O
and	O
no	B-negation
pulse	O
discrepancy	O
.	O

Scope	O
BTL	O
schedule	O
for	O
3	B-temporal
/	I-temporal
21	I-temporal
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

General	O
Appearance	O
:	O
Normal	B-labvalue
.	O

Cranial	O
nerves	O
VII	O
:	O
Abnormal	O
.	O

No	B-negation
Known	O
Drug	O
Allergies	O

External	O
inspection	O
of	O
ears	O
and	O
nose	O
:	O
Normal	B-labvalue

HEART	O
:	O
Regular	O
.	O

Hypothyroidism	O
244	O
.	O
9	O

I	O
have	O
personally	O
reviewed	O
current	O
radiology	O
results	O
.	O

Patient	O
gives	O
consent	O
to	O
schedule	O
the	O
surgery	O
.	O

take	O
insulin	O
timely	O
;	O

An	O

Pain	O
occurs	O
suddenly	O
and	O
resolves	O
quickly	O
.	O

Please	O
contact	O
client	O
services	O
if	O
you	O
have	O
questions	O
at	O

Cardiovascular	O
:	O
normal	O
,	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
,	O
no	B-negation
syncope	O
and	O
no	B-negation
edema	O
.	O

Results	O
/	O
Results	O
/	O
Data	O
Physical	O
Exam	O
Cholesterol	O
Urinalysis	O
Colonoscopy	O
EGD	O
EKG	O
Stress	O
Test	O
Echo	O
Cardiac	O
Cath	O
Peripheral	O
Vascular	O
Screen	O
Carotid	O
Vascular	O
Screen	O
AAA	O
ABI	O
/	O
PVR	O
Diabetes	O
Screen	O
Other	O
Mammogram	O
PAP	O
Dexa	O
Prostate	O
/	O
PSA	O

Oropharynx	O
:	O
Normal	O
.	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

Vitals	O
10Apr2012	B-temporal
12	B-temporal
:	I-temporal
58PM	I-temporal
BMI	O
Calculated	O
22	B-labvalue
.	I-labvalue
88	I-labvalue
BSA	O
Calculated	O
1	B-labvalue
.	I-labvalue
45	I-labvalue
Height	O
4	B-labvalue
ft	I-labvalue
11	I-labvalue
in	I-labvalue
Weight	O
113	B-labvalue
lb	I-labvalue
8	I-labvalue
oz	I-labvalue
Systolic	O
122	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
70	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Temperature	O
99	B-labvalue
F	I-labvalue
,	O
Oral	O
Heart	O
Rate	O
72	B-labvalue
,	O
L	O
Radial	O
Respiration	O
15	B-labvalue

Neutrophils	O
:	O
59	B-labvalue
%	I-labvalue
Reference	O
Range	O
40	B-reference_range
-	I-reference_range
74	I-reference_range

Lungs	O
Percussion	O
:	O
Normal	B-labvalue
.	O

Edited	O

Other	O
Symptoms	O
:	O
right	B-bodyloc
breat	I-bodyloc
mass	O
.	O

Pulmonary	O
:	O
The	O
patient	O
was	O
stable	O
from	O
a	O
pulmonary	O
standpoint	O
;	O
vital	O
signs	O
were	O
routinely	O
monitored	O
.	O

ENT	O
:	O
no	B-negation
hoarseness	O
,	O
no	B-negation
hearing	O
loss	O
,	O
no	B-negation
drainage	O
of	O
ear	B-bodyloc
,	O
no	B-negation
vertigo	O
,	O
no	B-negation
snoring	O
was	O
observed	O
,	O
no	B-negation
daytime	O
sleepiness	O
,	O
no	B-negation
mouth	B-bodyloc
sores	O
,	O
no	B-negation
tooth	B-bodyloc
problems	O
,	O
no	B-negation
dysphagia	O
and	O
no	B-negation
tinnitus	O

Cardiovascular	O
Peripheral	O
vascular	O
exam	O
:	O
Normal	B-labvalue

Occupation	O
:	O
Retired	O

3	O
.	O

;	O
Aug	B-temporal
7	I-temporal
2013	I-temporal
11	B-temporal
:	I-temporal
51AM	I-temporal
(	O
Author	O
)	O

Albuterol	O
Sulfate	O
1	B-strength
.	I-strength
25	I-strength
MG	I-strength
/	I-strength
3ML	I-strength
Inhalation	B-form
Nebulization	I-form
Solution	I-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
15Jan2013	B-temporal
)	O

Medications	O
on	O
Admission	O
:	O

1	O
+	O
pitting	O
edema	O
to	O
L	B-bodyloc
ankle	I-bodyloc
.	O

Neck	O
:	O
Normal	O
.	O

History	O
of	O
Current	O
Smoker	O

Never	O
A	O
Smoker	O

Both	O
cornea	O
were	O
normal	O
in	O
appearance	O
.	O

Denial	B-negation
Of	O
Any	O
Significant	O
Medical	O
History	O

Current	O
Meds	O
Keppra	O
500	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
12Sep2012	B-temporal
)	O
to	O

Postop	O
-	O
doing	O
well	O
,	O
no	B-negation
e	O
/	O
o	O
infection	O
.	O

History	O
of	O
Present	O
Illness	O
The	O
patient	O
is	O
being	O
seen	O
for	O
a	O
routine	O
clinic	O
follow	O
-	O
up	O
.	O

History	O
of	O
Tobacco	O
Use	O

Aug	B-temporal
11	I-temporal
2012	I-temporal
1	B-temporal
:	I-temporal
54PM	I-temporal
(	O
Author	O
)	O

He	O
has	O
not	O
been	O
exercising	O
but	O
plans	O
to	O
start	O
this	O
summer	O
.	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
neck	O
:	O
Normal	B-labvalue
.	O

Family	O
History	O
Family	B-subject
history	O
of	O
Migraine	O
Headache	O

ENT	O
:	O
hoarseness	O
,	O
but	O
no	B-negation
earache	O
,	O
no	B-negation
hearing	O
loss	O
,	O
no	B-negation
epistaxis	O
,	O
no	B-negation
nasal	B-bodyloc
discharge	O
and	O
no	B-negation
sore	O
throat	B-bodyloc
.	O

Patient	O
was	O
not	B-negation
observed	I-negation
to	O
be	O
obese	O
.	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
vomiting	O
,	O
no	B-negation
constipation	O
,	O
no	B-negation
diarrhea	O
,	O
no	B-negation
heartburn	O
and	O
no	B-negation
melena	O
.	O

Height	O
Comments	O
:	O
Reported	O

Social	O
History	O
Currently	O
In	O
School	O
Public	O

General	O
appearance	O
:	O
Normal	B-labvalue
.	O

Vitals	O
22Aug2011	B-temporal
02	B-temporal
:	I-temporal
47PM	I-temporal
BMI	O
Calculated	O
29	B-labvalue
.	I-labvalue
2	I-labvalue
BSA	O
Calculated	O
1	B-labvalue
.	I-labvalue
83	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
4	I-labvalue
in	I-labvalue
Weight	O
171	B-labvalue
lb	I-labvalue
Systolic	O
127	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
71	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Temperature	O
99	B-labvalue
F	I-labvalue
,	O
Oral	O
Heart	O
Rate	O
79	B-labvalue

Allergies	O
and	O
Adverse	O
Reactions	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

Skin	O

Past	O
Medical	O
History	O
History	O
of	O
Blood	O
Pressure	O
Isolated	O
Elevated	O
796	O
.	O
2	O

Postmenopausal	B-bodyloc
Bleeding	O
627	O
.	O
1	O

Active	O
Problems	O
Benign	B-severity
Essential	O
Hypertension	O
401	O
.	O
1	O

PROTEIN	O
,	O
TOTAL	O
6	B-labvalue
.	I-labvalue
6	I-labvalue
g	I-labvalue
/	I-labvalue
dl	I-labvalue
6	B-reference_range
.	I-reference_range
1	I-reference_range
-	I-reference_range
8	I-reference_range
.	I-reference_range
1	I-reference_range

On	O
his	O
last	O
visit	O
in	O
Clear	O
Lake	O
,	O
I	O
had	O
started	O
him	O
on	O
low	B-dosage
-	I-dosage
dose	I-dosage
clonazepam	O
.	O

Patient	O
Specific	O
Education	O
Given	O
;	O
Requested	O
for	O
:	O
30	B-temporal
Jul	I-temporal
2013	I-temporal
.	O

General	O
appearance	O
:	O
Normal	B-labvalue

Yellow	O
Fever	O
;	O
27	B-temporal
Jun	I-temporal
2008	I-temporal

f	O
RSV	O
MAB	O
(	O
Synagis	O
)	O
(	O
Lot	O
#	O
:	O
11E27	O
-	O
81	O
)	O
-	O
Administered	O
on	O
:	O
02/08/2013	B-temporal

Ferrous	O
Sulfate	O
325	B-strength
(	I-strength
65	I-strength
Fe	I-strength
)	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
3	B-frequency
TIMES	I-frequency
DAILY	B-frequency
;	O
Therapy	O
:	O
31May2012	B-temporal
to	O
(	O
Evaluate	O
:	O
26May2013	B-temporal
)	O
;	O
Last	O
Rx	O
:	O
31May2012	B-temporal

Disp	O
:	O
*	O
28	O
Tablet	O
(	O
s	O
)	O
*	O
Refills	O
:	O
*	O
0	O
*	O
8	O
.	O

;	O
Sep	B-temporal
12	I-temporal
2013	I-temporal
12	B-temporal
:	I-temporal
24AM	I-temporal
(	O
Author	O
)	O

Patient	O
reports	O
difficulty	O
getting	O
up	O
out	O
of	O
a	O
chair	O
.	O

Lymphatic	O

The	O
heart	O
rate	O
was	O
normal	B-labvalue
.	O

History	O
of	O
Appendectomy	O
2	O
.	O

Adult	O
Sleep	O
Apnea	O
780	O
.	O
57	O

Discussion	O
/	O
Signatures	O
Electronically	O
signed	O
by	O
:	O
SEE	O
-	O
LONG	O
WONG	O
,	O
NP	O
;	O
Dec	B-temporal
8	I-temporal
2012	I-temporal
1	B-temporal
:	I-temporal
18PM	I-temporal
(	O
Author	O
)	O

Examination	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue

REVIEW	O
OF	O
SYSTEMS	O
:	O
CONSTITUTIONAL	O
:	O
No	B-negation
fever	O
or	O
chills	O
.	O

Patient	O
here	O
to	O
see	O
Dr	O
.	O
Vasudevan	O
for	O
HRA	O

Assessment	O
of	O
range	O
of	O
motion	O
:	O
Normal	B-labvalue
.	O

He	O
was	O
seen	O
By	O
Dr	O
.	O
Shu	O
with	O
urology	O
for	O
stone	O
analisis	O
.	O

Nasal	B-bodyloc
obstruction	O
:	O
Mild	B-severity

ABI	O
/	O
PVR	O
:	O
NEVER	B-negation

Attestations	O
Advanced	O
Practitioner	O
Attestation	O
:	O

Episodes	O
started	O
about	O
1	B-temporal
month	I-temporal
ago	I-temporal
.	O

LDL	O
&	O
HDL	O
okay	O
;	O
take	O
meds	O
.	O

AzaTHIOprine	O
50	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Take	O
1	B-dosage
1	I-dosage
/	I-dosage
2	I-dosage
tablets	B-form
twice	B-frequency
a	I-frequency
day	I-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
05Feb2013	B-temporal
)	O

Relieving	O
factors	O
:	O
cool	O
environment	O
.	O

Chronic	B-course
Cough	O
786	O
.	O
2	O

Abdomen	O
:	O
Abdomen	B-bodyloc
:	O
non	O
-	O
tender	O
,	O
no	O
hepato	O
-	O
splenomegaly	O
and	O
no	B-negation
hernia	O
was	O
discovered	O
.	O

Bellaire	O
,	O
TX	O
77401	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
and	O
no	B-negation
cough	O
.	O

Past	O
history	O
is	O
significant	O
for	O
seven	O
pregnancies	O
,	O
five	O
term	O
deliveries	O
,	O
and	O
significant	O
past	O
history	O
of	O
tobacco	O
use	O
.	O

Sample	O
Type	O
/	O
Medical	O
Specialty	O
:	O
General	O
Medicine	O

A	O
mammogram	O
was	O
performed	O
.	O

General	O
appearance	O
:	O
Normal	B-labvalue

Cardiovascular	O

By	O
report	O
,	O
there	O
is	O
good	O
compliance	O
with	O
treatment	O
,	O
good	O
tolerance	O
of	O
treatment	O
and	O
good	O
symptom	O
control	O
.	O

Respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

Psychiatric	O
:	O
not	B-negation
suicidal	O
,	O
no	B-negation
sleep	O
disturbances	O
and	O
no	B-negation
anxiety	O
.	O

Plan	O
Follow	O
-	O
up	O
visit	O
in	O
3	O
months	O
Outpatient	O
Follow	O
-	O
up	O
Requested	O
for	O
:	O
18Jun2013	B-temporal

Respiratory	O
rate	O
:	O
the	O
respiratory	O
rate	O
was	O
normal	B-labvalue
.	O

Neurological	O
/	O
Psychiatric	O
:	O
Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

Eth	O
:	O
Crust	O

Examination	O
of	O
the	O
neck	O
:	O
Abnormal	O
The	O
neck	B-bodyloc
had	O
a	O
scar	O
(	O
L	O
,	O
s	O
/	O
p	O
cervical	O
Laminectomy	O
)	O
.	O

History	O
of	O
Present	O
Illness	O
She	O
has	O
been	O
taking	O
Fe	O
tabs	B-form
regularly	O
and	O
feels	O
better	O
.	O

[	O
QL	O
]	O
VITAMIN	O
D	O
,	O
25	O
-	O
HYDROXY	O
,	O
LC	O
/	O
MS	O
/	O
MS	O
Requested	O
for	O
:	O
20Mar2014	B-temporal

She	O
began	O
treatment	O
with	O
CIVI	O
-	O
CAD	O
in	O
December	B-temporal
2007	I-temporal
.	O

Hand	O
Clinic	O
-	O
please	O
call	O
[	O
*	O
*	O
Telephone	O
/	O
Fax	O
(	O
1	O
)	O
3009	O
*	O
*	O
]	O
to	O
schedule	O
an	O
appointment	O
for	O
[	O
*	O
*	O
2101-12-27	B-temporal
*	O
*	O
]	O
Completed	O
by	O
:	O
[	O
*	O
*	O
2101-12-22	B-temporal
*	O
*	O
]	O

Follow	O
up	O
1	O
week	O
for	O
wound	O
check	O
.	O

Plan	O
[	O
L	O
]	O
Drawing	O
Fee	O
Requested	O
for	O
:	O
19Mar2014	B-temporal

Comorbid	O
Illnesses	O
:	O
hypertension	O
,	O
hyperlipidemia	O
and	O
obesity	O
.	O

The	O
tongue	O
was	O
normal	O
.	O

Review	O
of	O
Systems	O

Surgical	O
History	O
History	O
of	O
Tonsillectomy	O

Pedal	O
pulses	O
:	O
Normal	B-labvalue
Dorsalis	O
pedis	O
pulse	O
was	O
2	O
+	O
on	O
the	O
right	O
and	O
2	O
+	O
on	O
the	O
left	O
.	O

Healthcare	O
Providers	O

LEUKOCYTES	O
Small	O
A	O

Tobacco	O
Use	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
,	O
no	B-negation
cough	O
,	O
no	B-negation
shortness	O
of	O
breath	O
during	O
exertion	O
,	O
no	B-negation
orthopnea	O
and	O
no	B-negation
PND	O
.	O

Family	O
History	O
Family	O
history	O
of	O
Diabetes	O
Mellitus	O
V18	O
.	O
0	O

Immunizations	O
:	O
no	B-negation
human	O
papilloma	O
virus	O
vaccine	O
,	O
with	O
acellular	O
pertussis	O
vaccine	O
.	O

RTC	O
in	O
3	O
months	O

14	I-strength
MG	I-strength
/	O
DAY	O
Transdermal	O
Patch	O
Biweekly	B-frequency
;	O
Therapy	O
:	O
27Feb2009	B-temporal
to	O
Requested	O

History	O
of	O
Ct	O
Lung	O
Pulmonary	O
Nodule	O
Multiple	O

Systolic	O
:	O
108	B-labvalue
,	O
LUE	O
,	O
Sitting	O

Weight	O
Comments	O
:	O
Reported	O

Vital	O
Signs	O
[	O
Data	O
Includes	O
:	O
Current	O
Encounter	O
]	O

Centrum	O
TABS	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
15Nov2012	B-temporal
)	O
to	O

XR	O
KNEE	O
,	O
BOTH	O
,	O
STANDING	O
,	O
AP	O
:	O
Images	O
acquired	O
,	O
not	O
reported	O
on	O
this	O
accession	O
number	O
.	O

BILIRUBIN	O
negative	B-labvalue

5	O
.	O

Bilateral	B-bodyloc
lower	I-bodyloc
extremity	I-bodyloc
swelling	O
-	O
ECHO	O
(	O
March	B-temporal
)	O
:	O
LVEF	O
60	B-labvalue
-	I-labvalue
65	I-labvalue
%	I-labvalue

FR	O
/	O
FS	O
:	O
Stent	O
in	O
place	O
,	O
crusting	O
debrided	O
.	O

The	O
last	O
menstrual	O
period	O
was	O
11/23/11	B-temporal
.	O

Motor	O
Strength	O
:	O
motor	O
strength	O
was	O
normal	B-labvalue
in	O
all	O
muscle	O
groups	O
.	O

PP	O
state	O
:	O
overall	O
doing	O
well	O
,	O
bottle	O
feeding	O
,	O
mood	O
stable	O
,	O
good	O
support	O
.	O

Endocrine	O
:	O
no	B-negation
proptosis	O
,	O
no	B-negation
muscle	B-bodyloc
weakness	O
,	O
no	B-negation
erectile	O
dysfunction	O
,	O
no	B-negation
deepening	O
of	O
the	O
voice	O
and	O
no	B-negation
feelings	O
of	O
weakness	O
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

[	O
QLH	O
]	O
HEMOGLOBIN	O
Done	O
:	O
06Oct2010	B-temporal
10	B-temporal
:	I-temporal
39AM	I-temporal

HM	O
,	O

ENT	O
:	O
no	B-negation
earache	O
,	O
no	B-negation
nasal	B-bodyloc
discharge	O
,	O
no	B-negation
sore	O
throat	B-bodyloc
and	O
no	B-negation
hoarseness	O
.	O

Pap	O
ThinPrep	O
Requested	O
for	O
:	O
04Mar2013	B-temporal

The	O
patient	O
presents	O
with	O
complaints	O
of	O
arthralgias	O
(	O
Most	O
likely	O
from	O
chronic	O
lifting	O
and	O
excessive	O
use	O
)	O
.	O

There	O
is	O
no	B-negation
erythema	O
,	O
swelling	O
of	O
canals	O
.	O

1	O
.	O

Hip	B-bodyloc
Fracture	O
820	O
.	O
8	O

Comment	O
:	O

Tussionex	O
Pennkinetic	O
ER	O
10	B-strength
-	I-strength
8	I-strength
MG	I-strength
/	I-strength
5ML	I-strength
Oral	B-route
Liquid	B-form
Extended	I-form
Release	I-form
;	O
Therapy	O
:	O
08Oct2012	B-temporal
to	O

The	O
abdomen	O
was	O
soft	O
and	O
nontender	O
.	O

Examination	O
of	O
liver	O
and	O
spleen	O
:	O
Normal	B-labvalue
.	O

Urethra	O
:	O
Normal	O
.	O

[	O
QLH	O
]	O
T4	O
,	O
FREE	O
23Feb2012	B-temporal
09	B-temporal
:	I-temporal
45AM	I-temporal
Hardwicke	O
,	O
Robin	O

FAMILY	O
HISTORY	O
:	O
Noncontributory	O
.	O

Breathing	O
was	O
normal	B-labvalue
.	O

Reason	O
For	O
Visit	O

Family	O
History	O
Family	B-subject
history	O
of	O
Benign	B-severity
Essential	O
Hypertension	O

Palpation	O
of	O
breasts	O
and	O
axillae	O
:	O
Normal	B-labvalue
.	O
No	B-negation
masses	O
,	O
skin	B-bodyloc
changes	O
.	O

Pain	O
Scale	O
:	O
8	B-labvalue

Psychiatric	O
:	O
no	B-negation
anxiety	O
.	O

The	O
patient	O
reports	O
persistent	O
symptoms	O
despite	O
appropriate	O
treatment	O
.	O

Chronic	B-course
Kidney	B-bodyloc
Disease	O
,	O
Stage	O
3	O
585	O
.	O
3	O

No	B-negation
rales	O
or	O
crackles	O
were	O
heard	O
.	O

4	O
.	O

MT	O
/	O
MM	O
:	O
Normal	O

PastMedicalHistisy	O
_	O
10	O
_	O
twCiteListControlStart	O
Histisy	O
of	O
Microscopic	O
Hematuria	O
599	O
.	O
72	O

FOL	O
today	B-temporal

Attending	O
Note	O

Plan	O
[	O
L	O
]	O
TSH	O
+	O
Free	O
T4	O
Requested	O
for	O
:	O
27Feb2014	B-temporal

There	O
was	O
clear	O
rhinorrhea	O
from	O
both	B-bodyloc
nares	I-bodyloc
.	O

Vivelle	O
-	O
Dot	O
0	B-strength
.	I-strength
0375	I-strength
MG	I-strength
/	I-strength
24HR	I-strength
Transdermal	B-route
Patch	B-form
Biweekly	B-frequency
;	O
APPLY	O
1	B-dosage
PATCH	B-form
TWICE	B-frequency
WEEKLY	I-frequency
AS	O
DIRECTED	O
;	O
Therapy	O
:	O
03Sep2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
03Sep2013	B-temporal
)	O
Requested	O
for	O
:	O
18Sep2013	B-temporal

Discussion	O
/	O
Signatures	O
Electronically	O
signed	O
by	O
:	O
George	O
Lopez	O
,	O
M	O
.	O
D	O
.	O
;	O

Surgical	O
History	O
History	O
of	O
Hysterectomy	O
V88	O
.	O
01	O

CKD	O
stage	B-severity
3	I-severity
-	I-severity
4	I-severity
:	O
Patient	O
with	O
improvement	B-labvalue
in	O
renal	O
function	O
after	O
passing	O
stone	O
.	O

of	O
the	O
American	O
Diabetes	O
Association	O
.	O

HEENT	O
:	O
The	O
pupils	O
are	O
equal	O
and	O
reactive	O
.	O

General	O
appearance	O
:	O
Normal	B-labvalue
.	O

Psychiatric	O
:	O
not	B-negation
suicidal	O
,	O
no	B-negation
sleep	O
disturbances	O
,	O
no	B-negation
anxiety	O
,	O
no	B-negation
depression	O
,	O
no	B-negation
personality	O
change	O
and	O
no	B-negation
emotional	O
problems	O
.	O

Cranial	O
Nerve	O
VII	O
:	O
facial	O
strength	O
was	O
intact	B-labvalue
bilaterally	I-labvalue
.	I-labvalue

Auscultation	O
:	O
no	B-negation
expiratory	O
wheezing	O
was	O
heard	O
and	O
no	B-negation
inspiratory	O
wheezing	O
was	O
heard	O
No	B-negation
rales	O
or	O
crackles	O
were	O
heard	O
.	O

EYES	O
:	O
no	B-negation
double	O
vision	O
and	O
no	B-negation
blurred	O
vision	O
.	O

Chronic	B-course
Sphenoidal	B-bodyloc
Sinusitis	O
473	O
.	O
3	O

f	O
Simvastatin	O
40	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
ONE	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
DAILY	B-frequency
AS	O
DIRECTED	O
;	O
Start	O
Date	O
:	O
06/24/2011	B-temporal
;	O
End	O
Date	O
:	O
01/01/1900	B-temporal
(	O
Active	O
)	O

Complications	O
:	O
presenting	O
no	B-negation
drainage	O
.	O

Immunizations	O

Patinet	O
states	O
that	O
he	O
is	O
able	O
to	O
walk	O
1000ft	O
before	O
legs	O
tire	O
and	O
give	O
out	O
.	O

Feelings	O
Of	O
Urinary	B-bodyloc
Urgency	O
788	O
.	O
63	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O
The	O
patient	O
is	O
a	O
17	O
-	O
year	O
-	O
old	O
female	O
,	O
who	O
presents	O
to	O
the	O
emergency	O
room	O
with	O
foreign	O
body	O
and	O
airway	O
compromise	O
and	O
was	O
taken	O
to	O
the	O
operating	O
room	O
.	O

Prophylaxis	O
:	O
The	O
patient	O
was	O
initally	O
started	O
on	O
a	O
heparin	O
drip	B-route
post	O
-	O
operatively	O
for	O
48	B-duration
hours	I-duration
and	O
subsequently	O
received	O
subcutaneous	B-route
heparin	O
after	O
discontinuation	O
of	O
the	O
drip	O
.	O

Indication	B-uncertain
:	O
Nasal	B-bodyloc
drainage	O
.	O

f	O
Lantus	O
SoloStar	O
100	B-strength
UNIT	I-strength
/	I-strength
ML	I-strength
Subcutaneous	B-route
Solution	B-form
;	O
Inject	B-route
20	B-dosage
units	I-dosage
a	B-frequency
.	I-frequency
m	I-frequency
.	O

Lifestyle	O
:	O
.	O

Exposed	O
To	O
Typhoid	O
V01	O
.	O
89	O

Current	O
Orders	O
[	O
H	O
]	O
Hemoglobin	O
Electrophoresis	O
and	O
Interpretation	O
Requested	O
for	O
:	O
19Feb2014	B-temporal

Discussion	O
/	O
Discussion	O
/	O
Summary	O

Headache	O
784	O
.	O
0	O

Assessment	O
of	O
stability	O
:	O
Normal	B-labvalue

FINAL	O
REPORT	O

He	O
is	O
a	O
25	O
-	O
year	O
-	O
old	O
male	O
who	O
first	O
began	O
having	O
problems	O
at	O
the	B-temporal
age	I-temporal
of	I-temporal
12	I-temporal
years	I-temporal
.	O

ENT	O
:	O
no	B-negation
earache	O
,	O
no	B-negation
hearing	O
loss	O
,	O
no	B-negation
epistaxis	O
,	O
no	B-negation
nasal	B-bodyloc
discharge	O
,	O
no	B-negation
sore	O
throat	B-bodyloc
and	O
no	B-negation
hoarseness	O
.	O

Diabetes	O
Mellitus	O
250	O
.	O
00	O

Examination	O
of	O
the	O
chest	O
:	O
Normal	B-labvalue
.	O

Blood	O
glucose	O
level	O
was	O
as	O
low	O
as	O
46	B-labvalue
.	O

Despite	O
frequent	O
decreases	O
in	O
her	O
insulin	O
regimen	O
,	O
she	O
continues	O
to	O
have	O
somewhat	B-severity
low	O
blood	O
glucoses	O
,	O
most	O
notably	O
in	O
the	O
morning	O
when	O
the	O
glucoses	O
have	O
been	O
in	O
the	O
70s	B-labvalue
despite	O
decreasing	O
her	O
Lantus	O
insulin	O
from	O
around	O
84	B-dosage
units	I-dosage
down	O
to	O
60	B-dosage
units	I-dosage
,	O
which	O
is	O
a	O
considerable	O
change	O
.	O

Pulmonary	O

Visit	O
For	O
:	O
Postpartum	O
Exam	O
V24	O
.	O
2	O

Examination	O
of	O
liver	O
and	O
spleen	O
:	O
Normal	B-labvalue
.	O

He	O
again	O
declines	O
thyroid	O
USG	O
;	O
he	O
understands	O
that	O
I	O
can	O
not	O
assess	O
for	O
presence	O
and	O
character	O
of	O
nodules	O
on	O
palpation	O
alone	O
.	O

Active	O
Problems	O
Abdominal	B-bodyloc
Pain	O
789	O
.	O
00	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
,	O
the	O
heart	O
rate	O
was	O
not	B-labvalue
fast	I-labvalue
,	O
the	O
heart	O
rate	O
was	O
not	B-labvalue
slow	I-labvalue
,	O
no	B-negation
intermittent	O
leg	B-bodyloc
claudication	O
and	O
no	B-negation
edema	O
.	O

Review	O
of	O
Systems	O

Microtia	O
Of	O
Both	O
Ears	B-bodyloc
744	O
.	O
23	O

LT	O

CombiPatch	O
0	B-strength
.	I-strength
05	I-strength
-	I-strength
0	I-strength
.	I-strength

No	B-negation
murmurs	O
were	O
heard	O
.	O

Neurological	O
:	O
memory	O
loss	O
,	O
poor	O
coordination	O
,	O
difficulty	O
writing	O
,	O
difficulty	O
walkingandfrequent	O
falls	O
,	O
but	O
no	B-negation
confusion	O
,	O
no	B-negation
decrease	O
in	O
concentrating	O
ability	O
,	O
no	B-negation
change	O
in	O
thought	O
patterns	O
,	O
no	B-negation
repeated	O
questioning	O
about	O
recent	O
events	O
,	O
no	B-negation
facial	O
weakness	O
,	O
no	B-negation
arm	O
weakness	O
,	O
no	B-negation
leg	B-bodyloc
weakness	O
,	O
denied	B-negation
anesthesia	O
,	O
no	B-negation
numbness	O
,	O
no	B-negation
tingling	O
,	O
no	B-negation
burning	O
sensation	O
,	O
no	B-negation
hyperesthesia	O
,	O
no	B-negation
convulsions	O
,	O
no	B-negation
dizziness	O
,	O
no	B-negation
fainting	O
,	O
no	B-negation
lightheadedness	O
,	O
no	B-negation
vertigo	O
,	O
no	B-negation
cluster	O
headache	O
,	O
no	B-negation
migraine	O
headache	O
,	O
no	B-negation
tension	O
-	O
type	O
headache	O
,	O
able	O
to	O

Neurological	O
:	O
alert	O
,	O
but	O
no	B-negation
dizziness	O
.	O

Pulmonary	O

Chloride	O
Lvl	O
102	B-labvalue
mEq	I-labvalue
/	I-labvalue
l	I-labvalue
95	B-reference_range
-	I-reference_range
109	I-reference_range

f	O
Vitamin	O
D	O
Deficiency	O
(	O
268	O
.	O
9	O
)	O
;	O
(	O
Active	O
)	O

Orientation	O
to	O
person	O
,	O
place	O
,	O
and	O
time	O
:	O
Normal	B-labvalue
.	O

[	O
QLH	O
]	O
IRON	O
,	O
TOTAL	O
Done	O
:	O
18Dec2012	B-temporal
11	B-temporal
:	I-temporal
30AM	I-temporal

History	O
of	O
Hypertension	O
401	O
.	O
9	O

Esophageal	B-bodyloc
Reflux	O
530	O
.	O
81	O

Respiratory	O
:	O
shortness	O
of	O
breath	O
during	O
exertion	O
,	O
but	O
no	B-negation
wheezing	O
,	O
no	B-negation
cough	O
,	O
no	B-negation
orthopnea	O
and	O
no	B-negation
PND	O
.	O

No	B-negation
mass	O
.	O

No	B-negation
dry	O
cough	O
.	O

She	O
now	O
presents	O
with	O
an	O
approximately	O
3	B-temporal
week	I-temporal
history	O
of	O
recurrent	B-course
headaches	O
and	O
head	B-bodyloc
pains	O
.	O

History	O
of	O
Sore	O
Throat	B-bodyloc
462	O

YAZ	O
3	B-strength
-	I-strength
0	I-strength
.	I-strength
02	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
19Nov2012	B-temporal
)	O
to	O

History	O
Of	O
Prior	B-temporal
Surgery	O
V15	O
.	O
29	O

Varicosital	O
changes	O
noted	O
bilaterally	B-bodyloc
.	O

Sample	O
Type	O
/	O
Medical	O
Specialty	O
:	O
Discharge	O
Summary	O

Integumentary	O
:	O
no	B-negation
skin	B-bodyloc
lesions	O
and	O
no	B-negation
skin	B-bodyloc
wound	O
.	O

Impingement	O
Of	O
The	O
Left	B-bodyloc
Shoulder	I-bodyloc
726	O
.	O
2	O

He	O
even	O
states	O
the	O
pain	O
was	O
so	O
intense	O
that	O
he	O
fell	O
.	O

History	O
of	O
Gout	O

UTP	O
-	O
OB	O
/	O
Patient	O
here	O
for	O
Postsurgical	O
Exam	O
.	O

Menorrhagia	O
626	O
.	O
2	O

Eyes	O
EOMI	O
;	O
anicteric	O
sclerae	O
.	O
No	B-negation
proptosis	O
or	O
lid	B-bodyloc
lag	O
.	O

The	O
speech	O
exhibited	O
a	O
normal	O
rhythm	O
,	O
normal	O
tone	O
,	O
coherency	O
,	O
normal	O
articulation	O
,	O
normal	O
volume	B-labvalue
and	I-labvalue
a	I-labvalue
normal	I-labvalue
rate	O
.	O

Potassium	O
Chloride	O
ER	O
10	B-strength
MEQ	I-strength
Oral	B-route
Capsule	B-form
Extended	I-form
Release	I-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
Requested	O
for	O
:	O
10Dec2013	B-temporal
;	O
Last	O
Rx	O
:	O
10Dec2013	B-temporal

Neurological	O
:	O
no	B-negation
confusion	O
,	O
no	B-negation
convulsions	O
,	O
no	B-negation
dizziness	O
,	O
no	B-negation
fainting	O
,	O
no	B-negation
limb	B-bodyloc
weakness	O
and	O
no	B-negation
difficulty	O
walking	O
.	O

Losartan	O
Potassium	O
-	O
HCTZ	O
100	B-strength
-	I-strength
25	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
EVERY	B-frequency
DAY	I-frequency
Requested	O
for	O
:	O
04Oct2013	B-temporal
;	O
Last	O
Rx	O
:	O
04Oct2013	B-temporal

Wash	O
incision	O
with	O
soap	O
and	O
water	O
and	O
pat	O
dry	O
.	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
CHAU	O
TRAN	O
,	O
M	O
.	O
D	O
.	O

Atrial	B-bodyloc
Fibrillation	O
427	O
.	O
31	O

Endocrine	O
:	O
no	B-negation
muscle	B-bodyloc
weakness	O
.	O

Chest	O

No	B-negation
exacerbating	O
factors	O
are	O
noted	O
.	O

History	O
of	O
Dental	O
Surgery	O

Palpatory	O
Findings	O
include	O
bilateral	B-bodyloc
muscle	I-bodyloc
spasms	O
.	O

Gastrointestinal	O
:	O
dysphagia	O
,	O
but	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
vomiting	O
,	O
no	B-negation
constipation	O
,	O
no	B-negation
diarrhea	O
and	O
no	B-negation
pain	O
on	O
swallowing	O

HOUSTON	O
,	O
TX	O
77008	O
Grtder	O
Female	O
Marital	O
Status	O
(	O
281	O
)	O
216	O
-	O
8227	O
(	O
Home	O
phone	O
)	O
Language	O
English	O
-	O
preferred	O
Reason	O
for	O
Referral	O

Abdomen	O
:	O
Normal	O
.	O

[	O
QLH	O
]	O
PROTHROMBIN	O
TIME	O
-	O
INR	O
Requested	O
for	O
:	O
03Apr2014	B-temporal

Examination	O
of	O
the	O
head	O
and	O
face	O
:	O
AbnormalMoon	O
face	O
.	O

The	O
posterior	B-bodyloc
pharynx	I-bodyloc
was	O
not	B-negation
erythematous	O
and	O
did	O
not	B-negation
have	I-negation
an	O
exudate	O
.	O

Neurological	O
:	O
not	O
alert	O
,	O
no	B-negation
confusion	O
,	O
no	B-negation
tinnitus	O
,	O
no	B-negation
dizziness	O
,	O
no	B-negation
tingling	O
and	O
no	B-negation
limb	B-bodyloc
weakness	O
.	O

History	O
of	O
Laparoscopy	O
With	O
Total	O
Hysterectomy	O

HAS	O
NEVER	O
HAD	O
A	O
BACK	O
X	O
-	O
RAY	O
.	O

Dysmenorrhea	O
.	O
No	B-negation
dyspareunia	O
.	O
Not	B-negation
taking	O
female	O
hormones	O
for	O
postmenopausal	O
HRT	O
.	O
Patient	O
has	O
no	B-negation
history	O
of	O
sexually	O
transmitted	O
infection	O
.	O
No	B-negation
history	O
of	O
pelvic	B-bodyloc
inflammatory	O
disease	O
.	O
No	B-negation
history	O
of	O
cervical	O
surgery	O
.	O
No	B-negation
history	O
of	O
hysterectomy	O
.	O

Social	O
History	O
Never	O
A	O
Smoker	O

Discussed	O
the	O
importance	O
of	O
DM	O
control	O
and	O
its	O
complications	O
.	O

5	O
.	O

Osteoporosis	O
733	O
.	O
00	O

Gestational	O
age	O
:	O
37	O
weeks	O
.	O

The	O
tonsils	O
were	O
normal	O
.	O

OB	O
History	O

Sexual	O
Activity	O
:	O
.	O

Orientation	O
to	O
person	O
,	O
place	O
and	O
time	O
:	O
Normal	B-labvalue
.	O

[	O
L	O
]	O
Pathology	O
Report	O
Requested	O
for	O
:	O
11Sep2013	B-temporal

Discussion	O
/	O
Discussion	O
/	O
Summary	O

Renal	B-bodyloc
Insufficiency	O
593	O
.	O
9	O

Constitutional	O
:	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
,	O
not	B-negation
feeling	O
poorly	O
(	O
malaise	O
)	O
,	O
not	B-negation
feeling	O
tired	O
(	O
fatigue	O
)	O
,	O
no	B-negation
recent	B-temporal
weight	O
gain	O
and	O
no	B-negation
recent	B-temporal
weight	O
loss	O
.	O

Varicose	O
Veins	B-bodyloc
With	O
Swelling	O
454	O
.	O
8	O

Dietician	O
Referral	O
Outpatient	O
Referral	O
Status	O
:	O
Complete	O
Done	O
:	O
10Feb2014	B-temporal

Post	O
op	O
followup	O
on	O
hyst	O
11/01/2013	B-temporal
.	O

Comments	O
:	O
Pregnancy	O
c	O
/	O
b	O
A2DM	O
,	O
on	O
glyburide	O
.	O

Otherwise	O
,	O
she	O
is	O
doing	O
well	O
.	O

Maternal	B-subject
history	O
of	O
Hypercholesterolemia	O

Constitutional	O
,	O
eye	O
,	O
otolaryngeal	O
,	O
cardiovascular	O
,	O
pulmonary	O
,	O
Sleep	O
,	O
gastrointestinal	O
,	O
genitourinary	O
,	O
musculoskeletal	O
,	O
skin	O
,	O
neurological	O
,	O
psychiatric	O
,	O
endocrine	O
and	O
hematologic	O
review	O
of	O
systems	O
are	O
normal	O
.	O

Cranial	O
nerves	O
III	O
,	O
IV	O
,	O
and	O
VI	O
:	O
the	O
extraocular	O
motions	O
were	O
intact	B-labvalue
.	O

;	O
Feb	B-temporal
14	I-temporal
2014	I-temporal
11	B-temporal
:	I-temporal
21AM	I-temporal
(	O
Author	O
)	O

Current	O
Meds	O
Butalbital	O
-	O
APAP	O
-	O
Caffeine	O
50-325-40	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
OR	I-dosage
2	I-dosage
TABLETS	B-form
EVERY	B-frequency
4	I-frequency
HOURS	I-frequency
AS	B-frequency
NEEDED	I-frequency
FOR	O
HEADACHE	O
.	O

Otolaryngeal	O
:	O
No	B-negation
earache	O
,	O
no	B-negation
discharge	O
from	O
the	O
ears	B-bodyloc
,	O
no	B-negation
nasal	B-bodyloc
discharge	O
,	O
no	B-negation
nasal	B-bodyloc
passage	O
blockage	O
,	O
no	B-negation
hoarseness	O
,	O
no	B-negation
choking	O
,	O
no	B-negation
mouth	B-bodyloc
sores	O
,	O
no	B-negation
spots	O
in	O
the	O
mouth	B-bodyloc
,	O
and	O
no	B-negation
bad	O
breath	O
.	O

Musculoskeletal	O

Test	O
Name	O
Result	O
Flag	O
Reference	O

1	O
.	O

ST	O
/	O
SE	O
/	O
Sphen	O
:	O
Not	O
visualized	O

Potassium	O
Lvl	O
4	B-labvalue
.	I-labvalue
1	I-labvalue
mEq	I-labvalue
/	I-labvalue
l	I-labvalue
3	B-reference_range
.	I-reference_range
5	I-reference_range
-	I-reference_range
5	I-reference_range
.	I-reference_range
1	I-reference_range

Nystatin	O
100000	B-strength
UNIT	I-strength
/	I-strength
GM	I-strength
External	B-form
Powder	I-form
;	O
APPLY	O
SPARINGLY	O
TO	O
AFFECTED	O
AREA	O
(	O
S	O
)	O
TWICE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
05Jun2012	B-temporal
)	O
to	O

Cancel	O
Reason	O
:	O
Lab	O
Cancellation	O

Triamterene	O
-	O
HCTZ	O
75	B-strength
-	I-strength
50	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
WITH	I-frequency
FOOD	I-frequency
;	O
Therapy	O
:	O
26Apr2013	B-temporal
to	O
(	O
Evaluate	O
:	O
08May2014	B-temporal
)	O
Requested	O
for	O
:	O
13May2013	B-temporal
;	O
Last	O
Rx	O
:	O
13May2013	B-temporal

Had	O
a	O
long	O
discussion	O
with	O
the	O
patient	O
'	O
s	O
wife	O
and	O
other	O
family	O
members	O
.	O

Maternal	B-subject
grandfather	I-subject
'	I-subject
s	I-subject
history	O
of	O
Reported	O
Family	B-subject
History	O
Of	O
Heart	B-bodyloc
Disease	O

Nasonex	O

Vitamin	O
D	O
1000	B-strength
UNIT	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
25Mar2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
25Mar2013	B-temporal
)	O

Comments	O
:	O
ETOP	O
+	O
D	O
&	O
C	O
.	O

Integumentary	O
:	O
no	B-negation
breast	B-bodyloc
pain	O
,	O
no	B-negation
breast	B-bodyloc
mass	O
,	O
no	B-negation
changes	O
in	O
mole	B-bodyloc
(	O
s	O
)	O
,	O
no	B-negation
rash	O
,	O
no	B-negation
itching	O
.	O

Coordination	O
:	O
Normal	B-labvalue
Coordination	O
:	O
normal	B-labvalue
balance	O
and	O
negative	O
Romberg	O
'	O
s	O
sign	O
.	O

No	B-negation
rales	O
or	O
crackles	O
were	O
heard	O
.	O

Cardiovascular	O

Occupation	O
:	O

Menstrual	O
History	O
.	O

General	O
appearance	O
:	O
Normal	B-labvalue
Well	O
developed	O
,	O
appears	O
healthy	O
,	O
comfortable	O
,	O
well	O
nourished	O
,	O
within	O
normal	O
limits	O
of	O
ideal	O
weight	O
,	O
clothing	O
appropriate	O
,	O
well	O
groomedandwell	O
hydrated	O
.	O

Atypical	O
Depressive	O
Disorder	O
296	O
.	O
82	O

Current	O
Orders	O

Previous	B-temporal
Surgery	O
:	O
Yes	O
.	O

Pulmonary	O

CC	O
:	O
F	O
/	O
u	O
T1DM	O
and	O
hyperlipidemia	O

The	O
patient	O
presents	O
with	O
complaints	O
of	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
(	O
On	O
Coumadin	O
)	O
.	O

Mood	O
and	O
Affect	O
:	O
appropriate	O
mood	O
and	O
appropriate	O
affect	O
.	O

6565	O
FANNIN	O

Physical	O
Exam	O

Hip	B-bodyloc
Injury	O

Never	O
A	O
Smoker	O

Social	O
History	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

She	O
also	O
has	O
a	O
history	O
of	O
C5	B-bodyloc
-	I-bodyloc
6	I-bodyloc
cervical	I-bodyloc
disk	I-bodyloc
with	O
spinal	B-bodyloc
cord	I-bodyloc
compression	O
without	B-negation
myelopathy	O
.	O

due	O
to	O
:	O
patient	O
did	O
not	O
come	O
to	O
our	O
facility	O
to	O
be	O
drawn	O

History	O
of	O
Nasal	B-bodyloc
Polyps	O
471	O
.	O
9	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
vomiting	O
and	O
no	B-negation
nausea	O
.	O

Pt	O
states	O
that	O
5	B-temporal
days	I-temporal
ago	I-temporal
she	O
visited	O
clinic	O
with	O
URI	O
symptoms	O
and	O
was	O
given	O
Tessalon	O
pearles	O
.	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
neck	O
:	O
Normal	B-labvalue
.	O

LDL	O
199	B-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
H	B-labvalue
0	B-reference_range
-	I-reference_range
129	I-reference_range

She	O
has	O
regular	O
dental	O
visits	O
.	O
She	O
denies	B-negation
vision	O
problems	O
.	O
She	O
denies	B-negation
hearing	O
loss	O
.	O

F	O
.	O
U	O
.	O

Docusate	O
Sodium	O
100	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
20Mar2014	B-temporal
)	O
to	O

History	O
of	O
Edema	O
782	O
.	O
3	O

Trimethobenzamide	O
HCl	O
300	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
Status	O
:	O
ACTIVE	O

Sodium	O
is	O
107	B-labvalue
,	O
with	O
68	B-labvalue
chloride	O
and	O
potassium	O
of	O
2	B-labvalue
.	I-labvalue
8	I-labvalue
.	O

f	O
Anaprox	O
DS	O
TABS	B-form
(	O
Active	O
)	O

Neurological	O
:	O
no	B-negation
dizziness	O
and	O
no	B-negation
fainting	O
.	O

T4	O
Free	O
1	B-labvalue
.	I-labvalue
03	I-labvalue
ng	I-labvalue
/	I-labvalue
dl	I-labvalue
0	B-reference_range
.	I-reference_range
76	I-reference_range
-	I-reference_range
1	I-reference_range
.	I-reference_range
46	I-reference_range

I	O
was	O
present	O
in	O
the	O
clinic	O
to	O
review	O
care	O
with	O
Dr	O
.	O
Mileur	O
and	O
I	O
agree	O
.	O

Gait	O
-	O
Swing	O
Phase	O
Foot	O
Drop	O
Right	O
736	O
.	O
79	O

Neurologic	O

f	O
HIB	O
(	O
Act	O
-	O
or	O
OmniHIB	O
)	O
(	O
Lot	O
#	O
:	O
UH687AB	O
)	O
-	O
Administered	O
on	O
:	O
01/11/2013	B-temporal

Counseling	O
/	O
Signatures	O
Electronically	O
signed	O
by	O
:	O
MANNIE	O
MAGID	O
,	O
M	O
.	O
D	O
.	O

;	O
Jun	B-temporal
10	I-temporal
2013	I-temporal
8	B-temporal
:	I-temporal
29AM	I-temporal
(	O
Author	O
)	O

Active	O
Problems	O
Joint	B-bodyloc
Pain	O
,	O
Localized	O
In	O
The	O
Hip	B-bodyloc
719	O
.	O
45	O

Vitals	O
12Apr2014	B-temporal
11	B-temporal
:	I-temporal
31AM	I-temporal
BMI	O
Calculated	O
35	B-labvalue
.	I-labvalue
22	I-labvalue
BSA	O
Calculated	O
1	B-labvalue
.	I-labvalue
83	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
1	I-labvalue
in	I-labvalue
Weight	O
186	B-labvalue
lb	I-labvalue
9	I-labvalue
oz	I-labvalue
Systolic	O
124	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
72	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Temperature	O
97	B-labvalue
.	I-labvalue
3	I-labvalue
F	I-labvalue
,	O
Temporal	O
Heart	O
Rate	O
82	B-labvalue
,	O
L	O
Radial	O
Pulse	O
Quality	O
Normal	B-labvalue
,	O
L	O
Radial	O
Respiration	O
16	B-labvalue
Respiration	O
Quality	O
Normal	B-labvalue

Attending	O
Note	O

Blood	O
Pressue	O
Comments	O
:	O
Reported	O

She	O
has	O
tongue	B-bodyloc
-	O
biting	O
,	O
urinary	O
incontinence	O
,	O
and	O
bowel	B-bodyloc
incontinence	O
,	O
which	O
she	O
is	O
quite	O
embarrassed	O
about	O
.	O

Denied	B-negation
request	O
fis	O
scooter	O
/	O
motorized	O
wheelchair	O
.	O

Psychiatric	O

Pulmonary	O

Examination	O
of	O
extremities	O
for	O
edema	O
and	O
/	O
or	O
varicosities	O
:	O
Normal	B-labvalue

Discussion	O
/	O
Plan	O
1	O
.	O

Alcohol	O

Migraine	O
Headache	O
346	O
.	O
90	O

-	O
Ovarian	B-bodyloc
tissue	I-bodyloc
with	O
multiple	O
benign	O
cysts	O
,	O
and	O
physiologic	O
changes	O
.	O

Hyst	O

There	O
was	O
a	O
visual	O
fields	O
exam	O
by	O
confrontation	O
performed	O
and	O
the	O
results	O
were	O
abnormal	O
.	O

Allergies	O

Edema	O
:	O
Normal	O
(	O
not	O
present	O
)	O
.	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

MT	O
/	O
MM	O
:	O
Pus	O

The	O
patient	O
is	O
currently	B-temporal
experiencing	O
symptoms	O
.	O

The	O
patient	O
is	O
likely	O
to	O
undergo	O
the	O
latter	O
procedure	O
.	O

Symptoms	O
are	O
located	O
in	O
the	O
left	B-bodyloc
medial	I-bodyloc
knee	I-bodyloc
.	O

Musculoskeletal	O

Synthroid	O
75	B-strength
MCG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
27Aug2013	B-temporal
)	O
to	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
LETICIA	O
CRUZ	O
,	O
P	O
.	O
A	O
.	O

PROCEDURES	O
:	O
Robotic	O
-	O
Assisted	O
laparoscopic	O
left	O
renal	O
cyst	O
decortication	O
and	O
cystoscopy	O
.	O

Breathy	O
.	O

Examination	O
of	O
the	O
abdomen	O
:	O
Normal	B-labvalue
Bowel	O
sounds	O
were	O
normal	O
.	O

Auscultation	O
of	O
heart	O
:	O
Abnormal	O
.	O

Multiple	O
chronic	B-course
problems	O

Review	O
of	O
Systems	O

(	O
THE	O
RASH	O
IS	O
IMPROVED	O
FURTHER	O
-	O
MAINLY	O
ON	O
PRESSURE	O
AREAS	O
OF	O
HER	O
TORSO	O
)	O
Cyanosis	O
(	O
mild	B-severity
)	O
(	O
fingers	B-bodyloc
and	I-bodyloc
toes	I-bodyloc
)	O
,	O
but	O
normal	B-labvalue
color	O
and	O
pigmentation	O
and	O
no	B-negation
diaphoresis	O
.	O

Dr	O
Pelini	O
was	O
informed	O
of	O
these	O
findings	O
at	O
1640	B-temporal
hrs	I-temporal
on	O
6/5/2012	B-temporal
by	O
Dr	O
.	O
George	O

Hematologic	O
/	O
Lymphatic	O
:	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
.	O

Inspection	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
Normal	B-labvalue

ENDOCRINE	O
:	O
no	B-negation
cold	O
intolerance	O
,	O
no	B-negation
heat	O
intolerance	O
and	O
no	B-negation
excessive	O
thirst	O
.	O

Exacerbating	O
factors	O
:	O
stress	O
,	O
weight	O
gainandexcess	O
dietary	O
salt	O
,	O
but	O
not	O
exacerbated	O
by	O
fatigue	O
,	O
not	O
exacerbated	O
by	O
alcohol	O
use	O
and	O
not	O
exacerbated	O
by	O
skipping	O
medications	O
.	O

Description	O
of	O
patient	O
'	O
s	O
judgement	O
and	O
insight	O
:	O
Normal	B-labvalue

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
vomiting	O
,	O
no	B-negation
constipation	O
and	O
no	B-negation
diarrhea	O
.	O

History	O
of	O
Home	O
Environment	O
Domestic	O
Violence	O

I	O
agree	O
with	O
all	O
components	O
of	O
the	O
exam	O
.	O

Disp	O
:	O
*	O
50	O
Capsule	O
(	O
s	O
)	O
*	O
Refills	O
:	O
*	O
2	O
*	O
9	O
.	O

Mood	O
and	O
affect	O
:	O
Normal	O
.	O

Vomiting	O
(	O
Symptom	O
)	O
787	O
.	O
03	O

Systolic	O
:	O
154	B-labvalue

no	B-negation
insomnia	O

No	B-negation
pulse	O
delay	O
and	O
no	B-negation
pulse	O
discrepancy	O
.	O

Neck	O

EMERGENCY	O
DEPARTMENT	O
COURSE	O
:	O
The	O
patient	O
did	O
request	O
a	O
pain	O
shot	O
and	O
the	O
patient	O
was	O
given	O
Dilaudid	O
of	O
4	B-strength
mg	I-strength
IM	B-form
without	B-negation
any	O
adverse	O
reaction	O
.	O

Patient	O
reports	O
that	O
his	O
blood	O
pressure	O
is	O
normal	O
at	O
120s	B-labvalue
/	I-labvalue
80s	I-labvalue
at	O
home	O
,	O
denies	B-negation
,	O
chest	B-bodyloc
pain	O
,	O
dizziness	O
,	O
palpitations	O
,	O
abnormally	O
high	O
ior	O
low	O
blood	O
pressures	O
at	O
home	O
.	O

Patient	O
does	O
not	B-negation
have	I-negation
a	O
history	O
of	O
a	O
positive	O
pap	O
smear	O
.	O

Rinne	O
'	O
s	O
test	O
:	O
bone	O
conduction	O
persists	O
longer	O
than	O
air	O
conduction	O
on	O
the	O
right	O
.	O

Anemia	O
285	O
.	O
9	O

Otoscopic	O
examination	O
:	O
Normal	B-labvalue

Oropharynx	O
:	O
Normal	O
.	O

She	O
is	O
also	O
requesting	O
a	O
referral	O
to	O
a	O
specialist	O
regarding	O
her	O
multinodular	B-bodyloc
goiter	O
.	O

10	O
.	O

Constitutional	O

Cranial	O
nerves	O
XII	O
:	O
there	O
was	O
no	B-negation
tongue	B-bodyloc
deviation	O
with	O
protrusion	O
.	O

History	O
of	O
Coronary	B-bodyloc
Artery	I-bodyloc
Disease	O

NovoLOG	O
FlexPen	O
100	B-strength
UNIT	I-strength
/	I-strength
ML	I-strength
Subcutaneous	B-route
Solution	B-form
;	O
ICR	O
1	O
:	O
12	O
(	O
B	O
&	O
L	O
)	O
;	O
1	O
:	O
15	O
-	O
18	O
(	O
S	O
)	O
;	O
CF	O
~	O
70	O
;	O
up	O
to	O
20	O
units	O
a	O
day	O
;	O
Therapy	O
:	O
24Nov2012	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
10Dec2012	B-temporal
)	O

Results	O
/	O
Assessment	O
Chronic	O
Cough	O
786	O
.	O
2	O

VITAL	O
SIGNS	O
:	O
Reveal	O
a	O
blood	O
pressure	O
of	O
*	O
,	O
temperature	O
of	O
*	O
,	O
respirations	O
*	O
,	O
and	O
pulse	O
of	O
*	O
.	O

She	O
notes	O
that	O
she	O
has	O
been	O
attending	O
speech	O
therapy	O
and	O
it	O
has	O
helped	O
.	O

Cranberry	O
CAPS	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
19Aug2013	B-temporal
)	O
to	O

History	O
of	O
Present	O
Illness	O

Lymphatics	O
:	O
no	B-negation
swollen	O
lymph	B-bodyloc
nodes	I-bodyloc
,	O
no	B-negation
node	B-bodyloc
tenderness	O

Hydrocodone	O
-	O
Acetaminophen	O
5	B-strength
-	I-strength
500	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
-	I-dosage
2	I-dosage
TABLETS	B-form
EVERY	B-frequency
4	I-frequency
-	I-frequency
6	I-frequency
HOURS	I-frequency
AS	O
NEEDED	O
FOR	O
PAIN	O
;	O
Therapy	O
:	O
17Aug2009	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
17Aug2009	B-temporal
)	O
Requested	O
for	O
:	O
17Aug2009	B-temporal

Cervical	O
Spine	O
:	O
Normal	O
(	O
full	O
range	O
of	O
motion	O
)	O
.	O

NEURO	O
:	O
Goodutone	O
,	O
good	B-labvalue
strength	O
,	O
Symmetrical	B-labvalue
reflexes	O
.	O

Cyproheptadine	O
HCl	O
4	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
TWICE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
30Dec2012	B-temporal
to	O
(	O
Evaluate	O
:	B-temporal
09Apr2013	I-temporal
)	O
Requested	O
for	O
:	O
09Jan2013	B-temporal
;	O
Last	O
Rx	O
:	B-temporal
09Jan2013	I-temporal

Symptoms	O
:	O
The	O
patient	O
is	O
currently	O
asymptomatic	O
.	O

Endocrine	O
:	O
no	B-negation
proptosis	O
,	O
no	B-negation
hot	O
flashes	O
,	O
no	B-negation
muscle	B-bodyloc
weakness	O
,	O
no	B-negation
deepening	O
of	O
the	O
voice	O
and	O
no	B-negation
feelings	O
of	O
weakness	O
.	O

Examination	O
of	O
sensation	O
:	O
Normal	B-labvalue
.	O

Lower	B-bodyloc
Back	I-bodyloc
Pain	O

[	O
QLH	O
]	O
LIPID	O
PANEL	O
Requested	O
for	O
:	O
06Nov2013	B-temporal

Celebrex	O
200	B-strength
mg	I-strength
saEnles	O
;	O
Lot	O
Number	O
#	O
V122218	O
;	O
expiration	O
date	O
07	B-temporal
/	I-temporal
2015	I-temporal
.	O

All	O
questions	O
were	O
answered	O
.	O

Furosemide	O
40	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
0	B-dosage
.	I-dosage
5	I-dosage
TABLET	B-form
Every	B-frequency
morning	I-frequency
Requested	O
for	O
:	O
30Oct2013	B-temporal
;	O
Last	O
Rx	O
:	O
30Oct2013	B-temporal

Genitourinary	O
:	O
no	B-negation
dysuria	O
,	O
no	B-negation
pelvic	B-bodyloc
pain	O
,	O
no	B-negation
vaginal	O
discharge	O
and	O
no	B-negation
unexplained	O
vaginal	B-bodyloc
bleeding	O
.	O

CARDIOVASCULAR	O
:	O
Regular	B-labvalue
rate	O
and	O
rhythm	O
;	O
no	B-negation
murmurs	O
,	O
rubs	O
,	O
or	O
gallmps	O
.	O

Const	O
:	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
were	O
reported	O
,	O
no	B-negation
loss	O
of	O
weight	O
was	O
noted	O
,	O
no	B-negation
weight	O
gain	O
and	O
does	O
not	B-negation
tire	O
easily	O
.	O

Negative	B-negation
for	I-negation
intraepithelial	O
lesion	O
or	O
malignancy	O
.	O

Posterior	O
tibialis	O
:	O
right	O
2	O
+	O
and	O
left	O
2	O
+	O
.	O

She	O
takes	O
Relpax	O
for	O
these	O
.	O

Test	O
Name	O
Result	O
Flag	O
Reference	O

Examination	O
of	O
digits	O
and	O
nails	O
:	O
Normal	B-labvalue
.	O

she	O
had	O
it	O
at	O
the	O
peak	O
of	O
her	O
symptoms	O
and	O
without	B-negation
treatment	O

Musculoskeletal	O

Current	O
Meds	O
ALPRAZolam	O
0	B-strength
.	I-strength
25	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
BEDTIME	B-frequency
;	O
Last	O
Rx	O
:	O
11Dec2013	B-temporal

General	O
appearance	O
:	O
Normal	B-labvalue
Appears	O
healthy	O
,	O
within	O
normal	O
limits	O
of	O
ideal	O
weight	O
,	O
well	O
hydrated	O
and	O
appearance	O
reflects	O
stated	O
age	O
.	O

2	O
.	O

Cranial	O
nerves	O
IX	O
and	O
X	O
:	O
there	O
was	O
normal	B-labvalue
movement	O
of	O
the	O
soft	O
palate	O
and	O
normal	B-labvalue
gag	O
.	O

HOUSTON	O
,	O
TX	O
77055	O
Gender	O
Female	O
Marital	O
Status	O
(	O
832	O
)	O
788	O
-	O
7771	O
(	O
Home	O
pEone	O
)	O
Language	O
English	O
-	O
preferred	O
Reason	O
for	O
Referral	O

The	O
patient	O
is	O
to	O
get	O
followup	O
exam	O
after	O
discharge	O
.	O

Constitutional	O
:	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
,	O
not	B-negation
feeling	O
poorly	O
(	O
malaise	O
)	O
and	O
not	B-negation
feeling	O
tired	O
(	O
fatigue	O
)	O
.	O

Constitutional	O

There	O
are	O
no	B-negation
retractions	O
or	O
secondary	O
muscle	B-bodyloc
use	O
.	O

9	B-temporal
/	I-temporal
2012	I-temporal
.	O

Use	O
excedrin	O
Migraine	O
,	O
also	O
CTscan	O
results	O
from	O
previous	O
physician	O

ZyrTEC	O
Allergy	O
CAPS	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
16Nov2012	B-temporal
)	O
to	O

Assigned	O
To	O
:	O
Derm	O
Call	O
Backs	O

He	O
had	O
a	O
workup	O
at	O
Texas	O
Children	O
'	O
s	O
Hospital	O
and	O
no	O
etiology	O
was	O
found	O
.	O

glu	O
.	O
)	O
:	O
Normal	O
.	O

Plan	O
[	O
QL	O
]	O
THYROID	O
PANEL	O
WITH	O
TSH	O
,	O
3RD	O
GENERATION	O
Requested	O
for	O
:	O
02Jul2013	B-temporal

Cerefolin	O
TABS	B-form
;	O
1	B-dosage
tab	B-form
daily	B-frequency
;	O
Status	O
:	O
ACTIVE	O

OB	O
History	O

This	O
is	O
associated	O
with	O
nausea	O
.	O

Previous	B-temporal
Surgery	O
:	O
Yes	O
.	O

f	O
No	O
Tobacco	O
Use	O
(	O
Denied	O
)	O

Assessment	O
1	O
.	O

Sleep	O
Medicine	O
Referral	O
Outpatient	O
Referral	O
Status	O
:	O
Complete	O
Done	O
:	O
07Aug2013	B-temporal

Secretions	O
:	O
None	B-negation

Psychiatric	O
:	O
no	B-negation
anxiety	O
,	O
no	B-negation
depression	O
and	O
no	B-negation
emotional	O
problems	O
.	O

Examination	O
of	O
the	O
head	O
and	O
face	O
:	O
Normal	B-labvalue

Systolic	O
:	O
120	B-labvalue
,	O
RUE	O
,	O
Sitting	O

Cranial	O
nerves	O
V	O
:	O
sensation	O
to	O
the	O
face	O
and	O
masseter	O
strength	O
were	O
intact	B-labvalue
.	O

Neck	B-bodyloc
No	B-negation
SC	O
fat	O
pad	O
;	O
No	B-negation
CLA	O
.	O
Thyroid	O
15	O
-	O
20	O
gm	O
;	O
.	O

Examination	O
of	O
cranial	O
nerves	O
:	O
Normal	B-labvalue
.	O

Exercise	O
encouraged	O

URINE	O
BLOOD	O
:	O
NEG	B-labvalue

Comorbid	O
Illnesses	O
:	O
diabetes	O
mellitus	O
.	O

3	O
.	O

Obstructive	O
Sleep	O
Apnea	O
327	O
.	O
23	O

Denied	O

Skin	O
:	O
Skin	O
:	O
normal	O
skin	B-bodyloc
turgor	O
and	O
no	B-negation
significant	O
rash	O
.	O

Past	O
Medical	O
History	O
1	O
.	O

Past	O
Medical	O
History	O
Denied	O

Past	O
treatment	O
has	O
included	O
inhaled	B-route
atrovent	O
.	O

Family	O
History	O
1	O
.	O

CQS	O
Questions	O

Musculoskeletal	O
:	O
joint	B-bodyloc
pain	O
,	O
joint	B-bodyloc
swelling	O
,	O
joint	O
stiffnessandlimb	O
pain	O
,	O
but	O
no	B-negation
limb	B-bodyloc
swelling	O
.	O

Examination	O
of	O
reflexes	O
:	O
Normal	B-labvalue
.	O

Abdomen	O

Mental	O
Status	O
:	O
A	O
mental	O
status	O
exam	O
was	O
performed	O
and	O
was	O
normal	B-labvalue
.	O

Percussion	O
of	O
chest	O
:	O
Normal	B-labvalue
.	O

Current	O
Meds	O
Albuterol	O
Sulfate	O
(	O
2	B-strength
.	I-strength
5	I-strength
MG	I-strength
/	I-strength
3ML	I-strength
)	O
0	O
.	O
083	O
%	O
Inhalation	B-form
Nebulization	I-form
Solution	I-form
;	O
USE	O
1	B-dosage
UNIT	I-dosage
DOSE	O
IN	O
NEBULIZER	O
every	B-frequency
4	I-frequency
hours	I-frequency
x	O
2	B-duration
days	I-duration
then	O
every	B-frequency
4	I-frequency
-	I-frequency
6	I-frequency
hours	I-frequency
as	O
needed	O
for	O
wheezing	O
/	O
coughing	O
;	O
Therapy	O
:	O
10Dec2012	B-temporal
to	O
(	O
Evaluate	O
:	O
08Jun2013	B-temporal
)	O
Requested	O
for	O
:	O
10Dec2012	B-temporal
;	O
Last	O
Rx	O
:	O
10Dec2012	B-temporal

Discussion	O
/	O
Discussion	O
/	O
Summary	O

Assessment	O
Lower	B-bodyloc
Back	I-bodyloc
Pain	O
724	O
.	O
2	O

History	O
of	O
Present	O
Illness	O

Social	O
History	O
Never	O
A	O
Smoker	O

Tobacco	O
Use	O

Eyes	O
:	O
No	B-negation
vision	O
problems	O
(	O
apparent	O
)	O
,	O
eyes	B-bodyloc
not	B-negation
crossed	O
,	O
eyes	B-bodyloc
not	B-negation
turneduout	O
,	O
and	O
no	B-negation
mucous	O
discharge	O
from	O
eyes	B-bodyloc
.	O

Benign	B-severity
Essential	O
Hypertension	O
401	O
.	O
1	O

Benign	O
Essential	O
Hypertension	O
401	O
.	O
1	O

Follow	O
-	O
up	O
visit	O
in	O
6	O
weeks	O
Outpatient	O
Follow	O
-	O
up	O
Status	O
:	O
Complete	O
Done	O
:	O
03Jun2013	B-temporal

Social	O
History	O
Never	O
A	O
Smoker	O

Current	O
Meds	O
GlyBURIDE	O
-	O
MetFORMIN	O
5	B-strength
-	I-strength
500	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Take	O
one	B-dosage
tablet	B-form
by	B-route
mouth	I-route
in	O
the	B-frequency
morning	I-frequency
and	O
two	B-dosage
tablets	B-form
by	B-route
mouth	I-route
in	B-frequency
the	I-frequency
evening	I-frequency
;	O
Therapy	O
:	O
20Dec2011	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
20Dec2011	B-temporal
)	O

Medications	O
:	O
The	O
patient	O
is	O
adherent	O
with	O
his	O
medication	O
regimen	O
.	O
He	O
denies	B-negation
medication	O
side	O
effects	O
.	O

Examination	O
of	O
sensation	O
:	O
Normal	B-labvalue
.	O

Pulmonary	O
:	O
No	B-negation
dyspnea	O
,	O
no	B-negation
cough	O
,	O
and	O
no	B-negation
wheezing	O
.	O

ABDOMEN	O
-	O
Soft	O
,	O
nontender	O
,	O
nondistended	O
with	O
nor8oactive	B-labvalue
BS	O
.	O

Neck	O
:	O
Normal	O
.	O

Mood	O
and	O
Affect	O
:	O
appropriate	B-labvalue
mood	I-labvalue
and	O
appropriate	B-labvalue
affect	I-labvalue
.	O

Neck	O

[	O
QLH	O
]	O
CBC	O
(	O
INCLUDES	O
DIFF	O
/	O
PLT	O
)	O
Status	O
:	O
Complete	O
Done	O
:	O
07Aug2013	B-temporal

trial	O
of	O
advair	O
and	O
proair	O

Sulfamethoxazole	O
-	O
TMP	O
DS	O
800	B-strength
-	I-strength
160	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
TWICE	B-frequency
DAILY	I-frequency
UNTIL	O
FINISHED	O
;	O
Therapy	O
:	O
10Oct2013	B-temporal
to	O
(	O
Evaluate	O
:	O
20Oct2013	B-temporal
)	O
Requested	O
for	O
:	O
10Oct2013	B-temporal
;	O
Last	O
Rx	O
:	O
10Oct2013	B-temporal

Since	O
his	O
last	O
visit	O
,	O
patient	O
'	O
s	O
symptoms	O
have	O
signicantly	O
improved	B-course
.	O

Genitourinary	O
:	O
no	B-negation
dysuria	O
,	O
no	B-negation
incontinence	O
,	O
no	B-negation
pelvic	B-bodyloc
pain	O
,	O
no	B-negation
dysmenorrhea	O
,	O
no	B-negation
genital	B-bodyloc
lesions	O
and	O
no	B-negation
testicular	B-bodyloc
pain	O
.	O

MetFORMIN	O
HCl	O
1000	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
TABLET	B-form
TWICE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
02Jul2010	B-temporal
to	O
(	O
Evaluate	O
:	O
02Dec2013	B-temporal
)	O
Requested	O
for	O
:	O
05Jun2013	B-temporal
;	O
Last	O
Rx	O
:	O
05Jun2013	B-temporal

Breath	O
sounds	O
were	O
not	B-negation
diminished	O
.	O

Globulin	O
2	B-labvalue
.	I-labvalue
8	I-labvalue
g	I-labvalue
/	I-labvalue
dl	I-labvalue
2	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
4	I-reference_range
.	I-reference_range
0	I-reference_range

Nasal	O
endoscopy	O
.	O

The	O
patient	O
is	O
currently	B-temporal
experiencing	O
symptoms	O
.	O

no	B-negation
fever	O
.	O
able	O
to	O
sleep	O
but	O
has	O
hard	O
time	O
due	O
to	O
cough	O
.	O

Constipation	O
564	O
.	O
00	O

Indomethacin	O
ER	O
75	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
Extended	I-form
Release	I-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
WITH	I-frequency
A	I-frequency
MEAL	I-frequency
;	O
Therapy	O
:	O
18Mar2014	B-temporal
to	O
(	O
Evaluate	O
:	O
17May2014	B-temporal
)	O
Requested	O
for	O
:	O
18Mar2014	B-temporal
;	O
Last	O
Rx	O
:	O
18Mar2014	B-temporal
;	O
Status	O
:	O
ACTIVE	O
-	O
Retrospective	O
Authorization	O
;	O
Edited	O

Examination	O
of	O
pupils	O
and	O
irises	O
:	O
Normal	B-labvalue
.	O

Results	O
/	O
Assessment	O
Routine	O
Gynecological	O
Exam	O
With	O
Cervical	O
Pap	O
Smear	O
V72	O
.	O
31	O

Discussion	O
/	O
Discussion	O
/	O
Summary	O

The	O
patient	O
is	O
being	O
seen	O
for	O
follow	O
-	O
up	O
of	O
hypothyroidism	O
.	O

Ms	O
.	O
Pittman	O
is	O
here	O
for	O
med	O
refills	O
and	O
to	O
make	O
sure	O
her	O
records	O
are	O
straightened	O
out	O
between	O
this	O
clinic	O
and	O
her	O
OBGYN	O
,	O
Dr	O
.	O
Sandra	O
Hurtado	O
,	O
who	O
she	O
is	O
no	O
longer	O
seeing	O
.	O

ALERT	O
AND	O
CHEERFUL	O
.	O

ENT	O
:	O
no	B-negation
hearing	O
loss	O
.	O

May	O
repeat	O

Educated	O
patient	O
that	O
there	O
are	O
concerns	O
with	O
infections	O
when	O
considering	O
to	O
aspirate	O
the	O
knee	O
after	O
total	O
knee	O
arthroplasty	O
.	O

I	O
have	O
discussed	O
the	O
case	O
with	O
the	O
resident	O
and	O
agree	O
with	O
the	O
diagnosis	O
and	O
plan	O
.	O

History	O
of	O
Present	O
Illness	O
She	O
was	O
last	O
here	O
in	O
2	B-temporal
/	I-temporal
2012	I-temporal
.	O

He	O
declined	O
to	O
have	O
his	O
A1c	O
checked	O
last	O
visit	O
.	O

Deep	O
tendon	O
reflexes	O
:	O
right	O
bicep	O
2	O
+	O
,	O
left	O
bicep	O
2	O
+	O
,	O
right	O
brachioradialis	O
2	O
+	O
,	O
left	O
brachioradialis	O
2	O
+	O
,	O
right	O
patella	O
2	O
+	O
,	O
left	O
patella	O
2	O
+	O
,	O
right	O
ankle	O
jerk	O
2	O
+	O
and	O
left	O
ankle	O
jerk	O
2	O
+	O
.	O

Denied	O

Cranial	O
Nerves	O
:	O

REASON	O
FOR	O
CONSULTATION	O
:	O
Possible	O
free	O
air	O
under	O
the	O
diaphragm	B-bodyloc
.	O

Past	O
Medical	O
History	O

Comments	O
:	O
GHTN	O
,	O
GDM	O
.	O

General	O
appearance	O
:	O
Normal	B-labvalue
.	O

It	O
does	O
not	O
occur	O
with	O
exertion	O
.	O

Discussion	O
/	O
Discussion	O
/	O
Summary	O
She	O
likely	B-uncertain
has	O
a	O
neutrophilic	O
inflammatory	O
substrate	O
.	O

Baby	O
delivered	O
operatively	O
,	O
Apgar	O
scores	O
were	O
8	B-labvalue
and	O
9	B-labvalue
initially	O
taken	O
to	O
level	O
2	O
satellite	O
nursery	O
and	O
arrangements	O
were	O
to	O
transfer	O
to	O
Children	O
'	O
s	O
Hospital	O
.	O

ENDOCRINE	O
:	O
no	B-negation
cold	O
intolerance	O
,	O
no	B-negation
heat	O
intolerance	O
and	O
no	B-negation
excessive	O
thirst	O
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

An	O
EMG	O
examination	O
showed	O
abnormal	O
spontaneous	O
activity	O
in	O
the	O
right	B-bodyloc
tibialis	I-bodyloc
anterior	I-bodyloc
and	O
peroneus	O
longus	O
muscles	O
.	O

The	O
duration	O
of	O
her	O
recent	O
periods	O
has	O
been	O
regular	O
.	O

Eyes	O

Palpation	O
of	O
breasts	O
and	O
axillae	O
:	O
Normal	B-labvalue

Complications	O
:	O
None	O
.	O

History	O
of	O
Edema	O
782	O
.	O
3	O

Bilateral	O
nipple	O
examination	O
revealed	O
normal	B-labvalue
appearance	I-labvalue
and	O
no	B-negation
discharge	O
.	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
KEVIN	O
COUPE	O
,	O
M	O
.	O
D	O
.	O

HEARING	O
-	O
Follows	B-labvalue
sound	I-labvalue

Hepatitis	O
B	O
;	O
09	B-temporal
Nov	I-temporal
2007	I-temporal

Genitourinary	O
:	O
no	B-negation
dysuria	O
.	O

Long	O
(	O
peron	O
.	O
)	O
Strength	O
:	O
5	B-labvalue
-	I-labvalue
/	I-labvalue
5	I-labvalue
.	O

ENT	O
:	O
nasal	B-bodyloc
discharge	O
.	O

Current	O
Meds	O
Divalproex	O
Sodium	O
ER	O
500	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
Extended	I-form
Release	I-form
24	I-form
Hour	I-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
BY	O
MOUTH	O
TWICE	O
DAILY	O
;	O
Therapy	O
:	O
29Mar2010	B-temporal
to	O
(	O
Evaluate	O
:	O
19Mar2014	B-temporal
)	O
Requested	O
for	O
:	O
19Nov2013	B-temporal
;	O
Last	O
Rx	O
:	O
19Nov2013	B-temporal
;	O
Status	O
:	O
ACTIVE	O
-	O
Retrospective	O
Authorization	O

Jugular	O
veins	O
:	O
Normal	O
.	O

The	O
patient	O
presents	O
with	O
complaints	O
of	O
heartburn	O
(	O
OCC	O
.	O

He	O
still	O
gets	O
a	O
lightheaded	O
sensation	O
of	O
vertical	O
movement	O
and	O
occasional	O
ringing	O
in	O
the	O
right	B-bodyloc
ear	I-bodyloc
triggered	O
by	O
movement	O
.	O

Additional	O
history	O
:	O
pt	O
.	O
uses	O
engery	O
drinks	O
for	O
fatigue	O
that	O
contains	O
Iodine	O
.	O

Symptoms	O
are	O
unchanged	O
.	O

Anemia	O
285	O
.	O
9	O

Potassium	O
of	O
3	B-labvalue
.	I-labvalue
2	I-labvalue
on	O
08/15/2007	B-temporal
.	O

Cardiovascular	O

This	O
is	O
a	O
34	O
years	O
old	O
female	O
with	O
DM	O
on	O
OAD	O
,	O
insulin	O
and	O
GLP1	O
-	O
RA	O
.	O

Maternal	B-subject
history	O
of	O
Colon	B-bodyloc
Cancer	O
V16	O
.	O
0	O

Cranial	O
nerves	O
XII	O
:	O
there	O
was	O
no	B-negation
tongue	B-bodyloc
deviation	O
with	O
protrusion	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Integumentary	O
:	O
normal	O
,	O
no	B-negation
breast	B-bodyloc
pain	O
,	O
no	B-negation
breast	B-bodyloc
mass	O
,	O
no	B-negation
changes	O
in	O
mole	O
(	O
s	O
)	O
,	O
no	B-negation
rash	O
,	O
no	B-negation
itching	O
.	O

History	O
of	O
Radiation	O
Therapy	O
V15	O
.	O
3	O

3	O
.	O

(	O
dystonic	O
eye	B-bodyloc
movements	O
)	O

Ischemic	O
Stroke	O
434	O
.	O
90	O

The	O
motor	O
nerve	O
conduction	O
of	O
the	O
right	O
peroneal	O
nerve	O
showed	O
increased	O
distal	O
latency	O
normal	O
amplitude	O
and	O
partial	O
motor	O
conduction	O
block	O
,	O
and	O
reduced	O
conduction	O
velocity	O
across	O
the	O
fibular	B-bodyloc
head	I-bodyloc
.	O

ElectronicCily	O
signed	O
by	O
:	O
Laura	O
Clark	O
Mar	B-temporal
6	I-temporal
2013	I-temporal
10	B-temporal
:	I-temporal
23AM	I-temporal
CST	O

The	O
patient	O
is	O
due	O
for	O
a	O
lipid	O
panel	O
.	O

Pulmonary	O

Neck	O

Cranial	O
Nerves	O
:	O

an	O
initial	O
evaluation	O
of	O
sinusitis	O
.	O

Menstrual	O
History	O
.	O

Cerebellar	O
:	O
the	O
cerebellar	O
function	O
was	O
normal	B-labvalue
.	O

Respiratory	O
rate	O
:	O
the	O
respiratory	O
rate	O
was	O
normal	B-labvalue
.	O

Assessment	O

UTP	O
-	O
OB	O
/	O
Patient	O
here	O
for	O
.	O

Weber	O
'	O
s	O
test	O
demonstrates	O
no	B-negation
lateralization	O
of	O
tone	O
.	O

Assessment	O
Sacroiliitis	O
720	O
.	O
2	O

The	O
tongue	O
was	O
normal	O
.	O

no	B-negation
CVA	O
tenderness	O

Reflexes	O
:	O
the	O
reflexes	O
were	O
normal	B-labvalue
and	O
the	O
deep	O
tendon	O
reflexes	O
were	O
normal	B-labvalue
Babinski	O
reflex	O
absent	B-labvalue
on	I-labvalue
the	I-labvalue
right	I-labvalue
and	O
absent	B-labvalue
on	I-labvalue
the	I-labvalue
left	I-labvalue
.	O

Suspect	B-uncertain
empty	O
nose	B-bodyloc
,	O
and	O
PND	O
as	O
driving	O
the	O
nasal	B-bodyloc
complaint	O
,	O
but	O
it	O
is	O
doubtful	O
that	O
this	O
complain	O
is	O
the	O
source	O
of	O
her	O
impairment	O
in	O
QOL	B-bodyloc

No	B-negation
abdominal	B-bodyloc
or	O
pelvic	B-bodyloc
pain	O
.	O

Endocrine	O
:	O
no	B-negation
hot	O
flashes	O
,	O
no	B-negation
changes	O
in	O
appetite	O
,	O
no	B-negation
unusual	O
sensitivity	O
to	O
changes	O
in	O
temperature	O
and	O
no	B-negation
feelings	O
of	O
excessive	O
thirst	O
.	O

History	O
of	O
Alcohol	O
Use	O

Constitutional	O
:	O
recent	B-temporal
2	O
lb	O
weight	O
loss	O
,	O
but	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
,	O
not	B-negation
feeling	O
poorly	O
(	O
malaise	O
)	O
and	O
not	B-negation
feeling	O
tired	O
(	O
fatigue	O
)	O
.	O

(	O
radial	O
)	O
:	O
Normal	O
.	O

Neurologic	O

No	B-negation
dysuria	O
.	O

Urethra	O
:	O
Normal	O
,	O
no	B-negation
discharge	O
.	O

Sample	O
Type	O
/	O
Medical	O

Irises	O
symmetrical	O
,	O
undilated	O
.	O

Discussion	O
/	O
Plan	O
1	O
.	O

Reason	O
For	O
Visit	O

Followup	O
will	O
be	O
in	O
ten	O
days	O
for	O
a	O
cystogram	O
and	O
catheter	O
removal	O
with	O
followup	O
in	O
the	O
office	O
at	O
that	O
time	O
.	O

CHIEF	O
COMPLAINT	O
:	O
Left	B-bodyloc
lower	I-bodyloc
extremity	I-bodyloc
injury	O
.	O

Cranial	O
Nerves	O
III	O
,	O
IV	O
,	O
and	O
VI	O
:	O
the	O
extraocular	O
motions	O
were	O
intact	B-labvalue
.	O

ValACYclovir	O
HCl	O
500	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
13Jul2012	B-temporal
to	O
(	O
Evaluate	O
:	O
14Sep2012	B-temporal
)	O
;	O
Last	O
Rx	O
:	O
16Jul2012	B-temporal

No	B-negation
murmurs	O
were	O
heard	O
.	O

0	I-reference_range
Hemoglobin	O
12	B-labvalue
.	I-labvalue
8	I-labvalue
g	I-labvalue
/	I-labvalue
dl	I-labvalue
L	B-labvalue
14	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
18	I-reference_range
.	I-reference_range

VITAL	O
SIGNS	O
:	O

5	I-reference_range
CO2	O
28	B-labvalue
mEq	I-labvalue
/	I-labvalue
l	I-labvalue
24	B-reference_range
-	I-reference_range
32	I-reference_range
Chloride	O
Lvl	O
105	B-labvalue
mEq	I-labvalue
/	I-labvalue
l	I-labvalue
95	B-reference_range
-	I-reference_range
109	I-reference_range
Crea	O
inine	O
Lvl	O
1	B-labvalue
.	I-labvalue
1	I-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
0	B-reference_range
.	I-reference_range
5	I-reference_range
-	I-reference_range
1	I-reference_range
.	I-reference_range

Allergies	O
No	B-negation
Known	O
Allergies	O

No	B-negation
Known	O
Drug	O
Ailergies	O
.	O
eg	O

3	O
.	O

Immunizations	O

Oropharynx	O
:	O
normal	O
mucosa	O
and	O
appearance	O
.	O

Musculoskeletal	O

Type	O
2	O
Diabetes	O
Mellitus	O
-	O
Uncomplicated	B-severity
,	O
Controlled	B-course
250	O
.	O
00	O

Keflex	O
TABS	B-form

Surgical	O
History	O

UTP	O
-	O
VaginalBleeding	B-bodyloc
(	O
Brief	O
)	O
c846da06	O
-	O
25ad	O
-	O
471d	O
-	O
b4f9	O
-	O
a8a8110eb0ccFoamStart	O
GroupHeading4Start	O
GroupHeading4End	O
GroupHeading6Start	O
GroupHeading6End	O
GroupHeading30Start	O
GroupHeading30End	O
GroupHeading216Start	O
Symptoms	O
:	O
pelvic	B-bodyloc
pressure	O
,	O
but	O
no	B-negation
pelvic	B-bodyloc
paip	O
,	O
no	B-negation
abdominal	B-bodyloc
discomfort	O
,	O
no	B-negation
uterine	B-bodyloc
contractions	O
and	O
no	B-negation
uterine	B-bodyloc
cramping	O
.	O

Urethra	O
:	O
Normal	O
.	O

Screening	O
:	O
Cancer	O
screening	O
reviewed	O
and	O
updated	O
.	O

Toyota	O
Camry	O
.	O

76	O
year	O
old	O
male	O
presents	O
today	O
for	O
8	B-temporal
week	I-temporal
follow	O
-	O
up	O
status	O
-	O
post	O
left	O
total	O
knee	O
arthroplasty	O
,	O
DOS	O
1/8/14	B-temporal
.	O

Retrospective	O
Authorization	O
;	O
Edited	O

Follow	O
-	O
up	O
visit	O
in	O
2	O
weeks	O
Outpatient	O
Follow	O
-	O
up	O
Requested	O
for	O
:	O
20Jul2013	B-temporal

BMI	O
Calculated	O
:	O
21	B-labvalue
.	I-labvalue
63	I-labvalue

Abdomen	O
:	O
Normal	O
.	O

f	O
Lexapro	O
20	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
(	O
Active	O
)	O

Name	O
:	O
Air	O
Under	O
Diaphragm	O
-	O
Consult	O

DIAGNOSTIC	O
DATA	O
:	O
1	O
.	O

Respiratory	O
:	O
shortness	O
of	O
breath	O
during	O
exertion	O
,	O
but	O
no	O
shortness	O
of	O
breathand	O
no	B-negation
cough	O
.	O

Plan	O
MetFORMIN	O
HCl	O
1000	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
EVERY	B-frequency
12	I-frequency
HOURS	I-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
27Jan2014	B-temporal
to	O
(	O
Evaluate	O
:	O
24Aug2014	B-temporal
)	O
Requested	O
for	O
:	O
25Feb2014	B-temporal
;	O
Last	O
Rx	O
:	O
25Feb2014	B-temporal
;	O
Edited	O

She	O
denies	B-negation
any	O
current	O
vaginal	B-bodyloc
bleeding	O
or	O
discharge	O
.	O

Discussion	O
/	O
Attending	O
Note	O

I	O
have	O
followed	O
him	O
for	O
several	B-temporal
years	I-temporal
.	O

Pertinent	O
medical	O
history	O
:	O
chronic	B-course
bronchitis	O
,	O
but	O
no	B-negation
asthma	O
,	O
no	B-negation
other	O
pulmonary	B-bodyloc
disease	O
,	O
no	B-negation
stroke	O
,	O
no	B-negation
gastroesophageal	B-bodyloc
reflux	O
disease	O
,	O
no	B-negation
diabetes	O
and	O
no	B-negation
obesity	O
.	O

Psychiatric	O

Never	O
Drank	O
Alcohol	O

Auscultation	O
:	O
diffuse	O
wheezing	O
was	O
heard	O
Crackles	O
were	O
heard	O
over	O
both	O
bases	O
.	O

CONSTITUTIONAL	O

Lymphocytes	O
#	O
:	O
1	B-labvalue
.	I-labvalue
6	I-labvalue
K	I-labvalue
/	I-labvalue
CMM	I-labvalue
Reference	O
Range	O
1	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
5	I-reference_range
.	I-reference_range
5	I-reference_range

History	O
of	O
Thyroid	B-bodyloc
Cancer	O

Family	O
History	O
Maternal	B-subject
history	O
of	O
Cancer	O

The	O
rhythm	O
was	O
sinus	B-labvalue
without	B-negation
ectopy	O
.	O

GENITOURINARY	O
:	O
No	B-negation
dysuria	O
.	O

Diabetes	O
,	O
still	O
with	O
some	O
problematic	O
low	O
blood	O
glucoses	O
,	O
most	O
notably	O
in	O
the	O
morning	O
.	O

Percussion	O
of	O
chest	O
:	O
Normal	B-labvalue
.	O

No	B-negation
rales	O
or	O
crackles	O
were	O
heard	O
.	O

Pupils	O
:	O
.	O

[	O
QLH	O
]	O
CMP	O
W	O
/	O
EGFR	O
Requested	O
for	O
:	O
04Apr2014	B-temporal

Inspection	O
of	O
wound	O
:	O
Normal	B-labvalue
.	O

2	O
.	O

Immunizations	O

This	O
is	O
the	O
case	O
of	O
a	O
very	O
pleasant	O
41	O
-	O
year	O
-	O
old	O
Caucasian	O
female	O
who	O
was	O
seen	O
in	O
clinic	O
as	O
an	O
initial	O
consultation	O
on	O
09/13/07	O
complaining	O
of	O
intense	B-severity
neck	B-bodyloc
pain	O
radiating	O
to	O
the	O
right	O
shoulder	O
blade	O
to	O
top	O
of	O
the	O
right	O
shoulder	O
in	O
to	O
the	O
right	O
upper	O
extremity	O
to	O
the	O
patient	O
'	O
s	O
hand	O
.	O

Results	O
/	O
Results	O
/	O
Data	O
Physical	O
Exam	O
Cholesterol	O
Urinalysis	O
Colonoscopy	O
EGD	O
EKG	O
Stress	O
Test	O
Echo	O
Cardiac	O
Cath	O
Peripheral	O
Vascular	O
Screen	O
Carotid	O
Vascular	O
Screen	O
AAA	O
ABI	O
/	O
PVR	O
Diabetes	O
Screen	O
Other	O
Mammogram	O
PAP	O
Dexa	O
Prostate	O
/	O
PSA	O

Family	O
History	O
:	O

4	O
.	O

PAP	O
Smear	O
:	O
7	B-temporal
/	I-temporal
2011	I-temporal

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
vomiting	O
,	O
no	B-negation
constipation	O
,	O
no	B-negation
diarrhea	O
,	O
no	B-negation
heartburn	O
and	O
no	B-negation
melena	O
.	O

History	O
of	O
Urinary	B-bodyloc
Tract	I-bodyloc
Infection	O
V13	O
.	O
02	O

f	O
No	O
Advance	O
Directives	O
available	O
.	O

The	O
rhythm	O
was	O
regular	O
.	O

;	O
Oct	B-temporal
24	I-temporal
2012	I-temporal
9	B-temporal
:	I-temporal
16AM	I-temporal
(	O
Author	O
)	O

3	O
.	O

Family	O
History	O
Maternal	B-subject
grandfather	I-subject
'	I-subject
s	I-subject
history	O
of	O
Arthritis	O
V17	O
.	O
7	O

ENT	O
:	O
no	B-negation
earache	O
,	O
no	B-negation
hearing	O
loss	O
,	O
no	B-negation
epistaxis	O
,	O
no	B-negation
nasal	B-bodyloc
discharge	O
,	O
no	B-negation
hoarseness	O
and	O
no	B-negation
sore	O
throat	B-bodyloc
.	O

Head	O
and	O
Face	O

Eyes	O
mucous	O
discharge	O
from	O
the	O
eyes	B-bodyloc
,	O
but	O
no	B-negation
red	O
eyes	B-bodyloc
.	O

Surgical	O
History	O
1	O
.	O

No	B-negation
Known	O
Drug	O
Allergies	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
BEHROOZ	O
SAFFARI	O
,	O
M	O
.	O
D	O
.	O

Infant	O
had	O
two	O
cardiac	O
echograms	O
done	O
.	O

No	B-negation
edema	O
.	O

Her	O
blood	O
pressure	O
has	O
been	O
varied	O
but	O
consistently	O
somewhat	O
high	B-labvalue
at	O
the	O
clinic	O
,	O
which	O
she	O
attributes	O
to	O
whitecoat	O
syndrome	O
and	O
says	O
the	O
longer	O
she	O
waits	O
,	O
the	O
higher	O
it	O
is	O
.	O

Adenoid	O
Pad	O
:	O
normal	O

No	B-negation
anterior	B-bodyloc
cervical	I-bodyloc
node	I-bodyloc
enlargement	O
,	O
no	B-negation
posterior	O
cervical	B-bodyloc
node	I-bodyloc
enlargement	O
,	O
no	B-negation
submandibular	O
node	O
enlargement	O
and	O
no	B-negation
supraclavicular	B-bodyloc
node	I-bodyloc
enlargement	O
.	O

ST	O
/	O
SE	O
/	O
Sphen	O
:	O
Normal	B-labvalue

History	O
of	O
General	O
Surgery	O

Palpation	O
of	O
the	O
face	O
and	O
sinuses	O
:	O
Normal	B-labvalue
.	O

29	O
yo	O
P2002	O
s	O
/	O
p	O
repeat	O
C	O
/	O
D	O
here	O
for	O
2	B-temporal
week	I-temporal
postop	O
check	O
,	O
T2DM	O
and	O
h	O
/	O
o	O
HSV	O

Chief	O
Complaint	O

Cranial	O
nerves	O
VIII	O
:	O
hearing	O
was	O
intact	B-labvalue
.	O

Patient	O
Specific	O
Education	O
Given	O
Done	O
:	O
14Jun2012	B-temporal

Patient	O
cell	O
:	O
281	O
599	O
9241	O
.	O

History	O
of	O
Pelvic	O
Repair	O

Sample	O
Name	O
:	O
Airway	O
Compromise	O
&	O
Foreign	O
Body	O
-	O
ER	O
Visit	O

Left	O
long	O
finger	O
flexor	O
digitorum	O
profundus	O
repair	O
6	O
.	O

Review	O
of	O
Systems	O

6	O
.	O

No	O
driving	O
etc	O
;	O
Therapy	O
:	O
31Jan2012	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
31Jan2012	B-temporal
)	O

Electronically	O
signed	O
by	O
:	O
JOHN	O
LINDSEY	O
,	O
M	O
.	O
D	O
.	O

Lab	O
orders	O
submitted	O
for	O
this	O
patient	O
were	O
not	O
performed	O

Hematologic	O
/	O
Lymphatic	O
:	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
,	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
and	O
no	B-negation
swollen	O
glands	B-bodyloc
.	O

Psych	O
not	B-negation
feeling	O
nervous	O
,	O
no	B-negation
anxiety	O
,	O
no	O
depressionand	O
no	B-negation
hallucinations	O
.	O

Urethral	O
meatus	O
:	O
Normal	O
.	O

[	O
QLH	O
]	O
CMP	O
W	O
/	O
EGFR	O
Requested	O
for	O
:	O
25Feb2014	B-temporal

Pt	O
.	O
here	O
to	O
see	O
Dr	O
.	O
Bar	O
-	O
Eli	O
for	O
physical	O
.	O

History	O
of	O
Esophageal	B-bodyloc
Reflux	O
530	O
.	O
81	O

;	O
Jan	B-temporal
4	I-temporal
2013	I-temporal
2	B-temporal
:	I-temporal
44PM	I-temporal
(	O
Author	O
)	O

2	O
'	O
PP	O
lunch	O
:	O
all	O
<	O
120	O

Houston	O
,	O
TX	O
77030	O

2	O
.	O

Donepezil	O
HCl	O
5	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
AT	B-frequency
BEDTIME	I-frequency
;	O
Therapy	O
:	O
15Jan2013	B-temporal
to	O
(	O
Evaluate	O
:	O
15Apr2013	B-temporal
)	O
Requested	O
for	O
:	O
15Jan2013	B-temporal
;	O
Last	O
Rx	O
:	O
15Jan2013	B-temporal

"	O
Patient	O
Specific	O
Education	O
Given	O
Done	O
:	O
24Mar2014	B-temporal

see	O
hra	O
risk	O
form	O
medicaid	O

Copaxone	O
can	O
cause	O
hypersensitivity	O
responses	O
.	O

Supervision	O
Of	O
Normal	O
First	O
Pregnancy	O
V22	O
.	O
0	O

White	O
Blood	O
Cell	O
:	O
4	B-labvalue
.	I-labvalue
1	I-labvalue
K	I-labvalue
/	I-labvalue
CMM	I-labvalue
Reference	O
Range	O
3	B-reference_range
.	I-reference_range
7	I-reference_range
-	I-reference_range
10	I-reference_range
.	I-reference_range
4	I-reference_range

Inspection	O
of	O
the	O
conjunctiva	O
and	O
lids	O
:	O
Normal	B-labvalue
.	O

T	O
.	O

Gastric	O
Emptying	O
Scan	O
Requested	O
for	O
:	O
17Jan2012	B-temporal

Reason	O
For	O
Visit	O

"	O
Drug	O
Use	O

Chief	O
Complaint	O

Denied	O

twNoteSignatureControlStart	O

Past	O
Medicrl	O
History	O

General	O
appearance	O
:	O
Normal	B-labvalue
.	O

Height	O
:	O
5	B-labvalue
ft	I-labvalue
2	I-labvalue
in	I-labvalue

I	O
have	O
discussed	O
the	O
case	O
of	O
Ms	O
.	O
GEE	O
with	O
the	O
resident	O
and	O
agree	O
with	O
the	O
diagnosis	O
of	O
well	O
9	O
month	O
old	O
with	O
nor8al	O
growth	O
and	O
development	O
.	O

;	O
Feb	B-temporal
24	I-temporal
2014	I-temporal
3	B-temporal
:	I-temporal
16PM	I-temporal
(	O
Author	O
)	O

Examination	O
of	O
pupils	O
and	O
irises	O
:	O
Normal	B-labvalue
.	O

Paternal	B-subject
history	O
of	O
Hypertension	O
V17	O
.	O
49	O

hemocult	O
-	O
negative	B-labvalue

He	O
still	O
has	O
had	O
no	B-negation
episodes	O
of	O
loss	O
of	O
awareness	O
.	O

Hypertension	O
401	O
.	O
9	O

Edema	O
:	O
Pitting	O
edema	O
.	O

Pulmonary	O

Examination	O
of	O
extremities	O
for	O
edema	O
and	O
/	O
or	O
varicosities	O
:	O
Normal	B-labvalue
No	B-negation
edema	O
.	O

No	B-negation
rales	O
or	O
crackles	O
were	O
heard	O
.	O

Chronic	B-course
Constipation	O
564	O
.	O
00	O

No	B-negation
nasal	B-bodyloc
passage	O
blockage	O
,	O
no	B-negation
hoarseness	O
,	O
no	B-negation
choking	O
,	O
no	B-negation
mouth	B-bodyloc
sores	O
,	O
no	B-negation
spots	O
in	O
the	O
mouth	B-bodyloc
,	O
and	O
no	B-negation
bad	O
breath	O
.	O

Joint	B-bodyloc
Pain	O
,	O
Localized	O
In	O
The	O
Shoulder	B-bodyloc
719	O
.	O
41	O

Head	O
and	O
Face	O

Surgical	O
History	O
History	O
of	O
Mitral	O
Valve	O
Replacement	O

Indication	O
:	O
Ostial	O
stenosisandPost	O
-	O
op	O
visit	O
.	O

Her	O
headache	O
also	O
improves	B-course
w	O
/	O
Vicodin	O
and	O
/	O
or	O
Motrin	O
.	O

Reviewed	O
07/30/2013	B-temporal
THSteps	O
Requirements	O
:	O

Cardiovascular	O

MUSCULOSKELETAL	O
:	O
no	B-negation
muscle	B-bodyloc
pain	O
and	O
no	B-negation
muscle	B-bodyloc
weakness	O
.	O

During	O
admission	O
,	O
the	O
patient	O
did	O
not	B-negation
exhibit	I-negation
any	O
signs	O
or	O
symptoms	O
of	O
pneumonia	O
.	O

Soleus	O
(	O
tib	O
.	O
)	O
Strength	O
:	O
5	B-labvalue
/	I-labvalue
5	I-labvalue
.	O

Test	O
Name	O
Result	O
Flag	O
Reference	O

Assessment	O
of	O
range	O
of	O
motion	O
:	O
Normal	B-labvalue
.	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
KRISTY	O
BAI	O
,	O
M	O
.	O
D	O
.	O

f	O
Losartan	O
Potassium	O
-	O
HCTZ	O
100	B-strength
-	I-strength
25	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
EVERY	B-frequency
MORNING	I-frequency
;	O
Start	O
Date	O
:	O
09/10/2010	B-temporal
;	O
End	O
Date	O
:	O
01/01/1900	B-temporal
(	O
Active	O
)	O

Eyes	O
:	O
No	B-negation
red	O
eyes	B-bodyloc
.	O

SB	O
EXAMS	O
(	O
+	O
)	O
FINDINGS	O
(	O
-	O
)	O

Sensation	O
:	O
No	B-negation
sensory	O
loss	O
.	O

1	O
)	O
Follow	O
up	O
on	O
bronchitis	O
.	O

History	O
of	O
Present	O
Illness	O

ENT	O
:	O
no	B-negation
earache	O
.	O

Examination	O
of	O
pupils	O
and	O
irises	O
:	O
Normal	B-labvalue
.	O

Discussion	O
/	O
Discussion	O
/	O
Summary	O

Examination	O
of	O
the	O
oropharynx	O
:	O
Normal	B-labvalue

Gemfibrozil	O
600	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
11Dec2013	B-temporal
to	O

History	O
of	O
Drug	O
Use	O

Speech	O
Phonation	O
Dysphonia	O
784	O
.	O
42	O

Pupils	O
:	O
.	O

Copaxone	O
20	B-strength
MG	I-strength
/	I-strength
ML	I-strength
Subcutaneous	B-route
Kit	O
;	O
INJECT	B-form
SUBCUTANEOUSLY	B-route
DAILY	B-frequency
AS	O
DIRECTED	O
;	O
Therapy	O
:	O
20Feb2008	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
20Feb2008	B-temporal
)	O
Requested	O
for	O
:	O
20Feb2008	B-temporal

Current	O
Meds	O
CefTAZidime	O
2	B-strength
GM	I-strength
Injection	B-form
Solution	I-form
Reconstituted	O
;	O
1g	B-strength
Ceftazidime	O
:	O
Mix	O
1	O
vial	O
w	O
/	O
1	O
vial	O
sterile	O
H20	O
.	O
0	O
Put	O
in	O
Neil	O
Med	O
,	O
add	O
H20	O
,	O
irrigate	O
each	O
nostril	O
w	O
/	O
50ml	B-dosage
TID	B-frequency
x	O
3	B-duration
weeks	I-duration
;	O
Therapy	O
:	O
10Sep2009	B-temporal
to	O
(	O
Evaluate	O
:	O
21Apr2011	B-temporal
)	O
Requested	O
for	O
:	O
24Feb2011	B-temporal
;	O
Last	O
Rx	O
:	O
24Feb2011	B-temporal

History	O
of	O
Diabetic	O
Peripheral	O
Neuropathy	O
Type	O
2	O
-	O
Uncontrolled	O
250	O
.	O
62	O

Allergies	O
1	O
.	O

Hyperlipidemia	O
272	O
.	O
4	O

Esophageal	B-bodyloc
Reflux	O
530	O
.	O
81	O

Generalized	O
Convulsive	O
Tonic	O
Seizure	O
With	O
Intractable	O
Seizure	O
345	O
.	O
11	O

Skin	O

Otoscopic	O
examination	O
:	O
Abnormal	O
.	O

UTP	O
-	O
OB	O
/	O

Diabetic	O
Foot	O
Exam	O
:	O

3	O
.	O

ENT	O
:	O
no	B-negation
earache	O
,	O
no	B-negation
hearing	O
loss	O
,	O
no	B-negation
epistaxis	O
,	O
no	B-negation
nasal	B-bodyloc
discharge	O
,	O
no	B-negation
hoarseness	O
and	O
no	B-negation
sore	O
throat	B-bodyloc
.	O

Itching	O
(	O
Pruritus	O
)	O
698	O
.	O
9	O

Pulmonary	O

No	B-negation
urinary	O
incontinence	O
.	O

Cut	O
aricept	O
to	O
half	O
,	O
husband	O
to	O
call	O
and	O
see	O
if	O
there	O
is	O
any	O
improvement	O
,	O
gait	O
and	O
balance	O
rehab	O

She	O
has	O
facial	B-bodyloc
assymetry	O
an	O
dneeds	O
to	O
work	O
on	O
tapping	O
her	O
teeth	O
together	O
and	O
pursing	O
her	O
lips	O
-	O
controlling	O
her	O
jaw	O
.	O

Delivered	O
:	O
2003	O
.	O

Previous	B-temporal
Resection	O
:	O
Yes	O
.	O

Family	O
history	O
of	O
Reported	O
Family	B-subject
History	O
Of	O
Cancer	O
Social	O
History	O

Musculoskeletal	O
:	O
no	B-negation
arthralgias	O
and	O
no	B-negation
joint	B-bodyloc
pain	O
.	O

Pupils	O
:	O
.	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
and	O
no	B-negation
cough	O
.	O

Assessment	O
Cerumen	O
Impaction	O
380	O
.	O
4	O

[	O
H	O
]	O
Obstetrics	O
Panel	O
(	O
includes	O
CBCw	O
/	O
Diff	O
,	O
RPR	O
,	O
HbsAg	O
,	O
RubIgG	O
,	O
Type	O
&	O
Screen	O
)	O

CounselingDocumeptatiop80b073a3	O
-	O
29fe	O
-	O
4f81	O
-	O
9167	O
-	O
250822535ffdFormStart	O
GroupHeading19Start	O
The	O
patient	O
was	O
counseled	O
regarding	O
instructisps	O
fis	O
managemept	O
,	O
risk	O
factor	O
reductisps	O
,	O
psognosis	O
,	O
patient	O
and	O
family	O
educatiop	O
,	O
risks	O
apd	O
benefits	O
of	O
treatmept	O
optisps	O
and	O
importance	O
if	O
compliance	O
w	O
th	O
treatmept	O
.	O

Right	O
normal	O
axillary	O
node	O
.	O

Admission	O
Date	O
:	O
[	O
*	O
*	O
2101-12-17	B-temporal
*	O
*	O
]	O
Discharge	O
Date	O
:	O
[	O
*	O
*	O
2101-12-22	B-temporal
*	O
*	O
]	O

Uterus	O
:	O
Normal	O

T4	O
Free	O
1	B-labvalue
.	I-labvalue
00	I-labvalue
ng	I-labvalue
/	I-labvalue
dl	I-labvalue
0	B-reference_range
.	I-reference_range
76	I-reference_range
-	I-reference_range
1	I-reference_range
.	I-reference_range
46	I-reference_range

Anesthesia	O
:	O
Topical	B-route
lidocaine	O
spray	B-form
and	O
Topical	B-route
oxymetazoline	O
spray	B-form
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

General	O
appearance	O
:	O
Normal	B-labvalue
.	O

Metoprolol	O
Tartrate	O
TABS	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
19Jul2012	B-temporal
)	O
to	O

Active	O
Problems	O
Acute	B-course
Venous	O
Thrombosis	O
Of	O
The	O
Deep	B-bodyloc
Vessels	I-bodyloc
Of	O
The	O
Lower	B-bodyloc
Extremity	I-bodyloc
453	O
.	O
40	O

Examination	O
of	O
the	O
skin	O
for	O
lesions	O
:	O
Abnormal	O
.	O
Left	B-bodyloc
inter	I-bodyloc
phalungeal	I-bodyloc
wound	O
,	O
dry	O
and	O
crusted	O
,	O
no	B-negation
active	O
drainage	O
,	O
non	O
tender	O
,	O
between	O
left	O
foot	O
1st	O
and	O
2nd	O
metatarsal	O
.	O

Disp	O
:	O
*	O
30	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E	O
.	O
C	O
.	O

Leg	B-bodyloc
Pain	O
With	O
Exercise	O
(	O
Leg	B-bodyloc
Claudication	O
)	O

"	O
Being	O
A	O
Social	O
Drinker	O
"	O

Maternal	B-subject
history	O
of	O
Type	O
2	O
Diabetes	O
Mellitus	O

Palpation	O
of	O
heart	O
:	O
Normal	B-labvalue

Risk	O
factors	O
:	O
obesity	O
and	O
physical	O
inactivity	O
,	O
but	O
no	O
alcohol	O
use	O
and	O
no	O
smoking	O
.	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
neck	O
:	O
Normal	B-labvalue
.	O

UTP	O
-	O
OB	O
/	O

CurrentMeds	O
_	O
4	O
_	O
twCiteListControlStart	O
No	B-negation
Reported	O
Medications	O

Weight	O
:	O
150	B-labvalue
lb	I-labvalue
4	I-labvalue
oz	I-labvalue

Results	O
/	O
Assessment	O
Visit	O
For	O
:	O
Pap	O
Smear	O
Vaginal	O
Malig	O
Neoplasm	O
Post	O
-	O
Hysterectomy	O
V67	O
.	O
01	O

Musculoskeletal	O
:	O
normal	O
,	O
no	B-negation
joint	B-bodyloc
pain	O
and	O
no	B-negation
limb	B-bodyloc
pain	O
.	O

Retrospective	O
Authorization	O

Repeat	O
lipids	O
in	O
3	B-labvalue
m	I-labvalue

Musculoskeletal	O
:	O

Vitamin	O
D	O
Deficiency	O
268	O
.	O
9	O

Electronically	O
signed	O
by	O
:	O
MICHAEL	O
ALTMAN	O
,	O
M	O
.	O
D	O
.	O

Bladder	O
:	O
Normal	O
.	O

Examination	O
of	O
the	O
abdomen	O
:	O
Normal	B-labvalue

Psychiatric	O
:	O
sleep	O
disturbances	O
,	O
anxiety	O
and	O
depression	O
,	O
but	O
not	B-negation
suicidal	O
.	O

History	O
of	O
Benign	B-severity
Paroxysmal	O
Positional	O
Vertigo	O
386	O
.	O
11	O

He	O
was	O
considered	O
for	O
a	O
deep	O
brain	O
stimulation	O
,	O
but	O
because	O
of	O
his	O
rigidity	O
and	O
lack	O
of	O
dyskinesias	O
,	O
he	O
was	O
not	O
felt	O
to	O
be	O
a	O
candidate	O
for	O
this	O
.	O

Breath	O
sounds	O
were	O
not	B-labvalue
diminished	I-labvalue
.	O

Breath	O
sounds	O
were	O
not	B-labvalue
diminished	I-labvalue
.	O

TRAUMA	O

Hal	O
.	O

[	O
U	O
]	O
XRAY	O
FOREARM	O
2	O
VWS	O
RIGHT	O
73090	O
Requested	O
for	O
:	O
08Apr2014	B-temporal

Abdomen	O

Ferrous	O
Sulfate	O
325	B-strength
(	I-strength
65	I-strength
)	I-strength
mg	I-strength
Tablet	B-form
Sig	O
:	O
One	B-dosage
(	I-dosage
1	I-dosage
)	I-dosage
Tablet	B-form
PO	B-route
DAILY	B-frequency
(	I-frequency
Daily	I-frequency
)	I-frequency
.	O

Menstrual	O
History	O
.	O

Cranial	O
Nerve	O
VIII	O
:	O
hearing	O
was	O
intact	B-labvalue
.	O

Orientation	O
to	O
person	O
,	O
place	O
and	O
time	O
:	O
Normal	B-labvalue
.	O

MCHC	O
:	O
34	B-labvalue
.	I-labvalue
5	I-labvalue
g	I-labvalue
/	I-labvalue
dL	I-labvalue
Reference	O
Range	O
31	B-reference_range
.	I-reference_range
5	I-reference_range
-	I-reference_range
35	I-reference_range
.	I-reference_range
7	I-reference_range

PredniSONE	O
5	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
TWICE	B-frequency
DAILY	I-frequency
;	O
Last	O
Rx	O
:	O
24May2013	B-temporal

(	O
She	O
has	O
rapid	O
speech	O
,	O
and	O
frequently	O
interrupts	O
.	O

There	O
are	O
no	O
TdaP	O
'	O
s	O
in	O
clinic	O
today	B-temporal
,	O
patient	O
will	O
receive	O
her	O
Tdap	O
at	O
6	B-temporal
week	I-temporal
postpartum	O
visit	O
.	O

[	O
QLH	O
]	O
LIPID	O
PANEL	O
Requested	O
for	O
:	O
25Feb2014	B-temporal

Musculoskeletal	O
:	O
no	B-negation
joint	B-bodyloc
swelling	O
,	O
no	B-negation
joint	B-bodyloc
stiffness	O
,	O
no	B-negation
limb	B-bodyloc
pain	O
and	O
no	B-negation
limb	B-bodyloc
swelling	O

Eyes	O

Dr	O
.	O
Malhotra	O
presents	O
again	O
for	O
the	O
debridement	O
of	O
the	O
left	O
ear	O
canal	O
and	O
mastoid	O
cavity	O
.	O

Family	B-subject
history	O
of	O
Colon	B-bodyloc
Cancer	O
V16	O
.	O
0	O

BSA	O
Calculated	O
:	O
1	B-labvalue
.	I-labvalue
61	I-labvalue

f	O
Prevnar	O
13	O
Intramuscular	B-route
Suspension	B-form
(	O
Lot	O
#	O
:	O
918174	O
)	O
-	O
Administered	O
on	O
:	O
11/16/2012	B-temporal

I	O
personally	O
performed	O
nasal	O
endoscopy	O
(	O
entire	O
procedure	O
)	O
.	O

Genitourinary	O
:	O
normal	O
.	O

Examination	O
of	O
reflexes	O
:	O
Normal	B-labvalue
.	O

Denied	B-negation
Surgery	O
.	O
eg	O

Cranial	O
nerves	O
V	O
:	O
sensation	O
to	O
the	O
face	O
and	O
masseter	O
strength	O
were	O
intact	B-labvalue
.	O

Hematologic	O
/	O
Lymphatic	O
:	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
.	O

HER	O
SYMPTOMS	O
ARE	O
WORSE	O
WHEN	O
SITTING	O
FOR	O
LONG	O
PERIODS	O
OF	O
TIME	O
OR	O
WHEN	O
LAYING	O
DOWN	O
.	O

30	I-reference_range
Cholestrrol	O
To	O
al	O
197	B-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
<	B-reference_range
=199	I-reference_range
HDL	O
Cholestrrol	O
48	B-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
L	B-labvalue
>	B-reference_range
=61	I-reference_range
LDL	O
116	B-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
H	B-labvalue
<	B-reference_range
=99	I-reference_range
Triglyceride	O
164	B-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
H	B-labvalue
<	B-reference_range
=149	I-reference_range
[	O
QLH	O
]	O
Differential	O
15Aug2013	B-temporal
01	B-temporal
:	I-temporal
10PM	I-temporal
JOHNSON	O
,	O
PHILIP	O
Test	O
Name	O
Resul	O
Flag	O
Referetce	O
Basophils	O
0	B-labvalue
.	I-labvalue
6	I-labvalue
%	I-labvalue
0	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
1	I-reference_range
.	I-reference_range

to	O

Examination	O
of	O
liver	O
and	O
spleen	O
:	O
Normal	B-labvalue
.	O

Interval	O
symptoms	O
:	O
denies	B-negation
heartburn	O
,	O
denies	B-negation
chest	B-bodyloc
pain	O
,	O
denies	B-negation
abdominal	B-bodyloc
pain	O
,	O
stable	O
acid	O
regurgitationanddenies	O
dysphagia	O
.	O

Examination	O
of	O
extremities	O
for	O
edema	O
and	O
/	O
or	O
varicosities	O
:	O
Normal	B-labvalue
No	B-negation
edema	O
.	O

NEUROLOGICAL	O
:	O
no	B-negation
seizures	O
.	O

Denies	B-negation
change	O
in	O
mole	B-bodyloc
,	O
bleeding	O
,	O
ulcer	O
,	O
known	O
skin	B-bodyloc
malignancies	O
.	O

Proventil	O
HFA	O
108	B-strength
(	I-strength
90	I-strength
Base	I-strength
)	I-strength
MCG	I-strength
/	I-strength
ACT	I-strength
Inhalation	B-route
Aerosol	B-form
Solution	I-form
;	O
INHALE	O
2	B-dosage
PUFFS	B-form
every	B-frequency
4	I-frequency
hours	I-frequency
as	B-frequency
needed	I-frequency
for	O
wheeze	O
and	O
cough	O
;	O
Therapy	O
:	O
03Dec2012	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
06Jan2014	B-temporal
)	O
Requested	O
for	O
:	O
06Jan2014	B-temporal

Explained	O
that	O
this	O
can	O
be	O
a	O
common	O
source	O
of	O
irritation	O
after	O
joint	O
replacement	O
surgery	O
.	O

Inspection	O
/	O
palpation	O
of	O
joints	O
,	O
bones	O
,	O
and	O
muscles	O
:	O
AbnormalRt	O
.	O

Heel	B-bodyloc
-	I-bodyloc
shin	I-bodyloc
dysmetria	O
was	O
present	O
bilaterally	O
.	O

Length	O
of	O
labor	O
:	O
12	O
hours	O
.	O

No	B-negation
Known	O
Drug	O
Allergies	O

Coun	O
/	O
Edu	O
g22	O

Examination	O
of	O
the	O
abdomen	O
:	O
Normal	B-labvalue
.	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Examination	O
of	O
pupils	O
and	O
irises	O
:	O
Normal	B-labvalue
.	O

ZC	O
/	O
sj	O
Electronically	O
signed	O
by	O
:	O
Sallye	O
Johnson	O
Scribe	O
Jul	B-temporal
21	I-temporal
2013	I-temporal
4	B-temporal
:	I-temporal
06AM	I-temporal
CST	O
Transcriptionist	O
/	O
Recorder	O
Electronically	O
signed	O
by	O
:	O
ZORAN	O
CUPIC	O
M	O
.	O
D	O
.	O

Atorvastatin	O
10	B-strength
mg	I-strength
Tablet	B-form
Sig	O
:	O
One	B-dosage
(	I-dosage
1	I-dosage
)	I-dosage
Tablet	B-form
PO	B-route
DAILY	B-frequency
(	I-frequency
Daily	I-frequency
)	I-frequency
.	O

Family	O
History	O
Family	B-subject
history	O
of	O
Denial	B-negation
Of	O
Any	O
Significant	O
Medical	O
History	O

RTC	O
for	O
postop	O
check	O
after	O
BTL	O
.	O

These	O
were	O
all	O
consistent	O
with	O
metastatic	O
disease	O
.	O

Physical	O
Exam	O

4	I-reference_range
eGFR	O
65	B-labvalue
ML	I-labvalue
/	I-labvalue
MIN	I-labvalue
/	I-labvalue
1	I-labvalue
.	I-labvalue
7	I-labvalue
The	O
eGFR	O
is	O
calcula	O
ed	O
using	O
the	O
CKD	O
-	O
EPI	O
formula	O
.	O

Vitals	O
UTP	O
Adult	O
Vital	O
Signs	O
[	O
Data	O
Includes	O
:	O
Current	O
Encounter	O
]	O
03Jan2013	B-temporal
11	B-temporal
:	I-temporal
32AM	I-temporal
BMI	O
Calculated	O
54	B-labvalue
.	I-labvalue
57	I-labvalue
BSA	O
Calculated	O
2	B-labvalue
.	I-labvalue
32	I-labvalue
Weight	O
308	B-labvalue
lb	I-labvalue
Systolic	O
116	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
85	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Temperature	O
97	B-labvalue
.	I-labvalue
5	I-labvalue
F	I-labvalue
,	O
Oral	O
Heart	O
Rate	O
83	B-labvalue
Pulse	O
Quality	O
Normal	B-labvalue
Respiration	O
20	B-labvalue
Respiration	O
Quality	O
Normal	B-labvalue

;	O
Dec	B-temporal
18	I-temporal
2013	I-temporal
8	B-temporal
:	I-temporal
43AM	I-temporal
(	O
Author	O
)	O

Pulmonary	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
PAUL	O
LEE	O
,	O
M	O
.	O
D	O
.	O

Gynecological	O
Problems	O
.	O

P	O
Vascular	O
Screen	O
:	O
NEVER	B-negation

MDPDS	O
:	O
consented	O
10/8/12	B-temporal
(	O
scanned	O
into	O
Allscripts	O
)	O
.	O

Examination	O
of	O
extremities	O
for	O
edema	O
and	O
/	O
or	O
varicosities	O
:	O
Normal	B-labvalue
.	O

NECK	O
:	O
Supple	O
,	O
no	B-negation
mass	O
or	O
lymphadenopathy	O
.	O

She	O
denies	B-negation
any	O
polyuria	O
,	O
polyuria	O
or	O
nocturia	O
.	O

Constitutional	O
:	O
recent	B-temporal
weight	O
loss	O
,	O
but	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
,	O
not	B-negation
feeling	O
poorly	O
(	O
malaise	O
)	O
,	O
not	B-negation
feeling	O
tired	O
(	O
fatigue	O
)	O
andno	O
recent	B-temporal
weight	O
gain	O
.	O

Parkinson	O
'	O
s	O
Disease	O
332	O
.	O
0	O

The	O
heart	O
rate	O
was	O
normal	B-labvalue
.	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
neck	O
:	O
Normal	B-labvalue
.	O

KETONES	O
:	O
-	O

Triglyceride	O
286	B-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
H	B-labvalue
<	B-reference_range
=149	I-reference_range
Referencearanges	O
are	O
based	O
on	O
the	O
clinical	O
guidelines	O
of	O
the	O
NHLBI	O
National	O

Sensory	O
exam	O
intact	B-labvalue
to	O
light	O
touch	O
,	O
pain	O
and	O
temperature	O
sensation	O
.	O

WISHES	O
TO	O
RESTART	O
P	O
.	O
T	O
.	O

Disp	O
:	O
*	O
70	O
Tablet	O
(	O
s	O
)	O
*	O
Refills	O
:	O
*	O
0	O
*	O
8	O
.	O

[	O
QLH	O
]	O
CMP	O
W	O
/	O
EGFR	O
Requested	O
fis	O
:	O
29Apr2013	B-temporal

Cardiovascular	O
Regular	B-labvalue
rate	O
and	O
rhythm	O
.	O
No	B-negation
edema	O
.	O

Counseling	O
/	O
Attestations	O
Advanced	O
Practitioner	O
Attestation	O
:	O

History	O
of	O
Drug	O
Use	O

Symptoms	O
are	O
improved	B-course
by	O
salt	O
water	O
gargles	O
,	O
but	O
not	O
by	O
antihistamines	O
.	O

Risk	O
factors	O
:	O
obesityandphysical	O
inactivity	O
,	O
but	O
no	O
alcohol	O
use	O
and	O
no	O
smoking	O
.	O

Height	O
:	O
5	B-labvalue
ft	I-labvalue
1	I-labvalue
in	I-labvalue

Physical	O
Exam	O

General	O
appearance	O
:	O
Normal	B-labvalue
Well	O
developedandwell	O
nourished	O
.	O

3	O
.	O

For	O
patients	O
>	O
49	O
years	O
of	O
age	O
,	O
the	O
reference	O
limit	O
for	O
Creatinine	O
is	O
approximately	O
13	B-reference_range
%	I-reference_range
higher	I-reference_range
for	O
people	O
identified	O
as	O
African	O
-	O
American	O
.	O

Obesity	O
278	O
.	O
00	O

No	B-negation
Known	O
Drug	O
Allergies	O

another	O
pill	O
prn	O
.	O

Constitutional	O

Pt	O
.	O
referred	O
for	O
abnormal	O
EKG	O
.	O

R	B-bodyloc
AFRS	I-bodyloc
Stage	O
3	O
:	O
Sinus	B-bodyloc
polyps	O
with	O
fungal	O
debris	O
/	O
mucin	O
.	O

general	O
medicine	O
,	O
odontalgi	O
,	O
multiple	O
dental	B-bodyloc
caries	O
,	O
dentist	O
,	O
dental	B-bodyloc
disease	O
,	O
extensive	O
dental	B-bodyloc
disease	O
,	O
teeth	O
pulled	O
,	O
lower	O
teeth	O
,	O
cervical	O
lymphadenopathy	O
,	O
dental	B-bodyloc
caries	O
,	O
toothache	O
,	O
erythema	O
,	O
swelling	O
,	O
teeth	O
,	O
dental	O
,	O

Ms	O
Blackshear	O
is	O
here	O
for	O
a	O
post	O
partum	O
check	O
and	O
is	O
doing	O
well	O
.	O

Active	O
Problems	O
Allergic	O
Rhinitis	O
Due	O
To	O
Pollen	O
477	O
.	O
0	O

[	O
QLH	O
]	O
CULTURE	O
,	O
URINE	O
,	O
ROUTINE	O

Signature	O
g36	O

Cranial	O
nerves	O
XII	O
:	O
there	O
was	O
no	B-negation
tongue	B-bodyloc
deviation	O
with	O
protrusion	O
.	O

Baby	O
was	O
also	O
given	O
Reglan	O
.	O

Benign	B-severity
Essential	O
Hypertension	O
401	O
.	O
1	O

PRSENTING	O
HISTORY	O
:	O
Ms	O
Dycus	O
is	O
a	O
28	O
-	O
year	O
-	O
old	O
woman	O
who	O
comes	O
in	O
for	O
evaluation	O
for	O
seizures	O
.	O

No	B-negation
dysuria	O
.	O

Pulmonary	O

She	O
notes	O
she	O
is	O
better	O
now	O
than	O
she	O
was	O
in	O
May	B-temporal
immediately	O
after	O
injection	O
.	O

Eyes	O

She	O
is	O
uncertian	O
of	O
her	O
dose	O
.	O

Light	O
touch	O
is	O
slightly	B-labvalue
diminished	I-labvalue
along	O
the	O
skin	O
graft	O
.	O

No	B-negation
CVA	O
tenderness	O
.	O

History	O
of	O
Present	O
Illness	O
Saw	O
orthopedist	O
who	O
suggested	O
possible	O
hip	O
replacement	O
in	B-temporal
the	I-temporal
future	I-temporal
.	O

Status	O
:	O
ACTIVE	O
-	O
Retrospective	O
Authorization	O

Headcahe	O
:	O

A	O
Pap	O
smear	O
was	O
performed	O
.	O

Patient	O
Specific	O
Education	O
Given	O
Done	O
:	O
07Oct2013	B-temporal

;	O
Dec	B-temporal
10	I-temporal
2012	I-temporal
1	B-temporal
:	I-temporal
30PM	I-temporal
(	O
Author	O
)	O

2	O
.	O

Individuals	O
with	O
unstable	B-labvalue
creatinineaconcentrations	O
,	O
including	O
pregnant	O

Platelet	O
293	B-labvalue
K	I-labvalue
/	I-labvalue
CMM	I-labvalue
133	B-reference_range
-	I-reference_range
450	I-reference_range

Denied	O

Allergies	O
Shellfish	O

History	O
of	O
alchohol	O
abuse	O

MUSCULOSKELETAL	O
:	O
Extremities	O
are	O
normal	O
with	O
good	O
motor	O
tone	O
and	O
strength	O
,	O
normal	O
reflexes	O
,	O
and	O
normal	O
joint	O
strength	O
and	O
sensation	O
.	O

Inspection	O
/	O
palpation	O
of	O
joints	O
,	O
bones	O
,	O
and	O
muscles	O
:	O
Normal	B-labvalue
.	O

Symptoms	O
are	O
improving	B-course
Pertinent	O
Medical	O
History	O
:	O
no	B-negation
prior	B-temporal
injury	O
to	O
same	O
area	O
,	O
no	B-negation
osteoarthritis	O
,	O
no	B-negation
rheumatologic	O
disease	O
and	O
no	B-negation
malignancy	O
(	O
Pain	O
at	O
bottom	O
of	O
the	O
right	B-bodyloc
heel	I-bodyloc
,	O
worse	O
in	O
the	B-temporal
mornings	I-temporal
get	O
better	O
at	O
the	O
end	O
of	O
the	O
day	O
)	O
.	O

RTO	O
1	O
-	O
2	O
weeks	O
or	O
sooner	O
if	O
needed	O
,	O
ED	O
precausions	O
and	O
Dentist	O
evaluation	O
discussed	O
.	O

Genitourinary	O
:	O
no	B-negation
dysuria	O
,	O
no	B-negation
urinary	O
frequency	O
,	O
no	B-negation
incontinence	O
,	O
no	B-negation
itching	O
or	O
burning	O
,	O
no	B-negation
urinary	O
hesitancy	O
and	O
no	B-negation
pelvic	B-bodyloc
pain	O
.	O

The	O
abdomen	O
was	O
soft	O
and	O
nontender	O
.	O

ebody	O

Social	O
History	O
Never	O
A	O
Smoker	O

He	O
has	O
a	O
h	O
/	O
o	O
bilateral	O
EAC	O
atresia	O
and	O
left	O
atresia	O
repair	O
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Chest	O
:	O
Normal	O
.	O

[	O
QLH	O
]	O
HEMOGLOBIN	O
A1c	O
Requested	O
for	O
:	O
21Mar2013	B-temporal

Description	O
:	O
Patient	O
has	O
had	O
multiple	O
problems	O
with	O
his	O
teeth	B-bodyloc
due	O
to	O
extensive	O
dental	O
disease	O
and	O
has	O
had	O
many	O
of	O
his	O
teeth	O
pulled	O
,	O
now	O
complains	O
of	O
new	B-course
tooth	B-bodyloc
pain	O
to	O
both	O
upper	O
and	O
lower	O
teeth	B-bodyloc
on	O
the	O
left	O
side	O
for	O
approximately	B-temporal
three	I-temporal
days	I-temporal
.	O
.	O

Physical	O
Exam	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
,	O
no	B-negation
cough	O
,	O
no	B-negation
shortness	O
of	O
breath	O
during	O
exertion	O
,	O
no	B-negation
orthopnea	O
and	O
no	B-negation
PND	O
.	O

Procedures	O

Eyes	O
:	O
eyes	B-bodyloc
not	B-negation
red	O
,	O
no	B-negation
purulent	O
discharge	O
from	O
the	O
eyes	B-bodyloc
,	O
no	B-negation
dryness	O
of	O
the	O
eyes	B-bodyloc
and	O
no	B-negation
itching	O
of	O
the	O
eyes	B-bodyloc
.	O

Reproductive	O
health	O
:	O
the	O
patient	O
is	O
postmenopausal	O
.	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
axillae	O
:	O
Normal	B-labvalue
.	O

Examination	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue
.	O

GlyBURIDE	O
5	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
14Feb2012	B-temporal
to	O
(	O
Evaluate	O
:	O
14Jun2012	B-temporal
)	O
Requested	O
for	O
:	O
16Mar2012	B-temporal
;	O
Last	O
Rx	O
:	O
16Mar2012	B-temporal

No	B-negation
rales	O
or	O
crackles	O
were	O
heard	O
.	O

Hematologic	O
/	O
Lymphatic	O
:	O
no	O
tendency	O
for	O
easy	O
bleedingandno	O
tendency	O
for	O
easy	O
bruising	O
.	O

Examination	O
of	O
the	O
oropharynx	O
:	O
Normal	B-labvalue
.	O

Palpation	O
of	O
chest	O
:	O
Normal	B-labvalue
.	O

Immunizations	O

Eyes	O

Attending	O
Note	O

No	B-negation
dry	O
cough	O
.	O

[	O
QH	O
]	O
HELICOBACTER	O
PYLORI	O
IGG	O
ANTIBODY	O
Done	O
:	O
18Dec2012	B-temporal
11	B-temporal
:	I-temporal
30AM	I-temporal

Headache	O
:	O
Moderate	B-severity

-	O
Tumor	O
is	O
confined	O
to	O
the	O
upper	B-bodyloc
uterine	I-bodyloc
segment	I-bodyloc
with	O
no	O
involvement	O
of	O
the	O
lower	O
uterine	O
segment	O
.	O

Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

Hydrochlorothiazide	O
12	B-strength
.	I-strength
5	I-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
ONCE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
09Sep2008	B-temporal
to	O
(	O
Evaluate	O
:	O
27Apr2012	B-temporal
)	O
Requested	O
for	O
:	O
03May2011	B-temporal
;	O
Last	O
Rx	O
:	O
03May2011	B-temporal

Pamphlet	O
given	O
to	O
patient	O
and	O
insurance	O
waiver	O
filled	O
out	O
in	O
office	O
today	O
.	O

Home	O
monitoring	O
:	O
The	O
patient	O
checks	O
his	O
blood	O
sugars	O
regularly	O
.	O
Glycemic	O
control	O
has	O
been	O
good	O
.	O
Glucose	O
this	B-temporal
a	I-temporal
.	I-temporal
m	I-temporal
.	O
90	B-labvalue
-	I-labvalue
120	I-labvalue
max	I-labvalue
PP	O
170	O
.	O

Physical	O
Exam	O

The	O
left	O
tympanic	O
membrane	O
was	O
normal	O
.	O

Social	O
History	O
History	O
of	O
Alcohol	O
Use	O

Abdomen	O

Heart	O
sounds	O
:	O
normal	B-labvalue
S1	O
,	O
normal	B-labvalue
S2	O
,	O
no	B-negation
S3	O
and	O
no	B-negation
S4	O
.	O

Musculoskeletal	O

US	O
Pelvic	O
with	O
Transvaginal	O
and	O
Pelvic	O
Doppler	O
76830	O
Requested	O
for	O
:	O
27Feb2014	B-temporal

Family	O
Hx	O
g7	O

Patella	B-bodyloc
osteophytes	O
on	O
medial	B-bodyloc
,	I-bodyloc
lateral	I-bodyloc
inferior	I-bodyloc
aspects	I-bodyloc
.	O

Diabetic	O
Peripheral	O
Neuropathy	O
357	O
.	O
2	O

Examination	O
of	O
sensation	O
:	O
Normal	B-labvalue
.	O

Motor	O
Survey	O
:	O
the	O
motor	O
survey	O
was	O
normal	B-labvalue
.	O

No	B-negation
rales	O
or	O
crackles	O
were	O
heard	O
.	O

Electronically	O
signed	O
by	O
:	O
YEN	O
I	O
CHEN	O
,	O
M	O
.	O
D	O
.	O

Segs	O
-	O
Bands	O
#	O
3	B-labvalue
.	I-labvalue
9	I-labvalue
K	I-labvalue
/	I-labvalue
CMM	I-labvalue
1	B-reference_range
.	I-reference_range
5	I-reference_range
-	I-reference_range
8	I-reference_range
.	I-reference_range
1	I-reference_range

Physical	O
Exam	O

Her	O
headaches	O
now	B-temporal
are	O
intermittent	B-course
with	O
also	O
head	B-bodyloc
pain	O
involving	O
the	O
posterior	B-bodyloc
aspect	I-bodyloc
and	I-bodyloc
anterior	I-bodyloc
aspect	I-bodyloc
of	I-bodyloc
her	I-bodyloc
forehead	I-bodyloc
,	O
at	O
times	O
with	O
radiation	O
from	O
her	O
neck	B-bodyloc
.	O

He	O
will	O
e	O
-	O
mail	O
me	O
after	O
he	O
has	O
been	O
on	O
the	O
Tigan	O
for	O
a	O
little	O
bit	O
to	O
let	O
me	O
know	O
if	O
he	O
can	O
tolerate	O
it	O
.	O

Obesity	O
278	O
.	O
00	O

GCS	O
50	B-labvalue
,	O
nontoxic	O
.	O

Cranial	O
nerves	O
IX	O
and	O
X	O
:	O
there	O
was	O
normal	B-labvalue
movement	O
of	O
the	O
soft	O
palate	O
and	O
normal	B-labvalue
gag	O
.	O

The	O
patient	O
'	O
s	O
counts	O
were	O
followed	O
throughout	O
admission	O
.	O

I	O
have	O
discussed	O
the	O
case	O
with	O
the	O
resident	O
and	O
agree	O
with	O
the	O
diagnosis	O
and	O
plan	O
.	O

Vaccines	O
Prophylactic	O
Need	O
Against	O
Influenza	O
V04	O
.	O
81	O

Citracal	O
+	O
D	O
TABS	O
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
03Nov2011	B-temporal
)	O
to	O

Synthroid	O
TABS	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
03Nov2011	B-temporal
)	O
to	O

Inspection	O
of	O
the	O
conjunctiva	O
and	O
lids	O
:	O
Normal	B-labvalue

Respiratory	O
:	O
normal	O
.	O

Active	O
Problems	O

Physical	O
Exam	O

LevETIRAcetam	O
500	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
4	B-dosage
TABLET	B-form
TWICE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
17Dec2009	B-temporal
to	O
(	O
Evaluate	O
:	O
03Dec2012	B-temporal
)	O
Requested	O
for	O
:	O
09Dec2011	B-temporal
;	O
Last	O
Rx	O
:	O
09Dec2011	B-temporal

Vitals	O
09Jul2012	B-temporal
10	B-temporal
:	I-temporal
29AM	I-temporal
BMI	O
Calculated	O
30	B-labvalue
.	I-labvalue
12	I-labvalue
BSA	O
Calculated	O
1	B-labvalue
.	I-labvalue
63	I-labvalue
Height	O
4	B-labvalue
ft	I-labvalue
11	I-labvalue
in	I-labvalue
Weight	O
149	B-labvalue
lb	I-labvalue
6	I-labvalue
oz	I-labvalue
Systolic	O
140	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
90	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Temperature	O
99	B-labvalue
F	I-labvalue
,	O
Oral	O
Heart	O
Rate	O
84	B-labvalue
,	O
L	O
Radial	O
Pulse	O
Quality	O
Normal	B-labvalue
,	O
L	O
Radial	O
Respiration	O
18	B-labvalue
Respiration	O
Quality	O
Normal	B-labvalue

WENDY	O
FONG	O
,	O
a	O
38	O
female	O
,	O
presents	O
today	B-temporal
with	O
the	O
complaint	O
of	O
.	O

Keywords	O
:	O

Declines	B-negation
Flu	O
vaccine	O
at	O
this	B-temporal
time	I-temporal
.	O

Genitourinary	O
:	O
no	B-negation
dysuria	O
.	O

History	O
of	O
Viral	O
Infection	O
079	O
.	O
99	O

Appendix	O
#	O
1	O

Aspirin	O
81	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
10Dec2013	B-temporal
)	O
to	O

Drug	O
Use	O
:	O
He	O
denies	O
drug	O
use	O
.	O

Hct	O
:	O
37	B-labvalue
.	I-labvalue
0	I-labvalue
%	I-labvalue
Reference	O
Range	O
36	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
48	I-reference_range
.	I-reference_range
0	O

Patient	O
today	O
with	O
ongoing	O
issues	O
with	O
diabetic	O
control	O
.	O

Under	O
the	O
primary	O
care	O
exception	O
I	O
did	O
not	O
personally	O
interview	O
or	O
examine	O
the	O
patient	O
.	O

Have	O
her	O
admitted	O
to	O
the	O
medical	O
service	O
for	O
treatment	O
of	O
her	O
hyponatremia	O
.	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
neck	O
:	O
Normal	B-labvalue
.	O

Examination	O
of	O
digits	O
and	O
nails	O
:	O
AbnormalDermatophytosis	O
.	O

Examination	O
of	O
thyroid	O
:	O
Normal	B-labvalue
.	O

were	O
reviewed	O
.	O

ENT	O
:	O
no	B-negation
earache	O
and	O
no	B-negation
sore	O
throat	B-bodyloc
.	O

4	O
.	O

[	O
LH	O
]	O
Vitamin	O
D	O
,	O
25	O
-	O
Hydroxy	O
,	O
Total	O
*	O
(	O
E	O
)	O
Requested	O
for	O
:	O
10Apr2012	B-temporal

No	B-negation
suicidal	O
or	O
homicidal	O
ideation	O
.	O

Family	B-subject
history	O
of	O
Obesity	O

Other	O
Symptoms	O
:	O
HIS	O
LIMB	B-bodyloc
PAINS	O
AND	O
PALM	O
/	O
PLANTAR	O
ITCH	O
RESOLVED	B-course
WHEN	O
HE	O
D	O
/	O
Ced	O
LASIX	O
AND	O
k	O
+	O
.	O

Otoscopic	O
examination	O
:	O
Normal	B-labvalue
.	O

MiraLax	O
Oral	B-form
Packet	I-form
;	O
Status	O
:	O
ACTIVE	O

tcb	O
for	O
removal	B-negation
of	I-negation
the	O
nevus	O
on	O
the	O
scalp	O

TSH	O
:	O
0	B-labvalue
.	I-labvalue
947	I-labvalue
uIU	I-labvalue
/	I-labvalue
ml	I-labvalue
Reference	O
Range	O
0	B-reference_range
.	I-reference_range
360	I-reference_range
-	I-reference_range
3	I-reference_range
.	I-reference_range
740	I-reference_range

Reflexes	O
:	O
the	O
reflexes	O
were	O
normal	B-labvalue
.	O

Birth	O
Control	O
:	O
.	O

Inspection	O
of	O
lips	O
,	O
teethand	O
gums	O
:	O
Normal	B-labvalue
.	O

ROS	O
g16	O

Cardiovascular	O

PredniSONE	O
10	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
15Jan2013	B-temporal
to	O
02Jul2013	B-temporal
;	O
Last	O
Rx	O
:	O
15Jan2013	B-temporal
;	O
Status	O
:	O
DISCONTINUED	O

Examination	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue
.	O

Examination	O
of	O
external	O
genitalia	O
and	O
vagina	O
:	O
Normal	B-labvalue

The	O
patient	O
is	O
being	O
seen	O
for	O
postpartum	O
follow	O
up	O
.	O

4	O
.	O

History	O
of	O
Alcohol	O

Head	O
and	O
Face	O
No	B-negation
moon	O
facies	O
.	O

Symptoms	O
resolved	B-course
its	O
own	O
.	O

Spiriva	O
HandiHaler	O
18	B-strength
MCG	I-strength
Inhalation	B-route
Capsule	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
03Nov2011	B-temporal
)	O
to	O

Attending	O
Note	O

Vitals	O
UTP	O
Adult	O
Vital	O
Signs	O
[	O
Data	O
Includes	O
:	O
Current	O
Encounter	O
]	O
09Apr2012	B-temporal
01	B-temporal
:	I-temporal
34PM	I-temporal
BMI	O
Calculated	O
:	O
26	B-labvalue
.	I-labvalue
38	I-labvalue
BSA	O
Calculated	O
:	O
1	B-labvalue
.	I-labvalue
84	I-labvalue
Height	O
:	O
5	B-labvalue
ft	I-labvalue
6	I-labvalue
in	I-labvalue
Weight	O
:	O
164	B-labvalue
lb	I-labvalue
2	I-labvalue
oz	I-labvalue
Systolic	O
:	O
111	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
:	O
74	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Heart	O
Rate	O
:	O
80	B-labvalue
O2	O
Saturation	O
:	O
96	B-labvalue

patietn	O
will	O
call	O
.	O

PROCEDURES	O
PERFORMED	O
:	O
Open	O
reduction	O
and	O
internal	O
fixation	O
(	O
ORIF	O
)	O
of	O
right	O
Schatzker	O
III	O
tibial	B-bodyloc
plateau	I-bodyloc
fracture	O
with	O
partial	O
medial	O
meniscectomy	O
.	O

No	B-negation
Known	O
Drug	O
Allergies	O

CHIEF	O
COMPLAINT	O
:	O
Toothache	O
.	O

Social	O
History	O
Denied	O

Assessment	O
of	O
respiratory	O
effort	O
was	O
significant	O
for	O
normal	B-labvalue
respiratory	O
rhythm	O
and	O
effort	O
.	O

ENT	O
:	O
no	B-negation
epistaxis	O
.	O

The	O
patient	O
'	O
s	O
family	O
requested	O
for	O
DNR	O
,	O
withdrawal	O
of	O
the	O
life	O
support	O
.	O

History	O
of	O
History	O
Of	O
Prior	O
Surgery	O

NEUROLOGICAL	O
/	O
PSYCHIATRIC	O

On	O
day	O
#	O
12	O
,	O
was	O
transferred	O
to	O
ABCD	O
.	O

2	O
.	O

Assessment	O
Asthma	O
493	O
.	O
90	O

Gestational	O
Diabetes	O
Mellitus	O
648	O
.	O
80	O

Admission	O
Date	O
:	O
[	O
*	O
*	O
2162-1-8	B-temporal
*	O
*	O
]	O
Discharge	O
Date	O
:	O
[	O
*	O
*	O
2162-1-13	B-temporal
*	O
*	O
]	O

Examination	O
of	O
the	O
palate	O
showed	O
no	B-negation
abnormalities	O
.	O

SOCIAL	O
HISTORY	O
:	O
Significant	O
history	O
of	O
alcohol	O
abuse	O
,	O
according	O
to	O
the	O
emergency	O
room	O
physician	O
,	O
who	O
sees	O
her	O
on	O
a	O
regular	O
basis	O
.	O

Throat	O
,	O
Neck	O
,	O
and	O
Back	O
Neck	O
:	O
Normal	O
.	O

WILL	O
GET	O
RELEASE	O
FOR	O
THESE	O
.	O

Head	O
and	O
Face	O

Discussion	O
/	O
Discussion	O
/	O
Summary	O

CONSTITUTIONAL	O

Difficulty	O
with	O
right	B-bodyloc
foot	I-bodyloc
balance	O

no	B-negation
urinary	O
incontinence	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Social	O
History	O
Never	O
A	O
Smoker	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
,	O
no	B-negation
intermittent	O
leg	B-bodyloc
claudication	O
and	O
no	B-negation
edema	O
.	O

Patient	O
denies	B-negation
chest	B-bodyloc
pain	O
,	O
dypsnea	O
,	O
dyspnea	O
on	O
exertion	O
.	O

Levothyroxine	O
Sodium	O
50	B-strength
MCG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
06Jun2013	B-temporal
to	O
(	O
Evaluate	O
:	O
04Jul2014	B-temporal
)	O
Requested	O
for	O
:	O
09Jul2013	B-temporal
;	O
Last	O
Rx	O
:	O
09Jul2013	B-temporal
;	O
Status	O
:	O
ACTIVE	O
-	O

Review	O
of	O
Systems	O

Social	O
History	O
"	O
Marital	O
History	O
-	O
Currently	O
Married	O

2	O
.	O

Potassium	O
Chloride	O
20	B-strength
MEQ	I-strength
/	I-strength
15ML	I-strength
(	O
10	B-strength
%	I-strength
)	O
Oral	B-route
Liquid	B-form
;	O
TAKE	O
15	B-dosage
ML	I-dosage
DAILY	B-frequency
Requested	O
for	O
:	O
21Jun2013	B-temporal
;	O
Last	O
Rx	O
:	O
21Jun2013	B-temporal

5	O
.	O

Vitals	O
05Jul2013	B-temporal
11	B-temporal
:	I-temporal
24AM	I-temporal
Systolic	O
146	B-labvalue
Diastolic	O
82	B-labvalue
Temperature	O
97	B-labvalue
.	I-labvalue
7	I-labvalue
F	I-labvalue
Heart	O
Rate	O
72	B-labvalue

Counseling	O
/	O
Signatures	O
Electronically	O
signed	O
by	O
:	O
LOURICE	O
ABDELMELEK	O
,	O
M	O
.	O
D	O
.	O

Liver	O
and	O
spleen	O
:	O
No	B-negation
hepatomegaly	O
or	O
splenomegaly	O
.	O

HOUSTON	O
,	O
TX	O
77083	O
Gender	O
Male	O
Maritao	O
Status	O
(	O
713	O
)	O
291	O
-	O
2720	O
(	O
Home	O
ptone	O
)	O
Language	O
English	O
-	O
pref	O
Ared	O
Reason	O
for	O
Ref	O
Aral	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
vomiting	O
,	O
no	B-negation
constipation	O
,	O
no	B-negation
diarrhea	O
,	O
no	B-negation
heartburn	O
and	O
no	B-negation
melena	O
.	O

There	O
was	O
no	B-negation
ligamentou	O
laxity	O
,	O
either	O
medially	O
or	O
laterally	O
.	O

The	O
patient	O
had	O
imaging	O
studies	O
that	O
showed	O
evidence	O
of	O
cervical	O
spondylosis	O
with	O
herniated	O
disk	O
and	O
stenosis	O
at	O
C4	O
-	O
C5	O
,	O
C5	O
-	O
C6	O
and	O
C6	O
-	O
C7	O
.	O

(	O
Recorded	O
:	O
27Jun2012	B-temporal
)	O
to	O

Eustachian	O
tube	O
opening	O
normal	O
.	O

He	O
had	O
a	O
minor	O
accident	O
while	O
working	O
on	O
his	O
tredmill	O
couple	O
of	O
months	O
back	O
and	O
developed	O
a	O
small	O
wound	O
between	O
his	O
1st	B-bodyloc
and	I-bodyloc
2nd	I-bodyloc
metatarsals	I-bodyloc
of	O
his	O
left	B-bodyloc
foot	I-bodyloc
.	O

Genitourinary	O
:	O
no	B-negation
dysuria	O
,	O
no	B-negation
feelings	O
of	O
urinary	O
urgency	O
and	O
no	B-negation
abnormal	O
urethral	B-bodyloc
discharge	O
.	O

3	O
.	O

Mild	B-severity
fixed	O
contracture	O
flexion	O
with	O
ROM	O
7	O
degrees	O
incomplete	O
extension	O
and	O
flexion	O
112	O
degrees	O
.	O

History	O
of	O
No	B-negation
Recent	B-temporal
Change	O
In	O
Medical	O
History	O

Visit	O
For	O
:	O
Follow	O
-	O
Up	O
Exam	O
V67	O
.	O
9	O

The	O
heart	O
rate	O
was	O
normal	B-labvalue
.	O

Respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

Lymphatic	O

Immunizations	O

Discussion	O
/	O
Signatures	O
Electronically	O
signed	O
by	O
:	O
MANNIE	O
MAGID	O
,	O
M	O
.	O
D	O
.	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
other	O
areas	O
:	O
Normal	B-labvalue

Discussion	O
/	O
Discussion	O
/	O
Summary	O

Oropharynx	O
:	O
Normal	O
.	O

Singulair	O
10	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
22Mar2013	B-temporal
)	O
to	O

History	O
of	O
Visit	O
For	O
:	O
Screening	O
Exam	O
STD	O
V74	O
.	O
5	O

Sodium	O
Lvl	O
141	B-labvalue
mEq	I-labvalue
/	I-labvalue
l	I-labvalue
135	B-reference_range
-	I-reference_range
145	I-reference_range

General	O
appearance	O
:	O
Normal	B-labvalue
.	O

Seizure	O
Disorder	O
345	O
.	O
90	O

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

Delivery	O
type	O
:	O
vaginal	O
.	O

Esophageal	B-bodyloc
Reflux	O
530	O
.	O
81	O

FAM	B-subject
HX	O
CA	O
:	O
BREAST	O
(	O
-	O
)	O
UTERINE	B-bodyloc
(	O
+	O
)	O
-	O
PGM	O
OVARIAN	O
(	O
-	O
)	O
COLON	O
(	O
-	O
)	O
CERVICAL	O
(	O
-	O
)	O

Veramyst	O
27	B-strength
.	I-strength
5	I-strength
MCG	I-strength
/	O
SPRAY	B-form
Nasal	B-route
Suspension	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
08Oct2012	B-temporal
)	O
to	O

Examination	O
of	O
the	O
gingiva	O
showed	O
no	B-negation
abnormalities	O
.	O

Attending	O
Note	O

BCM	O
-	O
desires	O
OCP	O
,	O
rx	O
given	O
for	O
micronor	O
given	O
breastfeeding	O
,	O
instructed	O
of	O
importance	O
to	O
take	O
at	O
same	O
time	O
each	O
day	O
.	O

Symptoms	O
:	O
The	O
patient	O
is	O
currently	O
asymptomatic	O
.	O

Clear	O
nasal	B-bodyloc
discharge	O
:	O
None	B-negation

Psychiatric	O

CurrentMeds	O
_	O
4	O
_	O
twCiteListControlEnd	O
CurrentMedsSectionEnd	O
AssessmentSectionStart	O
Assessment	O

Denied	O

The	O
abdomen	O
was	O
not	O
firm	O
and	O
not	O
No	B-negation
rebound	O
tenderness	O
.	O

NO	B-negation
AC	O
.	O

Will	O
f	O
/	O
u	O
with	O
PCP	O
for	O
DM	O
.	O

Head	O
and	O
Face	O

Height	O
Comments	O
:	O
Reported	O

Physical	O
Exam	O

Tdap	O
(	O
Adacel	O
)	O
;	O
INJECT	O
0	B-strength
.	I-strength
5	I-strength
ML	I-strength
Intramuscular	B-route
;	O
Dose	O
:	O
0	B-dosage
.	I-dosage
5ML	I-dosage
;	O
Route	O
:	O
Intramuscular	B-route
;	O
Site	O
:	O
Right	O
Deltoid	O
;	O
Done	O
:	O
14Oct2013	B-temporal
11	B-temporal
:	I-temporal
09AM	I-temporal
;	O
Status	O
:	O
Complete	O

Integumentary	O
:	O
no	B-negation
skin	B-bodyloc
lesions	O
.	O

Examination	O
of	O
the	O
abdomen	O
:	O
Normal	B-labvalue
The	O
abdomen	B-bodyloc
was	O
obese	O
.	O

Endocrine	O
:	O
no	B-negation
proptosis	O
,	O
no	B-negation
hot	O
flashes	O
,	O
no	B-negation
muscle	B-bodyloc
weakness	O
,	O
no	B-negation
deepening	O
of	O
the	O
voice	O
and	O
no	B-negation
feelings	O
of	O
weakness	O
.	O

History	O
of	O
Lower	B-bodyloc
Back	I-bodyloc
Pain	O
724	O
.	O
2	O

Constitutional	O

Nasal	B-bodyloc
obstruction	O
:	O
Mild	B-severity

Fossa	O
of	O
Rosenmueller	O
normal	O
.	O

Hydrocodone	O
-	O
Acetaminophen	O
10	B-strength
-	I-strength
325	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
EVERY	B-frequency
12	I-frequency
HOURS	I-frequency
PRN	B-frequency
;	O
Therapy	O
:	O
28Jul2011	B-temporal
to	O
(	O
Evaluate	O
:	O
11Aug2012	B-temporal
)	O

Dietary	O
counseling	O
,	O
management	O
for	O
mild	B-severity
nausea	O
sxs	O
,	O
Vit	O
B6	O
25mg	B-strength
TID	B-frequency

Cardiovascular	O
:	O
normal	O
,	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
radiating	O
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
,	O
no	B-negation
syncope	O
,	O
no	B-negation
increased	O
heart	B-bodyloc
rate	O
,	O
no	B-negation
edema	O
and	O
no	B-negation
intermittent	O
leg	B-bodyloc
claudication	O
.	O

Ovarian	B-bodyloc
Cyst	O
620	O
.	O
2	O

Electronically	O
signed	O
by	O
:	O
JACKIE	O
MATIJASEC	O
,	O
M	O
.	O
D	O
.	O

Assessment	O
Upper	B-bodyloc
Respiratory	I-bodyloc
Infection	O
465	O
.	O
9	O

[	O
QLH	O
]	O
TSH	O
,	O
3RD	O
GENERATION	O
W	O
/	O
REFLEX	O
TO	O
FT4	O
28May2012	B-temporal
12	B-temporal
:	I-temporal
00AM	I-temporal
Hardwicke	O
,	O
Robin	O

Fracture	O
Of	O
The	B-bodyloc
Ankle	I-bodyloc
824	O
.	O
8	O

Patient	O
has	O
home	O
health	O
daily	O
and	O
will	O
arrange	O
orders	O
to	O
be	O
sent	O
for	O
wound	O
care	O
.	O

Discussion	O
/	O
Discussion	O
/	O
Summary	O

Assessment	O
of	O
respiratory	O
effort	O
was	O
significant	O
for	O
normal	B-labvalue
respiratory	O
rhythm	O
and	O
effort	O
.	O

History	O
of	O
Hyperlipidemia	O
272	O
.	O
4	O

Vagina	O
and	O
external	O
genitalia	O
:	O
Normal	O
.	O

Maternal	O
grandmother	B-subject
'	O
s	O
history	O
of	O
Coronary	B-bodyloc
Artery	I-bodyloc
Disease	O
V17	O
.	O
49	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
constipation	O
,	O
no	B-negation
diarrhea	O
and	O
no	B-negation
melena	O

Results	O
/	O
Assessment	O
Diabetes	O
Mellitus	O
250	O
.	O
00	O

(	O
Medical	O
Transcription	O
Sample	O
Report	O
)	O

GroupHeading52End	O
GroupHeading53Start	O
GroupHeading53End	O
GroupHeading54Start	O
Skip	O
Inspectisp	O
of	O
skip	O
and	O
subcutaneius	O
tissue	O
:	O
Abnoamal	O
dermatosis	O
papulosa	O
nigra	O
on	O
the	O
face	B-bodyloc
Examinatisp	O
of	O
the	O
skip	O
for	O
lesions	O
:	O
Abnoamal	O
Skip	O
tag	O
(	O
s	O
)	O
noted	O
(	O
on	O
the	O
face	B-bodyloc
)	O
.	O

Social	O
History	O
Marital	O
History	O
-	O
Currently	O
Married	O

ENT	O
:	O
no	B-negation
earache	O
,	O
no	B-negation
hearing	O
loss	O
,	O
no	B-negation
epistaxis	O
,	O
no	B-negation
nasal	B-bodyloc
discharge	O
,	O
no	B-negation
sore	O
throat	B-bodyloc
and	O
no	B-negation
hoarseness	O
.	O

f	O
No	B-negation
Active	O
Medicrtions	O

[	O
QL	O
]	O
THYROID	O
PANEL	O
WITH	O
TSH	O
,	O
3RD	O
GENERATION	O
Requested	O
for	O
:	O
04Apr2014	B-temporal

Hx	O
of	O
constricted	O
brochiole	O

History	O
of	O
Implantation	O
Of	O
Subcortical	O
Neurostimulator	O

Examination	O
of	O
thyroid	O
:	O
Normal	B-labvalue
.	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
,	O
no	B-negation
cough	O
,	O
no	B-negation
shortness	O
of	O
breath	O
during	O
exertion	O
,	O
no	B-negation
orthopnea	O
,	O
no	B-negation
hemoptysis	O
and	O
no	B-negation
PND	O
.	O

2	O
.	O

Also	O
had	O
H	O
.	O
A	O
.	O
yesterday	B-temporal
-	O
nil	O
today	B-temporal
)	O
.	O

Endocrine	O
:	O
no	B-negation
muscle	B-bodyloc
weakness	O
.	O

DTaP	O
;	O
27	B-temporal
Jun	I-temporal
2011	I-temporal

[	O
QLH	O
]	O
TSH	O
,	O
3RD	O
GENERATION	O
W	O
/	O
REFLEX	O
TO	O
FT4	O
29Nov2012	B-temporal
10	B-temporal
:	I-temporal
35AM	I-temporal
Hardwicke	O
,	O
Robin	O

Description	O
of	O
patient	O
'	O
s	O
judgement	O
and	O
insight	O
:	O
Normal	B-labvalue
.	O

The	O
rhythm	O
was	O
regular	B-labvalue
.	O

Symptoms	O
are	O
improved	B-course
by	O
rest	O
and	O
sitting	O
up	O
.	O

SODIUM	O
141	B-labvalue
mmol	I-labvalue
/	I-labvalue
L	I-labvalue
135	B-reference_range
-	I-reference_range
146	I-reference_range

Patient	O
is	O
requesting	O
Home	O
Health	O
help	O
-	O
for	O
FSBG	O
checks	O

Examination	O
of	O
the	O
palate	O
showed	O
no	B-negation
abnormalities	O
.	O

Active	O
Problems	O

be	O
multiplied	O
by	O
the	O
estimatrd	O
BMI	O
.	O

Stressed	O
the	O
importance	O
of	O
consistent	O
MNT	O
and	O
med	O
compliance	O
in	O
DM	O
control	O
.	O

She	O
has	O
not	B-negation
had	O
any	O
new	O
relapses	O
.	O

Ocular	O
motility	O
:	O
Extraocular	O
muscles	O
intact	O
.	O

Hemoglobin	O
:	O
14	B-labvalue
.	I-labvalue
9	I-labvalue
g	I-labvalue
/	I-labvalue
dL	I-labvalue
Reference	O
Range	O
12	B-reference_range
.	I-reference_range
6	I-reference_range
-	I-reference_range
17	I-reference_range
.	I-reference_range
7	I-reference_range

no	B-negation
breast	B-bodyloc
symptoms	O
Patient	O
has	O
a	O
history	O
of	O
a	O
positive	O
pap	O
smear	O
.	O

SPECIFIC	O
GRAVITY	O
:	O
1	B-labvalue
.	I-labvalue
025	I-labvalue
Of	O
Interest	O

History	O
of	O
Ulcerative	O
Colitis	O
556	O
.	O
9	O

Type	O
2	O
Diabetes	O
Mellitus	O
250	O
.	O
00	O

Cough	O
-	O
Cont	O
.	O

f	O
Rotavirus	O
(	O
RotaTeq	O
)	O
;	O
#	O
1	O
(	O
Lot	O
#	O
:	O
0051AE	O
)	O
-	O
Administered	O
on	O
:	O
09/07/2012	B-temporal

Vitals	O
UTP	O
Adult	O
Vital	O
Signs	O
[	O
Data	O
Includes	O
:	O
Current	O
Encounter	O
]	O
18Feb2014	B-temporal
03	B-temporal
:	I-temporal
24PM	I-temporal
BMI	O
Calculated	O
:	O
21	B-labvalue
.	I-labvalue
16	I-labvalue
BSA	O
Calculated	O
:	O
1	B-labvalue
.	I-labvalue
63	I-labvalue
Weight	O
:	O
127	B-labvalue
lb	I-labvalue
Systolic	O
:	O
157	B-labvalue
Diastolic	O
:	O
75	B-labvalue
Heart	O
Rate	O
:	O
90	B-labvalue

Repeat	O
2	O
hour	O
EEG	O
showed	O
sharps	O
over	O
left	O
temporal	O
area	O
and	O
intermitent	O
slowing	O
over	O
left	B-bodyloc
temporal	I-bodyloc
area	O
.	O

Simvastatin	O
20	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
AT	I-frequency
BEDTIME	I-frequency
;	O
Therapy	O
:	O
07Jan2013	B-temporal
to	O
(	O
Evaluate	O
:	B-temporal
05Aug2013	I-temporal
)	O
Requested	O
fis	O
:	O
07Jan2013	B-temporal
;	O
Last	O
Rx	O
:	B-temporal
07Jan2013	I-temporal

Physical	O
Exam	O

HEAD	O
AND	O
FACE	O

UTP	O
-	O
OB	O
/	O

Ocular	O
motility	O
:	O
Extraocular	O
muscles	O
intact	B-labvalue
.	O

INFECTIOUS	O
DISEASE	O
:	O
The	O
patient	O
had	O
been	O
on	O
antibiotics	O
during	B-temporal
the	I-temporal
stay	I-temporal
at	O
Madera	O
.	O

History	O
of	O
Asthma	O
493	O
.	O
90	O

headache	O
,	O
no	B-negation
tension	O
-	O
type	O
headache	O
,	O
no	B-negation
headache	O
,	O
able	O
to	O
walk	O
,	O
no	B-negation
ataxia	O
,	O
not	B-negation
falling	O
and	O
not	B-negation
limping	O
.	O

She	O
did	O
not	B-negation
require	I-negation
transfusion	O
of	O
red	O
blood	O
cells	O
or	O
platelets	O
;	O
however	O
,	O
on	O
07/26/2008	B-temporal
her	O
ANC	O
did	O
dip	O
to	O
900	B-labvalue
and	O
she	O
was	O
placed	O
on	O
neutropenic	O
diet	O
.	O

Debridement	O
:	O

Monofilament	O
Testing	O
:	O
Normal	B-labvalue
tactile	O
sensation	O
with	O
monofilament	O
testing	O
throughout	O
both	O
feet	O
.	O

Requested	O
for	O
:	O
18Oct2013	B-temporal

Immunizations	O
status	O
:	O
up	O
to	O
date	O
.	O

Eyes	O
:	O
no	B-negation
eyesight	O
problems	O
.	O

On	O
a	O
chest	O
x	O
-	O
ray	O
for	O
what	O
appeared	O
to	O
be	O
shortness	O
of	O
breath	O
she	O
was	O
found	O
to	O
have	O
what	O
was	O
thought	B-uncertain
to	I-uncertain
be	I-uncertain
free	O
air	O
under	O
the	O
right	B-bodyloc
diaphragm	I-bodyloc
.	O

PLATELET	O
COUNT	O
250	B-labvalue
Thousand	I-labvalue
/	I-labvalue
u	I-labvalue
140	B-reference_range
-	I-reference_range
400	I-reference_range

Eyes	O

5	I-labvalue
.	O

Pregnancy	O
V22	O
.	O
2	O

Denied	O

Head	O
and	O
Face	O

Physical	O
Exam	O

Prostate	O
Specific	O
Ag	O
,	O
Serum	O
:	O
0	B-labvalue
.	I-labvalue
9	I-labvalue
ng	I-labvalue
/	I-labvalue
mL	I-labvalue
Reference	O
Range	O
0	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
4	I-reference_range
.	I-reference_range
0	I-reference_range

Allergies	O
Penicillins	O

Lipitor	O
40	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Therapy	O
:	O
12Sep2009	B-temporal
to	O
Requested	O
for	O
:	O
21Sep2009	B-temporal

WME	O

;	O
Dec	B-temporal
1	I-temporal
2011	I-temporal
9	B-temporal
:	I-temporal
41AM	I-temporal
(	O
Author	O
)	O

Requested	O
for	O
:	O
14Mar2014	B-temporal

Birth	O
Control	O
:	O
.	O

Neck	O

None	O
-	O
No	B-negation
Current	B-temporal
Medications	O
;	O
Therapy	O
:	O
04Mar2008	B-temporal
to	O
Requested	O
for	O
:	O
04Mar2008	B-temporal

Hemocults	O
were	O
all	B-labvalue
negative	I-labvalue
.	O
.	O

History	O
of	O
Bronchiolitis	O
466	O
.	O
19	O

Abdomen	O

glut	O
.	O
)	O
:	O
Normal	O
.	O

We	O
will	O
see	O
her	O
again	O
in	B-temporal
12	I-temporal
months	I-temporal
.	O

(	O
Rx	O
Temp	O
1508	O
)	O
;	O
Therapy	O
:	O

Pregnancy	O
Complicated	O
By	O
Anemia	O
648	O
.	O
20	O

Vicodin	O
TABS	B-form

Exacerbating	O
factors	O
:	O
stress	O
,	O
fatigue	O
and	O
skipping	O
medications	O
,	O
but	O
not	O
exacerbated	O
by	O
weight	O
gain	O
,	O
not	O
exacerbated	O
by	O
excess	O
dietary	O
salt	O
and	O
not	O
exacerbated	O
by	O
alcohol	O
use	O
.	O

Neck	O
:	O
Normal	O
.	O

Varicosital	O
changes	O
noted	O
bilaterally	B-bodyloc
.	O

Abdomen	O

Exercise	O

The	O
contents	O
were	O
aspirated	O
and	O
careful	O
dissection	O
of	O
the	O
cyst	O
wall	O
was	O
performed	O
.	O

Abdomen	O

Active	O
Problems	O
Ankle	B-bodyloc
Joint	I-bodyloc
Pain	O
719	O
.	O
47	O

Abdominal	B-bodyloc
aorta	I-bodyloc
:	O
no	B-negation
abnormalities	O
and	O
no	B-negation
bruit	O
heard	O
.	O

Assessment	O

No	B-negation
murmurs	O
were	O
heard	O
.	O

VLDL	O
Cholesterol	O
Cal	O
:	O
52	B-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue
Abnormal	O
High	O
Reference	O
Range	O
5	B-reference_range
-	I-reference_range
40	I-reference_range

Centrum	O
Silver	O
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
19Aug2013	B-temporal
)	O
to	O

To	O
home	O
.	O

Transient	B-course
Disorder	O
Of	O
Initiating	O
Or	O
Maintaiping	O
Sleep	O
307	O
.	O
41	O

Current	O
Orders	O
[	O
H	O
]	O
Culture	O
:	O
Wound	O
/	O
Abscess	O
w	O
/	O
Gram	O
Stain	O
Requested	O
for	O
:	O
17Sep2013	B-temporal

Marital	O
History	O
-	O
Separated	O

Neurologic	O

GroupHeading216End	O
TextFinding220Start	O
TextFinding220End	O
GroupHeading410Start	O
Associated	O
symptoms	O
:	O
no	B-negation
shoulder	B-bodyloc
paip	O
.	O

Denied	O

Diabetes	O
Mellitus	O
250	O
.	O
00	O

Visit	O
For	O
:	O
Screening	O
Exam	O
Malignant	O
Neoplasm	O
Breast	O
V76	O
.	O
10	O

Head	O
and	O
Face	O

Recent	O
and	O
remote	O
memory	O
:	O
Normal	B-labvalue
.	O

Phenytoin	O
Sodium	O
Extended	O
100	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
6	B-dosage
CAPSULE	B-form
TWICE	B-frequency
DAILY	I-frequency
Requested	O
for	O
:	O
29Sep2011	B-temporal
;	O
Last	O
Rx	O
:	O
29Sep2011	B-temporal

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

Complications	O
:	O
None	B-negation
.	O

Pt	O
for	O
2	O
hour	O
postprandial	O
at	O
postpartum	O
visit	O
.	O

Eyes	O

Left	O
Toe	O
.	O

-	O
-	O
He	O
will	O
follow	O
up	O
with	O
his	O
PCP	O
for	O
possible	B-uncertain
internal	O
hernia	O
and	O
mild	B-course
prostate	B-bodyloc
hypertrophy	O
which	O
were	O
noted	O
on	O
CT	O

History	O
of	O
Present	O
Illness	O

GroupHeading54End	O
GroupHeading55Start	O
GroupHeading55End	O
GroupHeading74Start	O
GroupHeading74End	O
GroupHeading69Start	O
GroupHeading69End	O
GroupHeading56Start	O
GroupHeading56End	O
GroupHeading57Start	O
GroupHeading57End	O
GroupHeading58Start	O
GroupHeading58End	O
GroupHeading71Start	O
GroupHeading71End	O
GroupHeading59Start	O
GroupHeading59End	O
GroupHeading60Start	O
GroupHeading60End	O
GroupHeading70Start	O
GroupHeading70End	O
GroupHeading61Start	O
GroupHeading61End	O
GroupHeading62Start	O
GroupHeading62End	O
GroupHeading63Start	O
GroupHeading63End	O

Neurological	O
:	O
no	B-negation
dizziness	O
and	O
no	B-negation
fainting	O
.	O

Assessment	O
of	O
muscle	O
strength	O
/	O
tone	O
:	O
Normal	B-labvalue

Gastrointestinal	O
:	O
constipation	O
,	O
but	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
vomiting	O
,	O
no	B-negation
diarrhea	O
,	O
no	B-negation
heartburn	O
and	O
no	B-negation
melena	O
.	O

Localized	O
Primary	O
Osteoarthritis	O
Of	O
The	O
Knee	B-bodyloc
715	O
.	O
16	O

Drug	O
Use	O

TSI	O
ENDOSCOPY	O
.	O

Review	O
of	O
Systems	O

No	B-negation
major	O
swelling	O
could	O
be	O
el	O
Gited	O
.	O

Mammogram	O
Screening	O
V76	O
.	O
12	O

Symptomatic	O
Menopause	O
627	O
.	O
2	O

Neurological	O
:	O
patient	O
is	O
alert	O
.	O

TECHNIQUE	O
:	O
The	O
veins	O
of	O
the	O
left	O
lower	O
extremity	O
were	O
evaluated	O
with	O
grayscale	O
,	O
color	O
-	O
flow	O
and	O
spectral	O
Doppler	O
ultrasound	O
.	O

Examination	O
of	O
thyroid	O
:	O
Normal	B-labvalue
.	O

Eyes	O
:	O
no	B-negation
eyesight	O
problems	O
.	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
MICHAEL	O
ADLER	O
,	O
M	O
.	O
D	O
.	O

1	O
.	O

Orientation	O
to	O
person	O
,	O
place	O
and	O
time	O
:	O
Normal	B-labvalue

No	B-negation
Known	O
Drug	O
Allergies	O

Brovana	O
15	B-strength
MCG	I-strength
/	I-strength
2ML	I-strength
Inhalation	B-form
Nebulization	I-form
Solution	I-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
24Jul2013	B-temporal
)	O
to	O

Tums	O
CHEW	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
15Nov2012	B-temporal
)	O
to	O

Paternal	B-subject
grandfather	I-subject
'	I-subject
s	I-subject
history	O
of	O
Colon	B-bodyloc
Cancer	O
V16	O
.	O
0	O

LORazepam	O
1	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
OTHER	O
Take	O
one	O
before	O
MRI	O
scan	O
.	O

Fossa	O
of	O
Rosenmueller	O
normal	B-labvalue
.	O

CARDIOVASCULAR	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
and	O
not	B-negation
expressed	O
as	O
feeling	O
short	O
of	O
breath	O
.	O

No	B-negation
rales	O
or	O
crackles	O
were	O
heard	O
.	O

Aspirin	O
81	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
06Sep2013	B-temporal
to	O

Cranial	O
Nerve	O
II	O
:	O
visual	O
acuity	O
and	O
visual	O
fields	O
were	O
intact	B-labvalue
.	O

NECK	O

Associated	O
symptoms	O
:	O
no	B-negation
extremity	B-bodyloc
pain	O
,	O
no	B-negation
extremity	B-bodyloc
numbness	O
,	O
no	B-negation
extremity	B-bodyloc
paresthesias	O
,	O
no	O
lower	O
extremity	O
ulcers	O
and	O
no	B-negation
abdominal	B-bodyloc
discomfort	O
.	O

GI	O
/	O
GU	O
:	O
Post	O
-	O
operatively	O
,	O
the	O
patient	O
was	O
given	O
IV	O
fluids	O
until	O
tolerating	O
oral	O
intake	O
.	O

History	O
of	O
Hysterectomy	O
V88	O
.	O
01	O

Constitutional	O
:	O
no	B-negation
fever	O
and	O
no	B-negation
chills	O
.	O

Flexion	O
110	O
deg	O
Extension	O
0	O
deg	O
.	O

Comments	O
:	O
PreE	O
.	O

Psychiatric	O
:	O
no	B-negation
depression	O
.	O

Was	O
also	O
offered	O
Affirm	O
.	O

Home	O
monitoring	O
:	O
The	O
patient	O
checks	O
her	O
blood	O
sugars	O
regularly	O
.	O
Glycemic	O
control	O
has	O
been	O
poor	O
.	O
The	O
patient	O
reports	O
no	B-negation
symptomatic	O
hypoglycemic	O
epsidodes	O
.	O
Now	O
on	O
40	B-dosage
units	I-dosage
of	O
Lantus	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O
Microinvasive	O
carcinoma	O
of	O
the	O
cervix	B-bodyloc
.	O

[	O
QLH	O
]	O
MICROALBUMIN	O
,	O
RANDOM	O
URINE	O
(	O
W	O
/	O
CREATININE	O
)	O
Requested	O
for	O
:	O
23Feb2011	B-temporal

Examination	O
of	O
the	O
head	O
and	O
face	O
:	O
Normal	B-labvalue
.	O

The	O
patient	O
is	O
doing	O
well	O
with	O
her	O
hyperlipidemia	O
goals	O
.	O

Symptoms	O
:	O
The	O
patient	O
is	O
currently	O
asymptomatic	O
.	O

Mean	O
Cell	O
Hemoglobin	O
Concentration	O
(	O
for	O
H	O
&	O
H	O
)	O
32	B-labvalue
.	I-labvalue
8	I-labvalue
g	I-labvalue
/	I-labvalue
dl	I-labvalue
32	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
36	I-reference_range
.	I-reference_range
0	I-reference_range

Current	O
Meds	O
GlyBURIDE	O
5	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Take	O
5	B-strength
mg	I-strength
(	O
1	B-dosage
tab	B-form
)	O
every	B-frequency
a	I-frequency
.	I-frequency
m	I-frequency
.	I-frequency
and	O
10	B-strength
mg	I-strength
(	O
2	B-dosage
tabs	B-form
)	O
every	B-frequency
p	I-frequency
.	I-frequency
m	I-frequency
.	I-frequency
before	I-frequency
bed	O
;	O
Therapy	O
:	O
17May2011	B-temporal
to	O
(	O
Evaluate	O
:	O
14Sep2011	B-temporal
)	O
;	O
Last	O
Rx	O
:	O
17May2011	B-temporal

Attending	O
Note	O

Diastolic	O
:	O
70	B-labvalue
,	O
LUE	O
,	O
Sitting	O

Cardiovascular	O

)	O
PO	B-route
Q24H	B-frequency
(	I-frequency
every	I-frequency
24	I-frequency
hours	I-frequency
)	I-frequency
.	O

Benign	B-severity
Essential	O
Hypertension	O
401	O
.	O
1	O

56yo	O
male	O
right	O
-	O
hand	O
dominant	O
OSH	O
transfer	O
with	O
traumatic	B-bodyloc
injury	O
to	O
left	O
hand	O
with	O
table	O
saw	O
at	O
approximately	O
1230p	O
today	O
.	O

Pulmonary	O

Procedure	O

Right	O
stent	O
little	O
high	O
.	O

Depression	O
-	O
stable	O
on	O
no	B-negation
meds	O
,	O
no	B-negation
SI	O
/	O
HI	O

Review	O
of	O
Systems	O
Orthopedic	O
ROS	O
Follow	O
Up	O
:	O

HEAD	O
AND	O
FACE	O

6	O

No	B-negation
rales	O
or	O
crackles	O
were	O
heard	O
.	O

The	O
neck	O
was	O
normal	O
in	O
appearance	O
and	O
was	O
supple	O
.	O

Fatigue	O
780	O
.	O
79	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

She	O
continues	O
to	O
have	O
seizsures	O
.	O

;	O
Apr	B-temporal
18	I-temporal
2014	I-temporal
3	B-temporal
:	I-temporal
09PM	I-temporal
(	O
Author	O
)	O

Skin	O

Vagina	O
and	O
external	O
genitalia	O
:	O
Normal	O
.	O

Give	O
Tdap	O
next	O
visit	O
as	O
did	O
not	O
get	O
during	O
pregnancy	O

(	O
Medical	O
Transcription	O
Sample	O
Report	O
)	O
GENERAL	O
:	O
Well	O
developed	O
,	O
well	O
nourished	O
,	O
alert	O
,	O
in	O
no	B-negation
acute	O
distress	O
.	O

pt	O
has	O
questions	O

Hypertension	O
401	O
.	O
9	O

She	O
was	O
able	O
to	O
bend	O
forward	O
to	O
about	B-labvalue
6070	I-labvalue
.	O

Integumentary	O
:	O
no	B-negation
rash	O
.	O

Sinus	O
CT	O
,	O
normal	B-labvalue
mini	O
-	O
CT	O
of	O
the	O
paranasal	O
sinuses	O
.	O

Current	O
Orders	O
[	O
N	O
]	O
Holter	O
Monitor	O
-	O
24	O
hr	O
.	O

Current	O
Meds	O
Aleve	O
TABS	B-form
;	O
TAKE	O
2	B-dosage
TABLET	B-form
Every	B-frequency
morning	I-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
20Aug2013	B-temporal
)	O
to	O

COMPLICATIONS	O
:	O
None	O
.	O

Motor	O
and	O
sensory	O
are	O
intact	O
to	O
the	O
extremities	O
.	O

Simvastatin	O
10	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
AT	I-frequency
BEDTIME	I-frequency
;	O
Therapy	O
:	O
16Jan2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
09Jan2014	B-temporal
)	O
Requested	O
for	O
:	O
09Jan2014	B-temporal

HydrALAZINE	O
HCl	O
25	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
1BID	O
-	O
TAKE	O
ONE	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
TWICE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
06Dec2007	B-temporal
to	O
(	O
Evaluate	O
:	O
02May2014	B-temporal
)	O
Requested	O
for	O
:	O
07May2013	B-temporal
;	O
Last	O
Rx	O
:	O
07May2013	B-temporal

OneTouch	O
Lancets	O
Miscellaneous	O
;	O
check	O
blood	O
sugar	O
4	O
x	O
daily	O
;	O
Therapy	O
:	O
15Apr2009	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
30Nov2009	B-temporal
)	O
Requested	O
for	O
:	O
30Nov2009	B-temporal

Orientation	O
to	O
person	O
,	O
place	O
and	O
time	O
:	O
Normal	B-labvalue
.	O

Treatment	O
plan	O
includes	O
alcohol	O
abstinence	O
.	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

NOSE	O
-	O
Pink	O
nasal	O
turbinates	O
,	O
septum	O
is	O
midline	O
.	O

RESPIRATORY	O
:	O
no	B-negation
wheezing	O
and	O
no	B-negation
cough	O
.	O

Integumentary	O
:	O
no	B-negation
skin	B-bodyloc
lesions	O
,	O
no	B-negation
skin	B-bodyloc
wound	O
,	O
no	B-negation
pruritus	O
,	O
no	B-negation
change	O
in	O
a	O
mole	B-bodyloc
,	O
no	B-negation
breast	B-bodyloc
pain	O
and	O
no	B-negation
breast	B-bodyloc
lump	O
.	O

Past	O
treatment	O
has	O
included	O
triptans	O
and	O
didnot	O
work	O
although	O
just	O
took	O
it	O
once	O
.	O

HENT	O
:	O
no	B-negation
headache	O
,	O
no	B-negation
earache	O
,	O
no	B-negation
difficulty	O
swallowing	O
,	O
no	B-negation
nosebleeds	O
and	O
no	B-negation
ringing	O
in	O
the	O
ears	B-bodyloc
.	O

Eyes	O

Birth	O
Weight	O
:	O
6lbs	B-labvalue
,	I-labvalue
11oz	I-labvalue

Examination	O
of	O
the	O
oropharynx	O
showed	O
no	B-negation
lesions	O
.	O

The	O
patient	O
has	O
normal	O
speech	O
and	O
normal	O
ambulation	O
.	O

History	O
of	O
Drug	O
Use	O

His	O
Foley	O
catheter	O
was	O
removed	O
on	O
the	B-temporal
morning	I-temporal
of	O
discharge	O
and	O
the	O
patient	O
subsequently	O
passed	O
the	O
voiding	O
trial	O
without	O
difficultly	O
.	O

Cranial	O
Nerves	O
:	O

Assessment	O
Visit	O
For	O
:	O
Postpartum	O
Exam	O
V24	O
.	O
2	O

Digital	O
Mammogram	O
(	O
screening	O
)	O
Requested	O
for	O
:	O
10May2011	B-temporal

History	O
of	O
Stroke	O
Syndrome	O
436	O

DOS	O
:	O
12/31/2012	B-temporal

History	O
of	O
Present	O
Illness	O

Nasal	O
Septum	O
:	O
midline	O

Lymphatic	O

Radiological	O
Data	O
Radiological	O
Data	O
Free	O
Text	O
:	O
Bilateral	O
knees	O
standing	O
AP	O
,	O
bilatearl	O
lateral	O
and	O
sunrise	O
views	O
:	O
Xrays	O
of	O
both	O
knees	O
demonstrate	O
no	O
new	O
findings	O
when	O
comparing	O
xrays	O
take	O
approximately	O
one	B-temporal
year	I-temporal
ago	I-temporal
.	O

Constitutional	O

Perimenopausal	O
Menorrhagia	O
627	O
.	O
0	O

ENT	O
:	O
no	B-negation
nasal	B-bodyloc
discharge	O
and	O
no	B-negation
sore	O
throat	B-bodyloc
.	O

Simple	B-severity
Goiter	O
240	O
.	O
0	O

No	B-negation
fever	O
,	O
chills	O
.	O

Examination	O
of	O
the	O
oropharynx	O
:	O
Normal	B-labvalue

SPINE	O
-	O
Straight	O
,	O
no	B-negation
defects	O
.	O

Patient	O
has	O
declined	B-negation
STD	O
screening	O
.	O

[	O
QLH	O
]	O
HEMOGLOBIN	O
A1c	O
Requested	O
fis	O
:	O
29Apr2013	B-temporal

Allergies	O
Sulfa	O
Drugs	O

Counseling	O
/	O
Signatures	O
Electronically	O
signed	O
by	O
:	O
LOURICE	O
ABDELMELEK	O
,	O
M	O
.	O
D	O
.	O

The	O
tongue	O
was	O
normal	O
.	O

[	O
O	O
]	O
Hemoglobin	O
A1c	O
(	O
in	O
office	O
)	O
Status	O
:	O
Resulted	O
-	O
Requires	O
Verification	O
,	O
Retrospective	O
Authorization	O
Done	O
:	O
01Jan0001	B-temporal
12	B-temporal
:	I-temporal
00AM	I-temporal

EARS	O
,	O
NOSE	O
,	O
MOUTH	O
AND	O
THROAT	O

Well	O
developed	O
,	O
appears	O
healthy	O
,	O
comfortable	O
,	O
well	O
nourished	O
,	O
overweight	O
,	O
clothing	O
appropriate	O
,	O
well	O
groomed	O
,	O
well	O
hydrated	O
,	O
appearance	O
reflects	O
stated	O
age	O
and	O
COLOR	O
NML	O
.	O

Mood	O
and	O
Affect	O
:	O
appropriate	B-labvalue
mood	I-labvalue
and	I-labvalue
appropriate	I-labvalue
affect	I-labvalue
.	O

Examination	O
of	O
gait	O
and	O
station	O
:	O
Abnormal	O

Hydroxychloroquine	O
Sulfate	O
200	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
TWICE	B-frequency
DAILY	I-frequency
Requested	O
for	O
:	O
21Dec2012	B-temporal
;	O
Last	O
Rx	O
:	O
21Dec2012	B-temporal

Lymphatic	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

Constitutional	O

Ocean	O
for	O
Kids	O
0	B-strength
.	I-strength
65	I-strength
%	I-strength
Nasal	B-form
Solution	I-form
;	O
USE	O
AS	O
DIRECTED	O
;	O
Therapy	O
:	O
25Mar2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
25Mar2013	B-temporal
)	O
Requested	O
for	O
:	O
25Mar2013	B-temporal
;	O
Status	O
:	O
ACTIVE	O
-	O
Retrospective	O
Authorization	O

Drug	O
Use	O

History	O
of	O
Present	O
Illness	O

[	O
U	O
]	O
XRAY	O
KNEE	O
1	O
OR	O
2	O
VWS	O
RIGHT	O
73560	O
Done	O
:	O
06Nov2013	B-temporal
12	B-temporal
:	I-temporal
00AM	I-temporal

Gastrointestinal	O
:	O
no	B-negation
constipation	O
,	O
no	B-negation
vomiting	O
,	O
no	O
diarrheaandappetite	O
has	O
not	O
decreased	O
.	O

Eyes	O

(	O
med	O
.	O

f	O
Never	O
A	O
Smoker	O
(	O
Active	O
)	O

Resp	O
:	O
no	B-negation
cough	O
,	O
no	B-negation
wheezing	O
,	O
not	B-negation
feeling	O
short	O
of	O
breath	O
,	O
no	B-negation
painful	O
inspirations	O
were	O
observed	O
,	O
no	B-negation
snoring	O
and	O
no	B-negation
tightness	O
due	O
to	O
taking	O
a	O
breath	O
.	O

Psychiatric	O
:	O
not	B-negation
suicidal	O
,	O
no	B-negation
sleep	O
disturbances	O
and	O
no	B-negation
anxiety	O
.	O

Chief	O
Complaint	O

Family	O
History	O
Family	B-subject
history	O
of	O
Hypertension	O
V17	O
.	O
49	O

Ovarian	B-bodyloc
Cyst	O
620	O
.	O
2	O

Discussed	O
plan	O
with	O
Attending	O

Ms	O
Wathen	O
was	O
having	O
too	O
much	O
pain	O
and	O
unable	O
to	O
complete	O
a	O
fully	O
physical	O
exam	O
,	O
especially	O
left	O
lower	O
extremity	O
.	O

The	O
patient	O
presents	O
with	O
complaints	O
of	O
eyesight	O
problems	O
.	O

On	O
admission	O
,	O
Mr	O
.	O
[	O
*	O
*	O
Known	O
lastname	O
6264	O
*	O
*	O
]	O
was	O
brought	O
to	O
the	O
operating	O
room	O
and	O
underwent	O
three	O
vessel	O
coronary	O
artery	O
bypass	O
grafting	O
by	O
Dr	O
.	O
[	O
*	O
*	O
First	O
Name	O
(	O
STitle	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
Name	O
(	O
STitle	O
)	O
*	O
*	O
]	O
.	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
and	O
no	B-negation
edema	O
.	O

Comorbid	O
Illnesses	O
:	O
hypertension	O
,	O
hyperlipidemia	O
,	O
obesity	O
and	O
BMI	O
49	B-labvalue
.	O

Integumentary	O
:	O
no	B-negation
skin	B-bodyloc
lesions	O
,	O
no	B-negation
skin	B-bodyloc
wound	O
,	O
no	B-negation
pruritus	O
,	O
no	B-negation
change	O
in	O
a	O
mole	B-bodyloc
,	O
no	B-negation
dry	O
skin	B-bodyloc
and	O
no	B-negation
unusual	O
growth	O
on	O
the	O
skin	B-bodyloc
.	O

Transient	O
cavity	O
dilation	O
c	O
/	O
w	O
severe	B-severity
multi	B-bodyloc
-	I-bodyloc
vessel	I-bodyloc
disease	O
.	O

Active	O
Problems	O
Acute	B-course
Pain	O
338	O
.	O
19	O

Hematologic	O
/	O
Lymphatic	O
:	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
,	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
,	O
no	B-negation
swollen	O
glands	B-bodyloc
and	O
no	B-negation
swollen	O
glands	B-bodyloc
in	O
the	O
neck	B-bodyloc
.	O

Carotid	O
Arteries	O
:	O
Normal	O
.	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
,	O
the	O
heart	O
rate	O
was	O
not	B-negation
fast	O
and	O
the	O
heart	O
rate	O
was	O
not	B-labvalue
slow	I-labvalue
.	I-labvalue

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
vomiting	O
,	O
no	B-negation
constipation	O
and	O
no	B-negation
diarrhea	O
.	O

Neurologic	O

UTP	O
-	O
OB	O
/	O
Patient	O
here	O
for	O
postpartum	O
checkandPostsurgical	O
Exam	O
.	O

Height	O
:	O
5	B-labvalue
ft	I-labvalue
9	I-labvalue
in	I-labvalue

Chief	O
Complaint	O

No	B-negation
dysmenorrhea	O
.	O

06/05/12	B-temporal
4	B-temporal
:	I-temporal
58	I-temporal
pm	I-temporal

[	O
QLH	O
]	O
BASIC	O
METABOLIC	O
PANEL	O
W	O
/	O
EGFR	O
Done	O
:	O
12Jan2010	B-temporal
09	B-temporal
:	I-temporal
27AM	I-temporal

Nasal	O
endoscopy	O
.	O

Family	O
History	O
Family	B-subject
history	O
of	O
Cancer	O

Assessment	O
of	O
muscle	O
strength	O
/	O
tone	O
:	O
Normal	B-labvalue

At	O
the	O
time	O
of	O
admission	O
,	O
she	O
had	O
just	O
a	O
trace	O
of	O
bilateral	O
lower	O
edema	O
.	O

Physical	O
Exam	O

were	O
reviewed	O
.	O

CoQ	O
-	O
10	O
CAPS	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
16Sep2013	B-temporal
)	O
to	O

Risk	O
Factors	O
:	O
no	O
smoking	O
,	O
no	B-negation
recent	B-temporal
trauma	O
and	O
no	B-negation
recent	B-temporal
surgery	O
.	O

Aricept	O
5	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
ONCE	B-frequency
every	I-frequency
morning	I-frequency
;	O
Therapy	O
:	O
14Jun2012	B-temporal
to	O

FINAL	O
REPORT	O

Disp	O
:	O
*	O
30	O
Tablet	O
(	O
s	O
)	O
*	O
Refills	O
:	O
*	O
0	O
*	O
10	O
.	O

Plan	O
Azithromycin	O
250	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
2	B-dosage
TABLETS	B-form
ON	O
DAY	B-temporal
1	I-temporal
THEN	O
TAKE	O
1	B-dosage
TABLET	B-form
A	B-frequency
DAY	I-frequency
FOR	B-duration
4	I-duration
DAYS	I-duration
;	O
Therapy	O
:	O
05Jan2012	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
05Jan2012	B-temporal
)	O

Examination	O
of	O
pupils	O
and	O
irises	O
:	O
Normal	B-labvalue
.	O

Cholesterol	O
Total	O
297	B-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
H	B-labvalue
120	B-reference_range
-	I-reference_range
200	I-reference_range

GI	O
:	O
no	B-negation
heartburn	O
,	O
no	B-negation
diarrhea	O
,	O
no	B-negation
nausea	O
,	O
no	B-negation
black	O
or	O
tarry	O
stools	O
,	O
no	B-negation
vomiting	O
and	O
no	B-negation
constipation	O
.	O

History	O
of	O
Present	O
Illness	O
76	O
y	O
/	O
o	O
pleasant	O
white	O
male	O
known	O
to	O
me	O
is	O
here	O
for	O
routine	O
follow	O
up	O
and	O
med	O
refill	O
.	O

[	O
QLH	O
]	O
TSH	O
,	O
3RD	O
GENERATION	O
Requested	O
for	O
:	O
29Oct2012	B-temporal

Review	O
of	O
Systems	O

She	O
started	O
to	O
have	O
some	O
pain	O
this	O
morning	O
and	O
it	O
got	O
worse	O
as	O
she	O
was	O
twisting	O
to	O
do	O
something	O
.	O

Multiple	O
chronic	O
medical	O
conditions	O

Maternal	B-subject
history	O
of	O
Hypertension	O
V17	O
.	O
49	O

Psychiatric	O

History	O
of	O
Essential	O
Hypertension	O
401	O
.	O
9	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

Patient	O
is	O
here	O
for	O
follow	O
up	O
.	O

16M	O
with	O
CRScNP	O
for	O
follow	O
up	O

Skin	B-bodyloc
findings	O
:	O
a	O
scar	O
.	O

Peripheral	O
Vision	O
:	O
Normal	B-labvalue
(	O
full	O
)	O
.	O

;	O
Dec	B-temporal
3	I-temporal
2012	I-temporal
3	B-temporal
:	I-temporal
31PM	I-temporal
(	O
Author	O
)	O

Symptoms	O
:	O
no	B-negation
dysuria	O
,	O
no	B-negation
urinary	O
frequency	O
,	O
no	B-negation
urinary	O
urgency	O
,	O
no	B-negation
urinary	O
incontinence	O
,	O
no	B-negation
hematuria	O
,	O
no	B-negation
nocturia	O
,	O
no	B-negation
malodorous	O
urine	O
,	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
back	B-bodyloc
pain	O
,	O
no	B-negation
fever	O
and	O
no	B-negation
chills	O

General	O
Appearance	O
:	O
Normal	B-labvalue
.	O

Depression	O
311	O

Description	O
of	O
patient	O
'	O
s	O
judgement	O
and	O
insight	O
:	O
Normal	B-labvalue
Judgment	O
:	O
intact	B-labvalue
judgment	O
and	O
intact	B-labvalue
insight	O
.	O

No	B-negation
red	O
eyes	B-bodyloc
.	O

Review	O
of	O
Systems	O

Subclinical	O
Hyperthyroidism	O
242	O
.	O
90	O

Current	O
Meds	O
Ensure	O
High	O
Protein	O
Oral	O
Liquid	O
;	O
Consume	O
3	O
times	O
daily	O
with	O
meals	O
or	O
between	O
meals	O
;	O
Therapy	O
:	O
26Sep2012	B-temporal
to	O
(	O
Evaluate	O
:	O
23Feb2013	B-temporal
)	O
;	O
Last	O
Rx	O
:	O
26Sep2012	B-temporal

Mom	O
voiced	O
understanding	O
of	O
the	O
plan	O
.	O

The	O
abdomen	O
was	O
soft	O
and	O
nontender	O
.	O

Tracleer	O
62	B-strength
.	I-strength
5	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Sig	O
:	O
mix	O
1	O
/	O
2	O
tablet	O
(	O
31	O
.	O
25mg	O
)	O
in	O
10	O
ml	O
water	O
and	O
give	O
2	O
.	O
9	O
ml	O
(	O
9mg	O
)	O
by	B-route
mouth	I-route
every	B-frequency
12	I-frequency
hours	I-frequency
;	O
Last	O
Rx	O
:	O
28Mar2013	B-temporal
;	O
Status	O
:	O
ACTIVE	O
-	O
Retrospective	O
Authorization	O

Left	O
Anter	O
.	O

Dr	O
.	O
Murphy	O
was	O
in	O
the	O
clinic	O
and	O
supervised	O
this	O
visit	O
.	O

Hemoccult	O
(	O
Stool	O
)	O
Requested	O
for	O
:	O
02Nov2012	B-temporal

Gastrointestinal	O
:	O
no	B-negation
vomiting	O
,	O
no	B-negation
constipation	O
and	O
no	B-negation
diarrhea	O
.	O

Anus	O
,	O
perineum	O
and	O
rectum	O
:	O
Normal	O

Skin	O

Endocrine	O
:	O
no	B-negation
hot	O
flashes	O
,	O
no	B-negation
muscle	B-bodyloc
weakness	O
and	O
no	B-negation
feelings	O
of	O
weakness	O
.	O

No	B-negation
posterior	O
cervical	O
node	O
enlargement	O
and	O
no	B-negation
supraclavicular	B-bodyloc
node	I-bodyloc
enlargement	O
.	O

Interval	O
symptoms	O
:	O
denies	B-negation
palpitations	O
,	O
denies	B-negation
tremor	O
,	O
denies	B-negation
hyperactivity	O
,	O
denies	B-negation
anxiety	O
,	O
new	O
onset	O
of	O
insomnia	O
and	O
new	O
onset	O
of	O
fatigue	O
.	O

Start	O
Oral	B-route
Prednisone	O
burst	O
and	O
taper	B-dosage
over	B-duration
12	I-duration
days	I-duration
-	O
-	O
counseled	O

Pt	O
came	O
in	O
for	O
follow	O
up	O
of	O
elevated	O
BP	O
readings	O
was	O
unable	O
to	O
keep	O
log	O
but	O
the	O
BP	O
today	B-temporal
was	O
140	B-labvalue
/	I-labvalue
90	I-labvalue
also	O
while	O
in	O
the	O
hospital	O
her	O
level	O
were	O
elevated	B-labvalue
"	O
it	O
becuase	O
I	O
'	O
m	O
on	O
so	O
many	O
pain	O
meds	O
"	O

Current	O
Meds	O
Aspirin	O
325	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
25Mar2014	B-temporal
)	O
to	O

Sleep	O
Disturbances	O
780	O
.	O
50	O

Describes	O
pain	O
as	O
coming	O
at	O
roughly	O
the	O
same	O
time	O
each	O
month	O
.	O

Assessment	O
of	O
hearing	O
:	O
Normal	B-labvalue
.	O

Birth	O
Control	O
:	O
hysterectomy	O
.	O

Review	O
of	O
Systems	O

Palpation	O
of	O
chest	O
:	O
Normal	B-labvalue
.	O

The	O
patient	O
was	O
given	O
nebulizer	O
treatment	O
and	O
Lasix	O
increased	O
the	O
same	O
to	O
resolve	O
the	O
problem	O
.	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Neck	O

History	O
of	O
Drug	O
Use	O

Inspection	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
Abnormal	O
Dry	O
skinandwrinkled	O
appearance	O
.	O

Right	O
Foot	O
:	O
The	O
foot	O
was	O
normal	O
.	O

CCil	O
or	O
return	O
to	O
the	O
office	O
for	O
evaluation	O
if	B-condition
symptoms	O
fail	B-course
to	I-course
improve	I-course
as	O
anticipated	O
or	O
new	B-course
symptoms	O
of	O
rash	O
,	O
fever	O
,	O
bloody	O
stool	O
appear	O
.	O

Wheezing	O
:	O
None	B-negation

Assessment	O
of	O
hearing	O
:	O
Normal	B-labvalue
.	O

No	B-negation
masses	O
palpated	O
.	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
,	O
no	B-negation
increased	O
heart	B-bodyloc
rate	O
,	O
no	B-negation
decrease	O
in	O
heart	B-bodyloc
rate	O
,	O
no	B-negation
edema	O
,	O
no	B-negation
intermittent	O
leg	B-bodyloc
claudication	O
and	O
no	B-negation
syncope	O
.	O

Fluticasone	O
Propionate	O
50	B-strength
MCG	I-strength
/	I-strength
ACT	I-strength
Nasal	B-route
Suspension	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
16Nov2012	B-temporal
)	O
to	O

Plan	O
Ortho	O
Plan	O
:	O

Gait	O
:	O
wide	O
-	O
based	O
.	O

*	O
Any	O
serious	O
change	O
in	O
your	O
symptoms	O
,	O
or	O
any	O
new	O
symptoms	O
that	O
concern	O
you	O
.	O

He	O
remained	O
in	O
a	O
normal	B-labvalue
sinus	O
rhythm	O
.	O

Constitutional	O
:	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
,	O
not	B-negation
feeling	O
tired	O
(	O
fatigue	O
)	O
andno	O
recent	B-temporal
weight	O
gain	O
.	O

She	O
also	O
noted	O
postcoital	O
spotting	O
.	O

Cranial	O
nerves	O
III	O
,	O
IV	O
,	O
and	O
VI	O
:	O
the	O
extraocular	O
motions	O
were	O
intact	B-labvalue
.	O

Constitutional	O

External	O
inspection	O
of	O
ears	O
and	O
nose	O
:	O
Normal	B-labvalue

Respiratory	O
effort	O
:	O
Normal	O
.	O

FR	O
/	O
FS	O
:	O
Not	O
visualized	O

Vitals	O
24Mar2014	B-temporal
02	B-temporal
:	I-temporal
55PM	I-temporal
BMI	O
Calculated	O
23	B-labvalue
.	I-labvalue
64	I-labvalue
BSA	O
Calculated	O
1	B-labvalue
.	I-labvalue
76	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
6	I-labvalue
in	I-labvalue
Weight	O
147	B-labvalue
lb	I-labvalue
1	I-labvalue
oz	I-labvalue
Systolic	O
131	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
74	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Temperature	O
97	B-labvalue
.	I-labvalue
7	I-labvalue
F	I-labvalue
,	O
Tympanic	O
Heart	O
Rate	O
53	B-labvalue
Respiration	O
16	B-labvalue
LMP	O
post	O
-	O
meno	O

ENT	O
:	O
no	B-negation
nasal	B-bodyloc
discharge	O
and	O
no	B-negation
sore	O
throat	B-bodyloc
.	O

Plan	O
Lovaza	O
1	B-strength
GM	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
2	B-dosage
CAPSULES	B-form
TWICE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
13Dec2013	B-temporal
to	O
(	O
Evaluate	O
:	O
13Mar2014	B-temporal
)	O
Requested	O
for	O
:	O
13Dec2013	B-temporal
;	O
Last	O
Rx	O
:	O
13Dec2013	B-temporal
;	O
Edited	O

Neurologic	O

Pedal	O
pulses	O
:	O
Normal	B-labvalue

1	O
2	O
3	O
4	O
Influenza	O
26Oct2007	B-temporal
22Oct2008	B-temporal
22Oct2008	B-temporal
12Oct2011	B-temporal

She	O
is	O
in	O
no	B-negation
apparent	O
distress	O
.	O

Glimepiride	O
1	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
1	B-dosage
/	I-dosage
2	I-dosage
tab	B-form
twice	B-frequency
a	I-frequency
day	I-frequency
with	I-frequency
food	I-frequency
;	O
Therapy	O
:	O
03Jan2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
03Jan2013	B-temporal
)	O

Physical	O
Exam	O

Chest	O

Current	B-temporal
treatment	O
includes	O
non	O
-	O
prescription	O
cold	O
medication	O
.	O

Blood	O
/	O
Hem	O
:	O
N	O
/	O
A	O
.	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
,	O
no	B-negation
cough	O
,	O
no	B-negation
shortness	O
of	O
breath	O
during	O
exertion	O
and	O
no	B-negation
orthopnea	O
.	O

Endocrine	O
:	O
no	B-negation
muscle	B-bodyloc
weakness	O
and	O
no	B-negation
deepening	O
of	O
the	O
voice	O
.	O

Reproductive	O
health	O
:	O
the	O
patient	O
is	O
perimenopausal	O
.	O

EKG	O
Requested	O
for	O
:	O
24Oct2012	B-temporal

GASTROINTESTINAL	O
:	O
no	B-negation
heartburn	O
,	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
diarrhea	O
,	O
no	B-negation
constipation	O
and	O
no	B-negation
vomiting	O
.	O

Discussion	O
/	O
Discussion	O
/	O
Summary	O

Inspection	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
Abnormal	O
.	O
Many	O
dark	O
macular	O
lesions	O
on	O
back	B-bodyloc
-	O
Seb	O
Keratoses	O
with	O
no	B-negation
signs	O
of	O
infection	O
/	O
noplastic	O
change	O
.	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
MICHAEL	O
CHATER	O
,	O
M	O
.	O
D	O
.	O

Bowel	O
sounds	O
equal	O
times	O
four	O
quadrants	O
.	O

Associated	O
symptoms	O
include	O
recent	B-temporal
weight	O
gain	O
,	O
but	O
no	B-negation
polyuria	O
and	O
no	B-negation
polydipsia	O
.	O

f	O
Living	O
With	O
Parents	O
Living	O
Together	O
(	O
Active	O
)	O

Encounters	O

Ergocalciferol	O
50000	B-dosage
UNIT	I-dosage
Oral	B-route
Capsule	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
WEEKLY	B-frequency
Requested	O
for	O
:	O
29Oct2013	B-temporal
;	O
Last	O
Rx	O
:	O
29Oct2013	B-temporal
;	O
Status	O
:	O
ACTIVE	O
-	O
Retrospective	O
Authorization	O

The	O
rhythm	O
was	O
regular	B-labvalue
.	O

She	O
had	O
a	O
2	O
hour	O
EEG	O
done	B-temporal
November	I-temporal
1st	I-temporal
.	O

Cervical	O
spondylosis	O
with	O
herniated	O
nucleus	O
pulposus	O
C4	O
-	O
C5	O
,	O
C5	O
-	O
C6	O
,	O
and	O
C6	O
-	O
C7	O
with	O
stenosis	O
.	O

Palpable	B-labvalue
dorsalis	O
pedis	O
amd	O
posterior	O
tibial	O
pulses	O
in	O
the	O
lower	O
extremities	O
.	O

Inspection	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
Abnormal	O
(	O
nevus	O
on	O
scalp	B-bodyloc
)	O
Nevus	O
on	O
the	O
head	B-bodyloc
.	O

Pulmonary	O

Ophthalmoscopic	O
examination	O
:	O
Normal	B-labvalue
.	O

Examination	O
of	O
the	O
abdomen	O
:	O
Normal	B-labvalue
The	O
abdomen	O
was	O
flat	O
.	O

Comorbid	O
Illnesses	O
:	O
coronary	B-bodyloc
artery	I-bodyloc
disease	O
,	O
diabetes	O
mellitus	O
and	O
hypertension	O
.	O

Called	O
pharmacy	O
713-218-4491	O
lm	O
on	O
vm	O
and	O
sent	O
retail	O
.	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
,	O
no	B-negation
cough	O
,	O
no	B-negation
shortness	O
of	O
breath	O
during	O
exertion	O
,	O
no	B-negation
orthopnea	O
and	O
no	B-negation
PND	O
.	O

Hypertension	O
401	O
.	O
9	O

Examination	O
of	O
liver	O
and	O
spleen	O
:	O
Normal	B-labvalue
.	O

The	O
patient	O
was	O
instructed	O
to	O
follow	O
up	O
with	O
Dr	O
.	O
XYZ	O
on	O
8/12/2008	B-temporal
at	O
1	B-temporal
:	I-temporal
50	I-temporal
p	I-temporal
.	I-temporal
m	I-temporal
.	O
and	O
was	O
given	O
prescription	O
for	O
pain	O
medications	O
as	O
well	O
as	O
laxative	O
.	O

Cranial	O
nerves	O
XI	O
:	O
shoulder	O
shrug	O
was	O
intact	B-labvalue
bilaterally	I-labvalue
.	O

Docusate	O
Sodium	O
100	B-strength
mg	I-strength
Capsule	B-form
Sig	O
:	O
One	B-dosage
(	I-dosage
1	I-dosage
)	I-dosage
Capsule	B-form
PO	B-route
BID	B-frequency
(	I-frequency
2	I-frequency
times	I-frequency
a	I-frequency
day	I-frequency
)	I-frequency
.	O

PHENobarbital	O
Powder	B-form

Chief	O
Complaint	O

Plan	O
_	O
2	O
_	O
twCiteListControlStart	O
NexIUM	O
40	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
Delayed	I-form
Release	I-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
BY	B-route
MOUTH	I-route
EVERY	B-frequency
DAY	I-frequency
;	O
Therapy	O
:	O
29Apr2013	B-temporal
to	O
(	O
Evaluate	O
:	O
27Aug2013	B-temporal
)	O
Requested	O
fis	O
:	O
29Apr2013	B-temporal
;	O
Last	O
Rx	O
:	B-temporal
29Apr2013	I-temporal
;	O

Ailergies	O
g24	O

History	O
of	O
Present	O
Illness	O
The	O
patient	O
is	O
being	O
seen	O
for	O
a	O
routine	O
clinic	O
follow	O
-	O
up	O
.	O

Height	O
:	O
5	B-labvalue
ft	I-labvalue
9	I-labvalue
in	I-labvalue

History	O
of	O
Bell	O
'	O
s	O
Palsy	O
351	O
.	O
0	O

Surgical	O
History	O
Denied	O

Examination	O
of	O
extremities	O
for	O
edema	O
and	O
/	O
or	O
varicosities	O
:	O
Normal	B-labvalue

The	O
sputum	O
is	O
described	O
as	O
yellow	O
.	O

Bystolic	O
5	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
20Aug2013	B-temporal
)	O
to	O

2	O
'	O
PP	O
bfast	O
:	O
all	O
<	O
120	O

Dorsalis	O
pedis	O
:	O
right	O
2	O
+	O
and	O
left	O
2	O
+	O
.	O

Assessment	O
Acute	B-course
Maxillary	B-bodyloc
Sinusitis	O
461	O
.	O
0	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
,	O
the	O
heart	O
rate	O
was	O
not	B-labvalue
fast	I-labvalue
,	O
the	O
heart	O
rate	O
was	O
not	B-labvalue
slow	I-labvalue
,	O
no	B-negation
intermittent	O
leg	B-bodyloc
claudication	O
and	O
no	B-negation
edema	O
.	O

Patient	O
attends	O
phlebotomy	O
and	O
donates	O
blood	O
every	O
3	B-temporal
-	I-temporal
4	I-temporal
months	I-temporal
,	O
recently	O
had	O
phlebotomy	O
fe	O
weeks	B-temporal
ago	I-temporal
.	O

Medications	O
:	O
The	O
patient	O
is	O
adherent	O
with	O
her	O
medication	O
regimen	O
.	O
She	O
denies	B-negation
medication	O
side	O
effects	O
.	O

Constitutional	O

Femoral	B-bodyloc
:	O
right	O
2	O
+	O
,	O
left	O
2	O
+	O
,	O
no	B-negation
bruit	O
on	O
the	O
right	O
and	O
no	B-negation
bruit	O
on	O
the	O
left	O
.	O

1	O
.	O

Neck	B-bodyloc
No	B-negation
SC	O
fat	O
pad	O
;	O
No	B-negation
CLA	O
.	O
Thyroid	O
25	O
-	O
30	O
gm	O
;	O
no	B-negation
discrete	O
mass	O
.	O

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

Procedure	O

Examination	O
of	O
extremities	O
for	O
edema	O
and	O
/	O
or	O
varicosities	O
:	O
Normal	B-labvalue

History	O
of	O
Lumbago	O
724	O
.	O
2	O

CurrentMeds	O
_	O
4	O
_	O
twCiteListControlStart	O
AmLODIPine	O
Besylate	O
10	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
DAILY	B-frequency
;	O
Therapy	O
:	O
21Aug2012	B-temporal
to	O
(	O
Evaluate	O
:	O
05Aug2013	B-temporal
)	O
Requested	O
fis	O
:	O
07Jan2013	B-temporal
;	O
Last	O
Rx	O
:	B-temporal
07Jan2013	I-temporal
Blood	O
Pressure	O
Monitor	O
KIT	O
;	O
USE	O
AS	O
DIRECTED	O
;	O
Therapy	O
:	O
06Aug2012	B-temporal
to	O
(	O
Evaluate	O
:	B-temporal
07Aug2012	I-temporal
)	O
;	O
Last	O
Rx	O
:	B-temporal
06Aug2012	I-temporal

She	O
has	O
recent	O
D	O
&	O
C	O
and	O
hysteroscopy	O
.	O

Risks	O
of	O
surgery	O
,	O
including	O
but	O
not	B-negation
limited	O
to	O
anesthesia	O
,	O
infection	O
,	O
bleeding	O
,	O
orbital	B-bodyloc
injury	O
,	O
intracranial	B-bodyloc
injury	O
,	O
anosmia	O
/	O
hyposmia	O
,	O
epiphora	O
,	O
voice	O
changes	O
,	O
need	O
for	O
additional	O
prodedures	O
,	O
etc	O
.	O

Cholesterol	O
Total	O
313	B-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
H	B-labvalue
120	B-reference_range
-	I-reference_range
200	I-reference_range

She	O
eventually	O
underwent	O
a	O
partial	O
resection	O
found	O
to	O
have	O
pathologic	O
grade	B-severity
2	I-severity
leiomyosarcoma	O
,	O
margins	O
were	O
impossible	O
to	O
assess	O
,	O
but	O
were	O
likely	O
positive	O
.	O

Past	O
Medical	O
History	O
History	O
of	O
Solitary	O
Thyroid	B-bodyloc
Nodule	O
241	O
.	O
0	O

Conitinue	O
flonase	O
spray	B-form
.	O

She	O
has	O
been	O
on	O
a	O
very	O
low	O
-	O
fat	O
diet	O
since	O
November	O
since	O
her	O
cholesterol	O
was	O
high	O
,	O
except	O
when	O
she	O
was	O
on	O
vacation	O
for	O
a	O
week	O
,	O
but	O
says	O
she	O
never	O
ate	O
a	O
lot	O
of	O
fat	O
and	O
attributes	O
her	O
cholesterol	O
more	O
to	O
hereditary	O
factors	O
.	O

He	O
notes	O
long	O
standing	O
sinus	B-bodyloc
trouble	O
with	O
sinus	B-bodyloc
congestion	O
and	O
ear	B-bodyloc
fullness	O
.	O

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

History	O
of	O
Knee	O
Arthroplasty	O

Pelvic	O
US	O
ordered	O
today	B-temporal
.	O

Active	O
Problems	O
g29	O

f	O
Not	O
Known	O

Psychiatric	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Surgical	O
History	O
History	O
of	O
Sinus	O
Surgery	O

2	O
.	O

I	O
was	O
present	O
and	O
available	O
in	O
clinic	O
.	O

Examination	O
of	O
sensation	O
:	O
Normal	B-labvalue
.	O

Counseling	O
/	O
Counseling	O
/	O
Edu	O
Diet	O
recommendations	O
:	O
weight	O
loss	O
diet	O
,	O
low	O
fat	O
diet	O
,	O
low	O
sodium	O
diet	O
.	O

ENT	O
:	O
no	B-negation
earache	O
,	O
no	B-negation
hearing	O
loss	O
,	O
no	B-negation
epistaxis	O
,	O
no	B-negation
nasal	B-bodyloc
discharge	O
and	O
no	B-negation
sore	O
throat	B-bodyloc
.	O

Examination	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue
.	O

Family	B-subject
history	O
of	O
Congestive	O
Heart	B-bodyloc
Failure	O

RTC	O
3	O
-	O
4	O
mos	O

Nasonex	O
50	B-strength
MCG	I-strength
/	I-strength
ACT	I-strength
Nasal	B-route
Suspension	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
03Nov2011	B-temporal
)	O
to	O

Inspection	O
/	O
palpation	O
of	O
joints	O
,	O
bones	O
,	O
and	O
muscles	O
:	O
Abnormal	O
.	O
Left	B-bodyloc
hand	I-bodyloc
dorsal	I-bodyloc
surface	I-bodyloc
,	O
slightly	B-severity
swollen	O
,	O
painful	O
to	O
pressure	O
over	O
area	O
of	O
scar	O
and	O
pain	O
on	O
lateral	O
flexion	O
over	O
wrist	B-bodyloc
area	I-bodyloc
.	I-bodyloc

Social	O
History	O
"	O
Smoker	O
,	O
Current	O
Status	O
Unknown	O
305	O
.	O
1	O

Examination	O
of	O
bladder	O
:	O
Normal	B-labvalue

Pertinent	O
medical	O
history	O
:	O
allergic	O
rhinitis	O
.	O

non	O
-	O
contributory	O

Paternal	B-subject
history	O
of	O
Epilepsy	O

3	O
.	O

ACTIVE	O
-	O
Retrospective	O
Authorization	O

The	O
patient	O
is	O
currently	B-temporal
experiencing	O
symptoms	O
.	O

Neurological	O
:	O
arm	B-bodyloc
weakness	O
,	O
leg	B-bodyloc
weakness	O
,	O
convulsionsandmigraine	O
headaches	O
.	O

ABDOMEN	O
:	O
Soft	O
,	O
and	O
with	O
deep	O
palpation	O
I	O
am	O
unable	O
to	O
arouse	O
the	O
patient	O
,	O
unable	B-negation
to	I-negation
elicit	I-negation
any	O
tenderness	O
.	O

4	O
)	O
Desires	O
future	O
fertility	O
.	O

No	B-negation
rhonchi	O
were	O
heard	O
.	O

The	O
patient	O
is	O
currently	O
asymptomatic	O
.	O

Diabetes	O
Mellitus	O
Poorly	B-course
Controlled	I-course
250	O
.	O
00	O

7	O
.	O

Stressed	O
the	O
importance	O
of	O
consistent	O
MNT	O
and	O
med	O
compliance	O
in	O
DM	O
control	O

Neurological	O
:	O
no	B-negation
confusion	O
,	O
no	B-negation
convulsions	O
,	O
no	B-negation
dizziness	O
,	O
no	B-negation
fainting	O
,	O
no	B-negation
limb	B-bodyloc
weakness	O
and	O
no	B-negation
difficulty	O
walking	O
.	O

Examination	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue
.	O

TSI	O
ENDOSCOPY	O
.	O

Past	O
Medical	O
History	O
History	O
of	O
Atrial	B-bodyloc
Fibrillation	O
427	O
.	O
31	O

Symptoms	O
:	O
scotoma	O
,	O
headache	O
,	O
phonophobia	O
and	O
nausea	O
.	O

I	O
have	O
recommended	O
a	O
physical	O
therapy	O
evaluation	O
for	O
gait	O
training	O
and	O
safety	O
.	O

Urine	O
Dipstick	O
(	O
In	O
Office	O
)	O
Done	O
:	O
14Oct2013	B-temporal
10	B-temporal
:	I-temporal
20AM	I-temporal

DIET	O
:	O
Regular	O
.	O

[	O
QLH	O
]	O
LIPID	O
PANEL	O
Requested	O
for	O
:	O
02Jul2012	B-temporal

Review	O
of	O
Systems	O

EYES	B-route
2	B-frequency
TIMES	I-frequency
DAILY	I-frequency
;	I-frequency
Therapy	O
:	O
(	O
Recorded	O
:	O
12Jul2013	B-temporal
)	O
to	O

Respiratory	O
:	O
no	B-negation
wheezing	O
and	O
no	B-negation
cough	O
.	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Diarrhea	O
(	O
Symptom	O
)	O
787	O
.	O
91	O

Normal	O
Routine	O
History	O
And	O
Physical	O
Adult	O
V70	O
.	O
0	O

(	O
832	O
)	O
325	O
-	O
7300	O
(	O
Work	O
ptone	O
)	O
Pharmacy	O
Walgreen	O
Drug	O
Store	O
03661	O

Review	O
of	O
Systems	O

Chief	O
Complaint	O

Gestational	O
age	O
:	O
6	O
weeks	O
.	O

Diastolic	O
:	O
87	B-labvalue

The	O
patient	O
also	O
had	O
a	O
glucose	O
tolerance	O
test	O
with	O
his	O
primary	O
care	O
physician	O
and	O
reports	O
that	O
this	O
test	O
was	O
completely	O
normal	B-labvalue
.	O

Homocysteinemia	O
270	O
.	O
4	O

Familial	O
Hypercholesterolemia	O
272	O
.	O
0	O

PastMedicalHistisy	O
_	O
10	O
_	O
twCiteListControlEnd	O
PastMedicalHistisySectispEnd	O
FamilyHistisySectispStart	O
Family	O
Histisy	O

Deep	O
tendon	O
reflexes	O
:	O
right	O
patella	O
2	O
+	O
and	O
left	O
patella	O
2	O
+	O
.	O

Height	O
:	O
5	B-labvalue
ft	I-labvalue
5	I-labvalue
in	I-labvalue

Stool	O
sample	O
for	O
occult	O
blood	O
:	O
Normal	B-labvalue
.	O

History	O
of	O
Sciatica	O
724	O
.	O
3	O

Levothyroxine	O
Sodium	O
100	B-strength
MCG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
EVERY	B-frequency
DAY	I-frequency
;	O
Therapy	O
:	O
20Dec2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
20Dec2013	B-temporal
)	O
Requested	O
for	O
:	O
25Feb2014	B-temporal
;	O
Edited	O

Current	O
Meds	O
Cymbalta	O
60	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
Delayed	I-form
Release	I-form
Particles	I-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
28Aug2013	B-temporal
to	O

MCH	O
:	O
32	B-labvalue
.	I-labvalue
0	I-labvalue
pg	I-labvalue
Reference	O
Range	O
26	B-reference_range
.	I-reference_range
6	I-reference_range
-	I-reference_range
33	I-reference_range
.	I-reference_range
0	I-reference_range

Psychiatric	O

[	O
QLH	O
]	O
HEPATIC	O
FUNCTION	O
PANEL	O
Requested	O
for	O
:	O
07Sep2011	B-temporal

Lisinopril	O
40	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
AS	O
DIRECTED	O
;	O
Therapy	O
:	O
07Apr2006	B-temporal
to	O
(	O
Evaluate	O
:	O
18Sep2014	B-temporal
)	O
Requested	O
for	O
:	O
23Sep2013	B-temporal
;	O
Last	O
Rx	O
:	O
23Sep2013	B-temporal

Abdomen	O
:	O
Normal	O
.	O

Assessment	O
Pharyngitis	O
462	O

Surgical	O
History	O
History	O
of	O
Appendectomy	O

Surgical	O
History	O
History	O
of	O
Cesarean	O
Section	O

Canal	O
is	O
patent	O
but	O
borderline	O
in	O
size	O
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

History	O
of	O
Present	O
Illness	O

Inspection	O
/	O
palpation	O
of	O
digits	O
and	O
nails	O
:	O
Normal	B-labvalue
without	B-negation
clubbing	O
or	O
cyanosis	O
.	O

Vagifem	O
10	B-strength
MCG	I-strength
Vaginal	O
Tablet	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
20Feb2013	B-temporal
)	O
to	O

HOSPITAL	O
COURSE	O
:	O
At	O
the	O
time	O
of	O
transfer	O
to	O
ABCD	O
,	O
these	O
were	O
the	O
following	O
issues	O
.	O

Family	O
Hx	O
g7	O

Eyes	O

Obesity	O
278	O
.	O
00	O

Psychiatric	O
:	O
no	B-negation
anxiety	O
,	O
no	B-negation
depression	O
and	O
no	B-negation
problems	O
.	O

Morbid	O
Obesity	O
278	O
.	O
01	O

Neck	O

UTP	O
-	O
Discussion	O
/	O

Cranial	O
Nerves	O
III	O
,	O
IV	O
,	O
and	O
VI	O
:	O
the	O
extraocular	O
motions	O
were	O
intact	B-labvalue
.	O

Abdomen	O
Soft	O
,	O
nontender	O
;	O
no	B-negation
purple	O
striae	O
.	O
No	B-negation
palpable	O
mass	O
or	O
organomegaly	O
.	O

No	B-negation
intranasal	B-bodyloc
mass	O
or	O
polyp	O
was	O
found	O
.	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
COURTNEY	O
PRESTON	O
,	O
M	O
.	O
D	O
.	O

We	O
will	O
schedule	O
a	O
phase	O
I	O
evaluation	O
.	O

Followup	O
Instructions	O
:	O

ACTIVITY	O
:	O
Resume	O
same	O
activity	O
.	O

2	O
.	O
5mm	O
posterocentral	O
protrusion	O
at	O
L5	B-bodyloc
-	I-bodyloc
S1	I-bodyloc
with	O
minimal	O
indentation	O
of	O
the	O
ventral	O
thecal	B-bodyloc
sac	I-bodyloc
.	O

Cranial	O
nerves	O
III	O
,	O
IV	O
,	O
and	O
VI	O
:	O
the	O
extraocular	O
motions	O
were	O
intact	B-labvalue
.	O

9	I-reference_range
)	O
;	O
Na	O
139	B-labvalue
,	O
K	O
5	B-labvalue
.	I-labvalue
4	I-labvalue
,	O
Cl	O
103	B-labvalue
,	O
CO2	O
25	B-labvalue
BUN	O
27	B-labvalue
,	O
glucose	O
183	B-labvalue
Ca	O
9	B-labvalue
.	I-labvalue
4	I-labvalue
,	O
WBC	O
7	B-labvalue
.	I-labvalue
1	I-labvalue
Hgb	O
11	B-labvalue
.	I-labvalue
4	I-labvalue
Hct	O
35	B-labvalue
.	I-labvalue
8	I-labvalue
Plt	O
197	B-labvalue
,	O
Ferritin	O
1526	B-labvalue
,	O
TIBC	O
243	B-labvalue
,	O
%	O
Iron	O
Sat	O
73	B-labvalue
%	I-labvalue
ASSESSMENT	O
:	O
A	O
53	O
-	O
year	O
-	O
old	O
man	O
with	O
hypertension	O
,	O
diabetes	O
,	O
CVA	O
,	O
with	O
CKD	O
stage	B-severity
III	I-severity
,	O
doing	O
well	O
.	O

Head	O
and	O
Face	O

Lisinopril	O
10	B-strength
mg	I-strength
Tablet	B-form
Sig	O
:	O
One	B-dosage
(	I-dosage
1	I-dosage
)	I-dosage
Tablet	B-form
PO	B-route
DAILY	B-frequency
(	I-frequency
Daily	I-frequency
)	I-frequency
.	O

I	O
have	O
seen	O
and	O
examined	O
SANDRA	O
ALLEN	O
with	O
the	O
resident	O
.	O

Abdomen	O
:	O
Normal	O
.	O

Psychiatric	O
:	O
not	B-negation
suicidal	O
,	O
no	O
depressionandno	O
personality	O
change	O
.	O

Compazine	O
TABS	B-form

History	O
of	O
Preterm	O
Infant	O

I	O
have	O
discussed	O
with	O
the	O
patient	O
and	O
her	O
mother	O
at	O
great	O
length	O
.	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
SANCAK	O
YUKSEL	O
,	O
M	O
.	O
D	O
.	O

DISPOSITION	O
:	O
Home	O
in	O
stable	O
condition	O
.	O

Deeper	O
subcutaneous	O
layers	O
intact	O
.	O

Hypothyroidism	O
244	O
.	O
9	O

Family	O
History	O
Family	B-subject
history	O
of	O
Breast	B-bodyloc
Cancer	O
V16	O
.	O
3	O

Apr	B-temporal
10	I-temporal
2012	I-temporal
1	B-temporal
:	I-temporal
31PM	I-temporal
(	O
Author	O
)	O

ENDOCRINE	O
:	O
no	B-negation
cold	O
intolerance	O
,	O
no	B-negation
heat	O
intolerance	O
and	O
no	B-negation
excessive	O
thirst	O
.	O

Subclinical	O
Hypothyroidism	O
244	O
.	O
9	O

Blood	O
pressure	O
129	B-labvalue
/	I-labvalue
69	I-labvalue
on	O
admission	O
.	O

He	O
sustained	O
an	O
injury	O
to	O
the	O
left	B-bodyloc
knee	I-bodyloc
.	O

1	O
.	O

Skin	O

Cranial	O
nerves	O
VII	O
:	O
facial	O
strength	O
was	O
intact	O
bilaterally	O
.	O

History	O
of	O
Major	O
Depression	O
,	O
Single	O
Episode	O
,	O
Without	B-negation
Psychotic	O
Features	O
,	O
With	O
Melancholia	O

Vitals	O
UTP	O
Adult	O
Vital	O
Signs	O
[	O
Data	O
Includes	O
:	O
Current	O
Encounter	O
]	O

Thyroid	O
:	O
Normal	O
.	O

Eyes	O
:	O
no	B-negation
purulent	O
discharge	O
from	O
the	O
eyes	B-bodyloc
.	O

Respiratory	O
rate	O
:	O
the	O
respiratory	O
rate	O
was	O
normal	B-labvalue
.	O

Sensory	O
exam	O
:	O
intact	B-labvalue
to	O
light	O
touch	O
,	O
intact	B-labvalue
pain	O
and	O
temperature	O
sensation	O
,	O
no	B-negation
dysesthesia	O
and	O
no	B-negation
hyperesthesia	O
.	O

Eth	O
:	O
Eo	O
mucin	O

She	O
is	O
to	O
take	O
the	O
Celebrex	O
twice	B-frequency
a	I-frequency
day	I-frequency
for	O
the	O
antiinflammatory	O
effect	O
.	O

History	O
of	O
Smoking	O

Examination	O
of	O
the	O
oropharynx	O
:	O
Normal	B-labvalue
.	O

Nasopharynx	O
:	O
Unable	O
to	O
visualize	O
.	O

Also	O
discussed	O
additional	O
diff	O
dx	O
including	O
adhesive	O
dz	O
,	O
bowel	B-bodyloc
process	O
.	O

Soft	O
Palate	O
:	O
normal	O
nasal	O
surface	O
with	O
symmectric	O
closure	O
.	O

Family	B-subject
history	O
of	O
Hypertension	O
V17	O
.	O
49	O

Examination	O
of	O
the	O
head	O
and	O
face	O
:	O
Normal	B-labvalue

The	O
patient	O
'	O
s	O
last	O
LDL	O
was	O
81	B-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue
.	O

Physical	O
Exam	O

FSBG	O
in	O
clinic	O
was	O
185	O
-	O
spoke	O
in	O
detail	O
to	O
son	O
and	O
patient	O
about	O
glucose	O
control	O
.	O

Social	O
History	O
Being	O
A	O
Social	O
Drinker	O

So	O
,	O
the	O
patient	O
is	O
being	O
prepared	O
for	O
discharge	O
at	O
this	O
point	O
.	O

He	O
maintained	O
stable	O
hemodynamics	O
as	O
he	O
weaned	O
from	O
inotropic	O
support	O
.	O

There	O
is	O
no	B-negation
meningismus	O
.	O

Discussion	O
/	O
Signatures	O
Electronically	O
signed	O
by	O
:	O
ALICE	O
CHIU	O
,	O
M	O
.	O
D	O
.	O

but	O
it	O
was	O
effort	O
dependent	O
,	O
and	O
exagerated	O

Pt	O
.	O
states	O
he	O
sometimes	O
has	O
SOB	O
,	O
numbness	O
on	O
hands	B-bodyloc
,	O
and	O
dizziness	O
.	O

Carbon	O
Dioxide	O
,	O
Total	O
:	O
22	B-labvalue
mmol	I-labvalue
/	I-labvalue
L	I-labvalue
Reference	O
Range	O
19	B-reference_range
-	I-reference_range
28	I-reference_range

The	O
patient	O
was	O
offered	O
discharge	O
instructions	O
on	O
toothache	O
but	O
states	O
that	O
he	O
already	O
has	O
it	O
.	O

43	O
y	O
/	O
o	O
P1	O
here	O
today	O
with	O
complaint	O
of	O
sharp	O
left	B-bodyloc
sided	I-bodyloc
pain	O
which	O
has	O
since	O
resolved	B-course
.	O

Cranial	O
nerves	O
II	O
:	O
visual	O
acuity	O
and	O
visual	O
fields	O
were	O
intact	B-labvalue
.	O

1	O
.	O

Left	O
Deltoid	O
Strength	O
:	O
4	B-labvalue
+	I-labvalue
/	I-labvalue
5	I-labvalue
Left	O
Tricep	O
(	O
radial	O
)	O
Strength	O
:	O
4	B-labvalue
+	I-labvalue
/	I-labvalue
5	I-labvalue
Left	O
Wrist	O
Ext	O
.	O

HEENT	O
:	O
Eyes	O
are	O
normal	O
with	O
clear	O
conjunctiva	O
and	O
cornea	O
bilaterally	O
.	O

Musculoskeletal	O
:	O
no	B-negation
joint	B-bodyloc
pain	O
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O
Looking	O
at	O
the	O
medical	O
chart	O
,	O
she	O
had	O
an	O
appendectomy	O
,	O
right	B-bodyloc
hip	I-bodyloc
fracture	O
from	O
a	O
fall	O
in	O
2005	B-temporal
,	O
and	O
TAH	O
/	O
BSO	O
.	O

[	O
QLH	O
]	O
CBC	O
(	O
INCLUDES	O
DIFF	O
/	O
PLT	O
)	O
Requested	O
for	O
:	O
20Mar2014	B-temporal

Idiopathic	O
Thrombocytopenic	O
Purpura	O
287	O
.	O
31	O

Results	O
/	O
Results	O
/	O
Data	O

6	O
.	O

ALKALINE	O
PHOSPHATASE	O
49	B-labvalue
u	I-labvalue
/	I-labvalue
l	I-labvalue
33	B-reference_range
-	I-reference_range
130	I-reference_range

Ibuprofen	O
800	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Therapy	O
:	O
21Jul2011	B-temporal
to	O

General	O
counseling	O
on	O
contraception	O
accepted	O
.	O

Associated	O
symptoms	O
:	O
no	B-negation
malaise	O
,	O
no	B-negation
generalized	O
weakness	O
,	O
no	B-negation
weight	O
loss	O
and	O
no	B-negation
dysuria	O
.	O

No	B-negation
rebound	O
tenderness	O
.	O

Libial	O
(	O
tib	O
.	O
)	O
:	O
Normal	O
.	O

Acute	B-course
renal	B-bodyloc
failure	O
.	O

Due	O
For	O
:	O
a	O
foot	O
exam	O
and	O
Had	O
eye	O
visit	O
in	O
Feb	B-temporal
2013	I-temporal
.	O

PLAN	O
:	O

Attends	O
day	O
care	O
.	O

CC	O
:	O
John	O
Yoo	O
,	O
MD	O

chronic	O
L5	B-bodyloc
-	I-bodyloc
S1	I-bodyloc
radiculopathy	O

Depression	O
311	O

The	O
patient	O
spent	O
the	O
next	O
several	O
days	O
on	O
the	O
floor	O
,	O
nonweightbearing	O
with	O
CPM	O
machine	O
in	O
place	O
,	O
developed	O
a	O
brief	O
period	O
of	O
dyspnea	O
,	O
which	O
seems	O
to	O
have	O
resolved	O
and	O
may	O
have	O
been	O
a	O
combination	O
of	O
bronchitis	O
,	O
thick	O
secretions	O
,	O
and	O
fluid	O
overload	O
.	O

There	O
is	O
no	B-negation
icterus	O
,	O
injection	O
,	O
or	O
discharge	O
.	O

He	O
states	O
that	O
he	O
continues	O
to	O
have	O
swelling	O
and	O
pain	O
.	O

Lisinopril	O
-	O
Hydrochlorothiazide	O
20	B-strength
-	I-strength
25	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
ONCE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
06Aug2012	B-temporal
to	O
(	O
Evaluate	O
:	B-temporal
05Aug2013	I-temporal
)	O
Requested	O
fis	O
:	O
07Jan2013	B-temporal
;	O
Last	O
Rx	O
:	B-temporal
07Jan2013	I-temporal

Symptoms	O
are	O
unchanged	B-course
.	O

Peripheral	O
Neuropathy	O
356	O
.	O
9	O

Gestational	O
age	O
:	O
34	O
weeks	O
.	O

The	O
patient	O
is	O
currently	B-temporal
experiencing	O
symptoms	O
.	O

CHARLIE	O
ROCKEMORE	O
presents	O
with	O
complaints	O
of	O
hip	B-bodyloc
pain	O
Symptoms	O
are	O
worsening	B-course
(	O
will	O
occasionally	O
give	O
out	O
while	O
walking	O
)	O

CONSTITUTIONAL	O
:	O
no	B-negation
nausea	O
,	O
no	B-negation
recent	B-temporal
weight	O
gain	O
,	O
no	B-negation
recent	B-temporal
weight	O
loss	O
,	O
no	B-negation
fever	O
and	O
no	B-negation
chills	O

INTEGUMENTARY	O
:	O
no	B-negation
rashes	O
and	O
no	B-negation
ulcers	O
.	O

Atorvastatin	O
Calcium	O
40	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
Requested	O
for	O
:	O
21Nov2013	B-temporal
;	O
Last	O
Rx	O
:	O
07Oct2013	B-temporal

UROBILINOGEN	O
:	O
-	O

Groin	O
(	O
Inguinal	B-bodyloc
)	O
Pain	O
Left	O
Side	O
789	O
.	O
09	O

Sensory	O
:	O
no	B-negation
sensory	O
abnormalities	O
were	O
noted	O
.	O

History	O
of	O
Type	O
1	O
Diabetes	O
Mellitus	O
With	O
Complication	O
250	O
.	O
91	O

Allergies	O
1	O
.	O

The	O
patient	O
continues	O
to	O
have	O
headaches	O
as	O
well	O
as	O
difficulties	O
w	O
/	O
short	O
-	O
term	O
memory	O
.	O

Allergies	O
g24	O

May	O
consider	O
further	O
vocal	O
cord	O
augmentation	O
in	O
the	O
future	O
if	O
results	O
are	O
still	O
unsatisfactory	O
after	O
completing	O
full	O
6	B-temporal
weeks	I-temporal
.	O

MAMMO	O
SCREENING	O
Requested	O
for	O
:	O
12Jan2012	B-temporal

Review	O
of	O
Systems	O

Cardiovascular	O
Peripheral	O
vascular	O
exam	O
:	O
Normal	B-labvalue

Denied	O

Ordered	O
;	O
For	O
:	O
Nasal	B-bodyloc
Polyps	O
(	O
471	O
.	O
9	O
)	O
;	O
Ordered	O
By	O
:	O
Stanley	O
,	O
Douglas	O
Performed	O
:	O
Due	O
:	O
17Jan2013	B-temporal
;	O
Last	O
Updated	O
By	O
:	O
Drake	O
,	O
Suzanne	O

[	O
QLH	O
]	O
CBC	O
(	O
INCLUDES	O
DIFF	O
/	O
PLT	O
)	O
23Feb2012	B-temporal
09	B-temporal
:	I-temporal
45AM	I-temporal
Hardwicke	O
,	O
Robin	O

Urine	O
Dipstick	O
(	O
In	O
Office	O
)	O
Requested	O
for	O
:	O
13Nov2012	B-temporal

Social	O
History	O
Marital	O
History	O
-	O
Currently	O
Married	O

Associated	O
symptoms	O
:	O
no	B-negation
hoarseness	O
,	O
no	B-negation
cough	O
,	O
no	B-negation
nausea	O
,	O
no	B-negation
vomiting	O
,	O
no	B-negation
hematemesis	O
,	O
no	B-negation
melena	O
and	O
no	B-negation
weight	O
loss	O
.	O

Review	O
of	O
Systems	O
Complete	O
-	O
Female	O
Neuro	O
Emphasis	O
:	O

Ms	O
Fretwell	O
is	O
an	O
established	O
patient	O
of	O
Dr	O
Lin	O
Jones	O
practice	O
with	O
known	O
diagnosis	O
of	O
left	B-bodyloc
knee	I-bodyloc
severe	B-severity
osteoathritis	O
for	O
about	O
2	B-temporal
years	I-temporal
.	O

ENT	O
:	O
sore	O
throatandsneezing	O
,	O
but	O
no	B-negation
earache	O
,	O
no	B-negation
epistaxis	O
,	O
no	B-negation
nasal	B-bodyloc
discharge	O
and	O
no	B-negation
hoarseness	O
(	O
has	O
noticed	O
redness	O
of	O
his	O
tonsil	B-bodyloc
/	O
throat	B-bodyloc
)	O
.	O

Symptomatic	O
Menopause	O
627	O
.	O
2	O

Physical	O
Exam	O

Weight	O
:	O
177	B-labvalue
lb	I-labvalue

Discussion	O
/	O
Signatures	O
Electronically	O
signed	O
by	O
:	O
LESLIE	O
GARB	O
,	O
M	O
.	O
D	O
.	O

Do	O
not	O
apply	O
lotions	O
creams	O
or	O
powders	O
to	O
incisions	O
.	O

General	O
appearance	O
:	O
Normal	B-labvalue
.	O

Past	O
Medical	O
History	O
History	O
of	O
Anxiety	O
Disorder	O
NOS	O
300	O
.	O
00	O

Social	O
History	O
Being	O
A	O
Social	O
Drinker	O

Vitals	O
02Nov2012	B-temporal
11	B-temporal
:	I-temporal
57AM	I-temporal
BMI	O
Calculated	O
33	B-labvalue
.	I-labvalue
05	I-labvalue
BSA	O
Calculated	O
2	B-labvalue
.	I-labvalue
32	I-labvalue
Height	O
6	B-labvalue
ft	I-labvalue
Weight	O
244	B-labvalue
lb	I-labvalue
Systolic	O
110	B-labvalue
Diastolic	O
72	B-labvalue
Temperature	O
96	B-labvalue
.	I-labvalue
9	I-labvalue
F	I-labvalue
Heart	O
Rate	O
60	B-labvalue

Metoprolol	O
Tartrate	O
50	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
3	B-frequency
TIMES	I-frequency
A	I-frequency
DAY	I-frequency
Requested	O
for	O
:	O
17Jun2013	B-temporal
;	O
Last	O
Rx	O
:	O
17Jun2013	B-temporal

Cardiovascular	O
:	O
chest	B-bodyloc
pain	O
,	O
but	O
no	B-negation
palpitations	O
,	O
the	O
heart	O
rate	O
was	O
not	B-labvalue
fast	I-labvalue
,	O
the	O
heart	O
rate	O
was	O
not	B-labvalue
slow	I-labvalue
,	O
no	B-negation
intermittent	O
leg	B-bodyloc
claudication	O
and	O
no	B-negation
edema	O
.	O

Social	O
History	O
Marital	O
History	O
-	O
Currently	O
Married	O

Social	O
History	O
Never	O
A	O
Smoker	O

Tenderness	O
:	O
distal	O
IT	O
band	O
.	O

Hydrochlorothiazide	O
12	B-strength
.	I-strength
5	I-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
24Oct2012	B-temporal
)	O
to	O

Super	O
B	O
Complex	O
TABS	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
AS	O
DIRECTED	O
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
31Oct2013	B-temporal
)	O

I	O
have	O
seen	O
and	O
examined	O
RUBY	O
DAVIS	O
with	O
the	O
resident	O
.	O

The	O
symptoms	O
occur	O
intermittently	O
.	O

Active	O
Problems	O
Hypothyroidism	O
244	O
.	O
9	O

No	B-negation
masses	O
palpated	O
.	O

AmLODIPine	O
Besylate	O
10	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
02Jun2005	B-temporal
to	O
(	O
Evaluate	O
:	O
15Jul2013	B-temporal
)	O
Requested	O
for	O
:	O
20Jul2012	B-temporal
;	O
Last	O
Rx	O
:	O
20Jul2012	B-temporal

Encounter	O
Background	O
Information	O
:	O
ROS	O
obtainable	O
.	O

[	O
QLH	O
]	O
TSH	O
,	O
3RD	O
GENERATION	O
Requested	O
for	O
:	O
02Nov2012	B-temporal

RTC	O
1	B-temporal
-	I-temporal
2	I-temporal
weeks	I-temporal
to	O
discuss	O
labs	O
,	O
sono	O
,	O
Mgmt	O
for	O
heavy	B-severity
bleeding	O
.	O

The	O
rhythm	O
was	O
regular	B-labvalue
.	O

The	O
abdomen	B-bodyloc
was	O
normal	O
to	O
percussionanddid	O
not	O
have	O
ascites	O
.	O

2	O
.	O

Examination	O
of	O
the	O
abdomen	O
:	O
Normal	B-labvalue
.	O

Femoral	O
and	O
pedal	O
pulses	O
:	O
No	B-negation
peripheral	O
edema	O
.	O

History	O
of	O
pneumonia	O
.	O

2	O
broncoscopy	O
procedures	O
to	O
relieve	O
consticted	O
/	O
scarring	O
in	O
bronchioles	O
4	B-temporal
/	I-temporal
2012	I-temporal

(	O
Medical	O
Transcription	O
Sample	O
Report	O
)	O

Coordination	O
:	O
Normal	B-labvalue

Examination	O
of	O
the	O
extremities	O
revealed	O
no	B-negation
fingernail	O
clubbing	O
,	O
well	O
perfused	O
fingers	O
,	O
well	O
perfused	O
toes	O
,	O
no	B-negation
Osler	O
'	O
s	O
nodes	O
,	O
no	B-negation
nail	B-bodyloc
splinter	O
hemorrhages	O
,	O
no	B-negation
upper	O
extremity	O
ischemia	O
and	O
no	B-negation
lower	B-bodyloc
extremity	I-bodyloc
ischemia	O
.	O

Anus	O
,	O
perineum	O
,	O
and	O
rectum	O
:	O
Normal	O
sphincter	O
tone	O
,	O
no	B-negation
masses	O
,	O
no	B-negation
prolapse	O
.	O

The	O
nasal	O
septum	O
was	O
normal	B-labvalue
.	O

BMI	O
Calculated	O
:	O
23	B-labvalue
.	I-labvalue
78	I-labvalue

Physical	O
Exam	O

He	O
is	O
swimming	O
even	O
in	O
the	O
winter	O
through	O
24	O
hour	O
fitness	O
.	O

ttp	O
mildly	B-severity
but	O
LN	O
is	O
>	O
6	O
cm	O
)	O

They	O
were	O
daily	O
until	O
December	B-temporal
of	O
2011	B-temporal
and	O
he	O
was	O
taking	O
frequent	O
analgesics	O
on	O
a	O
regular	O
basis	O
.	O

Cardiovascular	O

Nephrotic	O
Syndrome	O
Due	O
To	O
Minimal	B-severity
Change	O
Glomerulonephritis	O
581	O
.	O
3	O

Thyroid	O
:	O
Normal	O
.	O

Capillary	O
refill	O
:	O
normal	B-labvalue
in	O
the	O
toes	O
.	O

Her	O
symptoms	O
are	O
caused	O
by	O
no	O
known	O
event	O
.	O

Examination	O
of	O
pupils	O
and	O
irises	O
:	O
Normal	B-labvalue

Benign	B-severity
Essential	O
Hypertension	O
401	O
.	O
1	O

Diffuse	O
Nontoxic	O
Goiter	O
240	O
.	O
9	O

Tobacco	O
Use	O

Intellectual	O
Disabilities	O
319	O

[	O
LH	O
]	O
CBC	O
(	O
without	O
differential	O
)	O
09Dec2010	B-temporal
10	B-temporal
:	I-temporal
30AM	I-temporal
Hardwicke	O
,	O
Robin	O

Dysthymic	O
Disorder	O
300	O
.	O
4	O

Drug	O
Use	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

[	O
L	O
]	O
Blood	O
Drawing	O
Requested	O
for	O
:	O
16Nov2012	B-temporal

Musculoskeletal	O

FOLLOWUP	O
:	O
Follow	O
up	O
with	O
Dr	O
.	O
Y	O
in	O
7	O
to	O
10	O
days	O
in	O
office	O
.	O

f	O
Anemia	O
(	O
285	O
.	O
9	O
)	O
;	O
(	O
Active	O
)	O

A1c	O
okay	O
but	O
reported	O
PMBG	O
usually	O
high	O
.	O

Extremities	O
:	O
no	B-negation
clubbing	O
of	O
the	O
fingernails	B-bodyloc
and	O
no	B-negation
localized	O
cyanosis	O
.	O

Musculoskeletal	O

Mammogram	O
:	O
9	B-temporal
/	I-temporal
2012	I-temporal

Endocrine	O
:	O
erectile	O
dysfunction	O
No	B-negation
polydipsia	O
and	O
no	B-negation
polyuria	O
.	O

Flaxseed	O
Oil	O
CAPS	B-form
;	O
1000	B-strength
mg	I-strength
1	B-dosage
po	B-route
qd	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
10Dec2013	B-temporal
)	O
to	O

Funduscopic	O
exam	O
reveals	O
no	B-negation
hemorrhages	O
or	O
discopathy	O
.	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
constipation	O
,	O
no	B-negation
heartburn	O
and	O
no	B-negation
melena	O
.	O

Physical	O
Exam	O
Neurologic	O
Exam	O

ENT	O
:	O
no	B-negation
earache	O
,	O
no	B-negation
hearing	O
loss	O
,	O
no	B-negation
epistaxis	O
,	O
no	B-negation
nasal	B-bodyloc
discharge	O
,	O
no	B-negation
sore	O
throat	B-bodyloc
and	O
no	B-negation
hoarseness	O
.	O

Physical	O
Exam	O

Examination	O
of	O
extremities	O
for	O
edema	O
and	O
/	O
or	O
varicosities	O
:	O
NormalNo	O
edema	O
,	O
no	B-negation
calf	B-bodyloc
tenderness	O
,	O
negative	B-labvalue
Homan	O
'	O
s	O
sign	O
.	O

Show	O
a	O
normal	B-labvalue
white	O
blood	O
cell	O
count	O
with	O
no	O
shift	O
.	O

Atenolol	O
25	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Take	O
1	B-dosage
tablet	B-form
by	B-route
mouth	I-route
twice	B-frequency
a	I-frequency
day	I-frequency
;	O
Therapy	O
:	O
12Mar2013	B-temporal
to	O
(	O
Evaluate	O
:	O
10Jun2013	B-temporal
)	O
Requested	O
for	O
:	O
12Mar2013	B-temporal
;	O
Last	O
Rx	O
:	O
12Mar2013	B-temporal

Examination	O
of	O
digits	O
and	O
nails	O
:	O
Normal	B-labvalue
.	O

Immature	O
Granulocytes	O
:	O
0	B-labvalue
%	I-labvalue
Reference	O
Range	O
0	B-reference_range
-	I-reference_range
2	I-reference_range

She	O
is	O
too	O
symptomatic	O
with	O
pain	O
and	O
unstable	O
gait	O
for	O
physical	O
therapy	O
.	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
axillae	O
:	O
No	B-negation
lymphadenopathy	O
.	O

Palpation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

DOT	O
:	O
12/31/2012	B-temporal

MCV	O
:	O
93	B-labvalue
fL	I-labvalue
Reference	O
Range	O
79	B-reference_range
-	I-reference_range
97	I-reference_range

She	O
reports	O
no	B-negation
significant	O
hypoglycemia	O
or	O
nocturnal	O
hypoglycemia	O
.	O

Pre	O
-	O
Natal	O
Formula	O
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
31Jan2012	B-temporal
to	O

MUSCULOSKELETAL	O
:	O
No	B-negation
abnormalities	O
are	O
noted	O
to	O
back	O
,	O
arms	O
and	O
legs	O
.	O

Symptoms	O
:	O
wheezing	O
,	O
non	O
-	O
productive	O
cough	O
andclear	O
sputum	O
production	O
,	O
but	O
no	B-negation
dyspnea	O
,	O
no	B-negation
dyspnea	O
at	O
rest	O
,	O
no	B-negation
dyspnea	O
on	O
exertion	O
,	O
no	O
productive	O
cough	O
and	O
no	B-negation
change	O
in	O
sputum	B-bodyloc
quality	O
.	O

Childcare	O
is	O
provided	O
in	O
a	O
childcare	O
center	O
by	O
daycare	O
provider	O
(	O
s	O
)	O
.	O

Chief	O
Complaint	O

The	O
patient	O
also	O
has	O
,	O
according	O
to	O
her	O
husband	O
,	O
suffered	O
a	O
"	O
grand	O
mal	O
"	O
seizure	O
in	O
the	O
past	O
;	O
however	O
,	O
she	O
has	O
not	B-negation
had	I-negation
any	O
recent	O
generalized	O
seizure	O
activity	O
and	O
there	O
are	O
no	B-negation
reported	O
frank	O
staring	O
spells	O
.	O

3	O
.	O

multiple	O
irregular	O
scloerosis	O
with	O
osteophytes	O
also	O
noted	O
.	O

Following	O
the	O
procedure	O
,	O
he	O
was	O
brought	O
to	O
the	O
CSRU	O
for	O
invasive	O
monitoring	O
.	O

Cranial	O
nerves	O
IX	O
and	O
X	O
:	O
there	O
was	O
normal	B-labvalue
movement	O
of	O
the	O
soft	O
palate	O
and	O
normal	B-labvalue
gag	O
.	O

ENT	O
:	O
no	B-negation
sore	O
throat	B-bodyloc
.	O

Examination	O
of	O
pupils	O
and	O
irises	O
:	O
Normal	B-labvalue
.	O

Sciscoring	O
noted	O
without	B-negation
definite	O
increase	O
in	O
tone	O
,	O
?	B-uncertain
Spastic	O
gait	O

Brain	O
w	O
/	O
wo	O
contrast	O
MRI	O
and	O
MRA	O
:	O
Unremarkable	B-labvalue

A	O
mammogram	O
was	O
performed	O
.	O

Description	O
:	O
Open	O
reduction	O
and	O
internal	O
fixation	O
(	O
ORIF	O
)	O
of	O
right	B-bodyloc
Schatzker	O
III	O
tibial	B-bodyloc
plateau	I-bodyloc
fracture	O
with	O
partial	O
medial	O
meniscectomy	O
.	O

[	O
QLH	O
]	O
LIPID	O
PANEL	O
28May2012	B-temporal
12	B-temporal
:	I-temporal
00AM	I-temporal
Hardwicke	O
,	O
Robin	O

Never	O
Drank	O
Alcohol	O

Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

Current	O
Meds	O
Albuterol	O
Sulfate	O
(	B-strength
2	I-strength
.	I-strength
5	I-strength
MG	I-strength
/	I-strength
3ML	I-strength
)	I-strength
0	I-strength
.	I-strength
083	I-strength
%	I-strength
Inhalation	B-form
Nebulization	I-form
Solution	I-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
14Nov2011	B-temporal
)	O
to	O

Examination	O
of	O
Tongue	O
:	O
Normal	B-labvalue
.	O

Left	O
biceps	O
biopsy	O
:	O
moderate	B-severity
myopathy	O
with	O
mild	B-severity
inflammation	O
and	O
necrosis	O
.	O

HEAD	O
AND	O
FACE	O

Physical	O
Exam	O

Social	O
History	O
Problems	O

h	O
/	O
o	O
HSV	O
:	O
last	O
outbreak	O
>	B-temporal
1	I-temporal
yo	I-temporal
.	O

LYMPHATIC	O

Test	O
Name	O
Result	O
Flag	O
Reference	O
LEUKOCYTES	O
NEG	B-labvalue
NITRITE	O
NEG	B-labvalue
UROBILINOGEN	O
1	B-labvalue
O	O
PROTEIN	O
TRACE	O
O	O
pH	O
5	B-labvalue
O	O
URINE	O
BLOOD	O
NEG	B-labvalue
SPECIFIC	O
GRAVITY	O
1	B-labvalue
.	I-labvalue
020	I-labvalue
O	O
KETONES	O
NEG	B-labvalue
BILIRUBIN	O
+	O
+	O
O	O
GLUCOSE	O
NEG	B-labvalue
COLOR	O
URINE	O
DARK	B-labvalue
O	O
APPEARANCE	O
CLEAR	B-labvalue

;	O
Aug	B-temporal
4	I-temporal
2011	I-temporal
1	B-temporal
:	I-temporal
37PM	I-temporal
(	O
Author	O
)	O

Delivered	O
:	O
2004	B-temporal
.	O
Gestational	O
age	O
:	O
39	O
weeks	O
.	O

pa	O
irt	O
s	O
and	O
those	O
with	O
serious	B-severity
co	O
-	O
morbid	O
conditions	O
.	O

Sororal	B-subject
history	O
of	O
Hyperthyroidism	O

Special	O
Test	O
:	O
Deferred	B-labvalue
.	O

Neurological	O
:	O
N	O
/	O
A	O
.	O

,	O
buta	O
negative	B-labvalue
anterior	O
drawer	O
sign	O
.	O
,	O
a	B-labvalue
negative	I-labvalue
Lachman	O
'	O
s	O
test	O
.	O
,	O
no	B-negation
swelling	O
of	O
the	O
calf	B-bodyloc
.	O
anda	O
negative	B-labvalue
lateral	O
McMurray	O
meniscal	O
integrity	O
test	O
.	O

No	B-negation
Reported	O
Meditations	O
;	O
;	O
RPT	O
.	O
eg	O

No	B-negation
mass	O
.	O

Vitals	O
UTP	O
Adult	O
Vital	O
Signs	O
[	O
Data	O
Includes	O
:	O
Current	O
Encounter	O
]	O
06Aug2012	B-temporal
10	B-temporal
:	I-temporal
38AM	I-temporal
BMI	O
Calculated	O
:	O
29	B-labvalue
.	I-labvalue
15	I-labvalue
BSA	O
Calculated	O
:	O
1	B-labvalue
.	I-labvalue
78	I-labvalue
Weight	O
:	O
164	B-labvalue
lb	I-labvalue
8	I-labvalue
oz	I-labvalue
Systolic	O
:	O
144	B-labvalue
Diastolic	O
:	O
83	B-labvalue
Heart	O
Rate	O
:	O
69	B-labvalue

I	O
agree	O
with	O
the	O
history	O
,	O
exam	O
and	O
plan	O
of	O
care	O
as	O
documented	O
in	O
the	O
resident	O
note	O
.	O

The	O
patient	O
presents	O
for	O
follow	O
-	O
up	O
of	O
primary	O
hypertension	O
.	O

Eyes	O

Respiration	O
:	O
18	B-labvalue

1	O
Influenza	O
07Dec2005	B-temporal
Pneumococcal	O
24Sep2008	B-temporal

f	O
Vaginal	B-bodyloc
Discharge	O
(	O
623	O
.	O
5	O
)	O
;	O
(	O
Active	O
)	O

Marital	O
History	O
-	O
Single	O

NovoTwist	O
32G	O
X	O
5	O
MM	O
Miscellaneous	O
;	O
5	O
a	O
day	O
;	O
Therapy	O
:	O
24Nov2012	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
10Dec2012	B-temporal
)	O

The	O
patient	O
is	O
here	O
in	O
followup	O
because	O
of	O
her	O
spells	O
,	O
history	O
of	O
normal	O
pressure	O
hydrocephalus	O
,	O
gait	O
dysfunction	O
and	O
brain	B-bodyloc
cancer	O
and	O
seizure	O
disorder	O
.	O

Previous	B-temporal
Resection	O
:	O
No	B-negation
.	O

[	O
QLH	O
]	O
HEMOGLOBIN	O
Done	O
:	O
02Aug2010	B-temporal
12	B-temporal
:	I-temporal
05PM	I-temporal

Attending	O
Statement	O
g60	O

Her	O
last	O
seizure	O
was	O
6	B-temporal
days	I-temporal
ago	I-temporal
.	O

Atorvastatin	O
Calcium	O
20	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
ONE	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
EVERY	B-frequency
DAY	I-frequency
;	O
Therapy	O
:	O
14Feb2013	B-temporal
to	O
(	O
Evaluate	O
:	O
20May2014	B-temporal
)	O
Requested	O
for	O
:	O
21Nov2013	B-temporal
;	O
Last	O
Rx	O
:	O
21Nov2013	B-temporal

Pulmonary	O

Medicrtion	O

Uterus	O
and	O
cervix	O
,	O
hysterectomy	O
(	O
87	O
.	O
6	O
gm	O
)	O
:	O

Edited	O

Eye	O
,	O
otolaryngeal	O
,	O
cardiovascular	O
,	O
pulmonary	O
,	O
gastrointestinal	O
,	O
genitourinary	O
,	O
musculoskeletal	O
,	O
skin	O
,	O
psychiatric	O
,	O
endocrine	O
and	O
hematologic	O
review	O
of	O
systems	O
are	O
normal	O
.	O

Genitourinary	O
:	O
no	B-negation
dysuria	O
and	O
normal	O
scrotum	O
.	O

Physical	O
Exam	O

Patient	B-subject
'	I-subject
s	I-subject
father	I-subject
who	O
is	O
81	O
has	O
hypercholesterolemia	O
,	O
coronary	B-bodyloc
artery	I-bodyloc
disease	O
s	O
/	O
p	O
stent	O
placement	O
.	O
Mother	B-subject
who	O
is	O
81	O
y	O
/	O
o	O
has	O
diabetes	O
,	O
high	O
cholesterol	O
and	O
arthritis	O
.	O

left	O
long	O
finger	O
digital	O
artery	O
,	O
digital	O
nerve	O
radial	O
and	O
ulnar	O
repair	O
x2	O
5	O
.	O

The	O
patient	O
states	O
she	O
has	O
been	O
doing	O
poorly	O
with	O
her	O
Type	O
II	O
Diabetes	O
control	O
since	O
the	B-temporal
last	I-temporal
visit	I-temporal
.	O

Post	O
-	O
nasal	B-bodyloc
drip	O
:	O
Mild	B-severity

Palpation	O
of	O
the	O
face	O
and	O
sinuses	O
:	O
Normal	B-labvalue
.	O

Examination	O
of	O
extremities	O
for	O
edema	O
and	O
/	O
or	O
varicosities	O
:	O
Normal	B-labvalue
.	O

Chief	O
Complaint	O

COMPLICATIONS	O
:	O
None	O
.	O

The	O
tonsils	O
were	O
normal	O
.	O

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

History	O
of	O
Attention	O
-	O
Deficit	O
Hyperactivity	O
Disorder	O
314	O
.	O
01	O

HE	O
HAS	O
SEEN	O
HIS	O
CARD	O
.	O

Pedi	O
High	O
Risk	O
Medntro	O
Summary	O
Patient	O
Detail	O
for	O
IDREES	O
PEREA	O
MRN	O
:	O
3943405	O
Contact	O
IDREES	O
PEREA	O
Date	O
Of	O
Birth	O
June	B-temporal
28	I-temporal
,	I-temporal
2012	I-temporal
Address	O
15770	O
BELLAIRE	O
BLVD	O

Reason	O
For	O
Visit	O

History	O
of	O
Present	O
Illness	O
:	O

Well	O
developed	O
,	O
comfortable	O
,	O
normal	O
body	O
odor	O
,	O
does	O
not	O
smell	O
of	O
feces	O
,	O
does	O
not	O
smell	O
of	O
urine	O
,	O
well	O
nourished	O
,	O
overweight	O
,	O
clothing	O
appropriate	O
,	O
well	O
groomed	O
,	O
well	O
hydrated	O
,	O
appearance	O
reflects	O
stated	O
age	O
and	O
color	O
NML	O
.	O

The	O
patient	O
is	O
doing	O
well	O
with	O
her	O
blood	O
pressure	O
goals	O
.	O

Sample	O
Type	O
/	O
Medical	O
Specialty	O
:	O
Discharge	O
Summary	O

CONSULTATIONS	O
:	O
To	O
rehab	O
,	O
Dr	O
.	O
X	O
and	O
to	O
Internal	O
Medicine	O
for	O
management	O
of	O
multiple	O
medical	O
problems	O
including	O
hypothyroid	O
,	O
diabetes	O
mellitus	O
type	O
2	O
,	O
bronchitis	O
,	O
and	O
congestive	O
heart	B-bodyloc
failure	O
.	O

FR	O
/	O
FS	O
:	O
Not	O
visualized	O

2	O
.	O

Neurological	O
:	O
difficulty	O
walking	O
,	O
but	O
no	B-negation
confusion	O
,	O
no	B-negation
convulsions	O
,	O
no	B-negation
dizziness	O
,	O
no	B-negation
fainting	O
and	O
no	B-negation
limb	B-bodyloc
weakness	O
.	O

At	O
the	O
time	O
of	O
discharge	O
on	O
POD	O
#	O
4	O
,	O
the	O
patient	O
was	O
doing	O
well	O
,	O
afebrile	O
with	O
stable	O
vital	O
signs	O
,	O
tolerating	O
a	O
regular	O
diet	O
,	O
ambulating	O
,	O
voiding	O
without	O
assistance	O
,	O
and	O
pain	O
was	O
well	O
controlled	O
.	O

Optic	O
Disc	O
:	O
Normal	O
.	O

Problems	O
f	O
Joint	B-bodyloc
Pain	O
,	O
Localized	O
In	O
The	O
Shoulder	B-bodyloc
(	O
719	O
.	O
41	O
)	O
;	O
(	O
Active	O
)	O

Xanax	O
TABS	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
24Apr2013	B-temporal
)	O
to	O

Cardiovascular	O
:	O
lower	B-bodyloc
extremity	I-bodyloc
edema	O
,	O
but	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
and	O
no	B-negation
intermittent	O
leg	B-bodyloc
claudication	O
.	O

I	O
have	O
personally	O
interviewed	O
the	O
patient	O
with	O
the	O
resident	O
and	O
I	O
agree	O
with	O
the	O
assessment	O
and	O
plan	O
as	O
delineated	O
in	O
the	O
note	O
above	O
.	O

Cardiovascular	O

-	O
Endometrial	B-bodyloc
adenocarcinoma	O
,	O
endometrioid	O
type	O
,	O
with	O
focal	O
squamous	O
morular	O
metaplasia	O
.	O

Pap	O
Smear	O
(	O
+	O
)	O
Low	O
Grade	O
Squamous	O
Intraepithelial	O
Lesion	O
795	O
.	O
03	O

Visit	O
For	O
:	O
Screening	O
Exam	O
For	O
Malignant	O
Neoplasm	O
Cervix	O
V76	O
.	O
2	O

NEUROLOGICAL	O
/	O
PSYCHIATRIC	O

I	O
have	O
personally	O
interviewed	O
the	O
patient	O
with	O
the	O
resident	O
and	O
I	O
agree	O
with	O
the	O
assessment	O
and	O
plan	O
as	O
delineated	O
in	O
the	O
note	O
above	O
.	O

Systolic	O
:	O
159	B-labvalue

Omeprazole	O
40	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
Delayed	I-form
Release	I-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
19Nov2012	B-temporal
to	O
(	O
Evaluate	O
:	O
22Jun2014	B-temporal
)	O
Requested	O
for	O
:	O
24Mar2014	B-temporal
;	O
Last	O
Rx	O
:	O
24Mar2014	B-temporal

The	O
patient	O
presents	O
with	O
complaints	O
of	O
skin	B-bodyloc
lesion	O
(	O
FOR	O
PAST	B-temporal
2	I-temporal
MNTHS	I-temporal
HAS	O
NOTED	O
A	O
RASH	O
AND	O
SKIN	B-bodyloc
BREAKDOWN	O
ON	O
LT	B-bodyloc
LEG	I-bodyloc
WHICH	O
SHE	O
ATTRIBUTES	O
TO	O
HER	O
HIP	O
SURGERY	O
+	O
V	O
.	O
VEINS	O
)	O
.	O

Social	O
History	O
Former	O
Smoker	O
V15	O
.	O
82	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
and	O
no	B-negation
palpitations	O
.	O

History	O
of	O
Chest	B-bodyloc
Pain	O
786	O
.	O
50	O

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

The	O
heart	O
rate	O
was	O
bradycardic	O
.	O

No	B-negation
anterior	B-bodyloc
cervical	I-bodyloc
node	I-bodyloc
enlargement	O
,	O
no	B-negation
posterior	O
cervical	B-bodyloc
node	I-bodyloc
enlargement	O
,	O
no	B-negation
submandibular	B-bodyloc
node	I-bodyloc
enlargement	O
and	O
no	B-negation
supraclavicular	B-bodyloc
node	I-bodyloc
enlargement	O
.	O

Parent	O
was	O
given	O
age	O
appropriate	O
materiro	O
for	O
their	O
child	O
.	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
neck	O
:	O
Normal	B-labvalue
.	O

[	O
O	O
]	O
Lipid	O
Panel	O
(	O
In	O
Office	O
)	O
Done	O
:	O
18Apr2014	B-temporal
02	B-temporal
:	I-temporal
18PM	I-temporal

Allergies	O
No	B-negation
Known	O
Allergies	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
JACKIE	O
MATIJASEC	O
,	O
M	O
.	O
D	O
.	O

Discharge	O
Summary	O

History	O
of	O
Cataract	O
Surgery	O

Debridement	O
:	O

Normal	B-labvalue
Initial	O
Prenatal	O
Checkup	O
V22	O
.	O
1	O

[	O
QLH	O
]	O
Hemoglobin	O
and	O
Hematocrit	O
Done	O
:	O
06Dec2012	B-temporal
11	B-temporal
:	I-temporal
16AM	I-temporal

APPEARANCE	O
CLEAR	O

EARS	O
,	O
NOSE	O
,	O
MOUTH	O
AND	O
THROAT	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
,	O
no	B-negation
cough	O
,	O
no	B-negation
shortness	O
of	O
breath	O
during	O
exertion	O
,	O
no	B-negation
orthopnea	O
and	O
no	B-negation
PND	O
.	O

right	B-bodyloc
arm	I-bodyloc
numbness	O
and	O
right	B-bodyloc
hand	I-bodyloc
tingling	O
and	O
weakness	O
,	O
this	O
began	B-temporal
in	I-temporal
July	I-temporal
of	I-temporal
this	I-temporal
year	I-temporal
;	O
also	O
feels	O
a	O
burning	O
sensation	O
in	O
his	O
abdominal	B-bodyloc
musculature	I-bodyloc
after	O
moving	O
after	O
periods	O
of	O
rest	O

f	O
Zoloft	O
TABS	B-form
(	O
Active	O
)	O

Review	O
of	O
Systems	O

Former	O
Smoker	O
V15	O
.	O
82	O

Shellfish	O
-	O
derived	O
Products	O

No	B-negation
rhonchi	O
were	O
heard	O
.	O

Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

The	O
tonsils	O
were	O
normal	O
.	O

of	O
the	O
American	O
Diabetes	O
Association	O
.	O

Inspection	O
of	O
the	O
conjunctiva	O
and	O
lids	O
:	O
Normal	B-labvalue

Advance	O
diet	O
as	O
tolerated	O
.	O

Benign	B-severity
Adenoma	O
Of	O
The	O
Large	B-bodyloc
Intestine	I-bodyloc
211	O
.	O
3	O

Examination	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue

I	O
have	O
discussed	O
the	O
case	O
with	O
the	O
resident	O
and	O
agree	O
with	O
the	O
diagnosis	O
and	O
plan	O
.	O

The	O
oropharynx	O
is	O
normal	O
without	B-negation
any	I-negation
sign	I-negation
of	I-negation
infection	O
.	O

However	O
,	O
her	O
hip	B-bodyloc
pain	O
become	O
much	B-severity
severe	I-severity
within	O
the	O
past	B-temporal
3	I-temporal
to	I-temporal
4	I-temporal
months	I-temporal
.	O

Hep	O
Bs	O
Ag	O
:	O
Negative	B-labvalue
Reference	O
Range	O
Negative	B-reference_range

Male	O
.	O

Color	O
:	O
Normal	O

Current	O
Meds	O
Aspirin	O
81	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
19Aug2013	B-temporal
)	O
to	O

ZyrTEC	O
Allergy	O
TABS	B-form
;	O
Status	O
:	O
DISCONTINUED	O

Comorbid	O
problems	O
include	O
no	B-negation
cardiac	B-bodyloc
failure	O
,	O
no	B-negation
left	B-bodyloc
ventricular	I-bodyloc
hypertrophy	O
,	O
no	B-negation
stroke	O
,	O
no	B-negation
coronary	B-bodyloc
artery	I-bodyloc
disease	O
,	O
no	B-negation
hypertensive	O
nephropathy	O
and	O
no	B-negation
hypertensive	O
retinopathy	O
.	O

Marital	O
History	O
-	O
Divorced	O
V61	O
.	O
03	O

BUN	O
12	B-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
7	B-reference_range
-	I-reference_range
22	I-reference_range

Physical	O
Exam	O

Chief	O
Complaint	O

Neurologic	O
No	B-negation
tremors	O
.	O
Declined	O
foot	O
exam	O
.	O

Gynecological	O
Problems	O
.	O

No	B-negation
wheezing	O
was	O
heard	O
.	O

Left	O
Abduct	O
Thigh	O
(	O
sup	O
.	O

General	O
Appearance	O
:	O
Normal	O
.	O

History	O
of	O
Appendectomy	O

Examination	O
of	O
the	O
abdomen	O
:	O
AbnormalSlightly	O
hyperactive	O
BS	O
.	O

Musculoskeletal	O

Removal	O
Of	O
Implant	O
V54	O
.	O
01	O

Musculoskeletal	O
:	O
back	B-bodyloc
pain	O
,	O
butno	O
arthralgiasandno	O
joint	B-bodyloc
pain	O
.	O

Family	B-subject
history	O
of	O
Diabetes	O
Mellitus	O

Medications	O
include	O
levothyroxine	O
.	O

3	O
.	O

EARS	O
,	O
NOSE	O
,	O
MOUTH	O
AND	O
THROAT	O

TraMADol	O
HCl	O
50	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
4	B-frequency
TIMES	I-frequency
DAILY	I-frequency
AS	B-frequency
NEEDED	I-frequency
FOR	O
PAIN	O
;	O
Therapy	O
:	O
08Aug2013	B-temporal
to	O
(	O
Evaluate	O
:	O
18Aug2013	B-temporal
)	O
Requested	O
for	O
:	O
08Aug2013	B-temporal
;	O
Last	O
Rx	O
:	O
08Aug2013	B-temporal

The	O
thyroid	B-bodyloc
was	O
not	B-negation
enlarged	O
.	O

This	O
is	O
described	O
as	O
mild	O
and	O
unchanged	O
.	O

The	O
patient	O
has	O
never	O
smoked	O
cigarettes	O
.	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
and	O
no	B-negation
edema	O
.	O

Abdomen	O

Diabetic	O
Screen	O
:	O
11	B-temporal
/	I-temporal
2013	I-temporal

DAILY	I-frequency
;	O
Therapy	O
:	O
25Mar2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
25Mar2013	B-temporal
)	O
Requested	O
for	O
:	O
25Mar2013	B-temporal
;	O
Status	O
:	O
ACTIVE	O
-	O

Temperature	O
:	O
98	B-labvalue
.	I-labvalue
8	I-labvalue
F	I-labvalue
,	O
Oral	O

Social	O
History	O
Exercising	O
Regularly	O

Hematologic	O
/	O
Lymphatic	O
:	O
swollen	O
glandsandswollen	O
glands	O
in	O
the	O
neck	O
.	O

;	O
Nov	B-temporal
13	I-temporal
2012	I-temporal
11	B-temporal
:	I-temporal
50AM	I-temporal
(	O
Author	O
)	O

Betadine	O
was	O
used	O
to	O
prep	O
the	O
area	O
.	O

OReviewed	O
Lipid	O
,	O
CMP	O
,	O
HbA1c	O
,	O
Microalbumin	O
/	O
cr	O
ratio	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O
The	O
patient	O
is	O
a	O
60	O
-	O
year	O
-	O
old	O
female	O
patient	O
who	O
off	O
and	O
on	O
for	O
the	O
past	O
10	O
to	O
12	O
months	O
has	O
had	O
almost	O
daily	O
diarrhea	O
,	O
nausea	O
,	O
inability	O
to	O
eat	O
.	O

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

General	O
Appearance	O
:	O
Normal	O
.	O

Denies	B-negation
symptoms	O
of	O
discharge	O
,	O
pelvic	B-bodyloc
pain	O
,	O
sex	O
with	O
intercourse	O
.	O

He	O
notes	O
long	O
standing	O
sinus	B-bodyloc
trouble	O
with	O
sinus	B-bodyloc
congestion	O
and	O
ear	B-bodyloc
fullness	O
.	O

Fundoscopic	O
Exam	O
:	O
Normal	B-labvalue
.	O

By	O
report	O
,	O
there	O
is	O
good	O
compliance	O
with	O
treatment	O
,	O
good	O
tolerance	O
of	O
treatment	O
and	O
fair	O
symptom	O
control	O
.	O

Plan	O
Naproxen	O
500	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
EVERY	B-frequency
12	I-frequency
HOURS	I-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
04Apr2013	B-temporal
to	O
(	O
Evaluate	O
:	O
04Aug2013	B-temporal
)	O
Requested	O
for	O
:	O
05Jul2013	B-temporal
;	O
Last	O
Rx	O
:	O
05Jul2013	B-temporal

Chest	O

Oropharynx	O
:	O
Normal	B-labvalue
.	O

There	O
was	O
no	B-negation
nasal	B-bodyloc
discharge	O
.	O

History	O
of	O
Respiratory	B-bodyloc
Distress	O
Syndrome	O
Of	O
Newborn	O
769	O

Pelvic	O
Ultrasound	O

Social	O
History	O
Never	O
A	O
Smoker	O

Place	O
of	O
Delivery	O
:	O
MHH	O
.	O

Prior	O
to	O
that	O
,	O
she	O
has	O
not	B-negation
had	I-negation
any	O
seizures	O
since	O
her	O
discharge	O
from	O
the	O
hospital	O
June	B-temporal
8	I-temporal
.	O

Family	O
History	O
Problems	O

Requested	O
for	O
:	O
14Aug2013	B-temporal
;	O
Last	O
Rx	O
:	O
14Aug2013	B-temporal
;	O
Status	O
:	O
ACTIVE	O
-	O
Retrospective	O
Authorization	O
;	O

Therapy	O
:	O
31Jan2012	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
31Jan2012	B-temporal
)	O

Fatty	O
Liver	B-bodyloc
571	O
.	O
8	O

Pertinent	O
medical	O
history	O
:	O
no	B-negation
diabetes	O
,	O
no	B-negation
dyslipidemia	O
,	O
no	O
angina	O
and	O
no	B-negation
prior	B-temporal
coronary	B-bodyloc
revascularization	O
.	O

2	O
.	O

His	O
osy	O
of	O
Presrt	O
Illness	O

Psychiatric	O
:	O
no	B-negation
sleep	O
disturbances	O
,	O
no	B-negation
anxiety	O
and	O
no	B-negation
depression	O
.	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
,	O
no	B-negation
increased	O
heart	B-bodyloc
rate	O
,	O
no	B-negation
decrease	O
in	O
heart	B-bodyloc
rate	O
,	O
no	B-negation
edema	O
and	O
no	B-negation
intermittent	O
leg	B-bodyloc
claudication	O
.	O

Constitutional	O

Allergies	O
Egg	O
or	O
Chicken	O
-	O
derived	O
Drugs	O

Sinusitis	O
:	O
Z	O
-	O
pak	O
.	O

Posterior	O
tibialis	O
:	O
right	O
2	O
+	O
and	O
left	O
2	O
+	O
.	O

She	O
presented	O
now	O
after	O
informed	O
consent	O
for	O
the	O
above	O
procedure	O
,	O
understanding	O
the	O
inherent	O
risks	O
and	O
complications	O
and	O
risk	O
-	O
benefit	O
ratio	O
.	O

ABSOLUTE	O
LYMPHOCYTES	O
1534	B-labvalue
cells	I-labvalue
/	I-labvalue
uL	I-labvalue
850	B-reference_range
-	I-reference_range
3900	I-reference_range

Bilateral	B-bodyloc
1	O
+	O
pretibial	B-bodyloc
pitting	O
edema	O
.	O

[	O
QLH	O
]	O
PSA	O
,	O
TOTAL	O
Requested	O
for	O
:	O
14Oct2013	B-temporal

Pupils	O
and	O
irises	O
:	O
Equal	O
,	O
round	O
,	O
reactive	O
to	O
light	O
.	O

Place	O
of	O
Delivery	O
:	O
MHH	O
.	O

[	O
QLH	O
]	O
URINALYSIS	O
,	O
SCREEN	O
Requested	O
for	O
:	O
24Oct2012	B-temporal

Neomycin	O
-	O
Bacitracin	O
-	O
Polymyxin	O
OINT	O

The	O
patient	O
presents	O
with	O
complaints	O
of	O
left	B-bodyloc
hip	I-bodyloc
arthralgias	O
(	O
HAS	O
HAD	O
LT	O
HIP	O
REPLACEMENT	O
.	O

Physical	O
Exam	O

Mood	O
and	O
affect	O
:	O
Abnormal	B-labvalue
.	O

Examination	O
of	O
thyroid	O
:	O
Normal	B-labvalue
.	O

ACTIVE	O
-	O
Retrospective	O
Authorization	O

History	O
of	O
Skin	B-bodyloc
Cancer	O
V10	O
.	O
83	O

pH	O
6	B-labvalue
.	I-labvalue
5	I-labvalue

Triglyceride	O
74	B-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
0	B-reference_range
-	I-reference_range
200	I-reference_range

1	O
.	O

Exam	O
benign	O
,	O
patient	O
stable	O
,	O
asymptomatic	O

f	O
No	B-negation
Known	O
Drug	O
Aloergies	O
(	O
Active	O
)	O

Examination	O
of	O
gait	O
and	O
station	O
:	O
Normal	B-labvalue
.	O

[	O
QH	O
]	O
HELICOBACTER	O
PYLORI	O
IGG	O
ANTIBODY	O
Requested	O
for	O
:	O
19Apr2013	B-temporal

No	B-negation
fatigue	O
or	O
weakness	O
.	O

[	O
QLH	O
]	O
CMP	O
W	O
/	O
EGFR	O
Requested	O
for	O
:	O
18Dec2013	B-temporal

Examination	O
of	O
extremities	O
for	O
edema	O
and	O
/	O
or	O
varicosities	O
:	O
Normal	B-labvalue
.	O

LT	O

Mr	O
.	O
Ogden	O
is	O
a	O
56	O
-	O
year	O
-	O
old	O
man	O
who	O
has	O
had	O
Parkinson	O
disease	O
for	O
13	B-temporal
years	I-temporal
.	O

whent	O
to	O
ER	O
gave	O
Rx	O
for	O
muscle	O
relaxer	O
(	O
robaxin	O
)	O
and	O
ketoprophen	O
.	O

Complications	O
:	O
None	O
.	O

The	O
conjunctiva	O
were	O
normal	O
in	O
both	O
eyes	O
.	O

Eyes	O

The	O
spleen	B-bodyloc
was	O
nontender	O
and	O
not	B-negation
enlarged	O
.	O

Past	O
Medical	O
History	O
History	O
of	O
Abdomen	O
Ostomy	O
Type	O
Gastrostomy	O
V44	O
.	O
1	O

UTP	O
-	O
UTI	O
,	O
The	O
patient	O
is	O
being	O
seen	O
for	O
an	O
initial	O
evaluation	O
of	O
an	O
acute	B-course
urinary	B-bodyloc
tract	I-bodyloc
infection	O
.	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

[	O
Q	O
]	O
URINALYSIS	O
REFLEX	O
Done	O
:	O
28Feb2011	B-temporal
10	B-temporal
:	I-temporal
28AM	I-temporal

Pelvic	B-bodyloc
Pain	O
625	O
.	O
9	O

Social	O
History	O
Former	O
Smoker	O
V15	O
.	O
82	O

Well	O
healed	O
scar	O
.	O

No	B-negation
pitting	O
edema	O
or	O
varicosities	O
in	O
the	O
lower	B-bodyloc
extremities	I-bodyloc
.	O

Visit	O
For	O
:	O
Prenatal	O
Exam	O
High	O
-	O
risk	O
Pregnancy	O
V23	O
.	O
9	O

Abdomen	O

Drug	O
Use	O

Skin	O

Psychiatric	O
:	O
no	B-negation
depression	O
.	O

bodyM	O
;	O
ssage	O
g28	O

MetFORMIN	O
HCl	O
1000	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
ONE	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
TWICE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
26Sep2013	B-temporal
to	O
(	O
Evaluate	O
:	O
25Mar2014	B-temporal
)	O
Requested	O
for	O
:	O
26Sep2013	B-temporal
;	O
Last	O
Rx	O
:	O
26Sep2013	B-temporal

She	O
also	O
complains	O
of	O
pain	O
in	O
the	O
fourth	B-bodyloc
and	I-bodyloc
fifth	I-bodyloc
digit	I-bodyloc
of	I-bodyloc
her	I-bodyloc
right	I-bodyloc
hand	I-bodyloc
without	B-negation
weakness	O
or	O
sensory	O
loss	O
.	O

Wheezing	O
:	O
None	B-negation

Hemochromatosis	O
:	O
stable	O
,	O
reportedly	O
has	O
phlebotomy	O
every	O
3	B-temporal
-	I-temporal
4	I-temporal
months	I-temporal
,	O
recently	O
had	O
one	B-temporal
few	I-temporal
weeks	I-temporal
ago	I-temporal
.	O

Diabetes	O
Mellitus	O
250	O
.	O
00	O

Left	O
ring	O
finger	O
radial	O
digital	O
artery	O
repair	O
with	O
microvascular	O
anastomosis	O
7	O
.	O

Mean	O
Cell	O
Volume	O
:	O
81	B-labvalue
.	I-labvalue
1	I-labvalue
fL	I-labvalue
Reference	O
Range	O
81	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
99	I-reference_range
.	I-reference_range
0	I-reference_range

CARDIOVASCULAR	O
:	O
Regular	B-labvalue
rate	O
and	O
rhythm	O
.	O

Pt	O
has	O
had	O
prior	B-temporal
hx	O
of	O
similar	O
pain	O
.	O

Sense	O
of	O
smell	O
:	O
No	B-negation
problem	O

f	O
Normal	O
Routine	O
History	O
And	O
Phinatal	O
Adult	O
(	O
V70	O
.	O
0	O
)	O
;	O
(	O
Active	O
)	O

Problems	O
f	O
Essential	O
Thrombocytosis	O
(	O
238	O
.	O
71	O
)	O
;	O
(	O
Active	O
)	O

Her	O
dementia	O
has	O
been	O
stable	O
since	O
the	O
last	O
visit	O
.	O

Plan	O
_	O
2	O
_	O
twCiteListControlStart	O
Butalbital	O
-	O
APAP	O
-	O
Caff	O
-	O
Cod	O
50-325-40	B-strength
-	I-strength
30	I-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
4	B-frequency
TIMES	I-frequency
DAILY	I-frequency
AS	O
NEEDED	O
;	O
Therapy	O
:	O
05Apr2013	B-temporal
to	O
(	O
Evaluate	O
:	B-temporal
19Apr2013	I-temporal
)	O
;	O
Last	O
Rx	O
:	B-temporal
05Apr2013	I-temporal
Ordered	O
;	O
For	O
:	O
Headache	O
(	O
784	O
.	O
0	O
)	O
;	O
Rx	O
By	O
:	O
CHEN	O
,	O
YEN	O
I	O
;	O
Dispense	O
:	O
14	B-duration
Days	I-duration
;	O
#	O
:	O
56	O
Capsule	B-form
;	O
Refill	O
:	O
0	O
;	O
Print	O
Rx	O

(	O
713	O
)	O
486	O
-	O
9300	O
(	O
Work	O
phone	O
)	O
Created	O
May	B-temporal
23	I-temporal
,	I-temporal
2013	I-temporal
06	B-temporal
:	I-temporal
03	I-temporal
-	O
0500	O
By	O
Monica	O
Olvera	O

Visit	O
For	O
:	O
Screening	O
Exam	O
Osteoporosis	O
V82	O
.	O
81	O

Neurologic	O
No	B-negation
tremors	O
.	O
Monofilament	O
test	O
intact	B-labvalue
.	O
DTR	O
1	O
-	O
2	O
+	O
.	O

check	O
lipid	O
panel	O
continue	O
current	B-temporal
medication	O
management	O
.	O

Examination	O
of	O
extremities	O
for	O
edema	O
and	O
/	O
or	O
varicosities	O
:	O
Normal	B-labvalue
.	O

No	B-negation
masses	O
palpated	O
.	O

Viral	O
Gastroenteritis	O
008	O
.	O
8	O

Onuexamination	O
of	O
the	O
lumbosacral	O
spine	O
,	O
the	O
patient	O
was	O
welldeveloped	B-labvalue
,	O
wellnourished	B-labvalue
,	O
and	O
in	O
some	O
low	O
back	B-bodyloc
distress	O
.	O

[	O
QLH	O
]	O
LIPID	O
PANEL	O
Done	O
:	O
18Dec2012	B-temporal
11	B-temporal
:	I-temporal
30AM	I-temporal

Losartan	O
Potassium	O
25	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
ONE	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
EVERY	B-frequency
DAY	I-frequency
;	O
Therapy	O
:	O
15Jan2013	B-temporal
to	O
(	O
Evaluate	O
:	O
14Feb2013	B-temporal
)	O
Requested	O
for	O
:	O
13Jun2013	B-temporal
;	O
Last	O
Rx	O
:	O
15Jan2013	B-temporal

Instruments	O
:	O
Straight	O
suctionandCurved	O
suctions	O
.	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

Eyes	O
:	O
no	B-negation
eye	B-bodyloc
pain	O
,	O
eyes	B-bodyloc
not	B-negation
red	O
,	O
no	B-negation
eyesight	O
problems	O
and	O
no	B-negation
purulent	O
discharge	O
from	O
the	O
eyes	B-bodyloc
.	O

Surgical	O
Hi	O
tory	O
:	O
C	O
-	O
section	O
,	O
03/24/2006	B-temporal
and	O
nose	O
surgery	O
.	O

Paternal	B-subject
history	O
of	O
Hypertension	O
V17	O
.	O
49	O

[	O
QLH	O
]	O
HEMOGLOBIN	O
A1c	O
Requested	O
for	O
:	O
14Oct2013	B-labvalue

Palpation	O
of	O
the	O
face	O
for	O
sinus	B-bodyloc
tenderness	O
:	O
No	B-negation
maxillary	B-bodyloc
tenderness	O
.	O

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

Eyes	O
:	O
blurred	O
vision	O
.	O

Active	O
Problems	O
(	B-bodyloc
Lower	I-bodyloc
)	I-bodyloc
Leg	I-bodyloc
Localized	O
Swelling	O
Bilateral	O
729	O
.	O
81	O

Maternal	B-subject
grandmother	I-subject
'	I-subject
s	I-subject
history	O
of	O
Alzheimer	O
Disease	O

No	B-negation
decreased	O
response	O
to	O
tactile	O
stimulation	O
.	O

Examination	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue
.	O

Current	O
Meds	O

Mental	O
Status	O
:	O
A	O
mental	O
status	O
exam	O
was	O
performed	O
and	O
was	O
normal	B-labvalue
.	O

Lymphatic	O
:	O
Palpation	O
of	O
cervical	O
lymph	O
nodes	O
:	O
Normal	B-labvalue
No	B-negation
preauricular	B-bodyloc
node	I-bodyloc
enlargement	O
.	O
No	B-negation
submandibular	B-bodyloc
node	I-bodyloc
enlargement	O
.	O
No	B-negation
suboccipital	B-bodyloc
node	I-bodyloc
enlargement	O
.	O

Cardiovascular	O

No	B-negation
hernia	O
.	O

History	O
of	O
Type	O
2	O
Diabetes	O
Mellitus	O
250	O
.	O
00	O

:	O
receptionist	O

Assessment	O
of	O
stability	O
:	O
Normal	B-labvalue
.	O

713-448-4522	O
,	O
option	O
3	O
.	O

Routine	O
Gynecological	O
Exam	O
With	O
Cervical	O
Pap	O
Smear	O
V72	O
.	O
31	O

Cranial	O
Nerve	O
VIII	O
:	O
hearing	O
was	O
intact	B-labvalue
.	O

Mrs	O
.	O
Dycus	O
is	O
a	O
29	O
-	O
year	O
-	O
old	O
with	O
possible	B-uncertain
intractable	O
epilepsy	O
.	O

TrueTrack	O
Test	O
In	O
Vitro	O
Strip	O
;	O
Check	O
BG	O
2x	O
a	O
day	O
;	O
Therapy	O
:	O
03Jan2013	B-temporal
to	O

Denied	O
History	O
of	O
Drug	O
Use	O

Chief	O
Complaint	O

Discussion	O
/	O
Discussion	O
/	O
Summary	O

pH	O
5	B-labvalue
O	O

Social	O
History	O
History	O
of	O
Current	O
Smoker	O
V15	O
.	O
82	O

Palpation	O
of	O
breasts	O
and	O
axillae	O
:	O
Normal	B-labvalue

Follow	O
up	O
with	O
us	O
prn	O

HDL	O
Cholesterol	O
98	B-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
>	B-reference_range
=35	I-reference_range
-	O

Coronary	B-bodyloc
Artery	I-bodyloc
Disease	O
414	O
.	O
00	O

Family	O
history	O
of	O

Micronor	O
now	B-temporal
for	O
contraception	O
and	O
Tdap	O
today	B-temporal
.	O

Current	O
Orders	O
1	O
.	O

Gynecological	O
Problems	O
.	O

WBC	O
:	O
8	B-labvalue
.	I-labvalue
1	I-labvalue
x10E3	I-labvalue
/	I-labvalue
uL	I-labvalue
Reference	O
Range	O
4	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
10	I-reference_range
.	I-reference_range
5	I-reference_range

MUSCULOSKELETAL	O
:	O
no	B-negation
muscle	B-bodyloc
pain	O
and	O
no	B-negation
muscle	B-bodyloc
weakness	O
.	O

Orientation	O
to	O
person	O
,	O
place	O
and	O
time	O
:	O
Normal	B-labvalue
.	O

Never	O
Smoked	O

dyspnoeic	O
.	O

MCH	O
:	O
30	B-labvalue
.	I-labvalue
5	I-labvalue
pg	I-labvalue
Reference	O
Range	O
27	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
31	I-reference_range
.	I-reference_range
0	I-reference_range

Neck	O

Palpation	O
of	O
breasts	O
and	O
axillae	O
:	O
Normal	B-labvalue
.	O

Generalized	O
Osteoarthritis	O
Of	O
Multiple	O
Sites	O
715	O
.	O
09	O

Test	O
Name	O
Result	O
Flag	O
Reference	O

Potassium	O
Chloride	O
Crys	O
ER	O
20	B-strength
MEQ	I-strength
Oral	B-route
Tablet	B-form
Extended	I-form
Release	I-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
17Apr2013	B-temporal
to	O
(	O
Evaluate	O
:	O
19Sep2013	B-temporal
)	O
Requested	O
for	O
:	O
21Jun2013	B-temporal
;	O
Last	O
Rx	O
:	O
21Jun2013	B-temporal

Psychiatric	O
:	O
sleep	O
disturbances	O
,	O
but	O
no	B-negation
anxiety	O
and	O
no	B-negation
depression	O
.	O

Current	O
Meds	O
1	O
.	O

discharge	O
summary	O
,	O
open	O
reduction	O
,	O
internal	O
fixation	O
,	O
schatzker	B-bodyloc
iii	I-bodyloc
tibial	I-bodyloc
plateau	I-bodyloc
fracture	O
,	O
meniscectomy	O
,	O
tibial	B-bodyloc
plateau	I-bodyloc
fracture	O
,	O
orif	O
,	O
schatzker	O
,	O
fixation	O
,	O
reduction	O
,	O
tibial	O
,	O
fracture	O
,	O
plateau	O
,	O

it	O
hasn	O
'	O
t	O
worsened	O
over	B-temporal
the	I-temporal
last	I-temporal
day	I-temporal
.	O

Lymphatic	O

Lymphs	O
:	O
30	B-labvalue
%	I-labvalue
Reference	O
Range	O
14	B-reference_range
-	I-reference_range
46	I-reference_range

History	O
of	O
Visit	O
For	O
:	O
Well	O
Child	O
Visit	O
V20	O
.	O
2	O

Advanced	O
Practitioner	O
Attestation	O
.	O

UTP	O
-	O
OB	O
/	O

Posterior	O
tibialis	O
:	O
right	O
2	O
+	O
and	O
left	O
2	O
+	O
.	O

Triglyceride	O
93	B-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
0	B-reference_range
-	I-reference_range
200	I-reference_range

Assessment	O
of	O
muscle	O
strength	O
/	O
tone	O
:	O
Normal	B-labvalue

Birth	O
Weight	O
:	O
5lbs	B-labvalue
,	I-labvalue
4oz	I-labvalue

The	O
duration	O
of	O
her	O
recent	O
periods	O
has	O
been	O
regular	O
and	O
usually	O
last	O
4	O
-	O
5	O
days	O
.	O

History	O
of	O
Gallbladder	O
Surgery	O

Weber	O
'	O
s	O
test	O
demonstrates	O
no	B-negation
lateralization	O
of	O
tone	O
.	O

History	O
of	O
Indwelling	O
Broviac	O
Catheter	O
Catheter	O
Care	O
V58	O
.	O
81	O

Examination	O
of	O
the	O
head	B-bodyloc
and	O
face	B-bodyloc
revealed	O
no	B-negation
abnormalities	O
and	O
no	B-negation
scars	O
or	O
lesions	O
.	O

Blood	O
pressure	O
control	O
has	O
been	O
good	O
.	O

Disp	O
:	O
*	O
60	O
Tablet	O
(	O
s	O
)	O
*	O
Refills	O
:	O
*	O
0	O
*	O

Metoprolol	O
Succinate	O
ER	B-form
50	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
Extended	I-form
Release	I-form
24	I-form
Hour	I-form
;	O
TAKE	O
1	B-dosage
AND	I-dosage
1	I-dosage
/	I-dosage
2	I-dosage
TABLETS	B-form
DAILY	B-frequency
Requested	O
for	O
:	O
02Nov2012	B-temporal
;	O
Last	O
Rx	O
:	O
02Nov2012	B-temporal
;	O
Edited	O

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

Unable	O
to	O
really	O
gather	O
any	O
other	O
information	O
because	O
she	O
is	O
so	O
obtunded	O
.	O

Examination	O
of	O
cranial	O
nerves	O
:	O
Normal	B-labvalue
.	O

Ability	O
to	O
communicate	O
:	O
Normal	B-labvalue
.	O

The	O
surrounding	O
skin	O
findings	O
included	O
normal	O
appearance	O
and	O
normal	B-labvalue
skin	O
turgor	O
.	O

Dictated	O
Date	O
/	O
time	O
:	O
03/24/14	B-temporal
16	B-temporal
:	I-temporal
33	I-temporal

Assessment	O
of	O
stability	O
:	O
Normal	B-labvalue
.	O

Maternal	B-subject
uncle	I-subject
'	I-subject
s	I-subject
history	O
of	O
Alzheimer	O
Disease	O

(	O
NKDEP	O
)	O
which	O
additionally	O
recommends	O
that	O
when	O
the	O
eGFR	O
is	O
used	O
in	O
patients	O

Statement	O
of	O
Adequacy	O
SEE	O
NOTE	O

right	O
thumb	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

The	O
patient	O
was	O
intubated	O
and	O
it	O
was	O
felt	O
that	O
she	O
should	O
be	O
observed	O
to	O
see	O
if	O
the	O
airway	O
would	O
improve	O
upon	O
which	O
she	O
could	O
be	O
extubated	O
.	O

Allergies	O
1	O
.	O

I	O
have	O
seen	O
and	O
examined	O
LARRY	O
ALLEN	O
with	O
the	O
resident	O
.	O

Past	O
Medical	O
History	O

Denied	B-negation
Family	B-subject
history	O
of	O
Diabetes	O
Mellitus	O
.	O
eg	O

Family	B-subject
history	O
of	O
Coronary	B-bodyloc
Artery	I-bodyloc
Disease	O
V17	O
.	O
49	O

No	B-negation
complaints	O
today	O
but	O
would	O
like	O
to	O
have	O
tx	O
for	O
pain	O
.	O

The	O
patient	O
is	O
not	B-negation
allergic	O
to	O
tape	O
or	O
adhesives	O
.	O

(	O
Medical	O
Transcription	O
Sample	O
Report	O
)	O

Dymista	O
137	B-strength
-	I-strength
50	I-strength
MCG	I-strength
/	I-strength
ACT	I-strength
Nasal	B-route
Suspensisp	B-form
;	O
INSTILL	O
1	B-dosage
SQUIRT	I-dosage
TWICE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
06Nov2012	B-temporal
to	O
(	O
Evaluate	O
:	B-temporal
06Dec2012	I-temporal
)	O
;	O
Last	O
Rx	O
:	B-temporal
06Nov2012	I-temporal

History	O
of	O
Normal	O
Routine	O
History	O
And	O
Physical	O
Well	O
-	O
baby	O
(	O
Birth	O
-	O
2	O
Yr	O
)	O
V20	O
.	O
2	O

Rotator	B-bodyloc
Cuff	I-bodyloc
Sprain	O
(	O
Capsule	O
)	O
840	O
.	O
4	O

Gestational	O
age	O
:	O
6	O
weeks	O
.	O

Initially	O
occurred	O
about	O
twice	O
a	O
day	O
all	O
the	O
way	O
to	O
as	O
infrequently	O
as	O
twice	O
a	O
month	O
.	O

Plan	O
Amlodipine	O
Besy	O
-	O
Benazepril	O
HCl	O
10	B-strength
-	I-strength
20	I-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
2	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
08Oct2012	B-temporal
to	O
(	O
Evaluate	O
:	O
05Jul2013	B-temporal
)	O
Requested	O
for	O
:	O
08Oct2012	B-temporal
;	O
Last	O
Rx	O
:	O
08Oct2012	B-temporal
;	O
Edited	O

Cardiovascular	O
:	O
chest	B-bodyloc
pain	O
,	O
but	O
no	B-negation
palpitations	O
,	O
the	O
heart	O
rate	O
was	O
not	B-labvalue
fast	I-labvalue
,	O
the	O
heart	O
rate	O
was	O
not	B-labvalue
slow	I-labvalue
,	O
no	B-negation
intermittent	O
leg	B-bodyloc
claudication	O
and	O
no	B-negation
edema	O
(	O
ONE	O
YEAR	O
OF	O
SHARP	O
,	O
SUBSTERNAL	O
CHEST	B-bodyloc
PAIN	O
,	O
NO	B-negation
OTHER	O
CARDIAC	B-bodyloc
SYMPTOMS	O
.	O

Results	O
/	O
Results	O
/	O
Data	O
Glucose	O
(	O
Point	O
of	O
Care	O
In	O
Office	O
)	O
28Jan2013	B-temporal
01	B-temporal
:	I-temporal
31PM	I-temporal
INGRAM	O
,	O
JELANI	O

Lifestyle	O
:	O
Diet	O
:	O
He	O
does	O
not	O
have	O
a	O
healthy	O
diet	O
.	O

Active	O
Problems	O
Dermatophytosis	O
Of	O
The	O
Nails	B-bodyloc
110	O
.	O
1	O

Examination	O
of	O
bladder	O
:	O
NormalSurgically	O
absent	O
.	O
Surgically	O
absent	O
.	O
Surgically	O
absent	O
.	O

Ability	O
to	O
communicate	O
:	O
Normal	B-labvalue
.	O

Eggs	O

History	O
of	O
Present	O
Illness	O

UTP	O
-	O
OB	O
/	O

Palpation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Cardiovascular	O

Maternal	B-subject
history	O
of	O
Diabetes	O
Mellitus	O
V18	O
.	O
0	O

Examination	O
of	O
the	O
head	O
and	O
face	O
:	O
Normal	B-labvalue
.	O

[	O
QLH	O
]	O
MUMPS	O
VIRUS	O
ANTIBODY	O
(	O
IGG	O
)	O
Requested	O
for	O
:	O
12Nov2013	B-temporal

She	O
denies	B-negation
paresthesia	O
/	O
numbness	O
of	O
feet	B-bodyloc
:	O
No	B-negation
h	O
/	O
o	O
foot	B-bodyloc
ulcers	O
.	O

Previous	O
symptoms	O
:	O

Cardiovascular	O
:	O
lower	B-bodyloc
extremity	I-bodyloc
edema	O
,	O
but	O
no	B-negation
intermittent	O
leg	B-bodyloc
claudication	O
.	O

Genitourinary	O
:	O
unexplained	O
vaginal	B-bodyloc
bleeding	O
.	O

Review	O
of	O
Systems	O

[	O
QLH	O
]	O
CMP	O
W	O
/	O
EGFR	O
Requested	O
for	O
:	O
26Nov2012	B-temporal

Abdomen	O

History	O
of	O
Present	O
Illness	O
34yo	O
P2103	O
s	O
/	O
p	O
R	O
LTCS	O
on	O
8/3/13	B-temporal
at	O
37w	O
2	O
/	O
2	O
GHTN	O
,	O
A2GDM	O
,	O
Prior	B-temporal
C	O
/	O
S	O
x	O
2	O
presents	O
for	O
inc	O
and	O
BP	O
check	O
.	O

exogenous	O
sources	O
such	O
as	O
diet	O
or	O
supplementation	O
.	O

WRIST	O
PROBLEM	O

Patient	O
is	O
complaining	O
of	O
lump	O
in	O
her	O
throat	B-bodyloc
for	O
about	O
9	O
months	O
.	O

Physical	O
Exam	O

MT	O
/	O
MM	O
:	O
Pus	O

Fluticasone	O
Propionate	O
50	B-strength
MCG	I-strength
/	I-strength
ACT	I-strength
Nasal	B-form
Suspension	I-form
;	O
USE	O
2	B-dosage
SPRAYS	B-route
IN	O
EACH	O
NOSTRIL	O
ONCE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
16May2006	B-temporal
to	O
(	O
Evaluate	O
:	O
02Nov2011	B-temporal
)	O
Requested	O
for	O
:	O
05Jul2011	B-temporal
;	O
Last	O
Rx	O
:	O
05Jul2011	B-temporal

Hypertension	O
401	O
.	O
9	O

L	O
GPI	O
:	O
Amplitude	O
-	O
4	O
.	O
5	O
,	O
Pulse	O
Width	O
-	O
reduced	O
to	O
120	O
microseconds	O
,	O
Rate	O
-	O
160	O
,	O
Contacts	O
-	O
3	O
-	O
,	O
2	O
-	O
,	O
1	O
+	O
.	O

Head	O
and	O
face	O
:	O
Normocephalic	O
;	O
atraumatic	O
.	O

Menses	O
Abnoamal	O
626	O
.	O
9	O

Examination	O
of	O
extremities	O
for	O
edema	O
and	O
/	O
or	O
varicosities	O
:	O
Abnormal	O
2	O
+	O
pitting	O
edema	O
to	O
L	B-bodyloc
ankle	I-bodyloc
.	O

Psychiatric	O
:	O
anxiety	O
,	O
butnot	O
suicidalandno	O
depression	O
.	O

Genitourinary	O
:	O
no	B-negation
dysuria	O
,	O
no	B-negation
vaginal	B-bodyloc
pain	O
,	O
no	B-negation
vaginal	B-bodyloc
itching	O
,	O
no	B-negation
vaginal	B-bodyloc
odor	O
,	O
no	B-negation
vulvar	B-bodyloc
pain	O
,	O
no	B-negation
vulvar	B-bodyloc
itching	O
,	O
no	B-negation
bladder	B-bodyloc
pain	O
and	O
no	B-negation
burning	O
sensation	O
during	O
urination	O
(	O
urinary	O
frequency	O
)	O
.	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

Immunizations	O

Head	O
and	O
Face	O

She	O
has	O
a	O
history	O
of	O
menstrual	O
migraines	O
that	O
last	O
approximately	O
2	B-temporal
weeks	I-temporal
out	O
of	O
the	O
month	O
.	O

Birth	O
control	O
method	O
:	O
The	O
patient	O
is	O
not	O
currently	O
being	O
treated	O
for	O
this	O
problem	O
.	O

Symbicort	O
160	B-strength
-	I-strength
4	I-strength
.	I-strength
5	I-strength
MCG	I-strength
/	I-strength
ACT	I-strength
Inhalation	B-route
Aerosol	B-form
;	O
Therapy	O
:	O
27Apr2009	B-temporal
to	O
Requested	O
for	O
:	O
15Jun2009	B-temporal

Pt	O
denies	B-negation
postpartum	O
mood	O
changes	O
,	O
sadness	O
,	O
depression	O
.	O

This	O
is	O
a	O
routine	O
followup	O
visit	O
.	O

Hypertension	O
401	O
.	O
9	O

5850	O
ROGERDALE	O
ROAD	O

Appropriate	B-labvalue
skin	O
color	O
and	O
pigmentation	O
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Examination	O
of	O
the	O
head	O
and	O
face	O
:	O
Normal	B-labvalue

SUSAN	O
HARRIS	O
a	O
52	O
YO	O
female	O
presents	O
today	O
with	O
no	B-negation
complaints	O
.	O

Disp	O
:	O
*	O
60	O
Tablet	O
(	O
s	O
)	O
*	O
Refills	O
:	O
*	O
0	O
*	O
9	O
.	O

She	O
will	O
return	O
p	O
.	O
r	O
.	O
n	O
.	O

The	O
lungs	O
were	O
normal	B-labvalue
to	O
percussion	O
.	O

Omeprazole	O
40	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
Delayed	I-form
Release	I-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
16Mar2012	B-temporal
to	O
(	O
Evaluate	O
:	O
14Jun2012	B-temporal
)	O
Requested	O
for	O
:	O
16Mar2012	B-temporal
;	O
Last	O
Rx	O
:	O
16Mar2012	B-temporal

3/01/2013	B-temporal
.	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Inspection	O
of	O
lips	O
,	O
teethand	O
gums	O
:	O
Abnormal	O
Examination	O
of	O
the	O
teeth	O
revealed	O
upper	O
dentures	O
.	O

he	O
was	O
on	O
lotrel	O
2	B-frequency
a	I-frequency
day	I-frequency
and	O
he	O
is	O
now	O
on	O
one	O
a	O
day	O

Vitals	O
UTP	O
Pediatric	O
Vital	O
Signs	O
[	O
Data	O
Includes	O
:	O
Current	O
Encounter	O
]	O
24Mar2014	B-temporal
08	B-temporal
:	I-temporal
34AM	I-temporal
BMI	O
Calculated	O
15	B-labvalue
.	I-labvalue
75	I-labvalue
BSA	O
Calculated	O
0	B-labvalue
.	I-labvalue
53	I-labvalue
Height	O
2	B-labvalue
ft	I-labvalue
10	I-labvalue
.	I-labvalue
57	I-labvalue
in	I-labvalue
Weight	O
26	B-labvalue
lb	I-labvalue
14	I-labvalue
.	I-labvalue
34	I-labvalue
oz	I-labvalue
Temperature	O
97	B-labvalue
.	I-labvalue
1	I-labvalue
F	I-labvalue
,	O
Tympanic	O

Oropharynx	O
:	O
Normal	O
.	O

HOUSTON	O
,	O
TEXAS	O
77030	O

History	O
of	O
Present	O
Illness	O

Will	O
await	O
rebults	O
of	O
stone	O
workup	O
but	O
continue	O
conservative	O
management	O
at	O
this	O
time	O
.	O

TraMADol	O
HCl	O
50	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
4	B-frequency
TIMES	I-frequency
DAILY	I-frequency
AS	B-frequency
NEEDED	I-frequency
FOR	O
PAIN	O
;	O
Therapy	O
:	O
06Dec2012	B-temporal
to	O
(	O
Evaluate	O
:	O
14Dec2012	B-temporal
)	O
;	O
Last	O
Rx	O
:	O
06Dec2012	B-temporal

Gastrointestinal	B-bodyloc
bleed	O
.	O

Integumentary	O
:	O
no	B-negation
breast	B-bodyloc
pain	O
and	O
no	B-negation
breast	B-bodyloc
lump	O
.	O

;	O
Jul	B-temporal
2	I-temporal
2012	I-temporal
1	B-temporal
:	I-temporal
33PM	I-temporal
(	O
Author	O
)	O

Levothyroxine	O
Sodium	O
50	B-strength
MCG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
ONE	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
EVERY	B-frequency
DAY	I-frequency
;	O
Therapy	O
:	O
01Sep2013	B-temporal
to	O
(	O
Evaluate	O
:	O
28Feb2014	B-temporal
)	O
Requested	O
for	O
:	O
01Sep2013	B-temporal
;	O
Last	O
Rx	O
:	O
01Sep2013	B-temporal

0	I-reference_range
Mean	O
Crll	O
Hemoglobin	O
Concentration	O
(	O
for	O
H	O
&	O
H	O
)	O
31	B-labvalue
.	I-labvalue
9	I-labvalue
g	I-labvalue
/	I-labvalue
dl	I-labvalue
L	B-labvalue
32	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
36	I-reference_range
.	I-reference_range

Cough	O
786	O
.	O
2	O

LABORATORY	O
DATA	O
:	O
Please	O
see	O
the	O
hospital	O
chart	O
.	O

Plan	O
MetFORMIN	O
HCl	O
1000	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
EVERY	B-frequency
12	I-frequency
HOURS	I-frequency
DAILY	I-frequency
;	O
Last	O
Rx	O
:	O
29Oct2013	B-temporal
;	O
Status	O
:	O
DISCONTINUED	O
-	O
Replaced	O
,	O
Retrospective	O
Authorization	O

Lialda	O
1	B-strength
.	I-strength
2	I-strength
GM	I-strength
Oral	B-route
Tablet	B-form
Delayed	I-form
Release	I-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
03Nov2011	B-temporal
)	O
to	O

Sample	O
Type	O
/	O
Medical	O
Specialty	O
:	O
Discharge	O
Summary	O

Psychiatric	O

The	O
patient	O
has	O
a	O
history	O
of	O
Chiari	O
type	O
I	O
malformation	O
symptomatic	O
.	O

Tdap	O
;	O
INJECT	B-route
1	B-dosage
ML	I-dosage
Intramuscular	B-route
;	O
To	O
Be	O
Done	O
:	O
24Oct2012	B-temporal
;	O
Status	O
:	O
Hold	O
For	O
-	O
Administration	O

Delivered	O
:	O
2008	B-temporal
.	O
Gestational	O
age	O
:	O
36	O
weeks	O
.	O

History	O
of	O
Hay	O
Fever	O
477	O
.	O
9	O

BACK	B-bodyloc
PAIN	O

In	O
most	O
young	O
,	O
healthy	O

Hypopharynx	O
:	O
normal	O
mucosa	O
and	O
appearance	O

She	O
'	O
s	O
planning	O
on	O
getting	O
a	O
dental	O
device	O
to	O
cope	O
with	O
her	O
OSA	O
,	O
but	O
the	O
dentist	O
needs	O
her	O
baseline	O
sleep	O
study	O
to	O
proceed	O
.	O

The	O
abdomen	B-bodyloc
was	O
obese	O
.	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Otoscopic	O
examination	O
:	O
Normal	B-labvalue

Lymphatic	O

PROCEDURE	O
PERFORMED	O
:	O
Total	O
vaginal	O
hysterectomy	O
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

f	O
Normal	O
Routine	O
History	O
And	O
PtContro	O
Well	O
-	O
Baby	O
(	O
Birth	O
-	O
2	O
Yr	O
)	O
(	O
V20	O
.	O
2	O
)	O
;	O
(	O
Active	O
)	O

denies	O
smoking	O
,	O
drinking	O
or	O
illicit	O
drug	O
use	O

Social	O
History	O

Vitals	O
UTP	O
Adult	O
Vital	O
Signs	O
[	O
Data	O
Includes	O
:	O
Current	O
Encounter	O
]	O

15	O
minutes	O
was	O
spent	O
counseling	O
.	O

Assessment	O
of	O
muscle	O
strength	O
/	O
tone	O
:	O
Normal	B-labvalue
.	O

f	O
Maternal	B-subject
history	O
of	O
Diabetes	O
Mellitus	O
Comments	O
:	O
Mother	O
,	O
father	O
(	O
V18	O
.	O
0	O
)	O
;	O
(	O
Active	O
)	O

General	O
appearance	O
:	O
Normal	B-labvalue

Genitourinary	O

Pathologic	O
stage	O
summary	O
:	O
pT1a	O
pN0	O
pMX	O
.	O

Cognitive	O
Disorder	O
294	O
.	O
9	O

Psychiatric	O

Tx	O
for	O
hyponatremia	O
since	O
last	O
visit	O
.	O

I	O
appreciate	O
all	O
consultants	O
'	O
input	O
.	O

Cerebellar	O
:	O
the	O
cerebellar	O
function	O
was	O
normal	B-labvalue
.	O

Inspection	O
of	O
the	O
conjunctiva	O
and	O
lids	O
:	O
Normal	B-labvalue
.	O

Current	O
Meds	O
Aspirin	O
325	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
PRN	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
24Sep2013	B-temporal
)	O
to	O

Citalopram	O
Hydrobromide	O
20	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
AS	O
DIRECTED	O
;	O
Therapy	O
:	O
23Feb2012	B-temporal
to	O
(	O
Evaluate	O
:	O
09Aug2014	B-temporal
)	O
Requested	O
for	O
:	O
14Aug2013	B-temporal
;	O
Last	O
Rx	O
:	O
14Aug2013	B-temporal
;	O
Status	O
:	O

postpartum	O
-	O
doing	O
well	O
,	O
mood	O
stable	O
,	O
EPDS	O
6	O
/	O
30	O
,	O
baby	O
doing	O
well	O
.	O

Palpation	O
of	O
chest	O
:	O
Normal	B-labvalue
.	O

Counseling	O
/	O
Attestations	O
Advanced	O
Practitioner	O
Attestation	O
:	O

Hyperlipidemia	O
272	O
.	O
4	O

Headache	O
784	O
.	O
0	O

Psychiatric	O
:	O
no	B-negation
emotional	O
problems	O
.	O

Left	O
ring	O
finger	O
flexor	O
digitorum	O
profundus	O
repair	O
9	O
.	O

[	O
*	O
*	O
2162-1-13	B-temporal
*	O
*	O
]	O
07	B-temporal
:	I-temporal
30AM	I-temporal
BLOOD	O
Hct	O
-	O
23	B-labvalue
.	I-labvalue
4	I-labvalue
*	O
[	O
*	O
*	O
2162-1-11	B-temporal
*	O
*	O
]	O
01	B-temporal
:	I-temporal
00PM	I-temporal
BLOOD	O
WBC	O
-	O
9	B-labvalue
.	I-labvalue
4	I-labvalue
RBC	O
-	O
3	B-labvalue
.	I-labvalue
13	I-labvalue
*	O
Hgb	O
-	O
9	B-labvalue
.	I-labvalue
5	I-labvalue
*	O
Hct	O
-	O
25	B-labvalue
.	I-labvalue
8	I-labvalue
*	O
MCV	O
-	O
83	B-labvalue
MCH	O
-	O
30	B-labvalue
.	I-labvalue
4	I-labvalue
MCHC	O
-	O
36	B-labvalue
.	I-labvalue
8	I-labvalue
*	O
RDW	O
-	O
13	B-labvalue
.	I-labvalue
6	I-labvalue
Plt	O
Ct	O
-	O
157	B-labvalue
[	O
*	O
*	O
2162-1-8	B-temporal
*	O
*	O
]	O
10	B-temporal
:	I-temporal
55AM	I-temporal
BLOOD	O
WBC	O
-	O
12	B-labvalue
.	I-labvalue
3	I-labvalue
*	O
#	O
RBC	O
-	O
3	B-labvalue
.	I-labvalue
09	I-labvalue
*	O
#	O
Hgb	O
-	O
9	B-labvalue
.	I-labvalue
3	I-labvalue
*	O
Hct	O
-	O
25	B-labvalue
.	I-labvalue
5	I-labvalue
*	O
MCV	O
-	O
83	B-labvalue
MCH	O
-	O
30	B-labvalue
.	I-labvalue
2	I-labvalue
MCHC	O
-	O
36	B-labvalue
.	I-labvalue
6	I-labvalue
*	O
RDW	O
-	O
13	B-labvalue
.	I-labvalue
6	I-labvalue
Plt	O
Ct	O
-	O
179	B-labvalue
[	O
*	O
*	O
2162-1-13	B-temporal
*	O
*	O
]	O
07	B-temporal
:	I-temporal
30AM	I-temporal
BLOOD	O
K	O
-	O
4	B-labvalue
.	I-labvalue
3	I-labvalue
[	O
*	O
*	O
2162-1-11	B-temporal
*	O
*	O
]	O
01	B-temporal
:	I-temporal
00PM	I-temporal
BLOOD	O
Glucose	O
-	O
148	B-labvalue
*	O
UreaN	O
-	O
15	B-labvalue
Creat	O
-	O
0	B-labvalue
.	I-labvalue
9	I-labvalue
Na	O
-	O
136	B-labvalue
K	O
-	O
4	B-labvalue
.	I-labvalue
0	I-labvalue
Cl	O
-	O
95	B-labvalue
*	O
HCO3	O
-	O
28	B-labvalue
AnGap	O
-	O
17	B-labvalue

Signatures	O
Electronically	O
signed	O
by	O
:	O
ALICE	O
CHIU	O
,	O
M	O
.	O
D	O
.	O

Social	O
Hi	O
tory	O
:	O
The	O
patient	O
does	O
not	O
smoke	O
.	O

Discussion	O
/	O
Discussion	O
/	O
Summary	O

Examination	O
of	O
thyroid	O
:	O
Normal	B-labvalue
.	O

Family	O
History	O
Family	O
history	O
of	O
Type	O
1	O
Diabetes	O
Mellitus	O

Pen	O
Needles	O
31G	O
X	O
8	O
MM	O
MISC	O
;	O
B	O
-	O
D	O
ultra	O
fine	O
III	O
short	O
pen	O
needles	O
,	O
up	O
to	O
6	O
needles	O
daily	O
;	O
Therapy	O
:	O
25Feb2009	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
30Nov2009	B-temporal
)	O
Requested	O
for	O
:	O
30Nov2009	B-temporal

[	O
QLH	O
]	O
HEMATOCRIT	O
Done	O
:	O
03Nov2010	B-temporal
09	B-temporal
:	I-temporal
55AM	I-temporal

History	O
of	O
Tonsillectomy	O

Constitutional	O
:	O
no	B-negation
fever	O
and	O
no	B-negation
chills	O
.	O

He	O
reports	O
better	O
compliance	O
with	O
metformin	O
but	O
has	O
not	O
started	O
Glimepiride	O
until	O
only	O
recently	B-temporal
.	O

1	O
.	O

Scope	O
:	O
4	O
mm	O
30	O
degree	O
telescope	O
.	O

MCV	O
:	O
87	B-labvalue
.	I-labvalue
7	I-labvalue
fL	I-labvalue
Reference	O
Range	O
81	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
99	I-reference_range
.	I-reference_range
0	I-reference_range

8	O
.	O

Off	O
meds	O
,	O
explained	O
pros	O
/	O
cons	O
to	O
family	O
,	O
f	O
/	O
u	O
with	O
neurology	O

Respiratory	O
:	O
normal	O
.	O

ZyrTEC	O
Allergy	O
TABS	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
12Oct2012	B-temporal
)	O
to	O

Skin	O

Pupils	O
were	O
equal	O
in	O
size	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
.	O

The	O
patient	O
presents	O
with	O
complaints	O
of	O
gradual	O
onset	O
of	O
intermittent	O
episodes	O
of	O
moderate	B-severity
left	B-bodyloc
lateral	I-bodyloc
shoulder	I-bodyloc
pain	O
,	O
described	O
as	O
sharp	O
and	O
aching	O
,	O
non	O
-	O
radiating	O
.	O

Beta	O
blockade	O
was	O
resumed	O
with	O
most	O
of	O
his	O
other	O
preoperative	O
medications	O
.	O

Associated	O
symptoms	O
:	O
no	B-negation
fever	O
,	O
no	B-negation
weakness	O
,	O
no	B-negation
constipation	O
,	O
no	O
hematemesis	O
and	O
no	B-negation
melena	O
.	O

1	O
.	O

No	B-negation
wheezing	O
was	O
heard	O
.	O

Keratosis	O
Pilaris	O
757	O
.	O
39	O

Description	O
:	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
vomiting	O
,	O
no	B-negation
constipation	O
,	O
no	B-negation
diarrhea	O
,	O
no	B-negation
heartburn	O
and	O
no	B-negation
melena	O
.	O

History	O
of	O
Hysterectomy	O
V45	O
.	O
77	O

9	O
.	O

Health	O
Maintenance	O
V70	O
.	O
0	O

Neck	O

Neck	O

Vitals	O
03Dec2012	B-temporal
01	B-temporal
:	I-temporal
47PM	I-temporal
BMI	O
Calculated	O
30	B-labvalue
.	I-labvalue
8	I-labvalue
BSA	O
Calculated	O
2	B-labvalue
.	I-labvalue
15	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
10	I-labvalue
in	I-labvalue
Weight	O
215	B-labvalue
lb	I-labvalue
2	I-labvalue
oz	I-labvalue
Systolic	O
130	B-labvalue
,	O
RUE	O
,	O
Sitting	O
Diastolic	O
80	B-labvalue
,	O
RUE	O
,	O
Sitting	O
Temperature	O
98	B-labvalue
.	I-labvalue
3	I-labvalue
F	I-labvalue
,	O
Oral	O
Heart	O
Rate	O
60	B-labvalue
,	O
R	O
Radial	O
Respiration	O
16	B-labvalue

[	O
QLH	O
]	O
HEMOGLOBIN	O
Done	O
:	O
27Dec2010	B-temporal
01	B-temporal
:	I-temporal
30PM	I-temporal

Orders	O
g13	O

Examination	O
of	O
pupils	O
and	O
irises	O
:	O
Normal	B-labvalue

Chief	O
Complaint	O

Abdomen	O

I	O
will	O
review	O
the	O
blood	O
glucoses	O
again	O
next	O
week	O
.	O

Upper	O
Extremities	O
Normal	B-labvalue
Right	O
Deltoid	O
Strength	O
:	O
4	B-labvalue
+	I-labvalue
/	I-labvalue
5	I-labvalue
Right	O
Bicep	O
Strength	O
:	O
4	B-labvalue
-	I-labvalue
/	I-labvalue
5	I-labvalue
,	O
Left	O
Bicep	O
Strength	O
:	O
4	B-labvalue
-	I-labvalue
/	I-labvalue
5	I-labvalue
Right	O
Tricep	O
(	O
radial	O
)	O
Strength	O
:	O
4	B-labvalue
+	I-labvalue
/	I-labvalue
5	I-labvalue
Right	O
Wrist	O
Ext	O
.	O

f	O
(	O
Lower	B-bodyloc
)	I-bodyloc
Leg	I-bodyloc
Localized	O
Swelling	O
Bilateral	O
(	O
729	O
.	O
81	O
)	O
;	O
(	O
Active	O
)	O

She	O
reports	O
compliance	O
with	O
meds	O
.	O

Color	O
:	O
Normal	O

Immediately	O
after	O
the	O
incident	O
,	O
patient	O
reports	O
moderate	B-severity
pain	O
and	O
placed	O
clenched	O
injured	O
hand	O
in	O
right	O
hand	O
and	O
proceeded	O
to	O
emergency	O
department	O
.	O

Pt	O
does	O
not	B-negation
recall	O
being	O
told	O
she	O
had	O
diabetic	O
changes	O
.	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
axillae	O
:	O
Normal	B-labvalue
.	O

Respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

History	O
of	O
Cellulitis	O
682	O
.	O
9	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
,	O
the	O
heart	O
rate	O
was	O
not	B-labvalue
fast	I-labvalue
,	O
the	O
heart	O
rate	O
was	O
not	B-labvalue
slow	I-labvalue
,	O
no	B-negation
intermittent	O
leg	B-bodyloc
claudication	O
and	O
no	B-negation
edema	O
.	O

Physical	O
Exam	O

Immunizations	O

SHE	O
RATES	O
THE	O
PAIN	O
A	O
7	O
/	O
10	O
.	O

Omeprazole	O
20	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
Delayed	I-form
Release	I-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
03Nov2011	B-temporal
)	O
to	O

Voltaren	O
GEL	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
30Sep2013	B-temporal
)	O
to	O

MA	O
Digital	O
Mammo	O
Screening	O
Bil	O
G0202	O
Requested	O
for	O
:	O
27Feb2014	B-temporal

Const	O
:	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
were	O
reported	O
,	O
no	B-negation
loss	O
of	O
weight	O
was	O
noted	O
,	O
no	B-negation
weight	O
gain	O
and	O
does	O
not	B-negation
tire	O
easily	O
.	O

Neurologic	O

Examination	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue
The	O
neck	O
was	O
normal	O
in	O
appearance	O
and	O
was	O
supple	O
.	O

2	O
.	O

Neurologic	O

Vitals	O
18Dec2013	B-temporal
07	B-temporal
:	I-temporal
32AM	I-temporal
BMI	O
Calculated	O
38	B-labvalue
.	I-labvalue
24	I-labvalue
BSA	O
Calculated	O
2	B-labvalue
.	I-labvalue
06	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
4	I-labvalue
in	I-labvalue
Weight	O
224	B-labvalue
lb	I-labvalue
Systolic	O
136	B-labvalue
Diastolic	O
70	B-labvalue
Temperature	O
97	B-labvalue
.	I-labvalue
4	I-labvalue
F	I-labvalue
Heart	O
Rate	O
52	B-labvalue

Azithromycin	O
250	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
AS	O
DIRECTED	O
;	O
Therapy	O
:	O
06Nov2012	B-temporal
to	O
(	O
Evaluate	O
:	B-temporal
11Nov2012	I-temporal
)	O
;	O
Last	O
Rx	B-temporal
:	I-temporal
06Nov2012	I-temporal

f	O
No	O
Advance	O
Directives	O
available	O
.	O

Cortical	O
function	O
:	O
Normal	B-labvalue
.	O

There	O
were	O
no	B-negation
complications	O
with	O
the	O
procedure	O
.	O

White	O
Blood	O
Cell	O
5	B-labvalue
.	I-labvalue
7	I-labvalue
K	I-labvalue
/	I-labvalue
CMM	I-labvalue
3	B-reference_range
.	I-reference_range
7	I-reference_range
-	I-reference_range
10	I-reference_range
.	I-reference_range
4	I-reference_range

No	B-negation
Known	O
Allergies	O

Immunizations	O

left	O
hip	O
,	O
single	O
AP	O
standing	O
view	O
(	O
Patient	O
couldn	O
'	O
t	O
tolerated	O
excessive	O
pain	O
for	O
addition	O
view	O
)	O
reveals	O
markedly	O
collapse	O
of	O
femoral	B-bodyloc
head	I-bodyloc
and	O
joint	O
space	O
bone	O
on	O
bone	O
and	O
it	O
is	O
in	O
subluxation	O
.	O

Well	O
developed	O
,	O
appears	O
healthy	O
,	O
well	O
nourished	O
,	O
within	O
normal	O
limits	O
of	O
ideal	O
weight	O
,	O
well	O
hydrated	O
and	O
appearance	O
reflects	O
stated	O
age	O
.	O

Abdomen	O

Fundoscopic	O
Exam	O
:	O
Normal	O
.	O

Family	B-subject
history	O
of	O
Varicose	O
Veins	B-bodyloc

1	O
.	O

Examination	O
for	O
hernias	O
:	O
Normal	B-labvalue
.	O

complaining	O
of	O
persistent	O
right	B-bodyloc
knee	I-bodyloc
pain	O
She	O
has	O
had	O
both	O
knees	O
and	O
both	O
hips	O
replaced	O

Hearing	O
in	O
the	O
left	O
ear	O
:	O
normal	B-labvalue
.	O

;	O
Oct	B-temporal
31	I-temporal
2013	I-temporal
9	B-temporal
:	I-temporal
14AM	I-temporal
(	O
Author	O
)	O

Benign	O
Essential	O
Hypertension	O
401	O
.	O
1	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
NANCY	O
PACHUCA	O
,	O
M	O
.	O
D	O
.	O

Vivotif	O
Berna	O
Vaccine	O
Oral	B-route
Capsule	B-form
Delayed	I-form
Release	I-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
EVERY	B-frequency
OTHER	I-frequency
DAY	I-frequency
;	O
Therapy	O
:	O
08Oct2012	B-temporal
to	O
(	O
Evaluate	O
:	O
16Oct2012	B-temporal
)	O
Requested	O
for	O
:	O
08Oct2012	B-temporal
;	O
Last	O
Rx	O
:	O
08Oct2012	B-temporal
;	O

Insuling	O
regimen	O
was	O
started	O
last	O
visit	O
of	O
NPH	O
25	B-strength
/	I-strength
15	I-strength
,	O
Reg	O
10	O
/	O
10	O
but	O
on	O
2/2/12	B-temporal
it	O
was	O
noted	O
she	O
had	O
2	O
'	O
PP	O
recurrent	B-course
hypoglycemia	O
so	O
I	O
d	O
/	O
c	O
'	O
d	O
her	O
am	O
Regular	O
insulin	O
.	O

The	O
rhythm	O
was	O
regular	B-labvalue
.	O

3	O
.	O

Visit	O
For	O
:	O
Screening	O
Bacterial	O
/	O
Spirochetal	O
Disease	O
V74	O
.	O
9	O

Family	O
History	O

Has	O
not	O
had	O
anything	O
to	O
eat	O
or	O
drink	O
since	O
yesterday	B-temporal
.	O

Family	O
History	O
Paternal	B-subject
history	O
of	O
Heart	B-bodyloc
Disease	O
V17	O
.	O
49	O

No	B-negation
submandibular	B-bodyloc
gland	I-bodyloc
mass	O
/	O
tenderness	O
.	O

HOSPITAL	O
COURSE	O
:	O
The	O
patient	O
was	O
admitted	O
and	O
consented	O
for	O
operation	O
,	O
and	O
taken	O
to	O
the	O
operating	O
room	O
for	O
open	O
reduction	O
and	O
internal	O
fixation	O
of	O
right	B-bodyloc
Schatzker	I-bodyloc
III	I-bodyloc
tibial	I-bodyloc
plateau	I-bodyloc
fracture	O
and	O
partial	O
medial	O
meniscectomy	O
performed	O
without	O
incidence	O
.	O

Neck	O

Never	O
A	O
Smoker	O

Endocrine	O
:	O
muscle	B-bodyloc
weakness	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

She	O
has	O
no	B-negation
significant	O
interval	O
events	O
.	O

Throat	O
,	O
Neck	O
,	O
and	O
Back	O

All	O
surgical	O
wounds	O
were	O
clean	O
,	O
dry	O
and	O
intact	O
.	O

Clear	O
,	O
no	B-negation
drainage	O
.	O

Pre	O
op	O
for	O
ESS	O

Culture	O
:	O
None	B-negation

RPR	O
:	O
Non	O
Reactive	O
Reference	O
Range	O
Non	B-reference_range
Reactive	I-reference_range

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
and	O
no	B-negation
vomiting	O
.	O

Skin	O
palpation	O
:	O
normal	B-labvalue
turgor	O
.	O

ADMISSION	O
DIAGNOSIS	O
:	O
Right	B-bodyloc
tibial	I-bodyloc
plateau	I-bodyloc
fracture	O
.	O

-	O
-	O
Steroid	O
side	O
effects	O
discussed	O
in	O
depth	O
with	O
the	O
patient	O
(	O
hypertension	O
,	O
hyperglycemia	O
,	O
insomnia	O
,	O
mood	O
changes	O
,	O
osteporosis	O
,	O
avascular	B-bodyloc
hip	I-bodyloc
necrosis	O
)	O
.	O

Allergies	O
and	O
Adverse	O
Reactions	O

No	B-negation
frontal	B-bodyloc
tenderness	O
.	O

Sertraline	O
HCl	O
25	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Therapy	O
:	O
24Aug2012	B-temporal
to	O

Vitals	O
UTP	O
Adult	O
Vital	O
Signs	O
[	O
Data	O
Includes	O
:	O
Current	O
Encounter	O
]	O
22Jul2013	B-temporal
08	B-temporal
:	I-temporal
26AM	I-temporal
BMI	O
Calculated	O
45	B-labvalue
.	I-labvalue
07	I-labvalue
BSA	O
Calculated	O
2	B-labvalue
.	I-labvalue
42	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
8	I-labvalue
in	I-labvalue
Weight	O
297	B-labvalue
lb	I-labvalue
6	I-labvalue
oz	I-labvalue
Systolic	O
161	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
101	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Temperature	O
97	B-labvalue
.	I-labvalue
8	I-labvalue
F	I-labvalue
,	O
Oral	O
Heart	O
Rate	O
94	B-labvalue
,	O
L	O
Radial	O
Respiration	O
18	B-labvalue
Respiration	O
Quality	O
Normal	B-labvalue

CONSTITUTIONAL	O
:	O
no	B-negation
nausea	O
,	O
no	B-negation
recent	B-temporal
weight	O
gain	O
,	O
no	B-negation
recent	B-temporal
weight	O
loss	O
,	O
no	B-negation
fever	O
and	O
no	B-negation
chills	O

PSYCHIATRIC	O
:	O
no	B-negation
depression	O
and	O
no	B-negation
anxiety	O
.	O

Review	O
of	O
Systems	O

2	O
.	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	O
vomitingandno	O
diarrhea	O
.	O

Family	B-subject
history	O
of	O
Diabetes	O
Mellitus	O
V18	O
.	O
0	O

Physical	O
Exam	O

The	O
etiology	O
of	O
the	O
air	O
under	O
the	O
diaphragm	B-bodyloc
is	O
actually	O
a	O
colonic	B-bodyloc
air	O
that	O
is	O
anterior	B-bodyloc
superior	I-bodyloc
to	O
the	O
dome	O
of	O
the	O
diaphragm	O
,	O
near	O
the	O
dome	O
of	O
the	O
liver	O
.	O

Abdomen	O

saw	O
The	O
Dermatologist	O

She	O
states	O
for	O
the	B-temporal
past	I-temporal
couple	I-temporal
of	I-temporal
days	I-temporal
dry	O
cough	O
has	O
persisted	O
and	O
she	O
has	O
developed	O
diarrhea	O
.	O

History	O
of	O
Drug	O
Use	O

Constitutional	O
:	O
no	B-negation
fever	O
and	O
no	B-negation
chills	O
.	O

Disp	O
:	O
*	O
30	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E	O
.	O
C	O
.	O

The	O
patient	O
is	O
currently	O
asymptomatic	O
.	O

The	O
patient	O
was	O
given	O
a	O
prescription	O
for	O
Percocet	O
and	O
clindamycin	O
.	O

Inspection	O
of	O
the	O
nasal	O
mucosa	O
,	O
septum	O
and	O
turbinates	O
:	O
Abnormal	O
The	O
bilateral	O
nasal	O
mucosa	O
was	O
boggyandred	O
.	O

Medications	O
:	O
the	O
patient	O
is	O
not	O
adherent	O
to	O
her	O
medication	O
regimen	O
and	O
she	O
denies	B-negation
medication	O
side	O
effects	O
.	O

No	B-negation
masses	O
palpated	O
in	O
the	O
left	B-bodyloc
breast	I-bodyloc
.	O

Dexamethasone	O
Sodium	O
Phosphate	O
4	B-strength
MG	I-strength
/	I-strength
ML	I-strength
Injection	B-form
Solution	I-form
;	O
USE	O
AS	B-frequency
DIRECTED	I-frequency
;	O
Therapy	O
:	O
06Nov2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
06Nov2013	B-temporal
)	O
;	O
Status	O
:	O
ACTIVE	O
-	O
Retrospective	O
Authorization	O

Patient	O
returns	O
for	O
follow	O
up	O
on	O
echo	O
and	O
stress	O
test	O
.	O

Septum	O
:	O
Midline	O
.	O

History	O
of	O
Present	O
Illness	O

Lumbar	B-bodyloc
Neuritis	O
724	O
.	O
4	O

Skin	O

Examination	O
of	O
the	O
abdomen	O
:	O
Normal	B-labvalue
.	O

MetFORMIN	O
HCl	O
850	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
TWICE	B-frequency
DAILY	I-frequency
WITH	I-frequency
MEALS	I-frequency
;	O
Last	O
Rx	O
:	O
31Oct2012	B-temporal
;	O
Status	O
:	O
DISCONTINUED	O

Carotid	O
pulses	O
:	O
Normal	O
.	O

Psychiatric	O
:	O
no	B-negation
sleep	O
disturbances	O
.	O

History	O
of	O
Pancreatitis	O

Alcohol	O
"	O
Alcohol	O
"	O
Alcohol	O
"	O
Drug	O
Use	O
"	O
Drug	O
Use	O
"	O
Drug	O
Use	O
"	O
Tobacco	O
Use	O
"	O
Tobacco	O
Use	O
"	O
Tobacco	O
Use	O

2	O
.	O

No	B-negation
wheezing	O
was	O
heard	O
.	O

Weight	O
Comments	O
:	O
Reported	O

Dispo	O

RDW	O
14	B-labvalue
.	I-labvalue
1	I-labvalue
%	I-labvalue
11	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
15	I-reference_range
.	I-reference_range
0	I-reference_range

Vitals	O
27Aug2012	B-temporal
01	B-temporal
:	I-temporal
26PM	I-temporal
BMI	O
Calculated	O
24	B-labvalue
.	I-labvalue
64	I-labvalue
BSA	O
Calculated	O
1	B-labvalue
.	I-labvalue
5	I-labvalue
Height	O
4	B-labvalue
ft	I-labvalue
11	I-labvalue
in	I-labvalue
Weight	O
122	B-labvalue
lb	I-labvalue
4	I-labvalue
oz	I-labvalue
Systolic	O
120	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
72	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Temperature	O
98	B-labvalue
.	I-labvalue
4	I-labvalue
F	I-labvalue
,	O
Oral	O
Heart	O
Rate	O
72	B-labvalue
,	O
R	O
Radial	O
Pulse	O
Quality	O
Normal	B-labvalue
,	O
R	O
Radial	O
Respiration	O
16	B-labvalue
Respiration	O
Quality	O
Normal	B-labvalue
LMP	O
01Jul2012	B-labvalue

sensation	O
to	O
light	O
touch	O
is	O
intact	B-labvalue
.	O

2	O
.	O

Psychiatric	O
:	O
no	B-negation
anxiety	O
and	O
no	B-negation
depression	O
.	O

Physical	O
Exam	O
:	O

Due	O
to	O
back	B-bodyloc
injury	O
and	O
pain	O
.	O

Right	O
2	O
+	O
,	O
no	B-negation
bruit	O
heard	O
over	O
the	O
right	B-bodyloc
carotid	I-bodyloc
,	O
left	O
2	O
+	O
and	O
no	B-negation
bruit	O
heard	O
over	O
the	O
left	B-bodyloc
carotid	I-bodyloc
.	O

Inspection	O
of	O
breasts	O
:	O
Normal	B-labvalue
Both	O
breasts	O
:	O
normal	O
appearance	O
.	O

Hyperglycemia	O
790	O
.	O
29	O

Musculoskeletal	O

CONSULTATIONS	O
:	O
To	O
rehab	O
,	O
Dr	O
.	O
X	O
and	O
to	O
Internal	O
Medicine	O
for	O
management	O
of	O
multiple	O
medical	O
problems	O
including	O
hypothyroid	O
,	O
diabetes	O
mellitus	O
type	O
2	O
,	O
bronchitis	O
,	O
and	O
congestive	O
heart	B-bodyloc
failure	O
.	O

She	O
denies	B-negation
any	O
feelings	O
of	O
blues	O
or	O
depression	O
.	O

Pap	O
Smear	O
(	O
+	B-labvalue
)	O
Low	B-severity
Grade	I-severity
Squamous	O
Intraepithelial	O
Lesion	O
795	O
.	O
03	O

Electronically	O
signed	O
by	O
:	O
Raymond	O
Martin	O
,	O
M	O
.	O
D	O
.	O
;	O

Palpation	O
of	O
breasts	O
and	O
axillae	O
:	O
Normal	B-labvalue
.	O

(	O
Medical	O
Transcription	O
Sample	O
Report	O
)	O

He	O
has	O
had	O
continued	O
problems	O
with	O
festination	O
,	O
poor	O
arm	B-bodyloc
swing	O
,	O
and	O
inability	O
to	O
speak	O
clearly	O
.	O

Her	O
voice	O
does	O
tire	O
more	O
quickly	O
than	O
she	O
would	O
like	O
.	O

Active	O
Problems	O
Bacterial	O
Vaginosis	O
616	O
.	O
10	O

Triglyceride	O
80	B-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
0	B-reference_range
-	I-reference_range
200	I-reference_range

Breath	O
sounds	O
were	O
not	B-labvalue
diminished	I-labvalue
.	O

Exercise	O
includes	O
walking	O
and	O
biking	O
.	O

In	O
terms	O
of	O
her	O
frequent	O
falls	O
and	O
gait	O
imbalance	O
,	O
there	O
does	O
not	O
seem	O
to	O
be	O
a	O
significant	O
change	O
in	O
her	O
gait	O
.	O

Examination	O
of	O
the	O
anus	O
,	O
perineum	O
and	O
rectum	O
:	O
Normal	B-labvalue
.	O

No	B-negation
facial	B-bodyloc
skin	I-bodyloc
lesions	O
.	O

Eyes	O
:	O
itching	O
of	O
the	O
eyes	B-bodyloc
,	O
buteyes	O
not	O
red	O
and	O
no	B-negation
purulent	O
discharge	O
from	O
the	O
eyes	B-bodyloc
.	O

Discussion	O
/	O
SummarySectionEnd	O
VerifiedResultsSectionStart	O
Results	O

Examination	O
of	O
thyroid	O
:	O
Normal	B-labvalue
.	O

He	O
is	O
irrigiting	O
with	O
Betamethsone	O
/	O
MP	O
bid	B-frequency
.	O

Vitals	O
07Aug2013	B-temporal
10	B-temporal
:	I-temporal
24AM	I-temporal
BMI	O
Calculated	O
32	B-labvalue
.	I-labvalue
32	I-labvalue
BSA	O
Calculated	O
1	B-labvalue
.	I-labvalue
95	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
5	I-labvalue
in	I-labvalue
Weight	O
194	B-labvalue
lb	I-labvalue
Systolic	O
155	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
83	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Temperature	O
98	B-labvalue
F	I-labvalue
,	O
Oral	O
Heart	O
Rate	O
55	B-labvalue

No	B-negation
Known	O
Drug	O
Allergies	O

Chest	O

He	O
has	O
not	O
required	O
any	O
further	O
procrit	O
and	O
his	O
renal	O
function	O
has	O
improved	B-labvalue
,	O
with	O
current	O
eGFR	O
of	O
59	B-labvalue
.	O

RT	O

Skin	O

f	O
Normal	O
Routine	O
History	O
And	O
Phinatal	O
Adult	O
(	O
V70	O
.	O
0	O
)	O
;	O
(	O
Active	O
)	O

-	O
-	O
will	O
repeat	O
CT	O
chest	O
in	O
6	B-temporal
months	I-temporal
to	O
follow	O
up	O
on	O
the	O
solitary	O
nodule	O

Abdomen	O

2	O

States	O
her	O
mother	O
has	O
to	O
take	O
Fe	O
tabs	B-form
.	O

No	B-negation
fever	O
and	O
no	B-negation
recent	B-temporal
weight	O
change	O
(	O
unexpected	O
)	O
.	O

Bowel	O
sounds	O
were	O
normal	B-labvalue
.	O

Cranial	O
nerves	O
VIII	O
:	O
Abnormal	O
.	O

Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

ENT	O
:	O
hoarseness	O
,	O
hearing	O
loss	O
,	O
snoring	O
was	O
observedanddysphagia	O
,	O
but	O
no	B-negation
drainage	O
of	O
ear	B-bodyloc
,	O
no	B-negation
vertigo	O
,	O
no	B-negation
daytime	O
sleepiness	O
,	O
no	B-negation
mouth	B-bodyloc
sores	O
,	O
no	B-negation
tooth	O
problems	O
and	O
no	B-negation
tinnitus	O

Ms	O
Wathen	O
can	O
not	O
tolerate	O
any	O
amount	O
of	O
weight	O
bearing	O
activities	O
such	O
as	O
standing	O
and	O
walking	O
.	O

2	O
.	O

[	O
QLH	O
]	O
LIPID	O
PANEL	O
Requested	O
for	O
:	O
16Mar2012	B-temporal

The	O
tongue	O
was	O
normal	O
.	O

The	O
patient	O
for	O
5	O
.	O
25	O
minutes	O
of	O
a	O
modified	O
[	O
*	O
*	O
Doctor	O
First	O
Name	O
*	O
*	O
]	O
protocol	O
to	O
an	O
APHR	O
of	O
65	B-labvalue
%	I-labvalue
and	O
was	O
stopped	O
for	O
fatigue	O
.	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
LESLIE	O
GARB	O
,	O
M	O
.	O
D	O
.	O

On	O
a	O
chest	O
x	O
-	O
ray	O
for	O
what	O
appeared	O
to	O
be	O
shortness	O
of	O
breath	O
she	O
was	O
found	O
to	O
have	O
what	O
was	O
thought	O
to	O
be	O
free	O
air	O
under	O
the	O
right	B-bodyloc
diaphragm	I-bodyloc
.	O

Inflamed	O
Seborrheic	B-bodyloc
Keratosis	O
702	O
.	O
11	O

Folic	O
Acid	O
1	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
19Apr2013	B-temporal
)	O
to	O

Normal	O
Routine	O
History	O
And	O
Physical	O
Adult	O
V70	O
.	O
0	O

Advanced	O
non	O
-	O
small	O
cell	O
lung	B-bodyloc
carcinoma	O
with	O
left	B-bodyloc
malignant	O
pleural	O
effusion	O
status	O
post	O
chest	O
tube	O
insertion	O
status	O
post	O
chemical	O
pleurodesis	O
.	O

The	O
patient	O
has	O
resolution	B-course
of	O
the	O
pain	O
down	O
the	O
arm	O
,	O
but	O
she	O
does	O
have	O
some	O
tingling	O
of	O
the	O
right	O
thumb	B-bodyloc
and	O
right	O
index	O
finger	O
.	O

Examination	O
for	O
hernias	O
:	O
Normal	B-labvalue
.	O

History	O
of	O
General	O
Surgery	O

Procedure	O

Psychiatric	O

Dorzolamide	O
HCl	O
-	O
Timolol	O
Mal	O
22	B-strength
.	I-strength
3	I-strength
-	I-strength
6	I-strength
.	I-strength

The	O
patient	O
and	O
her	O
husband	O
wish	O
to	O
start	O
a	O
family	O
in	O
the	O
next	O
1	O
.	O
5	O
-	O
2	O
years	O
.	O

Patient	O
gives	O
consent	O
to	O
schedule	O
the	O
surgery	O
.	O

The	O
thyroid	O
was	O
not	O
enlarged	O
.	O

MetFORMIN	O
HCl	O
ER	B-form
500	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
Extended	I-form
Release	I-form
24	I-form
Hour	I-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
TWICE	O
DAILY	O
;	O
Therapy	O
:	O
10Feb2014	B-temporal
to	O
(	O
Evaluate	O
:	O
11May2014	O
)	O
Requested	O
for	O
:	O
10Feb2014	B-temporal
;	O
Last	O
Rx	O
:	O
10Feb2014	B-temporal
;	O
Edited	O

Ophthalmoscopic	O
examination	O
:	O
Normal	B-labvalue
.	O

6768	O
Highway	O
6	O
S	O
.	O

HEMATOCRIT	O
34	B-labvalue
.	I-labvalue
5	I-labvalue
%	I-labvalue
L	B-labvalue
35	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
45	I-reference_range
.	I-reference_range
0	I-reference_range

PROCEDURE	O
PERFORMED	O
DURING	O
THIS	O
HOSPITALIZATION	O
:	O
Total	O
thyroidectomy	O
.	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
groin	O
:	O
No	B-negation
lymphadenopathy	O
.	O

Skin	O

Surgical	O
History	O
1	O
.	O

Constitutional	O

ACTIVE	O
-	O
Retrospective	O
Authorizatisp	O

UTP	O
-	O
Headache	O
,	O

Special	O
Tests	O
:	O
Deferred	O
.	O

Sodium	O
Lvl	O
140	B-labvalue
mEq	I-labvalue
/	I-labvalue
l	I-labvalue
135	B-reference_range
-	I-reference_range
145	I-reference_range

Testosterone	O
,	O
Serum	O
:	O
212	B-labvalue
ng	I-labvalue
/	I-labvalue
dL	I-labvalue
Abnormal	O
Low	O
Reference	O
Range	O
348	B-reference_range
-	I-reference_range
1197	I-reference_range

Family	B-subject
history	O
of	O
Uterine	B-bodyloc
Cancer	O
V16	O
.	O
49	O

Examination	O
of	O
the	O
skin	O
for	O
lesions	O
:	O
Abnormal	O
.	O
(	O
VARICOSE	O
ECZEMA	O
WITH	O
SKIN	B-bodyloc
BREAKDOWN	O
)	O
.	O

Calcium	O
TABS	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
16Sep2013	B-temporal
)	O
to	O

Treatment	O
Plan	O

Neurologic	O

CC	O
:	O
F	O
/	O
u	O
DM	O
,	O
high	O
lipids	O

(	O
713	O
)	O
486	O
-	O
9300	O
(	O
Work	O
phone	O
)	O
Patirt	O
Contacts	O

Biopsy	O
showed	O
a	O
microinvasive	O
carcinoma	O
of	O
the	O
cervix	B-bodyloc
and	O
a	O
cone	O
biopsy	O
was	O
performed	O
on	O
02/12/2007	B-temporal
also	O
showing	O
microinvasive	O
carcinoma	O
with	O
a	O
1	O
mm	O
invasion	O
.	O

-	O
consider	O
h	O
/	O
o	O
loud	O
snoring	O
,	O
needs	O
sleep	O
study	O
.	O

The	O
deep	O
tendon	O
reflexes	O
were	O
abnormal	O
Biceps	O
:	O
right	O
1	O
+	O
and	O
left	O
1	O
+	O
.	O

Symptoms	O
:	O
foot	B-bodyloc
pain	O
,	O
but	O
no	B-negation
ankle	B-bodyloc
pain	O
,	O
no	B-negation
leg	B-bodyloc
pain	O
,	O
no	B-negation
localized	O
bruising	O
,	O
no	B-negation
localized	O
swelling	O
,	O
no	B-negation
localized	O
redness	O
,	O
no	B-negation
localized	O
warmth	O
,	O
no	B-negation
foot	B-bodyloc
stiffness	O
,	O
no	B-negation
limping	O
and	O
no	B-negation
refusal	O
to	O
bear	O
weight	O

;	O
Nov	B-temporal
21	I-temporal
2011	I-temporal
3	B-temporal
:	I-temporal
47PM	I-temporal
(	O
Author	O
)	O

Oropharynx	O
:	O
Normal	O
.	O

Family	B-subject
history	O
of	O
Diabetes	O
Mellitus	O
V18	O
.	O
0	O

The	O
patient	O
is	O
doing	O
well	O
with	O
her	O
diabetes	O
goals	O
(	O
see	O
above	O
)	O
.	O

The	O
patient	O
received	O
Botox	O
injection	B-form
last	O
May	O
which	O
per	O
parents	O
may	O
help	O
her	O
headache	O
,	O
shoulder	B-bodyloc
tighness	O
.	O

Infant	O
has	O
a	O
closed	O
PDA	B-bodyloc
.	O

Diabetes	O
Mellitus	O
Poorly	O
Controlled	O
250	O
.	O
02	O

[	O
L	O
]	O
Pap	O
Lb	O
,	O
Ct	O
-	O
Ng	O
,	O
rfx	O
HPV	O
ASCU	O
Requested	O
for	O
:	O
16Nov2012	B-temporal

Methocarbamol	O
750	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
TWICE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
28Aug2013	B-temporal
to	O

Upper	O
extremity	O
perpheral	O
neurological	O
exam	O
demonstrated	O
light	O
touch	O
intact	B-labvalue
for	O
both	O
upper	O
arms	O
,	O
forearms	O
,	O
and	O
hands	O
,	O
bilateral	O
upper	O
extremity	O
nerve	O
motor	O
function	O
,	O
and	O
intact	B-labvalue
bilateral	O
distal	O
pulses	O
.	O

Budesonide	O
0	B-strength
.	I-strength
5	I-strength
MG	I-strength
/	I-strength
2ML	I-strength
Inhalation	B-route
Suspension	B-form
;	O
USE	O
ONE	B-dosage
DOSE	O
IN	O
NEIL	O
MED	O
IRRIGATIONS	O
TWICE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
03Jan2013	B-temporal
to	O
(	O
Evaluate	O
:	O
22Mar2013	B-temporal
)	O
Requested	O
for	O
:	O
21Jan2013	B-temporal
;	O
Last	O
Rx	O
:	O
21Jan2013	B-temporal

MA	O
Breast	O
mammogram	O
screen	O
bilateral	O
77057	O
Requested	O
for	O
:	O
21Nov2013	B-temporal

PHYSICAL	O
EXAMINATION	O
:	O
VITAL	O
SIGNS	O
:	O
Blood	O
pressure	O
is	O
118	B-labvalue
/	I-labvalue
61	I-labvalue
,	O
pulse	O
67	B-labvalue
.	O

Orientation	O
to	O
person	O
,	O
place	O
and	O
time	O
:	O
Normal	B-labvalue
.	O

No	B-negation
weakness	O
of	O
any	O
exetremities	O
,	O
but	O
no	B-negation
paresthesias	O
,	O
no	B-negation
vertigo	O
and	O
no	B-negation
rhinorrhea	O
.	O

Clear	O
nasal	B-bodyloc
discharge	O
:	O
Mild	B-severity

Respiratory	O
:	O
cough	O
,	O
but	O
no	O
shortness	O
of	O
breathand	O
no	B-negation
wheezing	O
.	O

Review	O
of	O
Systems	O

Genitourinary	O
:	O
no	B-negation
dysuria	O
.	O

Patient	O
received	O
cefazolin	O
and	O
tetanus	O
booster	O
at	O
outside	O
hospital	O
.	O

Diet	O
recommendations	O
:	O
1800	O
calorie	O
diet	O
.	O

;	O
Nov	B-temporal
29	I-temporal
2011	I-temporal
1	B-temporal
:	I-temporal
58PM	I-temporal
(	O
Author	O
)	O

f	O
Zetia	O
10	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
ONE	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
EVERY	B-frequency
DAY	I-frequency
;	O
Start	O
Date	O
:	O
09/17/2007	B-temporal
;	O
End	O
Date	O
:	O
01/01/1900	B-temporal
(	O
Active	O
)	O

Nasal	O
mucosa	O
,	O
septum	O
,	O
and	O
turbinates	O
:	O
Normal	O
without	B-negation
edema	O
or	O
erythema	O
.	O

s	O
/	O
p	O
Tdap	O
and	O
flu	O
shot	O
.	O

Diabetic	O
Polyneuropathy	O
357	O
.	O
2	O

VESIcare	O
5	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
EVERY	B-frequency
DAY	I-frequency
;	O
Therapy	O
:	O
16Aug2012	B-temporal
to	O
(	O
Evaluate	O
:	O
12Nov2013	B-temporal
)	O
Requested	O
for	O
:	O
15Jul2013	B-temporal
;	O
Last	O
Rx	O
:	O
15Jul2013	B-temporal
;	O
Status	O
:	O
ACTIVE	O
-	O

The	O
patient	O
was	O
given	O
drug	O
precautions	O
for	O
the	O
use	O
of	O
these	O
medicines	O
.	O

MEDICATIONS	O
:	O
Unable	O
to	O
evaluate	O
.	O

Musculoskeletal	O

The	O
patient	O
'	O
s	O
symptoms	O
have	O
been	O
persistent	O
and	O
had	O
gotten	O
worse	O
with	O
subjective	O
weakness	O
of	O
the	O
right	O
upper	O
extremity	O
since	O
its	O
onset	O
for	O
several	O
weeks	O
now	O
.	O

Musculoskeletal	O
:	O
mid	B-bodyloc
back	I-bodyloc
pain	O
,	O
but	O
no	B-negation
joint	B-bodyloc
pain	O
,	O
no	B-negation
joint	B-bodyloc
swelling	O
and	O
no	B-negation
joint	B-bodyloc
stiffness	O
.	O

Skin	O
:	O
no	B-negation
change	O
in	O
skin	B-bodyloc
,	O
showed	O
no	B-negation
erythema	O
,	O
does	O
not	B-negation
show	I-negation
signs	I-negation
of	I-negation
slowing	O
healing	O
,	O
no	B-negation
rash	O
and	O
no	B-negation
itching	O
.	O

No	O
driving	O
etc	O
;	O
Therapy	O
:	O
31Jan2012	B-temporal
to	O
04Apr2012	B-temporal
;	O
Last	O
Rx	O
:	O
31Jan2012	B-temporal
;	O
Status	O
:	O

Abdomen	O

Assessed	O
(	B-bodyloc
Lower	I-bodyloc
)	I-bodyloc
Leg	I-bodyloc
Localized	O
Swelling	O
Bilateral	O
729	O
.	O
81	O

MCHC	O
:	O
34	B-labvalue
.	I-labvalue
8	I-labvalue
g	I-labvalue
/	I-labvalue
dl	I-labvalue
Reference	O
Range	O
32	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
36	I-reference_range
.	I-reference_range
0	I-reference_range

Possible	B-uncertain
Visual	O
Disturbances	O
368	O
.	O
9	O

Palpation	O
of	O
breasts	O
and	O
axillae	O
:	O
Normal	B-labvalue
No	B-negation
masses	O
palpated	O
in	O
the	O
right	B-bodyloc
breast	I-bodyloc
.	O

[	O
O	O
]	O
CXR	O
PA	O
/	O
Lat	O
Done	O
:	O
05Apr2013	B-temporal

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Additional	O
History	O
:	O
Last	O
A1c	O
:	O
6	B-labvalue
.	I-labvalue
5	I-labvalue
.	O

Patient	O
has	O
a	O
history	O
of	O
a	O
positive	O
pap	O
smear	O
.	O

Surgical	O
History	O
History	O
of	O
Gastric	O
Surgery	O

Denied	B-negation
Family	B-subject
history	O
of	O
Coronary	B-bodyloc
Artery	I-bodyloc
Disease	O

Hypothyroidism	O
(	O
244	O
.	O
9	O
)	O

The	O
baby	O
'	O
s	O
name	O
is	O
Malanie	O
.	O

MMR	O
-	O
VAR	O
(	O
ProQuad	O
)	O
;	O
07	B-temporal
Jan	I-temporal
2012	I-temporal

Palpation	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
AbnormalBruising	O
as	O
above	O
.	O

The	O
abdomen	O
was	O
normal	O
to	O
percussion	O
.	O

Neck	O

INTEGUMENTARY	O
:	O
no	B-negation
rashes	O
and	O
no	B-negation
ulcers	O
.	O

Mental	O
Status	O
:	O
A	O
mental	O
status	O
exam	O
was	O
performed	O
and	O
was	O
normal	O
.	O

Contraception	O
:	O
interested	O
in	O
the	O
implanon	O
.	O

UTP	O
-	O
Discussion	O
/	O

Current	O
Meds	O
Accu	O
-	O
Chek	O
FastClix	O
Lancets	O
Miscellaneous	O
;	O
Check	O
BG	O
5x	O
a	O
day	O
;	O
Therapy	O
:	O
15Apr2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
15Apr2013	B-temporal
)	O

We	O
do	O
not	O
feel	O
that	O
this	O
is	O
contriburing	O
to	O
his	O
nephrolithiasis	O
.	O

Arterial	O
Pulses	O
:	O
Normal	B-labvalue
(	O
equal	O
bilaterally	O
)	O
.	O

No	B-negation
hepatosplenomegaly	O
.	O

Active	O
Problems	O
Carpal	B-bodyloc
Tunnel	I-bodyloc
Syndrome	O
354	O
.	O
0	O

The	O
episodes	O
usually	O
was	O
preceded	O
just	O
by	O
a	O
lightheaded	O
sensation	O
.	O

UTP	O
-	O
OB	O
/	O

Optic	O
Disc	O
:	O
Normal	O
.	O

CT	O
abdomen	O
:	O
suspect	B-uncertain
internal	O
hernia	O

Delivery	O
type	O
:	O
vaginal	O
.	O

Never	O
A	O
Smoker	O

Perimenopausal	B-bodyloc
menorrhagia	O
:	O
repeat	O
pelvic	O
US	O

PSYCHIATRIC	O
:	O
The	O
patient	O
is	O
alert	O
and	O
oriented	O
x4	O
.	O

Chest	O
x	O
-	O
ray	O
was	O
clear	B-labvalue
.	O

No	B-negation
dysmenorrhea	O
.	O

*	O
Please	O
resume	O
all	O
regular	O
home	O
medications	O
and	O
take	O
any	O
new	O
meds	O
as	O
ordered	O
.	O

Active	O
Problems	O
Hyperlipidemia	O
272	O
.	O
4	O

Constitutional	O
:	O
no	B-negation
fever	O
and	O
no	B-negation
chills	O
.	O

Musculoskeletal	O
:	O
joint	B-bodyloc
pain	O
,	O
but	O
no	B-negation
limb	B-bodyloc
swelling	O
.	O

The	O
onset	O
of	O
the	O
symptoms	O
was	O
24	O
hour	O
after	O
he	O
went	O
to	O
Bowling	O
and	O
ate	O
some	O
food	O
.	O
eg	O

Hematologic	O
/	O
Lymphatic	O
:	O
no	B-negation
swollen	O
glands	B-bodyloc
in	O
the	O
neck	B-bodyloc
.	O

7	B-temporal
/	I-temporal
2010	I-temporal
.	O

Vitamin	O
D	O
Deficiency	O
268	O
.	O
9	O

The	O
patient	O
presents	O
with	O
complaints	O
of	O
sudden	O
onset	O
of	O
moderate	B-severity
incisional	O
pain	O
,	O
described	O
as	O
sharp	O
,	O
non	O
-	O
radiating	O
.	O

Motor	O
strength	O
4	O
/	O
4	O
bilateral	O
upper	O
and	O
lower	O
extremity	O
.	O

Skin	O
:	O
normal	B-labvalue
skin	O
color	O
and	O
pigmentation	O
,	O
normal	O
skin	B-bodyloc
turgor	O
and	O
no	B-negation
significant	O
rash	O
.	O

The	O
renal	O
bed	O
was	O
inspected	O
for	O
hemostasis	O
,	O
which	O
appear	O
to	O
be	O
adequate	O
.	O

Onset	O
was	O
gradual	O
2	B-temporal
-	I-temporal
3	I-temporal
day	I-temporal
(	I-temporal
s	I-temporal
)	I-temporal
ago	I-temporal
.	O

Inspection	O
of	O
lips	O
,	O
teethand	O
gums	O
:	O
Normal	B-labvalue
.	O

Well	O
developed	O
,	O
appears	O
healthy	O
,	O
well	O
nourished	O
,	O
within	O
normal	O
limits	O
of	O
ideal	O
weight	O
,	O
well	O
hydrated	O
and	O
appearance	O
reflects	O
stated	O
age	O
.	O

Collected	O
-	O
-	O

Examination	O
of	O
the	O
extremities	O
revealed	O
no	O
fingernail	O
clubbing	O
and	O
well	O
perfused	O
fingers	O
.	O

Pt	O
describes	O
the	O
diarrhea	O
as	O
loose	O
in	O
the	O
am	O
and	O
4	O
-	O
5	O
watery	O
stools	O
thereafter	O
.	O

with	O
extremes	O
of	O
body	O
mass	O
index	O
for	O
purposes	O
of	O
drug	O
dosing	O
,	O
the	O
eGFR	O
should	O

Review	O
of	O
Systems	O

History	O
of	O
External	B-bodyloc
Hemorrhoids	O
455	O
.	O
3	O

Pertinent	O
Results	O
:	O

Chief	O
Complaint	O

Family	B-subject
history	O
of	O
Cancer	O

Discussion	O
/	O
Discussion	O
/	O
Summary	O

The	O
heart	O
rate	O
was	O
normal	B-labvalue
.	O

Physical	O
Therapy	O
Referral	O
Outpatient	O
Referral	O
Requested	O
for	O
:	O
07Sep2012	B-temporal

Assessment	O
of	O
muscle	O
strength	O
/	O
tone	O
:	O
Normal	B-labvalue

Examination	O
of	O
pupils	O
and	O
irises	O
:	O
Normal	B-labvalue
.	O

Genitourinary	O
:	O
No	B-labvalue
change	I-labvalue
in	O
urine	O
volume	O
and	O
no	B-negation
dysuria	O
.	O

Cesarean	O
Delivery	O
-	O
Delivered	O
669	O
.	O
71	O

Carotid	O
pulses	O
:	O
Normal	B-labvalue
.	O

History	O
of	O
Vaginal	B-bodyloc
Discharge	O
623	O
.	O
5	O

AU	O
TIPP	O
.	O

Palpation	O
of	O
the	O
face	O
and	O
sinuses	O
:	O
Normal	B-labvalue

Will	O
plan	O
on	O
follmuing	O
labs	O
and	O
holding	O
procrit	O
at	O
this	B-temporal
time	I-temporal
.	O

Protein	O
,	O
Total	O
,	O
Serum	O
:	O
7	B-labvalue
.	I-labvalue
4	I-labvalue
g	I-labvalue
/	I-labvalue
dL	I-labvalue
Reference	O
Range	O
6	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
8	I-reference_range
.	I-reference_range
5	I-reference_range

Aggrenox	O
25	B-strength
-	I-strength
200	I-strength
MG	I-strength
Oral	B-route
Capsule	B-form
Extended	I-form
Release	I-form
12	I-form
Hour	I-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
TWICE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
15Nov2008	B-temporal
to	O
(	O
Evaluate	O
:	O
07Feb2013	B-temporal
)	O
Requested	O
for	O
:	O
27Dec2012	B-temporal
;	O
Last	O
Rx	O
:	O
09Nov2012	B-temporal

Examination	O
of	O
digits	O
and	O
nails	O
:	O
Normal	B-labvalue
.	O

Constitutional	O

Inspection	O
of	O
lips	O
,	O
teethand	O
gums	O
:	O
Normal	B-labvalue
.	O

ECG	O
-	O
12	O
Lead	O
Done	O
:	O
05Apr2013	B-temporal

She	O
reports	O
abnormal	O
menses	O
.	O
(	O
irregularity	O
)	O
.	O

Symptoms	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
abdominal	B-bodyloc
bloating	O
,	O
no	B-negation
abdominal	B-bodyloc
cramping	O
,	O
no	B-negation
diarrhea	O
,	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
,	O
no	B-negation
nausea	O
,	O
no	B-negation
vomiting	O
,	O
no	B-negation
anorexia	O
and	O
no	B-negation
constipation	O
.	O

She	O
will	O
get	O
55	O
units	O
in	O
the	O
morning	O
.	O

Middle	O
Turbinate	O
:	O
Normal	O
position	O
.	O

History	O
of	O
Lap	O
Total	O
Hysterect	O
Uterus	O
<	O
250g	O
With	O
Removal	O
Of	O
Tubes	O
/	O
Ovary	O

Well	O
developed	O
,	O
acutely	B-course
ill	O
,	O
comfortable	O
,	O
obese	O
,	O
clothing	O
appropriate	O
,	O
well	O
groomed	O
,	O
well	O
hydratedandtense	O
a	O
but	O
noac	O
.	O

The	O
patient	O
is	O
being	O
seen	O
for	O
a	O
routine	O
clinic	O
follow	O
-	O
up	O
of	O
essential	O
hypertension	O
.	O

Patient	O
has	O
declined	O
STD	O
screening	O
.	O

s	O
/	O
p	O
flu	O
vaccine	O
and	O
Tdap	O

Surgical	O
incision	O
(	O
the	O
incision	O
site	O
was	O
intact	O
and	O
with	O
no	B-negation
drainage	O
)	O
.	O

Lymphocytes	O
#	O
1	B-labvalue
.	I-labvalue
1	I-labvalue
K	I-labvalue
/	I-labvalue
CMM	I-labvalue
1	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
5	I-reference_range
.	I-reference_range
5	I-reference_range

He	O
has	O
developed	O
two	O
pustular	O
lesions	O
over	O
his	O
face	B-bodyloc
-	O
right	B-bodyloc
side	I-bodyloc
of	I-bodyloc
his	I-bodyloc
chin	I-bodyloc
draining	O
purulent	O
discharge	O
.	O

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

Varicose	O
Veins	B-bodyloc
With	O
Ulcer	O
And	O
Inflammation	O
454	O
.	O
2	O

Palpation	O
of	O
the	O
face	O
and	O
sinuses	O
:	O
Normal	B-labvalue
.	O

Throat	O
,	O
Neck	O
,	O
and	O
Back	O

Patient	O
seemed	O
willing	O
to	O
counsel	O
this	O
.	O

Swollen	O
jaw	O

Vitamin	O
D	O
Deficiency	O
268	O
.	O
9	O

Musculoskeletal	O
:	O
joint	B-bodyloc
pain	O
(	O
L	B-bodyloc
knee	I-bodyloc
due	O
to	O
2	O
surgeries	O
in	O
1990s	B-temporal
and	O
2004	B-temporal
t	O
ocorrect	O
PVNS	O
)	O
,	O
but	O
no	B-negation
arthralgias	O
,	O
no	B-negation
joint	B-bodyloc
swelling	O
,	O
no	B-negation
joint	B-bodyloc
stiffness	O
,	O
no	B-negation
limb	B-bodyloc
pain	O
and	O
no	B-negation
limb	B-bodyloc
swelling	O
.	O

Recorded	O
;	O
;	O
Last	O
Updated	O
By	O
:	O
Guizar	O
,	O
Rosio	O

This	O
is	O
a	O
pleasant	O
55	O
year	O
-	O
old	O
man	O
who	O
reported	O
a	O
vague	O
"	O
burning	O
"	O
feeling	O
in	O
his	O
chest	B-bodyloc
that	O
began	O
in	O
[	O
*	O
*	O
Month	O
(	O
only	O
)	O
205	O
*	O
*	O
]	O
of	O
this	B-temporal
year	I-temporal
.	O

Family	O
History	O
Maternal	B-subject
history	O
of	O
Reported	O
Family	B-subject
History	O
Of	O
Heart	B-bodyloc
Disease	O

;	O
Mar	B-temporal
3	I-temporal
2014	I-temporal
8	B-temporal
:	I-temporal
17AM	I-temporal
(	O
Author	O
)	O

3	O
.	O

;	O
Jun	B-temporal
18	I-temporal
2013	I-temporal
6	B-temporal
:	I-temporal
34PM	I-temporal
(	O
Author	O
)	O

Female	O
.	O

Test	O
Name	O
Result	O
Flag	O
Reference	O

Drug	O
Use	O

f	O
/	O
u	O
in	O
2	O
mths	O
for	O
H	O
&	O
P	O

AispEnies	O
_	O
20	O
_	O
twCiteListControlEnd	O
AispEniesSectispEnd	O
CurrentMedsSectispStart	O
Current	O
Meds	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Results	O
/	O
Results	O
/	O
Data	O
All	O
Results	O
[	O
Data	O
Includes	O
:	O
Last	O
1	O
Instance	O
]	O

No	B-negation
masses	O
palpated	O
.	O

EARS	O
,	O
NOSE	O
,	O
MOUTH	O
AND	O
THROAT	O

Spiriva	O
HandiHaler	O
18	B-strength
MCG	I-strength
Inhalation	B-route
Capsule	B-form
;	O
USE	O
1	B-dosage
INHALATION	B-route
(	O
1	O
CAPSULE	O
)	O
BY	B-route
MOUTH	I-route
DAILY	B-frequency
;	O
Therapy	O
:	O
12Jun2013	B-temporal
to	O
(	O
Evaluate	O
:	O
10Oct2013	B-temporal
)	O
Requested	O
for	O
:	O
12Jun2013	B-temporal
;	O
Last	O
Rx	O
:	O
12Jun2013	B-temporal

Previous	O
presentation	O
included	O
knee	B-bodyloc
pain	O
,	O
swelling	O
and	O
decreased	B-course
range	O
of	O
motion	O
.	O

Plan	O
Health	O
Maintenance	O
(	O
V70	O
.	O
0	O
)	O
,	O
Acute	B-course
Upper	B-bodyloc
Respiratory	I-bodyloc
Infection	O
(	O
465	O
.	O
9	O
)	O

Constitutional	O
:	O
feeling	O
tired	O
(	O
fatigue	O
)	O
,	O
but	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
,	O
not	B-negation
feeling	O
poorly	O
(	O
malaise	O
)	O
,	O
no	B-negation
recent	B-temporal
weight	O
gain	O
and	O
no	B-negation
recent	B-temporal
weight	O
loss	O
.	O

External	O
inspection	O
of	O
ears	O
and	O
nose	O
:	O
Normal	B-labvalue
.	O

f	O
RSV	O
MAB	O
(	O
Synagis	O
)	O
(	O
Lot	O
#	O
:	O
11G08	O
-	O
80	O
)	O
-	O
Administered	O
on	O
:	O
03/08/2013	B-temporal

UTP	O
-	O
Discussion	O
/	O
24yo	O
G2P2	O
s	O
/	O
p	O
CS	O
7/21/2012	B-temporal
,	O
here	O
for	O
postpartum	O
check	O
.	O

Inspection	O
of	O
the	O
nasal	O
mucosa	O
,	O
septum	O
and	O
turbinates	O
:	O
Normal	B-labvalue
.	O

Results	O
/	O
Assessment	O
Diabetes	O
Mellitus	O
250	O
.	O
00	O

Examination	O
of	O
the	O
palate	O
showed	O
no	B-negation
abnormalities	O
.	O

Hearing	O
left	O
ear	O
:	O
.	O

Retrospective	O
Authorization	O

Endocrine	O
:	O
no	B-negation
proptosis	O
and	O
no	B-negation
muscle	B-bodyloc
weakness	O
.	O

Neck	O
:	O
Abnormal	O
.	O

Comments	O
:	O
PreE	O
.	O

Family	O
History	O
Family	O
history	O
of	O
Hypertension	O
V17	O
.	O
49	O

improvement	B-course
of	O
symptoms	O
from	O
previous	O

Constitutional	O

SPECIFIC	O
GRAVITY	O
1	B-labvalue
.	I-labvalue
020	I-labvalue

History	O
of	O
Surgery	O
Excision	O
Of	O
Parotid	O
Tumor	O
/	O
Gland	O
Performed	O
in	O
1996	B-temporal
secondary	O
to	O
Cancer	O

History	O
of	O
Cataract	O
Extraction	O

Indication	B-uncertain
:	O
Persistent	O
dysphonia	O
.	O

CNS	O
:	O
Infant	O
had	O
a	O
head	O
ultrasound	O
done	O
to	O
rule	B-uncertain
out	I-uncertain
intracranial	B-bodyloc
abnormalities	O
and	O
intracranial	B-bodyloc
hemorrhage	O
.	O

Funduscopic	O
examination	O
is	O
normal	B-labvalue
.	O

Neck	O

Laparoscopy	O
incisions	O
.	O

Naproxen	O
500	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
2	B-dosage
TABLETS	B-form
BY	B-route
MOUTH	I-route
PRN	B-frequency
Requested	O
for	O
:	O
17Mar2014	B-temporal
;	O
Last	O
Rx	O
:	O
17Mar2014	B-temporal

Examination	O
of	O
digits	O
and	O
nails	O
:	O
Normal	B-labvalue
.	O

Cervix	O
:	O
Normal	O

Male	O
Erectile	O
Disorder	O
302	O
.	O
72	O

Comorbid	O
Illnesses	O
:	O
hypertension	O
and	O
hyperlipidemia	O
.	O

[	O
QLH	O
]	O
VITAMIN	O
E	O
(	O
TOCOPHEROL	O
)	O
Done	O
:	O
18Dec2012	B-temporal
11	B-temporal
:	I-temporal
30AM	I-temporal

Family	B-subject
history	O
of	O
Uterine	B-bodyloc
Cancer	O

and	O
swallow	O
one	B-dosage
DHA	O
gel	O
capsule	B-form
daily	B-frequency
;	O
Therapy	O
:	O
24Apr2013	B-temporal
to	O
(	O
Evaluate	O
:	O
20Nov2013	B-temporal
)	O

;	O
Apr	B-temporal
4	I-temporal
2012	I-temporal
10	B-temporal
:	I-temporal
15AM	I-temporal
(	O
Author	O
)	O

She	O
did	O
have	O
some	O
enemas	O
.	O

)	O
Sig	O
:	O
One	B-dosage
(	I-dosage
1	I-dosage
)	I-dosage
Tablet	B-form
,	I-form
Delayed	I-form
Release	I-form
(	O
E	O
.	O
C	O
.	O

Paternal	B-subject
grandmother	I-subject
'	I-subject
s	I-subject
history	O
of	O
Hypertension	O
V17	O
.	O
49	O

Single	O
nodule	O
was	O
palpated	O
on	O
the	O
left	O
.	O

[	O
QLH	O
]	O
VITAMIN	O
B12	O
Done	O
:	O
18Dec2012	B-temporal
11	B-temporal
:	I-temporal
30AM	I-temporal

Mammogram	O
:	O
2010	B-temporal

Urine	O
Dipstick	O
(	O
In	O
Office	O
)	O
14Oct2013	B-temporal
10	B-temporal
:	I-temporal
20AM	I-temporal
HUNG	O
,	O
SCOTT	O

UROBILINOGEN	O
NEG	B-labvalue

Patient	O
is	O
sexually	O
active	O
with	O
his	O
wife	O
and	O
recently	O
has	O
trouble	O
maintaining	O
erections	O
and	O
wants	O
to	O
try	O
viagra	O
.	O

History	O
of	O
Urinary	B-bodyloc
Tract	I-bodyloc
Infection	O
V13	O
.	O
02	O

Inspection	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
Abnormal	O
.	O

Physical	O
Exam	O

Genitourinary	O
:	O
nocturia	O
,	O
but	O
no	B-negation
incontinence	O
.	O

Endocrine	O
:	O
no	B-negation
proptosis	O
.	O

Indication	B-uncertain
:	O
Nasal	B-bodyloc
obstruction	O
/	O
congestion	O
and	O
Nasal	O
drainage	O
.	O

Chest	O
/	O
Breasts	O
:	O
normal	O
in	O
appearance	O
and	O
no	B-negation
palpable	O
masses	O
.	O

Eyes	O
:	O
no	B-negation
eyesight	O
problems	O
.	O

Not	O
well	O
developedandchronically	O
ill	O
,	O
butwell	O
nourished	O
.	O

Musculoskeletal	O

Follow	O
-	O
up	O
in	O
1	O
year	O
.	O

[	O
H	O
]	O
TSH	O
w	O
/	O
Rflx	O
Free	O
T4	O
09Dec2010	B-temporal
10	B-temporal
:	I-temporal
30AM	I-temporal
Hardwicke	O
,	O
Robin	O

Follow	O
-	O
up	O
visit	O

Examination	O
of	O
the	O
neck	O
:	O
Abnormal	O
.	O
TTP	O
on	O
the	O
left	B-bodyloc
paraspinal	I-bodyloc
m	O
.	O

Vitals	O
06Nov2013	B-temporal
08	B-temporal
:	I-temporal
26AM	I-temporal
BMI	O
Calculated	O
27	B-labvalue
.	I-labvalue
86	I-labvalue
BSA	O
Calculated	O
1	B-labvalue
.	I-labvalue
92	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
7	I-labvalue
in	I-labvalue
Weight	O
177	B-labvalue
lb	I-labvalue
8	I-labvalue
oz	I-labvalue
Systolic	O
138	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
88	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Temperature	O
96	B-labvalue
.	I-labvalue
6	I-labvalue
F	I-labvalue
,	O
Temporal	O
Heart	O
Rate	O
90	B-labvalue
,	O
L	O
Radial	O
Pulse	O
Quality	O
Normal	B-labvalue
,	O
L	O
Radial	O
Respiration	O
12	B-labvalue
Respiration	O
Quality	O
Normal	B-labvalue

His	O
calculation	O
ability	O
was	O
normal	O
.	O

Endocrine	O
:	O
no	B-negation
hot	O
flashes	O
,	O
no	B-negation
changes	O
in	O
appetite	O
,	O
no	B-negation
unusual	O
sensitivity	O
to	O
changes	O
in	O
temperature	O
and	O
no	B-negation
feelings	O
of	O
excessive	O
thirst	O
.	O

Hematologic	O
/	O
Lymphatic	O
:	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
,	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
and	O
no	B-negation
swollen	O
glands	B-bodyloc
in	O
the	O
neck	B-bodyloc
.	O

3	O
.	O

1	O
.	O

Cervical	O
Spine	O
:	O
Normal	O
(	O
exhibited	O
no	B-negation
muscle	B-bodyloc
spasm	O
)	O
.	O

History	O
of	O
Present	O
Illness	O

Thus	O
,	O
I	O
recommened	O
psychiatry	O
and	O
/	O
or	O
psychology	O
evaluation	O

Patient	O
Specific	O
Education	O
Given	O
Done	O
:	O
09Oct2013	B-temporal

History	O
of	O
Inguinal	O
Hernia	O
Repair	O
With	O
Excision	O
Of	O
Hydrocele	O

Lymph	O
nodes	O
in	O
neck	O
:	O
Normal	O
.	O
Lymph	O
nodes	O
in	O
axillae	O
:	O
Normal	O
.	O

No	B-negation
pulse	O
delay	O
and	O
no	B-negation
pulse	O
discrepancy	O
.	O

4	O
.	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
,	O
no	B-negation
cough	O
,	O
no	B-negation
shortness	O
of	O
breath	O
during	O
exertion	O
,	O
no	B-negation
orthopnea	O
and	O
no	B-negation
PND	O
.	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
vomiting	O
,	O
no	B-negation
constipation	O
,	O
no	B-negation
diarrhea	O
,	O
no	B-negation
heartburn	O
and	O
no	B-negation
melena	O
.	O

Current	O
Orders	O
[	O
QLH	O
]	O
HEMOGLOBIN	O
A1c	O
Requested	O
for	O
:	O
16Mar2012	B-temporal

Active	O
Problems	O

Calcium	O
Lvl	O
9	B-labvalue
.	I-labvalue
7	I-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
8	B-reference_range
.	I-reference_range
5	I-reference_range
-	I-reference_range
10	I-reference_range
.	I-reference_range
5	I-reference_range

Discolored	O
nasal	B-bodyloc
discharge	O
:	O
Moderate	B-severity

Allergies	O
Ibuprofen	O
CAPS	B-form

Patient	O
reports	O
increased	B-course
pain	O
with	O
running	O
.	O

Discussion	O
/	O
Discussion	O
/	O
Summary	O

Respiratory	O
failure	O
secondary	O
to	O
above	O
.	O

Well	O
developed	O
,	O
well	O
nourished	O
,	O
alert	O
,	O
in	O
no	B-negation
acute	O
distress	O
.	O

The	O
patient	O
presents	O
with	O
complaints	O
of	O
convulsions	O
(	O
left	B-bodyloc
side	I-bodyloc
sensation	O
change	O
)	O
.	O

C	O
/	O
o	O
wife	O
'	O
s	O
concern	O
for	O
his	B-course
decreased	I-course
labido	O
and	O
mentions	O
his	O
erections	O
are	O
less	O
hard	O
.	O

Neck	O
:	O
Normal	O
.	O

Ears	O
,	O
Nose	O
,	O
Mouth	O
,	O
and	O
Throat	O
:	O
the	O
ears	O
and	O
nose	O
were	O
normal	O
in	O
appearance	O
,	O
both	O
tympanic	O
membranes	O
were	O
normal	O
,	O
hearing	O
was	O
normal	B-labvalue
and	O
the	O
lip	O
and	O
gums	O
were	O
normal	O
.	O

COURSE	O
ON	O
ADMISSION	O
:	O

FamilyHistisy	O
_	O
70	O
_	O
twCiteListControlStart	O
Materpal	B-subject
histisy	O
of	O
Diabetes	O
Mellitus	O
V18	O
.	O
0	O

recommendations	O
of	O
the	O
American	O
Diabetes	O
Association	O
.	O

2	O
.	O

Carotid	O
Arteries	O
:	O
Normal	O
.	O

BSA	O
Calculated	O
:	O
2	B-labvalue
.	I-labvalue
31	I-labvalue

CONSTITUTIONAL	O

Vitals	O
UTP	O
Adult	O
Vital	O
Signs	O
[	O
Data	O
Includes	O
:	O
Current	O
Encounter	O
]	O

left	B-bodyloc
knee	I-bodyloc
swelling	O
,	O
pain	O

MetFORMIN	O
HCl	O
ER	B-form
500	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
Extended	I-form
Release	I-form
24	I-form
Hour	I-form
;	O
TAKE	O
2	B-dosage
TABLET	B-form
TWICE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
15Apr2013	B-temporal
to	O
(	O
Evaluate	O
:	O
02Jul2014	B-temporal
)	O
;	O
Last	O
Rx	O
:	O
03Jan2014	B-temporal

Examination	O
of	O
thyroid	O
:	O
Normal	B-labvalue
.	O

Anemia	O
of	O
chronic	B-course
disease	O
-	O
current	O
iron	O
panel	O
is	O
within	B-labvalue
normal	I-labvalue
limits	I-labvalue
and	O
he	O
is	O
iron	O
replere	O
.	O

pseudobulbar	O
affect	O
score	O
equal	O
to	O
9	B-labvalue
.	O

Patient	O
Name	O
:	O
SHELLY	O
SCOTT	O
Appointment	O
Date	O
:	O
4/2/2013	B-temporal
3:15:00	B-temporal
PM	I-temporal

The	O
patient	O
was	O
warned	O
about	O
the	O
interaction	O
that	O
canuoccur	O
between	O
alcohol	O
and	O
medications	O
.	O

Examination	O
of	O
reflexes	O
:	O
Normal	B-labvalue
.	O

Respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

Palpation	O
:	O
pain	O
upon	O
palpation	O
of	O
the	O
medial	O
joint	O
lineof	O
the	O
kneeandof	O
the	O
medial	O
collateral	O
ligament	O
.	O

36	O
yo	O
G5P1102	O
at	O
11w1d	O
by	O
LMP	O
c	O
/	O
w	O
doc	O
8	O
wk	O
CRL	O
with	O
T2DM	O
,	O
AMA	O
,	O
h	O
/	O
o	O
PPROM	O
with	O
PTB	O

Psychiatric	O
:	O
no	B-negation
anxiety	O
,	O
no	B-negation
depression	O

Peripheral	O
Vascular	O
Exam	O
:	O
Normal	B-labvalue
.	O

Total	O
time	O
of	O
encounter	O
was	O
30	O
minutesand20	O
minutes	O
was	O
spent	O
counseling	O
.	O

Pulses	O
:	O
2	B-labvalue
+	I-labvalue
in	I-labvalue
the	I-labvalue
posterior	I-labvalue
tibialis	I-labvalue
and	O
2	B-labvalue
+	I-labvalue
in	I-labvalue
the	I-labvalue
dorsalis	I-labvalue
pedis	I-labvalue
.	O

Marital	O
History	O
-	O
Currently	O
Married	O

No	B-negation
guarding	O
.	O

Keywords	O
:	O

Lymphatic	O

Estradiol	O
0	B-strength
.	I-strength
5	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
TWICE	B-frequency
DAILY	I-frequency
;	O
Last	O
Rx	O
:	O
31Oct2013	B-temporal

Complications	O
:	O
None	O
.	O

General	O
appearance	O
:	O
Normal	B-labvalue

No	B-negation
murmurs	O
were	O
heard	O
.	O
Peripheral	O
vascular	O
exam	O
:	O
Normal	B-labvalue
.	O

Heart	O
Rate	O
:	O
76	B-labvalue

Memory	O
and	O
mood	O
within	O
normal	O
limits	O
.	O

Pertinent	O
Results	O
:	O

Eyes	O

Completed	O
abx	O
2	B-temporal
days	I-temporal
ago	I-temporal
.	O

Chief	O
Complaint	O

History	O
of	O
Gestational	O
Diabetes	O
Mellitus	O
V12	O
.	O
21	O

HOUSTON	O
,	O
TEXAS	O
77030	O

f	O
Acute	B-course
Sore	O
Throat	B-bodyloc
(	O
462	O
)	O
;	O
(	O
Active	O
)	O

A	O
CT	O
head	O
was	O
ordered	O
for	O
the	O
patient	O
to	O
complete	O
at	O
a	O
memorial	O
system	O
hospital	O
.	O

Birth	O
control	O
method	O
:	O
.	O

Examination	O
of	O
the	O
cervix	O
revealed	O
erosions	O
and	O
friable	O
cervix	O
,	O
buta	O
nulliparous	O
cervix	O
.	O

[	O
L	O
]	O
Comprehensive	O
Metabolic	O
Panel	O
(	O
esoterix	O
)	O
Requested	O
for	O
:	O
02Nov2012	B-temporal

Current	O
Meds	O
Multi	O
-	O
Vitamin	O
Oral	B-route
Tablet	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
18Oct2012	B-temporal
)	O
to	O

Left	O
Ext	O
.	O

Pt	O
desires	O
a	O
trial	O
of	O
OCP	O
.	O

Vaccines	O
Prophylactic	O
Need	O
Against	O
Influenza	O
V04	O
.	O
81	O

General	O
appearance	O
:	O
Normal	B-labvalue
Well	O
developed	O
,	O
chronically	O
ill	O
,	O
comfortable	O
,	O
normal	O
body	O
odor	O
,	O
well	O
nourished	O
,	O
overweight	O
,	O
clothing	O
appropriate	O
,	O
well	O
groomed	O
,	O
well	O
hydrated	O
,	O
appearance	O
reflects	O
stated	O
ageandALERT	O
AND	O
CHEERFUL	O
.	O

929B	O
Gessner	O
,	O
Suite	O
100	O

Latex	O
Exam	O
Gloves	O
MISC	O

3	O
.	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
PHILIP	O
JOHNSON	O
,	O
M	O
.	O
D	O
.	O

Sensory	O
:	O
no	B-negation
sensory	O
abnormalities	O
were	O
noted	O
.	O

Palpation	O
of	O
heart	O
:	O
Normal	B-labvalue

f	O
Maternal	B-subject
history	O
of	O
Reported	O
Family	O
History	O
Of	O
Heart	B-bodyloc
Disease	O
Comments	O
:	O
Mother	O
-	O
CABG	O
x	O
4	O
vessels	O
in	O
her	O
60	O
'	O
s	O
(	O
Active	O
)	O

Lymphatic	O

They	O
were	O
daily	O
until	O
December	B-temporal
of	I-temporal
2011	I-temporal
and	O
he	O
was	O
taking	O
frequent	O
analgesics	O
on	O
a	O
regular	O
basis	O
.	O

Nasal	O
endoscopy	O
.	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Allograft	O
.	O

Sample	O
Name	O
:	O
Discharge	O
Summary	O
-	O
14	O

Hematologic	O
/	O
Lymphatic	O
:	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
,	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
and	O
no	B-negation
swollen	O
glands	B-bodyloc
.	O

History	O
of	O
Ear	O
Pressure	O
Equalization	O
Tube	O
,	O
Insertion	O
,	O
Bilaterally	O

No	B-negation
infectious	O
symptoms	O
.	O

Carotid	O
pulses	O
:	O
Normal	B-labvalue
.	O

Patient	O
is	O
58	O
yo	O
male	O
with	O
history	O
of	O
DM	O
type	O
I	O
,	O
HLD	O
,	O
HTN	O
,	O
homocysteinemia	O
,	O
PVD	O
s	O
/	O
p	O
bilateral	O
femoral	O
stents	O
who	O
presents	O
for	O
follow	O
up	O
.	O

Chest	O

[	O
QLH	O
]	O
CBC	O
(	O
INCLUDES	O
DIFF	O
/	O
PLT	O
)	O
Requested	O
fis	O
:	O
29Apr2013	B-temporal

NovoTwist	O
32G	O
X	O
5	O
MM	O
Miscellaneous	O
;	O
5	O
a	O
day	O
;	O
Therapy	O
:	O
24Nov2012	B-temporal
to	O

Acp	O
Staging	O
Stage	O
1	O
Hypertension	O
:	O
140	O
-	O
159	O
/	O
90	O
-	O
99	O
401	O
.	O
9	O

Orientation	O
to	O
person	O
,	O
place	O
and	O
time	O
:	O
Normal	B-labvalue
.	O

cxr	O

Irrigate	O
.	O

Denies	B-negation
daytime	O
fatigue	O
or	O
hypersomnolence	O
.	O

Description	O
of	O
patient	O
'	O
s	O
judgement	O
and	O
insight	O
:	O
Normal	B-labvalue
.	O

Chronic	B-course
Reflux	O
Esophagitis	O
530	O
.	O
11	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

Results	O
/	O
Assessment	O
Flank	B-bodyloc
Pain	O
Left	O
789	O
.	O
09	O

External	O
genitalia	O
and	O
vagina	O
:	O
Normal	O
,	O
no	B-negation
lesions	O
appreciated	O
.	O

Constitutional	O
:	O
recent	B-temporal
15	O
lb	O
weight	O
loss	O
and	O
feeling	O
tired	O
(	O
fatigue	O
)	O
.	O

-	O
-	O
he	O
had	O
some	O
blood	O
oozing	O
after	O
mild	B-severity
trauma	O
to	O
his	O
legs	O
on	O
wheelchair	O
when	O
he	O
was	O
in	O
the	O
office	O
today	B-temporal
.	O

for	O
repeat	O
pap	O
4	B-temporal
/	I-temporal
2012	I-temporal

[	O
QLH	O
]	O
PSA	O
,	O
TOTAL	O
Requested	O
for	O
:	O
02Nov2012	B-temporal

Electronically	O
signed	O
by	O
:	O
Raymond	O
Martin	O
,	O
M	O
.	O
D	O
.	O

Psychiatric	O

Examination	O
of	O
thyroid	O
:	O
Normal	B-labvalue
.	O

Current	O
Meds	O
Levothyroxine	O
Sodium	O
137	B-strength
MCG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
DAILYLAST	O
REFILL	O
.	O

T3	O
Free	O
:	O
3	B-labvalue
.	I-labvalue
36	I-labvalue
pg	I-labvalue
/	I-labvalue
ml	I-labvalue
Reference	O
Range	O
2	B-reference_range
.	I-reference_range
18	I-reference_range
-	I-reference_range
3	I-reference_range
.	I-reference_range
98	I-reference_range

Signatures	O
Electronically	O
signed	O
by	O
:	O
PAUL	O
LEE	O
,	O
M	O
.	O
D	O
.	O

Examination	O
of	O
the	O
head	O
and	O
face	O
revealed	O
no	B-negation
abnormalities	O
and	O
no	B-negation
scars	O
or	O
lesions	O
.	O

Hematologic	O
/	O
Lymphatic	O
:	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
and	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
.	O

Rx	O
:	O
04Sep2013	B-temporal
;	O
Edited	O

UTP	O
-	O
Discussion	O
/	O
26	O
y	O
/	O
o	O
G1	O
P0	O
,	O
LMP	O
:	O
3/27/2013	B-temporal
,	O
EDD	O
:	O
1/1/2014	B-temporal
,	O
@	O
6	O
weeks	O
0days	O
gestation	O
.	O

Diastolic	O
:	O
75	B-labvalue
,	O
LUE	O
,	O
Sitting	O

There	O
was	O
also	O
abnormal	O
motor	O
-	O
unit	O
morphology	O
with	O
in	O
the	O
tibialis	O
anterior	O
and	O
peroneus	O
longus	O
muscles	O
with	O
reduced	O
recruitment	O
pattern	O
.	O

Physical	O
Exam	O

Examination	O
of	O
the	O
head	O
and	O
face	O
:	O
Normal	B-labvalue
.	O

Impingement	O
Of	O
The	O
Right	O
Shoulder	B-bodyloc
726	O
.	O
2	O

History	O
of	O
Present	O
Illness	O

Under	O
the	O
primary	O
care	O
exception	O
I	O
did	O
not	O
personally	O
interview	O
or	O
examine	O
the	O
patient	O
.	O

The	O
patient	O
was	O
asked	O
to	O
return	O
to	O
the	O
emergency	O
room	O
,	O
should	O
he	O
have	O
any	O
worsening	O
of	O
his	O
condition	O
or	O
develop	O
any	O
other	O
problems	O
or	O
symptoms	O
of	O
concern	O
.	O

Oropharynx	O
:	O
Normal	O
with	O
no	B-negation
erythema	O
,	O
edema	O
,	O
exudate	O
or	O
lesions	O
.	O

Family	B-subject
history	O
of	O
Stroke	O
Syndrome	O
V17	O
.	O
1	O

Musculoskeletal	O
:	O
no	B-negation
arthralgias	O
,	O
no	B-negation
joint	B-bodyloc
pain	O
and	O
no	B-negation
joint	B-bodyloc
swelling	O
.	O

Keywords	O
:	O
discharge	O
summary	O
,	O
decortication	O
,	O
cystoscopy	O
,	O
pain	O
,	O
nausea	O
,	O
vomiting	O
,	O
renal	O
cyst	O
decortication	O
,	O
renal	B-bodyloc
cell	O
carcinoma	O
,	O
robotic	O
assisted	O
,	O
renal	B-bodyloc
cyst	O
,	O
renal	O
,	O
robotic	O
,	O
laparoscopic	O
,	O
nephrectomy	O
,	O
cysts	O
,	O
cell	O
,	O
carcinoma	O
,	O
discharge	O
,	O

Allergic	O
Rhinitis	O
477	O
.	O
9	O

Plan	O
1	O
.	O

GASTROINTESTINAL	O
:	O
no	B-negation
heartburn	O
,	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
diarrhea	O
,	O
no	B-negation
constipation	O
and	O
no	B-negation
vomiting	O
.	O

Left	O
Hamstrings	O
(	O
scait	O
.	O
)	O
:	O
Normal	O
.	O

5	O
.	O

Current	O
Meds	O

History	O
of	O
Hypercholesterolemia	O
272	O
.	O
0	O

Mental	O
Status	O
:	O
A	O
mental	O
status	O
exam	O
was	O
performed	O
and	O
was	O
normal	B-labvalue
.	O

Examination	O
of	O
the	O
penis	O
:	O
Normal	B-labvalue
.	O

CARDIOVASCULAR	O

Vitals	O
UTP	O
Adult	O
Vital	O
Signs	O
[	O
Data	O
Includes	O
:	O
Current	O
Encounter	O
]	O

Respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

Physical	O
Exam	O

Male	O
Erectile	O
Disorder	O
302	O
.	O
72	O

Results	O
/	O
Assessment	O
Abnormal	O
Electrocardiogram	O
794	O
.	O
31	O

Sertraline	O
HCl	O
100	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
17Feb2014	B-temporal
)	O
to	O

Examination	O
of	O
the	O
oropharynx	O
:	O
Normal	B-labvalue

Omeprazole	O
20	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
Delayed	I-form
Release	I-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
Requested	O
for	O
:	O
17Feb2014	B-temporal
;	O
Last	O
Rx	O
:	O
17Feb2014	B-temporal
;	O
Edited	O

Carotid	O
pulses	O
:	O
Normal	B-labvalue

History	O
of	O
Present	O
Illness	O
24	O
yo	O
G5P0414	O
s	O
/	O
p	O
PTSVD	O
2	O
/	O
2	O
PTL	O
on	O
11/18/12	O
.	O

Mupirocin	O
2	B-strength
%	I-strength
External	B-form
Ointment	I-form
;	O
APPLY	O
A	O
SMALL	O
AMOUNT	O
3	B-frequency
TIMES	I-frequency
DAILY	I-frequency
AS	O
DIRECTED	O
;	O
Therapy	O
:	O
17Sep2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
08Oct2013	B-temporal
)	O
Requested	O
for	O
:	O
08Oct2013	B-temporal

History	O
of	O
Present	O
Illness	O
Symptoms	O
:	O
weight	O
change	O
,	O
but	O
no	B-negation
peripheral	O
edema	O
,	O
no	B-negation
abdominal	B-bodyloc
swelling	O
,	O
no	B-negation
urinary	O
hesitancy	O
,	O
no	B-negation
dysuria	O
,	O
no	B-negation
flank	B-bodyloc
pain	O
,	O
no	B-negation
hematuria	O
,	O
no	B-negation
malaise	O
,	O
no	B-negation
anorexia	O
,	O
no	B-negation
fever	O
and	O
no	B-negation
visual	O
acuity	O
loss	O
.	O

Lyrica	O
CAPS	B-form

Her	O
symptoms	O
are	O
caused	O
by	O
no	O
known	O
event	O
.	O

Never	O
A	O
Smoker	O

discussed	O
the	O
possibility	O
of	O
lotrel	O
causing	O
the	O
cough	O

No	B-negation
skin	B-bodyloc
lesions	O
and	O
no	B-negation
lump	O
under	O
the	O
skin	B-bodyloc
.	O
eg	O

Musculoskeletal	O
:	O
joint	B-bodyloc
pain	O
(	O
SEE	O
HPI	O
)	O
,	O
but	O
no	B-negation
limb	B-bodyloc
pain	O
and	O
no	B-negation
limb	B-bodyloc
swelling	O
.	O

[	O
QLH	O
]	O
CMP	O
W	O
/	O
EGFR	O
Done	O
:	O
25Sep2013	B-temporal
12	B-temporal
:	I-temporal
14PM	I-temporal

He	O
also	O
reports	O
an	O
associated	O
mild	B-severity
SOB	O
.	O

Red	O
Cell	O
Diameter	O
Width	O
13	B-labvalue
.	I-labvalue
8	I-labvalue
%	I-labvalue
11	B-reference_range
.	I-reference_range
5	I-reference_range
-	I-reference_range
14	I-reference_range
.	I-reference_range
5	I-reference_range

Counseled	O
patient	O
that	O
she	O
needs	O
to	O
consider	O
psychiatry	O
or	O
psychology	O
evaluation	O
.	O

[	O
QL	O
]	O
COMPREHENSIVE	O
METABOLIC	O
PANEL	O
W	B-negation
/	I-negation
O	I-negation
eGFR	O
Requested	O
for	O
:	O
05Apr2013	B-temporal

Abdomen	O

[	O
QLH	O
]	O
CMP	O
Requested	O
for	O
:	O
23Feb2011	B-temporal

History	O
of	O
Pulmonary	B-bodyloc
Vein	I-bodyloc
Stenosis	O
747	O
.	O
49	O

[	O
QLH	O
]	O
CMP	O
W	O
/	O
EGFR	O
23Feb2012	B-temporal
09	B-temporal
:	I-temporal
45AM	I-temporal
Hardwicke	O
,	O
Robin	O

RTC	O
4	B-temporal
weeks	I-temporal
.	O

Mood	O
Disorder	O
Of	O
Unknown	O
(	O
Axis	O
III	O
)	O
Etiology	O
293	O
.	O
83	O

2	O
.	O

CREATININE	O
0	B-labvalue
.	I-labvalue
65	I-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
0	B-reference_range
.	I-reference_range
50	I-reference_range
-	I-reference_range
0	I-reference_range
.	I-reference_range
99	I-reference_range

Immunizations	O

No	B-negation
associated	O
symptoms	O
are	O
reported	O
.	O

Musculoskeletal	O
:	O
no	B-negation
arthralgias	O
,	O
no	B-negation
joint	B-bodyloc
pain	O
,	O
no	B-negation
joint	B-bodyloc
swelling	O
,	O
no	B-negation
joint	B-bodyloc
stiffness	O
,	O
no	B-negation
limb	B-bodyloc
pain	O
and	O
no	B-negation
limb	B-bodyloc
swelling	O
.	O

Sensory	O
:	O
no	B-negation
sensory	O
abnormalities	O
were	O
noted	O
.	O

Review	O
of	O
Systems	O

Navy	O
,	O
aviation	O
maintenance	O
supervisor	O

4	O
.	O

Test	O
Name	O
Result	O
Flag	O
Reference	O
Free	O
Thyroxine	O
Index	O
3	B-labvalue
.	I-labvalue
0	I-labvalue
1	B-reference_range
.	I-reference_range
2	I-reference_range
-	I-reference_range
4	I-reference_range
.	I-reference_range

INDICATION	O
:	O
Bronchospasm	O

Requested	O
for	O
:	O
24Apr2013	B-temporal
;	O
Last	O
Rx	O
:	O
24Apr2013	B-temporal
;	O
Status	O
:	O
ACTIVE	O
-	O
Retrospective	O
Authorization	O

Follow	O
up	O
for	O
the	O
generalized	O
dystonia	O
and	O
jaw	B-bodyloc
opening	O
dystonia	O
;	O
DBS	O
therapy	O
.	O

Lips	O
,	O
teeth	O
,	O
and	O
gums	O
:	O
Normal	O
.	O

There	O
were	O
no	B-negation
thyroid	B-bodyloc
nodules	O
.	O

No	B-negation
FHX	B-subject
of	O
CAD	O

CC	O
:	O
John	O
Kirkwood	O
,	O
MD	O

Description	O
:	O
Discharge	O
summary	O
of	O
patient	O
with	O
leiomyosarcoma	O
and	O
history	O
of	O
pulmonary	B-bodyloc
embolism	O
,	O
subdural	B-bodyloc
hematoma	O
,	O
pancytopenia	O
,	O
and	O
pneumonia	O
.	O

Babinski	O
reflex	O
absent	B-labvalue
on	I-labvalue
the	I-labvalue
right	I-labvalue
and	O
absent	B-labvalue
on	I-labvalue
the	I-labvalue
left	I-labvalue
.	O

Auscultation	O
of	O
lungs	O
:	O
Normal	O
.	O

Chief	O
Complaint	O

Eyes	O
:	O
no	B-negation
eyesight	O
problems	O
.	O

Review	O
of	O
Systems	O

PAM	O
WATKINS	O
a	O
57	O
female	O
presents	O
today	O
with	O
no	O
complaints	O
.	O

Cranial	O
Nerve	O
II	O
:	O
visual	O
acuity	O
and	O
visual	O
fields	O
were	O
intact	B-labvalue
.	O

Discussion	O
/	O
Attending	O
Note	O

Electronically	O
signed	O
by	O
:	O
PAMELA	O
PROMECENE	O
-	O
COOK	O
,	O
M	O
.	O
D	O
.	O

-	O
Benign	O
serous	O
cystadenoma	O
.	O

Ordered	O
mammogram	O
and	O
left	O
breast	O
US	O

Lymphatics	O
:	O
no	B-negation
adenopathy	O
.	O

Lower	B-bodyloc
Back	I-bodyloc
Pain	O
724	O
.	O
2	O

Nasal	O
mucosa	O
,	O
septum	O
,	O
and	O
turbinates	O
:	O
Normal	O
.	O

Allergies	O
Morphine	O
Derivatives	O

He	O
has	O
fund	O
of	O
knowledge	O
regarding	O
current	O
events	O
,	O
has	O
fund	O
of	O
knowledge	O
regarding	O
past	O
history	O
,	O
has	O
fund	O
of	O
knowledge	O
regarding	O
vocabulary	O
.	O

THE	O
PAIN	O
IN	O
THE	O
LEFT	B-bodyloc
HIP	I-bodyloc
IS	O
PULSATING	O
.	O

[	O
QL	O
]	O
VITAMIN	O
B12	O
/	O
FOLATE	O
,	O
SERUM	O
PANEL	O
Requested	O
for	O
:	O
29Oct2012	B-temporal

Mucinex	O
TBCR	O
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
16Nov2012	B-temporal
)	O
to	O

pt	O
is	O
here	O
to	O
see	O
Dr	O
.	O
Ingram	O
for	O
a	O
follow	O
up	O

Female	O
.	O

Cranial	O
Nerve	O
XII	O
:	O
there	O
was	O
no	B-negation
tongue	B-bodyloc
deviation	O
with	O
protrusion	O
.	O

Cervicitis	O
Chlamydia	O
Trachomatis	O
099	O
.	O
53	O

History	O
of	O
Present	O
Illness	O
The	O
patient	O
is	O
being	O
seen	O
for	O
the	O
first	O
time	O
in	O
consultation	O
at	O
the	O
request	O
of	O
Dr	O
.	O
Ron	O
Moses	O
.	O

Helicobacter	O
Pylori	O
(	O
H	O
.	O

Mixed	O
Hyperlipoproteinemia	O
272	O
.	O
2	O

Description	O
of	O
patient	O
'	O
s	O
judgement	O
and	O
insight	O
:	O
Normal	B-labvalue
.	O

[	O
QLH	O
]	O
FERRITIN	O
Requested	O
for	O
:	O
22Dec2011	B-temporal

[	O
QLH	O
]	O
CMP	O
W	O
/	O
EGFR	O
Requested	O
for	O
:	O
21Mar2013	B-temporal

Fundoscopic	O
Exam	O
:	O
Normal	B-labvalue
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Cranial	O
nerves	O
:	O
Normal	O
.	O

bottle	O
feeding	O

EYES	O

General	O
appearance	O
:	O
NormalComfortable	O
,	O
well	O
hydrated	O
,	O
no	B-negation
jaundice	O
,	O
pallor	O
or	O
cyanosis	O
,	O
obese	O
.	O

DISTRESS	O
.	O

persons	O
<	O
18	O
years	O
of	O
age	O
.	O

Patent	O
appears	O
mildly	B-severity
dyspneic	O
at	O
rest	O
,	O
but	O
it	O
is	O
only	O
intermittent	B-course
.	O

She	O
has	O
no	B-negation
known	O
diabetic	O
complications	O
.	O

6	O
.	O

Otolaryngeal	O
,	O
cardiovascular	O
,	O
pulmonary	O
,	O
genitourinary	O
,	O
musculoskeletal	O
,	O
skin	O
,	O
endocrine	O
and	O
hematologic	O
review	O
of	O
systems	O
are	O
normal	O
.	O

Cardiovascular	O

Temperature	O
:	O
99	B-labvalue
F	I-labvalue
,	O
Oral	O

SKIN	O
:	O
Inspection	O
within	O
normal	B-labvalue
limits	O
.	O

The	O
patient	O
is	O
to	O
continue	O
CPM	O
machine	O
while	O
in	O
bed	O
along	O
with	O
antiembolic	O
stockings	O
.	O

Social	O
History	O
Never	O
A	O
Smoker	O

It	O
would	O
last	O
for	O
a	O
number	O
of	O
minutes	O
.	O

Surgical	O
History	O
History	O
of	O
Cataract	O
Surgery	O

Allergies	O
Coumadin	O
TABS	B-form

The	O
tongue	O
was	O
normal	O
.	O

CONSTITUTIONAL	O

Examination	O
of	O
liver	O
and	O
spleen	O
:	O
Normal	B-labvalue
.	O

Bus	O
Fax	O
:	O
713-790-6366	O

Inspection	O
of	O
the	O
conjunctiva	O
and	O
lids	O
:	O
Normal	B-labvalue
.	O

This	O
will	O
last	O
30	O
to	O
60	O
seconds	O
before	O
she	O
has	O
her	O
seizure	O
.	O

Assessment	O
_	O
80	O
_	O
twCiteListControlEnd	O
AssessmentSectionEnd	O
PlanSectionStart	O
Plan	O

Right	O
Anter	O
.	O

Bladder	O
:	O
Normal	O
.	O

HPI	O

Systemit	O
:	O
Not	B-negation
feeling	O
tired	O
or	O
poorly	O
.	O

Recommended	O
follow	O
up	O
with	O
the	O
specialist	O
in	O
6	B-temporal
months	I-temporal
.	O

Surgical	O
History	O
History	O
of	O
Inguinal	O
Hernia	O
Repair	O

-	O
HTN	O
controlled	O
-	O
continue	O
lisinopril	O
40mg	B-strength
daily	B-frequency

Klor	O
-	O
Con	O
M10	O
10	B-strength
MEQ	I-strength
Oral	B-route
Tablet	B-form
Extended	I-form
Release	I-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
09Apr2007	B-temporal
to	O
(	O
Evaluate	O
:	O
27May2013	B-temporal
)	O
Requested	O
for	O
:	O
20Jun2012	B-temporal
;	O
Last	O
Rx	O
:	O
01Jun2012	B-temporal

History	O
of	O
Edema	O
782	O
.	O
3	O

Patient	O
Specific	O
Education	O
Given	O
Done	O
:	O
09Apr2012	B-temporal

[	O
Q	O
]	O
IRON	O
,	O
TIBC	O
AND	O
FERRITIN	O
PANEL	O
Requested	O
for	O
:	O
19Mar2014	B-temporal

Ischemic	O
Stroke	O
434	O
.	O
90	O

Palpation	O
of	O
heart	O
:	O
Normal	B-labvalue

The	O
heart	O
rate	O
was	O
normal	B-labvalue
.	O

Abdomen	O

Furosemide	O
40	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
Requested	O
fis	O
:	O
07Jan2013	B-temporal
;	O
Last	O
Rx	O
:	B-temporal
07Jan2013	I-temporal

0	I-reference_range
A	O
/	O
GaRatio	O
1	B-labvalue
.	I-labvalue
0	I-labvalue
0	B-reference_range
.	I-reference_range
7	I-reference_range
-	I-reference_range
1	I-reference_range
.	I-reference_range

Cardiovascular	O

Previous	O
Pap	O
NA	O

Assessment	O
Visit	O
For	O
:	O
Postsurgical	O
Exam	O
V67	O
.	O
00	O

Nose	B-bodyloc
bleeds	O
:	O
None	B-negation

Examination	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue
The	O
neck	O
was	O
normal	O
in	O
appearanceand	O
was	O
supple	O
.	O

Ordered	O
;	O
For	O
:	O
Palpitations	O
(	O
785	O
.	O
1	O
)	O
;	O
Ordered	O
By	O
:	O
CHEN	O
,	O
YEN	O
I	O
Perform	O
:	O
LabCorp	O
Due	O
:	O
06May2013	B-temporal

Skin	O

Rotation	O
to	O
the	O
right	O
was	O
not	O
restricted	O
and	O
was	O
painful	O
.	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
vomiting	O
,	O
no	B-negation
constipation	O
and	O
no	B-negation
diarrhea	O
.	O

MA	O
Digital	O
Mammo	O
Screening	O
Bil	O
G0202	O
Requested	O
for	O
:	O
25Feb2014	B-temporal

Cap	O
refill	O
is	O
brisk	B-labvalue
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

We	O
have	O
been	O
fairly	O
aggressively	O
,	O
downwardly	O
adjusting	O
her	O
insulins	O
,	O
both	O
the	O
Lantus	O
insulin	O
,	O
which	O
we	O
had	O
been	O
giving	O
at	O
night	O
as	O
well	O
as	O
her	O
sliding	B-form
scale	I-form
Humalog	O
insulin	O
prior	O
to	O
meals	O
.	O

BMI	O
Calculated	O
:	O
21	B-labvalue
.	I-labvalue
03	I-labvalue

There	O
was	O
spasm	O
on	O
either	O
side	O
of	O
the	O
mid	B-bodyloc
line	I-bodyloc
.	O

Hematologic	O
/	O
Lymphatic	O
:	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
,	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
and	O
no	B-negation
swollen	O
glands	B-bodyloc
.	O

Hyperglycemia	O
790	O
.	O
29	O

Humira	O
Pen	B-form
-	O
Psoriasis	O
Starter	O
40	B-strength
MG	I-strength
/	I-strength
0	I-strength
.	I-strength
8ML	I-strength
Subcutaneous	B-route
Kit	O
;	O
Therapy	O
:	O
24Nov2012	B-temporal
to	O

Prior	O
pregnancies	O
:	O
.	O

Ergocalciferol	O
50000	B-dosage
UNIT	I-dosage
Oral	B-route
Capsule	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
WEEKLY	B-frequency
;	O
Therapy	O
:	O
12Oct2012	B-temporal
to	O
(	O
Evaluate	O
:	O
19Feb2013	B-temporal
)	O
Requested	O
for	O
:	O
21Dec2012	B-temporal
;	O
Last	O
Rx	O
:	O
21Dec2012	B-temporal

Uterus	O
:	O
Normal	O

Mixed	O
Hyperlipoproteinemia	O
272	O
.	O
2	O

Social	O
History	O
Alcohol	O
Use	O

Never	O
A	O
Smoker	O

Test	O
Name	O
Result	O
Flag	O
Reference	O

Right	O
Foot	O
:	O

Review	O
of	O
Systems	O

She	O
has	O
been	O
compliant	O
w	O
th	O
her	O
medicatiops	O
.	O

Associated	O
symptoms	O
:	O
general	O
malaiseandleg	O
edema	O
,	O
but	O
no	B-negation
fever	O
,	O
no	B-negation
weakness	O
,	O
no	B-negation
hemoptysis	O
,	O
no	B-negation
orthopnea	O
,	O
no	B-negation
upper	B-bodyloc
respiratory	I-bodyloc
infection	O
symptoms	O
,	O
no	B-negation
chest	B-bodyloc
pain	O
and	O
no	B-negation
altered	O
mental	O
status	O
.	O

Physical	O
Exam	O

Surgical	O
History	O
History	O
of	O
Appendectomy	O

Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

Over	O
the	O
next	O
several	O
days	O
,	O
medical	O
therapy	O
was	O
optimized	O
.	O

Respiration	O
Quality	O
:	O
Normal	B-labvalue

Abdomen	O
is	O
nondistended	O
.	O

Plan	O
Patient	O
Specific	O
Education	O
Given	O
Done	O
:	O
28Nov2012	B-temporal

Improved	O
+	O
)	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Examination	O
of	O
the	O
abdomen	O
:	O
Normal	B-labvalue
.	O
Soft	O
,	O
non	O
-	O
tender	O
,	O
non	O
-	O
distended	O
,	O
no	B-negation
rebound	O
,	O
no	B-negation
guarding	O
.	O

Edema	O
:	O
Normal	O
(	O
not	B-negation
present	I-negation
)	O
.	O

3	O
.	O

Vicodin	O
TABS	B-form

At	O
peak	O
exercise	O
,	O
EKG	O
showed	O
1	O
-	O
1	O
.	O
5mm	O
of	O
horizontal	O
ST	O
segment	O
depression	O
in	O
II	O
and	O
lateral	O
leads	O
.	O

Vitamin	O
E	O
CAPS	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
15Nov2012	B-temporal
)	O
to	O

MRI	O
showed	O
inflammation	O
and	O
was	O
thought	O
to	O
be	O
secondary	O
to	O
rheumatoid	O
arthritis	O
.	O

Social	O
History	O
Being	O
A	O
Social	O
Drinker	O

Motor	O
Survey	O
:	O
the	O
motor	O
survey	O
was	O
normal	B-labvalue
.	O

Constitutional	O

TEMPORARY	O
DEFERRAL	O
-	O
Out	O
of	O
Supplies	O

Breath	O
sounds	O
were	O
not	B-negation
diminished	B-labvalue
.	O

Sensory	O
exam	O
intact	B-labvalue
to	O
light	O
touch	O
,	O
pain	O
and	O
temperature	O
sensation	O
.	O

Physical	O
Exam	O

Palpation	O
of	O
the	O
face	O
and	O
sinuses	O
:	O
Normal	B-labvalue
.	O

Family	O
History	O
Family	B-subject
history	O
of	O
Acute	B-course
Myocardial	B-bodyloc
Infarction	O
V17	O
.	O
3	O

Due	O
for	O
:	O
thyroid	O
stimulating	O
hormone	O
and	O
lipid	O
profile	O
.	O

Blood	O
pressure	O
was	O
repeated	O
143	B-labvalue
/	I-labvalue
85	I-labvalue
,	O
patient	O
not	B-negation
taken	O
blood	O
pressue	O
medication	O
today	O
and	O
reportedly	O
blood	O
pressure	O
has	O
been	O
stable	O
at	O
120s	B-labvalue
/	I-labvalue
80s	I-labvalue
,	O
medication	O
refilled	O
.	O

Fourth	O
pregnancy	O
:	O

Age	O
at	O
menarche	O
was	O
16	O
.	O

Electronically	O
signed	O
by	O
:	O
SUUR	O
BILICILER	O
,	O
M	O
.	O
D	O
.	O

Pedal	O
pulses	O
:	O
Normal	B-labvalue

Examination	O
of	O
sensation	O
:	O
Abnormal	O
.	O

Prediabetes	O
790	O
.	O
29	O

BMI	O
Calculated	O
:	O
42	B-labvalue
.	I-labvalue
33	I-labvalue

Eyes	O
:	O
no	B-negation
eye	B-bodyloc
pain	O
,	O
eyes	B-bodyloc
not	B-negation
red	O
,	O
no	B-negation
eyesight	O
problems	O
,	O
no	B-negation
purulent	O
discharge	O
from	O
the	O
eyes	B-bodyloc
,	O
no	B-negation
dryness	O
of	O
the	O
eyes	B-bodyloc
and	O
no	B-negation
itching	O
of	O
the	O
eyes	B-bodyloc
.	O

Head	O
and	O
face	O
:	O
Normocephalic	O
;	O
atraumatic	O
.	O

No	B-negation
masses	O
palpated	O
in	O
the	O
left	B-bodyloc
breast	I-bodyloc
.	O

Patient	O
has	O
no	B-negation
history	O
of	O
sexually	O
transmitted	O
infection	O
.	O
No	B-negation
history	O
of	O
pelvic	B-bodyloc
inflammatory	O
disease	O
.	O

Heart	O
sounds	O
:	O
normal	B-labvalue
S1	O
,	O
normal	B-labvalue
S2	O
,	O
no	B-negation
S3	O
and	O
no	B-negation
S4	O
.	O

His	O
memory	O
was	O
unimpaired	O
.	O

Current	O
Meds	O
g3	O

Systemic	O
Lupus	O
Erythematosus	O
710	O
.	O
0	O

DISCONTINUED	O

Assessment	O
Hypertension	O
401	O
.	O
9	O

The	O
rhythm	O
was	O
regular	B-labvalue
.	O

Taking	O
High	O
-	O
risk	O
Medication	O
V58	O
.	O
69	O

History	O
of	O
Cholecystectomy	O

He	O
was	O
therefore	O
referred	O
for	O
cardiac	O
surgical	O
intervention	O
.	O

follow	O
up	O
on	O
test	O
results	O

Co	O
Q	O
10	O
100	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
Therapy	O
:	O
13Jun2011	B-temporal
to	O

Never	O
A	O
Smoker	O

Complications	O
:	O
None	B-negation
.	O

Social	O
History	O
Never	O
A	O
Smoker	O

Med	O
refills	O

Will	O
hold	O
Vit	O
D	O
therapy	O
for	O
now	O

Benign	O
Essential	O
Hypertension	O
401	O
.	O
1	O

Third	O
pregnancy	O
:	O

breast	O
feeding	O
+	O
supplementing	O
.	O

Patients	O
with	O
extremes	O
in	O
muscle	B-bodyloc
mass	O
or	O
diet	O
.	O

Medications	O
:	O
Medication	O
(	O
s	O
)	O
:	O
a	O
calcium	O
channel	O
blocker	O
.	O

Active	O
Problems	O
Adult	O
Sleep	O
Apnea	O
780	O
.	O
57	O

[	O
QLH	O
]	O
HEMOGLOBIN	O
Done	O
:	O
21Sep2010	B-temporal
11	B-temporal
:	I-temporal
52AM	I-temporal

History	O
of	O
Hypertension	O
401	O
.	O
9	O

Assessment	O
of	O
respiratory	O
effort	O
was	O
significant	O
for	O
normal	B-labvalue
respiratory	O
rhythm	O
and	O
effort	O
.	O

Inspection	O
/	O
palpation	O
of	O
joints	O
,	O
bones	O
,	O
and	O
muscles	O
:	O
Normal	B-labvalue
.	O

[	O
QLH	O
]	O
LIPID	O
PANEL	O
Requested	O
for	O
:	O
14Oct2013	B-temporal

Constitutional	O

2	O
.	O

Immunizations	O

Full	O
range	O
of	O
motion	O
without	B-negation
pain	O
.	O

The	O
knee	O
condition	O
was	O
appropriately	O
treated	O
with	O
different	O
oral	B-route
NSAIDs	O
such	O
as	O
Celebrex	O
and	O
Mobic	O
.	O

another	O
pill	O
prn	O
.	O

Examination	O
of	O
the	O
abdomen	O
:	O
Normal	B-labvalue
.	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
axillae	O
:	O
Normal	B-labvalue
.	O

Sensory	O
:	O
no	B-negation
sensory	O
abnormalities	O
were	O
noted	O
.	O

Examination	O
of	O
the	O
neck	O
:	O
Abnormal	O
The	O
neck	B-bodyloc
had	O
a	O
buffalo	O
hump	O
.	O

Reassure	O
patient	O
that	O
the	O
"	O
nodule	O
"	O
she	O
feels	O
is	O
her	O
grasping	O
her	O
subcutaneous	O
fat	O
under	O
her	O
neck	O
.	O

Motions	O
seem	O
to	O
be	O
a	O
trigger	O
especially	O
riding	O
elevators	O
.	O

No	B-negation
guarding	O
.	O

s	O
/	O
p	O
repeat	O
c	O
/	O
s	O
-	O
wound	O
healing	O
well	O
,	O
staples	O
removed	O

Const	O
:	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
were	O
reported	O
,	O
no	B-negation
loss	O
of	O
weight	O
was	O
noted	O
,	O
no	B-negation
weight	O
gain	O
and	O
does	O
not	B-negation
tire	O
easily	O
.	O

Examination	O
of	O
external	O
genitalia	O
and	O
vagina	O
:	O
Normal	B-labvalue

The	O
patient	O
presents	O
with	O
complaints	O
of	O
constipation	O
(	O
From	O
FE	O
tabs	O
)	O
.	O

Motor	O
Survey	O
:	O
the	O
motor	O
survey	O
was	O
normal	B-labvalue
.	O

Review	O
of	O
Systems	O

There	O
was	O
a	O
negative	O
Murphy	O
'	O
s	O
signandnegative	O
psoas	O
sign	O
.	O

Medications	O
on	O
Admission	O
:	O

Pap	O
Source	O
Cervix	O

Respiratory	O
rate	O
:	O
the	O
respiratory	O
rate	O
was	O
normal	B-labvalue
.	O

Psychologatal	O
:	O
No	B-negation
hyperactive	O
behavior	O
.	O

swelling	O
.	O

Vitals	O
17Feb2014	B-temporal
11	B-temporal
:	I-temporal
26AM	I-temporal
BMI	O
Calculated	O
23	B-labvalue
.	I-labvalue
47	I-labvalue
BSA	O
Calculated	O
1	B-labvalue
.	I-labvalue
75	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
6	I-labvalue
in	I-labvalue
Weight	O
146	B-labvalue
lb	I-labvalue
Systolic	O
115	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
78	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Temperature	O
97	B-labvalue
.	I-labvalue
7	I-labvalue
F	I-labvalue
,	O
Tympanic	O
Heart	O
Rate	O
73	B-labvalue
Respiration	O
16	B-labvalue
LMP	O
MENO	O

Observed	O
mood	O
and	O
affect	O
:	O
appropriate	O
affectandappropriate	O
mood	O
.	O

Feeding	O
amounts	O
at	O
the	O
time	O
of	O
discharge	O
was	O
between	O
35	O
to	O
50	O
mL	O
per	O
feed	O
and	O
weight	O
was	O
1797	B-labvalue
grams	I-labvalue
.	O

History	O
of	O
Drug	O
Use	O

Psychiatric	O
:	O
not	B-negation
suicidal	O
,	O
no	B-negation
sleep	O
disturbances	O
,	O
no	B-negation
anxiety	O
and	O
no	B-negation
personality	O
change	O
.	O

Adnexa	O
Findings	O
:	O
cuff	B-labvalue
intact	I-labvalue
on	O
bimanual	O
exam	O
.	O

No	B-negation
masses	O
.	O

[	O
QLH	O
]	O
TESTOSTERONE	O
,	O
FREE	O
AND	O
TOTAL	O
,	O
LC	O
/	O
MS	O
/	O
MS	O
Requested	O
for	O
:	O
14Oct2013	B-temporal

GU	O
:	O
left	B-bodyloc
flank	I-bodyloc
pain	O
.	O

History	O
of	O
Drug	O
Use	O

Constitutional	O

Vocal	B-bodyloc
Cord	I-bodyloc
Disorder	O
478	O
.	O
5	O

Paternal	B-subject
history	O
of	O
Prostate	B-bodyloc
Cancer	O
V16	O
.	O
42	O

Hyperlipidemia	O
272	O
.	O
4	O

Percussion	O
of	O
chest	O
:	O
Normal	B-labvalue
.	O

Genitourinary	O
:	O
no	B-negation
dysuria	O
,	O
no	B-negation
incontinence	O
,	O
no	B-negation
urinary	O
hesitancy	O
,	O
no	B-negation
nocturia	O
,	O
no	B-negation
genital	B-bodyloc
lesions	O
and	O
no	B-negation
testicular	B-bodyloc
pain	O
.	O

BSA	O
Calculated	O
:	O
1	B-labvalue
.	I-labvalue
8	I-labvalue

No	B-negation
fevers	O
,	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
difficulty	O
with	O
urination	O
or	O
bowel	B-bodyloc
movments	O
.	O

Heart	O
sounds	O
:	O
normal	B-labvalue
S1	O
,	O
normal	B-labvalue
S2	O
,	O
no	B-negation
S3	O
and	O
no	B-negation
S4	O
.	O

Discolored	O
nasal	B-bodyloc
discharge	O
:	O
Mild	B-severity

MA	O
Bone	O
Density	O
DXA	O
Dual	O
Energy	O
Requested	O
for	O
:	O
24Oct2012	B-temporal

Cortical	O
function	O
:	O
Normal	B-labvalue

Electronically	O
signed	O
by	O
:	O
CUIE	O
QIU	O
,	O
M	O
.	O
D	O
.	O

CAD	O
DM2	O
-	O
dx	O
'	O
d	O
about	O
7	B-temporal
years	I-temporal
ago	I-temporal
HTN	O
Hyperlipidemia	O
GERD	O

UROBILINOGEN	O
:	O
NEG	B-labvalue

;	O
Apr	B-temporal
4	I-temporal
2012	I-temporal
9	B-temporal
:	I-temporal
53AM	I-temporal
(	O
Co	O
-	O
author	O
)	O

F	O
/	O
U	O
when	O
he	O
gets	O
back	O
from	O
Michigan	O
.	O

May	O
be	O
balanitis	O
.	O

Insulin	O
dose	O
adjusted	O
.	O

Examination	O
for	O
hernias	O
:	O
Normal	B-labvalue
.	O

HgA1C	O
7	B-labvalue
.	I-labvalue
9	I-labvalue
on	O
7/9/12	B-temporal

Past	O
Medical	O
History	O
History	O
of	O
Factor	O
V	O
Leiden	O
Mutation	O
289	O
.	O
81	O

Constitutional	O
:	O
feeling	O
tired	O
(	O
fatigue	O
)	O
and	O
lethargy	O
,	O
but	O
no	B-negation
fever	O
and	O
no	B-negation
chills	O
.	O

2	O
.	O

Left	B-bodyloc
facial	I-bodyloc
weakness	O
HB	O
2	O
/	O
6	O
.	O

2	O
.	O

Chief	O
Complaint	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
LESLIE	O
GARB	O
,	O
M	O
.	O
D	O
.	O

Age	O
:	O
9	O
month	O
old	O

Eyes	O
:	O
no	B-negation
eyesight	O
problems	O
.	O

Mother	O
has	O
been	O
administering	O
patient	O
ciprodex	O
4	B-dosage
drops	B-form
affected	B-route
right	I-route
ear	I-route
in	B-frequency
the	I-frequency
morning	I-frequency
and	I-frequency
in	I-frequency
the	I-frequency
evening	I-frequency
.	O

Vitals	O
24Feb2014	B-temporal
03	B-temporal
:	I-temporal
12PM	I-temporal
24Feb2014	B-temporal
02	B-temporal
:	I-temporal
32PM	I-temporal
BMI	O
Calculated	O
25	B-labvalue
.	I-labvalue
6	I-labvalue
BSA	O
Calculated	O
1	B-labvalue
.	I-labvalue
85	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
7	I-labvalue
in	I-labvalue
Weight	O
163	B-labvalue
lb	I-labvalue
2	I-labvalue
oz	I-labvalue
Systolic	O
130	B-labvalue
170	I-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
70	B-labvalue
96	I-labvalue
,	O
LUE	O
,	O
Sitting	O
Temperature	O
98	B-labvalue
.	I-labvalue
1	I-labvalue
F	I-labvalue
,	O
Oral	O
Heart	O
Rate	O
86	B-labvalue

[	O
QLH	O
]	O
CMP	O
W	O
/	O
EGFR	O
Done	O
:	O
21Mar2012	B-temporal
12	B-temporal
:	I-temporal
00AM	I-temporal

RESPIRATORY	O

States	O
baby	O
girl	O
is	O
in	O
NICU	O
due	O
to	O
pulmonary	B-bodyloc
stenosis	O
and	O
had	O
procedure	O
to	O
dilate	O
valve	O
however	O
now	O
has	O
a	O
cyanotic	O
leg	B-bodyloc
on	O
the	O
side	O
the	O
procedure	O
was	O
performed	O
and	O
is	O
being	O
worked	O
up	O
for	O
that	O
.	O

History	O
of	O
Alcohol	O
Use	O

2	O

Inspection	O
of	O
the	O
nasal	O
mucosa	O
,	O
septum	O
and	O
turbinates	O
:	O
Normal	B-labvalue
.	O

-	O
echo	O
is	O
Nl	B-labvalue

Patient	O
continues	O
to	O
recover	O
well	O
.	O

Heart	O
sounds	O
:	O
normal	B-labvalue
S1	O
,	O
normal	B-labvalue
S2	O
,	O
no	B-negation
S3	O
and	O
no	B-negation
S4	O
.	O

;	O
Feb	B-temporal
10	I-temporal
2014	I-temporal
9	B-temporal
:	I-temporal
45AM	I-temporal
(	O
Author	O
)	O

Involuntary	O
Movements	O
:	O
no	B-negation
involuntary	O
movements	O
were	O
seen	O
.	O

Male	O
.	O

Inspection	O
of	O
the	O
nasal	O
mucosa	O
,	O
septum	O
and	O
turbinates	O
:	O
Normal	B-labvalue
.	O

Physical	O
Exam	O

Patient	O
states	O
that	O
he	O
was	O
told	O
his	O
pulse	O
ox	O
in	O
Tier	O
was	O
86	B-labvalue
.	O

Endocrine	O
:	O
erectile	O
dysfunction	O
,	O
but	O
no	B-negation
muscle	B-bodyloc
weakness	O
.	O

IF	O
HE	O
EATS	O
TOO	O
LATE	O
RESPONDS	O
TO	O
PREVACID	O
)	O
.	O

We	O
will	O
mail	O
in	O
his	O
disability	O
papers	O
and	O
we	O
will	O
see	O
him	O
back	O
in	O
2	B-temporal
months	I-temporal
.	O

She	O
takes	O
Advil	O
prn	B-frequency

Abdomen	O

Allergies	O
Penicillins	O

-	O
Greatest	O
thickness	O
of	O
tumor	O
is	O
1	B-labvalue
.	I-labvalue
0	I-labvalue
cm	I-labvalue
and	O
is	O
entirely	O
intraluminal	B-labvalue
.	O

Sororal	B-subject
history	O
of	O
Thyroid	B-bodyloc
Disorder	O
V18	O
.	O
19	O

DISCHARGE	O
DIAGNOSES	O
:	O
Right	B-bodyloc
tibial	I-bodyloc
plateau	I-bodyloc
fracture	O
and	O
also	O
medial	O
meniscus	O
tear	O
on	O
the	O
right	O
side	O
.	O

Optic	O
Discs	O
:	O
the	O
optic	O
discs	O
were	O
normal	O
,	O
no	B-negation
papilledema	O
was	O
observed	O
and	O
the	O
discs	O
margins	O
were	O
sharp	O
in	O
both	O
eyes	O
.	O

Mupirocin	O
Powder	B-form
;	O
COMPOUND	O
:	O
Mupirocin	O
20mg	B-strength
Capsule	B-form
.	O

Screening	O
:	O
Cervical	O
cancer	O
screening	O
includes	O
Papanicolaou	O
cytology	O
last	O
yearandhuman	O
papilloma	O
virus	O
screening	O
last	B-temporal
year	I-temporal
.	O

SKIN	O
:	O
No	B-negation
rash	O
,	O
lesions	O
or	O
color	O
change	O
HEENT	O
:	O
Normrl	O
external	O
ear	O
canals	O
and	O
tympanic	O
membranes	O
bilateraily	O
.	O

Female	O
Pelvic	B-bodyloc
Pain	O
625	O
.	O
9	O

Fluticasone	O
Propionate	O
50	B-strength
MCG	I-strength
/	I-strength
ACT	I-strength
Nasal	B-route
Suspension	B-form
;	O
USE	O
2	B-dosage
SPRAYS	B-form
IN	O
EACH	B-route
NOSTRIL	I-route
ONCE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
20Aug2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
20Aug2013	B-temporal
)	O
Requested	O
for	O
:	O
20Aug2013	B-temporal

Palpation	O
of	O
the	O
face	O
for	O
sinus	B-bodyloc
tenderness	O
:	O
No	B-negation
maxillary	B-bodyloc
tenderness	O
.	O

Lips	O
,	O
teeth	O
,	O
and	O
gums	O
:	O
Normal	O
,	O
good	O
dentition	O
.	O

Diabetic	O
Peripheral	O
Neuropathy	O
357	O
.	O
2	O

Allergies	O
1	O
.	O

Gestational	O
age	O
:	O
32	O
weeks	O
.	O

Palpation	O
of	O
chest	O
:	O
Noamal	B-labvalue
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

A	O
/	O
G	O
Ratio	O
:	O
1	B-labvalue
.	I-labvalue
6	I-labvalue
Reference	O
Range	O
1	B-reference_range
.	I-reference_range
1	I-reference_range
-	I-reference_range
2	I-reference_range
.	I-reference_range
5	I-reference_range

Peripheral	O
vascular	O
exam	O
:	O
Normal	B-labvalue

Scope	O
:	O
3	O
mm	O
45	O
degree	O
telescopeand4	O
mm	O
30	O
degree	O
telescope	O
.	O

PredniSONE	O
20	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
3	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
04Aug2011	B-temporal
to	O
(	O
Evaluate	O
:	O
02Nov2011	B-temporal
)	O
;	O
Last	O
Rx	O
:	O
04Aug2011	B-temporal
;	O
Status	O
:	O
UNAUTHORIZED	O
-	O
Requires	O
Signature	O

CONSTITUTIONAL	O
:	O
The	O
patient	O
is	O
well	O
nourished	O
and	O
well	O
developed	O
.	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
LOURICE	O
ABDELMELEK	O
,	O
M	O
.	O
D	O
.	O

Pregnancy	O
-	O
induced	O
Hypertension	O
642	O
.	O
90	O

General	O
appearance	O
:	O
AbnormalOverweight	O
.	O

Type	O
1	O
Diabetes	O
Mellitus	O
250	O
.	O
01	O

Otoscopic	O
examination	O
:	O
Normal	B-labvalue
.	O
Bilateral	O
cerumen	O
impaction	O
;	O
Right	O
tubes	O
are	O
in	O
place	O
,	O
patent	O
,	O
and	O
dry	O
;	O
Left	O
tube	O
is	O
in	O
place	O
,	O
and	O
wet	O
.	O

Exam	O
benign	O
,	O
patient	O
stable	O
,	O
no	B-negation
warning	O
signs	O
,	O

Assessment	O
of	O
range	O
of	O
motion	O
:	O
Normal	B-labvalue
.	O

HEAD	O
AND	O
FACE	O

Mentax	O
1	B-strength
%	I-strength
External	B-form
Cream	I-form
;	O
APPLY	O
SPARINGLY	O
TO	O
AFFECTED	O
AREA	O
(	O
S	O
)	O
ONCE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
11Nov2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
11Nov2013	B-temporal
)	O
Requested	O
for	O
:	O
11Nov2013	B-temporal

Strength	O
Testing	O
:	O
Normal	O
strength	O
examination	O
.	O

Reason	O
For	O
Visit	O

or	O
a	O
specimen	O
was	O
not	O
available	O
from	O
your	O
office	O
.	O

Appropriate	B-labvalue
skin	O
color	O
and	O
pigmentation	O
.	O

She	O
denies	B-negation
that	O
the	O
tingling	O
is	O
painful	O
.	O

Examination	O
of	O
the	O
chest	O
:	O
Normal	B-labvalue
.	O

Results	O
/	O
Discussion	O
/	O
Discussion	O
/	O
Summary	O
1	O
.	O

Eyes	O

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

Desires	O
flu	O
vaccine	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
axillae	O
:	O
Normal	B-labvalue
.	O

Hearing	O
:	O
Abnormal	O
.	O

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

5	I-reference_range
Whi	O
e	O
Blood	O
Crll	O
5	B-labvalue
.	I-labvalue
8	I-labvalue
K	I-labvalue
/	I-labvalue
CMM	I-labvalue
3	B-reference_range
.	I-reference_range
7	I-reference_range
-	I-reference_range
10	I-reference_range
.	I-reference_range

History	O
of	O
Hypertension	O
401	O
.	O
9	O

History	O
of	O
Present	O
Illness	O

The	O
last	O
health	O
maintenance	O
visit	O
was	O
1	B-temporal
year	I-temporal
(	I-temporal
s	I-temporal
)	I-temporal
ago	I-temporal
.	O

History	O
of	O
Thrombophlebitis	O
Of	O
Deep	B-bodyloc
Vessels	I-bodyloc
Of	O
The	O
Lower	B-bodyloc
Extremity	I-bodyloc
V12	O
.	O
51	O

He	O
did	O
tend	O
to	O
get	O
a	O
panic	O
sensation	O
.	O

Electronically	O
signed	O
by	O
:	O
SAMER	O
FAKHRI	O
,	O
M	O
.	O
D	O
.	O

The	O
tongue	O
was	O
normal	O
.	O

Clinical	O
Info	O
NA	O

I	O
will	O
see	O
the	O
patient	O
back	O
for	O
followup	O
in	O
9	O
weeks	O
'	O
time	O
and	O
sooner	O
if	B-condition
there	O
are	O
any	O
new	B-course
neurologic	O
problems	O
.	O

Results	O
/	O
Results	O
/	O
Data	O

OG	O
tube	O
was	O
passed	O
.	O

Headaches	O
lasts	O
only	O
a	O
few	O
minutes	O
and	O
self	O
resolve	O
.	O

Risk	O
and	O
benefits	O
were	O
discussed	O
with	O
the	O
patient	O
.	O

No	B-negation
rhonchi	O
were	O
heard	O
.	O

Complications	O
:	O
peripheral	B-bodyloc
neuropathy	O
(	O
The	O
neuropathy	O
began	O
as	O
tingling	O
in	O
her	O
toes	B-bodyloc
approximately	O
6	B-temporal
weeks	I-temporal
ago	I-temporal
that	O
has	O
now	O
progressed	O
to	O
numbness	O
in	O
her	O
feet	B-bodyloc
and	O
tingling	O
in	O
her	O
legs	B-bodyloc
.	O

Facial	B-bodyloc
or	O
sinus	B-bodyloc
pain	O
:	O
Moderate	B-severity

Neurologic	O

Family	O
History	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
vomiting	O
,	O
no	B-negation
nausea	O
,	O
no	B-negation
constipation	O
,	O
no	B-negation
diarrhea	O
,	O
no	B-negation
melena	O
and	O
no	B-negation
heartburn	O
.	O

Neurological	O
:	O
no	B-negation
fainting	O

Description	O
:	O
Respiratory	B-bodyloc
distress	O
syndrome	O
,	O
intrauterine	B-bodyloc
growth	O
restriction	O
,	O
thrombocytopenia	O
,	O
hypoglycemia	O
,	O
retinal	B-bodyloc
immaturity	O
.	O

4	O
.	O

History	O
of	O
Present	O
Illness	O
The	O
patient	O
is	O
being	O
seen	O
for	O
a	O
routine	O
clinic	O
follow	O
-	O
up	O
of	O
essential	O
hypertension	O
.	O

Hyperlipidemia	O
272	O
.	O
4	O

pt	O
is	O
here	O
to	O
see	O
Dr	O
.	O
Moreno	O
for	O
physical	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
,	O
no	B-negation
cough	O
,	O
no	B-negation
shortness	O
of	O
breath	O
during	O
exertion	O
,	O
no	B-negation
orthopnea	O
and	O
no	B-negation
PND	O
.	O

Second	O
pregnancy	O
:	O
.	O

No	B-negation
fevers	O
,	O
vomiting	O
,	O
diarrhea	O
,	O
fussiness	O
.	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

Mood	O
and	O
Affect	O
:	O
appropriate	B-labvalue
mood	I-labvalue
and	I-labvalue
appropriate	I-labvalue
affect	I-labvalue
.	O

MCV	O
91	B-labvalue
.	I-labvalue
6	I-labvalue
fL	I-labvalue
80	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
100	I-reference_range
.	I-reference_range
0	I-reference_range

Pulmonary	O

I	O
was	O
physically	O
present	O
for	O
laryngoscopy	O
(	O
scopy	O
insertion	O
/	O
removal	O
)	O
.	O

Mastodynia	O
Of	O
The	O
Left	B-bodyloc
Breast	I-bodyloc
611	O
.	O
71	O

Electronically	O
signed	O
by	O
:	O
YEZAZ	O
GHOURI	O
,	O
M	O
.	O
D	O
.	O

Allergic	O
Rhinitis	O
477	O
.	O
9	O

Neurological	O
:	O
patient	O
is	O
alertandheadache	O
.	O

Current	O
Meds	O
Butalbital	O
-	O
ASA	O
-	O
Caffeine	O
50-325-40	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
EVERY	B-frequency
4	I-frequency
HOURS	I-frequency
AS	B-frequency
NEEDED	I-frequency
;	O
Therapy	O
:	O
08Oct2008	B-temporal
to	O
(	O
Evaluate	O
:	O
06Oct2013	B-temporal
)	O
Requested	O
for	O
:	O
09Apr2013	B-temporal
;	O
Last	O

History	O
of	O
Red	O
Blood	O
In	O
Bowel	B-bodyloc
Movement	O
(	O
Hematochezia	O
)	O
578	O
.	O
1	O

He	O
has	O
not	O
been	O
checking	O
his	O
BP	O
at	O
home	O
.	O

Hal	O
.	O

Simvastatin	O
40	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
AT	I-frequency
BEDTIME	I-frequency
;	O
Therapy	O
:	O
26Mar2012	B-temporal
to	O
(	O
Evaluate	O
:	O
30Oct2012	B-temporal
)	O
Requested	O
for	O
:	O
02Jul2012	B-temporal
;	O
Last	O
Rx	O
:	O
02Jul2012	B-temporal
;	O
Edited	O

Physical	O
Exam	O

Chief	O
Complaint	O

AF	O
is	O
soft	O
and	O
flat	O
.	O

Abdomen	O
:	O
Non	O
-	O
tender	O
,	O
no	B-negation
masses	O
.	O

No	O
changes	O
in	O
management	O
were	O
made	O
at	O
the	O
last	O
visit	O
.	O

2	O
.	O

Arthrodesis	O
with	O
anterior	O
interbody	O
fusion	O
C4	O
-	O
C5	O
,	O
C5	O
-	O
C6	O
,	O
and	O
C6	O
-	O
C7	O
.	O

Abdomen	O

Palpation	O
of	O
breasts	O
and	O
axillae	O
:	O
Normal	B-labvalue

The	O
eGFR	O
declines	O
with	O
age	O
.	O

Social	O
History	O

Diastolic	O
:	O
76	B-labvalue
,	O
RUE	O
,	O
Sitting	O

Past	O
Medical	O
History	O
History	O
of	O
Abnormal	O
Liver	B-bodyloc
Function	O
Test	O
790	O
.	O
6	O

Patients	O
pain	O
appears	O
to	O
be	O
in	O
the	O
distribution	O
of	O
his	O
IT	B-bodyloc
band	I-bodyloc
.	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
,	O
no	B-negation
cough	O
,	O
no	B-negation
orthopnea	O
and	O
no	B-negation
PND	O
.	O

Current	O
Meds	O
Digoxin	O
0	B-strength
.	I-strength
25	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
05Sep2012	B-temporal
to	O

Delivery	O
type	O
:	O
vaginal	O
.	O

Penicillins	O

SEIZURE	O
SEMIOLOGY	O
:	O
She	O
has	O
an	O
aura	O
,	O
where	O
she	O
feels	O
her	O
head	B-bodyloc
spin	O
and	O
ringing	O
in	O
the	O
ears	B-bodyloc
.	O

Temperature	O
:	O
98	B-labvalue
.	I-labvalue
1	I-labvalue
F	I-labvalue
,	O
Oral	O

Assessment	O
of	O
stability	O
:	O
Normal	B-labvalue
.	O

FR	O
/	O
FS	O
:	O
PolypoidandPolyps	O

Monocytes	O
#	O
0	B-labvalue
.	I-labvalue
3	I-labvalue
K	I-labvalue
/	I-labvalue
CMM	I-labvalue
0	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
0	I-reference_range
.	I-reference_range
8	I-reference_range

Neurological	O
:	O
no	B-negation
dizziness	O
and	O
no	B-negation
fainting	O
.	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
,	O
no	B-negation
cough	O
and	O
no	B-negation
shortness	O
of	O
breath	O
during	O
exertion	O
.	O

713-807-8491	O

Palpation	O
of	O
chest	O
:	O
Normal	B-labvalue
.	O

BUN	O
:	O
19	B-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue
Reference	O
Range	O
6	B-reference_range
-	I-reference_range
24	I-reference_range

Parents	O
state	O
for	O
the	O
first	O
1	O
-	O
2	O
days	O
following	O
re	O
-	O
charging	O
,	O
jaw	B-bodyloc
dystonia	O
appears	O
mildly	B-course
worsened	I-course
but	O
improves	O
once	O
charge	O
is	O
at	O
75	O
%	O
of	O
capacity	O
.	O

Constitutional	O
:	O
feeling	O
poorly	O
(	O
malaise	O
)	O
and	O
feeling	O
tired	O
(	O
fatigue	O
)	O
,	O
but	O
no	B-negation
fever	O
and	O
no	B-negation
chills	O
.	O

Right	O
Abduct	O
Thigh	O
(	O
sup	O
.	O

Review	O
of	O
Systems	O
Complete	O
-	O
Male	O
Neuro	O
Emphasis	O
:	O

Aspirin	O
81	B-strength
mg	I-strength
Tablet	B-form
,	I-form
Chewable	I-form
Sig	O
:	O
1	B-dosage
.	I-dosage
5	I-dosage
Tablet	B-form
,	I-form
Chewables	I-form
PO	B-route
DAILY	B-frequency
(	I-frequency
Daily	I-frequency
)	I-frequency
.	O

Sinuses	O
:	O
there	O
was	O
no	B-negation
tenderness	O
over	O
the	O
paranasal	B-bodyloc
sinuses	I-bodyloc
.	O

pt	O
is	O
here	O
to	O
see	O
Dr	O
.	O
Ingram	O
c	O
/	O
o	O
coughing	O
up	O
blood	B-bodyloc

XRAY	O
Knee	O
AP	O
and	O
lateral	O
Requested	O
for	O
:	O
05Jul2013	B-temporal

Epiglottis	O
and	O
Associated	O
Mucosal	O
Folds	O
:	O
normal	O

Physical	O
Exam	O

Cervical	O
lymph	O
nodes	O
are	O
nontender	O
and	O
appropriate	O
in	O
size	O
.	O

Retrospective	O
Authorization	O

Assessment	O
Pap	O
Smear	O
(	O
+	O
)	O
Low	O
Grade	O
Squamous	O
Intraepithelial	O
Lesion	O
795	O
.	O
03	O

Lightheadedness	O
780	O
.	O
4	O

MMR	O
-	O
VAR	O
(	O
ProQuad	O
)	O
;	O
27	B-temporal
Jun	I-temporal
2011	I-temporal

Assessment	O
of	O
muscle	O
strength	O
/	O
tone	O
:	O
Normal	B-labvalue
.	O

DOD	O
:	O
12/31/2012	B-temporal

History	O
of	O
Drug	O
Use	O

Language	O
:	O
Dysphasia	O
/	O
aphasia	O
.	O

History	O
of	O
Smoking	O

Cranial	O
nerves	O
III	O
,	O
IV	O
,	O
and	O
VI	O
:	O
the	O
extraocular	O
motions	O
were	O
intact	B-labvalue
.	O

Alkaline	O
phosphatase	O
of	O
96	B-labvalue
,	O
bilirubin	O
0	B-labvalue
.	I-labvalue
8	I-labvalue
.	O

NEUROLOGICAL	O
/	O
PSYCHIATRIC	O

Psychiatric	O

I	O
personally	O
performed	O
nasal	O
endoscopy	O
(	O
entire	O
procedure	O
)	O

Examination	O
of	O
the	O
oropharynx	O
:	O
Normal	B-labvalue

He	O
had	O
a	O
repeat	O
CT	O
which	O
showed	O
rebolution	O
of	O
the	O
obstructive	O
stone	O
in	O
the	O
left	B-bodyloc
ureteral	I-bodyloc
junction	I-bodyloc
and	O
only	O
a	O
single	O
stone	O
in	O
the	O
left	B-bodyloc
lower	I-bodyloc
pole	I-bodyloc
of	I-bodyloc
the	I-bodyloc
kidney	I-bodyloc
.	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

The	O
patient	O
presents	O
with	O
complaints	O
of	O
constant	O
episodes	O
of	O
speech	O
difficulties	O
.	O

PSYCHIATRIC	O
:	O
no	B-negation
depression	O
and	O
no	B-negation
anxiety	O
.	O

Hyperlipidemia	O
272	O
.	O
4	O

Rinne	O
'	O
s	O
test	O
:	O
bone	O
conduction	O
persists	O
longer	O
than	O
air	O
conduction	O
on	O
the	O
left	O
.	O

Current	O
Meds	O
No	B-negation
Reported	O
Medications	O

Active	O
Problems	O
Dyslipidemia	O
272	O
.	O
4	O

Posterior	O
tibialis	O
:	O
right	O
2	O
+	O
and	O
left	O
2	O
+	O
.	O

I	O
have	O
personally	O
reviewed	O
the	O
resident	O
note	O
.	O

History	O
of	O
Present	O
Illness	O

Motor	O
Strength	O
:	O
Head	O
and	O
Neck	O
Muscles	O
Normal	B-labvalue

Xopenex	O
HFA	O
45	B-strength
MCG	I-strength
/	I-strength
ACT	I-strength
Inhalation	B-route
Aerosol	B-form
;	O
INHALE	O
2	B-dosage
PUFFS	B-form
EVERY	B-frequency
4	I-frequency
-	I-frequency
6	I-frequency
HOURS	I-frequency
AS	O
NEEDED	O
;	O
Therapy	O
:	O
03Jan2013	B-temporal
to	O
(	O
Evaluate	O
:	O
02Jun2013	B-temporal
)	O
Requested	O
for	O
:	O
03Jan2013	B-temporal
;	O
Last	O

[	O
QLH	O
]	O
T4	O
,	O
FREE	O
Requested	O
for	O
:	O
04Apr2014	B-temporal

;	O
Mar	B-temporal
28	I-temporal
2013	I-temporal
10	B-temporal
:	I-temporal
37PM	I-temporal
(	O
Author	O
)	O

He	O
denies	B-negation
loss	O
of	O
consciousness	O
or	O
disorientation	O
.	O

Hematologic	O
/	O
Lymphatic	O
:	O
a	O
tendency	O
for	O
easy	O
bleedinganda	O
tendency	O
for	O
easy	O
bruising	O
.	O

I	O
am	O
asked	O
to	O
see	O
the	O
patient	O
today	O
with	O
ongoing	O
issues	O
around	O
her	O
diabetic	O
control	O
.	O

History	O
of	O
pulmonary	B-bodyloc
embolism	O
.	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
,	O
the	O
heart	O
rate	O
was	O
not	B-labvalue
fast	I-labvalue
,	O
the	O
heart	O
rate	O
was	O
not	B-labvalue
slow	I-labvalue
,	O
no	B-negation
intermittent	O
leg	B-bodyloc
claudication	O
and	O
no	B-negation
edema	O
.	O

A	O
Pap	O
smear	O
was	O
performed	O
.	O

Pulmonary	O

Levothyroxine	O
Sodium	O
75	B-strength
MCG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
DAILY	B-frequency
;	O
Therapy	O
:	O
27Feb2012	B-temporal
to	O
(	O
Evaluate	O
:	O
10Feb2014	B-temporal
)	O
Requested	O
for	O
:	O
14Aug2013	B-temporal
;	O
Last	O
Rx	O
:	O
14Aug2013	B-temporal
;	O
Status	O
:	O

The	O
patient	O
will	O
have	O
continued	O
pain	O
medication	O
coverage	O
with	O
Darvocet	O
and	O
Flexeril	O
.	O

Gastrointestinal	O
:	O
no	B-negation
bowel	B-bodyloc
incontinence	O
.	O

Bilateral	O
frontal	O
stents	O
.	O

The	O
abdomen	O
was	O
not	O
rigid	O
.	O

f	O
/	O
u	O
1	O
month	O

History	O
of	O
Tonsillectomy	O

Heart	O
sounds	O
:	O
abnormal	O
S1	O
andabnormal	O
S2	O
.	O

Allergies	O
:	O

Pulmonary	O

Examination	O
of	O
thyroid	O
:	O
Normal	B-labvalue
.	O

Leiomyosarcoma	O
,	O
the	O
patient	O
was	O
admitted	O
to	O
Hem	O
/	O
Onco	O
B	O
Service	O
under	O
attending	O
Dr	O
.	O
XYZ	O
for	O
cycle	O
six	O
of	O
continuous	B-frequency
IV	B-route
infusion	O
Cytoxan	O
,	O
Adriamycin	O
,	O
and	O
DTIC	O
,	O
which	O
she	O
tolerated	O
well	O
.	O

DISPOSITION	O
:	O

ALBUMIN	O
4	B-labvalue
.	I-labvalue
0	I-labvalue
g	I-labvalue
/	I-labvalue
dl	I-labvalue
3	B-reference_range
.	I-reference_range
6	I-reference_range
-	I-reference_range
5	I-reference_range
.	I-reference_range
1	I-reference_range

Integumentary	O
:	O
no	B-negation
breast	B-bodyloc
pain	O
,	O
no	B-negation
breast	B-bodyloc
mass	O
,	O
no	B-negation
changes	O
in	O
mole	B-bodyloc
(	O
s	O
)	O
,	O
no	B-negation
rash	O
,	O
no	B-negation
itching	O
.	O

Eyes	O
:	O
no	B-negation
eye	B-bodyloc
pain	O
,	O
eyes	B-bodyloc
not	B-negation
red	O
and	O
no	B-negation
eyesight	O
problems	O
.	O

S	O
.	O
O	O
.	O
B	O
.	O

Hypothyroidism	O
244	O
.	O
9	O

ROB	O

Risk	O
factors	O
:	O
oral	O
contraceptive	O
use	O
.	O

The	O
abdomen	O
was	O
soft	O
and	O
nontender	O
.	O

CBC	O
,	O
CMP	O
,	O
Lipid	O
panel	O
to	O
be	O
checked	O
.	O

Taking	O
pre	O
-	O
workout	O
energy	O
energy	O
/	O
muscle	O
builder	O
for	O
2	O
-	O
3	O
months	O
.	O

;	O
Apr	B-temporal
5	I-temporal
2013	I-temporal
11	B-temporal
:	I-temporal
44AM	I-temporal
(	O
Author	O
)	O

Last	O
Visit	O
:	O

Eyes	O

Signature	O

Head	O
and	O
Face	O

Bilateral	O
microtia	O
,	O
right	O
complete	O
atresia	O
,	O
left	O
repaired	O
atresia	O
.	O

Topicort	O
0	B-strength
.	I-strength
05	I-strength
%	I-strength
External	O
Ointment	B-form
;	O
APPLY	O
TWICE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
28Dec2012	B-temporal
to	O

DISCHARGE	O
MEDICATIONS	O
:	O
Resume	O
home	O
medications	O
,	O
but	O
increase	O
Lasix	O
to	O
80	B-strength
mg	I-strength
every	B-frequency
morning	I-frequency
,	O
Lovenox	O
30	B-strength
mg	I-strength
subcu	B-route
daily	B-frequency
x2	B-duration
weeks	I-duration
,	O
Vicodin	O
5	B-strength
/	I-strength
500	I-strength
mg	I-strength
one	B-dosage
to	I-dosage
two	I-dosage
every	B-frequency
four	I-frequency
to	I-frequency
six	I-frequency
hours	I-frequency
p	B-frequency
.	I-frequency
r	I-frequency
.	I-frequency
n	I-frequency
.	O
pain	O
,	O
Combivent	O
nebulizer	O
every	B-frequency
four	I-frequency
hours	I-frequency
while	O
awake	O
for	O
difficulty	O
breathing	O
,	O
Zithromax	O
one	B-duration
week	I-duration
250	B-strength
mg	I-strength
daily	B-frequency
,	O
and	O
guaifenesin	O
long	O
-	O
acting	O
one	B-dosage
twice	B-frequency
a	I-frequency
day	I-frequency
b	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	O

No	B-negation
decreased	O
response	O
to	O
stimulation	O
by	O
vibration	O
.	O

Uses	O
Safety	O
Equipment	O
-	O
Protective	O
Head	O
Gear	O

No	B-negation
dyspareunia	O
.	O

Nose	B-bodyloc
bleeds	O
:	O
None	B-negation

Vitals	O
16Apr2013	B-temporal
01	B-temporal
:	I-temporal
53PM	I-temporal
BMI	O
Calculated	O
30	B-labvalue
.	I-labvalue
36	I-labvalue
BSA	O
Calculated	O
1	B-labvalue
.	I-labvalue
76	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
2	I-labvalue
in	I-labvalue
Weight	O
165	B-labvalue
lb	I-labvalue
Systolic	O
110	B-labvalue
Diastolic	O
72	B-labvalue
Temperature	O
97	B-labvalue
.	I-labvalue
8	I-labvalue
F	I-labvalue
Heart	O
Rate	O
68	B-labvalue

HM	O
,	O

No	B-negation
rhonchi	O
were	O
heard	O
.	O

Pulmonary	O
Clear	B-labvalue
breath	O
sounds	O
.	O

History	O
of	O
Knee	O
Replacement	O

Inspection	O
of	O
breasts	O
:	O
Normal	B-labvalue
Both	O
breasts	O
:	O
normal	O
appearance	O
.	O

Hemoccult	O
(	O
Stool	O
)	O
Requested	O
for	O
:	O
24Oct2012	B-temporal

f	O
HydrALAZINE	O
HCl	O
10	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
EVERY	B-frequency
6	I-frequency
HOURS	I-frequency
;	O
Start	O
Date	O
:	O
07/17/2008	B-temporal
;	O
End	O
Date	O
:	O
01/01/1900	B-temporal
(	O
Active	O
)	O

Physical	O
Exam	O

Psychiatric	O

There	O
was	O
no	B-negation
medial	B-bodyloc
or	I-bodyloc
lateral	I-bodyloc
joint	I-bodyloc
line	I-bodyloc
tenderness	O
.	O

Results	O
/	O
Results	O
/	O
Data	O
All	O
Results	O
[	O
Data	O
Includes	O
:	O
Last	O
1	O
Instance	O
]	O

I	O
have	O
discussed	O
the	O
case	O
with	O
the	O
resident	O
and	O
agree	O
with	O
the	O
assessment	O
and	O
plan	O
as	O
delineated	O
in	O
the	O
note	O
above	O
.	O

ASSESSMENT	O
:	O
A	O
13	O
-	O
year	O
-	O
old	O
male	O
6	O
-	O
1	O
/	O
2	O
weeks	O
status	O
post	O
removal	O
of	O
hardware	O
from	O
left	O
tibia	O
.	O

Pulmonary	O

Examination	O
of	O
gait	O
and	O
station	O
:	O
Normal	B-labvalue
.	O

Inspection	O
/	O
palpation	O
of	O
joints	O
,	O
bones	O
,	O
and	O
muscles	O
:	O
Normal	B-labvalue
.	O

No	B-negation
rhonchi	O
were	O
heard	O
.	O

No	B-negation
masses	O
palpated	O
.	O

KETONES	O
negative	B-labvalue

Examination	O
of	O
bladder	O
:	O
Normal	B-labvalue

His	O
other	O
daughter	O
is	O
healthy	O
.	O

Examination	O
of	O
the	O
abdomen	O
:	O
Normal	B-labvalue
.	O

Results	O
/	O
Results	O
/	O
Data	O

Zoran	O
Cupic	O
,	O
M	O
.	O
D	O
.	O

Vitals	O
UTP	O
Adult	O
Vital	O
Signs	O
[	O
Data	O
Includes	O
:	O
Current	O
Encounter	O
]	O
25Feb2011	B-temporal
11	B-temporal
:	I-temporal
34AM	I-temporal
Height	O
:	O
5	B-labvalue
ft	I-labvalue
10	I-labvalue
.	I-labvalue
5	I-labvalue
in	I-labvalue
Weight	O
:	O
180	B-labvalue
lb	I-labvalue
Systolic	O
:	O
114	B-labvalue
Diastolic	O
:	O
76	B-labvalue
Heart	O
Rate	O
:	O
85	B-labvalue
Respiration	O
:	O
18	B-labvalue
BMI	O
:	O
25	B-labvalue
.	I-labvalue
46	I-labvalue
kg	I-labvalue
/	I-labvalue
m2	I-labvalue
BSA	O
:	O
2	B-labvalue
.	I-labvalue
01	I-labvalue
m2	I-labvalue

Endocrine	O
:	O
no	B-negation
muscle	B-bodyloc
weakness	O
,	O
no	B-negation
deepening	O
of	O
the	O
voice	O
and	O
no	B-negation
feelings	O
of	O
weakness	O
.	O

Views	O
:	O
lateral	O
and	O
skyline	O
views	O
were	O
performed	O
of	O
the	O
left	O
knee	O
.	O

Recent	O
and	O
remote	O
memory	O
:	O
Normal	B-labvalue

Left	O
Ext	O
.	O

Never	O
Drank	O
Alcohol	O

Vaginal	B-bodyloc
bleeding	O
-	O
Exam	O
on	O
Monday	O
at	O
TMC	O
office	O
did	B-negation
not	I-negation
show	I-negation
active	O
bleeding	O
.	O

Cardiovascular	O
:	O
Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

;	O
Apr	B-temporal
22	I-temporal
2013	I-temporal
9	B-temporal
:	I-temporal
04AM	I-temporal
(	O
Author	O
)	O

No	B-negation
canal	O
or	O
foraminal	B-bodyloc
stenosis	O
.	O

Musculoskeletal	O

Long	O
(	O
peron	O
.	O
)	O
:	O
Normal	O
.	O

Percussion	O
of	O
chest	O
:	O
Normal	B-labvalue
.	O

Review	O
of	O
Systems	O

when	O
stops	O
breastfeeding	O
instructed	O
to	O
call	O
clinic	O
for	O
alternative	O
combo	O
ocp	O
.	O

Secretions	O
:	O
None	B-negation

Discussed	O
the	O
importance	O
of	O
DM	O
control	O
and	O
its	O
complications	O
.	O

Active	O
Problems	O
Atrial	B-bodyloc
Fibrillation	O
427	O
.	O
31	O

Genitourinary	O

ABDOMEN	O
:	O
Soft	O
,	O
positive	B-labvalue
bouel	O
sounds	O
,	O
nontender	O
.	O

Former	O
Smoker	O

Examination	O
of	O
digits	O
and	O
nails	O
:	O
Normal	B-labvalue
.	O

Vitals	O
UTP	O
Adult	O
Vital	O
Signs	O
[	O
Data	O
Includes	O
:	O
Current	O
Encounter	O
]	O
15Aug2012	B-temporal
01	B-temporal
:	I-temporal
54PM	I-temporal
BMI	O
Calculated	O
26	B-labvalue
.	I-labvalue
2	I-labvalue
BSA	O
Calculated	O
1	B-labvalue
.	I-labvalue
84	I-labvalue
Weight	O
163	B-labvalue
lb	I-labvalue
Systolic	O
133	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
73	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Temperature	O
97	B-labvalue
.	I-labvalue
9	I-labvalue
F	I-labvalue
,	O
Oral	O
Heart	O
Rate	O
75	B-labvalue
,	O
L	O
Radial	O
Pulse	O
Quality	O
Normal	B-labvalue
,	O
L	O
Radial	O
Respiration	O
17	B-labvalue
Respiration	O
Quality	O
Normal	B-labvalue

3	O
.	O

Vitals	O
05Dec2011	B-temporal
02	B-temporal
:	I-temporal
32PM	I-temporal
BMI	O
Calculated	O
20	B-labvalue
.	I-labvalue
49	I-labvalue
BSA	O
Calculated	O
1	B-labvalue
.	I-labvalue
58	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
4	I-labvalue
in	I-labvalue
Weight	O
120	B-labvalue
lb	I-labvalue
Systolic	O
159	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
95	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Heart	O
Rate	O
90	B-labvalue

2	O
.	O

Past	O
Medical	O
History	O
History	O
of	O
Asthma	O
493	O
.	O
90	O

Lack	B-negation
of	O
brain	B-bodyloc
lesions	O
on	O
MRI	O
is	O
atypical	O
,	O
but	O
she	O
had	O
several	O
relapses	O
and	O
lesions	O
in	O
the	O
cord	B-bodyloc
.	O

-	O
No	B-negation
perineural	O
invasion	O
is	O
identified	O
.	O

Never	O
Used	O
Drugs	O

Current	O
Meds	O

PND	O
,	O
throat	B-bodyloc
irritation	O
.	O

General	O
appearance	O
:	O
No	B-negation
acute	B-course
distress	O
,	O
well	O
appearing	O
and	O
well	O
nourished	O
.	O

EYES	O

The	O
patient	O
was	O
seen	O
by	O
various	O
consultants	O
.	O

Pedal	O
pulses	O
:	O
Normal	B-labvalue
.	O
Peripheral	O
vascular	O
exam	O
:	O
Normal	B-labvalue
.	O

Assessment	O
Adenocarcinoma	O
Of	O
The	O
Uterus	B-bodyloc
179	O

Diabetes	O
Mellitus	O
250	O
.	O
00	O

Examination	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue

Alcohol	O

3	O
.	O

Pharyngeal	O
Findings	O
:	O

Household	O
risk	O
factors	O
:	O
no	O
passive	O
smoking	O
exposure	O
,	O
no	O
exposure	O
to	O
pets	O
and	O
no	O
firearms	O
in	O
the	O
home	O
.	O

Chronic	B-course
Cutaneous	B-bodyloc
Ulcer	O
707	O
.	O
9	O

9	B-temporal
/	I-temporal
2012	I-temporal
.	O

[	O
QLH	O
]	O
TSH	O
,	O
3RD	O
GENERATION	O
Requested	O
for	O
:	O
02Jul2012	B-temporal

History	O
of	O
Present	O
Illness	O

)	O

No	B-negation
Known	O
Allergies	O

Palpation	O
of	O
chest	O
:	O
Normal	B-labvalue
.	O

(	O
Patient	O
had	O
cluster	O
headache	O
and	O
MVA	O
on	O
11	B-temporal
/	I-temporal
23	I-temporal
,	O
he	O
went	O
to	O
the	O
hospital	O
on	O
11	B-temporal
/	I-temporal
24	I-temporal
and	O
received	O
CT	O
head	O
which	O
was	O
negative	B-negation
-	O
symptoms	O
have	O
been	O
negative	O
since	O
then	O
)	O

Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

PNV	O

CTA	O
aorta	O
showed	O
extensive	O
atherosclerosis	O
as	O
well	O
as	O
mild	O
to	O
moderate	B-severity
narrowing	O
of	O
R	O
superfiical	B-bodyloc
femoral	I-bodyloc
arterys	I-bodyloc
stent	O
with	O
narrowing	O
distal	O
to	O
the	O
stent	O
.	O

Review	O
of	O
Systems	O

Hyperlipidemia	O
272	O
.	O
4	O

Potassium	O
Lvl	O
4	B-labvalue
.	I-labvalue
4	I-labvalue
mEq	I-labvalue
/	I-labvalue
l	I-labvalue
3	B-reference_range
.	I-reference_range
5	I-reference_range
-	I-reference_range
5	I-reference_range
.	I-reference_range
1	I-reference_range

I	O
have	O
counseled	O
the	O
patient	O
at	O
great	O
length	O
and	O
answered	O
all	O
of	O
her	O
questions	O
.	O

His	O
vital	O
signs	O
indicated	O
hemodynamic	O
stability	O
and	O
he	O
had	O
no	B-negation
evidence	I-negation
of	I-negation
infection	O
.	O

Test	O
Name	O
Result	O
Flag	O
Reference	O

Chief	O
Complaint	O

Cranial	O
Nerves	O
:	O

She	O
is	O
living	O
at	O
home	O
by	O
herself	O
and	O
her	O
sister	O
is	O
her	O
primary	O
care	O
giver	O
.	O

Allergies	O
1	O
.	O

Muscle	O
Bulk	O
:	O
.	O

6	O
.	O

2	O
.	O

Sinusitis	O
and	O
dizziness	O
resolved	B-course
.	O

-	O
BG	O
log	O
reviewed	O
:	O
am	O
hypoglycemia	O
.	O

Allergies	O
and	O
Adverse	O
Reactions	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
neck	O
:	O
Normal	B-labvalue
.	O

No	B-negation
acute	B-course
osseous	B-bodyloc
pathology	O
.	O

Will	O
start	O
lisinopril	O
10	B-strength
mg	I-strength
daily	B-frequency
today	B-temporal
and	O
recheck	O
BP	O
in	B-temporal
4	I-temporal
weeks	I-temporal

Palpation	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
Normal	B-labvalue
.	O

Omeprazole	O
20	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
Delayed	I-form
Release	I-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Last	O
Rx	O
:	O
24Oct2012	B-temporal

Medications	O
:	O
The	O
patient	O
is	O
adherent	O
with	O
his	O
medication	O
regimen	O
.	O
He	O
denies	B-negation
medication	O
side	O
effects	O
.	O

Risk	O
factors	O
for	O
CAD	O
:	O
no	B-negation
DM	O
,	O
+	O
premature	O
h	O
/	O
o	O
CAD	O
(	O
father	B-subject
had	O
a	O
heart	B-bodyloc
attack	O
in	O
his	O
40ies	O
)	O
,	O
+	O
HTN	O
,	O
no	O
smoking	O
,	O
no	B-negation
HLD	O
.	O

Oropharynx	O
:	O
Normal	O
.	O

Disturbance	O
Of	O
Gait	O
781	O
.	O
2	O

Cervical	O
Spine	O
:	O
Normal	O
(	O
exhibited	O
no	B-negation
muscle	B-bodyloc
spasm	O
)	O
.	O

Description	O
of	O
patient	O
'	O
s	O
judgement	O
and	O
insight	O
:	O
Normal	B-labvalue
.	O

VitalsSectispStart	O
Vitals	O

4	O
.	O

LYMPHATIC	O

Axillary	O
nodes	O
:	O
.	O

Constitutional	O

Delivered	O
:	O
7/12/07	B-temporal
.	O

Bowel	O
sounds	O
were	O
normal	B-labvalue
.	O

The	O
patient	O
has	O
tenderness	O
to	O
tooth	B-bodyloc
#	I-bodyloc
12	I-bodyloc
as	O
well	O
as	O
tooth	B-bodyloc
#	I-bodyloc
21	I-bodyloc
.	I-bodyloc

RTO	O
2	O
-	O
4	O
weeks	O
or	O
sooner	O
if	O
needed	O
,	O
Option	O
of	O
getting	O
x	O
-	O
ray	O
of	O
the	O
foot	O
discussed	O
,	O
patient	O
declined	O
which	O
is	O
acceptable	O
.	O

Inspection	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
Normal	B-labvalue
.	O

Denied	O

She	O
has	O
regular	O
dental	O
visits	O
.	O

The	O
rhythm	O
was	O
regular	B-labvalue
.	O

Chloride	O
Lvl	O
103	B-labvalue
mEq	I-labvalue
/	I-labvalue
l	I-labvalue
95	B-reference_range
-	I-reference_range
109	I-reference_range

Alcohol	O

Skin	O

Palpation	O
of	O
the	O
face	O
and	O
sinuses	O
:	O
Normal	B-labvalue

Eczema	O
692	O
.	O
9	O

PROzac	O
CAPS	O
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
07Aug2013	B-temporal
)	O
to	O

6	O
.	O

-	O
-	O
Continue	O
Rebif	O
for	O
the	O
time	O
being	O
.	O

[	O
QLH	O
]	O
PTH	O
,	O
INTACT	O
(	O
WITHOUT	O
CALCIUM	O
)	O
Done	O
:	O
18Dec2012	B-temporal
11	B-temporal
:	I-temporal
30AM	I-temporal

Flat	B-labvalue
.	O

Attestations	O
Advanced	O
Practitioner	O
Attestation	O
:	O

History	O
of	O
Thyroid	O
Surgery	O
Total	O
Thyroidectomy	O

History	O
of	O

Facial	B-bodyloc
pressure	O
and	O
PND	O

Examination	O
of	O
the	O
abdomen	O
:	O
Normal	B-labvalue

UTP	O
-	O
Discussion	O
/	O
40	O
y	O
/	O
o	O
returns	O
8	O
weeks	O
s	O
/	O
p	O
RATLH	O
.	O

-	O
cont	O
Lisinopril	O
30	B-strength
mg	I-strength
po	B-route
daily	B-frequency

Cervical	O
Spine	O
:	O
Normal	O
(	O
showed	O
no	B-negation
tenderness	O
on	O
palpation	O
)	O
.	O

Anus	O
,	O
perineum	O
and	O
rectum	O
:	O
Normal	O

Radiological	O
Data	O
Radiologic	O
Interpretation	O
:	O

Family	O
History	O
1	O
.	O

History	O
of	O
Orofacial	O
Dyskinesia	O
333	O
.	O
82	O

Femoral	O
pulses	O
:	O
Normal	B-labvalue
.	O

Findings	O
-	O
Mammo	O
7	B-temporal
/	I-temporal
2010	I-temporal
cancer	O
.	O

Eyes	O
:	O
no	B-negation
eye	B-bodyloc
pain	O
and	O
eyes	B-bodyloc
not	B-negation
red	O
.	O

Hematologic	O
/	O
Lymphatic	O
:	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
,	O
no	B-negation
swollen	O
glands	B-bodyloc
and	O
no	B-negation
swollen	O
glands	B-bodyloc
in	O
the	O
neck	B-bodyloc

Signatures	O
Electronically	O
signed	O
by	O
:	O
SANAH	O
ALI	O
,	O
M	O
.	O
D	O
.	O
;	O

Diphenoxylate	O
-	O
Atropine	O
2	B-strength
.	I-strength
5	I-strength
-	I-strength
0	I-strength
.	I-strength

The	O
Diazoxide	O
was	O
restarted	O
again	O
.	O

eGFR	O
of	O
60	B-reference_range
-	I-reference_range
89	I-reference_range
may	O
be	O
normal	B-labvalue
in	I-labvalue
some	I-labvalue
popula	I-labvalue
ions	I-labvalue
,	I-labvalue
particularly	I-labvalue
the	I-labvalue
elderly	I-labvalue
,	O
for	O

;	O
Jan	B-temporal
5	I-temporal
2012	I-temporal
3	B-temporal
:	I-temporal
32PM	I-temporal
(	O
Author	O
)	O

Went	O
to	O
the	O
ER	O
following	O
accident	O
,	O
but	O
they	O
were	O
so	O
overbooked	O
with	O
trauma	O
cases	O
that	O
they	O
were	O
unable	O
to	O
evaluate	O
her	O
with	O
CT	O
head	O
.	O

Allergies	O
1	O
.	O

The	O
thyroid	O
was	O
normal	O
.	O

Consider	O
provers	O
every	O
3	O
m	O
if	O
no	O
cycle	O
(	O
pt	O
.	O
did	O
not	O
like	O
BCP	O
)	O

Diabetes	O
Mellitus	O
250	O
.	O
00	O

I	O
have	O
personally	O
reviewed	O
:	O
resident	O
note	O
.	O

Hemoglobin	O
14	B-labvalue
.	I-labvalue
3	I-labvalue
g	I-labvalue
/	I-labvalue
dl	I-labvalue
12	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
16	I-reference_range
.	I-reference_range
0	I-reference_range

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

Cycle	O
intervals	O
have	O
been	O
regular	O
.	O

Plan	O
US	O
Pelvic	O
with	O
Transvaginal	O
and	O
Pelvic	O
Doppler	O
76830	O
Requested	O
for	O
:	O
30Jul2013	B-temporal

Dr	O
.	O
Y	O
feels	O
she	O
could	O
be	O
discharged	O
today	O
and	O
will	O
have	O
her	O
return	O
to	O
see	O
him	O
in	O
a	O
week	O
.	O

Constitutional	O

PAIN	O
AT	O
EXTREMES	O
.	O

[	O
L	O
]	O
Pap	O
IG	O
,	O
Ct	O
-	O
Ng	O
,	O
HPV	O
-	O
hr	O
Requested	O
for	O
:	O
21Nov2013	B-temporal

Pneumovax	O
23	B-strength
25	I-strength
MCG	I-strength
/	I-strength
0	I-strength
.	I-strength
5ML	I-strength
Injection	B-form
Injectable	B-route
;	O
Administer	O
as	O
directed	O
;	O
To	O
Be	O
Done	O
:	O
31Oct2013	B-temporal
;	O
Status	O
:	O
Hold	O
For	O
-	O
Administration	O

Past	O
Medical	O
History	O

Appropriate	O
skin	O
color	O
and	O
pigmentation	O
.	O

Examination	O
of	O
thyroid	O
:	O
Normal	B-labvalue
.	O

Musculoskeletal	O

Respiratory	O
:	O
shortness	O
of	O
breath	O
,	O
but	O
no	B-negation
wheezing	O
,	O
no	B-negation
cough	O
,	O
no	B-negation
shortness	O
of	O
breath	O
during	O
exertion	O
,	O
no	B-negation
orthopnea	O
and	O
no	B-negation
PND	O
.	O

Assessment	O
Assessed	O

No	B-negation
frontal	B-bodyloc
tenderness	O
.	O

She	O
was	O
adviced	O
to	O
avoid	O
NSAIDs	O
due	O
to	O
other	O
chronic	B-course
conditions	O
.	O

Respiratory	O
:	O
cough	O
,	O
but	O
no	B-negation
shortness	O
of	O
breath	O
during	O
exertion	O
,	O
no	B-negation
orthopnea	O
and	O
no	B-negation
PND	O
.	O

The	O
mass	O
increased	B-course
in	I-course
size	I-course
.	O

Levothyroxine	O
Sodium	O
75	B-strength
MCG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
DAILY	B-frequency
;	O
Therapy	O
:	O
27Feb2012	B-temporal
to	O
(	O
Evaluate	O
:	O
07Aug2013	B-temporal
)	O
Requested	O
for	O
:	O
09Apr2013	B-temporal
;	O
Last	O
Rx	O
:	O
09Apr2013	B-temporal

Chief	O
Complaint	O
Back	B-bodyloc
Pain	O

Allergies	O
Medication	O

History	O
of	O
Palpitations	O
(	O
Symptom	O
)	O
785	O
.	O
1	O

Past	O
Medical	O
History	O
History	O
of	O
Depression	O
311	O

Denied	B-negation
Family	B-subject
history	O
of	O
Benign	B-course
Essentiai	O
Hypertension	O

Review	O
of	O
Systems	O

f	O
HIB	O
(	O
Lot	O
#	O
:	O
UH609AA	O
)	O
-	O
Administered	O
on	O
:	O
11/16/2012	B-temporal

Skin	O

3	O
.	O

[	O
QLH	O
]	O
CBC	O
(	O
INCLUDES	O
DIFF	O
/	O
PLT	O
)	O
Requested	O
for	O
:	O
14Jun2013	B-temporal

Surgical	O
History	O
History	O
of	O
CABG	O
(	O
CABG	O
)	O
V45	O
.	O
81	O

Respiratory	O
:	O
shortness	O
of	O
breath	O
,	O
wheezingandshortness	O
of	O
breath	O
during	O
exertion	O
,	O
butno	O
cough	O
,	O
no	B-negation
orthopnea	O
,	O
no	O
hemoptysisandno	O
PND	O
.	O

Examination	O
of	O
extremities	O
for	O
edema	O
and	O
/	O
or	O
varicosities	O
:	O
Abnormal	O
(	O
trace	O
edema	O
to	O
both	B-bodyloc
lower	I-bodyloc
legs	I-bodyloc
)	O

Psychiatric	O
:	O
no	B-negation
anxiety	O
.	O

Episodes	O
:	O
Partially	O
improve	O

Skin	O

f	O
Paternal	B-subject
history	O
of	O
Hypertension	O
(	O
V17	O
.	O
49	O
)	O
;	O
(	O
Active	O
)	O

Negative	B-negation
for	O
premature	O
CAD	O

Fracture	O
Of	O
The	O
Ankle	B-bodyloc
824	O
.	O
8	O

-	O
Discharge	O
Summary	O
Description	O
:	O
Neck	B-bodyloc
pain	O
with	O
right	O
upper	O
extremity	O
radiculopathy	O
and	O
cervical	O
spondylosis	O
with	O
herniated	O
nucleus	O
pulposus	O
C4	O
-	O
C5	O
,	O
C5	O
-	O
C6	O
,	O
and	O
C6	O
-	O
C7	O
with	O
stenosis	O
.	O

Patient	O
presents	O
for	O
a	O
follow	O
up	O
after	O
stress	O
test	O
and	O
an	O
echocardiogram	O
.	O

Recent	O
and	O
remote	O
memory	O
:	O
Intact	B-labvalue
.	O

He	O
denies	B-negation
loss	O
of	O
consciousness	O
or	O
disorientation	O
.	O

Cranial	O
Nerve	O
V	O
:	O
sensation	O
to	O
the	O
face	O
and	O
masseter	O
strength	O
were	O
intact	B-labvalue
.	O

Inspection	O
of	O
the	O
conjunctiva	O
and	O
lids	O
:	O
Normal	B-labvalue
.	O

PAP	O
Smear	O
:	O
9/26/2012	B-temporal

Tylenol	O
Severe	O
Allergy	O
12	B-strength
.	I-strength
5	I-strength
-	I-strength
500	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
USE	O
AS	B-frequency
NEEDED	I-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
14Dec2013	B-temporal
)	O
to	O

Never	O
Drank	O
Alcohol	O

Lips	O
,	O
teeth	O
,	O
and	O
gums	O
:	O
Normal	O
,	O
good	O
dentition	O
.	O

Allergies	O
Amoxicillin	O
TABS	B-form

Discussion	O
/	O
Signatures	O
Electronically	O
signed	O
by	O
:	O
JULIA	O
ADROGUE	O
,	O
M	O
.	O
D	O
.	O

She	O
eventually	O
underwent	O
surgical	O
resection	O
on	O
May	B-temporal
1	I-temporal
,	I-temporal
2008	I-temporal
with	O
small	O
area	O
of	O
residual	O
disease	O
,	O
but	O
otherwise	O
clear	O
margins	O
.	O

Musculoskeletal	O
:	O
arthralgias	O
,	O
joint	B-bodyloc
pain	O
,	O
joint	B-bodyloc
swelling	O
,	O
knee	B-bodyloc
problems	O
and	O
knee	B-bodyloc
swelling	O
,	O
but	B-bodyloc
no	I-bodyloc
hip	I-bodyloc
pain	O
,	O
no	B-negation
pain	O
in	O
the	O
thigh	B-bodyloc
,	O
no	B-negation
intermittent	O
knee	B-bodyloc
locking	O
,	O
no	B-negation
leg	B-bodyloc
pain	O
,	O
no	B-negation
ankle	B-bodyloc
pain	O
,	O
swelling	O
or	O
stiffness	O
,	O
no	B-negation
ankle	B-bodyloc
pain	O
,	O
no	B-negation
ankle	B-bodyloc
swelling	O
and	O
no	O
refusal	O
to	O
bear	O
weight	O
.	O

I	O
spent	O
40	O
minutes	O
with	O
the	O
patient	O
and	O
25	O
minutes	O
coordinating	O
care	O
.	O

Acute	B-course
Bronchitis	O
466	O
.	O
0	O

Aspirin	O
Low	B-dosage
Dose	I-dosage
81	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
15Nov2012	B-temporal
)	O
to	O

CHD	O
Risk	O
3	B-labvalue
.	I-labvalue
16	I-labvalue
L	B-labvalue
3	B-reference_range
.	I-reference_range
90	I-reference_range
-	I-reference_range
5	I-reference_range
.	I-reference_range
80	I-reference_range

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
and	O
no	B-negation
edema	O
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Mammogram	O
Screening	O
V76	O
.	O
12	O

7	B-temporal
/	I-temporal
12	I-temporal
:	O
implanon	O
placed	O

Neck	O

Never	O
A	O
Smoker	O

Neurological	O
:	O
no	B-negation
confusion	O
,	O
no	B-negation
convulsions	O
and	O
no	B-negation
dizziness	O
.	O

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

Past	O
Medical	O
History	O
History	O
of	O
Chlamydial	O
Disease	O
078	O
.	O
88	O

Eyes	O
:	O
no	B-negation
eye	B-bodyloc
pain	O
and	O
no	B-negation
eyesight	O
problems	O
.	O

AIRWAY	O
ENDOSCOPY	O
.	O

Neck	O

LDL	O
102	B-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
H	B-labvalue
<	B-reference_range
=99	I-reference_range
Referencearanges	O
are	O
based	O
on	O
the	O
clinical	O
guidelines	O
of	O
the	O
NHLBI	O
National	O

Past	O
Medical	O
History	O
History	O
of	O
Arthritis	O
V13	O
.	O
4	O

She	O
has	O
already	O
been	O
given	O
a	O
back	O
booklet	O
in	O
Spanish	O
.	O

Spent	O
20	O
/	O
25	O
mins	O
counseling	O

[	O
QLH	O
]	O
HEMATOCRIT	O
Done	O
:	O
17Nov2010	B-temporal
10	B-temporal
:	I-temporal
49AM	I-temporal

I	O
examined	O
and	O
discussed	O
the	O
patient	O
with	O
the	O
resident	O
and	O
agree	O
with	O
the	O
above	O
findings	O
,	O
assessment	O
and	O
plan	O
in	O
the	O
resident	O
note	O
.	O

Results	O
/	O
Assessment	O
Acute	B-course
Bronchitis	O
466	O
.	O
0	O

MRA	O
of	O
the	O
circle	O
of	O
Willis	O

Comments	O
:	O
PreE	O
.	O

Examination	O
of	O
the	O
oropharynx	O
:	O
Normal	B-labvalue
.	O

Examination	O
of	O
gait	O
and	O
station	O
:	O
Normal	B-labvalue
.	O

Max	O
:	O
Eo	O
mucin	O

He	O
has	O
not	O
needed	O
to	O
take	O
any	O
medications	O
for	O
the	O
headaches	O
.	O

[	O
QLH	O
]	O
MICROALBUMIN	O
,	O
RANDOM	O
URINE	O
(	O
W	O
/	O
CREATININE	O
)	O
Done	O
:	O
25Sep2013	B-temporal
12	B-temporal
:	I-temporal
14PM	I-temporal

Skin	O
:	O
no	B-negation
change	O
in	O
skin	B-bodyloc
,	O
showed	O
no	B-negation
erythema	O
,	O
does	O
not	B-negation
show	O
signs	O
of	O
slowing	O
healing	O
,	O
no	B-negation
rash	O
and	O
no	B-negation
itching	O
.	O

Patient	O
is	O
currently	O
taking	O
Glyburide	O
5	B-strength
mg	I-strength
BID	B-frequency
and	O
her	O
fasting	O
BS	O
'	O
s	O
are	O
all	B-labvalue
<	I-labvalue
100	I-labvalue
.	O

25	O
-	O
OHD3	O
indicates	O
both	O
endogenous	O
production	O
and	O

The	O
patient	O
drinks	O
caffeinated	O
beverages	O
,	O
2	O
per	O
day	O
.	O

Labia	O
minora	O
:	O
normal	O
.	O

Hepatitis	O
B	O
;	O
27	B-temporal
Jun	I-temporal
2011	I-temporal

Left	O
Gluteus	O
Max	O
.	O

Feet	O
-	O
nor8al	O
positioning	O
.	O

Chronic	B-course
Allergic	O
Conjunctivitis	O
372	O
.	O
14	O

Social	O
History	O
Alcohol	O
Use	O

The	O
neck	B-bodyloc
was	O
not	B-negation
swollen	O
,	O
was	O
non	O
-	O
tender	O
,	O
was	O
not	O
warm	O
,	O
had	O
no	O
massesand	O
was	O
not	O
indurated	O
.	O

Otoscopic	O
examination	O
:	O
Normal	B-labvalue
.	O

Patient	O
has	O
been	O
using	O
an	O
adaptive	O
skill	O
or	O
device	O
for	O
a	O
duration	O
of	O
4	O
months	O
.	O

Neck	O
:	O
Full	B-labvalue
ROM	O
,	O
butthe	O
appearance	O
of	O
the	O
neck	O
was	O
normal	B-labvalue
,	O
the	O
neck	O
was	O
supple	B-bodyloc
and	I-bodyloc
the	I-bodyloc
thyroid	I-bodyloc
was	O
not	B-negation
enlarged	O
.	O

Vitamin	O
D	O
1000	B-strength
UNIT	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
19Aug2013	B-temporal
)	O
to	O

Physical	O
Exam	O

;	O
Feb	B-temporal
18	I-temporal
2014	I-temporal
4	B-temporal
:	I-temporal
31PM	I-temporal
(	O
Author	O
)	O

She	O
took	O
prophylactic	O
valtrex	O
during	O
her	O
pregnancy	O
and	O
has	O
been	O
inconsistent	O
with	O
her	O
pills	O
in	O
the	O
postpartum	O
interval	O
.	O

Symptoms	O
:	O
Denies	B-negation
numbness	O
of	O
the	O
feet	B-bodyloc
,	O
denies	B-negation
a	O
foot	B-bodyloc
ulcer	O
,	O
denies	B-negation
foot	B-bodyloc
pain	O
,	O
denies	B-negation
vomiting	O
,	O
denies	B-negation
visual	O
impairment	O
and	O
denies	B-negation
Complaining	O
of	O
pain	O
on	O
soles	O
of	O
feet	B-bodyloc
in	B-temporal
the	I-temporal
morning	I-temporal
.	O

Neck	O

Pulmonary	O

5	I-reference_range
CO2	O
21	B-labvalue
mEq	I-labvalue
/	I-labvalue
l	I-labvalue
L	B-labvalue
24	B-reference_range
-	I-reference_range
32	I-reference_range
Chloride	O
Lvl	O
105	B-labvalue
mEq	I-labvalue
/	I-labvalue
l	I-labvalue
95	B-reference_range
-	I-reference_range
109	I-reference_range
CreatinineaLvl	O
2	B-labvalue
.	I-labvalue
8	I-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
H	B-labvalue
0	B-reference_range
.	I-reference_range
5	I-reference_range
-	I-reference_range
1	I-reference_range
.	I-reference_range

Patient	O
Specific	O
Education	O
Given	O
Done	O
:	O
18Oct2012	B-temporal

Examination	O
of	O
the	O
abdomen	O
:	O
Normal	B-labvalue
Bowel	O
sounds	O
were	O
normal	B-labvalue
.	O

Assessment	O
Dyslipidemia	O
272	O
.	O
4	O

Past	O
Medical	O
History	O
History	O
of	O
Joint	B-bodyloc
Pain	O
In	O
The	O
Left	B-bodyloc
Knee	I-bodyloc
719	O
.	O
46	O

He	O
was	O
not	B-negation
coughing	O
although	O
he	O
admits	O
that	O
sometimes	O
he	O
does	O
cough	O
.	O

;	O
Feb	B-temporal
10	I-temporal
2012	I-temporal
10	B-temporal
:	I-temporal
54AM	I-temporal
(	O
Author	O
)	O

Bydureon	O
2	B-strength
MG	I-strength
Subcutaneous	B-route
Suspension	B-form
Reconstituted	O
;	O
Inject	B-route
contents	O
of	O
1	B-dosage
vial	B-form
every	B-frequency
week	I-frequency
;	O
Therapy	O
:	O
12Jul2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
10Mar2014	B-temporal
)	O
Requested	O
for	O
:	O
10Mar2014	B-temporal

She	O
feels	O
a	B-severity
little	I-severity
fatigued	O
.	O

I	O
agree	O
with	O
the	O
history	O
,	O
exam	O
and	O
plan	O
of	O
care	O
as	O
documented	O
in	O
the	O
resident	O
note	O
.	O

Discharge	O
Disposition	O
:	O

Immunizations	O
1	O
2	O
3	O
Hepatitis	O
A	O
11Feb2013	B-temporal
27Aug2013	B-temporal
Hepatitis	O
B	O
11Feb2013	B-temporal
09Apr2013	B-temporal
27Aug2013	B-temporal
Influenza	O
27Oct2010	B-temporal
05Dec2013	B-temporal
Tdap	O
08Dec2011	B-temporal

Examination	O
of	O
the	O
anus	O
,	O
perineum	O
and	O
rectum	O
:	O
Normal	B-labvalue

He	O
is	O
clinically	O
asymptomatic	O
currently	O
and	O
will	O
contact	O
us	O
if	B-condition
there	O
is	O
any	O
change	O
in	O
his	O
neurological	O
status	O
.	O

Examination	O
of	O
pupils	O
and	O
irises	O
:	O
Normal	B-labvalue
.	O

The	O
patient	O
states	O
her	O
hyperlipidemia	O
has	O
been	O
stable	O
since	O
the	O
last	O
visit	O
.	O

May	O
repeat	O
another	O
pill	O
prn	B-frequency
.	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
,	O
no	B-negation
cough	O
and	O
no	B-negation
shortness	O
of	O
breath	O
during	O
exertion	O
.	O

UTP	O
-	O
OB	O
/	O
Patient	O
here	O
for	O
postpartum	O
check	O
.	O

Paternal	B-subject
history	O
of	O
Heart	B-bodyloc
Disease	O
V17	O
.	O
49	O

[	O
QLH	O
]	O
HEMOGLOBIN	O
Done	O
:	O
17Nov2010	B-temporal
10	B-temporal
:	I-temporal
49AM	I-temporal

Cranial	O
nerves	O
XI	O
:	O
shoulder	O
shrug	O
was	O
intact	B-labvalue
bilaterally	I-labvalue
.	O

Neck	O

Total	O
pregnancies	O
1	O
.	O

Hearing	O
Loss	O
389	O
.	O
9	O
s	O
/	O
p	O
BMT	O

Examination	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue

Peripheral	B-bodyloc
Vascular	I-bodyloc
Disease	O
443	O
.	O
9	O

No	O
driving	O
etc	O
;	O

Keywords	O
:	O
general	O
medicine	O
,	O
respiratory	O
,	O
abdomen	O
,	O
normal	B-labvalue
physical	O
exam	O
,	O
pulses	O
,	O
tenderness	O
,	O
strength	O
,	O
lymph	O
,	O
extremity	O
,	O
midline	O
,	O
range	O
,	O
motion	O
,	O
lesions	O
,	O
symmetrical	O
,	O

Vitals	O
29Nov2011	B-temporal
11	B-temporal
:	I-temporal
00AM	I-temporal
29Nov2011	B-temporal
10	B-temporal
:	I-temporal
34AM	I-temporal
BMI	O
Calculated	O
26	B-labvalue
.	I-labvalue
5	I-labvalue
BSA	O
Calculated	O
1	B-labvalue
.	I-labvalue
76	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
4	I-labvalue
in	I-labvalue
Weight	O
155	B-labvalue
lb	I-labvalue
4	I-labvalue
oz	I-labvalue
Systolic	O
128	B-labvalue
,	O
RUE	O
,	O
Sitting	O
140	O
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
82	B-labvalue
,	O
RUE	O
,	O
Sitting	O
90	O
,	O
LUE	O
,	O
Sitting	O
Temperature	O
98	B-labvalue
.	I-labvalue
1	I-labvalue
F	I-labvalue
,	O
Oral	O
Heart	O
Rate	O
62	B-labvalue
,	O
R	O
Radial	O
Respiration	O
16	B-labvalue

[	O
QLH	O
]	O
CBC	O
(	O
INCLUDES	O
DIFF	O
/	O
PLT	O
)	O
Done	O
:	O
18Dec2012	B-temporal
11	B-temporal
:	I-temporal
30AM	I-temporal

PREVIOUS	O
AED	O
:	O
included	O
phenobarbital	O
as	O
a	O
child	O
,	O
which	O
increased	B-course
her	O
seizure	O
frequency	O
;	O
Lyrica	O
,	O
which	O
had	O
no	O
effect	O
on	O
her	O
seizures	O
and	O
may	O
have	O
increased	B-course
them	O
as	O
well	O
;	O
and	O
Depakote	O
,	O
which	O
gave	O
her	O
hives	O
.	O

RTC	O
2	O
weeks	O

Normal	O
saline	O
sinus	B-route
rinse	B-form
.	O

Reflexes	O
are	O
normal	B-labvalue
.	O

Cortical	O
function	O
:	O
Normal	B-labvalue

Lower	B-bodyloc
Back	I-bodyloc
Injury	O

Musculoskeletal	O
:	O
no	B-negation
joint	B-bodyloc
pain	O
and	O
no	B-negation
limb	B-bodyloc
pain	O
.	O

Recent	B-temporal
and	O
remote	O
memory	O
:	O
Normal	B-labvalue

Palpation	O
of	O
the	O
face	O
and	O
sinuses	O
:	O
Normal	B-labvalue
.	O

Hyperlipidemia	O
272	O
.	O
4	O

Eyes	O
:	O
no	B-negation
eyesight	O
problems	O
.	O

Oral	O
Contraceptives	O
V25	O
.	O
01	O

Bronchospasm	O
519	O
.	O
11	O

Plan	O

Fasting	O
reference	O
interval	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Constitutional	O

Nasal	O
endoscopy	O
.	O

Examination	O
of	O
liver	O
and	O
spleen	O
:	O
Normal	B-labvalue
.	O

Echo	O
:	O
NEVER	B-negation

Hematologic	O
/	O
Lymphatic	O
:	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
,	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
,	O
no	B-negation
swollen	O
glands	B-bodyloc
and	O
no	B-negation
swollen	O
glands	B-bodyloc
in	O
the	O
neck	B-bodyloc
.	O

2	O
.	O

The	O
headache	O
is	O
located	O
in	O
the	O
temporal	B-bodyloc
areas	I-bodyloc
bilaterally	I-bodyloc
.	O

(	O
Medical	O
Transcription	O
Sample	O
Report	O
)	O

Exacerbating	O
factors	O
:	O
stress	O
,	O
weight	O
gainandskipping	O
medications	O
,	O
but	O
not	O
exacerbated	O
by	O
alcohol	O
use	O
.	O

MUSCULOSKELETAL	O
:	O
no	B-negation
muscle	B-bodyloc
pain	O
and	O
no	B-negation
muscle	B-bodyloc
weakness	O
.	O

MetFORMIN	O
HCl	O
1000	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
EVERY	B-frequency
12	I-frequency
HOURS	I-frequency
DAILY	I-frequency
Requested	O
for	O
:	O
29Oct2013	B-temporal
;	O
Last	O
Rx	O
:	O
29Oct2013	B-temporal
;	O
Status	O
:	O
ACTIVE	O
-	O
Retrospective	O
Authorization	O

General	O
appearance	O
:	O
NormalNAD	O
.	O

Patient	O
was	O
at	O
VA	O
hospital	O
1	B-temporal
month	I-temporal
ago	I-temporal
where	O
he	O
had	O
tracheostomy	O
removed	O
and	O
rehab	O
for	O
left	O
sided	O
weakness	O
.	O

Chronic	O
Common	O
Migraine	O
(	O
Without	B-negation
Aura	O
)	O
346	O
.	O
70	O

Examination	O
of	O
the	O
neck	O
:	O
Abnormal	O
.	O
Bilateral	O
anterioe	O
cervical	B-bodyloc
LAD	O
.	O

Eyes	O

Paternal	O
history	O
of	O
Hypertension	O
V17	O
.	O
49	O

Novocain	O

Assessment	O
of	O
respiratory	O
effort	O
was	O
significant	O
for	O
normal	B-labvalue
respiratory	O
rhythm	O
and	O
effort	O
.	O

May	O
repeat	O
another	O
pill	O
prn	O
.	O

I	O
,	O
Zoran	O
Cupic	O
,	O
M	O
.	O
D	O
.	O
,	O
have	O
personally	O
reviewed	O
the	O
above	O
transcribed	O
note	O
and	O
I	O
agree	O
with	O
the	O
content	O
of	O
this	O
note	O
.	O

No	B-negation
hypoglycemia	O
.	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
LEE	O
BAR	O
-	O
ELI	O
,	O
M	O
.	O
D	O
.	O
;	O

Hypothyroidism	O
244	O
.	O
9	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
,	O
no	B-negation
cough	O
,	O
no	B-negation
shortness	O
of	O
breath	O
during	O
exertion	O
,	O
no	B-negation
orthopnea	O
and	O
no	B-negation
PND	O
.	O

Vitals	O
03Jun2013	B-temporal
11	B-temporal
:	I-temporal
40AM	I-temporal
BMI	O
Calculated	O
19	B-labvalue
.	I-labvalue
33	I-labvalue
BSA	O
Calculated	O
1	B-labvalue
.	I-labvalue
77	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
10	I-labvalue
in	I-labvalue
Weight	O
135	B-labvalue
lb	I-labvalue
Systolic	O
135	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
79	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Temperature	O
88	B-labvalue
F	I-labvalue
,	O
Oral	O

Results	O
/	O
Results	O
/	O
Data	O
Physical	O
Exam	O
Cholesterol	O
Urinalysis	O
Colonoscopy	O
EGD	O
EKG	O
Stress	O
Test	O
Echo	O
Cardiac	O
Cath	O
Peripheral	O
Vascular	O
Screen	O
Carotid	O
Vascular	O
Screen	O
AAA	O
ABI	O
/	O
PVR	O
Diabetes	O
Screen	O
Other	O
Mammogram	O
PAP	O
Dexa	O
Prostate	O
/	O
PSA	O

right	B-bodyloc
foot	I-bodyloc
drop	O

History	O
of	O
Present	O
Illness	O
40	O
y	O
/	O
o	O
G4	O
P2022	O
,	O
LMP	O
:	O
presents	O
8	O
weeks	O
post	O
-	O
op	O
from	O
RATLH	O
/	O
Dx	O
cystoscopy	O
on	O
11/1/2013	B-temporal
.	O

Systolic	O
:	O
120	B-labvalue
,	O
RUE	O
,	O
Sitting	O

0	I-reference_range
Segs	O
-	O
Batds	O
#	O
3	B-labvalue
.	I-labvalue
2	I-labvalue
K	I-labvalue
/	I-labvalue
CMM	I-labvalue
1	B-reference_range
.	I-reference_range
5	I-reference_range
-	I-reference_range
8	I-reference_range
.	I-reference_range

5	O
.	O

Current	O
Meds	O
Lexapro	O
10	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
21Nov2013	B-temporal
)	O
to	O

Results	O
/	O
Assessment	O
X	O
-	O
Ray	O
Chest	O
Lungs	O
Solitary	O
Pulmonary	O
Nodule	O
(	O
_	O
_	O
_	O
Cm	O
)	O
518	O
.	O
89	O

Furuncle	O
On	O
The	O
Face	B-bodyloc
680	O
.	O
0	O

History	O
of	O
Dementia	O
294	O
.	O
8	O

This	O
patient	O
is	O
symptomatically	O
improved	O
but	O
still	O
has	O
some	O
conductive	O
hearing	O
loss	O
.	O

-	O
-	O
Consider	O
repeat	O
MRI	O
after	O
next	O
visit	O
.	O

Results	O
/	O
Assessment	O

Assessment	O
of	O
muscle	O
strength	O
/	O
tone	O
:	O
Normal	B-labvalue
Tremor	O
(	O
s	O
)	O
:	O
right	O
upper	O
extremity	O
resting	O
tremorandleft	O
upper	B-bodyloc
extremity	I-bodyloc
resting	O
tremor	O
.	O

Benzonatate	O
100	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
EVERY	B-frequency
6	I-frequency
HOURS	I-frequency
AS	B-frequency
NEEDED	I-frequency
;	O
Therapy	O
:	O
08Oct2013	B-temporal
to	O
(	O
Evaluate	O
:	O
24Oct2013	B-temporal
)	O
;	O
Last	O
Rx	O
:	O
08Oct2013	B-temporal

Vagina	O
and	O
external	O
genitalia	O
:	O
Normal	O
.	O

Alcohol	O

Neurological	O
:	O
not	O
alert	O
,	O
no	B-negation
confusion	O
,	O
no	B-negation
convulsions	O
,	O
no	B-negation
tinnitus	O
,	O
no	B-negation
dizziness	O
,	O
no	B-negation
fainting	O
,	O
no	B-negation
tingling	O
,	O
no	B-negation
diplopia	O
,	O
no	B-negation
limb	B-bodyloc
weakness	O
,	O
no	B-negation
difficulty	O
walking	O
and	O
no	B-negation
dysesthesia	O
.	O

Active	O
Problems	O
Anxiety	O
(	O
Symptom	O
)	O
300	O
.	O
00	O

Maternal	O
history	O
of	O
Diabetes	O
Mellitus	O
V18	O
.	O
0	O

No	B-negation
FHx	O
of	O
CAD	O
but	O
mom	O
aunt	B-subject
had	O
uterine	B-bodyloc
cancer	O
and	O
grandmother	B-subject
had	O
breast	B-bodyloc
cancer	O
The	O
patient	O
states	O
her	O
hyperlipidemia	O
has	O
been	O
poorly	O
controlled	O
since	O
the	O
last	O
visit	O
.	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Vitals	O
UTP	O
Adult	O
Vital	O
Signs	O
[	O
Data	O
Includes	O
:	O
Current	O
Encounter	O
]	O

Examination	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue
The	O
neck	O
was	O
normal	O
in	O
appearanceand	O
was	O
supple	O
.	O

The	O
patient	O
presents	O
with	O
complaints	O
of	O
gradual	O
onset	O
of	O
intermittent	O
episodes	O
of	O
mild	B-severity
productive	O
cough	O
.	O

I	O
would	O
like	O
to	O
try	O
Tigan	O
300	B-strength
mg	I-strength
twice	B-frequency
a	I-frequency
day	I-frequency
to	O
see	O
if	B-condition
we	O
can	O
combat	O
his	O
nausea	O
.	O

OB	O
History	O

Birth	O
Weight	O
:	O
3880	B-labvalue
gms	I-labvalue
.	O

Mr	O
.	O
Thomas	O
is	O
a	O
49	O
year	O
old	O
AAM	O
who	O
has	O
a	O
h	O
/	O
o	O
DM	O
,	O
HTN	O
,	O
obesity	O
.	O

Examination	O
of	O
the	O
oropharynx	O
:	O
Normal	B-labvalue

I	O
was	O
present	O
and	O
available	O
in	O
clinic	O
.	O

Breath	O
sounds	O
were	B-negation
not	I-negation
diminished	O
.	O

Examination	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue
The	O
neck	O
was	O
normal	O
in	O
appearanceand	O
was	O
supple	O
.	O

RDW	O
:	O
13	B-labvalue
.	I-labvalue
6	I-labvalue
%	I-labvalue
Reference	O
Range	O
11	B-reference_range
.	I-reference_range
5	I-reference_range
-	I-reference_range
14	I-reference_range
.	I-reference_range
5	I-reference_range

Results	O
/	O
Assessment	O
Routine	O
Gynecological	O
Exam	O
V72	O
.	O
31	O

ABORH	O
:	O
O	B-labvalue
POS	I-labvalue

Assessment	O
Allergic	O
Rhinitis	O
477	O
.	O
9	O

Physical	O
Exam	O
General	O
appearance	O
:	O
Normal	B-labvalue
.	O

The	O
left	O
tympanic	O
membrane	O
was	O
normal	O
.	O

Please	O
contact	O
client	O
services	O
if	O
you	O
have	O
questions	O
at	O

Tobacco	O
Use	O

Immunizations	O

Chief	O
Complaint	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
vomiting	O
and	O
no	B-negation
nausea	O
.	O

left	O
ring	O
finger	O
flexor	O
digitorum	O
profundus	O
repair	O
9	O
.	O

Chest	O
:	O
Symmetrical	O
rise	O
and	O
fall	O
.	O

[	O
Q	O
]	O
N	O
.	O

Chief	O
Complaint	O
:	O

The	O
patient	O
has	O
normal	O
gums	O
.	O

The	O
abdomen	O
was	O
soft	O
and	O
nontender	O
.	O

Diarrhea	O
-	O
most	O
likely	O
viral	O
related	O
.	O

;	O
Oct	B-temporal
8	I-temporal
2012	I-temporal
6	B-temporal
:	I-temporal
54PM	I-temporal
(	O
Author	O
)	O

Ophthalmoscopic	O
examination	O
:	O
Normal	B-labvalue
.	O

Musculoskeletal	O
:	O
the	O
cervicothoracolumbar	O
/	O
sacral	O
spine	O
had	O
a	O
normal	O
appearance	O
,	O
normal	O
movements	O
of	O
all	O
extremities	O
,	O
muscle	O
strengthand	O
tone	O
were	O
normalandOrtoloni	O
and	O
Barlow	O
'	O
s	O
tests	O
were	O
negative	B-labvalue
.	O

General	O
appearance	O
:	O
Normal	O
Well	O
developedandwell	O
nourished	O
.	O

2	O
.	O

GroupHeading77Start	O
GroupHeading77End	O
GroupHeading42Start	O
GroupHeading42End	O
GroupHeading43Start	O
GroupHeading43End	O
GroupHeading44Start	O
GroupHeading44End	O
GroupHeading45Start	O
GroupHeading45End	O
GroupHeading46Start	O
GroupHeading46End	O
GroupHeading47Start	O
Musculoskeletal	O
Inspectisp	O
/	O
palpation	O
of	O
joints	O
,	O
bones	O
,	O
and	O
muscles	O
:	O
Noamal	B-labvalue
GroupHeading47End	O
GroupHeading48Start	O
GroupHeading48End	O
GroupHeading49Start	O
GroupHeading49End	O
GroupHeading50Start	O
GroupHeading50End	O
GroupHeading51Start	O
GroupHeading51End	O
GroupHeading52Start	O

Psychiatric	O

No	B-negation
bronchial	O
breath	O
sounds	O
were	O
heard	O
.	O

History	O
of	O
Present	O
Illness	O

Tiredness	O
:	O
None	B-negation

Review	O
of	O
Systems	O

Klor	O
-	O
Con	O
TBCR	O
;	O
8	B-strength
meq	I-strength
daily	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
20Aug2013	B-temporal
)	O
to	O

No	B-negation
wheezing	O
was	O
heard	O
.	O

Vitals	O
08Oct2012	B-temporal
05	B-temporal
:	I-temporal
29PM	I-temporal
08Oct2012	B-temporal
04	B-temporal
:	I-temporal
47PM	I-temporal
BMI	O
Calculated	O
30	B-labvalue
.	I-labvalue
07	I-labvalue
BSA	O
Calculated	O
2	B-labvalue
.	I-labvalue
13	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
10	I-labvalue
in	I-labvalue
Weight	O
210	B-labvalue
lb	I-labvalue
Systolic	O
176	B-labvalue
,	O
RUE	O
,	O
Sitting	O
160	B-labvalue
Diastolic	O
92	B-labvalue
,	O
RUE	O
,	O
Sitting	O
100	O
Temperature	O
97	B-labvalue
.	I-labvalue
6	I-labvalue
F	I-labvalue
Heart	O
Rate	O
64	B-labvalue
Respiration	O
20	B-labvalue

Omeprazole	O
20	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
Delayed	I-form
Release	I-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
18Oct2012	B-temporal
)	O
to	O

Allergies	O
1	O
.	O

Cranial	O
Nerves	O
IX	O
and	O
X	O
:	O
there	O
was	O
normal	B-labvalue
movement	O
of	O
the	O
soft	O
palate	O
and	O
normal	B-labvalue
gag	O
.	O

Small	O
,	O
reversible	O
,	O
severe	B-severity
perfusion	O
defect	O
involving	O
the	B-bodyloc
LAD	I-bodyloc
territory	I-bodyloc
.	O

Debridement	O
:	O
None	B-negation
,	O

Edited	O

Chest	B-bodyloc
burning	O
,	O
mild	B-severity
SOB	O

[	O
QLH	O
]	O
HEMOGLOBIN	O
A1c	O
Requested	O
for	O
:	O
21Mar2012	B-temporal

Nausea	O
With	O
Vomiting	O
787	O
.	O
01	O

At	O
discharge	O
her	O
ANC	O
is	O
back	O
up	O
to	O
1100	B-labvalue
and	O
she	O
is	O
taken	B-negation
off	I-negation
neutropenic	O
diet	O
.	O

Mean	O
Platelet	O
Volume	O
9	B-labvalue
.	I-labvalue
0	I-labvalue
fL	I-labvalue
7	B-reference_range
.	I-reference_range
4	I-reference_range
-	I-reference_range
10	I-reference_range
.	I-reference_range
4	I-reference_range

Last	O
pap	O
1	B-temporal
.	I-temporal
5	I-temporal
years	I-temporal
ago	I-temporal
WNL	B-labvalue

3	O
.	O

(	O
713	O
)	O
486	O
-	O
1700	O
(	O
Work	O
pEone	O
)	O
Created	O
March	O
1	O
,	O
2013	O
16	O
:	O
50	O
-	O
0600	O
By	O
ERIC	O
SABONGHY	O

Examination	O
of	O
the	O
extremities	O
revealed	O
no	B-negation
fingernail	O
clubbing	O
and	O
well	O
perfused	O
fingers	B-bodyloc
.	O

History	O
of	O
Hypertension	O
401	O
.	O
9	O

Examination	O
of	O
scrotal	O
contents	O
:	O
Normal	B-labvalue
.	O

GENERAL	O
:	O
He	O
is	O
alert	O
,	O
awake	O
,	O
pleasant	O
.	O

SUMAtriptan	O
Succinate	O
50	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
EVERY	B-frequency
2	I-frequency
HOURS	I-frequency
AS	B-frequency
NEEDED	I-frequency
FOR	O
MIGRAINE	O
.	O

3	O
.	O

Past	O
Medical	O
History	O
1	O
.	O

Posterior	O
tibialis	O
:	O
right	O
1	O
+	O
and	O
left	O
1	O
+	O
.	O

Occupation	O
:	O
Retired	O

HEART	O
:	O
Regular	O
.	O

Thyroid	O
:	O
Normal	O
.	O

Attending	O
Note	O

ADMISSION	O
DIAGNOSES	O

The	O
trachea	O
was	O
midline	O
.	O

[	O
QLH	O
]	O
CBC	O
(	O
INCLUDES	O
DIFF	O
/	O
PLT	O
)	O
Done	O
:	O
12Jan2010	B-temporal
09	B-temporal
:	I-temporal
27AM	I-temporal

Examination	O
of	O
liver	O
and	O
spleen	O
:	O
Normal	B-labvalue
.	O

Routine	O
Gynecological	O
Exam	O
With	O
Cervical	O
Pap	O
Smear	O
V72	O
.	O
31	O

1	O
2	O
3	O
4	O
5	O
6	O
Influenza	O
30Oct2006	B-temporal
12Oct2007	B-temporal
22Oct2008	B-temporal
26Nov2008	B-temporal
08Oct2010	B-temporal
07Oct2011	B-temporal
Pneumococcal	O
14May2008	B-temporal
14May2008	B-temporal
Td	O
/	O
DT	O
2001	B-temporal
14Feb2000	B-temporal

MA	O
Bone	O
Density	O
DXA	O
Dual	O
Energy	O
77080	O
Requested	O
for	O
:	O
14Aug2013	B-temporal

Diabetes	O
Mellitus	O
With	O
Foot	B-bodyloc
Ulcer	O
250	O
.	O
80	O

significant	O
medial	B-bodyloc
joint	I-bodyloc
space	I-bodyloc
narrowing	O
,	O
no	B-negation
fracture	O
,	O
rx	O
:	O
naroxen	O
,	O
and	O
schedule	O
MRI	O
of	O
left	O
knee	O
.	O

Past	O
Medical	O
History	O
History	O
of	O
Asthma	O
493	O
.	O
90	O

[	O
QLH	O
]	O
HEMOGLOBIN	O
Done	O
:	O
10Dec2010	B-temporal
10	B-temporal
:	I-temporal
02AM	I-temporal

CoQ	O
-	O
10	O
CAPS	B-form
;	O
1200	B-strength
mg	I-strength
a	B-frequency
day	I-frequency
;	O
Status	O
:	O
ACTIVE	O

ALT	O
26	B-labvalue
u	I-labvalue
/	I-labvalue
l	I-labvalue
0	B-reference_range
-	I-reference_range
65	I-reference_range

Histisy	O
of	O
Tobacco	O
Use	O

SHE	O
DENIES	B-negation
ANY	O
RADIATION	O
OF	O
THE	O
PAIN	O
DOWN	O
HER	O
LEGS	B-bodyloc
,	O
AND	O
DENIES	B-negation
BOWEL	O
OR	O
BLADDER	B-bodyloc
INCONTINENCE	O
.	O

Benign	B-severity
Essential	O
Hypertension	O
401	O
.	O
1	O

Skin	O

Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

Genitourinary	O
:	O
normal	O
external	O
genitalia	O
,	O
no	B-negation
vaginal	B-bodyloc
discharge	O
,	O
normal	O
urethra	O
,	O
the	O
bladder	O
was	O
normal	O
on	O
palpationandthe	O
hymen	O
was	O
intact	O
.	O

Denied	O

Neck	O
:	O
Normal	O
.	O

Heme	O
/	O
Lymph	O
:	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
,	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
and	O
no	B-negation
swollen	O
glands	B-bodyloc
.	O

No	B-negation
masses	O
palpated	O
.	O

1	O
.	O

Tobacco	O
Use	O

Examination	O
of	O
gait	O
and	O
station	O
:	O
Abnormal	O
.	O

History	O
of	O
Intracranial	O
Stereotaxis	O
Globus	O
Pallidus	O

TraMADol	O
HCl	O
50	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
2	B-dosage
tabs	B-form
po	B-route
q	B-frequency
6	I-frequency
h	I-frequency
prn	B-frequency
pain	O
#	O
60	O
;	O
Therapy	O
:	O
06Apr2012	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
06Apr2012	B-temporal
)	O

Patient	O
Specific	O
Education	O
Given	O
Done	O
:	O
27Feb2014	B-temporal

Vaginal	O
delivery	O
.	O

AAA	O
:	O
NEVER	B-negation

Insomnia	O
780	O
.	O
52	O

Past	O
Medical	O
History	O
History	O
of	O
Acute	B-course
Upper	B-bodyloc
Respiratory	I-bodyloc
Infection	O
465	O
.	O
9	O

Dulcolax	O
10	B-strength
MG	I-strength
Rectal	B-form
Suppository	I-form
;	O
INSERT	O
1	B-dosage
SUPPOSITORY	B-form
RECTALLY	B-route
ONCE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
05Jun2012	B-temporal
)	O
to	O

Electronically	O
signed	O
by	O
:	O
VASEEM	O
ALI	O
,	O
M	O
.	O
D	O
.	O

Preventative	O
:	O
flu	O
shot	O
today	O
.	O

Examination	O
of	O
the	O
palate	O
showed	O
no	B-negation
abnormalities	O
.	O

Genitourinary	O
:	O
no	B-negation
dysuria	O
,	O
no	B-negation
urinary	O
frequency	O
,	O
no	B-negation
incontinence	O
and	O
no	B-negation
pain	O
.	O

Active	O
Problems	O
Type	O
2	O
Diabetes	O
Mellitus	O
250	O
.	O
00	O

5	O
.	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
vomiting	O
,	O
no	B-negation
diarrhea	O
and	O
no	B-negation
heartburn	O
.	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
Melissa	O
Thomas	O
,	O
M	O
.	O
D	O
.	O

I	O
have	O
seen	O
and	O
examined	O
CICOREY	O
HOLMES	O
with	O
the	O
resident	O
.	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
neck	O
:	O
Normal	B-labvalue
.	O

Percussion	O
of	O
chest	O
:	O
Normal	B-labvalue
.	O

Ability	O
to	O
communicate	O
:	O
Normal	B-labvalue
.	O

Inspection	O
of	O
the	O
nasal	O
mucosa	O
,	O
septum	O
and	O
turbinates	O
:	O
Normal	B-labvalue
.	O

Pt	O
also	O
complains	O
of	O
a	O
wart	O
on	O
the	O
3rd	O
digit	O
of	O
the	O
L	B-bodyloc
hand	I-bodyloc
near	O
the	O
knuckle	O
.	O

Cranial	O
nerves	O
VIII	O
:	O
hearing	O
was	O
intact	B-labvalue
.	O

Sodium	O
is	O
107	B-labvalue
,	O
with	O
68	B-labvalue
chloride	O
and	O
potassium	O
of	O
2	B-labvalue
.	I-labvalue
8	I-labvalue
.	O

Musculoskeletal	O

This	O
is	O
similar	O
to	O
a	O
Medrol	O
Dosepack	O
.	O

ActiveProblems	O
_	O
10	O
_	O
twCiteListControlEnd	O
ActiveProblemsSectispEnd	O
HistisyofPresentIllnessSectispStart	O
Histisy	O
of	O
Present	O
Illness	O

Examination	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue
.	O

Peripheral	O
Vision	O
:	O
Normal	B-labvalue
(	O
full	O
)	O
.	O

Betaxolol	O
HCl	O
0	B-strength
.	I-strength
5	I-strength
%	I-strength
Ophthalmic	B-route
Solution	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
16Sep2013	B-temporal
)	O
to	O

Constitutional	O
:	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
,	O
not	B-negation
feeling	O
poorly	O
(	O
malaise	O
)	O
,	O
not	B-negation
feeling	O
tired	O
(	O
fatigue	O
)	O
,	O
no	B-negation
recent	B-temporal
weight	O
gain	O
and	O
no	B-negation
recent	B-temporal
weight	O
loss	O
.	O

Review	O
of	O
Systems	O

Inspection	O
of	O
lips	O
,	O
teethand	O
gums	O
:	O
Normal	B-labvalue

NovoLOG	O
FlexPen	O
100	B-strength
UNIT	I-strength
/	I-strength
ML	I-strength
Subcutaneous	B-route
Solution	B-form
;	O
ICR	O
1	O
:	O
12	O
(	O
B	O
&	O
L	O
)	O
;	O
1	O
:	O
15	O
-	O
18	O
(	O
S	O
)	O
;	O
CF	O
~	O
70	O
;	O
up	O
to	O
20	O
units	O
aday	O
;	O
Therapy	O
:	O
24Nov2012	B-temporal
to	O

There	O
is	O
no	B-negation
radiation	O
.	O

HIB	O
;	O
05	B-temporal
Oct	I-temporal
2007	I-temporal

congestion	O
,	O
head	B-bodyloc
pressure	O
,	O
drainage	O
,	O
coughing	O
,	O
wheezing	O
x	O
2	O
-	O
3	O
days	O
jrcma	O
2	O
.	O
)	O
"	O
foot	O
and	O
leg	B-bodyloc
cramping	O
"	O
possibly	O
due	O
to	O
lasix	O
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Heart	O
sounds	O
:	O
normal	B-labvalue
S1	O
,	O
normal	B-labvalue
S2	O
,	O
no	B-negation
gallop	O
heard	O
,	O
no	B-negation
S3	O
,	O
no	B-negation
S4	O
and	O
no	B-negation
click	O
.	O

Pulmonary	O

Surgical	O
History	O
History	O
of	O
Cesarean	O
Section	O
Low	O
Transverse	O

Psychiatric	O

History	O
of	O
Present	O
Illness	O
The	O
patient	O
states	O
he	O
has	O
been	O
stable	O
with	O
his	O
Type	O
II	O
Diabetes	O
control	O
since	O
the	O
last	O
visit	O
.	O

Carotid	O
pulses	O
:	O
Normal	B-labvalue
.	O

Recent	O
and	O
remote	O
memory	O
:	O
Normal	B-labvalue

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Constitutional	O

History	O
of	O
Type	O
2	O
Diabetes	O
Mellitus	O
250	O
.	O
00	O

Bowel	O
and	O
bladder	O
function	O
returned	O
quickly	O
.	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Anesthesia	O
:	O
Topical	B-route
lidocaine	O
spray	B-form
and	O
Topical	B-route
oxymetazoline	O
spray	B-form
.	O

Surgical	O
History	O
History	O
of	O
Carotid	O
Thromboendarterectomy	O
Bilateral	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Neurologic	O

Assessment	O
of	O
muscle	O
strength	O
/	O
tone	O
:	O
Normal	B-labvalue

Assessment	O
Health	O
Maintenance	O
V70	O
.	O
0	O

Previous	B-temporal
Surgery	O
:	O
No	B-negation
.	O

Electronically	O
signed	O
by	O
:	O
JULIA	O
ADROGUE	O
,	O
M	O
.	O
D	O
.	O

History	O
of	O
Migraine	O
Headache	O
346	O
.	O
90	O

Sleep	O
Medicine	O
Referral	O
Outpatient	O
Referral	O
Status	O
:	O
Complete	O
Done	O
:	O
07Aug2013	B-temporal

She	O
recently	O
had	O
her	O
Prolia	O
shot	O
,	O
which	O
she	O
needs	O
every	O
six	O
months	O
,	O
on	O
August	B-temporal
1	I-temporal
,	I-temporal
2013	I-temporal
at	O
the	O
OBGYN	O
,	O
and	O
has	O
no	B-negation
more	O
shots	O
prescribed	O
.	O

Never	O
A	O
Smoker	O

Carotid	O
pulses	O
:	O
Normal	B-labvalue
.	O

Inspection	O
of	O
the	O
nasal	O
mucosa	O
,	O
septum	O
and	O
turbinates	O
:	O
Normal	B-labvalue
.	O

Genitourinary	O

Alert	O
and	O
cooperative	O
.	O

A1	O
pulley	O
release	O
10	O
.	O

Overall	O
,	O
she	O
states	O
that	O
her	O
headaches	O
and	O
head	B-bodyloc
pains	O
are	O
overall	B-course
better	I-course
and	O
have	O
improved	B-course
.	O

Symptoms	O
:	O
Denies	B-negation
chest	B-bodyloc
pain	O
,	O
denies	B-negation
intermittent	O
leg	B-bodyloc
claudication	O
,	O
denies	B-negation
muscle	B-bodyloc
pain	O
and	O
denies	B-negation
muscle	B-bodyloc
weakness	O
.	O

Systolic	O
:	O
112	B-labvalue
,	O
LUE	O
,	O
Sitting	O

Electronically	O
signed	O
by	O
:	O
SAMER	O
FAKHRI	O
,	O
M	O
.	O
D	O
.	O

Review	O
of	O
Systems	O

BCM	O
:	O
desires	O
IUD	O

The	O
abdomen	O
was	O
soft	O
and	O
nontender	O
.	O

Pain	O
interferes	O
with	O
ADLs	O
.	O

Surgical	O
History	O
History	O
of	O
Tubal	O
Ligation	O
V25	O
.	O
2	O

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

Always	O
clear	O
,	O
runs	O
posteriorly	O
mostly	O

The	O
patient	O
is	O
accompanied	O
with	O
her	O
mother	O
today	B-temporal
.	O

History	O
of	O
Drug	O
Use	O

I	O
agree	O
with	O
all	O
components	O
of	O
the	O
exam	O
.	O

Chief	O
Complaint	O

Surgical	O
History	O
Problems	O

Unclothed	O
pEnd	O
Grouexamination	O
including	O
length	O
,	O
weight	O
and	O
FOC	O

Colpo	O
,	O
cervical	O
bx	O
'	O
s	O
,	O
ECC	O
,	O
pap	O
done	B-temporal
today	I-temporal
.	O

or	O
a	O
specimen	O
was	O
not	O
available	O
from	O
your	O
office	O
.	O

I	O
personally	O
examined	O
the	O
patient	O
with	O
the	O
resident	O
I	O
agree	O
with	O
:	O
all	O
the	O
components	O
of	O
the	O
exam	O
.	O

Assessment	O
of	O
muscle	O
strength	O
/	O
tone	O
:	O
Normal	B-labvalue
.	O

Obstructive	O
Sleep	O
Apnea	O
327	O
.	O
23	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
other	O
areas	O
:	O
No	B-negation
lymphadenopathy	O
.	O

History	O
of	O
Tubal	O
Ligation	O
V25	O
.	O
2	O

PULMONARY	O
:	O
no	B-negation
wheeze	O
,	O
rales	O
or	O
crackles	O
,	O
clear	B-labvalue
to	O
auscultation	O
bilateraily	O
.	O

GroupHeading85End	O
GroupHeading32Start	O
Abdomen	O
Examinatisp	O
of	O
the	O
abdomen	O
:	O
Noamal	B-labvalue
GroupHeading32End	O
GroupHeading33Start	O
GroupHeading33End	O
GroupHeading34Start	O
GroupHeading34End	O
GroupHeading35Start	O
GroupHeading35End	O
GroupHeading36Start	O
GroupHeading36End	O
GroupHeading37Start	O
GroupHeading37End	O
GroupHeading38Start	O
GroupHeading38End	O
GroupHeading39Start	O
GroupHeading39End	O
GroupHeading40Start	O
GroupHeading40End	O
GroupHeading41Start	O
GroupHeading41End	O
GroupHeading75Start	O
GroupHeading75End	O
GroupHeading76Start	O
GroupHeading76End	O

Assessmept	O
_	O
80	O
_	O
twCiteListControlStart	O
Esseptial	O
Hypertension	O
401	O
.	O
9	O

Joint	B-bodyloc
Pain	O
,	O
Localized	O
In	O
The	O
Knee	O
719	O
.	O
46	O

HistisyofPreseptIllnessSectispEnd	O
PhytucalExamSectispStart	O
Phytucal	O
Exam	O

[	O
QLH	O
]	O
CMP	O
W	O
/	O
EGFR	O
11Jun2013	B-temporal
05	B-temporal
:	I-temporal
15PM	I-temporal
GUPTA	O
,	O
aASHISH	O
Test	O
Name	O
Result	O
Flag	O
Reference	O
ALT	O
15	B-labvalue
u	I-labvalue
/	I-labvalue
l	I-labvalue
0	B-reference_range
-	I-reference_range
65	I-reference_range
Albumin	O
Lvl	O
4	B-labvalue
.	I-labvalue
3	I-labvalue
g	I-labvalue
/	I-labvalue
dl	I-labvalue
3	B-reference_range
.	I-reference_range
5	I-reference_range
-	I-reference_range
5	I-reference_range
.	I-reference_range

Heart	O
Rate	O
:	O
80	B-labvalue

7	B-temporal
/	I-temporal
2011	I-temporal
.	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
neck	O
:	O
Normal	B-labvalue
.	O

Abdominal	O
aorta	O
:	O
Normal	O

A	O
mammogram	O
was	O
performed	O
.	O

No	B-negation
masses	O
were	O
palpated	O
.	O

-	O
-	O
may	O
be	O
dry	O
mouth	B-bodyloc
from	O
his	O
mouth	B-bodyloc
breathing	O
and	O
/	O
or	O
some	O
of	O
his	O
medications	O
.	O

Progesterone	O
Micronized	O
100	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
BEDTIME	B-frequency
;	O
Therapy	O
:	O
03Sep2013	B-temporal
to	O
(	O
Evaluate	O
:	O
31May2014	B-temporal
)	O
Requested	O
for	O
:	O
18Sep2013	B-temporal
;	O
Last	O
Rx	O
:	O
03Sep2013	B-temporal

Pupils	O
were	O
equal	O
in	O
size	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
.	O

Of	O
note	O
,	O
there	O
are	O
no	B-negation
other	O
enhancing	O
solid	O
masses	O
seen	O
on	O
this	O
MRI	O
.	O

patientsaand	O
thoseawith	O
seriousaco	O
-	O
morbidaconditions	O
.	O

Sensory	O
exam	O
:	O
intact	B-labvalue
to	O
light	O
touch	O
.	O

General	O
appearance	O
:	O
Normal	B-labvalue

3	O
.	O

No	B-negation
hepatosplenomegaly	O
,	O
no	B-negation
masses	O
,	O
no	B-negation
hernia	O
.	O

Review	O
of	O
Systems	O

Obstructive	O
Hypertrophic	O
Cardiomyopathy	O
425	O
.	O
1	O

No	B-negation
posterior	O
cervical	O
node	O
enlargement	O
and	O
no	B-negation
supraclavicular	B-bodyloc
node	I-bodyloc
enlargement	O
.	O

Review	O
of	O
Systems	O

eGFR	O
If	O
NonAfricn	O
Am	O
:	O
87	B-labvalue
mL	I-labvalue
/	I-labvalue
min	I-labvalue
/	I-labvalue
1	I-labvalue
.	I-labvalue
7	I-labvalue
Reference	O
Range	O
>	B-reference_range
59	I-reference_range

Constitutional	O

;	O
Dec	B-temporal
5	I-temporal
2011	I-temporal
3	B-temporal
:	I-temporal
40PM	I-temporal
(	O
Author	O
)	O

Anemia	O
Of	O
Chronic	B-course
Kidney	B-bodyloc
Disease	O
285	O
.	O
21	O

Salivary	O
glands	O
:	O
No	B-negation
parotid	B-bodyloc
gland	I-bodyloc
mass	O
/	O
tenderness	O
.	O

ALLERGIES	O
:	O
PENICILLIN	O
AND	O
CODEINE	O
.	O

ENT	O
:	O
no	B-negation
earache	O
,	O
no	B-negation
hearing	O
loss	O
,	O
no	B-negation
epistaxis	O
,	O
no	B-negation
nasal	B-bodyloc
discharge	O
,	O
no	B-negation
sore	O
throat	B-bodyloc
and	O
no	B-negation
hoarseness	O
.	O

Vagina	O
and	O
external	O
genitalia	O
:	O
Normal	O
.	O

Head	O
and	O
face	O
:	O
Abnormal	O
.	O

Solitasy	O
Thyroid	B-bodyloc
Nodule	O
241	O
.	O
0	O

Urine	O
Dipstick	O
(	O
In	O
Office	O
)	O
Done	O
:	O
17Feb2014	B-temporal
11	B-temporal
:	I-temporal
33AM	I-temporal

Bladder	O
:	O
Not	B-negation
distended	O
,	O
no	B-negation
tenderness	O
.	O

Previous	B-temporal
Surgery	O
:	O
No	B-negation
.	O

He	O
works	O
as	O
an	O
antique	O
dealer	O
.	O

2	O
.	O

External	O
genitalia	O
:	O
normal	O
.	O

Oropharynx	O
:	O
Normal	O
.	O

RTO	O
3	B-temporal
-	I-temporal
6	I-temporal
months	I-temporal
,	O
sooner	O
if	O
needed	O
.	O

Physical	O
Exam	O

REPORT	O
COMMENT	O
:	O

Thigh	O
(	O
obtur	O
.	O
)	O
:	O
Normal	O
.	O

WWE	O

Cranial	O
nerves	O
VIII	O
:	O
hearing	O
was	O
intact	B-labvalue
.	O

When	O
he	O
was	O
a	O
ninth	O
-	O
grade	O
the	O
spells	O
diminished	O
in	O
frequency	O
and	O
intensity	O
and	O
then	O
completely	O
stopped	O
.	O

UPT	O
:	O
positive	O

Never	O
Drank	O
Alcohol	O

Respiratory	O
:	O
no	O
shortness	O
of	O
breathand	O
no	B-negation
wheezing	O
.	O

Visit	O
For	O
:	O

Pneumo	O
;	O
every	O
5	O
years	O
;	O
Last	O
05Dec2007	B-temporal
;	O
Deferred	O
11Feb2013	B-temporal
;	O
Status	O
:	O
Temporary	O
Deferral	O

General	O
appearance	O
:	O
Normal	B-labvalue
.	O

Sample	O
Name	O
:	O
Death	O
Summary	O
-	O
1	O

He	O
struggles	O
with	O
eyelid	O
apraxia	O
and	O
dystonic	O
eye	B-bodyloc
movements	O
.	O

Inspection	O
of	O
the	O
nasal	O
mucosa	O
,	O
septum	O
and	O
turbinates	O
:	O
Normal	B-labvalue
.	O

Family	O
History	O
Family	O
history	O
of	O
No	O
Significant	O
Family	O
History	O

Abdomen	O

LT	O

Max	O
:	O
Normal	B-labvalue

Neurologic	O

Ankle	O
Clonus	O
absent	B-negation
on	O
the	O
right	O
and	O
absent	O
on	O
the	O
left	O
.	O

UTP	O
-	O
OB	O
/	O

Healthcare	O
Providers	O

Constitutional	O

Of	O
note	O
,	O
patient	O
is	O
a	O
nonsmoker	O
.	O

Continue	O
with	O
ice	O
,	O
compression	O
and	O
elevation	O
.	O

Cranial	O
nerves	O
VII	O
:	O
facial	O
strength	O
was	O
intact	B-labvalue
bilaterally	O
.	O

Past	O
Medical	O
History	O
History	O
of	O
Anxiety	O
(	O
Symptom	O
)	O
300	O
.	O
00	O

1	O
.	O

Assessment	O
of	O
respiratory	O
effort	O
was	O
significant	O
for	O
no	O
accessory	O
muscle	O
use	O
,	O
no	B-negation
air	O
hunger	O
,	O
no	B-negation
respiratory	O
distress	O
,	O
no	B-negation
nasal	B-bodyloc
flaring	O
,	O
respirations	O
were	O
not	B-labvalue
shallow	I-labvalue
,	O
no	B-negation
splinting	O
,	O
no	B-negation
intercostal	O
retractions	O
and	O
no	B-negation
subcostal	O
retractions	O
.	O

Postmenopausal	B-bodyloc
Osteoporosis	O
733	O
.	O
01	O

Drug	O
Use	O

Denied	O

His	O
discharge	O
chest	O
x	O
-	O
ray	O
was	O
notable	O
for	O
only	O
a	O
resolving	B-course
left	B-bodyloc
pleural	O
effusion	O
.	O

I	O
have	O
discussed	O
the	O
case	O
with	O
the	O
resident	O
and	O
agree	O
with	O
the	O
diagnosis	O
of	O
Generalized	O
dystonia	O
;	O
Jaw	B-bodyloc
opening	O
dystonia	O
;	O
DBS	O
programming	O
for	O
dystonia	O
symptoms	O
;	O
botulinum	O
toxin	O
ijections	O
.	O

The	O
patient	O
states	O
that	O
he	O
would	O
have	O
gone	O
to	O
see	O
his	O
regular	O
dentist	O
but	O
he	O
has	O
missed	O
so	O
many	O
appointments	O
that	O
they	O
now	O
do	O
not	O
allow	O
him	O
to	O
schedule	O
regular	O
appointments	O
,	O
he	O
has	O
to	O
be	O
on	O
standby	O
appointments	O
only	O
.	O

Total	O
thyroidectomy	O
.	O

repair	O
of	O
lacerations	O
,	O
20	O
-	O
cm	O
11	O
.	O

Examination	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue

The	O
patient	O
is	O
doing	O
well	O
with	O
her	O
blood	O
pressure	O
goals	O
.	O

General	O
appearance	O
:	O
Normal	B-labvalue
.	O

Coordination	O
:	O
Normal	B-labvalue
.	O

She	O
has	O
h	O
/	O
o	O
chlamydia	O
in	O
pregnancy	O
,	O
treated	O
with	O
negative	O
TOC	O
.	O

Patient	O
stopped	O
smoking	O
2	B-temporal
weeks	I-temporal
ago	I-temporal
and	O
states	O
he	O
feels	O
fatigued	O
and	O
agitated	O
.	O

Symptoms	O
are	O
improved	B-course
by	O
NSAIDs	O
.	O

[	O
QLH	O
]	O
TSH	O
,	O
3RD	O
GENERATION	O
Requested	O
for	O
:	O
21Nov2013	B-temporal

Neurologic	O

Associated	O
Symptoms	O
:	O
recent	B-temporal
weight	O
loss	O
,	O
but	O
no	B-negation
frequent	O
falls	O
.	O

She	O
is	O
too	O
symptomatic	O
with	O
pain	O
for	O
external	O
bracing	O
or	O
additional	O
physical	O
therapy	O
.	O

Patient	O
Specific	O
Education	O
Given	O
Done	O
:	O
04Sep2013	B-temporal

Gait	O
:	O
ataxic	O
.	O

Normal	O
mood	O
and	O
affect	O
.	O

History	O
of	O
Total	O
Abdominal	O
Hysterectomy	O
V45	O
.	O
77	O

Examination	O
of	O
gait	O
and	O
station	O
:	O
Normal	B-labvalue
.	O

No	B-negation
varicosities	O
.	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

Throat	O
,	O
Neck	O
,	O
and	O
Back	O

Diabetes	O
Mellitus	O
250	O
.	O
00	O

"	O
Alcohol	O

Demerol	O
SOLN	B-form

0	I-reference_range
Glucose	O
Lvl	O
74	B-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
70	B-reference_range
-	I-reference_range
99	I-reference_range
Adult	O
referencearange	O
values	O
reflect	O
the	O
clinical	O
guidelines	O

4	O
.	O

Cesarean	O
Delivery	O
-	O
Delivered	O
669	O
.	O
71	O

f	O
EOB	O
,	O
Provider	O
:	O
SCHROEDER	O
,	O
BARBARA	O
,	O
Status	O
:	O
Pen	O
,	O
Time	O
:	O
1	B-temporal
:	I-temporal
45	I-temporal
PM	I-temporal
06/05/2013	B-temporal

Comment	O
:	O
Vidri	O
e	O
,	O
Susan	O
-	O
26	B-temporal
Jul	I-temporal
2013	I-temporal
3	B-temporal
:	I-temporal
37	I-temporal
PM	I-temporal
TASK	O
CREATED	O

Pelvic	O
Ultrasound	O
showed	O
normal	B-labvalue
left	I-labvalue
ovary	I-labvalue
,	O
but	O
right	B-bodyloc
ovary	I-bodyloc
with	O
2cm	O
and	O
3cm	O
simple	O
cysts	O
.	O

She	O
has	O
not	O
been	O
exercising	O
.	O

Patient	O
denies	B-negation
any	O
chest	B-bodyloc
pain	O
,	O
SOB	O
,	O
DOE	O
,	O
no	B-negation
syncopy	O
,	O
no	B-negation
dizziness	O
,	O
no	B-negation
palpitations	O
,	O
no	B-negation
LE	B-bodyloc
edema	O
,	O
no	B-negation
orhtopnea	O
,	O
no	B-negation
PND	O
.	O

Emergency	O
Contact	O
:	O
INNER	O
WISDOM	O
,	O
UNK	O
Document	O
Details	O
SUMMARIZATION	O
OF	O
EPISODE	O
NOTE	O
Encounter	O
March	B-temporal
1	I-temporal
,	I-temporal
2013	I-temporal
16	B-temporal
:	I-temporal
50	I-temporal
+	I-temporal
0000	O
From	O
Enterprise	O
EHR	O
11	O
.	O
200	O
.	O
4288	O
.	O

We	O
discussed	O
the	O
available	O
treatments	O
and	O
nutritional	O
therapies	O
.	O

Examination	O
for	O
hernias	O
:	O
Normal	B-labvalue
.	O

Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

Brain	B-bodyloc
Cancer	O
191	O
.	O
9	O

Eyes	O
:	O
no	B-negation
quadrantanopsia	O
.	O

PSYCHIATRIC	O
:	O
Judgment	O
and	O
insight	O
adequate	O
.	O

The	O
patient	O
presents	O
with	O
complaints	O
of	O
vomiting	O
(	O
nausea	O
and	O
vomiting	O
-	O
started	O
6	B-temporal
days	I-temporal
ago	I-temporal
Not	B-negation
vomiting	O
at	O
present	B-temporal
but	O
still	O
nauseated	O
.	O

Levothyroxine	O
Sodium	O
75	B-strength
MCG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
AS	I-frequency
DIRECTED	I-frequency
;	O
Therapy	O
:	O
05Sep2012	B-temporal
to	O

Active	O
Problems	O
Abnormal	O
Liver	B-bodyloc
Function	O
Test	O
790	O
.	O
6	O

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

Consent	O
:	O
Risks	O
/	O
benefits	O
/	O
alternatives	O
reviewed	O
.	O

Dr	O
.	O
Malhotra	O
is	O
a	O
31	O
year	O
old	O
radiologist	O
with	O
the	O
h	O
/	O
o	O
bilateral	O
EAC	O
atresia	O
and	O
left	O
atresia	O
repair	O
many	B-temporal
years	I-temporal
ago	I-temporal
,	O
at	O
the	B-temporal
age	I-temporal
of	I-temporal
5	I-temporal
.	O

Plan	O
Anxiety	O
(	O
Symptom	O
)	O
(	O
300	O
.	O
00	O
)	O

Previous	B-temporal
nasal	B-bodyloc
fracture	O
:	O
No	B-negation

Pulmonary	O

Test	O
Performed	O
at	O
:	O

Symptoms	O
are	O
unchanged	O
.	O

Basos	O
:	O
0	B-labvalue
%	I-labvalue
Reference	O
Range	O
0	B-reference_range
-	I-reference_range
3	I-reference_range

Prior	O
pregnancies	O
:	O
.	O

Followup	O
Instructions	O
:	O

Headache	O
784	O
.	O
0	O

Name	O
:	O
Diabetes	O
Mellitus	O
-	O
SOAP	O
Note	O
-	O
2	O

Integumentary	O
:	O
no	B-negation
skin	B-bodyloc
lesions	O
,	O
no	B-negation
skin	B-bodyloc
wound	O
,	O
no	B-negation
pruritus	O
,	O
no	B-negation
change	O
in	O
a	O
mole	B-bodyloc
,	O
no	B-negation
dry	O
skin	B-bodyloc
and	O
no	B-negation
unusual	O
growth	O
on	O
the	O
skin	B-bodyloc
.	O

Cervical	O
Spine	O
:	O
Normal	O
(	O
showed	O
no	B-negation
tenderness	O
on	O
palpation	O
)	O
.	O

History	O
of	O
Present	O
Illness	O

Height	O
Comments	O
:	O
Reported	O

Interval	O
symptoms	O
:	O
denies	B-negation
irregular	O
menses	O
,	O
stable	B-course
amenorrhea	O
,	O
denies	B-negation
menorrhagia	O
,	O
stable	B-course
weight	O
gain	O
,	O
denies	B-negation
acne	O
,	O
denies	O
hirsutismanddenies	O
hair	O
loss	O
.	O

History	O
of	O
Present	O
Illness	O

Cholesterol	O
Education	O
Program	O
(	O
ATP	O
III	O
,	O
2001	O
)	O
.	O

Feeling	O
well	O
.	O

Paternal	B-subject
grandmother	I-subject
'	I-subject
s	I-subject
history	O
of	O
Diabetes	O
Mellitus	O
V18	O
.	O
0	O

JBRN	O

Denied	O

I	O
personally	O
performed	O
the	O
following	O
critical	O
portion	O
of	O
the	O
exam	O
:	O
all	O

Paternal	B-subject
history	O
of	O
Cancer	O

Patient	O
Specific	O
Education	O
Given	O
Done	O
:	O
13Dec2013	B-temporal

[	O
O	O
]	O
Xray	O
CHEST	O
2	O
VIEWS	O
FRONTAL	O
AND	O
LATERAL	O
Requested	O
for	O
:	O
21Mar2012	B-temporal

Examination	O
of	O
gait	O
and	O
station	O
:	O
Normal	B-labvalue
.	O

No	B-negation
rhonchi	O
were	O
heard	O
.	O

Social	O
History	O
Marital	O
History	O
-	O
Currently	O
Married	O

Symptoms	O
:	O
The	O
patient	O
is	O
currently	B-temporal
asymptomatic	O
.	O

f	O
Routine	O
Gynecologatal	O
Exam	O
WitH	O
Cervical	O
Pap	O
Smear	O
(	O
V72	O
.	O
31	O
)	O
;	O
(	O
Active	O
)	O

Family	O
history	O
of	O
CABG	O
(	O
CABG	O
)	O

[	O
L	O
]	O
CBC	O
+	O
Platelet	O
+	O
Hem	O
Review	O
Requested	O
for	O
:	O
16Nov2012	B-temporal

Retrospective	O
Authorization	O

Examination	O
of	O
digits	O
and	O
nails	O
:	O
Normal	B-labvalue
.	O

Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

Exposed	O
To	O
Herpes	O
Zoster	O
V01	O
.	O
79	O

Radial	O
lateral	O
collateral	O
ligament	O
repair	O
3	O
.	O

Denise	O
Hansen	O
,	O
PA	O
Phys	O
cian	O
Assistant	O

External	O
inspection	O
of	O
ears	O
and	O
nose	O
:	O
Normal	B-labvalue
.	O

Reflexes	O
:	O
2	B-labvalue
+	I-labvalue
and	O
symmetric	B-labvalue
.	O

Saw	O
a	O
GI	O
dr	O
who	O
did	O
an	O
US	O
and	O
was	O
told	O
to	O
have	O
her	O
L	O
ovary	O
checked	O
out	O
.	O

Episodes	O
started	O
2	B-temporal
days	I-temporal
ago	I-temporal
.	O

Inspection	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
AbnormalDermatophytosis	O
of	O
the	O
feet	O
right	O
mose	O
than	O
left	O
,	O
dried	O
,	O
scally	O
skin	B-bodyloc
on	O
feet	B-bodyloc
,	O
no	B-negation
cellulitis	O
,	O
no	B-negation
necrosis	O
,	O
no	B-negation
puncture	O
wound	O
,	O
no	B-negation
gangrene	O
.	O

Psychiatric	O
:	O
no	B-negation
sleep	O
disturbances	O
.	O

Palpation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

History	O
of	O
Present	O
Illness	O
26	O
y	O
/	O
o	O
G0	O
,	O
LMP	O
:	O
3/27/2013	B-temporal
,	O
presents	O
for	O
pregnancy	O
confirmation	O
.	O

Accu	O
-	O
Chek	O
SmartView	O
In	O
Vitro	O
Strip	O
;	O
Check	O
BG	O
4x	O
a	O
day	O
;	O
Therapy	O
:	O
15Apr2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
08May2013	B-temporal
)	O
Requested	O
for	O
:	O
08May2013	B-temporal

He	O
passed	O
the	O
stones	O
and	O
had	O
rebolution	O
of	O
his	O
hematuria	O
.	O

Proximal	B-bodyloc
formainal	I-bodyloc
narrowing	O
is	O
present	O
bilaterally	O
,	O
worse	O
on	O
the	O
right	O
.	O

Denied	O

Cellulitis	O
Of	O
The	O
Arm	B-bodyloc
682	O
.	O
3	O

CONSTITUTIONAL	O
:	O
no	B-negation
nausea	O
,	O
no	B-negation
recent	B-temporal
weight	O
gain	O
,	O
no	B-negation
recent	B-temporal
weight	O
loss	O
,	O
no	B-negation
fever	O
and	O
no	B-negation
chills	O

Family	O
History	O
Family	O
history	O
of	O
Cerebral	O
Artery	O
Occlusion	O

Bialteral	O
microtia	O
,	O
left	O
EAC	O
surgery	O
scar	O
,	O
right	O
BAHA	O
.	O

Evaluation	O
of	O
Associations	O
:	O
no	B-negation
deficiency	O
.	O

Recent	O
and	O
remote	O
memory	O
:	O
Normal	B-labvalue

FSBG	O
log	O
since	O
then	O
:	O

Review	O
of	O
Systems	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

On	O
[	O
*	O
*	O
2161-12-15	B-temporal
*	O
*	O
]	O
,	O
the	O
patient	O
underwent	O
an	O
ETT	O
for	O
CP	O
evaluation	O
.	O

Patient	O
underwent	O
anti	O
-	O
coagulation	O
tx	O
in	O
the	O
hospital	O
and	O
was	O
discharged	O
to	O
home	O
in	O
good	O
condition	O
on	O
POD	O
#	O
4	O
.	O

History	O
of	O
Insomnia	O
780	O
.	O
52	O

Of	O
note	O
,	O
discussing	O
possible	O
use	O
of	O
Topamax	O
,	O
she	O
reports	O
that	O
she	O
was	O
placed	O
on	O
Topamax	O
,	O
Lamictal	O
,	O
lithium	O
,	O
and	O
Zoloft	O
all	O
at	O
once	O
,	O
and	O
she	O
had	O
severe	B-severity
medication	O
side	O
effects	O
,	O
and	O
she	O
was	O
not	O
sure	O
if	O
this	O
was	O
due	O
to	O
the	O
Topamax	O
,	O
Lamictal	O
,	O
or	O
the	O
combination	O
of	O
all	O
4	O
medications	O
.	O

ENT	O
:	O
no	B-negation
epistaxis	O
.	O

Abdomen	O

Adnexa	O
/	O
parametria	O
:	O
Normal	O

No	B-negation
Known	O
Drug	O
Allergies	O

accession	O
number	O
.	O

The	O
patient	O
states	O
she	O
has	O
been	O
doing	O
well	O
with	O
her	O
blood	O
pressure	O
control	O
since	O
the	O
last	O
visit	O
.	O

The	O
thyroid	B-bodyloc
was	O
normaland	O
was	O
not	B-negation
enlarged	O
.	O

Musculoskeletal	O
:	O
.	O

Past	O
Medical	O
History	O
History	O
of	O
Bone	O
Pain	O
In	O
The	O
Knee	B-bodyloc

Secretions	O
:	O
None	B-negation

f	O
History	O
of	O
Gonococcal	O
Cervicitis	O
(	O
098	O
.	O
15	O
)	O
;	O
(	B-course
Resolved	I-course
)	O

Associated	O
symptoms	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
claudication	O
,	O
no	B-negation
syncope	O
,	O
no	B-negation
weakness	O
,	O
no	B-negation
paresthesias	O
and	O
no	B-negation
edema	O

Test	O
Name	O
Result	O
Flag	O
Reference	O
LEUKOCYTES	O
-	B-labvalue
NITRITE	O
-	B-labvalue
UROBILINOGEN	O
-	B-labvalue
PROTEIN	O
-	B-labvalue
pH	O
7	B-labvalue
O	O
URINE	O
BLOOD	O
-	B-labvalue
SPECIFIC	O
GRAVITY	O
1	B-labvalue
.	I-labvalue
005	I-labvalue
O	O
KETONES	O
-	B-labvalue
BILIRUBIN	O
-	B-labvalue
GLUCOSE	O
-	B-labvalue

(	O
peron	O
.	O
)	O
Strength	O
:	O
4	B-labvalue
+	I-labvalue
/	I-labvalue
5	I-labvalue
-	O
/	O
5	O
.	O

Family	O
history	O
of	O
Family	O
Health	O
Status	O
Siblings	O
1	O
Living	O
All	O
In	O
Good	O
Health	O

Assessment	O
of	O
range	O
of	O
motion	O
:	O
Abnormal	O
.	O
Abduction	O
of	O
lt	O
thigh	O
is	O
decreased	O
due	O
to	O
pain	O
and	O
stiffness	O
.	O

Inspection	O
of	O
lips	O
,	O
teethand	O
gums	O
:	O
Normal	B-labvalue

I	O
checked	O
PT	O
/	O
PTT	O
on	O
Monday	O
and	O
she	O
has	O
INR	O
subtherapeutic	O
1	B-labvalue
.	I-labvalue
77	I-labvalue
.	O

General	O
appearance	O
:	O
AbnormalObese	O
.	O

Currently	O
unemployed	O

Musculoskeletal	O

Genitourinary	O
:	O
no	B-negation
dysuria	O
and	O
no	B-negation
urinary	O
hesitancy	O
.	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
other	O
areas	O
:	O
Normal	B-labvalue
.	O

-	O
-	O
RTC	O
in	O
4	O
weeks	O
.	O

Biopsies	O
were	O
done	O
.	O

History	O
of	O
Present	O
Illness	O

Associated	O
symptoms	O
:	O
nauseaanddizziness	O
,	O
but	O
no	B-negation
loss	O
of	O
consciousness	O
.	O

Hypertension	O
401	O
.	O
9	O

Current	O
Meds	O
Clindamycin	O
HCl	O
300	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
1	B-dosage
tab	B-form
po	B-route
tid	B-frequency
x	O
10d	O
;	O
Therapy	O
:	O
10Oct2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
10Oct2013	B-temporal
)	O
Requested	O
for	O
:	O
10Oct2013	B-temporal

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Electronically	O
signed	O
by	O
:	O
DEEPA	O
VASUDEVAN	O
,	O
M	O
.	O
D	O
.	O

Examination	O
of	O
Tongue	O
:	O
Normal	B-labvalue
.	O

648	O
.	O
84	O

Glucose	O
Lvl	O
95	B-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
-	O

Perimenopausal	B-bodyloc
Menorrhagia	O
627	O
.	O
0	O

The	O
baby	O
is	O
a	O
boy	O
.	O

The	O
patient	O
does	O
not	B-negation
have	I-negation
any	O
known	O
heart	B-bodyloc
problems	O
;	O
high	O
blood	O
pressure	O
;	O
lung	B-bodyloc
problems	O
;	O
TB	O
;	O
diabetes	O
;	O
stomach	B-bodyloc
problems	O
;	O
kidney	B-bodyloc
problems	O
;	O
or	O
liver	B-bodyloc
problems	O
.	O

History	O
of	O
Esophageal	B-bodyloc
Reflux	O
530	O
.	O
81	O

2	O
.	O

Dermatophytosis	O
110	O
.	O
9	O

Psychiatric	O

Chest	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
and	O
no	B-negation
palpitations	O
.	O

Marital	O
History	O
-	O
Divorced	O
V61	O
.	O
0	O

Examination	O
of	O
pupils	O
and	O
irises	O
:	O
Normal	B-labvalue

I	O
have	O
seen	O
and	O
examined	O
THOMAS	O
TERRELL	O
with	O
the	O
resident	O
.	O

Integumentary	O
:	O
skin	O
lesionandskin	O
wound	O
.	O

Digits	O
and	O
nails	O
:	O
Normal	O
without	B-negation
clubbing	O
or	O
cyanosis	O
.	O

No	B-negation
anterior	B-bodyloc
cervical	I-bodyloc
node	I-bodyloc
enlargement	O
,	O
no	B-negation
posterior	B-bodyloc
cervical	I-bodyloc
node	I-bodyloc
enlargement	O
and	O
no	B-negation
submandibular	B-bodyloc
node	I-bodyloc
enlargement	O
.	O

Cardiovascular	O
Peripheral	O
vascular	O
exam	O
:	O
Normal	B-labvalue

Sildenafil	O
Citrate	O
Powder	B-form
;	O
(	O
2	B-strength
.	I-strength
5mg	I-strength
/	I-strength
ml	I-strength
)	O
:	O
Give	O
5	B-dosage
.	I-dosage
6	I-dosage
ml	I-dosage
(	I-dosage
14mg	I-dosage
)	I-dosage
via	B-route
G	I-route
button	I-route
every	B-frequency
6	I-frequency
hours	I-frequency
;	O
Therapy	O
:	O
20Nov2012	B-temporal
to	O
(	O
Evaluate	O
:	O
25Aug2013	B-temporal
)	O
Requested	O
for	O
:	O
28Mar2013	B-temporal
;	O
Last	O
Rx	O
:	O
28Mar2013	B-temporal
;	O
Status	O
:	O

Stopped	O
taking	O
it	O
in	O
early	B-temporal
January	I-temporal
,	O
when	O
she	O
found	O
out	O
she	O
was	O
pregnant	O
.	O

PROCEDURES	O
PERFORMED	O
:	O
Open	O
reduction	O
and	O
internal	O
fixation	O
(	O
ORIF	O
)	O
of	O
right	B-bodyloc
Schatzker	I-bodyloc
III	I-bodyloc
tibial	I-bodyloc
plateau	I-bodyloc
fracture	O
with	O
partial	O
medial	O
meniscectomy	O
.	O

He	O
denies	B-negation
any	O
fevers	O
,	O
cills	O
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
rate	O
and	O
rhythm	O
,	O
normal	B-labvalue
S1	O
and	O
S2	O
,	O
no	B-negation
murmurs	O
.	O

Left	O
Digit	O
Flex	O
.	O

having	O
pain	O
on	O
lower	O
back	B-bodyloc
,	O
shoulders	B-bodyloc
and	O
R	O
arm	B-bodyloc
after	O
MVA	O
on	O
12/25/2013	B-temporal
,	O
pain	O
at	O
8	B-labvalue
/	I-labvalue
10	I-labvalue

I	O
will	O
see	O
him	O
in	O
6	B-temporal
months	I-temporal
for	O
his	O
periodic	O
ear	O
cleaning	O
.	O

;	O
Jul	B-temporal
30	I-temporal
2013	I-temporal
9	B-temporal
:	I-temporal
45PM	I-temporal
(	O
Author	O
)	O

Abdomen	O
:	O
Normal	O
.	O

No	B-negation
edema	O
.	O

BMI	O
Calculated	O
:	O
33	B-labvalue
.	I-labvalue
42	I-labvalue

Chief	O
Complaint	O

dm	O
follwowed	O
by	O
endocrinology	O

Skin	O

2	O
'	O
PP	O
dinner	O
:	O
all	O
<	O
120	O
.	O

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

RT	O
Inferior	O
Turbinate	O

Ampicillin	O
CAPS	B-form

Signatures	O
Electronically	O
signed	O
by	O
:	O
MICHAEL	O
ADLER	O
,	O
M	O
.	O
D	O
.	O
;	O

Septum	O
:	O
Midline	O
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Neck	O

Will	O
get	O
hip	O
consult	O
report	O
from	O
Dr	O
.	O
Bloom	O
.	O

Lifestyle	O
:	O
.	O

2	O
.	O

Lungs	O
Percussion	O
:	O
Normal	B-labvalue
.	O

Sulfa	O
Drugs	O

Temperature	O
:	O
98	B-labvalue
.	I-labvalue
6	I-labvalue
F	I-labvalue
,	O
Oral	O

Musculoskeletal	O

ASTHMA	O

Surgical	O
History	O
History	O
of	O
Dilation	O
And	O
Curettage	O

Past	O
Medical	O
History	O
History	O
of	O
Stroke	O
Syndrome	O
436	O

Osteoarthritis	O
715	O
.	O
90	O

The	O
patient	O
underwent	O
respiratory	O
failure	O
,	O
requiring	O
intubation	O
,	O
mechanical	O
ventilatory	O
support	O
.	O

[	O
*	O
*	O
2101-12-17	B-temporal
*	O
*	O
]	O
07	B-temporal
:	I-temporal
15PM	I-temporal
GLUCOSE	O
-	O
100	B-labvalue
UREA	O
N	O
-	O
12	B-labvalue
CREAT	O
-	O
0	B-labvalue
.	I-labvalue
9	I-labvalue
SODIUM	O
-	O
136	B-labvalue
POTASSIUM	O
-	O
4	B-labvalue
.	I-labvalue
2	I-labvalue
CHLORIDE	O
-	O
104	B-labvalue
TOTAL	O
CO2	O
-	O
25	B-labvalue
ANION	O
GAP	O
-	O
11	B-labvalue
[	O
*	O
*	O
2101-12-17	B-temporal
*	O
*	O
]	O
07	B-temporal
:	I-temporal
15PM	I-temporal
estGFR	O
-	O
Using	O
this	O
[	O
*	O
*	O
2101-12-17	B-temporal
*	O
*	O
]	O
07	B-temporal
:	I-temporal
15PM	I-temporal
WBC	O
-	O
17	B-labvalue
.	I-labvalue
4	I-labvalue
*	O
#	O
RBC	O
-	O
4	B-labvalue
.	I-labvalue
48	I-labvalue
*	O
HGB	O
-	O
14	B-labvalue
.	I-labvalue
7	I-labvalue
HCT	O
-	O
42	B-labvalue
.	I-labvalue
1	I-labvalue
MCV	O
-	O
94	B-labvalue
MCH	O
-	O
32	B-labvalue
.	I-labvalue
7	I-labvalue
*	O
MCHC	O
-	O
34	B-labvalue
.	I-labvalue
9	I-labvalue
RDW	O
-	O
12	B-labvalue
.	I-labvalue
9	I-labvalue
[	O
*	O
*	O
2101-12-17	B-temporal
*	O
*	O
]	O
07	B-temporal
:	I-temporal
15PM	I-temporal
NEUTS	O
-	O
82	B-labvalue
.	I-labvalue
0	I-labvalue
*	O
LYMPHS	O
-	O
15	B-labvalue
.	I-labvalue
0	I-labvalue
*	O
MONOS	O
-	O
2	B-labvalue
.	I-labvalue
5	I-labvalue
EOS	O
-	O
0	B-labvalue
.	I-labvalue
1	I-labvalue
BASOS	O
-	O
0	B-labvalue
.	I-labvalue
3	I-labvalue
[	O
*	O
*	O
2101-12-17	B-temporal
*	O
*	O
]	O
07	B-temporal
:	I-temporal
15PM	I-temporal
PLT	O
COUNT	O
-	O
280	B-labvalue
[	O
*	O
*	O
2101-12-17	B-temporal
*	O
*	O
]	O
07	B-temporal
:	I-temporal
15PM	I-temporal
PT	O
-	O
11	B-labvalue
.	I-labvalue
6	I-labvalue
PTT	O
-	O
27	B-labvalue
.	I-labvalue
0	I-labvalue
INR	O
(	O
PT	O
)	O
-	O
1	B-labvalue
.	I-labvalue
0	I-labvalue

The	O
patient	O
is	O
currently	B-temporal
experiencing	O
symptoms	O
.	O

Musculoskeletal	O
:	O
joint	B-bodyloc
pain	O
.	O

Attending	O
Note	O

Constitutional	O

Denied	O

Internal	O
rotation	O
:	O
restricted	O
active	O
range	O
of	O
motion	O
30	O
degrees	O
.	O

Ms	O
.	O
Marchewka	O
is	O
a	O
27	O
-	O
year	O
-	O
old	O
white	O
female	O
with	O
probable	O
relapsing	B-course
-	I-course
remitting	I-course
multiple	O
sclerosis	O
.	O

Phone	O
:	O
(	O
713	O
)	O
253	O
-	O
6297	O
MRN	O
:	O
4209054	O

Immunizations	O

[	O
QLH	O
]	O
T3	O
,	O
FREE	O
11Nov2013	B-temporal
09	B-temporal
:	I-temporal
30AM	I-temporal
GOODINE	O
,	O
GLENDA	O

Associated	O
symptoms	O
include	O
no	B-negation
headache	O
and	O
no	B-negation
focal	O
neurologic	O
deficits	O
.	O

1	O
Influenza	O
18Sep2013	B-temporal
Tdap	O
03Jan2013	B-temporal
Zoster	O
27Feb2013	B-temporal

Pulmonary	O

Disp	O
:	O
*	O
60	O
Capsule	O
,	O
Sustained	O
Release	O
(	O
s	O
)	O
*	O
Refills	O
:	O
*	O
0	O
*	O
2	O
.	O

5	O
.	O

He	O
will	O
address	O
this	O
with	O
urology	O
next	B-temporal
month	I-temporal
.	O

The	O
sensory	O
exam	O
showed	O
normal	B-labvalue
vibratory	O
sensation	O
at	O
the	O
level	O
of	O
the	O
toes	O
and	O
normal	B-labvalue
position	O
sense	O
at	O
the	O
level	O
of	O
the	O
toes	O
.	O

Constitutional	O
:	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
and	O
no	B-negation
fatigue	O
.	O

History	O
of	O
pulmonary	B-bodyloc
embolism	O
.	O

Constitutional	O

No	B-negation
masses	O
palpated	O
.	O

GroupHeading15End	O
GroupHeading16Start	O
GroupHeading16End	O
GroupHeading17Start	O
GroupHeading17End	O
GroupHeading18Start	O
Pulmonasy	O
Auscultatiop	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Discussion	O
/	O
Signatures	O
Electronically	O
signed	O
by	O
:	O
KAZIM	O
SHEIKH	O
,	O
M	O
.	O
D	O
.	O

His	O
diet	O
and	O
activity	O
were	O
gradually	O
advanced	B-course
without	B-negation
complication	O
.	O

Electronically	O
signed	O
by	O
:	O
Brenda	O
Hakemack	O
,	O
M	O
.	O
D	O
.	O

Thyroid	O
:	O
Normal	O
.	O

Cranial	O
nerves	O
VIII	O
:	O
hearing	O
was	O
intact	B-labvalue
.	O

Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

Maternal	B-subject
grandfather	I-subject
'	O
s	O
history	O
of	O
Diabetes	O
Mellitus	O
V18	O
.	O
0	O

Language	O
:	O
No	B-negation
dysphasia	O
/	O
aphasia	O
was	O
observed	O
.	O

Medications	O
:	O
The	O
patient	O
is	O
adherent	O
with	O
her	O
medication	O
regimen	O
.	O
She	O
denies	B-negation
medication	O
side	O
effects	O
.	O

The	O
patient	O
is	O
currently	B-temporal
asymptomatic	O
.	O

Past	O
Medical	O
History	O
History	O
of	O
Benign	B-severity
Polyps	O
Of	O
The	O
Large	B-bodyloc
Intestine	I-bodyloc
V12	O
.	O
72	O

Disp	O
:	O
*	O
30	O
Tablet	O
,	O
Chewable	O
(	O
s	O
)	O
*	O
Refills	O
:	O
*	O
2	O
*	O
6	O
.	O

History	O
of	O
Crohn	O
'	O
S	O
Disease	O
555	O
.	O
9	O

History	O
of	O
Urinary	O
Calculus	O

Pt	O
will	O
continue	O
ibuprofen	O
and	O
RTC	O
if	B-condition
pain	O
worsens	B-course

No	B-negation
rebound	O
tenderness	O
.	O

Skin	O

Chief	O
Complaint	O

Cranial	O
Nerves	O
:	O

Examination	O
of	O
digits	O
and	O
nails	O
:	O
Normal	B-labvalue
.	O

P2002	O
,	O
s	O
/	O
p	O
2	O
c	O
/	O
d	O

Ears	O
,	O
Nose	O
,	O
Mouth	O
,	O
and	O
Throat	O

[	O
QLH	O
]	O
HEMOGLOBIN	O
A1c	O
Requested	O
for	O
:	O
23Feb2011	B-temporal

Current	O
Meds	O
Aspirin	O
81	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
06Jun2006	B-temporal
to	O
(	O
Evaluate	O
:	O
29Sep2012	B-temporal
)	O
Requested	O
for	O
:	O
20Jun2012	B-temporal
;	O
Last	O
Rx	O
:	O
01Jun2012	B-temporal

Former	O
Smoker	O
V15	O
.	O
82	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
constipation	O
,	O
no	B-negation
diarrhea	O
,	O
no	B-negation
heartburn	O
and	O
no	B-negation
melena	O
.	O

Palpation	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
Normal	B-labvalue
.	O

He	O
is	O
due	O
for	O
a	O
sleep	O
study	O
.	O

Percussion	O
of	O
chest	O
:	O
Normal	B-labvalue
.	O

Examination	O
of	O
liver	O
and	O
spleen	O
:	O
Normal	B-labvalue
.	O

Delivery	O
type	O
:	O
cesarean	O
delivery	O
.	O

[	O
QLH	O
]	O
PROTHROMBIN	O
TIME	O
-	O
INR	O
Done	O
:	O
09Oct2012	B-temporal
10	B-temporal
:	I-temporal
51AM	I-temporal

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Chief	O
Complaint	O

Inspection	O
of	O
the	O
conjunctiva	O
and	O
lids	O
:	O
Normal	B-labvalue
.	O

Specialty	O
:	O
Discharge	O
Summary	O
Sample	O

CurrentMeds	O
_	O
4	O
_	O
twCiteListControlEnd	O
CurrentMedsSectispEnd	O
ActiveProblemsSectispStart	O
Active	O
Problems	O

History	O
of	O
Mood	O
Disorder	O
Of	O
Unknown	O
(	O
Axis	O
III	O
)	O
Etiology	O
293	O
.	O
83	O

History	O
of	O
Iatrogenic	O
Hypothyroidism	O
244	O
.	O
3	O

Left	O
Hamstrings	O
.	O

Head	O
and	O
Face	O

Head	O
and	O
Face	O

Endocrine	O
:	O
no	B-negation
proptosis	O
,	O
no	B-negation
hot	O
flashes	O
,	O
no	B-negation
muscle	B-bodyloc
weakness	O
,	O
no	B-negation
deepening	O
of	O
the	O
voice	O
and	O
no	B-negation
feelings	O
of	O
weakness	O
.	O

Neck	O

Cranial	O
nerves	O
VIII	O
:	O
hearing	O
was	O
intact	B-labvalue
.	O

General	O
appearance	O
:	O
Normal	B-labvalue
.	O

Immunizations	O

RESPIRATORY	O
:	O
Lungs	O
are	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

Instructed	O
the	O
patient	O
she	O
would	O
need	O
to	O
be	O
off	O
Rebif	O
for	O
2	B-temporal
-	I-temporal
4	I-temporal
weeks	I-temporal
prior	O
to	O
conception	O
.	O

General	O
appearance	O
:	O
Normal	O

The	O
rhythm	O
was	O
regular	B-labvalue
.	O

Musculoskeletal	O
:	O
no	B-negation
limb	B-bodyloc
pain	O
and	O
no	B-negation
limb	B-bodyloc
swelling	O
.	O

Alert	O
and	O
oriented	O
.	O

Ears	O
,	O
Nose	O
,	O
Mouth	O
,	O
and	O
Throat	O
:	O
Otoscopic	O
examination	O
:	O
Normal	B-labvalue
.	O
Hearing	O
:	O
Normal	B-labvalue
.	O
External	O
inspection	O
of	O
ears	O
and	O
nose	O
:	O
Normal	B-labvalue
.	O
Nasal	O
mucosa	O
,	O
septum	O
,	O
and	O
turbinates	O
:	O
Normal	O
.	O
Lips	O
,	O
teeth	O
,	O
and	O
gums	O
:	O
Normal	O
.	O
Oropharynx	B-bodyloc
:	O
Abnormal	O
.	O

Cranial	O
nerves	O
VII	O
:	O
facial	O
strength	O
was	O
intact	B-labvalue
bilaterally	I-labvalue
.	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
,	O
the	O
heart	O
rate	O
was	O
not	B-labvalue
fast	I-labvalue
,	O
the	O
heart	O
rate	O
was	O
not	B-labvalue
slow	I-labvalue
and	O
no	B-negation
edema	O
.	O

Family	O
History	O

Requested	O
for	O
:	O
09Jul2013	B-temporal
;	O
Last	O
Rx	O
:	O
09Jul2013	B-temporal

Recent	O
and	O
remote	O
memory	O
:	O
Normal	B-labvalue
.	O

ClonazePAM	O
0	B-strength
.	I-strength
5	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
2	B-dosage
TABLET	B-form
Every	B-frequency
twelve	I-frequency
hours	I-frequency
;	O
Therapy	O
:	O
19Jul2010	B-temporal
to	O
(	O
Evaluate	O
:	O
13Sep2011	B-temporal
)	O
;	O
Last	O
Rx	O
:	O
17Mar2011	B-temporal

Cardiovascular	O
:	O
No	B-negation
palpitations	O
and	O
no	B-negation
cold	O
hands	B-bodyloc
or	O
feet	B-bodyloc
.	O

The	O
rhythm	O
was	O
regular	B-labvalue
.	O

Report	O
distress	O
and	O
disability	O
seem	O
out	O
of	O
proportion	O
to	O
stated	O
chief	O
complaint	O
of	O
excessive	O
nasal	B-bodyloc
discharge	O
.	O

Constitutional	O
:	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
and	O
not	B-negation
feeling	O
tired	O
(	O
fatigue	O
)	O
.	O

Extension	B-bodyloc
was	O
restricted	O
and	O
was	O
painful	O
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Blood	O
Pressue	O
Comments	O
:	O
Reported	O

Physical	O
Exam	O

Teeth	O
-	O
nor8al	O
for	O
age	O
.	O

Otoscopic	O
examination	O
:	O
Normal	B-labvalue
.	O

Results	O
/	O
Audiogram	O
showed	O

Constitutional	O
:	O
no	B-negation
fever	O
and	O
no	B-negation
chills	O
.	O

Chest	O

Emergency	O
Contact	O
:	O
DAVID	O
PEREA	O
,	O
(	O
832	O
)	O
640	O
-	O
1183	O
(	O
Home	O
ptone	O
)	O
Persanal	O
:	O
DEBRA	O
SIMMSON	O
APT	O
808	O
^	O
15770	O
BELLAIRE	O
BLVD	O
^	O
HOUSTON	O
(	O
713	O
)	O
291	O
-	O
2720	O
(	O
Home	O
ptone	O
)	O
Document	O
Details	O
SUMMARIZATION	O
OF	O
EPISODE	O
NOTE	O
Encounter	O
April	B-temporal
5	I-temporal
,	I-temporal
2013	I-temporal
19	B-temporal
:	I-temporal
58	I-temporal
+	O
0000	O
From	O
Enterprise	O
EHR	O
11	O
.	O
200	O
.	O
4288	O
.	O

Encounters	O

Diastolic	O
:	O
98	B-labvalue
,	O
LUE	O
,	O
Sitting	O

The	O
patient	O
progressively	O
got	O
deteriorated	O
.	O

VerifiedResults	O
_	O
0	O
_	O
twCiteListControlStart	O

MetroNIDAZOLE	O
500	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
2	B-dosage
TABLETS	B-form
EVERY	B-frequency
12	I-frequency
HOURS	I-frequency
;	O
Therapy	O
:	O
18Dec2013	B-temporal
to	O
(	O
Evaluate	O
:	O
20Dec2013	B-temporal
)	O
Requested	O
for	O
:	O
18Dec2013	B-temporal
;	O
Last	O
Rx	O
:	O
18Dec2013	B-temporal

Hyperlipidemia	O
272	O
.	O
4	O

Doxazosin	O
Mesylate	O
1	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
20Aug2013	B-temporal
)	O
to	O

;	O
Jul	B-temporal
20	I-temporal
2013	I-temporal
11	B-temporal
:	I-temporal
39AM	I-temporal
(	O
Author	O
)	O

Otolaryngeal	O
:	O
No	B-negation
hearing	O
loss	O
,	O
no	B-negation
earache	O
,	O
and	O
no	B-negation
discharge	O
from	O
the	O
ears	B-bodyloc
.	O

COLOR	O
URINE	O
DARK	B-labvalue
YELLOW	I-labvalue
O	O

A	O
Pap	O
smear	O
was	O
performed	O
.	O

Family	O
History	O
1	O
.	O

2	O
.	O

Active	O
Problems	O
Diabetes	O
Mellitus	O
250	O
.	O
00	O

Discharge	O
Diagnosis	O
:	O

Associated	O
symptoms	O
include	O
myalgias	O
,	O
weight	O
loss	O
and	O
change	O
in	O
bowel	O
habits	O
,	O
but	O
no	B-negation
poor	O
sleep	O
,	O
no	B-negation
impaired	O
memory	O
,	O
no	B-negation
impaired	O
concentration	O
,	O
no	B-negation
irritability	O
,	O
no	B-negation
headache	O
,	O
no	B-negation
nausea	O
,	O
no	B-negation
lightheadedness	O
,	O
no	B-negation
anxiety	O
,	O
no	B-negation
depression	O
,	O
no	B-negation
weight	O
gain	O
,	O
no	B-negation
heat	O
intolerance	O
and	O
no	B-negation
cold	O
intolerance	O
.	O

I	O
have	O
discussed	O
the	O
case	O
with	O
the	O
resident	O
and	O
agree	O
with	O
the	O
diagnosis	O
of	O
ER	O
follow	O
up	O
s	O
/	O
p	O
MVA	O
is	O
feeling	O
better	O
.	O

still	O
with	O
cough	O
,	O
sob	O
,	O
no	B-negation
wheezing	O
.	O

Skin	O
:	O
No	B-negation
skin	B-bodyloc
lesions	O
and	O
no	B-negation
lump	O
under	O
the	O
skin	B-bodyloc
.	O
eg	O

Advance	O
Directives	O

Gentamicin	O
in	O
Saline	O
SOLN	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
28Mar2013	B-temporal
)	O
to	O

Current	O
Meds	O
1	O
.	O

Examination	O
of	O
gait	O
and	O
station	O
:	O
Normal	B-labvalue
.	O

Language	O
:	O
No	B-negation
dysphasia	O
/	O
aphasia	O
was	O
observed	O
.	O

Past	O
Medical	O
History	O
History	O
of	O
Absolute	O
Glaucoma	O
Of	O
Both	O
Eyes	B-bodyloc
360	O
.	O
42	O

[	O
QLH	O
]	O
MICROALBUMIN	O
,	O
RANDOM	O
URINE	O
(	O
W	O
/	O
CREATININE	O
)	O
;	O
every	O
1	O
year	O
;	O
Last	O
04Apr2011	B-temporal
;	O
Deferred	O
11Feb2013	B-temporal
;	O
Status	O
:	O
Temporary	O
Deferral	O

She	O
may	O
need	O
SNU	O
placement	O
for	O
post	O
hospitalization	O
cares	O
.	O

Nasopharynx	O
:	O
Adenoids	B-labvalue
normal	I-labvalue
.	O

Neuro	O
Emphasis	O
:	O

Lips	O
,	O
teeth	O
,	O
and	O
gums	O
:	O
Normal	O
.	O

Maternal	B-subject
history	O
of	O
Hyperthyroidism	O

The	O
patient	O
is	O
currently	B-temporal
experiencing	O
symptoms	O
which	O
include	O
lochia	O
decreasing	B-course
,	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
dysuria	O
,	O
no	B-negation
constipation	O
,	O
no	B-negation
headache	O
,	O
no	B-negation
fever	O
,	O
no	B-negation
fatigue	O
,	O
no	B-negation
nausea	O
and	O
no	B-negation
vomiting	O

1	O
Fluzone	O
9	B-strength
MCG	I-strength
/	I-strength
STRAIN	I-strength
Intradermal	B-route
Device	O
07Nov2013	B-temporal

The	O
patient	O
may	O
return	O
all	O
activities	O
with	O
no	B-negation
limitations	O
.	O

Plan	O
PredniSONE	O
10	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Take	O
4	B-dosage
tabs	B-form
for	B-duration
2	I-duration
days	I-duration
,	O
then	O
3	B-dosage
tabs	B-form
for	B-duration
2	I-duration
days	I-duration
then	O
1	B-dosage
tab	B-form
for	O
2	B-dosage
days	O
then	O
stop	O
;	O
Therapy	O
:	O
18Oct2012	B-temporal
to	O
(	O
Evaluate	O
:	O
25Oct2012	B-temporal
)	O
Requested	O
for	O
:	O
18Oct2012	B-temporal
;	O
Last	O
Rx	O
:	O
18Oct2012	B-temporal
;	O
Edited	O

Constitutional	O

Reflexes	O
:	O
Normal	O
.	O
Sensation	O
:	O
Normal	O
.	O

Omeprazole	O
20	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
Delayed	I-form
Release	I-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
03Sep2013	B-temporal
)	O
to	O

Secondary	O
hyperthyroidism	O
.	O

Social	O
History	O
"	O
Being	O
A	O
Social	O
Drinker	O

Assessment	O
Benign	O
Essential	O
Hypertension	O
401	O
.	O
1	O

(	O
281	O
)	O
444	O
-	O
1201	O
(	O
Work	O
phone	O
)	O
Patient	O
Contacts	O

No	B-negation
laxity	O
.	O

He	O
denies	B-negation
any	O
further	O
feelings	O
of	O
lightheadedness	O
since	O
his	O
last	O
visit	O
.	O

Psychiatric	O
:	O
no	B-negation
emotional	O
problems	O
.	O

General	O
appearance	O
:	O
Abnormal	O
.	O

Carotid	O
pulses	O
:	O
Normal	B-labvalue
.	O

Gastrointestinal	O
:	O
N	O
/	O
A	O
.	O

4	O
.	O

Patient	O
does	O
not	B-negation
have	I-negation
a	O
history	O
of	O
a	O
positive	O
pap	O
smear	O
.	O

No	B-negation
wheezing	O
was	O
heard	O
.	O

Service	O
:	O
PLASTIC	O

Kyphsis	O
/	O
Scoliosis	O
to	O
R	O
.	O
DJD	O
B	O
hands	O
.	O

Examination	O
of	O
the	O
abdomen	O
:	O
Normal	B-labvalue
Bowel	O
sounds	O
were	O
normal	B-labvalue
.	O

[	O
QLH	O
]	O
HEMATOCRIT	O
Done	O
:	O
21Sep2010	B-temporal
11	B-temporal
:	I-temporal
52AM	I-temporal

History	O
of	O
Neonatal	O
Jaundice	O

Seizure	O
Disorder	O
345	O
.	O
90	O

Eyes	O

4	O
.	O

No	B-negation
rhonchi	O
were	O
heard	O
.	O

Adnexa	O
/	O
parametria	O
:	O
Normal	O
.	O

Uterus	O
:	O
Normal	O
.	O

Bowel	O
sounds	O
were	O
normal	B-labvalue
.	O

Polyuria	O
/	O
polydyspsia	O
does	O
not	O
appear	O
to	O
be	O
related	O
to	O
his	O
DM	O

Examination	O
of	O
thyroid	O
:	O
Normal	B-labvalue
.	O

Gynecological	O
Problems	O
.	O

Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

MT	O
/	O
MM	O
:	O
Eo	O
mucin	O

Past	O
Medical	O
History	O
Denied	O

Plan	O
g64	O

11	O
wks	O
with	O
T2DM	O
.	O

Results	O
/	O
Assessment	O
Diabetes	O
Mellitus	O
250	O
.	O
00	O

Musculoskeletal	O

The	O
posterior	B-bodyloc
pharynx	I-bodyloc
was	O
erythematous	O
,	O
butdid	O
not	O
have	O
an	O
exudate	O
and	O
did	O
not	B-negation
have	I-negation
white	O
patches	O
.	O

Femoral	O
pulses	O
:	O
Normal	B-labvalue

Results	O
/	O
Assessment	O
Type	O
1	O
Diabetes	O
Mellitus	O
250	O
.	O
01	O

Heart	O
sounds	O
:	O
normal	B-labvalue
S1	O
and	O
normal	B-labvalue
S2	O
.	O

I	O
am	O
also	O
decreasing	O
once	O
again	O
her	O
Humalog	O
sliding	B-form
scale	I-form
insulin	O
prior	O
to	O
meals	O
.	O

Never	O
A	O
Smoker	O

No	B-negation
Reported	O
Medications	O
;	O
;	O
RPT	O
.	O
eg	O

Hydromorphone	O
2	B-strength
mg	I-strength
Tablet	B-form
Sig	O
:	O
1	B-dosage
-	I-dosage
2	I-dosage
Tablets	B-form
PO	B-route
Q6H	B-frequency
(	I-frequency
every	I-frequency
6	I-frequency
hours	I-frequency
)	I-frequency
as	B-frequency
needed	I-frequency
for	O
pain	O
.	O

Medical	O
Decision	O
Making	O
:	O

PLAN	O
:	O

no	B-negation
CVA	O
tenderness	O

Respiratory	O
rate	O
:	O
the	O
respiratory	O
rate	O
was	O
normal	B-labvalue
.	O

2	O
.	O

No	B-negation
amenorrhea	O
.	O
Dysmenorrhea	O
.	O
No	B-negation
dyspareunia	O
.	O
Patient	O
has	O
no	B-negation
history	I-negation
of	I-negation
sexually	O
transmitted	O
infection	O
.	O
No	B-negation
history	I-negation
of	I-negation
pelvic	B-bodyloc
inflammatory	O
disease	O
.	O
No	B-negation
history	O
of	O
cervical	O
surgery	O
.	O
No	B-negation
history	O
of	O
hysterectomy	O
.	O

The	O
sensory	O
exam	O
showed	O
normal	B-labvalue
vibratory	O
sensation	O
at	O
the	O
level	O
of	O
the	O
toes	O
.	O

NEEDED	O
;	O
Therapy	O
:	O
08Oct2008	O
to	O
(	O
Evaluate	O
:	O
10Feb2014	O
)	O
Requested	O
for	O
:	O
14Aug2013	O
;	O
Last	O

RTC	O
in	O
4	O
wks	O
,	O
pt	O
d	O
/	O
w	O
Dr	O
.	O
Adler	O

Husband	O
states	O
that	O
the	O
patient	O
has	O
recurrent	B-course
falls	O
.	O

well	O
-	O
appearing	O

Neurological	O
:	O
no	B-negation
confusion	O
,	O
no	B-negation
convulsions	O
,	O
no	B-negation
dizziness	O
,	O
no	B-negation
fainting	O
,	O
no	B-negation
limb	B-bodyloc
weakness	O
and	O
no	B-negation
difficulty	O
walking	O
.	O

Wound	O
Location	O
:	O
.	O

Exposed	O
To	O
Herpes	O
Zoster	O
(	O
V01	O
.	O
79	O
)	O

Examination	O
of	O
the	O
head	O
and	O
face	O
:	O
Normal	B-labvalue

General	O
:	O
well	O
developed	O
male	O
in	O
no	B-negation
acute	B-course
distress	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Review	O
of	O
Systems	O

Delivered	O
:	O
2009	B-temporal
.	O

Baby	O
was	O
started	O
on	O
Mylicon	O
drops	B-form
and	O
glycerin	O
suppositories	B-form
.	O

Lymphatic	O

Keywords	O
:	O
general	O
medicine	O
,	O
free	O
air	O
,	O
hyponatremia	O
,	O
air	O
under	O
the	O
diaphragm	B-bodyloc
,	O
intra	B-bodyloc
abdominal	I-bodyloc
pathology	O
,	O
abdominal	O
,	O
pathology	O
,	O
obtunded	O
,	O
diaphragm	O
,	O

Past	O
Medical	O
History	O
1	O
.	O

Denied	O

Right	O
shoulder	O
;	O
Post	O
.	O

Left	O
Anter	O
.	O

Psychiatric	O

Facial	O
strength	O
:	O
Symmetric	B-labvalue
.	O

Family	B-subject
history	O
of	O
Cancer	O

Active	O
Problems	O
Abnormal	O
Electrocardiogram	O
794	O
.	O
31	O

Inspection	O
of	O
breasts	O
:	O
Normal	B-labvalue
.	O

Constitutional	O

Acute	B-course
Bronchitis	O
466	O
.	O
0	O

The	O
heart	O
rate	O
was	O
normal	B-labvalue
.	O

MAY	O
REPEAT	O
ONCE	B-frequency

No	B-negation
muscle	B-bodyloc
atrophy	O
was	O
seen	O
.	O
No	B-negation
muscle	B-bodyloc
hypertrophy	O
was	O
seen	O
.	O

Occupation	O
:	O

Active	O
Problems	O
Localized	O
Primary	O
Osteoarthritis	O
Of	O
Hip	B-bodyloc
715	O
.	O
15	O

Family	O
History	O
Non	O
-	O
Contributory	O

Electronically	O
signed	O
by	O
:	O
SAMER	O
FAKHRI	O
,	O
M	O
.	O
D	O
.	O

Vitals	O
26Mar2014	B-temporal
07	B-temporal
:	I-temporal
40PM	I-temporal
26Mar2014	B-temporal
07	B-temporal
:	I-temporal
19PM	I-temporal
26Mar2014	B-temporal
06	B-temporal
:	I-temporal
52PM	I-temporal
BMI	O
Calculated	O
38	B-labvalue
.	I-labvalue
09	I-labvalue
BSA	O
Calculated	O
1	B-labvalue
.	I-labvalue
84	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
Weight	O
194	B-labvalue
lb	I-labvalue
Systolic	O
160	B-labvalue
,	O
RUE	O
,	O
Sitting	O
Diastolic	O
80	B-labvalue
,	O
RUE	O
,	O
Sitting	O
Temperature	O
97	B-labvalue
F	I-labvalue
,	O
Oral	O
Heart	O
Rate	O
84	B-labvalue
,	O
R	O
Radial	O
Pulse	O
Quality	O
Regular	B-labvalue
,	O
R	O
Radial	O
Respiration	O
24	B-labvalue
O2	O
Saturation	O
90	B-labvalue
,	O
RA	O

Integumentary	O
:	O
no	B-negation
rash	O
and	O
no	B-negation
night	O
sweats	O
.	O

Associated	O
symptoms	O
:	O
no	B-negation
weight	O
loss	O
,	O
no	B-negation
menstrual	O
irregularity	O
,	O
no	B-negation
cold	O
intolerance	O
,	O
no	B-negation
diarrhea	O
,	O
no	B-negation
constipation	O
and	O
no	B-negation
vision	O
changes	O
.	O

Podiatry	O
Referral	O
Outpatient	O
Referral	O
Requested	O
for	O
:	O
17Jan2012	B-temporal

She	O
is	O
experiencing	O
normal	O
menses	O
.	O

He	O
has	O
undergone	O
MRI	O
of	O
the	O
abdomen	O
on	O
June	B-temporal
18	I-temporal
,	I-temporal
2008	I-temporal
revealing	O
an	O
enhancing	O
mass	O
of	O
the	O
upper	O
pole	O
of	O
the	O
left	B-bodyloc
kidney	I-bodyloc
consistent	O
with	O
his	O
history	O
of	O
renal	B-bodyloc
cell	O
carcinoma	O
.	O

Cardiovascular	O

The	O
duration	O
of	O
her	O
recent	O
periods	O
usually	O
last	O
3	O
days	O
.	O

Associated	O
symptoms	O
include	O
no	B-negation
headache	O
.	O

Current	O
Meds	O
1	O
.	O

Viagra	O
50	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
1	I-frequency
HOUR	I-frequency
BEFORE	I-frequency
sex	I-frequency
as	B-frequency
needed	I-frequency
,	O
;	O
Therapy	O
:	O
25Feb2014	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
25Feb2014	B-temporal
)	O
Requested	O
for	O
:	O
25Feb2014	B-temporal
;	O
Edited	O

FOLLOWUP	O
:	O
The	O
patient	O
will	O
follow	O
up	O
with	O
Dr	O
.	O
XYZ	O
for	O
a	O
postoperative	O
check	O
on	O
08/12/2008	B-temporal
at	O
1	B-temporal
:	I-temporal
50	I-temporal
p	I-temporal
.	I-temporal
m	I-temporal
.	O
and	O
he	O
was	O
made	O
aware	O
of	O
this	O
appointment	O
.	O

Mean	O
Platelet	O
Volume	O
8	B-labvalue
.	I-labvalue
8	I-labvalue
fL	I-labvalue
7	B-reference_range
.	I-reference_range
4	I-reference_range
-	I-reference_range
10	I-reference_range
.	I-reference_range
4	I-reference_range

IPV	O
;	O
05	B-temporal
Oct	I-temporal
2007	I-temporal

Respiratory	O
rate	O
:	O
tachypnea	O
was	O
noted	O
at	O
24	B-labvalue
breaths	I-labvalue
per	I-labvalue
minute	I-labvalue
.	O

EOSINOPHILS	O
3	B-labvalue
.	I-labvalue
9	I-labvalue
%	I-labvalue

Eyes	O
:	O
No	B-negation
BOV	O
,	O
but	O
no	B-negation
eye	B-bodyloc
pain	O
.	O

UTP	O
-	O
Complete	O
-	O
Female50f4265f	O
-	O
fcb5	O
-	O
4fac	O
-	O
bd62	O
-	O
4c3fe73ea6e3FoamStart	O
GroupHeading1Start	O
Constitutional	O
:	O
feeling	O
tired	O
(	O
fatigue	O
)	O
,	O
but	O
no	B-negation
fever	O
,	O
no	B-negation
recent	B-temporal
weight	O
gaip	O
and	O
no	B-negation
recent	B-temporal
weight	O
loss	O
.	O

Zonisamide	O
50	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
4	B-dosage
CAPSULE	B-form
BEDTIME	B-frequency
;	O
Therapy	O
:	O
29Sep2011	B-temporal
to	O
(	O
Evaluate	O
:	O
27Mar2012	B-temporal
)	O
Requested	O
for	O
:	O
29Sep2011	B-temporal
;	O
Last	O
Rx	O
:	O
29Sep2011	B-temporal

The	O
patient	O
presents	O
with	O
complaints	O
of	O
fatigue	O
(	O
no	O
change	O
from	O
baseline	O
)	O
Cough	O
,	O

Musculoskeletal	O
:	O
no	B-negation
joint	B-bodyloc
pain	O
and	O
no	B-negation
pain	O
.	O

Discussed	O
plan	O
with	O
Attending	O

UTP	O
-	O
UTI	O
,	O

The	O
patient	O
is	O
currently	B-temporal
experiencing	O
symptoms	O
.	O

Straight	O
leg	O
raise	O
is	O
negative	B-labvalue
bilaterally	O
.	O

Alk	O
Phos	O
72	B-labvalue
u	I-labvalue
/	I-labvalue
l	I-labvalue
39	B-reference_range
-	I-reference_range
136	I-reference_range

Adnexa	O
/	O
parametria	O
:	O
Normal	O

Place	O
of	O
Delivery	O
:	O
Brenham	O
.	O

LT	O
Inferior	O
Turbinate	O

Discussion	O
/	O
Discussion	O
/	O
Summary	O

By	O
the	O
nature	O
of	O
the	O
performed	O
surgery	O
,	O
he	O
needs	O
periodic	O
ear	O
cleaning	O
every	B-temporal
6	I-temporal
months	I-temporal
.	O

Current	O
Meds	O
Methocarbamol	O
500	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
Every	B-frequency
6	I-frequency
hours	I-frequency
PRN	B-frequency
muscle	B-bodyloc
pain	O
;	O
Therapy	O
:	O
08Aug2013	B-temporal
to	O
(	O
Evaluate	O
:	O
16Aug2013	B-temporal
)	O
Requested	O
for	O
:	O
08Aug2013	B-temporal
;	O
Last	O
Rx	O
:	O
08Aug2013	B-temporal

General	O
appearance	O
:	O
Normal	B-labvalue
.	O

Assessment	O
Headache	O
784	O
.	O
0	O

[	O
QLH	O
]	O
LIPID	O
PANEL	O
Requested	O
for	O
:	O
26Nov2012	B-temporal

X	O
-	O
ray	O
of	O
the	O
chest	O
shows	O
the	O
possibility	B-uncertain
of	O
free	O
air	O
;	O
therefore	O
,	O
a	O
CT	O
scan	O
was	O
obtained	O
because	O
of	O
the	O
patient	O
'	O
s	O
physical	O
examination	O
,	O
which	O
shows	O
no	B-negation
evidence	I-negation
of	O
intra	B-bodyloc
-	I-bodyloc
abdominal	I-bodyloc
pathology	O
.	O

External	O
inspection	O
of	O
ears	O
and	O
nose	O
:	O
Normal	B-labvalue
.	O

Thyroid	O
:	O
Normal	O
,	O
no	B-negation
thyromegaly	O
.	O

Inspection	O
/	O
palpation	O
of	O
joints	O
,	O
bones	O
,	O
and	O
muscles	O
:	O
Normal	B-labvalue
.	O

Neurological	O
:	O
no	B-negation
confusion	O
,	O
no	B-negation
convulsions	O
,	O
no	B-negation
dizziness	O
,	O
no	B-negation
fainting	O
,	O
no	B-negation
limb	B-bodyloc
weakness	O
and	O
no	B-negation
difficulty	O
walking	O
.	O

Pulmonary	O

Review	O
of	O
Systems	O

The	O
abdomen	O
was	O
soft	O
and	O
nontender	O
.	O

2012	B-temporal
MHH	O
Term	O
Female	O
8	O
lbs	O
12	O
oz	O
,	O
repeat	O
LTCS	O
,	O
SIPIH	O

EYES	O

Urine	O
Dipstick	O
(	O
In	O
Office	O
)	O
Requested	O
for	O
:	O
26Nov2012	B-temporal

Lyrica	O
100	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
TWICE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
28Aug2013	B-temporal
to	O

HLD	O
:	O

Abnormal	O
Thoughts	O
:	O
no	B-negation
abnormal	O
thoughts	O
reported	O
.	O

Simethicone	O
CHEW	O
;	O
Status	O
:	O
DISCONTINUED	O

Chief	O
Complaint	O

EARS	O
-	O
Canals	O
clear	O
.	O

;	O
Nov	B-temporal
21	I-temporal
2013	I-temporal
10	B-temporal
:	I-temporal
41AM	I-temporal
(	O
Author	O
)	O

History	O
of	O
Prostate	B-bodyloc
Cancer	O
V10	O
.	O
46	O

Aspirin	O
81	B-strength
mg	I-strength
Tablet	B-form
,	I-form
Delayed	I-form
Release	I-form
(	O
E	O
.	O
C	O
.	O

She	O
describes	O
this	O
as	O
mildandimproving	O
.	O

History	O
of	O
Drug	O
Use	O

The	O
patient	O
presents	O
with	O
complaints	O
of	O
skin	B-bodyloc
lesion	O
(	O
callus	O
of	O
Lt	B-bodyloc
leg	I-bodyloc
-	O
No	B-negation
INfection	O
)	O
.	O

CONDITION	O
UPON	O
DISPOSITION	O
:	O
Stable	O
.	O

2	O
.	O

Diet	O
and	O
activity	O
as	O
tolerated	O
.	O

;	O
Apr	B-temporal
16	I-temporal
2013	I-temporal
3	B-temporal
:	I-temporal
16PM	I-temporal
(	O
Author	O
)	O

Continue	O
speech	O
therapy	O

Abdominal	B-bodyloc
Aorta	I-bodyloc
:	O
no	B-negation
abnormalities	O
and	O
no	B-negation
bruit	O
heard	O
.	O

Respiratory	O
:	O
wheezing	O
.	O

The	O
conjunctiva	O
were	O
normal	O
in	O
both	O
eyes	O
.	O

Chief	O
Complaint	O

History	O
of	O
History	O
Of	O
1	O
Previous	O
Pregnancies	O
V61	O
.	O
5	O

Family	B-subject
history	O
of	O
Atherosclerosis	O
V17	O
.	O
49	O

Patient	O
also	O
has	O
a	O
couple	O
of	O
warty	O
lesions	O
on	O
the	O
right	B-bodyloc
thumb	I-bodyloc
area	O
would	O
like	O
to	O
evaluate	O
.	O

Type	O
2	O
Diabetes	O
Mellitus	O
250	O
.	O
00	O

She	O
is	O
also	O
experiencing	O
significant	O
left	B-bodyloc
knee	I-bodyloc
pain	O
during	O
night	O
time	O
,	O
which	O
is	O
causing	O
sleep	O
-	O
rest	O
disturbance	O
,	O
almost	O
nightly	B-temporal
.	O

General	O
appearance	O
:	O
Normal	B-labvalue
.	O
Comfortable	O
,	O
well	O
hydrated	O
,	O
no	B-negation
jaundice	O
,	O
pallor	O
or	O
cyanosis	O
.	O

Cranial	O
nerves	O
II	O
through	O
XII	O
appear	O
grossly	O
intact	O
.	O

Disp	O
:	O
*	O
90	O
Tablet	O
(	O
s	O
)	O
*	O
Refills	O
:	O
*	O
0	O
*	O
11	O
.	O

;	O
Apr	B-temporal
22	I-temporal
2013	I-temporal
9	B-temporal
:	I-temporal
13AM	I-temporal
(	O
Author	O
)	O

Mar	B-temporal
19	I-temporal
2013	I-temporal
11	B-temporal
:	I-temporal
41AM	I-temporal
CST	O
Co	O
-	O
author	O
I	O
have	O
seen	O
an	O
examined	O
the	O
patient	O
with	O
Dr	O
Edwards	O
and	O
I	O
agree	O
with	O
the	O
above	O
findings	O
and	O
plans	O
.	O

LMP	O
16Jun2012	B-temporal

Hygiene	O
measures	O
:	O
nasal	O
wash	O
,	O
room	O
humidifier	O

Hx	O
of	O
PE	O
post	O
-	O
op	O
on	O
warfarin	O
therapy	O
.	O

Lifestyle	O
:	O
.	O

Vital	O
Signs	O
g31	O

Weight	O
:	O
167	B-labvalue
lb	I-labvalue

Constitutional	O

Morphine	O
Derivatives	O

INTEGUMENTARY	O
:	O
no	B-negation
rashes	O
and	O
no	B-negation
ulcers	O
.	O

IBU	O
-	O
Tab	O
600	B-strength
MG	I-strength
TABS	B-form
;	O
Take	O
one	B-dosage
tab	B-form
po	B-route
BID	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
29Oct2012	B-temporal
)	O
to	O

[	O
L	O
]	O
Prostate	O
-	O
Specific	O
Ag	O
,	O
Serum	O

Sororal	B-subject
history	O
of	O
Rheumatoid	O
Arthritis	O

Coordination	O
:	O
Normal	B-labvalue
.	O

62	O
y	O
/	O
o	O
CM	O
with	O
PMHx	O
of	O
Osteopenia	O
,	O
HLD	O
pesents	O
c	O
/	O
o	O
4	O
day	O
h	O
/	O
o	O
non	O
-	O
productive	O
cough	O
sore	O
throat	B-bodyloc
and	O
nasal	B-bodyloc
congestion	O
.	O

Removal	O
Of	O
Implant	O
V54	O
.	O
01	O

Cranial	O
nerves	O
VII	O
:	O
facial	O
strength	O
was	O
intact	B-labvalue
bilaterally	I-labvalue
.	O

DIRECTED	O
;	O
Therapy	O
:	O
01Sep2011	B-temporal
to	O

Examination	O
of	O
the	O
abdomen	O
:	O
Normal	B-labvalue
The	O
abdomen	O
was	O
rounded	O
.	O

3	O
.	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
neck	O
:	O
Normal	B-labvalue
.	O

Atrial	B-bodyloc
Fibrillation	O
427	O
.	O
31	O

(	O
peron	O
.	O
)	O
:	O
Normal	O
.	O

Status	O
:	O
cleanandwell	O
-	O
healed	O
.	O

Psychiatric	O

Constitutional	O

Fossa	O
of	O
Rosenmueller	O
normal	O
.	O

Musculoskeletal	O
:	O
no	B-negation
limb	B-bodyloc
pain	O
and	O
no	B-negation
limb	B-bodyloc
swelling	O
(	O
improved	B-course
+	I-course
)	O
.	O

Inspection	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
Normal	B-labvalue
Normal	B-labvalue
color	O
and	O
pigmentation	O
,	O
no	B-negation
cyanosis	O
,	O
no	B-negation
diaphoresis	O
,	O
no	B-negation
erythema	O
and	O
no	B-negation
pallor	O
.	O

Occupation	O
:	O

Constitutional	O
:	O
no	B-negation
fever	O
and	O
no	B-negation
chills	O
.	O

Skin	O

Benign	B-severity
Essential	O
Hypertension	O
401	O
.	O
1	O

PreferaOB	O
One	O
22-6-1	B-strength
-	I-strength
200	I-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
14Mar2013	B-temporal
to	O
(	O
Evaluate	O
:	B-temporal
12Jun2013	I-temporal
)	O
Requested	O
for	O
:	O
14Mar2013	B-temporal
;	O
Last	O
Rx	O
:	O
14Mar2013	B-temporal
;	O
Edited	O

Came	O
back	O
because	O
parents	O
noticed	O
her	O
jaw	B-bodyloc
opening	O
dystonia	O
is	O
much	B-course
worse	I-course
after	O
I	O
decreased	O
her	O
pulse	O
width	O
-	O
became	O
constant	O
.	O

f	O
AUDIT	O
03/01/2013	B-temporal

Abdomen	O
:	O
Non	O
-	O
tender	O
,	O
no	B-negation
masses	O
.	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Psychiatric	O
:	O
anxiety	O
,	O
depression	O
,	O
no	O
emotional	O
problemsandstress	O
.	O

History	O
of	O
Esophageal	O
Dilation	O

The	O
patient	O
states	O
her	O
headache	O
improves	B-course
w	O
/	O
moving	O
her	O
head	O
to	O
the	O
right	O
or	O
lying	O
down	O
and	O
trying	O
to	O
sleep	O
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

NECK	O
:	O
Supple	O
,	O
no	B-negation
lymphadenopathy	O
or	O
JVD	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Results	O
/	O
Results	O
/	O
Data	O

CONSTITUTIONAL	O

Pulmonary	O

RTC	O
3	B-temporal
mon	I-temporal

Alcohol	O

HTN	O
:	O

Hydrochlorothiazide	O
12	B-strength
.	I-strength
5	I-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Last	O
Rx	O
:	O
24Oct2012	B-temporal

Diastolic	O
:	O
87	B-labvalue

Select	O
-	O
OB	O
+	O
DHA	O
29	B-strength
-	I-strength
1	I-strength
&	I-strength
250	I-strength
MG	I-strength
Oral	B-route
Miscellaneous	O
;	O
chew	O
or	O
swallow	O
oneblue	O
select	O
ob	O
caplet	O

Docusate	O
Sodium	O
100	B-strength
mg	I-strength
Capsule	B-form
Sig	O
:	O
One	B-dosage
(	I-dosage
1	I-dosage
)	I-dosage
Capsule	B-form
PO	B-route
BID	B-duration
(	I-duration
2	I-duration
times	I-duration
a	I-duration
day	I-duration
)	I-duration
.	O

Caltrate	O
600	O
+	O
D	O
600	B-strength
-	I-strength
400	I-strength
MG	I-strength
-	I-strength
UNIT	I-strength
Oral	B-route
Tablet	B-form
;	O
Therapy	O
:	O
24Nov2012	B-temporal
to	O

Cardiovascular	O

Pronated	O
Left	B-bodyloc
Foot	I-bodyloc
736	O
.	O
79	O

No	B-negation
murmurs	O
were	O
heard	O
.	O

Assessment	O

History	O
of	O
Hyperlipidemia	O
272	O
.	O
4	O

Pt	O
reports	O
nausea	O
on	O
and	O
off	O
for	O
several	O
years	O
.	O

She	O
is	O
currently	B-temporal
experiencing	O
flank	B-bodyloc
pain	O
.	O

History	O
of	O
Heart	O
Valve	O
Replacement	O
V43	O
.	O
3	O
Performed	O
in	O
2002	B-temporal
-	O
mitral	O
valve	O

Palpation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

GASTROINTESTINAL	O
:	O
no	B-negation
heartburn	O
,	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
diarrhea	O
,	O
no	B-negation
constipation	O
and	O
no	B-negation
vomiting	O
.	O

Motor	O
Survey	O
:	O
spasticity	O
of	O
the	O
left	B-bodyloc
side	I-bodyloc
was	O
present	O
.	O

[	O
QLH	O
]	O
TSH	O
,	O
3RD	O
GENERATION	O
Requested	O
for	O
:	O
25Feb2014	B-temporal

REFILL	O
PT	O
MUST	O
MAKE	O
OFFICE	O
APPT	O
/	O
LABS	O
;	O
Therapy	O
:	O
08Nov2012	B-temporal
to	O
(	O
Evaluate	O
:	O
07Oct2013	B-temporal
)	O

2	O
.	O

Examination	O
of	O
the	O
abdomen	O
:	O
Normal	B-labvalue
.	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
ALICE	O
CHIU	O
,	O
M	O
.	O
D	O
.	O

Ortho	O
Plan	O
:	O

Uterine	B-bodyloc
Scar	O
From	O
Previous	O
Cesarean	O
Delivery	O
-	O
Antepartum	O
Condition	O
Or	O
Complication	O
654	O
.	O
23	O

Paternal	B-subject
grandmother	I-subject
'	I-subject
s	I-subject
history	O
of	O
Breast	B-bodyloc
Cancer	O
V16	O
.	O
3	O

Tibial	O
(	O
peron	O
.	O
)	O
Strength	O
:	O
5	B-labvalue
-	I-labvalue
/	I-labvalue
5	I-labvalue
.	O

CONSTITUTIONAL	O

UTP	O
-	O
Headache	O
,	O
The	O
patient	O
is	O
being	O
seen	O
for	O
follow	O
-	O
up	O
from	O
an	O
emergency	O
room	O
visit	O
for	O
cluster	O
headache	O
.	O

General	O
Appearance	O
:	O
Normal	B-labvalue
.	O

Hypoglycemia	O
251	O
.	O
2	O

Cranial	O
nerves	O
XI	O
:	O
shoulder	O
shrug	O
was	O
intact	B-labvalue
bilaterally	O
.	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

History	O
of	O
Cesarean	O
Delivery	O
-	O
Delivered	O
669	O
.	O
71	O

(	O
shaking	O
palpatations	O
and	O
bad	O
feeling	O
with	O
low	O
sugars	O
not	B-negation
now	B-temporal
)	O
.	O

GlyBURIDE	O
-	O
MetFORMIN	O
5	B-strength
-	I-strength
500	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
2	B-dosage
TABLETS	B-form
BY	B-route
MOUTH	I-route
TWICE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
02Jun2005	B-temporal
to	O
(	O
Evaluate	O
:	O
26Mar2013	B-temporal
)	O
Requested	O
for	O
:	O
27Sep2012	B-temporal
;	O
Last	O
Rx	O
:	O
27Sep2012	B-temporal

Associated	O
symptoms	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
claudication	O
,	O
no	B-negation
near	O
syncope	O
,	O
no	B-negation
syncope	O
and	O
no	B-negation
weakness	O
.	O

Lymphatic	O

Pulmonary	O

f	O
Prevnar	O
13	O
Intramuscular	B-route
Suspension	B-form
-	O
Administered	O
on	O
:	O
08/27/2012	B-temporal

Hematologic	O
:	O
No	B-negation
easy	O
bleeding	O
and	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
.	O

I	O
diagnosed	O
her	O
with	O
a	O
symptomatic	O
Chiari	O
malformation	O
.	O

Results	O
/	O
Results	O
/	O
Data	O
[	O
QL	O
]	O
THYROID	O
PANEL	O
WITH	O
TSH	O
,	O
3RD	O
GENERATION	O
10Apr2014	B-temporal
11	B-temporal
:	I-temporal
00PM	I-temporal
ABDELMELEK	O
,	O
LOURICE	O

Never	O
Drank	O
Alcohol	O

Ambien	O
TABS	B-form

Tobacco	O
Use	O

Patient	O
states	O
she	O
has	O
a	O
PCP	O
,	O
Dr	O
.	O
Lee	O
,	O
who	O
she	O
will	O
f	O
/	O
u	O
with	O
for	O
her	O
T2DM	O
.	O

Head	B-bodyloc
and	O
Face	B-bodyloc
No	B-negation
moon	O
facies	O
.	O

[	O
Q	O
]	O
OCCULT	O
BLOOD	O
,	O
STOOL	O
,	O
DIAGNOSTIC	O
Requested	O
for	O
:	O
26Nov2012	B-temporal

RADIATE	O
INTO	O
LT	O
.	O

Left	O
Post	O
.	O

Palpation	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
Normal	B-labvalue
.	O

Compliance	O
with	O
treatment	O
plans	O
discussed	O
.	O

Musculosketal	O
pain	O
level	O
9	B-labvalue
(	O
0	B-reference_range
-	I-reference_range
10	I-reference_range
)	O
,	O
limitation	O
of	O
active	O
motion	O
was	O
demonstrated	O
,	O
a	O
popping	O
sound	O
was	O
heard	O
in	O
the	O
knee	B-bodyloc
,	O
nonspecific	O
pain	O
,	O
swelling	O
,	O
and	O
stiffness	O
,	O
but	O
no	B-negation
soft	B-bodyloc
tissue	I-bodyloc
swelling	O
,	O
no	B-negation
erythema	O
,	O
no	B-negation
feelings	O
of	O
weakness	O
,	O
no	B-negation
muscle	B-bodyloc
atrophy	O
was	O
seen	O
,	O
no	B-negation
muscle	B-bodyloc
cramps	O
,	O
no	B-negation
numbness	O
,	O
no	B-negation
tingling	O

These	O
changes	O
turned	O
to	O
downsloping	O
by	O
3	O
minutes	O
post	O
-	O
exercise	O
,	O
and	O
returned	O
to	O
baseline	O
by	O
7	O
minutes	O
of	O
recovery	O
.	O

Neck	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
RYAN	O
MURPHY	O
,	O
M	O
.	O
D	O
.	O

Denied	O

The	O
patient	O
was	O
comfortable	O
,	O
stabilized	O
,	O
breathing	O
well	O
.	O

Continue	O
lexapro	O
and	O
aricept	O
,	O
memory	O
stable	O
per	O
husband	O

Refer	O
back	O
to	O
podiatyry	O
.	O

-	O
Intramural	B-bodyloc
hyalinized	O
leiomyomas	O
.	O

Rdid	O
her	O
settings	O
and	O
pulse	O
width	O
now	O
180	O
.	O

Physical	O
Exam	O

Physical	O
Exam	O

She	O
has	O
stopped	O
OTC	O
analgesics	O
,	O
with	O
perhaps	O
some	B-course
improvement	I-course
in	O
head	B-bodyloc
pain	O
.	O

She	O
also	O
c	O
/	O
o	O
cough	O
&	O
cold	O
symptoms	O
3	O
-	O
4	O
days	O
.	O

4	O
.	O

MA	O
Digital	O
Mammo	O
Screening	O
Bil	O
Requested	O
for	O
:	O
06Jun2012	B-temporal

Family	B-subject
history	O
of	O
Irritable	O
Bowel	B-bodyloc
Syndrome	O

He	O
is	O
a	O
25	O
-	O
year	O
-	O
old	O
male	O
who	O
first	O
began	O
having	O
problems	O
at	O
the	O
age	O
of	O
12	B-temporal
years	I-temporal
.	O

1	O
Tdap	O
05Jul2011	B-temporal

Neurologic	O
No	B-negation
tremors	O
.	O
Monofilament	O
test	O
intact	B-labvalue
.	O

Neurologic	O

No	B-negation
masses	O
palpated	O
.	O

The	O
patient	O
has	O
normal	O
use	O
of	O
his	O
extremities	O
.	O

Chronic	B-course
Pain	O
338	O
.	O
29	O

Assessment	O

BSA	O
Calculated	O
:	O
1	B-labvalue
.	I-labvalue
77	I-labvalue

Fundoscopic	O
Exam	O
:	O
Normal	B-labvalue
.	O

Comments	O
:	O
2	O
/	O
2	O
PPROM	O
.	O

Current	O
Meds	O
g3	O

Patellofemoral	O
Joint	O
:	O
Meniscal	O
:	O
(	O
status	O
post	O
right	O
total	O
knee	O
replacement	O
)	O
Left	O
Knee	O
:	O
Appearance	O
:	O
Normal	O
.	O

Examination	O
of	O
the	O
abdomen	O
:	O
Normal	B-labvalue
Bowel	O
sounds	O
were	O
normal	B-labvalue
.	O

The	O
patient	O
presents	O
with	O
complaints	O
of	O
sudden	B-course
onset	I-course
of	O
constant	O
episodes	O
of	O
moderate	B-severity
r	O
>	O
l	B-bodyloc
facial	I-bodyloc
pain	O
,	O
radiating	O
to	O
the	O
right	B-bodyloc
jaw	I-bodyloc
(	O
R	B-bodyloc
sided	I-bodyloc
neck	I-bodyloc
swelling	O
.	O

Peripheral	O
vascular	O
system	O
:	O
Normal	B-labvalue
.	O

History	O
of	O
Smoking	O
Cigarettes	O

Psychiatric	O

Foot	B-bodyloc
pain	O
.	O

Assessment	O
of	O
stability	O
:	O
Normal	B-labvalue

Chief	O
Complaint	O

Chronic	B-course
Maxillary	B-bodyloc
Sinusitis	O
473	O
.	O
0	O
s	O
/	O
p	O
ESS	O
x	O
5	O
,	O
revision	O
B	O
-	O
IG	O
-	O
FESS	O
11/15/11	B-temporal
on	O
10mg	B-strength
prednisone	O
/	O
budesonide	O
irrigations	B-form
bid	B-frequency

The	O
husband	O
states	O
that	O
the	O
patient	O
has	O
an	O
intolerance	O
to	O
seizure	O
medications	O
in	O
the	O
past	O
and	O
is	O
not	O
inclined	O
to	O
restart	O
her	O
on	O
seizure	O
medication	O
.	O

ENT	O
:	O
no	B-negation
hoarseness	O
,	O
no	B-negation
hearing	O
loss	O
,	O
no	B-negation
drainage	O
of	O
ear	B-bodyloc
,	O
no	B-negation
vertigo	O
,	O
no	B-negation
snoring	O
was	O
observed	O
,	O
no	B-negation
daytime	O
sleepiness	O
,	O
no	B-negation
mouth	B-bodyloc
sores	O
,	O
no	B-negation
tooth	B-bodyloc
problems	O
,	O
no	B-negation
dysphagia	O
and	O
no	B-negation
tinnitus	O

Strength	O
and	O
tone	O
equal	O
bilaterally	O
,	O
stable	O
.	O

The	O
abdomen	O
was	O
rounded	O
.	O

PredniSONE	O
TABS	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
19Jul2012	B-temporal
)	O
to	O

Assessment	O
of	O
respiratory	O
effort	O
was	O
significant	O
for	O
normal	B-labvalue
respiratory	O
rhythm	O
and	O
effort	O
.	O

Examination	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue

The	O
abdomen	O
was	O
soft	O
and	O
nontender	O
.	O

Current	O
Meds	O
AcetaZOLAMIDE	O
250	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
Every	B-frequency
twelve	I-frequency
hours	I-frequency
;	O
Therapy	O
:	O
09Jan2014	B-temporal
to	O
(	O
Evaluate	O
:	O
15Jan2014	B-temporal
)	O
Requested	O
for	O
:	O
09Jan2014	B-temporal
;	O
Last	O
Rx	O
:	O
09Jan2014	B-temporal

Potassium	O
Chloride	O
Crys	O
ER	O
10	B-strength
MEQ	I-strength
Oral	B-route
Tablet	B-form
Extended	I-form
Release	I-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
EVERY	B-frequency
DAY	I-frequency
;	O
Therapy	O
:	O
14Jun2013	B-temporal
to	O
(	O
Evaluate	O
:	O
09Jun2014	B-temporal
)	O
Requested	O
for	O
:	O
14Jun2013	B-temporal
;	O
Last	O
Rx	O
:	O
14Jun2013	B-temporal
;	O
Status	O
:	O
ACTIVE	O
-	O
Retrospective	O
Authorization	O

fu	O
from	O
hopital	O
,	O
had	O
bleeeding	O
Diverticulosis	O
(	O
had	O
2	O
u	O
of	O
blood	O
trasfusion	O
2/24/14	B-temporal
)	O
)	O
and	O
cold	O
with	O
cough	O
x	O
3	B-temporal
d	I-temporal

ENT	O
:	O
no	B-negation
epistaxis	O
and	O
no	B-negation
sore	O
throat	B-bodyloc
.	O

History	O
of	O
Present	O
Illness	O

There	O
is	O
no	O
tenderness	O
over	O
the	O
sinuses	B-bodyloc
.	O

He	O
reported	O
that	O
he	O
had	O
difficulty	O
picking	O
up	O
stuff	O
with	O
his	O
arms	O
.	O

Examination	O
of	O
thyroid	O
:	O
Normal	B-labvalue
.	O

-	O
RTC	O
in	O
3	O
-	O
6	O
months	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Right	B-bodyloc
common	I-bodyloc
peroneal	I-bodyloc
neuropathy	O
across	O
the	O
fibular	B-bodyloc
head	I-bodyloc

Signatures	O
Electronically	O
signed	O
by	O
:	O
LOURICE	O
ABDELMELEK	O
,	O
M	O
.	O
D	O
.	O

Eye	O
Lids	O
:	O
.	O

No	B-negation
Known	O
Allergies	O

Upper	O
extremities	O
:	O
Normal	O
.	O
Lower	O
extremities	O
:	O
Normal	O
.	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

[	O
QLH	O
]	O
LIPID	O
PANEL	O
Requested	O
for	O
:	O
24Oct2012	B-temporal

Current	O
Orders	O
[	O
QLH	O
]	O
LEVETIRACETAM	O
(	O
KEPPRA	O
)	O
Requested	O
for	O
:	O
20May2013	B-temporal

Denied	O

PULMONARY	O
:	O
Clear	O
bilaterally	O
.	O

LMP	O
:	O
12/17/2010	B-temporal

The	O
patient	O
will	O
have	O
lab	O
work	O
at	O
Dr	O
.	O
XYZ	O
on	O
08/05/2008	B-temporal
and	O
she	O
will	O
also	O
return	O
to	O
the	O
cancer	O
center	O
on	O
08/12/2008	B-temporal
at	O
10	B-temporal
:	I-temporal
20	I-temporal
a	I-temporal
.	I-temporal
m	I-temporal
.	I-temporal

Different	O
oral	B-route
NSAIDs	O
,	O
both	O
OTC	O
and	O
prescriptions	O
and	O
pain	O
controller	O
,	O
Tramdol	O
,	O
Vicodin	O
and	O
Tylenol	O
were	O
used	O
to	O
treated	O
the	O
condition	O
.	O

Left	O
Quadriceps	O
.	O

Neck	O

Levothyroxine	O
Sodium	O
125	B-strength
MCG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
Requested	O
for	O
:	O
21Oct2013	B-temporal
;	O
Last	O
Rx	O
:	O
21Oct2013	B-temporal
;	O
Status	O
:	O
ACTIVE	O
-	O
Retrospective	O
Authorization	O

Review	O
of	O
Systems	O

16Apr2013	B-temporal
to	O
(	O
Evaluate	O
:	O
15Jun2013	B-temporal
)	O
Requested	O
for	O
:	O
16Apr2013	B-temporal
;	O
Last	O
Rx	O
:	O
16Apr2013	B-temporal
;	O
Edited	O

Normal	O
Routine	O
History	O
And	O
Physical	O
Adult	O
V70	O
.	O
0	O

Optimal	O
levels	O
are	O

Hydrochlorothiazide	O
25	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
ONCE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
09Jul2012	B-temporal
to	O
(	O
Evaluate	O
:	O
07Sep2012	B-temporal
)	O
Requested	O
for	O
:	O
09Jul2012	B-temporal
;	O
Last	O
Rx	O
:	O
09Jul2012	B-temporal
;	O
Edited	O

History	O
of	O
Reported	O
Prior	O
Surgical	O
/	O
Procedural	O
History	O

PEDS	O
wnouand	O
TB	O
screen	O
negative	B-labvalue
.	O

Constitutional	O
:	O
fatigue	O
,	O
but	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
and	O
no	B-negation
malaise	O
.	O

The	O
uterus	O
was	O
enlarged	O
8	O
-	O
10	O
weeks	O
,	O
butin	O
a	O
normal	O
position	O
and	O
nontender	O
.	O

Paternal	O
history	O
of	O
Reported	O
Family	B-subject
History	O
Of	O
Heart	B-bodyloc
Disease	O

[	O
L	O
]	O
Drawing	O
Fee	O
Requested	O
for	O
:	O
18Dec2013	B-temporal

NECK	O
:	O
Supple	O
and	O
symmetric	O
.	O

Palpation	O
of	O
the	O
face	O
and	O
sinuses	O
:	O
Normal	B-labvalue
Maxillary	O
sinuses	O
:	O
non	O
-	O
tender	O
on	O
the	O
right	O
and	O
non	O
-	O
tender	O
on	O
the	O
left	O
.	O

History	O
of	O
Alcohol	O
Use	O

I	O
personally	O
performed	O
the	O
following	O
critical	O
portion	O
of	O
the	O
exam	O
:	O
all	O

The	O
Zonisamide	O
is	O
not	O
helping	O
her	O
sleep	O
and	O
actually	O
gives	O
her	O
a	O
boost	O
of	O
energy	O
.	O

Orofacial	B-bodyloc
Dyskinesia	O
333	O
.	O
82	O

[	O
QLH	O
]	O
CMP	O
W	O
/	O
EGFR	O
Requested	O
for	O
:	O
21Mar2012	B-temporal

tendons	I-bodyloc
;	O
finger	B-bodyloc
is	O
cool	O
to	O
touch	O
,	O
capillary	O
refill	O
<	B-labvalue
2sec	I-labvalue
,	O
no	B-negation
dopplerable	O
signal	O
in	O
digital	B-bodyloc
arteries	I-bodyloc
distal	O
to	O
injury	O
;	O
patient	O
with	O
no	B-negation
sensation	O
over	B-bodyloc
digit	I-bodyloc
distal	I-bodyloc
to	O
injury	O
4th	B-bodyloc
digit	I-bodyloc
:	O
deep	O
laceration	O
on	O
volar	O
aspect	O
at	O
level	B-bodyloc
of	I-bodyloc
the	I-bodyloc
PIP	I-bodyloc
with	O
visualization	O
of	O
volar	O
aspect	O
of	O
PIP	O
joint	O
;	O
finger	B-bodyloc
is	O
cool	O
to	O
touch	O
,	O
capillary	O
refill	O
<	B-labvalue
2sec	I-labvalue
,	O
no	O
dopplerable	O
signal	O
in	O
radial	O
digital	O
artery	O
distal	O
to	O
injury	O
site	O
,	O
weakly	O
dopplerable	O
signal	O
in	O
ulnar	O
digital	O
artery	O
distal	O
to	O
injury	O
site	O
;	O
patient	O
with	O
no	O
sensation	O

Plan	O
Urine	O
Dipstick	O
(	O
In	O
Office	O
)	O
Done	O
:	O
09Oct2013	B-temporal
04	B-temporal
:	I-temporal
41PM	I-temporal

The	O
sensory	O
exam	O
showed	O
normal	B-labvalue
vibratory	O
sensation	O
at	O
the	O
level	O
of	O
the	O
toes	O
and	O
normal	B-labvalue
position	O
sense	O
at	O
the	O
level	O
of	O
the	O
toes	O
.	O

Hyperlipidemia	O
272	O
.	O
4	O

Examination	O
of	O
liver	O
and	O
spleen	O
:	O
Normal	B-labvalue
.	O

Musculoskeletal	O
:	O
no	B-negation
arthralgias	O
.	O

-	O
-	O
start	O
IVIG	O
0	B-strength
.	I-strength
4	I-strength
gram	I-strength
/	I-strength
kg	I-strength
once	B-frequency
a	I-frequency
week	I-frequency
for	B-duration
4	I-duration
weeks	I-duration
.	O

Left	O
Iliopsoas	O
(	O
femor	O
.	O
)	O
Strength	O
:	O
3	B-labvalue
+	I-labvalue
/	I-labvalue
5	I-labvalue
.	O

Triceps	O
:	O
right	O
1	O
+	O
and	O
left	O
1	O
+	O
.	O

Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

Constitutional	O
:	O
no	B-negation
fever	O
and	O
no	B-negation
chills	O
.	O

PEDS	O
class	O
E	O
:	O
No	B-negation
intervention	O
required	O
.	O
eg	O

Never	O
A	O
Smoker	O

Femoral	O
pulses	O
:	O
Normal	B-labvalue

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
,	O
no	B-negation
cough	O
and	O
no	B-negation
shortness	O
of	O
breath	O
during	O
exertion	O
.	O

Hyst	O

Physical	O
Exam	O

Marital	O
History	O
-	O
Divorced	O
V61	O
.	O
03	O

Immature	O
Grans	O
(	O
Abs	O
)	O
:	O
0	B-labvalue
.	I-labvalue
0	I-labvalue
x10E3	I-labvalue
/	I-labvalue
uL	I-labvalue
Reference	O
Range	O
0	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
0	I-reference_range
.	I-reference_range
1	I-reference_range

Examination	O
of	O
thyroid	O
:	O
Normal	B-labvalue
.	O

We	O
will	O
check	O
a	O
spot	O
urine	O
calcium	O
and	O
urine	O
protein	O
ratio	O
at	O
this	O
time	O
.	O

[	O
H	O
]	O
Basic	O
Metabolic	O
Panel	O
09Dec2010	B-temporal
10	B-temporal
:	I-temporal
30AM	I-temporal
Hardwicke	O
,	O
Robin	O

Fifth	O
pregnancy	O
:	O

HbA1c	O
to	O
be	O
checked	O
in	O
clinic	O
-	O
13	B-labvalue
.	I-labvalue
8	I-labvalue
%	I-labvalue

Examination	O
of	O
extremities	O
for	O
edema	O
and	O
/	O
or	O
varicosities	O
:	O
Normal	B-labvalue
No	B-negation
edema	O
.	O

She	O
is	O
ambulating	O
well	O
and	O
tolerating	O
a	O
regular	O
diet	O
.	O

Allon	O
,	O
M	O
.	O
D	O
.	O
713-467-4488	O

Sample	O
Name	O
:	O
Post	O
Thyroidectomy	O
-	O
Discharge	O
Summary	O

The	O
patient	O
seemed	O
to	O
be	O
recovering	O
well	O
.	O

I	O
agree	O
with	O
the	O
history	O
,	O
exam	O
and	O
plan	O
of	O
care	O
as	O
documented	O
in	O
the	O
resident	O
note	O
.	O

Diabetes	O
Mellitus	O
250	O
.	O
00	O

Post	O
-	O
Artificial	O
Menopause	O
State	O
627	O
.	O
4	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
vomiting	O
,	O
no	B-negation
nausea	O
,	O
no	B-negation
heartburn	O
and	O
diarrhea	O
.	O

Constitutional	O
:	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
and	O
not	B-negation
feeling	O
tired	O
(	O
fatigue	O
)	O
.	O

The	O
rhythm	O
was	O
regular	B-labvalue
.	O

Strained	O
Biceps	O
Tendon	O
840	O
.	O
8	O

Lower	O
extremity	O
peripheral	O
neurological	O
exam	O
demonstrated	O
light	O
touch	O
intact	B-labvalue
for	O
both	O
legs	O
,	O
ankles	O
,	O
and	O
feet	O
,	O
bilateral	O
foot	O
eversion	O
,	O
inversion	O
,	O
and	O
great	O
toe	O
extension	O
,	O
and	O
intact	B-labvalue
bilateral	O
distal	O
pulses	O
.	O

Examination	O
of	O
gait	O
and	O
station	O
:	O
Normal	B-labvalue
.	O

The	O
rhythm	O
was	O
regular	B-labvalue
.	O

[	O
QLH	O
]	O
LIPID	O
PANEL	O
Done	O
:	O
12Jan2010	B-temporal
09	B-temporal
:	I-temporal
27AM	I-temporal

NEUROLOGICAL	O
/	O
PSYCHIATRIC	O

There	O
is	O
no	O

4/07/2010	B-temporal
.	O

History	O
of	O
Present	O
Illness	O

History	O
of	O
Tobacco	O
Use	O

Essential	O
Hypertension	O
401	O
.	O
9	O

Delivery	O
type	O
:	O
vaginal	O
.	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
and	O
no	B-negation
palpitations	O
.	O

Will	O
send	O
to	O
E	O
.	O
R	O
.	O
at	O
M	O
.	O
S	O
.	O
W	O
.	O

See	O
colpo	O
note	O
for	O
more	O
details	O
.	O

Moderate	O
LV	O
systolic	O
dysfunction	O
(	O
EF	O
34	B-labvalue
%	I-labvalue
)	O
,	O
with	O
apical	O
and	O
inferior	O
hypokinesis	O
,	O
c	O
/	O
w	O
post	O
-	O
stress	O
running	O
.	O

History	O
of	O
Current	O
Smoker	O

Eyes	O

Discussion	O
/	O
Discussion	O
/	O
Summary	O
Allergic	O
Rhinitis	O
Currently	O
,	O
this	O
is	O
mild	B-severity
and	O
the	O
symptoms	O
are	O
unchanged	O
.	O

Coordination	O
:	O
Normal	B-labvalue

Due	O
to	O
long	O
distance	O
for	O
travel	O
,	O
patient	O
to	O
follow	O
up	O
with	O
Dr	O
.	O
Johnigan	O

Discussion	O
/	O
Plan	O

Integumentary	O
:	O
no	B-negation
skin	B-bodyloc
lesions	O
,	O
no	B-negation
breast	B-bodyloc
pain	O
and	O
no	B-negation
breast	B-bodyloc
lump	O
.	O

Palpation	O
of	O
the	O
face	O
and	O
sinuses	O
:	O
Normal	B-labvalue

Visit	O
For	O
:	O
Screening	O
Exam	O
Bact	O
/	O
Spirochetal	O
STD	O
V74	O
.	O
5	O

AST	O
(	O
SGOT	O
)	O
:	O
22	B-labvalue
IU	I-labvalue
/	I-labvalue
L	I-labvalue
Reference	O
Range	O
0	B-reference_range
-	I-reference_range
40	I-reference_range

The	O
patient	O
is	O
a	O
pleasant	O
and	O
cooperative	O
.	O

Examination	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue

Allergies	O
Adhesive	O
Tape	O
TAPE	O

Color	O
:	O
Normal	O

Medication	O

9	O
.	O

Since	O
September	B-temporal
he	O
has	O
had	O
some	O
episodes	O
where	O
he	O
gets	O
a	O
feeling	O
of	O
pressure	O
on	O
the	O
top	B-bodyloc
of	I-bodyloc
his	I-bodyloc
head	I-bodyloc
in	O
the	O
frontal	B-bodyloc
region	I-bodyloc
He	O
feels	O
a	O
pounding	O
sensation	O
in	O
the	O
orbits	B-bodyloc
that	O
is	O
slower	O
than	O
his	O
pulse	O
rate	O
.	O

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

Phase	O
I	O
evaluation	O

PSYCHIATRIC	O
:	O
no	B-negation
depression	O
and	O
no	B-negation
anxiety	O
.	O

Mr	O
.	O
Ogden	O
continues	O
to	O
be	O
quite	O
bradykinetic	O
.	O

History	O
of	O
Present	O
Illness	O

Review	O
of	O
Systems	O

HOUSTON	O
,	O
TX	O
77072	O
-	O
1602	O
JULIA	O
KENNY	O
,	O
M	O
.	O
D	O
.	O

Plan	O
Follow	O
-	O
up	O
visit	O
in	O
6	O
weeks	O
Outpatient	O
Follow	O
-	O
up	O
Requested	O
for	O
:	O
29Mar2013	B-temporal
Follow	O
up	O
in	O
6	O
weeks	O

On	O
a	O
chest	O
x	O
-	O
ray	O
for	O
what	O
appeared	O
to	O
be	O
shortness	O
of	O
breath	O
she	O
was	O
found	O
to	O
have	O
what	O
was	O
thought	O
to	O
be	O
free	O
air	O
under	O
the	O
right	B-bodyloc
diaphragm	I-bodyloc
.	O

Active	O
Problems	O
Abnormal	O
Electrocardiogram	O
794	O
.	O
31	O

F	O
/	O
U	O

Examination	O
of	O
pupils	O
and	O
irises	O
:	O
Normal	B-labvalue

Houston	O
,	O
TX	O
77083	O
-	O
1529	O

Disease	O
management	O
:	O
the	O
patient	O
is	O
doing	O
well	O
with	O
her	O
goals	O
.	O

Lower	B-bodyloc
leg	I-bodyloc
compartments	O
on	O
the	O
injured	O
side	O
:	O
soft	O
compartments	O
.	O

25	O
-	O
OHD2	O
is	O
an	O
indicator	O
of	O

Mr	O
.	O
[	O
*	O
*	O
Known	O
lastname	O
6264	O
*	O
*	O
]	O
also	O
notes	O
the	O
burning	O
sensation	O
has	O
occurred	O
at	O
rest	O
,	O
but	O
can	O
be	O
postural	O
-	O
depending	O
on	O
if	O
he	O
is	O
sitting	O
vs	O
.	O
laying	O
down	O
.	O

Recent	O
and	O
remote	O
memory	O
:	O
Normal	B-labvalue
.	O

Test	O
Name	O
Result	O
Flag	O
Reference	O

Allergic	O
Rhinitis	O
477	O
.	O
9	O

ADMITTING	O
DIAGNOSES	O
:	O
Respiratory	B-bodyloc
distress	O
syndrome	O
,	O
intrauterine	B-bodyloc
growth	O
restriction	O
,	O
thrombocytopenia	O
,	O
hypoglycemia	O
,	O
retinal	B-bodyloc
immaturity	O
.	O

Constitutional	O
:	O
feeling	O
tired	O
(	O
fatigue	O
)	O
,	O
butno	O
recent	B-temporal
weight	O
gain	O
,	O
no	B-negation
recent	B-temporal
weight	O
loss	O
,	O
no	O
feverandno	O
chills	O
.	O

Amitiza	O
24	B-strength
MCG	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
TWICE	B-frequency
DAILY	I-frequency
WITH	O
FOOD	O
;	O
Therapy	O
:	O
11Aug2010	B-temporal
-	O
;	O
Last	O
Rx	O
:	O
12Jul2012	B-temporal
;	O
Status	O
:	O
NEED	O
INFORMATION	O
-	O
Problem	O

Vision	O
screensubjective	O
(	O
red	O
reflex	O
&	O
cover	O
/	O
uncover	O
test	O
)	O

Type	O
1	O
Diabetes	O
Mellitus	O
250	O
.	O
01	O

Delivery	O
type	O
:	O
cesarean	O
delivery	O
.	O

Constitutional	O

Surgical	O
History	O
History	O
of	O
Breast	O
Surgery	O
Lumpectomy	O

Hematology	O
Comments	O
:	O
:	O

[	O
U	O
]	O
XRAY	O
KNEE	O
3	O
VWS	O
LEFT	O
73562	O
Done	O
:	O
18Mar2014	B-temporal
08	B-temporal
:	I-temporal
52AM	I-temporal

Endocrine	O
:	O
no	B-negation
muscle	B-bodyloc
weakness	O
and	O
no	B-negation
feelings	O
of	O
weakness	O
.	O

Homan	O
'	O
s	O
sign	O
and	O
no	B-negation
calf	B-bodyloc
tenderness	O
.	O

Patient	O
okay	O
to	O
return	O
to	O
work	O

Lidocaine	O
5	B-strength
%	I-strength
External	B-form
Patch	I-form
;	O
APPLY	O
1	B-dosage
PATCH	B-form
TO	O
THE	O
AFFECTED	O
AREA	O
AND	O
LEAVE	O
IN	O
PLACE	O
FOR	B-duration
12	I-duration
HOURS	I-duration
,	O
THEN	O
REMOVE	O
AND	O
LEAVE	O
OFF	O
FOR	O
12	O
HOURS	O
Requested	O
for	O
:	O
21Mar2014	B-temporal
;	O
Last	O
Rx	O
:	O
21Mar2014	B-temporal

f	O
[	O
QLH	O
]	O
HEMOGLOBIN	O
A1c	O
02/15/2013	B-temporal
6	O
months	O

QUEtiapine	O
Fumarate	O
25	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
21Feb2013	B-temporal
)	O
to	O

[	O
QLH	O
]	O
SED	O
RATE	O
BY	O
MODIFIED	O
WESTERGREN	O
Requested	O
for	O
:	O
29Oct2012	B-temporal

Inspection	O
of	O
breasts	O
:	O
Normal	B-labvalue

0	O
-	O
7	O
days	O
:	O
41	O
-	O
90	O
mg	O
/	O
dL	O

;	O
Aug	B-temporal
5	I-temporal
2011	I-temporal
11	B-temporal
:	I-temporal
55AM	I-temporal
(	O
Author	O
)	O

EYES	O
:	O
no	B-negation
double	O
vision	O
and	O
no	B-negation
blurred	O
vision	O
.	O

Visit	O
For	O
:	O
Postsurgical	O
Exam	O
V67	O
.	O
00	O

Previous	O
Biopsy	O
NA	O

Palpation	O
of	O
the	O
face	O
and	O
sinuses	O
:	O
Normal	B-labvalue

Constitutional	O

Posterior	O
pharynx	O
is	O
normal	O
.	O

The	O
heart	O
rate	O
was	O
normal	B-labvalue
.	O

Eyes	O
:	O
no	B-negation
eye	B-bodyloc
pain	O
,	O
eyes	B-bodyloc
not	B-negation
red	O
,	O
no	B-negation
eyesight	O
problems	O
and	O
no	B-negation
purulent	O
discharge	O
from	O
the	O
eyes	B-bodyloc
.	O

Associated	O
symptoms	O
:	O
no	B-negation
pelvic	B-bodyloc
pain	O
,	O
no	B-negation
fatigue	O
and	O
no	B-negation
sleep	O
disturbance	O
.	O

Ms	O
.	O
ABC	O
is	O
a	O
pleasant	O
66	O
-	O
year	O
-	O
old	O
Caucasian	O
female	O
who	O
first	O
palpated	O
a	O
mass	O
in	O
the	O
left	B-bodyloc
posterior	I-bodyloc
arm	I-bodyloc
in	O
spring	B-temporal
of	I-temporal
2007	I-temporal
.	O

He	O
needs	O
to	O
get	O
this	O
done	B-temporal
every	I-temporal
6	I-temporal
months	I-temporal
.	O

Otoscopic	O
examination	O
:	O
Normal	B-labvalue

[	O
QLH	O
]	O
TSH	O
,	O
3RD	O
GENERATION	O

Baclofen	O
20	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
3	B-frequency
TIMES	I-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
19Jul2010	B-temporal
to	O
(	O
Evaluate	O
:	O
03Dec2012	B-temporal
)	O
Requested	O
for	O
:	O
09Dec2011	B-temporal
;	O
Last	O
Rx	O
:	O
09Dec2011	B-temporal

Vitals	O
02Oct2013	B-temporal
03	B-temporal
:	I-temporal
54PM	I-temporal
BMI	O
Calculated	O
30	B-labvalue
.	I-labvalue
23	I-labvalue
BSA	O
Calculated	O
2	B-labvalue
.	I-labvalue
04	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
8	I-labvalue
in	I-labvalue
Weight	O
199	B-labvalue
lb	I-labvalue
8	I-labvalue
oz	I-labvalue
Systolic	O
118	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
84	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Heart	O
Rate	O
72	B-labvalue
,	O
R	O
Radial	O

This	O
picture	O
can	O
be	O
seen	O
in	O
statin	O
induced	O
autoimmune	O
myositis	O
,	O
infections	O
such	O
as	O
HIV	O
and	O
in	O
paraneoplastic	O
syndromes	O
.	O

Surgical	O
History	O
History	O
of	O
Cholecystectomy	O

Restart	O
ppi	O
.	O

Review	O
of	O
Systems	O

The	O
heart	O
rate	O
was	O
normal	B-labvalue
.	O

Esophageal	B-bodyloc
Reflux	O
530	O
.	O
81	O

Pertinent	O
medical	O
history	O
:	O
diabetes	O
and	O
dyslipidemia	O
.	O

Lymph	O
nodes	O
,	O
right	O
pelvic	O
,	O
lymphadenectomy	O
:	O

Assessment	O
of	O
stability	O
:	O
Normal	B-labvalue
.	O

thumb	O
surgery	O

Nasal	O
Mucosa	O
:	O
normal	O

Hemoccult	O
(	O
Stool	O
)	O
Requested	O
for	O
:	O
16Nov2012	B-temporal

Psychiatric	O
:	O
not	B-negation
suicidal	O
,	O
no	B-negation
sleep	O
disturbances	O
,	O
no	B-negation
anxiety	O
,	O
no	B-negation
depression	O
,	O
no	B-negation
personality	O
change	O
and	O
no	B-negation
emotional	O
problems	O
.	O

Chloride	O
,	O
Serum	O
:	O
102	B-labvalue
mmol	I-labvalue
/	I-labvalue
L	I-labvalue
Reference	O
Range	O
97	B-reference_range
-	I-reference_range
108	I-reference_range

Lantus	O
100	B-strength
UNIT	I-strength
/	I-strength
ML	I-strength
Subcutaneous	B-route
Solution	B-form
;	O
INJECT	O
15	B-dosage
UNIT	I-dosage
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
05Feb2013	B-temporal
)	O
to	O

Abdomen	O

Cardiovascular	O

[	O
QL	O
]	O
THYROID	O
PANEL	O
WITH	O
TSH	O
,	O
3RD	O
GENERATION	O
Requested	O
for	O
:	O
21Mar2013	B-temporal

Routine	O
Gynecological	O
Exam	O
V72	O
.	O
31	O

Palpation	O
of	O
the	O
face	O
and	O
sinuses	O
:	O
Normal	B-labvalue

Review	O
of	O
Systems	O

Dilation	O
and	O
curettage	O
performed	O
.	O

Constitutional	O

BCG	O
;	O
31	B-temporal
Aug	I-temporal
2007	I-temporal

Head	O
and	O
Face	O

Active	O
Problems	O
Bacterial	O
Vaginosis	O
616	O
.	O
10	O

Head	O
and	O
Face	O
:	O

Immunizations	O
Tdap	O
-	O
-	O
-	O
Series1	O
:	O
27Mar2013	B-temporal

Pt	O
'	O
s	O
home	O
nurse	O
,	O
Lisa	O
,	O
talled	O
with	O
today	O
'	O
s	O
INR	O
of	O
3	B-labvalue
.	I-labvalue
1	I-labvalue
.	O

Otoscopic	O
examination	O
:	O
Normal	B-labvalue
.	O

NEUROLOGICAL	O
:	O
Cranial	O
nerves	O
II	O
-	O
XII	O
grossly	O
intact	O
.	O

1	O
.	O

Paternal	B-subject
history	O
of	O
Coronary	B-bodyloc
Artery	I-bodyloc
Disease	O
V17	O
.	O
49	O

Previous	B-temporal
Surgery	O
:	O
Yes	O
.	O

The	O
episodes	O
occur	O
4	O
-	O
6	O
times	O
a	O
year	O
.	O

Topiramate	O
50	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
one	B-dosage
tablet	B-form
at	B-frequency
bedtime	I-frequency
;	O
Therapy	O
:	O
11Apr2012	B-temporal
to	O
(	O
Evaluate	O
:	O
09Aug2014	B-temporal
)	O
Requested	O
for	O
:	O
14Aug2013	B-temporal
;	O
Last	O
Rx	O
:	O
14Aug2013	B-temporal
;	O
Status	O
:	O
ACTIVE	O
-	O

The	O
nasal	O
turbinates	O
were	O
normal	O
.	O

f	O
Bronchopulmonary	O
Dysplasia	O
Of	O
Fetus	O
Or	O
Newborn	O
(	O
770	O
.	O
7	O
)	O
;	O
(	O
Active	O
)	O
f	O
Vaccines	O
Prophylactic	O
Need	O
Against	O
Influenzr	O
(	O
V04	O
.	O
81	O
)	O
;	O
(	O
Active	O
)	O

They	O
gradually	O
diminished	O
in	O
intensity	O
and	O
his	O
last	O
one	O
was	O
a	O
month	O
ago	O
.	O

Examination	O
of	O
thyroid	O
:	O
Normal	B-labvalue
.	O

The	O
baby	O
is	O
Pumping	O
.	O

Diet	O
recommendations	O
:	O
low	O
fat	O
diet	O
,	O
low	O
sodium	O
diet	O
.	O

Larynx	O
Under	O
Continuous	O
Light	O
:	O

Abdomen	O
Soft	O
;	O
nontender	O
;	O
no	B-negation
purple	O
striae	O
.	O
No	B-negation
palpable	O
mass	O
or	O
organomegaly	O
.	O

The	O
abdomen	O
was	O
normal	B-labvalue
to	O
percussion	O
.	O

Genitourinary	O
,	O
musculoskeletal	O
,	O
skin	O
,	O
endocrine	O
and	O
hematologic	O
review	O
of	O
systems	O
are	O
normal	O
.	O

Exforge	O
HCT	O
5-160-12	B-strength
.	I-strength
5	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
EVERY	B-frequency
DAY	I-frequency
;	O
Therapy	O
:	O
27Dec2012	B-temporal
to	O
(	O
Evaluate	O
:	O
25Feb2013	B-temporal
)	O

[	O
QLH	O
]	O
LIPID	O
PANEL	O
Requested	O
for	O
:	O
07Mar2011	B-temporal

Indication	O
:	O
Chronic	B-course
rhinosinusitis	O
follow	O
-	O
up	O
.	O

IMPROVED	O
-	O
SEE	O
HPI	O
)	O
.	O

pt	O
stated	O
he	O
'	O
s	O
getting	O
ready	O
to	O
have	O
denture	O
placed	O
.	O

Inspection	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
Abnormal	O
.	O
Facial	B-bodyloc
nodules	O
,	O
purulent	O
discharge	O
.	O

Eyes	O
:	O
no	B-negation
eyesight	O
problems	O
.	O

Appears	O
healthy	O
,	O
within	O
normal	O
limits	O
of	O
ideal	O
weight	O
,	O
well	O
hydrated	O
,	O
appearance	O
reflects	O
stated	O
ageandnml	O
color	O
.	O

CONSTITUTIONAL	O

Palpation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Breath	O
sounds	O
were	O
not	B-labvalue
diminished	I-labvalue
.	O

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

COMPARISON	O
:	O
None	O

SHE	O
HAD	O
ON	O
NUMBNESS	O
OR	O
TINGLING	O
IN	O
THE	O
LOWER	B-bodyloc
EXTREMITIES	I-bodyloc
.	O

Never	O
Drank	O
Alcohol	O

GI	O
:	O
No	B-negation
nausea	O
,	O
vomiting	O
,	O
or	O
diarrhea	O
.	O

The	O
patient	O
also	O
suffers	O
from	O
encephalopathy	O
from	O
her	O
brain	B-bodyloc
radiation	O
.	O

There	O
was	O
excessive	O
bleeding	O
.	O
Spotting	O
.	O

Plan	O
Enoxaparin	O
Sodium	O
40	B-strength
MG	I-strength
/	I-strength
0	I-strength
.	I-strength
4ML	I-strength
Subcutaneous	B-route
Solution	B-form
;	O
One	B-dosage
sub	I-dosage
injection	B-route
every	B-frequency
morning	I-frequency
daily	I-frequency
x	O
5	O
daysTO	O
BE	O
TAKEN	O
AFTER	O
SUGERY	O
MDD	O
:	O
1	O
TDD	O
:	O
1	O
;	O
Therapy	O
:	O
08Dec2012	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
08Dec2012	B-temporal
)	O

UTP	O
-	O
OB	O
/	O

Hypokalemia	O
276	O
.	O
8	O

[	O
QLH	O
]	O
IRON	O
AND	O
TOTAL	O
IRON	O
BINDING	O
CAPACITY	O
Done	O
:	O
28Feb2011	B-temporal
10	B-temporal
:	I-temporal
28AM	I-temporal

General	O
appearance	O
:	O
Normal	O
.	O

Basophils	O
#	O
0	B-labvalue
.	I-labvalue
0	I-labvalue
K	I-labvalue
/	I-labvalue
CMM	I-labvalue
0	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
0	I-reference_range
.	I-reference_range
2	I-reference_range

Monofilament	O
Testing	O
:	O
Normal	B-labvalue
tactile	O
sensation	O
with	O
monofilament	O
testing	O
throughout	O
both	O
feet	O
.	O

Cranial	O
nerves	O
V	O
:	O
sensation	O
to	O
the	O
face	O
and	O
masseter	O
strength	O
were	O
intact	B-labvalue
.	O

PMH	O
g32	O

He	O
had	O
no	B-negation
symptoms	O
the	B-temporal
next	I-temporal
2	I-temporal
days	I-temporal
,	O
up	O
to	O
this	O
morning	O
.	O

No	B-negation
masses	O
palpated	O
.	O

Orientation	O
to	O
person	O
,	O
place	O
,	O
and	O
time	O
:	O
Normal	B-labvalue
.	O

Microalbuminuria	O
791	O
.	O
0	O

T4	O
Free	O
:	O
1	B-labvalue
.	I-labvalue
07	I-labvalue
ng	I-labvalue
/	I-labvalue
dl	I-labvalue
Reference	O
Range	O
0	B-reference_range
.	I-reference_range
76	I-reference_range
-	I-reference_range
1	I-reference_range
.	I-reference_range
46	I-reference_range

Vitals	O
UTP	O
Adult	O
Vital	O
Signs	O
[	O
Data	O
Includes	O
:	O
Current	O
Encounter	O
]	O
25Jul2012	B-temporal
08	B-temporal
:	I-temporal
33AM	I-temporal
BMI	O
Calculated	O
:	O
31	B-labvalue
.	I-labvalue
78	I-labvalue
BSA	O
Calculated	O
:	O
1	B-labvalue
.	I-labvalue
9	I-labvalue
Height	O
:	O
5	B-labvalue
ft	I-labvalue
4	I-labvalue
in	I-labvalue
Weight	O
:	O
186	B-labvalue
lb	I-labvalue
2	I-labvalue
oz	I-labvalue
Systolic	O
:	O
126	B-labvalue
Diastolic	O
:	O
80	B-labvalue
Heart	O
Rate	O
:	O
80	B-labvalue

(	O
femor	O
.	O
)	O
Stremgth	O
:	O
4	O
+	O
/	O
5	O
.	O

Potassium	O
,	O
Serum	O
:	O
4	B-labvalue
.	I-labvalue
5	I-labvalue
mmol	I-labvalue
/	I-labvalue
L	I-labvalue
Reference	O
Range	O
3	B-reference_range
.	I-reference_range
5	I-reference_range
-	I-reference_range
5	I-reference_range
.	I-reference_range
2	I-reference_range

Acute	B-course
Bronchitis	O
466	O
.	O
0	O

Electronically	O
signed	O
by	O
:	O
LEE	O
BAR	O
-	O
ELI	O
,	O
M	O
.	O
D	O
.	O

Butalbital	O
-	O
ASA	O
-	O
Caffeine	O
50-325-40	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
EVERY	B-frequency
4	I-frequency
HOURS	I-frequency
AS	O

Integumentary	O
:	O
no	B-negation
skin	B-bodyloc
wound	O
and	O
no	B-negation
pruritus	O

Immunizations	O

ENT	O
:	O
no	B-negation
hearing	O
loss	O
,	O
no	B-negation
sore	O
throat	B-bodyloc
and	O
no	B-negation
hoarseness	O
.	O

Cardiovascular	O
:	O
palpitations	O
.	O

Psychiatric	O
:	O
no	B-negation
anxiety	O
and	O
no	B-negation
depression	O
.	O

Endocrine	O
:	O
normal	O
,	O
no	B-negation
hot	O
flashes	O
,	O
no	B-negation
changes	O
in	O
appetite	O
,	O
no	B-negation
unusual	O
sensitivity	O
to	O
changes	O
in	O
temperature	O
and	O
no	B-negation
feelings	O
of	O
excessive	O
thirst	O
.	O

Hematologic	O
/	O
Lymphatic	O
:	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
.	O

Vitals	O
13Dec2013	B-temporal
04	B-temporal
:	I-temporal
05PM	I-temporal
Systolic	O
130	B-labvalue
,	O
RUE	O
,	O
Sitting	O
Diastolic	O
80	B-labvalue
,	O
RUE	O
,	O
Sitting	O
Temperature	O
98	B-labvalue
.	I-labvalue
2	I-labvalue
F	I-labvalue
,	O
Oral	O
Heart	O
Rate	O
80	B-labvalue
,	O
R	O
Radial	O

Alert	O
and	O
cooperative	O

Paternal	O
history	O
of	O
Hypertension	O
V17	O
.	O
49	O

On	O
a	O
chest	O
x	O
-	O
ray	O
for	O
what	O
appeared	B-uncertain
to	I-uncertain
be	I-uncertain
shortness	O
of	O
breath	O
she	O
was	O
found	O
to	O
have	O
what	O
was	O
thought	B-uncertain
to	I-uncertain
be	I-uncertain
free	O
air	O
under	O
the	O
right	B-bodyloc
diaphragm	I-bodyloc
.	O

The	O
heart	O
rate	O
was	O
normal	B-labvalue
.	O

EXTREMITIES	O
:	O
No	B-negation
edema	O
,	O
clubbing	O
or	O
cyanosis	O
.	O

He	O
denies	B-negation
any	O
further	O
feelings	O
of	O
lightheadedness	O
since	O
his	O
last	O
visit	O
.	O

2	O
.	O

Patient	O
discharged	O
on	O
norco	O
,	O
valium	O
,	O
and	O
augmentin	O
.	O

general	O
medicine	O
,	O
free	O
air	O
,	O
hyponatremia	O
,	O
air	O
under	O
the	O
diaphragm	B-bodyloc
,	O
intra	B-bodyloc
abdominal	I-bodyloc
pathology	O
,	O
abdominal	O
,	O
pathology	O
,	O
obtunded	O
,	O
diaphragm	O
,	O

Psychiatric	O
:	O
no	B-negation
sleep	O
disturbances	O
.	O

Vitals	O
07Aug2013	B-temporal
02	B-temporal
:	I-temporal
24PM	I-temporal
Systolic	O
120	B-labvalue
Diastolic	O
70	B-labvalue
Temperature	O
98	B-labvalue
.	I-labvalue
7	I-labvalue
F	I-labvalue
Heart	O
Rate	O
80	B-labvalue

Generalized	O
Convulsive	O
Grand	O
Mal	O
Seizure	O
345	O
.	O
10	O

No	B-negation
guarding	O
.	O

Examination	O
of	O
cranial	O
nerves	O
:	O
Normal	B-labvalue
.	O

The	O
eGFR	O
calculation	O
is	O
not	O
valid	O
in	O
pregnancy	O
or	O
for	O

PSYCHIATRIC	O
:	O
no	B-negation
depression	O
and	O
no	B-negation
anxiety	O
.	O

HumaLOG	O
KwikPen	O
100	B-strength
UNIT	I-strength
/	I-strength
ML	I-strength
Subcutaneous	B-route
Solution	B-form
;	O
Use	O
as	O
directed	O
per	O
sliding	B-dosage
scale	I-dosage
;	O

Continue	O
f	O
/	O
u	O
with	O
with	O
back	O
surgeon	O
Continue	O
the	O
PT	O
RTC	O
in	O
4	O
weeks	O

Spent	O
20	O
minutes	O
with	O
patient	O
in	O
counseling	O
and	O
coordination	O
of	O
care	O
.	O

The	O
patient	O
denies	B-negation
any	O
rhinorrhea	O
.	O

Previous	B-temporal
Surgery	O
:	O
Yes	O
.	O

Current	O
Meds	O
Amlodipine	O
Besy	O
-	O
Benazepril	O
HCl	O
10	B-strength
-	I-strength
40	I-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
ONE	B-dosage
CAPSULE	B-form
BY	B-route
MOUTH	I-route
ONCE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
19Mar2013	B-temporal
to	O
(	O
Evaluate	O
:	O
17Jun2013	B-temporal
)	O
Requested	O
for	O
:	O
19Mar2013	B-temporal
;	O
Last	O
Rx	O
:	O
19Mar2013	B-temporal

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

No	B-negation
delusions	O
,	O
hallucinations	O
.	O

Occlusive	O
below	B-bodyloc
-	I-bodyloc
knee	I-bodyloc
thrombus	O
noted	O
.	O

"	O
Caffeine	O
Use	O

Constitutional	O

Initially	O
occurred	O
about	O
twice	O
a	O
day	O
all	O
the	O
way	O
to	O
as	O
infrequently	O
as	O
twice	O
a	O
month	O
.	O

Head	O
and	O
Face	O

Flexion	O
was	O
restricted	O
and	O
was	O
painful	O
.	O

Examination	O
of	O
thyroid	O
:	O
Normal	B-labvalue
.	O

These	O
episodes	O
last	O
5	O
minutes	O
to	O
all	O
day	O
.	O

Abdomen	O
:	O
Normal	O
.	O

History	O
of	O
Attention	O
-	O
Deficit	O
Hyperactivity	O
Disorder	O
314	O
.	O
01	O

ALBUMIN	O
/	O
GLOBULIN	O
RATIO	O
1	B-labvalue
.	I-labvalue
5	I-labvalue
CALC	O
1	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
2	I-reference_range
.	I-reference_range
5	I-reference_range

These	O
can	O
occur	O
almost	O
on	O
a	O
weekly	O
basis	O
,	O
sometimes	O
more	O
frequent	O
than	O
that	O
with	O
no	B-negation
trauma	O
.	O

Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

Eyes	O

History	O
of	O
Cesarean	O
Section	O

The	O
neck	O
was	O
supple	O
.	O

History	O
of	O
Tonsillectomy	O

Discussion	O
/	O
Discussion	O
/	O
Summary	O

[	O
QLH	O
]	O
TSH	O
,	O
3RD	O
GENERATION	O
W	O
/	O
REFLEX	O
TO	O
FT4	O
Done	O
:	O
21Mar2012	B-temporal
12	B-temporal
:	I-temporal
00AM	I-temporal

GroupHeading13End	O
GroupHeading12Start	O
Genitouripasy	O
:	O
no	B-negation
dysuria	O
,	O
no	B-negation
dysmensrrhea	O
and	O
no	B-negation
vaginal	B-bodyloc
discharge	O
.	O

I	O
agree	O
with	O
the	O
history	O
,	O
exam	O
and	O
plan	O
of	O
care	O
as	O
documented	O
in	O
the	O
resident	O
note	O
.	O

Signature	O
g36	O

EKG	O
Requested	O
for	O
:	O
16Nov2012	B-temporal

Gastrointestinal	O
:	O
no	B-negation
vomiting	O
,	O
no	B-negation
constipation	O
,	O
no	B-negation
diarrhea	O
and	O
no	B-negation
heartburn	O
.	O

Hydrochlorothiazide	O
12	B-strength
.	I-strength
5	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
22Jul2013	B-temporal
to	O
(	O
Evaluate	O
:	O
22Jul2014	B-temporal
)	O
Requested	O
for	O
:	O
22Jul2013	B-temporal
;	O
Last	O
Rx	O
:	O
22Jul2013	B-temporal
;	O
Edited	O

Patient	O
agrees	O
to	O
proceed	O
.	O

Family	B-subject
history	O
of	O
Hypercholesterolemia	O

Chief	O
Complaint	O

CT	O
HEAD	O
w	O
/	O
o	O
CONTRAST	O
Requested	O
for	O
:	O
17Nov2011	B-temporal

The	O
patient	O
coEes	O
in	O
coEndaining	O
of	O
low	B-bodyloc
back	I-bodyloc
pain	O
.	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
vomiting	O
,	O
no	B-negation
constipation	O
and	O
no	B-negation
diarrhea	O
.	O

The	O
left	B-bodyloc
tympanic	I-bodyloc
membrane	I-bodyloc
was	O
not	O
redand	O
was	O
not	B-negation
bulging	O
.	O

Adderall	O
TABS	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
AS	I-frequency
DIRECTED	I-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
31Jan2012	B-temporal
)	O
to	O

Active	O
Problems	O
Hyperlipidemia	O
272	O
.	O
4	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Surgical	O
History	O

The	O
patient	O
is	O
being	O
seen	O
for	O
a	O
routine	O
clinic	O
follow	O
-	O
up	O
of	O
hyperlipidemia	O
.	O

Ciprodex	O
0	B-strength
.	I-strength
3	I-strength
-	I-strength
0	I-strength
.	I-strength

;	O
Jan	B-temporal
20	I-temporal
2013	I-temporal
5	B-temporal
:	I-temporal
05PM	I-temporal
(	O
Author	O
)	O

1	O
Influenza	O
10Sep2013	B-temporal

OneTouch	O
Delica	O
Lancets	O
Miscellaneous	O
;	O
Check	O
BG	O
5	O
-	O
6x	O
a	O
day	O
;	O
Therapy	O
:	O
24Nov2012	B-temporal
to	O

FEEDING	O
AND	O
NUTRITION	O
:	O
Baby	O
was	O
on	O
TPN	O
and	O
p	O
.	O
o	O
.	O
feeds	O
had	O
been	O
started	O
and	O
were	O
advanced	O
1	O
ml	O
q	O
.	O
6h	O
.	O

Onychomycosis	O
Of	O
The	O
Toenails	O
110	O
.	O
1	O

Current	O
Orders	O
[	O
H	O
]	O
Vit	O
A	O
Done	O
:	O
18Dec2012	B-temporal
11	B-temporal
:	I-temporal
30AM	I-temporal

Vitamin	O
B	O
-	O
12	O
TABS	B-form
;	O
TAKE	O
2	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
25Jan2012	B-temporal
)	O
to	O

Congestive	O
Heart	B-bodyloc
Failure	O
428	O
.	O
0	O

GASTROINTESTINAL	O
:	O
no	B-negation
heartburn	O
,	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
diarrhea	O
,	O
no	B-negation
constipation	O
and	O
no	B-negation
vomiting	O
.	O

MRI	O
scan	O

I	O
agree	O
with	O
the	O
history	O
,	O
exam	O
and	O
plan	O
of	O
care	O
as	O
documented	O
in	O
the	O
resident	O
note	O
.	O

Sertraline	O
HCl	O
50	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
Requested	O
for	O
:	O
29Jul2013	B-temporal
;	O
Last	O
Rx	O
:	O
29Jul2013	B-temporal
;	O
Status	O
:	O
ACTIVE	O
-	O
Retrospective	O
Authorization	O

ENT	O
:	O
no	B-negation
earache	O
,	O
no	B-negation
hearing	O
loss	O
,	O
no	B-negation
epistaxis	O
,	O
no	B-negation
nasal	B-bodyloc
discharge	O
,	O
no	B-negation
hoarseness	O
and	O
no	B-negation
sore	O
throat	B-bodyloc
.	O

mom	O
dx	O
at	O
age	O
40	O
,	O
in	O
remission	O

I	O
have	O
discussed	O
the	O
case	O
with	O
the	O
resident	O
and	O
agree	O
with	O
the	O
diagnosis	O
and	O
plan	O
.	O

The	O
tonsils	O
were	O
normal	O
.	O

Piroxicam	O
20	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
AS	B-frequency
NEEDED	I-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
24Sep2013	B-temporal
)	O
to	O

Physical	O
Exam	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Difficulty	O
with	O
truncal	O
balance	O

Ambulatory	O
Health	O
Care	O
Facilities	O
SABA	O
SIDDIKI	O
Address	O
:	O
UNK	O

patient	O
reportsthat	O
he	O
has	O
been	O
self	O
adjusting	O
medication	O
recently	O
went	O
back	O
on	O
100	O
mg	O
twice	O
daily	O
for	O
the	B-temporal
past	I-temporal
week	I-temporal
.	O

Neurological	O
:	O
facial	B-bodyloc
weakness	O
,	O
leg	B-bodyloc
weakness	O
and	O
difficulty	O
walking	O
,	O
but	O
no	B-negation
confusion	O
,	O
no	B-negation
memory	O
loss	O
,	O
no	B-negation
decrease	O
in	O
concentrating	O
ability	O
,	O
no	B-negation
speech	O
difficulties	O
,	O
no	B-negation
change	O
in	O
thought	O
patterns	O
,	O
no	B-negation
repeated	O
questioning	O
about	O
recent	O
events	O
,	O
no	B-negation
arm	B-bodyloc
weakness	O
,	O
no	B-negation
hand	B-bodyloc
weakness	O
,	O
good	O
coordination	O
,	O
no	B-negation
difficulty	O
writing	O
,	O
no	B-negation
tremor	O
was	O
seen	O
,	O
denied	B-negation
anesthesia	O
,	O
no	B-negation
numbness	O
,	O
no	B-negation
tingling	O
,	O
no	B-negation
burning	O
sensation	O
,	O
no	B-negation
hyperesthesia	O
,	O
no	B-negation
convulsions	O
,	O
no	B-negation
dizziness	O
,	O
no	B-negation
fainting	O
,	O
no	B-negation
lightheadedness	O
,	O
no	B-negation
vertigo	O
,	O
no	B-negation
cluster	O
headache	O
,	O
no	B-negation
migraine	O

The	O
patient	O
states	O
his	O
hyperlipidemia	O
has	O
been	O
stable	O
since	O
the	O
last	O
visit	O
.	O

Mental	O
Status	O
:	O
Clear	O
and	O
coherent	O

DISCHARGE	O
CONDITION	O
:	O

Phynoderma	O
on	O
bilateral	B-bodyloc
lateral	I-bodyloc
elbows	I-bodyloc
,	O
lateral	O
R	O
knee	O
,	O
lateral	O
R	O
ankle	O
.	O

Cranial	O
Nerves	O
:	O

Oropharynx	O
:	O
normal	O
mucosa	O
and	O
appearance	O
.	O

Pregnancy	O
Test	O
Positive	B-labvalue
V72	O
.	O
42	O

Current	O
Meds	O
Flomax	O
0	B-strength
.	I-strength
4	I-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
09Jul2013	B-temporal
)	O
to	O

Lovaza	O
1	B-strength
GM	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
TWO	B-dosage
CAPSULES	B-form
BY	B-route
MOUTH	I-route
TWICE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
26Sep2013	B-temporal
to	O
(	O
Evaluate	O
:	O
25Mar2014	B-temporal
)	O
Requested	O
for	O
:	O
26Sep2013	B-temporal
;	O
Last	O
Rx	O
:	O
26Sep2013	B-temporal

Weight	O
:	O
230	B-labvalue
lb	I-labvalue

Left	O
long	O
finger	O
radial	O
digital	O
artery	O
repair	O
4	O
.	O

1	B-temporal
/	I-temporal
11	I-temporal
-	O
CBC	O
and	O
LFT	O
normal	B-labvalue
,	O
Vit	O
D	O
low	B-labvalue
end	I-labvalue
of	I-labvalue
normal	I-labvalue
.	O

Never	O
A	O
Smoker	O

Bus	O
:	O
(	O
832	O
)	O
325	O
-	O
7222	O

Levothyroxine	O
Sodium	O
50	B-strength
MCG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
DAILY	B-frequency
;	O
Therapy	O
:	O
30Sep2005	B-temporal
to	O
(	O
Evaluate	O
:	O
15Feb2013	B-temporal
)	O
Requested	O
for	O
:	O
20Jul2012	B-temporal
;	O
Last	O
Rx	O
:	O
20Jul2012	B-temporal

She	O
had	O
persistent	O
nausea	O
,	O
headache	O
,	O
neck	B-bodyloc
pain	O
throughout	O
this	O
hospitalization	O
.	O

Discharge	O
Instructions	O
:	O

I	O
have	O
seen	O
and	O
examined	O
FARHAD	O
ARDEHALI	O
with	O
the	O
resident	O
.	O

Mucous	O
membranes	O
are	O
moist	O
.	O

Examination	O
of	O
thyroid	O
:	O
Normal	B-labvalue
.	O

Well	O
developedandwell	O
nourished	O
.	O

The	O
patient	O
has	O
a	O
fair	O
complexion	O
.	O

Neurological	O
:	O
alert	O
,	O
limb	O
weaknessanddifficulty	O
walking	O
,	O
butno	O
tinnitus	O
,	O
no	B-negation
dizziness	O
,	O
no	B-negation
fainting	O
,	O
no	O
tinglingandno	O
diplopia	O
.	O

Constitutional	O

Asthma	O
493	O
.	O
90	O

Visit	O
For	O
:	O
Postpartum	O
Exam	O
V24	O
.	O
2	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O
The	O
patient	O
is	O
a	O
77	O
-	O
year	O
-	O
old	O
female	O
who	O
is	O
unable	O
to	O
give	O
any	O
information	O
.	O

Neck	O

Normal	B-labvalue
labs	O
-	O
NMO	O
IgG	O
,	O
ANA	O
,	O
ACE	O
,	O
CRP	O
,	O
CBC	O
,	O
dsDNA	O
,	O
CMP	O
,	O
HIV	O
,	O
SIFE	O
,	O
MMA	O
,	O
RF	O
,	O
RPR	O
,	O
ESR	O
,	O
SSA	O
&	O
B	O
,	O
Sm	O
,	O
TFT	O
,	O
Cu	O
,	O
B12	O
,	O
Lyme	O
IgM	O
.	O

CF	O
~	O
40	O
;	O
target	O
BG	O
<	O
120	O
;	O
up	O
to	O
50	O
units	O
a	O
day	O
;	O
Therapy	O
:	O
14Mar2014	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
14Mar2014	B-temporal
)	O

Sample	O
Type	O
/	O
Medical	O
Specialty	O
:	O

Chief	O
Complaint	O

Culture	O
:	O
Bilateral	O
,	O
middle	O
meatus	O

1	O
.	O

Current	O
Meds	O
Coreg	O
6	B-strength
.	I-strength
25	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
TWICE	B-frequency
DAILY	I-frequency
WITH	I-frequency
MEALS	I-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
29Oct2012	B-temporal
)	O
to	O

Denied	O

Examination	O
of	O
digits	O
and	O
nails	O
:	O
Abnormal	O
.	O
Thenar	O
and	O
Hypothenar	O
wasting	O
.	O

Stool	O
sample	O
for	O
occult	O
blood	O
:	O
Normal	B-labvalue
.	O

He	O
reports	O
no	O
recent	O
hospitalization	O
.	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
neck	O
:	O
Normal	B-labvalue
.	O

No	B-negation
rhonchi	O
were	O
heard	O
.	O

ACTIVITY	O
AND	O
LIMITATIONS	O
:	O
Nonweightbearing	O
to	O
the	O
right	O
lower	O
extremity	O
.	O

Hematologic	O
/	O
Lymphatic	O
:	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
,	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
,	O
no	B-negation
swollen	O
glands	B-bodyloc
and	O
no	B-negation
swollen	O
glands	B-bodyloc
in	O
the	O
neck	B-bodyloc
.	O

The	O
patient	O
presents	O
with	O
complaints	O
of	O
no	B-negation
intermittent	O
leg	B-bodyloc
claudication	O
(	O
no	O
change	O
from	O
baseline	O
)	O
.	O

Medications	O
:	O
The	O
patient	O
is	O
adherent	O
with	O
his	O
medication	O
regimen	O
.	O
(	O
currently	O
)	O
He	O
denies	B-negation
medication	O
side	O
effects	O
.	O

Physical	O
Exam	O

General	O
appearance	O
:	O
No	B-negation
acute	B-course
distress	O
,	O
well	O
appearing	O
and	O
well	O
nourished	O
.	O

Constitutional	O

History	O
of	O
Present	O
Illness	O

Test	O
Name	O
Result	O
Flag	O
Reference	O

1	O
.	O

Psychiatric	O
:	O
no	B-negation
anxiety	O
and	O
no	B-negation
depression	O
.	O

[	O
QL	O
]	O
THYROID	O
PANEL	O
WITH	O
TSH	O
,	O
3RD	O
GENERATION	O
Requested	O
for	O
:	O
17Feb2014	B-temporal

Examination	O
of	O
the	O
skin	O
for	O
lesions	O
:	O
Abnormal	O
(	O
on	O
the	O
finger	O
froim	O
a	O
ring	O
)	O

Assessment	O
of	O
muscle	O
strength	O
/	O
tone	O
:	O
Normal	B-labvalue
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Family	B-subject
history	O
of	O
Diabetes	O
Mellitus	O

NEUROLOGICAL	O
/	O
PSYCHIATRIC	O

The	O
patient	O
is	O
not	O
currently	O
being	O
treated	O
for	O
this	O
problem	O
.	O

The	O
thyroid	B-bodyloc
was	O
not	B-negation
enlarged	O
.	O

f	O
AmLODIPine	O
Besylate	O
10	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
.	O
;	O
Start	O
Date	O
:	O
09/17/2009	B-temporal
;	O
End	O
Date	O
:	O
01/01/1900	B-temporal
(	O
Active	O
)	O

Assessment	O
of	O
stability	O
:	O
Normal	B-labvalue

DISPOSITION	O
:	O
To	O
home	O
.	O

Pertinent	O
medical	O
history	O
:	O
no	B-negation
fibrocystic	O
breast	B-bodyloc
disease	O
,	O
no	O
extramammary	O
tissue	O
and	O
no	B-negation
mastitis	O
.	O

Emergency	O
Contact	O
:	O
CHEVONNE	O
THORNTON	O
,	O
(	O
713	O
)	O
486	O
-	O
6484	O
(	O
Home	O
phone	O
)	O
Document	O
Details	O
SUMMARIZATION	O
OF	O
EPISODE	O
NOTE	O
Encounter	O
February	B-temporal
15	I-temporal
,	I-temporal
2013	I-temporal
15	B-temporal
:	I-temporal
15	I-temporal
+	O
0000	O
From	O
Enterprise	O
EHR	O
11	O
.	O
200	O
.	O
4288	O
.	O

The	O
tonsils	O
were	O
asymmetric	O
.	O

History	O
of	O
Hypothyroidism	O
244	O
.	O
9	O

Abdominal	O
ultrasound	O
showed	O
gaseous	O
distention	O
without	B-negation
signs	O
of	O
obstruction	O
.	O

Examination	O
of	O
the	O
oropharynx	O
:	O
Normal	B-labvalue
.	O

MMG	O
and	O
bone	O
density	O
at	O
Women	O
Hospital	O

The	O
patient	O
has	O
had	O
bilateral	O
pallidotomies	O
.	O

G0P0	O
not	O
sexually	O
active	O
,	O
her	O
periods	O
have	O
been	O
irregular	O
for	O
last	O
couple	B-temporal
of	I-temporal
years	I-temporal
.	O
She	O
denies	O
smoking	O
social	O
drinker	O
and	O
no	O
illict	O
drug	O
use	O
.	O
doesnot	O
exercsie	O
BMI	O
68	B-labvalue
.	O

He	O
has	O
no	B-negation
significant	O
interval	O
events	O
.	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
MARK	O
ELLIS	O
,	O
NP	O
;	O
Jan	B-temporal
14	I-temporal
2014	I-temporal
10	B-temporal
:	I-temporal
49AM	I-temporal
(	O
Author	O
)	O

UTP	O
-	O
OB	O
/	O
Patient	O
here	O
for	O
.	O

No	B-negation
tenderness	O
or	O
effusion	O
.	O

Superficial	O
/	O
Primitive	O
Reflexes	O
:	O
primitive	O
reflexes	O
were	O
absent	B-labvalue
.	O

Benazepril	O
HCl	O
20	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
TWICE	B-frequency
DAILY	I-frequency
Requested	O
for	O
:	O
16Oct2013	B-temporal
;	O
Last	O
Rx	O
:	O
16Oct2013	B-temporal

Neurological	O
:	O
memory	O
loss	O
,	O
decreased	O
concentrating	O
abilityandheadache	O
,	O
butno	O
confusion	O
,	O
no	B-negation
speech	O
difficulties	O
,	O
no	B-negation
facial	B-bodyloc
weakness	O
,	O
no	B-negation
arm	B-bodyloc
weakness	O
,	O
no	B-negation
hand	B-bodyloc
weakness	O
,	O
no	B-negation
leg	B-bodyloc
weakness	O
,	O
good	O
coordination	O
,	O
no	B-negation
tremor	O
was	O
seen	O
,	O
denied	B-negation
anesthesia	O
,	O
no	B-negation
numbness	O
,	O
no	B-negation
tingling	O
,	O
no	B-negation
convulsions	O
,	O
no	B-negation
dizziness	O
,	O
no	B-negation
fainting	O
,	O
no	B-negation
lightheadedness	O
,	O
no	B-negation
vertigo	O
,	O
no	B-negation
difficulty	O
walking	O
,	O
able	O
to	O
walkandnot	O
falling	O
.	O

He	O
denies	B-negation
paresthesia	O
/	O
numbness	O
of	O
feet	B-bodyloc
.	O

1	O
.	O

f	O
Paternal	B-subject
history	O
of	O
Diabetes	O
Mellitus	O
(	O
V18	O
.	O
0	O
)	O
;	O
(	O
Active	O
)	O

Salivary	O
glands	O
:	O
No	B-negation
parotid	B-bodyloc
gland	I-bodyloc
mass	O
/	O
tenderness	O
.	O

Psychiatric	O
:	O
depression	O
and	O
emotional	O
problems	O
,	O
but	O
not	B-negation
suicidal	O
,	O
no	B-negation
sleep	O
disturbances	O
,	O
no	B-negation
anxiety	O
and	O
no	B-negation
personality	O
change	O
.	O

Palpation	O
of	O
cervical	O
lymph	O
nodes	O
:	O
Normal	B-labvalue
.	O

T2DM	O
follow	B-condition
up	I-condition
.	O

Hyperplasia	O
of	O
endometrium	B-bodyloc
which	O
correlates	O
to	O
her	O
menstrual	O
cycles	O
.	O

Pt	O
denies	B-negation
constipation	O
or	O
change	O
in	O
bowel	B-bodyloc
habits	O
.	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
other	O
areas	O
:	O
No	B-negation
lymphadenopathy	O
.	O

-	O
treadmill	O
is	O
Nl	B-labvalue

Cervix	O
:	O
Normal	O
.	O

Constitutional	O

Assessment	O
of	O
hearing	O
:	O
Normal	B-labvalue
.	O

Integumentary	O
:	O
skin	B-bodyloc
wound	O
,	O
but	O
no	B-negation
rash	O
,	O
no	B-negation
itching	O
,	O
no	B-negation
breast	B-bodyloc
pain	O
,	O
no	B-negation
breast	B-bodyloc
lump	O
and	O
no	B-negation
change	O
in	O
a	O
mole	O

Incision	O
:	O
N	O
/	O
A	O
.	O

Counselled	O
the	O
pt	O
about	O
the	O
importance	O
of	O
complinace	O
of	O
her	O
meduications	O
and	O
the	O
risk	O
involved	O
in	O
not	O
doing	O
so	O
,	O

RESPIRATORY	O
:	O
no	B-negation
wheezing	O
and	O
no	B-negation
cough	O
.	O

Posterior	O
oropharynx	O
:	O
No	B-negation
erythema	O
.	O

Last	O
time	O
about	O
year	B-temporal
ago	I-temporal
,	O
pt	O
on	O
progesterone	O
and	O
vivelle	O
due	O
to	O
hotflashes	O
.	O

3	O
.	O

San	O
Juan	O
Capistrano	O
,	O
CA	O
92690	O
-	O
6130	O
J	O
M	O
Nakamoto	O
MD	O
,	O
PhD	O

DISCHARGE	O
DIAGNOSIS	O
:	O
Left	B-bodyloc
renal	I-bodyloc
cell	O
carcinoma	O
,	O
left	B-bodyloc
renal	I-bodyloc
cyst	O
.	O

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

Marital	O
History	O
-	O
Single	O
And	O
Uninvolved	O

Given	O
relationship	O
of	O
symptom	O
improvement	B-course
with	O
allergy	O
treatment	O
,	O
previous	O
symptoms	O
were	O
likely	O
allergy	O
/	O
sinus	O
related	O
.	O
Patient	O
will	O
be	O
dismissed	O
from	O
Neurology	O
clinic	O
.	O

Inspection	O
of	O
the	O
conjunctiva	O
and	O
lids	O
:	O
Normal	B-labvalue
.	O

[	O
QLH	O
]	O
HEMOGLOBIN	O
A1c	O
Done	O
:	O
21Mar2012	B-temporal
12	B-temporal
:	I-temporal
00AM	I-temporal

Past	O
Medical	O
History	O
History	O
of	O
Complaint	O
Of	O
Allergic	O
Reaction	O
Seasonal	O

If	O
patient	O
decides	O
she	O
wants	O
the	O
implanon	O
,	O
will	O
make	O
appointment	O
for	O
her	B-temporal
1	I-temporal
week	I-temporal
after	O
her	O
postpartum	O
check	O
.	O

Head	O
and	O
Face	O

MetFORMIN	O
HCl	O
1000	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
TWICE	B-frequency
DAILY	I-frequency
WITH	I-frequency
MEALS	I-frequency
;	O
Therapy	O
:	O
14Feb2012	B-temporal
to	O
(	O
Evaluate	O
:	O
30Oct2012	B-temporal
)	O
Requested	O
for	O
:	O
02Jul2012	B-temporal
;	O
Last	O
Rx	O
:	O
02Jul2012	B-temporal
;	O
Edited	O

Was	O
prescribed	O
metformin	O
500mg	B-strength
BID	B-frequency
.	O

HDL	O
Cholesterol	O
34	B-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
L	B-labvalue
>	B-reference_range
=61	I-reference_range
Referencearanges	O
are	O
based	O
on	O
the	O
clinical	O
guidelines	O
of	O
the	O
NHLBI	O
National	O

Immunizations	O

Mood	O
and	O
Affect	O
:	O
appropriate	B-labvalue
mood	I-labvalue
and	I-labvalue
appropriate	I-labvalue
affect	I-labvalue
.	O

;	O
Dec	B-temporal
13	I-temporal
2013	I-temporal
8	B-temporal
:	I-temporal
15PM	I-temporal
(	O
Author	O
)	O

Palpation	O
of	O
the	O
face	O
and	O
sinuses	O
:	O
Normal	B-labvalue
.	O

Family	B-subject
history	O
of	O
Cervical	B-bodyloc
Cancer	O

Monocytes	O
:	O
10	B-labvalue
%	I-labvalue
Reference	O
Range	O
4	B-reference_range
-	I-reference_range
13	I-reference_range

Current	O
Meds	O
Azithromycin	O
250	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
2	B-dosage
TABLETS	B-form
ON	O
DAY	O
1	O
THEN	O
TAKE	O
1	B-dosage
TABLET	B-form
A	B-frequency
DAY	I-frequency
FOR	B-duration
4	I-duration
DAYS	I-duration
;	O
Therapy	O
:	O
29Dec2012	B-temporal
to	O
(	O
Evaluate	O
:	O
03Jan2013	B-temporal
)	O
;	O
Last	O
Rx	O
:	O
29Dec2012	B-temporal

C	O
/	O
D	O
x	O
2	O

Sertraline	O
HCl	O
25	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
09Jul2013	B-temporal
)	O
to	O

10	O
.	O

ALLERGIES	O
:	O
UNABLE	O
TO	O
EVALUATE	O
.	O

Hematocrit	O
:	O
43	B-labvalue
.	I-labvalue
2	I-labvalue
%	I-labvalue
Reference	O
Range	O
37	B-reference_range
.	I-reference_range
5	I-reference_range
-	I-reference_range
51	I-reference_range
.	I-reference_range
0	I-reference_range

Dermatitis	O
(	O
692	O
.	O
9	O
)	O

She	O
'	O
s	O
had	O
no	B-negation
relapses	O
her	O
last	O
visit	O
.	O

Occupation	O
:	O

Medications	O
:	O
The	O
patient	O
is	O
adherent	O
with	O
his	O
medication	O
regimen	O
.	O
He	O
denies	B-negation
medication	O
side	O
effects	O
.	O

Folic	O
Acid	O
1	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
05Feb2013	B-temporal
)	O
to	O

Medication	O
management	O
includes	O
beginning	O
antibiotics	O
.	O

Scope	O
:	O
4	O
mm	O
30	O
degree	O
telescope	O
.	O

Active	O
Problems	O
Contraceptives	O
V25	O
.	O
02	O

Review	O
of	O
Systems	O

The	O
tonsils	O
were	O
normal	O
.	O

Health	O
Maintenance	O
(	O
V70	O
.	O
0	O
)	O

Triamcinolone	O
Acetonide	O
0	B-strength
.	I-strength
1	I-strength
%	I-strength
External	B-route
Lotion	B-form
;	O
APPLY	O
SPARINGLY	O
AND	O
MASSAGE	O
IN	O
TWICE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
21Jun2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
21Jun2013	B-temporal
)	O
Requested	O
for	O
:	O
21Jun2013	B-temporal

Family	O
History	O
Maternal	B-subject
history	O
of	O
Hypertension	O
V17	O
.	O
49	O

There	O
was	O
no	B-negation
tenderness	O
in	O
the	O
groin	B-bodyloc
area	O
.	O

Examination	O
of	O
the	O
head	O
and	O
face	O
:	O
Normal	B-labvalue
.	O

No	B-negation
masses	O
palpated	O
in	O
the	O
left	B-bodyloc
breast	I-bodyloc
.	O

Breath	O
sounds	O
were	O
not	B-labvalue
diminished	I-labvalue
.	O

Pupils	O
:	O
.	O

Head	O
and	O
Face	O

HEMATOCRIT	O
Done	O
:	O
08Jun2009	B-temporal
01	B-temporal
:	I-temporal
50PM	I-temporal

Pedal	O
pulses	O
:	O
Normal	B-labvalue

He	O
describes	O
this	O
as	O
mildandworsening	O
.	O

GI	O
Stomach	O
UGI	O
and	O
Esophagus	O
Ba	O
swallow	O
Status	O
:	O
Complete	O
Done	O
:	O
21Mar2013	B-temporal

;	O
Feb	B-temporal
25	I-temporal
2014	I-temporal
2	B-temporal
:	I-temporal
09PM	I-temporal
(	O
Author	O
)	O

Oropharynx	O
:	O
Normal	O
.	O

Assessment	O
of	O
hearing	O
:	O
Normal	B-labvalue
.	O

Joint	B-bodyloc
Pain	O
,	O
Localized	O
In	O
The	O
Shoulder	B-bodyloc
719	O
.	O
41	O

Reflexes	O
:	O
the	O
reflexes	O
were	O
normal	B-labvalue
.	O

History	O
of	O
Present	O
Illness	O
Pt	O
is	O
a	O
57	O
yo	O
WF	O
here	O
for	O
f	O
/	O
u	O
bronchitis	O
.	O

Task	O
Name	O
:	O
Call	O
Back	O

History	O
of	O
Hypertension	O
401	O
.	O
9	O

Neuro	O
:	O
no	B-negation
numbness	O
,	O
no	B-negation
tremor	O
was	O
seen	O
,	O
no	B-negation
tingling	O
,	O
no	B-negation
seizures	O
were	O
observed	O
,	O
gait	O
is	O
steady	B-labvalue
and	O
no	B-negation
dizziness	O
.	O

Review	O
of	O
Systems	O

Constitutional	O
:	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
,	O
not	B-negation
feeling	O
poorly	O
(	O
malaise	O
)	O
,	O
no	B-negation
recent	B-temporal
weight	O
gain	O
and	O
no	B-negation
recent	B-temporal
weight	O
loss	O
.	O

Chronic	B-course
Obstructive	O
Pulmonary	B-bodyloc
Disease	O
496	O

Neurological	O
:	O
no	B-negation
dizziness	O
and	O
no	B-negation
fainting	O
.	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
vomiting	O
and	O
no	B-negation
diarrhea	O
.	O

Integumentary	O
:	O
no	B-negation
rash	O
and	O
no	B-negation
skin	B-bodyloc
wound	O
.	O

Physical	O
Exam	O
:	O

Taking	O
Blood	O
Thinners	O
For	O
A	B-temporal
Long	I-temporal
Time	I-temporal
V58	O
.	O
61	O

He	O
was	O
extubated	O
,	O
but	O
had	O
to	O
be	O
re	O
-	O
intubated	O
because	O
of	O
respiratory	O
failure	O
.	O

4	O
.	O

The	O
tongue	O
was	O
normal	O
.	O

History	O
of	O
Herpes	O
Simplex	O
Type	O
II	O
054	O
.	O
10	O

Benzonatate	O
200	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
3	B-frequency
TIMES	I-frequency
DAILY	I-frequency
AS	B-frequency
NEEDED	I-frequency
;	O
Therapy	O
:	O
29Dec2012	B-temporal
to	O
(	O
Evaluate	O
:	O
08Jan2013	B-temporal
)	O
Requested	O
for	O
:	O
31Dec2012	B-temporal
;	O
Last	O
Rx	O
:	O
29Dec2012	B-temporal

Sulfa	O
Drugs	O

Menorrhagia	O
626	O
.	O
2	O

RTC	O
4	O
weeks	O
.	O

History	O
of	O
Chronic	B-course
Reflux	O
Esophagitis	O
530	O
.	O
11	O

Review	O
of	O
Systems	O

To	O
address	O
this	O
situation	O
,	O
I	O
am	O
going	O
to	O
hold	O
her	O
Lantus	O
insulin	O
tonight	O
and	O
decrease	O
and	O
then	O
change	O
the	O
administration	O
time	O
to	O
in	O
the	O
morning	O
.	O

Peripheral	O
Vision	O
:	O
Normal	B-labvalue
(	O
full	B-labvalue
)	O

Hal	O
.	O

[	O
QLH	O
]	O
MICROALBUMIN	O
,	O
RANDOM	O
URINE	O
(	O
W	O
/	O
CREATININE	O
)	O
Requested	O
for	O
:	O
10Apr2012	B-temporal

(	O
Medical	O
Transcription	O
Sample	O
Report	O
)	O

Chronic	B-course
Frontal	B-bodyloc
Sinusitis	O
473	O
.	O
1	O

[	O
QLH	O
]	O
TSH	O
,	O
3RD	O
GENERATION	O
Requested	O
for	O
:	O
16Mar2012	B-temporal

OBESE	O
+	O
+	O
ALERT	O
AND	O
NO	B-negation
DISTRESS	O
.	O

[	O
U	O
]	O
XRAY	O
KNEE	O
,	O
BOTH	O
,	O
STANDING	O
,	O
AP	O
73565	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O
Mr	O
.	O
Savoy	O
is	O
a	O
53	O
-	O
year	O
-	O
old	O
African	O
American	O
male	O
with	O
a	O
history	O
of	O
CKD	O
stage	B-severity
3	I-severity
-	I-severity
4	I-severity
,	I-severity
hypertension	O
,	O
diabetes	O
,	O
and	O
a	O
CVA	O
,	O
here	O
for	O
follmuup	O
.	O

Allergies	O
_	O
20	O
_	O
twCiteListControlEnd	O
AllergiesSectionEnd	O
CurrentMedsSectionStart	O
Current	O
Meds	O

Musculoskeletal	O
:	O
no	B-negation
arthralgias	O
and	O
no	B-negation
joint	B-bodyloc
pain	O
.	O

Larynx	O
:	O
Unable	O
to	O
visualize	O
.	O

Reviewed	O
potential	O
risks	O
and	O
benefits	O
.	O

STRESS	O
RELATED	O
)	O
.	O

Patient	O
has	O
fully	O
recovered	O
from	O
surgery	O
and	O
may	O
resume	O
full	O
activities	O
.	O

External	O
inspection	O
of	O
ears	O
and	O
nose	O
:	O
Normal	B-labvalue

Breath	O
sounds	O
were	B-negation
not	I-negation
diminished	O
.	O

Family	O
History	O
Family	B-subject
history	O
of	O
Hypertension	O
V17	O
.	O
49	O

3	O
.	O

Past	O
Medical	O
History	O
History	O
of	O
Hoarseness	O
784	O
.	O
42	O

5	O
.	O

R	O
/	O
B	O
/	O
A	O
discussed	O
with	O
patient	O
including	O
1	O
/	O
200	O
risk	O
of	O
pregnancy	O
with	O
increased	O
risk	O
of	O
ectopic	O
if	O
gestation	O
occurs	O
.	O

Jaw	B-bodyloc
opening	O
persisent	O
:	O

Current	O
Smoker	O
She	O
lives	O
with	O
her	O
mother	O
.	O

MNT	O
stressed	O
.	O

Surgical	O
History	O
History	O
of	O
CABG	O
(	O
CABG	O
)	O
V45	O
.	O
81	O

Cough	O
786	O
.	O
2	O

-	O
follow	O
up	O
woth	O
PCP	O
tp	O
discuss	O

Palpation	O
of	O
breasts	O
and	O
axillae	O
:	O
NormalLeft	O
breast	B-bodyloc
with	O
scars	O
related	O
to	O
the	O
burn	O
.	O

Name	O
:	O
Hysterectomy	O
-	O
Discharge	O
Summary	O
-	O
2	O

History	O
of	O
Present	O
Illness	O

Cranial	O
nerves	O
I	O
:	O
the	O
olfactory	O
nerve	O
demonstrated	O
normal	O
function	O
.	O

Some	O
episodes	O
of	O
hypoglycemia	O
.	O

Dr	O
.	O
Achor	O
will	O
reviewed	O
the	O
patient	O
'	O
s	O
x	O
-	O
rays	O
and	O
plan	O
.	O

Current	O
Meds	O
Crestor	O
5	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
30Sep2013	B-temporal
to	O
(	O
Evaluate	O
:	O
01Apr2014	B-temporal
)	O
Requested	O
for	O
:	O
03Oct2013	B-temporal
;	O
Last	O
Rx	O
:	O
03Oct2013	B-temporal

No	B-negation
contraception	O
.	O

10	O
.	O

History	O
of	O
Present	O
Illness	O

Pantoprazole	O
40	B-strength
mg	I-strength
Tablet	B-form
,	I-form
Delayed	I-form
Release	I-form
(	O
E	O
.	O
C	O
.	O

The	O
eGFR	O
declines	B-labvalue
with	I-labvalue
age	I-labvalue
.	O

AT	O
L3	O
-	O
4	O
there	O
is	O
2	O
.	O
5	O
-	O
3mm	O
broad	O
based	O
posterior	O
protrusion	O
which	O
is	O
more	O
focal	O
centrally	O
.	O

[	O
QLH	O
]	O
T4	O
,	O
FREE	O
Requested	O
for	O
:	O
17Feb2014	B-temporal

This	O
has	O
occurred	O
with	O
and	O
without	O
activity	O
,	O
with	O
stress	O
and	O
could	O
last	O
up	O
to	O
one	O
day	O
.	O

PCI	O
of	O
the	O
RCA	O
was	O
attempted	O
but	O
unsuccessful	O
.	O

Normal	B-labvalue
S1	O
and	O
S2	O
sounds	O
are	O
noted	O
without	B-negation
gallop	O
.	O

Neurologic	O

[	O
H	O
]	O
Hemoglobin	O
Electrophoresis	O
and	O
Interpretation	O
Requested	O
for	O
:	O
21Dec2011	B-temporal

Musculoskeletal	O

Palpation	O
of	O
the	O
face	O
and	O
sinuses	O
:	O
Normal	B-labvalue

Review	O
of	O
Systems	O

ENT	O
:	O
no	B-negation
hoarseness	O
,	O
no	B-negation
hearing	O
loss	O
,	O
no	B-negation
drainage	O
of	O
ear	B-bodyloc
,	O
no	B-negation
vertigo	O
,	O
no	B-negation
snoring	O
was	O
observed	O
,	O
no	B-negation
daytime	O
sleepiness	O
,	O
no	B-negation
mouth	B-bodyloc
sores	O
,	O
no	B-negation
tooth	B-bodyloc
problems	O
,	O
no	B-negation
dysphagia	O
and	O
no	B-negation
tinnitus	O

Chief	O
Complaint	O

Past	O
Medical	O
History	O
History	O
of	O
Chronic	B-course
Kidney	B-bodyloc
Disease	O
,	O
Stage	B-severity
1	I-severity
585	O
.	O
1	O

-	O
1st	O
trimester	O
screen	O
ordered	O
for	O
2/13/12	B-temporal
,	O
as	O
well	O
as	O
genetic	O
counseling	O
.	O

Normal	B-labvalue
Examination	O
V70	O
.	O
0	O

Conjunctiva	O
:	O
.	O

30	I-reference_range
Cholesterol	O
Total	O
193	B-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
<	B-reference_range
=199	I-reference_range
Referencearanges	O
are	O
based	O
on	O
the	O
clinical	O
guidelines	O
of	O
the	O
NHLBI	O
National	O

Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

Test	O
Name	O
Result	O
Flag	O
Reference	O

No	B-negation
rales	O
or	O
crackles	O
were	O
heard	O
.	O

There	O
are	O
no	B-negation
relieving	O
measures	O
.	O

T	O
level	O
decreasing	O
trend	O
.	O

Inspection	O
of	O
the	O
nasal	O
mucosa	O
,	O
septum	O
and	O
turbinates	O
:	O
Normal	B-labvalue
.	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
,	O
no	B-negation
cough	O
,	O
no	B-negation
shortness	O
of	O
breath	O
during	O
exertion	O
,	O
no	B-negation
orthopnea	O
and	O
no	B-negation
PND	O
.	O

Constitutional	O

AmLODIPine	O
Besylate	O
5	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
30Sep2013	B-temporal
)	O

Neck	O
:	O
no	B-negation
neck	B-bodyloc
stiffness	O
.	O

The	O
abdomen	O
was	O
normal	B-labvalue
to	O
percussion	O
.	O

Gastrointestinal	O
:	O
nausea	O
,	O
constipation	O
,	O
diarrheaandheartburn	O
.	O

"	O
Smoker	O
,	O
Current	O
Status	O
Unknown	O
305	O
.	O
1	O

Right	O
Wrist	O
Flex	O
.	O

1	I-reference_range
VerifiedResul	O
s	O
_	O
0	O
_	O
twCiteLis	O
ControlEnd	O
VerifiedResul	O
sSec	O
ionEnd	O
Signa	O
uresSec	O
ionStart	O
Signa	O
uresSec	O
ionEnd	O

Lower	O
extremity	O
peripheral	O
neurological	O
exam	O
demonstrated	O
light	O
touch	O
intact	B-labvalue
for	O
both	O
legs	O
,	O
ankles	O
,	O
and	O
feet	O
,	O
bilateral	O
foot	O
eversion	O
,	O
inversion	O
,	O
and	O
great	O
toe	O
extension	O
,	O
and	O
intact	B-labvalue
bilateral	O
distal	O
pulses	O
.	O

Eyes	O

discharge	O
summary	O
,	O
open	O
reduction	O
,	O
internal	O
fixation	O
,	O
schatzker	O
iii	O
tibial	O
plateau	O
fracture	O
,	O
meniscectomy	O
,	O
tibial	O
plateau	O
fracture	O
,	O
orif	O
,	O
schatzker	O
,	O
fixation	O
,	O
reduction	O
,	O
tibial	O
,	O
fracture	O
,	O
plateau	O
,	O

Constitutional	O

No	B-negation
rhonchi	O
were	O
heard	O
.	O

The	O
neck	O
is	O
supple	O
.	O

No	B-negation
rales	O
or	O
crackles	O
were	O
heard	O
.	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
and	O
no	B-negation
vomiting	O
.	O

Endocrine	O
:	O
No	B-negation
excessive	O
sweating	O
and	O
no	B-negation
loss	O
of	O
hair	O
from	O
the	O
head	B-bodyloc
or	O
body	B-bodyloc
.	O

General	O
appearance	O
:	O
Normal	O
.	O

Motor	O
tone	O
:	O
.	O

;	O
Aug	B-temporal
16	I-temporal
2012	I-temporal
4	B-temporal
:	I-temporal
30PM	I-temporal
(	O
Author	O
)	O

Cardiovascular	O
Peripheral	O
vascular	O
exam	O
:	O
Normal	B-labvalue

Right	O
Gastroc	O
Soleus	O
(	O
tib	O
.	O
)	O
:	O
Normal	O
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Assessment	O
Assessed	O

I	O
have	O
personally	O
interviewed	O
the	O
patient	O
with	O
the	O
resident	O
and	O
I	O
agree	O
with	O
the	O
assessment	O
and	O
plan	O
as	O
delineated	O
in	O
the	O
note	O
above	O
.	O

The	O
wound	O
was	O
clean	O
and	O
dry	O
.	O

Inspection	O
of	O
lips	O
,	O
teethand	O
gums	O
:	O
Normal	B-labvalue

DBS	O
therapy	O
reducing	O
her	O
oromandibular	B-bodyloc
dystonia	O
;	O
Botox	O
300	B-strength
units	I-strength
for	O
next	O
time	O
for	O
face	O
and	O
neck	O
;	O
spasmodic	O
torticollis	O
worse	B-course
.	O

Prenatal	O
Vitamins	O
TABS	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
08May2013	B-temporal
)	O
to	O

He	O
denies	B-negation
fever	O
or	O
chills	O
.	O

ENT	O
:	O
no	B-negation
earache	O
.	O

Inspection	O
of	O
the	O
conjunctiva	O
and	O
lids	O
:	O
Normal	B-labvalue

Female	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O
Symptomatic	O
thyroid	B-bodyloc
goiter	O
.	O

Enoxaparin	O
Sodium	O
30	B-strength
MG	I-strength
/	I-strength
0	I-strength
.	I-strength

3	O
.	O

4	O
.	O

[	O
QLH	O
]	O
HEMATOCRIT	O
Done	O
:	O
20Oct2010	B-temporal
09	B-temporal
:	I-temporal
10AM	I-temporal

Benign	O
Essential	O
Hypertension	O
401	O
.	O
1	O

DOS	O
:	O
5/14/2013	B-temporal

Discussion	O
/	O
Attending	O
Note	O

Examination	O
of	O
urethra	O
:	O
Normal	B-labvalue

He	O
fell	O
down	O
when	O
he	O
tried	O
to	O
splint	O
once	O
.	O

New	O
OB	O
labs	O
and	O
viability	O
/	O
dating	O
scan	O
ordered	O

Plan	O
[	O
H	O
]	O
Culture	O
:	O
Respiratory	O
w	O
/	O
Gram	O
Stain	O
Requested	O
for	O
:	O
05Dec2011	B-temporal

Her	O
knee	B-bodyloc
symptoms	O
are	O
primary	O
pain	O
,	O
stiffness	O
and	O
swelling	O
.	O

Gynecological	O
Problems	O
.	O

f	O
Dyslipidemia	O
(	O
272	O
.	O
4	O
)	O
;	O
(	O
Active	O
)	O

Prior	O
pregnancies	O
:	O
.	O

No	B-negation
frontal	B-bodyloc
tenderness	O
.	O

Left	O
Gluteus	O
Max	O
.	O

[	O
QLH	O
]	O
LIPID	O
PANEL	O
Requested	O
for	O
:	O
03May2011	B-temporal

Comorbid	O
Illnesses	O
:	O
hyperlipidemia	O
.	O

Continue	O
current	B-temporal
regimen	O
as	O
written	O
.	O

One	O
Touch	O
Ultra	O
Test	O
Strips	O
;	O
Check	O
BG	O
6x	O
a	O
day	O
;	O
Therapy	O
:	O
24Nov2012	B-temporal
to	O

XRAY	O
Chest	O
2	O
views	O
71020	O
Done	O
:	O
24Mar2014	B-temporal
04	B-temporal
:	I-temporal
13PM	I-temporal

I	O
have	O
discussed	O
the	O
case	O
with	O
the	O
resident	O
and	O
agree	O
with	O
the	O
diagnosis	O
of	O
MS	O
.	O
I	O
have	O
personally	O
reviewed	O
:	O
resident	O
noteandcurrent	O
lab	O
results	O
.	O

Past	O
Medical	O
History	O
History	O
of	O
Hallucination	O
Auditory	O
780	O
.	O
1	O

[	O
QLH	O
]	O
CBC	O
(	O
INCLUDES	O
DIFF	O
/	O
PLT	O
)	O
Done	O
:	O
19Jul2011	B-temporal
12	B-temporal
:	I-temporal
28PM	I-temporal

Description	O
of	O
patient	O
'	O
s	O
judgement	O
and	O
insight	O
:	O
Normal	B-labvalue
.	O

She	O
started	O
a	O
new	O
job	O
.	O

Inspection	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
Abnormal	O
.	O

BUN	O
/	O
CREATININE	O
RATIO	O
NOT	O
APPLICABLE	O
CALC	O
6	B-reference_range
-	I-reference_range
22	I-reference_range

PEnd	O
GrouExam	O
g8	O

ECC	O
Requested	O
for	O
:	O
04Mar2013	B-temporal

Menstrual	O
History	O
.	O

Lymphatic	O

Constitutional	O
:	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
,	O
not	B-negation
feeling	O
poorly	O
(	O
malaise	O
)	O
,	O
not	B-negation
feeling	O
tired	O
(	O
fatigue	O
)	O
,	O
no	B-negation
recent	B-temporal
weight	O
gain	O
and	O
no	B-negation
recent	B-temporal
weight	O
loss	O
.	O

;	O
Feb	B-temporal
25	I-temporal
2014	I-temporal
1	B-temporal
:	I-temporal
08PM	I-temporal
(	O
Author	O
)	O

[	O
LH	O
]	O
CBC	O
(	O
without	O
differential	O
)	O
Requested	O
for	O
:	O
21Mar2012	B-temporal

Examination	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue

Associated	O
symptoms	O
:	O
no	B-negation
nipple	B-bodyloc
discharge	O
,	O
no	B-negation
skin	B-bodyloc
changes	O
,	O
no	B-negation
axillary	B-bodyloc
pain	O
,	O
no	B-negation
pruritus	O
,	O
no	B-negation
lymphadenopathy	O
,	O
no	B-negation
fever	O
and	O
no	B-negation
chills	O
.	O

Folic	O
Acid	O
1	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
5	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
02Apr2009	B-temporal
to	O
(	O
Evaluate	O
:	O
22Mar2014	B-temporal
)	O
Requested	O
for	O
:	O
23Sep2013	B-temporal
;	O
Last	O
Rx	O
:	O
23Sep2013	B-temporal

RESPIRATIONS	O
:	O
Clear	B-labvalue
to	O
auscultation	O
bilaterally	O
without	B-negation
shortness	O
of	O
breath	O
.	O

Atenolol	O
25	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
19Aug2013	B-temporal
)	O
to	O

Review	O
of	O
Systems	O

Chronic	B-course
rhinosinusitis	O
with	O
nasal	B-bodyloc
polyps	O
,	O
s	O
/	O
p	O
IG	O
-	O
ESS	O
,	O
stage	B-severity
3	I-severity
in	O
ethmoids	O
bilaterally	O

The	O
patient	O
is	O
doing	O
well	O
with	O
his	O
blood	O
pressure	O
goals	O
.	O

GENERAL	O
:	O
Aiert	O
and	O
cooperative	O
,	O
no	B-negation
respiratory	O
distress	O
EYES	O
:	O
conjunctiva	B-bodyloc
is	O
not	B-negation
injected	O
,	O
no	B-negation
jaundite	O
.	O

[	O
QLH	O
]	O
CBC	O
(	O
INCLUDES	O
DIFF	O
/	O
PLT	O
)	O
Status	O
:	O
Complete	O
Done	O
:	O
21Mar2013	B-temporal

Acute	B-course
Pancreatitis	O
577	O
.	O
0	O

HENT	O
:	O
no	B-negation
headache	O
,	O
no	B-negation
earache	O
,	O
no	B-negation
difficulty	O
swallowing	O
,	O
no	B-negation
nosebleeds	O
and	O
no	B-negation
ringing	O
in	O
the	O
ears	B-bodyloc
.	O

Allergies	O
Biaxin	O
TABS	B-form

He	O
is	O
complaints	O
on	O
his	O
medication	O
,	O
and	O
denies	B-negation
any	O
further	O
complaints	O
.	O

MEDICATIONS	O
:	O
see	O
ACoscripts	O
.	O

Assessment	O
of	O
range	O
of	O
motion	O
:	O
Normal	B-labvalue
.	O

Electronically	O
signed	O
by	O
:	O
ERIN	O
NICHOLSON	O
M	O
.	O
D	O
.	O
;	O
07/30/2013	B-temporal
10	B-temporal
:	I-temporal
19	I-temporal
PM	I-temporal
CST	O
.	O

History	O
of	O
Hysterectomy	O
V45	O
.	O
77	O

Lumbar	B-bodyloc
Radiculopathy	O
724	O
.	O
4	O

(	O
med	O
.	O

Weight	O
Comments	O
:	O
Reported	O

Place	O
of	O
Delivery	O
:	O
MHSW	O
.	O

BSA	O
Calculated	O
:	O
2	B-labvalue
.	I-labvalue
31	I-labvalue

Symptoms	O
:	O
no	B-negation
confusion	O
,	O
no	B-negation
visual	O
disturbance	O
and	O
no	B-negation
shortness	O
of	O
breath	O

In	O
ENT	O
clinic	O
patient	O
was	O
found	O
to	O
have	O
allergies	O
on	O
testing	O
and	O
was	O
instructed	O
in	O
allergy	O
avoidance	O
and	O
started	O
on	O
injections	O
.	O

Reminded	O
to	O
do	O
SMBG	O
.	O

Carotid	B-bodyloc
:	O
right	O
2	O
+	O
,	O
left	O
2	O
+	O
,	O
no	B-negation
bruit	O
on	O
the	O
right	O
and	O
no	B-negation
bruit	O
on	O
the	O
left	O
.	O

Active	O
Problems	O
Acute	B-course
Sinusitis	O
461	O
.	O
9	O

Leukemoid	O
reaction	O
,	O
likely	O
secondary	O
to	O
malignancy	O
.	O

Procedures	O

Active	O
Problems	O
Acute	B-course
Bronchitis	O
466	O
.	O
0	O

Electronically	O
signed	O
by	O
:	O
PAMELA	O
BERENS	O
,	O
M	O
.	O
D	O
.	O

Finally	O
,	O
the	O
patient	O
also	O
reports	O
a	O
tightness	O
in	O
the	O
area	O
of	O
his	O
heart	B-bodyloc
that	O
was	O
also	O
tender	O
to	O
touch	O
.	O

Assessment	O
of	O
hearing	O
:	O
Normal	B-labvalue
.	O

Denied	O

The	O
diagnostic	O
plan	O
includes	O
complete	O
blood	O
count	O
,	O
erythrocyte	O
sedimentation	O
rate	O
,	O
viral	O
serology	O
and	O
US	O
of	O
neck	O
.	O

I	O
will	O
get	O
immunoglobulins	O
w	B-labvalue
/	I-labvalue
u	I-labvalue
.	O

TraMADol	O
HCl	O
50	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Status	O
:	O
DISCONTINUED	O

f	O
/	O
u	O
for	O
labs	O
.	O

Birth	O
Weight	O
:	O
9lbs	B-labvalue

The	O
duration	O
of	O
her	O
recent	O
periods	O
has	O
been	O
regular	O
and	O
usually	O
last	O
5	O
days	O
.	O

Cardiovascular	O
Edema	O
:	O
Normal	O
(	O
not	B-negation
present	I-negation
)	O
.	O

Examination	O
of	O
gait	O
and	O
station	O
:	O
Normal	B-labvalue
.	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
JELANI	O
INGRAM	O
,	O
M	O
.	O
D	O
.	O

Plan	O
[	O
QH	O
]	O
CMP	O
W	O
/	O
EGFR	O
Requested	O
for	O
:	O
29Nov2011	B-temporal

Constitutional	O
:	O
no	O
feverandnot	O
feeling	O
tired	O
(	O
fatigue	O
)	O
.	O

She	O
denies	B-negation
hypoglycemia	O
.	O

History	O
of	O
Present	O
Illness	O
No	B-negation
s	O
/	O
s	O
PIH	O
.	O

CO2	O
26	B-labvalue
mEq	I-labvalue
/	I-labvalue
l	I-labvalue
24	B-reference_range
-	I-reference_range
32	I-reference_range

ProAir	O
HFA	O
108	B-strength
(	I-strength
90	I-strength
Base	I-strength
)	I-strength
MCG	I-strength
/	I-strength
ACT	I-strength
Inhalation	B-route
Aerosol	B-form
Solution	I-form
;	O
INHALE	O
2	B-dosage
PUFFS	B-form
EVERY	B-frequency
4	I-frequency
TO	I-frequency
6	I-frequency
HOURS	I-frequency
AS	B-frequency
NEEDED	I-frequency
;	O
Therapy	O
:	O
03Aug2011	B-temporal
to	O
(	O
Evaluate	O
:	O
29Feb2012	B-temporal
)	O
Requested	O
for	O
:	O
03Aug2011	B-temporal
;	O
Last	O
Rx	O
:	O
03Aug2011	B-temporal

Allergic	O
Rhinitis	O
477	O
.	O
9	O

Patient	O
is	O
a	O
25	O
y	O
.	O
o	O
.	O

Her	O
only	O
complaint	O
is	O
Constipation	O
.	O

Her	O
right	B-bodyloc
side	I-bodyloc
arm	I-bodyloc
and	O
leg	B-bodyloc
start	O
shaking	O
.	O

Her	O
A1c	O
is	O
5	B-labvalue
.	I-labvalue
5	I-labvalue
%	I-labvalue
.	O

Pertinent	O
medical	O
history	O
:	O
dyslipidemiaandobstructive	O
sleep	O
apnea	O
,	O
but	O
no	B-negation
diabetes	O
,	O
no	B-negation
retinopathy	O
,	O
no	B-negation
angina	O
,	O
no	B-negation
prior	B-temporal
coronary	O
revascularization	O
,	O
no	B-negation
cerebral	B-bodyloc
vascular	I-bodyloc
accident	O
and	O
no	B-negation
peripheral	B-bodyloc
artery	I-bodyloc
disease	O
.	O

Chief	O
Complaint	O

Neck	O

History	O
of	O
Missed	O
Abortion	O
632	O

Cranial	O
nerves	O
V	O
:	O
sensation	O
to	O
the	O
face	O
and	O
masseter	O
strength	O
were	O
intact	B-labvalue
.	O

Benign	B-severity
Essential	O
Hypertension	O
401	O
.	O
1	O

Lumbosacral	O
Spine	O
:	O
Normal	O
(	O
no	B-negation
tenderness	O
on	O
palpation	O
)	O

The	O
baby	O
is	O
currently	O
living	O
at	O
home	O
.	O

Sample	O
Name	O
:	O
ORIF	O
-	O
Discharge	O
Summary	O

There	O
was	O
erythema	O
and	O
swelling	O
,	O
but	O
not	B-negation
enlarged	O
and	O
no	O
concretions	O
of	O
both	O
tonsils	O
.	O

Naproxen	O
500	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
EVERY	B-frequency
12	I-frequency
HOURS	I-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
04Apr2013	B-temporal
to	O
(	O
Evaluate	O
:	O
04May2013	B-temporal
)	O
Requested	O
for	O
:	O
04Apr2013	B-temporal
;	O
Last	O
Rx	O
:	O
04Apr2013	B-temporal

History	O
of	O
Cough	O
786	O
.	O
2	O

Inspection	O
of	O
the	O
conjunctiva	O
and	O
lids	O
:	O
Normal	B-labvalue
.	O

Fluticasone	O
Propionate	O
50	B-strength
MCG	I-strength
/	I-strength
ACT	I-strength
Nasal	B-form
Suspension	I-form
;	O
USE	O
2	B-dosage
SPRAYS	B-route
IN	O
EACH	O
NOSTRIL	O
ONCE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
16May2006	B-temporal
to	O
(	O
Evaluate	O
:	O
08Aug2012	B-temporal
)	O
Requested	O
for	O
:	O
10Apr2012	B-temporal
;	O
Last	O
Rx	O
:	O
10Apr2012	B-temporal
;	O
Edited	O

Plan	O
[	O
QLH	O
]	O
CBC	O
(	O
INCLUDES	O
DIFF	O
/	O
PLT	O
)	O
Requested	O
for	O
:	O
12Nov2013	B-temporal

4	O
.	O

Plan	O
Pravastatin	O
Sodium	O
40	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
1	B-dosage
tab	B-form
at	B-frequency
night	I-frequency
;	O
Therapy	O
:	O
24Nov2012	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
10Dec2012	B-temporal
)	O

Assessment	O
Shortness	O
Of	O
Breath	O
786	O
.	O
05	O

Social	O
History	O
Marital	O
History	O
-	O
Currently	O
Married	O

No	B-negation
intra	B-bodyloc
-	I-bodyloc
abdominal	I-bodyloc
pathology	O
.	O

Your	O
labs	O
are	O
normal	B-labvalue
except	O
for	O
a	O
slight	O
hemoglobin	O
decrease	B-labvalue
.	O

VitalsSectispStart	O
Vitals	O
Vitals	O
_	O
11189	O
_	O
twCiteListControlStart	O
14Mar2013	B-temporal
09	B-temporal
:	I-temporal
34AM	I-temporal
14Mar2013	B-temporal
09	B-temporal
:	I-temporal
33AM	I-temporal
Systolic	O
110	B-labvalue
Diastolic	O
70	B-labvalue
Temperature	O
96	B-labvalue
.	I-labvalue
4	I-labvalue
F	I-labvalue
Heart	O
Rate	O
76	B-labvalue
LMP	O
10Feb2013	B-temporal
Vitals	O
_	O
11189	O
_	O
twCiteListControlEnd	O
VitalsSectispEnd	O
ChiefComplaintSectispStart	O
Chief	O
Complaint	O
pressure	O
when	O
uripates	O
ChiefComplaint	O
_	O
90	O
_	O
twCiteListControlStart	O
ChiefComplaint	O
_	O
90	O
_	O
twCiteListControlEnd	O
ChiefComplaintSectispEnd	O
AispEniesSectispStart	O
AispEnies	O

Palpation	O
of	O
heart	O
:	O
Normal	B-labvalue
PMI	O
,	O
no	B-negation
thrills	O
.	O

;	O
Jun	B-temporal
21	I-temporal
2013	I-temporal
12	B-temporal
:	I-temporal
10PM	I-temporal
(	O
Author	O
)	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
neck	O
:	O
Normal	B-labvalue
.	O

Reviewed	O
potential	O
risks	O
and	O
benefits	O
with	O
both	O
patient	O
and	O
sister	O
.	O

No	B-negation
masses	O
palpated	O
.	O

History	O
of	O
Chronic	B-course
Reflux	O
Esophagitis	O
530	O
.	O
11	O

Assessment	O
1	O
.	O

Inspection	O
of	O
the	O
nasal	O
mucosa	O
,	O
septum	O
and	O
turbinates	O
:	O
Normal	B-labvalue
.	O

History	O
of	O
Hypothyroidism	O
244	O
.	O
9	O

Flank	B-bodyloc
pain	O
:	O
Tylenol	O
as	O
needed	O
for	O
pain	O
.	O

ANA	O
:	O
(	O
+	O
)	O
1	B-labvalue
:	I-labvalue
160	I-labvalue
;	O
ESR	O
:	O
41	B-labvalue
;	O
HIV	O
1	O
and	O
2	O
:	O
(	O
-	O
)	O
;	O
AST	O
/	O
ALT	O
:	O
103	B-labvalue
/	I-labvalue
183	I-labvalue
;	O
CK	O
:	O
2819	B-labvalue
;	O

I	O
have	O
seen	O
and	O
examined	O
SPENCER	O
WILLIS	O
with	O
the	O
resident	O
.	O

3	O
.	O

Cranial	O
Nerve	O
V	O
:	O
sensation	O
to	O
the	O
face	O
and	O
masseter	O
strength	O
were	O
intact	B-labvalue
.	O

Plan	O
Patient	O
Specific	O
Education	O
Given	O
Done	O
:	O
22Apr2013	B-temporal

Assessment	O
of	O
muscle	O
strength	O
/	O
tone	O
:	O
Normal	B-labvalue
.	O

HTN	O
:	O
BP	O
reportedly	O
stable	O
at	O
home	O
,	O
continue	O
current	B-temporal
medication	O
management	O
,	O
monitor	O
blood	O
pressure	O
at	O
home	O
,	O
med	O
refilled	O
as	O
requested	O
.	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
neck	O
:	O
Normal	B-labvalue
.	O

The	O
patient	O
presents	O
with	O
complaints	O
of	O
stable	B-bodyloc
chest	I-bodyloc
pain	O
(	O
mild	B-severity
chest	B-bodyloc
pain	O
with	O
exertion	O
working	O
in	O
the	O
yard	O
-	O
see	O
below	O
)	O
.	O

Fish	O
Oil	O
1200	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
26Feb2014	B-temporal
)	O
to	O

The	O
thyroid	B-bodyloc
was	O
normal	O
and	O
was	O
not	B-negation
enlarged	O
.	O

Test	O
Name	O
Result	O
Flag	O
Reference	O

Bradycardia	O
:	O

Gait	O
:	O
the	O
gait	O
and	O
station	O
were	O
normal	B-labvalue
.	O

4	O

CHTN	O

"	O

Blood	O
Pressue	O
Comments	O
:	O
Reported	O

Pas	O
Medical	O
His	O
osy	O

Electronically	O
signed	O
by	O
:	O
Bal	O
Reddy	O
,	O
M	O
.	O
D	O
.	O

Patient	O
very	O
frustrated	O
by	O
PND	O
.	O

Last	O
visit	O
:	O
7/18/2012	B-temporal
:	O
Dr	O
.	O
Malhotra	O
is	O
here	O
for	O
ear	O
follow	O
up	O
.	O

Discharge	O
Diagnosis	O
:	O

Pertinent	O
medical	O
history	O
:	O
diabetes	O
,	O
dyslipidemia	O
and	O
prior	B-temporal
coronary	O
revascularization	O
.	O

Eczema	O
692	O
.	O
9	O

Sample	O
Name	O
:	O
Neck	B-bodyloc
Pain	O

No	B-negation
murmurs	O
were	O
heard	O
.	O

[	O
QLH	O
]	O
BASIC	O
METABOLIC	O
PANEL	O
W	O
/	O
EGFR	O
Requested	O
for	O
:	O
20Mar2014	B-temporal

TraZODone	O
HCl	O
100	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Therapy	O
:	O
27Jan2012	B-temporal
to	O

Plan	O
_	O
2	O
_	O
twCiteListControlEnd	O
likely	O
due	O
to	O
stress	O

glut	O
.	O
)	O
:	O
Normal	O
.	O

Vitals	O
_	O
11189	O
_	O
twCiteListControlStart	O
UTP	O
Adult	O
Vital	O
Signs	O
[	O
Data	O
Includes	O
:	O
Current	O
Encounter	O
]	O
BMI	O
Calculated	O
:	O
23	B-labvalue
.	I-labvalue
26	I-labvalue

Heart	O
sounds	O
:	O
normal	B-labvalue
S1	O
,	O
normal	B-labvalue
S2	O
,	O
no	O
S3andno	O
S4	O
.	O

Cranial	O
nerves	O
:	O
Normal	O
.	O

Physical	O
Exam	O

Congestion	O
:	O
Yes	O
.	O

Current	O
Meds	O
Amitriptyline	O
HCl	O
25	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
AT	B-frequency
BEDTIME	I-frequency
;	O
Therapy	O
:	O
26Apr2013	B-temporal
to	O
(	O
Evaluate	O
:	O
09Nov2013	B-temporal
)	O
Requested	O
for	O
:	O
13May2013	B-temporal
;	O
Last	O
Rx	O
:	O
13May2013	B-temporal

Inspection	O
/	O
palpation	O
of	O
joints	O
,	O
bones	O
,	O
and	O
muscles	O
:	O
Normal	B-labvalue

He	O
now	O
reports	O
headaches	O
once	O
weekly	O
,	O
only	O
occuring	O
after	O
being	O
outside	O
in	O
the	O
heat	O
.	O

Use	O
1	B-dosage
capsule	B-form
in	O
Neil	O
-	O
Med	O
,	O
add	O

Collected	O
-	O
-	O

Auscultation	O
of	O
lungs	O
:	O
Abnormal	O
.	O
Moderate	B-severity
wheezing	O
bilateral	O
,	O
bronchial	B-bodyloc
cough	O
.	O

The	O
trachea	O
was	O
midline	O
.	O

Onset	O
was	O
gradual	O
.	O

Past	O
Medical	O
History	O
1	O
.	O

I	O
talked	O
to	O
Anna	O
today	O
.	O

They	O
gradually	O
diminished	O
in	O
intensity	O
and	O
his	O
last	O
one	O
was	O
a	O
month	O
ago	O
.	O

History	O
of	O
Seizure	O
Disorder	O
345	O
.	O
90	O

;	O
Mar	B-temporal
24	I-temporal
2014	I-temporal
4	B-temporal
:	I-temporal
56PM	I-temporal
(	O
Author	O
)	O

Constitutional	O

ENDOCRINE	O
:	O
No	B-negation
polyuria	O
or	O
polydipsia	O
.	O

Gait	O
:	O
the	O
gait	O
and	O
station	O
were	O
normal	B-labvalue
.	O

2	O
.	O

Cardiovascular	O

History	O
of	O
Normal	B-labvalue
Initial	O
Prenatal	O
Checkup	O
V22	O
.	O
1	O

"	O
Progressive	O
weakness	O
"	O

UTP	O
-	O
OB	O
/	O

Libial	O
(	O
tib	O
.	O
)	O
:	O
Normal	O
.	O

2	O
.	O

PredniSONE	O
10	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
take	O
4	B-dosage
tabs	B-form
po	B-route
qd	B-frequency
x	O
4	B-duration
days	I-duration
thentake	O
3	B-dosage
tabs	B-form
po	B-route
qd	B-frequency
x	O
4	B-duration
days	I-duration
thentake	O
2	B-dosage
tabs	B-form
po	B-route
qd	B-frequency
x	O
4	B-duration
days	I-duration
thentake	O
1	B-dosage
tab	B-form
po	B-route
qd	B-frequency
until	O
next	O
visit	O
;	O
Therapy	O
:	O
22Aug2011	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
22Aug2011	B-temporal
)	O
Requested	O
for	O
:	O
22Aug2011	B-temporal
;	O
Edited	O

Family	O
History	O
Maternal	B-subject
grandmother	I-subject
'	I-subject
s	I-subject
history	O
of	O
Congestive	O
Heart	B-bodyloc
Failure	O

Outpatient	O
Physician	O
Consultation	O
V65	O
.	O
9	O

PlanSectispEnd	O
Counseling	O
/	O
EduSectispStart	O
Counseling	O
/	O
Edu	O

She	O
is	O
married	O
.	O

were	O
reviewed	O
.	O

Constitutional	O

Left	O
Foot	O
:	O

Associated	O
symptoms	O
include	O
no	B-negation
headache	O
,	O
no	B-negation
focal	O
neurologic	O
deficits	O
and	O
no	B-negation
memory	O
loss	O
.	O

Social	O
History	O
"	O
Never	O
A	O
Smoker	O

Examination	O
of	O
the	O
oropharynx	O
:	O
Normal	B-labvalue

Head	O
and	O
Face	O

Assessment	O
of	O
range	O
of	O
motion	O
:	O
Normal	B-labvalue
.	O

External	O
inspection	O
of	O
ears	O
and	O
nose	O
:	O
Normal	B-labvalue

He	O
describes	O
this	O
as	O
mild	O
and	O
worsening	O
.	O

Prefera	O
OB	O
TABS	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
26Oct2012	B-temporal
)	I-temporal
to	O

Cranial	O
nerves	O
VII	O
:	O
facial	O
strength	O
was	O
intact	B-labvalue
bilaterally	I-labvalue
.	O

Past	O
Medical	O
History	O
History	O
of	O
Asthma	O
493	O
.	O
90	O

Examination	O
of	O
reflexes	O
:	O
Normal	B-labvalue
.	O

Wheezing	O
:	O
Moderate	B-severity

NRBC	O
:	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
CUIE	O
QIU	O
,	O
M	O
.	O
D	O
.	O

Constitutional	O
:	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
,	O
not	B-negation
feeling	O
poorly	O
(	O
malaise	O
)	O
,	O
not	B-negation
feeling	O
tired	O
(	O
fatigue	O
)	O
,	O
no	O
recent	O
weight	O
gain	O
and	O
no	B-negation
recent	B-temporal
weight	O
loss	O
.	O

Encounters	O

Psychiatric	O

Genitourinary	O
:	O
normal	O
.	O

24Oct2011	B-temporal
(	O
2M	O
)	O
09Jan2012	B-temporal
(	O
4M	O
)	O
20Feb2012	B-temporal
(	O
6M	O
)	O
22Oct2012	B-temporal
(	O
14M	O
)	O

Chief	O
Complaint	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
vomiting	O
,	O
no	B-negation
diarrhea	O
,	O
no	B-negation
heartburn	O
and	O
no	B-negation
melena	O
.	O

I	O
agree	O
with	O
the	O
history	O
,	O
exam	O
and	O
plan	O
of	O
care	O
as	O
documented	O
in	O
the	O
resident	O
note	O
.	O

History	O
of	O
Routine	O
Gynecological	O
Exam	O
With	O
Cervical	O
Pap	O
Smear	O
V72	O
.	O
31	O

Diabetic	O
Foot	O
Exam	O
:	O

Diabetes	O
Mellitus	O
250	O
.	O
00	O

History	O
of	O
Anxiety	O
Disorder	O
NOS	O
300	O
.	O
00	O

Chief	O
Complaint	O

History	O
of	O
Hysterectomy	O
V88	O
.	O
01	O

Right	O
2	O
+	O
,	O
no	B-negation
bruit	O
heard	O
over	O
the	O
right	B-bodyloc
carotid	I-bodyloc
,	O
left	O
2	O
+	O
and	O
no	B-negation
bruit	O
heard	O
over	O
the	O
left	B-bodyloc
carotid	I-bodyloc
.	O

Iron	O
325	B-strength
(	O
65	O
Fe	O
)	O
MG	O
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
TWICE	B-frequency
DAILY	I-frequency
WITH	I-frequency
MEALS	I-frequency
;	O
Therapy	O
:	O
06Jun2013	B-temporal
to	O
(	O
Evaluate	O
:	O
03Dec2013	B-temporal
)	O
Requested	O
for	O
:	O
06Jun2013	B-temporal
;	O
Last	O
Rx	O
:	O
06Jun2013	B-temporal

Thought	O
Processes	O
:	O
normal	B-labvalue
.	O

The	O
nasal	O
mucosa	O
was	O
normal	O
.	O

Secretions	O
:	O
Clear	B-negation

Urethral	O
meatus	O
:	O
Normal	O
.	O

Vagina	B-bodyloc
:	O
pink	O
rugae	O
,	O
no	O
discharge	O
and	O
no	B-negation
active	O
bleeding	O
.	O

Constitutional	O

RT	O
Inferior	O
Turbinate	O

Skin	B-bodyloc
Abscess	O
Of	O
The	O
Foot	B-bodyloc
682	O
.	O
7	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
neck	O
:	O
Normal	B-labvalue
.	O

;	O
Apr	B-temporal
8	I-temporal
2014	I-temporal
12	B-temporal
:	I-temporal
29PM	I-temporal
(	O
Author	O
)	O

3	O
)	O
h	O
/	O
o	O
PPROM	O
at	O
27	O
weeks	O
with	O
PTB	O
at	O
31	O
wks	O
.	O

Zolpidem	O
Tartrate	O
10	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
AT	B-frequency
BEDTIME	I-frequency
AS	B-frequency
NEEDED	I-frequency
;	O
Last	O
Rx	O
:	O
18Dec2013	B-temporal

Discussion	O
/	O
Discussion	O
/	O
Summary	O

The	O
laceration	O
of	O
the	O
lip	B-bodyloc
nicely	O
healing	O
,	O
no	B-negation
active	O
bleeding	O
,	O
continue	O
current	B-temporal
antibiotics	O
management	O
.	O
sutures	O
are	O
disolvable	O
as	O
per	O
patient	O
.	O

Weight	O
:	O
111	B-labvalue
lb	I-labvalue
6	I-labvalue
oz	I-labvalue

Ability	O
to	O
communicate	O
:	O
Abnormal	O
.	O

General	O
appearance	O
:	O
Normal	B-labvalue
.	O

History	O
of	O
Present	O
Illness	O

Active	O
Problems	O
Benign	B-severity
Essential	O
Hypertension	O
401	O
.	O
1	O

Inspection	O
of	O
the	O
nasal	O
mucosa	O
,	O
septum	O
and	O
turbinates	O
:	O
Normal	B-labvalue
.	O

3	O
.	O

Patient	O
has	O
history	O
of	O
sexually	O
transmitted	O
infection	O
chlamydia	O
.	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
vomiting	O
,	O
no	B-negation
constipation	O
,	O
no	B-negation
diarrhea	O
,	O
no	B-negation
melena	O
and	O
no	B-negation
heartburn	O
.	O

Family	O
History	O
Family	B-subject
history	O
of	O
Migraine	O
Headache	O

Symptoms	O
:	O
Denies	B-negation
chest	B-bodyloc
pain	O
,	O
denies	B-negation
intermittent	O
leg	B-bodyloc
claudication	O
,	O
denies	B-negation
muscle	B-bodyloc
pain	O
and	O
denies	B-negation
muscle	B-bodyloc
weakness	O
.	O

Await	O
labs	O
and	O
Neurologist	O
consult	O
.	O
Add	O
baby	B-strength
ASA	O
QD	B-frequency

Ears	O
,	O
Nose	O
,	O
Mouth	O
and	O
Throat	O

Hyperlipidemia	O
272	O
.	O
4	O

History	O
of	O
Hypocalcemia	O
275	O
.	O
41	O

Lymphatic	O

Respiratory	O
:	O
shortness	O
of	O
breath	O
,	O
wheezing	O
,	O
cough	O
,	O
shortness	O
of	O
breath	O
during	O
exertion	O
and	O
orthopnea	O
,	O
but	O
no	B-negation
PND	O
.	O

;	O
Feb	B-temporal
1	I-temporal
2013	I-temporal
2	B-temporal
:	I-temporal
32PM	I-temporal
(	O
Author	O
)	O

BMI	O
Calculated	O
:	O
29	B-labvalue
.	I-labvalue
28	I-labvalue

;	O
Oct	B-temporal
2	I-temporal
2013	I-temporal
5	B-temporal
:	I-temporal
36PM	I-temporal
(	O
Author	O
)	O

[	O
LH	O
]	O
Vitamin	O
D	O
,	O
25	O
-	O
Hydroxy	O
,	O
Total	O
*	O
(	O
E	O
)	O
Requested	O
for	O
:	O
10May2011	B-temporal

7	O
.	O

Acute	B-course
Upper	B-bodyloc
Respiratory	I-bodyloc
Infection	O
(	O
465	O
.	O
9	O
)	O
;	O
-	O
possible	B-uncertain
croup	O
given	O
exposure	O
to	O
sib	O
(	B-negation
no	I-negation
coughing	O
during	O
PE	O
)	O

Endocrine	O
:	O
no	B-negation
proptosis	O
,	O
no	B-negation
hot	O
flashes	O
,	O
no	B-negation
muscle	B-bodyloc
weakness	O
,	O
no	B-negation
erectile	O
dysfunction	O
,	O
no	B-negation
deepening	O
of	O
the	O
voice	O
and	O
no	B-negation
feelings	O
of	O
weakness	O
.	O

Family	O
History	O
Paternal	O
grandmother	O
'	O
s	O
history	O
of	O
Breast	B-bodyloc
Cancer	O
V16	O
.	O
3	O

[	O
QLH	O
]	O
IRON	O
AND	O
TOTAL	O
IRON	O
BINDING	O
CAPACITY	O
Done	O
:	O
12Jan2010	B-temporal
09	B-temporal
:	I-temporal
27AM	I-temporal

Satisfactory	O
for	O
evaluation	O
.	O

Constitutional	O

Femoral	B-bodyloc
:	O
right	O
2	O
+	O
,	O
left	O
2	O
+	O
,	O
no	B-negation
bruit	O
on	O
the	O
right	O
and	O
no	B-negation
bruit	O
on	O
the	O
left	O
.	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
neck	O
:	O
Normal	B-labvalue
.	O

Hematologic	O
/	O
Lymphatic	O
:	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
,	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
,	O
no	B-negation
swollen	O
glands	B-bodyloc
and	O
no	B-negation
swollen	O
glands	B-bodyloc
in	O
the	O
neck	B-bodyloc
.	O

Gastrointestinal	O
:	O
no	B-negation
vomiting	O
and	O
no	B-negation
diarrhea	O
.	O

Inspection	O
of	O
wound	O
:	O
Normal	B-labvalue
.	O

Examination	O
of	O
the	O
head	O
and	O
face	O
:	O
Normal	B-labvalue

Counselled	O
patient	O
extensively	O
about	O
lifestyle	O
modificatiops	O
.	O

The	O
nasal	O
turbinates	O
were	O
normal	O
.	O

Penicillins	O

Color	O
:	O
Normal	O

LT	O

Past	O
Medical	O
History	O
History	O
of	O
Herpes	O
Simplex	O
054	O
.	O
9	O

Symptoms	O
:	O
excessive	O
daytime	O
sleepiness	O
,	O
snoring	O
,	O
impaired	O
concentration	O
and	O
memory	O
problems	O
,	O
but	O
no	B-negation
irritability	O
and	O
no	B-negation
restless	O
legs	B-bodyloc
.	O

9	O
.	O

CT	O
Chest	O
w	O
contrast	O
Requested	O
for	O
:	O
19Oct2012	B-temporal

[	O
LH	O
]	O
Vitamin	O
D	O
,	O
25	O
-	O
Hydroxy	O
,	O
Total	O
*	O
(	O
E	O
)	O
Requested	O
fis	O
:	O
29Apr2013	B-temporal

-	O
LA	B-bodyloc
enlargement	O

;	O
Dec	B-temporal
6	I-temporal
2012	I-temporal
1	B-temporal
:	I-temporal
08PM	I-temporal
(	O
Author	O
)	O

No	B-negation
wheezing	O
was	O
heard	O
.	O

Inspection	O
of	O
lips	O
,	O
teethand	O
gums	O
:	O
Normal	B-labvalue

No	B-negation
dyspareunia	O
.	O

ACTIVITY	O
AND	O
LIMITATIONS	O
:	O
Nonweightbearing	O
to	O
the	O
right	O
lower	O
extremity	O
.	O

Right	O
Foot	O
:	O
The	O
foot	B-bodyloc
was	O
normal	O
,	O
not	B-negation
swollen	O
,	O
not	B-negation
tender	O
and	O
not	B-negation
erythematous	O
.	O

2	O
.	O

Anxiety	O

External	O
inspection	O
of	O
ears	O
and	O
nose	O
:	O
Normal	B-labvalue
.	O

4	O
.	O

lives	O
with	O
daughter	O

Hepatitis	O
B	O
;	O
23	B-temporal
Aug	I-temporal
2007	I-temporal

Patient	O
has	O
a	O
history	O
of	O
a	B-labvalue
positive	I-labvalue
pap	O
smear	O
(	O
LSIL	O
,	O
2012	B-temporal
pregnancy	O
)	O
.	O

Past	O
Medical	O
History	O
Problems	O
History	O
of	O
Ischemic	O
Stroke	O
434	O
.	O
90	O

Eustachian	O
Tube	O
Dysfunction	O
381	O
.	O
81	O

UTP	O
-	O
HM	O
,	O

Social	O
History	O
Problems	O

Plan	O
_	O
2	O
_	O
twCiteListControlEnd	O
Rx	O
refills	O
given	O
fis	O
Nexium	O
40mg	B-strength
daily	B-frequency
fis	O
acid	O
reflux	O
symptoms	O
.	O

Cortical	O
function	O
:	O
Normal	B-labvalue
.	O

History	O
of	O
Present	O
Illness	O

PAST	O
MEDICAL	O
HISTORY	O
:	O
Extensive	O
and	O
well	O
documented	O
in	O
prior	O
charts	O
.	O

Respiratory	O
effort	O
:	O
No	B-negation
increased	O
work	O
of	O
breathing	O
or	O
signs	O
of	O
respiratory	B-bodyloc
distress	O
.	O

Endocrine	O
:	O
no	B-negation
proptosis	O
,	O
no	B-negation
hot	O
flashes	O
,	O
no	B-negation
muscle	B-bodyloc
weakness	O
,	O
no	B-negation
deepening	O
of	O
the	O
voice	O
and	O
no	B-negation
feelings	O
of	O
weakness	O
.	O

Psychiatric	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

10	I-reference_range
Red	O
Crll	O
Diame	O
er	O
Width	O
16	B-labvalue
.	I-labvalue
3	I-labvalue
%	I-labvalue
H	B-labvalue
11	B-reference_range
.	I-reference_range
5	I-reference_range
-	I-reference_range
14	I-reference_range
.	I-reference_range

Genitourinary	O
:	O
no	B-negation
dysuria	O
,	O
no	B-negation
incontinence	O
,	O
no	B-negation
pelvic	B-bodyloc
pain	O
,	O
no	B-negation
dysmenorrhea	O
,	O
no	B-negation
vaginal	O
discharge	O
and	O
no	B-negation
unexplained	O
vaginal	B-bodyloc
bleeding	O
.	O

There	O
was	O
no	B-negation
tenderness	O
over	O
the	O
sciatic	B-bodyloc
notches	I-bodyloc
.	O

Review	O
of	O
Systems	O
Complete	O
-	O
Male	O
Neuro	O
Emphasis	O
:	O

Spent	O
15	O
/	O
25	O
mins	O
counseling	O

No	B-negation
VB	O
/	O
LOF	O
/	O
ctx	O
.	O

Assessment	O
Ankle	B-bodyloc
Joint	I-bodyloc
Pain	O
719	O
.	O
47	O

History	O
of	O
Leiomyoma	O
Of	O
The	O
Uterus	B-bodyloc
218	O
.	O
9	O

Cervical	O
spondylosis	O
with	O
herniated	O
nucleus	O
pulposus	O
C4	O
-	O
C5	O
,	O
C5	O
-	O
C6	O
,	O
and	O
C6	O
-	O
C7	O
with	O
stenosis	O
.	O

Counseling	O
/	O
Counseling	O
/	O
Edu	O

PEG	O
-	O
3350	O
/	O
Electrolytes	O
236	B-strength
GM	I-strength
Oral	B-route
Solution	B-form
Reconstituted	O
;	O
take	O
on	O
glass	O
every	B-frequency
15	I-frequency
minutes	I-frequency
over	B-duration
4	I-duration
-	I-duration
6	I-duration
hrs	I-duration
;	O
Therapy	O
:	O
10Apr2012	B-temporal
to	O
(	O
Evaluate	O
:	O
11Apr2012	B-temporal
)	O
;	O
Last	O
Rx	O
:	O
10Apr2012	B-temporal

Attending	O
Note	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
neck	O
:	O
Normal	B-labvalue
.	O

NECK	O

-	O
-	O
May	O
check	O
with	O
his	O
cardiologist	O
and	O
see	O
if	O
it	O
is	O
possible	O
to	O
restart	O
Zetia	O
.	O

History	O
of	O
Pregnancy	O
-	O
induced	O
Hypertension	O
642	O
.	O
90	O

Vitamin	O
D	O
deficiency	O
:	O
Vitamin	O
D	O
levels	O
wnl	B-labvalue
.	O
iPTH	O
is	O
elevated	B-labvalue
at	O
94	B-labvalue
but	O
appropriately	O
so	O
,	O
given	O
his	O
CKD	O
status	O
.	O

Chronically	B-course
ill	O
.	O

The	O
tonsils	O
were	O
normal	O
.	O

Constitutional	O
:	O
no	B-negation
fever	O
and	O
no	B-negation
chills	O
.	O

-	O
well	O
-	O
controlled	O

Recovering	O
Alcoholic	O

Pt	O
has	O
missed	O
WCC	O
appts	O
,	O
stressed	O
importance	O
to	O
mom	O
of	O
RTC	O
for	O
WCC	O
.	O

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

Never	O
Drank	O
Alcohol	O

Examination	O
of	O
the	O
chest	O
:	O
Normal	B-labvalue
.	O

ENT	O
:	O
no	B-negation
hoarseness	O
,	O
no	B-negation
hearing	O
loss	O
,	O
no	B-negation
drainage	O
of	O
ear	B-bodyloc
,	O
no	B-negation
vertigo	O
,	O
no	B-negation
snoring	O
was	O
observed	O
,	O
no	B-negation
daytime	O
sleepiness	O
,	O
no	B-negation
mouth	B-bodyloc
sores	O
,	O
no	B-negation
tooth	B-bodyloc
problems	O
,	O
no	B-negation
dysphagia	O
and	O
no	B-negation
tinnitus	O

Current	O
Orders	O
[	O
Q	O
]	O
Comments	O
Done	O
:	O
28Feb2011	B-temporal
10	B-temporal
:	I-temporal
28AM	I-temporal

2	O
.	O

Medication	O
f	O
Provera	O
10	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
(	O
Active	O
)	O

Cefadroxil	O
500	B-strength
mg	I-strength
Capsule	B-form
Sig	O
:	O
One	B-dosage
(	I-dosage
1	I-dosage
)	I-dosage
Capsule	B-form
PO	B-route
twice	B-frequency
a	I-frequency
day	I-frequency
for	O
10	B-duration
days	I-duration
.	O

Lantus	O
SoloStar	O
100	B-strength
UNIT	I-strength
/	I-strength
ML	I-strength
Subcutaneous	B-route
Solution	B-form
;	O
INJECT	O
60	B-dosage
UNIT	I-dosage
IN	B-frequency
THE	I-frequency
MORNING	I-frequency
;	O
Therapy	O
:	O
25Feb2009	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
30Nov2009	B-temporal
)	O
Requested	O
for	O
:	O
30Nov2009	B-temporal

Physical	O
Exam	O

;	O
Nov	B-temporal
2	I-temporal
2012	I-temporal
12	B-temporal
:	I-temporal
24PM	I-temporal
(	O
Author	O
)	O

[	O
QLH	O
]	O
BASIC	O
METABOLIC	O
PANEL	O
W	O
/	O
EGFR	O
Done	O
:	O
11Nov2011	B-temporal
12	B-temporal
:	I-temporal
55PM	I-temporal

Workup	O
of	O
HIV	O
and	O
vasculitis	O
were	O
neg	O
so	O
fer	O
.	O

Palpation	O
of	O
breasts	O
and	O
axillae	O
:	O
Normal	B-labvalue

Vaccines	O
Prophylactic	O
Need	O
Against	O
Influenza	O
V04	O
.	O
81	O

Associated	O
symptoms	O
include	O
dyspnea	O
,	O
exercise	O
intolerance	O
,	O
fatigue	O
,	O
palpitations	O
,	O
weakness	O
,	O
orthopnea	O
,	O
chest	B-bodyloc
tightness	O
,	O
wheezing	O
,	O
anxiety	O
and	O
edema	O
,	O
but	O
no	B-negation
lightheadedness	O
,	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
choking	O
sensation	O
,	O
no	B-negation
fever	O
,	O
no	B-negation
hemoptysis	O
,	O
no	B-negation
sore	O
throat	B-bodyloc
,	O
no	B-negation
weight	O
gain	O
and	O
no	B-negation
leg	B-bodyloc
pain	O
.	O

UTP	O
-	O
OB	O
/	O
Patient	O
here	O
for	O
postpartum	O
check	O
.	O

Review	O
of	O
Systems	O

system	O
3	B-frequency
times	I-frequency
daily	I-frequency
to	O
deliver	O
medication	O
into	O
sinus	O
cavity	O
.	O

He	O
has	O
had	O
increasing	B-course
bradykinesia	O
.	O

f	O
Influenza	O
(	O
Lot	O
#	O
:	O
AFLLA577AA	O
)	O
-	O
Administered	O
on	O
:	O
11/02/2010	B-temporal

Otoscopic	O
examination	O
:	O
Normal	B-labvalue
.	O

Constitutional	O

MetroNIDAZOLE	O
0	B-strength
.	I-strength
75	I-strength
%	I-strength
Vaginal	B-form
Gel	I-form
;	I-form
INSERT	I-form
1	B-dosage
APPLICATORFUL	B-form
INTRAVAGINALLY	B-route
AT	B-frequency
BEDTIME	I-frequency
NIGHTLY	B-frequency
;	O
Therapy	O
:	O
18Dec2013	B-temporal
to	O
(	O
Evaluate	O
:	O
28Dec2013	B-temporal
)	O
Requested	O
for	O
:	O
18Dec2013	B-temporal
;	O
Last	O
Rx	O
:	O
18Dec2013	B-temporal

Patient	O
agrees	O
to	O
proceed	O
.	O

There	O
is	O
no	B-negation
absence	O
of	O
light	O
sensitivity	O
or	O
photophobia	O
.	O

Left	O
Adduct	O
.	O

Eyes	O
:	O
no	B-negation
blurred	O
vision	O
.	O

1	O
.	O

Constitutional	O
:	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
and	O
not	B-negation
tired	O
(	O
fatigue	O
)	O
.	O

Plan	O
Amoxicillin	O
875	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
EVERY	B-frequency
12	I-frequency
HOURS	I-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
20Jul2013	B-temporal
to	O
(	O
Evaluate	O
:	O
27Jul2013	B-temporal
)	O
Requested	O
for	O
:	O
20Jul2013	B-temporal
;	O
Last	O
Rx	O
:	O
20Jul2013	B-temporal
;	O
Edited	O

Cycle	O
intervals	O
have	O
been	O
regular	O
.	O

CONSTITUTIONAL	O
:	O
no	B-negation
nausea	O
,	O
no	B-negation
recent	B-temporal
weight	O
gain	O
,	O
no	B-negation
recent	B-temporal
weight	O
loss	O
,	O
no	B-negation
fever	O
and	O
no	B-negation
chills	O

ENDOCRINE	O
:	O
no	B-negation
cold	O
intolerance	O
,	O
no	B-negation
heat	O
intolerance	O
and	O
no	B-negation
excessive	O
thirst	O
.	O

follow	O
up	O
in	O
2	B-temporal
weeks	I-temporal
CBC	O
normal	B-labvalue

The	O
oral	O
mucosa	O
was	O
moist	O
.	O

Parkinson	O
'	O
s	O
Disease	O
332	O
.	O
0	O

Height	O
:	O
5	B-labvalue
ft	I-labvalue
2	I-labvalue
in	I-labvalue

The	O
incision	O
was	O
well	O
-	O
healed	O
,	O
intactandwithout	O
drainage	O
.	O

1	O
Pneumococcal	O
31Oct2000	B-temporal

Palpation	O
of	O
chest	O
:	O
Normal	B-labvalue
.	O

Cardiovascular	O

External	O
inspection	O
of	O
ears	O
and	O
nose	O
:	O
Normal	B-labvalue
.	O

Musculoskeletal	O
:	O
no	B-negation
muscle	B-bodyloc
weakness	O
and	O
no	B-negation
joint	B-bodyloc
pain	O
.	O

Allergies	O
No	B-negation
Known	O
Allergies	O

History	O
of	O
Migraine	O
Headache	O
346	O
.	O
90	O

Test	O
Name	O
Result	O
Flag	O
Reference	O

Latanoprost	O
0	B-strength
.	I-strength
005	I-strength
%	I-strength
Ophthalmic	B-route
Solution	B-form
;	O
INSTILL	O
1	B-dosage
DROP	B-form
IN	B-route
BOTH	I-route
EYES	I-route
AT	B-frequency
BEDTIME	I-frequency
;	O
Therapy	O
:	O
20Feb2008	B-temporal
to	O
(	O
Evaluate	O
:	O
02Jul2012	B-temporal
)	O
Requested	O
for	O
:	O
12Jul2013	B-temporal

Genitourinary	O
:	O
no	B-negation
dysuria	O
and	O
no	B-negation
nocturia	O
.	O

Eyes	O

T2DM	O
?	B-uncertain
:	O
on	O
Glyburide	O
5	B-strength
mg	I-strength
BID	B-frequency
,	O
fasting	O
BSs	O
are	O
wnl	O
.	O

History	O
of	O
Knee	O
Surgery	O

Head	O
and	O
Face	O

FamilyHistisy	O
_	O
70	O
_	O
twCiteListControlEnd	O
FamilyHistisySectispEnd	O
SocialHistisySectispStart	O
Social	O
Histisy	O

Cranial	O
nerves	O
II	O
:	O
visual	O
acuity	O
and	O
visual	O
fields	O
were	O
intact	B-labvalue
.	O

Lovaza	O
1	B-strength
GM	I-strength
Oral	B-route
Capsule	B-form
;	O
take	O
1	B-dosage
capsule	B-form
twice	B-frequency
a	I-frequency
day	I-frequency
;	O
Therapy	O
:	O
23Dec2013	B-temporal
to	O
(	O
Evaluate	O
:	O
19Sep2014	B-temporal
)	O
Requested	O
for	O
:	O
23Dec2013	B-temporal
;	O
Last	O
Rx	O
:	O
23Dec2013	B-temporal
;	O
Status	O
:	O
ACTIVE	O
-	O

Review	O
of	O
Systems	O

1	O
.	O

History	O
of	O
subdural	B-bodyloc
hematoma	O
.	O

Anemia	O
of	O
chronic	B-course
disease	O
.	O

Lisinopril	O
5	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
Requested	O
for	O
:	O
14Feb2014	B-temporal
;	O
Last	O
Rx	O
:	O
07Feb2014	B-temporal

Inspection	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
Abnormal	O
.	O

Pulmonary	O

to	O

Examination	O
of	O
pupils	O
and	O
irises	O
:	O
Normal	B-labvalue

Cranial	O
Nerve	O
XII	O
:	O
there	O
was	O
no	B-negation
tongue	B-bodyloc
deviation	O
with	O
protrusion	O
.	O

)	O
.	O

[	O
QLH	O
]	O
CBC	O
(	O
INCLUDES	O
DIFF	O
/	O
PLT	O
)	O
Requested	O
for	O
:	O
25Jul2012	B-temporal

PP	O
coping	O
well	O
with	O
infants	O
condition	O
.	O

PAP	O
normal	B-labvalue
at	O
last	B-temporal
visit	I-temporal
.	O

Pulmonary	O

She	O
obviously	O
speaks	O
both	O
English	O
and	O
Spanish	O
,	O
but	O
we	O
gave	O
the	O
booklet	O
to	O
her	O
in	O
Spanish	O
because	O
she	O
is	O
from	O
Columbia	O
.	O

The	O
patient	O
presents	O
with	O
complaints	O
of	O
gradual	O
onset	O
of	O
intermittent	O
episodes	O
of	O
mild	B-severity
left	B-bodyloc
flank	I-bodyloc
pain	O
,	O
described	O
as	O
dull	O
,	O
radiating	O
to	O
the	O
legs	O
.	O

Mupirocin	O
Powder	B-form
;	O
COMPOUND	O
:	O
Mupirocin	O
20mg	B-strength
Capsule	B-form
.	O

Endocrine	O
:	O
no	B-negation
hot	O
flashes	O
,	O
no	B-negation
changes	O
in	O
appetite	O
,	O
no	B-negation
unusual	O
sensitivity	O
to	O
changes	O
in	O
temperature	O
and	O
no	B-negation
of	O
excessive	O
thirst	O
.	O

Chief	O
Complaint	O

BMI	O
Calculated	O
:	O
53	B-labvalue
.	I-labvalue
86	I-labvalue

Patient	O
has	O
no	B-negation
history	O
of	O
sexually	O
transmitted	O
infection	O
.	O

Examination	O
of	O
extremities	O
for	O
edema	O
and	O
/	O
or	O
varicosities	O
:	O
Normal	B-labvalue
.	O

Alkaline	O
phosphatase	O
of	O
96	B-labvalue
,	O
bilirubin	O
0	B-labvalue
.	I-labvalue
8	I-labvalue
.	O

Risk	O
factors	O
:	O
obesity	O
and	O
physical	O
inactivity	O
,	O
but	O
no	O
alcohol	O
use	O
and	O
no	O
smoking	O
.	O

Examination	O
of	O
the	O
oropharynx	O
:	O
Normal	B-labvalue
.	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Discharge	O
Condition	O
:	O

Check	O
fasting	O
lipid	O
profile	O
today	B-temporal

LMP	O
:	O
11Jun2013	O

f	O
History	O
of	O
Diabetes	O
Mellitus	O
(	O
250	O
.	O
00	O
)	O
;	O
(	B-course
Resolved	I-course
)	O

Past	O
Medical	O
History	O
History	O
of	O
Cancer	O
199	O
.	O
1	O

[	O
QLH	O
]	O
BV	O
/	O
VAGINITIS	O
PANEL	O
DNA	O
PROBE	O
AFFIRM	O
Requested	O
for	O
:	O
08May2013	B-temporal

Results	O
/	O
Assessment	O

Ascorbic	O
Acid	O
500	B-strength
mg	I-strength
Tablet	B-form
Sig	O
:	O
One	B-dosage
(	I-dosage
1	I-dosage
)	I-dosage
Tablet	B-form
PO	B-route
BID	B-frequency
(	I-frequency
2	I-frequency
times	I-frequency
a	I-frequency
day	I-frequency
)	I-frequency
.	O

Dysthymic	O
Disorder	O
300	O
.	O
4	O

Female	O
.	O

Risk	O
factors	O
:	O
obesity	O
,	O
but	O
no	B-negation
physical	O
inactivity	O
,	O
no	O
alcohol	O
use	O
and	O
no	O
smoking	O
.	O

Neurological	O
:	O
no	B-negation
confusion	O
,	O
no	B-negation
convulsions	O
,	O
no	B-negation
dizziness	O
,	O
no	B-negation
fainting	O
,	O
no	B-negation
limb	B-bodyloc
weakness	O
and	O
no	B-negation
difficulty	O
walking	O
.	O

Psychiatric	O

Lymphatic	O

AIRWAY	O
ENDOSCOPY	O
.	O

Previous	B-temporal
allergy	O
testing	O
:	O
Never	B-negation

Follow	O
up	O
with	O
ophthalmalogist	O
as	O
scheduled	O
.	O

Psychiatric	O
:	O
no	B-negation
depression	O
.	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
,	O
no	B-negation
edema	O
,	O
no	B-negation
syncope	O
and	O
no	B-negation
intermittent	O
leg	B-bodyloc
claudication	O
.	O

Patient	O
Specific	O
Education	O
Given	O
Done	O
:	O
24Mar2014	B-temporal

Calcium	O
challenge	O
has	O
been	O
done	O
.	O

She	O
had	O
no	B-negation
further	O
complaints	O
throughout	O
the	O
hospitalization	O
with	O
any	O
shortness	O
of	O
breath	O
or	O
chest	B-bodyloc
pain	O
.	O

BSA	O
Calculated	O
:	O
1	B-labvalue
.	I-labvalue
87	I-labvalue

Examination	O
of	O
the	O
oropharynx	O
:	O
Normal	B-labvalue
.	O

Lialda	O
TBEC	O
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
20Feb2013	B-temporal
)	O
to	O

History	O
of	O
Present	O
Illness	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
,	O
the	O
heart	O
rate	O
was	O
not	B-labvalue
fast	I-labvalue
,	O
no	O
intermittent	O
leg	O
claudicationandno	O
edema	O
.	O

Herpes	O
Simplex	O
Type	O
Ii	O
054	O
.	O
10	O

Genitourinary	O
:	O
no	B-negation
dysuria	O
.	O

Family	B-subject
history	O
of	O
Cancer	O

Ensure	O
Plus	O
Oral	B-route
Liquid	B-form
;	O
1	B-dosage
can	O
three	B-frequency
times	I-frequency
a	I-frequency
day	I-frequency
;	O
Therapy	O
:	O
12Nov2010	B-temporal
to	O
(	O
Evaluate	O
:	O
10Jun2011	B-temporal
)	O
;	O
Last	O
Rx	O
:	O
12Nov2010	B-temporal

Red	O
Blood	O
In	O
Bowel	B-bodyloc
Movement	O
(	O
Hematochezia	O
)	O
578	O
.	O
1	O

The	O
surrounding	O
skin	O
findings	O
included	O
normal	O
appearance	O
.	O

Adnexa	O
/	O
Parametria	O
:	O
Normal	O
,	O
no	B-negation
masses	O
or	O
tenderness	O
.	O

Qvar	O
40	B-strength
MCG	I-strength
/	I-strength
ACT	I-strength
Inhalation	B-route
Aerosol	B-form
Solution	I-form
;	O
INHALE	O
2	B-dosage
PUFFS	B-form
TWICE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
03Jan2013	B-temporal
to	O
(	O
Complete	O
:	O
02Jun2013	B-temporal
)	O
Requested	O
for	O
:	O
03Jan2013	B-temporal
;	O
Last	O
Rx	O
:	O
03Jan2013	B-temporal
;	O
Status	O
:	O

According	O
to	O
the	O
husband	O
,	O
the	O
patient	O
has	O
not	B-negation
had	I-negation
any	O
generalized	O
seizures	O
or	O
focal	O
seizures	O
.	O

Inspection	O
of	O
lips	O
,	O
teethand	O
gums	O
:	O
Normal	B-labvalue
.	O

PSH	O
g33	O

Obtains	O
green	O
discharge	O
with	O
irrigation	O

Ambien	O
10	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
AT	B-frequency
BEDTIME	I-frequency
AS	B-frequency
NEEDED	I-frequency
FOR	O
SLEEP	O
;	O
Therapy	O
:	O
20Feb2008	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
20Feb2008	B-temporal
)	O
Requested	O
for	O
:	O
20Feb2008	B-temporal

Current	O
Orders	O

The	O
patient	O
reports	O
persistent	O
symptoms	O
despite	O
appropriate	O
treatment	O
.	O

Cardiovascular	O

Hypothyroidism	O
244	O
.	O
9	O

ALLERGY	O

History	O
of	O
Hypertension	O
401	O
.	O
9	O

f	O
/	O
u	O
with	O
next	O
episode	O
.	O

LUNGS	O
-	O
Clear	B-labvalue
to	O
auscultation	O

Integumentary	O
:	O
no	B-negation
skin	B-bodyloc
lesions	O
and	O
no	B-negation
skin	B-bodyloc
wound	O
.	O

Breath	O
sounds	O
were	B-negation
not	I-negation
diminished	O
.	O

Clear	B-labvalue
to	O
auscultation	O
.	O

The	O
baby	O
is	O
currently	O
in	O
the	O
hospital	O
.	O

Discussion	O
/	O
Signatures	O
Electronically	O
signed	O
by	O
:	O
MILINDA	O
MORRIS	O
,	O
M	O
.	O
D	O
.	O

Neurology	O
Referral	O
Outpatient	O
Referral	O
Requested	O
for	O
:	O
29Oct2012	B-temporal

He	O
denies	O
tobacco	O
.	O

Weight	O
:	O
304	B-labvalue
lb	I-labvalue

I	O
had	O
the	O
pleasure	O
of	O
evaluating	O
your	O
patient	O
,	O
EDWARD	O
JAMES	O
MORALES	O
.	O

Examination	O
of	O
pupils	O
and	O
irises	O
:	O
Normal	B-labvalue
.	O

OB	O
History	O

Using	O
his	O
FP	O
/	O
MP	O
irrigations	O
everyday	O
,	O
and	O
most	O
days	O
bid	O

Keppra	O
Swelling	O
and	O
becam	O
suicidal	O
/	O
violent	O
,	O
Trileptal	O
,	O
Lamictal	O
,	O
topamax	O

)	O
Sig	O
:	O
One	B-dosage
(	I-dosage
1	I-dosage
)	I-dosage
Tablet	B-form
,	I-form
Delayed	I-form
Release	I-form
(	O
E	O
.	O
C	O
.	O

Inspection	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
Normal	B-labvalue
.	O

History	O
of	O
Osteopenia	O
733	O
.	O
90	O

She	O
is	O
monogamous	O
with	O
a	O
male	O
partner	O
.	O
Depo	O
shots	B-form
for	O
birth	O
control	O
.	O

Review	O
of	O
Systems	O

No	B-negation
current	B-temporal
complaints	O
.	O

Genitourinary	O
:	O
no	B-negation
dysuria	O
,	O
no	B-negation
incontinence	O
,	O
no	B-negation
pelvic	B-bodyloc
pain	O
,	O
no	B-negation
dysmenorrhea	O
,	O
no	B-negation
vaginal	O
discharge	O
and	O
no	B-negation
unexplained	O
vaginal	B-bodyloc
bleeding	O
.	O

Examination	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue
.	O

Metabolic	O
screening	O
includes	O
last	O
DEXA	O
done	B-labvalue
2011	I-labvalue
.	O

;	O
Mar	B-temporal
4	I-temporal
2013	I-temporal
9	B-temporal
:	I-temporal
49PM	I-temporal
(	O
Author	O
)	O

History	O
of	O
Knee	O
Replacement	O

HOSPITAL	O
COURSE	O
:	O
Dr	O
.	O
ABC	O
apparently	O
could	O
not	O
advance	O
the	O
scope	O
into	O
the	O
cecum	O
and	O
therefore	O
warranted	O
a	O
barium	O
enema	O
.	O

Breast	O
cancer	O
screening	O
includes	O
last	O
mammogram	O
done	B-temporal
10	I-temporal
/	I-temporal
2012andmonthly	I-temporal
self	O
breast	O
examinations	O
.	O

ID	O
:	O
Post	O
-	O
operatively	O
,	O
the	O
patient	O
was	O
started	O
on	O
IV	B-route
cefazolin	O
,	O
then	O
switched	O
to	O
PO	B-route
cefadroxil	O
upon	O
discharge	O
.	O

2	O
.	O

Vitals	O
10Feb2014	B-temporal
08	B-temporal
:	I-temporal
34AM	I-temporal
Systolic	O
96	B-labvalue
,	O
RUE	O
Diastolic	O
60	B-labvalue
,	O
RUE	O
Temperature	O
97	B-labvalue
.	I-labvalue
6	I-labvalue
F	I-labvalue
,	O
Oral	O
Heart	O
Rate	O
60	B-labvalue
,	O
R	O
Radial	O

Symptoms	O
:	O
Denies	B-negation
chest	B-bodyloc
pain	O
,	O
denies	B-negation
intermittent	O
leg	B-bodyloc
claudication	O
,	O
denies	B-negation
muscle	B-bodyloc
pain	O
,	O
denies	B-negation
muscle	B-bodyloc
weakness	O
and	O
denies	O
.	O

Current	O
Meds	O
Hydrocortisone	O
1	B-strength
%	I-strength
External	B-route
Cream	B-form
;	O
APPLY	O
SPARINGLY	O
TO	O
AFFECTED	O
AREA	B-frequency
TWICE	I-frequency
DAILY	I-frequency
BUT	O
DO	O
NOT	O
USE	O
FOR	O
MORE	O
THAN	O
7	O
DAYS	O
IN	O
A	O
ROW	O
;	O
Therapy	O
:	O
14Oct2013	B-temporal
to	O
(	O
Evaluate	O
:	O
17Feb2014	B-temporal
)	O
Requested	O
for	O
:	O
06Jan2014	B-temporal
;	O
Last	O
Rx	O
:	O
06Jan2014	B-temporal

Hematologic	O
/	O
Lymphatic	O
:	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
,	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
,	O
no	B-negation
swollen	O
glands	B-bodyloc
and	O
no	B-negation
swollen	O
glands	B-bodyloc
in	O
the	O
neck	B-bodyloc
.	O

Dizziness	O
780	O
.	O
4	O

The	O
patient	O
states	O
she	O
has	O
been	O
doing	O
poorly	O
with	O
her	O
Type	O
II	O
Diabetes	O
control	O
since	O
the	O
last	O
visit	O
.	O

History	O
of	O
Shoulder	O
Surgery	O

Home	O
monitoring	O
:	O
The	O
patient	O
is	O
not	B-negation
checking	I-negation
blood	O
pressure	O
at	O
home	O
.	O

What	O
I	O
cannot	O
explain	O
is	O
why	O
her	O
glucoses	O
have	O
not	O
really	O
climbed	O
at	O
all	O
despite	O
the	O
decrease	O
in	O
insulin	O
.	O

Surrounding	O
Tissue	O
:	O
non	O
-	O
tender	O
.	O

Skin	B-bodyloc
Condition	O
709	O
.	O
9	O

Pupils	O
were	O
equal	O
in	O
size	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
.	O
The	O
right	O
pupil	O
was	O
normal	O
.	O
The	O
left	O
pupil	O
was	O
normal	O
.	O

Maternal	B-subject
grandfather	I-subject
'	I-subject
s	I-subject
history	O
of	O
Congenital	O
Heart	B-bodyloc
Disease	O

The	O
patient	O
presents	O
to	O
the	O
office	O
today	O
with	O
left	B-bodyloc
knee	I-bodyloc
pain	O
.	O

Keywords	O
:	O

She	O
was	O
evaluated	O
by	O
Dr	O
.	O
X	O
and	O
Dr	O
.	O
Y	O
and	O
a	O
decision	O
was	O
made	O
to	O
proceed	O
with	O
preoperative	O
chemotherapy	O
.	O

Hearing	O
right	O
ear	O
:	O
.	O

History	O
of	O
Acute	B-course
Upper	B-bodyloc
Respiratory	I-bodyloc
Infection	O
465	O
.	O
9	O

Requested	O
for	O
:	O
21Jul2011	B-temporal
;	O
Last	O
Rx	O
:	O
21Jul2011	B-temporal

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Diffuse	O
Nontoxic	O
Goiter	O
240	O
.	O
9	O

Ext	O
:	O
warm	O
,	O
no	B-negation
edema	O
,	O
no	B-negation
varicosities	O
Pulses	O
:	O
2	B-labvalue
+	I-labvalue
distally	I-labvalue
Neuro	O
:	O
nonfocal	O

Aloergies	O
and	O
Adverse	O
Reactions	O

Conjunctiva	O
:	O
.	O

Psychiatric	O

WWE	O
labs	O
&	O
retail	O
refiils	O

Gynecologic	O
Services	O
Intrauterine	O
Device	O
(	O
IUD	O
)	O
Removal	O
V25	O
.	O
12	O

Level	O
of	O
Consciousness	O
:	O
Alert	O
and	O
interactive	O

2	O
.	O

The	O
patient	O
reports	O
doing	O
well	O
.	O

Heart	O
:	O
S1	O
,	O
S2	O
heard	B-labvalue
,	O
no	B-negation
murmers	O
Lungs	O
:	O
crackles	O
bilateral	B-bodyloc
lungs	I-bodyloc
Abdomen	O
:	O
soft	O
,	O
nontender	O
BS	O
+	B-labvalue
Extremity	O
:	O
bilateral	B-bodyloc
lower	I-bodyloc
extremity	I-bodyloc
pitting	O
edema	O
2	O
+	O
,	O
no	B-negation
redness	O
,	O
warmth	O
,	O
equal	O
in	O
size	O
,	O
dry	O
,	O
bruises	O
,	O
bleeding	O
,	O
left	B-bodyloc
upper	I-bodyloc
extremity	I-bodyloc
swelling	O
2	O
+	O
pitting	O
edema	O
,	O
pulses	O
faintly	O
palpable	O
all	O
extremities	B-bodyloc

Plan	O
[	O
L	O
]	O
Drawing	O
Fee	O
Requested	O
for	O
:	O
03Apr2014	B-temporal

Palpation	O
of	O
lymph	O
nodes	O
in	O
neck	O
:	O
Normal	B-labvalue
.	O

ITs	O
resected	O
.	O

Psychiatric	O
:	O
no	B-negation
anxiety	O
and	O
no	B-negation
depression	O
.	O

Exforge	O
10	B-strength
-	I-strength
160	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
16Sep2013	B-temporal
)	O
to	O

I	O
had	O
the	O
pleasure	O
of	O
evaluating	O
your	O
patient	O
,	O
EDWARD	O
JAMES	O
MORALES	O
.	O

Examination	O
of	O
reflexes	O
:	O
Normal	B-labvalue
.	O

Cortical	O
function	O
:	O
Normal	B-labvalue
.	O

APT	O
808	O

DEXA	O
:	O
2010	B-temporal

[	O
LH	O
]	O
CBC	O
(	O
without	O
differential	O
)	O
Requested	O
for	O
:	O
12Sep2012	B-temporal

Inspection	O
of	O
the	O
nasal	O
mucosa	O
,	O
septum	O
and	O
turbinates	O
:	O
Normal	B-labvalue
.	O

17Nov2011	O
04	O
:	O
08PM	O

Norvasc	O
5	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
21Feb2013	B-temporal
)	O
to	O

Neurological	O
:	O
no	B-negation
dizziness	O
.	O

2	O
.	O

Thyroid	O
midline	O
,	O
non	B-negation
enlarged	O
.	O

Other	O
treatments	O
(	O
past	B-temporal
12	I-temporal
months	I-temporal
)	O
:	O
Nasal	B-route
saline	O
sprays	B-form

Family	B-subject
history	O
of	O
Hypertension	O

Eyes	O

History	O
of	O
Preterm	O
Infant	O
765	O
.	O
10	O

History	O
of	O
Alcohol	O
Use	O

Complications	O
:	O
None	B-negation
.	O

History	O
of	O
Inguinal	O
Hernia	O
Repair	O

Neurological	O
:	O
no	B-negation
confusion	O
,	O
no	B-negation
convulsions	O
,	O
no	B-negation
dizziness	O
,	O
no	B-negation
fainting	O
,	O
no	B-negation
limb	B-bodyloc
weakness	O
and	O
no	B-negation
difficulty	O
walking	O
.	O

Neurological	O
:	O
no	B-negation
dizziness	O
.	O

Flex	O
.	O

Her	B-subject
daughter	I-subject
had	O
simlilar	O
symptoms	O
which	O
have	O
now	B-temporal
resolved	B-course
with	O
supportive	O
care	O
.	O

Past	O
Medical	O
History	O
:	O

Discussion	O
/	O
Discussion	O
/	O
Summary	O

Encouraged	O
to	O
exercise	O
.	O

Weight	O
:	O
141	B-labvalue
lb	I-labvalue

;	O
Aug	B-temporal
16	I-temporal
2013	I-temporal
1	B-temporal
:	I-temporal
27PM	I-temporal
(	O
Co	O
-	O
author	O
)	O

Neurological	O
:	O
no	B-negation
confusion	O
.	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Respiratory	O
:	O
cough	O
,	O
but	O
no	O
shortness	O
of	O
breathand	O
no	B-negation
wheezing	O
.	O

Well	O
developed	O
,	O
appears	O
healthy	O
,	O
well	O
nourished	O
,	O
within	O
normal	O
limits	O
of	O
ideal	O
weight	O
,	O
well	O
hydrated	O
and	O
appearance	O
reflects	O
stated	O
age	O
.	O

DISCHARGE	O
INSTRUCTIONS	O
:	O
The	O
patient	O
is	O
to	O
be	O
transferred	O
to	O
ABCD	O
after	O
open	O
reduction	O
and	O
internal	O
fixation	O
of	O
right	B-bodyloc
tibial	I-bodyloc
plateau	I-bodyloc
fracture	O
and	O
partial	O
medial	O
meniscectomy	O
.	O

Examination	O
of	O
gait	O
and	O
station	O
:	O
Normal	B-labvalue
.	O

Examination	O
of	O
the	O
head	O
and	O
face	O
:	O
Normal	B-labvalue
.	O

Examination	O
of	O
the	O
head	O
and	O
face	O
:	O
Normal	B-labvalue

Cath	O
:	O
NEVER	B-negation

Healthcare	O
Providers	O

Alkaline	O
Phosphatase	O
,	O
S	O
:	O
75	B-labvalue
IU	I-labvalue
/	I-labvalue
L	I-labvalue
Reference	O
Range	O
44	B-reference_range
-	I-reference_range
102	I-reference_range

Chest	O
:	O
Normal	O
.	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

Cortical	O
function	O
:	O
Normal	B-labvalue

Physical	O
exam	O
is	O
within	O
normal	B-labvalue
limits	O
with	O
a	O
taut	O
normal	O
size	O
uterus	O
and	O
a	O
small	O
cervix	B-bodyloc
,	O
status	O
post	O
cone	O
biopsy	O
.	O

on	O
glyburide	O
/	O
metformin	O
5	B-strength
/	I-strength
500	I-strength
mg	I-strength
1	B-dosage
qam	B-frequency
and	O
2	B-dosage
qhs	B-frequency

Inspection	O
of	O
the	O
conjunctiva	O
and	O
lids	O
:	O
Normal	B-labvalue

Furosemide	O
20	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
2	B-dosage
TABLETS	B-form
BY	B-route
MOUTH	I-route
EVERY	B-frequency
MORNING	I-frequency
;	O
Therapy	O
:	O
04Apr2011	B-temporal
to	O
(	O
Evaluate	O
:	O
25Feb2013	B-temporal
)	O
Requested	O
for	O
:	O
27Dec2012	B-temporal
;	O
Last	O
Rx	O
:	O
27Nov2012	B-temporal

ENT	O
:	O
no	B-negation
earache	O
,	O
no	B-negation
hearing	O
loss	O
,	O
no	B-negation
epistaxis	O
,	O
no	B-negation
nasal	B-bodyloc
discharge	O
,	O
no	B-negation
sore	O
throat	B-bodyloc
and	O
no	B-negation
hoarseness	O
.	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
groin	O
:	O
No	B-negation
lymphadenopathy	O
.	O

Mood	O
and	O
Affect	O
:	O
appropriate	B-labvalue
mood	I-labvalue
and	I-labvalue
appropriate	I-labvalue
affect	I-labvalue
.	O

True	O
Vocal	O
Folds	O
:	O
immobile	O
at	O
right	O
and	O
normal	O
color	O
.	O

Eyes	O
:	O
no	B-negation
eye	B-bodyloc
pain	O
,	O
eyes	B-bodyloc
not	B-negation
red	O
,	O
no	B-negation
eyesight	O
problems	O
,	O
no	B-negation
purulent	O
discharge	O
from	O
the	O
eyes	B-bodyloc
,	O
no	B-negation
dryness	O
of	O
the	O
eyes	B-bodyloc
and	O
no	B-negation
itching	O
of	O
the	O
eyes	B-bodyloc
.	O

Electronically	O
signed	O
by	O
:	O
SAMER	O
FAKHRI	O
,	O
M	O
.	O
D	O
.	O

The	O
patient	O
is	O
currently	B-temporal
asymptomatic	O
.	O

Cranial	O
nerves	O
II	O
:	O
visual	O
acuity	O
and	O
visual	O
fields	O
were	O
intact	B-labvalue
.	O

Age	O
at	O
menarche	O
was	O
14	O
.	O

He	O
has	O
seen	O
Dr	O
.	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
.	O

16	B-temporal
:	I-temporal
33	I-temporal

The	O
abdomen	O
was	O
soft	O
and	O
nontender	O
.	O

Prior	O
pregnancies	O
:	O
.	O

Ears	O
,	O
Nose	O
,	O
Mouth	O
and	O
Throat	O

Seems	O
to	O
be	O
improving	B-course
)	O
,	O
joint	O
stiffnessandlimb	O
pain	O
,	O
but	O
no	B-negation
arthralgias	O
,	O
no	B-negation
joint	B-bodyloc
swelling	O
and	O
no	B-negation
limb	B-bodyloc
swelling	O
.	O

He	O
is	O
missing	O
several	O
teeth	B-bodyloc
.	O

Inspection	O
of	O
the	O
nasal	O
mucosa	O
,	O
septum	O
and	O
turbinates	O
:	O
Normal	B-labvalue
.	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

She	O
lost	O
3	O
-	O
lbs	O
.	O

Family	O
History	O
1	O
.	O

Denied	O

Previous	O
Surgery	O
:	O
Yes	O
.	O

Heme	O
/	O
Lymph	O
:	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
,	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
and	O
no	B-negation
swollen	O
glands	B-bodyloc
.	O

Benign	O
Pigmented	O
Nevus	O
216	O
.	O
9	O

Chief	O
Complaint	O

The	O
patient	O
is	O
doing	O
well	O
with	O
his	O
diabetes	O
goals	O
.	O

;	O
Jun	B-temporal
18	I-temporal
2013	I-temporal
1	B-temporal
:	I-temporal
05PM	I-temporal
(	O
Author	O
)	O

Results	O
/	O
Results	O
/	O
Data	O

Tdap	O
after	O
20	O
weeks	O
.	O

Examination	O
of	O
liver	O
and	O
spleen	O
:	O
Normal	B-labvalue
.	O

No	B-negation
masses	O
palpated	O
.	O

0	I-reference_range
Eosinophils	O
#	O
0	B-labvalue
.	I-labvalue
3	I-labvalue
K	I-labvalue
/	I-labvalue
CMM	I-labvalue
0	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
0	I-reference_range
.	I-reference_range

Appears	O
healthy	O
,	O
within	O
normal	O
limits	O
of	O
ideal	O
weight	O
,	O
well	O
hydratedandappearance	O
reflects	O
stated	O
age	O
.	O

Bone	O
density	O
study	O
was	O
performed	O
.	O

The	O
injury	O
resulted	O
from	O
a	O
direct	O
blow	O
.	O

"	O
History	O
of	O
Drug	O
Use	O

Examination	O
of	O
thyroid	O
:	O
Normal	B-labvalue
.	O

discussed	O
with	O
the	O
patient	O
'	O
s	O
family	O
follow	O
-	O
up	O
PRN	O

Ordered	O
;	O
For	O
:	O
Chronic	B-course
Frontal	B-bodyloc
Sinusitis	O
(	O
473	O
.	O
1	O
)	O
,	O
Chronic	B-course
Ethmoidal	B-bodyloc
Sinusitis	O
(	O
473	O
.	O
2	O
)	O
;	O
Ordered	O
By	O
:	O
LEE	O
,	O
PAUL	O
Performed	O
:	O
Due	O
:	O
01Sep2011	B-temporal
;	O
Last	O
Updated	O
By	O
:	O
Hinojosa	O
,	O
Lorena	O

ER	O
f	O
/	O
u	O
for	O
cluster	O
headaches	O
-	O
patient	O
received	O
CT	O
head	O
at	O
LBJ	O
and	O
reported	O
negative	B-labvalue
per	O
patient	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
constipation	O
and	O
no	B-negation
diarrhea	O
.	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
vomiting	O
and	O
no	B-negation
diarrhea	O
.	O

Review	O
of	O
Systems	O

She	O
continues	O
to	O
se	O
Dr	O
.	O
Nasir	O
in	O
Pain	O
Clinic	O
.	O

Lips	O
,	O
teeth	O
,	O
and	O
gums	O
:	O
Normal	B-labvalue
.	O

Cardiovascular	O

no	B-negation
CVA	O
tenderness	O

She	O
states	O
her	O
pain	O
is	O
well	B-course
-	I-course
controlled	I-course
.	O

Eyes	O
:	O
no	B-negation
eye	B-bodyloc
pain	O
,	O
eyes	B-bodyloc
not	B-negation
red	O
,	O
no	B-negation
eyesight	B-bodyloc
problems	O
,	O
no	B-negation
purulent	O
discharge	O
from	O
the	O
eyes	B-bodyloc
,	O
no	B-negation
dryness	O
of	O
the	O
eyes	B-bodyloc
and	O
no	B-negation
itching	O
of	O
the	O
eyes	B-bodyloc
.	O

Advised	O
trial	O
of	O
Indomethacin	O
.	O

Musculoskeletal	O

Active	O
Problems	O
Diabetes	O
Mellitus	O
Poorly	O
Controlled	O
250	O
.	O
00	O

Mucinex	O
600	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
Extended	I-form
Release	I-form
12	I-form
Hour	I-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
TWICE	B-frequency
DAILY	I-frequency
AS	B-frequency
NEEDED	I-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
10Dec2013	B-temporal
)	O
to	O

Heart	O
sounds	O
:	O
normal	B-labvalue
S1	O
,	O
normal	B-labvalue
S2	O
,	O
no	B-negation
S3	O
and	O
no	B-negation
S4	O
.	O

Pap	O
/	O
mamm	O
.	O

History	O
of	O
Hypertension	O
401	O
.	O
9	O

Social	O
History	O
Problems	O

Attending	O
Note	O

The	O
heart	O
rate	O
was	O
normal	B-labvalue
.	O

3	O
.	O

4	O
.	O

Counseling	O
/	O
Counseling	O
/	O
Edu	O
Diet	O
recommendations	O
:	O
high	O
fiber	O
diet	O
.	O

1	O
.	O

Past	O
Medical	O
History	O
History	O
of	O
Benign	O
Neoplasm	O
Of	O
The	O
Large	O
Intestine	O
211	O
.	O
3	O

Ethmoid	O
sinuses	O
:	O
non	O
-	O
tender	O
on	O
the	O
right	O
and	O
non	O
-	O
tender	O
on	O
the	O
left	O
.	O

[	O
QLH	O
]	O
CBC	O
(	O
INCLUDES	O
DIFF	O
/	O
PLT	O
)	O
Status	O
:	O
Complete	O
Done	O
:	O
21Mar2013	B-temporal

With	O
these	O
new	O
changes	O
his	O
headaches	O
have	O
nearly	O
resolved	B-course
.	O

No	B-negation
JVD	O
.	O

Assessment	O
of	O
respiratory	O
effort	O
:	O
Abnormal	O
.	O
Decreased	O
respiratory	B-bodyloc
effort	O
.	O

no	B-negation
axillary	O
lad	O
.	O

Social	O
History	O
Never	O
A	O
Smoker	O

LEUKOCYTES	O
:	O
-	O

He	O
now	O
reports	O
headaches	O
once	O
weekly	O
,	O
only	O
occuring	O
after	O
being	O
outside	O
in	O
the	O
heat	O
.	O

Results	O
/	O
Results	O
/	O
Data	O

Will	O
decrease	O
pm	B-frequency
NPH	O
to	O
10	B-dosage
units	I-dosage
and	O
monitor	O
closely	O
.	O

Will	O
await	O
labs	O
and	O
continue	O
FE	O
for	O
time	O
being	O
.	O

General	O
Health	O
:	O

He	O
still	O
gets	O
a	O
lightheaded	O
sensation	O
of	O
vertical	O
movement	O
and	O
occasional	O
ringing	O
in	O
the	O
right	B-bodyloc
ear	I-bodyloc
triggered	O
by	O
movement	O
.	O

Orientation	O
to	O
person	O
,	O
place	O
and	O
time	O
:	O
Normal	B-labvalue
.	O

Palpation	O
of	O
the	O
face	O
and	O
sinuses	O
:	O
Normal	B-labvalue
.	O

Therapy	O
is	O
based	O
on	O
measurement	O
of	O
Total	O
25	O
-	O
OHD	O
,	O

Patient	O
is	O
requesting	O
medictaion	O
to	O
help	O
with	O
his	O
erectile	B-bodyloc
dysfunction	O
.	O

The	O
abdomen	O
was	O
soft	O
and	O
nontender	O
.	O

No	B-negation
rales	O
or	O
crackles	O
were	O
heard	O
.	O

BUN	O
14	B-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
7	B-reference_range
-	I-reference_range
22	I-reference_range

IPV	O
;	O
11/09/2007	B-temporal

At	B-temporal
the	I-temporal
time	I-temporal
of	I-temporal
discharge	I-temporal
,	O
blood	O
glucose	O
levels	O
were	O
not	B-labvalue
being	I-labvalue
stable	I-labvalue
for	I-labvalue
24	I-labvalue
hours	I-labvalue
.	O

health	O
maintenance	O
evaluation	O
.	O

Head	O
and	O
Face	O

Social	O
History	O
Never	O
A	O
Smoker	O

Appears	O
healthy	O
,	O
well	O
nourished	O
and	O
well	O
hydrated	O
.	O

HDL	O
Cholesterol	O
99	B-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
>	B-reference_range
=35	I-reference_range

4	O
.	O

Examination	O
of	O
the	O
oropharynx	O
:	O
Normal	B-labvalue

Constitutional	O

Constitutional	O
:	O
no	B-negation
fever	O
and	O
no	B-negation
chills	O
.	O

Date	O
of	O
Visit	O
:	O
Jul	B-temporal
24	I-temporal
,	I-temporal
2013	I-temporal

ACTIVE	O
-	O
Retrospective	O
Authorization	O
;	O
Edited	O

He	O
denies	B-negation
polydipsia	O
,	O
polyuria	O
,	O
but	O
has	O
occasional	O
nocturia	O
.	O

Constitutional	O
:	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
,	O
not	B-negation
feeling	O
poorly	O
(	O
malaise	O
)	O
,	O
not	B-negation
feeling	O
tired	O
(	O
fatigue	O
)	O
,	O
no	B-negation
recent	B-temporal
weight	O
gain	O
and	O
no	B-negation
recent	B-temporal
weight	O
loss	O
.	O

Genitourinary	O
:	O
no	B-negation
dysuria	O
and	O
no	B-negation
incontinence	O
.	O

ProAir	O
HFA	O
108	B-strength
(	I-strength
90	I-strength
Base	I-strength
)	I-strength
MCG	I-strength
/	I-strength
ACT	I-strength
Inhalation	B-route
Aerosol	B-form
Solution	I-form
;	O
INHALE	B-route
2	B-dosage
PUFFS	B-form
EVERY	B-frequency
4	I-frequency
-	I-frequency
6	I-frequency
HOURS	I-frequency
,	O
SPACED	O
60	O
SECONDS	O
APART	O
;	O
Therapy	O
:	O
24Mar2014	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
24Mar2014	B-temporal
)	O
Requested	O
for	O
:	O
24Mar2014	B-temporal
;	O
Edited	O

Complications	O
:	O
coronary	B-bodyloc
artery	I-bodyloc
disease	O
,	O
but	O
no	B-negation
peripheral	O
neuropathy	O
,	O
no	B-negation
peripheral	B-bodyloc
vascular	I-bodyloc
disease	O
,	O
no	B-negation
gastroparesis	O
,	O
no	B-negation
nephropathy	O
and	O
no	B-negation
retinopathy	O
.	O

Carotid	O
pulses	O
:	O
Normal	O
.	O

Constitutional	O
:	O
feeling	O
tired	O
(	O
fatigue	O
)	O
.	O

Tympanic	O
membranes	O
are	O
clear	O
.	O

Family	O
History	O
Paternal	B-subject
grandfather	I-subject
'	I-subject
s	I-subject
history	O
of	O
Adenocarcinoma	O
Of	O
The	O
Lung	B-bodyloc
V16	O
.	O
1	O

OXcarbazepine	O
150	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
2	B-dosage
TABLETS	B-form
TWICE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
08Jun2012	B-temporal
to	O
(	O
Evaluate	O
:	O
03Jun2013	B-temporal
)	O
Requested	O
for	O
:	O
08Jun2012	B-temporal
;	O
Last	O
Rx	O
:	O
08Jun2012	B-temporal

Surgical	O
History	O
History	O
of	O
Hernia	O
Repair	O

Associated	O
symptoms	O
:	O
no	B-negation
myalgias	O
,	O
no	B-negation
paresthesias	O
,	O
no	B-negation
depression	O
,	O
no	B-negation
leg	B-bodyloc
swelling	O
,	O
no	B-negation
weight	O
loss	O
and	O
no	B-negation
palpitations	O

Examination	O
of	O
the	O
abdomen	O
:	O
Normal	B-labvalue
Bowel	O
sounds	O
were	O
normal	B-labvalue
.	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
,	O
no	B-negation
cough	O
andseasonal	O
allergies	O
.	O

Surgical	O
History	O

Examination	O
of	O
pupils	O
and	O
irises	O
:	O
Normal	B-labvalue

Inspection	O
of	O
the	O
conjunctiva	O
and	O
lids	O
:	O
Normal	B-labvalue
.	O

Hematologic	O
/	O
Lymphatic	O
:	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
,	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
,	O
no	B-negation
swollen	O
glands	B-bodyloc
and	O
no	B-negation
swollen	O
glands	B-bodyloc
in	O
the	O
neck	B-bodyloc
.	O

Birth	O
Weight	O
:	O
5lbs	B-labvalue
,	O
5lbs	O
,	O
5lbs	O
,	O
1oz	O

She	O
also	O
has	O
trouble	O
with	O
anxiety	O
,	O
and	O
is	O
seeing	O
a	O
psychiatrist	O
.	O

The	O
abdomen	O
was	O
soft	O
and	O
nontender	O
.	O

Active	O
Problems	O
Benign	B-severity
Essential	O
Hypertension	O
401	O
.	O
1	O

Physical	O
Exam	O

Recent	O
menstrual	O
periods	O
:	O
.	O

Neurological	O
:	O
no	B-negation
confusion	O
,	O
no	B-negation
dizziness	O
,	O
no	B-negation
limb	B-bodyloc
weakness	O
and	O
no	B-negation
difficulty	O
walking	O
.	O

Gestational	O
age	O
:	O
37	O
weeks	O
.	O

Proctitis	O
569	O
.	O
49	O

Physical	O
Exam	O

Musculoskeletal	O

Examination	O
of	O
thyroid	O
:	O
Normal	B-labvalue
.	O

The	O
abdomen	O
was	O
flat	O
.	O

Gestational	O
age	O
:	O
34	O
weeks	O
.	O

"	O
History	O
of	O
Alcohol	O
Use	O

Edited	O

Soleus	O
(	O
tib	O
.	O
)	O
:	O
Normal	O
.	O

Omeprazole	O
40	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
Delayed	I-form
Release	I-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
13Oct2011	B-temporal
to	O
(	O
Evaluate	O
:	O
11Feb2012	B-temporal
)	O
Requested	O
for	O
:	O
12Jan2012	B-temporal
;	O
Last	O
Rx	O
:	O
12Jan2012	B-temporal

Results	O
/	O
Results	O
/	O
Data	O
All	O
Results	O
[	O
Data	O
Includes	O
:	O
Current	O
Encounter	O
]	O

OTC	O
regimen	O
,	O
patient	O
given	O
illness	O
precaution	O
for	O
blood	O
loss	O
-	O
and	O
h	O
/	O
H	O
was	O
sent	O

[	O
QLH	O
]	O
HEMOGLOBIN	O
A1c	O
Requested	O
for	O
:	O
29Nov2011	B-temporal

Physical	O
Exam	O

No	B-negation
masses	O
palpated	O
.	O

CTA	O
,	O
chest	O
PE	O
study	O
showing	O
no	B-negation
evidence	I-negation
for	O
pulmonary	B-bodyloc
embolism	O
.	O

supply	O
;	O
Therapy	O
:	O
16Dec2009	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
16Dec2009	B-temporal
)	O
Requested	O
for	O
:	O
16Dec2009	B-temporal

Examination	O
of	O
gait	O
and	O
station	O
:	O
Normal	B-labvalue
.	O

Mood	O
and	O
Affect	O
:	O
appropriate	O
affect	O
,	O
anxious	O
and	O
not	B-negation
depressed	O
.	O

;	O
Jul	B-temporal
2	I-temporal
2012	I-temporal
1	B-temporal
:	I-temporal
34PM	I-temporal
(	O
Author	O
)	O

Delivery	O
type	O
:	O
cesarean	O
delivery	O
.	O

f	O
MetFORMIN	O
HCl	O
ER	O
500	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
Extended	I-form
Release	I-form
24	O
Hour	O
;	O
TAKE	O
4	B-dosage
TABLET	O
DAILY	B-frequency
;	O
Start	O
Date	O
:	O
02/15/2013	B-temporal
(	O
Active	O
)	O

Temperature	O
:	O
98	B-labvalue
.	I-labvalue
3	I-labvalue
F	I-labvalue
,	O
Oral	O

Methocarbamol	O
500	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Take	O
one	B-dosage
tab	B-form
po	B-route
BID	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
29Oct2012	B-temporal
)	O
to	O

Eyes	O
:	O
the	O
pupils	O
were	O
equal	O
in	O
size	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
.	O

BUTTOCK	O
AND	O
THIGH	O
.	O

f	O
Cervical	B-bodyloc
Incompetence	O
(	O
Obstetric	O
)	O
-	O
Antepartum	O
Condition	O
Or	O
Complication	O
(	O
654	O
.	O
53	O
)	O
;	O
(	O
Active	O
)	O

CARDIOVASCULAR	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
and	O
not	O
expressed	O
as	O
feeling	O
short	O
of	O
breath	O
.	O

CONSTITUTIONAL	O
:	O
no	B-negation
nausea	O
,	O
no	B-negation
recent	B-temporal
weight	O
gain	O
,	O
no	B-negation
recent	B-temporal
weight	O
loss	O
,	O
no	B-negation
fever	O
and	O
no	B-negation
chills	O

HPI	O
g2	O

Deep	O
tendon	O
reflexes	O
intact	B-labvalue
,	O
primitive	O
reflects	O
were	O
absent	B-labvalue
.	O

Vitals	O
18Apr2014	B-temporal
03	B-temporal
:	I-temporal
08PM	I-temporal
18Apr2014	B-temporal
02	B-temporal
:	I-temporal
17PM	I-temporal
BMI	O
Calculated	O
40	B-labvalue
.	I-labvalue
68	I-labvalue
BSA	O
Calculated	O
2	B-labvalue
.	I-labvalue
21	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
6	I-labvalue
in	I-labvalue
Weight	O
253	B-labvalue
lb	I-labvalue
2	I-labvalue
oz	I-labvalue
Systolic	O
120	B-labvalue
117	I-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
76	B-labvalue
81	I-labvalue
,	O
LUE	O
,	O
Sitting	O
Temperature	O
96	B-labvalue
.	I-labvalue
5	I-labvalue
F	I-labvalue
,	O
Tympanic	O
Heart	O
Rate	O
78	B-labvalue
Respiration	O
16	B-labvalue
Respiration	O
Quality	O
Normal	B-labvalue

RECOMMENDATIONS	O
&	O
TREATMENT	O
PLAN	O
:	O
1	O
)	O
The	O
patient	O
was	O
given	O
DexPak	O
Jr	O
.	O
10	B-duration
Day	I-duration
TaperPac	O
.	O

CurrentMeds	O
_	O
4	O
_	O
twCiteListControlStart	O
Aciphex	O
20	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
Delayed	I-form
Release	I-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	B-temporal
26Oct2012	I-temporal
)	O
to	O

eGFR	O
AFRICAN	O
AMERICAN	O
106	B-labvalue
ML	I-labvalue
/	I-labvalue
MIN	I-labvalue
/	I-labvalue
1	I-labvalue
.	I-labvalue
7	I-labvalue
>	B-reference_range
OR	I-reference_range
=	I-reference_range
60	I-reference_range

UTP	O
-	O
Discussion	O
/	O

Examination	O
of	O
the	O
abdomen	O
:	O
Normal	B-labvalue
.	O

f	O
POH	O
,	O
Provider	O
:	O
SABONGHY	O
,	O
ERIC	O
,	O
Status	O
:	O
Pen	O
,	O
Time	O
:	O
10	B-temporal
:	I-temporal
50	I-temporal
AM	I-temporal
03/08/2013	B-temporal

-	O
cont	O
Atorvastatin	O
20	B-strength
mg	I-strength
po	B-route
dailly	B-frequency

Symptoms	O
:	O
shoulder	B-bodyloc
stiffness	O
.	O

Chest	O
:	O
Normal	O
.	O

Kidney	B-bodyloc
stones	O
and	O
possible	O
balanitis	O
:	O
Patient	O
seen	O
by	O
urology	O
and	O
24	O
hour	O
urine	O
collection	O
was	O
performed	O
.	O

Inspection	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
Normal	B-labvalue

Multi	O
For	O
Her	O
50	O
+	O
CAPS	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
31Oct2013	B-temporal
)	O
to	O

Examination	O
of	O
thyroid	O
:	O
Normal	B-labvalue
.	O

MethylPREDNISolone	O
Acetate	O
80	B-strength
MG	I-strength
/	I-strength
ML	I-strength
Injection	B-form
Suspension	I-form
;	O
1	B-dosage
.	I-dosage
5	I-dosage
ml	I-dosage
=	O
120mg	B-dosage
;	O
Done	O
:	O
09Jan2014	B-temporal
11	B-temporal
:	I-temporal
59AM	I-temporal
;	O
Status	O
:	O
COMPLETE	O

;	O
Jan	B-temporal
12	I-temporal
2012	I-temporal
10	B-temporal
:	I-temporal
22AM	I-temporal
(	O
Author	O
)	O

[	O
QL	O
]	O
THYROID	O
PANEL	O
WITH	O
TSH	O
,	O
3RD	O
GENERATION	O
Requested	O
for	O
:	O
07Aug2013	B-temporal

UTP	O
-	O
Bronchitis	O
,	O

Comorbid	O
Illnesses	O
:	O
diabetes	O
mellitus	O
and	O
hypertension	O
.	O

twNoteSignatureControlStart	O
Electronically	O
signed	O
by	O
:	O
LOURICE	O
ABDELMELEK	O
,	O
M	O
.	O
D	O
.	O

Examination	O
of	O
the	O
abdomen	O
:	O
Normal	B-labvalue
The	O
abdomen	O
was	O
flat	O
.	O

Mometasone	O
Furoate	O
0	B-strength
.	I-strength
1	I-strength
%	I-strength
External	O
Cream	B-form
;	O
APPLY	O
SPARINGLY	O
TO	O
THE	O
AFFECTED	O
AREA	O
(	O
S	O
)	O
TWICE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
20Feb2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
19Aug2013	B-temporal
)	O
Requested	O
for	O
:	O
19Aug2013	B-temporal

Left	O
Quadriceps	O
.	O

Musculoskeletal	O
:	O
no	B-negation
arthralgias	O
and	O
no	B-negation
joint	B-bodyloc
pain	O
.	O

CeleBREX	O
CAPS	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
15Nov2012	B-temporal
)	O
to	O

[	O
QLH	O
]	O
HEMOGLOBIN	O
A1c	O
;	O
every	O
6	B-temporal
months	I-temporal
;	O
Last	O
03May2011	B-temporal
;	O
Next	O
29May2012	B-temporal
;	O
Status	O
:	O
Active	O

Endocrine	O
:	O
no	B-negation
muscle	B-bodyloc
weakness	O
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Mupirocin	O
2	B-strength
%	I-strength
External	B-form
Ointment	I-form
;	O
APPLY	O
A	O
SMALL	O
AMOUNT	O
3	B-frequency
TIMES	I-frequency
DAILY	I-frequency
AS	O
DIRECTED	O
;	O
Therapy	O
:	O
10Oct2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
10Oct2013	B-temporal
)	O
Requested	O
for	O
:	O
10Oct2013	B-temporal

Breath	O
sounds	O
were	O
diminished	B-labvalue
over	I-labvalue
the	I-labvalue
left	I-labvalue
midlung	I-labvalue
field	I-labvalue
.	O

8	O
.	O

History	O
of	O
Inguinal	B-bodyloc
Hernia	O
550	O
.	O
90	O

Social	O
History	O
Never	O
A	O
Smoker	O

Electronically	O
signed	O
by	O
:	O
RYAN	O
MURPHY	O
,	O
M	O
.	O
D	O
.	O

Current	O
Meds	O
Aspirin	O
EC	O
81	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
Delayed	I-form
Release	I-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
03Nov2011	B-temporal
)	O
to	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
groin	O
:	O
Normal	B-labvalue
.	O

Benign	B-severity
Essential	O
Hypertension	O
401	O
.	O
1	O

due	O
to	O
:	O
patient	O
did	O
not	O
come	O
to	O
our	O
facility	O
to	O
be	O
drawn	O

5	I-reference_range
Lymphocy	O
es	O
27	B-labvalue
.	I-labvalue
8	I-labvalue
%	I-labvalue
20	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
40	I-reference_range
.	I-reference_range

8	I-reference_range
Segmrt	O
rd	O
Neutrophils	O
55	B-labvalue
.	I-labvalue
7	I-labvalue
%	I-labvalue
45	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
75	I-reference_range
.	I-reference_range

The	O
patient	O
presents	O
with	O
complaints	O
of	O
dizziness	O
(	O
endorses	O
lightheadedness	O
for	O
1	B-temporal
week	I-temporal
duration	I-temporal
.	O

Inspection	O
of	O
breasts	O
:	O
Normal	B-labvalue

glut	O
.	O
)	O
:	O
Normal	O
.	O

Rinne	O
'	O
s	O
test	O
:	O
bone	O
conduction	O
persists	O
longer	O
than	O
air	O
conduction	O
on	O
the	O
right	O
.	O

Psychiatric	O

BCM	O
-	O
Pt	O
initially	O
desired	O
Mirena	O
,	O
but	O
given	O
h	O
/	O
o	O
chlamydia	O
pt	O
decided	O
against	O
IUD	O
after	O
being	O
counseled	O
on	O
risks	O
of	O
PID	O
.	O

nasal	O
endoscopy	O
today	B-temporal

Immunizatisps	O
_	O
0	O
_	O
twCiteListControlStart	O
1	O
Influenza	O
22May2012	B-temporal
Immunizatisps	O
_	O
0	O
_	O
twCiteListControlEnd	O
ImmunizatispsSectispEnd	O
HistisyofPreseptIllnessSectispStart	O
Histisy	O
of	O
Presept	O
Illness	O
51	O
yr	O
.	O

There	O
was	O
no	B-negation
jugular	B-bodyloc
-	I-bodyloc
venous	I-bodyloc
distention	O
.	O

History	O
of	O
Current	O
Smoker	O

Cardiovascular	O

Physical	O
Exam	O

Height	O
:	O
69	B-labvalue
.	I-labvalue
9	I-labvalue
cm	I-labvalue
,	O
Weight	O
:	O
7	B-labvalue
.	I-labvalue
6	I-labvalue
kg	I-labvalue
,	O
BMI	O
:	O
15	B-labvalue
.	I-labvalue
51	I-labvalue
,	O
BSA	O
:	O
0	B-labvalue
.	I-labvalue
37	I-labvalue
Temp	O
:	O
97	B-labvalue
.	I-labvalue
4	I-labvalue
F	I-labvalue
HC	O
:	O
45	B-labvalue
centimeter	I-labvalue
.	O
eg	O

Eyes	O
:	O
no	B-negation
eye	B-bodyloc
pain	O
,	O
eyes	B-bodyloc
not	B-negation
red	O
,	O
no	B-negation
eyesight	O
problems	O
,	O
no	B-negation
purulent	O
discharge	O
from	O
the	O
eyes	B-bodyloc
,	O
no	B-negation
dryness	O
of	O
the	O
eyes	B-bodyloc
and	O
no	B-negation
itching	O
of	O
the	O
eyes	B-bodyloc
.	O

The	O
patient	O
is	O
being	O
seen	O
for	O
a	O
routine	O
clinic	O
follow	O
-	O
up	O
of	O
essential	O
hypertension	O
.	O

RT	O

Associated	O
symptoms	O
:	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
,	O
no	B-negation
back	B-bodyloc
pain	O
,	O
no	B-negation
localized	O
numbness	O
and	O
no	B-negation
localized	O
weakness	O
.	O

F	O
/	O
u	O
with	O
GI	O

Type	O
I	O
Arnold	O
-	O
Chiari	O
Malformation	O
348	O
.	O
4	O

Plan	O

Immunotherapy	O
:	O
Never	B-negation

;	O
Oct	B-temporal
14	I-temporal
2013	I-temporal
6	B-temporal
:	I-temporal
17PM	I-temporal
(	O
Author	O
)	O

Instruments	O
:	O
Curved	O
suctions	O
.	O

HDL	O
Cholesterol	O
109	B-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
>	B-reference_range
=35	I-reference_range

[	O
QLH	O
]	O
Differential	O
23Feb2012	B-temporal
09	B-temporal
:	I-temporal
45AM	I-temporal
Hardwicke	O
,	O
Robin	O

Glimepiride	O
2	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
DAILY	B-frequency
WITH	I-frequency
BREAKFAST	I-frequency
;	O
Therapy	O
:	O
29Oct2012	B-temporal
to	O
(	O
Evaluate	O
:	O
31May2013	B-temporal
)	O
Requested	O
for	O
:	O
02Mar2013	B-temporal
;	O
Last	O
Rx	O
:	O
02Mar2013	B-temporal

Electronically	O
signed	O
by	O
:	O
MANNIE	O
MAGID	O
,	O
M	O
.	O
D	O
.	O

recently	B-temporal
stopped	O
supplement	O
and	O
fatigue	O
gets	O
better	O
.	O

Diovan	O
80	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
05Mar2013	B-temporal
)	O
to	O

Examination	O
of	O
the	O
head	O
and	O
face	O
:	O
Normal	B-labvalue
.	O

[	O
QLH	O
]	O
VITAMIN	O
B12	O
Requested	O
for	O
:	O
21Dec2011	B-temporal

Chest	O

Patient	O
notes	O
mild	B-severity
nausea	O
.	O

Examination	O
of	O
scrotal	O
contents	O
:	O
Normal	B-labvalue
.	O

Cranial	O
nerves	O
XI	O
:	O
shoulder	O
shrug	O
was	O
intact	B-labvalue
bilaterally	I-labvalue
.	O

UTP	O
-	O
Discussion	O
/	O
Pt	O
reports	O
abdmonal	B-bodyloc
pain	O
with	O
diarrhea	O
and	O
constipation	O
then	O
developed	O
L	O
back	B-bodyloc
and	O
L	B-bodyloc
abdominal	I-bodyloc
pain	O
.	O

Systolic	O
:	O
90	B-labvalue
,	O
RUE	O
,	O
Sitting	O

Weight	O
Loss	O
-	O
has	O
slowed	O
,	O
will	O
restart	O
Megace	O
PO	B-route
-	O
cont	O
.	O
diet	O
,	O
will	B-negation
not	I-negation
restart	O
Diabetes	O
Meds	O
for	O
now	O
-	O
but	O
asked	O
patient	O
to	O
check	O
his	O
FSBG	O

2	O
.	O

Bimanual	O
exam	O
findings	O
include	O
a	O
soft	O
cervix	O
,	O
but	O
no	B-negation
cervical	B-bodyloc
motion	O
tenderness	O
.	O

Examination	O
of	O
the	O
oropharynx	O
:	O
Normal	B-labvalue

VerifiedResults	O
_	O
0	O
_	O
twCiteListControlEnd	O
VerifiedResultsSectionEnd	O
SignaturesSectionStart	O
Signatures	O

Constitutional	O
:	O
not	B-negation
acting	O
fussy	O
and	O
no	B-negation
chills	O
.	O

Proprioception	O
was	O
normal	B-labvalue
.	O

History	O
of	O
Lumbago	O
724	O
.	O
2	O

No	B-negation
surrounding	O
erythema	O
,	O
no	B-negation
wound	O
discharge	O
.	O

Weight	O
:	O
146	B-labvalue
lb	I-labvalue

[	O
QLH	O
]	O
PARTIAL	O
THROMBOPLASTIN	O
TIME	O
,	O
ACTIVATED	O
Done	O
:	O
09Oct2012	B-temporal
10	B-temporal
:	I-temporal
51AM	I-temporal

2	O
.	O

Pedal	O
pulses	O
:	O
Normal	O
.	O

You	O
may	O
have	O
constipation	O
when	O
taking	O
narcotic	O
pain	O
medications	O
(	O
oxycodone	O
,	O
percocet	O
,	O
vicodin	O
,	O
hydrocodone	O
,	O
dilaudid	O
,	O
etc	O
.	O
)	O
;	O
you	O
should	O
continue	O
drinking	O
fluids	O
,	O
you	O
may	O
take	O
stool	O
softeners	O
,	O
and	O
should	O
eat	O
foods	O
that	O
are	O
high	O
in	O
fiber	O
.	O

Vitals	O
22Apr2013	B-temporal
08	B-temporal
:	I-temporal
29AM	I-temporal
BMI	O
Calculated	O
29	B-labvalue
.	I-labvalue
22	I-labvalue
BSA	O
Calculated	O
2	B-labvalue
.	I-labvalue
39	I-labvalue
Height	O
6	B-labvalue
ft	I-labvalue
4	I-labvalue
in	I-labvalue
Weight	O
240	B-labvalue
lb	I-labvalue
Systolic	O
137	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
84	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Heart	O
Rate	O
79	B-labvalue

Paternal	B-subject
history	O
of	O
Hypertension	O
V17	O
.	O
49	O

Neck	O
:	O
Normal	O

Never	O
A	O
Smoker	O

1	I-reference_range
Toeal	O
Protein	O
8	B-labvalue
.	I-labvalue
5	I-labvalue
g	I-labvalue
/	I-labvalue
dl	I-labvalue
H	B-labvalue
6	B-reference_range
.	I-reference_range
4	I-reference_range
-	I-reference_range
8	I-reference_range
.	I-reference_range

The	O
posterior	B-bodyloc
pharynx	I-bodyloc
was	O
erythematous	O
and	O
had	O
an	O
exudate	O
,	O
butwas	O
not	O
bulging	O
and	O
did	O
not	O
have	O
white	O
patches	O
.	O

Social	O
History	O
"	O
Being	O
A	O
Social	O
Drinker	O

UTP	O
-	O
Discussion	O
/	O
34yo	O
P2103	O
s	O
/	O
p	O
R	O
LTCS	O
8/3/13	B-temporal
at	O
37w	O
2	O
/	O
2	O
GHTN	O
,	O
GDM	O
and	O
Prior	B-temporal
C	O
/	O
S	O
x2	O
,	O
hypothyroid	O

6	O
.	O

Examination	O
of	O
sensation	O
:	O
Normal	B-labvalue
.	O

Symptoms	O
are	O
not	O
made	O
worse	O
by	O
swallowing	O
liquids	O
and	O
swallowing	O
solids	O
.	O

Bisacodyl	O
5	B-strength
mg	I-strength
Tablet	B-form
,	I-form
Delayed	I-form
Release	I-form
(	O
E	O
.	O
C	O
.	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
vomiting	O
,	O
no	B-negation
diarrhea	O
,	O
no	B-negation
heartburn	O
and	O
no	B-negation
melena	O

(	O
inf	O
.	O

History	O
of	O
Hypercholesterolemia	O
272	O
.	O
0	O

Elevated	O
AST	O
at	O
138	O
,	O
with	O
a	O
normal	B-labvalue
ALT	O
at	O
38	B-labvalue
.	O

Vitals	O
13Nov2012	B-temporal
11	B-temporal
:	I-temporal
05AM	I-temporal
13Nov2012	B-temporal
11	B-temporal
:	I-temporal
00AM	I-temporal
BMI	O
Calculated	O
20	B-labvalue
.	I-labvalue
91	I-labvalue
BSA	O
Calculated	O
1	B-labvalue
.	I-labvalue
55	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
3	I-labvalue
in	I-labvalue
Weight	O
118	B-labvalue
lb	I-labvalue
Systolic	O
150	B-labvalue
,	O
RUE	O
,	O
Sitting	O
Diastolic	O
96	B-labvalue
,	O
RUE	O
,	O
Sitting	O
Temperature	O
97	B-labvalue
.	I-labvalue
8	I-labvalue
F	I-labvalue
,	O
Oral	O
Heart	O
Rate	O
72	B-labvalue

Examination	O
of	O
extremities	O
for	O
edema	O
and	O
/	O
or	O
varicosities	O
:	O
Normal	B-labvalue

Constitutional	O
:	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
,	O
not	B-negation
feeling	O
poorly	O
(	O
malaise	O
)	O
,	O
not	B-negation
feeling	O
tired	O
(	O
fatigue	O
)	O
,	O
no	B-negation
recent	B-temporal
weight	O
gain	O
and	O
no	B-negation
recent	B-temporal
weight	O
loss	O
.	O

Plan	O
Follow	O
-	O
up	O
visit	O
in	O
4	O
days	O
Outpatient	O
Follow	O
-	O
up	O
Requested	O
for	O
:	O
14Jun2013	B-temporal

HOSPITAL	O
COURSE	O
:	O

-	O
Fetal	O
anatomy	O
US	O
at	O
22	O
weeks	O
with	O
4	O
chamber	O
view	O

Famotidine	O
10	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Therapy	O
:	O
04Aug2011	B-temporal
to	O

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

Constitutional	O

Cranial	O
nerves	O
VIII	O
:	O
hearing	O
was	O
intact	B-labvalue
.	O

RISK	O
FACTOR	O
:	O
unknown	O
family	O
history	O
,	O
heistory	O
of	O
physical	O
and	O
sexual	O
abuse	O

;	O
Sep	B-temporal
6	I-temporal
2012	I-temporal
4	B-temporal
:	I-temporal
31PM	I-temporal
(	O
Author	O
)	O

No	B-negation
facial	B-bodyloc
skin	I-bodyloc
lesions	O
.	O

UTP	O
-	O
Discussion	O
/	O
28	O
yo	O
G4P2113	O
s	O
/	O
p	O
repeat	O
LTCS	O
and	O
BTL	O
at	O
37	O
4	O
/	O
7	O
2	O
/	O
2	O
SIPIH	O
with	O
CHTN	O
,	O
T2DM	O
,	O
Depression	O
,	O
Asthma	O

Breath	O
sounds	O
were	B-negation
not	I-negation
diminished	O
.	O

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

Height	O
Comments	O
:	O
Reported	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
vomiting	O
,	O
no	B-negation
constipation	O
,	O
no	B-negation
diarrhea	O
,	O
no	B-negation
melena	O
and	O
no	B-negation
heartburn	O
.	O

Exacerbating	O
factors	O
:	O
alcohol	O
use	O
.	O

Metoprolol	O
Succinate	O
ER	B-form
50	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
Extended	I-form
Release	I-form
24	I-form
Hour	I-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
ONCE	B-frequency
DAILY	I-frequency
Requested	O
for	O
:	O
25Feb2014	B-temporal
;	O
Last	O
Rx	O
:	O
09Jan2014	B-temporal
;	O
Edited	O

OPHTHALMOLOGY	O
:	O
Exam	O
on	O
07/17/2006	B-temporal
showed	O
immature	O
retina	B-bodyloc
.	O

Bowel	O
sounds	O
were	O
normal	B-labvalue
.	O

Salivary	O
glands	O
:	O
No	B-negation
parotid	B-bodyloc
gland	I-bodyloc
mass	O
/	O
tenderness	O
.	O

Edema	O
:	O
Normal	O
(	O
not	B-negation
present	I-negation
)	O
.	O

Physical	O
Exam	O

History	O
of	O
Breast	B-bodyloc
Pain	O
611	O
.	O
71	O

TraMADol	O
HCl	O
50	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
EVERY	B-frequency
6	I-frequency
HOURS	I-frequency
AS	B-frequency
NEEDED	I-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
20Mar2014	B-temporal
)	O
to	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Plan	O

The	O
patient	O
states	O
his	O
current	O
toothache	O
is	O
to	O
both	O
upper	B-bodyloc
and	I-bodyloc
lower	I-bodyloc
teeth	I-bodyloc
on	O
the	O
left	O
side	O
for	O
approximately	B-temporal
three	I-temporal
days	I-temporal
.	O

Psychiatric	O

Third	O
pregnancy	O
:	O

Musculoskeletal	O
:	O
no	B-negation
arthralgias	O
,	O
no	B-negation
joint	B-bodyloc
pain	O
,	O
no	B-negation
joint	B-bodyloc
swelling	O
,	O
no	B-negation
joint	B-bodyloc
stiffness	O
,	O
no	B-negation
limb	B-bodyloc
pain	O
and	O
no	B-negation
limb	B-bodyloc
swelling	O
.	O

Dr	O
.	O
Moulik	O
notified	O
.	O

Family	B-subject
history	O
of	O
Cerebral	B-bodyloc
Atherosclerosis	O

Breast	O

WBC	O
:	O
7	B-labvalue
.	I-labvalue
9	I-labvalue
K	I-labvalue
/	I-labvalue
CMM	I-labvalue
Reference	O
Range	O
3	B-reference_range
.	I-reference_range
7	I-reference_range
-	I-reference_range
10	I-reference_range
.	I-reference_range
4	I-reference_range

Rx	O
OCPs	O
.	O

Eyes	O

Benign	O
Essential	O
Hypertension	O
401	O
.	O
1	O

MT	O
/	O
MM	O
:	O
PolypoidandPolyps	O

Platelet	O
:	O
245	B-labvalue
K	I-labvalue
/	I-labvalue
CMM	I-labvalue
Reference	O
Range	O
133	B-reference_range
-	I-reference_range
450	I-reference_range

Social	O
History	O
Former	O
Smoker	O
V15	O
.	O
82	O

8/29/11	B-temporal
-	O
MRI	O
brain	O
still	O
no	B-negation
lesions	O
,	O
MRI	O
cord	O
is	O
improved	B-labvalue
compared	O
to	O
previous	O
.	O

Symmetrical	O
expansion	O
.	O

Motor	O
Survey	O
:	O
the	O
motor	O
survey	O
was	O
normal	B-labvalue
.	O

Patient	O
states	O
hand	O
slipped	O
and	O
was	O
caught	O
by	O
table	O
saw	O
.	O

for	O
COPD	O

Pdan	O
g64	O

MetFORMIN	O
HCl	O
ER	B-form
(	O
OSM	O
)	O
1000	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
Extended	I-form
Release	I-form
24	I-form
Hour	I-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
TWICE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
06Nov2013	B-temporal
to	O
(	O
Evaluate	O
:	O
04Feb2014	B-temporal
)	O
Requested	O
for	O
:	O
06Nov2013	B-temporal
;	O
Last	O
Rx	O
:	O
06Nov2013	B-temporal
;	O
Edited	O

Femoral	O
pulses	O
:	O
Normal	B-labvalue
.	O

I	O
have	O
discussed	O
the	O
case	O
with	O
the	O
resident	O
and	O
agree	O
with	O
the	O
assessment	O
and	O
plan	O
as	O
delineated	O
in	O
the	O
note	O
above	O
.	O

Patient	O
does	O
not	B-negation
have	I-negation
a	O
history	O
of	O
a	O
positive	O
pap	O
smear	O
.	O

Psychiatric	O

History	O
of	O
subdural	O
hematoma	O
,	O
also	O
on	O
admission	O
the	O
patient	O
noted	O
some	O
mild	B-severity
intermittent	O
headaches	O
that	O
were	O
fleeting	B-course
in	O
nature	O
,	O
several	O
a	O
day	O
that	O
would	O
resolve	O
on	O
their	O
own	O
.	O

Endocrine	O
:	O
no	B-negation
proptosis	O
,	O
no	B-negation
hot	O
flashes	O
,	O
no	B-negation
muscle	B-bodyloc
weakness	O
,	O
no	B-negation
erectile	O
dysfunction	O
,	O
no	B-negation
deepening	O
of	O
the	O
voice	O
and	O
no	B-negation
feelings	O
of	O
weakness	O
.	O

Surgical	O
History	O
History	O
of	O
Appendectomy	O

Family	B-subject
history	O
of	O
Bladder	B-bodyloc
Cancer	O

She	O
notes	O
minimal	B-severity
discomfort	O
.	O

Psychiatric	O

History	O
of	O
Hypertension	O
401	O
.	O
9	O

Cranial	O
nerves	O
II	O
:	O
visual	O
acuity	O
and	O
visual	O
fields	O
were	O
intact	B-labvalue
.	O

Furuncle	O
On	O
The	O
Face	B-bodyloc
680	O
.	O
0	O

Assessment	O
of	O
respiratory	O
effort	O
was	O
significant	O
for	O
normal	B-labvalue
respiratory	O
rhythm	O
and	O
effort	O
.	O

03	O
:	O
45PM	O

Abdomen	O

Gastroenterology	O
Referral	O
Outpatient	O
anemia	O
f	O
.	O
h	O
.	O
of	O
polyps	O
.	O

[	O
QLH	O
]	O
HEMOGLOBIN	O
A1c	O
Requested	O
for	O
:	O
13Dec2013	B-temporal

IP	O
/	O
N	O
/	O
SF	O
Due	O
:	O
17Aug2013	B-temporal
;	O
Last	O
Updated	O
By	O
:	O
Fleming	O
,	O
Sonya	O

&	O
uln	O
.	O
)	O
:	O
Normal	O
.	O

left	O
long	O
finger	O
radial	O
digital	O
artery	O
repair	O
4	O
.	O

Past	O
Medical	O
History	O
History	O
of	O
Bipolar	O
Disorder	O
296	O
.	O
00	O

Hematologic	O
/	O
Lymphatic	O
:	O
a	O
tendency	O
for	O
easy	O
bleedinganda	O
tendency	O
for	O
easy	O
bruising	O
,	O
but	O
no	B-negation
swollen	O
glands	B-bodyloc
and	O
no	B-negation
swollen	O
glands	B-bodyloc
in	O
the	O
neck	B-bodyloc
.	O

3	O
.	O

Her	O
headaches	O
are	O
worse	B-course
with	O
stress	O
with	O
over	O
-	O
working	O
with	O
no	B-negation
precipitating	O
measures	O
.	O

1	O
.	O

Examination	O
of	O
the	O
head	O
and	O
face	O
:	O
Normal	B-labvalue
.	O

Social	O
History	O
Alcohol	O

Examination	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue
The	O
neck	O
was	O
normal	O
in	O
appearanceand	O
was	O
supple	O
.	O

Muscle	B-bodyloc
Spasm	O
728	O
.	O
85	O

&	O
uln	O
.	O
)	O
:	O
Normal	O
.	O

This	O
is	O
a	O
58	O
years	O
old	O
male	O
with	O
DM	O
(	O
LADA	O
)	O
on	O
combination	O
OAD	O
(	O
Glimepiride	O
restarted	O
last	O
visit	O
as	O
he	O
wasn	O
'	O
t	O
taking	O
it	O
since	O
his	O
initial	O
visit	O
)	O
.	O

Physical	O

Omeprazole	O
40	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
Delayed	I-form
Release	I-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
10May2013	B-temporal
to	O
(	O
Evaluate	O
:	O
09Jul2013	B-temporal
)	O
Requested	O
for	O
:	O
10May2013	B-temporal
;	O
Last	O
Rx	O
:	O
10May2013	B-temporal

4	I-reference_range
Estimated	O
Glomerular	O
Filtration	O
Rate	O
23	B-labvalue
ML	I-labvalue
/	I-labvalue
MIN	I-labvalue
/	I-labvalue
1	I-labvalue
.	I-labvalue
7	I-labvalue
The	O
eGFR	O
isacalculated	O
using	O
the	O
CKD	O
-	O
EPI	O
formula	O
.	O

Active	O
Problems	O
Anemia	O
285	O
.	O
9	O

ENT	O
:	O
no	B-negation
sore	O
throat	B-bodyloc
.	O

Chief	O
Complaint	O

Cranial	O
nerves	O
II	O
:	O
visual	O
acuity	O
and	O
visual	O
fields	O
were	O
intact	B-labvalue
.	I-labvalue

Taking	O
Blood	O
Thinners	O
For	O
A	B-temporal
Long	I-temporal
Time	I-temporal
V58	O
.	O
61	O

well	O
-	O
appearing	O

General	O
appearance	O
:	O
Normal	B-labvalue
.	O

History	O
of	O
Infective	O
Herpes	O
Zoster	O
Dermatitis	O
Of	O
Eyelid	O
053	O
.	O
20	O

Middle	O
Turbinate	O
:	O
Previous	B-temporal
resection	O
.	O

Senna	O
S	O
8	B-strength
.	I-strength
6	I-strength
-	I-strength
50	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
AS	B-frequency
NEEDED	I-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
05Feb2013	B-temporal
)	O
to	O

Nad	O
has	O
"	O
Polyps	O
"	O
Periods	O
have	O
not	O
been	O
heavy	O
.	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
neck	O
:	O
Normal	B-labvalue
.	O

Assessment	O

No	B-negation
Reported	O
Medications	O

HEMOGLOBIN	O
Done	O
:	O
08Jun2009	B-temporal
01	B-temporal
:	I-temporal
50PM	I-temporal

Review	O
of	O
Systems	O

The	O
patient	O
is	O
not	O
currently	O
being	O
treated	O
for	O
this	O
problem	O
.	O

[	O
L	O
]	O
Drawing	O
Fee	O
Requested	O
for	O
:	O
30Oct2013	B-temporal

Dental	O
evaluation	O
with	O
or	O
without	O
varnish	O
.	O
eg	O

History	O
of	O
Neonatal	O
Necrotizing	O
Enterocolitis	O
777	O
.	O
50	O

Peripheral	O
Vascular	O
Exam	O
:	O
Normal	B-labvalue
.	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
and	O
no	B-negation
palpitations	O
.	O

We	O
have	O
not	O
received	O
any	O
medical	O
records	O
for	O
this	O
testing	O
.	O

Constitutional	O

Escitalopram	O
Oxalate	O
10	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
08Jun2012	B-temporal
to	O
(	O
Evaluate	O
:	O
06Oct2012	B-temporal
)	O
Requested	O
for	O
:	O
08Jun2012	B-temporal
;	O
Last	O
Rx	O
:	O
08Jun2012	B-temporal

Hyperlipidemia	O
272	O
.	O
4	O

The	O
patient	O
presents	O
to	O
the	O
office	O
today	O
with	O
left	B-bodyloc
hip	I-bodyloc
pain	O
.	O

Active	O
Problems	O
Cough	O
786	O
.	O
2	O

Previous	B-temporal
Resection	O
:	O
Yes	O
.	O

Relieving	O
factors	O
:	O
not	O
relieved	O
by	O
steam	O
inhalation	O
and	O
not	O
relieved	O
by	O
warm	O
compresses	O
.	O

.	O

Active	O
Problems	O
Anemia	O
285	O
.	O
9	O

Assessment	O
1	O
.	O

Reason	O
For	O
Visit	O

Physical	O
Exam	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

Examination	O
of	O
the	O
palate	O
showed	O
no	B-negation
abnormalities	O
.	O

Tiredness	O
:	O
Mild	B-severity

She	O
is	O
to	O
follow	O
up	O
with	O
her	O
cardiologist	O
for	O
further	O
adjustments	O
.	O

Dorsalis	O
pedis	O
:	O
right	O
1	O
+	O
and	O
left	O
1	O
+	O
.	O

Miscarriage	O
first	O
trimester	O
.	O

1	O
.	O

Physical	O
Activity	O
and	O
Therapy	O
:	O
(	O
)	O
physical	O
therapy	O

No	B-negation
rales	O
or	O
crackles	O
were	O
heard	O
.	O

General	O
appearance	O
:	O
Abnormal	B-labvalue
.	O
Flat	O
affect	O
.	O

Examination	O
of	O
sensation	O
:	O
Normal	B-labvalue
.	O

Current	O
Meds	O
Enalapril	O
Maleate	O
10	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
07Dec2011	B-temporal
to	O
(	O
Evaluate	O
:	O
14Jun2012	B-temporal
)	O
Requested	O
for	O
:	O
16Mar2012	B-temporal
;	O
Last	O
Rx	O
:	O
16Mar2012	B-temporal

Review	O
of	O
Systems	O
UTP	O
-	O
Complete	O
-	O
Male	O
Neuro	O
Emphasis	O
:	O

BRAT	O
diet	O
was	O
reviewed	O
.	O

PHYSICAL	O
EXAM	O
VITAL	O
SIGNS	O
:	O
Temp	O
98	B-labvalue
.	I-labvalue
3	I-labvalue
,	O
heart	O
rate	O
82	B-labvalue
,	O
respiratory	O
rate	O
24	B-labvalue
,	O
and	O
blood	O
pressure	O
141	B-labvalue
/	I-labvalue
70	I-labvalue
.	O

Moved	O
from	O
South	O
dakota	O
3	O
-	O
4	O
years	O
back	O
uptodate	O
with	O
her	O
tetanus	O
.	O

f	O
History	O
of	O
Preterm	O
Infant	O
-	O
1	O
,	O
000	O
-	O
1	O
,	O
249	O
G	O
.	O

Conjunctiva	O
:	O
.	O

Fluticasone	O
Propionate	O
Powder	B-form
;	O
CMPD	O
Fluticasone	O
3	B-strength
mg	I-strength
Capsule	B-form
.	O

He	O
has	O
no	B-negation
significant	O
interval	O
events	O
.	O

Cortical	O
function	O
:	O
Normal	B-labvalue
.	O

MT	O
/	O
MM	O
:	O
Crust	O

Family	O
History	O
Family	B-subject
history	O
of	O
Coronary	B-bodyloc
Artery	I-bodyloc
Disease	O
V17	O
.	O
49	O

Arytenoids	O
:	O
normal	O

The	O
deep	O
tendon	O
reflexes	O
at	O
the	O
achilles	O
and	O
patellar	O
areas	O
were	O
present	B-labvalue
and	O
equro	B-labvalue
bilaterally	I-labvalue
.	O

Rotation	O
to	O
the	O
left	O
was	O
not	O
restricted	O
and	O
was	O
painful	O
.	O

All	O
the	O
motions	O
tested	O
were	O
painless	B-labvalue
.	O

3	O
.	O

Neck	O

;	O
Aug	B-temporal
8	I-temporal
2013	I-temporal
12	B-temporal
:	I-temporal
41PM	I-temporal
(	O
Author	O
)	O

Active	O
Problems	O
(	B-bodyloc
Lower	I-bodyloc
)	I-bodyloc
Leg	I-bodyloc
Localized	O
Swelling	O
Bilateral	O
729	O
.	O
81	O

Glucose	O
(	O
Point	O
of	O
Care	O
In	O
Office	O
)	O
Done	O
:	O
28Jan2013	B-temporal
01	B-temporal
:	I-temporal
31PM	I-temporal

[	O
QLH	O
]	O
CMP	O
W	O
/	O
EGFR	O
Requested	O
for	O
:	O
02Jul2013	B-temporal

Musculoskeletal	O
:	O
joint	B-bodyloc
pain	O
.	O

No	B-negation
wheezing	O
was	O
heard	O
.	O

Examination	O
of	O
the	O
chest	O
:	O
Normal	B-labvalue

[	O
QLH	O
]	O
TSH	O
,	O
3RD	O
GENERATION	O
W	O
/	O
REFLEX	O
TO	O
FT4	O
Requested	O
for	O
:	O
07Oct2013	B-temporal

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

Localized	O
Primary	O
Osteoarthritis	O
Of	O
The	O
Knee	B-bodyloc
715	O
.	O
16	O

Review	O
of	O
Systems	O

The	O
patient	O
describes	O
the	O
pain	O
as	O
sharp	B-course
.	O

Hypertension	O
:	O
Blood	O
pressure	O
is	O
controlled	B-labvalue
.	O

Examination	O
of	O
gait	O
and	O
station	O
:	O
Normal	B-labvalue
.	O

f	O
OneTouch	O
Ultra	O
Blue	O
In	O
Vitro	O
Strip	O
;	O
TEST	O
BLOOD	O
SUGAR	O
LEVEL	O
one	O
TIMES	O
DAILY	O
;	O
Start	O
Date	O
:	O
12/19/2006	B-temporal
;	O
End	O
Date	O
:	O
01/01/1900	B-temporal
(	O
Active	O
)	O

RESPIRATORY	O
:	O
no	B-negation
wheezing	O
and	O
no	B-negation
cough	O
.	O

Social	O
History	O
Former	O
Smoker	O
V15	O
.	O
82	O

Last	O
Friday	O
,	O
an	O
unknown	O
person	O
punched	O
patient	O
sever	O
times	O
on	O
the	O
left	O
side	O
of	O
the	O
cheek	O
/	O
jaw	O
while	O
he	O
was	O
waiting	O
in	O
the	O
traffic	O
light	O
in	O
West	O
airport	O
area	O
.	O

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

Expected	O
eGFR	O
for	O
>	O
20	O
yr	O
.	O

Allergies	O
1	O
.	O

A	O
pill	O
rolling	O
tremor	O
was	O
not	B-negation
observed	I-negation
on	O
the	O
right	O
and	O
not	O
observed	O
on	O
the	O
left	O
.	O

Nose	O
is	O
normal	O
without	B-negation
rhinorrhea	O
or	O
audible	O
congestion	O
.	O

No	B-negation
wheezing	O
was	O
heard	O
.	O

[	O
QLH	O
]	O
LIPID	O
PANEL	O
Requested	O
for	O
:	O
04Apr2014	B-temporal

Previous	O
Surgery	O
:	O
Yes	O
.	O

Social	O
History	O
Never	O
A	O
Smoker	O

Edema	O
:	O
Normal	O
(	O
not	B-negation
present	I-negation
)	O
.	O

SX	O
WITH	O
CHANGE	O
IN	O
WEATHER	O
)	O
.	O

No	B-negation
dyspareunia	O
.	O
Patient	O
has	O
history	O
of	O
sexually	O
transmitted	O
infection	O
chlamydia	O
,	O
trichomoniasis	O
.	O

[	O
QLH	O
]	O
HEMOGLOBIN	O
A1c	O
Requested	O
for	O
:	O
03May2011	B-temporal

No	B-negation
pneumothorax	O
.	O

;	O
Nov	B-temporal
26	I-temporal
2012	I-temporal
3	B-temporal
:	I-temporal
33PM	I-temporal
(	O
Author	O
)	O

BSA	O
Calculated	O
:	O
2	B-labvalue
.	I-labvalue
01	I-labvalue

4	O
.	O

-	O
-	O
Repeat	O
serum	O
CK	O
,	O
anti	O
-	O
Jo	O
1	O
antibody	O
,	O
lipid	O
profile	O
,	O
TSH	O
and	O
CMP	O

Disp	O
:	O
*	O
30	O
Tablet	O
(	O
s	O
)	O
*	O
Refills	O
:	O
*	O
0	O
*	O
7	O
.	O

Hepatitis	O
A	O
;	O
01/07/2012	B-temporal

She	O
has	O
no	B-negation
history	O
of	O
prophylactic	O
treatment	O
.	O

Review	O
of	O
Systems	O

HEME	O
/	O
LYMPH	O
:	O
No	B-negation
abnormal	O
lymph	B-bodyloc
nodes	I-bodyloc
,	O
no	B-negation
signs	I-negation
of	I-negation
bleeding	O
,	O
skin	B-bodyloc
purpura	O
,	O
petechiae	O
or	O
hemorrhage	O
.	O

The	O
rhythm	O
was	O
regular	B-labvalue
.	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

Presents	O
for	O
colpo	O
and	O
BTL	O
scheduling	O
.	O

Hematologic	O
/	O
Lymphatic	O
:	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
,	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
,	O
no	B-negation
swollen	O
glands	B-bodyloc
and	O
no	B-negation
swollen	O
glands	B-bodyloc
in	O
the	O
neck	B-bodyloc
.	O

He	O
has	O
had	O
loose	O
stools	O
,	O
non	B-negation
bloody	O
.	O

Will	O
refer	O
to	O
Dermatology	O
for	O
further	O
evaluation	O

Carotid	O
pulses	O
:	O
Normal	B-labvalue
.	O
Peripheral	O
vascular	O
exam	O
:	O
Normal	B-labvalue
.	O

Cardiac	O
palpation	O
within	O
normal	B-labvalue
limits	O
.	O

-	O
Parametria	O
,	O
bilateral	O
,	O
negative	B-negation
for	O
tumor	O
involvement	O
.	O

Discussion	O
/	O
Discussion	O
/	O
Summary	O

no	B-negation
insomnia	O

Cardiovascular	O

[	O
H	O
]	O
Lipid	O
Panel	O
w	O
/	O
c	O
LDL	O
09Dec2010	B-temporal
10	B-temporal
:	I-temporal
30AM	I-temporal
Hardwicke	O
,	O
Robin	O

Heart	O
sounds	O
:	O
normal	B-labvalue
S1	O
and	O
normal	B-labvalue
S2	O
.	O

Symptoms	O
:	O
no	B-negation
headache	O
,	O
no	B-negation
confusion	O
,	O
no	B-negation
visual	O
disturbance	O
,	O
no	B-negation
dizziness	O
and	O
no	B-negation
shortness	O
of	O
breath	O
.	O

Current	O
Meds	O
No	B-negation
Reported	O
Medications	O

Right	O
Toe	O
Ext	O
.	O

Septum	O
:	O
Midline	O
.	O

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

No	B-negation
submandibular	B-bodyloc
gland	I-bodyloc
mass	O
/	O
tenderness	O
.	O

The	O
patient	O
is	O
being	O
seen	O
for	O
routine	O
follow	O
-	O
up	O
of	O
.	O

Became	O
tearful	O
as	O
she	O
relayed	O
this	O
disabilty	O

Eyes	O

Genitourinary	O
:	O
no	B-negation
dysuria	O
,	O
no	B-negation
urinary	O
frequency	O
,	O
no	B-negation
incontinence	O
and	O
no	B-negation
pelvic	B-bodyloc
pain	O
.	O

Assessment	O
of	O
range	O
of	O
motion	O
:	O
Normal	B-labvalue
.	O
Limited	O
at	O
right	O
ankle	O
s	O
/	O
p	O
surgical	O
repair	O
.	O

Currently	B-temporal
irrigating	O
with	O
ceftazidime	O
/	O
fluticasone	O
irrigation	O
.	O

ProAir	O
HFA	O
108	B-strength
(	I-strength
90	I-strength
Base	I-strength
)	I-strength
MCG	I-strength
/	I-strength
ACT	I-strength
Inhalation	B-route
Aerosol	B-form
Solution	I-form
;	O
INHALE	B-route
2	B-dosage
PUFFS	B-form
EVERY	B-frequency
4	I-frequency
HOURS	I-frequency
AS	B-frequency
NEEDED	I-frequency
FOR	O
COUGH	O
AND	O
WHEEZE	O
;	O
Therapy	O
:	O
14Dec2013	B-temporal
to	O
(	O
Evaluate	O
:	O
13Jan2014	B-temporal
)	O
Requested	O
for	O
:	O
14Dec2013	B-temporal
;	O
Last	O
Rx	O
:	O
14Dec2013	B-temporal

Furthermore	O
,	O
no	B-negation
gross	O
lesions	O
were	O
encountered	O
in	O
the	O
bladder	O
.	O

BuPROPion	O
HCl	O
ER	O
(	O
XL	O
)	O
300	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
Extended	I-form
Release	I-form
24	I-form
Hour	I-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
AS	O
DIRECTED	O
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
24Sep2013	B-temporal
)	O
to	O

DOB	O
:	O
09/16/72	O

Inspection	O
/	O
palpation	O
of	O
joints	O
,	O
bones	O
,	O
and	O
muscles	O
:	O
Abnormalsignificant	O
swelling	O
,	O
but	O
no	B-negation
ecchymosis	O
,	O
no	B-negation
erythema	O
,	O
no	O
deformity	O
and	O
no	B-negation
warmth	O
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

History	O
of	O
Lower	B-bodyloc
Back	I-bodyloc
Pain	O
724	O
.	O
2	O

INTEGUMENTARY	O
:	O
no	B-negation
rashes	O
and	O
no	B-negation
ulcers	O
.	O

Associated	O
symptoms	O
:	O
nausea	O
,	O
but	O
no	B-negation
hoarseness	O
,	O
no	B-negation
cough	O
,	O
no	B-negation
hematemesis	O
,	O
no	B-negation
melena	O
and	O
no	B-negation
weight	O
loss	O

The	O
patient	O
uses	O
a	O
front	O
wheel	O
walker	O
.	O

Chest	O

Houston	O
,	O
TX	O
77090	O
-	O
3303	O

Neck	O
:	O
Normal	O
.	O

Palpation	O
of	O
the	O
face	O
and	O
sinuses	O
:	O
No	B-negation
sinus	B-bodyloc
tenderness	O
.	O

General	O
appearance	O
:	O
Abnormal	B-labvalue
Acutely	O
illandappears	O
tired	O
,	O
butwell	O
developedandwell	O
nourished	O
.	O

History	O
of	O
Acquired	O
Dystonia	O
Musculorum	O
Deformans	O
333	O
.	O
79	O

Gestational	O
age	O
:	O
40	O
weeks	O
.	O

Vitals	O
25Feb2014	B-temporal
01	B-temporal
:	I-temporal
18PM	I-temporal
BMI	O
Calculated	O
27	B-labvalue
.	I-labvalue
45	I-labvalue
BSA	O
Calculated	O
1	B-labvalue
.	I-labvalue
96	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
8	I-labvalue
in	I-labvalue
Weight	O
181	B-labvalue
lb	I-labvalue
2	I-labvalue
oz	I-labvalue
Systolic	O
141	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
74	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Temperature	O
97	B-labvalue
.	I-labvalue
5	I-labvalue
F	I-labvalue
,	O
Oral	O
Heart	O
Rate	O
55	B-labvalue

Assessment	O
of	O
respiratory	O
effort	O
was	O
significant	B-labvalue
for	I-labvalue
normal	I-labvalue
respiratory	I-labvalue
rhythm	I-labvalue
and	I-labvalue
effort	I-labvalue
.	O

Dehiscence	O
Of	O
Surgical	O
Wound	O
998	O
.	O
31	O

Under	O
the	O
primary	O
care	O
exception	O
I	O
did	O
not	O
personally	O
interview	O
or	O
examine	O
the	O
patient	O
.	O

Pravastatin	O
Sodium	O
20	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
03Sep2013	B-temporal
)	O

Middle	O
Turbinate	O
:	O
Normal	O
position	O
.	O

Plantar	B-bodyloc
Faceitis	O
:	O
supportive	O
care	O
,	O
comfortable	O
shoes	O
,	O
no	O
sandals	O
,	O
use	O
arch	O
support	O
insoles	O
,	O
massage	O
feet	O
,	O
weight	O
loss	O
,	O
avoid	O
repetative	O
trauma	O
,	O
weight	O
loss	O
highly	O
recommended	O
,	O
Trial	O
of	O
ibuprofen	O
as	O
directed	O
,	O
potential	O
side	O
effects	O
discussed	O
.	O

She	O
has	O
had	O
no	B-negation
significant	O
interval	O
events	O
.	O

Assessment	O
of	O
range	O
of	O
motion	O
:	O
Normal	B-labvalue
.	O

1st	B-bodyloc
digit	I-bodyloc
:	O
laceration	O
of	O
the	O
volar	O
aspect	O
along	O
the	O
MCP	B-bodyloc
,	O
no	B-negation
exposed	O
tendon	B-bodyloc
;	O
capillary	O
refill	O
<	B-labvalue
1sec	I-labvalue
;	O
sensation	O
to	O
light	O
touch	O
intact	B-labvalue
over	O
entire	O
digit	O
2d	B-bodyloc
digit	I-bodyloc
:	O
deep	O
laceration	O
along	O
radial	B-bodyloc
aspect	I-bodyloc
of	I-bodyloc
digit	I-bodyloc
from	O
MCP	B-bodyloc
and	I-bodyloc
extending	I-bodyloc
along	I-bodyloc
volar	I-bodyloc
aspect	I-bodyloc
exposing	O
flexor	O
tendons	B-bodyloc
;	O
capillary	O
refill	O
<	B-labvalue
1sec	I-labvalue
,	O
dopplerable	O
signal	O
over	O
both	O
radial	O
and	O
ulnar	O
digital	O
arteries	O
;	O
patient	O
reports	O
altered	O
sensorium	O
over	O
the	B-bodyloc
finger	I-bodyloc
3d	B-bodyloc
digit	I-bodyloc
:	O
deep	O
laceration	O
on	O
volar	O
aspect	O
between	O
the	B-bodyloc
MCP	I-bodyloc
and	O
PIP	B-bodyloc
joints	I-bodyloc
with	O
exposed	O
flexor	B-bodyloc

[	O
QLH	O
]	O
URINALYSIS	O
,	O
COMPLETE	O
Requested	O
for	O
:	O
08May2013	B-temporal

LEUKOCYTES	O
:	O
NEG	B-labvalue

Inspection	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
Normal	B-labvalue
.	O

Observed	O
mood	O
and	O
affect	O
:	O
appropriate	O
affectandappropriate	O
mood	O
.	O

Carotid	O
pulses	O
:	O
Normal	B-labvalue
.	O

Localized	O
Primary	O
Osteoarthritis	O
Of	O
The	O
Knee	B-bodyloc
715	O
.	O
16	O

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

Primary	O
Open	O
-	O
angle	O
Glaucoma	O
365	O
.	O
11	O

Screening	O
:	O
Cervical	O
cancer	O
screening	O
includes	O
last	O
Papanicolaou	O
cytology	O
done	B-temporal
10	I-temporal
/	I-temporal
2012	I-temporal
.	O

Chronic	B-course
obstructive	O
pulmonary	B-bodyloc
disease	O
.	O

Plan	O
[	O
QLH	O
]	O
CMP	O
W	O
/	O
EGFR	O
Requested	O
for	O
:	O
07Aug2013	B-temporal

[	O
QLH	O
]	O
LIPID	O
PANEL	O
Requested	O
for	O
:	O
21Mar2013	B-temporal

Colorectal	O
cancer	O
screening	O
includes	O
last	O
colonoscopy	O
done	B-temporal
2008andfecal	I-temporal
occult	O
blood	O
testing	O
last	B-temporal
year	I-temporal
.	O

RESPIRATORY	O
:	O
no	B-negation
wheezing	O
and	O
no	B-negation
cough	O
.	O

First	O
pregnancy	O
:	O

There	O
were	O
no	B-negation
thyroid	B-bodyloc
nodules	O
.	O

Mother	O
was	O
instructed	O
to	O
maintain	O
hydration	O
with	O
frequent	O
,	O
smCil	O
amount	O
of	O
clear	O
fluids	O
.	O

No	B-negation
dry	O
cough	O
,	O
no	B-negation
stridor	O
and	O
no	B-negation
mouth	B-bodyloc
breathing	O
.	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
,	O
the	O
heart	O
rate	O
was	O
not	B-labvalue
fast	I-labvalue
,	O
the	O
heart	O
rate	O
was	O
not	B-labvalue
slow	I-labvalue
,	O
no	B-negation
intermittent	O
leg	B-bodyloc
claudication	O
and	O
no	B-negation
edema	O
.	O

History	O
of	O
Never	O
Drank	O
Alcohol	O

Otherwise	O
,	O
other	O
muscles	O
were	O
normal	O
.	O

Left	O
Gastroc	O
.	O

Family	B-subject
history	O
of	O
Hypertension	O
V17	O
.	O
49	O

History	O
of	O
Open	O
Treatment	O
Of	O
Carpometacarpal	O
Thumb	O
Fract	O
.	O
/	O
Dislocation	O

Left	B-bodyloc
shoulder	I-bodyloc
pain	O
and	O
left	B-bodyloc
thumb	I-bodyloc
pain	O
related	O
to	O
using	O
hand	O
crane	O
at	O
work	O
The	O
patient	O
states	O
he	O
has	O
been	O
doing	O
well	O
with	O
his	O
Type	O
II	O
Diabetes	O
control	O
since	O
the	O
last	O
visit	O
.	O

Joint	B-bodyloc
Pain	O
,	O
Localized	O
In	O
The	O
Shoulder	B-bodyloc
719	O
.	O
41	O

Left	O
lateral	O
flexion	O
was	O
not	O
restricted	O
and	O
was	O
painful	O
.	O

2	O
.	O

no	B-negation
sutires	O
palpable	O
,	O
butboth	O
adenexa	O
were	O
normal	O
,	O
nontender	O
bilaterally	O
and	O
there	O
were	O
no	B-negation
adnexal	B-bodyloc
masses	O
.	O

SignCture	O
g36	O

Surgical	O
History	O
Problems	O

BSA	O
Calculated	O
:	O
2	B-labvalue
.	I-labvalue
46	I-labvalue

[	O
QH	O
]	O
HIV	O
AB	O
,	O
HIV	O
1	O
/	O
2	O
,	O
EIA	O
,	O
WITH	O
REFLEXES	O
Done	O
:	O
08May2013	B-temporal
03	B-temporal
:	I-temporal
45PM	I-temporal

Cardiovascular	O

General	O
appearance	O
:	O
AbnormalObese	O
.	O

Urinary	B-bodyloc
Frequency	O
788	O
.	O
41	O

Current	O
Meds	O
Acidophilus	O
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
BEDTIME	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
10Dec2013	B-temporal
)	O
to	O

General	O
appearance	O
:	O
Normal	B-labvalue

Examination	O
of	O
thyroid	O
:	O
Normal	B-labvalue
.	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
vomiting	O
,	O
no	B-negation
constipation	O
,	O
no	B-negation
diarrhea	O
,	O
no	B-negation
melena	O
and	O
no	B-negation
heartburn	O
.	O

Neck	O

Dr	O
.	O
Malhotra	O
presents	O
today	B-temporal
for	O
debridemen	O
of	O
his	O
left	O
ear	O
canal	O
and	O
mastoid	O
debridemen	O
.	O

History	O
of	O
Present	O
Illness	O
The	O
patient	O
is	O
being	O
seen	O
for	O
a	O
routine	O
clinic	O
follow	O
-	O
up	O
of	O
essential	O
hypertension	O
.	O

Nasal	O
Passages	O
Left	O
:	O
clear	O

[	O
QLH	O
]	O
TSH	O
,	O
3RD	O
GENERATION	O
W	O
/	O
REFLEX	O
TO	O
FT4	O
07Apr2011	B-temporal
09	B-temporal
:	I-temporal
42AM	I-temporal
Hardwicke	O
,	O
Robin	O

4	O
.	O

No	B-negation
vaginal	B-bodyloc
discharge	O
or	O
dysuria	O
.	O

Family	B-subject
history	O
of	O
Coronary	B-bodyloc
Artery	I-bodyloc
Disease	O

Neurological	O
:	O
no	B-negation
convulsions	O
.	O

Vitamin	O
D	O
deficiency	O
.	O

Eyes	O
:	O
no	O
eye	O
painandno	O
dryness	O
of	O
the	O
eyes	B-bodyloc
.	O

Social	O
History	O
"	O
Never	O
A	O
Smoker	O

Current	O
Meds	O
Ortho	O
Tri	O
-	O
Cyclen	O
(	B-strength
28	I-strength
)	I-strength
0	I-strength
.	I-strength
18	I-strength
/	I-strength
0	I-strength
.	I-strength
215	I-strength
/	I-strength
0	I-strength
.	I-strength

Electronically	O
signed	O
by	O
:	O
BERTHA	O
CAMPOS	O
,	O
P	O
.	O
A	O
.	O

Menstrual	O
History	O
.	O

Palpebral	B-bodyloc
Edema	O
374	O
.	O
82	O

Pulmonary	O

The	O
tongue	O
was	O
normal	O
.	O

History	O
of	O
Herpes	O
Simplex	O
Type	O
II	O
054	O
.	O
10	O

4	O
.	O

Phinatal	O
Exam	O
g8	O

Associated	O
symptoms	O
:	O
no	B-negation
eye	B-bodyloc
redness	O
and	O
no	B-negation
edema	O
.	O

Time	O
spent	O
in	O
counseling	O
and	O
/	O
or	O
coordination	O
of	O
care	O
for	O
this	O
patient	O
was	O
20	O
min	O
minutesandthis	O
time	O
was	O
greater	O
than	O
50	O
%	O
of	O
the	O
visit	O
.	O

Nasal	O
mucosa	O
,	O
septum	O
,	O
and	O
turbinates	O
:	O
Normal	O
.	O

Family	O
History	O
Maternal	B-subject
history	O
of	O
Breast	B-bodyloc
Cancer	O
V16	O
.	O
3	O

3	O
.	O

Denied	O

Discussion	O
/	O
Signatures	O
Electronically	O
signed	O
by	O
:	O
LESLIE	O
GARB	O
,	O
M	O
.	O
D	O
.	O

Full	B-labvalue
ROM	O

MetFORMIN	O
HCl	O
850	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
TWICE	B-frequency
DAILY	I-frequency
WITH	I-frequency
MEALS	I-frequency
;	O
Last	O
Rx	O
:	O
31Oct2012	B-temporal

Threatened	O
Premature	O
Labor	O
-	O
Antepartum	O
Condition	O
Or	O
Prior	B-temporal
Complicated	O
Delivery	O
644	O
.	O
03	O

Inspection	O
/	O
palpation	O
of	O
joints	O
,	O
bones	O
,	O
and	O
muscles	O
:	O
Normal	B-labvalue
.	O

[	O
QL	O
]	O
H	O
.	O

Cranial	O
Nerve	O
XI	O
:	O
shoulder	O
shrug	O
was	O
intact	B-labvalue
bilaterally	I-labvalue
.	O

Vaginal	B-bodyloc
Discharge	O
623	O
.	O
5	O

[	O
QLH	O
]	O
SED	O
RATE	O
BY	O
MODIFIED	O
WESTERGREN	O
Requested	O
for	O
:	O
12Nov2013	B-temporal

Examination	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue
.	O

;	O
Aug	B-temporal
4	I-temporal
2011	I-temporal
10	B-temporal
:	I-temporal
26AM	I-temporal
(	O
Author	O
)	O

Previous	B-temporal
MRI	O
showed	O
one	O
lesion	O
in	O
the	O
brain	B-bodyloc
and	O
two	O
enhancing	O
lesions	O
in	O
the	O
cord	B-bodyloc
.	O

History	O
of	O
Hearing	O
Loss	O
389	O
.	O
9	O

Atresia	O
Of	O
Auditory	O
Canal	O
(	O
External	O
)	O
744	O
.	O
02	O

Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Surgical	O
History	O
History	O
of	O
Cesarean	O
Section	O

Upper	O
Extremities	O
Normal	O

Eyes	O
:	O
no	B-negation
eye	B-bodyloc
pain	O
,	O
eyes	B-bodyloc
not	B-negation
red	O
,	O
no	B-negation
eyesight	O
problems	O
,	O
no	B-negation
purulent	O
discharge	O
from	O
the	O
eyes	B-bodyloc
,	O
no	B-negation
dryness	O
of	O
the	O
eyes	B-bodyloc
and	O
no	B-negation
itching	O
of	O
the	O
eyes	B-bodyloc
.	O

it	O
wasn	B-negation
'	I-negation
t	I-negation
originally	O
painful	O
but	O
now	B-temporal
it	O
is	O
.	O

Rx	O
:	O
14Aug2013	O

He	O
had	O
insomnia	O
and	O
decreased	B-course
appetite	O
after	O
the	O
steroid	O
treatment	O
.	O

Motor	O
Survey	O
:	O
the	O
motor	O
survey	O
was	O
normal	B-labvalue
.	O

History	O
of	O
Tonsillectomy	O

chronic	O
cough	O
,	O
thicker	O
sputum	O
white	O
/	O
clear	O

Eyes	O

History	O
of	O
Asthma	O
493	O
.	O
90	O

Integumentary	O
:	O
no	B-negation
rash	O
,	O
no	B-negation
skin	B-bodyloc
lesions	O
,	O
no	B-negation
skin	B-bodyloc
wound	O
,	O
no	B-negation
itching	O
,	O
no	B-negation
night	O
sweats	O
,	O
no	B-negation
breast	B-bodyloc
pain	O
,	O
no	B-negation
breast	B-bodyloc
lump	O
and	O
no	B-negation
change	O
in	O
a	O
mole	O
.	O

The	O
patient	O
presents	O
with	O
complaints	O
of	O
heartburn	O
(	O
SEE	O
HPI	O
)	O
.	O

1	O
Influenza	O
07Nov2012	B-temporal
Pneumococcal	O
20Oct2010	B-temporal

f	O
History	O
of	O
Visit	O
For	O
:	O
Ears	O
/	O
Hearing	O
pth	O
Following	O
Abn	O
Hearing	O
Screening	O
(	O
V72	O
.	O
11	O
)	O
;	O
(	O
Resolved	O
)	O

Patient	O
is	O
not	O
sexually	O
active	O
.	O

History	O
of	O
Joint	B-bodyloc
Pain	O
,	O
Localized	O
In	O
The	O
Knee	B-bodyloc
719	O
.	O
46	O

LMP	I-labvalue
15Mar2012	O

2	O
.	O

Cranial	O
Nerve	O
VIII	O
:	O
hearing	O
was	O
intact	B-labvalue
.	O

Neurologic	O

The	O
gait	O
was	O
stooped	O
and	O
shuffling	O
.	O

f	O
History	O
of	O
Neonatro	O
Hyperbilirubinemir	O
(	O
774	O
.	O
6	O
)	O
;	O
(	O
Resolved	B-course
)	O

Type	O
1	O
Diabetes	O
Mellitus	O
250	O
.	O
01	O

The	O
floor	O
of	O
the	O
mouth	O
is	O
normal	O
without	B-negation
any	O
abscess	O
,	O
suggestion	B-uncertain
of	O
Ludwig	O
'	O
s	O
syndrome	O
.	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

History	O
of	O
Present	O
Illness	O

No	B-negation
Known	O
Drug	O
Allergies	O

He	O
probably	B-uncertain
has	I-uncertain
AFRS	O
,	O
due	O
to	O
unilateral	O
disease	O
process	O
by	O
imaging	O
,	O
less	O
likely	B-uncertain
neoplasm	O
.	O

;	O
Apr	B-temporal
9	I-temporal
2012	I-temporal
2	B-temporal
:	I-temporal
12PM	I-temporal
(	O
Author	O
)	O

Patient	O
receiving	O
meds	O
from	O
PCP	O
.	O

Eyes	O
:	O
no	B-negation
eye	B-bodyloc
pain	O
,	O
eyes	B-bodyloc
not	B-negation
red	O
and	O
no	B-negation
eyesight	O
problems	O
.	O

History	O
of	O
Thyroid	B-bodyloc
Disorder	O
246	O
.	O
9	O

[	O
QLH	O
]	O
HEMOGLOBIN	O
Done	O
:	O
19Aug2010	B-temporal
12	B-temporal
:	I-temporal
47PM	I-temporal

History	O
of	O
Asthma	O
493	O
.	O
90	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
axillae	O
:	O
Normal	B-labvalue
.	O

His	O
sense	O
of	O
smell	O
is	O
unchanged	O
from	O
before	O

Patient	O
reports	O
on	O
Monday	B-temporal
(	O
6/10/2013	B-temporal
)	O
she	O
had	O
a	O
cold	O
sore	O
and	O
also	O
had	O
a	O
recent	B-temporal
evaluation	O
at	O
Doctor	O
'	O
s	O
Clinic	O
at	O
Hillcroft	O
/	O
59	O
for	O
a	O
urinary	B-bodyloc
tract	I-bodyloc
infection	O
on	O
6/11/2013	B-temporal
.	O

Advanced	O
Practitioner	O
Attestation	O
.	O

Physical	O
Exam	O

ENT	O
Referral	O
Outpatient	O
Referral	O
Requested	O
for	O
:	O
25Feb2014	B-temporal

Hernias	O
:	O
Normal	O
.	O

F	O
/	O
u	O
Rheum	O

Depression	O
311	O

Family	B-subject
history	O
of	O
Rectal	B-bodyloc
Cancer	O

Plan	O
Influenza	O
(	O
Split	O
)	O
;	O
every	B-frequency
1	I-frequency
year	I-frequency
;	I-frequency
Last	O
22Oct2008	B-temporal
;	O
Permanently	O
Deferred	O
;	O
Status	O
:	O
Permanent	O
Deferral	O

There	O
is	O
no	B-negation
erythema	O
or	O
swelling	O
.	O

Red	O
Blood	O
Cell	O
4	B-labvalue
.	I-labvalue
53	I-labvalue
M	I-labvalue
/	I-labvalue
CMM	I-labvalue
4	B-reference_range
.	I-reference_range
20	I-reference_range
-	I-reference_range
5	I-reference_range
.	I-reference_range
40	I-reference_range

Palpation	O
of	O
lymph	O
nodes	O
in	O
neck	O
:	O
No	B-negation
lymphadenopathy	O
.	O

History	O
of	O
Present	O
Illness	O
Paytin	O
is	O
a	O
2	O
y	O
/	O
o	O
AA	O
female	O
presenting	O
with	O
complaints	O
of	O
cough	O
and	O
bilateral	B-bodyloc
eye	I-bodyloc
drainage	O
x	O
3	B-temporal
days	I-temporal
worse	B-course
in	B-temporal
the	I-temporal
mornings	I-temporal
.	O

Pulmonary	O

2	O
.	O

Total	O
pregnancies	O
1	O
.	O
1	O
live	O
births	O
.	O
1	O
living	O
.	O
1	O
full	O
-	O
term	O
.	O
1	O
vaginal	O
delivery	O
(	O
s	O
)	O
.	O

Was	O
tx	O
with	O
cipro	O
/	O
medrol	O
dose	O
pack	O
.	O

Physical	O
Exam	O

Neck	O

Deep	O
tendon	O
reflexes	O
:	O
right	O
bicep	O
2	O
+	O
,	O
left	O
bicep	O
2	O
+	O
,	O
right	O
patella	O
2	O
+	O
,	O
left	O
patella	O
2	O
+	O
,	O
right	O
ankle	O
jerk	O
2	O
+	O
and	O
left	O
ankle	O
jerk	O
2	O
+	O
.	O

Endocrine	O
:	O
No	B-negation
intolerance	O
to	O
heat	O
,	O
no	B-negation
polydipsia	O
and	O
no	B-negation
polyuria	O
.	O

Septum	O
:	O
Midline	O
.	O

Congestive	O
Heart	B-bodyloc
Failure	O
428	O
.	O
0	O

Examination	O
of	O
digits	O
and	O
nails	O
:	O
Normal	B-labvalue
.	O

Abdomen	B-bodyloc
Obese	O
,	O
soft	O
,	O
nontender	O
,	O
no	B-negation
purple	O
striae	O
.	O
No	B-negation
palpable	O
mass	O
or	O
organomegaly	O
.	O

Current	B-temporal
asthma	O
treatments	O
:	O
Asthma	O
inhalers	O

General	O
appearance	O
:	O
Normal	O

Recently	O
d	O
/	O
c	O
'	O
d	O
off	O
5mg	B-strength
prednisone	O
qd	B-frequency
now	B-temporal
with	O
3	B-duration
weeks	I-duration
of	O
anosmia	O
,	O
nasal	B-bodyloc
congestion	O
,	O
clr	O
-	O
yellow	O
rhinorrhea	O
.	O

Description	O
of	O
patient	O
'	O
s	O
judgement	O
and	O
insight	O
:	O
Normal	B-labvalue

Height	O
:	O
4	B-labvalue
ft	I-labvalue
11	I-labvalue
in	I-labvalue

Sinuses	O
:	O
there	O
was	O
no	B-negation
tenderness	O
over	O
the	O
paranasal	B-bodyloc
sinuses	I-bodyloc
.	O

Palpation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

(	O
inf	O
.	O

Hearing	O
right	O
ear	O
:	O
.	O

Cough	O
786	O
.	O
2	O

Examination	O
of	O
thyroid	O
:	O
Normal	B-labvalue
.	O

Inspection	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
Normal	B-labvalue

Bladder	O
:	O
Normal	O
.	O

Immature	O
Cells	O
:	O

Pt	O
reports	O
skin	B-bodyloc
tingling	O
and	O
'	O
hyper	O
'	O
feeling	O
.	O

History	O
of	O
Hypertension	O
401	O
.	O
9	O

GHTN	O
d	O
/	O
c	O
'	O
d	O
on	O
labetalol	O
,	O
BP	O
at	O
home	O
mostly	O
140	B-labvalue
/	I-labvalue
90s	I-labvalue
.	O

Gait	O
evaluation	O
demonstrated	O
limping	O
on	O
the	O
leftandarrived	O
in	O
weigh	O
chair	O
and	O
unable	O
to	O
tolerate	O
weight	O
bearing	O
.	O

She	O
does	O
not	O
have	O
a	O
healthy	O
diet	O
.	O
She	O
has	O
weight	O
concerns	O
.	O
She	O
does	O
not	O
exercise	O
regularly	O
.	O
She	O
does	O
not	O
use	O
tobacco	O
.	O
She	O
consumes	O
alcohol	O
.	O
She	O
denies	O
drug	O
use	O
.	O

Examination	O
of	O
the	O
teeth	O
revealed	O
missing	O
teeth	B-bodyloc
.	O

Frequency	O
of	O
symptoms	O
:	O
Monthly	O

Then	O
continue	O
FP	O
/	O
MP	O
irrigations	O

Benefit	O
Plan	O

Motions	O
seem	O
to	O
be	O
a	O
trigger	O
especially	O
riding	O
elevators	O
.	O

Patient	O
is	O
a	O
25	O
y	O
.	O
o	O
.	O

Inspection	O
of	O
the	O
conjunctiva	O
and	O
lids	O
:	O
Normal	B-labvalue

Immunizations	O
*	O
*	O
Printed	O
in	O
Appendix	O
#	O
1	O
below	O
.	O

This	O
Pap	O
test	O
has	O
been	O
evaluated	O
with	O
computer	O

Bowel	O
sounds	O
were	O
normal	B-labvalue
.	O

Ordered	O
;	O
For	O
:	O
Benign	B-severity
Essential	O
Hypertension	O
(	O
401	O
.	O
1	O
)	O
;	O
Ordered	O
By	O
:	O
ABDELMELEK	O
,	O
LOURICE	O
Perform	O
:	O
In	O
Office	O
Due	O
:	O
07Sep2013	B-temporal
;	O
Last	O
Updated	O
By	O
:	O
Avellaneda	O
,	O
Mayra	O

ADMISSION	O
DIAGNOSIS	O
:	O
Microinvasive	O
carcinoma	O
of	O
the	O
cervix	B-bodyloc
.	O

History	O
of	O
Placement	O
Of	O
Intracranial	O
Neurostimulator	O
Pulse	O
Generator	O

Basophils	O
0	B-labvalue
.	I-labvalue
7	I-labvalue
%	I-labvalue
0	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
1	I-reference_range
.	I-reference_range
0	I-reference_range

Past	O
Medical	O
History	O
History	O
of	O
Nephrolithiasis	O
V13	O
.	O
01	O

She	O
does	O
work	O
on	O
her	O
feet	O
quite	O
a	O
bit	O
.	O

HOSPITAL	O
COURSE	O
:	O
The	O
patient	O
underwent	O
total	O
thyroidectomy	O
on	O
09/22/08	B-temporal
,	O
which	O
she	O
tolerated	O
very	O
well	O
and	O
remained	O
stable	O
in	O
the	O
postoperative	O
period	O
.	O

History	O
of	O
Hemorrhoids	O
455	O
.	O
6	O

Office	O
UA	O
unremarkable	B-labvalue
,	O
sent	O
cx	O
,	O
chest	O
xray	O
unchanged	O
from	O
last	B-temporal
month	I-temporal
,	O
check	O
final	O
read	O
.	O

Respiratory	O
:	O
shortness	O
of	O
breath	O
,	O
cough	O
and	O
shortness	O
of	O
breath	O
during	O
exertion	O
,	O
but	O
no	B-negation
wheezing	O
.	O

Electronically	O
signed	O
by	O
:	O
Susan	O
Pelini	O
,	O
M	O
.	O
D	O
.	O
;	O

(	O
NKDEP	O
)	O
which	O
additionally	O
recommrtds	O
that	O
when	O
the	O
eGFR	O
is	O
used	O
in	O
pa	O
irt	O
s	O

Head	O
and	O
Face	O

Examination	O
of	O
the	O
oropharynx	O
:	O
Normal	B-labvalue
Examination	O
of	O
the	O
palate	O
showed	O
no	B-negation
abnormalities	O
.	O

The	O
tonsils	O
were	O
normal	O
.	O

She	O
has	O
been	O
sedated	O
with	O
Ativan	O
and	O
came	O
into	O
the	O
emergency	O
room	O
obtunded	O
and	O
unable	O
to	O
give	O
any	O
history	O
.	O

BMI	O
Calculated	O
:	O
31	B-labvalue
.	I-labvalue
04	I-labvalue

Losartan	O
Potassium	O
100	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Last	O
Rx	O
:	O
24Oct2012	B-temporal

flu	O
vaccine	O
mhcma	O

Stasis	O
Dermatitis	O
454	O
.	O
1	O

Pupils	O
are	O
3	O
mm	O
and	O
equally	O
round	O
and	O
reactive	O
to	O
light	O
bilaterally	O
.	O

He	O
will	O
need	O
to	O
remain	O
on	O
supplemental	O
Iron	O
as	O
an	O
outpatient	O
for	O
his	O
anemia	O
.	O

Genitourinary	O
:	O
no	B-negation
urinary	O
incontinence	O
.	O

f	O
AphtHous	O
Ulcer	O
(	O
528	O
.	O
2	O
)	O
;	O
(	O
Active	O
)	O

Left	O
index	O
digital	O
artery	O
,	O
digital	O
nerve	O
repair	O
radial	O
and	O
ulnar	O
nerve	O
repair	O
x2	O
2	O
.	O

Observed	O
mood	O
and	O
affect	O
:	O
appropriate	O
affectandappropriate	O
mood	O
.	O

History	O
of	O
Chronic	O
Hepatitis	O
,	O
C	O
Virus	O
070	O
.	O
54	O

No	B-negation
masses	O
palpated	O
.	O

ABDOMEN	O
:	O
Soft	O
,	O
and	O
with	O
deep	O
palpation	O
I	O
am	O
unable	O
to	O
arouse	O
the	O
patient	O
,	O
unable	B-negation
to	O
elicit	O
any	O
tenderness	O
.	O

Pulse	O
ox	O
.	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
.	O

Globulin	O
,	O
Total	O
:	O
2	B-labvalue
.	I-labvalue
8	I-labvalue
g	I-labvalue
/	I-labvalue
dL	I-labvalue
Reference	O
Range	O
1	B-reference_range
.	I-reference_range
5	I-reference_range
-	I-reference_range
4	I-reference_range
.	I-reference_range
5	I-reference_range

Her	O
white	O
blood	O
cell	O
count	O
at	O
discharge	O
was	O
1	B-labvalue
.	I-labvalue
4	I-labvalue
and	O
her	O
hemoglobin	O
was	O
11	B-labvalue
.	I-labvalue
2	I-labvalue
with	O
a	O
platelet	O
count	O
of	O
140	B-labvalue
.	I-labvalue

Discussion	O
/	O
Signatures	O
Electronically	O
signed	O
by	O
:	O
Robin	O
Hardwicke	O
,	O
NP	O
;	O
Aug	B-temporal
14	I-temporal
2013	I-temporal
4	B-temporal
:	I-temporal
06PM	I-temporal
(	O
Author	O
)	O

Plan	O
Megestrol	O
Acetate	O
400	B-strength
MG	I-strength
/	I-strength
10ML	I-strength
Oral	B-route
Suspension	B-form
;	O
TAKE	O
20	B-dosage
ML	I-dosage
,	O
BY	O
MOUTH	O
,	O
DAILY	O
AS	O
DIRECTED	O
;	O
Therapy	O
:	O
06Dec2012	B-temporal
to	O
(	O
Evaluate	O
:	O
04Feb2013	B-temporal
)	O
Requested	O
for	O
:	O
06Dec2012	B-temporal
;	O
Last	O
Rx	O
:	O
06Dec2012	B-temporal
;	O
Edited	O

BMI	O
Calculated	O
:	O
29	B-labvalue
.	I-labvalue
16	I-labvalue

Psychiatric	O
:	O
not	B-negation
suicidal	O
,	O
no	B-negation
sleep	O
disturbances	O
,	O
no	B-negation
anxiety	O
,	O
no	B-negation
depression	O
,	O
no	B-negation
personality	O
change	O
and	O
no	B-negation
emotional	O
problems	O
.	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
JULIE	O
BORTOLOTTI	O
,	O
M	O
.	O
D	O
.	O

I	O
was	O
present	O
and	O
available	O
in	O
clinic	O
.	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
,	O
the	O
heart	O
rate	O
was	O
not	B-labvalue
fast	I-labvalue
,	O
no	B-negation
intermittent	O
leg	B-bodyloc
claudication	O
and	O
no	B-negation
edema	O
.	O

At	O
the	O
time	O
of	O
discharge	O
,	O
he	O
was	O
afebrile	O
.	O

Follow	O
-	O
up	O
visit	O
in	O
1	O
month	O
Outpatient	O
Follow	O
-	O
up	O
Done	O
:	O
01Dec2011	B-temporal
cultures	O
today	B-temporal

Septum	O
:	O
Midline	O
.	O

Therapy	O
:	O
31Jan2012	B-temporal
to	O
04Apr2012	B-temporal
;	O
Last	O
Rx	O
:	O
31Jan2012	B-temporal
;	O
Status	O
:	O
DISCONTINUED	O

UTP	O
-	O
HM	O
,	O
The	O
patient	O
presents	O
for	O
follow	O
-	O
up	O
of	O
primary	O
hypertension	O
.	O

Lymphatic	O

Discussion	O
/	O
Attending	O
Note	O

Inspection	O
of	O
lips	O
,	O
teethand	O
gums	O
:	O
Normal	B-labvalue
.	O

Post	O
-	O
nasal	B-bodyloc
drip	O
:	O
Moderate	B-severity

Healing	O
well	O
,	O
no	B-negation
erythema	O
,	O
induration	O
or	O
discharge	O
from	O
wound	O
.	O

Eyes	O
:	O
no	B-negation
eye	B-bodyloc
pain	O
,	O
eyes	B-bodyloc
not	B-negation
red	O
,	O
no	B-negation
eyesight	O
problems	O
and	O
no	B-negation
purulent	O
discharge	O
from	O
the	O
eyes	B-bodyloc
.	O

Surgical	O
incision	O
(	O
the	O
incision	O
site	O
was	O
intact	O
)	O
.	O

Past	O
Medical	O
History	O
History	O
of	O
Osteoarthritis	O
V13	O
.	O
4	O

Electronically	O
signed	O
by	O
:	O
Denise	O
Hansen	O
PA	O

f	O
History	O
of	O
Anemir	O
Of	O
Prematurity	O
(	O
776	O
.	O
6	O
)	O
;	O
(	O
Resolved	B-course
)	O

Chief	O
Complaint	O

Family	O
History	O
Family	B-subject
history	O
of	O
Cancer	O

Right	O
Hypothenar	O
(	O
uln	O
.	O
)	O
:	O
Normal	O
.	O

Constitutional	O
:	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
,	O
not	B-negation
feeling	O
poorly	O
(	O
malaise	O
)	O
,	O
not	B-negation
feeling	O
tired	O
(	O
fatigue	O
)	O
,	O
no	O
recent	O
weight	O
gain	O
and	O
no	B-negation
recent	B-temporal
weight	O
loss	O
.	O

;	O
Oct	B-temporal
1	I-temporal
2013	I-temporal
4	B-temporal
:	I-temporal
45PM	I-temporal
(	O
Author	O
)	O

URI	O
:	O
Supportive	O
care	O
with	O
rest	O
,	O
fluids	O
,	O
Robitussin	O
,	O
Allegra	O
and	O
Tylenol	O
.	O

Family	B-subject
history	O
of	O
Hypertension	O
V17	O
.	O
49	O

nonerythematous	O
,	O
equal	O
on	O
both	O
lower	O
extremities	O
.	O

Orientation	O
to	O
person	O
,	O
place	O
and	O
time	O
:	O
Normal	B-labvalue
.	O

Psychiatric	O

(	O
Medical	O
Transcription	O
Sample	O
Report	O
)	O

Age	O
at	O
menarche	O
was	O
12	O
.	O

History	O
of	O
Depression	O
311	O

Third	O
pregnancy	O
:	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
shortness	O
of	O
breath	O
during	O
exertion	O
,	O
no	B-negation
orthopnea	O
and	O
no	B-negation
PND	O

LABORATORY	O
STUDIES	O
:	O
White	O
count	O
6	B-labvalue
.	I-labvalue
7	I-labvalue
,	O
hemoglobin	O
13	B-labvalue
,	O
hematocrit	O
39	B-labvalue
.	I-labvalue
3	I-labvalue
.	O

Red	O
Blood	O
Cell	O
4	B-labvalue
.	I-labvalue
69	I-labvalue
M	I-labvalue
/	I-labvalue
CMM	I-labvalue
4	B-reference_range
.	I-reference_range
20	I-reference_range
-	I-reference_range
5	I-reference_range
.	I-reference_range
40	I-reference_range

Gastrointestinal	O
:	O
normal	O
,	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
vomiting	O
,	O
no	B-negation
nausea	O
,	O
no	B-negation
melena	O
and	O
no	B-negation
change	O
in	O
stool	O
.	O

Family	B-subject
history	O
of	O
Diabetes	O
Mellitus	O
V18	O
.	O
0	O

Const	O
:	O
no	B-negation
fever	O
,	O
no	B-negation
unexpected	O
change	O
in	O
weight	O
,	O
not	B-negation
tiring	O
easily	O
and	O
no	B-negation
night	O
sweats	O
.	O

Type	O
2	O
Diabetes	O
Mellitus	O
-	O
Uncomplicated	O
,	O
Controlled	B-course
250	O
.	O
00	O

There	O
is	O
no	B-negation
erythema	O
,	O
exudate	O
,	O
lesion	O
or	O
swelling	O
.	O

Examination	O
of	O
the	O
head	O
and	O
face	O
:	O
Normal	B-labvalue

Procedure	O

(	O
festination	O
with	O
gait	O
)	O

History	O
of	O
Present	O
Illness	O
The	O
patient	O
states	O
she	O
has	O
been	O
stable	O
with	O
her	O
Type	O
II	O
Diabetes	O
control	O
since	O
the	O
last	O
visit	O
.	O

Arthralgia	O
Of	O
The	O
Left	B-bodyloc
Knee	I-bodyloc
/	I-bodyloc
Patella	I-bodyloc
/	I-bodyloc
Tibia	I-bodyloc
/	I-bodyloc
Fibula	I-bodyloc
719	O
.	O
46	O

Symptoms	O
:	O
weight	O
gain	O
,	O
but	O
no	B-negation
fatigue	O
,	O
no	B-negation
weight	O
loss	O
,	O
no	B-negation
polyuria	O
,	O
no	B-negation
polydipsia	O
,	O
no	B-negation
exercise	O
intolerance	O
,	O
no	B-negation
dyspnea	O
and	O
no	B-negation
chest	B-bodyloc
pain	O
.	O

Active	O
Problems	O
Acute	B-course
Upper	B-bodyloc
Respiratory	I-bodyloc
Infection	O
465	O
.	O
9	O

Cranial	O
nerves	O
III	O
,	O
IV	O
,	O
and	O
VI	O
:	O
the	O
extraocular	O
motions	O
were	O
intact	B-labvalue
.	O

ABDOMEN	O
:	O
Soft	O
to	O
palpation	O
in	O
all	O
four	O
quadrants	O
.	O

Surgical	O
History	O
History	O
of	O
Nasal	O
Endoscopy	O
Polypectomy	O

Post	O
op	O
course	O
complicated	O
by	O
transient	O
right	B-bodyloc
arm	I-bodyloc
median	I-bodyloc
nerve	I-bodyloc
injury	O
that	O
resolved	B-course
spontaneously	O
.	O

Vitals	O
UTP	O
Adult	O
Vital	O
Signs	O
[	O
Data	O
Includes	O
:	O
Current	O
Encounter	O
]	O

Persistent	O
Sinus	B-bodyloc
Bradycardia	O
427	O
.	O
81	O

[	O
QLH	O
]	O
PSA	O
,	O
TOTAL	O
Requested	O
for	O
:	O
21Mar2012	B-temporal

Coronary	O
angiography	O
showed	O
a	O
right	O
dominant	O
system	O
with	O
90	O
%	O
stenosis	O
of	O
the	B-bodyloc
LAD	I-bodyloc
and	O
total	O
occlusions	O
of	O
the	O
second	B-bodyloc
obtuse	I-bodyloc
marginal	I-bodyloc
and	O
mid	B-bodyloc
right	I-bodyloc
coronary	I-bodyloc
artery	I-bodyloc
.	O

Edema	O
782	O
.	O
3	O

She	O
is	O
now	B-temporal
using	O
walker	O
in	O
home	O
and	O
wheel	O
chair	O
when	O
outside	O
the	O
house	O
.	O

Nasal	B-bodyloc
congestion	O
:	O
None	B-negation

Signatures	O
Electronically	O
signed	O
by	O
:	O
BARBARA	O
SCHROEDER	O
,	O
M	O
.	O
D	O
.	O

May	O
use	O
OTC	O
Imodium	O
as	O
needed	O
for	O
diarhea	O
.	O

Constitutional	O

pt	O
is	O
here	O
to	O
see	O
Dr	O
.	O
Bajwa	O
for	O
cough	O
and	O
congestion	O

Hypothyroidism	O
244	O
.	O
9	O

[	O
QLH	O
]	O
HEMATOCRIT	O
Done	O
:	O
02Aug2010	B-temporal
12	B-temporal
:	I-temporal
05PM	I-temporal

Examination	O
of	O
the	O
oropharynx	O
:	O
Normal	B-labvalue
The	O
oral	O
mucosa	O
was	O
moist	O
.	O

Cardiovascular	O

Jugular	O
Veins	O
:	O
the	O
JVP	O
was	O
not	B-labvalue
elevated	I-labvalue
.	O

Cranial	O
nerves	O
XI	O
:	O
shoulder	O
shrug	O
was	O
intact	B-labvalue
bilaterally	I-labvalue
.	O

Appearance	O
:	O
swelling	O
,	O
buteffusion	O
.	O

Triamcinolone	O
Acetonide	O
0	B-strength
.	I-strength
1	I-strength
%	I-strength
External	O
Cream	B-form
;	O
APPLY	O
SPARINGLY	O
TO	O
AFFECTED	O
AREA	O
(	O
S	O
)	O
2	B-frequency
TO	I-frequency
3	I-frequency
TIMES	I-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
16Nov2012	B-temporal
to	O
(	O
Evaluate	O
:	O
06Dec2012	B-temporal
)	O
Requested	O
for	O
:	O
16Nov2012	B-temporal
;	O
Last	O
Rx	O
:	O
16Nov2012	B-temporal
;	O
Edited	O

3	O
.	O

1	O
.	O

Plan	O
Left	O
cavity	O
and	O
ear	O
canal	O
cleaning	O
was	O
performed	O
.	O

MRI	O
Brain	O
w	O
contrast	O
Requested	O
for	O
:	O
17Oct2012	B-temporal

03	I-strength
&	I-strength
0	I-strength
.	I-strength
01	I-strength
MG	I-strength
Oral	B-route
Tablet	O
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O

Right	O
Anter	O
.	O

Medical	O
Decision	O
Making	O
:	O

Pt	O
states	O
that	O
back	B-bodyloc
pain	O
is	O
still	O
present	O
and	O
might	O
be	O
having	O
issues	O
with	O
her	O
kidneys	B-bodyloc
.	O

Symptoms	O
:	O
Denies	B-negation
impaired	O
vision	O
,	O
dyspnea	O
worsened	B-course
,	O
denies	B-negation
chest	B-bodyloc
pain	O
,	O
denies	B-negation
intermittent	O
leg	B-bodyloc
claudication	O
and	O
lower	B-bodyloc
extremity	I-bodyloc
edema	O
worsened	B-course
.	O

Symptoms	O
:	O
no	B-negation
headache	O
,	O
no	B-negation
confusion	O
,	O
no	B-negation
visual	O
disturbance	O
,	O
no	B-negation
dizziness	O
and	O
no	B-negation
shortness	O
of	O
breath	O
.	O

Inspection	O
/	O
palpation	O
of	O
joints	O
,	O
bones	O
,	O
and	O
muscles	O
:	O
Normal	B-labvalue

Lisinopril	O
40	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
EVERY	B-frequency
DAY	I-frequency
;	O
Therapy	O
:	O
09Sep2008	B-temporal
to	O
(	O
Evaluate	O
:	O
07Apr2012	B-temporal
)	O
Requested	O
for	O
:	O
13May2011	B-temporal
;	O
Last	O
Rx	O
:	O
13May2011	B-temporal

The	O
right	O
tympanic	O
membrane	O
was	O
normal	O
.	O

Symptoms	O
:	O
Denies	B-negation
impaired	O
vision	O
,	O
denies	B-negation
dyspnea	O
,	O
denies	B-negation
chest	B-bodyloc
pain	O
,	O
denies	B-negation
intermittent	O
leg	B-bodyloc
claudication	O
and	O
lower	B-bodyloc
extremity	I-bodyloc
edema	O
stable	B-course
.	O

Skin	O

TextFinding44End	O
TextFinding46Start	O
TextFinding46End	O
FreeTextBox48Start	O
FreeTextBox48End	O
GroupHeading50Start	O
Diet	O
recommendatisps	O
:	O
weight	O
loss	O
diet	O
,	O
low	O
fat	O
diet	O
,	O
low	O
sidium	O
diet	O
,	O
low	O
glycemic	O
index	O
diet	O
.	O

Right	O
Gastroc	O
.	O

Otoscopic	O
examination	O
:	O
Normal	B-labvalue

Cardiovascular	O

Fluzone	O
9	B-strength
MCG	I-strength
/	I-strength
STRAIN	I-strength
Intradermal	I-strength
Device	I-strength
;	O
INJECT	O
0	B-dosage
.	I-dosage
1	I-dosage
ML	I-dosage
Intradermal	B-route
;	O
Dose	O
:	O
.	B-dosage
1	I-dosage
;	O
Route	O
:	O
Intradermal	B-route
;	O
Site	O
:	O
Right	O
Arm	O
;	O
Done	O
:	O
26Nov2012	B-temporal
10	B-temporal
:	I-temporal
54AM	I-temporal
;	O
Status	O
:	O
Complete	O

Musculoskeletal	O
:	O
Back	B-bodyloc
pain	O
,	O
general	O
pain	O
,	O
and	O
limited	O
motion	O
.	O

Assessment	O
of	O
muscle	O
strength	O
/	O
tone	O
:	O
Normal	B-labvalue
.	O

Maternal	B-subject
history	O
of	O
Hypertension	O
V17	O
.	O
49	O

Cough	O
:	O
None	B-negation

Additional	O
History	O
:	O
T	O
.	O
C	O
144	B-labvalue
HDL63	O
LDL61	O
TRIGL	O
98	B-labvalue
.	O

Never	O
A	O
Smoker	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

6	O
.	O

Pseudoephedrine	O
Sinus	O
CAPS	B-form
;	O
Status	O
:	O
DISCONTINUED	O

Cranial	O
nerves	O
IX	O
and	O
X	O
:	O
there	O
was	O
normal	B-labvalue
movement	O
of	O
the	O
soft	O
palate	O
and	O
normal	B-labvalue
gag	O
.	O

Vitals	O
UTP	O
Adult	O
Vital	O
Signs	O
[	O
Data	O
Includes	O
:	O
Current	O
Encounter	O
]	O

Christie	O
Mileur	O

HEENT	O
:	O
Normocephalic	O
,	O
atraumatic	O
.	O

Reviewed	O
medicatiop	O
list	O
w	O
th	O
patient	O
in	O
detail	O
.	O

US	O
Thyroid	O
Requested	O
for	O
:	O
13Nov2012	B-temporal

A1c	O
6	B-labvalue
.	I-labvalue
6	I-labvalue
%	I-labvalue
;	O
LDL	O
89	B-labvalue
;	O
HDL	O
86	B-labvalue
;	O
TG	O
146	B-labvalue
;	O
TC	O
204	B-labvalue
;	O

Lips	O
,	O
teeth	O
,	O
gums	O
,	O
palate	O
without	O
lesion	O
.	O

CONSTITUTIONAL	O

Social	O
History	O
Marital	O
History	O
-	O
Currently	O
Married	O

[	O
QLH	O
]	O
CBC	O
(	O
INCLUDES	O
DIFF	O
/	O
PLT	O
)	O
Requested	O
for	O
:	O
31Oct2013	B-temporal

Anesthesia	O
:	O
Topical	B-route
lidocaine	O
spray	O
and	O
Topical	O
oxymetazoline	O
spray	B-route
.	O

Uterus	O
:	O
Normal	O
size	O
,	O
no	B-negation
tenderness	O
,	O
no	B-negation
masses	O
.	O

Seborrhic	O
Kertaosis	O
on	O
chest	B-bodyloc
/	O
back	B-bodyloc
/	O
L	O
face	O
.	O

LMP	O
:	O
the	O
LMP	O
was	O
approximately	O
1994	B-temporal
(	O
hyst	O
)	O
month	B-temporal
(	I-temporal
s	I-temporal
)	I-temporal
ago	I-temporal
.	O

No	B-negation
rales	O
or	O
crackles	O
were	O
heard	O
.	O

Patient	O
Specific	O
Education	O
Given	O
Done	O
:	O
10Feb2014	B-temporal

(	O
right	O
arytenoid	O
is	O
retracted	O
into	O
larynx	O
,	O
difficult	O
to	O
see	O
around	O
)	O
.	O

[	O
Q	O
]	O
COMPREHENSIVE	O
METABOLIC	O
PANEL	O
W	O
/	O
eGFR	O
(	O
REFL	O
)	O
Requested	O
for	O
:	O
11Apr2014	B-temporal

3	O
.	O

Metolazone	O
2	B-strength
.	I-strength
5	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
EVERY	B-frequency
OTHER	I-frequency
DAY	I-frequency
IN	O
THE	O
MORNING	O
;	O
Therapy	O
:	O
12Jan2010	B-temporal
to	O
(	O
Evaluate	O
:	O
09Apr2012	B-temporal
)	O
Requested	O
for	O
:	O
13Oct2011	B-temporal
;	O
Last	O
Rx	O
:	O
12Oct2011	B-temporal

Alert	O
and	O
cheeful	O
.	O

I	O
have	O
also	O
told	O
him	O
that	O
his	O
exam	O
is	O
now	O
almost	O
back	O
to	O
normal	O
in	O
the	O
right	O
foot	O
and	O
ankle	O
dorsiflexion	O
.	O

General	O
appearance	O
:	O
Normal	B-labvalue
.	O

History	O
of	O
Present	O
Illness	O

Paternal	B-subject
history	O
of	O
Type	O
2	O
Diabetes	O
Mellitus	O

Use	O
of	O
the	O
eGFR	O
is	O

Past	O
Medical	O
History	O
History	O
of	O
Atrial	B-bodyloc
Fibrillation	O
427	O
.	O
31	O

Examination	O
of	O
pupils	O
and	O
irises	O
:	O
Normal	B-labvalue

ElectronicCily	O
signed	O
by	O
:	O
POURAN	O
YOUSEFI	O
M	O
.	O
D	O
.	O
;	O
04/10/2013	B-temporal
12	B-temporal
:	I-temporal
20	I-temporal
PM	I-temporal
CST	O
;	O
Author	O
.	O
eg	O

Examination	O
of	O
sensation	O
:	O
Normal	B-labvalue
.	O

1	O
.	O

The	O
patient	O
complained	O
of	O
a	O
headache	O
which	O
is	O
present	O
over	O
the	O
right	O
side	O
of	O
the	O
head	O
where	O
she	O
had	O
MVA	B-bodyloc
injury	O
and	O
is	O
described	O
as	O
"	O
pinching	O
.	O
"	O
There	O
is	O
no	B-negation
associated	O
photophobia	O
or	O
phonophobia	O
,	O
no	B-negation
visual	O
disturbance	O
,	O
no	B-negation
N	O
/	O
V	O
,	O
no	B-negation
light	O
-	O
headedness	O
or	O
vertigo	O
.	O

Otoscopic	O
examination	O
:	O
Normal	B-labvalue
.	O

Home	O
With	O
Service	O

Family	B-subject
history	O
of	O
Denial	B-negation
Of	O
Any	O
Significant	O
Medical	O
History	O

Inspection	O
of	O
the	O
nasal	O
mucosa	O
,	O
septum	O
and	O
turbinates	O
:	O
Normal	B-labvalue
.	O

Symptoms	O
:	O
Denies	B-negation
numbness	O
of	O
the	O
feet	B-bodyloc
,	O
denies	B-negation
a	O
foot	B-bodyloc
ulcer	O
,	O
denies	B-negation
foot	B-bodyloc
pain	O
,	O
denies	B-negation
vomiting	O
and	O
denies	O
visual	O
impairment	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O
The	O
patient	O
is	O
a	O
13	O
-	O
year	O
-	O
old	O
male	O
approximately	O
6	O
-	O
1	O
/	O
2	O
weeks	O
status	O
post	O
removal	O
of	O
hardware	O
,	O
left	O
tibia	O
.	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

[	O
QLH	O
]	O
IRON	O
AND	O
TOTAL	O
IRON	O
BINDING	O
CAPACITY	O
Done	O
:	O
11Nov2011	B-temporal
12	B-temporal
:	I-temporal
55PM	I-temporal

Fundoscopic	O
Exam	O
:	O
Normal	B-labvalue
.	O

LAST	O

Mar	B-temporal
26	I-temporal
2013	I-temporal
8	B-temporal
:	I-temporal
34AM	I-temporal
CST	O
Co	O
-	O
author	O

Eyes	O
:	O
no	B-negation
discharge	O
from	O
the	O
eyes	B-bodyloc
.	O

Reduced	O
the	O
amplitude	O
because	O
teh	O
corner	O
of	O
her	O
mouth	O
was	O
twitching	O
at	O
the	O
higher	O
amplitude	O
.	O

BusPIRone	O
HCl	O
30	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
08Mar2013	B-temporal
to	O
(	O
Evaluate	O
:	O
07Apr2013	B-temporal
)	O
Requested	O
for	O
:	O
08Mar2013	B-temporal
;	O
Last	O
Rx	O
:	O
08Mar2013	B-temporal

A1	O
pulley	O
release	O
10	O
.	O

ALL	O
ROM	O
EXHIBIT	O
MOD	O
.	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
constipation	O
and	O
no	B-negation
diarrhea	O
.	O

Hematologic	O
/	O
Lymphatic	O
:	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
and	O
no	B-negation
swollen	O
glands	B-bodyloc
.	O

Cerebellar	O
:	O
the	O
cerebellar	O
function	O
was	O
normal	B-labvalue
.	O

Integumentary	O
:	O
no	B-negation
skin	B-bodyloc
lesions	O
,	O
no	B-negation
skin	B-bodyloc
wound	O
,	O
no	B-negation
itching	O
,	O
no	B-negation
breast	B-bodyloc
pain	O
,	O
no	B-negation
breast	B-bodyloc
lump	O
and	O
no	B-negation
change	O
in	O
a	O
mole	O
.	O

Hypertension	O
401	O
.	O
9	O

Follow	O
-	O
up	O
PRN	O
Outpatient	O
Follow	O
-	O
up	O
Requested	O
for	O
:	O
22Apr2013	B-temporal
Nasal	O
Endoscopy	O

Immunizations	O

Assessment	O
of	O
muscle	O
strength	O
/	O
tone	O
:	O
Normal	B-labvalue
.	O

Clidinium	O
-	O
Chlordiazepoxide	O
CAPS	B-form
;	O
TAKE	O
CAPSULE	B-form
PRN	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
24Sep2013	B-temporal
)	O
to	O

The	O
nasal	O
mucosa	O
was	O
normal	O
.	O

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

The	O
patient	O
reports	O
persistent	O
symptoms	O
despite	O
appropriate	O
treatment	O
.	O

Called	O
rx	O
in	O
to	O
pharmacy	O
713-218-4491	O
lm	O
on	O
vm	O
and	O
sent	O
electronically	O
.	O

Examination	O
of	O
the	O
abdomen	O
:	O
Normal	B-labvalue
The	O
abdomen	O
was	O
flat	O
.	O

LYMPHATIC	O

Eyes	O
:	O
eyes	O
are	O
not	O
red	O
and	O
no	B-negation
purulent	O
discharge	O
from	O
the	O
eyes	B-bodyloc
.	O

He	O
declined	O
the	O
instructions	O
.	O

Eyes	O

Ocular	O
motility	O
:	O
Extraocular	B-labvalue
muscles	I-labvalue
intact	I-labvalue
.	O

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

Patient	O
here	O
to	O
see	O
Dr	O
.	O
Zulfiqar	O
with	O
c	O
/	O
o	O
migraine	O
headache	O

Place	O
of	O
Delivery	O
:	O
MHH	O
.	O

MT	O
/	O
MM	O
:	O
Normal	B-labvalue

Past	O
Medical	O
History	O
History	O
of	O
Ecchymosis	O
459	O
.	O
89	O

History	O
of	O
Back	B-bodyloc
Pain	O
724	O
.	O
5	O

0	I-reference_range
Monocy	O
es	O
#	O
0	B-labvalue
.	I-labvalue
6	I-labvalue
K	I-labvalue
/	I-labvalue
CMM	I-labvalue
0	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
0	I-reference_range
.	I-reference_range

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
,	O
no	B-negation
cough	O
,	O
no	B-negation
shortness	O
of	O
breath	O
during	O
exertion	O
,	O
no	B-negation
orthopnea	O
and	O
no	B-negation
PND	O
.	O

No	B-negation
wheezing	O
was	O
heard	O
.	O

Cough	O
786	O
.	O
2	O

denies	B-negation
hx	O
of	O
cancer	O
,	O
diabetes	O
or	O
hypertension	O

1	O
Influenza	O
09Sep2009	B-temporal

57M	O
with	O
Right	B-bodyloc
sided	I-bodyloc
AFRS	O
presents	O
for	O
preop	O
visit	O
.	O

GDM	O
-	O
need	O
6w	O
2hr	O
GTT	O

Gait	O
evaluation	O
demonstrated	O
antalgia	O
bilaterallyandantalgia	O
on	O
the	O
right	O
.	O

Ibuprofen	O
600	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
TWICE	B-frequency
DAILY	I-frequency
WITH	I-frequency
MEALS	I-frequency
;	O
Therapy	O
:	O
28Aug2013	B-temporal

The	O
risks	O
,	O
benefits	O
and	O
anticipated	O
outcomes	O
of	O
the	O
procedure	O
,	O
the	O
risks	O
and	O
benefits	O
to	O
the	O
alterntive	O
of	O
the	O
procedure	O
,	O
and	O
the	O
roles	O
and	O
tasks	O
of	O
personnel	O
involved	O
were	O
discussed	O
with	O
the	O
patient	O
,	O
and	O
the	O
patient	O
consents	O
to	O
the	O
procedure	O
and	O
agrees	O
to	O
proceed	O
.	O

Current	O
Meds	O
Butalbital	O
-	O
APAP	O
-	O
Caffeine	O
50-300-40	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
EVERY	B-frequency
6	I-frequency
HOURS	I-frequency
PRN	B-frequency
for	O
pain	O
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
25Feb2014	B-temporal
)	O
to	O

Left	O
GPI	O
Right	O
GPI	O

Interval	O
symptoms	O
:	O
worsened	B-course
heartburn	O
,	O
denies	B-negation
chest	B-bodyloc
pain	O
,	O
stable	B-bodyloc
abdominal	I-bodyloc
pain	O
,	O
worsened	B-course
acid	O
regurgitationandstable	O
dysphagia	O
.	O

Temp	O
:	O
98	B-labvalue
.	I-labvalue
5	I-labvalue
F	I-labvalue
Tympanic	O
HR	O
:	O
56	B-labvalue
b	I-labvalue
/	I-labvalue
min	I-labvalue
;	O
Resp	O
:	O
16	B-labvalue
r	I-labvalue
/	I-labvalue
min	I-labvalue
;	O
LMP	O
:	O
01Nov2012	B-labvalue
;	O
.	O
eg	O

Headache	O
784	O
.	O
0	O

Urethral	O
meatus	O
:	O
Normal	O
.	O

3	O
.	O

Active	O
Problems	O
Carrier	O
Of	O
A	O
Group	O
B	O
Streptococcal	O
Infection	O
V02	O
.	O
51	O

Occupation	O
:	O

Plap	O
_	O
2	O
_	O
twCiteListControlEnd	O
4	O
4	O
/	O
7	O
WBD	O

Ocular	O
motility	O
:	O
Extraocular	O
muscles	O
intact	B-labvalue
.	O

Vitamin	O
D3	O
25	O
-	O
OH	O
51	B-labvalue
ng	I-labvalue
/	I-labvalue
ml	I-labvalue

Examination	O
of	O
the	O
palate	O
showed	O
no	B-negation
abnormalities	O
.	O

Mar	B-temporal
29	I-temporal
2012	I-temporal
9	B-temporal
:	I-temporal
49AM	I-temporal
(	O
Author	O
)	O

4	O
.	O

Lungs	O
Percussion	O
:	O
Normal	B-labvalue
.	O

Examination	O
of	O
liver	O
and	O
spleen	O
:	O
Normal	B-labvalue
.	O

Patient	O
notes	O
general	O
numbness	O
of	O
digits	B-bodyloc
[	O
*	O
*	O
1	B-temporal
-	I-temporal
26	I-temporal
*	O
*	O
]	O
and	O
inability	O
to	O
flex	O
digit	B-bodyloc
4	O
.	O

Counseling	O
/	O
Signatures	O
Electronically	O
signed	O
by	O
:	O
LOURICE	O
ABDELMELEK	O
,	O
M	O
.	O
D	O
.	O

Involuntary	O
Movements	O
:	O
no	B-negation
involuntary	O
movements	O
were	O
seen	O
.	O

Pupils	O
:	O
.	O

Assessment	O
of	O
hearing	O
:	O
Normal	B-labvalue
.	O

Current	O
Meds	O
Antara	O
130	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
27Dec2012	B-temporal
to	O
(	O
Evaluate	O
:	O
27Mar2013	B-temporal
)	O
Requested	O
for	O
:	O
27Dec2012	B-temporal
;	O
Last	O
Rx	O
:	O
27Dec2012	B-temporal

No	B-negation
wheezing	O
was	O
heard	O
.	O

[	O
QLH	O
]	O
CBC	O
(	O
INCLUDES	O
DIFF	O
/	O
PLT	O
)	O
Requested	O
for	O
:	O
12Sep2012	B-temporal

Family	B-subject
history	O
of	O
Thyroid	B-bodyloc
Cancer	O

Will	O
have	O
him	O
come	O
back	O
in	O
a	O
month	O
.	O

Lisinopril	O
20	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
EVERY	B-frequency
DAY	I-frequency
;	O
Therapy	O
:	O
07Oct2010	B-temporal
to	O
(	O
Evaluate	O
:	O
16Dec2012	B-temporal
)	O
Requested	O
for	O
:	O
27Dec2012	B-temporal
;	O
Last	O
Rx	O
:	O
17Sep2012	B-temporal

Discussion	O
/	O
Discussion	O
/	O
Summary	O

Review	O
of	O
Systems	O

Integumentary	O
:	O
no	B-negation
skin	B-bodyloc
lesions	O
.	O

Abdominal	O
aorta	O
:	O
Normal	B-labvalue
.	O

Surgical	O
History	O
History	O
of	O
Dilation	O
And	O
Curettage	O

Bilateral	O
nipple	O
examination	O
revealed	O
normal	B-labvalue
appearance	I-labvalue
.	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

Never	O
A	O
Smoker	O

Hydrocodone	O
-	O
Acetaminophen	O
10	B-strength
-	I-strength
325	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
1	B-dosage
tab	B-form
po	B-route
q6h	B-frequency
prn	B-frequency
pain	O
#	O
60	O
;	O
Therapy	O
:	O
06Apr2012	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
06Apr2012	B-temporal
)	O

-	O
Diabetes	O
Type	O
I	O
:	O
controlled	O
with	O
Hgb	O
A1c	O
6	B-labvalue
.	I-labvalue
6	I-labvalue
;	O
endocrinology	O
appointment	O
with	O
Dr	O
.	O
Wirfel	O
today	O

He	O
has	O
no	B-negation
pain	O
in	O
that	O
area	O
.	O

Echocardiogram	O
revealed	O
EF	O
60	B-labvalue
-	I-labvalue
65	I-labvalue
%	I-labvalue
.	O

Risks	O
of	O
surgery	O
,	O
including	O
but	O
not	B-negation
limited	O
to	O
anesthesia	O
,	O
infection	O
,	O
bleeding	O
,	O
orbital	B-bodyloc
injury	O
,	O
intracranial	B-bodyloc
injury	O
,	O
anosmia	O
/	O
hyposmia	O
,	O
epiphora	O
,	O
voice	O
changes	O
,	O
need	O
for	O
additional	O
prodedures	O
,	O
etc	O
.	O

B	O
-	O
12	O
-	O
SL	O
1000	B-strength
MCG	I-strength
Sublingual	B-route
Tablet	B-form
Sublingual	B-route
;	O
1	B-dosage
a	B-frequency
day	I-frequency
;	O
Therapy	O
:	O
03Jan2013	B-temporal
to	O

History	O
of	O
Prostate	O
Surgery	O

5	O
)	O
ROI	O
SWOBGYN	O
for	O
gc	O
/	O
chl	O
results	O
.	O

His	O
Jackson	O
-	O
Pratt	O
drain	O
was	O
discontinued	O
on	O
postoperative	O
day	O
#	O
3	O
that	O
being	O
the	O
day	O
of	O
discharge	O
.	O

PMH	O
g32	O

Left	O
Foot	O
:	O
The	O
foot	B-bodyloc
was	O
normal	O
,	O
not	B-negation
swollen	O
,	O
not	B-negation
tender	O
and	O
not	B-negation
erythematous	O
.	O

A	O
Pap	O
smear	O
was	O
performed	O
.	O

Hypertension	O
401	O
.	O
9	O

The	O
heart	O
rate	O
was	O
normal	B-labvalue
.	O

Cholesterol	O
Total	O
326	B-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
H	B-labvalue
120	B-reference_range
-	I-reference_range
200	I-reference_range

BD	O
Pen	O
Needle	O
Short	O
U	O
/	O
F	O
31G	O
X	O
8	O
MM	O
Miscellaneous	O
;	O
1	O
a	O
day	O
;	O
Therapy	O
:	O
15Apr2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
03Jan2014	B-temporal
)	O

ProAir	O
HFA	O
108	B-strength
(	I-strength
90	I-strength
Base	I-strength
)	I-strength
MCG	I-strength
/	I-strength
ACT	I-strength
Inhalation	B-route
Aerosol	B-form
Solution	I-form
;	O
Therapy	O
:	O
27Apr2009	B-temporal
to	O
Requested	O
for	O
:	O
15Jun2009	B-temporal

Palpation	O
of	O
lymph	O
nodes	O
in	O
groin	O
:	O
Normal	B-labvalue
.	O

No	B-negation
n	O
/	O
v	O
.	O

BSA	O
Calculated	O
:	O
2	B-labvalue
.	I-labvalue
02	I-labvalue

He	O
has	O
had	O
previous	O
major	O
trauma	O
back	O
in	O
2009	B-temporal
s	O
/	O
p	O
RLE	O
flap	O
repair	O
for	O
a	O
open	O
wound	O
with	O
complicated	O
fracture	O
.	O

Tobacco	O
Use	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

General	O
appearance	O
:	O
Normal	B-labvalue
.	O

Denied	O

Male	O
Erectile	O
Disorder	O
302	O
.	O
72	O

Symptoms	O
are	O
improved	B-course
by	O
inhaled	O
bronchodilator	O
use	O
.	O

[	O
QLH	O
]	O
HEMOGLOBIN	O
A1c	O
Requested	O
for	O
:	O
10Apr2012	B-temporal

f	O
Pap	O
Smear	O
Cervix	O
Abnormal	O
(	O
795	O
.	O
09	O
)	O
;	O
(	O
Active	O
)	O

Vitals	O
03Apr2014	B-temporal
01	B-temporal
:	I-temporal
27PM	I-temporal
03Apr2014	B-temporal
01	B-temporal
:	I-temporal
25PM	I-temporal
Systolic	O
128	B-labvalue
,	O
LUE	O
,	O
Sitting	O
122	O
,	O
RUE	O
,	O
Sitting	O
Diastolic	O
70	B-labvalue
,	O
LUE	O
,	O
Sitting	O
68	O
,	O
RUE	O
,	O
Sitting	O
Temperature	O
97	B-labvalue
.	I-labvalue
3	I-labvalue
F	I-labvalue
Heart	O
Rate	O
68	B-labvalue

The	O
patient	O
'	O
s	O
parents	O
are	O
comfortable	O
with	O
feeding	O
.	O

1	O
.	O

Psychiatric	O
:	O
no	B-negation
anxiety	O
and	O
no	O

External	O
inspection	O
of	O
ears	O
and	O
nose	O
:	O
Abnormal	O
.	O

TSH	O
13	B-labvalue
.	I-labvalue
100	I-labvalue
uIU	I-labvalue
/	I-labvalue
ml	I-labvalue
H	O
0	B-reference_range
.	I-reference_range
360	I-reference_range
-	I-reference_range
3	I-reference_range
.	I-reference_range
740	I-reference_range

HIB	O
;	O
09	B-temporal
Nov	I-temporal
2007	I-temporal

[	O
QH	O
]	O
HIV	O
AB	O
,	O
HIV	O
1	O
/	O
2	O
,	O
EIA	O
,	O
WITH	O
REFLEXES	O

Prolia	O
60	B-strength
MG	I-strength
/	I-strength
ML	I-strength
Subcutaneous	B-route
Solution	B-form
;	O
INJECT	O
SUBCUTANEOUSLY	B-route
60	B-strength
MG	I-strength
/	I-strength
1	I-strength
ML	I-strength
EVERY	B-frequency
6	I-frequency
MONTHS	I-frequency
;	O
Therapy	O
:	O
29Nov2012	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
29Nov2012	B-temporal
)	O
Requested	O
for	O
:	O
29Nov2012	B-temporal

Primary	O
Hypothyroidism	O
244	O
.	O
9	O

Check	O
CBC	O
and	O
ferritin	O
level	O
.	O

No	B-negation
wheezing	O
was	O
heard	O
.	O

Metoprolol	O
Succinate	O
ER	B-form
25	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
Extended	I-form
Release	I-form
24	I-form
Hour	I-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
BY	O
MOUTH	B-route
DAILY	B-frequency
;	O
Therapy	O
:	O
21Feb2011	B-temporal
to	O
(	O
Evaluate	O
:	O
07Feb2013	B-temporal
)	O
Requested	O
for	O
:	O
27Dec2012	B-temporal
;	O
Last	O

Qudriceps	O
atrophy	O
moreso	O
medially	O
Special	O
Tests	O
:	O
Deferred	B-labvalue
.	O

Associated	O
symptoms	O
include	O
no	B-negation
polyuria	O
and	O
no	B-negation
polydipsia	O
.	O

Disturbance	O
Of	O
Gait	O
781	O
.	O
2	O

CURRENT	O
MEDICATIONS	O
:	O
Prevacid	O
,	O
Humulin	O
,	O
Diprivan	O
,	O
Proventil	O
,	O
Unasyn	O
,	O
and	O
Solu	O
-	O
Medrol	O
.	O

Hematologic	O
/	O
Lymphatic	O
:	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
and	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
.	O

History	O
of	O
Hyperlipidemia	O
272	O
.	O
4	O

HOSPITAL	O
COURSE	O
:	O

Date	O
of	O
LMP	O
NA	O

Feosol	O
325	B-strength
(	I-strength
65	I-strength
Fe	I-strength
)	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
AS	O
DIRECTED	O
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
05Jun2012	B-temporal
)	O
to	O

Assessment	O
Assessed	O

Radial	O
:	O
right	O
2	O
+	O
and	O
left	O
2	O
+	O
.	O

Examination	O
of	O
thyroid	O
:	O
Normal	B-labvalue
.	O

She	O
reports	O
continued	O
left	B-bodyloc
temporal	I-bodyloc
headache	O
since	O
that	O
time	O
that	O
is	O
not	O
relieved	O
by	O
Relpax	O
.	O

Associated	O
symptoms	O
include	O
no	B-negation
focal	O
neurologic	O
deficits	O
and	O
no	B-negation
memory	O
loss	O
.	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
and	O
no	B-negation
palpitations	O
.	O

Raylynn	O
is	O
a	O
9	O
month	O
old	O
with	O
no	O
significant	O
PMH	O
who	O
presents	O
for	O
9	B-temporal
month	I-temporal
WCC	O
.	O

;	O
Nov	B-temporal
21	I-temporal
2013	I-temporal
10	B-temporal
:	I-temporal
43AM	I-temporal
(	O
Author	O
)	O

Will	O
add	O
lexapro	O
10	B-strength
mg	I-strength
and	O
may	O
go	O
up	O
to	O
20	B-strength
mg	I-strength
AM	B-frequency

AGAP	O
16	B-labvalue
.	I-labvalue
4	I-labvalue
mEq	I-labvalue
/	I-labvalue
l	I-labvalue
10	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
20	I-reference_range
.	I-reference_range
0	I-reference_range

Family	O
History	O
Problems	O

Pulmonary	B-bodyloc
nodule	O
:	O
Check	O
CT	O
scan	O

Inspection	O
/	O
palpation	O
of	O
joints	O
,	O
bones	O
,	O
and	O
muscles	O
:	O
AbnormalMidl	O
reproducible	O
tenderness	O
onn	O
the	O
plantar	O
aspect	O
of	O
the	O
right	B-bodyloc
heel	I-bodyloc
region	I-bodyloc
,	O
no	B-negation
deformilties	O
,	O
no	B-negation
edema	O
,	O
no	B-negation
effusion	O
.	O

Retrospective	O
Authorization	O
;	O
Edited	O

MRI	O
showed	O
left	B-bodyloc
hipocampus	I-bodyloc
decreased	O
size	O
but	O
no	B-negation
abnormal	O
signal	O
.	O

Assessment	O
of	O
muscle	O
strength	O
/	O
tone	O
:	O
Normal	B-labvalue
.	O

Scalp	O
and	O
Hair	O
:	O
inspection	O
of	O
the	O
scalp	B-bodyloc
showed	O
no	B-negation
abnormalities	O
.	O

Omeprazole	O
20	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
Delayed	I-form
Release	I-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
21Feb2013	B-temporal
)	O
to	O

CARDIOVASCULAR	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
and	O
not	O
expressed	O
as	O
feeling	O
short	O
of	O
breath	O
.	O

3	O
.	O

Patient	O
Specific	O
Education	O
Given	O
Done	O
:	O
08Aug2013	B-temporal
Endoscopy	O
today	B-temporal

No	B-negation
pathology	O
to	O
digits	O
or	O
nails	O
.	O

Palpation	O
of	O
the	O
face	O
and	O
sinuses	O
:	O
Normal	B-labvalue
.	O

Baby	O
was	O
tolerating	O
p	O
.	O
o	O
.	O
feeds	O
of	O
expressed	O
breast	O
milk	O
and	O
baby	O
began	O
to	O
experience	O
some	O
abdominal	B-bodyloc
distention	O
.	O

Advanced	O
Practitioner	O
Attestation	O
.	O

Allergies	O
Medication	O

[	O
QLH	O
]	O
TSH	O
,	O
3RD	O
GENERATION	O

1	O
.	O

Genitourinary	O
:	O
no	B-negation
dysuria	O
.	O

;	O
Dec	B-temporal
1	I-temporal
2011	I-temporal
9	B-temporal
:	I-temporal
34AM	I-temporal
(	O
Author	O
)	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

Digital	O
Mammogram	O
(	O
screening	O
)	O
Requested	O
for	O
:	O
29Mar2012	B-temporal

Neurologic	O

Nasal	O
Passages	O
Right	O
:	O
clear	O

1	O
Fluzone	O
9	B-strength
MCG	I-strength
/	O
STRAIN	O
Intradermal	B-route
Device	O
01Dec2012	B-temporal
Tdap	O
02Jul2013	B-temporal

Hypertensive	O
Heart	B-bodyloc
Disease	O
402	O
.	O
90	O

Completed	O
by	O
:	O
[	O
*	O
*	O
2162-1-13	B-temporal
*	O
*	O
]	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
PHILIP	O
JOHNSON	O
,	O
M	O
.	O
D	O
.	O

CARDIOVASCULAR	O
:	O
No	B-negation
chest	O
pain	O
.	O

Constitutional	O
:	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
,	O
not	B-negation
feeling	O
tired	O
(	O
fatigue	O
)	O
,	O
no	B-negation
recent	B-temporal
weight	O
gain	O
and	O
no	B-negation
recent	B-temporal
weight	O
loss	O
.	O

Lower	O
extremities	O
:	O
Normal	O
.	O

Left	O
Toe	O
Ext	O
.	O

[	O
L	O
]	O
Lipid	O
Panel	O
w	O
/	O
o	O
Chol	O
/	O
HDL	O
Ratio	O

Right	B-bodyloc
foot	I-bodyloc
drop	O

f	O
DTaP	O
-	O
HepB	O
-	O
IPV	O
(	O
Pediarix	O
)	O
(	O
Lot	O
#	O
:	O
AC21B344CA	O
)	O
-	O
Administered	O
on	O
:	O
11/16/2012	B-temporal

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

No	B-negation
wheezing	O
was	O
heard	O
.	O

The	O
abdomen	O
was	O
normal	O
to	O
percussisp	O
and	O
did	O
not	B-negation
have	I-negation
ascites	O
.	O

Benadryl	O
TABS	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
EVERY	B-frequency
4	I-frequency
TO	I-frequency
6	I-frequency
HOURS	I-frequency
AS	B-frequency
NEEDED	I-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
03Sep2013	B-temporal
)	O
to	O

7	O
.	O

Cardiovascular	O

Prior	O
pregnancies	O
:	O
.	O

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

History	O
of	O
Present	O
Illness	O
26	O
yo	O
G1P1001	O
here	O
for	O
postpartum	O
check	O
s	O
/	O
p	O
TSVD	O
.	O

Cycle	O
intervals	O
have	O
been	O
regular	O
and	O
occur	O
approximately	O
every	O
28	O
days	O
.	O

No	B-negation
other	O
complaints	O
.	O

Family	O
history	O
of	O
No	O
Significant	O
Family	O
History	O

Eyes	O

History	O
of	O
Drug	O
Use	O

History	O
of	O
Present	O
Illness	O
She	O
has	O
noticed	O
sudden	O
S	O
.	O
O	O
.	O
B	O
x	O
2days	B-temporal
.	I-temporal

Flex	O
.	O

Atorvastatin	O
Calcium	O
20	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
AT	I-frequency
BEDTIME	I-frequency
;	O
Therapy	O
:	O
11Sep2013	B-temporal
to	O
(	O
Complete	O
:	O
10Mar2014	B-temporal
)	O
Requested	O
for	O
:	O
11Sep2013	B-temporal
;	O
Last	O
Rx	O
:	O
11Sep2013	B-temporal
;	O
Status	O
:	O

Heme	O
/	O
Lymph	O
:	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
,	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
and	O
no	B-negation
swollen	O
glands	B-bodyloc
.	O

ENT	O
:	O
no	B-negation
earache	O
,	O
no	B-negation
hearing	O
loss	O
,	O
no	B-negation
epistaxis	O
,	O
no	B-negation
nasal	B-bodyloc
discharge	O
,	O
no	B-negation
sore	O
throat	B-bodyloc
and	O
no	B-negation
hoarseness	O
.	O

Persistent	O
Insomnia	O
307	O
.	O
42	O

Plan	O

Benign	B-severity
Prostatic	B-bodyloc
Hypertrophy	O
600	O
.	O
00	O

Denied	O

Abdomen	O
:	O
Normal	O
.	O

Unsure	O
about	O
tetanus	O
.	O

Vitamin	O
D	O
25	O
OH	O
:	O
15	B-labvalue
ng	I-labvalue
/	I-labvalue
ml	I-labvalue
Abnormal	O
Low	O
Reference	O
Range	O
30	B-reference_range
-	I-reference_range
100	I-reference_range

Appendix	O
#	O
1	O

Cranial	O
nerves	O
III	O
,	O
IV	O
,	O
and	O
VI	O
:	O
the	O
extraocular	O
motions	O
were	O
intact	B-labvalue
.	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
neck	O
:	O
No	B-negation
lymphadenopathy	O
.	O

Metoprolol	O
Tartrate	O
100	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
18Oct2012	B-temporal
to	O
(	O
Evaluate	O
:	O
17Mar2014	B-temporal
)	O
Requested	O
for	O
:	O
17Dec2013	B-temporal
;	O
Last	O
Rx	O
:	O
17Dec2013	B-temporal

;	O
Sep	B-temporal
5	I-temporal
2013	I-temporal
4	B-temporal
:	I-temporal
13PM	I-temporal
(	O
Author	O
)	O

History	O
of	O
Drug	O
Use	O

Electronically	O
signed	O
by	O
:	O
MANNIE	O
MAGID	O
,	O
M	O
.	O
D	O
.	O

Discussion	O
/	O
Chief	O
Complaint	O

Reason	O
For	O
Visit	O

INTERVAL	O
HISTORY	O
:	O
Zonegran	O
started	O
on	O
last	O
visit	O
in	O
addition	O
to	O
the	O
Dilantin	O
.	O

History	O
of	O
Alcohol	O
Use	O

Constitutional	O
:	O
normal	O
,	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
,	O
no	B-negation
malaise	O
and	O
no	B-negation
fatigue	O
.	O

History	O
of	O
Esophageal	B-bodyloc
Reflux	O

Comments	O
:	O
PPROM	O
at	O
27	O
wga	O
,	O
delivered	O
at	O
31	O
wga	O
for	O
NRFHTs	O
.	O

Family	O
History	O
Maternal	B-subject
history	O
of	O
Diabetes	O
Mellitus	O
V18	O
.	O
0	O

Skin	B-bodyloc
No	B-negation
open	O
lesions	O
.	O

History	O
of	O
Hysterectomy	O
V45	O
.	O
77	O

Palpation	O
of	O
the	O
face	O
and	O
sinuses	O
:	O
Normal	B-labvalue

4	O
.	O

The	O
operation	O
was	O
uneventful	O
.	O

Current	O
Meds	O
1	O
.	O

Chief	O
Complaint	O

Cranial	O
Nerves	O
IX	O
and	O
X	O
:	O
there	O
was	O
normal	B-labvalue
movement	O
of	O
the	O
soft	O
palate	O
and	O
normal	B-labvalue
gag	O
.	O

Feels	O
that	O
it	O
prevents	O
her	O
from	O
engaging	O
in	O
work	O
,	O
etc	O
.	O

0	I-reference_range
AST	O
17	B-labvalue
u	I-labvalue
/	I-labvalue
l	I-labvalue
0	B-reference_range
-	I-reference_range
37	I-reference_range
Bili	O
To	O
al	O
0	B-labvalue
.	I-labvalue
2	I-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
0	B-reference_range
.	I-reference_range
2	I-reference_range
-	I-reference_range
1	I-reference_range
.	I-reference_range

Examination	O
of	O
sensation	O
:	O
Normal	B-labvalue
.	O

Inspection	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
Abnormal	O

Past	O
Medical	O
History	O
History	O
of	O
Allergies	O
V15	O
.	O
09	O

Ordered	O
;	O
For	O
:	O
Dyspepsia	O
(	O
536	O
.	O
8	O
)	O
;	O
Ordered	O
By	O
:	O
ABDELMELEK	O
,	O
LOURICE	O
Perform	O
:	O
In	O
Office	O
Due	O
:	O
21Apr2013	B-temporal
;	O
Last	O
Updated	O
By	O
:	O
Gonzalez	O
,	O
Marla	O

Sample	O
Type	O
/	O
Medical	O
Specialty	O
:	O
General	O
Medicine	O

Potassium	O
Chloride	O
10	B-strength
mEq	I-strength
Capsule	B-form
,	I-form
Sustained	I-form
Release	I-form
Sig	O
:	O
Two	B-dosage
(	I-dosage
2	I-dosage
)	I-dosage
Capsule	B-form
,	I-form
Sustained	I-form
Release	I-form
PO	B-route
Q12H	B-frequency
(	I-frequency
every	I-frequency
12	I-frequency
hours	I-frequency
)	I-frequency
for	O
2	B-duration
weeks	I-duration
.	I-duration

No	B-negation
rebound	O
,	O
guarding	O
,	O
rigidity	O
or	O
ecchymosis	O
.	O

FR	O
/	O
FS	O
:	O
Normal	B-labvalue

;	O
Feb	B-temporal
10	I-temporal
2012	I-temporal
11	B-temporal
:	I-temporal
19AM	I-temporal
(	O
Author	O
)	O

Weight	O
:	O
157	B-labvalue
lb	I-labvalue
Systolic	O
:	O
120	B-labvalue
,	O
RUE	O
,	O
Sitting	O

Instruments	O
:	O
Straight	O
suction	O
.	O

Voice	O
was	O
breathy	O
.	O

Psychiatric	O
:	O
not	B-negation
suicidal	O
,	O
no	B-negation
sleep	O
disturbances	O
,	O
no	B-negation
anxiety	O
,	O
no	B-negation
depression	O
,	O
no	B-negation
personality	O
change	O
and	O
no	B-negation
emotional	O
problems	O
.	O

Examinatisp	O
of	O
extremities	O
fis	O
edema	O
apd	O
/	O
os	O
varicosities	O
:	O
Normal	B-labvalue
No	B-negation
edema	O
.	O

Heart	O
sounds	O
:	O
normal	B-labvalue
S1	O
,	O
normal	B-labvalue
S2	O
,	O
no	B-negation
S3	O
and	O
no	B-negation
S4	O
.	O

Special	O
Tests	O
:	O
SLR	O
POS	O
AT	O
40	O
DEG	O
-	O
IPSILAT	O
ON	O
LT	O
AND	O
CONTRALAT	O
.	O

He	O
was	O
circumcised	O
.	O

Constitutional	O

Peripheral	O
vascular	O
system	O
:	O
Normal	B-labvalue
.	O

Vitals	O
12Nov2013	B-temporal
11	B-temporal
:	I-temporal
13AM	I-temporal
Weight	O
128	B-labvalue
lb	I-labvalue
7	I-labvalue
oz	I-labvalue
Systolic	O
115	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
62	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Heart	O
Rate	O
104	B-labvalue
,	O
L	O
Radial	O

;	O
Mar	B-temporal
24	I-temporal
2014	I-temporal
2	B-temporal
:	I-temporal
04PM	I-temporal
(	O
Author	O
)	O

>	O
=30	O
ng	O
/	O
mL	O
.	O

This	O
is	O
a	O
follow	O
-	O
up	O
visit	O
for	O
Mr	O
.	O
Williams	O
who	O
is	O
a	O
56	O
-	O
year	O
-	O
old	O
gentleman	O
seen	O
in	O
our	O
clinic	O
for	O
right	B-bodyloc
-	I-bodyloc
sided	I-bodyloc
footdrop	O
that	O
was	O
in	O
association	O
of	O
a	O
60	O
pound	O
intentional	O
weight	O
loss	O
.	O

Cardiovascular	O

Give	O
coumadin	O
3mg	B-strength
Saturday	B-temporal
and	O
Tuesday	B-temporal

Focal	O
Torsion	O
Dystonia	O
333	O
.	O
89	O

History	O
of	O
Hypertension	O

Immunizations	O
g23	O

Denied	O

Plan	O
Enalapril	O
Maleate	O
10	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
07Dec2011	B-temporal
to	O
(	O
Evaluate	O
:	O
30Sep2012	B-temporal
)	O
Requested	O
for	O
:	O
02Jul2012	B-temporal
;	O
Last	O
Rx	O
:	O
02Jul2012	B-temporal
;	O
Edited	O

History	O
of	O
Total	O
Abdominal	O
Hysterectomy	O
With	O
Removal	O
Of	O
Both	O
Ovaries	O

[	O
QLH	O
]	O
CMP	O
W	O
/	O
EGFR	O
Requested	O
for	O
:	O
17Feb2014	B-temporal

Cardiovascular	O

-	O
good	O
chronotropic	O
response	O
with	O
exercise	O

9	O
.	O

CHLORIDE	O
109	B-labvalue
mmol	I-labvalue
/	I-labvalue
L	I-labvalue
98	B-reference_range
-	I-reference_range
110	I-reference_range

Edited	O

The	O
baby	O
is	O
an	O
ex	O
-	O
32	B-temporal
weeks	I-temporal
small	O
for	O
gestational	O
age	O
infant	O
with	O
birth	O
weight	O
1102	B-labvalue
.	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
George	O
Lopez	O
,	O
M	O
.	O
D	O
.	O

Discussion	O
/	O
Discussion	O
/	O
Summary	O

Vitals	O
29Oct2012	B-temporal
04	B-temporal
:	I-temporal
32PM	I-temporal
BMI	O
Calculated	O
37	B-labvalue
.	I-labvalue
52	I-labvalue
BSA	O
Calculated	O
2	B-labvalue
.	I-labvalue
45	I-labvalue
Height	O
6	B-labvalue
ft	I-labvalue
Weight	O
277	B-labvalue
lb	I-labvalue
Systolic	O
130	B-labvalue
,	O
RUE	O
,	O
Sitting	O
Diastolic	O
90	B-labvalue
,	O
RUE	O
,	O
Sitting	O
Temperature	O
97	B-labvalue
.	I-labvalue
8	I-labvalue
F	I-labvalue
,	O
Oral	O
Heart	O
Rate	O
68	B-labvalue
,	O
R	O
Radial	O
Pulse	O
Quality	O
Regular	B-labvalue
,	O
R	O
Radial	O

AGAP	O
14	B-labvalue
.	I-labvalue
1	I-labvalue
mEq	I-labvalue
/	I-labvalue
l	I-labvalue
10	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
20	I-reference_range
.	I-reference_range
0	I-reference_range

Synthroid	O
TABS	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
14Nov2011	B-temporal
)	O
to	O

Social	O
History	O
Alcohol	O
Use	O

A	O
left	B-bodyloc
inguinal	I-bodyloc
hernia	O
was	O
present	O
,	O
which	O
was	O
reducible	O
.	O

Never	O
Drank	O
Alcohol	O

NEUROLOGICAL	O
:	O
no	B-negation
seizures	O
.	O

Examination	O
of	O
thyroid	O
:	O
Normal	B-labvalue
.	O

HEMATOLOGY	O
:	O
The	O
patient	O
is	O
status	O
post	O
phototherapy	O
at	O
Madera	O
and	O
was	O
started	O
on	O
iron	O
.	O

Physical	O
Exam	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
plastic	O
surgery	O
service	O
on	O
[	O
*	O
*	O
2101-12-17	B-temporal
*	O
*	O
]	O
and	O
had	O
the	O
following	O
procedures	O
:	O

Examination	O
of	O
extremities	O
for	O
edema	O
and	O
/	O
or	O
varicosities	O
:	O
Normal	B-labvalue
.	O

Spinal	O
alignment	O
exhibits	O
increased	O
lordosis	O
and	O
no	B-negation
scoliosis	O
.	O

48	O
y	O
/	O
o	O
pleasant	O
male	O
is	O
here	O
for	O
recent	O
ED	O
follow	O
up	O
.	O

Review	O
of	O
Systems	O

Pupils	O
:	O
.	O

Current	O
Meds	O
AmLODIPine	O
Besylate	O
TABS	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
19Jul2012	B-temporal
)	O
to	O

Skin	O

Periarticular	B-bodyloc
osteophytes	O
on	O
medial	B-bodyloc
,	I-bodyloc
lateral	I-bodyloc
,	I-bodyloc
naterior	I-bodyloc
and	I-bodyloc
posterior	I-bodyloc
aspects	I-bodyloc
of	I-bodyloc
tibia	I-bodyloc
and	I-bodyloc
femur	I-bodyloc
.	O

Cognitive	O
Disorder	O
294	O
.	O
9	O

Patient	O
was	O
not	B-negation
observed	I-negation
to	O
be	O
obese	O
.	O

Metformin	O
850mg	B-strength
tid	B-frequency
Avandia	O
4mg	B-strength
[	O
*	O
*	O
Hospital1	O
*	O
*	O
]	O
HCTZ	O
50mg	B-strength
daily	B-frequency
Protonix	O
40mg	B-strength
daily	B-frequency
Lisinopril	O
40mg	B-strength
daily	B-frequency
Atenolol	O
25mg	B-strength
daily	B-frequency
Lipitor	O
10mg	B-strength
daily	B-frequency
ASA	O
81mg	B-strength
daily	B-frequency
-	O
instructed	O
to	O
take	O
4	B-dosage
tablets	B-form
the	B-frequency
day	I-frequency
prior	O
and	O
AM	B-temporal
of	O
cath	O
Glucosamine	O
chondroitin	O
1	B-dosage
tablet	B-form
[	O
*	O
*	O
Hospital1	O
*	O
*	O
]	O

4	O
.	O

DIAGNOSIS	O
:	O
1	O
)	O
ACUTE	B-course
LUMBOSACRAL	B-bodyloc
STRAIN	O
,	O
SUPERIMPOSED	O
ONTO	O
A	O
DEGENERATIVE	O
DISK	O
DISEASE	O
AT	O
L5S1	B-bodyloc
.	O

Inspection	O
of	O
breasts	O
:	O
Normal	B-labvalue

;	O
Oct	B-temporal
30	I-temporal
2013	I-temporal
1	B-temporal
:	I-temporal
04PM	I-temporal
(	O
Author	O
)	O

No	B-negation
wheezing	O
was	O
heard	O
.	O

General	O
appearance	O
:	O
Normal	B-labvalue
.	O

Drug	O
Use	O

Denied	O

1	O
.	O

Eos	O
(	O
Absolute	O
)	O
:	O
0	B-labvalue
.	I-labvalue
1	I-labvalue
x10E3	I-labvalue
/	I-labvalue
uL	I-labvalue
Reference	O
Range	O
0	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
0	I-reference_range
.	I-reference_range
4	I-reference_range

No	O
Reason	O
for	O
Referral	O
was	O
given	O
.	O

UTP	O
-	O
OB	O
/	O

Triglycerides	O
:	O
260	B-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue
Abnormal	O
High	O
Reference	O
Range	O
0	B-reference_range
-	I-reference_range
149	I-reference_range

[	O
L	O
]	O
Pathology	O
Report	O
Requested	O
for	O
:	O
24Jul2013	B-temporal

Obesity	O
278	O
.	O
00	O

Cranial	O
nerves	O
VIII	O
:	O
hearing	O
was	O
intact	B-labvalue
.	O

Assessment	O
_	O
80	O
_	O
twCiteListControlStart	O
Palpitations	O
785	O
.	O
1	O

Metoprolol	O
Succinate	O
ER	B-form
50	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
Extended	I-form
Release	I-form
24	I-form
Hour	I-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
24Sep2013	B-temporal
)	O
to	O

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

Interim	O
History	O
:	O
The	O
patient	O
'	O
s	O
parents	O
state	O
that	O
the	O
dramatic	O
response	O
of	O
the	O
DBS	O
adjustment	O
to	O
her	O
sensory	O
tricks	O
,	O
her	O
mouth	B-bodyloc
dystonia	O
.	O

Comments	O
:	O
28	O
wks	O
,	O
1020	O
g	O
(	O
765	O
.	O
14	O
)	O
;	O
(	O
Resolved	B-course
)	O

Estimated	O
Glomerular	O
Filtration	O
Rate	O
55	B-labvalue

2	O
.	O

I	O
was	O
present	O
and	O
available	O
in	O
clinic	O
.	O

[	O
QLH	O
]	O
T4	O
,	O
FREE	O
29Nov2012	B-temporal
10	B-temporal
:	I-temporal
35AM	I-temporal
Hardwicke	O
,	O
Robin	O

Since	O
right	O
hearing	O
improved	O
after	O
ear	O
tube	O
placement	O
,	O
we	O
need	O
to	O
check	O
the	O
left	O
hearing	O
.	O

History	O
of	O
Routine	O
Gynecological	O
Exam	O
V72	O
.	O
31	O

Examination	O
of	O
external	O
genitalia	O
and	O
vagina	O
:	O
Normal	B-labvalue

Allegra	O
Allergy	O
180	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
AS	B-frequency
NEEDED	I-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
10Dec2013	B-temporal
)	O
to	O

Ondansetron	O
HCl	O
4	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
EVERY	B-frequency
8	I-frequency
HOURS	I-frequency
PRN	B-frequency
nausea	O
,	O
vomiting	O
;	O
Therapy	O
:	O
04Mar2008	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
04Mar2008	B-temporal
)	O
Requested	O
for	O
:	O
04Mar2008	B-temporal

Mammogram	O
Screening	O
V76	O
.	O
12	O

Migraine	O
Headache	O
(	O
346	O
.	O
90	O
)	O

Neck	O

BSA	O
Calculated	O
:	O
1	B-labvalue
.	I-labvalue
75	I-labvalue

Kombiglyze	O
XR	O
2	B-strength
.	I-strength
5	I-strength
-	I-strength
1000	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
Extended	I-form
Release	I-form
24	I-form
Hour	I-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
TWICE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
27Dec2012	B-temporal
to	O
(	O
Evaluate	O
:	O
27Mar2013	B-temporal
)	O
Requested	O
for	O
:	O
27Dec2012	B-temporal
;	O
Last	O
Rx	O
:	O
27Dec2012	B-temporal

History	O
of	O
Depression	O
311	O

f	O
BD	O
Pen	O
Needle	O
Short	O
U	O
/	O
F	O
31G	O
X	O
8	O
MM	O
Miscellaneous	O
;	O
USE	O
oneNEEDLES	O
DAILY	O
;	O
Start	O
Date	O
:	O
04/19/2012	B-temporal
;	O
End	O
Date	O
:	O
01/01/1900	B-temporal
(	O
Active	O
)	O

;	O
Mar	B-temporal
31	I-temporal
2013	I-temporal
10	B-temporal
:	I-temporal
38PM	I-temporal
(	O
Author	O
)	O

Diabetic	O
Peripheral	O
Neuropathy	O
Type	O
1	O
250	O
.	O
61	O

Eyes	O
:	O
dryness	O
of	O
the	O
eyes	B-bodyloc
.	O

Never	O
A	O
Smoker	O

Speech	O
Phonation	O
Dysphonia	O
784	O
.	O
42	O

History	O
of	O
Graves	O
'	O
Disease	O
242	O
.	O
00	O

Bilateral	O
Indirect	O
Inguinal	B-bodyloc
Hernia	O
550	O
.	O
92	O

Physical	O
Exam	O

Constitutional	O
:	O
no	B-negation
fever	O
and	O
no	B-negation
chills	O
.	O

Esophageal	B-bodyloc
Reflux	O
530	O
.	O
81	O

She	O
denies	B-negation
fever	O
,	O
chills	O
,	O
ear	B-bodyloc
pain	O
,	O
CP	O
,	O
SOB	O
,	O
N	O
/	O
V	O
abd	B-bodyloc
pain	O
,	O
diahrehea	O
,	O
rash	O
and	O
recent	O
travel	O
.	O

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

HAD	O
A	O
COURSE	O
OF	O
P	O
.	O
T	O
.	O
7	O
MNTHS	O
AGO	O
.	O

aVerifiedResultsSectionSg2StaResults	O

External	O
inspection	O
of	O
ears	O
and	O
nose	O
:	O
Normal	B-labvalue
.	O

Normal	B-labvalue
motor	O
and	O
cerebellar	O
tests	O
.	O

Plan	O
NM	O
Thyroid	O
uptake	O
24	O
hr	O
Requested	O
for	O
:	O
18Oct2012	B-temporal

Looked	O
really	O
good	O
at	O
these	O
last	O
settings	O
.	O

No	B-negation
rebiund	O
tenderness	O
.	O

Postoperative	O
,	O
she	O
did	O
very	O
well	O
.	O

Examination	O
of	O
extremities	O
for	O
edema	O
and	O
/	O
or	O
varicosities	O
:	O
Normal	B-labvalue
.	O

HEMATOLOGIC	O
/	O
LYMPHATIC	O
:	O
No	B-negation
cervical	B-bodyloc
lymphadenopathy	O
is	O
palpated	O
.	O

No	B-negation
Known	O
Allergies	O

No	B-negation
incisional	O
pain	O
,	O
no	B-negation
incisional	O
drainage	O
,	O
no	B-negation
vaginal	B-bodyloc
discharge	O
,	O
no	B-negation
irregular	O
bleeding	O
,	O
no	B-negation
heavy	O
bleeding	O
,	O
lochia	O
,	O
no	B-negation
breast	B-bodyloc
pain	O
,	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
headache	O
,	O
no	B-negation
fever	O
,	O
no	B-negation
nausea	O
,	O
no	B-negation
vomiting	O
,	O
no	B-negation
depression	O
and	O
no	B-negation
suicidal	O
ideation	O
.	O

Patient	O
Status	O
:	O
The	O
patient	O
tolerated	O
the	O
procedure	O
well	O
.	O

The	O
patient	O
denies	B-negation
any	O
other	O
problems	O
or	O
complaints	O
.	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
LOURICE	O
ABDELMELEK	O
,	O
M	O
.	O
D	O
.	O

ENT	O
:	O
no	B-negation
earache	O
,	O
no	B-negation
hearing	O
loss	O
and	O
no	B-negation
nasal	B-bodyloc
discharge	O
.	O

Infant	O
was	O
transferred	O
to	O
Children	O
'	O
s	O
Hospital	O
for	O
higher	O
level	O
of	O
care	O
,	O
stayed	O
at	O
Children	O
'	O
s	O
Hospital	O
for	O
approximately	O
2	B-temporal
weeks	I-temporal
,	O
and	O
was	O
transferred	O
back	O
to	O
ABCD	O
where	O
he	O
stayed	O
until	O
he	O
was	O
discharged	O
on	O
08/16/2006	B-temporal
.	O

When	O
he	O
closes	O
his	O
eyes	O
he	O
has	O
to	O
forcibly	O
open	O
them	O
with	O
his	O
hands	O
.	O

Lasix	O
20	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
2	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
20Aug2013	B-temporal
)	O
to	O

Middle	O
Turbinate	O
:	O
Previous	B-temporal
resection	O
.	O

Cardiovascular	O

No	B-negation
murmurs	O
were	O
heard	O
.	O

No	B-negation
vaginal	B-bodyloc
discharge	O
,	O
lochia	O
,	O
no	B-negation
breast	B-bodyloc
pain	O
,	O
no	B-negation
cracked	O
nipples	B-bodyloc
,	O
no	B-negation
breastfeeding	O
problems	O
,	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
dysuria	O
,	O
no	B-negation
nausea	O
and	O
no	B-negation
vomiting	O
.	O

Denied	O

Head	O
and	O
Face	O

Patient	O
required	O
6	O
disolvable	O
stiches	O
on	O
the	O
lower	O
lip	O
.	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
Carlos	O
Moreno	O
,	O
M	O
.	O
D	O
.	O

I	O
have	O
discussed	O
the	O
case	O
with	O
the	O
resident	O
and	O
agree	O
with	O
the	O
assessment	O
and	O
plan	O
as	O
delineated	O
in	O
the	O
note	O
above	O
.	O

Patient	O
admits	O
that	O
he	O
has	O
not	O
bee	O
exercising	O
regularly	O
and	O
has	O
put	O
on	O
a	O
few	O
lbs	O
.	O

NITRITE	O
:	O
NEG	B-labvalue

Examination	O
of	O
the	O
oropharynx	O
:	O
Normal	B-labvalue

He	O
does	O
not	O
check	O
his	O
BG	O
regularly	O
.	O

Family	B-subject
history	O
of	O
Diabetes	O
Mellitus	O
V18	O
.	O
0	O

TSH	O
7	B-labvalue
.	I-labvalue
370	I-labvalue
uIU	I-labvalue
/	I-labvalue
ml	I-labvalue
H	B-labvalue
0	B-reference_range
.	I-reference_range
360	I-reference_range
-	I-reference_range
3	I-reference_range
.	I-reference_range
740	I-reference_range

The	O
patient	O
is	O
pleasant	O
and	O
cooperative	O
.	O

[	O
LH	O
]	O
Vitamin	O
D	O
,	O
25	O
-	O
Hydroxy	O
,	O
Total	O
*	O
(	O
E	O
)	O

Allergies	O
No	B-negation
Known	O
Allergies	O

f	O
[	O
H	O
]	O
Pap	O
ThinPrep	O
01/30/2013	B-temporal
Routine	O

distilled	O
water	O
,	O
irrigate	O
3	B-frequency
x	I-frequency
a	I-frequency
day	I-frequency
;	O
Therapy	O
:	O
03Jan2013	B-temporal
to	O
(	O
Evaluate	O
:	O
22Mar2013	B-temporal
)	O
Requested	O
for	O
:	O

Cranial	O
Nerves	O
:	O

Current	O
Meds	O
Duet	O
DHA	O
Balanced	O
13-13-1	B-strength
&	I-strength
374	I-strength
MG	I-strength
Oral	B-route
Miscellaneous	O
;	O
Take	O
one	B-frequency
daily	I-frequency
;	O
Therapy	O
:	O
24Jan2012	B-temporal
to	O
(	O
Evaluate	O
:	O
18Jan2013	B-temporal
)	O
;	O
Last	O
Rx	O
:	O
24Jan2012	B-temporal

No	B-negation
murmurs	O
were	O
heard	O
.	O

Denied	O

Motor	O
Strength	O
:	O
motor	O
strength	O
was	O
normal	B-labvalue
in	O
all	O
muscle	O
groups	O
.	O

Comparison	O
with	O
prior	O
films	O
:	O
findings	O
are	O
unchanged	O
.	O

Past	O
Medical	O
History	O
History	O
of	O
Denial	O
Of	O
Any	O
Significant	O
Medical	O
History	O

Allergies	O
No	B-negation
Known	O
Allergies	O

If	B-condition
HA	O
returns	O
come	O
back	O
sooner	O
.	O

75M	O
POV3	O
for	O
CRSwNP	O

Involuntary	O
Movements	O
:	O
no	B-negation
involuntary	O
movements	O
were	O
seen	O
.	O

The	O
eyelids	O
were	O
normal	O
bilaterally	O
.	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

History	O
of	O
Obesity	O
278	O
.	O
00	O

Patient	O
Specific	O
Education	O
Given	O
Done	O
:	O
17Feb2014	B-temporal

Palpation	O
of	O
the	O
face	O
for	O
sinus	B-bodyloc
tenderness	O
:	O
No	B-negation
maxillary	B-bodyloc
tenderness	O
.	O

5	O

Cranial	O
Nerves	O
III	O
,	O
IV	O
,	O
and	O
VI	O
:	O
the	O
extraocular	O
motions	O
were	O
intact	B-labvalue
.	O

Systolic	O
:	O
104	B-labvalue
,	O
LUE	O
,	O
Sitting	O

The	O
patient	O
is	O
being	O
seen	O
for	O
a	O
routine	O
clinic	O
follow	O
-	O
up	O
of	O
shoulder	B-bodyloc
pain	O
.	O

Patient	O
Specific	O
Education	O
Given	O
Done	O
:	O
08Apr2014	B-temporal

2	O
.	O

Wound	O
Location	O
:	O
.	O

Her	O
neurologic	O
examination	O
is	O
normal	B-labvalue
today	B-temporal
.	O

The	O
heart	O
rate	O
was	O
normal	B-labvalue
.	O

TraMADol	O
HCl	O
50	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
21Feb2013	B-temporal
)	O
to	O

f	O
Pregnancy	O
(	O
V22	O
.	O
2	O
)	O
;	O
(	O
Active	O
)	O

-	O
-	O
Read	O
by	O
:	O
George	O
,	O
Verghese	O

;	O
Oct	B-temporal
18	I-temporal
2012	I-temporal
7	B-temporal
:	I-temporal
28PM	I-temporal
(	O
Author	O
)	O

55	O
-	O
year	O
-	O
old	O
woman	O
with	O
relapsing	O
remitting	O
multiple	O
sclerosis	O
injecting	B-form
Copaxone	O
.	O

Never	O
A	O
Smoker	O

MA	O
Bone	O
Density	O
DXA	O
Dual	O
Energy	O
77080	O
Requested	O
for	O
:	O
25Feb2014	B-temporal

Patient	O
does	O
not	O
have	O
a	O
history	O
of	O
a	O
positive	O
pap	O
smear	O
.	O

Lymph	O
nodes	O
in	O
axillae	O
:	O
Normal	O
.	O

Memorial	O
City	O
Iro2man	O
Medisal	O
Summary	O
Patient	O
Detail	O
for	O
LOUISA	O
JANE	O
HUNTER	O
MRN	O
:	O
1378810	O
Contact	O
LOUISA	O
JANE	O
HUNTER	O
Date	O
Of	O
Birth	O
August	B-temporal
4	I-temporal
,	I-temporal
1941	I-temporal
Address	O
2056	O
antoine	O
dr	O

Constitutional	O

Esophageal	B-bodyloc
Reflux	O
530	O
.	O
81	O

MT	O
/	O
MM	O
:	O
NormalandPus	O

Associated	O
symptoms	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
calf	B-bodyloc
cramps	O
with	O
exertion	O
,	O
no	B-negation
myalgias	O
and	O
no	B-negation
nausea	O
.	O

Sleep	O
Medicine	O
Referral	O
Outpatient	O
Referral	O
Requested	O
for	O
:	O
25Feb2014	B-temporal

The	O
patient	O
reports	O
doing	O
well	O
.	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
LESLIE	O
GARB	O
,	O
M	O
.	O
D	O
.	O

History	O
of	O
Present	O
Illness	O
The	O
patient	O
is	O
being	O
seen	O
for	O
an	O
initial	O
evaluation	O
of	O
and	O
several	B-temporal
weeks	I-temporal
foot	B-bodyloc
pain	O
.	O

The	O
patient	O
underwent	O
liver	O
surgery	O
and	O
postoperatively	O
her	O
main	O
issue	O
was	O
that	O
of	O
some	O
degree	O
of	O
on	O
and	O
off	O
right	O
shoulder	B-bodyloc
pain	O
and	O
some	O
operative	O
site	O
soreness	O
,	O
which	O
was	O
treated	O
well	O
with	O
IV	B-route
morphine	O
.	O

left	O
ring	O
finger	O
radial	O
digital	O
artery	O
repair	O
with	O
microvascular	O
anastomosis	O
7	O
.	O

Examination	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue
.	O

Cranial	O
nerves	O
IX	O
and	O
X	O
:	O
there	O
was	O
normal	B-labvalue
movement	O
of	O
the	O
soft	O
palate	O
and	O
normal	B-labvalue
gag	O
.	O

Collected	O
-	O
-	O

Examination	O
of	O
liver	O
and	O
spleen	O
:	O
Normal	B-labvalue
.	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

Palpation	O
of	O
the	O
face	O
and	O
sinuses	O
:	O
Normal	B-labvalue
.	O

No	B-negation
contraception	O
.	O

Will	O
hold	O
with	O
rx	O
.	O
for	O
h	O
.	O
pylori	O
in	O
due	O
of	O
nausea	O
.	O
D	O
/	O
c	O
Cipro	O
.	O

Examination	O
of	O
liver	O
and	O
spleen	O
:	O
Normal	B-labvalue
.	O

Inc	O
AM	B-frequency
Levemir	O
.	O

Musculoskeletal	O
:	O
no	B-negation
arthralgias	O
,	O
no	B-negation
joint	B-bodyloc
pain	O
,	O
no	B-negation
joint	B-bodyloc
swelling	O
,	O
no	B-negation
joint	B-bodyloc
stiffness	O
,	O
no	B-negation
limb	B-bodyloc
pain	O
and	O
no	B-negation
limb	B-bodyloc
swelling	O
.	O

Carotid	O
Arteries	O
:	O
Normal	O
.	O

The	O
patient	O
pronounced	O
expired	O
at	O
01	O
:	O
40	O
hours	O
.	O

He	O
was	O
also	O
started	O
on	O
a	O
bowel	O
regimen	O
to	O
encourage	O
bowel	O
movement	O
.	O

Constitutional	O

Obstructive	O
Hypertrophic	O
Cardiomyopathy	O
425	O
.	O
1	O

Recent	O
and	O
remote	O
memory	O
:	O
Normal	B-labvalue
.	O

Plan	O
MetFORMIN	O
HCl	O
ER	B-form
500	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
Extended	I-form
Release	I-form
24	I-form
Hour	I-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
01Oct2013	B-temporal
to	O
(	O
Evaluate	O
:	O
30Mar2014	B-temporal
)	O
Requested	O
for	O
:	O
01Oct2013	B-temporal
;	O
Last	O
Rx	O
:	O
01Oct2013	B-temporal
;	O

3	O
.	O

Cardiovascular	O

Head	O
and	O
Face	O

1	O
Pneumococcal	O
17Jan2012	B-temporal

Cranial	O
Nerves	O
:	O

6	O
.	O

Hydrochlorothiazide	O
25	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
18Sep2007	B-temporal
-	O
Requested	O
for	O
:	O
24May2010	B-temporal
;	O
Last	O
Rx	O
:	O
24May2010	B-temporal
;	O
Status	O
:	O
NEED	O
INFORMATION	O
-	O
Rx	O
Benefit	O
Plan	O

No	B-negation
murmurs	O
were	O
heard	O
.	O

Orientation	O
to	O
person	O
,	O
place	O
and	O
time	O
:	O
Normal	B-labvalue
.	O

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

Impacted	O
cerumen	O
and	O
debris	O
were	O
removed	O
.	O

TRIGGERS	O
:	O
Her	O
triggers	O
are	O
heat	O
and	O
migraines	O
.	O

Review	O
of	O
Systems	O

NECK	O

Obturator	O
and	O
psoas	O
signs	O
are	O
negative	B-labvalue
.	O

Right	O
Iliopsoas	O
(	O
femor	O
.	O
)	O
Strength	O
:	O
/	O
5	O
.	O

During	O
programming	O
-	O
*	O
*	O
*	O
*	O
*	O
first	O
time	O
I	O
actually	O
saw	O
the	O
"	O
fog	O
"	O
come	O
over	O
her	O
withthe	O
wide	O
pulse	O
width	O
-	O
also	O
saw	O
her	O
regain	O
closure	O
of	O
her	O
mouthand	O
control	O
finally	O
at	O
the	O
above	O
settings	O
.	O

Nasal	B-bodyloc
mucosa	I-bodyloc
,	I-bodyloc
septum	I-bodyloc
,	I-bodyloc
and	I-bodyloc
turbinates	I-bodyloc
:	O
Abnormal	O
.	O

Persistent	O
swelling	O
and	O
stiffness	O
causing	O
signficant	B-bodyloc
knee	I-bodyloc
deformity	O
and	O
lacking	O
of	O
full	O
ROM	O
.	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
neck	O
:	O
Normal	B-labvalue
.	O

Krill	O
Oil	O
Ultra	O
Strength	O
1500	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
take	O
one	B-dosage
cap	B-form
daily	B-frequency
;	O
Therapy	O
:	O
14Aug2013	B-temporal
to	O

Neurological	O
:	O
headache	O
,	O
butno	O
convulsions	O
,	O
no	B-negation
dizziness	O
,	O
no	B-negation
fainting	O
,	O
no	B-negation
lightheadedness	O
,	O
no	B-negation
vertigo	O
,	O
no	B-negation
difficulty	O
walking	O
,	O
able	O
to	O
walk	O
,	O
no	O
ataxiaandnot	O
falling	O
.	O

Examination	O
of	O
pupils	O
and	O
irises	O
:	O
Normal	B-labvalue
.	O

Nasal	O
mucosa	O
,	O
septum	O
,	O
and	O
turbinates	O
:	O
Normal	O
.	O

Globulin	O
4	B-labvalue
.	I-labvalue
2	I-labvalue
g	I-labvalue
/	I-labvalue
dl	I-labvalue
H	B-labvalue
2	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
4	I-reference_range
.	I-reference_range

Hematologic	O
/	O
Lymphatic	O
:	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
,	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
,	O
no	B-negation
swollen	O
glands	B-bodyloc
and	O
no	B-negation
swollen	O
glands	B-bodyloc
in	O
the	O
neck	B-bodyloc
.	O

History	O
of	O
Present	O
Illness	O

Glucose	O
Lvl	O
91	B-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue

Femoral	O
pulses	O
:	O
Normal	B-labvalue
.	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
radiating	O
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
,	O
no	B-negation
intermittent	O
leg	B-bodyloc
claudication	O
,	O
no	B-negation
edema	O
and	O
no	B-negation
syncope	O
.	O

Examination	O
of	O
reflexes	O
:	O
Normal	B-labvalue
.	O

Paternal	B-subject
history	O
of	O
Diabetes	O
Mellitus	O
V18	O
.	O
0	O

General	O
:	O
no	B-negation
weight	O
loss	O
,	O
no	B-negation
weight	O
gain	O
,	O
appetite	O
is	O
not	O
poor	O
,	O
no	B-negation
chills	O
,	O
no	B-negation
fever	O
,	O
no	B-negation
night	O
sweats	O

Cough	O
:	O
Mild	B-severity

Hypertension	O
401	O
.	O
9	O

Caucasian	O
/	O
African	O
-	O
American	O
woman	O
w	O
/	O
PMH	O
significant	O
for	O
MVC	O
in	O
2006	B-temporal
w	O
/	O
TBI	O
w	O
/	O
resulting	O
left	B-bodyloc
-	I-bodyloc
sided	I-bodyloc
spastic	O
hemiparesis	O
,	O
seizure	O
d	O
/	O
o	O
,	O
and	O
dystonia	O
.	O

Cranial	O
nerves	O
IX	O
and	O
X	O
:	O
there	O
was	O
normal	B-labvalue
movement	O
of	O
the	O
soft	O
palate	O
and	O
normal	B-labvalue
gag	O
.	O

Metoprolol	O
Succinate	O
ER	B-form
50	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
Extended	I-form
Release	I-form
24	I-form
Hour	I-form
;	O
TAKE	O
2	B-dosage
TABLETS	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
02Nov2012	B-temporal
)	O
to	O

Collected	O
-	O
-	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
SARA	O
BERG	O
,	O
M	O
.	O
D	O
.	O

Lisa	O
verbalized	O
understanding	O
and	O
read	O
order	O
back	O
.	O

DUE	O
FOR	O
COLONOSCOPY	O
.	O

Vaccines	O
Prophylactic	O
Need	O
Against	O
Influenza	O
V04	O
.	O
81	O

No	B-negation
rhonchi	O
were	O
heard	O
.	O

the	O
patient	O
'	O
s	O
balance	O
was	O
impaired	O

[	O
QLH	O
]	O
CBC	O
(	O
INCLUDES	O
DIFF	O
/	O
PLT	O
)	O
Done	O
:	O
09Oct2012	B-temporal
10	B-temporal
:	I-temporal
51AM	I-temporal

Sleep	O
Apnea	O
780	O
.	O
57	O

Neck	O

No	B-negation
anterior	B-bodyloc
cervical	I-bodyloc
node	I-bodyloc
enlargement	O
and	O
no	B-negation
submandibular	B-bodyloc
node	I-bodyloc
enlargement	O
.	O

Symptoms	O
:	O
Denies	B-negation
chest	B-bodyloc
pain	O
,	O
denies	B-negation
intermittent	O
leg	B-bodyloc
claudication	O
,	O
denies	B-negation
muscle	B-bodyloc
pain	O
and	O
denies	B-negation
muscle	B-bodyloc
weakness	O
.	O

The	O
abdomen	O
was	O
soft	O
and	O
nontender	O
.	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
BERTHA	O
CAMPOS	O
,	O
P	O
.	O
A	O
.	O

History	O
of	O
Pregnancy	O
V22	O
.	O
2	O

She	O
was	O
intubated	O
and	O
fishbone	O
.	O

Results	O
/	O
Assessment	O
Hyperlipidemia	O
272	O
.	O
4	O

Examination	O
of	O
liver	O
and	O
spleen	O
:	O
Normal	B-labvalue
.	O

Social	O
History	O
Former	O
Smoker	O
V15	O
.	O
82	O

Physical	O
Exam	O
General	O
appearance	O
:	O
Normal	B-labvalue
.	O

She	O
was	O
given	O
prescription	O
for	O
Vicodin	O
for	O
pain	O
and	O
Synthroid	O
thyroid	O
hormone	O
,	O
and	O
otherwise	O
the	O
appropriate	O
wound	O
care	O
instructions	O
per	O
my	O
routine	O
wound	O
care	O
sheet	O
.	O

Facial	O
strength	O
:	O
Symmetric	O
.	O

Chief	O
Complaint	O

Assessment	O
Microalbuminuria	O
791	O
.	O
0	O

Electronically	O
signed	O
by	O
:	O
SAMER	O
FAKHRI	O
,	O
M	O
.	O
D	O
.	O

Examination	O
of	O
gait	O
and	O
station	O
:	O
Normal	B-labvalue
.	O

Psychiatric	O
:	O
no	B-negation
anxiety	O
and	O
no	B-negation
depression	O
.	O

The	O
heart	O
rate	O
was	O
normal	B-labvalue
.	O

2	O
.	O

No	B-negation
erythema	O
,	O
warmth	O
or	O
evidence	O
of	O
infection	O
.	O

Fundoscopic	O
Exam	O
:	O
Normal	B-labvalue
.	O

There	O
was	O
a	O
negative	B-labvalue
Murphy	O
'	O
s	O
sign	O
.	O

26	O
yo	O
F	O
with	O
PMH	O
of	O
SLE	O
,	O
GERD	O
,	O
Vit	O
D	O
def	O
here	O
for	O
f	O
/	O
u	O
appt	O

Hematologic	O
/	O
Lymphatic	O
:	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
,	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
and	O
no	B-negation
swollen	O
glands	B-bodyloc
.	O

Benign	B-severity
Essential	O
Hypertension	O
401	O
.	O
1	O

The	O
mass	O
increased	B-course
in	I-course
size	I-course
and	O
she	O
was	O
seen	O
by	O
her	O
primary	O
care	O
physician	O
and	O
referred	O
to	O
orthopedic	O
surgeon	O
.	O

I	O
agree	O
with	O
the	O
ndan	O
above	O
.	O
eg	O

Examination	O
of	O
reflexes	O
:	O
Normal	B-labvalue
.	O

Palpation	O
of	O
breasts	O
and	O
axillae	O
:	O
Normal	B-labvalue

Oropharynx	O
:	O
Normal	O
.	O

History	O
of	O
Asthma	O

Cranial	O
Nerve	O
VII	O
:	O
facial	O
strength	O
was	O
intact	B-labvalue
bilaterally	I-labvalue
.	O

Lumbosacral	O
Spine	O
:	O
Normal	O
(	O
no	B-negation
tenderness	O
on	O
palpation	O
)	O
.	O

[	O
QH	O
]	O
Pap	O
ThinPrep	O
w	O
/	O
Reflex	O
HPV	O
Requested	O
for	O
:	O
30Jul2013	B-temporal

Auscultation	O
of	O
lungs	O
:	O
Clear	B-labvalue
to	O
auscultation	O
.	O

Social	O
History	O
Alcohol	O
Use	O

Sample	O
Type	O
/	O
Medical	O
Specialty	O
:	O
Discharge	O
Summary	O

Inspection	O
of	O
the	O
conjunctiva	O
and	O
lids	O
:	O
Abnormal	O

Pt	O
is	O
currently	O
undecided	O
on	O
her	O
BCM	O
postpartum	O
and	O
is	O
currently	O
not	O
using	O
any	O
form	O
of	O
BCM	O
but	O
she	O
states	O
she	O
has	O
not	O
had	O
sexual	O
intercourse	O
since	O
she	O
delivered	O
on	O
10/3/2011	B-temporal
.	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
constipation	O
and	O
no	B-negation
diarrhea	O
.	O

Coordination	O
:	O
Normal	B-labvalue

Well	O
developed	O
,	O
appears	O
healthy	O
,	O
well	O
nourished	O
,	O
overweight	O
,	O
well	O
hydrated	O
and	O
awake	O
,	O
oriented	O
,	O
but	O
appears	O
tired	O
.	O

Sample	O
Name	O
:	O
Discharge	O
Summary	O
-	O
Nephrology	O
Description	O
:	O
P	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Constitutional	O

Mental	O
Status	O
:	O
A	O
mental	O
status	O
exam	O
was	O
performed	O
and	O
was	O
normal	B-labvalue
.	O

Asthma	O
493	O
.	O
90	O

.	O
eg	O

Review	O
of	O
Systems	O

Head	O
and	O
face	O
:	O
Normocephalic	O
;	O
atraumatic	O
.	O

Cardiovascular	O

Neurologic	O

Immunizations	O

Physical	O
Exam	O

Negative	O
nodes	O
.	O

Examination	O
of	O
external	O
genitalia	O
and	O
vagina	O
:	O
Normal	B-labvalue

Electronically	O
signed	O
by	O
:	O
CHAU	O
TRAN	O
,	O
M	O
.	O
D	O
.	O

Xopenex	O
HFA	O
45	B-strength
MCG	I-strength
/	I-strength
ACT	I-strength
Inhalation	B-route
Aerosol	B-form
;	O
INHALE	B-route
2	B-dosage
PUFFS	B-form
EVERY	B-frequency
4	I-frequency
HOURS	I-frequency
AS	B-frequency
NEEDED	I-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
12Jun2013	B-temporal
)	O
to	O

General	O
appearance	O
:	O
Normal	B-labvalue
.	O

Iodides	O

HEMATOLOGIC	O
/	O
LYMPHATIC	O
:	O
no	B-negation
anemia	O
,	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
and	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
.	O

She	O
has	O
irregular	O
eye	B-bodyloc
movements	O
prior	O
to	O
generalization	O
.	O

Dictated	O
Date	O
/	O
time	O
:	O
06/05/12	B-temporal
4	B-temporal
:	I-temporal
44	I-temporal
pm	I-temporal

Her	O
Dilantin	O
was	O
increased	O
to	O
400	B-strength
mg	I-strength
.	O

Heart	O
sounds	O
:	O
normal	B-labvalue
S1	O
,	O
normal	B-labvalue
S2	O
,	O
no	B-negation
S3	O
and	O
no	B-negation
S4	O
.	O

Urethral	O
meatus	O
:	O
Normal	O
.	O

[	O
QLH	O
]	O
TSH	O
,	O
3RD	O
GENERATION	O
W	O
/	O
REFLEX	O
TO	O
FT4	O
Requested	O
fis	O
:	O
29Apr2013	B-temporal

Allergies	O

History	O
of	O
Present	O
Illness	O

Reason	O
For	O
Visit	O

He	O
is	O
photosensitive	O
and	O
sound	O
sensitive	O
but	O
has	O
no	B-negation
nausea	O
or	O
vomiting	O
.	O

He	O
thinks	O
he	O
had	O
negative	B-negation
brain	O
imaging	O
studies	O
at	O
the	B-temporal
age	I-temporal
of	I-temporal
12	I-temporal
but	O
none	O
since	O
.	O

-	O
Negative	B-negation
for	O
metastatic	O
disease	O
(	O
0	O
of	O
4	O
lymph	B-bodyloc
nodes	I-bodyloc
)	O
.	O

*	O
Do	O
not	O
drive	O
or	O
operate	O
heavy	O
machinery	O
while	O
taking	O
any	O
narcotic	O
pain	O
medication	O
.	O

Maneuvers	O
demonstrated	O
a	O
negative	B-labvalue
Homan	O
'	O
s	O
sign	O
.	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
and	O
no	B-negation
vomiting	O
.	O

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

FINDINGS	O
:	O
The	O
common	O
femoral	O
,	O
superficial	O
femoral	O
,	O
and	O
popliteal	O
veins	O
demonstrate	O
normal	B-labvalue
compressibility	O
and	O
color	O
Doppler	O
signal	O
.	O

Palpation	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
Normal	B-labvalue
.	O

*	O
If	B-condition
you	O
develop	O
worsening	B-course
pain	O
,	O
loss	O
of	O
function	O
,	O
or	O
futher	B-course
loss	I-course
/	I-course
worsening	I-course
of	O
sensation	O
in	O
your	O
left	B-bodyloc
upper	I-bodyloc
extremity	I-bodyloc
*	O
If	B-condition
you	O
are	O
vomiting	O
and	O
cannot	O
keep	O
in	O
fluids	O
or	O
your	O
medications	O
.	O

Fosamax	O
TABS	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
03Nov2011	B-temporal
)	O
to	O

The	O
heart	O
rate	O
was	O
normal	B-labvalue
.	O

1	O
.	O

The	O
right	B-bodyloc
external	I-bodyloc
canal	I-bodyloc
was	O
not	B-negation
tender	O
,	O
was	O
not	O
swollenand	O
was	O
not	B-negation
erythematous	O
.	O

whom	O
the	O
CKD	O
-	O
EPI	O
formula	O
hasanotabeen	O
extensively	O
validated	O
.	O

;	O
Feb	B-temporal
18	I-temporal
2013	I-temporal
10	B-temporal
:	I-temporal
20AM	I-temporal
(	O
Author	O
)	O

Inspection	O
of	O
the	O
conjunctiva	O
and	O
lids	O
:	O
Normal	B-labvalue
.	O

History	O
of	O
Colon	O
Surgery	O
3	O
.	O

:	O
falsly	O
diagnosed	O
with	O
asthma	O
but	O
found	O
to	O
have	O
constricted	O
bronchial	B-bodyloc
tube	O
-	O
-	O
underwent	O
stent	O
11	B-temporal
/	I-temporal
09	I-temporal
but	O
recurrence	O
of	O
symptoms	O
after	O
a	B-temporal
few	I-temporal
months	I-temporal
.	O

;	O
Mar	B-temporal
21	I-temporal
2013	I-temporal
7	B-temporal
:	I-temporal
06PM	I-temporal
(	O
Author	O
)	O

Benign	B-severity
Essential	O
Hypertension	O
401	O
.	O
1	O

DTaP	O
;	O
01/07/2012	B-temporal

Omeprazole	O
20	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
Delayed	I-form
Release	I-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
EVERY	I-frequency
MORNING	I-frequency
BEFORE	O
BREAKFAST	O
;	O
Therapy	O
:	O
21Dec2012	B-temporal
to	O
(	O
Evaluate	O
:	O
19Jul2013	B-temporal
)	O
Requested	O
for	O
:	O
21Dec2012	B-temporal
;	O
Last	O
Rx	O
:	O
21Dec2012	B-temporal

Routine	O
Gynecological	O
Exam	O
With	O
Cervical	O
Pap	O
Smear	O
V72	O
.	O
31	O

Examination	O
of	O
the	O
abdomen	O
:	O
Normal	B-labvalue

Cranial	O
Nerve	O
XII	O
:	O
there	O
was	O
no	B-negation
tongue	B-bodyloc
deviation	O
with	O
protrusion	O
.	O

4	O
.	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
neck	O
:	O
Normal	B-labvalue
.	O

History	O
of	O
Alcohol	O

His	O
ENT	O
workup	O
was	O
apparently	O
negative	B-labvalue
except	O
for	O
allergy	O
-	O
related	O
symptoms	O
.	O

Vitals	O
UTP	O
Adult	O
Vital	O
Signs	O
[	O
Data	O
Includes	O
:	O
Current	O
Encounter	O
]	O
14Aug2013	B-temporal
01	B-temporal
:	I-temporal
13PM	I-temporal
BMI	O
Calculated	O
19	B-labvalue
.	I-labvalue
49	I-labvalue
BSA	O
Calculated	O
1	B-labvalue
.	I-labvalue
57	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
5	I-labvalue
in	I-labvalue
Weight	O
117	B-labvalue
lb	I-labvalue
Systolic	O
132	B-labvalue
,	O
RUE	O
,	O
Sitting	O
Diastolic	O
77	B-labvalue
,	O
RUE	O
,	O
Sitting	O
Temperature	O
98	B-labvalue
F	I-labvalue
,	O
Oral	O
Heart	O
Rate	O
98	B-labvalue
Respiration	O
16	B-labvalue

This	O
burning	O
sensation	O
has	O
occurred	O
with	O
activity	O
such	O
as	O
walking	O
up	O
a	O
steep	O
incline	O
or	O
even	O
on	O
a	O
flat	O
surface	O
,	O
occasionally	O
depending	O
on	O
what	O
he	O
had	O
just	O
eaten	O
.	O

Musculoskeletal	O

Cardiovascular	O
:	O
palpitations	O
and	O
fast	O
heart	B-bodyloc
rate	O
,	O
but	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
the	O
heart	O
rate	O
was	O
not	B-labvalue
slow	I-labvalue
,	O
no	B-negation
intermittent	O
leg	B-bodyloc
claudication	O
and	O
no	B-negation
edema	O
.	O

Cardiovascular	O

Need	O
to	O
Get	O
RA	O
records	O
on	O
most	B-temporal
previous	I-temporal
blood	O
work	O
from	O
dR	O
.	O
Richard	O
Rubin	O
,	O
f	O
/	O
u	O
Dr	O
.	O
Garb	O
or	O
myself	O
as	O
scheduled	O
.	O

Plan	O
Cervical	O
Biopsy	O
Requested	O
for	O
:	O
04Mar2013	B-temporal

OB	O
History	O

History	O
of	O
Alcohol	O
Use	O

At	O
that	O
time	O
he	O
had	O
episodes	O
where	O
he	O
would	O
get	O
a	O
sensation	O
of	O
lightheadedness	O
.	O

Vitals	O
25Feb2014	B-temporal
11	B-temporal
:	I-temporal
40AM	I-temporal
BMI	O
Calculated	O
43	B-labvalue
.	I-labvalue
39	I-labvalue
BSA	O
Calculated	O
2	B-labvalue
.	I-labvalue
28	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
6	I-labvalue
in	I-labvalue
Weight	O
270	B-labvalue
lb	I-labvalue
Systolic	O
135	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
98	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Temperature	O
97	B-labvalue
.	I-labvalue
4	I-labvalue
F	I-labvalue
,	O
Tympanic	O
Heart	O
Rate	O
76	B-labvalue
Respiration	O
16	B-labvalue
Respiration	O
Quality	O
Normal	B-labvalue
LMP	O
T	O
.	O

I	O
was	O
present	O
for	O
all	O
of	O
the	O
exam	O
.	O

Electronically	O
signed	O
by	O
:	O
MARTHA	O
AGUILAR	O
,	O
M	O
.	O
D	O
.	O

Cervical	B-bodyloc
Radiculopathy	O
723	O
.	O
4	O

He	O
denies	B-negation
overt	O
pain	O
with	O
ROM	O
of	O
the	O
knee	B-bodyloc
itself	O
.	O

Social	O
History	O

No	O
travel	O
,	O
no	B-negation
known	O
sick	O
contact	O
.	O

Vitals	O
UTP	O
Adult	O
Vital	O
Signs	O
[	O
Data	O
Includes	O
:	O
Current	O
Encounter	O
]	O

Her	O
GYN	O
put	O
her	O
on	O
Spironolactone	O
.	O

Amenorrhea	O
.	O

DIET	O
:	O
Regular	O
and	O
less	O
neutropenic	O
.	O

Plan	O
1	O
.	O

Tobacco	O
Use	O

Shortness	O
Of	O
Breath	O
786	O
.	O
05	O

Joint	B-bodyloc
Pain	O
,	O
Localized	O
In	O
The	O
Shoulder	B-bodyloc
719	O
.	O
41	O

Plan	O
Bystolic	O
5	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
27Dec2012	B-temporal
-	O
21Mar2013	B-temporal
;	O
Status	O
:	O

Musculoskeletal	O

Current	O
Meds	O

ABDOMEN	O
:	O
Soft	O
,	O
non	B-negation
tender	O
,	O
non	B-negation
distended	O
,	O
normal	B-labvalue
active	O
bowel	O
sounds	O
,	O
no	B-negation
guarding	O
,	O
no	B-negation
rebound	O
,	O
no	B-negation
hepatosplenomegaly	O
.	O
eg	O

Social	O
History	O
Alcohol	O
Use	O

Discussion	O
/	O
Discussion	O
/	O
Summary	O

No	B-negation
facial	B-bodyloc
skin	I-bodyloc
lesions	O
.	O

Maternal	B-subject
history	O
of	O
Diabetes	O
Mellitus	O
V18	O
.	O
0	O

Weight	O
:	O
161	B-labvalue
lb	I-labvalue

No	B-negation
murmurs	O
were	O
heard	O
.	O

Current	B-temporal
treatment	O
includes	O
good	O
sleep	O
hygiene	O
.	O

Notes	O
g14	O

Chief	O
Complaint	O

Endoscopy	O
Was	O
Performed	O
Using	O
:	O
flexible	O
fiberoptic	O
scope	O
.	O

)	O
,	O
but	O
no	B-negation
gastroparesis	O
,	O
no	B-negation
nephropathy	O
,	O
no	B-negation
retinopathy	O
and	O
no	B-negation
coronary	B-bodyloc
artery	I-bodyloc
disease	O
.	O

HumaLOG	O
100	B-strength
UNIT	I-strength
/	I-strength
ML	I-strength
Subcutaneous	B-route
Solution	B-form
;	O
INJECT	O
100	B-dosage
UNIT	I-dosage
DAILY	B-frequency
via	O
insulin	O
pump	B-route
;	O
Therapy	O
:	O
14May2008	B-temporal
to	O
(	O
Evaluate	O
:	O
11Aug2013	B-temporal
)	O
Requested	O
for	O
:	O
12Jul2013	B-temporal

Current	O
PEnd	O
Gians	O
:	O
MichaeouA	O
.	O

All	O
questions	O
were	O
answered	O
.	O

Patient	O
admits	O
that	O
he	O
has	O
not	O
been	O
compying	O
with	O
taking	O
his	O
medications	O
as	O
directed	O
and	O
has	O
been	O
self	O
managing	O
at	O
times	O
,	O
Denies	B-negation
poylyurea	O
,	O
polydipsea	O
,	O
polyphagia	O
or	O
hypoglycemia	O
.	O

Fish	O
Oil	O
1000	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
1	B-dosage
-	I-dosage
2	I-dosage
TABLETS	B-form
IN	B-frequency
THE	I-frequency
EVENING	I-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
25Mar2014	B-temporal
)	O
to	O

Fossa	O
of	O
Rosenmueller	O
normal	O
.	O

Ankle	O
Jerk	O
:	O
right	B-labvalue
1	I-labvalue
+	I-labvalue
and	O
left	B-labvalue
1	I-labvalue
+	I-labvalue
.	O

Examination	O
of	O
gait	O
and	O
station	O
:	O
Normal	B-labvalue
.	O

Red	O
Blood	O
Cell	O
:	O
3	B-labvalue
.	I-labvalue
53	I-labvalue
M	I-labvalue
/	I-labvalue
CMM	I-labvalue
Abnormal	O
Low	O
Reference	O
Range	O
4	B-reference_range
.	I-reference_range
20	I-reference_range
-	I-reference_range
5	I-reference_range
.	I-reference_range
40	I-reference_range

-	O
treadmill	O
Nl	O

Systolic	O
:	O
142	B-labvalue
,	O
LUE	O
,	O
Sitting	O

Cardiovascular	O
:	O
no	B-negation
edemaandthe	O
heart	O
rate	O
was	O
not	B-negation
fast	B-labvalue
.	O

Surgical	O
History	O
History	O
of	O
Cataract	O
Surgery	O

[	O
L	O
]	O
Pap	O
IG	O
,	O
Ct	O
-	O
Ng	O
,	O
rfx	O
HPV	O
ASCU	O
Requested	O
for	O
:	O
13Nov2012	B-temporal

This	O
would	O
last	O
a	O
short	O
time	O
and	O
then	O
his	O
vision	O
seemed	O
to	O
close	O
in	O
and	O
he	O
felt	O
off	O
balance	O
like	O
he	O
was	O
falling	O
forward	O
or	O
downward	O
.	O

Cut	O
aricept	O
to	O
half	O
,	O
husband	O
to	O
call	O
and	O
see	O
if	O
there	O
is	O
any	O
improvement	O
,	O
gait	O
and	O
balance	O
rehab	O

Examination	O
of	O
cranial	O
nerves	O
:	O
Normal	B-labvalue
.	O
No	B-negation
nystagmus	O
,	O
but	O
at	O
periphery	O
of	O
gaze	O
fells	O
slightly	B-severity
dizzy	O
.	O

Never	O
A	O
Smoker	O

Cardiovascular	O

Bellaire	O
Women	O
'	O
s	O
Center	O
Medical	O
Summasy	O
Patirt	O
Detail	O
for	O
SUSAN	O
QUARLES	O
MRN	O
:	O
4175675	O
Contact	O
SUSAN	O
QUARLES	O
Da	O
e	O
Of	O
Birth	O
March	B-temporal
17	I-temporal
,	I-temporal
1974	I-temporal
Address	O
1107	O
GROVEWOOD	O
LANE	O

Carotid	B-bodyloc
:	O
right	O
2	O
+	O
,	O
left	O
2	O
+	O
,	O
no	B-negation
bruit	O
on	O
the	O
right	O
and	O
no	B-negation
bruit	O
on	O
the	O
left	O
.	O

Abdomen	O

Pulmonary	O

Surgical	O
History	O
History	O
of	O
Anal	O
Fissurectomy	O

The	O
tonsils	O
were	O
normal	O
.	O

Endocrine	O
:	O
no	B-negation
proptosis	O
.	O

Auscultation	O
of	O
lungs	O
:	O
Abnormal	O
.	O

Assessment	O
of	O
range	O
of	O
motion	O
:	O
Normal	B-labvalue
.	O

[	O
QLH	O
]	O
LIPID	O
PANEL	O
Requested	O
for	O
:	O
10Apr2012	B-temporal

She	O
currently	O
takes	O
600	O
in	O
the	O
morning	O
and	O
600	O
at	O
night	O
.	O

Brief	O
Hospital	O
Course	O
:	O

Constitutional	O

Cardiovascular	O

NM	O
Bone	O
scan	O
Requested	O
for	O
:	O
17Oct2012	B-temporal

7	O
days	O
-	O
150	O
yrs	O
:	O
70	O
-	O
99	O
mg	O
/	O
dL	O
(	O
fasting	O
)	O
,	O
based	O
on	O
the	O
clinical	O

Keywords	O
:	O
discharge	O
summary	O
,	O
radiculopathy	O
,	O
cervical	O
spondylosis	O
,	O
neck	B-bodyloc
pain	O
,	O
anterior	O
cervical	O
discectomy	O
,	O
herniated	O
nucleus	O
pulposus	O
,	O
cervical	O
,	O
anterior	O
,	O
herniated	O
,	O

[	O
QLH	O
]	O
CBC	O
(	O
INCLUDES	O
DIFF	O
/	O
PLT	O
)	O
Requested	O
for	O
:	O
04Apr2014	B-temporal

Right	O
lateral	O
flexion	O
was	O
not	O
restricted	O
and	O
was	O
painful	O
.	O

RESPIRATORY	O

Comorbid	O
Illnesses	O
:	O
diabetes	O
mellitus	O
and	O
hypertension	O
.	O

[	O
QLH	O
]	O
CMP	O
W	O
/	O
EGFR	O
Requested	O
for	O
:	O
06Nov2013	B-temporal

Radiological	O
Data	O

Immunizations	O
status	O
:	O
.	O

Exforge	O
HCT	O
5-160-12	B-strength
.	I-strength
5	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
EVERY	B-frequency
DAY	I-frequency
;	O
Therapy	O
:	O
27Dec2012	B-temporal
-	O
21Mar2013	B-temporal
;	O
Status	O
:	O
DISCONTINUED	O

Left	O
hemiplegia	O
,	O
still	O
with	O
minimal	O
movement	O
in	O
his	O
LUE	B-bodyloc
,	O
able	O
to	O
move	O
his	O
left	O
leg	O
;	O
is	O
weight	O
bearing	O
at	O
home	O
(	O
did	O
not	O
test	O
today	O
)	O
.	O

Musculoskeletal	O
:	O
no	B-negation
arthralgias	O
,	O
no	B-negation
joint	B-bodyloc
pain	O
,	O
no	B-negation
joint	B-bodyloc
swelling	O
,	O
no	B-negation
joint	B-bodyloc
stiffness	O
,	O
no	B-negation
limb	B-bodyloc
pain	O
and	O
no	B-negation
limb	B-bodyloc
swelling	O
.	O

Promethazine	O
HCl	O
12	B-strength
.	I-strength
5	I-strength
MG	I-strength
Rectal	B-route
Suppository	B-form
;	O
INSERT	O
1	B-dosage
SUPPOSITORY	B-form
EVERY	B-frequency
6	I-frequency
HOURS	I-frequency
AS	B-frequency
NEEDED	I-frequency
FOR	O
NAUSEA	O
AND	O
VOMITING	O
;	O
Qty1	O
;	O
R1	O
;	O
Rx	O
.	O
eg	O

Inspection	O
of	O
the	O
nasal	O
mucosa	O
,	O
septum	O
and	O
turbinates	O
:	O
Normal	B-labvalue
.	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
and	O
no	B-negation
palpitations	O
.	O

Constitutional	O
:	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
,	O
not	B-negation
feeling	O
poorly	O
(	O
malaise	O
)	O
,	O
not	B-negation
feeling	O
tired	O
(	O
fatigue	O
)	O
andno	O
recent	B-temporal
weight	O
gain	O
.	O

History	O
of	O
Present	O
Illness	O

Calcium	O
,	O
Serum	O
:	O
9	B-labvalue
.	I-labvalue
9	I-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue
Reference	O
Range	O
8	B-reference_range
.	I-reference_range
7	I-reference_range
-	I-reference_range
10	I-reference_range
.	I-reference_range
2	I-reference_range

Hematologic	O
/	O
Lymphatic	O
:	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
and	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
.	O

Constitutional	O
:	O
recent	B-temporal
weight	O
gain	O
,	O
but	O
no	B-negation
fever	O
,	O
not	B-negation
feeling	O
poorly	O
(	O
malaise	O
)	O
and	O
not	B-negation
feeling	O
tired	O
(	O
fatigue	O
)	O
.	O

1	O
Pneumococcal	O
20Mar2009	B-temporal

Palpation	O
of	O
breasts	O
and	O
axillae	O
:	O
Normal	B-labvalue
.	O

Results	O
/	O
Physical	O
Exam	O

History	O
of	O
Dizziness	O
780	O
.	O
4	O

Past	O
evaluation	O
has	O
included	O
chest	O
x	O
-	O
ray	O
.	O

Gynecological	O
Problems	O
.	O

Past	O
Medical	O
History	O
History	O
of	O
Allergic	O
Rhinitis	O
477	O
.	O
9	O

She	O
only	O
takes	O
occ	O
.	O

The	O
abdomen	O
was	O
flat	O
.	O

Pt	O
.	O
denies	B-negation
CP	O
.	O

Auscultation	O
of	O
heart	O
:	O
Abnormal	O
.	O

GASTROINTESTINAL	O
:	O
no	B-negation
heartburn	O
,	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
diarrhea	O
,	O
no	B-negation
constipation	O
and	O
no	B-negation
vomiting	O
.	O

He	O
also	O
denies	B-negation
back	B-bodyloc
pain	O
which	O
he	O
complained	O
of	O
at	O
last	O
visit	O
.	O

SECONDARY	O
DIAGNOSIS	O
:	O
Migraine	O
headache	O
.	O

HOSPITAL	O
COURSE	O
:	O

Warfarin	O
Sodium	O
6	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
UP	O
TO	O
ONE	O
AND	O
ONE	B-dosage
-	I-dosage
HALF	I-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
EVERY	B-frequency
DAY	I-frequency
AS	O
DIRECTED	O
;	O
Therapy	O
:	O
06Jun2006	B-temporal
to	O
(	O
Evaluate	O
:	O
02Sep2013	B-temporal
)	O
Requested	O
for	O
:	O
07Sep2012	B-temporal
;	O
Last	O
Rx	O
:	O
07Sep2012	B-temporal

Drip	O
Or	O
Drainage	O
Down	O
Throat	B-bodyloc
From	O
Above	O
784	O
.	O
91	O

Otoscopic	O
examination	O
:	O
Normal	B-labvalue
.	O

Patient	O
agrees	O
to	O
proceed	O
.	O

[	O
U	O
]	O
XRAY	O
KNEE	O
1	O
OR	O
2	O
VWS	O
RIGHT	O
73560	O

Plan	O
Lisinopril	O
20	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
EVERY	B-frequency
DAY	I-frequency
;	O
Therapy	O
:	O
07Oct2010	B-temporal
-	O
;	O
Last	O
Rx	O
:	O
17Sep2012	B-temporal
;	O
Status	O
:	O
TEMPORARY	O
DEFERRAL	O

Active	O
Problems	O
g29	O

(	O
Medical	O
Transcription	O
Sample	O
Report	O
)	O

Allergic	O
Rhinitius	O
:	O

Head	O
/	O
Eyes	O
/	O
Ears	O
/	O
Nose	O
/	O
Throat	O
:	O
N	O
/	O
A	O
.	O

Simvastatin	O
20	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
15Aug2012	B-temporal
to	O

2	O
)	O
AMA	O

Motor	O
:	O
Normal	B-labvalue
Strength	O
.	O

Due	O
For	O
:	O
a	O
lipid	O
panel	O
,	O
a	O
urine	O
microalbumin	O
and	O
a	O
hemoglobin	O
A1C	O
.	O

Allergies	O
Medication	O

Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

Baby	O
improved	O
after	O
couple	O
of	O
days	O
when	O
p	O
.	O
o	O
.	O
feedings	O
were	O
restarted	O
.	O

I	O
wanted	O
him	O
to	O
take	O
0	B-strength
.	I-strength
25	I-strength
mg	I-strength
twice	B-frequency
a	I-frequency
day	I-frequency
as	O
needed	O
;	O
however	O
,	O
he	O
misunderstood	O
and	O
took	O
0	B-strength
.	I-strength
5	I-strength
mg	I-strength
and	O
stopped	O
it	O
because	O
he	O
was	O
too	O
sedated	O
on	O
it	O
.	O

Chief	O
Complaint	O

Pedal	O
pulses	O
:	O
Normal	B-labvalue
.	O

RBC	O
:	O
4	B-labvalue
.	I-labvalue
22	I-labvalue
M	I-labvalue
/	I-labvalue
CMM	I-labvalue
Reference	O
Range	O
4	B-reference_range
.	I-reference_range
20	I-reference_range
-	I-reference_range
5	I-reference_range
.	I-reference_range
40	I-reference_range

Integumentary	O
:	O
no	B-negation
skin	B-bodyloc
lesions	O
,	O
no	B-negation
skin	B-bodyloc
wound	O
,	O
no	B-negation
pruritus	O
,	O
no	B-negation
change	O
in	O
a	O
mole	O
,	O
no	B-negation
dry	O
skin	B-bodyloc
and	O
no	B-negation
unusual	O
growth	O
on	O
the	O
skin	B-bodyloc
.	O

Lower	O
Extremities	O
:	O
Right	O
Iliopsoas	O
(	O
femor	O
.	O
)	O
Strength	O
:	O
3	B-labvalue
+	I-labvalue
/	I-labvalue
5	I-labvalue
.	O
(	O
3	O
+	O
)	O
.	O

Creatinine	O
,	O
Serum	O
:	O
1	B-labvalue
.	I-labvalue
02	I-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue
Reference	O
Range	O
0	B-reference_range
.	I-reference_range
76	I-reference_range
-	I-reference_range
1	I-reference_range
.	I-reference_range
27	I-reference_range

"	O
Exercising	O
Regularly	O

33608	O
Ortega	O
Highway	O

He	O
was	O
also	O
found	O
to	O
have	O
conductive	O
hearing	O
loss	O
bilaterally	O
.	O

Social	O
History	O

Abdomen	O

No	B-negation
rhonchi	O
were	O
heard	O
.	O

CONSTITUTIONAL	O
:	O
no	B-negation
nausea	O
,	O
no	B-negation
recent	O
weight	O
gain	O
,	O
no	B-negation
recent	B-temporal
weight	O
loss	O
,	O
no	B-negation
fever	O
and	O
no	B-negation
chills	O

Uterus	O
:	O
Normal	O
.	O

Description	O
:	O
Possible	O
free	O
air	O
under	O
the	O
diaphragm	O
.	O

Zantac	O
75	B-dosage
TABS	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
10Oct2013	B-temporal
)	O
to	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
neck	O
:	O
Normal	B-labvalue
.	O

Examination	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue
.	O
Supple	O
,	O
no	B-negation
JVD	O
,	O
no	B-negation
adenopathy	O
,	O
no	B-negation
nuchal	B-bodyloc
rigidity	O
.	O

Alert	B-labvalue
and	O
cooperative	B-labvalue
.	O

History	O
of	O
Fracture	O
Of	O
Femur	B-bodyloc
821	O
.	O
00	O

External	O
rotation	O
:	O
restricted	O
active	O
range	O
of	O
motion	O
45	O
degrees	O
.	O

Advance	O
Directives	O

GENERAL	O
APPEARANCE	O
-	O
Active	B-labvalue
,	O
alert	B-labvalue
infant	O
,	O
well	B-labvalue
developed	I-labvalue
,	O
well	B-labvalue
nourished	I-labvalue
.	O

Description	O
:	O
The	O
patient	O
is	O
a	O
17	O
-	O
year	O
-	O
old	O
female	O
,	O
who	O
presents	O
to	O
the	O
emergency	O
room	O
with	O
foreign	O
body	O
and	O
airway	B-bodyloc
compromise	O
and	O
was	O
taken	O
to	O
the	O
operating	O
room	O
.	O

Results	O
/	O
Results	O
/	O
Data	O
Urine	O
Dipstick	O
(	O
In	O
Office	O
)	O
21Nov2013	B-temporal
10	B-temporal
:	I-temporal
22AM	I-temporal
CAMPOS	O
,	O
BERTHA	O

Assessment	O
of	O
hearing	O
:	O
Normal	B-labvalue
.	O

Reason	O
For	O
Visit	O

ENT	O
:	O
no	B-negation
epistaxis	O
and	O
no	B-negation
sore	O
throat	B-bodyloc
.	O

Ordered	O
;	O
For	O
:	O
Esophageal	B-bodyloc
Reflux	O
(	O
530	O
.	O
81	O
)	O
;	O
Ordered	O
By	O
:	O
ABDELMELEK	O
,	O
LOURICE	O
Perform	O
:	O
Hermann	O
Due	O
:	O
31Mar2013	B-temporal
;	O
Last	O
Updated	O
By	O
:	O
Fleming	O
,	O
Sonya	O

f	O
No	O
Significant	O
Medisal	O
Histisy	O

History	O
of	O
Cervicalgia	O
723	O
.	O
1	O

MA	O
Breast	O
mammogram	O
screen	O
bilateral	O
Requested	O
for	O
:	O
06Dec2012	B-temporal

Maternal	B-subject
history	O
of	O
Hypertension	O
V17	O
.	O
49	O

PHYSICAL	O
EXAMINATION	O
:	O
Please	O
see	O
the	O
hospital	O
chart	O
.	O

Color	O
:	O
Normal	B-labvalue

The	O
patient	O
was	O
instructed	O
to	O
contact	O
Dr	O
.	O
XYZ	O
'	O
s	O
office	O
for	O
fever	O
greater	O
than	O
101	O
.	O
5	O
,	O
intractable	O
pain	O
,	O
nausea	O
,	O
vomiting	O
,	O
or	O
any	O
other	O
concerns	O
.	O

DISCONTINUED	O

Current	O
Meds	O
Lipitor	O
20	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
19May2008	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
03Feb2010	B-temporal
)	O
Requested	O
for	O
:	O
21Nov2011	B-temporal

Physical	O
Exam	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

She	O
states	O
that	O
she	O
was	O
in	O
her	O
usual	O
state	O
of	O
health	O
until	O
approximately	O
3	O
weeks	O
ago	O
when	O
while	O
on	O
vacation	O
in	O
New	O
York	O
she	O
developed	O
headaches	O
which	O
for	O
the	O
first	O
week	O
or	O
so	O
were	O
daily	O
and	O
felt	O
"	O
like	O
before	O
surgery	O
"	O
.	O

feels	O
worse	O
when	O
she	O
takes	O
it	O
,	O
she	O
does	O
irrigations	O
with	O
mometasone	O
.	O

2	O
.	O

Pravastatin	O
Sodium	O
40	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
ONE	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
EVERY	B-frequency
DAY	I-frequency
;	O
Therapy	O
:	O
13Dec2013	B-temporal
to	O
(	O
Evaluate	O
:	O
13Mar2014	B-temporal
)	O
Requested	O
for	O
:	O
13Dec2013	B-temporal
;	O
Last	O
Rx	O
:	O
13Dec2013	B-temporal
;	O
Edited	O

History	O
of	O
Attention	O
-	O
deficit	O
Hyperactivity	O
Disorder	O
314	O
.	O
01	O

Sample	O
Type	O
/	O
Medical	O
Specialty	O
:	O
Discharge	O
Summary	O

Family	O
history	O
of	O
Reported	O
Family	O
History	O
Of	O
Heart	B-bodyloc
Disease	O

History	O
of	O
Esophageal	B-bodyloc
Reflux	O
530	O
.	O
81	O

Examination	O
of	O
the	O
head	O
and	O
face	O
:	O
Normal	B-labvalue

Left	O
Toe	O
.	O

History	O
of	O
Skin	O
:	O
A	O
Rash	O
782	O
.	O
1	O

Physical	O
Exam	O

History	O
of	O
Present	O
Illness	O

CXR	O
reveal	O
mild	B-severity
pleural	B-bodyloc
effusion	O
.	O

Past	O
Medical	O
History	O
History	O
of	O
Previously	O
Well	O

Never	O
.	O

No	B-negation
urinary	O
incontinence	O
.	O

Psychiatric	O
:	O
N	O
/	O
A	O
.	O

Family	B-subject
hi	O
tory	O
of	O
Hypertension	O
.	O
eg	O

Drug	O
Use	O

Neurologic	O

WHITE	O
BLOOD	O
CELL	O
COUNT	O
5	B-labvalue
.	I-labvalue
4	I-labvalue
Thousand	I-labvalue
/	I-labvalue
u	I-labvalue
3	B-reference_range
.	I-reference_range
8	I-reference_range
-	I-reference_range
10	I-reference_range
.	I-reference_range
8	I-reference_range

RT	O
Inferior	O
Turbinate	O

Patient	O
was	O
known	O
to	O
have	O
left	B-bodyloc
calf	I-bodyloc
DVT	O
below	B-bodyloc
knee	I-bodyloc
on	O
lovenox	O
initially	O
3	B-duration
days	I-duration
then	O
switched	O
to	O
ASA	O
81mg	B-strength
.	O

Right	B-bodyloc
knee	I-bodyloc
with	O
trace	B-severity
swelling	O
and	O
mild	B-severity
tenderness	O
.	O

Urine	O
Dipstick	O
(	O
In	O
Office	O
)	O
Requested	O
for	O
:	O
30Oct2013	B-temporal

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O
This	O
is	O
a	O
29	O
-	O
year	O
-	O
old	O
male	O
who	O
has	O
had	O
multiple	O
problems	O
with	O
his	O
teeth	B-bodyloc
due	O
to	O
extensive	O
dental	O
disease	O
and	O
has	O
had	O
many	O
of	O
his	O
teeth	O
pulled	O
.	O

Caduet	O
5	B-strength
-	I-strength
10	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
27Nov2007	B-temporal
to	O
(	O
Evaluate	O
:	O
05Apr2013	B-temporal
)	O
Requested	O
for	O
:	O
10Apr2012	B-temporal
;	O
Last	O
Rx	O
:	O
10Apr2012	B-temporal
;	O
Edited	O

Normal	O
Routine	O
History	O
And	O
Physical	O
Adult	O
V70	O
.	O
0	O

We	O
also	O
gave	O
the	O
patient	O
Amrix	O
15	B-strength
mg	I-strength
once	B-frequency
at	I-frequency
night	I-frequency
for	O
spasm	O
.	O

(	O
med	O
.	O

PREVIOUS	O
TREATMENTS	O

The	O
duration	O
of	O
her	O
recent	O
periods	O
has	O
been	O
regular	O
and	O
usually	O
last	O
4	O
days	O
.	O

Respiratory	O
:	O
shortness	O
of	O
breath	O
,	O
wheezing	O
,	O
cough	O
and	O
orthopnea	O
,	O
but	O
no	B-negation
shortness	O
of	O
breath	O
during	O
exertion	O
and	O
no	B-negation
PND	O
.	O

Associated	O
symptoms	O
include	O
no	O
focal	O
neurologic	O
deficits	O
and	O
no	B-negation
memory	O
loss	O
.	O

Pus	O
/	O
crust	O
at	O
FS	O
stent	O
.	O

Social	O
History	O
:	O
Household	O
members	O
include	O
spouse	O
.	O

Comorbid	O
Illnesses	O
:	O
hypertension	O
and	O
hyperlipidemia	O
.	O

A	O
Pap	O
smear	O
was	O
performed	O
.	O

Chronic	O
Cough	O
786	O
.	O
2	O

The	O
patient	O
is	O
calm	O
,	O
comfortable	O
,	O
in	O
no	B-negation
acute	B-course
distress	O
,	O
and	O
looks	O
well	O
.	O

Physical	O
Exam	O

Exacerbating	O
factors	O
:	O
bending	O
forwardandlying	O
down	O
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Review	O
of	O
Systems	O

Gout	O
274	O
.	O
9	O

Plan	O
Urine	O
Dipstick	O
(	O
In	O
Office	O
)	O
Done	O
:	O
25Feb2014	B-temporal
11	B-temporal
:	I-temporal
41AM	I-temporal

Symptoms	O
:	O
postnasal	B-bodyloc
drip	O
,	O
throat	B-bodyloc
itching	O
,	O
sore	O
throat	B-bodyloc
and	O
cough	O
,	O
but	O
no	B-negation
eye	B-bodyloc
itching	O
.	O

History	O
of	O
Present	O
Illness	O

Normal	O
Routine	O
History	O
And	O
Physical	O
Adult	O
V70	O
.	O
0	O

Strength	O
Testing	O
:	O
4	B-labvalue
/	I-labvalue
5	I-labvalue
forward	I-labvalue
flexion	I-labvalue
,	O
4	O
/	O
5	O
abductionand4	O
/	O
5	O
external	O
rotation	O
.	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O
Mr	O
.	O
ABC	O
is	O
a	O
70	O
-	O
year	O
-	O
old	O
male	O
who	O
has	O
been	O
diagnosed	O
with	O
a	O
left	O
renal	O
cell	O
carcinoma	O
with	O
multiple	O
renal	O
cysts	O
.	O

[	O
QLH	O
]	O
TSH	O
,	O
3RD	O
GENERATION	O
W	O
/	O
REFLEX	O
TO	O
FT4	O
Done	O
:	O
18Dec2012	B-temporal
11	B-temporal
:	I-temporal
30AM	I-temporal

Genitourinary	O
:	O
no	B-negation
dysuria	O
,	O
no	B-negation
incontinence	O
,	O
no	B-negation
pelvic	B-bodyloc
pain	O
,	O
no	B-negation
dysmenorrhea	O
,	O
no	B-negation
vaginal	O
discharge	O
and	O
no	B-negation
unexplained	O
vaginal	B-bodyloc
bleeding	O
.	O

Respiration	O
Quality	O
:	O
Normal	B-labvalue

Prescription	O
medication	O
:	O
Cetirizine	O
daily	B-frequency
at	I-frequency
bedtime	I-frequency
.	O

s	O
/	O
p	O
BTL	O
-	O
path	O
showed	O
complete	O
transection	O
of	O
both	O
tubes	O

Examination	O
of	O
pupils	O
and	O
irises	O
:	O
Normal	B-labvalue

Coronary	B-bodyloc
Arteriosclerosis	O
414	O
.	O
00	O

Cranial	O
nerves	O
III	O
,	O
IV	O
,	O
and	O
VI	O
:	O
the	O
extraocular	O
motions	O
were	O
intact	B-labvalue
.	O

Bladder	O
:	O
Normal	O
.	O

[	O
H	O
]	O
Free	O
T4	O
07Apr2011	B-temporal
09	B-temporal
:	I-temporal
42AM	I-temporal
Hardwicke	O
,	O
Robin	O

No	B-negation
pericardial	O
rub	O
.	O

The	O
spleen	B-bodyloc
was	O
nontender	O
and	O
not	B-negation
enlarged	O
.	O

BSA	O
Calculated	O
:	O
1	B-labvalue
.	I-labvalue
81	I-labvalue

General	O
appearance	O
:	O
Normal	B-labvalue
.	O

Never	O
A	O
Smoker	O

[	O
QL	O
]	O
THYROID	O
PANEL	O
WITH	O
TSH	O
,	O
3RD	O
GENERATION	O
Requested	O
for	O
:	O
26Nov2012	B-temporal

Discussion	O
/	O
Discussion	O
/	O
Summary	O
Impression	O
:	O
lymphadenopathy	O
.	O

Otoscopic	O
examination	O
:	O
Normal	B-labvalue
.	O

Review	O
of	O
Systems	O

Physical	O
Exam	O

Description	O
of	O
patient	O
'	O
s	O
judgement	O
and	O
insight	O
:	O
Normal	B-labvalue

Palpation	O
of	O
lymph	O
nodes	O
in	O
axillae	O
:	O
Normal	B-labvalue
.	O

Denied	O

Urinary	B-bodyloc
Tract	I-bodyloc
Infection	O
,	O
Geriatric	O
Presentation	O
599	O
.	O
0	O

Allergies	O
Flagyl	O
TABS	B-form

Libial	O
(	O
tib	O
.	O
)	O
Strength	O
:	O
5	B-labvalue
/	I-labvalue
5	I-labvalue
.	O

Complete	O
-	O
Male	O

History	O
of	O
Asymptomatic	O
Postmenopausal	O
Status	O
V49	O
.	O
81	O

EKG	O
Requested	O
for	O
:	O
02Nov2012	B-temporal

Pt	O
is	O
here	O
for	O
sinus	O
follow	O
up	O
.	O

Femoral	O
pulses	O
:	O
Normal	B-labvalue
.	O

Examination	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue
.	O

Right	O
Digit	O
Ext	O
.	O

History	O
of	O
Tubal	O
Ligation	O
V25	O
.	O
2	O

Zolpidem	O
Tartrate	O
10	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
AT	B-frequency
BEDTIME	I-frequency
AS	B-frequency
NEEDED	I-frequency
FOR	O
INSOMNIA	O
;	O
Therapy	O
:	O
26Apr2013	B-temporal
to	O
(	O
Evaluate	O
:	O
10Sep2013	B-temporal
)	O
;	O
Last	O
Rx	O
:	O
13May2013	B-temporal

Review	O
of	O
Systems	O

[	O
QLH	O
]	O
BASIC	O
METABOLIC	O
PANEL	O
W	O
/	O
EGFR	O
Done	O
:	O
28Feb2011	B-temporal
10	B-temporal
:	I-temporal
28AM	I-temporal

Pedal	O
pulses	O
:	O
Normal	B-labvalue

Dispense	O
2	O
packs	O
of	O
5	O
pens	O
for	O
a	O
30	O
day	O

Test	O
Name	O
Result	O
Flag	O
Reference	O
LEUKOCYTES	O
trace	O
O	O
NITRITE	O
wnl	O
UROBILINOGEN	O
wnl	O
PROTEIN	O
trace	O
O	O
pH	O
7	B-labvalue
O	O
URINE	O
BLOOD	O
wnl	O
SPECIFIC	O
GRAVITY	O
1	B-labvalue
.	I-labvalue
015	I-labvalue
O	O
KETONES	O
+	B-labvalue
small	O
O	O
BILIRUBIN	O
wnl	O
GLUCOSE	O
wnl	O

Abdomen	O

Omeprazole	O
40	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
Delayed	I-form
Release	I-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
16Mar2012	B-temporal
to	O
(	O
Evaluate	O
:	O
30Sep2012	B-temporal
)	O
Requested	O
for	O
:	O
02Jul2012	B-temporal
;	O
Last	O
Rx	O
:	O
02Jul2012	B-temporal
;	O
Edited	O

[	O
QLH	O
]	O
CBC	O
(	O
INCLUDES	O
DIFF	O
/	O
PLT	O
)	O
Requested	O
for	O
:	O
14Oct2013	B-temporal

Drug	O
Use	O

Eyes	O
EOMI	O
;	O
anicteric	O
sclerae	O
.	O
No	B-negation
proptosis	O
or	O
lid	B-bodyloc
lag	O
.	O

Hematologic	O
/	O
Lymphatic	O
:	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
and	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
.	O

The	O
current	O
time	O
she	O
gives	O
herself	O
3	O
injections	O
per	O
week	O
in	O
her	O
buttocks	O
.	O

Lipid	O
Panel	O
With	O
LDL	O
/	O
HDL	O
Ratio	O
Requested	O
for	O
:	O
10May2011	B-temporal

f	O
Child	O
Is	O
Cared	O
For	O
At	O
Home	O
(	O
Active	O
)	O

Family	B-subject
history	O
of	O
Uterine	B-bodyloc
Cancer	O

Thrombophlebitis	O
Of	O
Deep	B-bodyloc
Vessels	I-bodyloc
Of	I-bodyloc
The	I-bodyloc
Lower	I-bodyloc
Extremity	I-bodyloc
451	O
.	O
19	O

Assessment	O
Health	O
Maintenance	O
V70	O
.	O
0	O

Here	O
initally	O
check	O
was	O
160	B-labvalue
/	I-labvalue
98	I-labvalue
and	O
recheck	O
was	O
140	B-labvalue
/	I-labvalue
100	I-labvalue
and	O
pt	O
had	O
just	O
taken	O
labetalol	O
30min	O
prior	O
to	O
appt	O
.	O

1	O
.	O

Max	O
:	O
Normal	O

Eyes	O

Neurological	O
:	O
limb	B-bodyloc
weakness	O
and	O
difficulty	O
walking	O
,	O
but	O
no	B-negation
dizziness	O
and	O
no	B-negation
fainting	O
.	O

Vagina	O
:	O
good	O
apical	O
support	O
.	O

Hyperlipidemia	O
272	O
.	O
4	O

Continue	O
omeprazole	O
.	O

History	O
of	O
Sinus	O
Surgery	O

Observed	O
mood	O
and	O
affect	O
:	O
.	O

Family	B-subject
history	O
of	O
Gout	O
2	O
.	O

Lymphatic	O

Osteoporosis	O
(	O
733	O
.	O
00	O
)	O

Peripheral	O
Pulses	O
:	O
full	B-labvalue
.	O

Musculoskeletal	O
:	O
no	B-negation
arthralgias	O
,	O
no	B-negation
joint	B-bodyloc
pain	O
and	O
no	B-negation
joint	B-bodyloc
swelling	O
.	O

Chief	O
Complaint	O

Current	O
Meds	O
1	O
.	O

Current	O
Orders	O
[	O
H	O
]	O
Free	O
T4	O
Requested	O
for	O
:	O
16Jul2012	B-temporal

Individuals	O
with	O
unstable	O
creatinine	O
concentrations	O
,	O
including	O
pregnant	O

No	B-negation
varicosital	O
changes	O
.	O

ADMITTING	O
DIAGNOSES	O
:	O
Left	B-bodyloc
renal	I-bodyloc
cell	O
carcinoma	O
,	O
left	B-bodyloc
renal	I-bodyloc
cyst	O
.	O

Delivered	O
:	O
2005	B-temporal
.	O

Her	O
knee	B-bodyloc
pain	O
is	O
daily	B-course
constant	I-course
achy	O
with	O
intermittent	O
throbbing	O
sharp	O
,	O
and	O
scored	O
"	O
8	O
"	O
.	O

Surgical	O
History	O
History	O
of	O
Ankle	O
Surgery	O

Head	O
and	O
Face	O

pH	O
:	O
7	B-labvalue
Of	O
Interest	O

CV	O
-	O
RRR	O
,	O
no	B-negation
murmur	O
,	O
femoral	O
equal	O
pulses	O
bilaterally	O
.	O

Alcohol	O

UTP	O
-	O
OB	O
/	O

No	B-negation
tonsillar	O
enlargement	O
,	O
crypt	O
formation	O
or	O
abscess	O
.	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
,	O
no	B-negation
cough	O
,	O
no	B-negation
shortness	O
of	O
breath	O
during	O
exertion	O
,	O
no	B-negation
orthopnea	O
and	O
no	B-negation
PND	O
.	O

Examination	O
of	O
the	O
oropharynx	O
:	O
Normal	B-labvalue
.	O

Occupation	O
:	O

The	O
patient	O
does	O
not	O
exercise	O
.	O

Examination	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue
.	O
Supple	O
,	O
no	B-negation
JVD	O
.	O

Neg	B-labvalue
.	O
homan	O
'	O
s	O
sign	O
and	O
minimal	B-severity
calf	B-bodyloc
tenderness	O
.	O

General	O
Appearance	O
:	O
Normal	B-labvalue
.	O

Electronically	O
signed	O
by	O
:	O
LESLIE	O
GARB	O
,	O
M	O
.	O
D	O
.	O

Surgical	O
History	O
1	O
.	O

Heart	O
sounds	O
:	O
normal	B-labvalue
S1	O
,	O
normal	B-labvalue
S2	O
,	O
no	B-negation
S3	O
and	O
no	B-negation
S4	O
.	O

Meloxicam	O
7	B-strength
.	I-strength
5	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Take	O
1	B-dosage
tablet	B-form
by	B-route
mouth	I-route
twice	B-frequency
a	I-frequency
day	I-frequency
for	B-duration
30	I-duration
days	I-duration
;	O
Therapy	O
:	O
18Feb2014	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
18Feb2014	B-temporal
)	O

Hyperlipidemia	O
272	O
.	O
4	O

Allergies	O
1	O
.	O

[	O
QLH	O
]	O
TSH	O
,	O
3RD	O
GENERATION	O
W	O
/	O
REFLEX	O
TO	O
FT4	O
Requested	O
for	O
:	O
21Mar2012	B-temporal

Chronic	B-course
Frontal	B-bodyloc
Sinusitis	O
473	O
.	O
1	O

Examination	O
of	O
the	O
teeth	O
revealed	O
normal	B-labvalue
dentition	I-labvalue
.	O

Gastrointestinal	O
:	O
no	B-negation
bowel	B-bodyloc
incontinence	O
.	O

Associated	O
symptoms	O
:	O
difficulty	O
speaking	O
and	O
visn	O
probelm	O
for	O
1	O
hour	O
whic	O
goes	O
away	O
and	O
then	O
has	O
headache	O
5	O
/	O
10	O
last	O
for	O
the	O
rest	O
of	O
the	O
day	O
with	O
fatigue	O
.	O

Examination	O
of	O
both	O
breasts	O
revealed	O
a	O
normal	O
appearance	O
.	O

Attending	O
:	O
[	O
*	O
*	O
First	O
Name3	O
(	O
LF	O
)	O
5667	O
*	O
*	O
]	O

f	O
RSV	O
MAB	O
(	O
Synagis	O
)	O
(	O
Lot	O
#	O
:	O
10F02	O
-	O
81	O
)	O
-	O
Administered	O
on	O
:	O
10/11/2012	B-temporal

Constitutional	O
:	O
normal	O
.	O

[	O
QLH	O
]	O
URINALYSIS	O
,	O
COMPLETE	O
Requested	O
for	O
:	O
21Mar2012	B-temporal

10	B-temporal
/	I-temporal
09	I-temporal
-	O
Dysesthesias	O
in	O
the	O
soles	B-bodyloc
of	I-bodyloc
her	I-bodyloc
feet	I-bodyloc
which	O
resolved	B-course
.	O

Since	O
September	O
he	O
has	O
had	O
some	O
episodes	O
where	O
he	O
gets	O
a	O
feeling	O
of	O
pressure	O
on	O
the	O
top	O
of	O
his	O
head	O
in	O
the	O
frontal	O
region	O
He	O
feels	B-uncertain
a	O
pounding	O
sensation	O
in	O
the	O
orbits	B-bodyloc
that	O
is	O
slower	B-course
than	O
his	O
pulse	O
rate	O
.	O

Dizziness	O
780	O
.	O
4	O

CONSTITUTIONAL	O

General	O
appearance	O
:	O
Normal	O
.	O

Segs	O
:	O
73	B-labvalue
.	I-labvalue
4	I-labvalue
%	I-labvalue
Reference	O
Range	O
45	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
75	I-reference_range
.	I-reference_range
0	I-reference_range

f	O
No	O
Advance	O
Directives	O
available	O
.	O

Mammogram	O
Screening	O
V76	O
.	O
12	O

Plan	O
Metoprolol	O
Tartrate	O
50	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
Requested	O
for	O
:	O
18Feb2013	B-temporal
;	O
Last	O
Rx	O
:	O
18Feb2013	B-temporal
;	O
Edited	O

Attending	O
:	O
[	O
*	O
*	O
First	O
Name3	O
(	O
LF	O
)	O
1505	O
*	O
*	O
]	O

Patient	O
Specific	O
Education	O
Given	O
Done	O
:	O
24Feb2014	B-temporal

Mountain	O
Sickness	O
993	O
.	O
2	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Skin	O

Active	O
Problems	O
Pregnancy	O
V22	O
.	O
2	O

Carvedilol	O
TABS	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
03Nov2011	B-temporal
)	O
to	O

ebody	O

Brachioradialis	O
:	O
right	O
1	O
+	O
and	O
left	O
1	O
+	O
.	O

The	O
vascular	O
examination	O
was	O
within	O
nor8roulimits	O
and	O
showed	O
good	B-labvalue
pulses	I-labvalue
in	I-labvalue
both	I-labvalue
lower	I-labvalue
extremities	I-labvalue
.	O

Sy	O
temic	O
:	O
No	B-negation
illness	O
since	O
last	O
visit	O
and	O
not	B-negation
feeling	O
poorly	O
(	O
malaise	O
)	O
.	O

He	O
has	O
had	O
improvement	O
after	O
the	O
stents	O
(	O
2010	B-temporal
)	O
with	O
walking	O
distance	O
and	O
toe	B-bodyloc
nail	O
growth	O
.	O

History	O
of	O
Anxiety	O
Disorder	O
NOS	O
300	O
.	O
00	O

Lisinopril	O
5	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Therapy	O
:	O
13Jun2011	B-temporal
to	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Diastolic	O
:	O
87	B-labvalue

Emergency	O
Contact	O
:	O
RICHARD	O
QUARLES	O
,	O
(	O
832	O
)	O
788	O
-	O
1443	O
(	O
Home	O
phone	O
)	O
Documrt	O
Details	O
SUMMARIZATION	O
OF	O
EPISODE	O
NOTE	O
Encoun	O
er	O
May	B-temporal
23	I-temporal
,	I-temporal
2013	I-temporal
06	B-temporal
:	I-temporal
03	I-temporal
+	O
0000	O
From	O
Enterprise	O
EHR	O
11	O
.	O
200	O
.	O
4288	O
.	O

The	O
pain	O
intensity	O
increase	B-course
consistently	O
with	O
almost	O
all	O
weight	O
bearing	O
activities	O
.	O

Inspection	O
/	O
palpation	O
of	O
joints	O
,	O
bones	O
,	O
and	O
muscles	O
:	O
Abnormal	O
.	O

Chronic	B-course
Frontal	B-bodyloc
Sinusitis	O
473	O
.	O
1	O

;	O
Jun	B-temporal
14	I-temporal
2012	I-temporal
2	B-temporal
:	I-temporal
19PM	I-temporal
(	O
Author	O
)	O

The	O
patient	O
is	O
a	O
non	O
-	O
smoker	O
.	O

Cranial	O
nerves	O
XII	O
:	O
there	O
was	O
no	B-negation
tongue	B-bodyloc
deviation	O
with	O
protrusion	O
.	O

Multivitamins	O
TABS	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
27Jun2012	B-temporal
)	O
to	O

Electronically	O
signed	O
by	O
:	O
PHILIP	O
JOHNSON	O
,	O
M	O
.	O
D	O
.	O

Aug	B-temporal
15	I-temporal
2012	I-temporal
6	B-temporal
:	I-temporal
59PM	I-temporal
(	O
Author	O
)	O

;	O
Apr	B-temporal
9	I-temporal
2012	I-temporal
1	B-temporal
:	I-temporal
44PM	I-temporal
(	O
Author	O
)	O

SBE	O
-	O
Last	O
Pap	O
:	O
7	B-temporal
/	I-temporal
2011	I-temporal
Pt	O
.	O
denies	O
breast	O
,	O
uterine	O
,	O
ovarian	O
,	O
cervical	O
,	O
and	O
colon	O

Psychiatric	O

The	O
patient	O
is	O
also	O
advised	O
to	O
monitor	O
for	O
any	O
fevers	O
greater	O
than	O
100	O
.	O
5	O
and	O
should	O
she	O
have	O
any	O
further	O
problems	O
in	O
the	O
meantime	O
to	O
please	O
call	O
in	O
to	O
be	O
seen	O
sooner	O
.	O

PROTEIN	O
:	O
trace	O
Of	O
Interest	O

Height	O
:	O
5	B-labvalue
ft	I-labvalue
6	I-labvalue
in	I-labvalue

History	O
of	O
Right	B-bodyloc
Leg	I-bodyloc
Weakness	O

History	O
of	O
Drug	O
Use	O

Constant	O
bilateral	O
hand	B-bodyloc
and	O
feet	B-bodyloc
swelling	O
x2	B-temporal
months	I-temporal

Maternal	O
history	O
of	O
Hypertension	O
V17	O
.	O
49	O

Physical	O
Exam	O
:	O
NEVER	B-negation

Given	O
that	O
nerve	O
conductions	O
otherwise	O
look	O
unremarkable	O
it	O
is	O
not	O
necessary	O
to	O
do	O
HNPP	O
gene	O
testing	O
at	O
this	O
time	O
.	O

Height	O
:	O
5	B-labvalue
ft	I-labvalue
3	I-labvalue
in	I-labvalue

Ms	O
.	O
Davis	O
returns	O
to	O
clinic	O
today	O
for	O
evaluation	O
of	O
voice	O
change	O
after	O
right	B-bodyloc
vocal	I-bodyloc
cord	I-bodyloc
paralysis	O
subsequent	O
to	O
surgery	O
in	O
May	B-temporal
2013	I-temporal
.	O

Stools	B-bodyloc
are	O
hard	O
and	O
infrequent	O
.	O

Bowel	O
sounds	O
were	O
normal	B-labvalue
.	O

(	B-bodyloc
Lower	I-bodyloc
)	I-bodyloc
Leg	I-bodyloc
Localized	O
Swelling	O
Bilateral	O
729	O
.	O
81	O

MUSCULOSKELETAL	O
:	O
no	B-negation
muscle	B-bodyloc
pain	O
and	O
no	B-negation
muscle	B-bodyloc
weakness	O
.	O

No	B-negation
urinary	O
incontinence	O
.	O

Plan	O
Meclizine	O
HCl	O
12	B-strength
.	I-strength
5	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
3	B-frequency
TIMES	I-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
08Apr2014	B-temporal
to	O
(	O
Evaluate	O
:	O
13Apr2014	B-temporal
)	O
;	O
Last	O
Rx	O
:	O
08Apr2014	B-temporal

If	B-condition
vertigo	O
not	B-course
better	I-course
in	O
4	B-temporal
-	I-temporal
5	I-temporal
days	I-temporal
to	O
call	O
,	O
if	O
forearm	O
still	O
bothering	O
him	O
in	O
10	B-temporal
days	I-temporal
tcb	O

GroupHeading1End	O
GroupHeading2Start	O
GroupHeading2End	O
GroupHeading3Start	O
GroupHeading3End	O
GroupHeading4Start	O
GroupHeading4End	O
GroupHeading14Start	O
GroupHeading14End	O
GroupHeading13Start	O
Gastrointestinal	O
:	O
no	B-negation
constipation	O
.	O

Vitals	O
:	O
BP	O
118	B-labvalue
/	I-labvalue
56	I-labvalue
,	O
HR	O
66	B-labvalue
,	O
RR	O
14	B-labvalue
,	O
SAT	O
100	B-labvalue
%	I-labvalue
on	O
room	O
air	O

Anesthesia	O
:	O
Topical	B-route
lidocaine	O
spray	B-form
and	O
Topical	B-route
oxymetazoline	O
spray	B-form
.	O

Extremeties	O
:	O

Both	O
ovaries	O
in	O
place	O
.	O

DIAGNOSES	O
:	O

Patient	O
was	O
not	O
taking	O
any	O
beta	O
blocker	O
or	O
CCB	O
during	O
this	O
time	O
frame	O
)	O
.	O

RT	O

Lortab	O
TABS	B-form
;	O
5	B-dosage
/	I-dosage
500	I-dosage
take	O
one	B-dosage
tab	O
po	O
bid	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
29Oct2012	B-temporal
)	O
to	O

Cough	O
786	O
.	O
2	O

Hypercalcemia	O
,	O
likely	O
secondary	O
to	O
paraneoplastic	O
syndrome	O
from	O
the	O
non	O
-	O
small	O
cell	O
lung	B-bodyloc
CA	O
,	O
possible	O
metastases	O
to	O
the	O
bones	B-bodyloc
.	O

Current	O
Meds	O
Multivital	O
Oral	B-route
Tablet	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
08May2013	B-temporal
)	O
to	O

Examination	O
of	O
the	O
oropharynx	O
:	O
Normal	B-labvalue

Psoriatic	O
Arthropathy	O
696	O
.	O
0	O

Delivered	O
:	O
2013	B-temporal
.	O

HEAD	O
AND	O
FACE	O

Add	O
oral	B-route
abx	O
based	O
on	O
cultures	O
only	O
if	O
convincing	O
growthand	O
patient	O
not	O
better	O

4	O
.	O

The	O
patient	O
is	O
being	O
seen	O
for	O
follow	O
-	O
up	O
of	O
gastroesophageal	B-bodyloc
reflux	O
disease	O
.	O

f	O
No	B-negation
Known	O
Drug	O
Allergies	O
(	O
Active	O
)	O

NEUTROPHILS	O
59	B-labvalue
.	I-labvalue
0	I-labvalue
%	I-labvalue

[	O
QLH	O
]	O
CBC	O
(	O
INCLUDES	O
DIFF	O
/	O
PLT	O
)	O
Status	O
:	O
Complete	O
Done	O
:	O
02Jul2013	B-temporal

Baby	O
continued	B-course
to	I-course
experience	I-course
hypoglycemic	O
episodes	O
.	O

History	O
of	O
Present	O
Illness	O

RESPIRATORY	O

Acute	B-course
Upper	B-bodyloc
Respiratory	I-bodyloc
Infection	O
465	O
.	O
9	O

Dr	O
Zulfiqar	O
-	O
-	O
fu	O
/	O
Retinal	B-bodyloc
Hemorrhage	O
Blood	O
results	O

[	O
L	O
]	O
Drawing	O
Fee	O
Requested	O
for	O
:	O
14Jun2013	B-temporal

Ophthalmoscopic	O
examination	O
:	O
Normal	B-labvalue
.	O

Otherwise	O
he	O
has	O
been	O
eating	O
well	O
,	O
and	O
having	O
nor8al	B-labvalue
urination	O
and	O
bowel	O
movements	O
.	O
eg	O

Cardiovascular	O

Facility	O
:	O

T2DM	O
-	O

with	O
levels	O
<	O
20	O
ng	O
/	O
mL	O
indicative	O
of	O
Vitamin	O
D	O

Systolic	O
:	O
132	B-labvalue

Pain	O
increased	B-course
with	O
weight	O
bearing	O
.	O

4	B-temporal
weeks	I-temporal
ago	I-temporal
had	O
deep	O
massage	O
of	O
left	O
forearm	O
/	O
wrist	O
and	O
since	O
then	O
has	O
developed	O
pain	O
,	O
essentially	O
where	O
he	O
had	O
a	O
globus	O
tumour	O
removed	O
4	B-temporal
years	I-temporal
ago	I-temporal

The	O
abdomen	O
was	O
normal	B-labvalue
to	O
percussion	O
.	O

History	O
of	O
Present	O
Illness	O
The	O
patient	O
is	O
being	O
seen	O
for	O
a	O
routine	O
clinic	O
follow	O
-	O
up	O
.	O

Eyes	O

Bartholin	O
'	O
s	O
glands	B-bodyloc
:	O
normal	O
.	O

f	O
Muscle	B-bodyloc
Cramps	O
In	O
The	O
Thigh	B-bodyloc
(	I-bodyloc
Upper	I-bodyloc
Leg	I-bodyloc
)	O
(	O
729	O
.	O
82	O
)	O
;	O
(	O
Active	O
)	O

Discussion	O
/	O
Signatures	O
Electronically	O
signed	O
by	O
:	O
LESLIE	O
NOWITZ	O
,	O
M	O
.	O
D	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O
VITAL	O
SIGNS	O
:	O
Temperature	O
97	B-labvalue
.	I-labvalue
9	I-labvalue
oral	O
,	O
blood	O
pressure	O
is	O
146	B-labvalue
/	I-labvalue
83	I-labvalue
,	O
pulse	O
is	O
74	B-labvalue
,	I-labvalue
respirations	O
16	B-labvalue
,	O
oxygen	O
saturation	O
98	B-labvalue
%	I-labvalue
on	O
room	O
air	O
and	O
interpreted	O
as	O
normal	O
.	O

Laboratory	O
tests	O
verify	O
SS	O
#	O
1	O
and	O
#	O
2	O
obtained	O
;	O
check	O
results	O

Associated	O
symptoms	O
:	O
headache	O
,	O
but	O
no	B-negation
ear	B-bodyloc
pain	O
,	O
no	B-negation
ear	B-bodyloc
plugging	O
,	O
no	B-negation
facial	B-bodyloc
pain	O
,	O
no	B-negation
facial	B-bodyloc
pressure	O
,	O
no	B-negation
swollen	O
lymph	B-bodyloc
nodes	I-bodyloc
,	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
nausea	O
,	O
no	B-negation
vomiting	O
and	O
no	B-negation
diarrhea	O
.	O

Taking	O
Medication	O
For	O
Diabetes	O
Long	O
-	O
Term	O
Use	O
Of	O
Insulin	O
V58	O
.	O
67	O

Electronically	O
signed	O
by	O
:	O
LARISSA	O
STEWART	O
M	O
.	O
D	O
.	O
;	O
07/26/2013	B-temporal
4	B-temporal
:	I-temporal
32	I-temporal
PM	I-temporal
CST	O
;	O
Author	O
.	O
eg	O

Clear	O
nasal	B-bodyloc
discharge	O
:	O
Mild	B-severity

External	O
inspection	O
of	O
ears	O
and	O
nose	O
:	O
Normal	B-labvalue
.	O

Multiple	O
Sclerosis	O
340	O

Cardiovascular	O
:	O
no	B-negation
intermittent	O
leg	B-bodyloc
claudication	O
and	O
no	B-negation
edema	O
.	O

Symptoms	O
:	O
no	B-negation
headache	O
,	O
no	B-negation
confusion	O
,	O
no	B-negation
visual	O
disturbance	O
,	O
no	B-negation
dizziness	O
and	O
no	B-negation
shortness	O
of	O
breath	O
.	O

Surgical	O
History	O
Denied	O

General	O
appearance	O
:	O
Normal	B-labvalue
.	O

Bacterial	O
Vaginosis	O
616	O
.	O
10	O

Platelets	O
:	O
199	B-labvalue
x10E3	I-labvalue
/	I-labvalue
uL	I-labvalue
Reference	O
Range	O
140	B-reference_range
-	I-reference_range
415	I-reference_range

-	O
24	O
hour	O
urine	O
ordered	O
.	O

Assessment	O
of	O
stability	O
:	O
Normal	B-labvalue
.	O

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

(	O
832	O
)	O
325	O
-	O
7161	O
(	O
Work	O
phone	O
)	O
Created	O
February	B-temporal
15	I-temporal
,	I-temporal
2013	I-temporal
15	O
:	B-temporal
15	I-temporal
-	O
0600	O
By	O
SHAHLA	O
NADER	O
-	O
EFTEKHARI	O

Urinary	B-bodyloc
Symptoms	O
788	O
.	O
99	O

Denied	O

Shortness	O
Of	O
Breath	O
786	O
.	O
05	O

Endocrine	O
:	O
no	B-negation
proptosis	O
.	O

KETONES	O
NEG	B-labvalue

Nasal	B-bodyloc
congestion	O
:	O
Moderate	B-severity

Ordered	O
;	O
For	O
:	O
Dyspepsia	O
(	O
536	O
.	O
8	O
)	O
;	O
Ordered	O
By	O
:	O
ABDELMELEK	O
,	O
LOURICE	O
Perform	O
:	O
In	O
Office	O
Due	O
:	O
21Apr2013	B-temporal
;	O
Last	O
Updated	O
By	O
:	O
Gonzalez	O
,	O
Marla	O

In	O
most	O
young	O
,	O
healthy	O

Pulmonary	O

Cranial	O
nerves	O
IX	O
and	O
X	O
:	O
there	O
was	O
normal	B-labvalue
movement	O
of	O
the	O
soft	O
palate	O
and	O
normal	B-labvalue
gag	O
.	O

61y	O
M	O
s	O
/	O
p	O
B	O
revision	O
IG	O
-	O
FESS	O
/	O
FS	O
stent	O
placements	O
.	O

Ibuprofen	O
as	B-frequency
needed	I-frequency
for	O
pain	O
.	O

Ondansetron	O
8	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
Dispersible	I-form
;	I-form
DISSOLVE	I-form
1	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
EVERY	B-frequency
6	I-frequency
HOURS	I-frequency
AS	O
NEEDED	O
FOR	O
NAUSEA	O
;	O
Therapy	O
:	O
23Sep2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
23Sep2013	B-temporal
)	O
Requested	O
for	O
:	O
23Sep2013	B-temporal

No	B-negation
murmurs	O
were	O
heard	O
.	O

Respiratory	O
rate	O
:	O
the	O
respiratory	O
rate	O
was	O
normal	B-labvalue
.	O

Benign	B-severity
Essential	O
Hypertension	O
401	O
.	O
1	O

Keywords	O
:	O

Chief	O
Complaint	O

Integumentary	O
:	O
no	B-negation
skin	B-bodyloc
lesions	O
,	O
no	B-negation
skin	B-bodyloc
wound	O
,	O
no	B-negation
pruritus	O
,	O
no	B-negation
change	O
in	O
a	O
mole	O
,	O
no	B-negation
breast	B-bodyloc
pain	O
and	O
no	B-negation
breast	B-bodyloc
lump	O
.	O

GlucaGen	O
HypoKit	O
1	B-strength
MG	I-strength
Injection	B-form
Solution	I-form
Reconstituted	O
;	O
USE	O
AS	O
DIRECTED	O
in	B-condition
case	I-condition
of	I-condition
severe	B-severity
hypoglycemia	O
;	O
Therapy	O
:	O
24Nov2012	B-temporal
to	O

Endocrine	O
:	O
no	B-negation
proptosis	O
and	O
no	B-negation
hot	O
flashes	O
.	O

History	O
of	O
cocaine	O
and	O
canibus	O

Hearing	O
:	O
Normal	B-labvalue
.	O

The	O
tonsils	O
were	O
normal	O
.	O

Recommended	O
patient	O
to	O
report	O
incident	O
to	O
police	O
,	O

Family	B-subject
history	O
of	O
Type	O
2	O
Diabetes	O
Mellitus	O

Cervix	O
:	O
Absent	O
.	O

Senile	O
Dementia	O
With	O
Depressive	O
Features	O
290	O
.	O
21	O

Citalopram	O
Hydrobromide	O
20	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
AS	O
DIRECTED	O
;	O
Therapy	O
:	O
23Feb2012	B-temporal
to	O
(	O
Evaluate	O
:	O
22Sep2013	B-temporal
)	O
Requested	O
for	O
:	O
27Sep2012	B-temporal
;	O
Last	O
Rx	O
:	O
27Sep2012	B-temporal

1	O
.	O

Inspection	O
of	O
the	O
nasal	O
mucosa	O
,	O
septum	O
and	O
turbinates	O
:	O
Normal	B-labvalue
.	O

Tinnitus	O
388	O
.	O
30	O

Integumentary	O
:	O
skin	B-bodyloc
wound	O
(	O
small	O
blister	O
on	O
left	B-bodyloc
hand	I-bodyloc
which	O
is	O
doing	O
much	O
better	O
)	O
.	O

He	O
is	O
taking	O
sympbicort	O
and	O
BP	O
medication	O
and	O
zycam	O
.	O

[	O
QLH	O
]	O
TESTOSTERONE	O
,	O
TOTAL	O

Associated	O
symptoms	O
:	O
arthralgias	O
,	O
but	O
no	B-negation
myalgias	O
,	O
no	B-negation
paresthesias	O
,	O
no	B-negation
depression	O
,	O
no	O
leg	O
swelling	O
and	O
no	B-negation
palpitations	O
.	O

Fluzone	O
9	B-strength
MCG	I-strength
/	I-strength
STRAIN	I-strength
Intradermal	B-route
Device	O
;	O
INJECT	B-route
0	B-dosage
.	I-dosage
1	I-dosage
ML	I-dosage
Intradermal	B-route
;	O
To	O
Be	O
Done	O
:	O
24Oct2012	B-temporal
;	O
Status	O
:	O
Hold	O
For	O
-	O
Administration	O

No	B-negation
rales	O
or	O
crackles	O
were	O
heard	O
.	O

Examination	O
of	O
both	O
breasts	O
revealed	O
a	B-labvalue
normal	I-labvalue
appearance	O
.	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

Trichomonas	O
Vulvovaginitis	O
131	O
.	O
01	O

1	I-reference_range
To	O
al	O
Protein	O
6	B-labvalue
.	I-labvalue
9	I-labvalue
g	I-labvalue
/	I-labvalue
dl	I-labvalue
6	B-reference_range
.	I-reference_range
4	I-reference_range
-	I-reference_range
8	I-reference_range
.	I-reference_range

Ms	O
Fretwell	O
exhausted	O
conservative	O
non	O
-	O
surgical	O
treatment	O
options	O
.	O

Work	O
status	O
:	O
working	O
full	O
time	O
.	O

Active	O
Problems	O
Cluster	O
Headache	O
339	O
.	O
00	O

Current	O
Meds	O
1	O
.	O

Coronary	O
artery	B-bodyloc
disease	O
.	O

This	O
is	O
a	O
40	O
years	O
old	O
female	O
with	O
T1DM	O
since	B-temporal
8	I-temporal
years	I-temporal
oold	O
.	O

Current	O
Meds	O
AmLODIPine	O
Besylate	O
10	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
AS	O
DIRECTED	O
Requested	O
for	O
:	O
07Aug2013	B-temporal
;	O
Last	O
Rx	O
:	O
07Aug2013	B-temporal

Apr	B-temporal
4	I-temporal
2012	I-temporal
9	B-temporal
:	I-temporal
53AM	I-temporal
(	O
Co	O
-	O
author	O
)	O

Will	O
continue	O
current	O
tight	O
control	O
of	O
BP	O
and	O
DM	O
.	O

Symbicort	O
AERO	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
19Jul2012	B-temporal
)	O
to	O

The	O
risks	O
,	O
benefits	O
and	O
anticipated	O
outcomes	O
of	O
the	O
procedure	O
,	O
the	O
risks	O
and	O
benefits	O
to	O
the	O
alterntive	O
of	O
the	O
procedure	O
,	O
and	O
the	O
roles	O
and	O
tasks	O
of	O
personnel	O
involved	O
were	O
discussed	O
with	O
the	O
patient	O
,	O
and	O
the	O
patient	O
consents	O
to	O
the	O
procedure	O
and	O
agrees	O
to	O
proceed	O
.	O

NEUROLOGICAL	O
/	O
PSYCHIATRIC	O

MULTIPLE	O
DENTAL	O
CARIES	O
.	O

Test	O
Name	O
Result	O
Flag	O
Reference	O

Musculoskeletal	O

NECK	O
-	O
Supple	O
,	O
thyroid	O
nonpalpable	O
,	O
full	B-labvalue
ROM	O
,	O
no	B-negation
adenopathy	O
.	O

Respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

He	O
believes	O
the	O
lightheadedness	O
and	O
panic	O
sensation	O
was	O
stress	O
related	O
and	O
with	O
a	O
decreased	O
stress	O
level	O
in	O
his	O
life	O
now	O
,	O
he	O
is	O
no	B-negation
longer	I-negation
having	I-negation
the	O
symptoms	O
.	O

Surgical	O
History	O

Visit	O
For	O
:	O
Fit	O
/	O
Adjust	O
Insulin	O
Pump	B-route
V53	O
.	O
91	O

Caduet	O
5	B-strength
-	I-strength
10	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
27Nov2007	B-temporal
to	O
(	O
Evaluate	O
:	O
06May2012	B-temporal
)	O
Requested	O
for	O
:	O
06Feb2012	B-temporal
;	O
Last	O
Rx	O
:	O
06Feb2012	B-temporal

She	O
denies	O
missing	O
her	O
insulin	O
frequently	O
.	O

Chief	O
Complaint	O

No	B-negation
hearing	O
loss	O
.	O

DISTRESS	O
.	O

f	O
Erythromycin	O
Derivatives	O
(	O
Active	O
)	O

History	O
of	O
Laminectomy	O
Cervical	O

Chief	O
Complaint	O

Chief	O
Complaint	O

Recent	B-temporal
CT	O
results	O
revewed	O
and	O
scanned	O
,	O
no	B-negation
acute	B-course
fractures	O
,	O
missallignments	O
or	O
intracraneal	B-bodyloc
bleeds	O
.	O

PATIENT	O
:	O
NESIC	O
,	O
OLGA	O

follow	O
up	O
test	O
results	O

A	O
grade	O
2	O
diastolic	O
murmur	O
was	O
heard	O
at	O
the	O
apex	O
.	O

Musculoskeletal	B-bodyloc
DJD	O
B	O
UE	O
.	O

General	O
appearance	O
:	O
Normal	B-labvalue
.	O

If	B-condition
high	O
-	O
grade	O
lesion	O
,	O
will	O
schedule	O
at	O
time	O
of	O
BTL	O
.	O

(	O
Evaluate	O
:	O
13May2013	B-temporal
)	O
;	O
Last	O
Rx	O
:	O
03May2013	B-temporal

No	B-negation
genital	B-bodyloc
lesion	O
and	O
no	B-negation
vaginal	B-bodyloc
discharge	O
.	O

Hypertension	O
401	O
.	O
9	O

Palpable	B-labvalue
dorsalis	O
pedis	O
amd	O
posterior	O
tibial	O
pulses	O
in	O
the	O
lower	O
extremities	O
.	O

DM	O
:	O
Blood	O
sugars	O
reportedly	O
stable	O
at	O
120s	B-labvalue
.	O

Tamsulosin	O
HCl	O
0	B-strength
.	I-strength
4	I-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
Requested	O
for	O
:	O
18Jan2013	B-temporal
;	O
Last	O
Rx	O
:	O
18Jan2013	B-temporal

No	B-negation
dysuria	O
.	O

ROS	O
g16	O

History	O
of	O
Previously	O
Well	O

Orientation	O
to	O
person	O
,	O
place	O
and	O
time	O
.	O

Tobacco	O
Use	O

Rx	O
:	O
12Mar2013	B-temporal

Coronary	B-bodyloc
Arteriosclerosis	O
414	O
.	O
00	O

The	O
patient	O
presents	O
with	O
complaints	O
of	O
skin	B-bodyloc
lesion	O
(	O
GRANULOMA	O
ANNULARE	O
.	O

Patient	O
also	O
complains	O
of	O
left	B-bodyloc
arm	I-bodyloc
swelling	O
and	O
weakness	O
after	O
CVA	O
.	O

Constitutional	O
:	O
feeling	O
tired	O
(	O
fatigue	O
)	O
andrecent	O
weight	O
loss	O
,	O
but	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
and	O
not	B-negation
feeling	O
poorly	O
(	O
malaise	O
)	O
.	O

Examination	O
of	O
liver	O
and	O
spleen	O
:	O
Normal	B-labvalue
.	O

She	O
has	O
a	O
naturally	O
soft	O
voice	O
and	O
feels	O
she	O
can	O
speak	O
as	O
loudly	O
as	O
she	O
wishes	O
to	O
speak	O
.	O

Hematocrit	O
43	B-labvalue
.	I-labvalue
5	I-labvalue
%	I-labvalue
36	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
48	I-reference_range
.	I-reference_range
0	I-reference_range

-	O
Maternal	O
EKG	O
ordered	O
.	O

She	O
denies	B-negation
chest	B-bodyloc
pain	O
,	O
dyspnea	O
,	O
coughing	O
,	O
weakness	O
/	O
numbness	O
,	O
and	O
weight	O
loss	O
.	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
other	O
areas	O
:	O
Normal	B-labvalue

2	O
.	O

The	O
patient	O
'	O
s	O
temperature	O
was	O
closely	O
watched	O
for	O
signs	O
of	O
infection	O
.	O

7	O
.	O

Hemochromatosis	O
275	O
.	O
03	O

Genitourinary	O
:	O
no	B-negation
dysuria	O
,	O
no	B-negation
incontinence	O
,	O
no	B-negation
urinary	O
hesitancy	O
,	O
no	B-negation
nocturia	O
,	O
no	B-negation
genital	B-bodyloc
lesions	O
and	O
no	B-negation
testicular	B-bodyloc
pain	O
.	O

No	B-negation
Known	O
Drug	O
Allergies	O

Discharge	O
hemoglobin	O
10	B-labvalue
.	I-labvalue
8	I-labvalue
.	O

Gastrointestinal	O
:	O
normal	O
.	O

Language	O
:	O
No	B-negation
dysphasia	O
/	O
aphasia	O
was	O
observed	O
.	O

Cervical	O
Spine	O
:	O
Normal	O
(	O
full	B-labvalue
range	O
of	O
motion	O
)	O
.	O

Sample	O
Type	O
/	O
Medical	O
Specialty	O
:	O
Discharge	O
Summary	O

Maternal	B-subject
grandfather	I-subject
'	I-subject
s	I-subject
history	O
of	O
Cancer	O

Authorized	O
refill	O
Atenolol	O
50	B-strength
mg	I-strength
#	B-duration
30	I-duration
1	B-dosage
daily	B-frequency

Lumigan	O
0	B-strength
.	I-strength
01	I-strength
%	I-strength
Ophthalmic	B-route
Solution	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
16Sep2013	B-temporal
)	O
to	O

HYPOGLYCEMIA	O
:	O
Baby	O
began	O
to	O
experience	O
hypoglycemic	O
episodes	O
on	O
07/24/2006	B-temporal
.	O

Discussion	O
/	O
Plan	O
1	O
.	O

Tiredness	O
:	O
None	B-negation

1	O
2	O
3	O
4	O
5	O
DTP	O
/	O
DTaP	O
24Oct2011	B-temporal
(	O
2M	O
)	O
09Jan2012	B-temporal
(	O
4M	O
)	O
20Feb2012	B-temporal
(	O
6M	O
)	O
22Oct2012	B-temporal
(	O
14M	O
)	O
Hepatitis	O
A	O
22Oct2012	B-temporal
(	O
14M	O
)	O
17Jul2013	B-temporal
(	O
23M	O
)	O
Hepatitis	O
B	O
24Oct2011	B-temporal
(	O
2M	O
)	O
20Feb2012	B-temporal
(	O
6M	O
)	O
HIB	O
24Oct2011	B-temporal
(	O
2M	O
)	O
09Jan2012	B-temporal
(	O
4M	O
)	O
20Feb2012	B-temporal
(	O
6M	O
)	O
22Oct2012	B-temporal
(	O
14M	O
)	O
Influenza	O
20Feb2012	B-temporal
(	O
6M	O
)	O
22Mar2012	B-temporal
(	O
7M	O
)	O
22Oct2012	B-temporal
(	O
14M	O
)	O
03Dec2012	B-temporal
(	O
15M	O
)	O
14Oct2013	B-temporal
(	O
26M	O
)	O
MMR	O
22Oct2012	B-temporal
(	O
14M	O
)	O
Polio	O
24Oct2011	B-temporal
(	O
2M	O
)	O
09Jan2012	B-temporal
(	O
4M	O
)	O
20Feb2012	B-temporal
(	O
6M	O
)	O
Rotavirus	O
24Oct2011	B-temporal
(	O
2M	O
)	O
09Jan2012	B-temporal
(	O
4M	O
)	O
20Feb2012	B-temporal
(	O
6M	O
)	O
Varicella	O
22Oct2012	B-temporal
(	O
14M	O
)	O
Prevnar	O
13	O
Intramuscular	B-route
Suspension	B-form

Hypothyroidism	O
244	O
.	O
9	O

f	O
History	O
of	O
Patent	O
Ductus	O
Arteriosus	O
Comments	O
:	O
spontaneouslylresolved	O
(	O
747	O
.	O
0	O
)	O
;	O
(	O
Resolved	B-course
)	O

Past	O
Medical	O
History	O
History	O
of	O
G6PD	O
Deficiency	O
282	O
.	O
2	O

Thyroid	O
:	O
Normal	O
.	O

Her	O
GYN	O
placed	O
her	O
on	O
trial	O
of	O
Spironolactone	O
.	O

ENDOCRINE	O
:	O
no	B-negation
cold	O
intolerance	O
,	O
no	B-negation
heat	O
intolerance	O
and	O
no	B-negation
excessive	O
thirst	O
.	O

Surgical	O
History	O
Denied	O

Current	O
Meds	O
Alendronate	O
Sodium	O
70	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
ONE	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
ONCE	B-frequency
A	I-frequency
WEEK	I-frequency
;	O
Therapy	O
:	O
18Oct2012	B-temporal
to	O
(	O
Evaluate	O
:	O
16May2014	B-temporal
)	O
Requested	O
for	O
:	O
29Nov2013	B-temporal
;	O
Last	O
Rx	O
:	O
29Nov2013	B-temporal

Social	O
History	O
Alcohol	O
Use	O

Ipratropium	O
Bromide	O
0	B-strength
.	I-strength
03	I-strength
%	O
Nasal	B-route
Solution	B-form
;	O
INSTILL	O
2	B-dosage
SQUIRT	I-dosage
4	B-frequency
TIMES	I-frequency
DAILY	I-frequency
PRN	O
drainage	O
each	O
side	O
;	O
Therapy	O
:	O
04Sep2013	B-temporal
to	O
(	O
Evaluate	O
:	O
02Apr2014	B-temporal
)	O
Requested	O
for	O
:	O
04Sep2013	B-temporal
;	O
Last	O
Rx	O
:	O
04Sep2013	B-temporal
;	O
Edited	O

6	O
.	O

Cranial	O
nerves	O
V	O
:	O
sensation	O
to	O
the	O
face	O
and	O
masseter	O
strength	O
were	O
intact	B-labvalue
.	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
JULIE	O
BORTOLOTTI	O
,	O
M	O
.	O
D	O
.	O

The	O
episodes	O
usually	O
was	O
preceded	O
just	O
by	O
a	O
lightheaded	O
sensation	O
.	O

She	O
has	O
exhausted	O
non	O
-	O
surgical	O
treatment	O
options	O
.	O

Drug	O
Use	O

The	B-bodyloc
thyroid	I-bodyloc
was	O
not	B-negation
enlarged	O
.	O

Granuloma	O
Annulare	O
695	O
.	O
89	O

Normal	O
speech	O
.	O

Secretions	O
:	O
None	B-negation

Cornea	O
:	O
.	O

Pleural	B-bodyloc
Effusion	O
511	O
.	O
9	O

;	O
Apr	B-temporal
28	I-temporal
2011	I-temporal
6	B-temporal
:	I-temporal
57PM	I-temporal
(	O
Author	O
)	O

SUBJECTIVE	O
:	O

Neurological	O
review	O
of	O
systems	O
are	O
normal	O
.	O

;	O
May	B-temporal
18	I-temporal
2013	I-temporal
12	B-temporal
:	I-temporal
22PM	I-temporal
(	O
Author	O
)	O

Pupils	O
are	O
equal	O
,	O
round	O
,	O
and	O
reactive	O
.	O

External	O
inspection	O
of	O
ears	O
and	O
nose	O
:	O
Normal	B-labvalue
.	O

Tympanic	O
membranes	O
are	O
intact	O
without	B-negation
any	O
erythema	O
,	O
bulging	O
or	O
fluid	O
levels	O
or	O
bubbles	O
behind	O
it	O
.	O

I	O
agree	O
with	O
:	O
all	O
the	O
components	O
of	O
the	O
exam	O
.	O

7	O
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O
Unable	O
to	O
obtain	O
.	O

The	O
patient	O
is	O
currently	B-temporal
experiencing	O
symptoms	O
.	O

)	O
(	O
s	O
)	O
*	O
Refills	O
:	O
*	O
0	O
*	O
4	O
.	O

Examination	O
for	O
hernias	O
:	O
No	B-negation
hernia	O
appreciated	O
.	O

Neck	O
:	O
supple	O
,	O
no	B-negation
JVD	O
,	O
Heart	O
:	O
regular	B-labvalue
rate	O
,	O
normal	B-labvalue
s1s2	O
,	O
no	B-negation
murmur	O
or	O
rub	O
Lungs	O
:	O
clear	O
bilaterally	O

HIB	O
;	O
27	B-temporal
Jun	I-temporal
2011	I-temporal

Allergies	O
Sulfa	O
Drugs	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
JOHN	O
MOORE	O
,	O
P	O
.	O
A	O
.	O

Past	O
Medical	O
History	O
History	O
of	O
Denial	O
Of	O
Any	O
Significant	O
Medical	O
History	O

;	O
Oct	B-temporal
7	I-temporal
2013	I-temporal
11	B-temporal
:	I-temporal
41PM	I-temporal
(	O
Author	O
)	O

I	O
agree	O
with	O
:	O
all	O
the	O
components	O
of	O
the	O
exam	O
.	O

CARDIOVASCULAR	O

Esophageal	B-bodyloc
Reflux	O
530	O
.	O
81	O

She	O
reports	O
normal	O
menses	O
.	O
She	O
is	O
sexually	O
active	O
.	O

Follow	O
up	O
ED	O
,	O
medication	O
refill	O

Well	O
developed	O
,	O
well	O
nourished	O
and	O
overweight	O
.	O

Relpax	O
40	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
AT	O
ONSET	O
OF	O
MIGRAINE	O
.	O

Routine	O
postoperative	O
instructions	O
given	O
and	O
understood	O
.	O

TSH	O
6	B-labvalue
.	I-labvalue
920	I-labvalue
uIU	I-labvalue
/	I-labvalue
ml	I-labvalue
H	B-labvalue
0	B-reference_range
.	I-reference_range
360	I-reference_range
-	I-reference_range
3	I-reference_range
.	I-reference_range
740	I-reference_range

Impingement	O
Of	O
The	O
Right	B-bodyloc
Shoulder	I-bodyloc
726	O
.	O
2	O

When	O
stopped	O
PPI	O
had	O
resumption	B-course
of	O
symptoms	O
otherwise	O
symptoms	O
free	B-negation
.	O

2	O
.	O

Cranial	O
nerves	O
II	O
:	O
visual	O
acuity	O
and	O
visual	O
fields	O
were	O
intact	B-labvalue
.	O

History	O
of	O
Present	O
Illness	O

No	B-negation
sx	O
PreE	O
.	O

Keywords	O
:	O

eGFR	O
If	O
Africn	O
Am	O
:	O
100	B-labvalue
mL	I-labvalue
/	I-labvalue
min	I-labvalue
/	I-labvalue
1	I-labvalue
.	I-labvalue
7	I-labvalue
Reference	O
Range	O
>	B-reference_range
59	I-reference_range

Keywords	O
:	O
general	O
medicine	O
,	O
jugular	B-bodyloc
venous	I-bodyloc
distention	O
,	O
flank	O
,	O
bladder	O
,	O
normal	B-labvalue
physical	O
exam	O
,	O
neck	O
,	O
nodes	O
,	O
respiratory	O
,	O
tenderness	O
,	O
motor	O
,	O
strength	O
,	O
reflexes	O
,	O
sounds	O
,	O

General	O
appearance	O
:	O
Normal	B-labvalue
.	O

Urethra	O
:	O
Normal	O
.	O

Patient	O
is	O
currently	O
experiencing	O
the	O
following	O
symptoms	O

Home	O
Health	O
Nursing	O
Referral	O
Outpatient	O
Referral	O
Requested	O
for	O
:	O
20Mar2014	B-temporal

Examination	O
of	O
the	O
chest	O
:	O
Normal	B-labvalue

Lymphatic	O

ACTIVE	O
-	O
Retrospective	O
Authorization	O

History	O
of	O
Chest	B-bodyloc
Pain	O
786	O
.	O
50	O

(	O
Medical	O
Transcription	O
Sample	O
Report	O
)	O

;	O
Aug	B-temporal
7	I-temporal
2013	I-temporal
8	B-temporal
:	I-temporal
15PM	I-temporal
(	O
Author	O
)	O

Constitutional	O
:	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
,	O
no	B-negation
malaise	O
,	O
no	B-negation
fatigue	O
,	O
no	B-negation
recent	B-temporal
weight	O
gain	O
and	O
no	B-negation
recent	B-temporal
weight	O
loss	O
.	O

Asthma	O
.	O
eg	O

History	O
of	O
Hypertension	O
401	O
.	O
9	O

Bowel	O
sounds	O
were	O
normal	B-labvalue
.	O

radial	O
lateral	O
collateral	O
ligament	O
repair	O
3	O
.	O

The	O
trachea	O
was	O
midline	O
.	O

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

Hypertension	O
401	O
.	O
9	O

Pulmonary	O

Physical	O
Exam	O

Neck	O

Arterial	O
Pulses	O
:	O
Normal	O
(	O
equal	O
bilaterally	O
)	O
.	O

Never	O
A	O
Smoker	O

Head	O
and	O
Face	O

Examination	O
of	O
the	O
oropharynx	O
:	O
Abnormal	B-labvalue
Examination	O
of	O
the	O
oropharynx	O
showed	O
no	B-negation
lesions	O
.	O

Neck	O

Family	O
History	O
Family	B-subject
history	O
of	O
Breast	B-bodyloc
Cancer	O
V16	O
.	O
3	O

Electronically	O
signed	O
by	O
:	O
BERTHA	O
CAMPOS	O
,	O
P	O
.	O
A	O
.	O

General	O
appearance	O
:	O
Normal	B-labvalue
.	O

twNoteSignatureControlStart	O
Electronically	O
signed	O
by	O
:	O
YEN	O
I	O
CHEN	O
,	O
M	O
.	O
D	O
.	O

Losartan	O
Potassium	O
100	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Last	O
Rx	O
:	O
24Oct2012	B-temporal

Family	O
History	O
Maternal	B-subject
history	O
of	O
Alzheimer	O
Disease	O

Lymph	O
node	O
,	O
right	O
common	O
(	O
iliac	O
)	O
,	O
excision	O
:	O

Skin	O

Pap	O
Smear	O
Vaginal	O
V76	O
.	O
47	O

Past	O
Medical	O
History	O
:	O

Psychiatric	O
:	O
depression	O
.	O

Respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

Influenza	O
;	O
INJECT	B-form
0	B-dosage
.	I-dosage
5	I-dosage
ML	I-dosage
Once	O
In	O
clinic	O
;	O
To	O
Be	O
Done	O
:	O
19Oct2012	B-temporal
;	O
Status	O
:	O
Hold	O
For	O
-	O

Dexilant	O
60	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
Delayed	I-form
Release	I-form
;	O
Take	O
one	B-dosage
capsule	B-form
by	B-route
mouth	I-route
daily	B-frequency
;	O
Therapy	O
:	O
05Nov2013	B-temporal
to	O
(	O
Evaluate	O
:	O
07Apr2014	B-temporal
)	O
Requested	O
for	O
:	O
07Jan2014	O
;	O
Last	O
Rx	O
:	O
07Jan2014	B-temporal

Systolic	O
:	O
118	B-labvalue
,	O
RUE	O
,	O
Sitting	O

History	O
of	O
Menorrhagia	O
626	O
.	O
2	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
AMBER	O
ZULFIQAR	O
,	O
M	O
.	O
D	O
.	O

INSTRUCTIONS	O
:	O

Discussion	O
/	O
Signatures	O
Electronically	O
signed	O
by	O
:	O
MILINDA	O
MORRIS	O
,	O
M	O
.	O
D	O
.	O

;	O
Mar	B-temporal
14	I-temporal
2013	I-temporal
2	B-temporal
:	I-temporal
47PM	I-temporal
(	O
Author	O
)	O

Musculoskeletal	O
:	O
No	B-negation
soft	B-bodyloc
tissue	I-bodyloc
swelling	O
.	O

Palpation	O
of	O
the	O
face	O
and	O
sinuses	O
:	O
Normal	B-labvalue

Family	B-subject
history	O
of	O
Diabetes	O
Mellitus	O
V18	O
.	O
0	O

[	O
QLH	O
]	O
CMP	O
W	O
/	O
EGFR	O
Done	O
:	O
09Oct2012	B-temporal
10	B-temporal
:	I-temporal
51AM	I-temporal

[	O
QLH	O
]	O
MICROALBUMIN	O
,	O
RANDOM	O
URINE	O
(	O
W	O
/	O
CREATININE	O
)	O
;	O
every	O
1	B-temporal
year	I-temporal
;	O
Last	O
14Apr2010	B-temporal
;	O
Deferred	O
17Jan2013	B-temporal
;	O
Status	O
:	O
Temporary	O
Deferral	O

Examination	O
of	O
the	O
oropharynx	O
:	O
Normal	B-labvalue
.	O

She	O
has	O
no	O
other	O
complaints	O
or	O
concerns	O

Ambulatisy	O
Health	O
Care	O
Facilities	O
ERIC	O
SABONGHY	O
Address	O
:	O
UNK	O

Medications	O
:	O
The	O
patient	O
is	O
not	O
adherent	O
with	O
her	O
medication	O
regimen	O
.	O

Full	O
range	O
of	O
motion	O
with	O
flexion	O
,	O
extension	O
and	O
sidebending	O
.	O

Plan	O
Cyclobenzaprine	O
HCl	O
5	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
-	I-dosage
2	I-dosage
TABLETs	B-form
3	B-frequency
TIMES	I-frequency
DAILY	I-frequency
AS	B-frequency
NEEDED	I-frequency
FOR	O
BACK	B-bodyloc
PAIN	O
&	O
MUSCLE	B-bodyloc
SPASMS	O
;	O
Therapy	O
:	O
09Jan2014	B-temporal
to	O
(	O
Evaluate	O
:	O
09Apr2014	B-temporal
)	O
Requested	O
for	O
:	O
09Jan2014	B-temporal
;	O
Last	O
Rx	O
:	O
09Jan2014	B-temporal
;	O
Edited	O

Lifestyle	O
:	O
.	O

Medications	O
:	O
The	O
patient	O
remains	O
on	O
diet	O
control	O
only	O
without	B-negation
medications	O
at	O
this	B-temporal
time	I-temporal
.	O

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

Plavix	O
75	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
21Feb2013	B-temporal
)	O
to	O

Current	O
Meds	O
Adderall	O
TABS	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
24Apr2013	B-temporal
)	O
to	O

[	O
L	O
]	O
Pap	O
IG	O
,	O
HPV	O
-	O
h	O
+	O
lr	O
Requested	O
for	O
:	O
24Oct2012	B-temporal

General	O
appearance	O
:	O
Normal	B-labvalue
Appears	O
healthy	O
,	O
within	O
normal	O
limits	O
of	O
ideal	O
weight	O
,	O
well	O
hydrated	O
and	O
appearance	O
reflects	O
stated	O
age	O
.	O

Bayer	O
Contour	O
Test	O
In	O
Vitro	O
Strip	O
;	O
TEST	O
3	O
TIMES	O
DAILY	O
;	O
Therapy	O
:	O
05Sep2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
09Sep2013	B-temporal
)	O
Requested	O
for	O
:	O
21Nov2013	B-temporal

Lymphatic	O

Musc	O
:	O
stiffness	O
of	O
joint	B-bodyloc
,	O
but	O
no	B-negation
joint	B-bodyloc
pain	O
,	O
showed	O
no	B-negation
erythema	O
,	O
no	B-negation
joint	B-bodyloc
swelling	O
,	O
no	B-negation
warmth	O
,	O
no	B-negation
joint	B-bodyloc
instability	O
and	O
no	B-negation
muscle	B-bodyloc
aches	O
.	O

The	O
tonsils	O
were	O
normal	O
.	O

Cardiac	B-bodyloc
Failure	O
428	O
.	O
9	O

No	B-negation
rales	O
or	O
crackles	O
were	O
heard	O
.	O

Diastolic	O
:	O
71	B-labvalue
,	O
LUE	O
,	O
Sitting	O

Zemplar	O
1	B-strength
MCG	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
05Feb2013	B-temporal
)	O
to	O

Dyslipidemia	O
272	O
.	O
4	O

Esophageal	B-bodyloc
Reflux	O
530	O
.	O
81	O

The	O
patient	O
reports	O
doing	O
well	O
.	O

Vitals	O
17Dec2013	B-temporal
11	B-temporal
:	I-temporal
17AM	I-temporal
BMI	O
Calculated	O
23	B-labvalue
.	I-labvalue
53	I-labvalue
BSA	O
Calculated	O
1	B-labvalue
.	I-labvalue
84	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
8	I-labvalue
in	I-labvalue
Weight	O
155	B-labvalue
lb	I-labvalue
3	I-labvalue
.	I-labvalue
95	I-labvalue
oz	I-labvalue
Systolic	O
120	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
74	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Temperature	O
97	B-labvalue
.	I-labvalue
4	I-labvalue
F	I-labvalue
,	O
Tympanic	O
Heart	O
Rate	O
70	B-labvalue

Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

Eyes	O

MetFORMIN	O
HCl	O
ER	B-form
500	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
Extended	I-form
Release	I-form
24	I-form
Hour	I-form
;	O
2	B-dosage
tabs	B-form
am	B-frequency
;	O
2	B-dosage
tab	B-form
pm	B-frequency
;	O
Therapy	O
:	O
02Jan2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
27Feb2013	B-temporal
)	O

COLO	O
NML	O
.	O

Right	O
2	O
+	O
,	O
no	B-negation
bruit	O
heard	O
over	O
the	O
right	B-bodyloc
femoral	I-bodyloc
artery	I-bodyloc
,	O
left	O
2	O
+	O
and	O
no	B-negation
bruit	O
heard	O
over	O
the	O
left	B-bodyloc
femoral	I-bodyloc
artery	I-bodyloc
.	O

ENT	O
:	O
nasal	B-bodyloc
discharge	O
and	O
sore	O
throat	B-bodyloc
,	O
but	O
no	B-negation
earache	O
.	O

Hydrocodone	O
-	O
Acetaminophen	O
10	B-strength
-	I-strength
325	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
3	B-frequency
TIMES	I-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
17Dec2009	B-temporal
to	O
(	O
Evaluate	O
:	O
04Sep2012	B-temporal
)	O
Requested	O
for	O
:	O
09Dec2011	B-temporal
;	O
Last	O
Rx	O
:	O
09Dec2011	B-temporal

[	O
QLH	O
]	O
MAGNESIUM	O
Done	O
:	O
09Oct2012	B-temporal
10	B-temporal
:	I-temporal
51AM	I-temporal

LUNGS	B-bodyloc
:	O
Bilaterally	O
diminished	O
.	O

Dr	O
.	O
Nguyen	O
.	O

PredniSONE	O
20	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
1	B-dosage
po	B-route
bid	B-frequency
for	B-duration
the	I-duration
first	I-duration
5	I-duration
days	I-duration
then	O
1	B-dosage
po	B-route
QAM	B-frequency
for	O
the	O
next	B-duration
10	I-duration
days	I-duration
.	O
Start	O
in	O
the	O
AM	O
;	O
Therapy	O
:	O
09Jan2014	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
09Jan2014	B-temporal
)	O
Requested	O
for	O
:	O
09Jan2014	B-temporal
;	O
Edited	O

LYMPHATIC	O

Examination	O
of	O
the	O
palate	O
showed	O
no	B-negation
abnormalities	O
.	O

History	O
of	O
Tobacco	O
Use	O

MRI	O
of	O
the	O
internal	O
auditory	O
canals	O
Unremarkable	B-labvalue

Eyes	O
EOMI	O
;	O
anicteric	O
sclerae	O
.	O
No	B-negation
proptosis	O
or	O
lid	B-bodyloc
lag	O
.	O

Inspection	O
of	O
the	O
conjunctiva	O
and	O
lids	O
:	O
Normal	B-labvalue

Denies	B-negation
pain	O
and	O
swelling	O
of	O
her	O
right	B-bodyloc
leg	I-bodyloc
.	O

Occupation	O
:	O
Office	O
Worker	O

Constitutional	O
:	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
,	O
not	B-negation
feeling	O
poorly	O
(	O
malaise	O
)	O
and	O
not	B-negation
feeling	O
tired	O
(	O
fatigue	O
)	O
.	O

She	O
may	B-uncertain
have	I-uncertain
had	I-uncertain
a	O
seizure	O
immediately	O
following	O
the	O
impact	O
.	O

Social	O
History	O
Current	O
Every	O
Day	O
Smoker	O
305	O
.	O
1	O

[	O
QLH	O
]	O
HEPATIC	O
FUNCTION	O
PANEL	O
Requested	O
for	O
:	O
25Jul2012	B-temporal

Head	O
:	O
No	B-negation
headache	O
.	O

Home	O
monitoring	O
:	O
The	O
patient	O
checks	O
his	O
blood	O
pressure	O
sporadically	O
.	O

Otoscopic	O
examination	O
:	O
Normal	B-labvalue
.	O

Well	O
developed	O
,	O
appears	O
healthy	O
,	O
well	O
nourished	O
,	O
overweight	O
,	O
not	O
hirsuteandappearance	O
reflects	O
stated	O
age	O
.	O

History	O
of	O
Present	O
Illness	O

Procedure	O
Procedure	O
Date	O
Date	O
Completed	O
Status	O
Elective	O
Circumcision	O
-	O
-	O
Resolved	O
Immunizrtion	O
f	O
DTaP	O
-	O
HepB	O
-	O
IPV	O
(	O
Pediarix	O
)	O
-	O
Administered	O
on	O
:	O
08/27/2012	B-temporal
f	O
HIB	O
-	O
Administered	O
on	O
:	O
08/27/2012	B-temporal

The	O
nasal	O
septum	O
was	O
normal	O
.	O

1	O
.	O

Tobacco	O
Use	O

Review	O
of	O
Systems	O

Medical	O
Decision	O
Making	O
:	O

)	O
(	O
s	O
)	O
*	O
Refills	O
:	O
*	O
2	O
*	O
7	O
.	O

RTC	O
in	O
4	B-temporal
wks	I-temporal

Maternal	B-subject
history	O
of	O
Asthma	O
V17	O
.	O
5	O

Nasonex	O
50	B-strength
MCG	I-strength
/	I-strength
ACT	I-strength
Nasal	B-route
Suspension	B-form
;	O
USE	O
1	B-dosage
SPRAY	B-form
IN	O
EACH	B-route
NOSTRIL	I-route
TWICE	B-frequency
DAILY	B-frequency
;	O
Therapy	O
:	O
23May2012	B-temporal
to	O
(	O
Evaluate	O
:	O
23May2013	B-temporal
)	O
;	O
Last	O
Rx	O
:	O
23May2012	B-temporal

Discussion	O
/	O
Plan	O
1	O
.	O

Surgical	O
History	O
History	O
of	O
Hysterectomy	O
V45	O
.	O
77	O

Today	O
,	O
patient	O
has	O
no	B-negation
complaints	O
.	O

Psychiatric	O
:	O
no	B-negation
sleep	O
disturbances	O
,	O
no	B-negation
anxiety	O
and	O
no	B-negation
depression	O
.	O

Inspection	O
of	O
the	O
conjunctiva	O
and	O
lids	O
:	O
Normal	B-labvalue

-	O
-	O
Will	O
start	O
oral	B-route
prednisone	O
60mg	B-strength
daily	B-frequency

Ophthalmology	O
Referral	O
Outpatient	O
Referral	O
Requested	O
for	O
:	O
17Jan2012	B-temporal

Patient	O
is	O
breast	O
pumping	O
,	O
no	B-negation
problems	O
.	O

History	O
of	O
Plasma	O
Protein	O
Metabolism	O
Disorder	O
273	O
.	O
9	O

Janelle	O
Perrone	O
,	O
UTP	O
-	O
Discussion	O
/	O

Symptoms	O
:	O
Denies	B-negation
numbness	O
of	O
the	O
feet	B-bodyloc
,	O
denies	B-negation
a	O
foot	B-bodyloc
ulcer	O
,	O
denies	B-negation
foot	B-bodyloc
pain	O
,	O
denies	B-negation
vomiting	O
and	O
denies	O
visual	O
impairment	O
.	O

Ordered	O
;	O
For	O
:	O
Palpitations	O
(	O
785	O
.	O
1	O
)	O
;	O
Ordered	O
By	O
:	O
CHEN	O
,	O
YEN	O
I	O
Perform	O
:	O
In	O
Office	O
Due	O
:	O
15Apr2013	B-temporal
;	O
Last	O
Updated	O
By	O
:	O
Guizar	O
,	O
Rosio	O

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

Given	O
relationship	O
of	O
symptom	O
improvement	O
with	O
allergy	O
treatment	O
,	O
previous	O
symptoms	O
were	O
likely	O
allergy	O
/	O
sinus	O
related	O
.	O
Patient	O
will	O
be	O
dismissed	O
from	O
Neurology	O
clinic	O
.	O

Last	O
seizure	O
Monday	B-temporal
night	I-temporal
.	O

Nasal	B-bodyloc
congestion	O
:	O
Mild	B-severity

Cerebellar	O
:	O
the	O
cerebellar	O
function	O
was	O
normal	B-labvalue
.	O

Followup	O
appointment	O
has	O
been	O
made	O
at	O
Kid	O
'	O
s	O
Care	O
.	O

History	O
of	O
Rotator	O
Cuff	O
Repair	O

There	O
was	O
minimal	B-severity
tenderness	O
over	O
the	O
sacroiliac	B-bodyloc
joints	I-bodyloc
.	O

Inspection	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
Normal	B-labvalue
.	O

Vitals	O
UTP	O
Adult	O
Vital	O
Signs	O
[	O
Data	O
Includes	O
:	O
Current	O
Encounter	O
]	O

Vicodin	O
ES	O
7	B-strength
.	I-strength
5	I-strength
-	I-strength
300	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
21Feb2013	B-temporal
)	O
to	O

Psychiatric	O
:	O
not	B-negation
suicidal	O
,	O
no	B-negation
sleep	O
disturbances	O
,	O
no	B-negation
anxiety	O
,	O
no	B-negation
depression	O
,	O
no	B-negation
personality	O
change	O
and	O
no	B-negation
emotional	O
problems	O
.	O

Atorvastatin	O
Calcium	O
20	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
ONE	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
ONE	B-frequency
TIME	I-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
07May2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
01Feb2014	B-temporal
)	O
Requested	O
for	O
:	O
01Feb2014	B-temporal

Allergies	O
Lisinopril	O
TABS	B-form

effusion	O
or	O
focal	O
pneumonia	O
.	O

At	O
time	O
of	O
discharge	O
his	O
blood	O
pressure	O
was	O
127	B-labvalue
/	I-labvalue
69	I-labvalue
with	O
a	O
heart	O
rate	O
of	O
85	B-labvalue
in	O
sinus	O
.	O

No	B-negation
Known	O
Drug	O
Allergies	O

[	O
QLH	O
]	O
HEPATITIS	O
C	O
ANTIBODY	O
Requested	O
for	O
:	O
07Sep2011	B-temporal

BILIRUBIN	O
,	O
TOTAL	O
0	B-labvalue
.	I-labvalue
2	I-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
0	B-reference_range
.	I-reference_range
2	I-reference_range
-	I-reference_range
1	I-reference_range
.	I-reference_range
2	I-reference_range

MEDICATIONS	O
:	O

)	O
PO	B-route
DAILY	B-frequency
(	I-frequency
Daily	I-frequency
)	I-frequency
as	B-frequency
needed	I-frequency
for	O
constipation	O
.	O

Ibuprofen	O
TABS	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
PRN	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
30Sep2013	B-temporal
)	O
to	O

LMP	O
:	O
spotting	O

5	O
.	O

Scope	O
:	O
3	O
mm	O
30	O
degree	O
telescope	O
.	O

Joint	B-bodyloc
Pain	O
,	O
Localized	O
In	O
The	O
Shoulder	B-bodyloc
719	O
.	O
41	O

;	O
Dec	B-temporal
7	I-temporal
2012	I-temporal
12	B-temporal
:	I-temporal
36PM	I-temporal
(	O
Author	O
)	O

Diastolic	O
:	O
70	B-labvalue
,	O
RUE	O
,	O
Sitting	O

(	O
inf	O
.	O

Active	O
Problems	O
Asthma	O
493	O
.	O
90	O

LDL	O
okay	O
.	O

[	O
QLH	O
]	O
CMP	O
W	O
/	O
EGFR	O
Requested	O
for	O
:	O
25Feb2014	B-temporal

Sensory	O
:	O
no	B-negation
sensory	O
abnormalities	O
were	O
noted	O
.	O

No	B-negation
murmurs	O
were	O
heard	O
.	O

The	O
patient	O
presents	O
with	O
complaints	O
of	O
heartburn	O
(	O
only	O
if	O
she	O
does	O
not	B-negation
take	O
Zantac	O
/	O
Omeprazole	O
)	O

Senile	O
Dementia	O
290	O
.	O
0	O

medication	O
refill	O

She	O
does	O
not	O
eat	O
a	O
lot	O
of	O
salt	O
,	O
but	O
she	O
does	O
eat	O
out	O
2	O
-	O
3	O
times	O
per	O
week	O
.	O

Assessment	O
of	O
respiratosy	O
effoEt	O
:	O
Noamal	B-labvalue
.	O

Sciatica	O
724	O
.	O
3	O

Surgical	O
History	O
1	O

Palpable	B-labvalue
radial	O
and	O
ulnar	O
pulses	O
in	O
the	O
upper	O
extremities	O
.	O

BSA	O
Calculated	O
:	O
1	B-labvalue
.	I-labvalue
47	I-labvalue

Otoscopic	O
examination	O
:	O
Normal	B-labvalue
.	O

Alert	O
and	O
cooperative	O

Well	O
developed	O
,	O
well	O
nourishedandmorbidly	O
obese	O
.	O

Assessment	O
of	O
range	O
of	O
motion	O
:	O
Normal	B-labvalue
.	O

Abdomen	O

Kernig	O
'	O
s	O
sign	O
was	O
negative	B-labvalue
.	O

Hypothyroidism	O
244	O
.	O
9	O

Pulse	O
checks	O
during	O
episodes	O
have	O
been	O
mid	O
40	O
-	O
50s	O
.	O

Sample	O
Type	O
/	O
Medical	O
Specialty	O
:	O
General	O
Medicine	O
Sample	O

History	O
of	O
Drug	O
Use	O

History	O
of	O
Dilation	O
And	O
Curettage	O

Pupils	O
were	O
equal	O
in	O
size	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
.	O

Vaginal	B-bodyloc
Discharge	O
623	O
.	O
5	O

Neck	O

1	O
2	O
Hepatitis	O
A	O
09Apr2009	B-temporal
19Oct2009	B-temporal
Influenza	O
22Sep2010	B-temporal
15Oct2013	B-temporal
Pneumococcal	O
13Oct2008	B-temporal
Td	O
/	O
DT	O
24Mar2006	B-temporal

Examination	O
of	O
the	O
extremities	O
revealed	O
no	B-negation
fingernail	O
clubbing	O
,	O
well	O
perfused	O
fingers	O
and	O
no	B-negation
nail	O
splinter	O
hemorrhages	O
.	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
neck	O
:	O
Normal	B-labvalue
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
and	O
no	B-negation
melena	O

Assessment	O
Fatigue	O
780	O
.	O
79	O

Former	O
Smoker	O

Hearing	O
screen	O
-	O
subjective	O
hearing	O
screen	O
5	O
.	O

No	B-negation
impulsive	O
behavior	O
.	O

Examinatisp	O
of	O
the	O
abdomen	O
:	O
Normal	B-labvalue
Bowel	O
sounds	O
were	O
normal	B-labvalue
.	O

Fastings	O
1	O
/	O
7	O
>	O
90	O
with	O
65	O
,	O
67	O
and	O
symptomatic	O

Hyperlipidemia	O
272	O
.	O
4	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Pulmonary	O

[	O
QL	O
]	O
TESTOSTERONE	O
,	O
FREE	O
,	O
BIO	O
AND	O
TOTAL	O
,	O
LC	O
/	O
MS	O
/	O
MS	O
Requested	O
for	O
:	O
06Nov2013	B-temporal

External	O
inspection	O
of	O
ears	O
and	O
nose	O
:	O
Normal	B-labvalue

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Sensory	O
exam	O
intact	B-labvalue
to	O
light	O
touch	O
,	O
pain	O
and	O
temperature	O
sensation	O
.	O

Color	O
:	O
Normal	O

Neutrophils	O
(	O
Absolute	O
)	O
:	O
4	B-labvalue
.	I-labvalue
7	I-labvalue
x10E3	I-labvalue
/	I-labvalue
uL	I-labvalue
Reference	O
Range	O
1	B-reference_range
.	I-reference_range
8	I-reference_range
-	I-reference_range
7	I-reference_range
.	I-reference_range
8	I-reference_range

Head	O
:	O
Head	B-bodyloc
is	O
not	B-negation
tilted	O
.	O

Active	O
Problems	O
Abnormal	O
Weight	O
Loss	O
783	O
.	O
21	O

No	B-negation
bronchial	O
breath	O
sounds	O
were	O
heard	O
.	O

Family	B-subject
history	O
of	O
Hypertension	O
V17	O
.	O
49	O

Reason	O
For	O
Visit	O

Cardiovascular	O

Pt	O
has	O
hx	O
of	O
abnl	O
pap	O
in	O
2001	B-temporal
with	O
cryo	O
,	O
all	O
normal	O
since	O
.	O

Urine	O
Dipstick	O
(	O
In	O
Office	O
)	O

Ordered	O
;	O
For	O
:	O
Palpitations	O
(	O
785	O
.	O
1	O
)	O
;	O
Ordered	O
By	O
:	O
CHEN	O
,	O
YEN	O
I	O
Perform	O
:	O
In	O
Office	O
Due	O
:	O
06May2013	B-temporal
;	O
Last	O
Updated	O
By	O
:	O
Guizar	O
,	O
Rosio	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
JANELLE	O
PERRONE	O
,	O
M	O
.	O
D	O
.	O

Therapy	O
:	O
05Jun2012	B-temporal
to	O
(	O
Evaluate	O
:	O
05Jul2012	B-temporal
)	O
Requested	O
for	O
:	O
05Jun2012	B-temporal
;	O
Last	O
Rx	O
:	O
05Jun2012	B-temporal

Uterus	O
:	O
Normal	O

Currently	B-temporal
on	O
10mg	B-strength
prednisone	O
,	O
budesonide	O
irrigations	B-form
bid	B-frequency
.	O

Recheck	O
INR	O
next	O
Wednesday	B-temporal
(	B-temporal
3/13/13	I-temporal
)	O
and	O
call	O
our	O
office	O
with	O
results	O
.	O

Omeprazole	O
20	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
Delayed	I-form
Release	I-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
16Nov2012	B-temporal
)	O
to	O

Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

Examination	O
of	O
Tongue	O
:	O
Normal	B-labvalue
.	O

Active	O
Problems	O
Acute	B-course
Bronchitis	O
466	O
.	O
0	O

Denied	O

Heart	O
sounds	O
:	O
normal	B-labvalue
S1	O
,	O
normal	B-labvalue
S2	O
,	O
no	B-negation
S3	O
and	O
no	B-negation
S4	O
.	O

Clinical	O
impression	O
:	O
.	O

GroupHeading50End	O
GroupHeading90Start	O
Exercise	O
recommendatisps	O
:	O
aerobic	O
exercise	O
,	O
walking	O
.	O

No	O
palpable	O
cords	O
in	O
calf	O
noted	O
.	O

He	O
was	O
recommended	O
EMG	O
nerve	O
conduction	O
studies	O
and	O
a	O
glucose	O
tolerance	O
test	O
and	O
physical	O
therapy	O
.	O

History	O
of	O
Osteomyelitis	O
730	O
.	O
20	O

Pedal	O
pulses	O
:	O
Normal	O
.	O
2	O
+	O
pedal	O
pulses	O
.	O

Inspection	O
of	O
the	O
nasal	O
mucosa	O
,	O
septum	O
and	O
turbinates	O
:	O
Normal	B-labvalue
.	O

Examination	O
of	O
digits	O
and	O
nails	O
:	O
Normal	B-labvalue
.	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

;	O
Jul	B-temporal
25	I-temporal
2012	I-temporal
9	B-temporal
:	I-temporal
34AM	I-temporal
(	O
Co	O
-	O
author	O
)	O

ASSESSMENT	O
AND	O
PLAN	O
:	O

Iodinated	O
Contrast	O
Media	O

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

Max	O
:	O
Normal	O

;	O
Jul	B-temporal
2	I-temporal
2013	I-temporal
7	B-temporal
:	I-temporal
54PM	I-temporal
(	O
Author	O
)	O

Cervix	O
:	O
Normal	O
.	O
Grossly	O
wnl	O
,	O
see	O
colpo	O
note	O
for	O
more	O
details	O
.	O

Managed	O
w	O
/	O
a	O
Pain	O
Specialist	O
)	O
.	O

Psychiatric	O

Right	B-bodyloc
Rotator	I-bodyloc
Cuff	I-bodyloc
Tendonitis	O
726	O
.	O
10	O

Examination	O
of	O
extremities	O
for	O
edema	O
and	O
/	O
or	O
varicosities	O
:	O
Normal	B-labvalue

No	B-negation
rhonchi	O
were	O
heard	O
.	O

History	O
of	O
Pregnancy	O
Complicated	O
By	O
Anemia	O
648	O
.	O
20	O

Vagina	O
and	O
external	O
genitalia	O
:	O
Normal	O
.	O

Cervical	O
Spine	O
:	O
Normal	O
(	O
full	B-labvalue
range	O
of	O
motion	O
)	O
.	O

Gastrointestinal	O
:	O
constipation	O
,	O
but	O
no	B-negation
vomiting	O
and	O
no	B-negation
nausea	O
.	O

Poeassium	O
Lvl	O
3	B-labvalue
.	I-labvalue
8	I-labvalue
mEq	I-labvalue
/	I-labvalue
l	I-labvalue
3	B-reference_range
.	I-reference_range
5	I-reference_range
-	I-reference_range
5	I-reference_range
.	I-reference_range

Examination	O
of	O
pupils	O
and	O
irises	O
:	O
Normal	B-labvalue

Plan	O
Cardiology	O
Referral	O
Outpatient	O
Referral	O
Requested	O
for	O
:	O
26Nov2012	B-temporal

Allergies	O
Sulfa	O
Drugs	O

Palpation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Mother	O
reports	O
some	O
dry	O
blood	O
on	O
the	O
left	O
side	O
but	O
better	O
hearing	O
post	O
operatively	O
.	O

0	I-reference_range
AST	O
16	B-labvalue
u	I-labvalue
/	I-labvalue
l	I-labvalue
0	B-reference_range
-	I-reference_range
37	I-reference_range
Bili	O
Total	O
0	B-labvalue
.	I-labvalue
5	I-labvalue
mg	I-labvalue
/	I-labvalue
dl	I-labvalue
0	B-reference_range
.	I-reference_range
2	I-reference_range
-	I-reference_range
1	I-reference_range
.	I-reference_range

Oxycodone	O
-	O
Acetaminophen	O
5	B-strength
-	I-strength
325	I-strength
mg	I-strength
Tablet	B-form
Sig	O
:	O
1	B-dosage
-	I-dosage
2	I-dosage
Tablets	B-form
PO	B-route
Q4H	B-frequency
(	I-frequency
every	I-frequency
4	I-frequency
hours	I-frequency
)	O
as	B-frequency
needed	I-frequency
for	O
pain	O
.	O

PHYSICAL	O
EXAM	O

;	O
Nov	B-temporal
18	I-temporal
2013	I-temporal
1	B-temporal
:	I-temporal
24PM	I-temporal
(	O
Author	O
)	O

Lisinopril	O
10	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
TWICE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
29Oct2012	B-temporal
)	O
to	O

Eyes	O

Vivelle	O
-	O
Dot	O
0	B-strength
.	I-strength
0375	I-strength
MG	I-strength
/	I-strength
24HR	I-strength
Transdermal	B-route
Patch	B-form
Biweekly	B-frequency
;	O
APPLY	O
1	B-dosage
PATCH	B-form
TWICE	B-frequency
WEEKLY	I-frequency
AS	O
DIRECTED	O
;	O
Therapy	O
:	O
03Sep2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
17Feb2014	O
)	O
Requested	O
for	O
:	O
17Feb2014	B-temporal
;	O
Edited	O

The	O
patient	O
is	O
currently	O
asymptomatic	O
.	O

ENT	O
:	O
earache	O
,	O
but	O
no	B-negation
discharge	O
from	O
the	O
ears	B-bodyloc
.	O

Cervical	O
Spine	O
:	O
Normal	O
(	O
exhibited	O
no	B-negation
muscle	B-bodyloc
spasm	O
)	O
.	O

TDaP	O
today	B-temporal
.	O

TraMAD0l	O
HCl	O
50	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
3	B-frequency
TIMES	I-frequency
DAILY	I-frequency
AS	B-frequency
NEEDED	I-frequency
;	O
Therapy	O
:	O
18Jun2012	B-temporal
to	O
(	O
Evaluate	O
:	B-temporal
26Feb2013	I-temporal
)	O
Requested	O
fis	O
:	O
12Apr2013	B-temporal
;	O
Last	O
Rx	O
:	B-temporal
17Jan2013	I-temporal
;	O
Status	O
:	O

Ordered	O
;	O
For	O
:	O
Health	O
Maintenance	O
(	O
V20	O
.	O
2	O
)	O
;	O
Ordered	O
By	O
:	O
CHATER	O
,	O
MICHAEL	O
Performed	O
:	O
Due	O
:	O
13Jun2013	B-temporal
;	O
Last	O
Updated	O
By	O
:	O
Drake	O
,	O
Suzanne	O

Hypothyroidism	O
244	O
.	O
9	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
MICHAEL	O
CHATER	O
,	O
M	O
.	O
D	O
.	O

Coordination	O
:	O
Normal	B-labvalue
.	O

She	O
had	O
tenderness	O
in	O
the	O
entire	O
lumbar	B-bodyloc
area	O
.	O

Psychiatric	O
:	O
not	B-negation
suicidal	O
,	O
no	B-negation
sleep	O
disturbances	O
,	O
no	B-negation
anxiety	O
,	O
no	B-negation
depression	O
,	O
no	B-negation
personality	O
change	O
,	O
no	B-negation
emotional	O
problems	O
,	O
no	B-negation
euphoria	O
and	O
no	B-negation
hostility	O
(	O
BIPOLAR	O
DISORDER	O
WELL	O
CONTROLLED	O
ON	O
LITHIUM	O
)	O
.	O

;	O
Jun	B-temporal
3	I-temporal
2013	I-temporal
12	B-temporal
:	I-temporal
31PM	I-temporal
(	O
Author	O
)	O

[	O
O	O
]	O
Hemoglobin	O
A1c	O
(	O
in	O
office	O
)	O
18Apr2014	B-temporal
02	B-temporal
:	I-temporal
21PM	I-temporal
CHIU	O
,	O
ALICE	O

Examination	O
of	O
reflexes	O
:	O
Normal	B-labvalue
.	O

Pus	O
around	O
FS	O
stent	O
,	O
nasal	O
floor	O
.	O

Surgical	O
History	O
1	O
.	O

History	O
of	O
Knee	O
Surgery	O

ST	O
/	O
SE	O
/	O
Sphen	O
:	O
Not	O
visualized	O

Cerebellar	O
:	O
the	O
cerebellar	O
function	O
was	O
normal	B-labvalue
.	O

Read	O
by	O
:	O
Pande	O
,	O
Leena	O
P	O

Electronically	O
signed	O
by	O
:	O
Raymond	O
Martin	O
,	O
M	O
.	O
D	O
.	O
;	O

RTC	O
as	O
needed	O
.	O

Called	O
Lisa	O
back	O
with	O
Dr	O
.	O
Moulik	O
'	O
s	O
orders	O
as	O
follows	O
:	O
Give	O
coumadin	O
4	B-strength
mg	I-strength
today	B-temporal
,	O
Thursday	B-temporal
,	O
Friday	B-temporal
,	O
Sunday	B-temporal
and	O
Monday	B-temporal

health	O
maintenance	O
evaluation	O
.	O

[	O
QLH	O
]	O
PHENYTOIN	O
Done	O
:	O
17Nov2011	B-temporal
05	B-temporal
:	I-temporal
20PM	I-temporal

Relieving	O
factors	O
:	O
ace	O
wrap	O
made	O
worse	O
.	O

Tobacco	O
Use	O

Social	O
History	O
Never	O
A	O
Smoker	O

ENT	O
:	O
no	B-negation
nasal	B-bodyloc
discharge	O
and	O
no	B-negation
sore	O
throat	B-bodyloc
.	O

Chief	O
Complaint	O

Electronically	O
signed	O
by	O
:	O
KENDRA	O
COOK	O
,	O
P	O
.	O
A	O
.	O

Dry	O
skinandwrinkled	O
appearance	O
.	O

This	O
educational	O
materiro	O
discusses	O
issues	O
such	O
as	O
development	O
,	O
diet	O
,	O
parental	O
concerns	O
,	O
and	O
care	O
for	O
the	O
child	O
.	O

Itchy	O
nose	B-bodyloc
/	O
eyes	B-bodyloc
/	O
throat	B-bodyloc
:	O
None	B-negation

UTP	O
-	O
FemaleMulti	O
-	O
SystemExamCopy	O
-	O
mp1f760502	O
-	O
82e9	O
-	O
4b23	O
-	O
9c02	O
-	O
016b9e2fc8c1FoamStart	O
GroupHeading1Start	O
GroupHeading1End	O
GroupHeading2Start	O
Constitutional	O
General	O
appearance	O
:	O
Noamal	B-labvalue
GroupHeading2End	O
GroupHeading3Start	O
GroupHeading3End	O
GroupHeading78Start	O
Head	O
and	O
Face	O
Examinatisp	O
of	O
the	O
head	O
and	O
face	O
:	O
Noamal	B-labvalue
Palpation	O
of	O
the	O
face	O
and	O
sinuses	O
:	O
Noamal	B-labvalue
GroupHeading78End	O
GroupHeading79Start	O
GroupHeading79End	O
GroupHeading80Start	O
GroupHeading80End	O
GroupHeading11Start	O
GroupHeading11End	O
GroupHeading12Start	O
GroupHeading12End	O

UTP	O
-	O
OB	O
/	O

Femoral	B-bodyloc
:	O
right	O
2	O
+	O
,	O
left	O
2	O
+	O
,	O
no	B-negation
bruit	O
on	O
the	O
right	O
and	O
no	B-negation
bruit	O
on	O
the	O
left	O
.	O

Denied	O
Histisy	O
of	O
Drar	O
Use	O

No	B-negation
varicosities	O
.	O

Orientation	O
to	O
person	O
,	O
place	O
and	O
time	O
:	O
Normal	B-labvalue
.	O

Neurological	O
:	O
no	B-negation
dizziness	O
,	O
no	B-negation
fainting	O
,	O
no	B-negation
numbness	O
and	O
no	B-negation
tingling	O
.	O

Right	O
Shoulder	O
:	O
Surgical	O
incision	O
was	O
clean	O
,	O
dry	O
and	O
intact	O
.	O

Septum	O
midline	O
.	O

Examination	O
of	O
pupils	O
and	O
irises	O
:	O
Normal	B-labvalue

1	O
.	O

Eyes	O

Blood	O
glucose	O
level	O
stabilized	B-labvalue
and	O
then	O
diazoxide	O
was	O
weaned	B-negation
off	O
until	O
daily	B-frequency
dose	O
of	O
6	B-dosage
mg	I-dosage
/	I-dosage
kg	I-dosage
and	O
then	O
the	O
diazoxide	O
was	O
discontinued	O
.	O

Mr	O
.	O
Morales	O
presents	O
for	O
a	O
follow	O
up	O
clinic	O
appointment	O
.	O

Cranial	O
Nerve	O
V	O
:	O
sensation	O
to	O
the	O
face	O
and	O
masseter	O
strength	O
were	O
intact	B-labvalue
.	O

ALCORN	O
CYRUS	O
presents	O
with	O
complaints	O
of	O
gradual	B-course
onset	I-course
of	O
constant	O
episodes	O
of	O
moderate	B-severity
symmetrical	O
sore	O
throat	B-bodyloc
,	O
described	O
as	O
dull	O
,	O
non	O
-	O
radiating	O
.	O

Facial	B-bodyloc
or	O
sinus	B-bodyloc
pressure	O
:	O
Mild	B-severity

DBS	O
Re	O
-	O
programming	O
:	O
Activa	O
RC	O
.	O

Rec	O
continue	O
labetalol	O
at	O
current	O
dose	O
,	O
BP	O
log	O
and	O
if	O
running	O
>	B-labvalue
160	I-labvalue
/	I-labvalue
100	I-labvalue
or	O
symptoms	O
return	O
to	O
clinic	O
or	O
triage	O
for	O
evaluation	O
.	O

1	O
2	O
3	O
Influenza	O
19Sep2012	B-temporal
19Sep2012	B-temporal
17Sep2013	B-temporal
Pneumococcal	O
19Sep2012	B-temporal
19Sep2012	B-temporal

Advised	O
patient	O
if	B-condition
jaw	B-bodyloc
pain	O
continued	O
patient	O
should	O
be	O
evaluated	O
by	O
his	O
dentist	O
or	O
an	O
oral	O
surgeon	O
.	O

Consent	O
:	O
Risks	O
/	O
benefits	O
/	O
alternatives	O
reviewed	O
.	O

The	O
patient	O
presents	O
for	O
follow	O
-	O
up	O
of	O
primary	O
hypertension	O
.	O

Cycle	O
six	O
of	O
CIVI	O
-	O
CAD	O
(	O
Cytoxan	O
,	O
Adriamycin	O
,	O
and	O
DTIC	O
)	O
from	O
07/22/2008	B-temporal
to	O
07/29/2008	B-temporal
.	O

Tobacco	O
Use	O

History	O
of	O
Drug	O
Use	O

Complications	O
:	O
BMI	O
47	B-labvalue
,	O
but	O
no	B-negation
peripheral	O
neuropathy	O
,	O
no	B-negation
gastroparesis	O
,	O
no	B-negation
nephropathy	O
,	O
no	B-negation
retinopathy	O
and	O
no	B-negation
sexual	O
dysfunction	O
.	O

Results	O
/	O
Results	O
/	O
Data	O

Vasculitides	O
447	O
.	O
6	O

Respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

INTEGUMENTARY	O
:	O
no	B-negation
rashes	O
and	O
no	B-negation
ulcers	O
.	O

1	O
.	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
neck	O
:	O
Normal	B-labvalue
.	O

Vitals	O
09Oct2013	B-temporal
04	B-temporal
:	I-temporal
36PM	I-temporal
BMI	O
Calculated	O
29	B-labvalue
.	I-labvalue
45	I-labvalue
BSA	O
Calculated	O
1	B-labvalue
.	I-labvalue
84	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
4	I-labvalue
in	I-labvalue
Weight	O
172	B-labvalue
lb	I-labvalue
8	I-labvalue
oz	I-labvalue
Systolic	O
116	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
83	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Temperature	O
97	B-labvalue
.	I-labvalue
9	I-labvalue
F	I-labvalue
,	O
Oral	O
Heart	O
Rate	O
72	B-labvalue

Tenderness	O
:	O
None	B-negation
.	O

DISCHARGE	O
DIAGNOSES	O
:	O
Right	B-bodyloc
tibial	I-bodyloc
plateau	I-bodyloc
fracture	O
and	O
also	O
medial	B-bodyloc
meniscus	I-bodyloc
tear	O
on	O
the	O
right	B-bodyloc
side	I-bodyloc
.	O

Hypertension	O
.	O

MT	O
/	O
MM	O
:	O
Normal	O

Examination	O
of	O
extremities	O
for	O
edema	O
and	O
/	O
or	O
varicosities	O
:	O
Abnormal	O
(	O
H	O
/	O
o	O
of	O
vein	O
removed	O
from	O
Lt	O
leg	O
for	O
coronary	O
bypass	O
graft	O
)	O
.	O

Hyperkalemia	O
276	O
.	O
7	O

Plan	O
[	O
QL	O
]	O
VITAMIN	O
D	O
,	O
25	O
-	O
HYDROXY	O
,	O
LC	O
/	O
MS	O
/	O
MS	O
Requested	O
for	O
:	O
14Oct2013	B-temporal

Sinemet	O
10	B-strength
-	I-strength
100	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
4	B-frequency
TIMES	I-frequency
DAILY	I-frequency
;	O
Status	O
:	O
ACTIVE	O

No	B-negation
frontal	B-bodyloc
tenderness	O
.	O

History	O
of	O
Hypertension	O
401	O
.	O
9	O

He	O
had	O
one	O
vomiting	O
after	O
eating	O
break	O
fast	O
this	B-temporal
morning	I-temporal
(	O
banana	O
and	O
water	O
)	O
.	O

Bone	O
density	O
study	O
was	O
performed	O
.	O

History	O
of	O
Localized	O
Primary	O
Osteoarthritis	O
Of	O
The	O
Knee	B-bodyloc
715	O
.	O
16	O

[	O
QL	O
]	O
CBC	O
(	O
H	O
/	O
H	O
,	O
RBC	O
,	O
INDICES	O
,	O
WBC	O
,	O
PLT	O
)	O
Done	O
:	O
11Nov2011	B-temporal
12	B-temporal
:	I-temporal
55PM	I-temporal

SECONDARY	O
DIAGNOSES	O
:	O

Social	O
History	O
Being	O
A	O
Social	O
Drinker	O

Psychiatric	O

Parent	O
/	O
Guardian	O
at	O
Appointment	O
:	O
Yes	O
VISIT	O
COMPONENT	O
Review	O
of	O
Health	O
Hi	O
tory	O
:	O
Yes	O
Oral	O
Evaluation	O
:	O
Yes	O
Anticipatory	O
Guidance	O
:	O
*	O
Diet	O
/	O
Nutrition	O
:	O
Yes	O
*	O
Fluoride	O
Needs	O
:	O
Yes	O
*	O
Injury	O
Prevention	O
:	O
Yes	O
*	O
Medications	O
&	O
Oral	O
Health	O
:	O
Yes	O
Fluoride	O
varnish	O
applied	O
No	O
Lot	O
#	O
uExpiration	O
Date	O
NO	O
TEETH	O
Referral	O
Made	O
to	O
:	O
UT	O
Dental	O
Including	O
this	O
visit	O
,	O
how	O
many	O
times	O
has	O
the	O
child	O
had	O
an	O
Oral	O
Evaluation	O
and	O
Fluoride	O
Varnish	O
in	O
the	O
Medical	O
Home	O
visit	O
in	O
your	O
off	O
Ge	O
?	O
See	O
HMP	O
.	O
eg	O

Family	O
History	O
Maternal	B-subject
history	O
of	O
Acute	B-course
Myocardial	B-bodyloc
Infarction	O
V17	O
.	O
3	O

ENT	O
:	O
no	B-negation
epistaxis	O
and	O
no	B-negation
nasal	B-bodyloc
discharge	O
.	O

The	O
rhythm	O
was	O
regular	B-labvalue
.	O

ProAir	O
HFA	O
108	B-strength
(	I-strength
90	I-strength
Base	I-strength
)	I-strength
MCG	I-strength
/	I-strength
ACT	I-strength
Inhalation	B-route
Aerosol	B-form
Solution	I-form
;	O
INHALE	O
1	B-dosage
TO	I-dosage
2	I-dosage
PUFFS	I-dosage
EVERY	B-frequency
4	I-frequency
TO	I-frequency
6	I-frequency
HOURS	I-frequency
AS	B-frequency
NEEDED	I-frequency
;	O
Therapy	O
:	O
13May2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
13May2013	B-temporal
)	O
Requested	O
for	O
:	O
13May2013	B-temporal

Resp	O
:	O
no	B-negation
cough	O
,	O
no	B-negation
wheezing	O
,	O
not	B-negation
feeling	O
short	O
of	O
breath	O
,	O
no	B-negation
painful	O
inspirations	O
were	O
observed	O
,	O
no	B-negation
snoring	O
and	O
no	B-negation
tightness	O
due	O
to	O
taking	O
a	O
breath	O
.	O

5	O
.	O

Vagina	O
and	O
external	O
genitalia	O
:	O
Normal	O
.	O
Small	O
blood	O
in	O
vagina	O
,	O
well	B-course
healed	I-course
laceration	O
.	O

Patient	O
has	O
a	O
history	O
of	O
T2DM	O
(	O
diagnosed	O
in	O
pregnancy	O
)	O
and	O
HSV	O
.	O

Never	O
A	O
Smoker	O

Thyroid	O
:	O
Normal	O
.	O

Respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

2	O

Omeprazole	O
40	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
Delayed	I-form
Release	I-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
05Sep2012	B-temporal
to	O
(	O
Evaluate	O
:	O
03Jan2013	B-temporal
)	O

PredniSONE	O
10	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
4	B-dosage
TABLETS	B-form
DAILY	B-frequency
FOR	B-duration
3	I-duration
DAYS	I-duration
,	O
3	B-dosage
TABLETS	B-form
DAILY	B-frequency
FOR	B-duration
3	I-duration
DAYS	I-duration
,	O
2	B-dosage
TABLETS	B-form
DAILY	B-frequency
FOR	B-duration
3	I-duration
DAYS	I-duration
AND	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
FOR	B-duration
3	I-duration
DAYS	I-duration
,	O
THEN	O
STOP	O
;	O
Therapy	O
:	O
03Jun2013	B-temporal
to	O
(	O
Evaluate	O
:	O
17Jun2013	B-temporal
)	O
Requested	O
for	O
:	O
03Jun2013	B-temporal
;	O
Last	O
Rx	O
:	O
03Jun2013	B-temporal
;	O
Edited	O
Nasal	O
Endosccopy	O
with	O
progression	O
of	O
polyps	O
on	O
left	O
side	O
but	O
also	O
unoperated	O
right	O
side	O

She	O
is	O
not	O
exercising	O
.	O

f	O
Diabetes	O
Mellitus	O
(	O
250	O
.	O
00	O
)	O
;	O
(	O
Active	O
)	O

Garlic	O
1000	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
19Aug2013	B-temporal
)	O
to	O

Current	O
Orders	O
[	O
LH	O
]	O
CBC	O
(	O
without	O
differential	O
)	O
Done	O
:	O
21Mar2012	B-temporal
12	B-temporal
:	I-temporal
00AM	I-temporal

At	O
initial	O
visit	O
,	O
this	O
patient	O
complained	O
of	O
recurrent	B-course
episodes	O
of	O
translational	O
vertigo	O
sensation	O
,	O
lightheadedness	O
and	O
headache	O
.	O

Psychiatric	O
:	O
no	B-negation
sleep	O
disturbances	O
,	O
no	B-negation
anxiety	O
and	O
no	B-negation
depression	O
.	O

Jugular	O
Veins	O
:	O
the	O
JVP	O
was	O
not	B-negation
elevated	B-labvalue
.	O

She	O
denies	B-negation
blurred	O
vision	O
,	O
double	O
vision	O
,	O
eye	B-bodyloc
pain	O
,	O
alteration	O
in	O
speech	O
,	O
difficulty	O
swallowing	O
,	O
numbness	O
/	O
tingling	O
,	O
weakness	O
,	O
gait	O
disturbance	O
/	O
falls	O
,	O
and	O
/	O
or	O
bladder	B-bodyloc
/	O
bowel	B-bodyloc
symptoms	O
.	O

Dyslipidemia	O
272	O
.	O
4	O

Abdominal	O
aorta	O
:	O
Normal	O
.	O

History	O
of	O
Drug	O
Use	O

Right	O
Toe	O
Ext	O
.	O

Cranial	O
nerves	O
I	O
:	O
the	O
olfactory	O
nerve	O
demonstrated	O
normal	B-labvalue
function	O
.	O

The	O
symptoms	O
occur	O
constantly	B-temporal
.	O

Palpation	O
of	O
heart	O
:	O
Normal	B-labvalue

Assessment	O
Lymphadenopathy	O
785	O
.	O
6	O

;	O
Dec	B-temporal
30	I-temporal
2013	I-temporal
3	B-temporal
:	I-temporal
56PM	I-temporal
(	O
Author	O
)	O

Occlusive	O
thrombus	O
is	O
noted	O
in	O
one	O
of	B-bodyloc
the	I-bodyloc
paired	I-bodyloc
peroneal	I-bodyloc
veins	I-bodyloc
,	O
the	O
posterior	O
tibial	O
vein	O
is	O
patent	O
.	O

Heart	O
sounds	O
:	O
normal	B-labvalue
S1	O
,	O
normal	B-labvalue
S2	O
,	O
no	B-negation
S3	O
and	O
no	B-negation
S4	O
.	O

No	B-negation
pitting	O
edema	O
or	O
varicosities	O
in	O
the	O
lower	B-bodyloc
extremities	I-bodyloc
.	O

Psychiatric	O
:	O
normal	O
,	O
no	B-negation
anxiety	O
,	O
no	B-negation
depression	O
and	O
no	B-negation
emotional	O
problems	O
.	O

Gait	O
:	O
the	O
gait	O
and	O
station	O
were	O
normal	O
.	O

Optic	O
Disc	O
:	O
Normal	O
.	O

Overall	O
feels	O
improved	O
;	O
although	O
still	O
with	O
frontal	B-bodyloc
pressure	O
.	O

CBGs	O
usually	O
80s	B-labvalue
to	I-labvalue
140s	I-labvalue
.	O

Vaccines	O
Prophylactic	O
Need	O
Against	O
Influenza	O
V04	O
.	O
81	O

Amitriptyline	O
HCl	O
75	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
2	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Status	O
:	O
ACTIVE	O

Cranial	O
nerves	O
:	O
Cranial	O
nerves	O
II	O
-	O
XII	O
intact	O
.	O

Postpartum	O
:	O
for	O
postpartum	O
check	O
in	O
4	B-temporal
weeks	I-temporal
.	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
,	O
no	B-negation
cough	O
,	O
no	B-negation
shortness	O
of	O
breath	O
during	O
exertion	O
,	O
no	B-negation
orthopnea	O
and	O
no	B-negation
PND	O
.	O

[	O
QLH	O
]	O
Differential	O
Done	O
:	O
18Dec2012	B-temporal
11	B-temporal
:	I-temporal
30AM	I-temporal

Ganglion	O
Of	O
The	O
Hand	B-bodyloc
727	O
.	O
42	O

Lymphatic	O

Description	O
of	O
patient	O
'	O
s	O
judgement	O
and	O
insight	O
:	O
Normal	B-labvalue
.	O

(	O
unable	O
to	O
fully	O
articulate	O
words	O
,	O
uses	O
a	O
voice	O
writer	O
)	O

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

MUSCULOSKELETAL	O
:	O
No	B-negation
back	B-bodyloc
pain	O
.	O

Exacerbating	O
factors	O
:	O
not	O
exacerbated	O
by	O
stress	O
,	O
not	O
exacerbated	O
by	O
fatigue	O
and	O
not	O
exacerbated	O
by	O
weight	O
gain	O
.	O

The	O
nasal	O
mucosa	O
was	O
normal	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O
Significant	O
for	O
diabetes	O
,	O
hypertension	O
,	O
asthma	O
,	O
cholecystectomy	O
,	O
and	O
total	O
hysterectomy	O
and	O
cataract	O
.	O

Cholesterol	O
,	O
Total	O
:	O
225	B-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue
Abnormal	O
High	O
Reference	O
Range	O
100	B-reference_range
-	I-reference_range
199	I-reference_range

Physical	O
Exam	O

Frontal	O
sinuses	O
:	O
non	O
-	O
tender	O
on	O
the	O
right	O
and	O
non	O
-	O
tender	O
on	O
the	O
left	O
.	O

Neck	B-bodyloc
No	B-negation
SC	O
fat	O
pad	O
;	O
No	B-negation
CLA	O
.	O
Thyroid	O
is	O
15	O
gm	O
;	O
no	B-negation
palpable	O
mass	O
.	O

She	O
denies	B-negation
any	O
recent	B-temporal
MRIs	O
.	O

Current	O
Meds	O
No	O
Reported	O
Medications	O

Viagra	O
100	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
/	I-dosage
2	I-dosage
to	I-dosage
1	I-dosage
TABLET	B-form
AS	O
NEEDED	O
>	O
;	O
Therapy	O
:	O
14Oct2013	B-temporal
to	O
(	O
Complete	O
:	O
19Nov2013	B-temporal
)	O
Requested	O
for	O
:	O
14Oct2013	B-temporal
;	O
Last	O
Rx	O
:	O
14Oct2013	B-temporal
;	O
Edited	O

Birth	O
Weight	O
:	O
4lbs	B-labvalue
,	I-labvalue
3oz	I-labvalue

PROTEIN	O
:	O
NEG	B-labvalue

Maternal	O
history	O
of	O
Stroke	O
Syndrome	O
V17	O
.	O
1	O

T4	O
Free	O
0	B-labvalue
.	I-labvalue
76	I-labvalue
ng	I-labvalue
/	I-labvalue
dl	I-labvalue
0	B-reference_range
.	I-reference_range
76	I-reference_range
-	I-reference_range
1	I-reference_range
.	I-reference_range
46	I-reference_range

UTP	O
-	O
Headache	O
,	O
The	O
patient	O
is	O
being	O
seen	O
for	O
an	O
initial	O
evaluation	O
of	O
an	O
existing	O
diagnosis	O
of	O
migraine	O
headache	O
.	O

Weight	O
Comments	O
:	O
Reported	O

Hypothyroidism	O
244	O
.	O
9	O

Pantoprazole	O
Sodium	O
40	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
Delayed	I-form
Release	I-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
13Oct2010	B-temporal
)	O
to	O

Sample	O
Type	O
/	O
Medical	O
Specialty	O
:	O
Discharge	O
Summary	O

The	O
right	O
tympanic	O
membrane	O
was	O
normal	O
.	O

Op	O
.	O

ADMISSION	O
DIAGNOSIS	O
:	O
Symptomatic	O
thyroid	B-bodyloc
goiter	O
.	O

0	I-reference_range
TSH	O
3	B-labvalue
.	I-labvalue
940	I-labvalue
uIU	I-labvalue
/	I-labvalue
mL	I-labvalue
0	B-reference_range
.	I-reference_range
450	I-reference_range
-	I-reference_range
4	I-reference_range
.	I-reference_range
500	I-reference_range

History	O
of	O
Hypertension	O
401	O
.	O
9	O

Postmenopausal	B-bodyloc
Osteoporosis	O
733	O
.	O
01	O

Allergies	O
1	O
.	O

Time	O
spent	O
in	O
counseling	O
and	O
/	O
or	O
coordination	O
of	O
care	O
for	O
this	O
patient	O
this	O
time	O
was	O
greater	O
than	O
50	O
%	O
of	O
the	O
visit	O
.	O

Abdominal	O
aorta	O
:	O
Normal	O

Carotid	O
Arteries	O
:	O
Normal	B-labvalue
.	O

UTP	O
-	O
Discussion	O
/	O
1	O
.	O

left	O
ring	O
finger	O
radial	O
and	O
ulnar	O
digital	O
nerve	O
repair	O
x2	O
8	O
.	O

Eyes	O
:	O
no	B-negation
eye	B-bodyloc
pain	O
,	O
eyes	B-bodyloc
not	B-negation
red	O
,	O
no	B-negation
eyesight	O
problems	O
,	O
no	B-negation
purulent	O
discharge	O
from	O
the	O
eyes	B-bodyloc
,	O
no	B-negation
dryness	O
of	O
the	O
eyes	B-bodyloc
and	O
no	B-negation
itching	O
of	O
the	O
eyes	B-bodyloc
.	O

Symptoms	O
:	O
cough	O
,	O
but	O
no	B-negation
hemoptysis	O
,	O
no	B-negation
dyspnea	O
,	O
no	B-negation
wheezing	O
,	O
no	B-negation
nasal	B-bodyloc
congestion	O
,	O
no	B-negation
rhinorrhea	O
,	O
no	B-negation
postnasal	B-bodyloc
drainage	O
,	O
no	B-negation
sore	O
throat	B-bodyloc
,	O
no	B-negation
hoarseness	O
,	O
no	B-negation
foul	O
taste	O
in	O
mouth	B-bodyloc
,	O
no	B-negation
dysphagia	O
,	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
heartburn	O
,	O
no	B-negation
fever	O
and	O
no	B-negation
night	O
sweats	O

Genitourinary	O

Carvedilol	O
12	B-strength
.	I-strength
5	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Therapy	O
:	O
17Apr2013	B-temporal
to	O

Musculoskeletal	O

Associated	O
symptoms	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
claudication	O
,	O
no	B-negation
near	O
syncope	O
,	O
no	B-negation
syncope	O
,	O
no	B-negation
weakness	O
,	O
no	B-negation
paresthesias	O
and	O
no	B-negation
edema	O
.	O

Anesthesia	O
:	O
Topical	B-route
lidocaine	O
spray	B-form
and	O
Topical	B-route
oxymetazoline	O
spray	B-form
.	O

Inspection	O
of	O
breasts	O
:	O
Normal	B-labvalue

Denies	B-negation
any	O
headaches	O
,	O
visual	O
changes	O
,	O
nose	B-bodyloc
bleeds	O
,	O
hearing	O
loss	O
,	O
double	O
vision	O
,	O
unilateral	O
weakness	O
or	O
numbness	O
,	O
neck	B-bodyloc
pain	O
,	O
locked	O
jaw	B-bodyloc
,	O
difficulty	O
chewing	O
,	O
or	O
other	O
concerns	O
.	O

Date	O
of	O
Birth	O
:	O
[	O
*	O
*	O
2045-5-15	B-temporal
*	O
*	O
]	O
Sex	O
:	O
M	O

He	O
is	O
accompan	O
ed	O
by	O
his	O
mother	O
today	O
,	O
who	O
acts	O
as	O
primary	O
historian	O
.	O

Left	O
Quadriceps	O
.	O

Hypothyroidism	O
244	O
.	O
9	O

First	O
pregnancy	O
:	O

dissection	O
of	O
dorsal	O
vein	O
for	O
vein	O
graft	O
harvest	O

Diastolic	O
:	O
70	B-labvalue
,	O
RUE	O
,	O
Sitting	O

Palpation	O
of	O
the	O
face	O
for	O
sinus	B-bodyloc
tenderness	O
:	O
No	B-negation
maxillary	B-bodyloc
tenderness	O
.	O

Abdomen	B-bodyloc
:	O
Abnormal	O
.	O
Soft	O
,	O
obese	O
,	O
nontender	O
,	O
2	O
cm	O
x	O
2cmx	O
1	O
cm	O
periumbilical	B-bodyloc
defect	O
-	O
packed	O
with	O
wet	O
to	O
dry	O
and	O
lower	O
incision	O
pole	O
5	O
mm	O
superficial	O
separation	O
packed	O
iwth	O
iodoform	O
wick	O
.	O

His	O
muscle	O
biopsy	O
showed	O
little	O
inflammation	O
with	O
several	O
necrotic	O
fibers	O
.	O

[	O
QLH	O
]	O
CBC	O
(	O
INCLUDES	O
DIFF	O
/	O
PLT	O
)	O
Requested	O
for	O
:	O
26Nov2012	B-temporal

breast	B-bodyloc
symptoms	O
Patient	O
does	O
not	B-negation
have	I-negation
a	O
history	O
of	O
a	O
positive	O
pap	O
smear	O
.	O

;	O
Jan	B-temporal
28	I-temporal
2013	I-temporal
1	B-temporal
:	I-temporal
52PM	I-temporal
(	O
Author	O
)	O

Respiration	O
:	O
18	B-labvalue

keratosis	O
pilaris	O
.	O

Never	O
A	O
Smoker	O

Inspection	O
of	O
the	O
nasal	O
mucosa	O
,	O
septum	O
and	O
turbinates	O
:	O
Normal	B-labvalue
.	O

History	O
of	O
Osteoarthritis	O
V13	O
.	O
4	O

Penicillins	O

Subacromial	O
Bursitis	O
On	O
The	O
Left	O
726	O
.	O
19	O

Thyroid	O
:	O
Normal	O
.	O

History	O
of	O
Dyslipidemia	O
272	O
.	O
4	O

Voltaren	O
1	B-strength
%	I-strength
Transdermal	B-route
Gel	B-form
;	O
APPLY	O
SPARINGLY	B-frequency
TO	O
AFFECTED	O
AREA	O
(	O
S	O
)	O
TWICE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
13Nov2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
13Nov2013	B-temporal
)	O
Requested	O
for	O
:	O
13Nov2013	B-temporal

no	O
f	O
/	O
c	O
.	O
no	B-negation
cong	O
or	O
drainage	O
.	O

Social	O
History	O
:	O

Palpation	O
of	O
the	O
face	O
for	O
sinus	B-bodyloc
tenderness	O
:	O
No	B-negation
maxillary	B-bodyloc
tenderness	O
.	O

Right	O
Post	O
.	O

Losartan	O
Potassium	O
-	O
HCTZ	O
100	B-strength
-	I-strength
12	I-strength
.	I-strength
5	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
03Feb2014	B-temporal
to	O
(	O
Evaluate	O
:	O
04May2014	B-temporal
)	O
Requested	O
for	O
:	O
03Feb2014	B-temporal
;	O
Last	O
Rx	O
:	O
03Feb2014	B-temporal
;	O
Status	O
:	O

f	O
/	O
u	O
in	O
2	O
weeks	O
with	O
Reddy	O
or	O
Ingram	O

At	O
this	O
point	O
,	O
we	O
will	O
follow	O
her	O
symptoms	O
clinically	O
.	O

Range	O
of	O
Motion	O
:	O
Full	O
.	O

GroupHeading6End	O
GroupHeading7Start	O
GroupHeading7End	O
GroupHeading8Start	O
GroupHeading8End	O
GroupHeading9Start	O
GroupHeading9End	O
GroupHeading10Start	O
GroupHeading10End	O
GroupHeading15Start	O
Neck	O
Examinatisp	O
of	O
the	O
neck	O
:	O
Normal	B-labvalue
The	O
neck	O
was	O
supple	O
.	O

f	O
Hyperlipidemia	O
(	O
272	O
.	O
4	O
)	O
;	O
(	O
Active	O
)	O

Throat	O
,	O
Neck	O
,	O
and	O
Back	O
Neck	O
:	O
Normal	O
.	O

Pancytopenia	O
.	O

Rhythm	O
Disorder	O
427	O
.	O
9	O

Pulse	O
oximetry	O
*	O
%	O
.	O

Diphenoxylate	O
-	O
Atropine	O
TABS	B-form
;	O
TAKE	O
TABLET	B-form
PRN	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
24Sep2013	B-temporal
)	O
to	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
axillae	O
:	O
Normal	B-labvalue
.	O

History	O
of	O
Nasal	B-bodyloc
Polyps	O
471	O
.	O
9	O

Her	O
symptoms	O
are	O
caused	O
by	O
no	O
known	O
event	O
.	O

SocialHistisy	O
_	O
10	O
_	O
twCiteListControlEnd	O
SocialHistisySectispEnd	O
ReviewofSystemsSectispStart	O
Review	O
of	O
Systems	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
,	O
no	B-negation
syncope	O
and	O
no	B-negation
edema	O
.	O

Anemia	O
285	O
.	O
9	O

UTP	O
-	O
OB	O
/	O
Patient	O
here	O
for	O
pelvic	B-bodyloc
pain	O
.	O

Duet	O
DHA	O
Balanced	O
27	B-strength
-	I-strength
1	I-strength
&	I-strength
430	I-strength
MG	I-strength
MISC	O
;	O
Take	O
1	B-dosage
tab	B-form
daily	B-frequency
;	O
Therapy	O
:	O
24Jan2012	B-temporal
to	O
(	O
Evaluate	O
:	O
23May2012	B-temporal
)	O
;	O
Last	O
Rx	O
:	O
24Jan2012	B-temporal

Orientation	O
to	O
person	O
,	O
place	O
and	O
time	O
:	O
Normal	B-labvalue
.	O

Abdomen	O
:	O
Normal	O
.	O

Hypercholesterolemia	O
272	O
.	O
0	O

No	B-negation
bronchial	B-bodyloc
breath	I-bodyloc
sounds	O
were	O
heard	O
.	O

Prior	O
pregnancies	O
:	O
.	O

Vitals	O
02Jul2012	B-temporal
09	B-temporal
:	I-temporal
37AM	I-temporal
BMI	O
Calculated	O
23	B-labvalue
.	I-labvalue
45	I-labvalue
BSA	O
Calculated	O
1	B-labvalue
.	I-labvalue
67	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
4	I-labvalue
in	I-labvalue
Weight	O
137	B-labvalue
lb	I-labvalue
6	I-labvalue
oz	I-labvalue
Systolic	O
110	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
74	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Temperature	O
98	B-labvalue
.	I-labvalue
2	I-labvalue
F	I-labvalue
,	O
Oral	O
Heart	O
Rate	O
78	B-labvalue
,	O
L	O
Radial	O
Pulse	O
Quality	O
Normal	B-labvalue
,	O
L	O
Radial	O
Respiration	O
18	B-labvalue
Respiration	O
Quality	O
Normal	B-labvalue
LMP	O
meno	O

Plan	O
Lidoderm	O
5	B-strength
%	I-strength
External	B-form
Patch	I-form
;	O
APPLY	O
AS	O
DIRECTED	O
.	O

He	O
also	O
does	O
not	O
keep	O
up	O
on	O
his	O
hydration	O
and	O
salt	O
rebrriction	O
.	O

Vitals	O
UTP	O
Adult	O
Vital	O
Signs	O
[	O
Data	O
Includes	O
:	O
Current	O
Encounter	O
]	O
07Sep2012	B-temporal
11	B-temporal
:	I-temporal
42AM	I-temporal
BMI	O
Calculated	O
:	O
26	B-labvalue
.	I-labvalue
52	I-labvalue
BSA	O
Calculated	O
:	O
1	B-labvalue
.	I-labvalue
66	I-labvalue
Weight	O
:	O
144	B-labvalue
lb	I-labvalue
2	I-labvalue
oz	I-labvalue
Systolic	O
:	O
133	B-labvalue
Diastolic	O
:	O
79	B-labvalue
Heart	O
Rate	O
:	O
69	B-labvalue

[	O
QLH	O
]	O
CBC	O
(	O
INCLUDES	O
DIFF	O
/	O
PLT	O
)	O
Requested	O
for	O
:	O
13Nov2012	B-temporal

Family	O
History	O
Fraternal	B-subject
history	O
of	O
Heart	B-bodyloc
Disease	O
V17	O
.	O
49	O

Motor	O
Strength	O
:	O
motor	O
strength	O
was	O
normal	B-labvalue
in	O
all	O
muscle	O
groups	O
.	O

ASSESSMENT	O
AND	O
PLAN	O
:	O
Mr	O
.	O

Patient	O
agrees	O
to	O
proceed	O
.	O

Episodes	O
started	O
2	B-temporal
months	I-temporal
ago	I-temporal
.	O

Baby	O
is	O
doing	O
well	O
and	O
was	O
present	O
at	O
this	O
appointment	O
.	O

CT	O
chest	O
:	O
2	O
.	O
5mm	O
solitary	O
nodule	O
in	O
left	B-bodyloc
apex	I-bodyloc

Urinalysis	O
:	O
2/25/14	B-temporal

Pupils	O
were	O
equal	O
in	O
size	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
.	O

Sore	O
Throat	B-bodyloc

Abnormal	O
ECG	O
:	O

She	O
also	O
has	O
a	O
history	O
of	O
HSV	O
,	O
last	O
outbreak	O
>	B-temporal
1	I-temporal
year	I-temporal
ago	I-temporal
.	O

1	B-dosage
Influenza	O
Approx	O
06Oct2012	B-temporal
Pneumococcal	O
Approx	O
06Nov2011	B-temporal
Td	O
/	O
DT	O
Approx	O
06Nov2004	B-temporal

Endocrine	O
:	O
muscle	O
weaknessandfeelings	O
of	O
weakness	O
.	O

Current	O
Meds	O
CloNIDine	O
HCl	O
0	B-strength
.	I-strength
1	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
21Feb2013	B-temporal
)	O
to	O

No	B-negation
murmurs	O
were	O
heard	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O
Left	O
lower	O
extremity	O
is	O
examined	O
.	O

Otoscopic	O
examination	O
:	O
Normal	B-labvalue
.	O

Examination	O
of	O
the	O
abdomen	O
:	O
Abnormal	O
The	O
abdomen	B-bodyloc
was	O
obese	O
.	O

Assessment	O
_	O
80	O
_	O
twCiteListControlStart	O
Menses	O
Abnoamal	O
626	O
.	O
9	O

Conjunctiva	O
and	O
lids	O
:	O
No	B-negation
swelling	O
,	O
erythema	O
or	O
discharge	O
.	O

The	O
trachea	O
was	O
midline	O
.	O

Hip	B-bodyloc
Pain	O

No	B-negation
erythema	O
,	O
warmth	O
or	O
evidence	O
of	O
infection	O
.	O

The	O
patient	O
has	O
no	O
concerns	O
about	O
alcohol	O
abuse	O
.	O

Recent	O
and	O
remote	O
memory	O
:	O
Normal	B-labvalue
.	O

Bowel	O
sounds	O
were	O
normal	B-labvalue
.	O

Senile	O
Dementia	O
290	O
.	O
0	O

Blood	O
pressure	O
control	O
has	O
been	O
good	O
.	O

Cardiovascular	O

Nitrostat	O
0	B-strength
.	I-strength
4	I-strength
MG	I-strength
Sublingual	B-route
Tablet	B-form
Sublingual	B-route
;	O
PLACE	O
1	B-dosage
TABLET	B-form
UNDER	B-route
THE	I-route
TONGUE	I-route
EVERY	B-frequency
5	I-frequency
MINUTES	I-frequency
FOR	O
UP	O
TO	O
3	B-dosage
DOSES	O
AS	O
NEEDED	O
FOR	O
CHEST	B-bodyloc
PAIN	O
.	O
CALL	O
911	O
IF	B-condition
PAIN	O
PERSISTS	O
;	O
Therapy	O
:	O
05Sep2012	B-temporal
to	O

Discontinue	O
norco	O
and	O
valium	O
and	O
switch	O
to	O
ove	O
rthe	O
caounter	O
ibuprofen	O
as	B-frequency
needed	I-frequency
as	O
directed	O
.	O

EYES	O
:	O
no	B-negation
double	O
vision	O
and	O
no	B-negation
blurred	O
vision	O
.	O

Musculoskeletal	O

Citalopram	O
Hydrobromide	O
20	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
ONE	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
ONE	B-frequency
TIME	I-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
30Jan2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
13Jan2014	B-temporal
)	O
Requested	O
for	O
:	O
13Jan2014	B-temporal
4	O
.	O

Uterus	O
:	O
Absent	O
.	O

-	O
No	B-negation
lymphovascular	O
invasion	O
is	O
identified	O
.	O

Involuntary	O
Movements	O
:	O
no	B-negation
involuntary	O
movements	O
were	O
seen	O
.	O

Gynecologic	O
Services	O
Intrauterine	O
Device	O
(	O
IUD	O
)	O
Insertion	O
V25	O
.	O
11	O

Associated	O
symptoms	O
include	O
no	B-negation
headache	O
,	O
no	O
focal	O
neurologic	O
deficitsandno	O
memory	O
loss	O
.	O

Phenytoin	O
Sodium	O
Extended	O
100	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
6	B-dosage
CAPSULE	B-form
TWICE	B-frequency
DAILY	I-frequency
Requested	O
for	O
:	O
17Nov2011	B-temporal
;	O
Last	O
Rx	O
:	O
17Nov2011	B-temporal

The	O
patient	O
presents	O
with	O
complaints	O
of	O
cough	O
(	O
just	O
finished	O
a	O
dose	O
of	O
amoxicillin	O
to	O
get	O
ready	O
for	O
dental	O
work	O
)	O
.	O

The	O
conjunctiva	O
were	O
normal	O
in	O
both	O
eyes	O
.	O

Reason	O
For	O
Visit	O

History	O
of	O
Present	O
Illness	O
The	O
patient	O
is	O
being	O
seen	O
for	O
a	O
routine	O
clinic	O
follow	O
-	O
up	O
.	O

Current	O
Meds	O
Cozaar	O
100	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
24Oct2012	B-temporal
)	O
to	O

Reason	O
For	O
Visit	O

Marital	O
History	O

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

Date	O
of	O
Birth	O
:	O
02/08/2013	B-temporal
.	O

Coordination	O
:	O
Normal	B-labvalue
.	O

Heart	O
sounds	O
:	O
normal	B-labvalue
S1	O
,	O
normal	B-labvalue
S2	O
,	O
no	B-negation
S3	O
and	O
no	B-negation
S4	O
.	O

Family	B-subject
history	O
of	O
Ovarian	B-bodyloc
Cancer	O

Surgical	O
History	O
History	O
of	O
Complete	O
Colonoscopy	O
For	O
Polyp	O
Removal	O

She	O
still	O
has	O
been	O
getting	O
P	O
.	O
T	O
.	O

Eyelids	O
:	O
There	O
was	O
blepharitis	O
of	O
both	B-bodyloc
upper	I-bodyloc
eyelids	O
,	O
blepharitis	O
of	O
both	B-bodyloc
lower	I-bodyloc
eyelids	O

Cardiovascular	O
Peripheral	O
vascular	O
exam	O
:	O
Normal	B-labvalue

Hematologic	O
/	O
Lymphatic	O
:	O
a	O
tendency	O
for	O
easy	O
bruising	O
.	O

Examination	O
of	O
urethra	O
:	O
Normal	B-labvalue

CARDIOVASCULAR	O
:	O
No	B-negation
jugular	B-bodyloc
venous	I-bodyloc
distention	O
or	O
carotid	B-bodyloc
bruits	O
.	O

Paternal	B-subject
grandfather	I-subject
'	I-subject
s	I-subject
history	O
of	O
Renal	B-bodyloc
Failure	O

Open	O
Wound	O
Of	O
The	O
Lip	B-bodyloc
873	O
.	O
43	O

0	I-reference_range
Eosinophils	O
5	B-labvalue
.	I-labvalue
8	I-labvalue
%	I-labvalue
H	B-labvalue
0	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
4	I-reference_range
.	I-reference_range

Description	O
of	O
patient	O
'	O
s	O
judgement	O
and	O
insight	O
:	O
Normal	B-labvalue

Palpation	O
of	O
breasts	O
and	O
axillae	O
:	O
Normal	B-labvalue
No	B-negation
masses	O
palpated	O
in	O
the	O
right	B-bodyloc
breast	I-bodyloc
.	O

Assessment	O
Chronic	B-course
Ethmoidal	B-bodyloc
Sinusitis	O
473	O
.	O
2	O

PAST	O
SURGICAL	O
HISTORY	O
:	O
Looking	O
at	O
the	O
medical	O
chart	O
,	O
she	O
had	O
an	O
appendectomy	O
,	O
right	B-bodyloc
hip	I-bodyloc
fracture	O
from	O
a	O
fall	O
in	O
2005	O
,	O
and	O
TAH	O
/	O
BSO	O
.	O

Psychiatric	O
:	O
normal	O
.	O

No	B-negation
mass	O
.	O

Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

Neuro	O
:	O
no	B-negation
numbness	O
,	O
no	B-negation
tremor	O
was	O
seen	O
,	O
no	B-negation
tingling	O
,	O
no	B-negation
seizures	O
were	O
observed	O
,	O
gait	O
is	O
steady	B-labvalue
and	O
no	B-negation
dizziness	O
.	O

Codeine	O
Derivatives	O

Ears	O
are	O
normal	O
bilaterally	O
without	O
any	O
sign	O
of	O
infection	O
.	O

Signature	O
g36	O

R	O
:	O
present	O
TEOAES	O
with	O
large	O
volume	O
consistent	O
with	O
patent	O
tubes	O

PriLOSEC	O
20	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
Delayed	I-form
Release	I-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
24Oct2012	B-temporal
)	O
to	O

Test	O
Name	O
Result	O
Flag	O
Reference	O

Current	O
Meds	O
Allopurinol	O
300	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
ONE	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
EVERY	B-frequency
DAY	I-frequency
;	O
Therapy	O
:	O
06Jul2013	B-temporal
to	O
(	O
Evaluate	O
:	O
04Oct2013	B-temporal
)	O
Requested	O
for	O
:	O
06Jul2013	B-temporal
;	O
Last	O
Rx	O
:	O
06Jul2013	B-temporal

No	B-negation
Known	O
Drug	O
Allergies	O

Cranial	O
nerves	O
XI	O
:	O
shoulder	O
shrug	O
was	O
intact	B-labvalue
bilaterally	I-labvalue
.	O

Denied	O

Bowel	O
sounds	O
were	O
normal	B-labvalue
.	O

Symptoms	O
:	O
Denies	B-negation
numbness	O
of	O
the	O
feet	B-bodyloc
,	O
denies	B-negation
a	O
foot	B-bodyloc
ulcer	O
,	O
denies	B-negation
foot	B-bodyloc
pain	O
,	O
denies	B-negation
vomiting	O
and	O
denies	B-negation
visual	O
impairment	O
.	O

Respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

Left	O
radical	O
nephrectomy	O
.	O

TSI	O
ENDOSCOPY	O
.	O

BMI	O
Calculated	O
:	O
38	B-labvalue
.	I-labvalue
98	I-labvalue

Neurological	O
:	O
no	B-negation
dizziness	O
and	O
no	B-negation
fainting	O
.	O

History	O
of	O
Present	O
Illness	O

)	O
PO	B-route
Q24H	B-duration
(	I-duration
every	I-duration
24	I-duration
hours	I-duration
)	I-duration
.	O

Complete	O
-	O
Female	O

Mean	O
Cell	O
Hemoglobin	O
Concentration	O
(	O
for	O
H	O
&	O
H	O
)	O
:	O
32	B-labvalue
.	I-labvalue
6	I-labvalue
g	I-labvalue
/	I-labvalue
dl	I-labvalue
Reference	O
Range	O
32	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
36	I-reference_range
.	I-reference_range
0	I-reference_range

I	O
examined	O
and	O
discussed	O
the	O
patient	O
with	O
the	O
resident	O
and	O
agree	O
with	O
the	O
above	O
findings	O
,	O
assessment	O
and	O
plan	O
in	O
the	O
resident	O
note	O
.	O

Hypertension	O
401	O
.	O
9	O

[	O
Q	O
]	O
SUREPATH	O
PAP	O
Requested	O
for	O
:	O
25Feb2014	B-temporal

Examination	O
of	O
reflexes	O
:	O
Normal	B-labvalue
.	O

Eyes	O

Hydrocodone	O
-	O
Acetaminophen	O
7	B-strength
.	I-strength
5	I-strength
-	I-strength
500	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
TABLET	B-form
3	B-frequency
TIMES	I-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
22Sep2006	B-temporal
to	O
(	O
Evaluate	O
:	O
21Jan2014	B-temporal
)	O
Requested	O
for	O
:	O
28Jul2013	B-temporal
;	O
Last	O
Rx	O
:	O
25Jul2013	B-temporal

Patient	O
requires	O
the	O
use	O
of	O
a	O
wheelchair	O
for	O
mobility	O
.	O

26	O
yo	O
F	O
with	O
PMH	O
of	O
SLE	O
here	O
for	O
f	O
/	O
u	O
and	O
complaints	O
of	O
diarrhea	O
.	O

Previous	B-temporal
Surgery	O
:	O
Yes	O
.	O

Patient	O
says	O
it	O
occurs	O
everyday	B-temporal
,	O
and	O
may	O
last	B-temporal
for	I-temporal
two	I-temporal
hours	I-temporal
.	O

She	O
is	O
sexually	O
active	O
.	O

Cranial	O
Nerves	O
IX	O
and	O
X	O
:	O
there	O
was	O
normal	B-labvalue
movement	O
of	O
the	O
soft	O
palate	O
and	O
normal	O
gag	O
.	O

Orientation	O
to	O
person	O
,	O
place	O
and	O
time	O
:	O
Normal	B-labvalue

The	O
sensory	O
exam	O
showed	O
normal	B-labvalue
vibratory	O
sensation	O
at	O
the	O
level	O
of	O
the	O
toes	O
.	O

Results	O
/	O
Assessment	O
Abnormal	O
Liver	B-bodyloc
Function	O
Test	O
790	O
.	O
6	O

Abdominal	O
aorta	O
:	O
Normal	B-labvalue
.	O

History	O
of	O
Present	O
Illness	O
restrained	O
Driver	O
stopped	O
@	O
light	O
and	O
was	O
rear	O
-	O
ended	O
@	O
~	O
80	O
MPH	O
,	O
No	O
airbaig	O
deployment	O
12	B-temporal
/	I-temporal
25	I-temporal
@	O
6	B-temporal
:	I-temporal
30	I-temporal

follow	O
up	O
on	O
BP	O
,	O
and	O
cold	O
and	O
cough	O

Spent	O
15	O
/	O
25	O
discussing	O
her	O
regimen	O
;	O
MNT	O

[	O
QLH	O
]	O
LIPID	O
PANEL	O
Requested	O
for	O
:	O
23Feb2011	B-temporal

Her	O
total	O
cholesterol	O
is	O
increasing	B-labvalue
and	O
triglycerides	O
are	O
increasing	B-labvalue
.	O

Integumentary	O
:	O
no	B-negation
skin	B-bodyloc
lesions	O
.	O

Patient	O
did	O
not	O
get	O
the	O
license	O
plate	O
number	O
and	O
did	O
not	O
know	O
the	O
person	O
,	O
patient	O
was	O
seen	O
in	O
the	O
Priority	O
Emergency	O
Room	O
evaluated	O
,	O
head	O
and	O
face	O
CT	O
showed	O
no	B-negation
fractures	O
or	O
other	O
acute	B-course
findings	O
.	O

Cervical	O
Spine	O
:	O
Normal	O
(	O
showed	O
no	B-negation
tenderness	O
on	O
palpation	O
)	O
.	O

Past	O
Medical	O
History	O
History	O
of	O
Constipation	O
564	O
.	O
00	O

Medications	O
:	O
the	O
patient	O
is	O
not	O
adherent	O
to	O
his	O
medication	O
regimen	O
(	O
Has	O
been	O
taking	O
3	B-frequency
times	I-frequency
/	I-frequency
week	I-frequency
for	O
the	B-temporal
last	I-temporal
month	I-temporal
because	O
of	O
symptoms	O
of	O
lightheadedness	O
and	O
nausea	O
.	O

ACTIVE	O
-	O
Retrospective	O
Authorization	O

Eustachian	O
tube	O
opening	O
normal	O
.	O

PNV	O

Progesterone	O
Micronized	O
100	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
BEDTIME	B-frequency
;	O
Therapy	O
:	O
03Sep2013	B-temporal
to	O
(	O
Evaluate	O
:	O
14Nov2014	B-temporal
)	O
Requested	O
for	O
:	O
17Feb2014	B-temporal
;	O
Last	O
Rx	O
:	O
17Feb2014	B-temporal
;	O
Edited	O

CARDIOVASCULAR	O
:	O
Heart	O
is	O
regular	B-labvalue
rate	O
and	O
rhythm	O
without	B-negation
murmur	O
,	O
rub	O
,	O
or	O
gallop	O
.	O

Co	O
Q	O
10	O
CAPS	O
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
03Nov2011	B-temporal
)	O
to	O

The	O
patient	O
is	O
unable	O
to	O
state	O
whether	O
or	O
not	O
she	O
has	O
episodes	O
of	O
loss	O
of	O
time	O
.	O

Psych	O
not	B-negation
feeling	O
nervous	O
,	O
no	B-negation
anxiety	O
,	O
no	O
depressionand	O
no	B-negation
hallucinations	O
.	O

Pregnancy	O
V22	O
.	O
2	O

Rx	O
:	O
03Jan2013	B-temporal
;	O
Status	O
:	O
ACTIVE	O
-	O
Retrospective	O
Authorization	O

Pulses	O
:	O
2	O
+	O
in	O
the	O
posterior	O
tibialis	O
and	O
2	O
+	O
in	O
the	O
dorsalis	O
pedis	O
.	O

Gestational	O
age	O
:	O
12	O
weeks	O
.	O

Review	O
of	O
Systems	O

Pupils	O
were	O
equal	O
in	O
size	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
.	O

Social	O
History	O
Alcohol	O
Use	O

Examination	O
of	O
the	O
palate	O
showed	O
no	B-negation
abnormalities	O
.	O

The	O
baby	O
'	O
s	O
name	O
is	O
Omarie	O
Charles	O
.	O

Centrum	O
Ultra	O
Womens	O
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
15Apr2013	B-temporal
to	O
(	O
Evaluate	O
:	O
15Apr2014	B-temporal
)	O

History	O
of	O
Depression	O

Vitals	O
_	O
11189	O
_	O
twCiteListControlStart	O
29Apr2013	B-temporal
08	B-temporal
:	I-temporal
44AM	I-temporal
BMI	O
Calculated	O
46	B-labvalue
.	I-labvalue
04	I-labvalue
BSA	O
Calculated	O
2	B-labvalue
.	I-labvalue
38	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
7	I-labvalue
in	I-labvalue
Weight	O
293	B-labvalue
lb	I-labvalue
6	I-labvalue
oz	I-labvalue
Systolic	O
132	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
86	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Temperature	O
97	B-labvalue
.	I-labvalue
9	I-labvalue
F	I-labvalue
,	O
Oral	O
Heart	O
Rate	O
72	B-labvalue
,	O
L	O
Radial	O
Pulse	O
Quality	O
Normal	B-labvalue
,	O
L	O
Radial	O
Respiratisp	O
16	B-labvalue
Respiratisp	O
Quality	O
Normal	B-labvalue
Vitals	O
_	O
11189	O
_	O
twCiteListControlEnd	O
VitalsSectispEnd	O
ChiefComplaintSectispStart	O
Chief	O
Complaint	O
Patient	O
is	O
here	O
to	O
see	O
Dr	O
.	O
Reddy	O
fis	O
bloodwork	O
order	O
and	O
acid	O
reflex	O
ChiefComplaint	O
_	O
90	O
_	O
twCiteListControlStart	O

Musculoskeletal	O
:	O
arthralgias	O
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

SPECIFIC	O
GRAVITY	O
1	B-labvalue
.	I-labvalue
020	I-labvalue
O	O

twNoteSignatureControlEnd	O
SignaturesSectispEnd	O

May	O
repeat	O

Chief	O
Complaint	O

.	O

Gynecologic	O
Services	O
Contraceptive	O
Management	O
V25	O
.	O
9	O

Examination	O
of	O
the	O
abdomen	O
:	O
Normal	B-labvalue
.	O

Never	O
Drank	O
Alcohol	O

Mood	O
stable	O
.	O

Associated	O
symptoms	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
claudication	O
,	O
no	B-negation
near	O
syncope	O
,	O
no	B-negation
syncope	O
,	O
no	B-negation
weakness	O
,	O
no	O
paresthesias	O
and	O
no	B-negation
edema	O
.	O

Plan	O
Clotrimazole	O
1	B-strength
%	I-strength
External	O
Cream	B-form
;	O
APPLY	O
2	B-frequency
-	I-frequency
3	I-frequency
TIMES	I-frequency
DAILY	I-frequency
TO	O
AFFECTED	O
AREA	O
(	O
S	O
)	O
;	O
Therapy	O
:	O
21Jun2013	B-temporal
to	O
(	O
Evaluate	O
:	O
05Jul2013	B-temporal
)	O
Requested	O
for	O
:	O
21Jun2013	B-temporal
;	O
Last	O
Rx	O
:	O
21Jun2013	B-temporal
;	O
Edited	O

Upper	O
extremities	O
:	O
Normal	O
.	O
Lower	O
extremities	O
:	O
Normal	O
.	O

Williams	O
is	O
a	O
56	O
-	O
year	O
-	O
old	O
gentleman	O
with	O
right	O
footdrop	O
related	O
to	O
right	O
peroneal	O
neuropathy	O
at	O
the	O
fibular	B-bodyloc
head	I-bodyloc
.	O

Vitals	O
28Jan2013	B-temporal
01	B-temporal
:	I-temporal
25PM	I-temporal
BMI	O
Calculated	O
28	B-labvalue
.	I-labvalue
38	I-labvalue
BSA	O
Calculated	O
1	B-labvalue
.	I-labvalue
81	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
4	I-labvalue
in	I-labvalue
Weight	O
166	B-labvalue
lb	I-labvalue
4	I-labvalue
oz	I-labvalue
Systolic	O
170	B-labvalue
,	O
RUE	O
,	O
Sitting	O
Diastolic	O
60	B-labvalue
,	O
RUE	O
,	O
Sitting	O
Temperature	O
98	B-labvalue
F	I-labvalue
,	O
Oral	O
Heart	O
Rate	O
56	B-labvalue
,	O
R	O
Radial	O
Respiration	O
18	B-labvalue

Examination	O
of	O
reflexes	O
:	O
Normal	B-labvalue
.	O

Light	O
Touch	O
:	O
Sensation	O
to	O
light	O
touch	O
:	O
diminished	O
right	B-bodyloc
arm	I-bodyloc
,	O
but	O
normal	O
left	O
arm	O
.	O

Stasis	O
Dermatiis	O
b	O
.	O

This	O
occurred	O
1	B-temporal
week	I-temporal
(	I-temporal
s	I-temporal
)	I-temporal
ago	I-temporal
at	O
work	O
.	O

Urine	O
Dipstick	O
(	O
In	O
Office	O
)	O
Requested	O
for	O
:	O
16Nov2012	B-temporal

AB	O
Screen	O
:	O
Negative	B-labvalue

Current	O
Meds	O
Atorvastatin	O
Calcium	O
20	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
AS	O
DIRECTED	O
;	O
Therapy	O
:	O
23Oct2012	B-temporal
to	O
(	O
Evaluate	O
:	O
28May2013	B-temporal
)	O
Requested	O
for	O
:	O
27Feb2013	B-temporal
;	O
Last	O
Rx	O
:	O
27Feb2013	B-temporal

HSV	O

APPEARANCE	O
:	O
CLEAR	O

Constitutional	O
:	O
no	B-negation
fever	O
,	O
no	O
chillsandno	O
fatigue	O
.	O

Examination	O
of	O
external	O
genitalia	O
and	O
vagina	O
:	O
Normal	B-labvalue

No	B-negation
PIH	O
symptoms	O
.	O

MNT	O
reiterated	O
.	O

Surgical	O
History	O
History	O
of	O
Cesarean	O
Section	O

Hyperlipidemia	O
272	O
.	O
4	O

Electronically	O
signed	O
by	O
:	O
Eugene	O
Boisaubin	O
,	O
M	O
.	O
D	O
.	O

;	O
Jan	B-temporal
5	I-temporal
2012	I-temporal
10	B-temporal
:	I-temporal
42PM	I-temporal
(	O
Author	O
)	O

Restless	O
Legs	B-bodyloc
Syndrome	O
333	O
.	O
94	O

Plan	O
Montelukast	O
Sodium	O
10	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
AT	B-frequency
BEDTIME	I-frequency
;	O
Therapy	O
:	O
03Jun2013	B-temporal
to	O
(	O
Evaluate	O
:	O
02Aug2013	B-temporal
)	O
Requested	O
for	O
:	O
03Jun2013	B-temporal
;	O
Last	O
Rx	O
:	O
03Jun2013	B-temporal
;	O
Edited	O

Chief	O
Complaint	O

VitalsSectionStart	O
Vitals	O

Mean	O
Cell	O
Hemoglobin	O
30	B-labvalue
.	I-labvalue
6	I-labvalue
pg	I-labvalue
27	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
31	I-reference_range
.	I-reference_range
0	I-reference_range

GENITOURINARY	O
:	O
No	B-negation
bladder	B-bodyloc
tenderness	O
,	O
negative	B-negation
flank	B-bodyloc
pain	O
.	O

Denied	O

Endocrine	O
:	O
normal	O
.	O

Musculoskeletal	O

no	B-negation
CVA	B-bodyloc
tenderness	O
GroupHeading32End	O
GroupHeading33Start	O
GroupHeading33End	O
GroupHeading34Start	O
GroupHeading34End	O
GroupHeading35Start	O
GroupHeading35End	O
GroupHeading36Start	O
GroupHeading36End	O
GroupHeading37Start	O
GroupHeading37End	O
GroupHeading38Start	O
GroupHeading38End	O
GroupHeading39Start	O
GroupHeading39End	O
GroupHeading40Start	O
GroupHeading40End	O
GroupHeading41Start	O
GroupHeading41End	O
GroupHeading75Start	O
GroupHeading75End	O
GroupHeading76Start	O
GroupHeading76End	O
GroupHeading77Start	O
GroupHeading77End	O
GroupHeading42Start	O

Examination	O
of	O
pupils	O
and	O
irises	O
:	O
Normal	B-labvalue
.	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
.	O

Pulmonary	O
Embolism	O
415	O
.	O
19	O

Genitourinary	O
:	O
no	B-negation
dysuria	O
,	O
no	B-negation
incontinence	O
,	O
no	B-negation
urinary	O
hesitancy	O
,	O
no	B-negation
nocturia	O
,	O
no	B-negation
genital	B-bodyloc
lesions	O
and	O
no	B-negation
testicular	B-bodyloc
pain	O
.	O

URINE	O
BLOOD	O
:	O
-	O

7	O
.	O

Codeine	O
Derivatives	O

TMs	O
pearly	O
grey	O
bilaterally	O

Pulmonary	O

Involuntary	O
Movements	O
:	O
no	B-negation
involuntary	O
movements	O
were	O
seen	O
.	O

Family	O
History	O
Paternal	B-subject
grandmother	I-subject
'	I-subject
s	I-subject
history	O
of	O
Diabetes	O
Mellitus	O
V18	O
.	O
0	O

Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

Current	O
Meds	O
1	O
.	O

Surgical	O
History	O
History	O
of	O
Dilation	O
And	O
Curettage	O

Gynecological	O
Problems	O
.	O

History	O
of	O
Cath	O
Stent	O
Placement	O

Assessment	O
of	O
muscle	O
strength	O
/	O
tone	O
:	O
Normal	B-labvalue
.	O

to	O

Adnexa	O
/	O
parametria	O
:	O
Normal	O
.	O

History	O
of	O
Present	O
Illness	O

NEUROLOGIC	O
:	O
Normal	B-labvalue
Glasgow	O
Coma	O
Scale	O
.	O

[	O
QLH	O
]	O
CMP	O
W	O
/	O
EGFR	O
Requested	O
for	O
:	O
31Oct2013	B-temporal

Palpation	O
of	O
lymph	O
nodes	O
in	O
groin	O
:	O
Normal	B-labvalue
.	O

Edited	O

Testicular	O
Hydrocele	O
603	O
.	O
9	O

Plan	O
Ortho	O
Micronor	O
0	B-strength
.	I-strength
35	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
27Mar2013	B-temporal
to	O
(	O
Evaluate	O
:	O
26Mar2014	B-temporal
)	O
Requested	O
for	O
:	O
27Mar2013	B-temporal
;	O
Last	O
Rx	O
:	O
27Mar2013	B-temporal
;	O
Edited	O

Follow	O
-	O
up	O
visit	O
in	O
3	O
months	O
Outpatient	O
Follow	O
-	O
up	O
Requested	O
for	O
:	O
18Dec2013	B-temporal

Past	O
Medical	O
History	O

No	B-negation
discharge	O
.	O

Blood	O
pressure	O
*	O
,	O
pulse	O
*	O
,	O
respirations	O
*	O
,	O
temperature	O
*	O
degrees	O
F	O
.	O

Unable	O
to	O
really	O
gather	O
any	O
other	O
information	O
because	O
she	O
is	O
so	O
obtunded	O
.	O

Never	O
A	O
Smoker	O

Genitourinary	O
:	O
N	O
/	O
A	O
.	O

Active	O
Problems	O
Abdomen	B-bodyloc
Tenderness	O
Direct	O
Epigastric	B-bodyloc
789	O
.	O
66	O

Left	O
Interossei	O
(	O
uln	O
.	O
)	O
:	O
Normal	O
.	O

Pt	O
denies	O
smoking	O
,	O
Alcohol	O
or	O
illicit	O
drug	O
use	O

One	O
epidsode	O
of	O
panic	O
attack	O
on	O
11/11/2012	B-temporal
with	O
palpitation	O
and	O
sweating	O
.	O

Skin	O

Gastrointestinal	O
:	O
no	B-negation
constipation	O
,	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
nausea	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
and	O
no	B-negation
cough	O
.	O

Palpation	O
of	O
the	O
face	O
and	O
sinuses	O
:	O
Normal	B-labvalue
.	O

Red	O
Cell	O
Diameter	O
Width	O
13	B-labvalue
.	I-labvalue
4	I-labvalue
%	I-labvalue
11	B-reference_range
.	I-reference_range
5	I-reference_range
-	I-reference_range
14	I-reference_range
.	I-reference_range
5	I-reference_range

Abdomen	O

Associated	O
symptoms	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
claudication	O
,	O
no	B-negation
near	O
syncope	O
,	O
no	B-negation
syncope	O
,	O
no	B-negation
weakness	O
,	O
no	O
paresthesias	O
and	O
no	B-negation
edema	O
.	O

History	O
of	O
Total	O
Abdominal	O
Hysterectomy	O
V45	O
.	O
77	O

Nystatin	O
100000	B-strength
UNIT	I-strength
/	I-strength
GM	I-strength
External	B-route
Cream	B-form
;	O
RPT	O

Age	O
at	O
menarche	O
was	O
12	O
.	O

Appears	O
healthy	O
,	O
within	O
normal	O
limits	O
of	O
ideal	O
weight	O
,	O
well	O
hydrated	O
,	O
appearance	O
reflects	O
stated	O
ageandiusing	O
a	O
walker	O
.	O

Esophageal	B-bodyloc
Reflux	O
530	O
.	O
81	O

Physical	O
Exam	O

Chief	O
Complaint	O

Omeprazole	O
20	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
Delayed	I-form
Release	I-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
Requested	O
for	O
:	O
04Oct2013	B-temporal
;	O
Last	O
Rx	O
:	O
04Oct2013	B-temporal

First	O
pregnancy	O
:	O

Pedal	O
pulses	O
:	O
Normal	B-labvalue
.	O
Peripheral	O
vascular	O
exam	O
:	O
Normal	B-labvalue
.	O

History	O
of	O
Present	O
Illness	O
UTP	O
-	O
HM	O
,	O

Cardiovascular	O

Musculoskeletal	O
:	O
arthralgias	O
,	O
but	O
no	B-negation
joint	B-bodyloc
swelling	O
and	O
no	B-negation
limb	B-bodyloc
pain	O
.	O

Lymphatic	O

A	O
Pap	O
smear	O
was	O
performed	O
.	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
KENDRA	O
COOK	O
,	O
P	O
.	O
A	O
.	O

Right	O
Hamstrings	O
(	O
sciat	O
.	O
)	O
:	O
Normal	O
.	O

Never	O
Used	O
Drugs	O

Cranial	O
nerves	O
:	O
Normal	B-labvalue
.	O

Hematologic	O
/	O
Lymphatic	O
:	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
,	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
,	O
no	B-negation
swollen	O
glands	B-bodyloc
and	O
no	B-negation
swollen	O
glands	B-bodyloc
in	O
the	O
neck	B-bodyloc
.	O

31	O
year	O
old	O
CF	O
with	O
no	B-negation
significant	O
PMH	O
came	O
in	O
with	O
c	O
/	O
o	O
nasal	B-bodyloc
stufiines	O
,	O
headache	O
for	O
4	O
days	O
.	O
also	O
migrane	O
headache	O
with	O
increase	B-course
frequency	O
The	O
patient	O
is	O
being	O
seen	O
for	O
an	O
initial	O
evaluation	O
of	O
an	O
upper	B-bodyloc
respiratory	I-bodyloc
infection	O
.	O

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

Chest	O
:	O
Normal	O
.	O

Neurological	O
:	O
no	B-negation
confusion	O
,	O
no	B-negation
dizziness	O
,	O
no	B-negation
fainting	O
,	O
no	B-negation
limb	B-bodyloc
weakness	O
and	O
no	B-negation
difficulty	O
walking	O
.	O

No	B-negation
edema	O
.	O

Ability	O
to	O
communicate	O
:	O
Normal	B-labvalue
.	O

Palpation	O
of	O
chest	O
:	O
Normal	B-labvalue
.	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
CHAU	O
TRAN	O
,	O
M	O
.	O
D	O
.	O

There	O
have	O
been	O
no	O
changes	O
to	O
her	O
regimen	O
since	O
she	O
ws	O
last	O
seen	O
in	O
this	O
clinic	O
.	O

Approximately	O
one	O
liter	O
of	O
cystic	O
fluid	O
was	O
drained	O
during	O
the	O
procedure	O
.	O

9	O
.	O

Complications	O
:	O
presenting	O
no	B-negation
drainage	O
.	O

General	O
Appearance	O
:	O
Normal	B-labvalue
.	O

Pneumo	O
(	O
Prevnar	O
)	O
;	O
27	B-temporal
Jun	I-temporal
2011	I-temporal

Her	O
migraines	O
have	O
been	O
about	O
the	O
same	O
,	O
about	O
3x	O
/	O
week	O
,	O
with	O
the	O
duration	O
and	O
severity	O
much	O
less	O
than	O
they	O
were	O
before	O
menopause	O
,	O
and	O
they	O
only	O
get	O
worse	O
if	O
she	O
has	O
not	O
had	O
her	O
Botox	O
injections	B-route
in	O
a	O
while	O
.	O

4	I-reference_range
[	O
QLH	O
]	O
CMP	O
W	O
/	O
EGFR	O
15Aug2013	B-temporal
01	B-temporal
:	I-temporal
10PM	I-temporal
JOHNSON	O
,	O
PHILIP	O
Test	O
Name	O
Resul	O
Flag	O
Referetce	O
ALT	O
23	B-labvalue
u	I-labvalue
/	I-labvalue
l	I-labvalue
0	B-reference_range
-	I-reference_range
65	I-reference_range
Albumin	O
Lvl	O
4	B-labvalue
.	I-labvalue
1	I-labvalue
g	I-labvalue
/	I-labvalue
dl	I-labvalue
3	B-reference_range
.	I-reference_range
5	I-reference_range
-	I-reference_range
5	I-reference_range
.	I-reference_range

Cervical	O
Spine	O
:	O
Normal	O
(	O
full	B-labvalue
range	O
of	O
motion	O
)	O
.	O

No	B-negation
Known	O
Drug	O
Allergies	O

Family	O
History	O
Family	B-subject
history	O
of	O
Malignant	O
Melanoma	O
Of	O
The	O
Skin	B-bodyloc
V16	O
.	O
8	O

Cervical	O
Spine	O
:	O
Normal	O
(	O
full	O
range	O
of	O
motion	O
)	O
.	O

Pulmonary	O

Delivery	O
type	O
:	O
cesarean	O
delivery	O
.	O

ACTIVE	O
-	O
Retrospective	O
Authorization	O

Review	O
of	O
Systems	O

Surgical	O
History	O
History	O
of	O
Cesarean	O
Section	O

3	O
.	O

OB	O
History	O

and	O
cardiac	O
consult	O
from	O
Dr	O
.	O
Jain	O
.	O

Follow	O
-	O
up	O
as	O
Directed	O
Outpatient	O
Follow	O
-	O
up	O
Requested	O
for	O
:	O
19Nov2012	B-temporal

2	O
.	O

Hydrochlorothiazide	O
12	B-strength
.	I-strength
5	I-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
21Feb2013	B-temporal
)	O
to	O

Family	B-subject
history	O
of	O
Hypertension	O
V17	O
.	O
49	O

Current	B-temporal
treatment	O
includes	O
stretching	O
regimen	O
and	O
ibuprofen	O
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

The	O
patient	O
'	O
s	O
postoperative	O
course	O
was	O
relatively	O
uneventful	O
.	O

ST	O
/	O
SE	O
/	O
Sphen	O
:	O
Normal	B-labvalue

The	O
patient	O
was	O
able	O
to	O
heel	O
walk	O
and	O
toe	O
walk	O
without	B-labvalue
difficulty	I-labvalue
.	O

Visit	O
For	O
:	O
Screening	O
Exam	O
Bact	O
/	O
Spirochetal	O
STD	O
V74	O
.	O
5	O

Thigh	O
(	O
obtur	O
.	O
)	O
:	O
Normal	O
.	O

Pt	O
for	O
post	O
op	O
check	O
.	O

Neurologic	O

PLAN	O
:	O
The	O
patient	O
was	O
given	O
a	O
list	O
of	O
local	O
dental	O
clinics	O
that	O
he	O
can	O
follow	O
up	O
with	O
or	O
he	O
can	O
choose	O
to	O
stay	O
with	O
his	O
own	O
dentist	O
that	O
he	O
wishes	O
.	O

Examination	O
of	O
thyroid	O
:	O
Normal	B-labvalue
.	O

Abdominal	O
Aorta	O
:	O
no	B-negation
abnormalities	O
and	O
no	B-negation
bruit	O
heard	O
.	O

The	O
nasal	O
septum	O
was	O
normal	O
.	O

Assessment	O
1	O
.	O

Rinne	O
'	O
s	O
test	O
:	O
bone	O
conduction	O
persists	O
longer	O
than	O
air	O
conduction	O
on	O
the	O
left	O
.	O

Wheezing	O
:	O
None	B-negation

Eyes	O
:	O
no	B-negation
eye	B-bodyloc
pain	O
,	O
eyes	B-bodyloc
not	B-negation
red	O
,	O
no	B-negation
dryness	O
of	O
the	O
eyes	B-bodyloc
,	O
no	B-negation
itching	O
of	O
the	O
eyes	B-bodyloc
,	O
no	B-negation
discharge	O
from	O
the	O
eyes	B-bodyloc
and	O
no	B-negation
eyesight	O
problems	O
.	O

Musculoskeletal	O
:	O
no	B-negation
joint	B-bodyloc
pain	O
and	O
no	B-negation
limb	B-bodyloc
pain	O
.	O

[	O
QLH	O
]	O
MICROALBUMIN	O
,	O
RANDOM	O
URINE	O
(	O
W	O
/	O
CREATININE	O
)	O
Requested	O
for	O
:	O
03May2011	B-temporal

Pt	O
c	O
/	O
o	O
episodes	O
of	O
sharp	O
,	O
shooting	O
pain	O
in	O
RLQ	B-bodyloc
adjacent	I-bodyloc
to	I-bodyloc
incision	I-bodyloc
site	I-bodyloc
,	O
occuring	O
approx	O
4x	O
/	O
day	O
for	O
the	B-temporal
last	I-temporal
3	I-temporal
days	I-temporal
.	O

Orientation	O
to	O
person	O
,	O
place	O
and	O
time	O
:	O
Normal	B-labvalue

[	O
QLH	O
]	O
TSH	O
,	O
3RD	O
GENERATION	O
Requested	O
for	O
:	O
24Oct2012	B-temporal

Aspirin	O
81	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
07Nov2012	B-temporal
)	O
to	O

Last	O
Tdap	O
unknown	O
.	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
other	O
areas	O
:	O
Normal	B-labvalue

Menstrual	O
History	O
.	O

[	O
LH	O
]	O
CBC	O
(	O
without	O
differential	O
)	O
Requested	O
for	O
:	O
25Feb2014	B-temporal

Psychiatric	O

Vitals	O
UTP	O
Adult	O
Vital	O
Signs	O
[	O
Data	O
Includes	O
:	O
Current	O
Encounter	O
]	O

Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

Abdomen	O

Cranial	O
nerves	O
VIII	O
:	O
hearing	O
was	O
intact	B-labvalue
.	O

Postmenopausal	B-bodyloc
Bleeding	O
627	O
.	O
1	O

Examination	O
of	O
the	O
head	O
and	O
face	O
:	O
Normal	B-labvalue

Pancytopenia	O
.	O

The	O
patient	O
skin	O
graft	O
is	O
well	O
-	O
healed	O
and	O
benign	O
.	O

Eyes	O

Inspection	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
Normal	B-labvalue
.	O

Metoprolol	O
Tartrate	O
50	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
TWICE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
05Sep2012	B-temporal
to	O

Attending	O
Note	O

The	O
site	O
was	O
injected	O
with	O
2	O
mL	O
of	O
1	O
%	O
LidocaineandmL	O
40mg	B-dosage
/	I-dosage
mL	I-dosage
Triamcinolone	O
.	O

Musculoskeletal	O

;	O
Jun	B-temporal
14	I-temporal
2013	I-temporal
10	B-temporal
:	I-temporal
38AM	I-temporal
(	O
Author	O
)	O

Plan	O
:	O
Iontophoresis	O
ITB	O
with	O
phyiscal	O
therapy	O
to	O
include	O
lower	O
extremity	O
strengthening	O

No	B-negation
lesions	O
.	O

f	O
RSV	O
MAB	O
(	O
Synagis	O
)	O
(	O
Lot	O
#	O
:	O
10G14	O
-	O
80	O
)	O
-	O
Administered	O
on	O
:	O
02/08/2013	B-temporal

Tobacco	O
Use	O

Never	O
A	O
Smoker	O

Integumentary	O
:	O
no	B-negation
pruritus	O
.	O

Head	O
and	O
Face	O
No	B-negation
moon	O
facies	B-bodyloc
.	O

Assessment	O
of	O
muscle	O
strength	O
/	O
tone	O
:	O
Normal	B-labvalue
.	O

Review	O
of	O
Systems	O

The	O
patient	O
was	O
admitted	O
to	O
undergo	O
left	O
renal	O
cyst	O
decortication	O
as	O
well	O
as	O
a	O
cystoscopy	O
.	O

Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

False	O
Vocal	O
Folds	O
:	O
normal	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
,	O
the	O
heart	O
rate	O
was	O
not	B-labvalue
fast	I-labvalue
,	O
no	B-negation
intermittent	O
leg	B-bodyloc
claudication	O
and	O
no	B-negation
edema	O
.	O

Cranial	O
nerves	O
II	O
:	O
visual	O
acuity	O
and	O
visual	O
fields	O
were	O
intact	B-labvalue
.	O

General	O
appearance	O
:	O
Normal	B-labvalue
.	O

Past	O
evaluation	O
has	O
included	O
head	B-bodyloc
CT	O
and	O
normal	O
.	O

Surgical	O
History	O
1	O
.	O

Examination	O
of	O
gait	O
and	O
station	O
:	O
Normal	B-labvalue
.	O

Collected	O
-	O
-	O

Lymphatic	O

Aspirin	O
81	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
05Jun2012	B-temporal
)	O
to	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
groin	O
:	O
Normal	B-labvalue
.	O

Seizure	O
Disorder	O
345	O
.	O
90	O

Had	O
removal	O
of	O
scar	O
tissue	O
3	B-temporal
/	I-temporal
12	I-temporal
with	O
resolution	B-course
of	O
symptoms	O

Soleus	O
(	O
tib	O
.	O
)	O
:	O
Normal	O
.	O

Surgical	O
History	O
History	O
of	O
Cholecystectomy	O

Max	O
:	O
Clr	O
mucusNo	O
recirculation	O
noted	O
today	O
.	O

f	O
History	O
of	O
Dependence	O
On	O
Supplemental	O
Oxygen	O
(	O
V46	O
.	O
2	O
)	O
;	O
(	B-course
Resolved	I-course
)	O

[	O
QLH	O
]	O
HEMOGLOBIN	O
A1c	O
Requested	O
for	O
:	O
18Dec2013	B-temporal

4	O
.	O

Facial	B-bodyloc
or	O
sinus	B-bodyloc
pain	O
:	O
Mild	B-severity

Dr	O
.	O
Ghouri	O
.	O

Gastroenterology	O
Referral	O
Outpatient	O
Referral	O
Requested	O
for	O
:	O
12Jan2012	B-temporal

Follow	O
-	O
up	O
visit	O
in	O
3	B-temporal
months	I-temporal
Outpatient	O
Follow	O
-	O
up	O
Requested	O
for	O
:	O
10Feb2014	B-temporal

Joints	O
,	O
bones	O
,	O
and	O
muscles	O
:	O
Abnormal	O
.	O

No	B-negation
dyspareunia	O
.	O

;	O
Nov	B-temporal
21	I-temporal
2013	I-temporal
10	B-temporal
:	I-temporal
49AM	I-temporal
(	O
Author	O
)	O

Anxiety	O
(	O
Symptom	O
)	O
300	O
.	O
00	O

History	O
of	O
Benign	B-severity
Prostatic	B-bodyloc
Hypertrophy	O
600	O
.	O
00	O

It	O
would	O
last	O
for	O
a	O
number	O
of	O
minutes	O
.	O

Dr	O
.	O
Murphy	O
was	O
in	O
the	O
clinic	O
and	O
supervised	O
this	O
visit	O
.	O

Respiratory	O
rate	O
:	O
the	O
respiratory	O
rate	O
was	O
normal	B-labvalue
.	O

Vertical	O
midline	O
incision	O
.	O

Rx	O
:	O
09Apr2013	B-temporal

History	O
of	O
Dependence	O
On	O
Supplemental	O
Oxygen	O
V46	O
.	O
2	O

General	O
appearance	O
:	O
Normal	B-labvalue
.	O

The	O
heart	O
rate	O
was	O
normal	B-labvalue
.	O

Glucosamine	O
Chond	O
Complex	O
/	O
MSM	O
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
AS	O
DIRECTED	O
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
08Oct2013	B-temporal
)	O
to	O

Inspection	O
of	O
the	O
nasal	O
mucosa	O
,	O
septum	O
and	O
turbinates	O
:	O
Normal	B-labvalue
.	O

Metoprolol	O
Tartrate	O
25	B-strength
mg	I-strength
Tablet	B-form
Sig	O
:	O
One	B-dosage
(	I-dosage
1	I-dosage
)	I-dosage
Tablet	B-form
PO	B-route
BID	B-frequency
(	I-frequency
2	I-frequency
times	I-frequency
a	I-frequency
day	I-frequency
)	I-frequency
.	O

-	O
-	O
Continue	O
Vitamin	O
D	O
replacement	O
.	O

Eth	O
:	O
Normal	B-labvalue

Bilirubin	O
,	O
Total	O
:	O
0	B-labvalue
.	I-labvalue
5	I-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue
Reference	O
Range	O
0	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
1	I-reference_range
.	I-reference_range
2	I-reference_range

6	I-reference_range
Alk	O
Phos	O
80	B-labvalue
u	I-labvalue
/	I-labvalue
l	I-labvalue
39	B-reference_range
-	I-reference_range
136	I-reference_range
AGAP	O
17	B-labvalue
.	I-labvalue
8	I-labvalue
mEq	I-labvalue
/	I-labvalue
l	I-labvalue
10	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
20	I-reference_range
.	I-reference_range

Nasal	B-bodyloc
obstruction	O
:	O
None	B-negation

Denied	O

Follow	O
-	O
up	O
visit	O
in	O
3	B-temporal
months	I-temporal
Outpatient	O
Follow	O
-	O
up	O
Done	O
:	O
04Sep2013	O
Nasal	O
endoscopy	O
today	B-temporal

;	O
Mar	B-temporal
19	I-temporal
2014	I-temporal
11	B-temporal
:	I-temporal
18AM	I-temporal
(	O
Author	O
)	O

Plan	O
Benign	B-severity
Essential	O
Hypertension	O
(	O
401	O
.	O
1	O
)	O

Ordered	O
;	O
For	O
:	O
Pregnancy	O
Test	O
Positive	B-labvalue
(	O
V72	O
.	O
42	O
)	O
;	O
Ordered	O
By	O
:	O
ABDELMELEK	O
,	O
LOURICE	O
Performed	O
:	O
Due	O
:	O
24Mar2013	B-temporal
;	O
Last	O
Updated	O
By	O
:	O
Fleming	O
,	O
Sonya	O
PlapSectispEnd	O
SignaturesSectispStart	O
Signatures	O

Codeine	O
Derivatives	O

SX	O
.	O

She	O
wants	O
a	O
referral	O
for	O
a	O
sleep	O
study	O
.	O

General	O
appearance	O
:	O
Normal	O
Well	O
developed	O
,	O
appears	O
healthy	O
and	O
well	O
nourished	O
.	O

Electronically	O
signed	O
by	O
:	O
PAUL	O
LEE	O
,	O
M	O
.	O
D	O
.	O

No	B-negation
varicosities	O
.	O

Mood	O
and	O
affect	O
:	O
Normal	O
.	O

Pupils	O
:	O
.	O

Proteinuria	O
791	O
.	O
0	O

Abdominal	B-bodyloc
pain	O
.	O

Risk	B-condition
factors	I-condition
for	O
CAD	O
:	O
+	O
smoking	O
,	O
trying	O
to	O
quit	O
,	O
HTN	O
,	O
+	O
HLD	O
,	O
no	B-negation
DM	O
,	O
+	O
family	B-subject
h	O
/	O
o	O
premature	O
CAD	O
.	O

Neurologicro	O
:	O
No	B-negation
convulsions	O
.	O

The	O
patient	O
was	O
given	O
nebulizer	O
treatment	O
and	O
Lasix	O
increased	O
the	O
same	O
to	O
resolve	O
the	O
problem	O
.	O

Due	O
to	O
this	O
,	O
she	O
has	O
had	O
seizures	O
,	O
lacks	O
a	O
rotator	B-bodyloc
cuff	I-bodyloc
in	O
both	B-bodyloc
extremities	I-bodyloc
,	O
and	O
has	O
neck	B-bodyloc
spasms	O
.	O

Examination	O
of	O
the	O
oropharynx	O
:	O
Normal	B-labvalue
.	O

Ability	O
to	O
communicate	O
:	O
Stridor	O
:	O
None	O
.	O

Inferior	O
Turbinates	O
:	O
normal	O
bilat	O

Electronically	O
signed	O
by	O
:	O
LESLIE	O
GARB	O
,	O
M	O
.	O
D	O
.	O

Symptoms	O
are	O
worsening	B-course
.	O
,	O
joint	B-bodyloc
pain	O
andmuscle	O
aches	O
,	O
butshowed	O
no	B-negation
erythema	O
,	O
no	B-negation
joint	B-bodyloc
swelling	O
,	O
no	B-negation
warmth	O
,	O
no	B-negation
joint	B-bodyloc
instability	O
and	O
no	B-negation
stiffness	O
of	O
joint	B-bodyloc
.	O

THIS	O
IS	O
THE	O
PATIENT	O
'	O
S	O
FIRST	O
TIME	O
VISIT	O
TO	O
THIS	O
OFFICE	O
.	O

Influenza	O
;	O
Injected	B-form
IM	I-form
;	O
To	O
Be	O
Done	O
:	O
31Oct2013	B-temporal
;	O
Status	O
:	O
Hold	O
For	O
-	O
Administration	O

Obesity	O
278	O
.	O
00	O

Inspection	O
of	O
the	O
nasal	O
mucosa	O
,	O
septum	O
and	O
turbinates	O
:	O
Normal	B-labvalue
.	O

ChiefComplaint	O
_	O
90	O
_	O
twCiteListControlEnd	O
ChiefComplaintSectispEnd	O
CurrentMedsSectispStart	O
Current	O
Meds	O

Patient	O
was	O
not	B-negation
observed	I-negation
to	O
be	O
obese	O
.	O

Scar	O
was	O
noted	O
which	O
was	O
located	O
(	O
on	O
the	O
back	B-bodyloc
)	O
.	O

This	O
patient	O
is	O
symptomatically	O
improved	O
but	O
still	O
has	O
some	O
conductive	O
hearing	O
loss	O
.	O

Examination	O
of	O
the	O
head	O
and	O
face	O
:	O
Normal	B-labvalue

Pap	O
Comment	O
SEE	O
NOTE	O

Weight	O
Comments	O
:	O
Reported	O

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

Examination	O
of	O
the	O
head	O
and	O
face	O
:	O
Normal	B-labvalue
.	O

History	O
of	O
Varicose	O
Veins	O
454	O
.	O
9	O

[	O
QL	O
]	O
VITAMIN	O
D	O
,	O
25	O
-	O
HYDROXY	O
,	O
LC	O
/	O
MS	O
/	O
MS	O
Done	O
:	O
28Feb2011	B-temporal
10	B-temporal
:	I-temporal
28AM	I-temporal

Delivered	O
:	O
2007	B-temporal
.	O

Social	O
History	O
Never	O
A	O
Smoker	O

Head	O
and	O
Face	O

Iodine	O
Tincture	B-form
SWAB	O

The	O
thyroid	B-bodyloc
was	O
normal	O
and	O
did	O
not	B-negation
have	I-negation
a	O
bruit	O
.	O

Salivary	O
glands	O
:	O
No	B-negation
parotid	B-bodyloc
gland	I-bodyloc
mass	O
/	O
tenderness	O
.	O

Reference	O
Ranges	O
:	O

Examination	O
of	O
the	O
chest	O
:	O
Normal	B-labvalue
Chest	B-bodyloc
:	O
normal	O
appearance	O
and	O
no	B-negation
tenderness	O
.	O

Physical	O
Exam	O

Neurological	O
:	O
no	B-negation
dizziness	O
and	O
no	B-negation
fainting	O
.	O

(	O
peron	O
.	O
)	O
:	O
Normal	O
.	O

Integumentary	O
:	O
no	B-negation
pruritus	O
and	O
no	B-negation
dry	O
skin	B-bodyloc
.	O

Weight	O
:	O
175	B-labvalue
lb	I-labvalue

Pap	O
Smear	O
Cervical	O
V76	O
.	O
2	O

Mometasone	O
Furoate	O
0	B-strength
.	I-strength
1	I-strength
%	O
External	O
Cream	B-form
;	O
APPLY	O
SPARINGLY	O
TO	O
AFFECTED	O
AREAS	O
TWICE	B-frequency
DAILY	I-frequency
.	O
(	O
AM	O
AND	O
PM	O
)	O
;	O
Therapy	O
:	O
21Jan2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
21Jan2013	B-temporal
)	O
Requested	O
for	O
:	O
21Jan2013	B-temporal

4	O
.	O

I	O
personally	O
examined	O
Ms	O
.	O
RAYLYNN	O
ASHAN	O
GEE	O
with	O
the	O
resident	O
.	O

Clinical	O
impression	O
:	O
seborrhea	O
.	O

Examination	O
of	O
thyroid	O
:	O
Normal	B-labvalue
.	O

The	O
trachea	O
was	O
midline	O
.	O

No	B-negation
egophony	O
or	O
tactile	O
fremitus	O
.	O

Eustachian	O
tube	O
opening	O
normal	B-labvalue
.	O

Procedure	O
:	O
Shoulder	O
Injection	O
.	O

Respiration	O
:	O
20	B-labvalue

Also	O
,	O
the	O
patient	O
is	O
concerned	O
about	O
a	O
possible	O
penile	B-bodyloc
lesion	O
.	O

General	O
appearance	O
:	O
Normal	B-labvalue
.	O
Comfortable	O
,	O
alert	O
and	O
oriented	O
x3	O
,	O
no	B-negation
jaundice	O
,	O
pallor	O
or	O
cyanosis	O
.	O

Furosemide	O
20	B-strength
mg	I-strength
Tablet	B-form
Sig	O
:	O
One	B-dosage
(	I-dosage
1	I-dosage
)	I-dosage
Tablet	B-form
PO	B-route
BID	B-frequency
(	I-frequency
2	I-frequency
times	I-frequency
a	I-frequency
day	I-frequency
)	I-frequency
for	O
2	B-duration
weeks	I-duration
.	O

Hyperlipidemia	O
272	O
.	O
4	O

PROCEDURES	O
DURING	O
HOSPITALIZATION	O
:	O

History	O
of	O
Congenital	O
Malformations	O

Last	O
pap	O
3	B-temporal
/	I-temporal
13	I-temporal
,	O
wnl	O

Current	O
Meds	O
Synthroid	O
25	B-strength
MCG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
AS	I-frequency
DIRECTED	I-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
18Oct2012	B-temporal
)	O
to	O

Symptoms	O
:	O
facial	B-bodyloc
swelling	O
,	O
but	O
no	B-negation
visual	O
problems	O
,	O
no	B-negation
hearing	O
problems	O
,	O
no	B-negation
facial	B-bodyloc
rash	O
,	O
no	B-negation
facial	B-bodyloc
weakness	O
,	O
no	B-negation
facial	B-bodyloc
paresthesias	O
,	O
no	B-negation
fever	O
,	O
no	B-negation
facial	B-bodyloc
redness	O
,	O
no	B-negation
facial	O
pressure	O
and	O
no	B-negation
facial	B-bodyloc
warmth	O

[	O
QLH	O
]	O
T4	O
,	O
FREE	O

She	O
was	O
evaluated	O
for	O
evolving	B-course
preeclampsia	O
and	O
had	O
a	O
C	O
-	O
section	O
secondary	O
to	O
the	O
nonreassuring	O
fetal	O
status	O
.	O

Femoral	O
pulses	O
:	O
Normal	B-labvalue
.	O

10Sep2009	B-temporal
to	O
(	O
Evaluate	O
:	O
21Apr2011	B-temporal
)	O
Requested	O
for	O
:	O
24Feb2011	B-temporal
;	O
Last	O
Rx	O
:	O
24Feb2011	B-temporal

Family	B-subject
history	O
of	O
Reported	O
Prior	B-temporal
Thyroid	B-bodyloc
Disease	O

f	O
Immune	O
Globulin	O
(	O
Human	O
)	O
INJ	O
(	O
Active	O
)	O

DISCHARGE	O
INSTRUCTIONS	O
:	O
The	O
patient	O
is	O
to	O
be	O
transferred	O
to	O
ABCD	O
after	O
open	O
reduction	O
and	O
internal	O
fixation	O
of	O
right	B-bodyloc
tibial	I-bodyloc
plateau	I-bodyloc
fracture	O
and	O
partial	O
medial	O
meniscectomy	O
.	O

Inspection	O
of	O
the	O
conjunctiva	O
and	O
lids	O
:	O
Normal	B-labvalue
.	O

recommendations	O
of	O
the	O
American	O
Diabetes	O
Association	O
.	O

Physical	O
Exam	O

tinnitus	O

1	O
.	O

Pravastatin	O
Sodium	O
40	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
AT	I-frequency
BEDTIME	I-frequency
;	O
Therapy	O
:	O
23Feb2014	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
23Feb2014	B-temporal
)	O
Requested	O
for	O
:	O
23Feb2014	B-temporal

Chief	O
Complaint	O

The	O
rhythm	O
was	O
regular	B-labvalue
.	O

Psychiatric	O
:	O
not	B-negation
suicidal	O
,	O
no	B-negation
sleep	O
disturbances	O
,	O
no	B-negation
anxiety	O
,	O
no	B-negation
depression	O
,	O
no	B-negation
personality	O
change	O
and	O
no	B-negation
emotional	O
problems	O
.	O

Gastrointestinal	O
:	O
(	O
decreased	B-course
appetite	O
)	O
.	O

AMERICAN	O
91	B-labvalue
ML	I-labvalue
/	I-labvalue
MIN	I-labvalue
/	I-labvalue
1	I-labvalue
.	I-labvalue
7	I-labvalue
>	B-reference_range
OR	I-reference_range
=	I-reference_range
60	I-reference_range

Examination	O
of	O
the	O
head	O
and	O
face	O
revealed	O
no	B-negation
abnormalities	O
.	O

Associated	O
symptoms	O
include	O
no	O
focal	O
neurologic	O
deficits	O
and	O
no	B-negation
memory	O
loss	O
.	O

[	O
L	O
]	O
CMP14	O
Requested	O
for	O
:	O
24Oct2012	B-temporal

Lymph	O
nodes	O
,	O
left	O
pelvic	O
,	O
lymphadenectomy	O
:	O

Assessment	O
Cluster	O
Headache	O
339	O
.	O
00	O

Auscultation	O
of	O
lungs	O
:	O
Noamal	B-labvalue
.	O

Ryan	O
Murphy	O
,	O
MD	O
UTP	O
-	O
Discussion	O
/	O

Palpation	O
of	O
lymph	O
nodes	O
in	O
neck	O
:	O
Normal	B-labvalue
.	O

Family	O
History	O
Paternal	B-subject
grandfather	I-subject
'	I-subject
s	I-subject
history	O
of	O
Acute	B-course
Myocardial	B-bodyloc
Infarction	O
V17	O
.	O
3	O

Vitamin	O
D	O
1000	B-strength
UNIT	I-strength
Oral	B-route
Capsule	B-form
;	O
TAKE	O
AS	O
DIRECTED	O
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
24Aug2011	B-temporal
)	O
to	O

Heart	O
sounds	O
:	O
the	O
heart	O
sounds	O
were	O
distant	B-labvalue
,	O
but	O
normal	B-labvalue
S1	O
and	O
normal	B-labvalue
S2	O
.	O

ENT	O
:	O
no	B-negation
earache	O
and	O
no	B-negation
hearing	O
loss	O
.	O

The	O
heart	O
rate	O
was	O
normal	B-labvalue
.	O

Hyperthyroidism	O
242	O
.	O
90	O

History	O
of	O
Lower	B-bodyloc
Back	I-bodyloc
Pain	O
Chronic	O
724	O
.	O
2	O

GI	O
:	O
no	B-negation
heartburn	O
,	O
no	B-negation
diarrhea	O
,	O
no	B-negation
nausea	O
,	O
no	B-negation
black	O
or	O
tarry	O
stools	O
,	O
no	B-negation
vomiting	O
and	O
no	B-negation
constipation	O
.	O

She	O
is	O
not	B-negation
compliant	O
w	O
th	O
her	O
diet	O
and	O
has	O
poor	O
dietasy	O
habits	O
.	O

Patient	O
could	O
not	O
tolearte	O
further	O
adjustment	O
today	B-temporal
(	O
c	O
/	O
o	O
headache	O
and	O
increased	B-course
dystonia	O
)	O

and	O
swallow	O
one	B-dosage
DHA	O
gel	B-form
capsule	I-form
daily	B-frequency
;	O
Therapy	O
:	O
12Dec2011	B-temporal
to	O
(	O
Evaluate	O
:	O
09Jul2012	B-temporal
)	O
;	O
Last	O
Rx	O
:	O
12Dec2011	B-temporal

Exelon	O
PT24	O
;	O
APPLY	O
1	B-dosage
PATCH	B-form
DAILY	B-frequency
AS	O
DIRECTED	O
;	O
Status	O
:	O
ACTIVE	O

Home	O
With	O
Service	O

He	O
is	O
currently	O
being	O
seen	O
by	O
Dr	O
.	O
Mcpherson	O
and	O
further	O
intervention	O
is	O
still	O
in	O
the	O
question	O
.	O

No	B-negation
murmur	O
,	O
gallops	O
,	O
clicks	O
,	O
heaves	O
or	O
rub	O
.	O

Complications	O
:	O
no	B-negation
peripheral	O
neuropathy	O
,	O
no	B-negation
nephropathy	O
and	O
no	B-negation
retinopathy	O
.	O

Genitourinary	O

Family	B-subject
history	O
of	O
Diabetes	O
Mellitus	O
V18	O
.	O
0	O

General	O
appearance	O
:	O
Normal	O
Appears	O
healthy	O
,	O
within	O
normal	O
limits	O
of	O
ideal	O
weight	O
,	O
well	O
hydrated	O
and	O
appearance	O
reflects	O
stated	O
age	O
.	O

[	O
QLH	O
]	O
LIPID	O
PANEL	O
Requested	O
fis	O
:	O
29Apr2013	B-temporal

Onset	O
was	O
gradual	O
.	O

Family	O
History	O
1	O
.	O

BSA	O
Calculated	O
:	O
1	B-labvalue
.	I-labvalue
79	I-labvalue

RBC	O
:	O
4	B-labvalue
.	I-labvalue
66	I-labvalue
x10E6	I-labvalue
/	I-labvalue
uL	I-labvalue
Reference	O
Range	O
4	B-reference_range
.	I-reference_range
14	I-reference_range
-	I-reference_range
5	I-reference_range
.	I-reference_range
80	I-reference_range

Recent	O
and	O
remote	O
memory	O
:	O
Normal	B-labvalue

Paternal	O
history	O
of	O
Father	O
Deceased	O
At	O
Age	O
_	O
_	O
_	O
_	O

Cardiovascular	O
:	O
heart	O
rate	O
and	O
rhythm	O
were	O
normal	B-labvalue
,	O
normal	B-labvalue
S1	O
and	O
S2	O
,	O
no	B-negation
murmursandthe	O
pedal	O
pulses	O
were	O
full	O
.	O

Plantar	O
wart	O
right	B-bodyloc
thumb	I-bodyloc
:	O
options	O
discussed	O
.	O

ENT	O
:	O
hearing	O
loss	O
,	O
butno	O
epistaxis	O
,	O
no	B-negation
nasal	B-bodyloc
discharge	O
,	O
no	O
hoarsenessandno	O
sore	O
throat	B-bodyloc
.	O

F	O
/	O
U	O
in	O
6	O
weeks	O

Urine	O
Dipstick	O
(	O
In	O
Office	O
)	O
Requested	O
for	O
:	O
02Nov2012	B-temporal

Assessmept	O
_	O
80	O
_	O
twCiteListControlEnd	O
AssessmeptSectispEnd	O
PlanSectispStart	O
Plan	O

Examination	O
of	O
the	O
chest	O
:	O
Abnormal	O
A	O
chest	B-bodyloc
deformity	O
was	O
noted	O
(	O
Kyphosis	O
)	O
.	O

Current	B-temporal
treatment	O
includes	O
ACE	O
inhibitor	O
.	O

Skin	B-bodyloc
Neoplasm	O
Of	O
Uncertain	O
Behavior	O
238	O
.	O
2	O

Lump	O
in	O
throat	B-bodyloc
.	O

History	O
of	O
Hypothyroidism	O
244	O
.	O
9	O

CURRENT	O
MEDICATIONS	O
:	O
OxyContin	O
and	O
Vicodin	O
.	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
,	O
no	B-negation
cough	O
,	O
no	B-negation
orthopnea	O
and	O
no	B-negation
PND	O
.	O

Pulmonary	O

Electronically	O
signed	O
by	O
:	O
PAUL	O
TOSCANO	O
P	O
.	O
A	O
.	O
;	O
03/26/2013	B-temporal
10	B-temporal
:	I-temporal
17	I-temporal
AM	I-temporal
CST	O
;	O
Author	O
.	O
eg	O

Uterus	O
:	O
Normal	O
.	O

Musculoskeletal	O
:	O
limb	B-bodyloc
pain	O
,	O
but	O
no	B-negation
arthralgias	O
,	O
no	B-negation
joint	B-bodyloc
pain	O
,	O
no	B-negation
joint	B-bodyloc
swelling	O
,	O
no	B-negation
joint	B-bodyloc
stiffness	O
and	O
no	B-negation
limb	B-bodyloc
swelling	O
.	O

Examination	O
of	O
the	O
abdomen	O
:	O
Normal	B-labvalue

Nystatin	O
100000	B-strength
UNIT	I-strength
/	I-strength
ML	I-strength
Mouth	B-route
/	O
Throat	B-route
Suspension	B-form
;	O
Rx	O
.	O
eg	O

History	O
of	O
Tonsillectomy	O

Alendronate	O
Sodium	O
70	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
ONCE	B-frequency
WEEKLY	I-frequency
;	O
Therapy	O
:	O
24Mar2011	B-temporal
to	O
(	O
Evaluate	O
:	O
15Jun2013	B-temporal
)	O
Requested	O
for	O
:	O
20Jun2012	B-temporal
;	O
Last	O
Rx	O
:	O
20Jun2012	B-temporal

Temporary	O
Gastrostomy	O
Neonatal	O
(	O
For	O
Feeding	O
)	O
V44	O
.	O
1	O

Sample	O
Name	O
:	O
Air	O
Under	O
Diaphragm	O
-	O
Consult	O

Hypothyroid	O
-	O
will	O
need	O
recheck	O
TFTs	O
next	O
visit	O
,	O
on	O
levothyroxine	O
50	B-strength
mcg	I-strength
.	O

There	O
is	O
no	B-negation
throat	O
swelling	O
,	O
no	B-negation
sore	O
throat	O
,	O
no	B-negation
difficulty	O
swallowing	O
solids	O
or	O
liquids	O
.	O

SOCIAL	O
HISTORY	O
:	O
Negative	O
for	O
illicit	O
drugs	O
,	O
alcohol	O
,	O
and	O
tobacco	O
.	O

Recommend	O
to	O
repeat	O
ultrasound	O
.	O

No	B-negation
hearing	O
loss	O
.	O

Pulmonary	O

Normal	O
hair	O
texture	O
and	O
distribution	O
.	O

There	O
was	O
no	B-negation
exudate	O
on	O
either	B-bodyloc
tonsil	I-bodyloc
.	O

There	O
was	O
some	O
retained	O
stool	O
in	O
that	O
area	O
and	O
the	O
patient	O
had	O
a	O
somewhat	O
prolonged	O
hospital	O
course	O
on	O
the	O
remaining	O
barium	O
from	O
the	O
colon	O
.	O

Current	O
Meds	O

)	O
Sig	O
:	O
One	B-dosage
(	O
1	O
)	O
Tablet	B-form
,	I-form
Delayed	I-form
Release	I-form
(	O
E	O
.	O
C	O
.	O

Hepatitis	O
B	O
;	O
12/07/2007	B-temporal

General	O
appearance	O
:	O
Normal	B-labvalue
Appears	O
healthy	O
,	O
within	O
normal	O
limits	O
of	O
ideal	O
weight	O
,	O
well	O
hydrated	O
and	O
appearance	O
reflects	O
stated	O
age	O
.	O

Constitutional	O

Physical	O
Exam	O

Denied	O

Drug	O
Use	O

Never	O
A	O
Smoker	O

Examination	O
of	O
liver	O
and	O
spleen	O
:	O
Normal	B-labvalue
.	O

f	O
Normal	O
Routine	O
Histisy	O
And	O
PEnd	O
ReSenior	O
Citizen	O
(	O
65	O
-	O
80	O
)	O
(	O
V70	O
.	O
0	O
)	O
;	O
(	O
Active	O
)	O

post	O
-	O
op	O
left	O
knee	O

Vitals	O
14Oct2013	B-temporal
10	B-temporal
:	I-temporal
13AM	I-temporal
BMI	O
Calculated	O
41	B-labvalue
.	I-labvalue
92	I-labvalue
BSA	O
Calculated	O
2	B-labvalue
.	I-labvalue
39	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
9	I-labvalue
in	I-labvalue
Weight	O
283	B-labvalue
lb	I-labvalue
Systolic	O
135	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
90	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Temperature	O
97	B-labvalue
.	I-labvalue
6	I-labvalue
F	I-labvalue
,	O
Tympanic	O
Heart	O
Rate	O
72	B-labvalue
Respiration	O
16	B-labvalue

Weight	O
:	O
177	B-labvalue
lb	I-labvalue

1	O
.	O

Palpation	O
of	O
cervical	O
lymph	O
nodes	O
:	O
Normal	B-labvalue
.	O

Patient	O
:	O
WILLIS	O
,	O
SPENCER	O
;	O
DOB	O
:	O
11/20/1924	O
;	O
MRN	O
:	O
373664	O

The	O
patient	O
does	O
not	O
drink	O
alcohol	O
.	O

No	B-negation
rhonchi	O
were	O
heard	O
.	O

Anus	O
,	O
perineum	O
and	O
rectum	O
:	O
Normal	O

OF	O
4	O
VIEWS	O
Requested	O
for	O
:	O
16Apr2013	B-temporal

Description	O
:	O
N	O

Well	O
developed	O
,	O
well	O
nourishedandwithin	O
normal	O
limits	O
of	O
ideal	O
weight	O
.	O

Dorsalis	O
pedis	O
:	O
right	O
2	O
+	O
and	O
left	O
2	O
+	O
.	O

Strain	O
Of	O
Adductor	O
Muscle	O
,	O
Fascia	O
,	O
And	O
Tendon	O
Of	O
Thigh	B-bodyloc
843	O
.	O
9	O

Pt	O
is	O
here	O
today	O
to	O
see	O
Dr	O
.	O
Zulfiqar	O
for	O
a	O
elevated	O
BP	O
readings	O
follow	O
up	O
.	O

[	O
QLH	O
]	O
VITAMIN	O
B1	O
,	O
WHOLE	O
BLOOD	O
Done	O
:	O
18Dec2012	B-temporal
11	B-temporal
:	I-temporal
30AM	I-temporal

External	O
inspection	O
of	O
ears	O
and	O
nose	O
:	O
Normal	B-labvalue
.	O

Abdomen	O

Cholesterol	O
Education	O
Program	O
(	O
ATP	O
III	O
,	O
2001	O
)	O
.	O

Patient	O
denies	O
smoking	O
,	O
alcohol	O
,	O
drugs	O
.	O

(	O
status	O
post	O
left	O
total	O
knee	O
replacement	O
)	O

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

Tylenol	O
CAPS	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
08Oct2013	B-temporal
)	O
to	O

Inspection	O
of	O
the	O
conjunctiva	O
and	O
lids	O
:	O
Normal	B-labvalue
.	O

Family	O
History	O
Family	B-subject
history	O
of	O
Cancer	O

I	O
personally	O
performed	O
nasal	O
endoscopy	O
(	O
entire	O
procedure	O
)	O

Cervix	O
:	O
Normal	O
.	O

The	O
patient	O
has	O
been	O
struggling	O
with	O
constipation	O
but	O
has	O
been	O
on	O
Miralax	O
and	O
this	O
seems	O
to	O
be	O
helping	O
.	O

Right	O
Foot	O
:	O

Abdomen	O
/	O
Rectal	O

Alcohol	O
Use	O

Hyperlipidemia	O
272	O
.	O
4	O

GroupHeading410End	O
TextFinding412Start	O
TextFinding412End	O
GroupHeading244Start	O
GroupHeading244End	O
GroupHeading264Start	O
GroupHeading264End	O
GroupHeading270Start	O
GroupHeading270End	O
GroupHeading334Start	O
GroupHeading334End	O
GroupHeading90Start	O
GroupHeading90End	O
GroupHeading92Start	O
GroupHeading92End	O
GroupHeading94Start	O
GroupHeading94End	O
UTP	O
-	B-bodyloc
VaginalBleeding	I-bodyloc
(	O
Brief	O
)	O
c846da06	O
-	O
25ad	O
-	O
471d	O
-	O
b4f9	O
-	O
a8a8110eb0ccFoamEnd	O
HistisyofPresentIllnessSectispEnd	O
PastMedicalHistisySectispStart	O
Past	O
Medical	O
Histisy	O

By	O
discharge	O
,	O
he	O
was	O
near	O
his	O
preoperative	O
weight	O
with	O
room	O
air	O
oxygen	O
saturations	O
of	O
97	B-labvalue
%	I-labvalue
.	O

History	O
of	O
Alcohol	O

5	O
.	O

Chief	O
Complaint	O
g1	O
Patient	O
here	O
today	O
to	O
see	O
Dr	O
.	O
Yousefi	O
for	O
vomiting	O
and	O
nausea	O
.	O

She	O
has	O
not	O
been	O
evaluated	O
with	O
an	O
EEG	O
in	O
years	O
.	O

Inspection	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
Normal	B-labvalue
.	O

Leg	B-bodyloc
Localized	O
Swelling	O
Left	O
729	O
.	O
81	O

Cymbalta	O
20	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
Delayed	I-form
Release	I-form
Particles	I-form
;	O
TAKE	O
2	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
17Dec2009	B-temporal
to	O
(	O
Evaluate	O
:	O
03Jun2013	B-temporal
)	O
Requested	O
for	O
:	O
08Jun2012	B-temporal
;	O
Last	O
Rx	O
:	O
08Jun2012	B-temporal

Examination	O
of	O
extremities	O
for	O
edema	O
and	O
/	O
or	O
varicosities	O
:	O
Normal	B-labvalue
.	O

Upper	O
Back	B-bodyloc
Pain	O
(	O
Between	O
Shoulder	O
Blades	O
)	O
724	O
.	O
1	O

Assessment	O
1	O
.	O

I	O
have	O
reviewed	O
the	O
EMG	O
results	O
with	O
him	O
.	O

History	O
of	O
Pancreatitis	O

2/11/2013	B-temporal
.	O

Ave	O
~	O
130units	O
q	O
.	O
o	O
.	O
d	O
.	O

Facial	B-bodyloc
or	O
sinus	B-bodyloc
pressure	O
:	O
Mild	B-severity

Cranial	O
nerves	O
XI	O
:	O
shoulder	O
shrug	O
was	O
intact	B-labvalue
bilaterally	O
.	O

Cranial	O
Nerves	O
:	O

No	B-negation
rales	O
or	O
crackles	O
were	O
heard	O
.	O

Naproxen	O
250	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Therapy	O
:	O
28Aug2013	B-temporal
to	O

Atorvastatin	O
Calcium	O
20	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
07Dec2006	B-temporal
to	O
(	O
Evaluate	O
:	O
16Nov2013	B-temporal
)	O
Requested	O
for	O
:	O
20May2013	B-temporal
;	O
Last	O
Rx	O
:	O
20May2013	B-temporal
;	O
Status	O
:	O
ACTIVE	O
-	O

Height	O
:	O
5	B-labvalue
ft	I-labvalue
2	I-labvalue
in	I-labvalue

Examination	O
of	O
gait	O
and	O
station	O
:	O
Normal	B-labvalue
.	O

no	B-negation
CVA	O
tenderness	O

Integumentary	O
:	O
no	B-negation
rash	O
.	O

Cranial	O
nerves	O
IX	O
and	O
X	O
:	O
there	O
was	O
normal	B-labvalue
movement	O
of	O
the	O
soft	O
palate	O
and	O
normal	B-labvalue
gag	O
.	O

0	I-reference_range
Hemoglobin	O
13	B-labvalue
.	I-labvalue
4	I-labvalue
g	I-labvalue
/	I-labvalue
dl	I-labvalue
L	O
14	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
18	I-reference_range
.	I-reference_range
0	I-reference_range

Musculoskeletal	O

Home	O
monitoring	O
:	O
The	O
patient	O
checks	O
her	O
blood	O
sugars	O
regularly	O
.	O
(	O
fasting	O
about	O
110	O
-	O
120	O
but	O
had	O
two	O
episodes	O
where	O
really	O
low	O
40	O
'	O
s	O
)	O
The	O
patient	O
reports	O
symptomatic	O
hypoglycemic	O
episodes	O
.	O
(	O
four	O
times	O
,	O
two	O
times	O
checked	O
sugar	O
in	O
the	B-labvalue
40	I-labvalue
'	O
s	O
,	O
twice	O
just	O
felt	O
symptoms	O
)	O
.	O

Electronically	O
signed	O
by	O
:	O
MICHAEL	O
ADLER	O
,	O
M	O
.	O
D	O
.	O

Orientation	O
to	O
person	O
,	O
place	O
and	O
time	O
:	O
Normal	B-labvalue

F	O
.	O
U	O
.	O

Test	O
Name	O
Result	O
Flag	O
Reference	O
HEMOGLOBIN	O
A1c	O
5	B-labvalue
.	I-labvalue
5	I-labvalue
O	O

EYES	O

Pedal	O
pulses	O
:	O
2	B-labvalue
+	I-labvalue
bilaterally	I-labvalue
.	O

T	O
.	O
Hyst	O
.	O

Social	O
History	O
Marital	O
History	O
-	O
Currently	O
Married	O

Time	O
spent	O
in	O
counseling	O
and	O
/	O
or	O
coordination	O
of	O
care	O
for	O
this	O
patient	O
was	O
60	O
minutes	O
and	O
this	O
time	O
was	O
greater	O
than	O
50	O
%	O
of	O
the	O
visit	O
.	O

Patient	O
'	O
s	O
post	O
-	O
operative	O
course	O
was	O
complicated	O
by	O
development	O
of	O
PE	O
on	O
1st	O
post	O
-	O
op	O
day	O
.	O

LT	O
Inferior	O
Turbinate	O

ROM	O
:	O
Full	O
.	O

I	O
will	O
see	O
the	O
patient	O
back	O
in	O
followup	O
in	O
6	O
months	O
time	O
,	O
sooner	O
if	O
there	O
are	O
any	O
changes	O
.	O

Inspection	O
of	O
the	O
conjunctiva	O
and	O
lids	O
:	O
Normal	B-labvalue
.	O

Bulging	O
Disc	B-bodyloc
(	I-bodyloc
C5	I-bodyloc
-	I-bodyloc
C6	I-bodyloc
)	I-bodyloc
Bilateral	O
722	O
.	O

The	O
patient	O
presents	O
with	O
returning	B-course
headaches	O
and	O
head	B-bodyloc
pains	O
.	O

Left	O
Post	O
.	O

No	B-negation
fever	O
/	O
chills	O
.	O

As	O
for	O
the	O
cough	O
patient	O
states	O
robitusssin	O
helped	O
control	O
the	O
cough	O
recently	O
.	O

Monofilament	O
Testing	O
:	O

3	O
.	O

Clear	B-labvalue
to	O
percussion	O
.	O

History	O
of	O
Present	O
Illness	O

[	O
QLH	O
]	O
LIPID	O
PANEL	O
Requested	O
for	O
:	O
18Dec2013	B-temporal

Head	O
and	O
Face	O

No	B-negation
murmurs	O
were	O
heard	O
.	O

Peripheral	O
vascular	O
exam	O
:	O
Normal	B-labvalue

Cranial	O
nerves	O
V	O
:	O
sensation	O
to	O
the	O
face	O
and	O
masseter	O
strength	O
were	O
intact	B-labvalue
.	O

General	O
appearance	O
:	O
Normal	B-labvalue
Well	O
developed	O
,	O
appears	O
healthy	O
,	O
well	O
nourished	O
,	O
underweight	O
,	O
well	O
groomed	O
,	O
well	O
hydrated	O
,	O
appearance	O
reflects	O
stated	O
ageandCLOR	O
NML	O
.	O

Current	O
Meds	O
Accu	O
-	O
Chek	O
Aviva	O
Plus	O
In	O
Vitro	O
Strip	O
;	O
USE	O
6	O
-	O
8	O
STRIPs	O
DAILY	O
;	O
Therapy	O
:	O
11Jun2013	B-temporal
to	O
(	O
Evaluate	O
:	O
05Sep2014	B-temporal
)	O
Requested	O
for	O
:	O
16Dec2013	B-temporal
;	O
Last	O
Rx	O
:	O
10Sep2013	B-temporal

Percussion	O
of	O
chest	O
:	O
Normal	B-labvalue
.	O

Examination	O
of	O
urethra	O
:	O
Normal	B-labvalue

Examination	O
of	O
pupils	O
and	O
irises	O
:	O
Normal	B-labvalue
.	O

The	O
neck	O
was	O
normal	O
in	O
appearanceand	O
was	O
supple	O
.	O

EXTREMITIES	O
-	O
Full	B-labvalue
ROM	O
,	O
hip	O
skinfolds	O
symmetric	O
.	O

Nasal	O
mucosa	O
,	O
septum	O
,	O
and	O
turbinates	O
:	O
Normal	B-labvalue
.	O

She	O
returns	O
to	O
the	O
Movement	O
Disorders	O
Clinic	O
for	O
Botox	O
treatment	O
for	O
her	O
oromandibular	B-bodyloc
dystonia	O
and	O
headache	O
.	O

P	O
/	O
E	O

1	O
2	O
3	O
4	O
5	O
6	O
Influenza	O
30Oct2006	B-temporal
05Dec2007	B-temporal
05Dec2007	B-temporal
25Nov2008	B-temporal
06Dec2010	B-temporal
28Nov2011	B-temporal
Pneumococcal	O
28Jul2006	B-temporal
05Dec2007	B-temporal
05Dec2007	B-temporal
Td	O
/	O
DT	O
1995	B-temporal
09Aug2006	B-temporal

Pulmonary	O
Clear	B-labvalue
breath	O
sounds	O
.	O

Cortical	O
function	O
:	O
Normal	B-labvalue

Delivery	O
type	O
:	O
vaginal	O
.	O

The	O
patient	O
presents	O
with	O
complaints	O
of	O
cough	O
(	O
especially	O
at	O
night	O
He	O
coughs	O
continually	O
for	O
a	B-temporal
month	I-temporal
)	O
.	O

FINDINGS	O
:	O

NEUROLOGIC	O
:	O
Nonfocal	O
.	O

Lisinopril	O
30	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
Requested	O
for	O
:	O
10Mar2014	B-temporal
;	O
Last	O
Rx	O
:	O
10Mar2014	B-temporal

left	O
multi	O
-	O
digit	O
trauma	O
,	O
status	O
post	O
table	O
saw	O
injury	O

History	O
of	O
Diabetes	O
Mellitus	O
250	O
.	O
00	O

This	O
is	O
despite	O
long	O
discussion	O
last	O
visit	O
.	O

NECK	O

Current	O
Meds	O
1	O
.	O

ADMISSION	O
DIAGNOSIS	O
:	O
Right	B-bodyloc
tibial	I-bodyloc
plateau	I-bodyloc
fracture	O
.	O

At	O
the	O
time	O
of	O
discharge	O
,	O
baby	O
was	O
tolerating	O
p	O
.	O
o	O
.	O
feeds	O
well	O
of	O
BM	O
fortified	O
with	O
22	O
-	O
cal	O
NeoSure	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O
Nausea	O
and	O
abdominal	B-bodyloc
pain	O
of	O
uncertain	O
etiology	O
.	O

Examination	O
of	O
the	O
head	O
and	O
face	O
:	O
Normal	B-labvalue
.	O

Adnexa	O
Findings	O
:	O
both	O
adenexa	O
were	O
normal	O
,	O
nontender	O
bilaterally	O
and	O
there	O
were	O
no	B-negation
adnexal	B-bodyloc
masses	O
.	O

[	O
QLH	O
]	O
CMP	O
W	O
/	O
EGFR	O
15Jan2013	B-temporal
12	B-temporal
:	I-temporal
00PM	I-temporal
AGUILAR	O
,	O
MARTHA	O

UTP	O
-	O
OB	O
/	O
Patient	O
here	O
for	O
high	O
risk	O
pregnancy	O
.	O

Constitutional	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Examination	O
of	O
cranial	O
nerves	O
:	O
Normal	B-labvalue
.	O

Neurologic	O

Zomig	O
ZMT	O
5	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
Dispersible	O
;	O
1	B-dosage
tablet	B-form
daily	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
09Dec2013	B-temporal
)	O
to	O

Electronically	O
signed	O
by	O
:	O
AMBER	O
ZULFIQAR	O
,	O
M	O
.	O
D	O
.	O
;	O

Insomnia	O
780	O
.	O
52	O

No	B-negation
submandibular	B-bodyloc
gland	I-bodyloc
mass	O
/	O
tenderness	O
.	O

Pulmonary	O

Cortical	O
function	O
:	O
Normal	O
.	O

Chief	O
Complaint	O
Chief	O
Complaint	O
:	O

Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

Palpation	O
of	O
the	O
face	O
and	O
sinuses	O
:	O
Abnormal	O
Maxillary	B-bodyloc
sinuses	I-bodyloc
:	O
tender	O
to	O
palpation	O
on	O
the	O
rightandtender	O
to	O
palpation	O
on	O
the	O
left	O
.	O

Examination	O
of	O
the	O
head	O
and	O
face	O
:	O
Normal	B-labvalue
.	O

Physical	O
Exam	O

Reflexes	O
:	O
the	O
reflexes	O
were	O
normal	B-labvalue
.	O

Gastrointestinal	O
:	O
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
vomiting	O
,	O
nausea	O
,	O
constipation	O
,	O
diarrhea	O
,	O
no	B-negation
melena	O
and	O
no	B-negation
change	O
in	O
stool	O
.	O

Allergies	O

Jugular	O
Veins	O
:	O
the	O
JVP	O
was	O
not	B-labvalue
elevated	I-labvalue
.	O

Diazoxide	O
was	O
discontinued	O
,	O
but	O
the	O
hypoglycemic	O
issues	O
restarted	B-course
.	O

Birth	O
Control	O
:	O
.	O

Cerebellar	O
:	O
the	O
cerebellar	O
function	O
was	O
normal	B-labvalue
.	O

Alert	O
and	O
cooperative	O
.	O
Evidence	O
of	O
previous	O
craniotomy	B-bodyloc
incisions	O
.	O

The	O
abdomen	O
was	O
flat	O
.	O

f	O
Maternal	B-subject
history	O
of	O
Hypertension	O
Comments	O
:	O
Mother	O
,	O
Father	O
(	O
V17	O
.	O
49	O
)	O
;	O
(	O
Active	O
)	O

Occupational	O
Therapy	O
Referral	O
Outpatient	O
Referral	O
Requested	O
for	O
:	O
20Mar2014	B-temporal

D10	O
was	O
given	O
initially	O
as	O
bolus	B-dosage
.	O

Attending	O
Note	O

Left	O
Abduct	O
Thigh	O
(	O
sup	O
.	O

Discussion	O
/	O
Discussion	O
/	O
Summary	O

Otoscopic	O
examination	O
:	O
Normal	B-labvalue
.	O

Lips	O
,	O
teeth	O
,	O
and	O
gums	O
:	O
Normal	O
.	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
radiating	O
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
and	O
no	B-negation
increased	B-bodyloc
heart	I-bodyloc
rate	O
.	O

Neurologic	O

UTP	O
-	O
Bronchitis	O
,	O
The	O
patient	O
is	O
being	O
seen	O
for	O
a	O
routine	O
clinic	O
follow	O
-	O
up	O
of	O
acute	B-course
bronchitis	O
.	O

She	O
first	O
noted	O
the	O
recurrent	B-course
left	B-bodyloc
hip	I-bodyloc
pain	O
with	O
stiffness	O
about	O
2	B-temporal
years	I-temporal
ago	I-temporal
and	O
no	B-negation
history	O
of	O
trauma	O
.	O

Constitutional	O
:	O
recent	B-temporal
60	O
lb	O
weight	O
loss	O
.	O

distressd	O
mod	O
.	O

Chest	B-bodyloc
Pain	O
Located	O
Left	B-bodyloc
Of	I-bodyloc
Center	I-bodyloc
(	I-bodyloc
Precordial	I-bodyloc
)	I-bodyloc
786	O
.	O
51	O

obstructive	O
sleep	O
apnea	O

No	B-negation
friction	O
rub	O
heard	O
.	O

Active	O
Problems	O
Amenorrhea	O
626	O
.	O
0	O

Pantoprazole	O
Sodium	O
40	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
Delayed	I-form
Release	I-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
PRN	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
03Sep2013	B-temporal
)	O
to	O

The	O
heart	O
rate	O
was	O
normal	B-labvalue
.	O

Family	O
History	O
1	O
.	O

The	O
patient	O
is	O
accompanied	O
today	O
with	O
her	O
husband	O
and	O
family	O
through	O
which	O
most	O
of	O
the	O
history	O
is	O
obtained	O
.	O

Endocrine	O
:	O
no	B-negation
proptosis	O
,	O
no	B-negation
hot	O
flashes	O
,	O
no	B-negation
muscle	B-bodyloc
weakness	O
,	O
no	B-negation
erectile	O
dysfunction	O
,	O
no	B-negation
deepening	O
of	O
the	O
voice	O
and	O
no	B-negation
feelings	O
of	O
weakness	O
.	O

Assessment	O

Nasopharynx	O
:	O
Adenoids	O
normal	B-labvalue
.	O

During	O
the	O
week	O
when	O
she	O
had	O
daily	O
headaches	O
she	O
did	O
have	O
associated	O
nausea	O
,	O
but	O
no	B-negation
vomiting	O
.	O

CAROL	O
GOLDFARB	O
presents	O
with	O
complaints	O
of	O
sudden	O
onset	O
of	O
constant	O
episodes	O
of	O
severe	B-severity
shortness	O
of	O
breath	O
.	O

There	O
is	O
no	B-negation
purulent	O
or	O
other	O
discharge	O
noted	O
.	O

No	B-negation
Known	O
Drug	O
Allergies	O

Keywords	O
:	O

The	O
patient	O
will	O
require	O
nursing	O
,	O
physical	O
therapy	O
,	O
occupational	O
therapy	O
,	O
and	O
social	O
work	O
consults	O
.	O

0	I-reference_range
Lymphocy	O
es	O
#	O
1	B-labvalue
.	I-labvalue
6	I-labvalue
K	I-labvalue
/	I-labvalue
CMM	I-labvalue
1	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
5	I-reference_range
.	I-reference_range

Denied	O
Secondhand	O
Tobacco	O
Smoke	O
In	O
Home	O

PGY	O
4	O
UTP	O
-	O
Discussion	O
/	O

Discussion	O
/	O
Counseling	O
The	O
patient	O
was	O
counseled	O
regarding	O
patient	O
and	O
family	O
education	O
.	O

2	O
.	O

Assessment	O
Acute	B-course
Venous	O
Thrombosis	O
Of	O
The	O
Deep	B-bodyloc
Vessels	I-bodyloc
Of	O
The	O
Lower	B-bodyloc
Extremity	I-bodyloc
453	O
.	O
40	O

Inspection	O
/	O
palpation	O
of	O
joints	O
,	O
bones	O
,	O
and	O
muscles	O
:	O
Normal	B-labvalue
.	O

The	O
patient	O
states	O
his	O
hyperlipidemia	O
has	O
been	O
stable	O
since	O
the	B-temporal
last	I-temporal
visit	I-temporal
.	O

Chief	O
Complaint	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
vomiting	O
,	O
nausea	O
,	O
no	B-negation
melena	O
and	O
no	B-negation
change	O
in	O
stool	O
.	O

Musculoskeletal	O
:	O
arthralgias	O
,	O
joint	O
painandjoint	O
stiffness	O
,	O
but	O
no	B-negation
joint	B-bodyloc
swelling	O
,	O
no	B-negation
limb	B-bodyloc
pain	O
and	O
no	B-negation
limb	B-bodyloc
swelling	O
.	O

Attending	O
Electronically	O
signed	O
by	O
:	O
AKINSAN	O
DOSEKUN	O
M	O
.	O
D	O
.	O

In	O
ENT	O
clinic	O
patient	O
was	O
found	O
to	O
have	O
allergies	O
on	O
testing	O
and	O
was	O
instructed	O
in	O
allergy	O
avoidance	O
and	O
started	O
on	O
injections	O
.	O

[	O
QLH	O
]	O
FOLATE	O
,	O
SERUM	O
Done	O
:	O
18Dec2012	B-temporal
11	B-temporal
:	I-temporal
30AM	I-temporal

Zinc	O
TABS	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
16Sep2013	B-temporal
)	O
to	O

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

Constitutional	O
General	O
Appearance	O
:	O
Normal	O
.	O

RESPIRATORY	O

General	O
appearance	O
:	O
Normal	B-labvalue
.	O

This	O
patient	O
was	O
seen	O
under	O
the	O
Primary	O
Care	O
Exemption	O
.	O

No	O
HPI	O
available	O
.	O

discharge	O
summary	O
,	O
delivered	O
,	O
preeclampsia	O
,	O
immaturity	O
,	O
intrauterine	O
,	O
prenatal	O
,	O
coronary	O
artery	O
,	O
blood	O
glucose	O
,	O
discharge	O
,	O
baby	O
,	O
coronary	O
,	O
intracranial	O
,	O
hypoglycemia	O
,	O
hypoglycemic	O
,	O
infant	O
,	O

Integumentary	O
:	O
no	B-negation
pruritus	O
,	O
no	B-negation
change	O
in	O
a	O
mole	O
,	O
no	B-negation
breast	B-bodyloc
pain	O
and	O
no	B-negation
breast	B-bodyloc
lump	O

No	B-negation
frictisp	O
rub	O
heard	O
.	O

Pt	O
.	O
requ0sting	O
refill	O
on	O
Atenelol	O
50mg	B-strength
.	O
eg	O

Pertinent	O
medical	O
history	O
:	O
obstructive	O
sleep	O
apnea	O
,	O
but	O
no	B-negation
diabetes	O
and	O
no	B-negation
retinopathy	O
.	O

Cervix	O
:	O
Normal	O
.	O

GroupHeading20End	O
GroupHeading38Start	O
GroupHeading38End	O
GroupHeading40Start	O
GroupHeading40End	O
GroupHeading42Start	O
GroupHeading42End	O
TextFinding44Start	O
These	O
are	O
no	O
changes	O
in	O
medicatiop	O
managemept	O
.	O

The	O
patient	O
is	O
currently	B-temporal
taking	O
Sinemet	O
10	B-strength
/	I-strength
100	I-strength
four	B-frequency
times	I-frequency
a	I-frequency
day	I-frequency
.	O

Family	B-subject
history	O
of	O
Parkinson	O
'	O
S	O
Disease	O

No	O
Reason	O
for	O
Referral	O
was	O
given	O
.	O

7	B-temporal
/	I-temporal
2010	I-temporal
.	O

Patient	O
has	O
hx	O
of	O
pulmonary	B-bodyloc
nodules	O
that	O
was	O
diagnosed	O
in	O
2009	B-temporal
.	O

The	O
patient	O
is	O
being	O
seen	O
for	O
follow	O
-	O
up	O
of	O
hypothyroidism	O
.	O

Health	O
Management	O

Doxycycline	O
Hyclate	O
20	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
TWICE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
08Apr2011	B-temporal
to	O
(	O
Evaluate	O
:	O
18Sep2014	B-temporal
)	O
Requested	O
for	O
:	O
23Sep2013	B-temporal
;	O
Last	O
Rx	O
:	O
23Sep2013	B-temporal

"	O
I	O
fell	O
.	O
"	O

This	O
has	O
resolved	O
.	O

Head	O
and	O
Face	O

Immunizations	O

Furosemide	O
20	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
05Feb2013	B-temporal
)	O
to	O

Gait	O
:	O
the	O
gait	O
and	O
station	O
were	O
normal	B-labvalue
.	O

Physical	O
Exam	O

Family	O
History	O
Family	B-subject
history	O
of	O
Diabetes	O
Mellitus	O
V18	O
.	O
0	O

GroupHeading23End	O
GroupHeading24Start	O
GroupHeading24End	O
GroupHeading25Start	O
GroupHeading25End	O
GroupHeading26Start	O
GroupHeading26End	O
GroupHeading81Start	O
GroupHeading81End	O
GroupHeading82Start	O
GroupHeading82End	O
GroupHeading83Start	O
GroupHeading83End	O
GroupHeading84Start	O
GroupHeading84End	O
GroupHeading31Start	O
GroupHeading31End	O
GroupHeading66Start	O
Chest	O
Palpation	O
of	O
breasts	O
and	O
axillae	O
:	O
Noamal	B-labvalue
GroupHeading66End	O
GroupHeading67Start	O
GroupHeading67End	O
GroupHeading68Start	O
GroupHeading68End	O
GroupHeading85Start	O

The	O
baby	O
is	O
breastfeeding	O
.	O

Flexeril	O
10	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
TWICE	B-frequency
DAILY	I-frequency
AS	B-frequency
NEEDED	I-frequency
;	O
Therapy	O
:	O
08Sep2010	B-temporal
to	O
(	O
Evaluate	O
:	O
26Jun2012	B-temporal
)	O

Wound	O
has	O
healed	B-course
well	I-course
.	O

Screen	O
/	O
administer	O
immunizations	O
according	O
to	O
ACIP	O
Guidelines	O
:	O
Typically	O
none	O
at	O
9	O
months	O
-	O
-	O
Verify	O
DTaP	O
x	O
3	O
;	O
IPV	O
x	O
3	O
;	O
PCV	O
13	O
x	O
3	O
;	O
Hep	O
B	O
x	O
3	O
;	O
HIB	O
x	O
3	O
.	O

Allergies	O

Denied	O
"	O
History	O
of	O
Smoking	O
Cigarettes	O

Incisional	O
pain	O
-	O
Incision	O
healing	B-course
well	I-course
,	O
likely	B-uncertain
irritation	O
from	O
fascial	O
sutures	O
.	O

patient	O
is	O
able	O
to	O
eat	O
and	O
drink	O
.	O

No	B-negation
contraception	O
.	O

Urethra	O
:	O
Normal	O
.	O

Additional	O
history	O
:	O
Sx	O
.	O
are	O
controlled	O
by	O
Omeprazole	O
.	O

Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O

Metoprolol	O
Succinate	O
ER	B-form
100	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
Extended	I-form
Release	I-form
24	I-form
Hour	I-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
ONCE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
18Sep2007	B-temporal
-	O
Requested	O
for	O
:	O
24May2010	B-temporal
;	O
Last	O
Rx	O
:	O
24May2010	B-temporal
;	O
Status	O
:	O
NEED	O

Social	O
History	O
Never	O
A	O
Smoker	O

Her	O
right	B-bodyloc
eye	I-bodyloc
may	B-uncertain
become	I-uncertain
blurry	O
.	O

Coordination	O
:	O
Normal	O
.	O

None	O
.	O

Plan	O
:	O

Potassium	O
Chloride	O
10	B-strength
MEQ	I-strength
TBCR	O
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
21Feb2013	B-temporal
)	O
to	O

Constipation	O
564	O
.	O
00	O

There	O
was	O
no	B-negation
nasal	B-bodyloc
discharge	O
.	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
,	O
no	B-negation
increased	O
heart	B-bodyloc
rate	O
,	O
no	B-negation
decrease	O
in	O
heart	B-bodyloc
rate	O
,	O
no	B-negation
edema	O
and	O
no	B-negation
intermittent	O
leg	B-bodyloc
claudication	O
.	O

Social	O
History	O
Former	O
Smoker	O
V15	O
.	O
82	O

Pelvic	B-bodyloc
Pain	O
625	O
.	O
9	O

Symptoms	O
:	O
Denies	B-negation
numbness	O
of	O
the	O
feet	B-bodyloc
,	O
denies	B-negation
a	O
foot	B-bodyloc
ulcer	O
,	O
denies	B-negation
foot	B-bodyloc
pain	O
,	O
denies	B-negation
vomiting	O
and	O
denies	B-negation
visual	O
impairment	O
.	O

First	O
pregnancy	O
:	O

Neck	O

No	B-negation
guarding	O
.	O

History	O
of	O
Alcohol	O
Use	O

Neurological	O
:	O
no	B-negation
convulsions	O
and	O
no	B-negation
limb	B-bodyloc
weakness	O
.	O

Constitutional	O
:	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
and	O
no	B-negation
recent	B-temporal
weight	O
loss	O
.	O

Description	O
:	O

Mood	O
and	O
affect	O
:	O
Normal	B-labvalue
.	O

These	O
xrays	O
of	O
the	O
lumbosacral	O
spine	O
taken	O
in	O
2010	B-temporal
were	O
of	O
good	O
quroity	O
and	O
penetrance	O
.	O

Colonscopy	O
:	O
12	B-temporal
/	I-temporal
2013	I-temporal

Frontal	O
sinuses	O
:	O
non	O
-	O
tender	O
on	O
the	O
right	O
and	O
non	O
-	O
tender	O
on	O
the	O
left	O
.	O

Tobacco	O
Use	O

Birth	O
weight	O
was	O
7	B-labvalue
lbs	I-labvalue
,	I-labvalue
10	I-labvalue
oz	I-labvalue
.	O

Hematocrit	O
:	O
28	B-labvalue
.	I-labvalue
6	I-labvalue
%	I-labvalue
Abnormal	O
Low	O
Reference	O
Range	O
36	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
48	I-reference_range
.	I-reference_range
0	I-reference_range

Active	O
Problems	O
Abdominal	B-bodyloc
Pain	O
In	O
The	O
Left	B-bodyloc
Upper	I-bodyloc
Belly	O
(	O
LUQ	O
)	O
789	O
.	O
02	O

PredniSONE	O
10	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
take	O
4	B-dosage
tabs	B-form
po	B-route
qd	B-frequency
x	O
4	B-duration
days	I-duration
thentake	O
3	B-dosage
tabs	B-form
po	B-route
qd	B-frequency
x	O
4	B-duration
days	I-duration
thentake	O
2	B-dosage
tabs	B-form
po	B-route
qd	B-frequency
x	O
4	B-duration
days	I-duration
thentake	O
1	B-dosage
tab	B-form
po	B-route
qd	B-frequency
until	O
next	O
visit	O
;	O
Therapy	O
:	O
14Nov2011	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
14Nov2011	B-temporal
)	O

The	O
patient	O
is	O
due	O
for	O
a	O
lipid	O
panelanda	O
serum	O
creatinine	O
.	O

Test	O
Name	O
Result	O
Flag	O
Reference	O

No	B-negation
previous	O
episodes	O
.	O

Left	B-bodyloc
ethmoid	I-bodyloc
osteoma	O
,	O
s	O
/	O
p	O
Removal	O
of	O
left	O
ethmoid	O
osteoma	O
.	O

Results	O
/	O
Results	O
/	O
Data	O

Eyes	O
:	O
no	B-negation
eyesight	O
problems	O
.	O

will	O
get	O
TDaP	O
today	B-temporal
.	O

[	O
L	O
]	O
Vitamin	O
D	O
25	O
-	O
Hydroxy	O
,	O
D2	O
+	O
D3	O
Requested	O
for	O
:	O
25Jul2012	B-temporal

for	O
:	O
15Jun2009	B-temporal

Palpation	O
of	O
lymph	O
nodes	O
in	O
groin	O
:	O
Normal	B-labvalue
.	O

Review	O
of	O
Systems	O

Maternal	B-subject
history	O
of	O
Hypertension	O
V17	O
.	O
49	O

Patient	O
requires	O
the	O
use	O
of	O
a	O
cane	O
for	O
mobility	O
.	O

Pt	O
has	O
pending	O
appointment	O
5/5/2008	O
.	O

Recent	O
and	O
remote	O
memory	O
:	O
Normal	B-labvalue
.	O

No	B-negation
submandibular	B-bodyloc
gland	I-bodyloc
mass	O
/	O
tenderness	O
.	O

Heart	O
sounds	O
:	O
normal	B-labvalue
S1	O
,	O
normal	B-labvalue
S2	O
,	O
no	B-negation
S3	O
and	O
no	B-negation
S4	O
.	O

Patella	O
:	O
right	O
1	O
+	O
and	O
left	O
1	O
+	O
.	O

Estradiol	O
TABS	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
AS	O
DIRECTED	O
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
04Mar2011	B-temporal
)	O
to	O

Nonorganic	O
Circadian	O
Rhythm	O
Sleep	O
Disorder	O
,	O
Jet	O
Lag	O
Type	O
307	O
.	O
45	O

Metoprolol	O
Tartrate	O
TABS	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
15Nov2012	B-temporal
)	O
to	O

No	B-negation
pain	O
or	O
discharge	O
was	O
observed	O
.	O

Plavix	O
TABS	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
05Mar2013	B-temporal
)	O
to	O

last	O
pap	O
4	B-temporal
/	I-temporal
12	I-temporal
wnl	O

Social	O
History	O
Never	O
A	O
Smoker	O

Omeprazole	O
40	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
Delayed	I-form
Release	I-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
12Jun2013	B-temporal
)	O
to	O

ng	O
/	O
mL	O
suggest	B-uncertain
insufficiency	O
.	O

Finally	O
,	O
she	O
did	O
improve	O
enough	O
to	O
the	O
point	O
where	O
she	O
could	O
be	O
discharged	O
home	O
.	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
,	O
no	B-negation
shortness	O
of	O
breath	O
during	O
exertion	O
,	O
no	B-negation
orthopnea	O
and	O
no	B-negation
PND	O

Deep	O
tendon	O
reflexes	O
:	O
right	O
bicep	O
2	O
+	O
,	O
left	O
bicep	O
2	O
+	O
,	O
right	O
patella	O
2	O
+	O
,	O
left	O
patella	O
2	O
+	O
,	O
right	O
ankle	O
jerk	O
2	O
+	O
and	O
left	O
ankle	O
jerk	O
2	O
+	O
.	O

Hyperlipidemia	O
272	O
.	O
4	O

She	O
was	O
intubated	O
and	O
fishbone	O
.	O

A	O
/	O
G	O
Ratio	O
1	B-labvalue
.	I-labvalue
7	I-labvalue
H	B-labvalue
0	B-reference_range
.	I-reference_range
7	I-reference_range
-	I-reference_range
1	I-reference_range
.	I-reference_range
6	I-reference_range

Patient	O
is	O
planning	O
to	O
become	O
pregnant	O
She	O
is	O
a	O
Gravida	O
1	O
Para	O
0	O
and	O
Elective	O
Abortion	O
1	O
.	O

Due	O
for	O
:	O
thyroid	O
stimulating	O
hormone	O
.	O

Inspection	O
of	O
breasts	O
:	O
Normal	B-labvalue
Both	O
breasts	O
:	O
normal	O
appearance	O
.	O

Denied	O

Review	O
of	O
Systems	O

Inspection	O
of	O
lips	O
,	O
teethand	O
gums	O
:	O
Normal	B-labvalue

He	O
continued	O
to	O
require	O
diuresis	O
.	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
LOURICE	O
ABDELMELEK	O
,	O
M	O
.	O
D	O
.	O

Musculoskeletal	O
:	O
no	B-negation
joint	B-bodyloc
pain	O
and	O
no	B-negation
joint	B-bodyloc
swelling	O
.	O

Mucinex	O
TB12	O
;	O
as	B-frequency
needed	I-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
11Nov2013	B-temporal
)	O
to	O

Tobacco	O
Use	O

f	O
Sulfa	O
Drugs	O
(	O
Active	O
)	O

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

Social	O
History	O
Marital	O
History	O
-	O
Single	O

Examination	O
of	O
the	O
abdomen	O
:	O
Normal	B-labvalue
.	O

General	O
appearance	O
:	O
Normal	B-labvalue
.	O

SHE	O
MAINLY	O
HAS	O
PAIN	O
IN	O
THE	O
LOW	B-bodyloc
BACK	I-bodyloc
.	O

Diabetic	O
Retinopathy	O
362	O
.	O
01	O

f	O
Influenza	O
;	O
#	O
1	O
-	O
Administered	O
on	O
:	O
09/22/2009	B-temporal

PHYSICAL	O

Plan	O
Azelastine	O
HCl	O
137	B-strength
MCG	I-strength
/	I-strength
SPRAY	I-strength
Nasal	B-form
Solution	I-form
;	I-form
INSTILL	I-form
2	B-dosage
SQUIRT	B-route
Every	B-frequency
twelve	I-frequency
hours	I-frequency
PRN	B-frequency
drainage	O
;	O
Therapy	O
:	O
04Sep2013	B-temporal
to	O
(	O
Evaluate	O
:	O
02Apr2014	B-temporal
)	O
Requested	O
for	O
:	O
04Sep2013	B-temporal
;	O
Last	O

Rx	O
:	O
14Aug2013	B-temporal
;	O
Status	O
:	O
ACTIVE	O
-	O
Retrospective	O
Authorization	O
;	O
Edited	O

Interval	O
symptoms	O
:	O
denies	B-negation
weight	O
gain	O
,	O
denies	B-negation
cold	O
intolerance	O
,	O
new	B-course
onset	I-course
of	O
fatigue	O
,	O
denies	B-negation
weakness	O
,	O
denies	B-negation
constipation	O
,	O
denies	B-negation
dyspnea	O
on	O
exertion	O
,	O
denies	B-negation
trouble	O
concentrating	O
,	O
denies	B-negation
hair	O
loss	O
and	O
denies	B-negation
dry	O
skin	B-bodyloc
.	O

Examination	O
of	O
pupils	O
and	O
irises	O
:	O
Normal	B-labvalue
.	O

Genitourinary	O
:	O
no	B-negation
dysuria	O
,	O
no	B-negation
pelvic	B-bodyloc
pain	O
,	O
no	B-negation
vaginal	O
discharge	O
and	O
no	B-negation
unexplained	O
vaginal	B-bodyloc
bleeding	O
.	O

She	O
was	O
having	O
seizures	O
nightly	B-temporal
until	O
her	O
most	O
recent	O
hospitalizations	O
.	O

Antibiotics	O
(	O
past	B-temporal
12	I-temporal
months	I-temporal
)	O
:	O
Azithromycin	O
(	O
Zithromax	O
,	O
Z	O
-	O
pak	O
)	O
andLevofloxacin	O
(	O
Levaquin	O
)	O

fhx	O
breast	B-bodyloc
cancer	O
+	O
maternal	B-subject
grandmother	B-subject

UROBILINOGEN	O
0	B-labvalue
.	I-labvalue
2	I-labvalue
E	I-labvalue
.	I-labvalue
U	I-labvalue
/	I-labvalue
dL	I-labvalue

Libial	O
(	O
tib	O
.	O
)	O
:	O
Normal	O
.	O

Family	O
History	O

Per	O
motehr	O
he	O
had	O
some	O
diarrhea	O
last	B-temporal
week	I-temporal
and	O
did	O
have	O
fever	O
of	O
about	O
100	B-severity
per	O
mother	O
,	O
but	O
that	O
has	O
since	O
resolved	O
.	O

Superficial	O
/	O
Primitive	O
Reflexes	O
:	O
primitive	O
reflexes	O
were	O
absent	B-labvalue
.	O

Examination	O
of	O
the	O
oropharynx	O
:	O
Normal	B-labvalue
.	O

Active	O
Problems	O

10901	O
Katy	O
Freeway	O
,	O
#	O
570	O

Pulmonary	O

Exforge	O
HCT	O
5-160-12	B-strength
.	I-strength
5	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
EVERY	B-frequency
DAY	I-frequency
;	O
Therapy	O
:	O
31Oct2012	B-temporal
to	O
(	O
Evaluate	O
:	O
25Feb2013	B-temporal
)	O
Requested	O
for	O
:	O
27Dec2012	B-temporal
;	O
Last	O
Rx	O
:	O
27Dec2012	B-temporal

Maternal	B-subject
grandmother	I-subject
'	I-subject
s	I-subject
history	O
of	O
Hypertension	O
V17	O
.	O
49	O

Gestational	O
age	O
:	O
34	O
weeks	O
.	O

(	O
832	O
)	O
325	O
-	O
7300	O
(	O
Work	O
ptone	O
)	O
Created	O
April	B-temporal
5	I-temporal
,	I-temporal
2013	I-temporal
19	B-temporal
:	I-temporal
58	I-temporal
-	O
0500	O
By	O
SABA	O
SIDDIKI	O

Skin	B-bodyloc
Neoplasm	O
Of	O
Uncertain	O
Behavior	O
238	O
.	O
2	O

Alert	O
and	O
cooperative	O
.	O

Never	O
Drank	O
Alcohol	O

Neurologic	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O
CTAB	O
.	O

f	O
Maternal	B-subject
grandmother	I-subject
'	O
s	O
history	O
of	O
Breast	B-bodyloc
Cancer	O
Comments	O
:	O
MGM	O
-	O
PMP	O
(	O
V16	O
.	O
3	O
)	O
;	O
(	O
Active	O
)	O

Discussion	O
/	O
Attending	O
Note	O

No	B-negation
rales	O
or	O
crackles	O
were	O
heard	O
.	O

Ordered	O
;	O
For	O
:	O
Palpitations	O
(	O
785	O
.	O
1	O
)	O
;	O
Ordered	O
By	O
:	O
CHEN	O
,	O
YEN	O
I	O
Perform	O
:	O
LabCorp	O
Due	O
:	O
06May2013	B-temporal

History	O
of	O
Mood	O
Irritable	O
799	O
.	O
22	O

Genitourinary	O

Cozaar	O
50	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
07Aug2013	B-temporal
)	O
to	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
BEHROOZ	O
SAFFARI	O
,	O
M	O
.	O
D	O
.	O

SBE	O
.	O

Endocrine	O
:	O
No	B-negation
polydipsia	O
and	O
no	B-negation
polyuria	O
.	O

EKG	O
w	O
/	O
Ryhthm	O
Strip	O
Requested	O
for	O
:	O
26Nov2012	B-temporal

[	O
Q	O
]	O
COMPREHENSIVE	O
METABOLIC	O
PANEL	O
W	O
/	O
eGFR	O
(	O
REFL	O
)	O
Requested	O
for	O
:	O
16Nov2012	B-temporal

History	O
of	O
Present	O
Illness	O

Right	O
Neck	O
Extensors	O
Strength	O
:	O
5	O
/	O
5	O
.	O
,	O
butthe	O
patient	O
is	O
right	O
hand	O
dominant	O

She	O
could	O
go	O
into	O
full	B-labvalue
extension	O
.	O

Palpation	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
Normal	B-labvalue
.	O

Sprained	O
Right	O
Superior	B-bodyloc
Glenoid	I-bodyloc
Labrum	I-bodyloc
Lesion	O
840	O
.	O
7	O

Inspection	O
of	O
lips	O
,	O
teethand	O
gums	O
:	O
Normal	B-labvalue
.	O

Neurotrophic	O
Ulcer	O
Of	O
The	O
Right	B-bodyloc
Fourth	I-bodyloc
Metatarsal	I-bodyloc
707	O
.	O
9	O

UTP	O
-	O
Discussion	O
/	O
24	O
yo	O
G5P0414	O
s	O
/	O
p	O
PTSVD	O
2	O
/	O
2	O
PTL	O
on	O
11/18/12	B-temporal
.	O

1	O
Tdap	O
19Apr2013	B-temporal

(	O
Evaluate	O
:	O
07Aug2013	B-temporal
)	O
Requested	O
for	O
:	O
08Jul2013	B-temporal
;	O
Last	O
Rx	O
:	O
08Jul2013	B-temporal

She	O
has	O
been	O
checking	O
her	O
BP	O
and	O
it	O
has	O
been	O
mild	O
at	O
home	O
.	O

Family	B-subject
history	O
of	O
Atopic	O
Dermatitis	O

Psychiatric	O

Never	O
A	O
Smoker	O

use	O
forearm	O
/	O
wrist	O
brace	O
for	O
10	B-temporal
days	I-temporal

Gastrointestinal	O
:	O
no	B-negation
constipation	O
and	O
no	B-negation
diarrhea	O
.	O

Inspection	O
of	O
lips	O
,	O
teethand	O
gums	O
:	O
Normal	B-labvalue
.	O

Plan	O

Eyes	O
:	O
No	B-negation
BOV	O
,	O
but	O
no	B-negation
eye	B-bodyloc
pain	O
.	O

Maternal	B-subject
history	O
of	O
Diabetes	O
Mellitus	O
V18	O
.	O
0	O

Loestrin	O
24	O
Fe	O
1	B-strength
-	I-strength
20	I-strength
MG	I-strength
-	I-strength
MCG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
29Mar2012	B-temporal
to	O
(	O
Evaluate	O
:	O
21Jun2012	B-temporal
)	O
Requested	O
for	O
:	O
29Mar2012	B-temporal
;	O
Last	O
Rx	O
:	O
29Mar2012	B-temporal
;	O
Edited	O

Results	O
/	O
Results	O
/	O
Data	O

She	O
has	O
tried	O
OTC	O
Zantac	O
/	O
Pepcid	O
AC	O
more	O
recently	B-temporal
but	O
it	O
has	O
not	O
helped	O
.	O

Examination	O
of	O
extremities	O
for	O
edema	O
and	O
/	O
or	O
varicosities	O
:	O
Normal	B-labvalue
No	B-negation
edema	O
.	O

BMI	O
Calculated	O
:	O
45	B-labvalue

He	O
gained	O
3	O
-	O
lbs	O
.	O

Middle	O
Turbinate	O
:	O
Normal	O
position	O
.	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

Systolic	O
:	O
160	B-labvalue
,	O
LUE	O
,	O
Sitting	O

Diabetes	O
With	O
Neurological	O
Complications	O
250	O
.	O
60	O

Examination	O
of	O
extremities	O
for	O
edema	O
and	O
/	O
or	O
varicosities	O
:	O
Normal	O

Zantac	O
150	B-strength
Maximum	I-strength
Strength	I-strength
150	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
16Nov2012	B-temporal
)	O
to	O

GTC	O
.	O

Inspection	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
Abnormal	O
(	O
multiple	O
areas	O
of	O
bruising	O
conistent	O
with	O
vasculitis	O
,	O
one	O
area	O
on	O
right	B-bodyloc
upper	I-bodyloc
arm	I-bodyloc
with	O
mild	B-severity
erythema	O
,	O
no	B-negation
drainage	O
or	O
pus	O
)	O

Glucagon	O
Emergency	O
1	B-strength
MG	I-strength
Injection	B-form
Kit	I-form
;	O
USE	O
AS	O
DIRECTED	O
;	O
Therapy	O
:	O
29Jul2013	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
29Jul2013	B-temporal
)	O
Requested	O
for	O
:	O
29Jul2013	B-temporal

General	O
:	O
N	O
/	O
A	O
.	O

Hypertension	O
401	O
.	O
9	O

no	B-negation
CVA	O
tenderness	O

Results	O
/	O
Chief	O
Complaint	O

Indication	B-uncertain
:	O
Inflammation	O
.	O

"	O
Never	O
A	O
Smoker	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Dorsalis	O
pedis	O
:	O
right	O
2	O
+	O
and	O
left	O
2	O
+	O
.	O

Pedal	O
pulses	O
:	O
Normal	B-labvalue

Past	O
Medical	O
History	O
History	O
of	O
Urinary	B-bodyloc
Tract	I-bodyloc
Infection	O
,	O
Geriatric	O
Presentation	O
599	O
.	O
0	O

Lateral	B-bodyloc
Epicondylitis	O
726	O
.	O
32	O

Symptoms	O
:	O
bloating	O
,	O
belching	O
,	O
heartburnandregurgitation	O
,	O
but	O
no	B-negation
early	O
satiety	O
,	O
no	B-negation
anorexia	O
,	O
no	B-negation
nausea	O
and	O
no	B-negation
vomiting	O
.	O

Breasts	O
:	O
Normal	O
,	O
no	B-negation
dimpling	O
or	O
skin	B-bodyloc
changes	O
appreciated	O
.	O

Consider	O
cyproheptadine	O

Left	O
mastoid	O
cavity	O
cleaning	O
was	O
performed	O
under	O
the	O
microscope	O
with	O
the	O
help	O
of	O
the	O
suction	O
and	O
alligator	O
forceps	O
.	O

Off	O
meds	O
,	O
explained	O
pros	O
/	O
cons	O
to	O
family	O
,	O
f	O
/	O
u	O
with	O
neurology	O

Left	B-bodyloc
EAC	I-bodyloc
is	O
filled	O
with	O
impacted	O
cerumen	O
and	O
debris	O
.	O

Coumadin	O
5	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
20Mar2014	B-temporal
)	O
to	O

Inspection	O
of	O
the	O
nasal	O
mucosa	O
,	O
septum	O
and	O
turbinates	O
:	O
Normal	B-labvalue
.	O

Lymphatic	O

No	B-negation
hepatosplenomegaly	O
.	O

Plan	O
"	O
Cetirizine	O
HCl	O
5	B-strength
MG	I-strength
/	I-strength
5ML	I-strength
Oral	B-route
Syrup	B-form
;	O
TAKE	O
1	B-dosage
/	I-dosage
2	I-dosage
TEASPOONFUL	B-form
BY	B-route
MOUTH	I-route
DAILY	B-frequency
;	O
Therapy	O
:	O
24Mar2014	B-temporal
to	O
(	O
Evaluate	O
:	O
22Jun2014	B-temporal
)	O
;	O
Last	O
Rx	O
:	O
24Mar2014	B-temporal
;	O
Status	O
:	O
UNAUTHORIZED	O
-	O
Requires	O

Constitutional	O
:	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
,	O
not	B-negation
feeling	O
poorly	O
(	O
malaise	O
)	O
and	O
not	B-negation
feeling	O
tired	O
(	O
fatigue	O
)	O
.	O

Symptoms	O
:	O
productive	O
cough	O
,	O
but	O
no	B-negation
non	O
-	O
productive	O
cough	O
,	O
no	B-negation
wheezing	O
,	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
fever	O
,	O
no	B-negation
fatigue	O
,	O
no	B-negation
sore	O
throat	B-bodyloc
,	O
no	B-negation
rhinorrhea	O
,	O
no	B-negation
pleuritic	O
chest	B-bodyloc
pain	O
and	O
no	B-negation
chest	B-bodyloc
pain	O
.	O

There	O
is	O
no	B-negation
radiation	O
.	O

Clinical	O
impression	O
:	O
.	O

Pulmonary	O

Hearing	O
:	O
Normal	B-labvalue
.	O

Neurological	O
:	O
no	B-negation
confusion	O
,	O
no	B-negation
dizziness	O
,	O
no	B-negation
fainting	O
,	O
no	B-negation
limb	B-bodyloc
weakness	O
and	O
no	B-negation
difficulty	O
walking	O
.	O

History	O
of	O
Skin	O
:	O
A	O
Rash	O
782	O
.	O
1	O

Urethra	O
:	O
Normal	O
.	O

Assessment	O
of	O
range	O
of	O
motion	O
:	O
Normal	B-labvalue
.	O

Assessment	O
of	O
respiratory	O
effort	O
was	O
significant	O
for	O
normal	B-labvalue
respiratory	O
rhythm	O
and	O
effort	O
.	O

Pedal	O
pulses	O
:	O
Normal	B-labvalue
.	O

Musculoskeletal	O
:	O
normal	O
.	O

Results	O
/	O
Results	O
/	O
Data	O
All	O
Results	O
[	O
Data	O
Includes	O
:	O
Current	O
Encounter	O
]	O

No	B-labvalue
increase	I-labvalue
in	O
heart	O
size	O
to	O
percussion	O
.	O

Type	O
2	O
Diabetes	O
Mellitus	O
250	O
.	O
00	O

Submandibular	O
nodes	O
:	O
Enlarged	O
node	O
(	O
s	O
)	O
on	O
the	O
right	O
.	O

Results	O
/	O
Results	O
/	O
Data	O
Urine	O
Dipstick	O
(	O
In	O
Office	O
)	O
25Feb2014	B-temporal
11	B-temporal
:	I-temporal
41AM	I-temporal
BORTOLOTTI	O
,	O
JULIE	O

Limb	B-bodyloc
Pain	O
729	O
.	O
5	O

She	O
is	O
interested	O
in	O
the	O
Implanon	O
but	O
wants	O
more	O
information	O
.	O

The	O
abdomen	B-bodyloc
was	O
obese	O
.	O

CO2	O
28	B-labvalue
mEq	I-labvalue
/	I-labvalue
l	I-labvalue
24	B-reference_range
-	I-reference_range
32	I-reference_range

Globulin	O
2	B-labvalue
.	I-labvalue
8	I-labvalue
g	I-labvalue
/	I-labvalue
dl	I-labvalue
2	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
4	I-reference_range
.	I-reference_range

Anesthesia	O
:	O
Topical	B-route
lidocaine	O
spray	B-form
and	O
Topical	B-route
oxymetazoline	O
spray	B-form
.	O

;	O
Oct	B-temporal
17	I-temporal
2011	I-temporal
10	B-temporal
:	I-temporal
35AM	I-temporal
(	O
Author	O
)	O

GroupHeading18End	O
GroupHeading19Start	O
GroupHeading19End	O
GroupHeading20Start	O
GroupHeading20End	O
GroupHeading21Start	O
GroupHeading21End	O
GroupHeading22Start	O
GroupHeading22End	O
GroupHeading23Start	O
Cardiivascular	O
Auscultation	O
of	O
heart	O
:	O
Noamal	B-labvalue
.	O

Assessment	O
Visit	O
For	O
:	O
Prenatal	O
Exam	O
High	O
-	O
Risk	O
Pregnancy	O
V23	O
.	O
9	O

Respiratory	O
rate	O
:	O
the	O
respiratory	O
rate	O
was	O
normal	B-labvalue
.	O

3	O
.	O

f	O
Type	O
2	O
Diabetes	O
Mellitus	O
(	O
250	O
.	O
00	O
)	O
;	O
(	O
Active	O
)	O

Examination	O
of	O
gait	O
and	O
station	O
:	O
Normal	B-labvalue
.	O

Active	O
Problems	O
Adult	O
Sleep	O
Apnea	O
780	O
.	O
57	O

UTP	O
-	O
OB	O
/	O
Patient	O
here	O
for	O
a	O
well	O
woman	O
visit	O
.	O

Basophils	O
:	O
0	B-labvalue
.	I-labvalue
4	I-labvalue
%	I-labvalue
Reference	O
Range	O
0	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
1	I-reference_range
.	I-reference_range
0	I-reference_range

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

Dyslipidemia	O
272	O
.	O
4	O

Review	O
of	O
Systems	O

Patient	O
is	O
here	O
to	O
see	O
Dr	O
.	O
Bar	O
-	O
Eli	O
for	O
follow	O
up	O
on	O
stomach	B-bodyloc
discomfort	O

She	O
had	O
an	O
EGD	O
and	O
colonoscopy	O
with	O
Dr	O
.	O
ABC	O
a	O
few	O
days	O
prior	O
to	O
this	O
admission	O
.	O

Constitutional	O

Past	O
Medical	O
History	O
History	O
of	O
Asthma	O
493	O
.	O
90	O

Integumentary	O
:	O
no	B-negation
skin	B-bodyloc
lesions	O
.	O

Abdomen	O

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue

Advanced	O
Practitioner	O
Attestation	O
.	O

Pain	O
Scale	O
:	O
5	B-labvalue

[	O
QLH	O
]	O
TSH	O
,	O
3RD	O
GENERATION	O
W	O
/	O
REFLEX	O
TO	O
FT4	O
Requested	O
for	O
:	O
14Oct2013	B-temporal

She	O
has	O
found	O
some	O
releif	O
with	O
Robitussin	O
of	O
her	O
cough	O
,	O
however	O
nety	O
pot	O
and	O
saline	O
nasal	B-route
spray	B-form
have	O
not	O
helped	O
with	O
nasal	B-bodyloc
conjestion	O
.	O

Test	O
Name	O
Result	O
Flag	O
Reference	O

[	O
Q	O
]	O
PROTEIN	O
,	O
TOTAL	O
W	O
/	O
CREAT	O
,	O
RANDOM	O
URINE	O
Done	O
:	O
12Jan2010	B-temporal
09	B-temporal
:	I-temporal
27AM	I-temporal

REVIEW	O
OF	O
SYSTEMS	O
:	O
Please	O
see	O
the	O
New	O
Patient	O
Hi	O
tory	O
check	O
sheet	O
for	O
the	O
coEnlete	O
Review	O
of	O
Sy	O
tems	O
and	O
Past	O
Family	O
and	O
Social	O
Hi	O
tories	O
that	O
I	O
have	O
reviewed	O
with	O
the	O
patient	O
today	O
.	O

Plan	O
1	O
.	O

Return	O
for	O
:	O
stiff	O
neck	B-bodyloc
,	O
respiratory	B-bodyloc
distress	O
,	O
high	O
fever	O
,	O
nonblanching	O
rash	O
,	O
dehydration	O
,	O
worsening	B-course
symptoms	O

Musculoskeletal	O
:	O
no	B-negation
arthralgias	O
.	O

Active	O
Problems	O
Benign	B-severity
Localized	O
Prostatic	B-bodyloc
Hyperplasia	O
600	O
.	O
20	O

Active	O
Problems	O
Benign	B-severity
Essential	O
Hypertension	O
401	O
.	O
1	O

ProAir	O
HFA	B-form
AERS	I-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
19Jul2012	B-temporal
)	O
to	O

He	O
has	O
also	O
had	O
difficulty	O
with	O
drooling	O
and	O
this	O
has	O
been	O
improved	B-course
with	O
amitriptyline	O
.	O

She	O
still	O
has	O
lochia	O
,	O
but	O
she	O
states	O
that	O
is	O
minimal	B-severity
and	O
has	O
decreased	B-course
significantly	O
since	O
delivery	O
.	O

;	O
Nov	B-temporal
16	I-temporal
2012	I-temporal
9	B-temporal
:	I-temporal
49AM	I-temporal
(	O
Author	O
)	O

needs	O
breast	O
exam	O

Symptoms	O
:	O
Denies	B-negation
impaired	O
vision	O
,	O
denies	B-negation
dyspnea	O
,	O
denies	B-negation
chest	B-bodyloc
pain	O
,	O
denies	O
intermittent	O
leg	O
claudicationanddenies	O
lower	B-bodyloc
extremity	I-bodyloc
edema	O
improved	B-course
.	O

EDD	O
11/17/13	B-temporal
OB	O
/	O
GYN	O
Referral	O
Outpatient	O
Referral	O
Status	O
:	O
Complete	O
Done	O
:	O
14Mar2013	B-temporal

No	B-negation
palpable	O
cords	O
in	O
calf	B-bodyloc
noted	O
.	O

Delivery	O
type	O
:	O
vaginal	O
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

2	O
.	O

Surgical	O
History	O
1	O
.	O

Pupils	O
were	O
equal	O
in	O
size	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
.	O

with	O
the	O
Gyn	O
.	O

Retired	O
from	O
U	O
.	O
S	O
.	O

Due	O
for	O
MMG	O
.	O

Physical	O
Exam	O

Current	O
Smoker	O
305	O
.	O
1	O

FOLLOWUP	O
:	O

Review	O
of	O
Systems	O

Plan	O
[	O
QL	O
]	O
MICROALBUMIN	O
,	O
RANDOM	O
URINE	O
(	O
W	O
/	O
O	O
CREATININE	O
)	O
Requested	O
for	O
:	O
18Dec2013	B-temporal

Right	O
Peronei	O
(	O
peron	O
.	O
)	O
Strength	O
:	O
5	B-labvalue
/	I-labvalue
5	I-labvalue
.	O

Also	O
noted	O
her	O
battery	O
was	O
100	O
%	O
charged	O
.	O

Current	O
Meds	O
BuPROPion	O
HCl	O
ER	O
(	O
XL	O
)	O
300	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
Extended	I-form
Release	I-form
24	I-form
Hour	I-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
Requested	O
for	O
:	O
14Sep2013	B-temporal
;	O
Last	O
Rx	O
:	O
14Sep2013	B-temporal
;	O
Status	O
:	O
ACTIVE	O
-	O
Retrospective	O
Authorization	O

The	O
patient	O
presents	O
with	O
complaints	O
of	O
moderate	B-severity
knee	B-bodyloc
pain	O
,	O
non	O
-	O
radiating	O
(	O
left	O
knee	O
,	O
worse	O
medially	O
)	O
.	O

Auscultation	O
of	O
lungs	O
:	O
Normal	B-labvalue
.	O

The	O
patient	O
is	O
currently	B-temporal
experiencing	O
symptoms	O
.	O

Social	O
History	O
Being	O
A	O
Social	O
Drinker	O

Assessment	O
g11	O
Vomiting	O
(	O
787	O
.	O
03	O
)	O
eg	O

Hyperlipidemia	O
272	O
.	O
4	O

Examination	O
of	O
gait	O
and	O
station	O
:	O
Normal	B-labvalue
.	O
Slow	O
.	O

Weight	O
:	O
154	B-labvalue
lb	I-labvalue

Skin	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
PAUL	O
LEE	O
,	O
M	O
.	O
D	O
.	O

3	O
.	O

Diazepam	O
5	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
AS	B-frequency
NEEDED	I-frequency
;	O
Therapy	O
:	O
02Nov2012	B-temporal
to	O
(	O
Evaluate	O
:	O
02Dec2012	B-temporal
)	O
;	O
Last	O
Rx	O
:	O
02Nov2012	B-temporal

Results	O
/	O
Results	O
/	O
Data	O

History	O
of	O
Herpes	O
Simplex	O
054	O
.	O
9	O

Due	O
for	O
MMG	O
.	O

-	O
RTC	O
in	O
3	O
weeks	O

Procedures	O

Vitals	O
UTP	O
Adult	O
Vital	O
Signs	O
[	O
Data	O
Includes	O
:	O
Current	O
Encounter	O
]	O
10Jan2014	B-temporal
10	B-temporal
:	I-temporal
36AM	I-temporal
BMI	O
Calculated	O
28	B-labvalue
.	I-labvalue
52	I-labvalue
BSA	O
Calculated	O
2	B-labvalue
.	I-labvalue
31	I-labvalue
Weight	O
227	B-labvalue
lb	I-labvalue
Systolic	O
123	B-labvalue
,	O
RUE	O
,	O
Sitting	O
Diastolic	O
68	B-labvalue
,	O
RUE	O
,	O
Sitting	O
Temperature	O
97	B-labvalue
.	I-labvalue
6	I-labvalue
F	I-labvalue
,	O
Oral	O
Heart	O
Rate	O
82	B-labvalue
,	O
R	O
PT	O
Pulse	O
Quality	O
Normal	B-labvalue
,	O
R	O
PT	O
Respiration	O
16	B-labvalue
Respiration	O
Quality	O
Normal	B-labvalue
Pain	O
Scale	O
0	B-labvalue

Hemoglobin	O
:	O
9	B-labvalue
.	I-labvalue
3	I-labvalue
g	I-labvalue
/	I-labvalue
dl	I-labvalue
Abnormal	O
Low	O
Reference	O
Range	O
12	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
16	I-reference_range
.	I-reference_range
0	I-reference_range

Hematologic	O
/	O
Lymphatic	O
:	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
,	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
,	O
no	B-negation
swollen	O
glands	B-bodyloc
and	O
no	B-negation
swollen	O
glands	B-bodyloc
in	O
the	O
neck	B-bodyloc
.	O

GENERAL	O

On	O
[	O
*	O
*	O
2161-12-24	B-temporal
*	O
*	O
]	O
,	O
patient	O
underwent	O
cardiac	O
catheterization	O
which	O
showed	O
severe	B-severity
three	O
vessel	B-bodyloc
disease	O
and	O
depressed	O
left	B-bodyloc
ventricular	I-bodyloc
function	O
at	O
35	O
%	O
.	O

No	B-negation
wheezing	O
was	O
heard	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O
Vitals	O
as	O
in	O
the	O
chart	O
.	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
,	O
no	B-negation
intermittent	O
leg	B-bodyloc
claudication	O
and	O
no	B-negation
edema	O
.	O

Chief	O
Complaint	O

He	O
has	O
previously	O
been	O
seen	O
by	O
Dr	O
.	O
Ondo	O
and	O
Dr	O
.	O
Jankovic	O
.	O

Psychiatric	O
:	O
not	B-negation
suicidal	O
,	O
no	B-negation
sleep	O
disturbances	O
,	O
no	B-negation
anxiety	O
,	O
no	B-negation
depression	O
,	O
no	B-negation
personality	O
change	O
and	O
no	B-negation
emotional	O
problems	O
.	O

Lymphatic	O

Colored	O
drainage	O

post	O
-	O
c	O
/	O
d	O
check	O

(	O
sciat	O
.	O
)	O
Strength	O
:	O
4	B-labvalue
+	I-labvalue
/	I-labvalue
5	I-labvalue
.	O

Patient	O
states	O
she	O
did	O
not	B-negation
have	I-negation
any	O
vomiting	O
issues	O
until	O
yesterday	B-temporal
afternoon	O
.	O

Neck	O

Examination	O
of	O
digits	O
and	O
nails	O
:	O
Normal	B-labvalue
.	O

Assessment	O
of	O
hearing	O
:	O
Normal	B-labvalue
.	O

Palpation	O
of	O
the	O
face	O
and	O
sinuses	O
:	O
Normal	B-labvalue

Patient	O
discussion	O
:	O
follow	O
-	O
up	O
PRN	O
.	O

Musculoskeletal	O
:	O
(	O
Patient	O
w	O
/	O
pain	O
for	O
which	O
she	O
takes	O
multiple	O
medications	O
.	O

Family	B-subject
history	O
of	O
Heart	B-bodyloc
Disease	O

APT	O
122	O

History	O
of	O
Smoking	O
Cigarettes	O

Monofilament	O
Testing	O
:	O

History	O
of	O
Sinus	O
Surgery	O

cough	O
and	O
hypertension	O
Needs	O
typhoid	O
inject	O

Inspection	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
Normal	B-labvalue
(	O
freckels	O
on	O
face	O
,	O
arms	O
,	O
back	O
)	O
Fair	O
complexion	O
.	O

Signatures	O
Electronically	O
signed	O
by	O
:	O
MARK	O
ELLIS	O
,	O
NP	O
;	O
Nov	B-temporal
10	I-temporal
2013	I-temporal
1	B-temporal
:	I-temporal
33PM	I-temporal
(	O
Author	O
)	O

History	O
of	O
Drug	O
Use	O

Medications	O
include	O
omeprazole	O
(	O
Prilosec	O
)	O
.	O

Repeat	O
sono	O
3	B-temporal
months	I-temporal
.	O

Clinical	O
Summary	O

ROM	O
examination	O
of	O
the	O
lefthip	O
demonstrates	O
crepitus	O
with	O
motion	O
.	O

Integumentary	O
:	O
rash	O
.	O

Assessment	O
Hypertension	O
401	O
.	O
9	O

Ordered	O
;	O
For	O
:	O
Diabetes	O
Mellitus	O
(	O
250	O
.	O
00	O
)	O
;	O
Ordered	O
By	O
:	O
ELLIS	O
,	O
MARK	O
Due	O
:	O
11Nov2013	B-temporal
;	O
Last	O
Updated	O
By	O
:	O
Reed	O
,	O
Jennifer	O

Denied	O

Height	O
:	O
5	B-labvalue
ft	I-labvalue
6	I-labvalue
in	I-labvalue

History	O
of	O
Present	O
Illness	O

Chest	O

Normal	B-labvalue
Examination	O
(	O
V70	O
.	O
0	O
)	O

Examination	O
of	O
the	O
oropharynx	O
:	O
Normal	B-labvalue
.	O

Exforge	O
5	B-strength
-	I-strength
320	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
ONE	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
EVERY	B-frequency
DAY	I-frequency
;	O
Therapy	O
:	O
21Mar2013	B-temporal
to	O
(	O
Evaluate	O
:	O
20May2013	B-temporal
)	O
Requested	O
for	O
:	O
21Mar2013	B-temporal
;	O
Last	O
Rx	O
:	O
21Mar2013	B-temporal
;	O
Edited	O

Active	O
Problems	O
Benign	B-severity
Essential	O
Hypertension	O
401	O
.	O
1	O

Cardiovascular	O

Breath	O
sounds	O
were	O
not	B-labvalue
diminished	I-labvalue
.	O

History	O
of	O
Present	O
Illness	O

CARDIOVASCULAR	O
:	O
No	B-negation
chest	B-bodyloc
pain	O
or	O
palpitations	O
.	O

Disp	O
:	O
*	O
30	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E	O
.	O
C	O
.	O

General	O
appearance	O
:	O
Normal	B-labvalue
.	O

Heart	O
sounds	O
:	O
normal	B-labvalue
S1	O
and	O
normal	B-labvalue
S2	O
.	O

Physical	O
Exam	O

CONDITION	O
ON	O
DISCHARGE	O
:	O
Stable	O
.	O

Examination	O
of	O
the	O
head	O
and	O
face	O
:	O
Normal	B-labvalue
.	O

Coordination	O
:	O
normal	B-labvalue
balance	O
and	O
negative	O
Romberg	O
'	O
s	O
sign	O
.	O

Musculoskeletal	O

The	O
eyelids	O
were	O
normal	O
bilaterally	O
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O
RRR	O
.	O

Otoscopic	O
examination	O
:	O
Normal	B-labvalue
.	O

The	O
patient	O
reports	O
doing	O
poorly	O
.	O

Return	O
in	O
3	B-temporal
weeks	I-temporal

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
,	O
the	O
heart	O
rate	O
was	O
not	B-labvalue
fast	I-labvalue
,	O
the	O
heart	O
rate	O
was	O
not	B-labvalue
slow	I-labvalue
,	O
no	B-negation
intermittent	O
leg	B-bodyloc
claudication	O
and	O
no	B-negation
edema	O
.	O

Assessment	O
Osteoarthritis	O
Of	O
The	O
Hip	B-bodyloc
Left	O
715	O
.	O
95	O

She	O
believes	O
she	O
may	O
have	O
caught	O
it	O
from	O
0ne	O
if	O
hes	O
4	O
grandchildren	O
who	O
live	O
w	O
th	O
her	O
currently	O
.	O

I	O
have	O
discussed	O
the	O
case	O
with	O
the	O
resident	O
and	O
agree	O
with	O
the	O
diagnosis	O
and	O
plan	O
.	O

There	O
have	O
been	O
reported	O
blank	O
staring	O
spells	O
.	O

Patient	O
requires	O
the	O
use	O
of	O
the	O
following	O
adaptive	O
skills	O
or	O
devices	O
:	O

Color	O
:	O
Normal	O

Two	O
views	O
of	O
the	O
right	O
tibia	O
obtained	O
today	O
,	O
which	O
reveal	O
a	O
healed	B-course
tibia	B-bodyloc
fracture	O
status	O
post	O
removal	O
of	O
hardware	O
.	O

Vitals	O
18Oct2012	B-temporal
02	B-temporal
:	I-temporal
30PM	I-temporal
BMI	O
Calculated	O
26	B-labvalue
.	I-labvalue
69	I-labvalue
BSA	O
Calculated	O
2	B-labvalue
.	I-labvalue
21	I-labvalue
Height	O
6	B-labvalue
ft	I-labvalue
2	I-labvalue
in	I-labvalue
Weight	O
208	B-labvalue
lb	I-labvalue
Systolic	O
129	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
88	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Heart	O
Rate	O
64	B-labvalue

HEMATOLOGIC	O
/	O
LYMPHATIC	O
:	O
no	B-negation
anemia	O
,	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
and	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
.	O

-	O
Discussed	O
risks	O
of	O
T2DM	O
to	O
pregnancy	O
,	O
including	O
macrosomia	O
,	O
neonatal	O
hypoglycemia	O
and	O
electrlyte	O
disturbances	O
,	O
stillbirth	O
,	O
anomolies	O
,	O
and	O
pre	O
-	O
eclampsia	O
.	O

Cervix	O
:	O
Normal	O

Follow	O
-	O
up	O
visit	O
in	O
2	O
weeks	O
Outpatient	O
Follow	O
-	O
up	O
Status	O
:	O
Complete	O
Done	O
:	O
07Jan2013	B-temporal

Right	O
Hamstring	O
(	O
sciat	O
.	O
)	O
Strength	O
:	O
4	B-labvalue
+	I-labvalue
/	I-labvalue
5	I-labvalue
.	O

2	O
.	O

GLUCOSE	O
:	O
-	O

Cranial	O
nerves	O
V	O
:	O
sensation	O
to	O
the	O
face	O
and	O
masseter	O
strength	O
were	O
intact	B-labvalue
.	O

Constitutional	O
:	O
no	B-negation
fever	O
and	O
no	B-negation
chills	O
.	O

Mental	O
Status	O
:	O
oriented	O
to	O
person	O
,	O
place	O
,	O
and	O
time	O
.	O

Mother	O
has	O
full	O
custody	O
.	O

Respiratory	O
:	O
cough	O
,	O
but	O
no	O
shortness	O
of	O
breathand	O
no	B-negation
wheezing	O
.	O

f	O
History	O
of	O
Esophagerl	B-bodyloc
Reflux	O
(	O
530	O
.	O
81	O
)	O
;	O
(	O
Resolved	O
)	O

Fluticasone	O
Propionate	O
50	B-strength
MCG	I-strength
/	I-strength
ACT	I-strength
Nasal	B-route
Suspension	B-form
;	O
USE	O
1	B-dosage
SPRAY	B-form
IN	O
EACH	B-route
NOSTRIL	I-route
TWICE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
29Dec2012	B-temporal
to	O
(	O
Evaluate	O
:	O
18Jan2013	B-temporal
)	O
Requested	O
for	O
:	O
31Dec2012	B-temporal
;	O
Last	O
Rx	O
:	O
29Dec2012	B-temporal

Anus	O
,	O
perineum	O
and	O
rectum	O
:	O
Normal	O

8	O
.	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
and	O
no	O

Electronically	O
signed	O
by	O
:	O
KRISTAL	O
TAYLOR	O
,	O
M	O
.	O
D	O
.	O

I	O
think	O
his	O
overall	O
neurological	O
complaints	O
are	O
related	O
to	O
do	O
this	O
and	O
possibly	O
his	O
allergies	O
.	O

General	O
appearance	O
:	O
AbnormalObese	O
.	O

Pertinent	O
Medical	O
History	O
:	O
hypertension	O
,	O
COPD	O
and	O
diabetes	O
,	O
but	O
not	B-negation
valvular	B-bodyloc
heart	I-bodyloc
disease	O
,	O
CHF	O
,	O
lung	B-bodyloc
malignancy	O
,	O
pulmonary	B-bodyloc
embolism	O
,	O
coagulopathy	O
,	O
anemia	O
and	O
hyperthyroidism	O
.	O

Skin	O

Lyrica	O
75	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
1	B-dosage
cap	B-form
Daily	B-frequency
;	O
Therapy	O
:	O
25Jul2012	B-temporal
to	O

Likely	B-uncertain
type	O
2	O
DM	O
although	O
dx	O
in	O
pregnancy	O
-	O
fasting	O
glucose	O
ok	B-labvalue
.	O

an	O
initial	O
evaluation	O
of	O
an	O
existing	O
diagnosis	O
of	O
a	O
knee	B-bodyloc
injury	O
.	O

Genitourinary	O
:	O
no	B-negation
dysuria	O
,	O
no	B-negation
incontinence	O
,	O
no	B-negation
urinary	O
hesitancy	O
and	O
no	B-negation
nocturia	O
.	O

Tdap	O
-	O
-	O
-	O
Series1	O
:	O
08Oct2012	B-temporal

f	O
No	O
Advance	O
Directives	O
available	O
.	O

Cytotechnologist	O
SEE	O
NOTE	O

57	O
year	O
old	O
female	O
,	O
s	O
/	O
p	O
hysterectomy	O
and	O
bilateral	O
oophorectomy	O
is	O
requesting	O
Pap	O
,	O
overdue	O
for	O
mammogram	O
/	O
DEXA	O
,	O
up	O
to	O
date	O
with	O
colonoscopy	O
.	O

Performed	O
in	O
2010	O

21Jan2013	B-temporal
;	O
Last	O
Rx	O
:	O
21Jan2013	B-temporal

Respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

The	O
thyroid	B-bodyloc
was	O
not	B-negation
enlarged	O
.	O

Current	O
Meds	O
Focalin	O
XR	O
20	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
Extended	I-form
Release	I-form
24	I-form
Hour	I-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
22Aug2013	B-temporal
)	O
to	O

Abdomen	O
:	O
Normal	O
.	O

She	O
is	O
seeing	O
Rheum	O
for	O
psoriatric	O
arthropathy	O
:	O
she	O
is	O
on	O
Humira	O
.	O

Previous	B-temporal
Surgery	O
:	O
Yes	O
.	O

Use	O
of	O
the	O
eGFR	O
is	O

[	O
QL	O
]	O
CBC	O
(	O
H	O
/	O
H	O
,	O
RBC	O
,	O
INDICES	O
,	O
WBC	O
,	O
PLT	O
)	O
Done	O
:	O
28Feb2011	B-temporal
10	B-temporal
:	I-temporal
28AM	I-temporal

Vaccines	O
Prophylactic	O
Need	O
Against	O
Influenza	O
V04	O
.	O
81	O

Pt	O
with	O
AFRS	O
doing	O
well	O
symptomatically	O
but	O
endoscopically	O
showing	O
polyps	O

[	O
QLH	O
]	O
TSH	O
,	O
3RD	O
GENERATION	O
Requested	O
for	O
:	O
05Apr2013	B-temporal

[	O
QLH	O
]	O
CBC	O
(	O
INCLUDES	O
DIFF	O
/	O
PLT	O
)	O

Surgical	O
History	O
History	O
of	O
Dental	O
Surgery	O

Phenergan	O
/	O
Codeine	O
SYRP	B-form
;	O
PRN	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
09Dec2013	B-temporal
)	O
to	O

Levothyroxine	O
Sodium	O
88	B-strength
MCG	I-strength
Oral	B-route
Tablet	B-form
;	O
Therapy	O
:	O
30Jul2013	B-temporal
to	O

Left	O
normal	O
axillary	O
node	O
.	O

f	O
Never	O
A	O
SiteLi	O
(	O
Active	O
)	O

Calcium	O
TABS	B-form
;	O
600	B-strength
mg	I-strength
.	O

Review	O
of	O
Systems	O

He	O
had	O
4	O
episodes	O
of	O
vomiting	O
after	O
each	O
time	O
he	O
ate	O
.	O

HEENT	O
:	O
Atraumatic	O
.	O

Throat	O
,	O
Neck	O
,	O
and	O
Back	O

Family	O
History	O
Paternal	O
history	O
of	O
Coronary	B-bodyloc
Artery	I-bodyloc
Disease	O
V17	O
.	O
49	O

Penicillins	O

Neurologic	O

Denied	O

SHE	O
HAS	O
ALSO	O
TRIED	O
TRAMADOL	O
,	O
WHICH	O
DOESN	O
'	O
T	O
HELP	O
.	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
and	O
no	B-negation
cough	O
.	O

Vitals	O
18Oct2012	B-temporal
12	B-temporal
:	I-temporal
13PM	I-temporal
BMI	O
Calculated	O
21	B-labvalue
.	I-labvalue
38	I-labvalue
BSA	O
Calculated	O
1	B-labvalue
.	I-labvalue
68	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
6	I-labvalue
in	I-labvalue
Weight	O
133	B-labvalue
lb	I-labvalue
Systolic	O
110	B-labvalue
Diastolic	O
70	B-labvalue
Temperature	O
97	B-labvalue
.	I-labvalue
4	I-labvalue
F	I-labvalue
Heart	O
Rate	O
60	B-labvalue

Current	O
Meds	O
Accu	O
-	O
Chek	O
Comfort	O
Curve	O
In	O
Vitro	O
Strip	O
;	O
USE	O
3	O
STRIP	O
DAILY	O
;	O
Therapy	O
:	O
16Jan2006	B-temporal
to	O
(	O
Last	O
Rx	O
:	O
10Jun2008	B-temporal
)	O
Requested	O
for	O
:	O
10Jun2008	B-temporal

2005	B-temporal
Brenham	O
"	O
8	O
mo	O
"	O
Female	O
,	O
9lbs	O
,	O
Cesarean	O
section	O
,	O
?	B-uncertain
AOAP	O
,	O
preE	O

Epiglottis	O
and	O
Associated	O
Mucosal	O
Folds	O
:	O
normal	O

The	O
abdomen	O
was	O
soft	O
and	O
nontender	O
.	O

Address	O
:	O
9506	O
SOUTH	O
FITZGERALD	O
WAY	O
Date	O
Of	O
Birth	O
:	O
4/23/1964	B-temporal
MISSOURI	O
CITY	O
,	O
TX	O
77459	O
Language	O
:	O
ENGLISH	O
Current	O
Medications	O
No	B-negation
Reported	O
Medications	O
Allergies	O
No	B-negation
Known	O
Drug	O
Allergies	O
Document	O
and	O
Provider	O
Details	O
Document	O
:	O
Clinical	O
Summary	O

Fish	O
Oil	O
CAPS	O
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
20Feb2013	B-temporal
)	O
to	O

Referral	O
to	O
podiatrist	O
for	O
management	O
of	O
left	B-bodyloc
foot	I-bodyloc
infection	O
.	O

Genitourinary	O
:	O
no	B-negation
dysuria	O
.	O

PULMONARY	O
:	O
Positive	O
cough	O
.	O

Family	O
History	O
:	O

Examination	O
of	O
gait	O
and	O
station	O
:	O
Normal	B-labvalue
.	O

He	O
says	O
that	O
he	O
is	O
completely	O
free	O
to	O
return	O
to	O
all	O
activities	O
.	O

"	O
Tobacco	O
Use	O

Psychiatric	O

f	O
Familial	O
(	O
Benign	B-course
Essential	O
)	O
Tremor	O
(	O
333	O
.	O
1	O
)	O
;	O
(	O
Active	O
)	O

Antihistamine	O
with	O
decongestant	O
for	B-duration
1	I-duration
week	I-duration
and	O
then	O
just	O
antihistmaine	O

Meloxicam	O
15	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
16Nov2012	B-temporal
)	O
to	O

Vitals	O
02Jul2013	B-temporal
03	B-temporal
:	I-temporal
48PM	I-temporal
Systolic	O
110	B-labvalue
Diastolic	O
70	B-labvalue
Temperature	O
97	B-labvalue
.	I-labvalue
2	I-labvalue
F	I-labvalue
Heart	O
Rate	O
68	B-labvalue

Lymphatic	O

Bilateral	O
Indirect	O
Inguinal	B-bodyloc
Hernia	O
550	O
.	O
92	O

Hematologic	O
/	O
Lymphatic	O
:	O
no	B-negation
tendency	O
for	O
easy	O
bleeding	O
,	O
no	B-negation
tendency	O
for	O
easy	O
bruising	O
and	O
no	B-negation
swollen	O
glands	B-bodyloc
.	O

Denies	B-negation
nausea	O
/	O
vomiting	O
.	O

f	O
His	O
osy	O
of	O
Visit	O
For	O
:	O
Prenatal	O
Exam	O
High	O
-	O
risk	O
Elderly	O
Primigravida	O
(	O
V23	O
.	O
81	O
)	O
;	O
(	O
Resolved	B-course
)	O

Plan	O
[	O
U	O
]	O
XRAY	O
HIPS	O
BILATERAL	O
MIN	O
2	O
VWS	O
AND	O
AP	O
PELVIS	O
73520	O
Done	O
:	O
06Nov2013	B-temporal
01	B-temporal
:	I-temporal
26PM	I-temporal

Examination	O
of	O
pupils	O
and	O
irises	O
:	O
Normal	B-labvalue
.	O

THE	O
PAIN	O
CAME	O
ON	O
GRADUALLY	O
AFTER	O
SHE	O
BECAME	O
A	O
CAREGIVER	O
FOR	O
HER	O
85	O
YEAR	O
OLD	O
NEIGHBOR	O
,	O
WHOM	O
SHE	O
HAS	O
TO	O
LIFT	O
UP	O
4	O
-	O
5	O
TIMES	O
A	O
DAY	O
.	O

First	O
pregnancy	O
:	O

Language	O
:	O
No	B-negation
dysphasia	O
/	O
aphasia	O
was	O
observed	O
.	O

Examination	O
of	O
the	O
extremities	O
revealed	O
no	B-negation
fingernail	B-bodyloc
clubbing	O
,	O
well	O
perfused	O
fingers	O
,	O
well	O
perfused	O
toes	O
and	O
no	B-negation
nail	B-bodyloc
splinter	O
hemorrhages	O
.	O

rose	O
to	O
97	B-labvalue
on	O
2	O
l	O
O2	O
in	O
5	B-temporal
mins	I-temporal
.	O

it	O
has	O
been	O
present	O
for	O
the	B-temporal
last	I-temporal
week	I-temporal
and	O
getting	O
worse	O
.	O

Auscultation	O
of	O
heart	O
:	O
Normal	B-labvalue
.	O

Chief	O
Complaint	O

Hematologic	O
/	O
Lymphatic	O
:	O
normal	O
.	O

Reproductive	O
health	O
:	O
the	O
patient	O
is	O
postmenopausal	O
.	O

VerifiedResults	O
_	O
0	O
_	O
twCiteListControlSg2Sta	O
[	O
QLH	O
]	O
LIPID	O
PANEL	O
11Jun2013	B-temporal
05	B-temporal
:	I-temporal
15PM	I-temporal
GUPTA	O
,	O
aASHISH	O
Test	O
Name	O
Result	O
Flag	O
Reference	O
CHDaRisk	O
5	B-labvalue
.	I-labvalue
68	I-labvalue
4	B-reference_range
.	I-reference_range
00	I-reference_range
-	I-reference_range
7	I-reference_range
.	I-reference_range

Ability	O
to	O
communicate	O
:	O
Normal	B-labvalue
.	O

Abdomen	O

Gout	O
274	O
.	O
9	O

Right	O
around	O
the	B-temporal
6	I-temporal
month	I-temporal
mark	O
he	O
states	O
that	O
his	O
hearing	O
becomes	O
increasingly	B-severity
muffled	O
.	O

Skin	O

Pedal	O
pulses	O
:	O
Normal	B-labvalue
.	O

Musc	O
:	O

Description	O
of	O
patient	O
'	O
s	O
judgement	O
and	O
insight	O
:	O
Normal	B-labvalue

History	O
of	O
Short	O
Bowel	B-bodyloc
Syndrome	O
579	O
.	O
3	O

G5P1102	O

left	B-bodyloc
knee	I-bodyloc
reveals	O
varus	O
deformity	O
with	O
decreased	O
joint	B-bodyloc
space	O
of	O
bone	O
on	O
bone	O
with	O
degenerative	O
sclerotic	O
changes	O
in	O
medial	B-bodyloc
compartment	I-bodyloc
.	O

Pregnancy	O
Test	O
Positive	B-labvalue
V72	O
.	O
42	O

In	O
the	O
interim	O
patient	O
has	O
been	O
started	O
on	O
Allergy	O
Injections	O
by	O
ENT	O
.	O

Vitamin	O
C	O
CHEW	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
15Nov2012	B-temporal
)	O
to	O

Claritin	O
TABS	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
31Jan2012	B-temporal
)	O
to	O

Pt	O
denies	B-negation
travel	O
,	O
sick	O
contacts	O
,	O
change	O
in	O
eating	O
habits	O
,	O
antibiotic	O
use	O
,	O
N	O
/	O
V	O
,	O
abdominal	B-bodyloc
cramping	O
or	O
blood	O
in	O
stool	O
.	O

Patient	O
Specific	O
Education	O
Given	O
Done	O
:	O
04Mar2013	B-temporal

Denies	B-negation
difficulty	O
with	O
swallowing	O
,	O
aspiration	O
symptoms	O
.	O

LMP	O
:	O
25Feb2013	O

History	O
of	O
Drug	O
Use	O

Lovastatin	O
40	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
21Feb2013	B-temporal
)	O
to	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
and	O
no	B-negation
cough	O
.	O

3	O
.	O

Motor	O
Strength	O
:	O
motor	O
strength	O
was	O
normal	B-labvalue
in	O
all	O
muscle	O
groups	O
.	O

His	O
pre	O
-	O
treatment	O
sinus	O
CT	O
06/15/2012	B-temporal
showed	O
complete	O
opacification	O
of	O
the	O
right	B-bodyloc
frontal	I-bodyloc
sinus	I-bodyloc
and	O
anterior	O
ethmoids	O
and	O
lobulated	O
density	O
in	O
the	O
ethmoid	B-bodyloc
infundibulum	O
.	O

History	O
of	O
Benign	B-severity
Polyps	O
Of	O
The	O
Large	O
Intestine	O
V12	O
.	O
72	O

MetFORMIN	O
HCl	O
1000	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
TWICE	B-frequency
DAILY	I-frequency
WITH	I-frequency
MEALS	I-frequency
;	O
Therapy	O
:	O
14Feb2012	B-temporal
to	O
(	O
Evaluate	O
:	O
25Sep2012	B-temporal
)	O
Requested	O
for	O
:	O
27Jun2012	B-temporal
;	O
Last	O
Rx	O
:	O
27Jun2012	B-temporal

Left	O
Toe	O
Ext	O
.	O

History	O
of	O
Hypercholesterolemia	O
272	O
.	O
0	O

History	O
of	O
Present	O
Illness	O
Current	B-temporal
treatment	O
includes	O
oral	O
agents	O
.	O

He	O
has	O
been	O
weightbearing	O
as	O
tolerated	O
.	O

Vitals	O
UTP	O
Adult	O
Vital	O
Signs	O
[	O
Data	O
Includes	O
:	O
Current	O
Encounter	O
]	O

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

Active	O
Problems	O
Depression	O
311	O

Cranial	O
nerves	O
:	O
Normal	B-labvalue
.	O

Assessment	O
Visit	O
For	O
:	O
Postpartum	O
Exam	O
V24	O
.	O
2	O

Discussion	O
/	O
Discussion	O
/	O
Summary	O

6	I-reference_range
Alk	O
Phos	O
118	B-labvalue
u	I-labvalue
/	I-labvalue
l	I-labvalue
39	B-reference_range
-	I-reference_range
136	I-reference_range
AGAP	O
16	B-labvalue
.	I-labvalue
0	I-labvalue
mEq	I-labvalue
/	I-labvalue
l	I-labvalue
10	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
20	I-reference_range
.	I-reference_range

History	O
of	O
Alcohol	O
Use	O

Current	O
Meds	O
No	B-negation
Reported	O
Medications	O

Assessment	O
Chronic	B-course
Ethmoidal	B-bodyloc
Sinusitis	O
473	O
.	O
2	O

There	O
was	O
a	B-labvalue
negative	I-labvalue
Murphy	O
'	O
s	O
sign	O
.	O

for	O
TdaP	O
and	O
Influenza	O
vaccination	O
today	B-temporal

Denied	O

ClonazePAM	O
1	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
TWICE	B-frequency
DAILY	I-frequency
;	O
Therapy	O
:	O
28Jul2011	B-temporal
to	O

Pt	O
advised	O
to	O
document	O
symptoms	O
of	O
hypoglycemia	O
and	O
associated	O
BG	O
.	O

Compression	O
Arthralgia	O
Of	O
The	O
Left	O
Pelvis	O
/	O
Hip	O
/	O
Femur	O
719	O
.	O
45	O

Discussion	O
/	O
Signatures	O
Electronically	O
signed	O
by	O
:	O
ALYSIA	O
ROBICHAU	O
,	O
M	O
.	O
D	O
.	O

Breath	O
sounds	O
were	O
diminished	B-labvalue
over	I-labvalue
both	I-labvalue
lungs	I-labvalue
.	O

Ordered	O
Metformin	O
500	B-strength
po	B-route
qday	B-frequency

Physical	O
Exam	O

Mammogram	O
today	B-temporal
,	O
f	O
/	O
u	O
in	O
6	B-temporal
months	I-temporal
,	O
continue	O
to	O
assess	O
screening	O

1	O
.	O

Physical	O
Exam	O

The	O
drain	O
was	O
removed	O
.	O

1	O
.	O

Denied	O

Endocrine	O
:	O
no	B-negation
muscle	B-bodyloc
weakness	O
.	O

Otoscopic	O
examination	O
:	O
Abnormal	O
.	O

9085	O
Site	O
Endocrinology	O

Follow	O
Up	O
:	O
Return	O
to	O
the	O
clinic	O
in	O
1	O
month	O
(	O
s	O
)	O

Lumbar	B-bodyloc
Disc	I-bodyloc
Disorder	O
With	O
Myelopathy	O
722	O
.	O
73	O

f	O
Obesity	O
(	O
278	O
.	O
00	O
)	O
;	O
(	O
Active	O
)	O

Neck	O

[	O
O	O
]	O
Xray	O
SPINE	O
LUMBOSACRAL	O
MIN	O
.	O

43	O
year	O
old	O
AAF	O
with	O
h	O
/	O
o	O
back	B-bodyloc
injury	O
s	O
/	O
p	O
MVA	O
in	O
December	B-temporal
came	O
in	O
for	O
follow	O
up	O
on	O
elevated	O
BP	O
readings	O
:	O
Ordered	O
HCTZ	O
25	B-strength
mg	I-strength
po	B-route
qday	B-frequency
,	O
keep	O
a	O
BP	O
log	O
and	O
RTC	O
in	O
4	O
weeks	O
Reviewed	O
the	O
labs	O
results	O
with	O
her	O
Continue	O
f	O
/	O
u	O
with	O
Dr	O
Melton	O
for	O
pain	O
management	O

The	O
ultrasound	O
was	O
negative	B-labvalue
for	O
intracranial	B-bodyloc
hemorrhage	O
.	O

"	O
History	O
of	O
Smoking	O

Maternal	B-subject
history	O
of	O
Colon	B-bodyloc
Cancer	O
V16	O
.	O
0	O

Neurological	O
:	O
no	B-negation
confusion	O
,	O
no	B-negation
dizziness	O
,	O
no	B-negation
fainting	O
and	O
no	B-negation
difficulty	O
walking	O
.	O

Psychiatric	O

Associated	O
symptoms	O
:	O
headaches	O
,	O
but	O
no	B-negation
earaches	O
,	O
no	B-negation
dental	B-bodyloc
pain	O
,	O
no	B-negation
jaw	B-bodyloc
joint	I-bodyloc
pain	O
,	O
no	B-negation
rhinorrhea	O
,	O
no	B-negation
postnasal	B-bodyloc
drainage	O
,	O
no	B-negation
nasal	B-bodyloc
congestion	O
,	O
no	B-negation
fatigue	O
,	O
no	B-negation
nausea	O
and	O
no	B-negation
vomiting	O
.	O

Jugular	O
Veins	O
:	O
the	O
JVP	O
was	O
not	B-labvalue
elevated	I-labvalue
.	O

Palpation	O
of	O
heart	O
:	O
Normal	B-labvalue
PMI	O
,	O
no	B-negation
thrills	O
.	O

5	O
.	O

Physical	O
Exam	O

Dizziness	O
and	O
headache	O

Current	O
Meds	O
Colace	O
100	B-strength
MG	I-strength
Oral	B-route
Capsule	B-form
;	O
Take	O
one	B-dosage
tablet	B-form
1	B-frequency
-	I-frequency
2	I-frequency
times	I-frequency
per	I-frequency
day	I-frequency
as	B-frequency
needed	I-frequency
to	O
prevent	O
constipation	O
;	O
Therapy	O
:	O
08Jun2012	B-temporal
to	O
(	O
Evaluate	O
:	O
06Oct2012	B-temporal
)	O
;	O
Last	O
Rx	O
:	O
08Jun2012	B-temporal

Denied	O

NEUROLOGICAL	O
:	O
no	B-negation
seizures	O
.	O

Otoscopic	O
examination	O
:	O
Normal	B-labvalue
.	O

Psychiatric	O

twNoteSignatureControlEnd	O
SignaturesSectionEnd	O

Asthma	O

Denied	O
1	O
.	O

ABSOLUTE	O
EOSINOPHILS	O
211	B-labvalue
cells	I-labvalue
/	I-labvalue
uL	I-labvalue
15	B-reference_range
-	I-reference_range
500	I-reference_range

Vitamin	O
D	O
(	O
Ergocalciferol	O
)	O
50000	B-dosage
UNIT	I-dosage
Oral	B-route
Capsule	B-form
;	O
TAKE	O
1	B-dosage
CAPSULE	B-form
WEEKLY	B-frequency
;	O
Therapy	O
:	O
10Feb2014	B-temporal
to	O
(	O
Evaluate	O
:	O
11May2014	B-temporal
)	O
Requested	O
for	O
:	O
10Feb2014	B-temporal
;	O
Last	O
Rx	O
:	O
10Feb2014	B-temporal
;	O
Edited	O

Surgical	O
History	O
History	O
of	O
Cesarean	O
Section	O

Musculoskeletal	O
:	O
no	B-negation
arthralgias	O
and	O
no	B-negation
joint	B-bodyloc
pain	O
.	O

Vitals	O
01Dec2011	B-temporal
09	B-temporal
:	I-temporal
00AM	I-temporal
BMI	O
Calculated	O
22	B-labvalue
.	I-labvalue
2	I-labvalue
BSA	O
Calculated	O
1	B-labvalue
.	I-labvalue
63	I-labvalue
Height	O
5	B-labvalue
ft	I-labvalue
4	I-labvalue
in	I-labvalue
Weight	O
130	B-labvalue
lb	I-labvalue
Systolic	O
125	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Diastolic	O
81	B-labvalue
,	O
LUE	O
,	O
Sitting	O
Heart	O
Rate	O
71	B-labvalue

;	O
Jul	B-temporal
5	I-temporal
2013	I-temporal
12	B-temporal
:	I-temporal
10PM	I-temporal
(	O
Author	O
)	O

[	O
LH	O
]	O
Vitamin	O
D	O
,	O
25	O
-	O
Hydroxy	O
,	O
Total	O
*	O
(	O
E	O
)	O
23Feb2012	B-temporal
09	B-temporal
:	I-temporal
45AM	I-temporal
Hardwicke	O
,	O
Robin	O

Language	O
:	O
No	B-negation
dysphasia	O
/	O
aphasia	O
was	O
observed	O
.	O

Alcohol	O

Respiratory	O
:	O
no	B-negation
shortness	O
of	O
breath	O
,	O
no	B-negation
wheezing	O
and	O
no	B-negation
cough	O
.	O

Past	O
Medical	O
History	O
History	O
of	O
Brain	B-bodyloc
Tumor	O
239	O
.	O
6	O

Abdominal	B-bodyloc
Aorta	I-bodyloc
:	O
no	B-negation
abnormalities	O
and	O
no	B-negation
bruit	O
heard	O
.	O

Birth	O
Weight	O
:	O
8lbs	B-labvalue
,	I-labvalue
8oz	I-labvalue

History	O
of	O
Cellulitis	O
682	O
.	O
9	O

Assessment	O
Chronic	B-course
Ethmoidal	B-bodyloc
Sinusitis	O
473	O
.	O
2	O

Right	O
Adduct	O
.	O

Gastrointestinal	O
:	O
heartburn	O
,	O
but	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
vomiting	O
,	O
no	B-negation
constipation	O
and	O
no	B-negation
diarrhea	O
.	O

UTP	O
-	O
Discussion	O
/	O
56	O
year	O
old	O
s	O
/	O
p	O
TAH	O
/	O
BSO	O
and	O
staging	O
Nov	B-temporal
15	I-temporal
,	I-temporal
2012	I-temporal
for	O
grade	O
2	O
endometrioid	O
endometrial	B-bodyloc
adenocarcinoma	O
stage	O
IA	O
-	O
presents	O
with	O
small	O
superficial	O
wound	O
separation	O
near	O
umbilicus	B-bodyloc
.	O

Hematologic	O
/	O
Lymphatic	O
:	O
no	B-negation
swollen	O
glands	B-bodyloc
.	O

The	O
patient	O
is	O
due	O
for	O
liver	O
function	O
tests	O
.	O

He	O
exercises	O
regularly	O
.	O

Inspection	O
of	O
skin	O
and	O
subcutaneous	O
tissue	O
:	O
Abnormal	B-labvalue
.	O
Abcess	O
from	O
prev	O
visit	O
improved	B-course
in	O
size	O
and	O
redness	O
.	O

Mental	O
Status	O
:	O
A	O
mental	O
status	O
exam	O
was	O
performed	O
and	O
was	O
normal	B-labvalue
.	O

Social	O
History	O
Current	O
Some	O
Day	O
Smoker	O
305	O
.	O
1	O

Ordered	O
;	O
For	O
:	O
Esophageal	B-bodyloc
Reflux	O
(	O
530	O
.	O
81	O
)	O
;	O
Ordered	O
By	O
:	O
ABDELMELEK	O
,	O
LOURICE	O
Perform	O
:	O
Hermann	O
Due	O
:	O
31Mar2013	B-temporal
;	O
Last	O
Updated	O
By	O
:	O
Fleming	O
,	O
Sonya	O

History	O
of	O
Present	O
Illness	O

She	O
denies	B-negation
apy	O
CP	O
,	O
SOB	O
,	O
dizziness	O
,	O
HA	O
or	O
blurred	O
vision	O
.	O

Due	O
to	O
hypoglycemia	O
d	O
/	O
c	O
glyburide	O
,	O
cont	O
metformin	O
and	O
keep	O
bg	O
log	O
.	O

Social	O
History	O
Former	O
Smoker	O
V15	O
.	O
82	O

Gastrointestinal	O
:	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
vomiting	O
,	O
no	B-negation
constipation	O
and	O
no	B-negation
diarrhea	O
.	O

GroupHeading14Start	O
GroupHeading14End	O
GroupHeading13Start	O
GroupHeading13End	O
GroupHeading4Start	O
GroupHeading4End	O
GroupHeading5Start	O
GroupHeading5End	O
GroupHeading6Start	O
GroupHeading6End	O
GroupHeading7Start	O
GroupHeading7End	O
GroupHeading8Start	O
GroupHeading8End	O
GroupHeading9Start	O
GroupHeading9End	O
GroupHeading10Start	O
GroupHeading10End	O
GroupHeading15Start	O
Neck	O
Examinatisp	O
of	O
the	O
neck	O
:	O
Noamal	B-labvalue
GroupHeading15End	O
GroupHeading16Start	O
GroupHeading16End	O
GroupHeading17Start	O
GroupHeading17End	O
GroupHeading18Start	O
Pulmopasy	O

Sensory	O
:	O
no	B-negation
sensory	O
abnormalities	O
were	O
noted	O
.	O

Examination	O
of	O
digits	O
and	O
nails	O
:	O
Normal	B-labvalue
.	O

Sebaceous	O
Cyst	O
706	O
.	O
2	O

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

See	O
scanned	O
reults	O
.	O

Larynx	O
Under	O
Continuous	O
Light	O
:	O

Current	O
Meds	O
Amoxicillin	O
CAPS	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
15Nov2012	B-temporal
)	O
to	O

Headaches	O
lasts	O
only	O
a	O
few	O
minutes	O
and	O
self	O
resolve	O
.	O

Never	O
A	O
Smoker	O

3	O
.	O

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

Gastroenteritis	O
558	O
.	O
9	O

Review	O
of	O
Systems	O

Possible	O
free	O
air	O
under	O
the	O
diaphragm	O
.	O

Neck	O

Description	O
of	O
patient	O
'	O
s	O
judgement	O
and	O
insight	O
:	O
Normal	B-labvalue

-	O
Tumor	O
is	O
polypoid	O
,	O
and	O
shows	O
no	B-negation
appreciable	O
myometrial	O
invasion	O
.	O

The	O
patient	O
expressed	O
understanding	O
and	O
agreed	O
to	O
proceed	O
.	O

Results	O
/	O
Results	O
/	O
Data	O
All	O
Results	O
[	O
Data	O
Includes	O
:	O
Current	O
Encounter	O
]	O

Neck	O

Gait	O
:	O
a	O
steppage	O
gait	O
was	O
noted	O
on	O
the	O
right	O
.	O

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

[	O
H	O
]	O
Pap	O
ThinPrep	O
29Nov2012	B-temporal
04	B-temporal
:	I-temporal
30PM	I-temporal
Hardwicke	O
,	O
Robin	O

5	O
.	O

Middle	O
Turbinate	O
:	O
Normal	O
position	O
.	O

Neurologic	O

Pt	O
is	O
doing	O
well	O
today	B-temporal
with	O
no	B-negation
sinonasal	O
complaints	O
.	O

1403	O
FM	O
1960	O
Rd	O
.	O

Family	B-subject
history	O
:	O
hypertension	O
,	O
dyslipidemiaandobesity	O
.	O

These	O
episodes	O
last	O
5	O
minutes	O
to	O
all	O
day	O
.	O

Activity	O
Status	O
:	O
Ambulatory	O
-	O
Independent	O

Lymphatic	O

Patient	O
is	O
not	O
sexually	O
active	O
.	O

Flovent	O
HFA	O
44	B-strength
MCG	I-strength
/	I-strength
ACT	I-strength
Inhalation	B-route
Aerosol	B-form
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
14Nov2011	B-temporal
)	O
to	O

Secretions	O
:	O
None	O

HENT	O
:	O
no	B-negation
headache	O
,	O
no	B-negation
earache	O
,	O
no	B-negation
difficulty	O
swallowing	O
,	O
no	B-negation
nosebleeds	O
and	O
no	B-negation
ringing	O
in	O
the	O
ears	B-bodyloc
.	O

Examination	O
of	O
the	O
oropharynx	O
:	O
Normal	B-labvalue

Ears	O
,	O
Nose	O
,	O
Mouthand	O
Throat	O

Brudzinski	O
'	O
s	O
sign	O
was	O
negative	B-labvalue
.	O

Jugular	O
Veins	O
:	O
the	O
JVP	O
was	O
not	B-labvalue
elevated	I-labvalue
.	O

GASTROINTESTINAL	O
:	O
no	B-negation
heartburn	O
,	O
no	B-negation
abdominal	B-bodyloc
pain	O
,	O
no	B-negation
diarrhea	O
,	O
no	B-negation
constipation	O
and	O
no	B-negation
vomiting	O
.	O

Baso	O
(	O
Absolute	O
)	O
:	O
0	B-labvalue
.	I-labvalue
0	I-labvalue
x10E3	I-labvalue
/	I-labvalue
uL	I-labvalue
Reference	O
Range	O
0	B-reference_range
.	I-reference_range
0	I-reference_range
-	I-reference_range
0	I-reference_range
.	I-reference_range
2	I-reference_range

Constitutional	O
:	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
,	O
not	B-negation
feeling	O
poorly	O
(	O
malaise	O
)	O
and	O
not	B-negation
feeling	O
tired	O
(	O
fatigue	O
)	O
.	O

Social	O
History	O
Drug	O
Use	O

Complains	O
of	O
new	B-course
tooth	B-bodyloc
pain	O
.	O

Sample	O
Type	O
/	O
Medical	O

No	B-negation
focal	O
weakness	O
or	O
numbness	O
.	O

;	O
Mar	B-temporal
19	I-temporal
2014	I-temporal
9	B-temporal
:	I-temporal
10AM	I-temporal
(	O
Author	O
)	O

Eyes	O

The	O
patient	O
is	O
being	O
seen	O
for	O
postpartum	O
follow	O
up	O
.	O

Review	O
of	O
Systems	O

Dr	O
.	O
Murphy	O
was	O
in	O
the	O
clinic	O
and	O
supervised	O
this	O
visit	O
.	O

Yellow	O
mucoid	O
.	O

There	O
was	O
a	B-labvalue
normal	I-labvalue
red	O
reflex	O
in	O
both	O
eyes	O
.	O

Discussion	O
/	O
Discussion	O
/	O
Summary	O

Pulmonary	O

Synthroid	O
137	B-strength
MCG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
20Aug2013	B-temporal
)	O
to	O

Pulmonary	O

53y	O
F	O
s	O
/	O
p	O
B	O
IG	O
-	O
FESS	O
for	O
nasal	B-bodyloc
polyposis	O
/	O
L	O
ethmoid	B-bodyloc
osteoma	O
for	O
f	O
/	O
u	O
.	O

History	O
of	O
Pancreatitis	O

f	O
History	O
of	O
Acute	B-course
Upper	O
Respiratory	O
Infection	O
(	O
465	O
.	O
9	O
)	O
;	O
(	B-course
Resolved	I-course
)	O

Rx	O
:	O
09Nov2012	O

Lisinopril	O
20	B-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
BY	B-route
MOUTH	I-route
DAILY	B-frequency
AT	I-frequency
BEDTIME	I-frequency
;	O
Therapy	O
:	O
27Apr2010	B-temporal
to	O
(	O
Evaluate	O
:	O
02Nov2011	B-temporal
)	O
Requested	O
for	O
:	O
06May2011	B-temporal
;	O
Last	O
Rx	O
:	O
06May2011	B-temporal

Chief	O
Complaint	O

Gestational	O
age	O
:	O
8	O
months	O
weeks	O
.	O

Constitutional	O

He	O
has	O
no	B-negation
other	O
concerns	O
today	B-temporal
.	O

[	O
QLH	O
]	O
TSH	O
,	O
3RD	O
GENERATION	O
W	O
/	O
REFLEX	O
TO	O
FT4	O
23Feb2012	B-temporal
09	B-temporal
:	I-temporal
45AM	I-temporal
Hardwicke	O
,	O
Robin	O

Never	O
Drank	O
Alcohol	O

The	O
patient	O
describes	O
the	O
pain	O
as	O
throbbing	O
.	O

She	O
received	O
treatment	O
for	O
both	O
.	O

Hemorrhoids	O
455	O
.	O
6	O

Constitutional	O

Integumentary	O
:	O
no	B-negation
skin	B-bodyloc
lesions	O
and	O
no	B-negation
skin	B-bodyloc
wound	O
.	O

Blood	O
Pressue	O
Comments	O
:	O
Reported	O

Caucasian	O
/	O
African	O
-	O
American	O
woman	O
w	O
/	O
PMH	O
significant	O
for	O
MVC	O
in	O
2006	B-temporal
w	O
/	O
TBI	O
w	O
/	O
resulting	O
left	B-bodyloc
-	I-bodyloc
sided	I-bodyloc
spastic	O
hemiparesis	O
,	O
seizure	O
d	O
/	O
o	O
,	O
and	O
dystonia	O
.	O

General	O
Health	O
:	O
The	O
patient	O
'	O
s	O
health	O
since	O
the	O
last	O
visit	O
is	O
described	O
as	O
good	O
.	O

The	O
patient	O
'	O
s	O
LDL	O
goal	O
is	O
<	B-labvalue
100mg	I-labvalue
/	I-labvalue
dl	I-labvalue
mg	O
/	O
dL	O
.	O
The	O
patient	O
'	O
s	O
last	O
LDL	O
was	O
91mg	B-labvalue
/	I-labvalue
dl	I-labvalue
mg	O
/	O
dL	O
.	O

Lungs	O
clear	O
.	O

Patient	O
is	O
doing	O
well	O
at	O
this	O
time	O
.	O

Mom	O
works	O
outside	O
the	O
home	O
.	O

established	O
patient	O
here	O
today	O
for	O
a	O
chief	O
complaint	O
of	O
Eyes	B-bodyloc
discharge	O
and	O
cough	O
.	O

Unremarkable	B-labvalue
MRI	O
of	O
the	O
Brain	O

Facility	O
:	O

Valsartan	O
-	O
Hydrochlorothiazide	O
160	B-strength
-	I-strength
12	I-strength
.	I-strength
5	I-strength
MG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
;	O
Therapy	O
:	O
(	O
Recorded	O
:	O
12Jun2013	B-temporal
)	O
to	O

Keywords	O
:	O
discharge	O
summary	O
,	O
leiomyosarcoma	O
,	O
embolism	O
,	O
hematoma	O
,	O
pneumonia	O
,	O
acute	O
intracranial	B-bodyloc
abnormalities	O
,	O
white	O
blood	O
,	O
platelet	O
count	O
,	O
blood	O
cells	O
,	O
neutropenic	O
diet	O
,	O
subdural	B-bodyloc
hematoma	O
,	O
pulmonary	B-bodyloc
embolism	O
,	O
intracranial	O
,	O
pancytopenia	O
,	O
neutropenic	O
,	O
subdural	O
,	O
pulmonary	O
,	O

Start	O
treatment	O
for	O
excessive	O
nasal	B-bodyloc
discharge	O

The	O
patient	O
is	O
doing	O
well	O
with	O
her	O
diabetes	O
goals	O
.	O

There	O
is	O
no	B-negation
murmur	O
.	O

IDX	O
MRN	O
#	O
:	O
4336981	O
07/16/13	B-temporal
INITIAL	O
EXAMINATION	O
:	O
HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O
THE	O
PATIENT	O
PRESENTS	O
WITH	O
LOW	B-bodyloc
BACK	I-bodyloc
PAIN	O
.	O

Pylori	O
)	O
Infection	O
041	O
.	O
86	O

Assessment	O
of	O
respiratory	O
effort	O
:	O
Normal	B-labvalue
.	O

History	O
of	O
Diverticulitis	O
Of	O
Colon	B-bodyloc
562	O
.	O
11	O

Social	O
History	O
Never	O
A	O
Smoker	O

PHARYNX	O
-	O
Mouth	O
pink	O
,	O
mucous	O
membranes	O
moi	O
t	O
.	O

Examination	O
of	O
extremities	O
for	O
edema	O
and	O
/	O
or	O
varicosities	O
:	O
Normal	B-labvalue

"	O
Exercising	O
Regularly	O

43	O
year	O
old	O
CF	O
with	O
h	O
/	O
o	O
HTN	O
,	O
HLP	O
,	O
DM	O
came	O
in	O
for	O
follow	O
up	O
for	O
retinal	B-bodyloc
hemorrhage	O
and	O
lab	O
results	O
Pt	O
not	O
taking	O
any	O
meds	O
currently	O
Pt	O
works	O
at	O
MHH	O
ER	O
saw	O
an	O
optemtristwas	O
told	O
that	O
she	O
has	O
hemorrhage	O
in	O
her	O
retina	O
.	O
went	O
to	O
see	O
the	O
retinal	O
speciast	O
and	O
was	O
told	O
that	O
her	O
eyes	B-bodyloc
were	O
normal	O
no	B-negation
hemorrhage	O
.	O

Right	O
Post	O
.	O

Assessment	O
Chronic	B-course
Pansinusitis	O
473	O
.	O
8	O

Constitutional	O
:	O
normal	O
,	O
no	B-negation
fever	O
,	O
no	B-negation
chills	O
and	O
no	B-negation
fatigue	O
.	O

Cardiovascular	O
:	O
normal	O
.	O

-	O

Family	B-subject
history	O
of	O
Denial	B-negation
Of	O
Any	O
Significant	O
Medical	O
History	O

Eyes	O

Vitals	O
UTP	O
Adult	O
Vital	O
Signs	O
[	O
Data	O
Includes	O
:	O
Current	O
Encounter	O
]	O

Cardiovascular	O
:	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
no	B-negation
radiating	O
chest	B-bodyloc
pain	O
,	O
no	B-negation
palpitations	O
,	O
not	B-negation
expressed	O
as	O
feeling	O
short	O
of	O
breath	O
,	O
no	B-negation
edema	O
,	O
no	B-negation
intermittent	O
leg	B-bodyloc
claudication	O
and	O
no	B-negation
syncope	O
.	O

Alcohol	O

Surgical	O
History	O

Allergies	O
No	B-negation
Known	O
Allergies	O

Since	O
that	O
time	O
,	O
her	O
seizure	O
frequency	O
has	O
decreased	B-course
.	O

Orientation	O
to	O
person	O
,	O
place	O
and	O
time	O
:	O
Normal	B-labvalue

Cranial	O
nerves	O
IX	O
and	O
X	O
:	O
there	O
was	O
normal	B-labvalue
movement	O
of	O
the	O
soft	O
palate	O
and	O
normal	B-labvalue
gag	O
.	O

Discussion	O
/	O
Signatures	O
Electronically	O
signed	O
by	O
:	O
MANNIE	O
MAGID	O
,	O
M	O
.	O
D	O
.	O

History	O
of	O
Exploratory	O
Laparotomy	O

History	O
of	O
Diabetes	O
Mellitus	O
250	O
.	O
00	O

Interval	O
Events	O
:	O
Lost	O
weight	O
,	O
easting	O
better	O
,	O
episodes	O
of	O
hypoglycemia	O
.	O

History	O
of	O
Inguinal	O
Hernia	O
Repair	O
With	O
Excision	O
Of	O
Hydrocele	O

Pain	O
increased	B-course
with	O
initiation	O
of	O
activity	O
.	O

25	I-strength
MG	I-strength
-	I-strength
35	I-strength
MCG	I-strength
Oral	B-route
Tablet	B-form
;	O
TAKE	O
1	B-dosage
TABLET	B-form
DAILY	B-frequency
AS	O

Results	O
/	O
Assessment	O

